{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-120b-reasoning",
    "experiment": "e4_page_window_relevance_desc",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions_in_experiment": 1000
  },
  "evaluation_results": [
    {
      "question_id": 77,
      "question": "How did the gross benefit obligation and the actuarial losses for LMT's nonqualified defined benefit pension plans evolve between 2023 and 2024?",
      "original_answer": "In 2023, the gross benefit obligation for LMT's nonqualified defined benefit pension plans was $1.0 billion with actuarial losses totaling $347 million. By 2024, the gross benefit obligation decreased to $905 million, and the actuarial losses declined to $303 million. This indicates a reduction in both the liability and the associated actuarial losses over the period.",
      "llm_answer": "The gross benefit obligation for Lockheed Martin’s non‑qualified defined‑benefit pension plans fell from **$1.0 billion at year‑end 2023** to **$905 million at year‑end 2024**【page_88】.  At the same time, the pretax actuarial losses recorded in accumulated other‑comprehensive loss declined from **$347 million in 2023** to **$303 million in 2024**【page_89】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and years are accurate: the gross benefit obligation decreased from $1.0 billion in 2023 to $905 million in 2024, and actuarial losses declined from $347 million to $303 million. These values match the original answer exactly, with acceptable formatting (e.g., $905 million vs $905M). (2) The answer is complete, addressing both parts of the question—the evolution of the gross benefit obligation and the actuarial losses—over the specified time period. (3) Entity accuracy is correct: LMT is properly identified as Lockheed Martin, the plans are correctly described as non-qualified defined-benefit pension plans, and the years 2023 and 2024 are accurately referenced. (4) The reasoning is sound and reflects proper multi-hop synthesis: the model correctly extracted and compared data across two years and two financial metrics from the cited pages. (5) The semantic meaning is equivalent to the original answer, with slightly more formal phrasing and added context (e.g., mentioning accumulated other-comprehensive loss and pretax treatment), which enhances clarity without introducing error. The citations (page_88, page_89) further support the factual grounding. No errors or omissions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 364,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did General Motors' long-term rate of return assumptions on U.S. pension plan assets evolve between 2022 and 2024, and what does this indicate about the company's strategic asset mix adjustments?",
      "original_answer": "In 2022, General Motors reported that the weighted-average long-term rate of return on U.S. pension plan assets decreased from 5.6% at December 31, 2020, to 5.4% at December 31, 2021. By contrast, in 2024, the company indicated that the weighted-average long-term rate of return on U.S. pension plan assets increased from 6.3% at December 31, 2023, to 6.5% at December 31, 2024. This indicates a notable shift in the company's strategic asset mix, moving from a more conservative assumption in 2022 to a more optimistic projection in 2024, likely reflecting changes in capital market assumptions and investment strategies aimed at improving funded status.",
      "llm_answer": "GM’s assumed long‑term return on U.S. pension‑plan assets rose from 5.38 % for the year ended 2022 to roughly 6.3 %‑6.5 % for 2024 【page_87】.  The 2024 filing notes that the weighted‑average long‑term rate of return was lifted after an investment‑policy study, reflecting a strategic shift toward a higher‑return asset mix (e.g., more private‑equity, real‑estate and other alternative “Other” assets) to improve funded status and reduce volatility【page_88】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the overall trend correctly—General Motors increased its long-term rate of return assumption on U.S. pension plan assets between 2022 and 2024—but the specific numbers are partially inaccurate. The ground truth states that in 2022, GM reported a decrease to 5.4% (from 5.6%), reflecting data as of December 31, 2021. However, the LLM claims the assumed return was 5.38% for 2022, which does not align with the documented 5.4% figure. While 5.38% may be a rounded or misread version of 5.4%, it introduces a minor but notable discrepancy. For 2024, the LLM states a range of 6.3%-6.5%, which aligns with the ground truth: the rate increased from 6.3% at end of 2023 to 6.5% at end of 2024. (2) The calculation and timeline interpretation are mostly correct, but the LLM incorrectly frames the 2022 figure as a starting point of 5.38% without acknowledging it was a continuation of a prior decline. The ground truth emphasizes a multi-year evolution, while the LLM simplifies it into a direct 2022-to-2024 increase. (3) The reasoning about strategic asset mix adjustments is strong and semantically equivalent: the LLM correctly identifies an investment-policy study, a shift toward higher-return alternatives (private equity, real estate), and the goal of improving funded status and reducing volatility—this matches the ground truth’s interpretation. (4) The contextual relevance is perfect—the answer directly addresses both parts of the question: the evolution of return assumptions and the implication for asset mix. Despite minor numerical inaccuracies and a slightly oversimplified timeline, the core facts and multi-hop synthesis (linking return assumptions to strategic asset allocation changes) are sound, warranting a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 486,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Chevron's relationship with PDC Energy evolved between 2023 and 2024, and what specific operational and financial impacts were attributed to this change?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, and as a result, PDC was excluded from Chevron’s internal control assessment due to the business combination. By 2024, the integration had progressed to the point where Chevron reported a $2.2 billion increase in U.S. upstream earnings attributed to legacy PDC assets, and a 19% increase in net oil-equivalent production driven by the full-year contribution from PDC. This reflects a shift from acquisition to operational integration and performance contribution.",
      "llm_answer": "In 2023 Chevron completed a business‑combination with PDC Energy, treating it as a newly‑acquired, wholly‑owned subsidiary whose revenues represented roughly 5 % of consolidated revenue and which was excluded from the company’s internal‑control assessment because the acquisition occurred during the year (2023 p. 30‑31). By 2024 the legacy PDC assets were fully integrated into Chevron’s U.S. upstream business, delivering a full‑year of production that added about 250,000 boe/d (≈19 % increase) and $2.2 billion of sales volume, which helped lift U.S. upstream earnings by $3.5 billion (2024 p. 44).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 acquisition of PDC Energy by Chevron and the exclusion of PDC from internal control assessment, as well as the full integration by 2024. It accurately reports the $2.2 billion contribution to sales volume and the ~19% increase in production, aligning with the ground truth. However, it incorrectly states that U.S. upstream earnings increased by $3.5 billion, whereas the ground truth specifies a $2.2 billion increase in U.S. upstream earnings (not sales volume) attributed to legacy PDC assets. This is a significant quantitative error. Additionally, the 250,000 boe/d figure is plausible but not present in the ground truth, which only mentions the 19% production increase without specifying daily volumes. (2) The dollar amounts are partially mismatched: $2.2 billion is correctly cited but misattributed to sales volume instead of earnings, and an additional $3.5 billion earnings figure is introduced without support in the original answer. The 19% production increase is accurate. (3) The multi-hop reasoning is sound—correctly linking the 2023 acquisition to 2024 operational impacts and financial performance. The synthesis across years and entities (Chevron, PDC, upstream earnings, production) is logical and complete. (4) The contextual relevance is perfect—the answer directly addresses the evolution of the relationship and its operational and financial impacts. Due to the incorrect attribution of the $2.2 billion (to sales instead of earnings) and the unsupported $3.5 billion earnings claim, the quantitative accuracy is reduced, but the core facts and reasoning remain strong, warranting a correctness score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 462,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did Southern Company's treatment and valuation of energy-related derivatives change between 2022 and 2024, particularly in terms of unrealized gains (losses) and their presentation in financial statements?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred, specifically as of December 31, 2021, and 2020. By 2024, the company shifted its disclosure focus to the fair value of energy-related derivatives, interest rate derivatives, and foreign currency derivatives, which were presented as either assets or liabilities in the balance sheets, typically under 'Other' or separately as 'Risk Management Activities'. This indicates a change in both the valuation approach and the presentation of these instruments in financial disclosures.",
      "llm_answer": "In the 2022 Form 10‑K Southern Company reported unrealized gains on its energy‑related regulatory hedges as a $155 million net gain (with a $7 million loss for the gas unit) and presented those amounts as separate regulatory assets and liabilities on the balance sheet【page_324】. By the 2024 filing the company netted the derivative positions, showing energy‑related regulatory‑hedge assets of $45 million and liabilities of $122 million, and added cash‑flow/fair‑value‑hedge line items with $32 million of assets and $659 million of liabilities; it also disclosed large fair‑value losses on interest‑rate hedges (‑$269 million) and foreign‑currency hedges (‑$218 million)【page_283】【page_282】. This reflects a shift from reporting unrealized gains as distinct regulatory‑asset amounts to a net fair‑value presentation of derivative assets and liabilities, with losses now recognized in the balance sheet and OCI.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific numerical values such as a $155 million net gain in 2022, $45 million in assets and $122 million in liabilities in 2024 for energy-related derivatives, and additional figures for interest-rate and foreign currency hedges. However, the ground truth does not provide any of these specific dollar amounts, nor does it mention a $155 million gain or losses by segment (e.g., gas unit). These numbers appear to be fabricated or misattributed, severely undermining quantitative accuracy. There is no verification in the original answer that such figures were reported for the years 2021, 2020, or 2024. (2) The calculation of netting positions or presentation changes is plausible, but without confirmation of the base numbers, the quantitative foundation is unsound. The LLM introduces precise figures not present in the ground truth, which claims only a shift in disclosure focus and presentation format, not specific balances. (3) Qualitatively, the LLM correctly identifies a shift in presentation—from separate regulatory asset/liability recognition in 2022 to a net fair value presentation in 2024, including expanded disclosure of cash flow and fair value hedges. It also correctly notes the inclusion of interest rate and foreign currency derivatives in later disclosures, aligning with the ground truth’s claim of broadened scope. The reasoning about a change in valuation approach and balance sheet presentation is logically sound and reflects multi-hop synthesis across years and disclosure types. (4) Contextually, the response is highly relevant, directly addressing how treatment and presentation evolved over time. Despite incorrect numbers, the conceptual shift described—moving from deferral of unrealized gains under regulatory hedging to fair value recognition in balance sheets and OCI—is consistent with the original answer’s core message. The major flaw is the invention of specific financial figures, which drastically reduces factual correctness, but the directional and qualitative insights are largely accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 558,
        "total_tokens": 1970
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Chevron's financial relationship with Tengizchevroil evolve between 2022 and 2024, particularly in terms of its investment carrying value and equity earnings?",
      "original_answer": "In 2022, Chevron disclosed that its carrying value of its investment in Tengizchevroil (TCO) was about $100 higher than its underlying equity in TCO's net assets, with a significant portion of the investment tied to a $4,500 loan to fund the FGP/WPMP development. By 2024, Chevron's financial stake in Tengizchevroil had grown substantially, with its investment and advances reaching $27,368 million in 2024, compared to $26,954 million in 2023. Additionally, Chevron's equity in earnings from TCO declined from $4,386 million in 2022 to $3,033 million in 2024, indicating a reduction in profitability from the venture over this period.",
      "llm_answer": "- 2022: Chevron’s 50 % stake in Tengizchevroil was recorded at a carrying amount about **$100 higher** than the affiliate’s underlying net‑asset equity, and the equity‑method share of earnings from TCO was **$4.386 billion**【page_78†L31-L38】【page_84†L31-L34】.  \n\n- 2024: At 31 December 2024 the carrying value of the TCO investment was **about $73 higher** than the underlying equity, and equity earnings from TCO had fallen to **$3.033 billion**【page_85†L1-L7】【page_84†L31-L34】.  \n\nThus, between 2022 and 2024 the excess of Chevron’s carrying value over TCO’s net‑asset equity narrowed from roughly $100 to $73, while its equity earnings from the joint venture declined from $4.386 billion to $3.033 billion.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the key financial metrics for Chevron's relationship with Tengizchevroil in 2022 and 2024: the carrying value excess over equity and equity earnings. It accurately reports the $4.386 billion equity earnings in 2022 and $3.033 billion in 2024, matching the ground truth. However, the ground truth does not mention the $73 higher carrying value in 2024; this specific figure is absent from the original answer, which only notes the overall investment and advances of $27,368 million in 2024. Thus, while the trend of narrowing excess may be consistent, the precise $73 figure lacks support in the provided ground truth. Additionally, the LLM omits the detail about the $4,500 million loan funding the FGP/WPMP project, a significant component of the 2022 carrying value explanation. 2) Quantitatively, the equity earnings figures are correct ($4.386B and $3.033B), and the comparison across years is accurate. The $73 excess in 2024 is plausible but not confirmed in the ground truth, which focuses on total investment value rather than the difference from net assets in that year. The absence of the $4.5 billion loan reference reduces completeness. 3) The reasoning is sound in tracking changes in carrying value differential and equity earnings over time, showing a logical multi-hop synthesis between 2022 and 2024. However, the lack of mention of the loan weakens the full explanation of the investment's composition. 4) Despite minor omissions and the introduction of a specific $73 figure not present in the ground truth, the LLM captures the core evolution: declining earnings and a narrowing gap in carrying value. The answer remains contextually relevant and factually aligned on the main points, warranting a high score but not perfect due to missing key contextual details and unverified specifics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 498,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Walmart's ownership stake in Alert Innovation evolve between fiscal 2023 and fiscal 2024, and what specific transaction occurred to change its relationship with the entity?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, which was previously consolidated as a variable interest entity, resulting in Walmart becoming a 100% owner. However, by fiscal 2024, Walmart had subsequently sold and deconsolidated Alert Innovation, indicating a complete exit from the entity. This marks a full transformation from full ownership to no ownership within a single fiscal year.",
      "llm_answer": "Walmart’s stake in Alert Innovation went from a variable‑interest relationship to full ownership in fiscal 2023 when it bought out the non‑controlling interest for about $0.4 billion, making the company a 100 % owner. The 2024 filing shows the ownership remained at 100 % through fiscal 2024, with no further change until a planned sale in fiscal 2025. The transaction that altered the relationship was the $0.4 billion acquisition of Alert Innovation, converting it from a variable‑interest entity into a wholly‑owned subsidiary【page_66】【page_65】.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that Walmart acquired Alert Innovation for $0.4 billion in fiscal 2023 and that it became a 100% owner, it incorrectly claims that ownership remained at 100% through fiscal 2024 and that a sale is 'planned in fiscal 2025'. The ground truth states that Walmart had already sold and deconsolidated Alert Innovation by fiscal 2024, indicating a complete exit — not a future plan. This misrepresents the timeline and outcome. (2) Quantitatively, the $0.4 billion acquisition amount is correct, and the 100% ownership post-acquisition is accurate. However, the claim of continued ownership into fiscal 2024 and a future sale in 2025 contradicts the ground truth that the sale occurred *by* fiscal 2024. (3) The multi-hop reasoning is flawed: the model fails to synthesize the full evolution — from variable interest to full ownership to complete divestiture — and instead stops at continued ownership, missing the deconsolidation entirely. It also introduces a non-supported 'planned sale in 2025', which is not in the original answer. (4) Contextual relevance is moderate because the answer addresses the ownership change and transaction, but the incorrect timeline and missing deconsolidation severely undermine factual correctness. The model captures part of the story but gets the critical outcome wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 389,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions change from fiscal year 2022 to 2023, and what does this indicate about the company's exposure management strategy?",
      "original_answer": "In fiscal year 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI) with $32.5 million expected to be reclassified into earnings within 12 months. By fiscal year 2023, Starbucks had shifted its position significantly, reporting foreign currency - other derivative assets of $1.9 million in current assets and $1.7 million in long-term assets, while carrying derivative liabilities of $4.7 million in current liabilities and $4.1 million in long-term liabilities. This indicates a substantial reduction in overall foreign currency - other derivative exposure and a shift from unrealized gains in equity to more balanced short- and long-term asset and liability positions.",
      "llm_answer": "In FY 2022 Starbucks held foreign‑currency‑other derivative assets of $39.9 million in current assets and $33.5 million in long‑term assets (about $73.4 million total) with only $0.3 million of related liabilities. By FY 2023 the asset balances fell to $32.0 million (current) and $22.9 million (long‑term) – $54.9 million total – while the liability side grew to $2.0 million. The reduction in net foreign‑currency‑other exposure (from roughly $73 million to $53 million) and the modest rise in liabilities indicate that Starbucks trimmed its hedge positions and is managing its foreign‑exchange risk more tightly, aligning hedges more closely with anticipated cash‑flow needs.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in FY 2022, Starbucks reported a foreign currency - other derivative asset of $55.3 million in Accumulated Other Comprehensive Income (AOCI), not broken down into current and long-term assets as stated by the LLM. The LLM incorrectly reports $39.9 million in current assets and $33.5 million in long-term assets for FY 2022, which does not match the source data. Similarly, for FY 2023, the LLM states asset balances of $32.0 million (current) and $22.9 million (long-term), but the ground truth reports only $1.9 million in current assets and $1.7 million in long-term assets — a major discrepancy. The liability figures are also wrong: the LLM reports $2.0 million total liabilities in FY 2023, while the truth shows $4.7 million current and $4.1 million long-term liabilities (total $8.8 million). (2) Calculations are therefore incorrect: the LLM’s claimed total asset reduction from $73.4M to $54.9M and net exposure are unsupported by actual data. The real shift is from a $55.3M AOCI asset position to minimal asset and significant liability positions, indicating a much more dramatic de-risking or unwinding of hedges than the LLM suggests. (3) The multi-hop reasoning is flawed because the LLM misrepresents the structure of the derivative positions (e.g., confusing AOCI unrealized gains with balance sheet assets) and fails to recognize the strategic shift from equity-based unrealized gains to on-balance-sheet assets and liabilities. (4) Despite incorrect numbers and mischaracterization of accounts, the LLM attempts to interpret the trend toward reduced exposure and tighter risk management, which aligns somewhat with the conclusion in the original answer, hence partial credit for contextual relevance and qualitative directionality. However, due to severe quantitative errors and misunderstanding of financial reporting structure, the overall correctness is very low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 536,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Medtronic's treatment of A Preferred Shares evolve between fiscal years 2022 and 2024, and what specific action was taken regarding these shares in 2022?",
      "original_answer": "In fiscal year 2022, Medtronic redeemed 1,872 A Preferred Shares for $0.075 million during the third quarter, and no A Preferred Shares were outstanding by April 29, 2022. By fiscal year 2024, no A Preferred Shares remained outstanding, indicating that the company did not reissue or reintroduce this class of shares after the redemption in 2022. This shows a discontinuation of the A Preferred Shares following their redemption.",
      "llm_answer": "By fiscal 2022 Medtronic had a small number of A Preferred Shares outstanding (1,872) and, in the third quarter of that year, **redeemed those shares for $0.075 million**, leaving the class with zero shares outstanding at April 29, 2022【page_81】. In the 2024 filing the company still reports that the authorized 500 thousand A Preferred Shares exist but **no A Preferred Shares are outstanding** as of April 26, 2024【page_81】, indicating that after the 2022 redemption the shares remained unissued.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Medtronic redeemed 1,872 A Preferred Shares for $0.075 million in the third quarter of fiscal year 2022, and that no shares were outstanding by April 29, 2022. It also accurately states that as of April 26, 2024, no A Preferred Shares were outstanding, which aligns with the ground truth. The key facts—number of shares, dollar amount, timing, and outcome—are all correct. (2) Quantitative accuracy is perfect: 1,872 shares, $0.075 million, April 29, 2022, and April 26, 2024 are all factually correct and match the original answer. Format variations (e.g., $0.075 million) are acceptable and equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from fiscal years 2022 and 2024 to show that after redemption, the shares were not reissued. The only minor difference is that the LLM mentions the authorized 500 thousand shares still exist, which adds context not in the original answer but does not contradict it. The conclusion that the shares remained unissued after 2022 is logically consistent with the ground truth's 'discontinuation' interpretation. (4) The answer is fully relevant, directly addressing both parts of the question: the 2022 action and the evolution through 2024. The slight variation in wording (‘unissued’ vs ‘discontinued’) does not affect factual correctness—both imply no active shares—and thus the answer deserves a high score. Only a 9 due to the slightly less definitive characterization of 'discontinuation' as implied rather than explicitly stated.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 433,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did Comcast's financial relationship with Atairos evolve between 2022 and 2023, particularly in terms of equity income (losses) driven by fair value adjustments on underlying investments?",
      "original_answer": "In 2022, Comcast's equity in net income (losses) from investees, particularly Atairos, showed a loss of $(434) million due to fair value adjustments on its underlying investments. In contrast, by 2023, Atairos generated income of $1.1 billion for Comcast, reflecting a significant turnaround. This change indicates a substantial improvement in the performance of Atairos's underlying investments over the period.",
      "llm_answer": "Comcast’s equity‑in‑net‑income of investees swung from a loss in 2022 to a gain in 2023. In 2022 the line was a $(537) million loss, reflecting a $(434) million loss on its Atairos investment from fair‑value adjustments on the underlying assets; by 2023 the Atairos fair‑value adjustments produced a $1.1 billion gain, turning the equity‑in‑net‑income line into a $789 million gain and lifting total investment‑and‑other‑income to a positive $1.252 billion 【page_39】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key evolution in Comcast's financial relationship with Atairos between 2022 and 2023, noting a shift from a loss to a gain driven by fair value adjustments. The $434 million loss in 2022 and $1.1 billion gain in 2023 from Atairos are accurately reported and match the ground truth. However, the LLM introduces a $(537) million total loss for 2022 and a $789 million gain in equity-in-net-income for 2023, which are not mentioned in the original answer and appear to be additional aggregated figures not requested by the question. These numbers, while possibly accurate from the source document, go beyond the scope of the original answer and introduce unverified details. (2) The core numbers related to Atairos — $(434) million loss in 2022 and $1.1 billion income in 2023 — are correct and properly attributed to fair value adjustments. The calculation of the turnaround is logically sound, but the inclusion of the broader equity-in-net-income figures (e.g., $537M, $789M) without grounding in the original answer reduces quantitative accuracy. (3) The multi-hop reasoning is strong: the model correctly links Comcast’s equity income changes to Atairos and attributes them to fair value adjustments on underlying investments, synthesizing across time and entities. (4) The answer is highly contextually relevant, directly addressing the evolution of the financial relationship. However, the addition of extraneous financial aggregates not present in the ground truth slightly undermines factual precision, warranting a score of 8 for correctness and 7 for quantitative accuracy despite strong qualitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 461,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure slightly declined to 296 billion cubic feet. This minor decrease suggests limited growth or a strategic reallocation of resources in the region during that period.",
      "llm_answer": "COP’s proved natural‑gas reserves in the Asia Pacific/Middle East segment slipped in its core (consolidated) operations – from 312 BCF (plus 7 BCF undeveloped) at year‑end 2023 to 296 BCF (plus 7 BCF undeveloped) at year‑end 2024 – but the equity‑affiliate portion, which is entirely located in that region, rose sharply from 5,275 BCF to 5,870 BCF. Overall, regional reserves grew modestly, signalling that ConocoPhillips is leaning on its equity‑affiliate investments to deepen its strategic foothold in the Asia Pacific/Middle East gas market.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces significant factual inaccuracies not present in the ground truth. While it correctly states the 2023 and 2024 natural gas reserves for COP's consolidated operations (312 BCF and 296 BCF), it adds unverified data about 'undeveloped' reserves (7 BCF) and, more critically, introduces a large equity-affiliate component (5,275 BCF rising to 5,870 BCF) that is not mentioned or supported by the original answer. These figures are entirely absent from the ground truth and represent a major fabrication. (2) The quantitative accuracy is partially correct for the consolidated reserves numbers (312 and 296 BCF), which match the original answer. However, the addition of undeveloped reserves and especially the equity-affiliate reserves (which are not in the ground truth) introduces severe inaccuracies. The claim of 'overall regional reserves grew modestly' is false based on the provided ground truth, which only reports a decline from 312 to 296 BCF. (3) The reasoning is flawed because it assumes a multi-hop synthesis involving equity affiliates and consolidated operations, but the original answer does not mention or imply such a breakdown. The conclusion that COP is 'leaning on equity-affiliate investments' is unsupported by the provided data and represents an incorrect inference. (4) Contextual relevance is moderate because the answer addresses the geographic region and time frame correctly and attempts to interpret strategic positioning, but the strategic conclusion is based on invented data. The original answer suggests limited growth or reallocation due to a minor decline, while the LLM answer claims expansion via affiliates—directly contradicting the ground truth's implication. Thus, despite correct mention of the core numbers, the inclusion of fabricated data and incorrect synthesis leads to a mostly incorrect answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 509,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the revenue performance of ENBREL in Canada evolve between 2022 and 2024, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ENBREL in Canada generated $113 million in revenue, which declined to $47 million in 2023, and further dropped to $28 million in 2024. This indicates a consistent downward trend in revenue, suggesting a shrinking market presence or reduced demand for ENBREL in Canada over this period.",
      "llm_answer": "ENBREL’s Canadian sales fell sharply, from $73 million in 2022 to $47 million in 2023 (‑36 %) and then to $28 million in 2024 (‑40 % YoY)【page_72†L13-L16】【page_71†L13-L16】. The roughly 62 % drop over the three‑year span signals a rapidly contracting Canadian market for ENBREL, indicating weakening demand and a declining market trajectory.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $47 million revenue in 2023 and $28 million in 2024, which match the ground truth. However, it incorrectly states the 2022 revenue as $73 million instead of the correct $113 million. This error affects the overall accuracy of the percentage decline calculations. (2) The claimed 36% YoY drop from 2022 to 2023 is based on $73M → $47M, but the actual drop from $113M → $47M is approximately 58.4%, not 36%. The 2023–2024 drop from $47M to $28M is correctly calculated as ~40% and is accurate. The total three-year decline is stated as roughly 62%, but the actual decline from $113M to $28M is ~75.2%, making the LLM's overall percentage misleading. (3) The reasoning correctly infers a declining market trajectory due to falling revenues, which aligns with the ground truth’s conclusion. The multi-hop synthesis across years is present and logical, despite the incorrect starting value. (4) The contextual relevance is high as the answer addresses both parts of the question—revenue evolution and market trajectory. The qualitative reasoning is sound, but the quantitative inaccuracies—especially the wrong 2022 figure—significantly reduce factual correctness. Hence, correctness is scored at 6 due to partial accuracy with major numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1156,
        "completion_tokens": 364,
        "total_tokens": 1520
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Qualcomm's approach to linking human capital advancements with executive compensation evolved from fiscal 2023 to fiscal 2024, and what specific performance modifier range was applied in fiscal 2024?",
      "original_answer": "In fiscal 2023, Qualcomm indicated that human capital advancements would be considered in determining executives' fiscal 2024 bonus. By fiscal 2024, this approach evolved into a more defined structure where progress toward human capital advancements served as a non-financial performance modifier that could adjust executives' bonus payouts by a multiplier ranging from 0.9 to 1.1. This represents a shift from a general consideration to a quantified performance modifier in executive compensation.",
      "llm_answer": "Qualcomm first introduced a link between human‑capital progress and executive bonuses in fiscal 2023, describing the consideration as a non‑financial factor but without a defined multiplier range (QCOM_10k_2023.pdf p.16). In fiscal 2024 the HR and Compensation Committee formalized the link by applying a non‑financial performance modifier that can adjust an executive’s bonus payout by a multiple of **0.9 to 1.1** (QCOM_10k_2024.pdf p.16).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately describes the evolution of Qualcomm's approach: in fiscal 2023, human capital advancements were mentioned as a non-financial consideration without a defined multiplier, and in fiscal 2024, they were formalized into a performance modifier with a specified range. (2) The quantitative value '0.9 to 1.1' is correctly reported, matching the ground truth exactly. (3) The multi-hop reasoning is sound—comparing the treatment of human capital in executive compensation across two fiscal years using appropriate document sources (2023 and 2024 10-Ks). (4) All entities (Qualcomm, fiscal years 2023 and 2024, executive compensation, bonus modifier) are correctly identified and synthesized. The answer is semantically equivalent to the ground truth, with slightly different but accurate phrasing. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 272,
        "total_tokens": 1522
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has the therapeutic scope of Breyanzi evolved between 2022 and 2024, based on the specific indications and approvals documented in those years?",
      "original_answer": "In 2022, Breyanzi was associated with trials for 3L+ Chronic Lymphocytic Leukemia (TRANSCEND-CLL-004) and 3L+ Follicular Lymphoma (TRANSCEND-FL), both with expected timing in 2023/24. By 2024, Breyanzi received FDA accelerated approvals for two distinct indications: relapsed or refractory Follicular Lymphoma (FL) after at least two prior lines of therapy (approved in May 2024), and relapsed or refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) after at least two prior lines of therapy, including a Bruton tyrosine kinase inhibitor and a B-cell lymphoma 2 inhibitor (approved in March 2024). This reflects a shift from being in late-stage trials to having concrete accelerated approvals in specific patient populations.",
      "llm_answer": "In the 2022 Form 10‑K Breyanzi was listed only for relapsed or refractory large B‑cell lymphoma (LBCL) after ≥ two prior lines of therapy (see 2022 filing, page 22). By the 2024 filing the product had earned FDA accelerated approvals for relapsed or refractory follicular lymphoma (May 2024), CLL/SLL (March 2024) and mantle‑cell lymphoma (May 2024), and a Japanese approval for FL after one prior line (August 2024), expanding Breyanzi’s use to three additional B‑cell malignancies and to earlier lines of therapy (see 2024 filing, pages 45 & 44; summary statement on page 46).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) According to the ground truth, in 2022 Breyanzi was not yet approved for large B-cell lymphoma (LBCL) in the context of the question—it was in trials for CLL and FL. However, the LLM incorrectly states that in the 2022 Form 10-K, Breyanzi was listed only for LBCL, which contradicts the original answer stating it was in trials for 3L+ CLL and FL. (2) The LLM claims Breyanzi received FDA accelerated approvals for three indications: FL (May 2024), CLL/SLL (March 2024), and mantle-cell lymphoma (May 2024). However, the ground truth only confirms two approvals: FL (May 2024) and CLL/SLL (March 2024)—there is no mention of mantle-cell lymphoma approval. This is a major factual error. (3) The LLM also mentions a Japanese approval for FL after one prior line in August 2024, which is not present in the original answer and cannot be verified against the ground truth. (4) The original answer emphasizes a shift from late-stage trials in 2022 to concrete accelerated approvals in 2024 for FL and CLL/SLL, with specific criteria (e.g., prior BTK and BCL-2 inhibitors for CLL/SLL). The LLM fails to mention these key eligibility criteria and misrepresents the 2022 status. (5) While the LLM correctly identifies the May 2024 FL and March 2024 CLL/SLL approvals in terms of timing, it adds unverified approvals and omits critical details, leading to a partially correct but overall misleading response. Quantitative accuracy is low due to incorrect indications and unverified dates (e.g., August 2024 Japan approval). Qualitative accuracy suffers from flawed multi-hop reasoning—incorrectly characterizing 2022 status and overstating 2024 approvals. Contextual relevance is moderate as it addresses the general theme of expanding indications but does so with incorrect data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 502,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the financial performance of Disney's Resorts and Vacations segment evolved from 2023 to 2024, and how does this compare to the overall revenue growth of the Parks & Experiences segment?",
      "original_answer": "The Resorts and Vacations segment saw an increase in revenue from $7,949 million in 2023 to $8,375 million in 2024, representing a 5% growth. This growth was slightly below the overall Parks & Experiences revenue growth of 5%, which increased from $32,549 million in 2023 to $34,151 million in 2024. The Resorts and Vacations segment remained a significant contributor to the overall Parks & Experiences division, maintaining a consistent proportion of total revenue despite the modest growth difference.",
      "llm_answer": "Disney’s Resorts & Vacations revenue rose from $7.949 billion in 2023 to $8.375 billion in 2024 – a 5% increase 【page_47】.  The broader Parks & Experiences segment grew its total revenue from $32.549 billion to $34.151 billion, also about a 5% rise 【page_49】, so the Resorts & Vacations segment’s growth was essentially in line with the segment‑wide revenue growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all financial figures: Resorts & Vacations revenue increased from $7,949 million (=$7.949 billion) in 2023 to $8,375 million (=$8.375 billion) in 2024, representing a 5% growth. The Parks & Experiences segment grew from $32,549 million to $34,151 million, also a 5% increase—both numbers and percentages match the ground truth exactly. (2) Calculations are accurate: (8,375 - 7,949)/7,949 ≈ 5.36%, which rounds to 5% as stated; similarly, (34,151 - 32,549)/32,549 ≈ 4.92%, also reasonably rounded to 5%. The LLM correctly concludes the growth rates were essentially equal. (3) The multi-hop reasoning is sound—comparing segment-specific performance to overall division growth is properly executed. However, the LLM omits the point that Resorts & Vacations maintained a consistent proportion of total revenue, which was included in the original answer and adds contextual depth. (4) Despite this minor omission, the core facts, numbers, and synthesis are correct. The answer is semantically very close to the ground truth, with only slight reduction in completeness. Hence, correctness is 9/10, with full marks for quantitative accuracy and contextual relevance, and a 9 in qualitative accuracy due to the missing nuance about revenue proportion stability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 365,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has the structure and value of CVS's forward contracts associated with accelerated share repurchase (ASR) transactions evolved between 2023 and 2024?",
      "original_answer": "In 2023, CVS executed a $2.0 billion ASR with Citibank, N.A., which was accounted for as an initial treasury stock transaction of $1.6 billion and a forward contract of $0.4 billion. The forward contract was classified as an equity instrument and recorded within capital surplus, with the final 20% of shares received in February 2023. In 2024, CVS entered into a larger $3.0 billion ASR with Morgan Stanley, accounted for as an initial treasury stock transaction of $2.6 billion and a forward contract of $0.4 billion. The forward contract was similarly classified and recorded, but the remaining 15% of shares were received later, in March 2024. Despite the increase in the ASR size, the forward contract value remained constant at $0.4 billion, indicating a shift in the proportion of the ASR allocated to the forward contract component.",
      "llm_answer": "In 2023 CVS completed a $2 billion fixed‑dollar ASR with Citibank that was recorded as a $1.6 billion initial treasury‑stock purchase plus a $0.4 billion forward contract placed in capital surplus and later re‑classified to treasury stock when the final 20 % of shares were delivered in February 2023【page_175】. In 2024 the company entered a larger $3 billion ASR with Morgan Stanley that was accounted for as a $2.6 billion initial treasury‑stock purchase and a $0.4 billion forward contract (still recorded in capital surplus and re‑classified in March 2024)【page_175】. Thus, while the forward‑contract amount remained $0.4 billion, its proportion of the total ASR fell from 20 % in 2023 to roughly 13 % in 2024 as the overall ASR size increased.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the $2.0 billion 2023 ASR with Citibank and the $3.0 billion 2024 ASR with Morgan Stanley, the $1.6B/$2.6B initial treasury stock transactions, and the $0.4B forward contract in both years. The dates of final share receipt (February 2023, March 2024) are accurate. The forward contract value remaining constant at $0.4 billion is correctly noted. (2) Quantitative accuracy is perfect: all dollar amounts, percentages (20%, 13%), and calculations (20% of $2B = $0.4B; ~13.3% of $3B = $0.4B) are correct. The proportional decrease from 20% to ~13% is accurately computed and stated. (3) The multi-hop reasoning is sound—comparing the structure and value of forward contracts across two years, identifying the shift in proportion despite constant dollar value. The only minor discrepancy is the claim that the forward contract was 're-classified to treasury stock', while the original answer states it was 'recorded within capital surplus' and implies settlement upon delivery, but does not explicitly mention reclassification. This is a subtle accounting nuance and does not materially misrepresent the outcome. (4) The answer is fully contextually relevant, directly addressing the evolution in structure and value. The synthesis across years and entities (CVS, Citibank, Morgan Stanley) is accurate. The conclusion about the declining proportion of the forward component is valid and insightful. Overall, the answer matches the ground truth in substance and adds minor interpretive clarity (e.g., calculating 13%), warranting a high score with only a slight deduction in qualitative accuracy due to the reclassification wording.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 462,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Duke Energy's disclosure regarding the Master Retirement Trust's pension asset valuation methodology evolve from 2023 to 2024, particularly in terms of transparency around fair value categorization?",
      "original_answer": "In 2023, Duke Energy disclosed the allocation percentages of the Master Retirement Trust among its subsidiaries and noted that certain investments measured at fair value using the net asset value per share practical expedient were not categorized in the fair value hierarchy. In 2024, the company maintained the same allocation percentages but added a new disclosure element — a reconciliation of beginning and ending balances of the Master Retirement Trust's qualified pension and other post-retirement assets, specifically those valued using significant unobservable inputs (Level 3). This represents a significant increase in transparency regarding the fair value categorization of pension assets.",
      "llm_answer": "In the 2023 filing Duke Energy already broke out the Master Retirement Trust’s pension assets by the fair‑value hierarchy—Level 1, Level 2, Level 3—and added a “Not Categorized (b)” column for assets measured using a net‑asset‑value‑per‑share practical expedient, with a footnote explaining that those items are not placed in the hierarchy (see Note 17 discussion and the table on page 219). The 2024 filing repeats the same structure—Level 1, Level 2, Level 3 and a “Not Categorized (b)” column with the same footnote—and the narrative describing valuation methods for equity, debt and short‑term funds is unchanged (see Note 17 discussion and the table on page 228). Thus, the company’s disclosure of its pension‑asset valuation methodology remained consistent, preserving the same level of transparency around fair‑value categorization from 2023 to 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its conclusion, directly contradicting the ground truth. While it correctly notes that Duke Energy used a 'Not Categorized (b)' column in both years for investments measured using the net asset value per share practical expedient, it fails to identify the key evolution in disclosure: the addition of a Level 3 reconciliation in 2024. The ground truth states that in 2024, Duke Energy added a new disclosure — a reconciliation of beginning and ending balances for pension and post-retirement assets valued using significant unobservable inputs (Level 3), which represents increased transparency. The LLM incorrectly asserts that the disclosure structure and transparency 'remained consistent' between 2023 and 2024, missing this critical enhancement. This is a major factual omission that reverses the correct interpretation of the evolution in transparency. The entity (Duke Energy), years (2023, 2024), and general context (Master Retirement Trust, fair value hierarchy) are accurate, and the description of the 'Not Categorized' treatment is correct, supporting a moderate contextual relevance score. However, the failure to detect and report the new Level 3 reconciliation — the central point of increased transparency — results in a low correctness score. No numerical values are misstated per se, but the absence of recognition of the new reconciliation table (which includes quantitative data) undermines quantitative accuracy. The reasoning is flawed as it draws a conclusion of 'no change' when a significant multi-hop change (same structure + new reconciliation = increased transparency) occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 449,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did Pfizer's financial obligations and revenue recognition related to Paxlovid change between 2023 and 2024, particularly concerning the U.S. government's inventory return and the creation of the U.S. Strategic National Stockpile?",
      "original_answer": "In 2023, Pfizer recorded a non-cash revenue reversal of $3.5 billion related to the expected return of 6.5 million EUA-labeled Paxlovid treatment courses previously purchased by the U.S. government. In 2024, this estimate was adjusted based on the actual return of 5.1 million treatment courses, resulting in a favorable final adjustment of $771 million. Additionally, in 2024, Pfizer recognized $442 million of revenue in connection with the creation of the U.S. Strategic National Stockpile (SNS) of 1.0 million Paxlovid treatment courses for future pandemic preparedness. These developments reflect a shift from revenue reversal and inventory transition in 2023 to revenue recognition and strategic stockpile establishment in 2024.",
      "llm_answer": "In 2023 Pfizer booked a $3.5 billion non‑cash revenue reversal for Paxlovid, reflecting an estimated return of 6.5 million EUA‑labeled treatment courses from the U.S. government. In 2024 that reversal was trimmed by a $771 million favorable adjustment after only 5.1 million courses were actually returned, and the company recorded $442 million of revenue for supplying a 1‑million‑course U.S. Strategic National Stockpile (SNS) at no cash cost—reducing Paxlovid‑related deferred revenue from $5.1 billion at year‑end 2023 to $2.2 billion at year‑end 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, all numbers are accurate: the $3.5 billion non-cash revenue reversal in 2023 for 6.5 million Paxlovid courses is correctly stated; the $771 million favorable adjustment in 2024 due to the actual return of 5.1 million courses is precise; and the $442 million revenue recognized in 2024 for the 1 million course U.S. Strategic National Stockpile (SNS) is correct. The LLM also adds a synthesis-level detail—Pfizer’s deferred revenue reduction from $5.1 billion to $2.2 billion—which is consistent with the net impact of these adjustments and further demonstrates accurate reasoning. (2) The answer is complete, addressing both years and both key events: the 2023 revenue reversal due to expected returns and the 2024 developments involving the final return adjustment and SNS revenue. (3) Entity accuracy is perfect: Pfizer, Paxlovid, U.S. government, EUA-labeled courses, and the Strategic National Stockpile are all correctly identified and contextualized. (4) The multi-hop reasoning is sound: the LLM correctly infers the net effect on deferred revenue by combining the reversal, adjustment, and new revenue recognition, which demonstrates deep synthesis across multiple financial events. (5) Semantic equivalence is maintained—the LLM conveys the same core narrative as the original answer: a shift from revenue reversal in 2023 to partial reversal unwind and new revenue recognition in 2024. Minor wording differences do not affect factual accuracy. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 436,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the financial performance of ERLEADA evolved between 2022 and 2023, and what does this indicate about its role in J&J's oncology portfolio?",
      "original_answer": "ERLEADA's sales increased from $1,881 million in 2022 to $2,387 million in 2023, representing a 26.9% growth. This indicates that ERLEADA has become a more prominent contributor to J&J's oncology segment, which saw overall growth of 10.5% in 2023. The strong performance of ERLEADA contrasts with the decline in other key oncology products like IMBRUVICA and ZYTIGA, suggesting that ERLEADA is playing an increasingly important role in sustaining J&J's oncology revenue.",
      "llm_answer": "ERLEADA’s sales rose from $1.9 billion in 2022 to $2.4 billion in 2023—a 26.9% year‑over‑year increase (27.5% operational growth)【page_31】. This boost helped lift total oncology revenue 10.5% and was highlighted as a driver of share‑gain and market growth in metastatic castration‑resistant prostate cancer, signaling that ERLEADA is becoming a key growth engine within J&J’s oncology portfolio【page_32】【page_33】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports ERLEADA's sales growth from $1.9 billion in 2022 to $2.4 billion in 2023, which aligns with the ground truth values of $1,881 million and $2,387 million when rounded. The calculated year-over-year growth rate of 26.9% is accurate and matches the ground truth. The mention of 10.5% overall oncology revenue growth is also correct. 2) Quantitative accuracy is perfect: the dollar amounts are appropriately rounded ($1.9B ≈ $1,881M; $2.4B ≈ $2,387M), and the percentage increase is correctly computed: (2387 - 1881) / 1881 ≈ 26.9%. The additional detail of 27.5% operational growth is a nuance not in the ground truth but does not contradict it and may reflect FX-adjusted performance. 3) The reasoning is sound: the LLM correctly infers that ERLEADA is becoming a key growth driver in J&J’s oncology portfolio, supported by its strong sales growth and contribution to overall segment performance. While the ground truth contrasts ERLEADA’s growth with declines in IMBRUVICA and ZYTIGA, the LLM omits this comparative detail but still reaches a logically consistent conclusion about ERLEADA’s strategic importance. 4) The answer is contextually relevant, directly addressing both parts of the question—financial performance evolution and strategic role—using appropriate evidence. The only minor shortcoming is the lack of explicit contrast with other products’ performance, which slightly reduces qualitative completeness. Overall, the answer is factually correct, well-reasoned, and highly relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 420,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the global sales performance of ERLEADA evolve from 2022 to 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA reported worldwide sales of $1,291 million, with a significant growth rate of 70.0% compared to the previous year. By 2023, the product's global sales increased further to $2,387 million, reflecting a 26.9% growth from 2022. This indicates that ERLEADA continued to experience strong market adoption and revenue expansion, albeit at a slower growth rate compared to the prior year, suggesting a maturing growth phase in its lifecycle.",
      "llm_answer": "ERLEADA’s worldwide net sales rose sharply, from $1.291 billion in FY 2022 (U.S. $813 m + International $478 m) to $2.387 billion in FY 2023—a year‑over‑year increase of roughly 27% (about $1.1 billion)【page_85】【page_31】.  The company attributes the rise to continued share‑gain and market growth, indicating a strong, accelerating trajectory for the prostate‑cancer product【page_32】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports ERLEADA's global sales of $1.291 billion in 2022 and $2.387 billion in 2023, matching the ground truth exactly. The year-over-year growth is stated as 'roughly 27%', which aligns with the ground truth's 26.9% (calculated as (2,387 - 1,291) / 1,291 ≈ 0.849, or 84.9% increase from 2021 to 2022, and (2,387 - 1,291) / 1,291 ≈ 0.849, but the 26.9% growth from 2022 to 2023 is accurate: (2,387 - 1,291) / 1,291 ≈ 0.849 is incorrect — correction: (2,387 - 1,291) = 1,096; 1,096 / 1,291 ≈ 0.849 is actually 84.9%, but wait — this is a critical error in reasoning. Actually, the ground truth states 70.0% growth from 2021 to 2022 and 26.9% from 2022 to 2023. The LLM correctly calculates the 2022–2023 growth as ~27%, which matches 26.9% — so the calculation is correct. The LLM does not mention the 70% growth in 2022, but focuses only on the 2022–2023 change, which is acceptable given the question's focus on evolution from 2022 to 2023. (2) All numeric values are accurate: $1.291 billion (2022), $2.387 billion (2023), and ~27% growth (matches 26.9%). The breakdown into U.S. and international sales ($813M + $478M = $1,291M) is correct and adds contextual detail not in the ground truth but factually consistent. (3) The multi-hop reasoning is sound: the model synthesizes sales figures across years and correctly computes growth. It attributes the increase to 'continued share-gain and market growth,' which aligns with the ground truth's implication of strong market adoption. However, the LLM describes the trajectory as 'accelerating,' which contradicts the ground truth's observation that growth slowed from 70% to 26.9%, indicating a maturing phase, not acceleration. This is a qualitative inaccuracy in interpretation. (4) Despite this, the answer is highly factually accurate and relevant. The correctness score is 9 because all quantitative data is correct and the answer addresses the evolution from 2022 to 2023, but the mischaracterization of the trajectory as 'accelerating' slightly undermines the qualitative accuracy. Contextual relevance is perfect — it directly answers the question with supporting data and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1204,
        "completion_tokens": 585,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did NVDA's debt management strategy evolve regarding the 0.584% Notes Due 2024 between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a balance of $1,250 million for the 0.584% Notes Due 2024, with an effective interest rate of 0.66%. By fiscal year 2024, NVDA disclosed in its 10-K filing that it repaid these notes in fiscal year 2025, resulting in no remaining balance for this instrument as of January 26, 2025. This indicates a shift in NVDA's debt management strategy, where it chose to retire the obligation before or shortly after the due date rather than rolling it over or extending it.",
      "llm_answer": "In FY 2023 NVIDIA carried the 0.584 % notes due 2024 as a $1.25 billion short‑term liability with no explicit repayment plan disclosed. By FY 2024 the same $1.25 billion of 0.584 % notes remained on the balance sheet, but the filing added a footnote stating the company would retire those notes in FY 2025, showing a shift from simply holding the short‑term debt to actively planning its early repayment.【page_72】【page_72】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.25 billion balance (equivalent to $1,250 million) of the 0.584% Notes Due 2024 in both fiscal years 2023 and 2024, matching the ground truth. The interest rate is not mentioned in the LLM answer, but this does not detract significantly from the core focus on debt management strategy evolution. The key point—that NVDA planned to retire the notes in FY 2025—is accurately conveyed, aligning with the original answer's claim of repayment in fiscal year 2025 resulting in zero balance as of January 26, 2025. (2) Quantitative values are correct: $1.25 billion = $1,250 million, and the note's coupon rate (0.584%) is accurately repeated. The effective interest rate (0.66%) from the ground truth is omitted, but this is a secondary detail not central to the strategy shift described. (3) The multi-hop reasoning is sound: the model synthesizes information across two fiscal years and infers a strategic shift—from carrying the debt without a disclosed plan in FY2023 to disclosing a retirement plan in FY2024. This correctly reflects a change in debt management approach. (4) The answer is contextually fully relevant, directly addressing how the strategy evolved. The only minor shortcoming is the omission of the effective interest rate and the precise post-repayment status (zero balance), though the retirement intent is clearly stated. Overall, the answer captures the essential factual and inferential content of the ground truth, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 421,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Honeywell's investment in Mortgage/Asset-backed securities evolve between 2022 and 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, Honeywell reported $982 million invested in Mortgage/Asset-backed securities under U.S. Plans. By 2023, this amount had significantly decreased to $10 million under Non-U.S. Plans. This represents a reduction of $972 million, or over 98%, indicating a major shift in Honeywell's investment strategy concerning Mortgage/Asset-backed securities.",
      "llm_answer": "Honeywell’s mortgage‑ and asset‑backed‑securities holdings fell sharply. For its U.S. pension plans the balance dropped from $1,119 million in 2022 to $676 million in 2023, and for its non‑U.S. plans it fell from $31 million to $10 million — a combined reduction of about $464 million 【page_109】【page_110】.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Honeywell had $982 million invested in Mortgage/Asset-backed securities under U.S. Plans in 2022 and only $10 million under Non-U.S. Plans in 2023, with no mention of U.S. plans in 2023. However, the LLM claims $1,119 million in U.S. plans in 2022 and $676 million in 2023, and $31 million to $10 million in non-U.S. plans, which contradicts the ground truth. The combined reduction of $464 million in the LLM answer is incorrect; the actual reduction is $972 million (from $982M to $10M), a drop of over 98%. (2) The numbers cited by the LLM ($1,119M, $676M, $31M) do not match the ground truth ($982M, $10M), and the calculation of a $464M reduction is based on incorrect inputs. The correct reduction is $972M. (3) The multi-hop reasoning is partially sound in that the model attempts to compare two years and calculate a change across plans, but it fails to correctly identify the entities and amounts involved. It incorrectly attributes the 2022 amount to U.S. plans and introduces a non-U.S. 2022 figure not present in the ground truth, which only reports U.S. plans in 2022 and Non-U.S. in 2023. This suggests a misreading of the data or incorrect synthesis. (4) The contextual relevance is high because the answer addresses the evolution and magnitude of change in Mortgage/Asset-backed securities, but the factual inaccuracies severely undermine correctness. Quantitative accuracy is low due to wrong base figures and miscalculated change. Qualitative accuracy is slightly higher because the direction of change (sharp decrease) is correct, but the reasoning and entity mapping are flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 464,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role in the company's funding mix and their fair value classification?",
      "original_answer": "In 2022, securitized debt obligations were described as a key component of Capital One's diversified funding strategy, used alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances to maintain access to wholesale funding sources. By 2023, the company disclosed that the carrying value of securitized debt obligations was $18,043 million, with an estimated fair value of $18,067 million, all classified under Level 2 of the fair value hierarchy. This indicates that while the company continued to rely on securitized debt obligations as a funding source, the 2023 data provides more specific transparency into their valuation and classification, showing a shift toward more detailed disclosure and potentially more structured risk management.",
      "llm_answer": "In 2022 Capital One reported $16.97 billion of securitized debt obligations, which it described as a core element of its diversified wholesale‑funding mix alongside deposits, senior/subordinated notes and other borrowings (Funding discussion) and measured the liabilities at fair value using Level 2 inputs (Table of financial liabilities)【page_113】【page_211】. By year‑end 2023 the balance had grown to $18.04 billion, remained classified as Level 2 fair‑value, and continued to be a principal source of long‑term funding, with the company maintaining a large shelf‑registration capacity to issue additional securitized obligations (Funding discussion and borrowing‑capacity note)【page_210】【page_112】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $16.97 billion in 2022 (implied from context, though not in original answer, but not contradicted) and $18.04 billion in 2023 (equivalent to $18,043 million in ground truth). The 2023 fair value of $18,067 million is not mentioned in the LLM answer, but the carrying value and Level 2 classification are correctly reported. (2) The LLM correctly identifies that securitized debt obligations remained classified under Level 2 of the fair value hierarchy in both years, matching the ground truth. (3) The qualitative reasoning is sound: the LLM correctly synthesizes that securitized debt remained a key part of the funding mix, and notes continued shelf registration capacity, which supports the idea of ongoing strategic use. (4) The only minor omission is the lack of mention of the 2023 fair value ($18,067 million), which the original answer uses to highlight increased transparency and valuation detail. However, this does not undermine the core conclusion about continued use and classification. The LLM emphasizes growth in balance and sustained classification, which is consistent with the evolution described in the ground truth. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses funding mix role and fair value classification across both years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 393,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did JPMorgan's treatment of CECL capital transition provisions under U.S. capital rules evolve from 2023 to 2024, and what was the quantitative change in the CECL-related capital benefit during this period?",
      "original_answer": "In 2023, JPMorgan reported a $1.4 billion benefit from the CECL capital transition provisions included in its CET1 capital. By 2024, this benefit had decreased to $720 million, reflecting a phased reduction in the CECL-related capital benefit as the provisions were being phased in under U.S. capital rules. The capital metrics indicated that the CECL benefit was fully phased in by January 1, 2025.",
      "llm_answer": "JPMorgan’s CECL capital‑transition adjustment was being phased out under the U.S. rules – in 2023 CET1 capital still included a $1.4 billion CECL benefit, but by year‑end 2024 that benefit had fallen to $720 million, a reduction of roughly $680 million (the difference between $1.4 bn and $720 m)【page_104】【page_105】【page_99】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $1.4 billion in 2023 and $720 million in 2024 are accurately reported. The reduction of roughly $680 million ($1.4B - $720M = $680M) is correctly calculated. (2) The answer addresses both parts of the question: it describes the evolution of JPMorgan's treatment of CECL capital transition provisions (phased reduction under U.S. rules) and provides the quantitative change ($680M decrease). (3) Entities are accurate—JPMorgan, CECL, CET1 capital, and the years 2023 and 2024 are correctly identified. (4) The reasoning is sound: the model correctly infers that the decline reflects a phase-out under regulatory rules, which matches the multi-hop synthesis required. The only minor omission is that the original answer notes the provisions were fully phased in by January 1, 2025—a detail not included in the LLM response—hence a slight deduction in qualitative accuracy. However, this does not undermine the core correctness. Semantic equivalence is maintained, and the answer is contextually fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 318,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the terms and capacity of Salesforce's Revolving Loan Credit Agreement evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Salesforce had a $3.0 billion unsecured revolving credit facility under the Revolving Loan Credit Agreement, which was scheduled to mature in December 2025. By fiscal 2024, this agreement was replaced with a new $5.0 billion unsecured revolving credit facility that matures in October 2029. The increase in capacity and the extension of the maturity date reflect a strategic enhancement of the company’s credit resources.",
      "llm_answer": "In fiscal 2023 Salesforce’s revolving‑loan facility was a $3.0 billion unsecured credit line that matured in December 2025 (the “Prior Credit Agreement”)【page_52】. By fiscal 2024 the company entered a new agreement in October 2024 that replaced the prior facility, expanding the credit amount to $5.0 billion and extending the maturity to October 2029【page_51】, thereby adding $2 billion of borrowing capacity and a longer term.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: the $3.0 billion unsecured facility in fiscal 2023 maturing in December 2025 is accurately stated, and the replacement in fiscal 2024 with a $5.0 billion facility maturing in October 2029 is correctly reported. (2) Quantitative accuracy is perfect: dollar amounts ($3.0B → $5.0B), maturity dates (Dec 2025 → Oct 2029), and the implied $2.0B increase in capacity are all correct. Minor formatting (e.g., $2 billion vs $2.0 billion) is acceptable. (3) Multi-hop reasoning is sound: the model correctly synthesizes changes across fiscal years, identifies the replacement of the old agreement, and captures the strategic enhancement in terms and capacity. (4) Semantic equivalence is achieved—though wording differs slightly (e.g., 'entered a new agreement in October 2024'), this aligns with fiscal 2024 reporting and does not misrepresent timing. Citations to page numbers add verifiability. No errors in entities, metrics, or logic. The answer fully addresses the evolution in terms and capacity as required.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 316,
        "total_tokens": 1526
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did UPS's relationship with Coyote evolve between 2022 and 2024, and what financial impact did this change have on UPS in 2024?",
      "original_answer": "In 2022, UPS had an active business relationship with Coyote, operating it as a branded subsidiary that provided truckload brokerage services in the U.S. and Europe. Coyote was integrated into UPS’s broader supply chain offerings, leveraging the UPS fleet and third-party carrier networks to provide customized transportation solutions. However, by 2024, UPS had completed the divestiture of Coyote, recording a pre-tax gain of $156 million ($152 million after tax) as a result of the transaction. This change marks a full transition from a strategic business unit to a divested asset, reflecting a shift in UPS's supply chain strategy.",
      "llm_answer": "In 2022 UPS described Coyote as a “Coyote‑branded subsidiary” that provided its U.S. and European truckload‑brokerage services within the Supply Chain Solutions segment【page_7】. By 2024 UPS had sold the business – the divestiture was completed in Q3 2024 and produced a pre‑tax gain of $156 million (about $152 million after tax) that was recorded as other income for the year【page_31】 (the gain also appears as a $4 million non‑GAAP adjustment in the 2024 MD&A【page_29】).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: the pre-tax gain of $156 million and after-tax gain of $152 million are correctly reported, and the Q3 2024 completion of the divestiture aligns with the timeline. The mention of the $4 million non-GAAP adjustment in the 2024 MD&A (page 29) adds precision beyond the original answer, without contradicting it. (2) The answer addresses both parts of the question: the evolution of the relationship (from branded subsidiary in 2022 to divestiture in 2024) and the financial impact in 2024 (the gain recorded as other income). (3) Entities are correctly identified—UPS, Coyote, the Supply Chain Solutions segment—and the years (2022, 2024) and financial metrics (pre-tax, after-tax, non-GAAP adjustment) are accurate. (4) The reasoning is sound and reflects proper multi-hop synthesis: it connects the operational role of Coyote in 2022 with its financial treatment post-divestiture in 2024, correctly interpreting the income statement impact. The inclusion of specific document references (page numbers) further supports the accuracy and traceability. Overall, the answer is factually equivalent to the ground truth, with slightly more detail, and fully satisfies the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 364,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Union Pacific's relationship with chassis evolved between 2023 and 2024, particularly in terms of total units and ownership structure?",
      "original_answer": "In 2023, Union Pacific had a total of 48,340 chassis units, with 30,635 owned and 17,705 leased. By 2024, the total number of chassis dropped significantly to 5,553 units, with only 4,356 owned and 1,197 leased. This represents a transformation in Union Pacific's relationship with chassis, shifting from a heavy reliance on both owned and leased chassis to a much smaller, still mixed but significantly reduced footprint. The drastic reduction in total chassis units indicates a strategic shift in how the company manages this asset class.",
      "llm_answer": "In 2023 Union Pacific reported a chassis fleet of 48,340 units – 30,635 owned and 17,705 leased【UNP_10k_2023.pdf page_19】. By the end of 2024 the fleet had contracted to 5,553 chassis, of which 4,356 were owned and 1,197 leased【UNP_10k_2024.pdf page_19】, so total chassis fell sharply and the owned‑to‑leased mix shifted toward a higher share of owned units.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values are correct: 2023 totals (30,635 owned + 17,705 leased = 48,340) and 2024 totals (4,356 owned + 1,197 leased = 5,553) match the original answer exactly. Number formats and breakdowns are precise. (2) Quantitative accuracy is perfect—no calculation errors, and the sharp reduction from 48,340 to 5,553 units is correctly noted. (3) The reasoning is sound: the LLM identifies the significant contraction and correctly observes a shift toward a higher proportion of owned units (from ~63% owned in 2023 to ~78% in 2024), which is a valid qualitative insight. (4) The answer addresses both parts of the question—total units and ownership structure—across 2023 and 2024, demonstrating proper multi-hop synthesis between the two years and ownership types. The only minor limitation is that it doesn't explicitly characterize the change as a 'strategic shift' or 'transformation' as in the original, slightly reducing qualitative depth. However, the factual and contextual core is fully preserved. Citations to the 10-Ks add credibility. Semantic equivalence is strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 326,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Boeing's treatment and disclosure of aluminum agreements evolved between 2022 and 2024, particularly in terms of their classification as derivatives and the time horizon for these agreements?",
      "original_answer": "In 2022, Boeing disclosed that its aluminum agreements were classified as derivatives but were not designated for hedge accounting treatment, with changes in fair value recorded in earnings immediately. The agreements were described in the context of long-term strategic sourcing objectives and non-U.S. business requirements. By 2024, the disclosure evolved to indicate that these aluminum agreements were now part of a broader set of commodity contracts hedging forecasted transactions through 2028. This represents a shift from purely strategic sourcing to a more structured hedging strategy with a defined time horizon extending to 2028.",
      "llm_answer": "In the 2022 Form 10‑K Boeing said that its purchase‑ and sale‑agreements for aluminum “are derivatives for accounting purposes but are not designated for hedge accounting” and that the fair‑value changes are taken to earnings immediately, describing them only as supporting “long‑term strategic sourcing objectives” (see 2022 p. 80). By the 2024 filing the company still classifies the aluminum contracts as derivative instruments that do not receive hedge‑accounting treatment, but now discloses that its commodity contracts – including the aluminum agreements – are used to hedge forecasted transactions “through 2028,” giving a specific multi‑year horizon (see 2024 p. 111).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: in 2022, Boeing classified aluminum agreements as derivatives not designated for hedge accounting, with fair value changes recorded in earnings, tied to strategic sourcing (cited p.80). By 2024, these agreements were included in commodity contracts hedging forecasted transactions through 2028 (cited p.111). (2) Quantitative accuracy is perfect: the time horizon 'through 2028' is correctly reported, and no numerical errors exist. Format and citation details (page numbers) are accurately preserved. (3) The multi-hop reasoning is sound—correctly identifying the evolution in classification (still derivatives without hedge accounting) and the new strategic context (hedging through 2028). The only minor omission is that the 2024 disclosure frames aluminum agreements as part of a broader set of commodity hedges, which the LLM mentions but could have emphasized more clearly. (4) The answer is fully relevant, directly addressing the evolution in classification and time horizon. Wording differs slightly but maintains semantic equivalence. No factual inaccuracies. A score of 9 is justified due to slightly less emphasis on the 'broader set of commodity contracts' context in 2024, but core information is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 367,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Procter & Gamble's exposure to currency rate risk evolved between the fiscal years ended June 30, 2023 and June 30, 2024, particularly in terms of its hedging instruments and confidence in mitigating near-term exchange rate fluctuations?",
      "original_answer": "Procter & Gamble's exposure to currency rate risk remained materially unchanged between the fiscal years ended June 30, 2023 and June 30, 2024. The company continued to use forward contracts and currency swaps with maturities of less than 18 months to manage exchange rate risk. Additionally, P&G maintained its assessment that, at a 95% confidence level based on historical currency rate movements, the impact of a near-term change in currency rates would not materially affect its financial statements in either reporting period.",
      "llm_answer": "Procter & Gamble’s currency‑rate risk profile was essentially unchanged from FY 2023 to FY 2024.  The company still relies on its natural‑hedge plus short‑term forward contracts and currency swaps (generally under 18 months) to manage exchange‑rate exposure, and it states that, based on its derivative positions, it is 95 % confident that a near‑term change in currency rates would not materially affect its financial statements in either year【page_31】.  Moreover, the 2024 filing notes that its market‑risk exposures “have not changed materially versus the previous reporting period,” confirming that the exposure and hedging approach remained consistent with FY 2023【page_31】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Procter & Gamble's currency risk exposure remained materially unchanged between FY2023 and FY2024; the company continues to use forward contracts and currency swaps with maturities under 18 months; and it maintains a 95% confidence level that near-term exchange rate fluctuations will not materially affect financial statements. (2) Quantitative elements—specifically the 95% confidence level and the less-than-18-month maturity of hedging instruments—are accurately reported with no calculation issues. (3) The multi-hop reasoning is sound: the answer synthesizes information across both fiscal years, confirms consistency in hedging instruments, and correctly references the unchanged nature of market-risk exposures as stated in the 2024 filing. (4) The inclusion of a citation (page_31) adds contextual support, and the slight rewording (e.g., 'natural-hedge plus short-term forward contracts') does not alter the factual meaning. All aspects of the question—evolution of risk, hedging instruments, and confidence in mitigation—are fully and correctly addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 332,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How has Adobe's positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its functional scope and integration with other Adobe products?",
      "original_answer": "In 2022, Frame.io was listed among Adobe's trademarks, indicating it was an established product within Adobe's portfolio but with no detailed description of its functionality or integration. By 2024, Frame.io was actively described as a 'cloud-native creative collaboration platform' with expanded capabilities such as real-time upload, review and approval, frame-accurate commenting, and Camera to Cloud functionality. It was also integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and positioned as part of Adobe GenStudio for large-scale content production. This reflects a significant evolution from a trademarked asset to a core collaborative tool deeply embedded in Adobe's creative workflow.",
      "llm_answer": "In Adobe’s 2022 Form 10‑K (see the sections on pages 95‑99) Frame.io is not mentioned, indicating it was not presented as a core Adobe offering at that time. By the 2024 Form 10‑K (page 12), Adobe describes Frame.io as a cloud‑native creative‑collaboration platform that supports real‑time upload, review, frame‑accurate commenting, “Camera‑to‑Cloud” ingest and even casting, location‑scouting and marketing‑campaign workflows, and is directly integrated with Premiere Pro, After Effects, Photoshop, Lightroom, Workfront and offered through GenStudio—showing a much broader functional scope and deep integration across Adobe’s suite.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Frame.io was not mentioned in Adobe's 2022 Form 10-K (consistent with being only a trademark at that time in the original answer), and by 2024 is described as a 'cloud-native creative collaboration platform' with expanded functionality—this matches the evolution described in the original answer. The functional capabilities listed—real-time upload, review, frame-accurate commenting, Camera-to-Cloud—are all correct and consistent. (2) There are no numeric values, dates, or financial figures in dispute; all references to years (2022, 2024) and document types (Form 10-K) are accurate. (3) The multi-hop reasoning is sound: the model infers from absence in 2022 to deeper integration in 2024, correctly synthesizing changes in positioning and integration over time. It accurately notes integration with Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, and inclusion in GenStudio—matching all entities in the ground truth. (4) The only minor deviation is that the LLM adds 'casting, location-scouting and marketing-campaign workflows' not explicitly mentioned in the original answer; however, these are plausible extensions of Frame.io’s functionality and do not contradict the core facts. This slight over-specification prevents a perfect 10 but does not undermine correctness. Overall, the answer is factually sound, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 405,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between the 2022 and 2023 fiscal years, particularly in terms of the carrying value of its investment and the nature of its financial disclosures?",
      "original_answer": "In the 2022 filing, AMD disclosed that the carrying value of its investment in the ATMP JV was $69 million as of December 25, 2021, and $63 million as of December 26, 2020. Additionally, AMD provided detailed figures regarding purchases from and resales to the ATMP JV, including purchases of $1.1 billion in 2021 and $831 million in 2020. In contrast, the 2023 filing omits any mention of the carrying value of the investment and specific transaction figures, only reiterating the structural details of the relationship, such as AMD's 15% equity interest and the accounting method used. This indicates a reduction in the level of financial disclosure regarding the ATMP JV, even though the nature of the relationship and AMD's equity stake remained unchanged.",
      "llm_answer": "AMD’s 15 % equity interest in the ATMP joint venture is still accounted for under the equity method with no obligation to fund the JV 【page_77】.  The carrying amount of the investment grew from about **$83 million at the end of FY 2022** to roughly **$99 million at the end of FY 2023** 【page_78】, and the 2023 filing adds more granular disclosures – $1.7 billion of purchases each year, payables of $363 million (down from $463 million), receivables of $9 million (up from $2 million), and larger equity‑income gains ($16 million in 2023 vs $14 million in 2022) 【page_78】, reflecting a deeper financial interaction with the JV.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and contradicts the ground truth in multiple critical aspects. (1) Quantitative Accuracy: The LLM claims the carrying value increased from $83 million at the end of FY 2022 to $99 million at the end of FY 2023. However, the ground truth states that the disclosed carrying values were $69 million as of December 25, 2021 (end of FY 2021), and $63 million as of December 26, 2020 — with no updated carrying value provided in the 2023 filing. Thus, the LLM fabricates numbers not present in the source and misrepresents the timeline. Additionally, the LLM claims $1.7 billion in purchases each year, but the ground truth reports $1.1 billion in 2021 and $831 million in 2020 — values not repeated in the 2023 filing. The receivables, payables, and equity income figures cited by the LLM are also not corroborated by the ground truth and appear invented. (2) Completeness: While the LLM attempts to address the evolution of the financial relationship, it fails to note the key point — that the 2023 filing omitted detailed disclosures about carrying value and transaction amounts, which is the central change. Instead, it falsely claims more granular disclosures were added. (3) Entity Accuracy: The reference to AMD’s 15% equity interest and equity method accounting aligns with the ground truth and is correct. However, all financial figures and trends are wrong. (4) Reasoning: The LLM’s conclusion — that there is deeper financial interaction and increased transparency — is the opposite of the truth, which is a reduction in disclosure. This indicates a complete failure in multi-hop reasoning and synthesis. (5) Semantic Equivalence: The answer conveys the opposite meaning of the original, despite using similar terminology. The contextual relevance is moderate because it addresses the right topic (AMD-ATMP JV), but factual accuracy is severely lacking.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 511,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did Honeywell's revenue from Commercial Aviation Original Equipment evolve between 2023 and 2024, and what does this indicate about its position in the aerospace sector?",
      "original_answer": "Honeywell's revenue from Commercial Aviation Original Equipment decreased from $2,397 million in 2023 to $2,223 million in 2024. This decline suggests a contraction in this segment despite overall growth in the Aerospace Technologies division, indicating a potential weakening in original equipment demand or supply constraints in this specific product line.",
      "llm_answer": "Honeywell’s Commercial Aviation Original Equipment revenue slipped from **$2.397 billion in 2023 to $2.223 billion in 2024** – a decline of roughly $174 million (about 7 %)【page_68】.  While the drop signals a modest slowdown in new‑equipment sales, the still‑large dollar amount shows Honeywell remains a major OEM supplier and retains a solid foothold in the aerospace market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the revenue figures for Honeywell's Commercial Aviation Original Equipment: $2.397 billion in 2023 and $2.223 billion in 2024, matching the ground truth of $2,397 million and $2,223 million. The format variation (billion vs million) is acceptable and numerically equivalent. The calculated decline of $174 million (approximately 7%) is accurate: 2,397 - 2,223 = 174; (174 / 2,397) ≈ 7.26%, which rounds to about 7%, so the percentage is reasonably stated. (2) The answer addresses both parts of the question: it describes the revenue evolution (decline from 2023 to 2024) and interprets what this indicates about Honeywell’s position in the aerospace sector. (3) Entity accuracy is correct: Honeywell, Commercial Aviation Original Equipment, and the years 2023 and 2024 are all properly identified. (4) The reasoning is mostly sound. The LLM correctly infers a slowdown in new-equipment sales, which aligns with the ground truth’s suggestion of weakening demand or supply constraints. However, the ground truth adds context about overall growth in the Aerospace Technologies division, which the LLM omits. This missing nuance slightly weakens the qualitative analysis, as it doesn't acknowledge that the decline occurred despite broader divisional growth, which strengthens the implication of segment-specific issues. The LLM’s conclusion that Honeywell remains a major supplier is reasonable but slightly less critical than the ground truth’s emphasis on potential weakening. Overall, the answer is factually correct and contextually relevant, with only a minor omission in qualitative depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 447,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How did the global revenue contribution from Heart Failure Devices evolve between 2023 and 2024, and what was the percentage change in this segment's total revenue?",
      "original_answer": "In 2023, the global revenue from Heart Failure Devices was $1,161 million, while in 2024, this figure increased to $1,279 million. This represents a 10.2% increase in total revenue for the Heart Failure Devices segment. The growth was consistent across both U.S. and international markets, with minimal impact from exchange rate fluctuations, indicating strong underlying demand and market expansion.",
      "llm_answer": "The Heart Failure Devices segment produced **$1.161 billion in 2023** and **$1.279 billion in 2024**, an increase of roughly $118 million. This growth corresponds to a **10.2 % rise in total revenue** (10.3 % when foreign‑exchange effects are excluded)【page_30†L31-L34】【page_29†L31-L34】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the global revenue for Heart Failure Devices as $1.161 billion in 2023 and $1.279 billion in 2024, which matches the ground truth ($1,161 million and $1,279 million). The percentage increase is accurately calculated as 10.2%, aligning with the ground truth. The minor discrepancy of mentioning '10.3% when foreign-exchange effects are excluded' is additional context not contradicted by the original answer, which notes minimal impact from exchange rate fluctuations. (2) All numeric values are correct and consistent across formats (billion vs million). The $118 million increase is accurate: $1,279M - $1,161M = $118M. The 10.2% growth is correctly computed: (118 / 1161) ≈ 0.1016 ≈ 10.2%. (3) The multi-hop reasoning is sound—revenue figures across two years are correctly compared and synthesized into a percentage change. The LLM adds minor supplemental detail (FX exclusion) but does not misrepresent the core facts. (4) The answer is fully contextually relevant, addressing both parts of the question: evolution of revenue and percentage change. The only reason for not scoring a 10 is the slight introduction of an unverified figure (10.3% ex-FX), which, while plausible and consistent, was not in the original truth statement. Otherwise, all key facts, calculations, and entities are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 376,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How has IBM's treatment of the 0.300% Notes due 2028 evolved between the 2022 and 2023 filings?",
      "original_answer": "In the 2022 filing, the 0.300% Notes due 2028 were referenced as part of a list of debt instruments, with their rights defined in Exhibit 4.1 to Form 8-K filed February 10, 2020, and incorporated by reference. By 2023, the 0.300% Notes due 2028 were formally listed in the table of registered securities with a specific trading symbol (IBM 28B) and explicitly called out as a distinct class of notes registered on the New York Stock Exchange. This reflects a shift from general incorporation by reference to explicit disclosure and formal registration.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the 0.300 % Notes due 2028 are not mentioned in the excerpted sections (pages 28‑32 contain no reference to that security), whereas the 2023 Form 10‑K lists the “0.300 % Notes due 2028” (IBM 28B) among the securities registered under Section 12(b) 【page 1】. Thus, between the two filings IBM went from omitting a separate disclosure of the 2028 note to formally registering and listing it as a distinct security.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key evolution: in 2022, the 0.300% Notes due 2028 were not explicitly detailed in the excerpted sections and were incorporated by reference via Exhibit 4.1 to the February 10, 2020 Form 8-K, while in 2023 they were formally listed with trading symbol IBM 28B on the NYSE under Section 12(b). The percentage (0.300%), year (2028), and symbol (IBM 28B) are all accurate. (2) Quantitative accuracy is perfect: the interest rate (0.300%), maturity year (2028), and trading symbol (IBM 28B) match the ground truth. No calculations are required. (3) The reasoning is mostly sound but omits a key nuance: the ground truth notes that in 2022 the notes were referenced as part of a list of debt instruments via incorporation by reference, whereas the LLM states they were 'not mentioned' in the 2022 10-K, which is too strong and factually imprecise—they were referenced indirectly. This mischaracterization affects the qualitative accuracy. (4) Despite this, the LLM captures the core shift from omission in the main disclosure to explicit registration and listing, which is the central point. Contextual relevance is excellent as it directly addresses the evolution between filings. Correctness is docked to 7 due to the overstatement about absence in 2022, though the overall conclusion about increased formalization is valid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 381,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How has Apple's financial performance in the Rest of Asia Pacific region evolved from 2022 to 2023, based on changes in net sales and operating income?",
      "original_answer": "In 2022, Apple's Rest of Asia Pacific segment reported net sales of $29,375 million and operating income of $11,569 million. In 2023, these figures increased to $29,615 million in net sales and $12,066 million in operating income. This represents a moderate growth in both metrics, with net sales rising by $240 million (0.8%) and operating income increasing by $497 million (4.3%).",
      "llm_answer": "In the Rest of Asia Pacific segment, Apple’s net sales rose modestly from $29.375 billion in 2022 to $29.615 billion in 2023, while operating income increased more sharply from $11.569 billion to $12.066 billion over the same period (page 50). This reflects a slight uptick in sales and a stronger gain in profitability for the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures from the ground truth: net sales of $29,375 million (presented as $29.375 billion) in 2022 and $29,615 million ($29.615 billion) in 2023, and operating income of $11,569 million ($11.569 billion) in 2022 rising to $12,066 million ($12.066 billion) in 2023. These are numerically equivalent, with acceptable formatting variation (billions vs millions). (2) While the LLM does not explicitly state the absolute or percentage changes ($240 million and 0.8% for sales; $497 million and 4.3% for operating income), it accurately describes the trend — 'modestly' for sales and 'more sharply' for operating income — which aligns with the ground truth's characterization of 'moderate growth' and the stronger relative increase in operating income. The omission of exact change values is a minor completeness gap but does not undermine factual correctness. (3) The multi-hop reasoning is sound: the model correctly synthesizes year-over-year performance across two financial metrics (net sales and operating income) for the 'Rest of Asia Pacific' region, correctly attributing the data to Apple and the relevant time period. (4) The answer is contextually relevant and semantically equivalent to the ground truth in conveying the evolution of Apple's financial performance in the region. The reference to 'page 50' suggests proper sourcing from a 10-K filing. The qualitative accuracy is slightly reduced due to the lack of explicit change calculations, but the overall interpretation remains accurate. Thus, the answer is highly correct with only minor omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1180,
        "completion_tokens": 446,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How has the vesting period for stock options issued under the 2007 Omnibus Incentive Plan evolved between grants made prior to 2022 and those made after December 31, 2021, based on disclosures in the 2022 and 2024 10-K filings?",
      "original_answer": "In the 2022 10-K filing, stock options granted prior to 2022 under the 2007 Omnibus Incentive Plan generally vested pro rata over a five-year period, while those granted after December 31, 2021, under the amended and restated plan, generally vested pro rata over a four-year period. The 2024 10-K confirms that stock options granted prior to 2022 continued to vest pro rata over a five-year period, and those granted after December 31, 2021, also continued to vest pro rata over a four-year period. This indicates a consistent reduction in the vesting period from five to four years for post-2021 grants, showing a structural change in the incentive plan's vesting terms over time.",
      "llm_answer": "The company’s 2007 Omnibus Incentive Plan originally provided that stock‑option awards granted before 2022 vest pro‑rata over a **five‑year** period (with a ten‑year expiration) 【page_116】.  After the plan was amended, options granted **after December 31 2021** now vest pro‑rata over a **four‑year** period (still terminating ten years from the grant date) 【page_96】.  Thus, the standard vesting schedule was shortened by one year for post‑2021 grants.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns with the ground truth in all key aspects. (1) Quantitative accuracy: The vesting periods (five-year for pre-2022 grants, four-year for post-December 31, 2021 grants) and the ten-year expiration are accurately reported. Dates and time periods match the original answer. (2) Completeness: The answer addresses the evolution of vesting periods between pre- and post-2021 grants, citing the change from five to four years. While it does not explicitly mention the 2024 10-K confirmation (as in the original answer), this is a minor omission since the core evolution is correctly described using the 2022 filing and the amendment. (3) Entity accuracy: The 2007 Omnibus Incentive Plan, correct time boundary (after December 31, 2021), and vesting terms are all correctly identified. (4) Reasoning: The multi-hop synthesis between plan amendment and vesting change is sound and logically presented. The conclusion that the vesting schedule was shortened by one year is accurate. (5) Semantic equivalence: The LLM conveys the same essential information as the ground truth, though slightly less detailed regarding the 2024 confirmation. This does not detract from the correctness of the core claim. The answer is concise, relevant, and factually precise, warranting a high score with only a slight deduction for incomplete temporal confirmation across both filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 387,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How has CVS's approach to validating the fair value estimates for its Level 2 debt securities evolved from 2022 to 2023, particularly in terms of price adjustments and secondary source comparisons?",
      "original_answer": "In 2022, CVS obtained one price for each of its Level 2 debt securities and did not adjust any of those prices at December 31, 2021 or 2020. The company compared selected sample prices quarterly to secondary sources and reviewed variances over a specified threshold. In 2023, the company maintained the same validation methodology, obtaining one price per Level 2 debt security without any adjustments at December 31, 2023 or 2022, and continued to compare prices quarterly to secondary sources. Despite maintaining the same process, the emphasis on consistent internal validation by the investment team appears to have remained stable, indicating a sustained but unchanging approach to fair value estimation.",
      "llm_answer": "CVS used the same validation routine in both years. For 2022 and again in 2023 the company obtained one price for each Level 2 debt security, made **no year‑end price adjustments**, and each quarter **sampled those prices against a secondary source**, reviewing any variance that exceeded a set threshold and also comparing them with the internal investment team’s independent fair‑value estimates. The 2023 filing explicitly notes that no adjustments were made at December 31, 2023 (or 2022) and that the secondary‑source comparison process remained unchanged from the prior year【page_153】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CVS obtained one price per Level 2 debt security in both 2022 and 2023, made no price adjustments at year-end (specifically noted for December 31, 2023, 2022, 2021, and 2020), and continued quarterly comparisons to secondary sources with threshold-based variance reviews. The mention of internal investment team validation is consistent with the original answer’s emphasis on stable internal validation processes. (2) Quantitative accuracy is perfect: all dates and methodological details (e.g., no adjustments, quarterly sampling, threshold review) are correctly reported. Format variations (e.g., 'no year-end price adjustments') are semantically equivalent. (3) Multi-hop reasoning is sound—LLM correctly synthesizes that the process remained unchanged across years and correctly infers continuity in methodology, even noting the explicit confirmation in the 2023 filing. (4) The only minor shortcoming is that the original answer highlights the *lack of evolution* in the approach as the central point, while the LLM focuses on process consistency without explicitly stating that there was no evolution—though this is implied. This slight nuance in emphasis prevents a perfect 10, but overall the answer is factually complete, contextually relevant, and semantically equivalent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 383,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How did CVS's classification and valuation methodology for privately-placed equity securities evolve between 2022 and 2023, particularly in terms of fair value determination and unobservable inputs?",
      "original_answer": "CVS maintained a consistent classification of privately-placed equity securities as Level 3 in both 2022 and 2023, indicating no active market for these securities. However, the company emphasized in both years that it uses an internal analysis of financial statements and cash flow projections to determine fair value. In 2022, the significant unobservable inputs included earnings and revenue multiples, discount for lack of marketability, and comparability adjustments. In 2023, the same unobservable inputs were referenced, but with an added emphasis on the potential impact of changes in these inputs on fair value measurements, suggesting a more detailed sensitivity analysis or increased scrutiny of these inputs in the valuation process.",
      "llm_answer": "CVS treated privately‑placed equity securities the same way in both years – they were classified in **Level 3** because no active market exists, and their fair value was derived from an **internal analysis of the investment’s financial statements and cash‑flow projections**.  The valuation relied on **unobservable inputs** such as earnings and revenue multiples, a discount for lack of marketability and comparability adjustments, and this approach was unchanged from 2022 (page 148) to 2023 (page 153).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that CVS classified privately-placed equity securities as Level 3 in both 2022 and 2023, and accurately describes the use of internal financial statement and cash flow analyses for fair value determination. The unobservable inputs—earnings and revenue multiples, discount for lack of marketability, and comparability adjustments—are correctly listed and noted as consistent across both years. Entity accuracy, years, and financial terminology are all correct, and the response is contextually relevant. However, the LLM omits a key qualitative evolution mentioned in the ground truth: in 2023, CVS placed added emphasis on the sensitivity of fair value to changes in unobservable inputs, indicating enhanced scrutiny or more detailed sensitivity analysis. This nuance is important to the question’s focus on 'evolution' in methodology. While the core facts and inputs are accurately reported, the failure to note this shift in emphasis results in a partial loss of qualitative accuracy. There are no quantitative inaccuracies, and the reasoning is sound but incomplete in capturing the full multi-hop comparison across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 326,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How did the total net revenue from Alphagan/Combigan change between 2023 and 2024, and what was the trend in its international revenue during this period?",
      "original_answer": "The total net revenue from Alphagan/Combigan decreased from $272 million in 2023 to $248 million in 2024, reflecting an 8.8% decline. During the same period, its international revenue slightly increased from $151 million in 2023 to $153 million in 2024, representing a 1.5% growth.",
      "llm_answer": "The total net revenue for Alphagan/Combigan fell from $272 million in 2023 to $248 million in 2024 – a decline of about $24 million (roughly an 8‑9% drop)【page_43】.  In contrast, the international portion rose modestly, from $151 million in 2023 to $153 million in 2024, showing a slight increase in overseas sales【page_43】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key numerical values: total net revenue decreased from $272 million in 2023 to $248 million in 2024, and international revenue increased from $151 million to $153 million. These match the ground truth exactly. (2) The calculation of the decline ($24 million) is accurate, and the approximate percentage drop of '8–9%' aligns with the ground truth 8.8%. The international growth of $2 million corresponds to a 1.5% increase, which the LLM acknowledges as a 'slight increase' though it does not explicitly state the percentage—this minor omission prevents a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes trends in total vs. international revenue across two years for the same product line, addressing both parts of the question. (4) The answer is contextually complete and relevant, with appropriate emphasis on the contrast between declining total revenue and rising international sales. The only minor shortcoming is the lack of explicit mention of the 1.5% international growth rate, but the trend is correctly characterized as modest. Overall, the answer is factually precise and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 344,
        "total_tokens": 1497
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Chevron's relationship with PDC Energy evolved from 2023 to 2024, and what specific operational impact did this change have on Chevron's overall production performance?",
      "original_answer": "In 2023, Chevron acquired PDC Energy, Inc. (PDC), and as a result, PDC was excluded from Chevron's internal control assessment over financial reporting due to the timing of the acquisition. By 2024, Chevron's relationship with PDC had evolved from a newly acquired entity to an integral operational component, as evidenced by the 7% increase in Chevron's worldwide oil-equivalent production, which was attributed in part to the full-year contribution from legacy PDC operations. This indicates that PDC Energy transitioned from being a recent acquisition in 2023 to a key contributor to Chevron's production growth in 2024.",
      "llm_answer": "In 2023 Chevron completed a business‑combination acquisition of PDC Energy, turning the company into a wholly‑owned subsidiary (it was even excluded from internal‑control testing that year)【page_30】. By 2024 PDC’s assets were fully integrated into Chevron’s operations, and the “full‑year of legacy PDC Energy production” helped lift Chevron’s worldwide oil‑equivalent output about 7 % to roughly 3.3 million barrels per day【page_9】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Chevron acquired PDC Energy in 2023 and that PDC was excluded from internal control assessment, matching the ground truth. It accurately states that by 2024, PDC's full-year contribution led to a 7% increase in Chevron's worldwide oil-equivalent production. The mention of 'roughly 3.3 million barrels per day' is consistent with typical reporting around Chevron's production levels, though the exact baseline isn't in the ground truth—this is a reasonable inference and not contradictory. (2) Quantitatively, all key figures are correct: the 7% production increase and the 2023 acquisition timing are accurate. The reference to exclusion from internal control testing aligns with the original answer. The addition of '3.3 million barrels per day' is not in the ground truth but does not conflict with it and adds context without introducing error. (3) The multi-hop reasoning is sound: the model connects the 2023 acquisition to 2024 operational integration and correctly attributes part of the production growth to PDC’s legacy operations. It synthesizes information across time and operational impact logically. (4) The answer is contextually fully relevant, addressing both the evolution of the relationship and the operational impact on production. The only minor gap is that it doesn't explicitly state PDC transitioned from 'recent acquisition' to 'integral component' in conceptual terms, but this is implied operationally. Thus, the answer is factually excellent with only slight room for conceptual completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 433,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has UPS's investment in cold-chain logistics capabilities evolved from 2023 to 2024, and what specific acquisitions contributed to this change?",
      "original_answer": "In 2023, UPS expanded its cold-chain logistics capabilities through the acquisition of Bomi Group and MNX Global Logistics, aiming to enhance its healthcare logistics services. By 2024, this strategic focus intensified with the acquisition of Frigo-Trans and Biotech & Pharma Logistics in Germany for approximately $440 million, signaling a significant increase in international investment in complex cold-chain logistics. This represents a shift from general expansion to targeted, high-value international acquisitions in the cold-chain sector.",
      "llm_answer": "UPS expanded its cold‑chain logistics capability in 2023 by buying MNX Global Logistics—a global, time‑critical, temperature‑sensitive logistics provider—and by leveraging its earlier Bomi Group purchase, as described in the Supply‑Chain Solutions overview (see page 6). In 2024 the company’s investment shifted to integrating those assets, with goodwill reflecting the 2024 completion of purchase‑accounting for the 2023 MNX Global Logistics acquisition (see page 101), and no additional cold‑chain‑specific acquisitions were announced for 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) It correctly identifies the 2023 acquisitions of MNX Global Logistics and Bomi Group, which aligns with the original answer. However, it falsely claims that no additional cold-chain-specific acquisitions were made in 2024, directly contradicting the ground truth that UPS acquired Frigo-Trans and Biotech & Pharma Logistics in Germany in 2024 for approximately $440 million. (2) The quantitative accuracy is low because the $440 million figure is entirely omitted, and the mention of 'goodwill' and 'purchase-accounting' from page 101 appears to misinterpret financial reporting timing as evidence of no new acquisitions, which is not supported by the ground truth. There are no correct numerical values related to 2024 in the LLM answer. (3) The reasoning is flawed: instead of recognizing the 2024 acquisitions as a continuation and intensification of UPS's cold-chain strategy, the model incorrectly infers that integration of prior acquisitions means no new investments occurred. This fails the multi-hop requirement to connect 2023 and 2024 strategic moves and misrepresents the evolution of investment. (4) While the answer is relevant to UPS's cold-chain logistics and addresses the time frame, it provides an inaccurate narrative of strategic shift, missing the key 2024 acquisitions and the increased international focus. Thus, despite some correct entity mentions in the 2023 context, the core of the answer—how investment evolved into 2024—is factually wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 422,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Linde plc's non-employee director restricted stock unit award program evolved between 2022 and 2024, particularly in terms of governance structure and long-term shareholder alignment mechanisms?",
      "original_answer": "In 2022, Linde plc introduced the Non-Employee Director Restricted Stock Unit Award under the 2021 Linde plc Long Term Incentive Plan, establishing a framework for equity-based compensation tied to long-term performance metrics. This initiative was part of a broader suite of incentive programs aimed at aligning director interests with those of shareholders. By 2024, the company expanded this framework by introducing the Linde plc Non-employee Director Deferral Program, adopted by the Board of Directors on July 30, 2024. This deferral program enhances governance by allowing directors to defer receipt of stock units, thereby reinforcing long-term alignment with shareholder value creation. The evolution from a basic restricted stock unit award to a more sophisticated deferral mechanism indicates Linde’s strategic emphasis on strengthening board accountability and promoting sustained corporate governance standards.",
      "llm_answer": "In the 2022 Form 10‑K the company’s non‑employee‑director RSU awards were simply granted under the 2021 Long‑Term Incentive Plan (exhibit 10.0e) and, historically, under the 2009 Praxair LTIP (exhibit 10.11h) 【page_105】【page_107】. By the 2024 filing Linde had added a dedicated Non‑Employee Director Deferral Program (adopted by the Board on July 30 2024, exhibit 10.16) and amended both the Linde Compensation Deferral Programme (effective 1 Jan 2024, exhibit 10.08b) and the 2009 LTIP (effective 29 Jan 2024, exhibit 10.10c), thereby creating a formal deferral mechanism and enhanced Board/Compensation‑Committee oversight that more tightly ties director equity compensation to long‑term shareholder value 【page_94】【page_95】【page_96】. This evolution moves the program from a straightforward RSU grant to a structured governance framework with deferred vesting and performance‑linked features designed to align directors’ interests with shareholders over the long term.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Linde used the 2021 Long-Term Incentive Plan for non-employee director RSU awards, and by 2024, it introduced the Non-Employee Director Deferral Program, adopted on July 30, 2024. The mention of amendments to the Linde Compensation Deferral Programme (effective Jan 1, 2024) and the 2009 LTIP (effective Jan 29, 2024) adds detail not in the original answer but does not contradict it and reflects deeper document support. (2) Quantitative accuracy is perfect: dates (July 30, 2024; Jan 1, 2024; Jan 29, 2024) are correctly cited, and no numerical errors exist. Format variations (e.g., 'exhibit 10.16') are properly used and consistent with SEC filing references. (3) Multi-hop reasoning is sound: the LLM synthesizes information across years (2022 to 2024), programs (LTIP, deferral program), and governance mechanisms, correctly inferring that the evolution reflects stronger alignment with shareholder value and enhanced oversight. (4) The only minor shortcoming is that the original answer emphasizes 'long-term performance metrics' in 2022, while the LLM answer does not explicitly confirm performance-linking in the initial RSU structure—though it correctly notes such features in the 2024 enhancements. This slight omission prevents a perfect 10 but does not undermine the overall correctness. Semantic equivalence is maintained, and contextual relevance is excellent, with direct citation of exhibits and pages enhancing credibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 425,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did General Motors' financial and legal relationship with Stellantis evolve between 2022 and 2024, particularly regarding indemnification obligations and investment gains?",
      "original_answer": "In 2022, General Motors reported a gain of $0.2 billion related to Stellantis N.V. (Stellantis) warrants, indicating a positive financial relationship. However, by 2024, the relationship had evolved into a more complex and potentially costly one. GM had agreed to indemnify Stellantis for certain liabilities tied to pre-sale emissions claims, product liabilities, and recalls related to the 2017 sale of the Opel/Vauxhall business. Additionally, GM faced potential future liabilities from ongoing investigations into Opel’s historical conduct in Europe. Unlike the earlier gains, GM's 2024 disclosures highlighted contingent liabilities and legal risks rather than financial benefits from its relationship with Stellantis.",
      "llm_answer": "In the 2022 filing GM disclosed a $0.2 billion non‑operating gain tied to Stellantis N.V. warrants (see page 36) and noted that it had already entered an indemnification agreement with Stellantis arising from the 2017 Opel/Vauxhall sale, though the liability was not quantified. By the 2024 filing the same indemnification obligations remain in force—subject to caps, thresholds and time‑limits and judged immaterial (page 93‑94)—while the Stellantis‑related warrant gain is no longer highlighted, indicating it has been realized or is no longer material to the 2024 results.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.2 billion gain in 2022 from Stellantis warrants, matching the ground truth in both amount and year. It also accurately notes the indemnification agreement related to the 2017 Opel/Vauxhall sale, which is a key legal relationship element. The 2024 update correctly reflects that indemnification obligations remain but are deemed immaterial with caps and thresholds, aligning with the shift toward contingent liabilities. However, the LLM omits explicit mention of the specific liability categories—pre-sale emissions claims, product liabilities, and recalls—which are central to the evolution of the legal relationship. It also does not mention ongoing investigations into Opel’s historical conduct in Europe, a key risk highlighted in the ground truth. (2) All numeric values ($0.2 billion, years 2022 and 2024) are accurate and correctly attributed. No calculations are required, and the amounts match exactly. Format is consistent and acceptable. (3) The reasoning is sound in connecting the 2022 gain with the continued indemnification into 2024, showing an understanding of the timeline and financial-legal shift. However, the multi-hop synthesis is incomplete—while the indemnification is mentioned, the specific nature and expansion of risks in 2024 are underdeveloped. The conclusion that the warrant gain is no longer highlighted because it is realized or immaterial is reasonable but not explicitly confirmed in the ground truth. (4) The answer is highly relevant and addresses the core of the financial and legal evolution. The omission of specific liability types and investigations prevents a top score, but the overall trajectory from gain to contingent liability is correctly conveyed. Quantitative accuracy is perfect, and contextual relevance is strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 494,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolved from 2022 to 2024, particularly in terms of their financial presentation and categorization?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of energy-related derivatives not designated as hedging instruments on the statements of income for prior years (2021, 2020, and 2019), indicating a focus on income statement impacts. By 2024, the company shifted its disclosure to emphasize the fair value of energy-related derivatives as either assets or liabilities on the balance sheets, specifically categorized under 'Other' or 'Risk Management Activities'. This represents a shift from income-focused reporting to balance sheet-oriented transparency.",
      "llm_answer": "In the 2022 Form 10‑K Southern Company disclosed energy‑related derivatives mainly through their earnings and OCI effects – tables of cash‑flow‑hedge gains/losses and the impact of non‑designated contracts (see 2022 pp. 325‑327). By the 2024 filing the company added a dedicated balance‑sheet schedule that breaks out energy‑related derivatives into “regulatory‑hedge,” “cash‑flow/fair‑value‑hedge,” and “non‑designated” categories, shows current vs. non‑current assets and liabilities, reports gross amounts, offsets and net amounts, and includes a footnote on cash‑collateral (see 2024 pp. 281‑285). This reflects a shift from a simple income‑statement/OCI disclosure to a more granular, categorized presentation of derivative positions on the balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution in Southern Company's derivative disclosures from 2022 to 2024. In 2022, the focus was on income statement effects (earnings and OCI), which matches the ground truth's mention of pre-tax effects on the statements of income for prior years. By 2024, the shift to balance sheet presentation is accurately described, including categorization under regulatory-hedge, cash-flow/fair-value-hedge, and non-designated derivatives, as well as current vs. non-current classification—this goes beyond the ground truth’s summary but adds valid detail. (2) There are no numeric values (e.g., dollar amounts) in either answer, so quantitative accuracy is not compromised; dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes across two filings, correctly inferring a shift in financial presentation from income-focused to balance-sheet-oriented reporting. (4) The LLM provides more granular detail than the original answer (e.g., mention of gross/net amounts, cash collateral, specific footnote pages), which enhances completeness without introducing errors. The only minor gap is that the original emphasizes categorization under 'Other' or 'Risk Management Activities', while the LLM specifies more detailed subcategories—this is a difference in level of detail, not inaccuracy. Overall, the semantic meaning and factual core are preserved and enhanced. Hence, a high score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 438,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did GILD's strategic relationship with Arcus evolve between 2023 and 2024, particularly in terms of equity ownership and governance influence?",
      "original_answer": "In 2023, GILD owned approximately 19.9% of Arcus' issued and outstanding voting stock and had two designees on Arcus' board of directors. In January 2024, GILD made an additional $320 million equity investment in Arcus, increasing its ownership to 33%, and expanded its board representation to three designees. This represents a significant increase in both financial commitment and governance influence over Arcus within a year.",
      "llm_answer": "In 2023 Gilead owned roughly 19.9 % of Arcus’s voting stock and had two Gilead‑appointed directors on Arcus’s board. In January 2024 Gilead announced a $320 million equity investment that lifted its stake to about 33 % and increased its board representation to three designees, giving it a larger ownership position and greater governance influence over Arcus (see page 77).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: GILD's 19.9% ownership in 2023, two board designees, the January 2024 $320 million investment, the increase to 33% ownership, and expansion to three board designees. (2) Quantitative accuracy is perfect: percentages (19.9%, 33%), dollar amount ($320 million), and timing (January 2024) match the original. Format variations (e.g., 'about 33%' vs '33%') are acceptable and do not affect factual correctness. (3) The multi-hop reasoning is sound—information is synthesized across time (2023 to 2024) and domains (equity ownership and governance), correctly showing an evolution in both financial stake and control. (4) The answer addresses both parts of the question: equity ownership and governance influence. Entity names (GILD/Gilead, Arcus) and years are correct. The inclusion of a citation (page 77) adds context without detracting from accuracy. All scoring categories warrant top marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 291,
        "total_tokens": 1491
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maturity date and borrowing capacity of the 2021 Multicurrency Credit Facility evolved between 2022 and 2023?",
      "original_answer": "In 2022, the 2021 Multicurrency Credit Facility had a maximum borrowing capacity of $6.0 billion with a maturity date of June 30, 2025. By 2023, the borrowing capacity remained at $6.0 billion, but the maturity date was extended to July 1, 2026. This reflects a one-year extension of the facility’s term without any increase in the total commitment amount, indicating a strategic move to maintain financial flexibility over a longer horizon.",
      "llm_answer": "In the 2022 Form 10‑K the 2021 Multicurrency Credit Facility was reported with a maturity of June 30 2025 and a total borrowing capacity of $6.0 billion (see page 49, “Amendments to Bank Facilities”). The 2023 Form 10‑K notes a June 29 2023 amendment that pushed the facility’s maturity out to July 1 2026, while leaving the commitment unchanged at $6.0 billion (see page 52). Thus, between 2022 and 2023 the maturity was extended by roughly one year, but the borrowing capacity remained the same.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: the 2022 maturity date is correctly stated as June 30, 2025, and the 2023 update shows the new maturity date of July 1, 2026, which reflects a one-year extension (June 30, 2025 to July 1, 2026 is approximately one year). The borrowing capacity of $6.0 billion is consistently reported for both years, matching the original answer. (2) The answer is complete, addressing both parts of the question—evolution of maturity date and borrowing capacity—between 2022 and 2023. (3) Entity accuracy is correct: the facility name (2021 Multicurrency Credit Facility), time periods (2022 and 2023), and document sources (Form 10-Ks) are properly identified. (4) The reasoning is sound and demonstrates multi-hop synthesis by comparing disclosures across two years’ filings and correctly interpreting the amendment’s impact. The mention of the June 29, 2023 amendment adds contextual precision not in the original answer but consistent with likely source data. (5) Semantic equivalence is strong: though the LLM uses slightly different phrasing (e.g., 'pushed the facility’s maturity out' vs 'extended'), the meaning is identical. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 363,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Chevron's utilization of imported crude oil in U.S. refining operations evolved between 2023 and 2024, and what changes in refinery capacity utilization accompanied this trend?",
      "original_answer": "Chevron's reliance on imported crude oil in U.S. refining operations remained consistent at approximately 60% of refinery inputs in both 2023 and 2024. However, the utilization of U.S. refineries changed: in 2023, crude unit distillation capacity utilization averaged 90.8%, while in 2024 it decreased to 86.6%. This indicates that while the company's dependency on imported crude oil remained stable, the overall operational intensity of its U.S. refineries declined slightly in 2024.",
      "llm_answer": "Chevron’s U.S. refineries continued to rely on imported crude for roughly the same share of feedstock – about 60 percent of total refinery inputs in both 2023 and 2024 【page_17】.  At the same time, refinery utilization slipped: average crude‑unit distillation capacity utilization fell from about 90.8 percent in 2023 to 86.6 percent in 2024 (overall refinery utilization dropped from 89.8 percent to 87.9 percent) 【page_18】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that Chevron's reliance on imported crude oil remained at approximately 60% in both 2023 and 2024, matching the ground truth. It accurately reports the drop in crude unit distillation capacity utilization from 90.8% in 2023 to 86.6% in 2024, which aligns with the original answer. Additionally, it provides extra detail—overall refinery utilization decreasing from 89.8% to 87.9%—that is not in the ground truth but does not contradict it and may reflect additional data from the source document (page 18). (2) All numeric values are factually correct and precisely reported. There are no calculation errors. The formatting of percentages is consistent and accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across years and metrics (imported crude share and capacity utilization), correctly identifying that imported crude dependency remained stable while operational utilization declined. The only minor shortcoming is the addition of a slightly more detailed metric (overall utilization) not present in the ground truth, but this does not detract from accuracy. (4) The answer is fully relevant to the question, addressing both the evolution of imported crude use and accompanying changes in refinery utilization. The slight expansion beyond the original answer enhances completeness without introducing error. Thus, the answer is highly accurate, with only a minor deviation in scope (additional metric), warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 426,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did UPS's hedging position in British Pound Sterling evolve between 2023 and 2024, and what does this shift indicate about the company's currency risk management strategy?",
      "original_answer": "In 2023, UPS reported a British Pound Sterling (GBP) hedge position of 663 million units, which decreased to 536 million units in 2024. This represents a reduction of 127 million units, or approximately 19.15%. The decrease indicates a strategic move to reduce exposure to GBP, suggesting that UPS may have reassessed its currency risk related to the British Pound and opted for a more conservative hedging approach or a lower anticipated risk in that currency during the later year.",
      "llm_answer": "UPS’s GBP‑denominated hedge shrank from a notional $663 million at 12/31/2023 to $536 million at 12/31/2024 – a drop of roughly $127 million (about 19%)【page_130】【page_137】.  The reduction signals that UPS is scaling back its exposure to the British pound, likely aligning hedge amounts with revised cash‑flow forecasts and tightening its currency‑risk management to reflect a lower expected GBP impact.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the GBP hedge position was $663 million in 2023 and decreased to $536 million in 2024, a reduction of $127 million. The percentage drop is correctly approximated as 19%, which aligns with the ground truth calculation of 19.15% (127/663 ≈ 0.1915). Minor rounding is acceptable and common in financial reporting. (2) The answer addresses both parts of the question: it describes the evolution of the hedging position (quantitative change) and interprets the strategic implication (reduced exposure, conservative risk management). (3) Entities are correct: UPS, British Pound Sterling (GBP), and the years 2023 and 2024 are properly identified. (4) The reasoning is sound and reflects multi-hop synthesis: the model infers from the reduced hedge notional that UPS is adjusting its currency risk strategy, possibly due to revised cash flow forecasts or lower expected GBP volatility—this interpretation is consistent with and supported by the ground truth. The inclusion of citation markers 【page_130】【page_137】 suggests grounding in source documents. Overall, the answer is factually precise, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 350,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the fair value of money market investments held by Bank of America evolved between 2023 and 2024, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "The fair value of money market investments held by Bank of America increased from $1.2 billion at December 31, 2023, to $1.3 billion at December 31, 2024. This indicates a modest growth in the company's short-term investment holdings, suggesting a slight expansion in liquidity management or short-term capital deployment strategies over the year.",
      "llm_answer": "Bank of America’s money‑market holdings rose from a fair value of **$1.2 billion at 31 Dec 2023** to **$1.3 billion at 31 Dec 2024**【page_113】. The $0.1 billion increase (about 8 %) shows the bank is modestly expanding its short‑term, highly‑liquid assets, underscoring a focus on preserving liquidity and flexibility in its cash‑management strategy.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values $1.2 billion (2023) and $1.3 billion (2024) are accurate, and the $0.1 billion increase is correctly calculated. The 8% growth is a valid approximation (0.1 / 1.2 ≈ 8.33%, rounded to 8% is acceptable). (2) The dates (December 31, 2023, and December 31, 2024) are correctly cited. (3) Entity accuracy is correct: Bank of America is the subject, and 'money market investments' are properly referred to as 'money-market holdings'. (4) The reasoning is sound: the increase indicates a modest expansion in short-term, liquid assets, which aligns with the ground truth's interpretation of enhanced liquidity management or short-term capital deployment. The LLM adds slight elaboration (e.g., 'preserving liquidity and flexibility') that is semantically consistent and contextually appropriate. (5) The answer addresses both parts of the question: the evolution of fair value and its implication for short-term investment strategy. Multi-hop synthesis is accurate, drawing correct inferences from two time points. All criteria are met with high precision and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 329,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the maximum expected volume of natural gas subject to physical supply contracts with sell-back options changed across Southern Company's subsidiaries between 2022 and 2024?",
      "original_answer": "In 2022, the maximum expected volume of natural gas subject to such contracts was 26 million mmBtu for Southern Company as a whole, with individual volumes of 6 million mmBtu for Alabama Power, 8 million mmBtu for Georgia Power, 4 million mmBtu for Mississippi Power, and 8 million mmBtu for Southern Power. By 2024, this volume had decreased to 15 million mmBtu company-wide, with corresponding reductions in each subsidiary's volume: 4 million mmBtu for Alabama Power, 6 million mmBtu for Georgia Power, 2 million mmBtu for Mississippi Power, and 3 million mmBtu for Southern Power. This represents a consistent reduction across all entities.",
      "llm_answer": "The maximum expected volume of natural gas covered by physical supply contracts with sell‑back options fell from 26 million mmBtu in the 2022 filing (6 mmBtu for Alabama Power, 8 mmBtu for Georgia Power, 4 mmBtu for Mississippi Power and 8 mmBtu for Southern Power) to 15 million mmBtu in the 2024 filing (4 mmBtu for Alabama Power, 6 mmBtu for Georgia Power, 2 mmBtu for Mississippi Power and 3 mmBtu for Southern Power) – a drop of 11 million mmBtu overall【page_319】【page_281】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: the total volume decreased from 26 million mmBtu in 2022 to 15 million mmBtu in 2024, with correct subsidiary breakdowns (Alabama Power: 6 → 4, Georgia Power: 8 → 6, Mississippi Power: 4 → 2, Southern Power: 8 → 3 million mmBtu). (2) The calculation of an 11 million mmBtu overall drop is correct (26 - 15 = 11). (3) The multi-hop reasoning is sound—information is correctly synthesized across Southern Company’s subsidiaries and across two time points (2022 and 2024), demonstrating a consistent reduction trend. (4) Entity names, years, and the specific metric (maximum expected volume of natural gas under physical supply contracts with sell-back options) are accurately identified and reported. (5) The answer is semantically equivalent to the original, with slightly more concise phrasing but no loss of meaning. Minor formatting variation (e.g., 'mmBtu' vs 'million mmBtu') does not affect accuracy. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 303,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the integration and application of the Firefly Vector Model evolved across Adobe's product suite between 2023 and 2024?",
      "original_answer": "In 2023, the Firefly Vector Model was integrated into Adobe Express, enabling users to generate custom images and text effects from text prompts in over 100 languages. By 2024, the Firefly Vector Model had expanded its application beyond Adobe Express and was now also integrated into Adobe Illustrator, powering features like Generative Recolor, which allows users to create different color palettes using text prompts and apply them to vector graphics. This represents a significant expansion of the Firefly Vector Model’s functionality and reach within Adobe’s creative tools, moving from a single-app integration to becoming a core AI-driven feature across multiple professional-grade applications.",
      "llm_answer": "In fiscal 2023 Adobe positioned the Firefly Vector Model as a core component of its Firefly generative‑AI family, delivering fully editable vector graphics via text prompts and embedding it natively in Photoshop, Illustrator, Adobe Express, Acrobat and Adobe Stock, while also offering the model through Firefly Services and Custom Models for enterprise customers (page 11; page 12). By fiscal 2024 Adobe reaffirmed that same native integration across Photoshop, Illustrator, Premiere Pro and Express and highlighted expanded enterprise‑focused Firefly Services and Custom Models that let businesses train and use custom vector models for brand‑specific use cases (page 11; page 12).",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. While both mention Adobe Express and Illustrator, the original answer states that Firefly Vector Model was integrated into Adobe Express in 2023 and expanded to Illustrator in 2024. In contrast, the LLM claims full native integration across Photoshop, Illustrator, Adobe Express, Acrobat, and Adobe Stock in fiscal 2023 — which contradicts the ground truth timeline and scope. Additionally, the LLM incorrectly includes Photoshop and Premiere Pro as having Firefly Vector Model integration in both years, which is not supported by the original answer. The mention of 'Generative Recolor' — a key 2024 advancement — is missing entirely. (2) Quantitatively, the years (2023 and 2024) are correctly referenced, and no numerical values (e.g., dollar amounts, percentages) are misstated, so the score is moderate. However, the incorrect attribution of integrations across multiple apps in 2023 constitutes a major factual deviation. (3) The multi-hop reasoning is flawed: the question asks for evolution between 2023 and 2024, requiring accurate before-and-after mapping of product integrations. The LLM fails this by asserting broad integration from the start (2023), leaving little room for meaningful evolution, and omits the key 2024 feature (Generative Recolor in Illustrator). It also introduces Firefly Services and Custom Models for enterprise use, which, while possibly true, are not part of the ground truth and distract from the core product suite evolution. (4) Despite inaccuracies, the response remains contextually relevant — it discusses the right topic (Firefly Vector Model integration across Adobe products) and attempts to show progression — hence a decent relevance score. However, due to major factual and qualitative errors in entity mapping and timeline, the correctness and qualitative accuracy scores are low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 521,
        "total_tokens": 1863
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2023 to 2024, and what implications does this have for the company's HIV business strategy?",
      "original_answer": "In 2023, Biktarvy was a major revenue driver for GILD, generating $11,850 million in total product sales globally, representing a growth from $10,390 million in 2022. By 2024, although Biktarvy remained central to GILD's HIV portfolio, the company highlighted increased risks around its reliance on HIV products, particularly those containing TAF like Biktarvy, due to potential shifts in treatment paradigms and growing generic competition. This indicates that while Biktarvy continued to be a key asset, GILD faced mounting pressure to diversify or innovate within its HIV pipeline to sustain revenue growth.",
      "llm_answer": "In 2023 Biktarvy generated $11.85 billion in sales (U.S., Europe and other markets combined), accounting for roughly two‑thirds of Gilead’s $18.2 billion HIV portfolio and a large share of total revenue 【page_65】. The 2024 filing again stresses that HIV products are a “substantial portion of our revenue” and that any loss of market share would force a scale‑back of operations, underscoring that Biktarvy remains a cornerstone of Gilead’s HIV franchise 【page_18】【page_20】. Consequently, Gilead’s HIV strategy will continue to protect and grow Biktarvy’s market position while pursuing new indications or products to offset competitive and pricing pressures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $11.85 billion sales figure for Biktarvy in 2023 matches the ground truth of $11,850 million (equivalent values, different formatting). The mention of HIV products as a 'substantial portion of revenue' in 2024 is consistent with the original answer's emphasis on continued centrality despite risks. (2) All numbers are correct: $11.85B = $11,850M, and the contextual framing of Biktarvy’s dominance in the HIV portfolio is supported. (3) Qualitatively, the LLM correctly infers that Biktarvy remains a cornerstone and that GILD must protect its position amid competitive pressures, which aligns with the ground truth’s emphasis on risks from generic competition and treatment paradigm shifts. However, the LLM omits explicit mention of TAF-based product risks and the specific growth from 2022 to 2023 ($10,390M → $11,850M), which slightly weakens the multi-hop synthesis. (4) Contextually, the answer fully addresses the evolution from 2023 to 2024 and implications for strategy—highlighting reliance, risk, and strategic response—making it highly relevant. The reasoning is sound, though slightly less detailed than the ground truth on the nature of emerging threats. Overall, minor omissions prevent a perfect 10, but the core facts, numbers, and logic are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 377,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the status and financial structure of the Series 2018-1A Securities evolve between 2022 and 2023, particularly in terms of outstanding principal and interest rate?",
      "original_answer": "In 2022, the Series 2018-1A Securities had an aggregate principal amount of $500.0 million and an interest rate of 3.652%. By 2023, the outstanding principal had slightly decreased to $496.8 million, while the interest rate remained unchanged at 3.652%. This indicates a minor reduction in the principal amount over the year without any modification to the interest rate.",
      "llm_answer": "In the 2022 filing the Series 2018‑1A Securities were described as a $500 million securitization carrying a 3.652 % coupon, with no principal payments required before the anticipated March 2028 repayment date【page_118】. By the 2023 filing the outstanding balance had slipped to $496.8 million (versus $496.1 million a year earlier) but the interest rate remained unchanged at 3.652 %【page_108】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports the $500.0 million principal in 2022 and the $496.8 million outstanding principal in 2023, matching the ground truth exactly. The interest rate of 3.652% is accurately reported as unchanged between years. These values are factually correct and quantitatively precise. (2) All numeric values—$500 million, $496.8 million, and 3.652%—are accurate and consistent with the ground truth. The mention of '$496.1 million a year earlier' refers to the 2022 balance as reported in the 2023 filing (i.e., prior-year figure), which aligns with typical reporting lags and does not contradict the ground truth; it adds context without inaccuracy. (3) The reasoning is sound: the model correctly synthesizes data from two annual filings (2022 and 2023) to show a reduction in principal while holding the interest rate constant. It appropriately infers continuity in the interest rate and tracks principal amortization. The only minor shortcoming is the addition of forward-looking context (March 2028 repayment) not requested in the question, which is relevant but not required. (4) The answer is semantically equivalent to the ground truth, with slightly more detail (e.g., repayment structure), but no factual deviation. Scores reflect high accuracy, with a minor deduction in qualitative accuracy only because the answer introduces a small amount of extraneous detail without affecting correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 396,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did UPS's relationship with Coyote evolve from 2023 to 2024 in terms of financial impact and strategic direction?",
      "original_answer": "In 2023, UPS recorded a $111 million impairment charge related to the Coyote trade name due to declining market conditions and a strategic evaluation of the business. By 2024, this strategic evaluation culminated in the September 2024 divestiture of Coyote, which significantly impacted UPS's Supply Chain Solutions revenue, contributing to a decrease primarily driven by Coyote's exit. This marks a clear evolution from impairment and strategic review in 2023 to full divestiture in 2024.",
      "llm_answer": "In 2023 UPS still owned the Coyote truck‑load brokerage business but, after a market‑driven slowdown, it recorded a $111 million impairment on the Coyote trade name (with $482 million of goodwill still on the books) and began evaluating strategic alternatives for the unit. By 2024 UPS had sold Coyote, recognized a $156 million gain on the divestiture and eliminated the associated operating costs (about $949 million of forward‑ing expenses), signaling a clear strategic shift to exit the Coyote business.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $111 million impairment charge in 2023 related to the Coyote trade name, aligning with the ground truth. However, it introduces several figures not present in the original answer or not verifiable from the provided context: the $482 million of goodwill, the $156 million gain on divestiture, and $949 million in eliminated operating costs (forwarding expenses). These numbers are not mentioned in the ground truth and cannot be confirmed as accurate, representing significant quantitative inaccuracies. (2) The date of the divestiture (September 2024) is missing in the LLM answer, though the 2024 timeframe is correctly noted. The strategic direction — evaluating and then exiting Coyote — is accurately conveyed, showing correct multi-hop reasoning across 2023 and 2024. (3) The reasoning is logically sound in connecting impairment to strategic review to divestiture, and the entities (UPS, Coyote, Supply Chain Solutions implied context) are correct. However, the addition of unverified financial figures undermines factual reliability. (4) The answer is contextually relevant and addresses both financial impact and strategic direction. While the core evolution (impairment to divestiture) is correct, the inclusion of unsupported numbers reduces the correctness score. The qualitative accuracy is moderate due to correct structure and entities, but quantitative accuracy is low due to unverified figures. Hence, overall correctness is partially accurate but compromised by fabrication of specific financials.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 431,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Linde plc's structure of Performance Share Unit Awards evolve between 2022 and 2024, particularly in terms of the performance metrics used for grants beginning in 2019?",
      "original_answer": "In 2022, Linde plc disclosed two forms of Performance Share Unit Awards under the Amended and Restated 2009 Praxair, Inc. Long Term Incentive Plan: one with Return on Capital performance metrics (Exhibit 10.11k) and another with Total Shareholder Return performance metrics (Exhibit 10.11l). By 2024, these same forms of Performance Share Unit Awards remained in place, as evidenced by Exhibits 10.10l and 10.10m, which correspond directly to the 2019 grants with the same performance metrics. This indicates that the company maintained the same dual structure for Performance Share Unit Awards tied to 2019 grants, without introducing new metrics or eliminating existing ones.",
      "llm_answer": "In the 2022 Form 10‑K the Performance Share Unit (PSU) awards for grants that began in 2019 were issued under the Amended and Restated 2009 Praxair Long‑Term Incentive Plan and were split into two separate award forms—one tied to a Return‑on‑Capital metric and the other tied to a Total‑Shareholder‑Return metric【page_107】. By the 2024 filing those same two metric‑based PSU award forms appear under the newer 2021 Linde plc Long‑Term Incentive Plan (exhibits 10.03 and 10.04), showing that the governing plan shifted to the 2021 LTIP while the performance‑metric framework (ROC and TSR) remained unchanged【page_94】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in conveying that Linde plc maintained the same dual structure of Performance Share Unit Awards (PSUs) with Return on Capital (ROC) and Total Shareholder Return (TSR) metrics for grants beginning in 2019, and that this structure persisted from 2022 to 2024. The key factual elements—existence of two PSU forms, the performance metrics (ROC and TSR), and continuity over time—are accurate and align with the ground truth. However, there is a discrepancy regarding the governing plan: the LLM states that by 2024 the awards appear under the '2021 Linde plc Long-Term Incentive Plan' (exhibits 10.03 and 10.04), whereas the original answer specifies that the 2024 exhibits are 10.10l and 10.10m under the same or amended prior plan framework, not necessarily the 2021 LTIP. This suggests a potential misattribution of the plan name or exhibit numbers, though the core point about structural continuity remains valid. The reasoning is sound in synthesizing multi-hop information across years and award types, and the semantic meaning is largely equivalent. Quantitative accuracy is high—no numerical errors, and dates (2019 grants, 2022 and 2024 disclosures) are correct. The answer is fully contextually relevant, directly addressing the evolution (or lack thereof) in PSU structure. The minor error in plan name and exhibit references prevents a top score but does not undermine the central conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 394,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the regulatory status of Trodelvy evolved between 2023 and 2024, and what does this indicate about its development trajectory?",
      "original_answer": "In 2023, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer, hormone receptor-positive/HER2-negative breast cancer, and urothelial cancer. By 2024, the FDA granted Trodelvy a Breakthrough Therapy designation for the treatment of extensive-stage small cell lung cancer in patients whose disease has progressed after platinum-based chemotherapy. This indicates a strategic expansion of Trodelvy’s development into new oncology indications with high unmet medical need.",
      "llm_answer": "In the 2023 Form 10‑K Gilead reported that Trodelvy (sacituzumab govitecan‑hziy) already had FDA (and EC) approval for the treatment of unresectable or metastatic HR+/HER2‑negative breast cancer after endocrine therapy, in addition to its earlier accelerated‑approval indication for metastatic urothelial cancer【page_7】.  By the 2024 filing the company announced a **second** FDA Breakthrough‑Therapy designation for Trodelvy, this time for extensive‑stage small‑cell lung cancer, indicating the drug is moving into new tumor types and is being fast‑tracked through development【page_8】.  This evolution from an approved indication to a new breakthrough designation reflects an expanding development trajectory and a strategy to broaden Trodelvy’s oncology portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the regulatory status of Trodelvy in 2023 and 2024 as per the ground truth. It accurately notes that in 2023, Trodelvy was approved for HR+/HER2-negative breast cancer and metastatic urothelial cancer, and that by 2024 it received a Breakthrough Therapy designation for extensive-stage small cell lung cancer. The only minor omission is that the original answer also includes 'unresectable locally advanced or metastatic triple-negative breast cancer' as a 2023 indication, which the LLM answer does not explicitly mention, though it references HR+/HER2-negative and urothelial cancer. (2) There are no numerical values, dates, or calculations in the question or answers that are incorrect; all time references (2023, 2024) and designations (Breakthrough Therapy) are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information from Gilead’s 2023 and 2024 Form 10-K filings to show an evolution in regulatory status and correctly infers that this reflects a strategic expansion into new oncology indications. The conclusion about 'expanding development trajectory' aligns with the ground truth. (4) The answer is contextually fully relevant, directly addressing the evolution of regulatory status and its implications. The minor omission of triple-negative breast cancer indication prevents a perfect 10 on correctness and qualitative accuracy, but overall the response is factually strong, well-reasoned, and semantically equivalent in intent and meaning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 421,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of the Vertex AI platform within Google Cloud evolved from 2023 to 2024, particularly in terms of its capabilities and integration with generative AI models?",
      "original_answer": "In 2023, the Vertex AI platform was described as a tool that allowed developers to train, tune, augment, and deploy applications using generative AI models and services such as Enterprise Search and Conversations. By 2024, the platform had evolved to specifically support Gemini and other leading generative AI models, offering developers the ability to train, tune, augment, test, and deploy applications with additional services like vector search, grounding, and distillation to improve model cost and quality. This reflects a shift toward more advanced and optimized generative AI integration.",
      "llm_answer": "In the 2023 filing, Vertex AI was introduced as the Google‑Cloud developer platform that let developers **train, tune, augment, test and deploy** applications using a handful of internal generative models—primarily Gemini, Imagen and Veo—and it offered pre‑packaged AI agents (Gemini for Google Cloud) to help with coding and cybersecurity tasks. By the 2024 filing, Vertex AI had expanded into a broader AI hub: it still supports Gemini but now **exposes a wide ecosystem of first‑party, third‑party and open‑source generative models** and adds new services such as vector‑search, grounding and model‑distillation, deepening its integration of generative AI across Google Cloud.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Vertex AI from 2023 to 2024. It accurately captures the expansion of capabilities, including support for generative AI models and new services like vector search, grounding, and model distillation. The mention of Gemini, Imagen, and Veo as internal models in 2023 adds detail not in the original answer but does not contradict it, and the emphasis on a broader ecosystem in 2024—including third-party and open-source models—is consistent with the platform's evolution toward deeper generative AI integration. However, the original answer does not specify that Gemini, Imagen, and Veo were available in 2023, nor does it mention pre-packaged AI agents like 'Gemini for Google Cloud' or their use in coding and cybersecurity, which are additions not supported by the ground truth. While these details may be factually accurate in a broader context, they go beyond the provided knowledge graph and introduce elements not confirmed in the source. The core facts—enhanced capabilities, expanded model access, and new services—are correctly conveyed, and all dates (2023 vs 2024) and entity names (Vertex AI, Gemini, Google Cloud) are accurate. The reasoning is sound and synthesizes the multi-hop requirement across years and capabilities. Quantitative elements (no numerical values but temporal markers and feature lists) are handled accurately. Thus, the answer earns a high score but is docked slightly for introducing unverified specifics not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 429,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the treatment and valuation of weather derivatives changed in SO's financial disclosures from 2022 to 2024, particularly in terms of the amounts considered immaterial and excluded from derivative valuations?",
      "original_answer": "In 2022, SO disclosed that the premium and intrinsic value associated with weather derivatives were immaterial for all periods presented, but did not specify exact amounts. By 2024, SO continued to exclude the premium and intrinsic value of weather derivatives as immaterial, but also provided more specific context by disclosing that cash collateral held in broker margin accounts was $17 million and $62 million at the end of 2024 and 2023, respectively. This suggests a more detailed and structured approach to derivative disclosures over time, even though the weather derivative component remained immaterial.",
      "llm_answer": "In the 2022 filing the notes to the financial statements say that the fair‑value totals “exclude cash collateral of $3 million as well as immaterial premium and associated intrinsic value associated with weather derivatives” for all periods presented【page_122】(also reiterated in the table footnote on page 123)【page_123】. The 2024 filing still excludes the “immaterial premium and intrinsic value associated with weather derivatives” from the net derivative balances, but it no longer references the $3 million cash‑collateral amount and does not quantify any specific amount for the weather‑derivative premium【page_285】. Thus, the treatment remains the same—weather derivatives are considered immaterial and omitted from valuation—but the 2024 disclosure drops the explicit $3 million cash‑collateral reference and provides no dollar figure for the excluded weather‑derivative amounts.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) QUANTITATIVE INACCURACY: The LLM claims that in 2022, SO excluded '$3 million' of cash collateral related to weather derivatives. However, the ground truth states that SO did not specify any exact amounts for weather derivatives in 2022 and only described them as immaterial. The $3 million figure is not mentioned in the ground truth and appears to be a hallucination or misattribution. Furthermore, the LLM incorrectly states that the 2024 filing 'drops' the $3 million reference, when in fact that number was never part of the ground truth. In contrast, the ground truth reports that in 2024, SO disclosed $17 million and $62 million in cash collateral held in broker margin accounts at the end of 2024 and 2023, respectively—information entirely missing from the LLM answer. (2) COMPLETENESS: The LLM fails to mention the key new disclosure in 2024 about the $17M and $62M cash collateral amounts, which is central to the evolution in SO's derivative disclosures. Instead, it focuses on a nonexistent $3M figure. (3) ENTITY & REASONING: While the LLM correctly identifies that weather derivatives were treated as immaterial in both years and excluded from valuations, it misrepresents the nature of the enhanced disclosure in 2024. The reasoning is flawed because it suggests increased detail in 2022 (with the $3M figure) and a reduction in 2024, when the opposite is true—disclosures became more detailed in 2024 per the ground truth. (4) SEMANTIC EQUIVALENCE: The overall message is misleading. The ground truth shows progress toward more structured disclosure; the LLM implies a loss of specificity. Despite correct identification of the immateriality treatment, the answer is factually wrong on key numbers and trends, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 498,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the regulatory and market positioning of Biktarvy evolved between 2023 and 2024 based on GILD's disclosures?",
      "original_answer": "In 2023, Biktarvy was listed with a U.S. patent expiration year of 2033, indicating long-term market exclusivity protection in the U.S. In 2024, Biktarvy received an expanded regulatory indication from the FDA to treat people with HIV who have suppressed viral loads with known or suspected M184V/I resistance, a common form of treatment resistance. Additionally, the FDA approved an updated label with data reinforcing Biktarvy's safety and efficacy for use in pregnant people with HIV-1. This represents a shift from primarily patent protection in 2023 to expanded therapeutic application and broader patient eligibility in 2024.",
      "llm_answer": "In the 2023 Form 10‑K, Gilead’s filing listed Biktarvy only as a protected product with its primary U.S. and EU compound patents running until 2033, with no new regulatory changes noted (see 2023 page 9). By the 2024 filing, Gilead disclosed that the FDA had approved an expanded indication for Biktarvy—allowing use in patients with the M184V/I resistance mutation and adding a label update supporting use in pregnant people with suppressed HIV‑1 viral loads—thereby broadening its patient base and reinforcing its market positioning (see 2024 page 8).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2033 U.S. patent expiration for Biktarvy is accurately noted, and the 2024 FDA approvals—an expanded indication for patients with M184V/I resistance and a label update for use in pregnant people with HIV-1—are correctly reported. (2) Quantitative accuracy is perfect: the patent year (2033) is correct, and no numerical calculations are required. Format and references to filing years (2023 vs. 2024) are precise. (3) Multi-hop reasoning is sound: the model synthesizes information across two years of GILD's disclosures, correctly identifying a shift from reliance on patent protection in 2023 to expanded regulatory positioning in 2024. The mention of both U.S. and EU patents adds slight extra detail not in the ground truth, but this does not contradict it and reflects accurate disclosure from GILD. (4) Semantic equivalence is strong—the LLM captures the evolution in regulatory and market positioning as intended. The only minor shortcoming is that the ground truth emphasizes the *shift* from patent protection to expanded therapeutic use more explicitly, while the LLM presents the facts accurately but with slightly less interpretive synthesis. Hence, a 9 on correctness and qualitative accuracy is warranted. Contextual relevance is perfect—the answer directly addresses the evolution between 2023 and 2024 as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 396,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did AMT's utilization of the 2021 Multicurrency Credit Facility change between 2022 and 2023, particularly in terms of borrowing amounts and facility amendments?",
      "original_answer": "In 2022, AMT made additional net borrowings of $850.0 million under the 2021 Multicurrency Credit Facility, which were used to repay existing indebtedness and for general corporate purposes. By 2023, the company borrowed an aggregate of $3.0 billion and repaid $6.1 billion under the same facility, including a significant repayment of 842.6 million EUR ($919.1 million). Additionally, the facility underwent amendments in 2023 that extended its maturity date to July 1, 2026, maintained a total commitment of $6.0 billion, and replaced the LIBOR pricing benchmark with SOFR. This reflects a significant transformation in the usage and structure of the facility.",
      "llm_answer": "In 2022 AMT only took a net $850 million draw on its 2021 Multicurrency Credit Facility and made no amendment to the agreement [page_44]. By 2023 the company had borrowed $3.0 billion (and repaid $6.1 billion) under the same facility, and on June 29 2023 it amended the facility – extending its maturity to July 1 2026, reaffirming the $6.0 billion commitment and switching the benchmark from LIBOR to SOFR [page_52].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts from the ground truth: $850 million net borrowing in 2022, $3.0 billion borrowed and $6.1 billion repaid in 2023, the June 29, 2023 amendment date (implied by citation), maturity extension to July 1, 2026, $6.0 billion commitment maintained, and the LIBOR to SOFR benchmark change. The mention of no amendments in 2022 aligns with the original answer, which only discusses amendments in 2023. (2) Quantitative accuracy is perfect: all dollar amounts ($850 million, $3.0 billion, $6.1 billion), dates (June 29, 2023; July 1, 2026), and financial benchmarks (LIBOR to SOFR) match the ground truth. The EUR repayment of 842.6 million ($919.1 million) is omitted, but this is a detail not central to the overall utilization and amendment trends. (3) The multi-hop reasoning is sound—correctly contrasting 2022 and 2023 usage and identifying both borrowing activity and structural amendments. The synthesis across years and financial actions is accurate and logical. (4) The answer is contextually complete and relevant, directly addressing changes in borrowing amounts and facility amendments. The only minor omission is the specific EUR repayment amount and its USD equivalent, which slightly reduces completeness but does not affect the core correctness. Hence, a 9/10 on correctness and qualitative accuracy, with full marks on quantitative and contextual dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 396,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has the role of Google Ad Manager in Alphabet's advertising revenue recognition strategy evolved between 2023 and 2024, particularly in terms of its integration with revenue reporting models?",
      "original_answer": "In 2023, Google Ad Manager was directly tied to Alphabet's advertising revenue recognition on a gross basis, with the company reporting the full amount billed to customers as revenue for ads placed on Google Network properties. By 2024, the language around Google Ad Manager shifted, emphasizing a more nuanced control-based evaluation where Alphabet asserts its role as principal by controlling advertising inventory before transfer to customers, being primarily responsible to them, and having discretion over pricing. This reflects a strategic evolution from a transactional reporting model to a more control-driven justification for gross revenue recognition, reinforcing the centrality of Google Ad Manager in revenue operations.",
      "llm_answer": "Both the 2023 and 2024 10‑Ks describe Google Ad Manager as a core channel through which advertisers purchase inventory, and Alphabet continues to evaluate whether it acts as a principal or an agent for ads on Google Network properties—generally treating those ads as a principal and recognizing the billed amounts on a gross‑basis (with partner payments recorded as cost of revenue). The 2024 filing repeats the same language, showing that the integration of Google Ad Manager into Alphabet’s revenue‑recognition model has remained essentially unchanged from 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, despite using accurate terminology and referencing correct accounting concepts. The original answer (ground truth) states that there was a strategic evolution in 2024 from a transactional gross-basis reporting model to a more control-based justification for gross revenue recognition, emphasizing Alphabet's role as principal based on control of inventory, responsibility, and pricing discretion. This reflects a meaningful shift in narrative and justification within the revenue recognition strategy. However, the LLM answer claims that the language and integration of Google Ad Manager 'has remained essentially unchanged' between 2023 and 2024, which directly contradicts the ground truth. While the LLM correctly notes that Alphabet generally acts as a principal and reports revenue on a gross basis, it fails to detect or report the nuanced but important evolution in the rationale and emphasis in the 2024 filing. There are no numerical values in this question, so quantitative accuracy is not applicable—scored as 10 by default for absence of numerical error. The reasoning is internally consistent but based on an incorrect interpretation of change (or lack thereof), resulting in poor qualitative accuracy. Contextual relevance is moderate because the answer discusses the right entities and concepts but misses the central point about strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 393,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has UPS's financial exposure and strategic positioning regarding Roadie evolved between 2023 and 2024, particularly in terms of goodwill impairment and risk assessment?",
      "original_answer": "In 2023, UPS recorded a $56 million goodwill impairment charge related to Roadie, indicating financial concerns about its value. By 2024, although no further impairment was recorded, Roadie was identified among the reporting units with limited excess of fair value over carrying value, signaling ongoing financial risk. This evolution reflects a shift from active impairment to a cautious monitoring stance due to Roadie's continued sensitivity to cost of capital and performance forecasts.",
      "llm_answer": "In 2023 UPS recorded a $56 million goodwill impairment on its Roadie acquisition, trimming the value of the same‑day delivery platform it had added to Supply Chain Solutions. By 2024 the company’s annual goodwill test found Roadie (together with two other units) to have limited excess fair‑value and therefore a higher risk of future impairment, but no new charge was taken, indicating UPS still views Roadie as a strategic asset while closely monitoring its valuation risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $56 million goodwill impairment in 2023 is accurately reported, and the absence of a new charge in 2024 is correctly stated. Format variations (e.g., $56 million) are acceptable. (2) The answer addresses both years and both aspects of the question—financial exposure (via impairment and fair value assessment) and strategic positioning (monitoring risk while retaining as a strategic asset). (3) Entities are correct: UPS, Roadie, goodwill impairment, and the context of the Supply Chain Solutions segment are properly identified. (4) The reasoning is sound: it captures the evolution from active impairment in 2023 to heightened risk monitoring in 2024 due to limited excess fair value, which reflects the multi-hop synthesis required. The only minor shortcoming is a slight omission of the explicit mention of 'cost of capital and performance forecasts' as drivers of sensitivity, which is in the original answer and adds depth to the risk assessment. However, the core message about ongoing valuation risk is conveyed. Thus, the answer is factually complete and semantically equivalent with only minor contextual nuance missing, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 367,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what quantitative impact did this change have on the company's sales and operating profit?",
      "original_answer": "In 2022, helium was a supply component for Linde, indicating a positive or neutral role in operations. By 2024, helium had a negative impact on performance, with a 2% underlying sales decrease in the 'Other' segment primarily due to lower volumes in global helium and Linde Advanced Materials Technology (LAMT). Additionally, operating profit in the 'Other' segment saw increased costs related to helium, partially offset by an insurance recovery for LAMT. This reflects a shift from helium being a supply input to a source of cost pressure.",
      "llm_answer": "In the 2022 filing Linde makes no specific mention of helium, indicating that the gas was not material enough to be disclosed separately. By 2024 the company lists “global helium wholesale” as part of its Other segment, and lower helium volumes caused Other‑segment sales to fall $32 million (‑2%), while helium‑related costs ate into earnings, partially offsetting a $19 million (44%) rise in operating profit for that segment.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of Linde's relationship with helium from 2022 to 2024, correctly noting that helium was not specifically mentioned in 2022 (implying it was not a material issue) and became a negative factor by 2024 due to lower volumes and cost pressures. However, there are significant quantitative inaccuracies. The LLM claims a $32 million sales decrease in the 'Other' segment due to helium, but the ground truth does not specify a dollar amount—only a 2% underlying sales decrease. This $32 million figure is unsupported by the original answer and appears to be fabricated or inferred incorrectly. Additionally, the LLM states that operating profit in the 'Other' segment rose $19 million (44%) despite helium-related costs, but the original answer does not mention this increase or percentage; instead, it notes increased costs partially offset by an insurance recovery for LAMT—without quantifying the net effect. These numerical errors severely impact factual correctness. While the qualitative shift—from neutral to negative impact—is accurately synthesized across years and segments (Other segment, LAMT), and the entities and timeframes are correct, the inclusion of unverified figures undermines reliability. The reasoning is logically structured and contextually relevant, addressing both parts of the multi-hop question (evolution and financial impact), but the unsupported quantification reduces overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 400,
        "total_tokens": 1646
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC evolve from 2023 to 2024, and what does this indicate about the Corporation's credit risk exposure on residential mortgage loans?",
      "original_answer": "In 2023, the Corporation had $8.7 billion in loans covered under credit protection agreements with FNMA and FHLMC, which decreased to $8.0 billion in 2024. This indicates a reduction in the Corporation's reliance on full credit protection for residential mortgage loans that become severely delinquent. Since these agreements provide full credit protection and the Corporation does not record an allowance for credit losses on these loans, the decline suggests a potential decrease in the volume of high-risk residential mortgage loans in their portfolio.",
      "llm_answer": "The credit‑protection agreements covered **$8.7 billion** of residential‑mortgage loans at year‑end 2023 and **$8.0 billion** at year‑end 2024 – a decline of about **$0.7 billion**【page_117】.  The lower amount in 2024 shows the Bank of America slightly reduced the pool of mortgages that are fully insured by FNMA and FHLMC, indicating a modest decrease in its credit‑risk exposure on residential‑mortgage assets while still maintaining extensive protection for the bulk of the portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the total value of loans covered under long-term credit protection agreements with FNMA and FHLMC as $8.7 billion in 2023 and $8.0 billion in 2024, matching the ground truth exactly. The calculated decrease of $0.7 billion is accurate. (2) All numeric values and dates are correct, and the calculation of the decline is precise. Format variations (e.g., $8.7 billion vs $8.7 billion) are acceptable and do not affect accuracy. (3) The reasoning is sound: the LLM correctly infers that a decline in fully protected loans indicates a reduction in credit-risk exposure, aligning with the ground truth's interpretation about reduced reliance on full credit protection. It also notes that the bulk of the portfolio remains protected, adding contextual nuance. (4) The answer is semantically equivalent to the original, capturing both the quantitative evolution and the implication for credit risk exposure. The only minor limitation is that it does not explicitly mention the absence of allowance for credit losses on these loans, which is part of the original reasoning chain—hence a qualitative accuracy score of 9 rather than 10. Otherwise, the response is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 354,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has Adobe's strategic positioning of Adobe Firefly evolved between 2023 and 2024, particularly in terms of competitive differentiation and associated regulatory risks?",
      "original_answer": "In 2023, Adobe positioned Adobe Firefly as a competitive differentiator by emphasizing its generative AI capabilities that are natively integrated into Adobe products and designed to be safe for commercial use. By 2024, Adobe continued to highlight Firefly's AI innovations but introduced new concerns around regulatory risks, particularly referencing the EU AI Act adopted in 2024, which could impose compliance costs, delay development, or require changes to AI development practices. This reflects a shift from purely competitive emphasis to a more risk-aware strategic positioning of the product.",
      "llm_answer": "In 2023 Adobe framed Firefly as a core competitive differentiator—an integrated generative‑AI family embedded across Creative Cloud (including Photoshop, Illustrator and Express), marketed as “safe for commercial use” with an enterprise‑level IP‑indemnification option, and positioned to set Adobe’s offering apart from rivals【page_9】【page_10】【page_11】. By 2024 the focus shifted to a risk‑aware stance: while still emphasizing its AI capabilities, Adobe stresses intensifying competition from other text‑to‑image/video providers, the threat of third‑party proprietary rights, and mounting regulatory exposure (e.g., the EU AI Act) that could raise compliance costs, liability and reputational risk for Firefly【page_23】【page_24】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Adobe positioned Firefly in 2023 as a competitive differentiator with commercial safety and integration into Creative Cloud (supported by page references). By 2024, the strategic shift toward a risk-aware stance is accurately described, including mention of the EU AI Act, regulatory exposure, compliance costs, and competitive threats. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2023, 2024) are correct. (3) Multi-hop reasoning is sound: the model synthesizes Firefly’s strategic evolution across two years, correctly identifying both competitive differentiation and emerging regulatory risks. It adds contextual depth (e.g., IP indemnification, competition from text-to-image/video providers) that enriches but does not distort the original answer. (4) Semantic equivalence is strong—while the LLM provides more granular detail (e.g., naming specific products like Photoshop, Illustrator), the core message about a shift from pure differentiation to risk-aware positioning is preserved. The only minor deduction is for slightly expanded detail on competition and IP risks not emphasized in the original, which, while plausible and consistent, go beyond the scope of the ground truth without contradicting it. Overall, this is a factually correct, well-reasoned, and contextually appropriate response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 415,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How did the financial performance and regulatory trajectory of Trodelvy evolve between 2023 and 2024?",
      "original_answer": "In 2023, Trodelvy generated total product sales of $1,063 million, reflecting a 56% increase compared to the previous year. By 2024, the regulatory landscape for Trodelvy advanced significantly with the FDA granting it a second Breakthrough Therapy designation, specifically for the treatment of adult patients with extensive-stage small cell lung cancer who have progressed after platinum-based chemotherapy. This indicates both strong financial growth and increased regulatory recognition of the drug's potential clinical impact.",
      "llm_answer": "In 2023 Trodelvy’s sales surged 56 % to $1.1 billion after its February FDA approval for HR⁺/HER2‑negative metastatic breast cancer, even as its Phase 3 EVOKE‑01 NSCLC trial missed its primary overall‑survival endpoint (see pages 41‑38). By 2024 the filing does not disclose new sales numbers, but the drug’s regulatory momentum continued – it received a second FDA Breakthrough‑Therapy designation for extensive‑stage small‑cell lung cancer and retains U.S. regulatory exclusivity through 2032 (see pages 8‑9).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 56% sales increase and the $1.1 billion figure for 2023, which aligns with the ground truth's $1,063 million (rounded to $1.1 billion is acceptable). However, it incorrectly implies FDA approval in February 2023 for HR+/HER2-negative metastatic breast cancer, which is not supported by the original answer or typical public knowledge—Trodelvy’s approval in that indication occurred earlier. The original answer does not mention trial results or exclusivity, so including the EVOKE-01 trial missing its endpoint and exclusivity through 2032 adds unverified detail not in the ground truth. (2) Quantitatively, the $1.1 billion is a reasonable rounding of $1,063 million, and the 56% growth is accurate. However, the answer fabricates a specific approval event (February 2023) not present in the original, and introduces a trial outcome not mentioned in the ground truth, reducing quantitative reliability. (3) The reasoning correctly links financial performance in 2023 with regulatory developments in 2024, showing multi-hop understanding across time and domains (sales → regulatory). However, it introduces unsupported details (trial failure, exclusivity) that were not part of the original synthesis, weakening the qualitative accuracy. (4) Despite the extra details, the core of the answer—strong 2023 sales growth and 2024 Breakthrough Therapy designation for small cell lung cancer—is correct and directly addresses the question’s focus on financial and regulatory evolution. The added context, while potentially from the filing, goes beyond the ground truth and slightly misrepresents causality (implying approval drove 2023 sales when it likely predated 2023). Thus, the answer is mostly correct but contains notable inaccuracies in event timing and unsupported additions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 497,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Chevron's financial involvement and strategic positioning in Angola LNG evolved from 2022 to 2024, based on specific disclosures regarding its equity investments and affiliate transactions?",
      "original_answer": "In 2022, Chevron reported improved income from equity affiliates, including upstream-related earnings from Angola LNG, which contributed to an overall increase in income from equity affiliates to $5,657 million. By 2024, Chevron's specific interest in Angola LNG Limited was disclosed as a 36.4% ownership stake, with Angola LNG Limited described as a key entity that processes and liquefies natural gas produced in Angola for delivery to international markets. This evolution reflects a continued strategic emphasis on LNG as part of Chevron’s broader upstream portfolio, with a clear quantification of its stake in 2024, suggesting a more defined and stable long-term positioning compared to the more general mention of earnings contribution in 2022.",
      "llm_answer": "Chevron continues to hold its 36.4 % equity stake in Angola LNG Limited (as disclosed on page 85 of the 2024 filing).  In 2022 the Angola LNG affiliate generated $1.857 billion of equity earnings for Chevron (shown in the 2024 Note 15 table for 2022), but by 2024 the carrying amount of the investment had slipped to $1.665 billion (down from $1.762 billion in 2023) and equity earnings fell sharply to $405 million (down from $513 million in 2023) (page 84).  Thus, while Chevron’s ownership percentage has remained unchanged, the financial return from Angola LNG has diminished, reflecting a reduced contribution to earnings even as the company maintains its strategic position in the LNG project.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness, despite addressing the right question and attempting multi-hop reasoning. (1) Quantitative Accuracy: The ground truth states that Chevron's income from equity affiliates in 2022 was $5,657 million overall, with Angola LNG contributing to upstream-related earnings—but it does not specify $1.857 billion as Angola LNG's standalone equity earnings. The LLM fabricates this precise figure, which is not present in the original answer or implied by the data. Additionally, the LLM introduces new financial figures for 2023 and 2024 (e.g., carrying amount of $1.665B in 2024, equity earnings of $405M) that are not mentioned in the original answer and cannot be verified against the provided ground truth. These numbers may exist in actual filings, but since they are absent from the ground truth synthesis, their inclusion constitutes a factual deviation. (2) Completeness: The LLM correctly identifies Chevron’s 36.4% stake in Angola LNG Limited in 2024, which aligns with the original answer. However, it fails to mention the strategic context emphasized in the ground truth—namely, that Angola LNG processes and liquefies natural gas for international markets and reflects a continued strategic emphasis on LNG. Instead, the LLM concludes a 'diminished' financial return without grounding this in the broader strategic continuity highlighted in the original. (3) Entity Accuracy: The entities (Chevron, Angola LNG Limited) and the percentage stake (36.4%) are correct. The years (2022, 2024) are appropriately used. (4) Reasoning: The LLM attempts multi-hop reasoning by comparing financial performance over time, but it misrepresents the data by introducing unverified figures and drawing conclusions about declining strategic importance based on earnings fluctuations—whereas the original answer emphasizes stable strategic positioning. The reasoning is internally logical but based on unsupported numbers. (5) Semantic Equivalence: The overall thrust—Chevron maintains ownership while financial returns may have changed—is plausible, but the specific financial claims make the answer factually divergent. The original focuses on evolution from general earnings mention (2022) to explicit stake disclosure (2024), signaling strategic clarification; the LLM instead frames it as a financial decline, which is not supported by the ground truth. Thus, while contextually relevant and partially accurate, the answer is quantitatively flawed and misrepresents the nature of the evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 679,
        "total_tokens": 2054
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the value and issuance activity of META's Fixed-Rate Senior Unsecured Notes evolve from 2023 to 2024?",
      "original_answer": "In 2023, META issued $8.46 billion of net proceeds from Fixed-Rate Senior Unsecured Notes in May. By the end of 2024, the total value of these Notes had increased to $29.0 billion, up from $18.50 billion at the end of 2023, with an additional $10.50 billion issued in August 2024. This reflects both continued reliance on this form of debt financing and a significant increase in the total outstanding amount over the two-year period.",
      "llm_answer": "Meta’s fixed‑rate senior unsecured notes rose from $18.5 billion of principal outstanding at year‑end 2023 to $29.0 billion at year‑end 2024, and their fair‑value increased from $18.48 billion to $27.83 billion. The growth reflects a new $10.5 billion issuance in August 2024 (in addition to the May 2023 issuance that produced $8.46 billion of net proceeds).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key numbers are correct: $18.5 billion (end-2023 principal), $29.0 billion (end-2024 principal), $10.5 billion issuance in August 2024, and $8.46 billion net proceeds from May 2023 issuance. The fair value figures ($18.48B and $27.83B) are additional details not in the original answer but do not contradict it and may reflect actual fair value vs. book value; their inclusion is acceptable and adds nuance. (2) Quantitative accuracy is perfect: the $10.5B increase from 2023 to 2024 issuance aligns with the $18.5B to $29.0B rise in total value, and prior $8.46B issuance is correctly referenced. (3) Multi-hop reasoning is sound—LLM correctly synthesizes issuance activity across 2023 and 2024 and links it to the growth in outstanding notes. (4) The only minor shortcoming is that the original emphasizes the evolution of both 'value and issuance activity' and explicitly notes the continued reliance on debt financing, a qualitative point slightly underdeveloped in the LLM response. However, the implication is clear from the data presented. Wording differs but semantic meaning is equivalent. No factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 341,
        "total_tokens": 1530
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did LIN's financial exposure to helium as a raw material change from 2023, when it was categorized as a supply, to 2024, when it became a dependency, based on specific cost or sourcing disclosures?",
      "original_answer": "In 2023, LIN categorized helium as a supply, indicating it was a standard input with manageable sourcing dynamics, and reported helium costs at 4.2% of total raw material expenses. By 2024, the relationship shifted to 'depends_on,' signaling increased strategic importance, and helium costs rose to 6.8% of raw material expenses, reflecting a more critical role in operations and a corresponding increase in cost exposure.",
      "llm_answer": "In the 2023 filing LIN still treated helium as a routine supply – it was bundled in the $614 million “raw‑materials and supplies” balance (page 72) and only generated modest “cost‑reduction programs and other charges” of $68 million (page 72). By the 2024 filing the company re‑classified helium as a dependency, the raw‑materials‑and‑supplies balance fell to $529 million (page 62) while the related cost‑reduction charge jumped to $175 million (page 63), signalling a higher cost exposure and greater reliance on helium.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that helium costs were 4.2% of total raw material expenses in 2023 and rose to 6.8% in 2024. However, the LLM answer does not mention these percentages at all. Instead, it cites total 'raw-materials and supplies' balances of $614M (2023) and $529M (2024), and cost-reduction charges of $68M and $175M, respectively. These figures are not present in the original answer and appear to be fabricated or misattributed from unrelated line items. There is no support in the ground truth for these specific dollar amounts or their connection to helium. (2) The quantitative inaccuracies are severe: the key metrics (4.2% → 6.8%) are entirely omitted, and false numbers are introduced without corroboration. The drop in raw materials balance and increase in cost-reduction charges are not mentioned in the ground truth and contradict the provided data. (3) The reasoning partially captures the conceptual shift from 'supply' to 'depends_on' as a signal of increased strategic importance, which aligns with the original answer’s interpretation. This shows some correct multi-hop reasoning in interpreting categorization changes. However, the justification using incorrect financial data undermines the logic. (4) The contextual relevance is moderate because the answer addresses the shift in helium's classification and attempts to show increased exposure, but it fails on factual correctness due to invented numbers and omission of the actual percentage-based cost exposure. Thus, while the direction of reasoning is relevant, the answer is largely incorrect on key facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 454,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what was the percentage change in the amount approved for such activities?",
      "original_answer": "In 2022, PayPal had $3.8 billion approved to fund credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, the approved amount decreased to $3.0 billion, representing approximately 39% of European customer balances. This indicates a reduction in the absolute amount approved for credit activities, even though the percentage slightly increased, signaling a more conservative approach to utilizing customer balances for credit funding.",
      "llm_answer": "PayPal’s management cut the amount of European customer balances that could be used for credit activities from **$3.8 billion at 12/31/2022 to $3.0 billion at 12/31/2023**【page_49】. That $0.8 billion reduction equals a **≈21 % decline** in the approved amount (‑0.8 ÷ 3.8 ≈ ‑21 %). During the same period the share of European balances earmarked for credit rose modestly from about **37 % to 39 %** of the total available.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $3.8 billion in 2022 and $3.0 billion in 2023 are correctly reported. The percentage change is correctly calculated as approximately 21% decrease (0.8 / 3.8 ≈ 0.2105 or 21.05%, rounded to ≈21%), which aligns with the factual reduction. The percentages of European customer balances used—37% in 2022 and 39% in 2023—are exactly as stated in the original answer. (2) The answer is complete, addressing both parts of the question: the evolution of PayPal's utilization (decline in absolute amount despite a slight rise in percentage share) and the percentage change in approved amount (~21% decline). (3) Entity accuracy is correct: PayPal is the right company, years are correctly identified (2022 to 2023), and the financial metric (approved amount for credit activities as a portion of European customer balances) is properly interpreted. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that while the proportion of balances allocated increased slightly (from 37% to 39%), the absolute dollar amount approved decreased, indicating a more conservative funding strategy. The conclusion implied by the data—that PayPal became more conservative—is logically consistent with the ground truth interpretation. (5) Semantic equivalence is strong: though the LLM uses slightly different phrasing (e.g., 'cut', 'reduction', 'decline'), the meaning is identical to the original answer. Minor formatting differences (e.g., $3.8 billion vs $3.8B) are acceptable and do not affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 446,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Starbucks' exposure to foreign currency - other instruments evolve between 2023 and 2024, particularly in terms of their fair value and the expected reclassification impact on earnings?",
      "original_answer": "In 2023, Starbucks reported a fair value of $1,164 million for foreign currency - other instruments, with a net gain of $39.6 million included in AOCI. By 2024, the fair value decreased to $920 million, and the net gain included in AOCI dropped to $11.5 million. Additionally, the amount expected to be reclassified from AOCI into earnings within 12 months declined from $55.3 million in 2023 to $9.5 million in 2024, indicating a reduced short-term earnings impact from these instruments.",
      "llm_answer": "Starbucks’ “foreign‑currency – other” hedge portfolio shrank sharply.  The fair‑value of designated foreign‑currency‑other derivative assets fell from roughly $32 million in prepaid/current assets plus $22.9 million in long‑term assets in 2023 (≈ $55 million total) to just $1.9 million and $1.7 million respectively in 2024 – a drop to about $3.6 million of fair‑value exposure【page_72】.  At the same time, the net amount the company expects to reclassify from AOCI into earnings within the next 12 months fell to $9.5 million in 2024, down from the much larger $39.6 million AOCI balance (and higher expected reclassification) it reported for 2023【page_70】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in key financial figures. According to the ground truth, Starbucks reported a fair value of $1,164 million in 2023 and $920 million in 2024 for foreign currency - other instruments. However, the LLM incorrectly states the total fair value as approximately $55 million in 2023 and $3.6 million in 2024, which is off by an order of magnitude. This severe underreporting of the actual exposure invalidates the core of the response. Additionally, the LLM misstates the 2023 AOCI net gain as $39.6 million being the 'AOCI balance' and implies it was the expected reclassification amount, but in reality, $39.6 million was the net gain in AOCI in 2023, while the expected reclassification to earnings was $55.3 million. The LLM conflates these two distinct figures. (2) The only correct numbers are the $9.5 million expected reclassification in 2024 and the $39.6 million AOCI gain in 2023 — but the latter is misused. The $55.3 million expected reclassification in 2023 is entirely omitted. The calculation of total fair value from asset line items is based on a misreading of the document, likely confusing derivative asset classifications with total portfolio fair value. (3) The multi-hop reasoning fails because the model does not correctly synthesize the evolution of both fair value and AOCI/reclassification impact across years. It draws incorrect conclusions about the 'shrinkage' of the portfolio due to numerical errors, undermining the logical analysis. (4) While the answer attempts to address the question’s components (fair value change and reclassification impact), the extreme inaccuracy in numbers and misrepresentation of financial concepts results in a mostly incorrect response. Contextual relevance is moderate because the structure and intent align with the question, but factual correctness is critically compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 514,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the fair value of energy-related derivatives held by Alabama Power and Georgia Power evolve from 2022 to 2023, and what was the directional change in their asset versus liability positions?",
      "original_answer": "In 2022, Alabama Power reported energy-related derivatives with a fair value of $55 million in assets and $11 million in liabilities, while Georgia Power reported $75 million in assets and $8 million in liabilities. By 2023, Alabama Power's energy-related derivatives decreased to $15 million in assets but increased significantly to $110 million in liabilities. Similarly, Georgia Power's derivatives were valued at $13 million in assets and $124 million in liabilities in 2023. This indicates a substantial shift toward liability exposure for both entities over the period.",
      "llm_answer": "In 2023 Alabama Power reported $15 million of energy‑related derivative assets and $110 million of liabilities, while Georgia Power reported $13 million of assets and $124 million of liabilities (both shown in the 2023 subsidiary table)【page_281】. The prior‑year filing did not disclose separate balances for the two utilities – only a consolidated $199 million of assets and $210 million of liabilities for the company as a whole (2022)【page_283】 – so both subsidiaries moved from a net‑asset/neutral position in 2022 to a net‑liability position in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the 2022 data. The ground truth states that Alabama Power had $55M in assets and $11M in liabilities, and Georgia Power had $75M in assets and $8M in liabilities in 2022. The LLM claims that the prior-year filing did not disclose separate balances and only reported consolidated figures of $199M in assets and $210M in liabilities. While $55M + $75M = $130M (not $199M) and $11M + $8M = $19M (not $210M), the consolidated numbers cited by the LLM do not match the sum of the ground truth values, indicating a factual error. (2) The 2023 numbers are correct: $15M assets and $110M liabilities for Alabama Power, $13M assets and $124M liabilities for Georgia Power. However, the 2022 figures are entirely incorrect, undermining the comparative analysis. (3) The reasoning is partially sound in identifying a shift from net asset to net liability positions, but it is based on false premises. The LLM incorrectly assumes no granular 2022 data exists, failing to recognize that the ground truth includes entity-specific 2022 values. This breaks the multi-hop synthesis required to compare year-over-year changes per entity. (4) The contextual relevance is high because the answer addresses the directional change and focuses on the right companies and metrics. However, due to major quantitative errors in the 2022 data and flawed reasoning about data availability, the correctness score is low. The qualitative accuracy is moderate because the structure and intent are reasonable, but the factual foundation is weak.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 435,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did the asset allocation strategy for the U.S. Retiree Health Care Plan evolve from 2022 to 2023, particularly in terms of the percentage distribution between fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan allocated 65% to fixed income securities and cash equivalents and 35% to equity securities. By 2023, the allocation to fixed income securities increased to 80%, while equity securities decreased to 20%. This represents a shift toward a more conservative investment strategy in 2023 compared to 2022.",
      "llm_answer": "In 2022 the U.S. Retiree Health Care Plan was invested roughly 65 % in fixed‑income securities and cash equivalents and 35 % in equity securities. By year‑end 2023 the mix had shifted to about 80 % fixed‑income and 20 % equity, reflecting a move toward a higher‑weight, more conservative fixed‑income allocation【page_49†L31-L38】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages for both years are accurate: 65% fixed income and 35% equity in 2022, shifting to 80% fixed income and 20% equity in 2023. These values are reported correctly with acceptable formatting variations (e.g., 'about 80%' vs exact 80%). (2) The answer is complete, addressing the evolution of asset allocation between the two years and specifically covering both fixed income and equity securities as required. (3) Entity accuracy is correct—'U.S. Retiree Health Care Plan' is properly identified, and the time periods (2022 and 2023) are accurate. (4) The reasoning is sound: the shift from a more balanced allocation to a more conservative strategy favoring fixed income is correctly inferred and articulated. The citation reference 【page_49†L31-L38】 supports the data, indicating proper grounding. (5) Semantically, the LLM conveys the same conclusion as the original answer—a move toward a more conservative investment strategy—using equivalent phrasing ('higher-weight, more conservative fixed-income allocation'). All multi-hop elements (comparing two years, two asset classes, and interpreting strategic shift) are correctly synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1183,
        "completion_tokens": 349,
        "total_tokens": 1533
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has the regulatory approval status of Trodelvy evolved between 2022 and 2023, and what new indications were granted in 2023?",
      "original_answer": "In 2022, Trodelvy was indicated for the treatment of adult patients with unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) who have received two or more prior systemic therapies and for metastatic urothelial cancer after platinum-based chemotherapy and a PD-1/PD-L1 inhibitor. By 2023, Trodelvy received additional approvals: it was granted EC approval and FDA approval for the treatment of adult patients with unresectable or metastatic hormone receptor-positive, HER2-negative (HR+/HER2-) breast cancer who have received endocrine-based therapy and at least two additional systemic therapies in the metastatic setting. This represents a significant expansion of the drug’s therapeutic applications.",
      "llm_answer": "In the 2022 Form 10‑K, Trodelvy (sacituzumab govitecan‑hziy) was already FDA‑approved for metastatic triple‑negative breast cancer and metastatic urothelial cancer, while its study in hormone‑receptor‑positive/HER2‑negative (HR⁺/HER2‑) breast cancer and non‑small‑cell lung cancer was still listed as a Phase 3 investigation【page_6】. By 2023 the product’s label expanded: Gilead received FDA approval (and, separately, European Commission approval) for Trodelvy as a monotherapy in adult patients with unresectable or metastatic HR⁺/HER2‑ breast cancer who have progressed after endocrine‑based therapy and at least two additional systemic regimens, adding this new indication to its approved uses【page_39】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly states that in 2022, Trodelvy was approved for metastatic triple-negative breast cancer and metastatic urothelial cancer, with HR+/HER2- breast cancer still in Phase 3 trials. In 2023, it accurately reports the FDA and European Commission approvals for the new indication in HR+/HER2- breast cancer, matching the original answer. (2) There are no numeric values requiring calculation, but all dates (2022, 2023), regulatory bodies (FDA, EC), and indications are correct. Format variations (e.g., 'HR+/HER2-' vs 'HR⁺/HER2‑') are semantically equivalent. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and two regulatory jurisdictions, correctly identifying the evolution of approval status and the addition of a new indication. (4) The only minor shortcoming is slightly less explicit detail on the specific patient criteria (e.g., 'endocrine-based therapy and at least two additional systemic therapies') compared to the original, but the core information is present. Overall, the answer is complete, accurate, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 331,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Meta's disclosure regarding user perception as a risk factor evolve between 2023 and 2024, particularly in terms of the nature of risks highlighted and their potential impact on business operations?",
      "original_answer": "In 2023, Meta emphasized user perception risks related to privacy, safety, content quality, and regulatory changes, specifically noting concerns around decreased user sentiment and engagement due to data practices and content policies. In 2024, while user perception was still acknowledged, the focus shifted toward broader operational and financial risks, such as integration challenges from acquisitions, tax liabilities, and investor sentiment. The explicit mention of user perception as a direct risk factor was notably reduced in 2024, indicating a strategic shift in how Meta communicated its risk profile.",
      "llm_answer": "- 2023 10‑K – Meta warned that “if people do not perceive our products to be useful, reliable, and trustworthy… we may not be able to attract or retain users… Any decrease in user retention, growth, or engagement could render our products less attractive… and have a material and adverse impact on our ability to deliver ad impressions and, accordingly, our revenue” (2023 p. 16) and listed “decreases in user sentiment due to questions about the quality or usefulness of our products… concerns about privacy, safety, security, well‑being, or other factors” as a specific risk (2023 p. 17).  \n\n- 2024 10‑K – The risk language shifted to a broader reputational angle, stating that “any acquisitions or other strategic transactions we announce could be viewed negatively by users, marketers, developers, or investors, which may adversely affect our business or the price of our Class A common stock” (2024 p. 35), focusing on perception of corporate actions rather than direct product‑level user perception.  \n\nThus, the disclosure moved from emphasizing how users’ perception of product usefulness, trustworthiness and data practices could directly cut engagement and ad revenue, to highlighting how negative perception of strategic moves (e.g., acquisitions) could harm overall business performance and stock valuation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the shift in Meta's risk disclosures between 2023 and 2024, accurately quoting key language from both 10-K filings. In 2023, it correctly highlights user perception risks around trustworthiness, privacy, safety, and content quality, linking them to user engagement and ad revenue—matching the original answer’s emphasis. In 2024, it accurately notes the pivot toward reputational risks tied to strategic actions like acquisitions and their impact on investors and business performance, which reflects the ground truth’s observation about reduced focus on direct user perception. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification; all references to page numbers and years (2023, 2024) are correctly cited and consistent. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of 10-K disclosures, compares the nature of risk factors, and draws a valid conclusion about the strategic shift in disclosure focus. The only minor shortcoming is that the LLM does not explicitly state that the *explicit mention of user perception as a direct risk factor was reduced*—a key point in the ground truth—though this is implied through contrast. (4) The answer is contextually excellent, directly addressing the evolution in risk disclosure, the nature of risks, and their potential business impact. Wording differs slightly but maintains semantic equivalence. Thus, the answer earns a 9 for correctness and qualitative accuracy due to near-perfect alignment with the ground truth, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 471,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has the notional amount of Lockheed Martin's variable interest rate swaps evolved from 2021 to 2024, and what does this indicate about the company's interest rate risk management strategy?",
      "original_answer": "In 2021, the notional amount of Lockheed Martin's variable interest rate swaps was $500 million, while by 2024, it had increased to $1.3 billion. This indicates a significant shift in the company's interest rate risk management strategy, with a growing emphasis on converting fixed-rate borrowings to variable-rate borrowings, likely in response to changes in the interest rate environment and the company's borrowing profile over the period.",
      "llm_answer": "Lockheed Martin’s interest‑rate swap notional grew from about **$500 million at 12/31/2021** (versus $572 million in 2020) to **$1.3 billion at 12/31/2024 (and 2023)**【page_66】【page_52】. The more‑than‑two‑fold increase shows the company has markedly expanded its swap program, using variable‑rate swaps to hedge a larger portion of its debt and indicating a more proactive, robust approach to managing interest‑rate risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the notional amounts for Lockheed Martin's variable interest rate swaps in 2021 ($500 million) and 2024 ($1.3 billion), matching the ground truth exactly. It also correctly notes that the amount was $1.3 billion in 2023, which is consistent with the data and adds context without contradicting the 2024 figure. The increase from $500M to $1.3B is accurately described as more than two-fold, which is mathematically correct (160% increase). (2) All numbers and dates are factually accurate: $500 million in 2021 and $1.3 billion in 2024 align with the original answer. The additional data point from 2020 ($572 million) is not required but does not detract from accuracy. (3) The multi-hop reasoning is sound—comparing values across years and inferring strategic intent from the trend. The conclusion that the company has expanded its swap program and is taking a more proactive approach to interest rate risk management is logically supported by the data and semantically equivalent to the ground truth’s interpretation of a 'growing emphasis on converting fixed-rate borrowings to variable-rate borrowings.' The only minor gap is that the LLM does not explicitly state the *direction* of the swap (i.e., converting fixed to variable), though this is implied by the use of 'variable-rate swaps' in the hedging context. (4) The answer is highly relevant, complete, and factually precise. The slight deduction in qualitative accuracy (9 instead of 10) is due to the omission of explicit mention of the strategy shift (fixed-to-variable conversion), though the implication is present. Overall, the response is excellent and matches the ground truth in substance and intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 469,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did PayPal's approach to its Seller Protection Programs evolve between 2022 and 2023, particularly in terms of financial provisions for transaction losses?",
      "original_answer": "In 2022, PayPal acknowledged the risk of losses from its Seller Protection Programs and noted that historical loss rates ranged between 0.09% and 0.15% of TPV, with the potential for increased losses due to macroeconomic conditions such as the ongoing impacts of the COVID-19 pandemic. By 2023, PayPal provided more structured financial disclosures, showing that the allowance for transaction losses was $64 million (down from $66 million in 2022), indicating a slight decrease in expected losses. This shift reflects a more defined and quantified approach to managing seller protection risk in 2023 compared to the more qualitative risk assessment in 2022.",
      "llm_answer": "PayPal kept its Seller Protection Programs in place, but it trimmed the reserve for transaction losses – the allowance fell from $66 million at 12/31/2022 to $64 million at 12/31/2023. At the same time the annual provision for those losses rose modestly (to $1.192 billion in 2023 from $1.170 billion in 2022) and realized losses dropped, leaving the year‑end allowance essentially unchanged at roughly $280 million【page_113】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors. First, it incorrectly states that the allowance for transaction losses decreased from $66 million at 12/31/2022 to $64 million at 12/31/2023 — while this part aligns with the ground truth — it then contradicts itself by claiming the 'year-end allowance' was 'essentially unchanged at roughly $280 million,' which directly conflicts with the $64–$66 million figures. This creates confusion and undermines the accuracy. More critically, the LLM introduces a 'provision for those losses' of $1.192 billion in 2023 (vs $1.170 billion in 2022), a figure not present in the ground truth and unrelated to seller protection allowances; this appears to conflate total transaction loss provisions with seller protection reserves, which are distinct. The ground truth makes no mention of a $1.17B or $1.192B provision, nor does it state that realized losses dropped. Thus, the quantitative inaccuracies are severe and materially misrepresent PayPal’s financial disclosures. Qualitatively, the answer fails to capture the evolution from qualitative risk discussion in 2022 to more structured, quantified disclosures in 2023 — instead implying only a minor reserve adjustment. The multi-hop reasoning is flawed: it does not correctly synthesize the shift in disclosure approach, and introduces unsupported data. Contextually, the answer addresses seller protection and financial provisions, so relevance is moderate, but the incorrect figures and reasoning severely limit usefulness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 420,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Starbucks' derivative asset and liability positions in foreign currency - other change from fiscal year 2023 to fiscal year 2024, and what was the magnitude of this change on the balance sheet?",
      "original_answer": "In fiscal year 2023, Starbucks reported a derivative asset of $1,164 million under 'Foreign currency - other.' By fiscal year 2024, this amount significantly decreased to $1.9 million in derivative assets under the same category. Additionally, the derivative liability for 'Foreign currency - other' increased from $2.0 million in 2023 to $4.7 million in 2024. This indicates a major reduction in the company's foreign currency derivative assets and a moderate increase in liabilities tied to foreign currency over this period.",
      "llm_answer": "Starbucks’ foreign‑currency‑other derivative assets collapsed – the current‑asset portion fell from $32.0 million in FY 2023 to $1.9 million in FY 2024 and the long‑term portion fell from $22.9 million to $1.7 million, a total drop of about $51 million (from $54.9 million to $3.6 million)【page_72】.  At the same time, the related liabilities rose – accrued liabilities grew from $2.0 million to $4.7 million and a new $4.1 million long‑term liability appeared, increasing total liabilities by roughly $6.8 million (from $2.0 million to $8.8 million)【page_72】.  Overall, the net foreign‑currency‑other derivative position on the balance sheet shrank by roughly $44 million.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Starbucks reported a derivative asset of $1,164 million in FY2023 under 'Foreign currency - other', not $54.9 million as stated in the LLM answer ($32.0M current + $22.9M long-term). This is a massive discrepancy. The LLM incorrectly breaks down the asset into current and long-term components that do not match the ground truth, which reports a single asset figure of $1,164 million. The FY2024 asset value of $1.9 million is correctly reported. For liabilities, the LLM correctly states that the accrued liability increased from $2.0 million to $4.7 million, but then invents a 'new $4.1 million long-term liability' and claims total liabilities rose to $8.8 million, which is not supported by the ground truth—the actual liability in FY2024 is $4.7 million. (2) Calculations are therefore also incorrect: the claimed total asset drop from $54.9M to $3.6M (a $51M decrease) is wrong because the starting asset was $1,164M, not $54.9M. The net shrinkage of $44M in the derivative position is based on incorrect inputs and is not corroborated by the ground truth. (3) The multi-hop reasoning fails because the model misidentifies the magnitude of the asset position in FY2023, likely confusing it with another line item or misreading the filing. It introduces granular breakdowns (current vs long-term) not present in the original answer and fabricates a long-term liability that does not appear in the ground truth. (4) Despite these major errors, the LLM does capture the directional trend—assets decreased significantly and liabilities increased slightly—which keeps contextual relevance moderate. However, the quantitative inaccuracies are severe enough to make the answer largely incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 497,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial impact of energy-related derivatives on natural gas cost and revenue hedging positions evolve from 2022 to 2023?",
      "original_answer": "In 2022, energy-related derivatives had a negative impact of $117 million on natural gas revenues and a $27 million negative impact on the cost of natural gas. In 2023, the impact shifted positively with a $59 million gain on the cost of natural gas, while the revenue impact remained neutral at $0. This indicates a transformation in the role and effectiveness of these derivatives in managing natural gas exposure.",
      "llm_answer": "In 2022 Southern Company’s energy‑related cash‑flow hedges produced a **$37 million gain** on the cost of natural gas, while the non‑designated derivative impact on natural‑gas revenues was a **$11 million loss**. By 2023 the cash‑flow hedge result had **reversed to a $44 million loss** on natural‑gas cost, and the revenue‑hedge impact was essentially neutral (no material gain or loss), with the non‑designated hedge on natural‑gas cost turning to a **$59 million gain** after a $65 million loss in 2022【page_294†L9-L15】【page_295†L9-L15】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both magnitude and direction of financial impacts. According to the ground truth, in 2022, energy-related derivatives had a $117 million negative impact on natural gas revenues and a $27 million negative impact on cost. However, the LLM claims a $37 million gain on cost and only an $11 million loss on revenue—both incorrect in sign and value. In 2023, the ground truth states a $59 million gain on cost and $0 impact on revenue, which partially aligns with the LLM’s mention of a $59 million gain on non-designated hedges for cost and neutral revenue impact. However, the LLM incorrectly introduces a $44 million loss from cash-flow hedges and a prior $65 million loss in 2022, which contradicts the ground truth. (2) Quantitative accuracy is poor: none of the 2022 figures match ($117M vs $11M revenue impact; $27M cost loss vs $37M gain), and the LLM fabricates additional figures (e.g., $44M loss, $65M prior loss) not present in the original answer. Only the $59M gain in 2023 on cost is correct. (3) The reasoning is flawed—instead of showing a clear evolution from negative to positive impacts, the LLM presents a contradictory and more complex picture involving multiple types of hedges (cash-flow vs non-designated) not mentioned in the original answer, suggesting incorrect multi-hop synthesis or misattribution of data across different derivative categories. (4) Contextual relevance is moderate because the answer addresses the general topic (evolution of derivative impacts on natural gas cost/revenue) and correctly identifies a shift in cost impact by 2023, but the incorrect numbers and added complexity reduce usefulness. The answer fails to reflect the actual transformation described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 488,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did Walmart's treatment of its Deferred Compensation Matching Plan evolve between the 2023 and 2024 10-K filings, particularly in terms of its documentation status and effective date?",
      "original_answer": "In the 2023 10-K filing, the Deferred Compensation Matching Plan was newly introduced as 'Walmart Inc. Deferred Compensation Matching Plan, as amended and restated effective November 8, 2023.' By the 2024 10-K filing, the plan was no longer labeled as newly introduced but was instead referenced as being 'incorporated by reference' to the 2024 Annual Report on Form 10-K, indicating that it had become an established, ongoing plan. The effective date remained unchanged at November 8, 2023, suggesting no substantive changes to the plan’s implementation timeline, but its treatment shifted from being newly introduced to being formally integrated into the company's long-term compensation framework.",
      "llm_answer": "In Walmart’s 2023 Form 10‑K the Deferred Compensation Matching Plan was only incorporated by reference to Exhibit 10.1 (no asterisk, not attached) and described as “as amended and restated effective November 8, 2023”【page_84】. By the 2024 Form 10‑K the plan is still listed as Exhibit 10.1 but now carries an asterisk indicating it is filed herewith as an exhibit (i.e., attached)【page_84 (asterisk version)】, and the amendment’s effective date remains November 8, 2023【page_84】.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the effective date of the Deferred Compensation Matching Plan as November 8, 2023, in both the 2023 and 2024 10-K filings, which matches the ground truth. It also accurately notes the plan's presence in Exhibit 10.1 in both years and the change in asterisk notation indicating it was newly filed as an attachment in 2024. These details are factually correct and supported by the cited page references. (2) Quantitatively, all dates and exhibit numbers are accurate, with no errors in numbers or references. (3) However, the LLM mischaracterizes the nature of the evolution. The original answer emphasizes a shift in documentation status from being 'newly introduced' in 2023 to being 'incorporated by reference' and established in 2024, reflecting integration into the long-term framework. The LLM incorrectly states that in 2023 the plan was 'incorporated by reference' (implying it was not attached), but in 2024 it was 'filed herewith' due to the asterisk. This contradicts standard SEC filing conventions: an asterisk typically means 'filed herewith' only if not previously filed; if incorporated by reference, it means the exhibit is not attached but available elsewhere. The LLM reverses the implication: being newly introduced in 2023 likely meant it was attached (with asterisk), while in 2024 it became incorporated by reference (no asterisk). The reasoning is thus flawed in interpreting exhibit labeling conventions. (4) While the LLM provides specific exhibit-level detail not in the ground truth, it misinterprets the significance of the asterisk and the direction of change in documentation status, undermining the qualitative accuracy. The core date is correct, but the synthesis of how the plan’s treatment evolved is incorrect. Hence, correctness is partially accurate but misses the key conceptual shift described in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 515,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the disclosure and treatment of LTIP Units evolved between 2023 and 2024, particularly in terms of their dilutive effect and accrual policy?",
      "original_answer": "In 2023, LTIP Units were described as potentially dilutive securities that are convertible into units and exchangeable for common stock, with no material dilutive effect reported for the years 2023, 2022, and 2021. The company stated it does not adjust net income attributable to common stockholders or weighted average shares outstanding due to no dilutive impact. In 2024, the disclosure simplified, stating that LTIP Units are potentially dilutive but again noting no material dilutive effect for the years 2024, 2023, and 2022. Additionally, the accrual policy remained consistent, stating that distributions are accrued when declared. The treatment of LTIP Units remained stable with no significant change in dilutive impact or accrual policy.",
      "llm_answer": "In the 2023 filing the company noted that “potentially dilutive securities include … long‑term incentive performance units, or LTIP units… No securities had a material dilutive effect” and that “we accrue dividends when they are declared” (per‑share) and “we accrue distributions when they are declared” (operating‑partnership)【page_111】【page_112】. The 2024 filing repeats the same language – LTIP units are still listed as potentially dilutive but “had no material dilutive effect” for 2024, and the company continues to accrue dividends and distributions when declared【page_114】. Thus, the disclosure and treatment of LTIP units have not changed; they remain non‑material for dilution and the accrual policy is unchanged.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original answer. (1) It accurately captures that LTIP Units were disclosed as potentially dilutive in both 2023 and 2024 with no material dilutive effect reported for the respective years, matching the ground truth. The accrual policy—distributions accrued when declared—is correctly stated for both years. (2) There are no numeric values requiring calculation (e.g., percentages, dollar amounts), but the temporal scope (2023, 2022, 2021 in 2023 filing; 2024, 2023, 2022 in 2024 filing) is correctly reflected. (3) The multi-hop reasoning—comparing disclosures across two years and synthesizing changes (or lack thereof) in dilutive effect and accrual policy—is sound and complete. (4) The answer directly addresses both parts of the question: evolution in disclosure/treatment, dilutive effect, and accrual policy. Wording differs slightly but meaning is preserved. No factual errors, omissions, or misinterpretations. All scores are 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 288,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Meta's compliance approach to the EU-U.S. Data Privacy Framework (EU-U.S. DPF) evolved between 2023 and 2024, particularly in response to regulatory actions and decisions?",
      "original_answer": "In 2023, Meta was in the process of implementing steps to comply with corrective orders from the Irish Data Protection Commission (IDPC) following a EUR €1.2 billion fine and a directive to suspend unlawful data transfers to the U.S. under Standard Contractual Clauses (SCCs). At that time, the EU-U.S. DPF had just been finalized, and Meta viewed its implementation as a key milestone to address data transfer compliance. By 2024, Meta had implemented compliance measures with the corrective orders and was actively engaging with regulators on new compliance models, such as the 'subscription for no ads' alternative introduced in November 2023. In 2024, the European Commission opened formal proceedings into the compliance of this model with the Digital Markets Act (DMA), issuing preliminary findings in July 2024 that suggested non-compliance. This reflects a shift from foundational compliance with the EU-U.S. DPF framework to navigating more complex regulatory scrutiny around specific business models under evolving EU laws.",
      "llm_answer": "In its 2023 Form 10‑K Meta said it was appealing the Irish Data Protection Commission’s €1.2 bn fine over its SCC‑based transfers and was taking corrective steps to bring its processing into line with the newly adopted EU‑U.S. Data Privacy Framework and the July 2023 adequacy decision (2023 p.10‑11). By the 2024 filing Meta still relies on the DPF but has broadened its compliance program – it has moved to a consent‑based advertising model, launched a “subscription for no ads” option, and is actively engaging with EU regulators in DMA proceedings while continuing to monitor the DPF’s legal stability and implement any additional steps required (2024 p.10‑11).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Meta was responding to the €1.2 billion fine from the Irish Data Protection Commission (IDPC) in 2023, the EU-U.S. DPF was newly adopted, and Meta was implementing corrective steps. By 2024, Meta had broadened its compliance approach, including launching a 'subscription for no ads' model and engaging with regulators under the DMA. (2) Quantitative accuracy is perfect: the €1.2 billion fine is correctly cited, and no incorrect numbers or dates are present. The reference to the July 2023 adequacy decision is accurate and matches the timeline. (3) Multi-hop reasoning is sound: the answer synthesizes information across 2023 and 2024 filings, connects regulatory actions (IDPC fine, DPF adoption, DMA scrutiny), and correctly identifies the evolution from foundational compliance to more complex regulatory engagement. The only minor omission is that the original answer notes the European Commission issued preliminary findings of non-compliance in July 2024, which the LLM answer does not explicitly mention—though it does reference ongoing DMA proceedings, which is partially correct. (4) The answer is contextually relevant, directly addressing how Meta’s compliance approach evolved in response to regulatory actions. Wording differs but semantic meaning is equivalent. Minor deduction in qualitative accuracy for not fully capturing the 2024 DMA preliminary findings, but overall excellent performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 415,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Linde's approach to green hydrogen production evolved between 2023 and 2024, particularly in terms of production methods and emphasis on renewable energy sources?",
      "original_answer": "In 2023, Linde described green hydrogen as being produced primarily through electrolysis using renewable energy or from steam methane reforming of biomethane, and it was presented as one of the company's clean energy offerings alongside blue hydrogen. By 2024, the company had expanded its description to emphasize green hydrogen as 'renewable hydrogen' produced by electrolysis using renewable energy and water as feedstock, and it was clearly differentiated from low-carbon (blue) hydrogen. Additionally, in 2024, Linde placed more emphasis on the carbon intensity metric to differentiate production methods, indicating a more refined and strategic framing of green hydrogen within the broader context of clean energy solutions.",
      "llm_answer": "In the 2023 filing Linde said that green hydrogen could be made either by electro‑lysis powered with renewable electricity **or** by steam‑methane reforming of biomethane (2023 10‑K p. 4). By the 2024 filing the company had narrowed its definition to renewable hydrogen produced **solely** by electro‑lysis using renewable energy and water, dropping the biomethane route and placing a stronger emphasis on clean‑energy power sources (2024 10‑K p. 4).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Linde's 2023 definition of green hydrogen as including both electrolysis using renewable energy and steam methane reforming (SMR) of biomethane, and the shift in 2024 to a narrower definition based solely on electrolysis using renewable energy and water. This matches the original answer's claim about a refined framing and exclusion of the biomethane route. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2023, 2024) and page references (p. 4) are consistent and plausible. (3) The multi-hop reasoning is sound: the model synthesizes changes in definition and emphasis across two years, correctly inferring a strategic narrowing and increased focus on renewable-powered electrolysis. The only minor omission is that the LLM answer does not explicitly mention the increased emphasis on 'carbon intensity' as a differentiating metric in 2024, which is included in the ground truth and represents a subtle but important aspect of Linde’s strategic framing. (4) Despite this omission, the core evolution in production methods and emphasis on renewable sources is accurately conveyed, with correct entities (Linde, green hydrogen, electrolysis, biomethane, renewable energy), correct years, and proper contextualization. The answer is semantically equivalent to the ground truth with slightly less detail on the carbon intensity metric. Hence, correctness and qualitative accuracy are high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 437,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Southern Company's relationship with Sequent evolve between 2022 and 2023, and what were the financial implications of this change?",
      "original_answer": "Southern Company's relationship with Sequent evolved from a business ownership relationship in 2022 to a completed divestiture in 2023. In 2022, Southern Company Gas completed the sale of Sequent to Williams Field Services Group for $159 million, recognizing a pre-tax gain of $121 million. Additionally, the sale resulted in $85 million of additional tax expense due to changes in state apportionment rates. By 2023, Sequent was no longer part of Southern Company's portfolio, and the financial impact of the sale was fully reflected in the company's financial statements, with the gain from the sale reported as a $121 million pre-tax benefit. This marked a complete transformation in the relationship, shifting from operational integration to full separation.",
      "llm_answer": "Southern Company sold its Sequent wholesale‑gas business (completed July 1, 2021); the 2022 filing notes that the transaction produced a pre‑tax gain of about $121 million (≈$92 million after‑tax) and $85 million of additional tax expense, and that wholesale gas services ceased to be a reportable segment【page_57】. The 2023 filing confirms that, because of the Sequent sale, wholesale gas services is no longer a reportable segment in 2023 (or 2022) and continues to reflect the same $121 million pre‑tax gain and $85 million tax expense from the sale【page_302】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key financial figures—the $121 million pre-tax gain and $85 million additional tax expense—which match the ground truth. However, it incorrectly states the sale was completed on July 1, 2021, which directly contradicts the original answer stating the sale occurred in 2022. This is a critical factual error affecting the timeline of Southern Company's relationship with Sequent. The original answer specifies that the divestiture was completed in 2022, not 2021, and that by 2023 Sequent was fully separated. The LLM’s claim that the sale occurred in 2021 undermines the evolution of the relationship between 2022 and 2023, which is the core of the question. (2) Quantitatively, the dollar amounts ($121M gain, $85M tax expense) are accurate and consistently reported across years, but the incorrect date invalidates the temporal progression. The after-tax gain of ~$92 million is not mentioned in the ground truth and appears to be an inference; while mathematically plausible, it introduces unverified information. (3) The reasoning partially captures the multi-hop aspect: it connects the sale to the removal of wholesale gas as a reportable segment in both 2022 and 2023 filings, showing synthesis across years. However, because the sale is misdated, the analysis of the 2022–2023 evolution is flawed—the relationship did not evolve during those years if the sale already occurred in 2021. (4) Contextual relevance is high because the answer addresses both the nature of the relationship change and financial implications, citing appropriate segments from filings. Despite correct financial data and logical structure, the incorrect timeline significantly reduces factual accuracy, warranting a moderate correctness score of 6.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 484,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Walmart's relationship with the Allswell brand evolved between 2023 and 2024, and what does this indicate about its strategic positioning within the company's private brand portfolio?",
      "original_answer": "In 2023, Walmart introduced the Allswell brand as part of its private brand offerings, indicating its initial entry into the market. By 2024, the brand was not only retained but explicitly listed among other mature private brands like 'bettergoods,' 'Equate,' and 'Great Value,' suggesting that Allswell has transitioned from a newly introduced brand to a more established part of Walmart's private label strategy. This evolution indicates that Allswell has likely gained traction and is being positioned as a core component of Walmart’s private brand portfolio.",
      "llm_answer": "Walmart’s 2023 10‑K lists Allswell among its U.S. private‑brand lines, and the 2024 filing again includes Allswell in the same private‑brand roster (see page 7 in both filings). The brand’s continued presence shows that Walmart has not altered its relationship with Allswell – it remains a core private label – signalling that Walmart is deliberately keeping Allswell as part of its broader private‑brand strategy to reinforce everyday low‑price leadership and capture higher margins.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. It accurately states that Allswell was listed in both the 2023 and 2024 10-K filings as part of Walmart's private-brand lines, confirming its continued presence. The claim that Allswell remains a 'core private label' is consistent with the original answer's assertion that it has transitioned to an established part of Walmart’s portfolio. The reasoning about strategic positioning—emphasizing everyday low-price leadership and higher margins—is a reasonable interpretation supported by the context, though slightly more interpretive than the original. There are no errors in entities (Walmart, Allswell, 2023, 2024), and the multi-hop synthesis across two years of filings is correctly executed. The only minor difference is that the original answer explicitly notes Allswell's introduction in 2023 and evolution into a mature brand by 2024, which the LLM implies but does not explicitly state. However, the LLM’s conclusion about strategic continuity effectively captures the same insight. All factual elements are accurate, and the answer is fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 324,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has the strategic importance of Embedded Processing products evolved from 2022 to 2023 based on TXN's revenue composition and strategic emphasis?",
      "original_answer": "In 2022, Embedded Processing products were described as one of two core segments, positioned alongside Analog as a key part of the business, though no specific revenue figures were disclosed. By 2023, Embedded Processing remained a strategic focus area, and notably, it partially offset a decline in Analog revenue, contributing to a $17.52 billion total revenue. This indicates that while Embedded Processing maintained its strategic importance, it also played a more pronounced compensatory role in the revenue mix during a year of overall revenue decline.",
      "llm_answer": "In 2023 Texas Instruments’ Embedded‑Processing revenue rose to $3.37 billion, a 3 % increase over the $3.26 billion earned in 2022, and its share of total revenue grew from roughly 16 % of $20.0 billion to about 19 % of $17.5 billion [page_20]. The 2023 MD&A reiterates that analog and embedded‑processing products are the core of TI’s business model and a primary driver of cash‑flow generation, emphasizing that this segment remains a central strategic focus [page_19][page_18].",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific revenue figures for Embedded Processing in 2022 ($3.26B) and 2023 ($3.37B), as well as total revenues ($20.0B in 2022, $17.5B in 2023), which are not present in the original ground truth answer. The ground truth explicitly states that 'no specific revenue figures were disclosed' for 2022, making the inclusion of $3.26B and $3.27B in the LLM answer factually incorrect with respect to the provided knowledge base. The 3% growth and percentage share increase from 16% to 19% are derived from these numbers but are not verifiable against the ground truth, which does not provide such granularity. (2) While the total revenue of $17.52B in 2023 in the ground truth is closely approximated as $17.5B (acceptable rounding), the $20.0B total revenue for 2022 and Embedded Processing segment figures are unsupported in the original answer, indicating fabrication or hallucination of data. These quantitative inaccuracies significantly affect the correctness score. (3) The qualitative reasoning is strong: the LLM correctly identifies that Embedded Processing remained a strategic focus alongside Analog, and it infers a growing relative importance due to rising share of total revenue during a period of overall decline—aligning with the ground truth's point about Embedded Processing partially offsetting Analog's decline. The citation of strategic emphasis from the 2023 MD&A supports the continuity of strategic importance. (4) Contextual relevance is excellent—the response directly addresses the evolution of strategic importance through both revenue composition and stated strategic emphasis. However, the hallucinated numerical data undermines quantitative accuracy, preventing a higher score. Despite this, the core qualitative insight—that Embedded Processing gained relative strategic weight in compensating for Analog's decline—is consistent with the ground truth, warranting a solid but not high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 531,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has Chevron's involvement in Angola LNG evolved from 2022 to 2024, and what does this indicate about its strategic positioning in the LNG market?",
      "original_answer": "In 2022, Chevron's involvement in Angola LNG was referenced in the context of its production volumes, indicating operational participation. By 2024, Chevron's stake in Angola LNG Limited was explicitly stated as a 36.4% interest, highlighting a more defined and structured investment approach. This evolution suggests a strategic shift toward securing a stable position in the LNG market through formalized equity stakes.",
      "llm_answer": "In 2022 Chevron’s Angola LNG affiliate was listed as part of its production portfolio and generated $1,857 million of equity earnings (see page 8 and the equity‑earnings line for Angola LNG in page 84). By 2024 the investment balance had fallen to $1,665 million and equity earnings to $405 million, although Chevron still owns a 36.4 % stake in the project (see page 84 and the ownership‑percentage note in page 85), indicating that while the company retains a sizable LNG foothold, the Angola LNG asset’s contribution to earnings has weakened, suggesting a strategic re‑balancing toward other LNG opportunities or market‑driven adjustments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures—$1,857 million and $405 million in equity earnings, and investment balances of $1,665 million—that are not present in the original answer and cannot be verified against the ground truth. The ground truth does not mention any financial performance metrics for Angola LNG, only production volumes in 2022 and a 36.4% stake in 2024. These fabricated numbers significantly undermine factual accuracy. (2) While the 36.4% stake in 2024 is correctly reported and aligns with the ground truth, the inclusion of unverified dollar amounts and the claim of declining earnings and investment balance are unsupported and likely incorrect, as no such data appears in the original knowledge base. There is no indication in the ground truth that Chevron’s involvement decreased financially—only that its stake became more explicitly defined. (3) The multi-hop reasoning is partially sound in that it identifies a progression from operational involvement to a defined equity stake, but it overreaches by inferring a strategic re-balancing due to declining earnings, which is not supported by the evidence provided in the original answer. The conclusion about strategic re-positioning based on earnings decline is speculative and not aligned with the ground truth, which frames the evolution as a move toward a more structured investment. (4) The contextual relevance is high because the answer addresses Chevron’s evolving role in Angola LNG and attempts to interpret strategic implications. However, the correctness score is low due to the introduction of false quantitative data, which fundamentally misrepresents the situation. The qualitative accuracy is moderate because entity identification (Chevron, Angola LNG, 36.4% stake) and timeframes are correct, but reasoning is flawed by unsupported financial claims.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 506,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the financial contribution and production status of the CH-53K program evolved between 2021 and 2024, and what does this indicate about its role within Lockheed Martin's RMS division?",
      "original_answer": "In 2021, the CH-53K program contributed to a $540 million increase in RMS net sales, driven by higher production volume alongside the Black Hawk and CRH programs. Additionally, it contributed to a $140 million increase in operating profit due to higher risk retirements and production volume. By 2024, the CH-53K program was described as being in a 'production ramp-up' phase, contributing $1.1 billion to higher product sales within RMS, indicating a shift from early-stage production and risk retirement to a more mature, high-volume production phase. This evolution shows that the CH-53K has transitioned from a developing program with growing financial impact to a key growth driver within RMS.",
      "llm_answer": "In 2021 the CH‑53K helped lift RMS’s overall sales by $540 million (the bulk of the $794 million RMS net‑sales increase) and added roughly $140 million of operating profit through higher production volume and risk retirements for the Sikorsky helicopter line【page_50】. By 2024 the filing notes that “higher production volume on CH‑53K program” was a key driver of the segment’s higher product‑sales growth, signalling a continued production ramp‑up even though a specific dollar amount is not disclosed【page_34】. Together, these trends show the CH‑53K moving from an early‑stage sales contributor in 2021 to a core, growth‑driving program that underpins RMS’s helicopter portfolio and overall revenue outlook.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $540 million contribution to RMS net sales and $140 million increase in operating profit in 2021, aligning with the ground truth. However, it introduces an unsupported detail — that this $540 million constituted 'the bulk of the $794 million RMS net-sales increase' — which is not present in the original answer and cannot be verified from the provided context, making it a minor factual overreach. In 2024, the original answer specifies a $1.1 billion contribution to higher product sales, but the LLM states that 'a specific dollar amount is not disclosed,' which contradicts the ground truth. This is a significant omission affecting quantitative accuracy. (2) The core numbers for 2021 are accurate ($540M sales, $140M profit), but the 2024 financial figure of $1.1 billion is missing, likely due to incorrect interpretation of the source document. The LLM incorrectly implies no dollar amount was disclosed, when the ground truth explicitly includes $1.1 billion. (3) The multi-hop reasoning is otherwise sound: the LLM correctly infers the program's evolution from early-stage contributor to a core growth driver, synthesizing production ramp-up and financial impact across years. The qualitative assessment of the CH-53K’s growing strategic role within RMS is consistent with and well-supported by the evidence. (4) The correctness score is 8 due to the missing $1.1 billion figure in 2024, which is a key data point; however, the reasoning, entity accuracy (CH-53K, RMS, Sikorsky), and timeline (2021 to 2024) are all correct. Quantitative accuracy is penalized for the omission and the unsupported $794M claim, but qualitative and contextual scores remain high due to strong synthesis and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 479,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did PayPal's use of macroeconomic factors in its loss curves for revolving consumer credit products evolve between 2022 and 2023?",
      "original_answer": "In 2022, PayPal applied macroeconomic factors such as forecasted trends in unemployment and benchmark credit card charge-off rates to its revolving consumer credit loss curves, using a single scenario deemed most appropriate for the economic conditions. By 2023, the company updated its expected credit loss models for revolving consumer receivables to include forecasted trends in household disposable income and retail e-commerce sales, replacing unemployment rates after the first quarter of 2023. This reflects a shift in the macroeconomic indicators used to inform loss curves for this segment.",
      "llm_answer": "In the 2022 filing PayPal said its revolving‑credit loss curves were built on historical loss data plus macro‑economic inputs of **forecasted unemployment trends and benchmark credit‑card charge‑off rates**, applying a **≈ 2‑year forecast horizon** for the revolving portfolio【page_54】. By the 2023 filing the company had **expanded the macro‑economic assumptions** to also include **forecasted household disposable‑income and retail e‑commerce sales** (while still using unemployment through Q1 2023), **lengthened the forecast period to roughly 5 years + (about 5 years 7 months)**, and updated the revolving‑credit loss models in Q2 2023 (the changes were not material)【page_70】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution in PayPal's use of macroeconomic factors in its loss curves between 2022 and 2023. It correctly identifies the 2022 inputs (forecasted unemployment trends and benchmark credit card charge-off rates) and notes the 2023 expansion to include household disposable income and retail e-commerce sales, while accurately stating that unemployment was still used through Q1 2023. The LLM adds specific details not in the original answer—such as the forecast horizon increasing from ~2 years to ~5 years and 7 months—which are consistent with typical model enhancements but not explicitly mentioned in the ground truth. Since these details do not contradict the original and are plausible elaborations (possibly from the cited pages), they do not reduce accuracy. The core multi-hop reasoning—comparing model inputs and changes across years—is sound and correctly synthesized. All entities (PayPal, revolving credit, correct years) are accurate. The only minor deviation is that the original answer emphasizes the *replacement* of unemployment after Q1 2023, while the LLM says 'still using unemployment through Q1 2023'—which is semantically equivalent. No calculation errors. The added forecast horizon detail improves completeness without introducing inaccuracy. Thus, the answer is factually correct, complete, and contextually precise, warranting a 9/10 due to slight over-elaboration on timing details not in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 407,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Starbucks' foreign currency debt-related gains or losses included in AOCI change from 2023 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2023, Starbucks reported a foreign currency debt-related loss of $6.3 million included in OCI before reclassifications, while in 2024, the company reported a gain of $135.2 million in AOCI related to foreign currency debt. This indicates a significant shift from a loss to a substantial gain, suggesting a reversal in the company's exposure to foreign currency fluctuations over this period.",
      "llm_answer": "Starbucks recorded **$135.2 million** of net gains on foreign‑currency‑denominated debt in AOCI for fiscal 2024, down from **$140.2 million** in fiscal 2023 – a decline of about **$5 million**. The lower gain indicates that the impact of foreign‑currency fluctuations on its hedged debt was slightly reduced, suggesting a modest easing of exposure (or more effective hedging) to currency movements in 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude of the change in foreign currency debt-related gains/losses. The ground truth states that Starbucks had a loss of $6.3 million in 2023 and a gain of $135.2 million in 2024, representing a shift from loss to large gain. However, the LLM claims gains of $140.2 million in 2023 and $135.2 million in 2024, implying a decrease in gains, which is entirely wrong. This misrepresents the financial reality and trend. (2) The numbers are incorrect: the 2023 figure is stated as $140.2 million gain instead of a $6.3 million loss, introducing an error of over $146 million. The 2024 number ($135.2 million) is correct. The claimed 'decline of $5 million' is based on false inputs and is therefore also incorrect. (3) The multi-hop reasoning fails because the model did not correctly retrieve or synthesize the data across years. It incorrectly characterizes both the 2023 value and the trend, leading to a flawed conclusion about reduced exposure or better hedging. In reality, the shift from a small loss to a large gain suggests a significant reversal in currency movements affecting debt, not a modest change. (4) The contextual relevance is moderate because the answer addresses the right topic (AOCI, foreign currency debt, exposure implications), but the qualitative and quantitative inaccuracies severely undermine the correctness. The reasoning would be plausible if the numbers were right, but they are not. Hence, low scores for correctness and quantitative accuracy, slightly higher for qualitative reasoning due to structural coherence, and moderate for relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 451,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the fair value of energy-related derivatives for Alabama Power and Georgia Power change between 2022 and 2023, and what was the overall trend in their combined liabilities related to these derivatives?",
      "original_answer": "In 2022, Alabama Power reported a net liability of $144 million related to derivatives in non-designated hedging relationships, including energy-related derivatives. In 2023, Alabama Power had $15 million in assets and $110 million in liabilities related to energy-related derivatives, resulting in a net liability of $95 million. Georgia Power had $13 million in assets and $124 million in liabilities related to energy-related derivatives in 2023, yielding a net liability of $111 million. Therefore, the combined net liability for energy-related derivatives across both entities decreased from $255 million in 2022 to $206 million in 2023, indicating a reduction in exposure.",
      "llm_answer": "The two utilities’ energy‑related derivative assets dropped sharply – the combined fair‑value went from $199 million in 2022 (the total shown for Southern Company’s energy‑related derivatives) to just $28 million in 2023 (Alabama Power $15 million and Georgia Power $13 million)【page_283】【page_281】.  By contrast, their combined derivative liabilities rose, increasing from $210 million in 2022 to $234 million in 2023 (Alabama Power $110 million + Georgia Power $124 million)【page_281】, showing an upward trend in liabilities.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in both assets and liabilities for 2022, particularly fabricating a $199 million combined asset value and $210 million liability value for 2022 that are not supported by the ground truth. The ground truth states that in 2022, Alabama Power had a net liability of $144 million (with no asset figure provided), and no data is given for Georgia Power in 2022. The LLM incorrectly assumes Southern Company's total energy-related derivatives represent the combined assets of the two utilities in 2022, which is unsupported. (2) For 2023, the LLM correctly reports Alabama Power’s $15 million in assets and $110 million in liabilities, and Georgia Power’s $13 million in assets and $124 million in liabilities, resulting in a correct combined liability of $234 million. However, it misrepresents the 2022 baseline: the ground truth only provides Alabama Power’s 2022 net liability of $144 million and does not mention Georgia Power’s 2022 derivatives, so the LLM’s claim of $210 million in combined 2022 liabilities is speculative and incorrect. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize that only Alabama Power reported a net liability in 2022 ($144 million), and Georgia Power’s data is only available for 2023. It incorrectly infers full 2022 data for both entities. The conclusion that liabilities increased is incorrect—the ground truth shows a decrease from $255 million (Alabama $144M + Georgia’s implied $111M in 2022, though not stated) to $206 million in 2023. However, the ground truth explicitly calculates a decrease from $255M to $206M, implying Georgia Power had a $111M net liability in 2022. The LLM does not make this inference and instead uses incorrect component values. (4) The contextual relevance is moderate—it addresses the right entities and topic, and correctly reports 2023 figures, but the core quantitative claims about trends are reversed (claims liabilities increased when they decreased). Due to major errors in 2022 data reconstruction and trend direction, the correctness score is low despite partial accuracy in 2023 data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 577,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Walmart's financial relationship with Alert Innovation evolve between fiscal 2023 and fiscal 2024, particularly in terms of acquisition and subsequent disposition activities?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, bringing its ownership to approximately 100%. However, in fiscal 2024, Walmart sold and deconsolidated the Alert Innovation entity, signaling a complete exit from the investment. This represents a full evolution from acquisition to divestiture within a one-year span.",
      "llm_answer": "In fiscal 2023 Walmart completed a $0.4 billion acquisition of Alert Innovation, taking its ownership to roughly 100 % ( “During fiscal 2023 … completed a $0.4 billion acquisition of Alert Innovation, bringing our ownership to approximately 100 %” – page 44). No further purchase‑or‑sale of Alert Innovation is mentioned for fiscal 2024, indicating the company simply held the subsidiary that year; the entity was not disposed of until it was sold and de‑consolidated in fiscal 2025 (“The Alert Innovation entity was subsequently sold and deconsolidated in fiscal 2025” – page 44).",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $0.4 billion acquisition in fiscal 2023 and Walmart's ownership reaching approximately 100%, which matches the ground truth. However, it incorrectly states that the sale and deconsolidation occurred in fiscal 2025, directly contradicting the ground truth that this occurred in fiscal 2024. This is a critical factual error affecting the core of the question about the evolution between fiscal 2023 and 2024. (2) Quantitatively, the $0.4 billion amount and 100% ownership are accurate, earning partial credit. The misstatement of the year of divestiture (fiscal 2025 vs. 2024) is a major date error that undermines the timeline. (3) The multi-hop reasoning fails because the model incorrectly extends the timeline beyond the two-year window specified in the question. It also cites page 44 for both statements, suggesting it had access to the correct document, but misrepresents the fiscal year of the disposition, indicating a failure in information synthesis. (4) The contextual relevance is fair because the answer addresses acquisition and disposition activities as asked, but the incorrect fiscal year for the sale severely compromises the correctness. The answer suggests continuity into fiscal 2025, which distorts the actual one-year flip from acquisition to divestiture, making the overall narrative factually wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 383,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the regulatory approval status of Trodelvy evolve between 2022 and 2023, and what does this indicate about Gilead's oncology strategy?",
      "original_answer": "In 2022, Trodelvy was part of Gilead's marketed product portfolio and contributed to growth in the oncology franchise, though no specific regulatory updates were mentioned. By 2023, Trodelvy received both FDA and EC approvals for the treatment of adult patients with unresectable locally advanced or metastatic HR+/HER2- breast cancer who had received prior endocrine-based therapy and at least two additional systemic therapies. This regulatory progress indicates a strategic focus by Gilead on expanding the therapeutic applications of Trodelvy and strengthening its position in the oncology market, particularly in breast cancer treatment.",
      "llm_answer": "In the 2022 filing Gilead reported that Trodelvy already had U.S. FDA full approval for metastatic triple‑negative breast cancer (TNBC) and accelerated approval for urothelial cancer, and it was also authorized in the EU and Canada for TNBC (see 2022 page 39). By the 2023 filing the company added new FDA and European Commission approvals for Trodelvy as a monotherapy in HR⁺/HER2‑negative breast cancer, expanding the label beyond its original indications (see 2023 page 39). This progression shows Gilead deliberately broadening Trodelvy’s approved uses across multiple tumor types, underscoring an oncology strategy that leans on expanding existing assets to build a diversified, growth‑driven cancer franchise.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022, Trodelvy was already approved for metastatic triple-negative breast cancer (TNBC) and urothelial cancer, with authorizations in the U.S., EU, and Canada—consistent with Gilead's 2022 10-K (page 39). While the original answer does not list these specific 2022 indications, they are factually correct and provide helpful context. (2) For 2023, the LLM accurately reports the new FDA and European Commission approvals for HR+/HER2-negative breast cancer, matching the ground truth in both regulatory bodies and indication. No numeric values are incorrect; dates (2022 vs. 2023) are properly attributed. (3) The reasoning is sound: the LLM correctly infers that label expansion across tumor types reflects a strategic effort to grow Gilead’s oncology franchise by maximizing existing assets—this is a valid interpretation supported by both filings. (4) The answer fully addresses both parts of the question: evolution of regulatory status and implications for oncology strategy. The only minor gap is that the original answer emphasizes 'unresectable locally advanced or metastatic' disease, which the LLM omits but includes the clinically equivalent 'HR+/HER2-negative breast cancer' indication. This does not affect factual correctness. Overall, the answer demonstrates strong multi-hop synthesis across years and regulatory jurisdictions, with excellent contextual relevance and precise qualitative and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 421,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Simon Property Group's financial relationship with ABG evolved between 2023 and 2024, particularly in terms of capital transactions and strategic positioning?",
      "original_answer": "In 2023, Simon Property Group (SPG) engaged in multiple capital transactions with ABG, including recognizing a non-cash pre-tax gain of $36.4 million from a dilution of ownership in ABG during the second quarter and an additional $145.8 million gain in the third quarter due to further dilution from SPARC Group issuing equity. Additionally, SPG had a long-standing strategic partnership with ABG dating back to 2021, involving licensing ventures such as Forever 21, Brooks Brothers, and Eddie Bauer, which resulted in significant gains. In 2024, SPG no longer reported active capital transactions with ABG, such as gains from dilution or new equity investments. Instead, the 2024 filing only referenced historical transactions, such as the 2021 sale of a portion of SPG’s ABG interest for a pre-tax gain of $18.8 million and the 2022 acquisition of Reebok assets alongside a strategic partnership. This indicates a shift from active financial engagement and restructuring with ABG in 2023 to a more stable, historically referenced relationship in 2024.",
      "llm_answer": "In 2023 Simon gradually reduced its ABG stake – selling a portion of its interest in the fourth quarter (pre‑tax gain $157.1 m) and, through a series of ABG‑initiated capital transactions, saw its ownership diluted from roughly 11.8 % to about 9.6 % (non‑cash gains of $36.4 m, $12.4 m and $10.3 m)【page_71】. By contrast, in the first quarter of 2024 Simon sold its remaining ABG interest for $1.2 billion, generating a $414.8 million pretax gain and fully exiting the partnership【page_73】—a clear strategic shift from a minority, joint‑venture partner to a cash‑focused divestiture that frees capital for its core REIT operations.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Simon Property Group (SPG) did not sell its remaining ABG interest in Q1 2024 for $1.2 billion or record a $414.8 million gain. Instead, the 2024 filings only referenced historical transactions with ABG and reported no new capital transactions. The LLM incorrectly asserts a major divestiture in 2024 that is not supported by the ground truth. Additionally, the claimed 2023 gains of $36.4M, $12.4M, and $10.3M do not match the ground truth, which reports a $36.4M gain in Q2 and a $145.8M gain in Q3 (from SPARC equity issuance), not the smaller, fragmented gains cited. The $157.1M gain in Q4 2023 is also not mentioned in the original answer. (2) The quantitative inaccuracies are severe: the total gains reported by the LLM for 2023 sum to $216.2M ($36.4M + $12.4M + $10.3M + $157.1M), which does not align with the ground truth total of $182.2M ($36.4M + $145.8M). The 2024 gain of $414.8M and sale price of $1.2B are entirely fabricated. Ownership percentages (11.8% to 9.6%) are not mentioned in the ground truth and cannot be verified. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers an active 2024 divestiture based on 2023 activity, whereas the ground truth indicates a cessation of active transactions in 2024. The strategic shift described—exiting the partnership to free capital—is speculative and not supported by the original answer, which notes only historical references in 2024 filings. (4) The contextual relevance is moderate because the answer addresses capital transactions and strategic positioning, but the factual foundation is incorrect, undermining both qualitative and quantitative accuracy. The correctness score is low due to major factual and numerical errors that change the fundamental narrative of SPG’s relationship with ABG.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 509,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Chevron's relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2024, particularly in terms of financial reporting and investment value?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was included in Chevron’s consolidated financial disclosures, specifically in Note 8 on page 70 of the 10-K filing, indicating it was a consolidated subsidiary. By 2024, the company was reported as an equity method investee under 'Downstream' in the Investments and Advances section, with a disclosed investment value of $8,571 million as of December 31, 2024, up from $7,765 million in 2023. This reflects a shift from full consolidation to an equity method investment, suggesting a structural or ownership change in Chevron’s relationship with the entity.",
      "llm_answer": "In the 2022 filing Chevron disclosed that it owned 50 % of Chevron Phillips Chemical Company LLC and recorded the equity‑method investment with $867 million of equity earnings (Note 8, summarized financial data)【page_32】. By the 2024 filing the ownership remained 50 %, but the carrying amount of the investment had risen to $8.571 billion and equity earnings grew to $903 million, and Chevron now also reports a $669 million loan to CPC for the Golden Triangle Polymers Project (Note 15, pages 84‑85)【page_84】【page_85】. Thus, while the ownership stake stayed the same, the financial reporting shows a larger investment balance and added loan exposure, indicating an increase in the value of Chevron’s stake in CPC.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding Chevron's accounting treatment of Chevron Phillips Chemical Company LLC (CPC). The original answer correctly states that in 2022, CPC was a consolidated subsidiary (fully consolidated in financial statements), but by 2024 it was reported as an equity method investee. However, the LLM claims that in 2022, Chevron already accounted for CPC using the equity method — this directly contradicts the ground truth and misrepresents the evolution of the relationship. This is a critical error in both entity classification and financial reporting methodology. (2) Quantitatively, the LLM correctly reports the 2024 investment value of $8,571 million (i.e., $8.571 billion) and mentions equity earnings of $903 million in 2024, but it incorrectly states the 2022 equity earnings as $867 million — the ground truth does not provide this figure for 2022 under equity method accounting because CPC was still consolidated then. The LLM also introduces a $669 million loan in 2024 (from Note 15), which may be factually present but is not part of the core evolution in investment value or reporting method and distracts from the main shift. The 2023 investment value of $7,765 million is omitted entirely. (3) The multi-hop reasoning is flawed: the key insight in the original answer is the shift from consolidation to equity method — a major structural change implying reduced control or ownership change — but the LLM assumes a constant 50% equity method investment throughout, missing this pivotal transition. This undermines the logical synthesis across years. (4) Despite these major errors, the answer is contextually relevant — it addresses the right company, correct time frame, and discusses investment value trends and financial disclosures. Some numbers (like the 2024 carrying amount) are accurate, and the mention of Note 8 and Note 15 shows document engagement. However, the core misrepresentation of accounting treatment severely limits correctness. Thus, the correctness score is low (4), quantitative accuracy is moderate (5 — numbers partially right but used in wrong context), qualitative accuracy is poor due to flawed reasoning (4), and contextual relevance remains high (8) as the response stays on topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 613,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did the status and financial impact of Meta's Facilities Consolidation Strategy evolve between the end of 2023 and the end of 2024?",
      "original_answer": "At the end of 2023, Meta had 'substantially completed' its facilities consolidation initiatives as part of the 2022 Restructuring, indicating the process was still ongoing. By the end of 2024, the company reported that it had 'completed the 2022 restructuring initiatives,' which included the facilities consolidation strategy, showing the process had reached full completion. Additionally, the 2024 disclosure included a financial summary of the 2022 Restructuring pre-tax charges across three years (2022–2024), indicating a retrospective quantification of the financial impact that was not explicitly detailed in 2023.",
      "llm_answer": "By the end of 2023 Meta said the facilities‑consolidation effort was “substantially completed” but still part of a broader $2.255 billion restructuring outlay for the year (the $389 million facilities‑consolidation component is included in that total)【page_104】【page_105】. By December 31 2024 the company reported that the 2022 restructuring – including the facilities‑consolidation plan – was fully completed, and the only remaining restructuring expense was $389 million, which the filing notes is entirely attributable to facilities consolidation【page_102】. This reflects a shift from a partially‑finished, larger‑scale restructuring in 2023 to a fully‑finished, isolated $389 million impact in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the evolution of Meta's Facilities Consolidation Strategy from 'substantially completed' in 2023 to 'fully completed' in 2024, aligning with the ground truth's core narrative. It accurately identifies that the 2022 restructuring, including facilities consolidation, was completed by the end of 2024 and references the $389 million figure tied to facilities consolidation. However, there are key quantitative inaccuracies: the $2.255 billion restructuring outlay mentioned for 2023 is not present in the ground truth and appears to conflate data across years or components without verification. The original answer does not specify a $389 million charge for facilities consolidation in 2023, nor does it state that this was the only remaining expense in 2024—rather, it emphasizes a retrospective summary of total pre-tax charges over 2022–2024, which the LLM omits. The LLM incorrectly implies that the entire $389 million was incurred in 2024 as the 'remaining' cost, which misrepresents the temporal distribution of expenses. While the qualitative progression (substantially completed → fully completed) is correct and contextually relevant, the financial impact is misrepresented due to unsupported figures and flawed attribution. The reasoning is partially sound but lacks proper multi-hop synthesis of the full three-year financial summary mentioned in the original. Thus, while the directional status change is accurate, the financial details are partially fabricated or misstated, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 426,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2024, particularly in terms of strategic focus and program status?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a key growth area that was dependent on U.S. Government authorization and funding, indicating that the programs were still in a development phase with uncertain future funding. By 2024, the company was actively producing hypersonic strike weapons under multiple programs with the U.S. Air Force and Army, showing a shift from a funding-dependent future initiative to an active production program. This evolution reflects a significant advancement in the maturity and strategic importance of hypersonics within Lockheed Martin's portfolio.",
      "llm_answer": "In the 2022 Form 10‑K, Lockheed Martin listed hypersonics only as a “key growth area” that could be limited by budget pressures and the need to transition development programs into production (2022 p. 14). By the 2024 filing, hypersonics had become a core element of its 21st Century Security strategy, with Skunk Works and the Missiles & Fire Control and Space segments actively designing, developing and fielding multiple hypersonic strike‑weapon programs for the Army, Navy and Air Force (2024 p. 3‑5).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Lockheed Martin's evolving involvement in hypersonics from 2022 to 2024: in 2022, hypersonics were a 'key growth area' dependent on funding and transition to production, while by 2024, the company was actively designing, developing, and fielding multiple programs across military branches. This matches the original answer’s core claim of a shift from development/funding-dependent status to active production. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but all years (2022, 2024) and document references (page numbers) are correctly cited—no factual inaccuracies. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of 10-K filings, correctly infers strategic evolution, and identifies relevant business segments (Skunk Works, Missiles & Fire Control, Space) and customer branches (Army, Navy, Air Force), adding specificity beyond the original answer. (4) The LLM answer is semantically equivalent and slightly more detailed than the ground truth, though it does not explicitly use the phrase 'strategic focus' or 'program status'—but it effectively conveys both through context. The only minor shortcoming is that it doesn’t explicitly state the 'shift from funding-dependent to production' in comparative terms as clearly as the original, but this is implied. Hence, a score of 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 450,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Southern Company's treatment and disclosure of energy-related derivatives evolve from 2022 to 2023, particularly in terms of their designation and financial impact?",
      "original_answer": "In 2022, Southern Company reported the pre-tax effects of unrealized derivative gains (losses) from energy-related derivatives that were designated as regulatory hedging instruments and deferred. By 2023, the company expanded its disclosure to include the pre-tax effects of energy-related derivatives not designated as hedging instruments on its statements of income, covering the years 2023, 2022, and 2021. This indicates a shift from focusing only on regulatory hedging instruments to providing a broader view of its energy-related derivative activities.",
      "llm_answer": "In the 2022 filing Southern Company reported its energy‑related derivatives almost exclusively as regulatory hedges and cash‑flow/fair‑value hedges, showing modest net gains – for example, a $34 million gain in AOCI for Southern Company (page 325) and a $9 million unrealized gain on regulatory hedges (page 324), with the balance‑sheet net amounts for regulatory hedges recorded as $50 million for Alabama Power, $67 million for Georgia Power and $52 million for Mississippi Power (page 322). By 2023 the company kept the same designations but the financial impact reversed: regulatory hedges posted large unrealized losses (e.g., $(257) million for Southern Company, page 293) and cash‑flow hedges generated losses in AOCI (e.g., $(81) million for Southern Company, page 293) and a $(44) million loss on natural‑gas cash‑flow hedges (page 294), while non‑designated energy derivatives produced a $59 million benefit (page 295).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several specific numerical values and page references that are not present in the original answer (ground truth), and there is no verification that these numbers ($34M gain in AOCI, $9M unrealized gain, $50M, $67M, $52M balance-sheet amounts, $(257)M loss, etc.) are accurate or sourced correctly from the actual filings. The ground truth does not mention any specific dollar amounts or page numbers, nor does it discuss AOCI impacts, cash-flow/fair-value hedges, or individual subsidiary balances. Instead, the original answer focuses on a qualitative shift in disclosure practices: from reporting only regulatory hedging instruments in 2022 to including non-designated derivatives across 2023, 2022, and 2021 in 2023. The LLM incorrectly emphasizes changes in financial *impact* (e.g., gains turning into losses) rather than the evolution in *disclosure and designation practices*, which is the core of the question. While the mention of 'non-designated energy derivatives' in 2023 aligns with the ground truth, the overall framing misrepresents the nature of the evolution. The reasoning is partially sound in identifying different derivative categories but fails the multi-hop synthesis by not connecting the change in treatment to expanded retrospective disclosure. Quantitative accuracy is low due to unverifiable and likely fabricated figures. Qualitative accuracy is moderate because some concepts (regulatory vs. non-designated) are relevant, but the emphasis is misplaced. Contextual relevance is fair since the topic is related, but the focus on financial swings rather than disclosure evolution misses the key point.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 449,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did Gilead's intellectual property strategy regarding Truvada evolve between 2022 and 2023, particularly in terms of patent disclosures?",
      "original_answer": "In 2022, Gilead highlighted the October 2020 loss of exclusivity of Truvada in the United States as a transitory headwind, indicating that the product was no longer protected under patent, which likely affected revenue. In 2023, Gilead provided structured disclosures regarding the patent expiration dates of its principal products, including Truvada, focusing on the actual or estimated expiration dates in the U.S. and the EU. This represents a shift from acknowledging a past loss of exclusivity to proactively disclosing future intellectual property timelines for key products.",
      "llm_answer": "In the 2022 Form 10‑K Gilead noted that Truvada had lost U.S. exclusivity in October 2020 and was facing generic competition, but it did not list any Truvada‑specific patents or expiration dates in its patent‑expiration tables. By the 2023 filing, Truvada still appears in the product list yet remains absent from the disclosed patent tables, and the IP discussion shifts to broader filing and settlement activities rather than new Truvada patents—indicating that Gilead’s strategy continued to rely on managing generic competition rather than adding fresh patent disclosures for Truvada.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative details: it correctly states that Truvada lost U.S. exclusivity in October 2020 (matching the ground truth), and accurately reflects that in 2022, Gilead acknowledged the loss of exclusivity and generic competition. It also correctly notes that Truvada was not included in patent expiration tables in 2022, and remains absent in 2023 disclosures. These details align with the ground truth. However, the LLM answer diverges in interpretation: while the original answer emphasizes a strategic shift in 2023 toward structured, forward-looking disclosure of IP timelines for key products (including Truvada), the LLM interprets the absence of Truvada in patent tables as evidence of no new disclosures and a continued focus on managing generics. This downplays the evolution highlighted in the ground truth—namely, that Gilead began systematically disclosing expiration dates for principal products in 2023, even if Truvada itself was not the focus of new patents. The LLM correctly observes what is not in the filings but underemphasizes the broader strategic shift in disclosure practices. Thus, while entities, dates, and facts are correct (quantitative accuracy = 10), the qualitative interpretation of the strategy’s evolution is partially incomplete, missing the proactive transparency shift. Contextual relevance is high as it directly addresses the question’s focus on patent disclosures between 2022 and 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 404,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did SPG's use of the Supplemental Facility evolve between 2022 and 2024, particularly in terms of borrowing and repayment activities?",
      "original_answer": "In 2022, SPG borrowed $1.05 billion under the Supplemental Facility in January 2022, which was used to fund the early extinguishment of nine mortgages with a principal balance of $1.16 billion. This borrowing was repaid shortly after issuance. By 2024, SPG again utilized the Supplemental Facility, borrowing €750.0 million ($815.4 million U.S. dollar equivalent) in November 2023, which was repaid on November 17, 2023. Additionally, in 2024, SPG issued new senior unsecured notes to redeem other outstanding notes at maturity, indicating a shift in financing strategy. The evolution shows a continued reliance on the Supplemental Facility for short-term financing needs but with a more structured approach to repayment and refinancing.",
      "llm_answer": "In the 2022 filing SPG disclosed that it had drawn $1.05 billion from the Supplemental Facility on December 14 2021 and then used proceeds from a $500 million floating‑rate and $700 million fixed‑rate senior‑note issuance to repay the entire $1.05 billion balance on January 12 2022【page_73】. By the 2024 filing the facility had been amended (October 2021) to a $3.5‑$4.5 billion borrowing capacity and was being used for Euro‑denominated borrowings; the company repaid €750 million of those borrowings on November 17 2023 after swapping the loans to a fixed rate, leaving the facility largely unused but still available for future draws【page_69】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in dates and borrowing/repayment sequence. The ground truth states SPG borrowed $1.05 billion in January 2022, but the LLM claims it was drawn on December 14, 2021, and repaid on January 12, 2022 — this misaligns the timeline and implies the borrowing occurred in 2021, not 2022. Additionally, the LLM incorrectly states that the $1.05 billion was repaid using proceeds from $500M floating-rate and $700M fixed-rate notes, which is not in the original answer and introduces unsupported detail. The €750 million borrowing is correctly noted as repaid on November 17, 2023, which aligns with the ground truth (though the original specifies it was borrowed in November 2023 and repaid the same month, which the LLM partially captures). (2) Quantitative accuracy is partially correct: $1.05 billion and €750 million figures are accurate, and the U.S. dollar equivalent ($815.4M) is omitted but not contradicted. However, the LLM fabricates a $500M + $700M = $1.2B note issuance to repay a $1.05B loan, which is both numerically and factually incorrect. The amendment date of the facility to €3.5–4.5B in October 2021 conflicts with the original answer’s focus on 2022–2024 evolution and appears misplaced. (3) The multi-hop reasoning is partially sound — the model recognizes SPG used the Supplemental Facility in both periods and repaid borrowings, showing short-term use. It also identifies a shift toward Euro-denominated borrowing, which aligns with the 2024 activity. However, it misses the key point that in 2024, SPG issued new senior unsecured notes to redeem maturing notes — an important strategic shift mentioned in the original. The LLM instead emphasizes the swap to fixed rate and facility availability, which adds detail but distracts from the core evolution. (4) Contextual relevance is high — the answer addresses the evolution of SPG’s use of the Supplemental Facility, discusses borrowing and repayment in both years, and attempts to synthesize changes over time. Despite factual errors, it remains focused on the question. Correctness score is 6 due to correct identification of key amounts and some timeline elements, but docked for significant date and causal inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 603,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the role of cash buffer needs in MetLife's capital management strategy evolved from 2022 to 2024, particularly in terms of liquidity levels and their impact on capital allocation decisions?",
      "original_answer": "In 2022, MetLife maintained a short-term liquidity position of $12.4 billion and a total liquid asset base of $223.0 billion, reflecting a strong buffer to meet business requirements under both normal and stress scenarios. The company emphasized its belief in having ample liquidity and highlighted active monitoring and adjustment of liquidity and capital plans. By 2024, the narrative shifted to a more cautious tone, noting that maintaining or increasing cash buffers could limit capital available for innovation, acquisitions, and shareholder returns. This indicates that while liquidity remained a strategic priority, the implications of holding larger cash buffers became more pronounced, potentially constraining other capital deployment opportunities.",
      "llm_answer": "In the 2022 Form 10‑K MetLife highlighted that it already held a sizable liquidity cushion – $12.4 billion of short‑term cash and equivalents and $223 billion of liquid assets at year‑end – but warned that “cash‑buffer needs” could limit its ability to pay dividends or repurchase stock【page_122】. By the 2024 filing the company describes the cash buffer as an active management tool, stating that it “maintains a buffer of cash and other liquid assets, and may increase it. As a result, we may have less capital to devote to other uses, such as innovation, acquisitions, development and return of capital to shareholders” and again cites cash‑buffer needs as a factor that could restrict dividend or share‑repurchase payments【page_33】. Thus, the role of the cash buffer has shifted from a passive risk‑factor with ample liquidity in 2022 to a strategic lever in 2024 that is deliberately adjusted and directly influences how much capital is allocated to growth and shareholder‑return initiatives.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $12.4 billion short-term liquidity and $223.0 billion total liquid assets in 2022 are accurately reported (minor formatting difference: $223 billion vs $223.0 billion is acceptable). No calculations were required. (2) The answer addresses all parts of the question: evolution from 2022 to 2024, liquidity levels, and impact on capital allocation. It correctly identifies the shift in tone and strategic role of cash buffers. (3) Entity accuracy is strong: MetLife, correct years (2022 and 2024), and relevant financial terms (liquidity, capital allocation, shareholder returns) are all correct. (4) Reasoning is sound: the LLM correctly synthesizes the multi-hop insight that while liquidity was ample in 2022, by 2024 the company explicitly framed the cash buffer as an active management tool that trades off against innovation, acquisitions, and shareholder returns. The characterization of the shift from 'passive risk-factor' to 'strategic lever' is a valid interpretation supported by the filings. The only minor shortcoming is the claim that in 2022 MetLife 'warned' that cash-buffer needs could limit dividends/share repurchases — the original answer does not include this warning in 2022, only the 2024 caution. This slight overstatement prevents a perfect 10 on qualitative accuracy, but the overall semantic meaning and strategic evolution are correctly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 410,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did Starbucks' exposure to 'Foreign currency - other' derivatives evolve between 2022 and 2023, particularly in terms of asset and liability classifications?",
      "original_answer": "In 2022, Starbucks reported 'Foreign currency - other' derivative liabilities of $0.3 million under accrued liabilities and no corresponding asset value. By 2023, the company had a derivative asset of $1.9 million under prepaid expenses and other current assets and a derivative liability of $4.7 million under accrued liabilities for the same category. This indicates a significant increase in exposure and a shift toward a more balanced treatment across asset and liability classifications.",
      "llm_answer": "Starbucks’ “Foreign currency – other” derivative assets fell from $39.9 million in prepaid expenses/other current assets plus $33.5 million in other long‑term assets (≈ $73.4 million total) in 2022 to $32.0 million and $22.9 million respectively (≈ $54.9 million total) in 2023【page_68†L31-L38】【page_72†L31-L38】. At the same time, the liability side grew from a modest $0.3 million recorded as accrued liabilities in 2022 to $2.0 million of accrued liabilities in 2023, with no other‑long‑term liability reported in either year【page_68†L45-L50】【page_72†L45-L50】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is almost entirely incorrect and fails to match the ground truth in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The numbers cited are completely wrong. The original answer states that in 2022, Starbucks had *no asset* for 'Foreign currency - other' derivatives, only a $0.3 million liability. However, the LLM claims $73.4 million in total assets in 2022, citing $39.9M in current assets and $33.5M in long-term assets — which contradicts the ground truth. In 2023, the correct asset is $1.9 million (current), but the LLM reports $54.9 million total assets — again, grossly inaccurate. The liability increase from $0.3M to $4.7M in 2023 per the original answer is misrepresented as only $2.0M in the LLM response. (2) Completeness: The LLM fails to capture the key evolution — a shift from pure liability to a dual asset-liability position — and instead fabricates large asset values in both years. (3) Entity Accuracy: While the company (Starbucks) and derivative category ('Foreign currency - other') are correctly identified, the years (2022 vs 2023) are misapplied with incorrect data. (4) Reasoning: The multi-hop reasoning is flawed; the LLM appears to have extracted data from unrelated derivative categories or misread the tables, failing to synthesize the correct trend. (5) Semantic Equivalence: The LLM suggests decreasing assets and increasing liabilities, but the truth is that assets *emerged* (from zero) and liabilities *increased significantly*. The direction and magnitude of change are both wrong. The cited page references (e.g., page_68, page_72) may point to real sections, but the data extracted is not aligned with the ground truth. Overall, the answer fabricates material financial figures and misrepresents the nature of Starbucks' derivative exposure evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 493,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has The Coca-Cola Company's relationship with Coca-Cola FEMSA evolved from 2023 to 2024, particularly in terms of its strategic engagement and financial stake?",
      "original_answer": "In 2023, Coca-Cola FEMSA was one of The Coca-Cola Company's five largest independent bottling partners, operating in multiple countries including Mexico, Brazil, and Argentina, and collectively these top five bottlers accounted for 42% of Coca-Cola's worldwide unit case volume. By 2024, the relationship had evolved significantly, as Coca-Cola FEMSA transitioned from being a key bottler to becoming an equity method investee in which The Coca-Cola Company held a 28% ownership stake. This shift indicates a deeper financial commitment and alignment beyond the traditional bottler-concentrate supplier model.",
      "llm_answer": "In 2023 Coca‑Cola FEMSA was highlighted as one of the Company’s five largest independent bottling partners, with the relationship framed around collaborative bottler agreements, an incidence‑based concentrate‑pricing model and discretionary marketing‑support initiatives, but the filing only referred to a generic equity‑method investment without disclosing the exact ownership percentage. By 2024 the Company’s 10‑K explicitly reports that it owns **28 % of Coca‑Cola FEMSA’s outstanding shares** under the equity‑method, with a carrying value of **$1.8 billion** and a fair value of **$4.5 billion**, showing a clearly quantified and sizable financial stake while the strategic partnership (bottler agreements, pricing alignment and marketing support) remains in place.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the 28% ownership stake in Coca-Cola FEMSA is accurately reported, along with the $1.8 billion carrying value and $4.5 billion fair value in 2024. These figures are not in the original answer but are consistent with a deeper level of financial detail that enhances accuracy without contradicting the ground truth. The original answer correctly notes the shift to a 28% equity stake; the LLM adds precise valuation data, which improves completeness and precision. (2) The timeline is correct—2023 describes the bottler relationship without specifying ownership percentage, and 2024 confirms the explicit disclosure of 28%. (3) Entity accuracy is strong: The Coca-Cola Company, Coca-Cola FEMSA, equity method accounting, and the strategic context (bottler agreements, pricing, marketing) are all correctly identified. (4) Multi-hop reasoning is sound: the LLM synthesizes the evolution from operational partnership to formal equity investment, recognizing that the strategic engagement continues alongside deeper financial integration. The only minor shortcoming is that the original answer emphasizes the broader context of the top five bottlers accounting for 42% of unit case volume—a detail omitted in the LLM response. While not critical to the core question about the relationship evolution, it represents a small completeness gap. However, the LLM compensates with richer financial data. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 446,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Intel's strategic positioning of FPGAs evolved between 2022 and 2024, particularly in terms of their role within adjacent products and their broader production focus?",
      "original_answer": "In 2022, Intel positioned FPGAs as part of its 'adjacent products' within the Client Computing Group (CCG), Data Center Group (DCG), and Internet of Things Group (IOTG), indicating a supporting role within comprehensive platform solutions. By 2024, FPGAs were explicitly listed under direct product definitions, signaling a shift toward a more central production focus. This reflects a transformation in the strategic importance of FPGAs, moving from a supplementary role to a core product offering.",
      "llm_answer": "In the 2022 filing Intel grouped FPGAs with its “adjacent products” – the non‑platform items (e.g., modems, Ethernet, silicon‑photonic, Mobileye, NSG and PSG) that complement its core CPU/SoC platforms 【page_113】. By the 2024 filing, Intel is positioning FPGAs as a primary architecture alongside CPUs, GPUs and AI accelerators under the “xPU” umbrella, and is emphasizing programmable networking devices (IPU) that off‑load work from CPUs, signaling a shift to a broader, production‑focused role for FPGAs 【page_103】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that in 2022, FPGAs were categorized as 'adjacent products'—supporting Intel's core platforms—and by 2024, they were elevated to a more central role under the 'xPU' architecture alongside CPUs, GPUs, and AI accelerators. The mention of IPUs (Infrastructure Processing Units) as programmable networking devices offloading CPU work further supports the strategic shift toward production focus. While the original answer emphasizes FPGAs moving from 'adjacent products' in CCG, DCG, and IOTG to being directly listed in product definitions, the LLM captures the same evolution using different but semantically equivalent framing (e.g., 'primary architecture' and 'xPU umbrella'). There are no numeric inaccuracies (quantitative accuracy is perfect), and all entities—Intel, FPGAs, 2022, 2024, PSG (Programmable Solutions Group)—are correctly referenced. The reasoning is sound and reflects proper multi-hop synthesis across filings. The only minor gap is that the LLM does not explicitly name the business groups (CCG, DCG, IOTG) as in the original, but this omission does not detract from the core correctness. Thus, the answer is highly accurate, contextually relevant, and well-reasoned, warranting a 9/10 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 369,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did ConocoPhillips' financial activity related to the Lower 48 region evolve from 2022 to 2023, particularly in terms of asset acquisition and depreciation, depletion, and amortization expenses?",
      "original_answer": "In 2022, ConocoPhillips noted that purchases in the Lower 48 were driven by the Concho acquisition, indicating a strategic expansion in that region. The depreciation, depletion, amortization, and impairments expense for the Lower 48 was $4,854 million. In 2023, the company's expense for the same category in the Lower 48 increased to $5,729 million, showing a significant rise of $875 million. This increase suggests continued investment and asset utilization in the Lower 48 following the acquisition.",
      "llm_answer": "In 2023 ConocoPhillips spent more on its Lower 48 assets than in the prior year – capital expenditures rose to **$6.49 billion** from **$5.63 billion** in 2022 (page 135) – while the segment’s **depreciation, depletion and amortization expense increased to $5.73 billion from $4.85 billion** a year earlier (page 134).  At the same time, “investments in and advances to affiliates” for the Lower 48 fell to **$118 million** from **$235 million** in 2022, indicating a shift from affiliate‑type acquisitions to higher direct capital spending (page 134).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: D&D&A expense increased from $4.85 billion in 2022 to $5.73 billion in 2023, matching the ground truth values of $4,854 million and $5,729 million (rounded appropriately). The $875 million increase is accurately reflected as ~$875 million (actual: $875M difference between $5,729M and $4,854M). (2) The LLM adds contextual detail not in the original answer—capital expenditures rising from $5.63B to $6.49B and a decline in 'investments in and advances to affiliates'—which is relevant and supports the conclusion of a shift in investment strategy. These details are consistent with the theme of evolving financial activity and enhance completeness. (3) The reasoning is sound: the model correctly infers a strategic shift in asset investment based on multi-hop data (expense trends, capex, affiliate spending), which is a logical extension of the original answer. (4) Entity accuracy is perfect: ConocoPhillips, Lower 48, correct years (2022–2023), and correct financial metrics (DD&A, capex). (5) The only reason for not scoring 10 is that the original answer emphasizes the Concho acquisition as the 2022 driver, which the LLM omits—this is a minor omission in qualitative context, but the core financial evolution is correctly captured. Overall, the answer is factually excellent, contextually rich, and semantically equivalent in intent and accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 404,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial impact on gross margins?",
      "original_answer": "In 2022, Emerson completed the acquisition of AspenTech, contributing approximately $6.0 billion in cash, paying $87.69 per share to Heritage AspenTech stockholders, and retaining $168 million in AspenTech's balance sheet. The acquisition positively impacted gross margins by 0.6 percentage points in 2023. By 2024, Emerson owned 55% of AspenTech on a fully diluted basis, and AspenTech continued to operate under its former name and ticker symbol 'AZPN.' The acquisition's financial impact persisted, contributing to a gross margin increase of 1.8 percentage points to 50.8% in 2024, despite a negative impact from acquisition-related inventory step-up amortization of $231 million, which reduced margins by 1.3 percentage points.",
      "llm_answer": "Emerson’s tie‑up with AspenTech began in 2022 when it contributed its own industrial‑software businesses and $6 billion in cash to create “New AspenTech,” emerging as the accounting acquirer with a **55 % equity stake** in the combined company【page_56】.  By the 2024 filing Emerson owned **about 57 % of AspenTech** and announced a cash offer to buy the remaining shares at $240 each, moving toward full ownership【page_25】.  The AspenTech acquisition lifted Emerson’s gross margin by roughly **0.6 percentage points in 2023** (to 49.0 %) and gross margin continued to rise to **50.8 % in 2024**, although the 2024 gain was driven mainly by other acquisitions and pricing effects, with AspenTech’s contribution embedded in the higher‑margin software and control segment【page_26】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also significant inaccuracies. It correctly identifies the $6.0 billion cash contribution in 2022 and the 0.6 percentage point gross margin boost in 2023. It also correctly notes the 50.8% gross margin in 2024. However, it incorrectly states that Emerson initially held a 55% stake in 2022, whereas the ground truth indicates that 55% ownership was reached by 2024, not at the time of acquisition. Additionally, the LLM claims Emerson owned 'about 57%' by 2024, which contradicts the ground truth of 55%. The $240 per share offer to buy remaining shares is not mentioned in the original answer and appears to be fabricated or misattributed. The LLM downplays AspenTech’s direct contribution to the 2024 margin increase, attributing it instead to 'other acquisitions and pricing effects,' while the ground truth explicitly states AspenTech contributed to a 1.8 percentage point increase despite a $231 million amortization drag. (2) Key number mismatches: ownership stake (55% vs. 57%), missing $87.69 per share payment and $168 million retained balance sheet amount, omission of $231 million inventory step-up amortization that reduced margins by 1.3 points. The 0.6 point margin impact in 2023 and 50.8% in 2024 are correct. (3) Multi-hop reasoning is partially sound—LLM connects ownership evolution and margin impacts across years—but fails to accurately synthesize the financial mechanics of the acquisition (e.g., per-share price, retained cash, amortization impact). The claim about a $240 offer introduces unsupported information. (4) Correctness score is 6 due to partial factual accuracy with core financial figures and timeline, but major errors in ownership percentages and omission of key financial details. Quantitative accuracy is low (5) due to incorrect or missing numbers. Qualitative accuracy is moderate (7) as reasoning structure is logical but based on flawed data. Contextual relevance is high (9) as the response addresses the required topics of ownership and margin impact.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 555,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has the treatment and availability of shares under the 2015 Director Stock Plan evolved between 2022 and 2024, particularly in terms of share recovery and issuance mechanics?",
      "original_answer": "In 2022, the 2015 Director Stock Plan specified that each share issued under the plan reduced the number of shares remaining for issuance by one, and shares recovered from expired, forfeited, or cash-settled awards were again available for issuance. By 2024, the plan had a total of 35,395,894 shares authorized for issuance as of January 1, 2015, with 37,608,213 shares recovered for issuance between 2015 and 2024. However, 42,343,146 shares were covered by new awards and reinvested dividends since 2015, leaving 30,660,961 shares available for future issuance. This reflects a net reduction in available shares over time despite ongoing share recovery, indicating a shift in the balance between new issuances and recovered shares.",
      "llm_answer": "The 2015 Director Stock Plan’s recovery‑and‑issuance rules did not change – both the 2022 and 2024 filings state that shares freed by forfeiture, cash settlement, exchange, tax‑withholding or partial performance‑share payout are added back to the plan’s pool, and any share‑settled SARs are counted only net of shares tendered (see page 335 & page 312). However, the amounts have shifted: in 2022 the plan reported 31.5 million shares recovered for issuance and 34.1 million shares still available (page 334), while the 2024 filing shows recoveries rising to 35.8 million (total recovered 37.6 million) and the available pool falling to 30.7 million (page 311). This reflects more shares being reclaimed but also more being used for new awards, reducing the remaining balance.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies that the share recovery and issuance mechanics remained unchanged between 2022 and 2024—shares from forfeitures, cash settlements, and other mechanisms are added back to the pool, and SARs are counted net of shares tendered. This matches the original answer’s description of recovery mechanics. (2) Quantitatively, the LLM reports 31.5 million shares recovered in 2022 and 34.1 million available, which are reasonable approximations of the ground truth data (though exact cumulative recovery by 2024 is 37.6 million, the LLM correctly notes the increase to 35.8 million recovered by 2024 and rounds the final available shares to 30.7 million, matching the ground truth’s 30,660,961). The ground truth provides cumulative figures from 2015–2024, while the LLM focuses on reported values in the 2022 and 2024 filings, which may explain minor discrepancies in phrasing but not in substance. (3) The multi-hop reasoning is sound: the model correctly synthesizes that despite increased share recovery, the available pool decreased due to higher new award issuances, reflecting a net reduction—this is a key insight from the ground truth. (4) The answer is contextually excellent, directly addressing the evolution in treatment and availability, and correctly interpreting the balance between recoveries and issuances. The only minor limitation is that the LLM does not explicitly mention the total authorized shares (35,395,894) from 2015, but this does not detract from the core analysis. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 459,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Starbucks' relationship with the Global Coffee Alliance evolved from fiscal year 2022 to fiscal year 2023 in terms of strategic emphasis and revenue contribution?",
      "original_answer": "In fiscal year 2022, the Global Coffee Alliance contributed to the growth of the Channel Development segment, which saw a $250 million increase in revenue driven by product sales and royalty income from the alliance. By fiscal year 2023, the strategic emphasis on the Global Coffee Alliance had evolved, with Starbucks explicitly highlighting its licensing relationship with Nestlé under the alliance as a core channel for product distribution, indicating a deeper integration and ongoing importance to Starbucks' global licensing and product expansion strategy. This evolution reflects a shift from viewing the alliance primarily as a revenue driver to positioning it as a strategic enabler of global product reach and brand extension.",
      "llm_answer": "In fiscal 2022 Starbucks called the Global Coffee Alliance a key growth engine, noting that product‑sales and royalty revenue from the alliance contributed about $216 million (the bulk of a $249 million rise in “Other” revenues) and helped lift its Channel Development segment by $250 million. In the fiscal 2023 filing the alliance is mentioned only as a licensing channel for grocery and food‑service sales—still a strategic partnership, but the filing does not break out a specific revenue amount, suggesting the focus has shifted to broader brand‑licensing rather than being highlighted as a major revenue driver.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in its qualitative assessment of the evolution of Starbucks' relationship with the Global Coffee Alliance, noting a shift from revenue emphasis in FY2022 to broader strategic licensing in FY2023. However, there is a significant quantitative inaccuracy: the LLM states that the alliance contributed about $216 million (as the bulk of a $249 million rise in 'Other' revenues), while the ground truth specifies a $250 million increase in the Channel Development segment driven by the alliance. The $216M and $249M figures do not appear in the original answer and are likely misattributed or miscalculated, though the general direction of growth is correctly tied to the alliance. (2) The fiscal years are correctly identified, and the absence of a specific revenue figure in FY2023 is accurately noted. However, the original answer does not mention an 'Other' revenue category—this appears to be an incorrect mapping by the LLM, possibly confusing segment reporting. The $250M figure in the original is explicitly tied to Channel Development, not inferred from a residual 'Other' bucket. (3) The multi-hop reasoning is sound in recognizing that the strategic emphasis evolved from revenue contribution to a deeper licensing and distribution role via Nestlé, which aligns with the original answer’s claim of a shift from revenue driver to strategic enabler. The synthesis across years and strategic framing is appropriate and reflects understanding. (4) The contextual relevance is high—the answer directly addresses both strategic emphasis and revenue contribution across the two fiscal years. Despite the numerical inaccuracies, the core narrative about evolving strategic focus is preserved, warranting a correctness score of 7. The quantitative accuracy is penalized due to unsupported specific figures, but qualitative and contextual scores remain strong due to correct reasoning and framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 524,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has NEE's financial stake and involvement in the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's equity method investments totaled $6,159 million, and the Mountain Valley Pipeline was listed among key equity method investees alongside NEP OpCo, Sabal Trail, and Silver State South Solar, with NEE's interest ranging from approximately 32% to 55%. By 2023, NEE's total equity method investments were $6,156 million, with its interest in the principal entities, including the Mountain Valley Pipeline, ranging from approximately 32.8% to 52.6%. The shift from a broader range (32%–55%) in 2022 to a narrower range (32.8%–52.6%) in 2023 suggests a slight adjustment in ownership stakes, potentially reflecting a more refined or strategic investment posture. Additionally, in 2023, the Mountain Valley Pipeline was specifically noted in the context of Nonrecurring Fair Value Measurements, indicating a possible revaluation or change in financial treatment.",
      "llm_answer": "NEE’s equity‑method investment that includes the Mountain Valley Pipeline fell from a $4.968 billion carrying amount in 2022 to $3.963 billion in 2023, and the gap between the carrying amount and underlying equity swung from a $2.589 billion positive in 2022 to a $(1.205) billion negative in 2023 – a change driven by a $2.4 billion impairment tied to the pipeline 【page_95】【page_96】.  This sizable write‑down shows NEE has markedly reduced its financial stake in the non‑core gas‑pipeline project, indicating a strategic shift away from that exposure and a focus on its core renewable‑energy and regulated‑utility businesses.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) QUANTITATIVE INACCURACY: The LLM claims NEE's carrying amount for the Mountain Valley Pipeline (MVP) investment dropped from $4.968 billion in 2022 to $3.963 billion in 2023 and attributes a $2.4 billion impairment to MVP. However, the ground truth does not support these specific figures or the attribution of such an impairment to MVP alone. Instead, the original answer states that NEE’s total equity method investments were $6,159 million in 2022 and $6,156 million in 2023 — nearly flat overall — with MVP included among several equity investees. There is no mention of a $2.4 billion impairment tied specifically to MVP. The LLM also introduces a 'gap between carrying amount and underlying equity' swinging from +$2.589B to -$1.205B, which is not present in the ground truth and appears to be a misinterpretation or hallucination. (2) ENTITY & CONTEXTUAL ERROR: While MVP is correctly identified as an equity method investee, the LLM incorrectly isolates it as the driver of a major impairment, whereas the original answer only notes that in 2023, MVP was mentioned in the context of Nonrecurring Fair Value Measurements — a subtle but important distinction that does not imply a write-down. (3) REASONING FLAW: The conclusion that NEE is strategically exiting gas pipelines in favor of renewables is speculative and not directly supported by the provided ground truth, which only notes a slight narrowing of ownership ranges (32%–55% to 32.8%–52.6%) and a change in financial disclosure treatment. The LLM overinterprets limited data to assert a dramatic strategic shift. (4) COMPLETENESS: The answer fails to mention the key point about the narrowing ownership range, which is central to the original answer’s interpretation of a 'refined investment posture.' Instead, it fabricates detailed financials not present in the source. (5) SEMANTIC EQUIVALENCE: The overall meaning diverges significantly — the LLM suggests a major divestment and impairment, while the truth indicates minor stake adjustments and potential revaluation. Despite addressing the general topic and citing plausible document pages, the answer is factually incorrect on core financials and conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 604,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Medtronic's InterStim Therapy product line evolved between 2022 and 2024 in terms of neurostimulator offerings and therapeutic indications?",
      "original_answer": "In 2022, InterStim therapy was described with a range of neurostimulators including InterStim II, InterStim Micro, and InterStim X, targeting symptoms of overactive bladder, urinary retention, and bowel incontinence. By 2024, the product line continued to include InterStim II and InterStim X, now specifically labeled as 'recharge-free' neurostimulators, and retained its focus on overactive bladder and urinary retention, but expanded its therapeutic scope to include 'chronic fecal incontinence.' This reflects a refinement in product positioning and a broadening of clinical applications over the two-year period.",
      "llm_answer": "By fiscal 2022 Medtronic’s InterStim portfolio had been expanded to include the newly‑launched InterStim Micro neurostimulator (with SureScan MRI‑compatible leads) together with the existing InterStim II and InterStim X devices, all marketed for over‑active bladder, urinary retention and bowel incontinence【page_41】. In the 2024 filing the line still consists of InterStim II and InterStim X as recharge‑free systems and InterStim Micro as a rechargeable neurostimulator, now highlighted for over‑active bladder, “non‑obtrusive” urinary retention and chronic fecal incontinence, underscoring continued growth and refined positioning of the three devices【page_39】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the neurostimulator offerings in 2022 (InterStim II, InterStim Micro, InterStim X) and their indications (overactive bladder, urinary retention, bowel incontinence), aligning with the ground truth. In 2024, it accurately notes the continued presence of InterStim II and InterStim X as recharge-free systems and includes InterStim Micro as rechargeable, which is consistent with product evolution. The expansion to 'chronic fecal incontinence' in 2024 is correctly captured, though the LLM uses 'chronic fecal incontinence' while the original says 'chronic fecal incontinence' — semantically equivalent. However, the original answer does not explicitly label InterStim Micro as rechargeable, so this addition, while plausible, is not confirmed in the ground truth and introduces a detail not present in the source. (2) There are no numerical values requiring calculation, so quantitative accuracy is high, with correct years (2022, 2024) and product names. (3) The multi-hop reasoning is sound: the model synthesizes product lineup and indications across two time points from Medtronic’s filings. The only minor overreach is specifying InterStim Micro as rechargeable, which isn’t in the ground truth but may be inferred from context; however, this risks inaccuracy without explicit confirmation. (4) The answer is contextually relevant, fully addressing the evolution in neurostimulator offerings and therapeutic indications. The core facts are correct, but the added detail about rechargeability slightly exceeds the ground truth, warranting a score of 8 for correctness and qualitative accuracy. Quantitative accuracy is 9 due to correct dates and entities, and contextual relevance is perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 475,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Simon Property Group's financial stake and strategic relationship with Authentic Brands Group (ABG) evolve from 2022 to 2024?",
      "original_answer": "In 2022, Simon Property Group held a 1.37% interest in ABG and had merged Forever 21 operations into SPARC Group after increasing its stake to 50% alongside ABG. By 2024, Simon sold a portion of its ABG stake, realizing a pre-tax gain of $18.8 million, and later acquired additional interests in ABG for $100 million in cash, indicating a dynamic evolution in their financial relationship.",
      "llm_answer": "In 2022 Simon still owned a non‑controlling equity interest in Authentic Brands Group of roughly 10 % (≈10.4 % after the December 2021 purchase of $100 million of ABG shares) and deepened its strategic tie‑up with ABG – it entered a long‑term Reebok licensing partnership in Q1 2022 and swapped its Eddie Bauer licensing venture for additional ABG equity in Q4 2022.  Throughout 2023 a series of ABG capital transactions gradually diluted Simon’s holding to the high‑single‑digit range (≈9.6 % after the Q4‑2023 sale) and, in the first quarter of 2024, Simon sold its remaining ABG stake for about $1.2 billion, ending the equity investment and the direct ownership relationship.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Simon Property Group held a 1.37% interest in ABG in 2022, not ~10.4% as claimed. The LLM incorrectly states that Simon sold its 'remaining' ABG stake in Q1 2024 for $1.2 billion, completely contradicting the ground truth, which states Simon sold only a portion of its stake (realizing a $18.8M gain) and then *acquired additional interests* for $100M in cash—indicating an ongoing and deepening relationship, not an exit. (2) Quantitative accuracy is very low: the 10.4%, 9.6%, and $1.2 billion figures are all incorrect; the $100M cash investment is misrepresented as occurring in 2021 rather than 2024; and the $18.8M pre-tax gain from partial sale is omitted entirely. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize the evolution of the relationship, incorrectly concluding it ended in 2024 when in fact it evolved through both a sale and a new investment. The strategic moves like Reebok licensing and Eddie Bauer swap are not in the ground truth and appear fabricated or misattributed. (4) Contextual relevance is moderate because the answer addresses the general theme of financial and strategic evolution between Simon and ABG, but the specific facts, direction of stake changes, and key events are incorrect, undermining overall correctness. The answer conveys the opposite conclusion (exit vs. continued engagement), warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 412,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has ConocoPhillips' investment activity in the Lower 48 region evolved from 2021 to 2023, particularly in terms of depreciation, depletion, and amortization expenses?",
      "original_answer": "ConocoPhillips' depreciation, depletion, and amortization (DD&A) expenses in the Lower 48 region increased from $4,067 million in 2021 to $5,729 million in 2023, indicating a significant rise in asset utilization or investment activity. This reflects a growing emphasis on the Lower 48 as a core operational area for the company.",
      "llm_answer": "ConocoPhillips’ depreciation, depletion and amortization (DD&A) expense for its Lower 48 segment rose each year – $4.07 billion in 2021, $4.85 billion in 2022 and $5.73 billion in 2023【page_133】. The upward trend reflects a growing investment base and higher asset utilization in the Lower 48 region over the 2021‑2023 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the DD&A expenses for ConocoPhillips in the Lower 48 region for 2021 ($4.07 billion), 2022 ($4.85 billion), and 2023 ($5.73 billion), which align with the ground truth values of $4,067 million (2021) and $5,729 million (2023), with 2022 data being an accurate intermediate point not in the original answer but consistent with the trend. Minor rounding is acceptable: $4.07 billion = $4,070 million ≈ $4,067 million; $5.73 billion = $5,730 million ≈ $5,729 million. 2) All numbers are quantitatively accurate within acceptable rounding. The upward trend is correctly identified and supports the conclusion of increased investment or asset utilization. 3) The reasoning is sound: the LLM infers growing investment activity from rising DD&A, which is a valid interpretation. It adds a year (2022) not in the original answer, but this reflects deeper insight and does not contradict the ground truth. 4) The answer is semantically equivalent and contextually complete, addressing both the evolution over time and the implication of the trend. The only minor limitation is that the original answer emphasizes 'growing emphasis on the Lower 48 as a core operational area,' which the LLM implies but does not explicitly state—hence a 9 on qualitative accuracy. Overall, the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 378,
        "total_tokens": 1548
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Verizon's (VZ) treatment and valuation approach for international bonds evolved from 2023 to 2024 based on their 10-K disclosures?",
      "original_answer": "In 2023, Verizon described that international bonds were valued using matrix prices with input from independent third-party valuation sources as part of the broader fixed income securities category. By 2024, international bonds were specifically itemized in a detailed table with a total value of $12 million, broken down into $10 million in Level 1 and $2 million in Level 2 inputs. This represents a shift from a general description in 2023 to a more transparent and segmented valuation approach in 2024, indicating a more refined disclosure strategy and possibly a more structured approach to valuing international bonds.",
      "llm_answer": "Verizon still classifies international bonds as fixed‑income securities measured at fair value using market‑based matrix pricing and independent third‑party inputs (Level 2, with any observable prices placed in Level 1) (page_93). In 2023 the pension plan held $341 million of international bonds (Level 2 $338 M, Level 1 $3 M) and the other post‑retirement benefit plan held $12 million (Level 1 $10 M, Level 2 $2 M) (page_92; page_95), while in 2024 the pension‑plan exposure fell to $113 million (entirely Level 2) and the other benefit plan rose to $15 million (Level 1 $11 M, Level 2 $4 M) (page_94; page_95). The valuation approach itself remained unchanged, but the size of the holdings and their level‑hierarchy classification shifted between the two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the ground truth. (1) Quantitative Accuracy: The original answer states that in 2024, international bonds were specifically itemized with a total value of $12 million ($10M Level 1, $2M Level 2). However, the LLM claims the other post-retirement benefit plan held $15 million in 2024 (Level 1 $11M, Level 2 $4M), which contradicts the ground truth. Additionally, the LLM introduces $341 million for pension plan holdings in 2023, which is not mentioned in the original answer and appears to be from a different context (possibly pension assets, not general international bond valuation). These numbers are not supported by the ground truth and indicate major quantitative errors. (2) Completeness & Entity Accuracy: The question asks about Verizon's treatment and valuation approach for international bonds in its 10-K disclosures, not specifically within pension or post-retirement plans. The LLM incorrectly narrows the scope to benefit plans, which is not reflected in the original answer. The original answer describes a shift in disclosure strategy for international bonds broadly, not tied to specific plans. This misidentification of context and entities undermines accuracy. (3) Reasoning: The LLM concludes the valuation approach 'remained unchanged,' directly contradicting the original answer, which identifies a clear evolution from general description in 2023 to specific itemization and segmentation in 2024. This failure to recognize the shift in disclosure transparency and structure indicates flawed multi-hop reasoning. (4) Semantic Equivalence: Despite some correct terminology (e.g., matrix pricing, Level 1/Level 2 inputs), the core facts—valuation evolution, amounts, and context—are incorrect. The LLM appears to conflate data from pension plan disclosures with overall corporate valuation practices. While the response is relevant to Verizon and fair value disclosures, the factual divergence is substantial. Hence, low scores on correctness, quantitative, and qualitative accuracy; moderate contextual relevance due to topical alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 570,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Emerson's relationship with AspenTech evolve between 2022 and 2024, particularly in terms of financial stake and operational integration?",
      "original_answer": "In 2022, Emerson had a financial stake in AspenTech valued at $8,326 million, as shown in the balance sheet following acquisitions and currency adjustments. By 2024, Emerson's relationship had transformed significantly: it contributed the AspenTech Industrial Software Business along with $6.0 billion in cash to form 'New AspenTech,' retaining a 55% ownership stake in the newly structured company. This indicates a strategic restructuring rather than a simple financial investment, with increased operational integration and a formalized majority ownership.",
      "llm_answer": "In 2022 Emerson completed the “Heritage AspenTech” transaction, contributing its Open Systems International and Geological Simulation Software businesses plus about $6 billion of cash to create a new, independent AspenTech in which Emerson owned roughly 55 % of the common stock (2022 p. 59). By 2024 Emerson’s ownership had risen to about 57 % and the company announced a cash offer to purchase the remaining shares, moving toward full acquisition (2024 p. 25), while AspenTech’s software operations had been integrated into Emerson’s Software & Control segment, contributing to higher segment sales and margin improvements (2024 p. 24‑27).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 Emerson had a financial stake in AspenTech valued at $8,326 million on its balance sheet, not the result of a transaction creating a new AspenTech at that time. The LLM incorrectly states that in 2022 Emerson contributed businesses and $6 billion to create a new AspenTech with 55% ownership, which contradicts the ground truth—this event occurred in 2024, not 2022. The LLM also claims ownership increased to 57% by 2024 and that Emerson made a cash offer for the remaining shares, which is not supported by the original answer. The original states Emerson retained a 55% stake in 'New AspenTech' after the 2024 restructuring, with no mention of a move toward full acquisition. (2) Quantitative inaccuracies include misplacing the $6 billion cash contribution and 55% ownership to 2022 instead of 2024, inventing a 57% ownership stake, and fabricating a buyout offer. The $8,326 million 2022 stake from the ground truth is entirely omitted. (3) The multi-hop reasoning is flawed: the LLM conflates the timing and nature of the transaction, failing to correctly sequence the evolution from financial stake (2022) to operational integration and majority ownership (2024). It incorrectly implies integration occurred after a 2022 restructuring, when the ground truth indicates the major transformation was in 2024. (4) Despite these errors, the answer is contextually relevant, addressing financial stake and operational integration, and correctly noting integration into Emerson’s Software & Control segment. However, core facts and timeline are incorrect, warranting a low correctness and quantitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 471,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did Starbucks' position in interest rate swaps evolve between 2022 and 2023, particularly in terms of their classification and associated liabilities?",
      "original_answer": "In 2022, Starbucks had an interest rate swap classified as a long-term liability with a value of $34.0 million. By 2023, the company's interest rate swaps were categorized under both current and long-term liabilities, with $0.4 million listed under accrued liabilities (current) and $19.2 million under other long-term liabilities. This reflects a shift in the classification and a net decrease in the overall liability associated with interest rate swaps from $34.0 million in 2022 to $19.6 million in 2023.",
      "llm_answer": "In 2022 Starbucks listed its interest‑rate swaps only as a designated fair‑value hedge with no asset balance and a $34 million liability recorded in “Other long‑term liabilities” (plus a $12 million accrued “interest rates” liability). By 2023 the swap remained a designated fair‑value hedge, but a $0.4 million asset appeared under prepaid expenses and the liability rose to $41.4 million in other long‑term liabilities, with the separate “interest rates” accrued liability no longer shown. This shows the swap moved from a pure liability position to a net‑liability position that grew in size and was re‑classified.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022 Starbucks had a $34.0 million liability for interest rate swaps classified under long-term liabilities. The LLM incorrectly adds a $12 million 'accrued interest rates' liability not mentioned in the original answer and not supported by the ground truth. In 2023, the ground truth states liabilities were split into $0.4 million current (accrued liabilities) and $19.2 million long-term, totaling $19.6 million — a decrease from 2022. However, the LLM claims the liability increased to $41.4 million in long-term liabilities and introduces a $0.4 million asset (prepaid expenses), which contradicts the ground truth that reports only liabilities. The direction of change (increase vs. decrease) is therefore incorrect. (2) Quantitative accuracy is poor: the 2023 liability is overstated by over 100% ($41.4M vs $19.6M actual), and the $12M accrued interest in 2022 is unsupported. The only correct number is the $0.4M current liability in 2023, though it misrepresents it as an asset. (3) Multi-hop reasoning is flawed: the model fails to correctly synthesize the evolution of classification and value. It incorrectly infers that the liability grew and was reclassified with an offsetting asset, when in fact the total liability decreased and was split between current and long-term categories. The conclusion that the position moved to a 'net-liability that grew in size' is factually wrong. (4) Contextual relevance is moderate — the answer addresses interest rate swaps and classification changes, but the incorrect data and reasoning severely undermine accuracy. Correctness score is low due to major quantitative and qualitative errors that reverse the actual trend and misstate key facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 490,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How did NextEra Energy Resources' financial commitment and involvement in the Mountain Valley Pipeline evolve from 2022 to 2023?",
      "original_answer": "In 2022, NextEra Energy Resources recorded an impairment charge of approximately $0.8 billion related to its equity method investment in the Mountain Valley Pipeline, which was fully written off due to the very low probability of pipeline completion. By 2023, despite the ongoing challenges, NEE's subsidiary NEER maintained a 32.8% equity investment in the joint venture and committed to a 20-year natural gas transportation agreement with an annual obligation of approximately $70 million, subject to the completion of construction.",
      "llm_answer": "In the 2022 filing, NextEra Energy Resources recorded a first‑quarter impairment of roughly $0.8 billion (about $0.6 billion after tax) that completely wrote off its ~ $0.6 billion equity‑method stake in Mountain Valley Pipeline and added a $0.2 billion liability for its share of future ARO costs【page_92】. By the 2023 filing the company still had a planned equity contribution – listed under “Other (i)” as an equity contribution in 2024 for the pipeline’s construction【page_108】 – and entered into a 20‑year, roughly $70 million‑per‑year natural‑gas transportation agreement with the joint‑venture (where NEER holds a 32.8 % equity interest) that is contingent on the pipeline’s completion【page_109】. This shows a shift from a write‑off and liability in 2022 to a continued, albeit future‑oriented, financial commitment and contractual involvement in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $0.8 billion impairment charge in 2022 (including $0.6 billion after-tax write-off and $0.2 billion liability for ARO costs) matches the context and is consistent with the knowledge graph. The 2023 details—32.8% equity interest, $70 million annual obligation, 20-year transportation agreement, and future equity contribution planned for 2024—are all factually correct and properly cited. (2) The answer correctly interprets the evolution: a full write-off in 2022 due to low completion probability, followed by continued financial commitment in 2023 contingent on completion. (3) Multi-hop reasoning is sound—synthesizing impairment data from 2022 with forward-looking commitments in 2023, across different sections of filings. (4) Minor deduction in qualitative accuracy because the original answer emphasizes the 'very low probability of completion' as the reason for the write-off, which the LLM mentions implicitly but not explicitly. However, the core reasoning and factual synthesis remain strong. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses the evolution of financial commitment and involvement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 357,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has The Coca-Cola Company's investment in equity and debt securities related to its captive insurance company reinsuring group annuity insurance contracts evolved between 2023 and 2024?",
      "original_answer": "In 2023, The Coca-Cola Company reported that its captive insurance company reinsuring group annuity insurance contracts held $1,643 million in equity and debt securities as part of its solvency capital funds. By 2024, this amount increased to $1,883 million, indicating a growth in the company's investment in these securities over the year.",
      "llm_answer": "The captive’s portfolio of marketable equity and debt securities grew from $1.643 billion at December 31 2023 to $1.883 billion at December 31 2024 — an increase of about $240 million, indicating a higher allocation of capital to the captive that reinsures the group annuity insurance contracts.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the portfolio value was $1.643 billion (i.e., $1,643 million) at the end of 2023 and increased to $1.883 billion ($1,883 million) by the end of 2024. The format variation (billion vs. million) is acceptable and numerically consistent. (2) The calculation of the increase (~$240 million) is accurate: $1,883M - $1,643M = $240M. (3) The entity identification is correct—The Coca-Cola Company’s captive insurance company reinsuring group annuity contracts is properly referenced, and the time periods (December 31, 2023, and December 31, 2024) align with the annual reporting structure. (4) The reasoning is sound: the answer correctly infers that the increase reflects a higher capital allocation, which is a valid interpretation of the growth in investment. The multi-hop synthesis—linking the captive insurer, its purpose (reinsuring annuity contracts), and the evolution of its investment portfolio across two years—is complete and logically presented. All aspects of the question are addressed with factual precision and contextual clarity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 328,
        "total_tokens": 1498
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of production status and strategic positioning within Intel's product roadmap?",
      "original_answer": "In 2022, Intel was incurring higher period charges related to the ramp-up of Intel 4, indicating early-stage production challenges and investment. By 2024, Intel 4 had transitioned to high-volume manufacturing in Ireland and became the process node for the high-volume Intel Core Ultra processor, marking its strategic importance in Intel's product roadmap. This evolution shows a shift from initial investment and production ramp-up in 2022 to full-scale production and product integration by 2024.",
      "llm_answer": "In the 2022 filing Intel still described Intel 4 as a new node that was “ramp‑up”‑related, noting higher period charges tied to its early production (2022 10‑K p. 24). By the 2024 filing Intel said Intel 4 had transitioned to high‑volume manufacturing in Ireland, is already powering the Core Ultra client processors launched in 2023, and is slated to grow its share of processor output and serve as a key EUV‑based step in Intel’s roadmap through 2025 (2024 10‑K p. 9‑10, 11).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, Intel described Intel 4 as in ramp-up with higher period charges (citing 2022 10-K p.24), and by 2024 it had transitioned to high-volume manufacturing in Ireland, powering the Core Ultra processors. The strategic positioning as a key EUV-based node through 2025 is an additional detail consistent with the evolution narrative. (2) There are no numeric or date inaccuracies—years (2022, 2023, 2024, 2025), product names (Intel Core Ultra), and locations (Ireland) are correct. The mention of EUV (extreme ultraviolet) technology adds technical context without contradicting the original. (3) Multi-hop reasoning is sound: the answer synthesizes information across two years of filings, correctly tracing the evolution from early production challenges to high-volume manufacturing and strategic roadmap integration. (4) The only minor gap is that the original emphasizes the 'shift from initial investment to full-scale production' as a conceptual arc, which the LLM implies but does not explicitly summarize. However, all factual components supporting that conclusion are present and correctly cited. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually complete and contextually appropriate, warranting a high score with only a slight deduction in qualitative accuracy for less explicit synthesis of the overarching strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 408,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did Emerson's strategic relationship with AspenTech evolve between 2022 and 2024, particularly in terms of ownership structure and financial integration?",
      "original_answer": "In 2022, AspenTech was described as a strategic partner of Emerson, with no mention of ownership stakes or integration into Emerson's financials. By 2024, Emerson had merged its industrial software business with AspenTech, creating 'New AspenTech,' and retained a 55% ownership stake in the newly formed entity. This marked a significant shift from a partnership to a partially owned subsidiary structure. Additionally, AspenTech's financials were now integrated into Emerson's results, with the acquisition positively impacting gross margins by 0.6 percentage points in 2023 and influencing SG&A expenses in 2024 due to the deeper integration.",
      "llm_answer": "In fiscal 2022 Emerson formed “New AspenTech” by contributing two stand‑alone software businesses and cash, receiving a 55 % equity stake and only partially consolidating AspenTech’s results (the first half of FY 2022 excluded its earnings)【page_7】. By 2024 Emerson’s holding had risen to roughly 57 % and it announced a $240‑per‑share cash offer to acquire the remaining shares, moving toward full ownership, and AspenTech’s results are now fully integrated into Emerson’s financials—shown in the segment reporting, intangibles amortization, acquisition‑related inventory step‑up and a specific “AspenTech Micromine purchase‑price hedge” line item【page_25】【page_26】【page_27】【page_28】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the merger to form 'New AspenTech' occurred in 2024, not in fiscal 2022 as claimed by the LLM. The LLM incorrectly states that the merger and 55% ownership stake were established in FY2022, which contradicts the original timeline where AspenTech was only a strategic partner in 2022 with no ownership. Additionally, the LLM claims Emerson's stake increased to 57% by 2024 and that a $240-per-share offer was made for full acquisition—details not present in the ground truth, which only confirms a 55% stake and no move toward full ownership. (2) Quantitative inaccuracies include the incorrect fiscal year for the 55% stake (2022 vs actual 2024), the fabricated 57% ownership, and the unsupported $240-per-share cash offer. The integration details like 'segment reporting', 'intangibles amortization', and 'AspenTech Micromine purchase-price hedge' may reflect deeper integration but are not mentioned in the ground truth and appear to overstate or misrepresent the extent and nature of financial integration. (3) The multi-hop reasoning is flawed: the model fails to correctly sequence the evolution from partnership (2022) to partial ownership (2024), instead reversing the timeline and inventing an acquisition path. It also conflates partial consolidation in the past with full integration in the future, which is not supported. (4) Despite these major factual errors, the answer is contextually relevant—it addresses ownership structure and financial integration as asked, and cites plausible aspects of financial reporting integration. However, core facts about timing, ownership percentages, and strategic direction are incorrect, severely undermining correctness. The qualitative reasoning shows an understanding of what types of changes matter (ownership %, consolidation, financial line items), but applies them to a distorted timeline and fabricated events.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 531,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Intel's approach to the Intel 4 process node evolved from 2022 to 2024, particularly in terms of its manufacturing readiness and performance improvements?",
      "original_answer": "In 2022, Intel 4 was newly introduced as part of a restructured naming convention for manufacturing process nodes, signaling its position as a next-generation node following Intel 7. By 2024, Intel 4 had transitioned from a conceptual roadmap item to a fully realized product, with high-volume manufacturing ramped up in Ireland. Intel 4, as the company's first EUV lithography node, delivered a 20% performance-per-watt improvement over Intel 7 and was used in the production of the Intel Core Ultra processor, which began shipping in 2023. This represents a significant evolution from its initial naming in 2022 to full-scale production and performance quantification by 2024.",
      "llm_answer": "In the 2022 Form 10‑K Intel only announced “Intel 4” as the new name for its 10 nm Enhanced SuperFin node – a roadmap‑level rebranding with the process still in development (2022 p. 115). By the 2024 filing Intel 4 had become its first EUV‑lithography node, delivering roughly a 20 % performance‑per‑watt improvement over Intel 7, moving into high‑volume production in Ireland in 2024, and already powering shipped products such as the Core Ultra processors (2024 p. 10‑11; 2024 p. 9).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Intel 4 was rebranded from 10nm Enhanced SuperFin in 2022 (per 2022 10-K, p.115), it became Intel's first EUV node, delivered a 20% performance-per-watt improvement over Intel 7, entered high-volume manufacturing in Ireland in 2024, and powered the Core Ultra processors that began shipping in 2023. The mention of '2024' for production ramp aligns with the original answer's timeline as the ramp occurred in early 2024. (2) Quantitative accuracy is perfect: the 20% performance-per-watt gain is correctly cited, and all dates (2022 naming, 2024 production) match. (3) Multi-hop reasoning is sound—LLM correctly synthesized information across 2022 and 2024 filings to show evolution from roadmap item to production node. (4) Contextual relevance is high, directly addressing both manufacturing readiness (from development to high-volume production) and performance improvements (20% gain, EUV adoption). Minor wording differences (e.g., 'roadmap-level rebranding' vs 'conceptual roadmap item') do not affect factual equivalence. Citations to specific pages in the 10-Ks add precision. No errors in entities: Intel, Intel 4, Intel 7, Core Ultra, EUV, Ireland manufacturing site—all correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 363,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has the role and positioning of InterStim Micro evolved within MDT's Pelvic Health therapies between 2022 and 2024?",
      "original_answer": "In 2022, InterStim Micro was listed as one of several neurostimulators within MDT's Pelvic Health product portfolio, which also included InterStim X and InterStim II, used to treat overactive bladder, urinary retention, and fecal incontinence. By 2024, InterStim Micro was specifically highlighted as the rechargeable neurostimulator option, differentiated from the recharge-free InterStim X and InterStim II. This indicates a more defined strategic positioning of InterStim Micro as the rechargeable variant within the broader InterStim therapy lineup, with an emphasis on its continued global growth and adoption.",
      "llm_answer": "In the 2022 10‑K, InterStim Micro was listed simply as one of the Specialty‑Therapies pelvic‑health neurostimulators (with InterStim X and InterStim II) used to treat over‑active bladder, non‑obstructive urinary retention and chronic fecal incontinence. By the 2024 filing, the company frames InterStim Micro as the rechargeable member of an “InterStim therapy” suite—positioned alongside the newer recharge‑free InterStim X and InterStim II devices and highlighted as a growth driver for its Pelvic‑Health portfolio—showing a shift from a basic product listing to a strategic, differentiated role within a broader therapy platform.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All entities are correct: InterStim Micro, InterStim X, InterStim II, Medtronic (MDT), Pelvic Health therapies, and the relevant indications (overactive bladder, urinary retention, fecal incontinence) are accurately mentioned. The timeframes (2022 and 2024) are correctly used. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct use of years, which are accurate. (3) The multi-hop reasoning is sound: the LLM correctly infers a strategic shift in positioning from 2022 (where InterStim Micro was listed as one of several neurostimulators) to 2024 (where it is explicitly differentiated as the rechargeable option in a therapy suite). The emphasis on growth and differentiation from recharge-free models is correctly captured. (4) The LLM uses slightly different phrasing (e.g., 'Specialty-Therapies pelvic-health neurostimulators', 'growth driver') but maintains semantic equivalence. The only minor gap is that the original answer explicitly notes 'continued global growth and adoption', which is implied but not directly stated in the LLM response—hence a score of 9 instead of 10 on qualitative accuracy. Overall, the answer is highly accurate, relevant, and correctly synthesizes information across years and product positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 390,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the disclosure around the dilutive effect of LTIP Units evolved from 2022 to 2024, particularly in terms of material impact across reporting periods?",
      "original_answer": "In 2022, the disclosure stated that LTIP units were exchangeable for common stock and that no securities had a material dilutive effect for the years ended December 31, 2021, 2020, and 2019. By 2024, the disclosure simplified to state that no securities had a material dilutive effect for the years ended December 31, 2024, 2023, and 2022, without explicitly referencing the exchangeability of LTIP units into common stock. This indicates a reduction in the level of detail provided about LTIP units' conversion features, while maintaining the same conclusion regarding dilution impact.",
      "llm_answer": "The 2022 filing noted that LTIP units (and other exchangeable units) were “potentially dilutive securities” but that “no securities had a material dilutive effect for the years ended December 31, 2021, 2020 and 2019” (see page 115). The 2024 filing repeats the same conclusion – LTIP units are listed as potentially dilutive yet “no securities had a material dilutive effect for the years ended December 31, 2024, 2023 and 2022” (see page 114) – and confirms that no adjustments to net income or weighted‑average shares are made. Thus, the disclosure’s substance has not changed (LTIP units remain immaterially dilutive), but the language has been updated to explicitly cover the most recent three reporting periods.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in both quantitative and qualitative aspects. (1) Quantitatively, all dates and periods are accurate: the 2022 filing references dilutive impact for 2021, 2020, and 2019; the 2024 filing covers 2024, 2023, and 2022—this matches the ground truth exactly. There are no numerical or date inaccuracies. (2) The LLM correctly identifies that LTIP units were described as potentially dilutive in both periods and that no material dilutive effect was reported, which aligns with the ground truth's conclusion. (3) On reasoning: the LLM captures the continuity in substance—that no material dilution occurred—but correctly notes the updated disclosure period. However, it misses a key qualitative nuance emphasized in the ground truth: the 2024 filing no longer explicitly mentions that LTIP units are exchangeable for common stock, indicating a reduction in detail about conversion mechanics. The LLM mentions LTIP units are 'listed as potentially dilutive' but does not highlight the omission of exchangeability language, which is central to the evolution of the disclosure. (4) Despite this omission, the answer remains contextually relevant and factually sound in its core claims. The conclusion about unchanged substance and updated reporting periods is valid, but the lack of emphasis on reduced detail about conversion features slightly weakens the qualitative accuracy. Hence, correctness is high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 398,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has MetLife's approach to managing cash buffer needs in relation to stock repurchases evolved from 2022 to 2024, particularly in terms of remaining repurchase authorization and liquidity considerations?",
      "original_answer": "In 2022, MetLife had $1.5 billion remaining under its $3.0 billion common stock repurchase authorization as of December 31, 2021, indicating a significant but partially utilized capacity for returning capital to shareholders. By 2024, the company emphasized increased caution around cash buffer needs, noting that maintaining or increasing liquidity buffers could limit capital available for repurchases, acquisitions, and innovation. This reflects a shift from a more active repurchase posture in 2022 to a more conservative liquidity strategy in 2024, influenced by regulatory, market, and internal capital considerations.",
      "llm_answer": "In the 2022 Form 10‑K MetLife disclosed that its board had authorized a $3 billion share‑repurchase program and that $1.5 billion of that authorization remained available at 12/31/2021, while warning that a cash‑buffer requirement could limit the amount it could use for repurchases【page_50】. By the 2024 filing the company still emphasizes that it “maintains a buffer of cash and other liquid assets, and may increase it,” noting that a larger buffer would leave less capital for dividend or share‑repurchase activity, but it no longer cites a specific remaining repurchase amount, reflecting a shift toward a broader liquidity‑first approach rather than a defined repurchase target【page_33】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $3.0 billion share repurchase authorization and the $1.5 billion remaining as of December 31, 2021 (reported in the 2022 10-K), which matches the ground truth. It also accurately reflects the shift in tone by 2024, emphasizing increased focus on liquidity buffers and reduced emphasis on specific repurchase amounts. The absence of a cited remaining authorization in 2024 is correctly noted. (2) All numeric values—$3 billion total authorization, $1.5 billion remaining—are factually correct and properly contextualized with the correct date (12/31/2021). No calculations are required, but the synthesis of the remaining amount from the prior year is accurate. (3) The multi-hop reasoning is sound: the model connects information from the 2022 and 2024 filings to infer a strategic shift from active repurchases to a more conservative, liquidity-first posture. It correctly interprets the qualitative change in language around capital deployment. (4) The answer is semantically equivalent to the ground truth, with only minor differences in phrasing (e.g., 'liquidity-first approach' vs 'more conservative liquidity strategy'). The omission of explicit mention of 'regulatory, market, and internal capital considerations' slightly reduces qualitative accuracy but does not undermine the core correctness. Contextual relevance is perfect—the response directly addresses the evolution in cash buffer management and repurchase strategy across the specified period.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 418,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Starbucks' foreign currency - other derivative asset and liability positions evolve from fiscal year 2022 to 2023, and what specific changes occurred in their balance sheet classifications?",
      "original_answer": "In fiscal year 2022, Starbucks reported foreign currency - other derivative assets of $103.9 million recognized in OCI before reclassifications and $22.0 million reclassified from AOCI to earnings. By fiscal year 2023, the foreign currency - other derivative assets on the balance sheet were reported as $1.9 million in prepaid expenses and other current assets and $1.7 million in other long-term assets as of October 1, 2023, while derivative liabilities were $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. This represents a significant reduction in asset positions compared to the prior year, with a shift in balance sheet classification.",
      "llm_answer": "In FY 2022 Starbucks reported foreign‑currency‑other derivative assets of $39.9 million in prepaid expenses and other current assets and $33.5 million in other long‑term assets (total ≈ $73.4 million) and a $0.3 million accrued‑liability position 【page_68】. By FY 2023 those asset balances had fallen to $32.0 million (current) and $22.9 million (long‑term) – a total of about $54.9 million – while the liability rose to $2.0 million in accrued liabilities (with no long‑term liability) 【page_72】. The balance‑sheet classification (current vs. long‑term for assets and accrued liabilities for the liability) stayed the same, but the asset amount declined and the liability amount increased.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both asset and liability figures for both fiscal years. For FY 2022, the LLM incorrectly states that Starbucks reported $39.9 million in prepaid expenses and $33.5 million in other long-term assets, totaling $73.4 million in foreign currency - other derivative assets. However, the ground truth indicates that the $103.9 million was recognized in OCI before reclassifications, not split across balance sheet line items as current and long-term assets. Additionally, the $22.0 million reclassified from AOCI to earnings is omitted entirely. For FY 2023, the LLM reports $32.0 million (current) and $22.9 million (long-term) in assets, but the correct figures are $1.9 million in prepaid expenses and $1.7 million in other long-term assets—over 15x lower than reported by the model. Similarly, the LLM states a $2.0 million accrued liability with no long-term liability, while the truth is $4.7 million in accrued liabilities and $4.1 million in other long-term liabilities. (2) All calculations and comparisons are therefore incorrect. The model suggests a decline from ~$73.4M to ~$54.9M in assets, whereas the actual decline is from $103.9M (OCI) to a net balance sheet total of $3.6M. The liability increase is misrepresented in both magnitude and classification. (3) The multi-hop reasoning fails: the model misinterprets the nature of the FY 2022 data (OCI amount vs. balance sheet classification), does not recognize the shift in classification approach (from OCI-based reporting to direct balance sheet disclosure), and incorrectly assumes consistent classification categories across years. It also fails to note the significant reduction and reclassification shift emphasized in the original answer. (4) Scores reflect severe quantitative errors (2/10), poor reasoning due to misinterpretation of financial concepts and missing synthesis (3/10), partial contextual relevance as it addresses the general topic of derivative positions over time (6/10), and a very low overall correctness score (2/10) due to pervasive factual inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 568,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Procter & Gamble's global cash management strategy evolved in relation to its restructuring activities and corporate-level financial performance between fiscal 2022 and fiscal 2024?",
      "original_answer": "In fiscal 2022, Procter & Gamble incurred restructuring costs within its historical range of $250 to $500 million before tax, with $147 million in restructuring accruals as of June 30, 2022. Corporate net earnings improved by $872 million to $485 million, partly due to tax benefits and lower restructuring charges. By fiscal 2024, restructuring costs increased significantly to $659 million before tax, including $216 million in non-cash foreign currency translation losses. Corporate net earnings decreased by $1.0 billion, largely due to the $1.4 billion impairment charge of the Gillette intangible asset and incremental restructuring charges. This indicates a shift toward more aggressive restructuring actions, particularly in Enterprise Markets like Nigeria, which impacted both cash flow and earnings. The global cash management strategy remained focused on liquidity and tax considerations, but faced increased pressure from these restructuring activities and impairment charges.",
      "llm_answer": "P&G’s global cash‑management framework—centered on using operating cash to fund dividends, share repurchases and acquisitions while maintaining sizable foreign‑currency cash balances—remained in place, but it became more defensive as restructuring intensified and corporate earnings turned negative. In fiscal 2022 restructuring costs stayed within the $250‑$500 million historical range, about 65 % were cash‑settled and corporate earnings posted a $485 million profit; by fiscal 2024 restructuring outlays rose to $659 million (including $216 million of non‑cash FX translation losses), corporate earnings fell to a $1.43 billion loss, and the company leaned on higher operating cash ($19.8 billion), its $6.1 billion of overseas cash and undrawn credit facilities to preserve liquidity.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of P&G's cash management strategy and correctly identifies increased restructuring costs and declining corporate earnings. However, there are key quantitative inaccuracies. According to the ground truth, in fiscal 2022, corporate net earnings improved by $872 million to reach $485 million (i.e., prior year was a $387 million loss), but the LLM states 'corporate earnings posted a $485 million profit'—which, while directionally correct, omits the comparative improvement and misrepresents the context. More critically, the LLM claims corporate earnings fell to a '$1.43 billion loss' in fiscal 2024, whereas the ground truth states a decrease of $1.0 billion in corporate net earnings (not a $1.43B loss), primarily due to a $1.4B impairment charge. This is a significant misstatement of magnitude and metric (confusing earnings change with total earnings). Additionally, the LLM introduces a '65% cash-settled' figure and '$19.8 billion operating cash' and '$6.1 billion overseas cash' figures not present in the original answer, adding unsupported detail. (2) Restructuring costs are mostly correct: $659 million in fiscal 2024 including $216 million non-cash FX losses matches the ground truth. The fiscal 2022 range of $250–$500 million is correctly cited. However, the $147 million restructuring accrual as of June 30, 2022, from the original answer is omitted. (3) The multi-hop reasoning is sound: the model connects restructuring costs, earnings trends, and cash management implications across years and infers a more defensive posture, which aligns with the ground truth’s conclusion about increased pressure on cash strategy. The mention of Enterprise Markets like Nigeria is missing, but the overall synthesis of financial performance and restructuring impact is logical. (4) Scores reflect that core facts and trends are correct (hence 7/10 correctness), but quantitative accuracy is reduced due to unsupported numbers and misrepresentation of earnings figures. Qualitative reasoning and contextual relevance remain high as the answer addresses the strategic evolution appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 577,
        "total_tokens": 2032
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has NVIDIA's positioning and application of Omniverse evolved between 2022 and 2023, particularly in terms of its integration with enterprise solutions and simulation technologies?",
      "original_answer": "In 2022, NVIDIA Omniverse was positioned primarily as a virtual world simulation and collaboration platform for 3D workflows, emphasizing its availability as a software subscription for enterprise use and free for individuals. It was highlighted in use cases such as virtual car showrooms, surgical training, and architectural walkthroughs, and was integrated with DRIVE Sim software for automotive simulation and validation. By 2023, Omniverse had evolved into a more robust development platform and operating system for building virtual world simulation applications. It was increasingly tied to industrial enterprises for digitalizing complex physical assets and processes, including digital twins of factories and real-time 3D product configurators. Additionally, it was more explicitly linked to NVIDIA's accelerated computing infrastructure both on-premises and in the cloud, indicating a broader integration with enterprise-grade simulation and AI workflows.",
      "llm_answer": "In the 2022 filing NVIDIA described Omniverse primarily as a real‑time 3‑D design‑collaboration and virtual‑world simulation platform offered as a software subscription for enterprise use, emphasizing its role in digital‑cockpit development, NVIDIA DRIVE Sim for autonomous‑vehicle testing, and building digital twins, product configurators and autonomous‑robot validation (2022 p. 7‑9, 6). By the 2023 filing the company has repositioned Omniverse as “Omniverse Enterprise,” an enterprise‑grade suite that powers industrial digitalization, metaverse/3‑D‑internet applications and broader simulation of factories, robots and vehicles, and is now tightly integrated with NVIDIA AI Enterprise, vGPU cloud services and its data‑center infrastructure, reflecting deeper enterprise integration and an expanded simulation focus (2023 p. 5‑7, 6).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, Omniverse was positioned as a real-time 3D collaboration and simulation platform with use cases in automotive (DRIVE Sim), digital twins, and enterprise subscriptions; by 2023, it evolved into a more enterprise-focused platform (Omniverse Enterprise), integrated with NVIDIA AI Enterprise, vGPU cloud services, and data center infrastructure. These developments reflect deeper integration with enterprise solutions and simulation technologies, as required by the question. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—thus, quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across two years of filings, identifying the shift from a collaboration tool to an enterprise operating system for industrial digitalization. It captures the expanded scope (factories, robots, vehicles), new integrations (AI Enterprise, cloud infrastructure), and rebranding to 'Omniverse Enterprise'. (4) The only minor shortcoming is that the LLM answer does not explicitly mention specific 2022 use cases like virtual car showrooms, surgical training, or architectural walkthroughs from the original answer, though it does reference digital twins and product configurators. This slight omission in contextual detail prevents a perfect 10 on qualitative accuracy, but the core evolution is accurately captured. Overall, the answer is semantically equivalent, contextually relevant, and factually correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 447,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did AMT's financial commitments related to communications sites evolve from 2023 to 2024, particularly in terms of anticipated spending and future obligations?",
      "original_answer": "In 2023, AMT anticipated spending approximately $450 million related to data center assets as part of its construction plans for 2,500 to 3,500 communications sites globally. By 2024, the company disclosed a much larger financial commitment, with an estimated undiscounted future cash outlay of $4.5 billion for asset retirement obligations tied to leased sites hosting communications infrastructure. This indicates a significant increase in long-term financial exposure related to communications sites, shifting from near-term capital allocation planning in 2023 to a more mature and substantial obligation structure in 2024.",
      "llm_answer": "In 2023 AMT actually spent $849.3 million on discretionary capital projects – a mix that included building 3,198 communications sites worldwide and about $395 million of data‑center spend (see 2023 10‑K p.48). For 2024 the company now expects to spend only $790‑$820 million on discretionary projects, covering the construction of roughly 2,500‑3,500 sites and about $450 million of data‑center spend (see 2024 10‑K p.49). At the same time, the 2024 filing flags ongoing operating‑lease commitments for those sites – nearly $987 million due in 2025 and similarly large lease payments through 2029 – indicating that future obligations to retain the communications sites remain substantial (see 2024 10‑K p.56).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of accurate and inaccurate information, with significant deviations from the ground truth in key financial commitments and misinterpretation of the nature of the obligations. (1) Quantitative Accuracy: The LLM incorrectly states that AMT spent $849.3 million in 2023 on discretionary capital projects including $395 million on data centers (from 2023 10-K p.48), but the original answer refers to *anticipated* spending of $450 million on data center assets related to 2,500–3,500 sites — not actual spend. The LLM confuses actual capital expenditures with forward-looking plans. For 2024, the LLM cites anticipated discretionary spending of $790–$820 million with $450 million for data centers, which aligns partially with the original answer’s mention of ~$450 million for data center assets, but this is not the core financial commitment highlighted in the ground truth. Crucially, the LLM fails to mention the $4.5 billion asset retirement obligation (ARO) for leased sites — a central point in the original answer — instead citing $987 million in lease payments due in 2025 and beyond. This is a major factual omission and misrepresentation of the scale and type of obligation. (2) Completeness: The question asks about evolution in financial commitments, particularly anticipated spending and future obligations. The LLM covers anticipated 2024 spending but misses the critical shift from near-term capex to long-term ARO liabilities. The $4.5 billion ARO is entirely absent, which undermines the core of the multi-hop comparison. (3) Entity Accuracy: Correctly identifies AMT, years (2023–2024), and references to 10-K pages. However, it conflates 'discretionary capital projects' and 'data center spend' with broader financial commitments related to communications sites, which in the ground truth specifically includes long-term AROs. (4) Reasoning: The reasoning is flawed — it interprets lease payment disclosures as the primary future obligation, while the original answer emphasizes a qualitative shift to a $4.5 billion undiscounted ARO liability, indicating maturation of long-term exposure. The LLM does not synthesize the evolution from construction capex to retirement liabilities, which is the key insight. (5) Semantic Equivalence: While some elements (e.g., $450 million data center spend, site construction range) are semantically close, the absence of the $4.5 billion ARO and mischaracterization of obligations result in a materially different narrative. The LLM suggests a decrease in spending ($849M to $790–820M), while the ground truth highlights a massive increase in long-term liability. Thus, despite some correct numbers, the overall correctness is low due to missing the central financial commitment shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 728,
        "total_tokens": 2066
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has ExxonMobil's characterization of asset divestitures in relation to strategic objectives evolved between 2023 and 2024, particularly in terms of the language used to describe the proceeds from these transactions?",
      "original_answer": "In 2023, ExxonMobil described proceeds from asset sales as part of 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments,' emphasizing a disciplined review process to ensure assets align with strategic goals. By 2024, the company refined its language, referring more broadly to 'proceeds from asset sales and returns of investments,' maintaining the same strategic alignment rationale but streamlining the description. This evolution indicates a more consolidated framing of divestiture proceeds without specific mention of subsidiaries or equipment sales, suggesting a possible shift toward a more generalized narrative around asset management.",
      "llm_answer": "In both the 2023 and 2024 filings ExxonMobil says it divests assets that “are no longer meeting the Corporation’s strategic objectives or are worth considerably more to others,” so the strategic‑objective framing has not changed. What has shifted is the wording around the cash received: the 2023 definition refers to “proceeds associated with sales of subsidiaries, property, plant and equipment, and sales and returns of investments,” while the 2024 definition streamlines this to “proceeds from asset sales and returns of investments,” emphasizing the proceeds as a single, unified cash‑flow component.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the strategic rationale for divestitures remains unchanged between 2023 and 2024, and the evolution in language around proceeds is accurately described. The 2023 terminology 'sales of subsidiaries, property, plant and equipment, and sales and returns of investments' is correctly contrasted with the 2024 streamlined version 'proceeds from asset sales and returns of investments.' (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all descriptive financial terms are used correctly and consistently with the source. (3) The multi-hop reasoning—comparing language across two years and identifying both continuity in strategic framing and change in terminology—is sound and well-executed. (4) The only minor shortcoming is that the LLM does not explicitly note the 'disciplined review process' mentioned in the 2023 context, which slightly reduces completeness in qualitative nuance. However, the core insight about consolidation and generalization of the narrative is preserved. Overall, the answer is semantically equivalent and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 343,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2023, based on the changes in consolidated asset and liability amounts?",
      "original_answer": "In 2022, Comcast's consolidated balance sheet included $9.7 billion in assets and $8.1 billion in liabilities related to Universal Beijing Resort. By 2023, these figures had decreased to $7.8 billion in assets and $7.2 billion in liabilities. This indicates a reduction in both the scale of assets and liabilities associated with the Universal Beijing Resort, suggesting either asset depreciation, debt repayment, or a strategic reduction in the resort's financial footprint within Comcast's consolidated statements.",
      "llm_answer": "Comcast’s exposure to Universal Beijing Resort rose modestly. The 2022 filing shows that the consolidated balance sheet included about **$7.5 billion of assets and $7.0 billion of liabilities** for the resort (see Note 9 on page 103 of the 2022 10‑K). By year‑end 2023 those figures had increased to **$7.8 billion of assets and $7.2 billion of liabilities** (page 87 of the 2023 10‑K), reflecting roughly a $0.3 billion rise in assets and a $0.2 billion rise in liabilities and therefore a slight increase in Comcast’s financial exposure.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that in 2022, Comcast reported $9.7 billion in assets and $8.1 billion in liabilities for Universal Beijing Resort, but the LLM incorrectly reports $7.5 billion in assets and $7.0 billion in liabilities. These numbers do not match the ground truth and misrepresent the starting point. The 2023 figures ($7.8B assets, $7.2B liabilities) are correctly stated by the LLM, but the 2022 figures are wrong. (2) Calculations are based on incorrect inputs: the LLM claims a 'rise' of $0.3B in assets and $0.2B in liabilities, but in reality, assets decreased from $9.7B to $7.8B (a $1.9B drop), and liabilities decreased from $8.1B to $7.2B (a $0.9B drop). This results in a significant error in both magnitude and direction of change. (3) The multi-hop reasoning is flawed because the model failed to correctly extract and compare the 2022 figures, leading to an incorrect conclusion about the trend. Instead of a 'modest rise', there was a clear reduction in financial exposure. (4) Contextual relevance is high because the answer addresses the right entities (Comcast, Universal Beijing Resort), time periods (2022–2023), and financial metrics (consolidated assets/liabilities), and even cites specific 10-K pages. However, the factual inaccuracies in the numbers and the resulting incorrect conclusion severely undermine correctness and qualitative reasoning. The answer contradicts the ground truth in both data and interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 419,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the nature of Customer Demand Volatility as a risk factor for Caterpillar evolved between 2023 and 2024, particularly in relation to its impact on financial performance and supply chain stability?",
      "original_answer": "In 2023, Customer Demand Volatility was described as being primarily driven by economic uncertainties, including the lingering effects of a global pandemic, which led to inflationary pressures, supply chain disruptions, and labor inefficiencies, all of which limited Caterpillar's ability to meet customer demand. By 2024, while the risk remained, the focus shifted slightly to include broader commodity price changes, material price increases, and significant disruptions to supply chains or shortages of labor and material as key contributors to financial performance risks. This evolution indicates a broadening of the risk profile to include more systemic supply-side challenges alongside demand volatility.",
      "llm_answer": "In the 2023 Form 10‑K Caterpillar warned that “fluctuations in demand for our products and services … may adversely impact our financial results or our ability to meet commitments to customers” (2023 10‑K p. 13), treating demand volatility as a broad macro‑economic risk. By the 2024 filing the language was sharpened: the company now says that when demand falls short of expectations it can lead to excess inventories, higher costs and reduced profitability, and that such shortfalls can trigger supply‑chain inefficiencies and transportation delays (2024 10‑K p. 14). Thus the risk factor has evolved from a generic caution about demand swings to a more concrete description of how demand volatility directly pressures earnings and disrupts the supply chain.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of Customer Demand Volatility as a risk factor from 2023 to 2024 for Caterpillar, citing appropriate shifts in language and emphasis between the two 10-K filings. The 2023 characterization as a macroeconomic risk tied to broader uncertainties and the 2024 refinement to include specific financial and supply chain consequences (excess inventory, higher costs, reduced profitability, supply chain inefficiencies) are factually consistent with the original answer. (2) There are no numerical values, dates, or financial metrics in dispute; all references to years (2023, 2024) and document types (10-K) are correct. Page numbers cited (p. 13, p. 14) are plausible and do not contradict the knowledge graph. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings and infers a meaningful shift in risk framing—from generic demand swings to concrete operational and financial impacts. While the original answer emphasizes supply-side factors (commodity prices, material/labor shortages) as newly integrated into the risk profile, the LLM answer focuses more on the downstream effects of demand shortfalls. This is a slight difference in emphasis but not a factual error, as both reflect valid interpretations of the evolving risk narrative. (4) The answer is contextually relevant, directly addressing the question about evolution in risk nature, impact on financial performance, and supply chain stability. The only reason for not scoring a 10 is the omission of explicit mention of commodity and material price increases as part of the broadened risk in 2024, which slightly reduces completeness in capturing the full scope of the shift. However, the core evolution in risk articulation is accurately conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 503,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value and valuation methodology of Net derivative assets (liabilities) evolve from 2022 to 2024?",
      "original_answer": "In 2022, the fair value of Net derivative assets (liabilities) was $19 million as of December 31, 2021, with changes in value primarily tied to derivative activity such as issuances ($68 million), settlements ($-37 million), and transfers ($6 million). By 2024, the fair value had increased significantly to $58 million as of December 31, 2023. Additionally, the valuation methodology shifted from being primarily based on realized and unrealized gains/losses reported in net income to being assessed using discounted cash flows with a focus on observable inputs like swap rates (3-5%, weighted average of 4%). This indicates both a material increase in value and a methodological shift toward more transparent and observable valuation techniques.",
      "llm_answer": "In the 2022 filing the net derivative liabilities were recorded at a year‑end fair value of **$5 million** (balance Dec 31 2022) and were valued using a **discounted‑cash‑flow model** that relied on **swap‑rate inputs** (the unobservable range was 1‑2 % with a weighted‑average of 2 %). By the 2024 filing the same liability had grown to a **$69 million** fair‑value balance (Dec 31 2024) and the valuation method remained a **discounted‑cash‑flow approach** with **swap‑rate inputs**, but the swap‑rate range widened to **about 4 %** (weighted‑average 4 %). Throughout the period the liability stayed classified as a Level 3 measurement. (Sources: 2022 Level 3 roll‑forward and Table 17.3 – pages 215‑216; 2024 Level 3 roll‑forward and Table 17.3 – pages 215‑217)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple critical factual errors. First, it reports the 2022 fair value as $5 million as of December 31, 2022, but the ground truth states the fair value was $19 million as of December 31, 2021, with no direct 2022 year-end figure provided in the original answer—however, the LLM incorrectly assigns a $5M value to 2022 that contradicts the upward trend to $58M by 2023. More importantly, the LLM claims the 2024 value is $69 million as of December 31, 2024, but the ground truth reports $58 million as of December 31, 2023—so both the amount and the date are wrong. Additionally, the LLM states the valuation methodology in 2022 already used a discounted cash flow model with swap rates (1–2%, weighted average 2%), but the ground truth says the methodology *shifted* to this approach by 2024, implying it was not the primary method in 2022. Instead, the original answer states that changes in 2022 were tied to derivative activity (issuances, settlements, transfers), not DCF models. (2) Quantitative accuracy is severely compromised: the dollar values ($5M vs implied $19M, $69M vs $58M), dates (Dec 31, 2024 vs Dec 31, 2023), and interest rate inputs (1–2% vs 3–5% in 2024) are all incorrect. The LLM also fabricates a '2024 filing' with data for Dec 31, 2024, which is outside the 2022–2024 evolution period referenced in the question and not supported by the ground truth. (3) The multi-hop reasoning is flawed: the model fails to recognize that the methodology *changed* from activity-based reporting to DCF with observable inputs by 2024. Instead, it claims the same DCF methodology was used in both years, contradicting the core insight of a methodological shift. It also misattributes the Level 3 classification continuity, which was not mentioned in the ground truth. (4) Contextual relevance is moderate because the answer addresses fair value and valuation methodology over time, but the factual inaccuracies and incorrect synthesis undermine correctness. The mention of sources like 'Table 17.3' and 'Level 3 roll-forward' suggests plausible formatting but does not align with the actual truth data. Overall, major factual and reasoning errors justify a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 596,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has NVIDIA's GeForce NOW cloud gaming offering evolved from 2022 to 2023 in terms of its positioning within the company's broader GPU and cloud platform ecosystem?",
      "original_answer": "In 2022, GeForce NOW was positioned as a cloud platform enabling gamers to access interactive graphics applications from nearly any device, emphasizing its role in extending NVIDIA’s graphics leadership and ecosystem reach. It was mentioned alongside other cloud platforms like vGPU for enterprise use. By 2023, GeForce NOW was more specifically integrated into the broader NVIDIA accelerated computing platform narrative, and its positioning shifted to emphasize cloud gaming as part of a suite of GPU-driven services, including AI training platforms like NVIDIA DGX Cloud. This evolution reflects a more strategic alignment of GeForce NOW with NVIDIA’s expanding cloud infrastructure and software offerings, particularly in the context of gaming as a service.",
      "llm_answer": "In the 2022 Form 10‑K NVIDIA only referenced GeForce NOW as one of its “cloud platforms” that, together with vGPU, lets interactive graphics applications be accessed on any device – a supporting role to its GPU hardware (see page 11). By the 2023 filing the service is listed as a distinct component of the Graphics segment, described as the “GeForce NOW game‑streaming service and related infrastructure” that leverages NVIDIA’s GPUs and cloud infrastructure, indicating a more prominent, integrated position within the company’s GPU‑and‑cloud ecosystem (see pages 5 and 7, and page 6).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies the evolution of GeForce NOW from 2022 to 2023 in NVIDIA's 10-K filings: in 2022, it was mentioned as one of several cloud platforms (alongside vGPU) enabling access to graphics applications, while in 2023, it gained a more distinct and integrated role within the Graphics segment as a game-streaming service leveraging NVIDIA's GPU and cloud infrastructure. The LLM accurately reflects the shift in positioning—moving from a supporting role to a more strategically integrated component of the GPU-and-cloud ecosystem. It also correctly references the document structure (page numbers), which supports traceability. The only minor shortcoming is that it does not explicitly mention the broader narrative of NVIDIA’s accelerated computing platform or the connection to AI training services like DGX Cloud, which the original answer includes as part of the 2023 strategic alignment. However, the core facts, entities (GeForce NOW, vGPU, GPU hardware, cloud infrastructure), years (2022 vs 2023), and reasoning about increased integration are correct. There are no numerical inaccuracies (quantitative accuracy is perfect), and the answer is highly relevant to the question. The reasoning is sound and represents valid multi-hop synthesis across two years of filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 378,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors influenced this change?",
      "original_answer": "In 2022, Inlyta had total global revenue of $1,003 million, while in 2023, its revenue increased to $1,036 million, representing a 3% growth. This growth was primarily driven by continued adoption of Inlyta in combination with immune checkpoint inhibitors for the first-line treatment of advanced renal cell carcinoma (RCC) in the U.S., and growth in emerging markets. However, this increase was partially offset by lower volumes and lower net prices in certain European markets.",
      "llm_answer": "Inlyta’s sales rose modestly from $1,003 million in 2022 to $1,036 million in 2023 (≈3% worldwide), with U.S. revenue increasing from $618 million to $642 million (≈4%) and international revenue from $385 million to $394 million (≈3%)【page_44】. The uptick was driven primarily by greater U.S. adoption of Inlyta in combination with immune‑checkpoint inhibitors for first‑line treatment of advanced renal‑cell carcinoma, while lower volumes and reduced net price in some European markets partially offset the growth【page_44】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key financial figures from the ground truth: Inlyta's global revenue of $1,003 million in 2022 and $1,036 million in 2023, representing approximately 3% growth. It also accurately breaks this down into U.S. revenue ($618M to $642M, ~4% growth) and international revenue ($385M to $394M, ~3% growth), which, while not present in the original answer, are consistent with the total and do not contradict the ground truth. These additional details appear to be correctly sourced from the referenced document (page_44). (2) All calculations are accurate: the percentage changes are correctly approximated (~3% and ~4%), and the sum of U.S. and international revenue matches the global total in both years (e.g., $642M + $394M = $1,036M). (3) The reasoning and synthesis are sound: the LLM correctly identifies the primary driver of growth—increased U.S. adoption of Inlyta in combination with immune checkpoint inhibitors for first-line treatment of advanced RCC—and notes the offsetting pressure from lower volumes and net prices in certain European markets, exactly as stated in the ground truth. (4) The only reason for not scoring a 10 is that the original answer does not include the U.S./international revenue split; while this information is accurate and enhances the response, it goes beyond the provided ground truth without confirmation from the knowledge graph. However, since it does not introduce errors and supports the correct conclusion, the answer remains highly accurate. Semantic equivalence is maintained, and the response fully addresses both parts of the question: revenue performance and influencing factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 458,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the treatment and valuation of network location intangibles evolved from 2023 to 2024, particularly in terms of amortization assumptions and impairment review processes?",
      "original_answer": "In 2023, the company amortized network location intangibles on a straight-line basis over their estimated useful lives, with a weighted average amortization period of 15 years as of December 31, 2023. The focus was on the relationship between these intangibles and tower assets, particularly in terms of potential revenue growth from leasing excess capacity. By 2024, the company expanded its disclosures to include a more detailed impairment review process for network location intangibles, assessing impairment on an individual tower basis and identifying specific triggers such as lack of tenant leases or expenses exceeding revenues. Additionally, while amortization remained a key treatment, the company's broader discussion of asset retirement obligations in 2024, including a $470 million increase in liability due to revised settlement dates, indirectly impacts the valuation and useful life assumptions for these intangible assets.",
      "llm_answer": "In 2023 the company amortized acquired network‑location intangibles on a straight‑line basis over the shorter of the ground‑lease term (including renewal options) and a maximum of about 20 years, giving a weighted‑average remaining amortization period of roughly 15 years 【page_103】. For 2024 the amortization range was expanded to 2‑30 years and the useful lives of those intangibles were aligned with the newly‑extended 30‑year tower life, so the assets are now amortized over a longer horizon 【page_95】【page_96】. The impairment review also became more explicit: network‑location intangibles are examined each year on a tower‑by‑tower basis for lease‑occupancy or cash‑flow shortfalls, with any loss measured against projected undiscounted or discounted future cash flows and recorded in the period the impairment is identified 【page_96】【page_95】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. While it correctly identifies the 15-year weighted average amortization period in 2023 and the shift to more detailed impairment reviews in 2024, it introduces significant inaccuracies regarding amortization periods. The original answer states that in 2023, the weighted average was 15 years, but does not specify a 20-year maximum or ground-lease linkage—this detail is absent from the ground truth. The LLM claims that in 2024, the amortization range was expanded to 2–30 years and aligned with a 30-year tower life, which is not supported by the original answer. The ground truth does not mention any extension of amortization periods or a formal 30-year horizon; instead, it emphasizes enhanced impairment review processes and indirect impacts from asset retirement obligations. (2) The $470 million increase in liability due to revised settlement dates is completely omitted in the LLM answer, representing a major quantitative and contextual gap. This figure is a key part of the valuation evolution in 2024. Additionally, the LLM fabricates a 2–30 year amortization range and 30-year tower life alignment not present in the original. (3) The multi-hop reasoning is partially sound—LLM correctly infers that impairment reviews became more granular (tower-by-tower), matching the original’s mention of individual tower assessments and triggers like lease or revenue issues. However, it overreaches by introducing new amortization ranges and useful life assumptions not in the source. (4) The contextual relevance is high because the answer addresses both amortization and impairment, the two core aspects of the question. Qualitative accuracy is moderate due to correct identification of impairment triggers and review frequency but undermined by unsupported details. Quantitative accuracy is low due to invented ranges and omission of the $470M liability change. Correctness score reflects partial accuracy with significant factual deviations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 546,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, particularly in terms of its upstream growth portfolio and production capacity?",
      "original_answer": "In 2023, ExxonMobil highlighted Guyana as a key component of its upstream growth portfolio, noting four additional discoveries on the Stabroek Block and the startup of the Prosperity FPSO vessel, which brought production to nearly 440 kbd in the fourth quarter. By 2024, Guyana was formally categorized under 'Advantaged Assets' within the updated earnings drivers, reflecting its strategic elevation alongside the Permian and LNG projects as a core contributor to earnings through volume/mix growth. This shift indicates a transition from a discovery and early production phase in 2023 to a more mature, financially impactful asset in 2024.",
      "llm_answer": "In the 2023 filing ExxonMobil highlighted Guyana as a centerpiece of its upstream growth, reporting four new Stabroek‑Block discoveries, the start‑up of the Prosperity FPSO (reaching name‑plate in Jan 2024), combined production from three FPSOs of > 390 kbd in 2023 and almost 440 kbd in Q4 2023, and the scheduled addition of Yellowtail, Uaru and a sixth Whiptail FPSO to reach six vessels by 2027 【page_52】. In the 2024 filing Guyana is now grouped with the Permian and LNG as an “advantaged asset” in the company’s low‑cost‑of‑supply growth portfolio, confirming its continued strategic priority but framing it more as a key advantaged project rather than detailing new production milestones 【page_37】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of ExxonMobil's strategic emphasis on Guyana from 2023 to 2024. In 2023, it accurately notes Guyana's role in upstream growth, citing four new discoveries on the Stabroek Block, the startup of the Prosperity FPSO (with nameplate capacity reached in January 2024), and production levels of over 390 kbd for the year and nearly 440 kbd in Q4 2023 — all consistent with the ground truth. In 2024, it correctly identifies Guyana’s reclassification as an 'advantaged asset' alongside Permian and LNG, signaling strategic elevation. (2) Quantitative accuracy is excellent: all production figures (390 kbd, 440 kbd), timing (Q4 2023, Jan 2024), and project names (Prosperity, Yellowtail, Uaru, Whiptail) are correct. The mention of six FPSOs by 2027 is additional context not contradicted by the ground truth. (3) The multi-hop reasoning is sound — the model synthesizes information across two years’ filings to show a shift from discovery/early production to strategic maturity. The only minor shortcoming is that the ground truth emphasizes the formal categorization in 'earnings drivers' and the financial impact through 'volume/mix growth,' which the LLM implies but does not explicitly state. (4) Contextual relevance is perfect — the answer directly addresses upstream growth portfolio and production capacity evolution. Overall, the answer is factually complete and semantically equivalent to the ground truth, warranting a high correctness score with only a slight deduction in qualitative accuracy for missing the explicit earnings driver framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 442,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the X1 platform's integration with third-party streaming services evolved between 2022 and 2023, and what does this evolution indicate about Comcast's strategy in reducing cord-cutting and increasing average revenue per user (ARPU)?",
      "original_answer": "In 2022, the X1 platform integrated third-party streaming services such as Disney+ and Netflix, and provided access to Peacock's premium tier, with Comcast earning commission revenue from the sale of these services. By 2023, the X1 platform continued to support third-party integrations but now included Xumo Play, NBC, and Sky as part of the NOW TV service, which was specifically marketed to residential broadband customers. This expansion indicates a strategic pivot toward enhancing the value of broadband subscriptions and bundling streaming access to retain customers and potentially increase ARPU through deeper content integration and commission-generating partnerships.",
      "llm_answer": "In 2022 the X1 platform’s streaming integration was largely delivered through the Xumo Stream Box (formerly Flex), which gave customers voice‑activated search and access to third‑party DTC services such as Peacock, Disney+ and Netflix and allowed X1’s search to surface those apps alongside linear channels【page_5】. By 2023 Comcast added its own NOW DTC streaming brand and embedded third‑party services directly into the X1 interface—offering ad‑supported Peacock, free Xumo Play, NBC and Sky channels without a set‑top‑box and expanding unified search across all content【page_6】【page_7】. This deeper, more seamless integration shows Comcast’s strategy to retain cord‑cutters within its ecosystem and boost ARPU by bundling streaming subscriptions, earning commissions and delivering higher‑value, all‑in‑one video experiences.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: in 2022, X1 integrated third-party services like Disney+, Netflix, and Peacock via the Xumo Stream Box (Flex), enabling unified search and commission revenue. In 2023, Comcast expanded integration by embedding services directly into X1, including Xumo Play, NBC, and Sky via NOW TV, without requiring a set-top box. The mention of ad-supported Peacock and free Xumo Play is consistent with the strategic direction. (2) There are no numeric values to verify, so quantitative accuracy is 10. (3) The multi-hop reasoning is sound—correctly synthesizing evolution across years and platforms, and inferring strategic intent around ARPU and cord-cutting. The only minor gap is that the LLM does not explicitly name NOW TV as being marketed to broadband customers, though it references NOW as a DTC brand, which is semantically close. Also, the LLM adds contextual detail (e.g., voice-activated search, unified search) not in the original but supported by citations and relevant. (4) The answer fully addresses both parts of the question: evolution of integration and strategic implications. The conclusion about bundling, commissions, and ecosystem retention matches the ground truth’s emphasis. Wording differs but meaning is equivalent. Thus, correctness is 9 due to slight omission of NOW TV’s broadband targeting, but overall highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 397,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Caterpillar's relationship with FG Wilson evolved between 2023 and 2024 in terms of its distribution network coverage for electric power generation systems?",
      "original_answer": "In 2023, FG Wilson's electric power generation systems were distributed through a network of 110 distributors covering 109 countries. By 2024, this distribution network had slightly contracted to 108 distributors, now covering 158 countries. This indicates a minor reduction in the number of distributors but an expansion in the geographic reach of the network. The change suggests a strategic shift toward optimizing distributor efficiency while broadening market access.",
      "llm_answer": "In the 2023 Form 10‑K Caterpillar said the FG Wilson‑branded electric power‑generation systems were sold through a worldwide network of **110 distributors covering 109 countries**【page_65】.  \nThe 2024 filing shows that network has shifted to **108 distributors but now reaches 158 countries**【page_66】, meaning the dealer count fell slightly while the geographic coverage expanded markedly.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 110 distributors in 2023 covering 109 countries, and 108 distributors in 2024 covering 158 countries. These match the original answer exactly. (2) The answer is complete, addressing both years, the change in distributor count, and the expansion in geographic coverage. (3) Entities are correctly identified: Caterpillar, FG Wilson, electric power generation systems, and the correct years (2023 and 2024). (4) The reasoning is sound: the LLM correctly infers a slight reduction in distributors but a significant expansion in country coverage, indicating a strategic shift toward efficiency and broader market access, which aligns with the original conclusion. The use of source citations (page_65, page_66) further supports fidelity to the source documents. Semantic equivalence is maintained with clear, concise rewording that preserves all factual content. No errors in logic, calculation, or synthesis across time periods.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 299,
        "total_tokens": 1519
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Capital One's exposure to securitized debt obligations change between 2022 and 2024, particularly in terms of the carrying value and fair value of these obligations?",
      "original_answer": "In 2022, Capital One reported that the assets and liabilities of consolidated VIEs, including securitized debt obligations, were primarily composed of loan receivables and debt securities issued by the VIEs, with the liabilities reported under 'securitized debt obligations' on the consolidated balance sheets. By 2024, the carrying value of 'Securitized debt obligations' was $18,043 million, with a fair value of $18,067 million, all categorized under Level 2 of the fair value hierarchy. This indicates that Capital One maintained a significant exposure to securitized debt obligations, with a slight increase in fair value relative to carrying value, suggesting stable valuation and continued involvement in securitization activities.",
      "llm_answer": "In 2022 Capital One reported securitized‑debt obligations – the liabilities of its securitization‑related VIEs – with a total carrying amount of roughly $15.2 billion (credit‑card $13.0 billion + auto $2.2 billion) and did not disclose a fair‑value estimate for those obligations【page_179】. By year‑end 2024 the liability had fallen to $14.3 billion on the balance sheet and the company estimated its fair value at $14.335 billion, indicating a modest reduction in book exposure and a fair‑value amount slightly above the carrying amount【page_220】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The ground truth states that in 2024, the carrying value of securitized debt obligations was $18,043 million ($18.043 billion) with a fair value of $18,067 million ($18.067 billion). The LLM incorrectly reports these as $14.3 billion and $14.335 billion, respectively—missing over $3.7 billion in exposure. Additionally, the LLM claims a 2022 carrying amount of $15.2 billion (sum of $13B credit card + $2.2B auto), but the original answer does not provide a total carrying value for 2022, only a qualitative description. There is no support in the ground truth for this specific sum or breakdown. (2) Completeness: While the LLM attempts to address changes in carrying and fair values between 2022 and 2024, it fabricates precise figures for 2022 and misrepresents 2024 data, failing to reflect the actual increase in exposure. (3) Entity Accuracy: The company (Capital One) and metric (securitized debt obligations) are correctly identified, and the years (2022, 2024) are accurate. (4) Reasoning: The multi-hop synthesis is flawed—the LLM incorrectly infers a reduction in exposure when the ground truth indicates continued significant involvement with stable valuation and a higher carrying/fair value in 2024. The conclusion of 'modest reduction' contradicts the ground truth's implication of sustained or increased exposure. (5) Semantic Equivalence: The overall message is inconsistent with the original—LLM suggests declining exposure; ground truth shows high and stable exposure with precise 2024 values. Minor contextual elements like Level 2 fair value hierarchy are omitted. Due to major numerical inaccuracies and incorrect trend interpretation, the correctness score is low despite addressing the general topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 498,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has McDonald's use of line of credit agreements evolved between 2023 and 2024 in relation to its financing activities and cash flow management?",
      "original_answer": "In 2023, McDonald's cash used for financing activities totaled $4.4 billion, a decrease of $2.2 billion compared to 2022, primarily due to increased bond issuances. The company's cash and equivalents balance was $4.6 billion at the end of 2023, reflecting sufficient liquidity supported by cash from operations and access to commercial paper borrowings and line of credit agreements. In 2024, cash used for financing activities increased to $7.5 billion, a rise of $3.1 billion compared to 2023, driven by decreased bond issuances. The company's cash and equivalents balance dropped to $1.1 billion at year-end 2024, with the prior year's higher balance attributed to the timing of debt issuances that funded 2024's required cash outflows. The company continued to rely on its line of credit agreements and commercial paper to meet short-term funding needs. This indicates a shift from surplus liquidity and bond financing in 2023 to a more cash-constrained environment in 2024, with greater reliance on existing credit facilities.",
      "llm_answer": "In 2023 McDonald’s noted that it could meet short‑term funding needs through commercial‑paper borrowings and its line‑of‑credit agreements, but the filing gave no detail on the size of that facility and financing cash outflows were $4.4 billion, largely offset by new bond issuances. By 2024 the company still relied on those same sources but now disclosed a $4.0 billion committed line of credit and $7.4 billion of borrowing capacity remaining under a $15 billion authority, while financing cash outflows rose to $7.5 billion as bond issuances fell—indicating a greater reliance on its line of credit to fund operations, dividends and share repurchases.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in McDonald's use of line of credit agreements between 2023 and 2024. (1) Quantitatively, it correctly states that financing cash outflows were $4.4 billion in 2023 and increased to $7.5 billion in 2024, aligning with the ground truth. It accurately notes the shift from bond issuances to greater reliance on credit facilities. The disclosure of a $4.0 billion committed line of credit and $7.4 billion of borrowing capacity under a $15 billion authority is consistent with typical SEC filing details, though the original answer does not include these specific facility sizes—this additional detail is plausible and does not contradict the ground truth; it enhances rather than distorts. (2) The calculation of the $3.1 billion increase in financing outflows ($7.5B - $4.4B) is implied and correct. (3) The reasoning is sound: the LLM correctly infers increased reliance on line of credit in 2024 due to reduced bond issuances and higher financing outflows, which matches the multi-hop logic in the original answer. (4) The entities (McDonald’s, 2023, 2024, financing activities, line of credit, commercial paper) are correct. The only minor limitation is that the LLM omits the specific year-end cash balances ($4.6B in 2023, $1.1B in 2024), which are key indicators of the liquidity shift. However, the conclusion about greater reliance on credit lines is well-supported. The answer is semantically equivalent in intent and mostly complete, warranting a high score but not perfect due to the omission of cash balance figures critical to the liquidity narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 443,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has the role of the Worldwide Business Conduct Manual in reinforcing internal controls evolved between 2022 and 2024, and what does this indicate about Procter & Gamble's approach to governance?",
      "original_answer": "In 2022, the Worldwide Business Conduct Manual was described as reinforcing the company's commitment to conducting business with integrity and within the letter and spirit of the law, emphasizing its role in supporting internal controls through policies, segregation of duties, and employee development. In 2024, while the core description remained similar, the manual was more specifically tied to governance frameworks such as the oversight activities of the Global Leadership Council and the responsibilities of the Disclosure Committee in evaluating significant business activities. This indicates a shift toward emphasizing structured governance mechanisms alongside ethical conduct, suggesting a more integrated approach to internal control over time.",
      "llm_answer": "Both the 2022 and 2024 Form 10‑K filings say that “strong internal controls is an objective that is reinforced through our Worldwide Business Conduct Manual,” which spells out the company’s commitment to conduct business with integrity and in accordance with both the letter and spirit of the law. The manual’s role has remained essentially unchanged – it continues to be a cornerstone of P&G’s internal‑control framework – signalling that the company’s governance approach is steady, purpose‑driven and firmly anchored in its global conduct standards.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in stating that the Worldwide Business Conduct Manual reinforced internal controls in both 2022 and 2024 and that it emphasizes integrity and legal compliance. There are no numeric inaccuracies, so quantitative accuracy is perfect. However, the answer incorrectly claims the manual's role has 'remained essentially unchanged,' which contradicts the ground truth. The original answer highlights a meaningful evolution in 2024: the manual became more specifically tied to formal governance structures like the Global Leadership Council and the Disclosure Committee, indicating a shift toward more structured governance integration. The LLM answer fails to capture this multi-hop nuance and instead asserts continuity, missing a key qualitative development. While the response is relevant and correctly identifies the manual’s general role, it lacks completeness in addressing the evolution between years and thus misrepresents the progression in P&G’s governance approach. This omission significantly affects qualitative accuracy and overall correctness, though the core facts about the manual’s existence and purpose are sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 327,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Exxon's strategic positioning in Guyana evolved between 2023 and 2024, as reflected in its long-lived asset disclosures and earnings driver definitions?",
      "original_answer": "In 2023, Exxon disclosed $9,689 million in long-lived assets in Guyana, indicating it was already a significant contributor among non-U.S. assets. By 2024, Guyana was explicitly named as part of Exxon's 'Advantaged Assets' under the new 'Advantaged Volume Growth' earnings driver, which includes key growth projects like Guyana and LNG. This evolution shows that Guyana transitioned from being a quantitatively notable asset in 2023 to a strategically emphasized growth engine in 2024.",
      "llm_answer": "In the 2023 filing Exxon reported that its long‑lived assets in Guyana had risen to **$9.7 billion** (up from $6.8 billion in 2022) – a clear sign that the company was expanding its capital base there【page_115】.  By the 2024 filing, Guyana is no longer just a balance‑sheet line item; it is singled out in the new earnings‑driver framework as an **“Advantaged Asset”** that drives “Advantaged Volume Growth” alongside Permian and LNG projects【page_37】.  Together, the larger asset base and its elevation to a strategic growth driver show Exxon’s positioning in Guyana has moved from expanding investment to being a core, high‑value growth focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $9.7 billion figure for Guyana's long-lived assets in 2023 is correctly reported (matches $9,689 million in original answer, rounded appropriately). The mention of an increase from $6.8 billion in 2022 adds context not in the original answer but is factually consistent and enhances understanding. (2) The qualitative evolution from a significant asset to a strategically emphasized 'Advantaged Asset' under the 'Advantaged Volume Growth' earnings driver in 2024 is correctly identified and matches the original answer's core insight. (3) Multi-hop reasoning is sound: the model synthesizes asset disclosures (2023) with strategic framing in earnings drivers (2024) across filings, correctly inferring a strategic elevation. (4) Minor deduction in quantitative accuracy only because the original answer did not reference 2022 data, so that addition—while accurate—slightly extends beyond the provided ground truth. However, it does not detract from correctness. Overall, the answer captures the same semantic meaning with excellent reasoning, completeness, and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 332,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Capital One's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, based on the disclosed figures and descriptions?",
      "original_answer": "In 2022, Capital One identified securitized debt obligations as part of its diversified funding mix, which also included deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. While no specific dollar value was disclosed in 2022, the company emphasized the strategic importance of securitized debt obligations in maintaining access to wholesale funding. By 2024, Capital One disclosed that its securitized debt obligations had a carrying value of $14,264 million and an estimated fair value of $14,335 million. This represents a concrete quantification of the instrument's role in the company's capital structure, showing an increased transparency and continued use of this funding source.",
      "llm_answer": "In the 2022 filing Capital One noted that its long‑term funding was $42.3 billion and was “primarily” composed of securitized debt obligations and senior notes, having issued $6.25 billion of securitized debt in 2021 (Table 33, p. 114). By the 2024 filing the balance‑sheet amount of securitized debt obligations had fallen to $14.3 billion (fair value $14.3 billion) at year‑end 2024, down from $18.0 billion a year earlier (p. 219‑220), indicating that while securitizations remain a funding source, their relative share has declined between 2022 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The LLM incorrectly states that Capital One's long-term funding in 2022 was $42.3 billion and 'primarily' composed of securitized debt obligations and senior notes, which is not supported by the ground truth—no specific dollar value for securitized debt was disclosed in 2022. It also claims $6.25 billion of securitized debt was issued in 2021, but this detail is absent from the ground truth and cannot be verified. Most critically, the LLM asserts that securitized debt fell from $18.0 billion in 2023 to $14.3 billion in 2024, but the ground truth only provides 2024 figures ($14,264 million carrying value), with no 2023 value mentioned. The $18.0 billion figure is fabricated. (2) Completeness: While the question asks about the evolution from 2022 to 2024, the LLM invents data for 2023 and misrepresents 2022 disclosures, failing to accurately reflect the lack of specific figures in 2022. (3) Entity Accuracy: The company (Capital One) and metric (securitized debt obligations) are correct, and the years referenced are appropriate. (4) Reasoning: The multi-hop reasoning is flawed—the conclusion that the 'relative share has declined' is based on invented data and contradicts the ground truth, which shows increased transparency and continued use, not a decline. (5) Semantic Equivalence: The overall message of the LLM answer (declining reliance) contradicts the ground truth (continued strategic use with increased disclosure). Despite referencing the right concept—securitized debt as a funding source—the answer introduces false numbers and trends, resulting in a mostly incorrect assessment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 466,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has NVIDIA's Omniverse platform evolved in terms of its positioning and enterprise adoption between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Omniverse was described as 'real-time 3D design collaboration and virtual world simulation software' aimed at empowering creators to collaborate across leading design applications. By fiscal year 2023, Omniverse had evolved into a more robust enterprise-focused development platform and operating system for building virtual world simulation applications. It was made available as a software subscription for enterprise use and offered free for individual users, with industrial enterprises adopting its 3D and simulation technologies to digitalize complex physical assets and environments, including digital twins of factories and real-time 3D product configurators. This indicates a strategic shift from a creative collaboration tool to a broader enterprise simulation and digital twin platform.",
      "llm_answer": "In FY 2022 NVIDIA described Omniverse as a virtual‑world simulation and real‑time 3‑D design‑collaboration platform, offered as a software subscription for enterprises (free for individuals) and already being used in early enterprise apps such as virtual car showrooms, surgical training and architectural walkthroughs【page_9】. By FY 2023 the company re‑positioned Omniverse as a full development platform and operating system for enterprise‑grade digital‑twin and simulation workloads, emphasizing that industrial enterprises are adopting it to build digital twins of factories, real‑time 3‑D product configurators and to test and validate autonomous robots and vehicles【page_6】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core evolution of NVIDIA's Omniverse platform as the ground truth. (1) It correctly identifies the FY2022 positioning of Omniverse as a real-time 3D design collaboration and virtual world simulation platform, noting its availability as a subscription for enterprises and free for individuals, along with early enterprise use cases (e.g., virtual car showrooms, surgical training). This aligns with the original answer’s emphasis on creative collaboration. (2) For FY2023, the LLM correctly captures the strategic shift to a full development platform and operating system for enterprise-grade digital twin and simulation workloads, including adoption by industrial enterprises for factory digital twins, 3D product configurators, and testing autonomous systems—matching the ground truth’s key points. (3) The multi-hop reasoning is sound: it synthesizes information across fiscal years and correctly infers a strategic repositioning from creative tool to enterprise simulation platform. (4) Minor omission: the LLM does not explicitly state that the FY2022 version was aimed at 'empowering creators to collaborate across design applications,' which adds slight context to the initial positioning. However, this does not detract from the overall factual correctness. All entities (NVIDIA, Omniverse, fiscal years 2022 and 2023, enterprise adoption) are accurate. No numeric values are incorrect—dates and descriptions are consistent and semantically equivalent. The answer is fully contextually relevant and addresses both positioning and adoption changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 438,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Pfizer's financial relationship with Viatris evolved between 2022 and 2023, particularly in terms of net amounts due under their various agreements?",
      "original_answer": "In 2022, the net amounts due to Viatris under the agreements were $94 million as of December 31, 2022. By 2023, this amount had decreased to $33 million as of December 31, 2023. This indicates a significant reduction in the net financial obligations between the two companies over the period, suggesting a winding down or stabilization of transitional financial arrangements established post-separation.",
      "llm_answer": "Pfizer’s payable to Viatris under the post‑spin‑off agreements dropped sharply – it was **$94 million at 12/31/2022** and fell to **$33 million at 12/31/2023**【page_73】.  This $61 million reduction shows that Pfizer’s outstanding obligations to Viatris have markedly decreased over the year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the net amounts due from Pfizer to Viatris as $94 million on December 31, 2022, and $33 million on December 31, 2023, matching the ground truth exactly. The calculated reduction of $61 million is accurate (94 - 33 = 61). 2) All numeric values, dates, and calculations are correct. Format variations (e.g., $94 million) are acceptable and semantically equivalent. 3) The reasoning is sound: the answer identifies the decrease in obligations and interprets it as a reduction in outstanding payables, which aligns with the ground truth's implication of winding down transitional arrangements. It correctly synthesizes information across time periods (2022 to 2023) and entities (Pfizer and Viatris). 4) The only minor limitation is that the LLM answer frames the relationship primarily as Pfizer’s payable to Viatris, while the original answer more broadly refers to 'net amounts due under the agreements'—a slightly more neutral and comprehensive term. However, given the context and direction of the amounts, this interpretation is reasonable. The LLM answer is factually correct, contextually relevant, and conveys the essential evolution in the financial relationship. Thus, it earns a high score but not perfect due to slight nuance in framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 357,
        "total_tokens": 1533
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2023 and 2024, and what specific changes in project activity or classification reflect this evolution?",
      "original_answer": "In 2023, ExxonMobil's operations in Guyana were characterized by active exploration and development, with 12.6 net exploratory and development wells completed, and key projects such as Payara, Yellowtail, and Uaru underway. By 2024, Guyana was formally classified as part of ExxonMobil's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, signaling a strategic elevation of its importance alongside the Permian Basin and LNG. This reclassification reflects a shift from operational reporting to strategic prioritization, indicating increased emphasis on Guyana as a core growth asset.",
      "llm_answer": "In 2023 ExxonMobil presented Guyana as a principal ongoing activity — reporting 4.6 million offshore acres, the start‑up of the Payara development (Prosperity FPSO), continued work on Yellowtail and the newly funded Uaru project, and 12.6 net exploratory‑development wells completed (see 2023 page 20). By the 2024 filing, Guyana is no longer just an operating update; it is explicitly listed as an “Advantaged Asset” under the Advantaged Volume‑Growth driver (grouped with Permian and LNG) (see 2024 page 37), indicating its elevation to a core high‑value growth project. This re‑classification reflects a shift from routine development reporting to a strategic emphasis on Guyana as a key growth asset.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Correctly identifies the evolution of ExxonMobil's strategic emphasis on Guyana from operational activity in 2023 to strategic prioritization in 2024. Key projects (Payara, Yellowtail, Uaru) and the 12.6 net exploratory and development wells are accurately mentioned. (2) Quantitative accuracy: The number of wells (12.6) is correct. However, the LLM states '4.6 million offshore acres' — while this figure may appear in the filing, it is not present in the ground truth and was not part of the original answer; this is a minor addition but not factually incorrect based on known filings. No calculation errors. (3) Multi-hop reasoning is sound: the answer correctly synthesizes information across 2023 and 2024 filings, noting the shift from project-level reporting to strategic classification under 'Advantaged Assets' alongside Permian and LNG, which reflects proper cross-year and cross-context analysis. (4) Semantic equivalence is strong — the LLM captures the strategic reclassification and its implications accurately. The only minor deviation is the inclusion of acreage not referenced in the ground truth, but it does not detract from correctness. Overall, the answer reflects excellent factual alignment, reasoning, and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 371,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the weighted-average interest rate and face value of senior notes with maturities greater than 10 years evolve from 2022 to 2023?",
      "original_answer": "In 2022, the weighted-average interest rate for senior notes with maturities greater than 10 years was 3.67%, with a face value of $54.536 billion. In 2023, the interest rate remained unchanged at 3.8%, but the face value slightly decreased to $53.4 billion. This indicates a slight reduction in long-term debt in this category, while the interest rate stayed stable.",
      "llm_answer": "In 2022 the senior‑note portfolio with maturities > 10 years carried a weighted‑average interest rate of **3.8 %** and a face‑value of **$52.8 billion**. By the end of 2023 the same class of notes still had a weighted‑average rate of **3.8 %**, but the face‑value grew to **$53.4 billion**.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numeric values. According to the ground truth, in 2022 the weighted-average interest rate was 3.67%, not 3.8%, and the face value was $54.536 billion, not $52.8 billion. The 2023 interest rate is correctly stated as 3.8% and face value as $53.4 billion, matching the ground truth. However, the LLM incorrectly states that the face value increased from 2022 to 2023, when in fact it decreased from $54.536B to $53.4B. (2) Quantitative accuracy is low: the 2022 interest rate is off by 0.13 percentage points, and the 2022 face value is understated by over $1.7 billion. These are material errors in a financial context. The 2023 values are correct. (3) The reasoning is partially sound in that the model identifies the need to compare two years and two metrics (interest rate and face value), but it fails in accurate synthesis across time periods. The conclusion that face value 'grew' is incorrect based on the true data, indicating flawed multi-hop comparison. (4) Contextual relevance is high because the answer addresses the right entities (senior notes, maturities >10 years), time frame (2022–2023), and metrics. However, due to major numerical inaccuracies in the 2022 data and the resulting incorrect trend interpretation, the overall correctness score is limited to 4.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1162,
        "completion_tokens": 377,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the nuclear decommissioning trusts managed by Alabama Power and Georgia Power shift their domestic equity investment allocations and valuation methodologies between 2023 and 2024, particularly in terms of Level 1 and Level 2 input classifications?",
      "original_answer": "In 2023, Alabama Power reported $396 million in domestic equity investments under Level 1 inputs and $169 million under Level 2 inputs, totaling $565 million. Georgia Power reported $255 million in Level 1 and $1 million in Level 2, totaling $256 million. By 2024, Alabama Power’s domestic equity investments increased to $443 million in Level 1 and $208 million in Level 2, totaling $651 million. Georgia Power saw its Level 1 domestic equity investments rise to $321 million while Level 2 remained at $1 million, totaling $322 million. This indicates a strategic shift toward higher allocations in domestic equities, particularly through more actively traded (Level 1) instruments, which may reflect a more transparent or liquid investment approach in line with evolving trust management strategies.",
      "llm_answer": "In the 2023 filing the nuclear‑decommissioning trusts of both Alabama Power and Georgia Power reported their domestic‑equity holdings almost entirely under **Level 2 – Significant Other Observable Inputs** (Alabama Power $443 million, Georgia Power $321 million, with only $208 million and $1 million, respectively, in the Level 3 column)【page_278】. By the 2024 filing those holdings are no longer shown in the Level 2 column; the trusts now value the investments using quoted market prices (Level 1) and a **net‑asset‑value (NAV) practical expedient**, moving the measurement away from Level 2 observable‑input pricing to a Level 1/NAV approach【page_279】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresents both the data and the direction of change between 2023 and 2024. (1) QUANTITATIVE INACCURACY: The LLM incorrectly states that in 2023, Alabama Power reported $443 million in Level 2 domestic equity investments and Georgia Power $321 million — this is false. According to the ground truth, in 2023, Alabama Power had $396M in Level 1 and $169M in Level 2 (not $443M in Level 2), and Georgia Power had $255M in Level 1 and $1M in Level 2. The $443M and $321M figures are actually the 2024 Level 1 values, not 2023 Level 2. The LLM also incorrectly assigns $208M to Level 3 for Alabama Power, which is not mentioned in the original answer and contradicts the provided data. (2) TEMPORAL CONFUSION: The LLM reverses the timeline, claiming that in 2023 investments were mostly in Level 2 and then moved to Level 1 in 2024 — while the ground truth shows both companies already had substantial Level 1 allocations in 2023, with a continued increase in Level 1 by 2024. The shift toward Level 1 is correct in direction but misrepresented in magnitude and starting point. (3) ENTITY AND METRIC ERROR: The LLM introduces 'NAV practical expedient' and claims a move away from Level 2 to Level 1/NAV, but the original answer does not mention NAV or a change in valuation methodology beyond increased Level 1 classification. There is no evidence in the ground truth that Level 2 was abandoned or that NAV was newly adopted. (4) REASONING FLAW: The multi-hop synthesis is flawed — the model fails to correctly extract year-specific allocations per company and misattributes values, leading to an incorrect narrative of a 'shift from Level 2 to Level 1', when in fact both companies already used Level 1 significantly in 2023. The conclusion about methodology change is speculative and unsupported. (5) CONTEXTUAL RELEVANCE: The answer attempts to address the question’s focus on shifts in allocations and valuation methodologies, so it remains contextually relevant, but the factual foundation is so flawed that the analysis is invalid. Minor point: citation of 'page_278' and 'page_279' suggests document grounding but does not compensate for factual inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 590,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has NVIDIA's strategic positioning of CUDA evolved from 2022 to 2023 in terms of its role within the company's full-stack computing platform and its integration across different end markets?",
      "original_answer": "In 2022, CUDA was positioned as a fundamental building block of NVIDIA's accelerated computing platform, supporting a variety of end markets such as Gaming, Data Center, Professional Visualization, and Automotive through a unified underlying architecture. It was described as essential for leveraging GPU capabilities across these markets. By 2023, CUDA's role had evolved into being the foundational programming model within NVIDIA's full-stack computing infrastructure, extending its integration beyond traditional markets into domain-specific verticals such as healthcare, telecom, automotive, and manufacturing. Additionally, in 2023, CUDA was positioned as the base layer supporting hundreds of domain-specific software libraries, SDKs, and APIs, which were not explicitly emphasized in 2022. This indicates a strategic shift from CUDA being a foundational component to becoming the core enabler of a broader, more vertically integrated software stack aimed at accelerating deployment across computationally intensive workloads.",
      "llm_answer": "In the 2022 filing NVIDIA described CUDA as a “fundamental building block” of its unified architecture that enables its full‑stack platform across all of its end‑markets—gaming, data‑center, professional visualization and automotive—and highlighted a massive developer ecosystem of roughly three million users (see page 9; page 11). By the 2023 filing, CUDA is positioned even more centrally: it is called the “foundational CUDA programming model that runs on all NVIDIA GPUs” and is bundled with the CUDA‑X libraries, APIs and SDKs, forming the core of a full‑stack solution that now spans GPUs, DPUs, CPUs and networking and is explicitly tied to each market segment (see page 4; page 6). This evolution shows CUDA moving from a key building block to the primary software foundation of NVIDIA’s end‑to‑end, cross‑market platform.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies CUDA's evolution from a 'fundamental building block' in 2022 to a more central, 'foundational programming model' in 2023, accurately reflecting NVIDIA's strategic shift. The mention of CUDA-X libraries, APIs, and SDKs in 2023 matches the ground truth's emphasis on domain-specific software libraries and full-stack integration. The end markets cited (gaming, data center, professional visualization, automotive) are consistent, and the expansion into broader market segments is implied through the 'end-to-end, cross-market platform' phrasing. (2) There are no numeric values in the original or LLM answer that conflict; the LLM mentions a 'three million' developer ecosystem, which is not in the ground truth but appears to be a factual addition from the actual 2022 filing. Since this detail does not contradict the ground truth and is likely accurate, it does not reduce correctness. (3) The multi-hop reasoning is sound: the LLM synthesizes CUDA’s role across two years, compares its positioning, and infers increased strategic centrality based on language changes in the filings. The conclusion that CUDA evolved from a key component to the 'primary software foundation' is a valid interpretation of the shift described in the ground truth. (4) The only minor gap is that the LLM does not explicitly name the new verticals (healthcare, telecom, manufacturing) emphasized in 2023, though it captures the broader trend of expanded market integration. This omission prevents a perfect 10 but does not undermine the core accuracy. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 467,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did Pfizer's financial obligations and contractual relationships with Viatris evolve from 2022 to 2023, particularly in terms of transitional service agreements and net amounts owed?",
      "original_answer": "In 2022, Pfizer disclosed that amounts recorded under transitional service agreements (TSAs) and master services agreements (MSAs) with Viatris were not material to operations, and the TSA services were largely completed by the end of 2022. By 2023, services under the TSAs were fully completed as of December 31, 2023, and the net amounts due to Viatris under the agreements decreased from $94 million in 2022 to $33 million in 2023. This reflects a reduction in intercompany financial obligations and the winding down of transitional support following the 2020 spin-off of the Upjohn Business into Viatris.",
      "llm_answer": "In the 2022 filing Pfizer still referenced “transitional manufacturing and supply agreements … with Viatris” after the Upjohn spin‑off, and the balance owed under those arrangements was $94 million at year‑end 2022. By the 2023 filing the TSAs were “largely completed as of December 31 2023” and the net amount due to Viatris had fallen to $33 million (2023)【page_113】【page_73】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key financial and contractual evolution between Pfizer and Viatris from 2022 to 2023. It accurately reports the $94 million balance owed in 2022 and the reduction to $33 million in 2023, which matches the ground truth. The completion of TSAs by December 31, 2023 is also correctly stated. (2) Quantitative accuracy is perfect: both dollar amounts ($94M and $33M) and the date (December 31, 2023) are correct. No calculations are required beyond the implied decrease, which is factually sound. (3) The multi-hop reasoning is mostly sound—linking the decline in net amounts owed with the completion of TSAs post-spin-off. However, the LLM omits explicit mention that TSA services were largely completed by end of 2022 and fully completed by end of 2023, slightly weakening the timeline clarity. It also does not mention Master Services Agreements (MSAs), only referring broadly to transitional manufacturing and supply agreements. While TSAs are the focus, MSAs were part of the original disclosure. (4) Despite minor omissions in contextual detail, the core facts, numbers, and synthesis are correct, and the answer directly addresses the question’s focus on financial obligations and contractual evolution. Wording differences do not affect semantic accuracy. Hence, a high score of 9 is justified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 377,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the relationship between retail deregulation pressures and Duke Energy's environmental regulation compliance costs evolved from 2022 to 2023?",
      "original_answer": "In 2022, Duke Energy highlighted that retail deregulation could result in unrecovered costs, including those related to above-market purchased power commitments from qualifying facilities (QFs) under PURPA, which could hinder the recovery of environmental compliance costs through regulatory rate structures. By 2023, the company noted increased regulatory emphasis on environmental compliance, including EPA regulations on CO2 emissions and cooling water intake structures, as well as new state-level carbon reduction goals more aggressive than the company’s own plans. These developments suggest that deregulation pressures have compounded the challenge of recovering rising environmental compliance costs, as competitive market conditions limit the ability to pass on these expenses to customers.",
      "llm_answer": "In the 2022 filing Duke Energy warned that retail‑deregulation or restructuring could spark competition that leaves “unrecovered costs” and stranded‑asset losses, while at the same time “numerous environmental laws and regulations… can result in increased capital, operating and other costs” that may not be fully recoverable through rates 【page_26】. The 2023 filing repeats the same deregulation risk – “increased competition and unrecovered costs… if the retail jurisdictions… become subject to deregulation” 【page_27】 – and adds newer EPA actions (e.g., the 2022 CCR‑rule interpretation) and the same concern that “the Duke Energy Registrants may not be successful in recovering… costs incurred to comply with new environmental regulations” 【page_28】. Thus, the relationship has not fundamentally changed; rather, the 2023 report reinforces and expands the earlier warning, highlighting that deregulation pressures continue to magnify the financial impact of rising environmental‑compliance costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All factual elements are correct: Duke Energy's 2022 and 2023 concerns about retail deregulation leading to unrecovered costs and challenges in recovering environmental compliance costs are accurately represented. The mention of PURPA-related risks in 2022 is implied through 'above-market purchased power commitments from qualifying facilities,' which the LLM indirectly acknowledges via context on stranded assets and unrecovered costs. (2) There are no numeric values, dates, or calculations in the question or answers that conflict — the reference to the '2022 CCR-rule interpretation' is consistent with the timeframe and regulatory developments cited in the original answer. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across two years of filings, identifying continuity in deregulation risks and an escalation in environmental regulation (e.g., EPA actions), concluding that deregulation pressures continue to exacerbate cost recovery challenges. This matches the original answer’s conclusion. (4) The only minor shortcoming is that the LLM does not explicitly name PURPA or state-level carbon reduction goals being more aggressive than Duke’s own plans — details present in the original answer. However, it captures the essence by referencing new EPA actions and repeated cost recovery risks. Wording differs slightly but semantic equivalence is strong. Thus, the answer is factually correct, contextually appropriate, and well-reasoned, meriting a high score with only slight deduction for minor omission of specificity around state-level goals.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 456,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did the retail share of Skoal oral tobacco products change between 2023 and 2024, and how does this contrast with the pricing strategy applied to Skoal during 2023?",
      "original_answer": "The retail share of Skoal oral tobacco products decreased from 9.3% in 2023 to 7.6% in 2024, reflecting a decline in market presence. This contrasts with the pricing strategy in 2023, where multiple price increases were applied to Skoal products, including a $0.11 per can increase effective January 23, 2024 (announced in 2023), following earlier increases of $0.09, $0.09, and $0.08 per can in May, February, and January 2022, respectively. The cumulative effect of these increases may have impacted consumer demand, contributing to the drop in retail share.",
      "llm_answer": "Skoal’s retail share fell from 9.5 % in 2023 to 7.6 % in 2024 – a drop of roughly 1.9 percentage points 【page_46】【page_48】. Yet in 2023 the company pursued a price‑increase strategy for Skoal, raising its list price by $0.09 per can in January, $0.10 per can in April, and another $0.09 per can in August 【page_49】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2024 retail share (7.6%) and the general trend of decline, but reports the 2023 retail share as 9.5% instead of the correct 9.3%, introducing a factual inaccuracy. The drop is stated as roughly 1.9 percentage points, which would be consistent with a decline from 9.5% to 7.6%, but the actual drop from 9.3% to 7.6% is 1.7 percentage points, so the calculation based on the reported numbers is internally consistent but built on an incorrect initial value. (2) Regarding pricing, the LLM states three increases in 2023: $0.09 in January, $0.10 in April, and $0.09 in August. However, the ground truth indicates that the $0.11 increase (effective January 23, 2024, but announced in 2023) was the key 2023 pricing action, and the earlier increases referenced occurred in 2022 (January, February, May), not in 2023. Thus, the LLM misattributes prior-year price hikes to 2023 and reports different amounts ($0.09, $0.10, $0.09) that do not match the documented $0.11 increase. (3) The multi-hop reasoning is partially sound—the model correctly contrasts declining market share with a pricing strategy involving increases, which aligns with the causal interpretation in the original answer. However, because the price increases are incorrectly dated and quantified, the synthesis is based on flawed data, weakening the validity of the contrast. (4) The contextual relevance is high, as the answer addresses both parts of the question—market share change and pricing strategy—and attempts to draw a meaningful comparison. For these reasons, the correctness score is 6 (partially correct but with significant quantitative errors), quantitative accuracy is 5 (major number/date inaccuracies), qualitative accuracy is 7 (reasoning structure is sound but based on incorrect inputs), and contextual relevance is 9 (fully on-topic and responsive).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 511,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How did Amgen's investment in 'Other short-term interest-bearing securities' evolve between 2023 and 2024, and what does this indicate about the company's short-term investment strategy?",
      "original_answer": "Amgen's investment in 'Other short-term interest-bearing securities' remained unchanged at $138 million in both 2023 and 2024. This stability suggests that the company maintained a consistent approach to this segment of its short-term investment portfolio over the two-year period.",
      "llm_answer": "Amgen’s “Other short‑term interest‑bearing securities” were $138 million at the end of 2023 and $135 million at the end of 2024 – a modest $3 million (about 2 %) drop【page_133】.  The near‑flat balance, as part of a larger $11.5 billion pool of cash equivalents, shows Amgen is keeping a stable, low‑risk, highly liquid short‑term investment position, consistent with its policy to preserve principal safety and maintain ample liquidity.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Amgen's investment in 'Other short-term interest-bearing securities' decreased from $138 million in 2023 to $135 million in 2024, implying a $3 million (2%) drop. However, the ground truth confirms the amount remained unchanged at $138 million in both years. This is a critical factual error affecting the core of the response. (2) The calculation of a 2% decrease is based on incorrect input values and is therefore invalid. The correct value in both years is $138 million, so there is no change. While the mention of an $11.5 billion pool of cash equivalents may provide relevant context, it does not compensate for the primary inaccuracy. (3) The reasoning about Amgen maintaining a stable, low-risk, highly liquid short-term investment strategy is plausible and aligns with the ground truth's interpretation of stability. However, the conclusion is drawn from incorrect data, undermining the validity of the multi-hop synthesis. The model correctly identifies the strategic implication but bases it on a false premise. (4) The contextual relevance is high because the answer addresses both parts of the question—evolution of investment and strategic implication—and includes appropriate financial context. However, the quantitative inaccuracy severely impacts correctness, warranting a low score in that domain. The qualitative reasoning is partially sound but compromised by incorrect data. Final scores reflect partial credit for structure and interpretation, but significant deduction for factual and numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1189,
        "completion_tokens": 433,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the nature of General Dynamics' involvement in Abrams Main Battle Tank Upgrades evolved from 2022 to 2024, particularly in terms of contract scope and value?",
      "original_answer": "In 2022, General Dynamics received a $360 million contract from the Army for Abrams main battle tank upgrades, mission control units, and systems technical support. By 2024, the company's involvement had evolved to include both production and support services, as evidenced by a $350 million contract for Abrams upgrades, engineering and logistics support, and system and sustainment technical support services. Additionally, a separate $285 million contract was awarded for producing Abrams tanks in the SEPv3 configuration for Romania. This indicates a shift from primarily upgrade-focused contracts to a broader scope that includes both upgrades and production of new configurations, with an increase in total contract value.",
      "llm_answer": "In 2022 GD reported two Army contracts for Abrams upgrades – a $360 million award that bundled the upgrades with mission‑control units and systems technical support, and a separate $350 million award covering upgrades plus engineering, logistics and sustainment services (2022 p. 42‑44). By 2024 the filing shows a single $350 million contract that combines the upgrades with engineering, logistics and sustainment technical support, indicating a broader support scope but essentially the same (slightly lower) contract value (2024 p. 44).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that in 2022, General Dynamics received two contracts: one for $360 million and another for $350 million. However, the ground truth confirms only one $360 million contract in 2022. The $350 million contract described in the LLM answer as being from 2022 is actually from 2024. This misattribution of contracts to the wrong year severely undermines the answer's validity. Additionally, the LLM fails to mention the separate $285 million contract awarded in 2024 for producing Abrams tanks in the SEPv3 configuration for Romania, which is a key part of the evolution in contract scope and value. (2) Quantitatively, the numbers themselves ($360M, $350M, $285M) are accurate in isolation, but their assignment to years and purposes is incorrect. The LLM incorrectly reports a $350M contract in 2022 that does not exist in the ground truth, and omits the $285M Romania production contract in 2024. The claim that the 2024 contract value is 'slightly lower' is misleading because the total value of contracts in 2024 ($350M + $285M = $635M) is substantially higher than the 2022 $360M contract. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize information across years and contracts. It incorrectly infers continuity between a non-existent 2022 $350M contract and the actual 2024 $350M contract, and misses the critical shift from upgrades to include new production (Romania contract), which is central to the evolution in scope. (4) Contextual relevance is moderate because the answer discusses contracts related to Abrams upgrades and support services, but due to incorrect entity-year mappings and omission of a major contract, the overall picture of evolving involvement is inaccurate. The conclusion that scope broadened but value remained similar is factually wrong given the increase in total contract value and expansion into new production.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 531,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did AIG's financial relationship with Corebridge evolve from 2023 to 2024, particularly in terms of borrowing arrangements and income recognition?",
      "original_answer": "In 2023, AIG disclosed that Corebridge had the ability to continue borrowing through February 25, 2025, indicating an ongoing financial arrangement. By 2024, AIG's relationship with Corebridge had transformed, as AIG began recognizing equity method income tied to Corebridge’s stock price changes and dividends received since June 9, 2024. This shift reflects a change from a borrowing-based relationship to one focused on equity-based returns.",
      "llm_answer": "In 2023 AIG still consolidated Corebridge’s debt – the roll‑forward shows Corebridge’s senior notes, junior subordinated debt and a $250 million DDTL facility that AIG could draw on and for which it had a guarantee‑reimbursement agreement (2023 Form 10‑K, p. 112‑113). By 2024, after deconsolidating Corebridge, AIG no longer reports that debt; instead it holds an equity‑method investment and records Corebridge’s earnings as equity‑method income (e.g., $1.574 billion pre‑tax income and $601 million equity‑method income for June‑Dec 2024) in net investment income, while any borrowing is limited to the non‑guaranteed DDTL facility that Corebridge can continue to use (2024 Form 10‑K, p. 108‑109).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of AIG's financial relationship with Corebridge from 2023 to 2024, noting the shift from debt consolidation to equity-method income recognition. The 2023 borrowing arrangements are accurately described, including the DDTL facility and guarantee-reimbursement agreement, with correct reference to AIG's ability to draw on it. In 2024, the deconsolidation and transition to equity-method accounting are correctly stated, including the recognition of $1.574 billion pre-tax income and $601 million equity-method income for June–December 2024. (2) Quantitatively, the dollar amounts are precise and contextually appropriate. While the ground truth does not include specific figures like $1.574B or $601M, these numbers are consistent with a detailed 10-K disclosure and do not contradict the original answer—they add granularity rather than introduce error. The date June 9, 2024, from the ground truth (start of equity income recognition) is closely reflected in the LLM’s reference to June–December 2024, which is a reasonable reporting period alignment. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and two financial reporting frameworks (consolidation vs. equity method), correctly inferring the structural shift in the relationship. (4) The LLM enhances the original answer with specific financial data from the 10-K, demonstrating deeper contextual support without deviating from the core truth. The only minor limitation is the absence of explicit mention of Corebridge’s borrowing ability extending to February 25, 2025, though it does note Corebridge can continue using the DDTL facility, which captures the essence. Overall, the answer is factually correct, well-reasoned, and contextually rich.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 501,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2022, Tesla was actively selling the Solar Roof and improving installation efficiency through collaboration with real estate developers and builders. The company emphasized its engineering efforts to combine aesthetics, durability, and power generation. By 2024, however, Tesla's 10-K highlights that the future of the Solar Roof (alongside other products) 'depends in large part' on overcoming production ramp challenges, including bottlenecks, supplier risks, and cost control. This reflects a shift from product development and sales emphasis to a more complex production and dependency landscape.",
      "llm_answer": "In the 2022 Form 10‑K Tesla described the Solar Roof simply as a product it sells directly and through partners, emphasizing design, installation‑efficiency improvements and warranty coverage (see 2022 p.5‑6). By the 2024 filing the company warns that the Solar Roof’s launch and production ramp have encountered delays and now depend on the ability to scale new manufacturing processes and secure critical inputs—such as battery‑cell supply and other component suppliers—highlighting broader supply‑chain and strategic‑dependency risks (see 2024 p.17‑19). This marks a shift from a straightforward product description to a more cautious stance that stresses production challenges and reliance on key suppliers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Tesla's evolving approach to the Solar Roof between 2022 and 2024: in 2022, the focus was on selling the product, design, installation efficiency, and warranties; by 2024, the emphasis shifted to production ramp challenges and supply chain dependencies. These points match the original answer’s core claims. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or the answers, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model synthesizes information across two different 10-K filings (2022 and 2024), correctly inferring a strategic shift based on changes in disclosure tone and content. The mention of 'battery-cell supply' as a critical input is slightly more specific than the original answer’s general 'supplier risks,' but this is a reasonable inference given Tesla’s broader product ecosystem and does not constitute an error. The original answer emphasizes bottlenecks, supplier risks, and cost control—themes all reflected in the LLM response using synonymous language. (4) The LLM answer is contextually relevant, directly addressing production challenges and strategic dependencies as asked. The only minor shortcoming is that the original answer highlights collaboration with real estate developers and builders in 2022, which the LLM omits, instead referring more generally to 'partners.' This is a small loss in specificity but does not undermine the overall correctness. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 468,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the retail share of Skoal in the U.S. oral tobacco market changed between 2023 and 2024, and what does this indicate about its competitive positioning?",
      "original_answer": "In 2023, Skoal held a 9.3% retail share in the U.S. oral tobacco market, which decreased to 7.6% in 2024. This decline indicates a weakening in Skoal's competitive positioning within the oral tobacco segment over this period. The drop in market share for Skoal contrasts with the growth seen in other products like on!, which increased from 6.8% to 8.3% during the same timeframe.",
      "llm_answer": "Skoal’s retail share slipped from 9.3 % in 2023 to 7.6 % in 2024 – a decline of roughly 1.7 percentage points 【page_48】. The drop shows Skoal is losing market share to rival oral‑tobacco brands, indicating a weakening competitive position in the U.S. oral‑tobacco market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports Skoal's retail share as 9.3% in 2023 and 7.6% in 2024, matching the ground truth exactly. The calculated decline of 1.7 percentage points is accurate (9.3 - 7.6 = 1.7). (2) All numeric values and dates are correct, and the calculation of the change in market share is precise. Format variations (e.g., spacing in '9.3 %') do not affect factual accuracy. (3) The reasoning is sound: the model correctly infers that the decline indicates Skoal is losing ground to competitors and that its competitive positioning is weakening, which aligns with the ground truth. However, the LLM answer omits the specific contrast with on!'s growth (from 6.8% to 8.3%), which was part of the original answer and added contextual depth to the competitive dynamics. This makes the answer slightly less complete in terms of multi-hop synthesis across competing brands. (4) Despite this minor omission, the core facts, calculations, and conclusion are correct and semantically equivalent to the ground truth. The answer fully addresses the question about Skoal’s market share change and its implications. Thus, the correctness score is 9 due to high accuracy with a small loss in completeness; quantitative accuracy is perfect; qualitative accuracy is high but not full due to missing comparative context; contextual relevance is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1166,
        "completion_tokens": 379,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the risk associated with the concentration of device share among premium tier companies evolved between 2023 and 2024, particularly in terms of its potential impact on Qualcomm's pricing power and revenue stability?",
      "original_answer": "In 2023, Qualcomm highlighted that the concentration of device share among a few premium tier companies was contributing to a trend of deriving a significant portion of revenues from a small number of customers, particularly Chinese OEMs. This concentration was noted to potentially result in lower prices for Qualcomm's products due to the purchasing power of these companies. In 2024, the risk factor remained present, but the emphasis shifted slightly to underscore the broader implications of this concentration, including the potential for even greater pricing pressure and revenue fluctuation due to the timing and success of customer product introductions. The continued reliance on a small group of customers, especially those developing their own integrated circuits or using competitors, suggests that the risk has not only persisted but potentially intensified, increasing its impact on Qualcomm's pricing power and revenue stability.",
      "llm_answer": "In the 2023 Form 10‑K Qualcomm already warned that a “significant portion of our revenues … comes from a small number of customers and licensees, particularly from their sale of premium‑tier handset devices” and that this concentration “could negatively affect our business and results of operations”【page_18】. The 2024 filing repeats that warning and goes a step further, stating that the “concentration of device share among a few companies, and the corresponding purchasing power of these companies, may result in lower prices for our products, which could have an adverse effect on our revenues and margins” and that this could cause greater pricing‑power erosion and revenue volatility【page_18】【page_19】. Thus, the risk has not disappeared but has been sharpened in 2024, with a clearer emphasis on the threat to Qualcomm’s pricing power and revenue stability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly identifies that in 2023, Qualcomm highlighted revenue concentration among a few premium-tier customers, particularly Chinese OEMs, and the associated risk to pricing and operations. In 2024, it accurately notes the continued risk with an intensified focus on pricing pressure and revenue volatility. While the LLM does not explicitly name 'Chinese OEMs' or mention competitors and in-house chip development (a minor omission), it captures the core evolution: increased emphasis on pricing power erosion and revenue instability. (2) There are no numerical values, dates, or financial figures in the question or answer that require verification—only qualitative risk descriptions, which are correctly cited with reference to the 2023 and 2024 10-Ks. (3) The multi-hop reasoning is sound: the model synthesizes risk disclosures across two years, compares the language, and correctly infers that the risk has not only persisted but been more sharply articulated in 2024. (4) The answer is contextually fully relevant, directly addressing the evolution of risk, its impact on pricing power, and revenue stability. The only reason for not scoring a 10 is the slight omission of specific details about customer self-sufficiency (in-house chips) and competitive substitution, which are part of the intensified risk in 2024 per the original answer. However, the core message about heightened pricing and revenue risk is clearly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 421,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "Given Amgen's approach to managing short-term liquidity, how did its allocation to money market mutual funds evolve between 2023 and 2024?",
      "original_answer": "Amgen's allocation to money market mutual funds remained unchanged at $10,266 million in both 2023 and 2024. The disclosed investment values for money market mutual funds under available-for-sale investments were identical in both years, indicating no shift in this portion of the company's short-term investment strategy.",
      "llm_answer": "Amgen’s short‑term liquidity strategy is to keep its investment portfolio “safe, liquid and low‑risk,” limiting holdings to short‑term debt and money‑market instruments (see the investment‑policy description).  Accordingly, the fair‑value of its money‑market mutual‑fund holdings grew from $10.266 billion at the end of 2023 to $10.354 billion at the end of 2024 – an increase of about $88 million.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that Amgen's allocation to money market mutual funds increased from $10.266 billion in 2023 to $10.354 billion in 2024. The ground truth confirms that the allocation remained unchanged at $10,266 million (i.e., $10.266 billion) in both years. The claimed increase of $88 million is therefore inaccurate. (2) Quantitative accuracy is severely compromised: while the 2023 figure is correctly stated as $10.266 billion, the 2024 figure is wrong. The correct value is $10,266 million in both years, so there is no change. The LLM incorrectly reports $10.354 billion for 2024, which does not match the disclosed data. (3) The qualitative reasoning is partially sound—the LLM correctly identifies Amgen’s short-term liquidity strategy as focused on safety, liquidity, and low risk, and references appropriate investment categories. However, it fails in the critical multi-hop task of comparing the exact disclosed values across two years from the filings, leading to an erroneous conclusion about a shift in strategy. (4) Contextual relevance is high because the response addresses the right concept (short-term liquidity and money market funds) and cites the correct type of financial instrument and policy context. However, the core factual error in the numerical trend severely undermines the correctness. The correctness_score is low due to the major quantitative inaccuracy, despite relevant context and reasonable explanation of strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 414,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has General Dynamics' participation in the Capital Construction Fund evolved between 2022 and 2024, particularly in terms of the amount of U.S. government accounts receivable pledged to the fund?",
      "original_answer": "In 2022, General Dynamics had U.S. government accounts receivable pledged to the Capital Construction Fund (CCF) of $295 million as of December 31, 2021. By 2024, the amounts pledged to the CCF had increased to $315 million on December 31, 2023, and $333 million on December 31, 2024. This indicates a steady increase in GD's participation in the CCF over the period, reflecting a growing utilization of the tax deferral benefits offered by the program.",
      "llm_answer": "In the 2022 filing General Dynamics disclosed that it had **$295 million** of U.S. government accounts receivable pledged to the Capital Construction Fund (the most recent amount reported for the prior years)【page_67】. By year‑end 2023 the pledged amount had risen to **$315 million**, and by year‑end 2024 it increased further to **$333 million**【page_68】—showing a modest, steady growth in its CCF participation over the period.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: $295 million as of the end of 2021 (reported in 2022), $315 million as of December 31, 2023, and $333 million as of December 31, 2024. The formatting ($295 million vs $295 million) is acceptable and semantically equivalent. (2) The answer is complete, addressing the evolution of General Dynamics' participation in the Capital Construction Fund from 2022 to 2024, specifically focusing on the pledged receivables as requested. (3) Entity accuracy is correct—General Dynamics, Capital Construction Fund (CCF), U.S. government accounts receivable, and the correct time periods are all properly identified. (4) The reasoning is sound: the LLM correctly interprets the multi-hop nature of the data (tracking changes over three reporting points) and synthesizes the trend of increasing pledges, concluding a 'steady growth,' which aligns with the ground truth's 'steady increase.' The use of source citations (page_67, page_68) further supports fidelity to the source material. Overall, the answer is factually precise, contextually relevant, and demonstrates correct multi-hop synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 341,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of its tax implications and investment income following the IPO and subsequent deconsolidation?",
      "original_answer": "In 2023, AIG's ownership in Corebridge dropped below 80% after Corebridge's IPO on September 19, 2022, resulting in the tax deconsolidation of Corebridge from AIG’s U.S. federal income tax group. This deconsolidation had significant tax implications, including restrictions on future consolidated tax filings for five years and the retention of Corebridge's net operating losses and tax credit carryforwards by Corebridge entities. By 2024, AIG no longer consolidated Corebridge's financials, and instead, AIG reported its investment in Corebridge under the equity method, recognizing $X in equity method income for the period from June 10, 2024, to December 31, 2024, based on dividends received and changes in Corebridge's stock price. This marks a shift from a consolidated tax and financial reporting relationship to a more arms-length investment relationship.",
      "llm_answer": "After the 2022 IPO, AIG’s stake in Corebridge fell below the 80 % threshold in 2023, causing a tax‑deconsolidation that removed Corebridge’s net operating losses and tax‑credit carryforwards from AIG’s consolidated tax group for the next five years 【page_255】. In 2024 AIG formally deconsolidated Corebridge on June 9, 2024, re‑classifying its remaining 48.4 % interest as an equity‑method investment; it now records dividends and fair‑value changes in Net investment income (down to $5.2 bn in 2024 from $11.1 bn in 2023) and recognized a $4.8 bn loss on the deconsolidation that included a $545 m tax expense 【page_108】【page_109】【page_110】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in numbers and dates, despite capturing the general narrative of AIG's evolving relationship with Corebridge. The deconsolidation date is incorrectly stated as June 9, 2024, while the original answer specifies the ownership drop occurred in 2023 after the September 19, 2022 IPO, triggering tax deconsolidation then. The LLM claims formal deconsolidation happened in 2024, which contradicts the ground truth that tax deconsolidation occurred in 2023 when ownership fell below 80%. (2) Quantitative inaccuracies include: reporting a $5.2B net investment income in 2024 'down from $11.1B in 2023'—this figure is not mentioned in the ground truth and appears fabricated; the $4.8B deconsolidation loss and $545M tax expense are not in the original answer and contradict its silence on such figures; the 48.4% ownership stake is specific but unverified in the ground truth. The original answer mentions 'X' for equity income, indicating unknown or unspecified value, so providing a precise $5.2B is incorrect. (3) The multi-hop reasoning is partially sound: the model correctly links IPO → ownership drop → tax deconsolidation → change in reporting method. However, it misorders events by placing formal deconsolidation in 2024, whereas tax deconsolidation already occurred in 2023. It also conflates tax deconsolidation with financial deconsolidation. The shift to equity method is correctly identified, but the timing (from June 10, 2024) is more precise in the ground truth, while LLM says June 9 without matching context. (4) Contextual relevance is high—the answer addresses tax implications, investment income, IPO, and deconsolidation as required. Qualitative accuracy is moderate because core concepts are present but details are distorted. Quantitative accuracy is low due to unsupported numbers. Correctness score is 6 due to correct conceptual framework but significant factual and numerical errors undermining reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 541,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Tesla's approach to Solar Roof production and its dependencies evolved from 2022 to 2024, particularly in terms of operational strategy and supply chain challenges?",
      "original_answer": "In 2022, Tesla emphasized improving Solar Roof installation capabilities by onboarding and training new installers and collaborating with real estate developers to reduce installation time and costs. The company also highlighted the need to maintain adequate battery cell supply and hire additional skilled electricians to support the ramp. By 2024, Tesla's focus had shifted to broader manufacturing and supply chain risks, with Solar Roof production now described as being dependent on the company's ability to manage global component procurement, avoid bottlenecks, and maintain cost-effective production amid potential supplier failures and inflationary pressures. The evolution reflects a shift from localized installer development to systemic supply chain and production scalability concerns.",
      "llm_answer": "In the 2022 filing Tesla described an expansion‑focused strategy for Solar Roof – simplifying online ordering, onboarding and training new installers, and partnering with developers and builders to cut installation time and cost, while noting that sufficient battery‑cell supply and additional skilled electricians would be required (2022 p. 34). By the 2024 filing the tone had shifted to a risk‑mitigation view: the company acknowledges delays in ramping Solar Roof and treats the product’s supply‑chain dependencies – especially battery‑cell availability, raw‑material price volatility and electrician labor shortages – as ongoing constraints that could impede production (2024 p. 17‑19). This reflects a move from an aggressive operational rollout to a more cautious approach centered on managing supply‑chain challenges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Tesla's 2022 strategy focused on installer onboarding, developer partnerships, and addressing battery supply and electrician hiring (correctly cited from 2022 p. 34). By 2024, the focus shifted to supply chain risks including battery-cell availability, raw material costs, and labor shortages (accurately referenced from 2024 pp. 17–19). (2) There are no numeric values requiring calculation, but the years (2022, 2024) and page references are correctly cited, satisfying quantitative accuracy. (3) The multi-hop reasoning is sound—comparing Tesla’s evolving strategy across two years and synthesizing shifts in operational emphasis from expansion to risk mitigation. The LLM correctly infers a strategic pivot from localized rollout efforts to systemic supply chain concerns. (4) The only minor shortcoming is that the original answer explicitly mentions 'global component procurement' and 'supplier failures' as 2024 risks, which the LLM paraphrases as 'supply-chain dependencies' and 'raw-material price volatility'—semantically close but slightly less specific. However, this does not undermine the overall correctness. The answer is fully contextually relevant, directly addressing operational strategy and supply chain evolution as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 376,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Duke Energy's estimated total cost to permanently close all coal ash basins in North Carolina and South Carolina evolved from 2022 to 2023, and what does this indicate about the company's progress under the Coal Ash Act?",
      "original_answer": "In 2022, Duke Energy estimated the total cost to permanently close all coal ash basins in North Carolina and South Carolina to be approximately $8 billion to $9 billion. By 2023, this estimate had decreased to approximately $7 billion to $8 billion, indicating a downward adjustment in projected costs. Additionally, the amount already spent on these closures increased from approximately $3.1 billion through 2021 (as reported in 2022) to approximately $4 billion through 2023. This evolution suggests that Duke Energy has made measurable progress in implementing closure plans under the Coal Ash Act, with more basins excavated and cost estimates refined over time.",
      "llm_answer": "In the 2022 filing Duke Energy said the total cost to permanently close all North Carolina and South Carolina coal‑ash basins was roughly $8 billion‑$9 billion, with about $3.1 billion already spent. The 2023 filing reduced the estimate to about $7 billion‑$8 billion and shows spending has risen to roughly $4 billion. The lower cost outlook and higher cumulative spend indicate the company is making measurable progress in meeting its Coal Ash Act closure obligations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the 2022 cost estimate of $8B–$9B, the 2023 revised estimate of $7B–$8B, the amount spent rising from $3.1B (through 2021, as reported in 2022) to $4B (through 2023). These numbers match the original answer exactly, with acceptable formatting variations (e.g., 'roughly' for 'approximately', en-dash in '$8 billion-$9 billion'). (2) Quantitative accuracy is perfect—no calculation errors, and the progression in spending and cost estimates is correctly presented. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two years (2022 and 2023 filings), compares evolving cost projections and actual spending, and draws the appropriate conclusion about progress under the Coal Ash Act. (4) The conclusion—that the lower cost outlook and higher spending indicate measurable progress—is logically supported and matches the original answer’s interpretation. All parts of the question are addressed: evolution of cost estimates from 2022 to 2023 and what it indicates about progress. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 333,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did the retail share of the 'on!' oral tobacco product evolved between 2023 and 2024, and what does this indicate about its market position relative to the overall oral tobacco product segment during this period?",
      "original_answer": "The retail share of the 'on!' oral tobacco product increased from 6.8% in 2023 to 8.3% in 2024. This indicates that 'on!' gained market share during this period. In contrast, the total oral tobacco product segment saw a decline in retail share, dropping from 42.5% in 2023 to 37.5% in 2024. This divergence suggests that 'on!' strengthened its position within the broader oral tobacco market between these years.",
      "llm_answer": "The on! brand’s retail share rose from 6.8 % in 2023 to 8.3 % in 2024 – a gain of about 1.5 percentage points【page_48】. At the same time, the overall oral‑tobacco‑products segment’s retail share fell from 42.5 % to 37.5 %【page_48】【page_49】, showing that on! improved its market position relative to a segment that was losing share overall.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages for 'on!' retail share (6.8% in 2023, 8.3% in 2024) and the overall oral tobacco segment (42.5% in 2023, 37.5% in 2024) are accurately reported. The implied gain of 1.5 percentage points is correct (8.3 - 6.8 = 1.5). (2) The answer is complete, addressing both the evolution of 'on!'s retail share and its market position relative to the broader segment. (3) Entities—'on!' brand, oral tobacco product segment, correct years—are accurately identified. (4) The reasoning is sound: the LLM correctly infers that 'on!' gained share while the overall segment declined, indicating relative market strengthening. The use of citation markers (e.g., 【page_48】) suggests grounding in source material. Semantic equivalence is maintained with the original answer, with no factual discrepancies. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 276,
        "total_tokens": 1481
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Qualcomm's reliance on Chinese OEMs for revenue evolved from 2023 to 2024, and what implications does this have for its business stability?",
      "original_answer": "In 2023, Qualcomm derived a significant portion of its revenues from a small number of Chinese OEMs, highlighting its dependency on their device share growth in China and other regions. By 2024, this dependency persisted, with the company continuing to emphasize that it derives a significant portion of its revenues from these same OEMs. This ongoing reliance indicates that any political, economic, or market shifts affecting Chinese OEMs could continue to pose a risk to Qualcomm's revenue stability, particularly given the persistent U.S./China trade and national security tensions mentioned in both filings.",
      "llm_answer": "In its 2023 10‑K Qualcomm already disclosed that a “significant portion of our revenues” came from a small number of Chinese OEMs, which were “increasing … their device share in China and in certain regions outside of China”【page_18】. The 2024 filing shows that this reliance has not waned – the company still derives a large share of revenue from Chinese OEMs, highlighted by about $560 million of Huawei product revenue in fiscal 2024 before the export‑license was revoked, and it notes that Chinese OEMs continue to grow their market share【page_20】【page_19】. The continued concentration makes Qualcomm more vulnerable to U.S./China trade restrictions, OEM vertical‑integration and payment‑delay risks, thereby threatening the stability of its revenue stream.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core evolution of Qualcomm's reliance on Chinese OEMs from 2023 to 2024, noting that the dependency persisted. It accurately reflects the qualitative risk factors such as U.S./China trade tensions, OEM vertical integration, and payment delays. However, the $560 million figure for Huawei product revenue in fiscal 2024 is not present in the ground truth and cannot be verified from the provided original answer. This introduces a potential factual inaccuracy or over-specificity not supported by the ground truth, though it may be present in the actual 10-K. (2) The use of 'about $560 million' is a specific quantitative claim absent from the original answer, which makes no mention of dollar figures for Huawei or any OEM. Since the ground truth does not confirm or deny this number, it cannot be considered fully quantitatively accurate. Other dates (fiscal 2023, 2024) and references to page numbers are consistent with document-based reasoning. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings, identifies continuity in risk disclosure, and links reliance on Chinese OEMs to broader geopolitical and business risks. It connects market share growth, revenue concentration, and external risks logically. (4) The contextual relevance is excellent—the answer directly addresses both parts of the question: evolution over time and implications for business stability. The qualitative accuracy is high due to correct entity identification (Qualcomm, Chinese OEMs, Huawei), accurate timeframes, and proper risk characterization. The correctness score is 9 because the core facts and reasoning are accurate and comprehensive, but the unverified $560M figure prevents a perfect score due to potential hallucination or unsupported specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 502,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did Amgen's composition of total available-for-sale investments evolve between 2022 and 2023, particularly in terms of specific security types held?",
      "original_answer": "In 2022, Amgen reported total available-for-sale investments of $4,335 million, which included $1,676 million in marketable securities alongside $2,659 million in cash and cash equivalents. By 2023, Amgen no longer held any marketable securities or U.S. Treasury bills, and instead, the entire $10,404 million in total available-for-sale investments was composed of $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities. This reflects a strategic shift toward more liquid and short-term interest-bearing instruments.",
      "llm_answer": "Amgen’s available‑for‑sale portfolio grew from $4.3 billion in 2022 to $10.4 billion in 2023. In 2022 the mix was $1.7 billion of U.S. Treasury bills and $2.7 billion of money‑market mutual funds (no other short‑term securities), whereas in 2023 the Treasury‑bill holding fell to zero, money‑market mutual funds rose to $10.3 billion and a new $138 million position in other short‑term interest‑bearing securities was added【page_133】.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the composition of Amgen's 2022 portfolio. According to the ground truth, in 2022, Amgen held $1,676 million in marketable securities (not U.S. Treasury bills) and $2,659 million in cash and cash equivalents (not money market mutual funds). The LLM incorrectly states that in 2022, the portfolio consisted of $1.7 billion in U.S. Treasury bills and $2.7 billion in money-market mutual funds, which is factually wrong. In reality, by 2023, Amgen shifted entirely to $10,266 million in money market mutual funds and $138 million in other short-term interest-bearing securities, with no U.S. Treasury bills held. The LLM correctly notes that Treasury bills fell to zero and that a new $138 million position was added, but misrepresents the 2022 composition. (2) Quantitative accuracy is partially correct in totals: $4.3 billion (vs. $4,335 million) and $10.4 billion (vs. $10,404 million) are acceptable rounding approximations. However, the allocation breakdown is incorrect—$2.7 billion attributed to money market funds in 2022 is false (they were not reported as such in 2022); the $10.3 billion figure in 2023 is close to the actual $10,266 million. (3) The reasoning shows an attempt at multi-hop comparison across years and asset types, but the synthesis is flawed due to incorrect source data interpretation. The model fails to reflect the actual shift from marketable securities and cash equivalents to money market funds, instead inventing a shift from Treasury bills to money market funds. (4) Contextual relevance is high—the answer addresses the evolution of investment composition over time and identifies key security types. However, due to major factual errors in entity types (mislabeling marketable securities as Treasury bills, misallocating money market funds in 2022), the qualitative and quantitative accuracy scores are low. Correctness is penalized heavily because the core factual foundation of the answer is unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 542,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the presence of Shake Shack as a tenant evolved across SPG's premium outlet properties between 2022 and 2023?",
      "original_answer": "In 2022, Shake Shack was listed as a tenant at Woodbury Common Premium Outlets in New York. By 2023, Shake Shack not only remained at Woodbury Common but also expanded its presence to Las Vegas Outlets North Premium in Nevada. This indicates a strategic expansion of Shake Shack’s footprint within SPG's portfolio of properties over the two years.",
      "llm_answer": "In the 2022 10‑K, Shake Shack is listed only among the tenants of Woodbury Common Premium Outlets (2022 10‑K p. 35) 【page_35】. The 2023 10‑K shows the same single listing – Shake Shack appears again at Woodbury Common Premium Outlets (2023 10‑K p. 35) 【page_35】. No other premium‑outlet property added or dropped Shake Shack, so its presence remained unchanged between 2022 and 2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is factually incorrect and contradicts the ground truth. According to the original answer, Shake Shack expanded from being present only at Woodbury Common Premium Outlets in 2022 to also being present at Las Vegas Outlets North Premium in Nevada by 2023. However, the LLM claims that Shake Shack's presence 'remained unchanged' between 2022 and 2023, appearing only at Woodbury Common in both years. This misrepresents the evolution of Shake Shack’s tenancy and fails the core requirement of the question, which is to describe how its presence evolved. The LLM cites page 35 of both the 2022 and 2023 10-K filings as sources, but either misreads or fails to detect the addition of Shake Shack in a new location in the 2023 report. The reasoning is flawed, as it concludes no change occurred when the ground truth confirms an expansion. While the mention of Woodbury Common is correct, the failure to identify the new location in Las Vegas renders the answer substantially incomplete and factually wrong. Quantitative accuracy is low because the key fact—expansion to a second outlet—is missing. Qualitative accuracy is poor due to incorrect synthesis across years. Contextual relevance is moderate because the answer addresses the right topic and properties but draws the wrong conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 362,
        "total_tokens": 1537
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did the classification of retirement annuity contracts within the fair value hierarchy evolve between 2022 and 2024, and what does this indicate about GD's valuation methodology for these assets?",
      "original_answer": "In 2022, retirement annuity contracts were part of Level 3 assets, indicating that their fair value was determined using unobservable inputs. By 2024, these contracts remained in Level 3, but the disclosure noted that investments valued using net asset value (NAV) as a practical expedient were now included in the tables for reconciliation to total plan assets, which was not explicitly stated in 2022. This suggests a refinement in disclosure practices rather than a change in hierarchy classification, indicating that while the valuation methodology remained complex and less observable, GD improved transparency in how these assets are reported.",
      "llm_answer": "In the 2022 filing the “retirement annuity contracts” were reported as Level 3 assets – the only category in the hierarchy that uses significant unobservable inputs (see page 93). The 2024 filing still places these contracts in Level 3 (see page 94), indicating GD has not moved them to a more observable level and continues to value them using internal models and judgment rather than quoted market prices.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that retirement annuity contracts were classified as Level 3 assets in both 2022 and 2024, which aligns with the ground truth. It accurately reflects that Level 3 involves significant unobservable inputs and that GD continued to use internal models and judgment, indicating no change in hierarchy classification—this addresses the core of the question. The quantitative accuracy is perfect: years (2022, 2024), asset levels (Level 3), and references to specific pages are correct. However, the LLM omits a key qualitative point from the original answer: the 2024 filing included a new disclosure about investments valued using net asset value (NAV) as a practical expedient being included in reconciliation tables, which was not explicitly stated in 2022. This reflects a refinement in disclosure transparency, a nuance the LLM fails to mention. While the reasoning is sound in concluding that the valuation methodology remained largely unchanged, the absence of this enhanced disclosure detail limits completeness and slightly weakens the synthesis of multi-hop information across years. The answer remains contextually relevant and factually accurate on the main point—no change in hierarchy—but misses a subtler evolution in reporting practice. Hence, a score of 8 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 393,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of potential equity dilution and income recognition?",
      "original_answer": "In 2023, AIG had a stake in Corebridge that included a potential equity dilution mechanism tied to Blackstone's right to exchange its ownership interest in Corebridge for AIG common shares, which would have introduced up to 24.1 million additional shares in 2022 (and 4.4 million in 2023) had the IPO not occurred before 2024. However, since the IPO occurred on September 19, 2022, this exchange right was terminated. By 2024, AIG's relationship with Corebridge had shifted from a stakeholding to an equity method investment, where AIG reported income based on dividends received and changes in Corebridge's stock price from June 9, 2024 onwards. This reflects a transformation from a potential equity dilution scenario to a post-divestiture equity income model.",
      "llm_answer": "In 2023 AIG still consolidated Corebridge, owning 52.2 % of the company, and the only dilution‑related issue was a Blackstone exchange right that had been terminated after Corebridge’s 2022 IPO (4.4 million potential shares were excluded from diluted EPS)【page_242】. By 2024 AIG had sold a large block of Corebridge shares, de‑consolidated the business and now treats its remaining stake as an equity‑method investment, recognizing dividends and fair‑value changes—including a $282 million gain on a later sale to Nippon—in net investment income, while the earlier potential equity dilution no longer applies【page_108】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of AIG's financial relationship with Corebridge from 2023 to 2024, noting the termination of Blackstone's exchange right post-IPO and the shift to an equity-method investment in 2024. However, there are minor quantitative inaccuracies: the original answer states that up to 4.4 million shares were potentially dilutive in 2023 (not 2022 as implied in the LLM's reference to '4.4 million potential shares were excluded from diluted EPS'), and the IPO date is incorrectly referenced as occurring in 2022 (September 19, 2022 per ground truth), which conflicts with the 2023 context. The LLM correctly identifies the $282 million gain from a sale to Nippon, but this detail is not in the original answer and may reflect over-inference or external knowledge. (2) The percentage stake (52.2%) is accurate for 2023, and the de-consolidation and equity-method accounting shift in 2024 align with the ground truth. However, the original answer does not mention Nippon or a $282 million gain, making that addition factually unsupported by the provided truth. (3) The multi-hop reasoning is strong: the model correctly synthesizes the termination of dilution risk post-IPO and the transition from ownership to equity-method accounting. It accurately contrasts the pre- and post-divestiture financial treatment. (4) Despite minor date and number misstatements (e.g., attributing 4.4M dilution to 2023 but citing a 2022 IPO that terminated it), the core narrative is factually sound and contextually complete. The addition of unverified details (Nippon sale) slightly reduces quantitative accuracy but does not undermine the overall correctness. Hence, a score of 8 is justified—core facts are correct, but with small but notable data inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 488,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Comcast's financial exposure to Universal Beijing Resort evolved from 2022 to 2024, based on its debt disclosures and consolidation treatment?",
      "original_answer": "In 2022, Comcast disclosed that Universal Beijing Resort had $3.6 billion in debt as of December 31, 2021, and $2.5 billion as of December 31, 2020. By 2024, Comcast clarified that Universal Beijing Resort had $3.4 billion in debt outstanding as of December 31, 2024, and $3.5 billion as of December 31, 2023. This indicates that the debt levels stabilized after earlier reductions, and Comcast now consolidates Universal Beijing Resort as a variable interest entity (VIE), with its assets and liabilities fully included in Comcast’s consolidated balance sheets at $7.3 billion in assets and $7.0 billion in liabilities as of 2024.",
      "llm_answer": "In the 2022 Form 10‑K Comcast disclosed that its 30 % equity interest in Universal Beijing Resort is treated as a variable‑interest entity that it consolidates, and the VIE’s debt that is not guaranteed by Comcast was about **$3.6 billion** (see the “Debt Not Guaranteed” line for Universal Beijing Resort in the debt table)【page_71】.  By the 2024 filing the same VIE is still consolidated, but the outstanding debt had fallen to **$3.4 billion** (including a $3.0 billion term loan) and the consolidated balance sheet now shows **$7.3 billion of assets and $7.0 billion of liabilities** for the resort, indicating a modest reduction in exposure while the consolidation treatment and the maximum loss risk (limited to the 30 % equity stake) remain unchanged【page_86】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key financial exposure metrics for Universal Beijing Resort across 2022 and 2024, with accurate debt figures: $3.6 billion as of end-2021 (disclosed in 2022 filing) and $3.4 billion as of end-2024 (disclosed in 2024 filing). It omits the $2.5 billion (end-2020) and $3.5 billion (end-2023) figures from the ground truth, which slightly reduces completeness but does not distort the trend. The $7.3 billion in assets and $7.0 billion in liabilities as of 2024 are correctly reported. (2) Quantitative accuracy is high: all cited numbers match the ground truth or are correctly interpreted from disclosures. The mention of a $3.0 billion term loan adds detail not in the ground truth but does not contradict it. The omission of 2020 and 2023 debt levels is a minor gap but not an error. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across years, identifies the consistent consolidation treatment as a VIE, and links debt exposure to balance sheet inclusion. It accurately notes that Comcast consolidates the entity despite a 30% equity stake, which reflects proper understanding of VIE accounting. (4) The answer is contextually fully relevant, directly addressing the evolution of financial exposure and consolidation treatment. The conclusion about 'modest reduction in exposure' is a reasonable interpretation of the declining debt from $3.6B to $3.4B and is supported by the data. Only the omission of one year's debt figure prevents a perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 423,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the structure of aircraft trade-in commitments changed between 2022 and 2023, particularly in terms of customer eligibility and risk exposure?",
      "original_answer": "In 2022, the Aerospace segment had outstanding options with 'some customers' to trade in aircraft as partial consideration for new aircraft purchases, indicating a broader or less-specific customer eligibility. By 2023, the eligibility was narrowed to 'some Gulfstream customers,' suggesting a more specific subset of customers was offered trade-in options. Additionally, while both years acknowledged the risk associated with adverse market changes affecting trade-in values, 2023 introduced a more specific framing by highlighting Gulfstream, a key business jet brand, which may indicate a strategic focus or increased risk concentration in that segment. Despite these structural changes, both years reported that the estimated change in fair market values from the commitment date was 'not material.'",
      "llm_answer": "The trade‑in framework is essentially unchanged – the company still offers customers either an option that sets the aircraft’s fair‑market value about 45 days before delivery or a commitment that locks in a predetermined trade‑in price, with any excess over FMV recorded as a revenue reduction (2022 p.77; 2023 p.79). The only shift in eligibility is that the 2023 filing narrows the language to “some Gulfstream customers” rather than the broader “some customers” used in 2022, while the exposure to market‑value risk for the predetermined‑price commitments remains the same.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the key change in customer eligibility from 'some customers' in 2022 to 'some Gulfstream customers' in 2023, reflecting a narrowing of eligibility. It also accurately notes that the structure of trade-in options (fair-market value vs. predetermined price) remained unchanged, which is consistent with the original answer's implication of structural continuity despite eligibility refinement. (2) There are no numeric values or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The reasoning is sound: the model correctly synthesizes information across 2022 and 2023 filings, identifies the shift in customer specificity, and acknowledges unchanged risk exposure related to market-value fluctuations. It even adds a relevant detail about revenue reduction treatment, which is consistent with filing disclosures and enhances completeness without contradicting the ground truth. (4) The only minor gap is that the LLM does not explicitly mention the 'not material' assessment of fair value changes, which is included in the original answer and represents a small omission in completeness. However, this does not undermine the core correctness. Overall, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop reasoning across years and customer segments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 398,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2022 and 2024, particularly in terms of its production status and strategic positioning within Tesla's product lineup?",
      "original_answer": "In 2022, Tesla had only announced the Tesla Semi as part of its planned electric vehicles, indicating it was in the conceptual and development phase. By 2024, Tesla had moved the Tesla Semi into 'pilot production' at its Nevada facility, signaling a significant advancement in its development and a step closer to commercialization. This evolution reflects Tesla's strategic shift from merely planning the vehicle to actively preparing it for market entry.",
      "llm_answer": "In the 2022 filing Tesla only described the Semi as a “planned commercial electric vehicle” among its future models, without any production timeline (2022 p.5). By the 2024 filing the Semi had progressed to “pilot production” at the Nevada plant and is explicitly grouped with newer models such as the Cybertruck as part of Tesla’s effort to expand capacity for next‑generation vehicles (2024 p.36). This shows the Semi moving from a concept‑stage announcement in 2022 to early‑stage manufacturing and a strategic pillar of the company’s expanding product lineup by 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately reflects Tesla's progression of the Semi from a 'planned commercial electric vehicle' in 2022 (concept/development phase) to 'pilot production' in 2024, which matches the ground truth's description. (2) There are no numerical values requiring calculation, but the years (2022 and 2024) are correctly cited and contextualized with appropriate phases of development. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different filings (2022 and 2024), identifying the evolution in both production status and strategic positioning. It further enriches the answer by linking the Semi to the Cybertruck and Tesla’s broader capacity expansion, which is consistent with the strategic shift described in the ground truth. (4) The answer is semantically equivalent to the original, with added contextual precision (e.g., citing page numbers and grouping with Cybertruck) that enhances rather than distorts the meaning. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 314,
        "total_tokens": 1578
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the valuation allowance related to Altria's investment in Cronos evolve between 2022 and 2024, and what does this indicate about the company's expectations regarding the realizability of associated deferred tax assets?",
      "original_answer": "Between 2022 and 2024, the valuation allowance related to Altria's investment in Cronos increased from $379 million in 2022 to $402 million in 2024. This indicates that Altria continued to maintain significant uncertainty regarding the realizability of deferred tax assets associated with the Cronos investment, as the company still did not expect the temporary difference to reverse in the foreseeable future. The steady increase in the allowance suggests a cautious stance by Altria in recognizing the full value of these assets.",
      "llm_answer": "Altria’s valuation allowance tied to its Cronos investment rose modestly – about $379 million at year‑end 2022, $397 million at year‑end 2023 and $402 million at year‑end 2024 (see the valuation‑allowance reconciliation in the 2024 filing)【page_84】. Because the allowance essentially equals the Cronos deferred‑tax asset each year, the company is still treating the tax benefit as largely unrealizable, maintaining a full or near‑full allowance on those assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $379 million in 2022, $397 million in 2023 (not in original answer but consistent with progression), and $402 million in 2024—these match or are reasonably inferred from the trend in the ground truth. The ground truth does not specify 2023, so the inclusion of $397M is a minor extrapolation but does not contradict and improves completeness. (2) The answer correctly identifies the increasing trend in the valuation allowance, which indicates Altria's continued doubt about the realizability of deferred tax assets—this reasoning is sound and consistent with the original answer. (3) The multi-hop reasoning is appropriate: linking the rising allowance to the company's expectations about temporary difference reversal and tax benefit realizability. (4) The LLM adds contextual value by referencing the 'valuation-allowance reconciliation' in the 2024 filing (page 84), enhancing credibility. The only minor shortcoming is that it does not explicitly state that the increase suggests a 'cautious stance'—a qualitative nuance present in the original—but the implication is clearly conveyed through 'still treating the tax benefit as largely unrealizable.' Thus, the answer is factually complete, numerically precise, and contextually relevant, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 407,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did the financial treatment and valuation impact of Amgen's investment in BeiGene evolve between 2023 and 2024?",
      "original_answer": "In 2023, Amgen changed the accounting method for its investment in BeiGene from the equity method to fair value, resulting in gains recognized in connection with this revaluation. By 2024, the investment contributed net unrealized losses within Amgen's Other income (expense), net, reflecting a shift from gains in 2023 to losses in 2024 due to market or valuation changes. This evolution shows a reversal in the financial benefit derived from the BeiGene investment over the two years.",
      "llm_answer": "In 2023 Amgen changed its accounting for the BeiGene stake from the equity‑method to a fair‑value model, so that changes in the investment’s market value were recorded in earnings; the first‑quarter fair‑value adjustment produced a large unrealized gain that drove the $2.8 billion of other income reported for 2023 【page_78】. By 2024 the fair‑value approach was retained, but the investment’s value fell, generating net unrealized losses on the BeiGene holding and reducing other income to $506 million for the year 【page_77】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately describes the change in accounting method from equity method to fair value in 2023, which led to gains being recognized in earnings, and correctly notes that in 2024, the same fair-value approach resulted in unrealized losses. (2) The quantitative details are precise: the $2.8 billion other income in 2023 and $506 million in 2024 are factually correct and match the context from the cited pages. These figures reflect the shift from gains to losses, and the model correctly attributes them to the BeiGene investment's valuation changes. (3) The multi-hop reasoning is sound—synthesizing the accounting policy change in 2023 with its financial impact and then tracking the reversal in 2024 under the same method shows strong logical and financial understanding. (4) All entities (Amgen, BeiGene, 'Other income (expense), net'), years (2023, 2024), and financial terms (equity method, fair value, unrealized gains/losses) are correctly identified and used. The answer is semantically equivalent to the original, with added specificity (e.g., first-quarter adjustment, exact income figures) that enhances clarity without introducing error. All scoring categories warrant the highest rating.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 357,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the positioning and market strategy for Disney+ Hotstar evolved between 2023 and 2024, particularly in terms of its regional branding and service structure?",
      "original_answer": "In 2023, Disney+ Hotstar was described as a DTC service primarily in India that offered general entertainment, family, and sports programming. It was positioned as a distinct regional brand within Disney’s broader Direct-to-Consumer portfolio. By 2024, while still branded as Disney+ Hotstar in India and Southeast Asia, the company had merged its previously separate Star+ and Disney+ services in Latin America into a single Disney+ product offering by the end of June 2024. This indicates a strategic shift toward consolidating regional streaming services under the Disney+ brand umbrella, streamlining offerings, and possibly enhancing content integration across markets.",
      "llm_answer": "In the 2023 filing Disney+ Hotstar was described as a direct‑to‑consumer service “primarily in India” that offers general‑entertainment, family and sports programming (2023 p. 4). By the 2024 filing the company says the service is branded Disney+ Hotstar in India and certain other Southeast Asian markets and is deliberately kept out of any multi‑product bundles, remaining a standalone offering (2024 p. 57; 2024 p. 58).",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses a key component of the strategic evolution described in the ground truth. (1) What was correct: The LLM accurately states that in 2023, Disney+ Hotstar was positioned as a DTC service primarily in India offering general entertainment, family, and sports content. It also correctly notes that in 2024, the Disney+ Hotstar brand remained in India and parts of Southeast Asia and was maintained as a standalone service, not included in multi-product bundles. These details align with the original answer and are factually consistent. (2) Quantitative accuracy: There are no numerical values, dates, or financial figures in the response, so no quantitative inaccuracies exist. The years 2023 and 2024 are used appropriately in context. (3) Multi-hop reasoning assessment: The LLM fails to mention the critical strategic shift in Latin America—specifically, the merger of Star+ and Disney+ into a single Disney+ service by June 2024. This omission significantly weakens the answer’s completeness and qualitative accuracy, as the consolidation under the Disney+ brand in Latin America is a core part of the market strategy evolution. The answer focuses only on the continuity of Disney+ Hotstar in India and Southeast Asia without addressing the broader regional rebranding and integration trend. (4) Justification for scores: Correctness is scored 6 because the answer provides accurate but incomplete information—key facts are missing. Quantitative accuracy is 10 because no numbers are misstated. Qualitative accuracy is 6 due to incomplete reasoning and failure to synthesize the Latin America development, which is essential to understanding the strategic shift. Contextual relevance is 8 because the response stays on topic and cites relevant branding and structural details, even if not fully comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 500,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did PayPal's approach to its Protection Programs evolve between 2023 and 2024, particularly in terms of risk exposure and loss recovery mechanisms?",
      "original_answer": "In 2023, PayPal disclosed that the costs associated with its protection programs were recorded in 'transaction and credit losses' during the period the payment transaction was completed, and it did not provide a separate service to customers under these programs. By 2024, PayPal introduced more detailed disclosures around its protection programs, highlighting that it incurs substantial losses from these programs due to customer disputes and faces challenges in recovering losses from merchants, especially in cases involving fraud or merchant insolvency. Additionally, PayPal noted that it may face increased exposure due to evolving fraud schemes and potential regulatory changes affecting chargeback requirements. This indicates a shift toward more explicit risk acknowledgment and a broader understanding of potential financial impact.",
      "llm_answer": "In the 2023 filing PayPal described its purchase‑ and seller‑protection programs mainly as a line‑item cost – “we estimate and record associated costs in transaction and credit losses during the period the payment transaction is completed” (2023 p. 77). By the 2024 filing the discussion had expanded to stress heightened risk exposure – e.g., possible changes in card‑network charge‑back rules, reimbursement rights, and the threat of losing card‑acceptance if losses become excessive – and to note that while the company “actively seeks to recover transaction losses where possible, such recoveries may be insufficient” (2024 p. 24).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly captures the evolution of PayPal's Protection Programs between 2023 and 2024: in 2023, costs were recorded in 'transaction and credit losses' during the transaction period, with no separate service designation; by 2024, PayPal emphasized increased risk exposure, challenges in loss recovery, and external risks like changing chargeback rules and merchant insolvency. The LLM accurately reflects that recoveries are pursued but may be insufficient. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—no discrepancies exist. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, correctly identifying the shift from minimal disclosure to expanded risk acknowledgment. It references specific page numbers (2023 p.77, 2024 p.24), which supports fidelity to source material. (4) The only minor shortcoming is that the LLM omits explicit mention of 'fraud schemes' and 'regulatory changes' as drivers of increased exposure, though it does mention 'changes in card-network charge-back rules', which overlaps with regulatory aspects. It also does not explicitly state that PayPal does not provide a separate service under these programs in 2023, though this is a finer detail. Overall, the semantic meaning and key factual progression are preserved, warranting a high correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 415,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has NextEra Energy's relationship with solar generation facilities evolved from 2022 to 2024, particularly in terms of ownership structure and financial exposure?",
      "original_answer": "In 2022, NextEra Energy Resources was actively divesting ownership stakes in solar generation facilities, including the sale of a 100% ownership interest in a 100 MW solar facility in Arizona and the sale of a 90% ownership interest in a portfolio that included four solar facilities. These transactions resulted in significant cash proceeds and the recognition of gains. By 2024, the company's relationship had transformed into a more complex structure involving equity stakes and consolidated variable interest entities (VIEs). For example, NextEra consolidated eight VIEs owning solar generation facilities with approximately 765 MW of capacity and held a 10% direct ownership interest in additional solar facilities. This shift indicates a strategic move from outright ownership and divestiture to a more diversified and financially leveraged stake through VIEs, with increased financial exposure through guarantees and credit support.",
      "llm_answer": "In the 2022 filing NextEra had begun divesting its solar assets by selling Class B non‑controlling interests – it kept a controlling stake but recorded redeemable non‑controlling interests that could require cash repayments if certain contingencies were triggered (2022 p.79‑80). By the 2024 filing the company’s solar portfolio is largely held through variable‑interest entities: eight subsidiaries own 50‑67 % of solar‑focused VIEs (and a separate VIE holds a 10 % stake), which are consolidated as the primary beneficiary, and the associated debt is secured only by the solar assets with no recourse to NextEra’s general credit (2024 p.97; solar now 23 % of NEER’s depreciable plant, 2024 p.95).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution in NextEra Energy's relationship with solar generation facilities from 2022 to 2024, correctly identifying a strategic shift from divestiture to a VIE-based ownership structure. However, there are key quantitative inaccuracies: the LLM states that in 2022, NextEra sold 'Class B non-controlling interests' and retained control, but the ground truth specifies full or near-full divestitures (e.g., 100% sale of a 100 MW Arizona facility, 90% sale of a portfolio), which contradicts the claim of maintaining controlling stakes. Additionally, the LLM claims in 2024 that 'eight subsidiaries own 50–67% of solar-focused VIEs', while the ground truth states that NextEra consolidated eight VIEs with ~765 MW capacity, without specifying percentage ownership—this 50–67% range is unsupported. The 10% stake mentioned in the LLM answer aligns with the ground truth, but the phrasing 'a separate VIE holds a 10% stake' lacks clarity and context. The LLM correctly notes consolidation as primary beneficiary and non-recourse debt, which reflects accurate qualitative understanding of financial exposure. It also adds relevant context about solar comprising 23% of NEER’s depreciable plant (2024), which enhances completeness though not in the original answer. The reasoning correctly synthesizes a multi-hop narrative across years and structures, but the inclusion of unsupported percentages and mischaracterization of 2022 transactions reduces quantitative accuracy. Overall, the answer is semantically close and contextually relevant, with sound logic but flawed specifics on ownership percentages and transaction types.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 450,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did ACN's investment in Mutual Fund Debt Securities evolve from 2022 to 2023, and what was the change in valuation methodology as reflected in the fair value hierarchy levels?",
      "original_answer": "In 2022, ACN reported Mutual Fund Debt Securities valued at $379,989 with the entire amount categorized under Level 2 of the fair value hierarchy. In 2023, this investment decreased to $253,025, and the valuation remained entirely under Level 2. The decrease in value indicates a reduction in exposure to Mutual Fund Debt Securities over the year, while the valuation methodology remained consistent, relying on observable market data.",
      "llm_answer": "In 2022 Accenture’s non‑U.S. defined‑benefit pension plans carried $379.989 million of mutual‑fund debt securities, which were measured at Level 2 of the fair‑value hierarchy (quoted prices for similar instruments)【page_89】. The 2023 filing no longer reports any mutual‑fund debt securities, indicating the holding was eliminated and the Level 2 valuation was removed (i.e., the fair‑value measurement shifted away from Level 2).",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the 2022 value of $379,989 thousand (interpreted as $379.989 million), it incorrectly states that mutual-fund debt securities were eliminated in 2023. The ground truth shows the investment decreased to $253,025 (thousand), not eliminated. The LLM claims 'no longer reports any,' which is false. Additionally, the LLM asserts the Level 2 valuation was removed, but the ground truth confirms the 2023 amount was still entirely in Level 2, so no methodology change occurred. (2) Quantitatively, the 2022 figure is accurate with acceptable formatting variation ($379.989 million = $379,989,000). However, the 2023 value is completely wrong—the LLM reports $0 instead of $253,025,000. The change in investment value (~$127 million decrease) is therefore misrepresented. (3) The multi-hop reasoning fails: the model incorrectly infers disappearance of the asset class and a shift in valuation methodology, when both the value and hierarchy level are available and unchanged in methodology. It does not synthesize the correct data points across years accurately. (4) Contextual relevance is moderate—the response addresses the right topic (Mutual Fund Debt Securities, fair value hierarchy, Level 2) and cites a plausible document location, but the core conclusions about elimination and methodology shift are incorrect, undermining the answer's validity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 401,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Chevron's financial stake and involvement in Tengizchevroil evolved between 2022 and 2023?",
      "original_answer": "In 2022, Chevron's carrying value of its investment in Tengizchevroil was $23,727 million with a reported equity in earnings of $1,238 million. By 2023, Chevron disclosed that its carrying value was approximately $80 million higher than its underlying equity in Tengizchevroil's net assets, indicating a more complex valuation approach. Additionally, Chevron highlighted that it provided a loan of $4,500 million to Tengizchevroil to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This shows a significant deepening of Chevron's financial involvement and strategic commitment to the partnership in 2023 compared to 2022.",
      "llm_answer": "Chevron still owns a 50 % equity interest in Tengizchevroil. The carrying value of that investment grew modestly from $26.5 billion at year‑end 2022 to $27.0 billion at year‑end 2023, but Chevron’s share of TCO’s earnings fell from $4.386 billion in 2022 to $3.375 billion in 2023. The company also continues to fund TCO with a loan of about $4.5 billion (see Note 15, page 82).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Chevron's carrying value in Tengizchevroil was $23,727 million ($23.727 billion) in 2022, not $26.5 billion as stated. The 2023 carrying value is reported as $27.0 billion in the LLM answer, but the ground truth does not provide an exact updated carrying value—only that it was approximately $80 million higher than its underlying equity in net assets. The LLM also incorrectly states Chevron’s share of earnings as $4.386 billion in 2022 and $3.375 billion in 2023, whereas the ground truth reports $1,238 million ($1.238 billion) in 2022 and no specific earnings figure for 2023. These numbers are off by more than a factor of 3, indicating major quantitative errors. (2) The loan amount of $4.5 billion is correctly reported and aligns with the ground truth. However, the LLM misrepresents the growth in carrying value and earnings, which are central to the question. (3) The multi-hop reasoning is partially present—the LLM attempts to compare 2022 and 2023 financials and notes continued involvement via the loan. However, it fails to capture the key qualitative shift in 2023: the disclosure of a complex valuation approach and the strategic significance of the loan for the FGP/WPMP projects, which the ground truth emphasizes. (4) The contextual relevance is fair because the answer addresses Chevron’s stake and financial involvement over the two years, but the severe numerical inaccuracies undermine correctness. The qualitative reasoning is weakened by incorrect data inputs, leading to misleading conclusions about the evolution of Chevron’s involvement.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 456,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has Disney's relationship with ABC Network evolved between 2023 and 2024, particularly in terms of its strategic positioning within Disney's broader entertainment ecosystem?",
      "original_answer": "In 2023, ABC Network was positioned as a core component of Disney's 'Linear Networks' within the Entertainment segment, specifically highlighting its domestic footprint through eight owned ABC television stations and its role in content distribution. By 2024, ABC Network's role had evolved, with its programming becoming more integrated into Disney's direct-to-consumer platforms, such as Hulu and Disney+. Specifically, content from ABC Network was made available on Hulu's SVOD service one day after its linear airing. This shift indicates a strategic move toward digital integration and away from traditional linear distribution. Additionally, while ABC Network was still referenced in the context of affiliate fees in 2023, 2024 emphasized its contribution to streaming services rather than standalone linear revenue.",
      "llm_answer": "In 2023 Disney described ABC simply as a core “Domestic” linear network within the Entertainment segment – one of the broadcast‑television properties (along with Disney, Freeform, FX and National Geographic) that, together with eight owned stations, delivered news, daytime, primetime and unscripted programming to a broad audience (page 78). By 2024 the filing shows ABC has become a more integrated hub: ESPN now programs the sports daypart on ABC (branded “ESPN on ABC”) (page 9), ABC’s reach is highlighted as covering almost 100 % of U.S. households (page 5), and its shows are fed to Disney’s streaming arm – with ABC content appearing on Hulu one day after linear airing (page 7). Thus, ABC’s role has shifted from a standalone broadcast outlet to a strategic conduit that links Disney’s linear, sports and Direct‑to‑Consumer businesses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: ABC's role in 2023 as part of Disney's Linear Networks with eight owned stations, its integration into streaming via Hulu with next-day availability, and the shift toward digital distribution are all accurately reflected. The mention of 'ESPN on ABC' programming sports content is an additional accurate detail supported by Disney's 2024 filing, enhancing the answer without contradicting the ground truth. (2) Quantitative elements are correct: 'eight owned stations' and 'almost 100% of U.S. households' match expectations; no calculations were required. The 2023 and 2024 timeframes are correctly applied. (3) Multi-hop reasoning is sound: the LLM synthesizes ABC’s structural role, content distribution evolution, and cross-segment integration (linear, sports, DTC), demonstrating strong understanding of strategic positioning shifts. (4) The only minor gap is that the original answer emphasizes the decline in focus on affiliate fees in 2024, which the LLM omits. However, the core strategic evolution—integration with streaming and broader ecosystem—is clearly and correctly conveyed. Wording differs but semantic meaning is equivalent. Thus, the answer is excellent with only a slight omission in contextual nuance, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 383,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has General Dynamics' positioning of the ASCOD vehicle within its Land Systems portfolio evolved between 2022 and 2023, and what does this indicate about potential shifts in production focus or investment allocation?",
      "original_answer": "In 2022, General Dynamics explicitly stated it was 'producing and upgrading' the ASCOD vehicle, indicating active development and enhancement of the platform. By 2023, the company's disclosure shifted to simply 'offering' the ASCOD, without specific mention of production or upgrades. This change in language suggests a potential shift in focus away from active investment or development of the ASCOD platform, possibly reallocating resources to other vehicle programs like the Piranha 5 and AJAX, which are explicitly called out in both years with continued production and international deployments.",
      "llm_answer": "In the 2022 filing General Dynamics described the ASCOD as a “highly versatile tracked combat vehicle” offered by its European Land Systems (ELS) unit, while Land Systems was building 399 new LAVs for the Canadian army【page_11】. The 2023 filing keeps the ASCOD in the same ELS product line with the same description, but Land Systems’ LAV production fell to 360 units【page_11】—a modest reduction that signals a slight re‑allocation of capacity away from LAVs, yet no new emphasis or expanded investment in the ASCOD itself.",
      "correctness_score": 3,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually misaligned with the ground truth. While it correctly identifies General Dynamics and the ASCOD vehicle in the context of European Land Systems (ELS), it introduces unrelated information about LAV production for the Canadian army (399 units in 2022, 360 in 2023), which is not mentioned in the original answer and distracts from the core question about ASCOD's strategic positioning. The ground truth focuses on a shift in language from 'producing and upgrading' in 2022 to merely 'offering' in 2023, indicating reduced investment. The LLM fails to report this critical change in disclosure language, which is central to the question. (2) The numbers cited (399 and 360 LAV units) may be accurate within the filings, but they are irrelevant to the question about ASCOD and introduce a false narrative about capacity reallocation based on LAV production changes—this is not supported by the ground truth. There are no calculations in the answer, so quantitative accuracy is limited to correct number reporting, which is acceptable but off-topic. (3) The multi-hop reasoning is flawed: the model does not connect the change in ASCOD's description across years, which is essential for assessing shifts in production focus or investment. Instead, it infers a 'slight re-allocation of capacity' based on LAV production changes, which is not substantiated in the ground truth. The original answer points to explicit mentions of continued investment in Piranha 5 and AJAX as evidence of shifting priorities—this synthesis is entirely missing. (4) The contextual relevance is moderate because the answer discusses General Dynamics' land systems and product lines, but it fails to address the actual evolution of ASCOD's positioning. The qualitative accuracy is low due to incorrect reasoning and omission of key evidence. Correctness score is low because the answer misses the primary factual shift (language change in disclosures) and provides an alternative, unsupported explanation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 543,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has PayPal's utilization of European customer balances for credit activities evolved between 2023 and 2024, and what does this shift indicate about the company's credit funding strategy?",
      "original_answer": "In 2023, PayPal had approved $3.0 billion of European customer balances for credit activities, representing approximately 39% of balances made available for corporate use. By 2024, the approved amount had decreased to $2.0 billion, or 26% of European customer balances. This indicates a strategic shift toward reducing reliance on customer balances for credit funding, potentially in favor of external financing sources, as evidenced by PayPal's multi-year agreement to sell consumer installment receivables, which saw $20.8 billion in loans sold in 2024 compared to $5.5 billion in 2023.",
      "llm_answer": "In 2023 PayPal had approved the use of $3.0 billion of European customer balances – about 39 % of the balances available for corporate use – to fund credit activities (2023 10‑K, p. 71). By year‑end 2024 that amount fell to $2.0 billion, or roughly 26 % of the available balances (2024 10‑K, p. 46). The drop signals that PayPal is pulling back on relying on its European deposits for credit funding and is likely shifting toward external or more diversified sources of capital to support its loan‑and‑advance programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: $3.0 billion approved in 2023 (39%) and $2.0 billion in 2024 (26%) are accurately reported, with correct years and percentages. The source citations (2023 10-K, p. 71; 2024 10-K, p. 46) add credibility and match expected disclosure locations. (2) Quantitative accuracy is perfect—dollar amounts and percentages match the original answer exactly, and no calculation errors are present. (3) The reasoning is sound: the decrease in utilization is correctly interpreted as a strategic pullback from using European customer balances for credit funding. The inference about a shift toward external or diversified capital sources is logically supported by the trend. However, the LLM omits the specific evidence of PayPal’s multi-year receivables sale agreement and the significant increase in loans sold—from $5.5B in 2023 to $20.8B in 2024—which is a key data point in the ground truth that strengthens the conclusion about external financing. This omission slightly weakens the qualitative completeness of the reasoning, though the core logic remains valid. (4) The answer is fully contextually relevant, directly addressing both parts of the question: the evolution between 2023 and 2024, and the strategic implication. Overall, the answer is factually excellent with only a minor gap in supporting detail, warranting a 9/10 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 397,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the valuation and categorization of equity securities within NEE's Special Use Funds evolve between 2022 and 2024, and what does this indicate about changes in transparency or investment composition?",
      "original_answer": "In 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (with an estimated fair value of $907 million) for NEE and $672 million (with an estimated fair value of $672 million) for FPL, without detailed categorization by valuation levels. By 2024, the equity securities in the Special Use Funds had grown significantly, with NEE holding $2,614 million in Level 1 equity securities and FPL holding $1,028 million in Level 1 equity securities, alongside more granular disclosures that included Level 2 and Level 3 valuations. This indicates a substantial increase in equity investments and a shift toward more transparent and detailed reporting of asset valuation methodologies.",
      "llm_answer": "In the 2022 Form 10‑K, NEE reported equity securities in its Special‑Use Funds of about $5.5 billion, split between Level 1 ($2.5 bn) and Level 2 ($3.0 bn) with no Level 3 holdings【page_89】. By the 2024 filing the equity portion had risen to $6.2 billion, with Level 1 at $2.6 bn, Level 2 at $3.3 bn and a new $229 million classified as Level 3【page_89】. The appearance of a Level 3 component and the larger total balance indicate that the funds have become more diversified into less‑observable securities and that NEE now provides greater transparency by disclosing the fair‑value hierarchy of these investments.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, in 2022, NEE's Special Use Funds reported equity securities at a carrying amount of $906 million (fair value $907 million) for NEE and $672 million for FPL, with no detailed categorization by valuation levels (Level 1, 2, or 3). However, the LLM claims $5.5 billion total in 2022 with $2.5 billion in Level 1 and $3.0 billion in Level 2, which is entirely incorrect and misrepresents both the total amount and the existence of level-based disclosures in 2022. Similarly, for 2024, the ground truth states NEE held $2,614 million in Level 1 equity securities and FPL held $1,028 million in Level 1, with additional Level 2 and Level 3 disclosures introduced. The LLM incorrectly reports a total of $6.2 billion across all levels, with $2.6 billion Level 1, $3.3 billion Level 2, and $229 million Level 3 — figures not supported by the ground truth and conflating NEE and FPL data. (2) The quantitative inaccuracies are severe: the LLM inflates 2022 equity securities from ~$906M (NEE) to $5.5B, a nearly 6x overstatement, and fabricates level-based breakdowns that did not exist in 2022. The 2024 numbers also do not align — while $2.6 billion Level 1 is close to NEE’s $2,614 million, the LLM omits that FPL also holds Level 1 securities and incorrectly aggregates or invents Level 2 and Level 3 amounts. (3) The multi-hop reasoning is flawed: the model fails to distinguish between NEE and FPL, conflates total fund values with equity securities, and incorrectly assumes granular fair value hierarchy disclosures existed in 2022 when they did not. The conclusion about increased diversification into less-observable securities (Level 3) is based on fabricated data. (4) While the LLM attempts to address transparency improvements — a valid inference if supported — it does so using incorrect data, undermining the reasoning. The contextual relevance is moderate because it addresses valuation evolution and transparency, but the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 562,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the scope and utilization of Accenture's share purchase program evolve from fiscal 2022 to fiscal 2023, particularly in terms of shares acquired under the public program versus those acquired through employee-related transactions?",
      "original_answer": "In fiscal 2022, Accenture purchased 1,964,612 Class A ordinary shares under the publicly announced open-market share purchase program for an aggregate price of $576 million. Additionally, 97,251 shares were acquired through employee-related transactions, such as share withholding for payroll tax obligations, which do not affect the aggregate available authorization. In fiscal 2023, there is no mention of shares purchased under the public program, but the company continued acquiring shares through employee-related transactions under equity share plans. This indicates a shift where the public share purchase program saw reduced or no activity, while employee-related share acquisitions remained consistent.",
      "llm_answer": "In fiscal 2022 Accenture repurchased 2,061,863 Class A shares in the fourth quarter, of which 1,964,612 (about 95 %) were bought under its publicly announced open‑market share‑repurchase program and 97,251 (about 5 %) were acquired in employee‑related transactions such as payroll‑tax withholding (see page 33). The 2023 filing (pages 81‑85) does not provide a new breakdown of purchases, indicating that the open‑market program – which has no expiration and an outstanding authorization of $6.129 billion (see footnote 4, page 33) – continued to be the primary vehicle for repurchases, with employee‑related purchases remaining a small, separate component.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains partial factual accuracy but introduces significant errors in interpretation and reasoning. The fiscal 2022 numbers are correct: 1,964,612 shares under the public program and 97,251 through employee-related transactions, matching the ground truth. However, the LLM incorrectly states that 2,061,863 shares were repurchased in total in Q4 2022, which is not supported by the original answer and adds unverified detail. (2) The dollar amount of $576 million from the ground truth is missing in the LLM response, a key quantitative omission. The LLM also fabricates information about the continuation of the open-market program in fiscal 2023, claiming it remained the 'primary vehicle' despite the original answer stating there is 'no mention' of public program purchases in 2023. This directly contradicts the ground truth, which infers a reduction or pause in public repurchases. (3) The multi-hop reasoning fails: while the LLM correctly identifies the two types of share acquisitions, it misinterprets the absence of 2023 data as evidence of continuation, when the ground truth draws the opposite conclusion — a shift toward inactivity in the public program. The LLM does not recognize the significance of missing 2023 disclosures, which is central to the evolution described in the original answer. (4) Contextual relevance is high because the response addresses the right entities (Accenture, share purchase programs, employee-related transactions) and time frame (2022–2023), but the qualitative inaccuracy in logic and unsupported quantitative claims reduce correctness significantly. Minor formatting variations (e.g., spacing in '$6.129 billion') are acceptable, but core reasoning flaws and missing financial data prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 479,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did Chevron's financial reporting relationship with Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of its consolidation status and investment accounting approach?",
      "original_answer": "In 2022, Chevron Phillips Chemical Company LLC was consolidated into Chevron’s financial statements, as indicated by the inclusion of 'Note 8: Summarized Financial Data - Chevron Phillips Chemical Company LLC' among other consolidated subsidiaries. However, in 2023, Chevron explicitly stated that its investment in Chevron Phillips Chemical Company LLC was accounted for using the equity method, and it was no longer consolidated under Chevron U.S.A. Inc.'s financial data. This reflects a significant structural change where Chevron transitioned from consolidating the entity to reporting its investment under the equity method, altering how its financial performance is reflected in Chevron’s consolidated results.",
      "llm_answer": "Chevron’s 50 % stake in Chevron Phillips Chemical Company LLC was treated the same way in both years – it was not consolidated but reported as an equity‑method investment (2022 Note 8, p. 31; 2023 Note 8, p. 75).  In 2023 the joint‑venture’s net equity continued to be shown as a separate line item on the consolidated balance sheet (“Total CPChem net equity” on p. 76), confirming that the consolidation status and the equity‑method accounting approach did not change from 2022 to 2023.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim that Chevron's accounting treatment of Chevron Phillips Chemical Company LLC (CPChem) remained unchanged between 2022 and 2023. According to the ground truth, CPChem was consolidated in 2022 (as evidenced by the inclusion of its summarized financial data in Note 8 among consolidated subsidiaries), but in 2023, Chevron explicitly transitioned to equity-method accounting and ceased consolidation. The LLM incorrectly asserts that CPChem was accounted for under the equity method in both years, directly contradicting the ground truth. The citation of 'Note 8' in both years does not override the substantive change in accounting treatment described in the original answer. Additionally, the mention of 'Total CPChem net equity' as a balance sheet line item in 2023 does not confirm lack of change—it may reflect disclosure requirements under equity-method accounting post-deconsolidation. The 50% stake ownership might be factually accurate, but the central conclusion about no change in consolidation status and accounting approach is wrong. This represents a failure in multi-hop reasoning: the model did not correctly interpret the shift in financial reporting structure despite apparent access to document references. While the answer addresses the right entities and time frame (Chevron, CPChem, 2022–2023), the factual inaccuracy on the key point of consolidation vs. equity method severely undermines correctness. Quantitative accuracy is low because the critical qualitative financial change (consolidation status) is misrepresented, even if percentages like '50%' are plausible. Contextual relevance is moderate since the response discusses the correct topic and cites relevant notes, but draws the wrong conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 482,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Hydra-70 rockets in General Dynamics' Combat Systems segment evolved from 2022 to 2023, particularly in terms of contract involvement and production capacity expansion?",
      "original_answer": "In 2022, General Dynamics received a $175 million contract for the production of Hydra-70 rockets as part of its Combat Systems segment. By 2023, the company's role had evolved significantly, with OTS (Orbital Technologies Corporation, part of Combat Systems) maintaining a market-leading position in the supply of Hydra-70 rockets and expanding its production capacity. Specifically, OTS received awards to increase metal parts production capacity for munitions from 18,000 to 86,000 rounds per month by 2025, which includes Hydra-70 rockets as part of its broader munitions portfolio.",
      "llm_answer": "In the 2022 filing, Hydra‑70 rockets were mentioned only in a $175 million Army contract to produce the rockets 【page 42】. By the 2023 filing, they are highlighted as a core, market‑leading munitions product and OTS secured awards to expand metal‑parts capacity for Hydra‑70 rockets from 18,000 to 86,000 rounds per month (and propellant capacity to 16 million lb/yr) 【page 12】, shifting the focus from a single production contract to a broad capacity‑building effort.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $175 million 2022 contract for Hydra-70 rockets and the expansion of production capacity from 18,000 to 86,000 rounds per month by 2025 as part of OTS awards. The numbers, dates, and dollar amounts are accurate and match the ground truth. The mention of propellant capacity (16 million lb/yr) is additional context not in the original answer but does not contradict it and may be present in the source filing. (2) Quantitative accuracy is perfect: $175M, 18,000 to 86,000 rounds/month are all correct. The timeline (awards in 2023 for expansion) aligns with the ground truth, even if the completion year (2025) is omitted in the LLM answer—this is a minor omission, not an error. (3) The multi-hop reasoning is sound: the LLM synthesizes information across 2022 and 2023 filings to show evolution from a single contract to a broader capacity-building role. It correctly identifies OTS (Orbital Technologies Corporation) as the entity involved and links it to the Combat Systems segment. The shift in strategic focus is accurately characterized. (4) The answer is contextually relevant and fully addresses both parts of the question: contract involvement (2022 contract) and production capacity expansion (2023 awards). The only minor shortcoming is the lack of explicit mention that the capacity expansion is for metal parts and includes Hydra-70 as part of a broader munitions portfolio, which slightly reduces completeness. However, the core facts and synthesis are correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 428,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has PayPal's treatment of the Global Restricted Stock Unit Award Grant Notice evolved between the 2023 and 2024 filings, particularly in terms of its documentation status and associated agreements?",
      "original_answer": "In the 2023 filing, the Global Restricted Stock Unit Award Grant Notice was listed as Exhibit 10.07+ and was associated with the PayPal Holdings, Inc. 2015 Equity Incentive Award Plan, with its form incorporated by reference from 10-12B/A filed on May 14, 2015. By 2024, the same form of the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) remained in place, still referencing the 2015 plan and incorporated by reference from the same 10-12B/A filing on May 14, 2015. However, in the 2024 filing, there was an updated form of the Global Performance Based Restricted Stock Unit Award Grant Notice (Exhibit 10.08+), which was now filed under the amended and restated plan and was linked to a more recent 10-Q filing on April 30, 2024. This indicates that while the base RSU grant notice remained unchanged, the performance-based variant saw active revision and documentation updates in 2024.",
      "llm_answer": "In the 2023 Form 10‑K PayPal listed the Global Restricted Stock Unit Award Grant Notice (Exhibit 10.07+) as an exhibit “incorporated by reference” – a Form 10‑12B/A originally filed on May 14 2015 that includes the accompanying Restricted Stock Unit Award Agreement under the 2015 Equity Incentive Award Plan, and it was not filed with the 10‑K itself【page_124】. The 2024 Form 10‑K repeats the same Exhibit 10.07+ with the same documentation status and agreement (still incorporated by reference, same filing date)【page_121】, while also adding a separate performance‑based RSU grant notice (Exhibit 10.08+), indicating no change to the original global RSU notice’s treatment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the Global Restricted Stock Unit Award Grant Notice is correctly identified as Exhibit 10.07+ in both 2023 and 2024 filings, incorporated by reference from the May 14, 2015 10-12B/A, under the 2015 Equity Incentive Award Plan. The LLM correctly notes no change in documentation status between years for this exhibit. It also accurately identifies the addition of Exhibit 10.08+ (performance-based RSU notice) in 2024, though it does not explicitly state that this new form is linked to a more recent 10-Q filing on April 30, 2024, nor that it is under the amended and restated plan—minor omissions affecting completeness. (2) Quantitative accuracy is perfect: dates (May 14, 2015), exhibit numbers (10.07+, 10.08+), and filing types (10-12B/A, 10-K) are all correct. (3) Multi-hop reasoning is sound—LLM synthesizes across years and exhibits, correctly concluding no change in the base RSU notice. (4) Semantic equivalence is strong; wording differs but meaning aligns closely with ground truth. The only reason for not scoring 10 is the omission of specific details about the 2024 performance-based notice’s linkage to the amended plan and the April 30, 2024 10-Q, which were present in the original answer and relevant to the 'evolution' aspect of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 383,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the role of Opdivo within Bristol-Myers Squibb's portfolio evolved from 2022 to 2024, based on its revenue performance and new regulatory approvals?",
      "original_answer": "In 2022, Opdivo generated $7,523 million in revenue, indicating it was a major contributor to Bristol-Myers Squibb's oncology portfolio. By 2024, Opdivo received a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of adult patients with unresectable or metastatic urothelial carcinoma. This regulatory expansion demonstrates a strategic evolution in Opdivo’s therapeutic application and reinforces its continued importance in the company's oncology pipeline, despite not showing a significant revenue increase from earlier years.",
      "llm_answer": "In the 2022 filing Opdivo was a core revenue engine, delivering about $7.5 billion in net product sales and ranking among BMS’s top three products【page_110】. By 2024 the drug’s role has broadened from a single‑indication blockbuster to a multi‑indication platform: BMS added a sub‑cutaneous formulation (Opdivo Qvantig, Dec 2024) and new approvals for urothelial carcinoma (Mar 2024), resectable NSCLC (Oct 2024), and the Opdivo + Yervoy combo for MSI‑H/dMMR colorectal cancer (Dec 2024)【page_45】【page_44】, underscoring its continued strategic importance and expanding market reach.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Opdivo as a major revenue contributor in 2022 with approximately $7.5 billion, which aligns with the ground truth of $7,523 million (minor rounding is acceptable). However, the LLM introduces several new FDA approvals in 2024—specifically for resectable NSCLC (Oct 2024), MSI-H/dMMR colorectal cancer (Dec 2024), and a subcutaneous formulation (Opdivo Qvantig, Dec 2024)—that are not present in the ground truth. The only confirmed approval in the original answer is for urothelial carcinoma in March 2024. These additional approvals are factually unsupported by the provided truth and represent significant overstatement. (2) The revenue figure is quantitatively accurate within acceptable rounding, but the dates and number of approvals are incorrect. The mention of Dec 2024 approvals is particularly problematic as it postdates the evaluation period (through 2024) and may not be reflected in filings available by year-end. (3) The reasoning correctly infers that Opdivo’s role is evolving strategically and that regulatory expansions reinforce its importance—this multi-hop synthesis from revenue + approvals to strategic evolution is sound. However, the synthesis is based partly on non-existent data, weakening the validity. (4) The contextual relevance is high because the answer addresses both revenue performance and regulatory developments, and interprets their strategic implications appropriately. The qualitative accuracy is moderate due to correct framing but flawed factual inputs. Quantitative accuracy is low due to incorrect dates and unverified approvals, despite correct revenue figures. Correctness score reflects partial accuracy: core revenue fact is right, but key 2024 developments are exaggerated or invented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 485,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Chevron's financial involvement and strategic support for Chevron Phillips Chemical Company LLC evolve between 2022 and 2023, particularly in terms of project funding and investment structure?",
      "original_answer": "In 2022, Chevron highlighted its 50% ownership in Chevron Phillips Chemical Company LLC (CPChem), emphasizing ongoing investments in global manufacturing facilities and expansion projects, such as the planned 1-hexene unit in Old Ocean, Texas, and a C3 splitter at Cedar Bayou, with targeted start-ups in 2023. By 2023, Chevron's involvement had evolved to include a direct loan of $387 million to fund a portion of the Golden Triangle Polymers Project in Orange, Texas, in which CPChem owns 51%. This indicates a shift from general equity ownership and project announcements in 2022 to more direct financial support and structured investment in specific projects in 2023.",
      "llm_answer": "In 2022 Chevron’s involvement in CPChem was limited to its 50 % equity stake and a $6.8 billion investment balance, with strategic support focused on CPChem’s planned Old Ocean 1‑hexene unit and Cedar Bayou C3‑splitter projects slated for 2023 (2022 10‑K Chemicals Operations, pp. 18‑19). By 2023 the equity stake remained 50 %, but the investment balance rose to $7.8 billion and Chevron added a $387 million loan to fund the Golden Triangle Polymers Project in Orange, Texas—where CPChem holds a 51 % interest—signaling a larger financial commitment and the use of direct project‑level financing (2023 10‑K Note 15, p. 82).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Chevron maintained a 50% ownership stake in CPChem in both 2022 and 2023; the $387 million loan in 2023 to fund the Golden Triangle Polymers Project (in which CPChem holds 51%) is accurately reported; and the Old Ocean 1-hexene unit and Cedar Bayou C3 splitter projects are correctly cited as 2022-announced projects with 2023 start-ups. (2) Quantitative accuracy is excellent: the $387 million loan is correctly stated, and while the $6.8B and $7.8B investment balances are not in the original answer, they do not contradict it and are plausible contextual additions (likely from the cited 10-K Note 15). No calculation errors. (3) Multi-hop reasoning is sound: the LLM correctly infers a strategic shift from general equity-level support in 2022 to direct project-level financing in 2023, which is the core of the evolution described in the ground truth. (4) The only minor shortcoming is that the original answer emphasizes the 'shift' in strategic support more explicitly, while the LLM presents facts clearly but with slightly less interpretive synthesis. However, the conclusion about 'larger financial commitment and direct project-level financing' captures the essence. Wording differences are acceptable under semantic equivalence. All entities (Chevron, CPChem, Golden Triangle Polymers Project, locations, ownership percentages) are correct. The answer is fully relevant and responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 416,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did PayPal's protection programs evolve between 2023 and 2024 in terms of financial commitments and disclosures regarding transaction loss reserves?",
      "original_answer": "In 2023, PayPal disclosed that it estimated and recorded costs associated with protection programs in transaction and credit losses, but did not specify the exact amounts for the allowance for transaction losses or negative customer balances. In 2024, PayPal provided more detailed disclosures, including specific figures: the allowance for transaction losses increased from $64 million in 2023 to $86 million in 2024, and the allowance for negative customer balances rose from $218 million to $256 million. This indicates a significant increase in PayPal's financial commitments and potential risk exposure under its protection programs in 2024 compared to the prior year.",
      "llm_answer": "By 2024 PayPal had raised the reserves that back its consumer‑merchant protection programs. The allowance for transaction losses grew from $64 million at the end of 2023 to $86 million at the end of 2024 (the total allowance balance rose from $282 million to $342 million), and the allowance for negative customer balances increased from $218 million to $256 million, with the 2024 filing adding a detailed reconciliation showing a $1.114 billion provision, $1.218 billion of realized losses and $164 million of recoveries. These figures show a larger financial commitment and more granular disclosure of the protection‑program loss reserves compared with 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the increase in PayPal's allowance for transaction losses from $64 million in 2023 to $86 million in 2024, and for negative customer balances from $218 million to $256 million, matching the original answer exactly. (2) The additional detail about the total allowance balance rising from $282 million to $342 million (i.e., $64 + $218 = $282 and $86 + $256 = $342) is mathematically correct and adds context without contradicting the ground truth. (3) The mention of a detailed reconciliation in the 2024 filing—$1.114 billion provision, $1.218 billion realized losses, $164 million recoveries—represents a factual enhancement not in the original answer but does not conflict with it; such granularity supports the claim of increased disclosure. (4) The reasoning is sound: the LLM correctly infers that higher reserves and more detailed reporting indicate increased financial commitment and risk exposure. The only minor limitation is that the original answer does not include the $1.114B/$1.218B/$164M figures, so their inclusion, while plausible, cannot be fully verified from the ground truth—hence not a full 10. However, since they are consistent with the direction and magnitude of increased disclosures, they do not reduce correctness significantly. All entities (PayPal, 2023–2024, protection programs, transaction losses, negative balances) are accurate and properly contextualized. The answer fully addresses the evolution in financial commitments and disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 430,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has McDonald's strategic framing of its relationship with franchisees changed between 2022 and 2024, particularly in terms of franchising as a core business model and the role of franchisee co-investment?",
      "original_answer": "In 2022, McDonald's described its relationship with franchisees in neutral, structural terms, emphasizing the division of responsibilities such as franchised arrangements and license agreements, and presenting franchisees as co-participants in operating restaurants. By 2024, the framing evolved significantly, with franchising being described as 'paramount' to delivering food quality, customer experience, and profitability. The 2024 filing also emphasized the importance of franchisee co-investment, noting that it enables McDonald's to achieve high restaurant performance. This represents a shift from a descriptive to a more strategic and value-laden framing of the franchisee relationship.",
      "llm_answer": "In the 2022 filing McDonald’s merely described its franchise system as a component of the business – “The Company franchises and operates … All restaurants are operated either by the Company or by franchisees, including conventional franchisees, developmental licensees or affiliates” (2022 p. 43) – without stressing franchising as a strategic priority or mentioning co‑investment. By the 2024 filing the tone shifts to a strategic partnership: the company says it is “primarily a franchisor and believes franchising is paramount” (2024 p. 3) and adds that it may “co‑invest with franchisees to fund improvements” and that its “heavily franchised business model” generates stable, predictable revenue (2024 p. 4). This reflects a move from a descriptive to a core‑business framing that highlights franchisee co‑investment as a key growth lever.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately captures the shift in McDonald's strategic framing between 2022 and 2024: from a neutral, structural description of franchisees as operators to a strategic emphasis on franchising as 'paramount' and the importance of co-investment. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across two years of filings, identifying both the change in tone (from descriptive to strategic) and the introduction of franchisee co-investment as a key element in 2024. (4) The LLM supports its claims with direct, correctly attributed quotes from the 2022 and 2024 filings (e.g., 'primarily a franchisor and believes franchising is paramount' from p.3, 2024), demonstrating accurate entity and year alignment. The answer is semantically equivalent to the ground truth, using slightly different phrasing (e.g., 'core-business framing' vs 'strategic and value-laden framing') but conveying the same meaning. All aspects of the question—franchising as a core model and franchisee co-investment—are addressed with high precision and contextual fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 367,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the FDA's authorization of Marlboro HeatSticks evolved between 2022 and 2023, and what does this indicate about Altria's regulatory progress with heated tobacco products?",
      "original_answer": "In 2022, the FDA had not yet authorized Marlboro HeatSticks and was considering them on a case-by-case basis regarding graphic health warnings. By 2023, the FDA had authorized PMTAs for three new tobacco-flavored varieties of Marlboro HeatSticks in January 2023, marking a significant regulatory milestone. This indicates that Altria made notable progress in securing FDA approval for its heated tobacco product line, which is a key part of its innovation strategy.",
      "llm_answer": "- In the 2022 Form 10‑K Altria reported that the FDA had **authorized PMTAs for three new tobacco‑flavored Marlboro HeatSticks in January 2023** (see MO 2022 p. 35).  \n- In the 2023 Form 10‑K the company noted that the FDA **has not exempted Marlboro HeatSticks from the graphic‑warning rule and is still reviewing the marketing order on a case‑by‑case basis**, with no further exemption action taken to date (see MO 2023 p. 37).  \n\nTogether, these disclosures show that Altria has moved from gaining its first FDA marketing authorizations for HeatSticks to still awaiting full regulatory clearance—demonstrating incremental progress but continued hurdles for its heated‑tobacco products.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of key facts and dates, but contains a subtle misrepresentation in reasoning that affects the overall interpretation. (1) Quantitatively, the dates and events are accurate: the 2022 10-K correctly notes the January 2023 FDA authorization of three tobacco-flavored Marlboro HeatSticks, and the 2023 10-K accurately states that the FDA has not exempted HeatSticks from the graphic warning rule and is reviewing on a case-by-case basis. These details align with the ground truth. (2) The numbers and dates are correct—January 2023 authorization is properly cited, and no incorrect financial or temporal data is present. (3) However, the reasoning missteps: the LLM frames the situation as Altria 'gaining first FDA marketing authorizations' but then 'still awaiting full regulatory clearance', implying the 2023 authorization was the first ever. The ground truth emphasizes the 2023 authorization as a 'significant regulatory milestone', suggesting progress, whereas the LLM's 'incremental progress but continued hurdles' understates the achievement and introduces a slightly negative framing not supported by the original answer. The original answer highlights 'notable progress', while the LLM emphasizes ongoing hurdles, which shifts the qualitative interpretation. (4) Despite this, the answer is contextually relevant, cites correct sources, and synthesizes information across two years of filings. The core facts are present and accurate, warranting a correctness score of 7 due to the accurate data but slightly flawed synthesis and tone.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 432,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did the valuation of mutual fund equity securities held by ACN evolve between 2022 and 2023, and what does this shift indicate about the company's investment positioning in this category?",
      "original_answer": "In 2022, ACN reported $239,293 (in millions) in mutual fund equity securities. By 2023, this figure decreased to $196,226 (in millions), indicating a reduction of $43,067 (in millions). This decline suggests a strategic shift or reallocation away from mutual fund equity securities during the period.",
      "llm_answer": "In fiscal 2022 Accenture’s non‑U.S. defined‑benefit plans held mutual‑fund equity securities valued at $239,293 (Level 1 $4,954 + Level 2 $234,339)【page_89】. The 2023 filing does not present a comparable dollar amount, but the company’s 2023 target allocation raises the equity share of non‑U.S. plan assets from 21% in 2022 to 27%【page_88】, indicating a strategic shift toward a higher equity exposure in this investment category.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual inaccuracies and misses the core quantitative shift. While it correctly reports the 2022 value of $239,293 million in mutual fund equity securities (citing Level 1 and Level 2 breakdowns), it incorrectly states that the 2023 filing does not present a comparable dollar amount. In fact, the ground truth confirms that the 2023 value was $196,226 million — a specific and reportable figure. The LLM fails to report this number, which is central to the question. (2) The calculation of the decrease ($43,067 million) is omitted entirely. Instead, the model cites a shift in target allocation (from 21% to 27% equity) as evidence of strategic movement toward higher equity exposure. However, this contradicts the actual decline in mutual fund equity holdings, suggesting either a misinterpretation or conflation of target allocation with actual holdings. The cited percentage change refers to overall equity exposure in non-U.S. plan assets, not specifically mutual fund equities, making it contextually misleading. (3) The multi-hop reasoning is flawed: the model should have compared actual reported values across 2022 and 2023 to assess evolution in valuation, then inferred positioning. Instead, it substitutes actual data with forward-looking targets, breaking the logical chain. (4) Scores reflect major factual omission (missing 2023 value and decline amount), incorrect implication of increased exposure despite a clear decrease in holdings, and failure to synthesize the correct trend. The answer is contextually relevant in discussing investment positioning but fails on core accuracy and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 453,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Chevron's involvement in Angola LNG Limited evolved from 2022 to 2023, particularly in terms of its operational focus and investment emphasis?",
      "original_answer": "In 2022, Chevron operated and held a 36.4% interest in Angola LNG Limited, emphasizing its role in processing and liquefying associated natural gas from multiple fields and operators in Angola. The company was also involved in developing non-associated gas resources to supply the Angola LNG plant. By 2023, Chevron continued to hold the same 36.4% interest, but the disclosure shifted focus to its broader portfolio of equity affiliates and non-equity investments, with Angola LNG Limited being listed alongside other major investments like Tengizchevroil and Chevron Phillips Chemical Company LLC. This indicates a shift in disclosure emphasis from operational development to financial stake and integration within Chevron’s global portfolio.",
      "llm_answer": "In the 2022 filing Chevron’s Angola LNG Limited stake was described in operational terms – a 36.4 % interest in an on‑shore LNG plant that processes associated gas and for which Chevron was still developing non‑associated gas supplies to feed the plant (page 13). By the 2023 filing the emphasis had shifted to the financial side, reporting a lower investment balance ($1.76 billion versus $1.96 billion in 2022) and a steep drop in equity earnings ($513 million versus $1,857 million in 2022) for its Angola LNG investment (page 82), indicating a move from active operational development toward a more investment‑focused stance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Chevron held a 36.4% interest in Angola LNG Limited in both 2022 and 2023, consistent with the original answer. The operational focus in 2022 on processing associated gas and developing non-associated gas supplies is accurately described. In 2023, the shift in disclosure emphasis from operational development to financial metrics is correctly identified. (2) Quantitative accuracy is excellent: the reported investment balance dropped from $1.96 billion in 2022 to $1.76 billion in 2023, and equity earnings fell from $1.857 billion to $513 million—both figures match the ground truth contextually and numerically (minor formatting: $1,857 million = $1.857 billion). These numbers support the conclusion of a shift toward financial emphasis. (3) Multi-hop reasoning is sound: the model correctly synthesized information across two years of filings, comparing operational language in 2022 with financial disclosures in 2023, and inferred a strategic shift in reporting focus. (4) The only minor limitation is that the LLM does not explicitly mention that Angola LNG was grouped with other major equity affiliates like Tengizchevroil and Chevron Phillips Chemical in 2023, which adds context to the portfolio integration point in the original answer. However, the core conclusion about a shift to an investment-focused stance is well-supported and semantically equivalent. Wording differences do not affect factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 419,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did MMM's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what was the magnitude of this change?",
      "original_answer": "In 2022, MMM held $14 million in Certificates of Deposit/Time Deposits, as disclosed in the fair value measurements. By 2023, this amount increased to $49 million, indicating a significant growth in this category of investment. This represents an increase of $35 million, or approximately 250%, from the prior year.",
      "llm_answer": "MMM’s investment in certificates of deposit/time deposits rose from **$21 million at year‑end 2022 to $49 million at year‑end 2023**【page_64】.  That is an increase of **$28 million**, or roughly a 133 % jump in the balance.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. According to the ground truth, MMM held $14 million in Certificates of Deposit/Time Deposits in 2022, not $21 million as stated by the LLM. The 2023 value of $49 million is correct in both answers. Therefore, the dollar increase should be $35 million ($49M - $14M), not $28 million as claimed. The percentage increase is also incorrect: the LLM reports ~133%, but the correct percentage increase is approximately 250% ($35M / $14M). These errors directly impact the core of the question, which asks about the evolution and magnitude of change. (2) Number verification: 2022 value: incorrect (LLM: $21M vs. truth: $14M); 2023 value: correct ($49M); change in dollars: incorrect (LLM: $28M vs. truth: $35M); percentage change: incorrect (LLM: ~133% vs. truth: ~250%). (3) Multi-hop reasoning: The LLM correctly identifies the need to compare two years and calculate the change, showing sound reasoning structure, but the faulty input data (wrong 2022 value) leads to incorrect synthesis. The citation to 'page_64' suggests a source was used, but it conflicts with the verified ground truth. (4) Scores justified as follows: Correctness scored 4 due to partial correctness (right direction, correct 2023 value) but major errors in key figures; Quantitative accuracy is low (4) due to wrong base value and derived calculations; Qualitative accuracy is moderate (6) because the logic and structure are sound, and the entity (MMM, investment type, years) are correct; Contextual relevance is high (9) as the answer addresses the right question with appropriate framing and terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1131,
        "completion_tokens": 458,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of the percentage of franchised restaurants between 2021 and 2024?",
      "original_answer": "In 2021, 93% of McDonald's restaurants were franchised, while by 2024, this percentage increased to approximately 95%. This indicates a slight but deliberate shift toward further reliance on franchisees to operate McDonald's restaurants, reinforcing the company's strategic emphasis on franchising as a core business model.",
      "llm_answer": "In 2021, McDonald’s reported that 37,295 of its 40,031 restaurants – about 93 % – were franchised. By year‑end 2024, that share had risen to roughly 95 % of its 43,477 restaurants, showing a modest increase in the proportion of franchised locations.【page_3】【page_3】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: in 2021, 37,295 of 40,031 restaurants equals approximately 93%, and by 2024, the franchised share rose to roughly 95% of 43,477 total restaurants, which aligns with the stated trend. (2) The answer is complete, addressing both the starting and ending percentages and the overall trend between 2021 and 2024. (3) Entity accuracy is correct—McDonald's is the subject, and the years (2021 and 2024) and metric (percentage of franchised restaurants) are properly identified. (4) The reasoning is sound: the LLM correctly infers a modest increase in the proportion of franchised locations, reflecting a strategic shift consistent with the original answer’s interpretation. Minor wording differences (e.g., 'modest increase' vs 'slight but deliberate shift') do not affect semantic equivalence—the core message about increased reliance on franchising is preserved. All multi-hop elements (comparing two time points, calculating proportions, interpreting trend) are handled accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1144,
        "completion_tokens": 312,
        "total_tokens": 1456
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the effective date and structure of the 2015 Stock Compensation Plan for Non-Employee Directors evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was described as 'amended and restated effective March 31, 2021.' By 2023, the plan was further amended and restated, with a new effective date of 'October 26, 2022.' This indicates that the plan underwent at least one additional amendment during the 2022–2023 period, reflecting a structural or procedural update to the plan’s terms.",
      "llm_answer": "In the 2022 Form 10‑K the “2015 Stock Compensation Plan for Non‑Employee Directors” was described as an amendment‑and‑restatement **effective March 31 2021** (see Exhibit 10.21) and the plan provided **703,256 shares** for future issuance (Item 12)【page_117】【page_114】.  \n\nIn the 2023 Form 10‑K the same plan was updated to an amendment‑and‑restatement **effective October 26 2022** (see Exhibit 10.22) and the share pool was reduced to **approximately 589,927 shares** (Item 12)【page_110】【page_107】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and provides more detailed information than the original ground truth. (1) All factual elements are correct: the effective dates of the plan amendments—March 31, 2021 (as reported in 2022) and October 26, 2022 (as reported in 2023)—are correctly stated. (2) Quantitative accuracy is perfect: the share counts (703,256 in 2022 and ~589,927 in 2023) are accurately reported with correct directional change (reduction), even though the original answer did not include share numbers. These figures support the conclusion of a structural update. (3) The multi-hop reasoning is sound—information is correctly synthesized across two years of Form 10-K filings, linking the plan’s evolution over time. (4) The answer exceeds the ground truth in detail by including share authorization data, which strengthens the explanation of structural changes. The only reason for not scoring a 10 is that the original ground truth did not mention share amounts, so while the added detail is correct and useful, it slightly exceeds the scope of the specific evolution asked (effective date and structure). However, the share pool change is a valid part of structural evolution, so the response remains semantically aligned and highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 350,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did Accenture's financial relationship with Duck Creek Technologies evolve between fiscal years 2022 and 2023, particularly in terms of investment valuation and reported financial impact?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with a carrying amount of $138,902, and was accounted for using the equity method. By fiscal 2023, the investment resulted in a $253 million gain, which was specifically called out in the financial statements as impacting the adjusted earnings per share and effective tax rate calculations. This indicates a shift from a long-term equity stake to a more active financial realization event.",
      "llm_answer": "In fiscal 2022 Accenture’s 16 % equity‑method stake in Duck Creek Technologies was carried at $138.9 million, with an estimated fair value of about $223.2 million (page 70). By fiscal 2023 the company recorded a $253 million investment gain on that stake, reflecting a sizable appreciation and a material positive impact on earnings (page 40).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts: Accenture's 16% ownership in Duck Creek Technologies, the $138.9 million carrying amount (vs. $138,902 in original, rounded appropriately), the fair value of $223.2 million (vs. $223,166, minor rounding difference), and the $253 million gain in fiscal 2023. These numeric values are accurate within acceptable formatting and rounding variations. (2) Quantitative accuracy is excellent—dollar amounts, percentages, and fiscal years match the ground truth. The LLM correctly identifies the equity method, carrying amount, fair value, and the realized gain. (3) The reasoning is sound: it captures the evolution from a long-term equity investment in 2022 to a significant financial gain in 2023, indicating a shift in financial relationship. The answer implies the material impact on earnings, aligning with the original answer’s mention of impact on adjusted EPS and tax rate, though it does not explicitly state that the gain affected the effective tax rate or adjusted EPS calculations. This is a minor omission. (4) Contextual relevance is high—the response directly addresses the evolution of the financial relationship, investment valuation, and financial impact. The only reason for not scoring a 10 is the slight lack of specificity around the gain’s impact on adjusted EPS and tax rate, which were explicitly mentioned in the original answer and are important for full multi-hop synthesis. Overall, the answer is factually correct, well-synthesized, and semantically equivalent with only minor contextual omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 435,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has the therapeutic application of Breyanzi evolved between 2022 and 2024, and what specific new indications were approved in 2024 that expand its market potential?",
      "original_answer": "In 2022, Breyanzi was indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. By 2024, Breyanzi received two new approvals: in March 2024 for the treatment of adult patients with relapsed or refractory CLL or SLL who have received at least two prior lines of therapy, and in May 2024 for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) who have received at least two prior lines of systemic therapy. These new indications significantly expand the patient populations eligible for Breyanzi treatment.",
      "llm_answer": "In the 2022 filing Breyanzi was described as a CD19‑directed CAR‑T therapy approved only for adult patients with relapsed or refractory large B‑cell lymphoma after ≥ two prior lines of systemic therapy【page_72】. By 2024 the product had added several new B‑cell‑malignancy indications – FDA accelerated approvals for relapsed or refractory follicular lymphoma (May 2024)【page_45】, CLL/SLL (March 2024)【page_45】 and mantle‑cell lymphoma (May 2024)【page_45】, plus a Japanese approval for high‑risk follicular lymphoma after one prior line (August 2024)【page_44】 – expanding Breyanzi’s market to multiple B‑cell cancers and earlier lines of therapy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2022 indication and two of the 2024 approvals — follicular lymphoma (FL) in May 2024 and CLL/SLL in March 2024 — which aligns with the ground truth. However, it introduces a significant factual error by claiming an approval for mantle cell lymphoma (MCL) in May 2024, which is not present in the original answer or supported by the ground truth. Additionally, it mentions a Japanese approval for high-risk FL after one prior line in August 2024, which expands beyond the scope of the original answer and is not corroborated by the provided truth. (2) Dates for the CLL/SLL (March 2024) and FL (May 2024) approvals are accurate and match the ground truth. However, the addition of MCL and the Japanese approval introduces incorrect dates and regulatory events, reducing quantitative accuracy. The mention of 'accelerated approvals' and specific months is plausible but not confirmed in the ground truth, which only states approvals without specifying 'accelerated' status. (3) The reasoning correctly synthesizes the expansion of indications over time and captures the multi-hop nature of the question — comparing 2022 to 2024 and identifying new patient populations. However, the inclusion of unverified indications (MCL, Japan) reflects a failure in accurate information synthesis, possibly due to overextrapolation or hallucination. (4) The answer is contextually relevant and well-structured, addressing both the evolution and market expansion. Despite the extra, incorrect approvals, the core correct additions (CLL/SLL and FL) support a moderate correctness score. The answer would have scored higher if not for the unsupported claims that materially affect factual reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 471,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has 3M's approach to estimating and recording insurance receivables related to legal proceedings under ASC 450 evolved between 2022 and 2023, particularly in relation to respirator mask/asbestos litigation?",
      "original_answer": "In 2022, 3M referenced its compliance with ASC 450 for recording liabilities related to legal proceedings but did not specifically mention the methodology for estimating insurance receivables. By 2023, the company explicitly described applying the loss recovery and/or gain contingency models under ASC 450 and ASC 610-30 to estimate insurance receivables, including analysis of policy terms, case law, and claim nature. Additionally, the number of individual claimants in respirator mask/asbestos litigation increased from approximately 4,028 in 2022 to 4,042 in 2023, indicating a growing exposure that likely influenced the more detailed approach to insurance receivables in 2023.",
      "llm_answer": "In the 2022 filing 3M only described its ASC 450 practice for accruing legal‑liability losses – it noted that it records a liability when a loss is probable and reasonably estimable, but it gave no separate discussion of how it estimates or records insurance recoveries for those claims. By the 2023 filing the company added a distinct “Process for Disclosure and Recording of Insurance Receivables Related to Legal Proceedings,” explaining that it now analyzes policy terms, exclusions, relevant case law and its own experience to determine a recognizable insurance‑receivable amount under ASC 450 (and ASC 610‑30). The 2023 note also discloses that, for the respirator‑mask/asbestos litigation, the company has an immaterial insurance‑receivable balance and continues to pursue coverage, showing a more granular, policy‑driven and transparent approach than in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, 3M discussed ASC 450 for recording legal liabilities but did not detail its approach to insurance receivables, and that in 2023, it introduced a more explicit methodology involving ASC 450 and ASC 610-30, including analysis of policy terms, case law, and claim nature—this matches the original answer. (2) There are no numeric discrepancies; while the original answer includes the number of claimants (4,028 in 2022, 4,042 in 2023), the LLM answer omits this specific data point but does not contradict it. The absence of this quantitative detail prevents a perfect score, though the omission does not impair the core explanation of the evolution in accounting approach. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in disclosure practices between two years, links them to specific accounting standards, and contextualizes the increased transparency in relation to ongoing litigation. (4) The LLM adds value by noting the immateriality of the insurance receivable balance in 2023 and continued pursuit of coverage, which is consistent with the spirit of the original answer’s implication of growing exposure influencing disclosure. This suggests deeper insight without introducing error. Overall, the answer is factually correct, contextually relevant, and semantically equivalent, with only minor incompleteness regarding the claimant count.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 409,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did PepsiCo's relationship with Naked evolve between 2022 and 2023, particularly in terms of its operational involvement and financial stake?",
      "original_answer": "In 2022, PepsiCo sold its Tropicana, Naked, and other select juice brands to PAI Partners while retaining a 39% noncontrolling interest in a newly formed joint venture, The Beachbody Company (TBG), which operates across North America and Europe. Additionally, PepsiCo acted as the exclusive distributor for TBG's portfolio of brands, including Naked, for small-format and foodservice customers via chilled direct-store-delivery. By 2023, PepsiCo no longer directly distributed Naked products and instead primarily disclosed its relationship through its retained 39% noncontrolling interest in TBG, with no further operational involvement in the distribution of Naked products. This represents a shift from active distribution to a purely financial stake.",
      "llm_answer": "In 2022 PepsiCo sold the Naked juice brand (along with Tropicana) to PAI Partners, but kept a 39 % non‑controlling interest in the new Tropicana Brands Group (TBG) and became the exclusive U.S. distributor for TBG’s portfolio—including Naked—through chilled direct‑store‑delivery (DSD) [PEP_10k_2022 page 8]. The 2023 filing repeats that PepsiCo still holds the 39 % non‑controlling stake in TBG and continues to act as the exclusive distributor for the joint‑venture’s brands, showing no change in either its operational role or its financial ownership of Naked between 2022 and 2023 [PEP_10k_2023 page 5].",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core conclusion about PepsiCo's operational involvement in 2023. While it correctly states that in 2022, PepsiCo sold Naked to PAI Partners and retained a 39% noncontrolling interest in TBG while becoming the exclusive distributor for TBG’s brands including Naked via chilled DSD, it incorrectly claims that this distribution role continued into 2023. The ground truth explicitly states that by 2023, PepsiCo no longer directly distributed Naked products and had ceased operational involvement, maintaining only the 39% financial stake. This misrepresents a key evolution in the relationship. (2) Quantitatively, the 39% noncontrolling interest is correctly cited in both years, and the years (2022, 2023) are accurate. The numeric and percentage data are correct, hence a score of 8 for quantitative accuracy—minor deduction only because the implication of unchanged status affects interpretation of the stake’s context. (3) The multi-hop reasoning fails: the model should have contrasted the 2022 operational role with the 2023 disclosure to identify the shift from operational to financial-only involvement. Instead, it asserts no change, which contradicts the ground truth. Entity names (PAI Partners, TBG, Naked, Tropicana) are mostly correct, though 'Tropicana Brands Group' is used informally and not confirmed as the official name in the knowledge graph. (4) Contextual relevance is moderate—the answer addresses the financial stake and distribution role as asked, but due to the critical error in portraying continuity rather than change, the overall correctness score is low at 3. The answer captures part of the truth but misses the central transformation in the relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 475,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the accounting treatment or disclosure around the ExtraBucks Rewards program evolved between 2023 and 2024, particularly regarding the recognition of revenue and the determination of performance obligations?",
      "original_answer": "In 2023, the ExtraBucks Rewards program was described as creating an additional performance obligation at the time of the initial transaction, with revenue allocated based on relative standalone selling prices that consider historical redemption patterns. Revenue was recognized as the rewards were redeemed, and unredeemed rewards were reflected as a contract liability. In 2024, the disclosure remained consistent in terms of revenue recognition timing and contract liability treatment, but the language around performance obligations became more refined, emphasizing that the determination of an additional performance obligation was specifically tied to customers who accumulate ExtraBucks based on historical spending levels. The 2024 filing also included more structured language around how the Company allocates transaction prices and evaluates standalone selling prices, suggesting a more mature and formalized approach to the program’s accounting treatment.",
      "llm_answer": "In the 2023 filing (see page 131 & 133) CVS said that ExtraBucks Rewards are a **separate performance obligation** at the time of the original purchase; the transaction price is allocated between the sale and the rewards based on their relative standalone selling price, revenue for the rewards is recognized **only when the rewards are redeemed**, and any un‑redeemed balance is recorded as a contract liability (breakage is recognized only for gift cards).  \n\nThe 2024 filing (see page 125 & 126) repeats the same treatment—ExtraBucks Rewards remain a distinct performance obligation, revenue is allocated and recognized upon redemption, and unredeemed rewards stay on the contract‑liability balance—while providing a more detailed breakdown of the liability changes (including acquisition‑related adjustments) but **no substantive change** to the underlying revenue‑recognition policy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in both 2023 and 2024, ExtraBucks Rewards are treated as a separate performance obligation, revenue is allocated based on relative standalone selling prices, recognized upon redemption, and unredeemed amounts are recorded as contract liabilities. The LLM correctly notes no substantive change in policy between years. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable in that sense—however, the LLM accurately references page numbers (131, 133 in 2023; 125, 126 in 2024), which supports traceability and does not contradict the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosures across two years and identifies consistency in accounting treatment while noting enhanced detail in 2024 (e.g., more structured disclosure around liability changes and acquisition-related adjustments). (4) The only minor shortcoming is that the LLM does not explicitly mention the 2024 refinement regarding customers who accumulate ExtraBucks based on historical spending levels, nor the emphasis on a more formalized approach to standalone selling price evaluation—details present in the ground truth. However, the phrase 'more detailed breakdown of the liability changes' captures part of this nuance. Thus, while slightly less comprehensive than the original answer, the LLM conveys substantively equivalent information with high fidelity. Scores reflect strong performance with a small deduction in qualitative accuracy for missing subtle but relevant elaboration in 2024 disclosures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1480,
        "completion_tokens": 468,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Netflix's reliance on integrated payment partners evolved between 2023 and 2024, based on the specific details provided in the cost of revenues section for each year?",
      "original_answer": "In 2023, Netflix specifically mentioned that payment processing fees paid to integrated payment partners were part of other operating costs within the cost of revenues. In 2024, the company continued to reference payment processing fees paid to integrated payment partners as part of other operating costs, but the overall structure of the cost of revenues section was streamlined, removing some of the granular details about these fees. This indicates that while the relationship persisted, the level of explicit detail about the financial impact of integrated payment partners decreased, suggesting a shift in disclosure strategy rather than a substantive discontinuation of the relationship.",
      "llm_answer": "Both the 2023 and 2024 cost‑of‑revenues disclosures list “payment‑processing fees, including those we pay to our integrated payment partners” as a line‑item within other operating costs. However, neither filing calls out a material change in those fees—in 2024 the cost‑of‑revenues rise is attributed mainly to higher content amortization, while the 2023 increase is tied to content‑related expenses—so Netflix’s reliance on integrated payment partners appears essentially unchanged between the two years.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in stating that payment-processing fees, including those paid to integrated payment partners, were included in other operating costs in both 2023 and 2024, which aligns with the ground truth. There are no numeric inaccuracies, and the entities (Netflix, integrated payment partners, cost of revenues, years 2023 and 2024) are correctly identified—hence a high quantitative accuracy score. However, the LLM misses a key qualitative shift emphasized in the original answer: the 2024 filing streamlined the cost of revenues section and reduced granular disclosure about these fees, indicating a change in disclosure strategy. The LLM interprets the continued mention of the line item as evidence of unchanged reliance, but it fails to recognize that the reduced detail represents an evolution in how Netflix reports its reliance, even if the operational relationship persists. This omission affects the depth of the multi-hop reasoning, as the question asks about the evolution of reliance 'based on the specific details provided,' which includes disclosure changes. While the answer is contextually relevant and correctly identifies the surface-level consistency, it does not fully capture the nuanced evolution in transparency, leading to a moderate correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 369,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has 3M's approach to managing PFAS contamination in Minnesota evolved from 2022 to 2023, particularly in response to regulatory changes and new health-based standards?",
      "original_answer": "In 2022, 3M had substantially completed remediation work at the Cottage Grove site and was continuing operational and maintenance activities at Oakdale and Woodbury sites in Minnesota under the May 2007 Settlement Agreement and Consent Order. The company was also addressing PFAS discharges at its Decatur, Alabama facility under a 2020 interim Consent Order with ADEM, which included obligations for on-site and off-site investigations and future capital improvements. By 2023, the Minnesota Department of Health issued updated, more stringent Health Based Values (HBVs) for PFOA and PFOS in January 2024, prompting 3M to evaluate the potential impact on its obligations under the SACO. Additionally, MPCA issued a Notice of Violation in March 2023 alleging PFAS in stormwater discharge at 3M’s Hutchinson facility, and in December 2022, MPCA issued an order addressing stormwater from the Cottage Grove facility. In January 2024, MPCA proposed a new Clean Water Act permit for Cottage Grove with significantly revised, often below-quantification-level limits on PFAS, indicating a tightening regulatory environment that 3M is actively engaging with.",
      "llm_answer": "In 2022 3M’s Minnesota program was focused on meeting the May 2007 Settlement Agreement and Consent Order – it had completed remediation at the Oakdale and Woodbury sites, substantially finished work at the Cottage Grove plant and was addressing MPCA‑directed storm‑water PFAS issues through a remediation plan and a December 2022 order 【page_127】. By 2023 the company was responding to a new MPCA Notice of Violation for storm‑water PFAS discharges at Cottage Grove, submitted a written corrective‑action response, and began negotiating a draft Clean Water Act permit that imposes far tighter PFAS limits (some below the limit of quantification) while also evaluating the impact of the Minnesota Department of Health’s newly‑issued, more stringent health‑based values for PFOA and PFOS 【page_99】【page_98】. This marks a shift from completing remediation to actively managing compliance with stricter regulatory limits and updated health‑based standards.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key developments in 3M's approach to PFAS contamination in Minnesota from 2022 to 2023, with accurate synthesis of regulatory changes and company responses. (1) Correct elements include: reference to the May 2007 Settlement Agreement and Consent Order; substantial completion of remediation at Cottage Grove; ongoing operational activities at Oakdale and Woodbury; the December 2022 MPCA order for Cottage Grove; the March 2023 Notice of Violation (though misattributed to Cottage Grove instead of Hutchinson); engagement with stricter PFAS limits under a proposed Clean Water Act permit; and evaluation of new health-based values (HBVs) issued by the Minnesota Department of Health in January 2024. (2) Quantitative accuracy is high: all dates (December 2022, January 2024, March 2023) are correctly cited, and the sequence of regulatory actions aligns with the ground truth. The only error is the misattribution of the March 2023 Notice of Violation to Cottage Grove instead of the Hutchinson facility, which is a factual inaccuracy affecting entity-location mapping. (3) Multi-hop reasoning is sound—LLM connects 3M’s evolving compliance strategy to updated regulations and health standards, showing a shift from remediation completion to proactive regulatory engagement. However, the omission of Decatur, Alabama context (mentioned in ground truth) is a minor gap, though not directly relevant to Minnesota focus. (4) The answer is contextually excellent, directly addressing the evolution in 3M’s approach in response to regulatory and health standard changes. The mislocation of the NOV prevents a 9–10 on correctness, but core facts, dates, and synthesis remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 468,
        "total_tokens": 2000
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did PepsiCo's use of foreign currency derivatives evolve between 2022 and 2023, and what does this indicate about its foreign exchange risk management strategy?",
      "original_answer": "In 2022, PepsiCo reported a total notional value of $3.0 billion for its foreign currency derivatives, while in 2023, this value increased to $3.8 billion. This indicates a strategic expansion in the use of foreign currency derivatives to manage foreign exchange risk, likely in response to increased exposure or volatility in international markets. Additionally, the company emphasized the use of these derivatives to offset changes in the underlying hedged items, resulting in no material net impact on earnings in 2023.",
      "llm_answer": "PepsiCo’s foreign‑currency derivative program grew from a $3.0 billion notional amount at the end of 2022 to $3.8 billion at the end of 2023, with net‑investment hedges rising from $2.9 billion to $3.0 billion and the fair‑value of its foreign‑exchange hedges increasing from about $88 million to $105 million (cash‑flow hedges $46 million → $34 million and non‑designated hedges $42 million → $71 million)【page_103】【page_105】. This expansion and the broader mix of cash‑flow and non‑designated contracts illustrate a more active, comprehensive foreign‑exchange risk‑management approach that relies on derivatives—including net‑investment hedges—to offset currency exposure rather than for speculative purposes【page_104】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in PepsiCo's total notional value of foreign currency derivatives from $3.0 billion in 2022 to $3.8 billion in 2023, matching the ground truth. It adds more granular detail not present in the original answer—such as breakdowns by hedge type (net-investment, cash-flow, non-designated) and fair-value changes—which are consistent with typical 10-K disclosures and do not contradict the ground truth. These additional figures ($2.9B → $3.0B net-investment hedges, $88M → $105M fair value, etc.) are plausible and supported by citation to specific pages, though they go beyond the scope of the ground truth. (2) All cited numbers are quantitatively accurate or reasonably inferred extensions of the core fact. The primary metric (total notional value) is correct, and no calculation errors are present. The LLM does not misstate any figures from the ground truth. (3) The reasoning is sound: the model correctly infers that the increase in notional value and diversification of hedge types indicate a more active and comprehensive risk management strategy, aligning with the ground truth’s conclusion about strategic expansion. It appropriately emphasizes hedging for risk mitigation rather than speculation, consistent with the original answer’s point about 'no material net impact on earnings.' (4) The answer is semantically equivalent and even exceeds the original in depth, while maintaining factual alignment. The only reason for not scoring a 10 is that the original answer emphasizes the 'no material net impact on earnings' outcome in 2023, which the LLM mentions indirectly via purpose ('to offset currency exposure') but does not explicitly state as a result. Otherwise, the response is fully relevant, accurate, and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 490,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has ExxonMobil's approach to capitalizing on improving living standards evolved between 2022 and 2023, particularly in terms of chemical production capacity additions and geographic focus?",
      "original_answer": "In 2022, ExxonMobil highlighted the completion of a joint venture ethane cracker near Corpus Christi, Texas, and plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown, Texas, by 2026, as part of its strategy to meet growing demand driven by improving living standards. By 2023, the company shifted focus toward expanding performance polymers and linear alpha olefins capacity in Baytown, Texas, and advancing a 100% foreign-owned petrochemical complex in Dayawan, China, with over 2.5 million metric tons per year of polyethylene and polypropylene capacity. This reflects a strategic evolution from domestic advanced recycling and integrated U.S. projects to high-performance product expansions and significant foreign investment in China to meet local demand.",
      "llm_answer": "In the 2022 filing ExxonMobil emphasized building new chemical capacity – completing an ethane‑cracker joint‑venture near Corpus Christi and restarting Gulf‑Coast projects in Baytown, Texas and Baton Rouge, Louisiana – while also taking a final investment decision on a multi‑billion‑dollar, fully foreign‑owned petrochemical complex in the Dayawan park in Guangdong, China (2022 p. 67). By 2023 the company had moved from construction to operation, launching a 400 k‑t/yr performance‑polymers line and a 350 k‑t/yr linear‑alpha‑olefins unit in Baytown, Texas, and continued to invest in the Dayawan complex that will house >2.5 m t/yr of polyethylene and polypropylene capacity, showing a shift to operating new capacity while maintaining a dual US‑China geographic focus (2023 p. 59).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core strategic evolution from 2022 to 2023 correctly, noting the shift toward high-performance polymers and continued investment in China. However, there are key quantitative inaccuracies. In 2022, the original answer specifies plans for up to 500,000 metric tons annually of advanced recycling capacity in Baytown by 2026, which the LLM omits entirely. Instead, the LLM incorrectly states that ExxonMobil restarted Gulf Coast projects in Baytown and Baton Rouge in 2022, which is not in the ground truth. (2) For 2023, the LLM reports launching a 400 k-t/yr performance polymers line and a 350 k-t/yr linear alpha olefins unit, totaling 750,000 metric tons. While this aligns broadly with the original answer’s mention of expanding performance polymers and linear alpha olefins in Baytown, the specific capacities (400k and 350k) are not in the ground truth, which does not provide exact figures. The >2.5 million metric tons/year polyethylene and polypropylene capacity in Dayawan, China, is correctly reported. (3) The multi-hop reasoning is sound in identifying the strategic shift from domestic U.S. projects (ethane cracker) to operating high-performance units and advancing a foreign-owned complex in China. The dual US-China focus is correctly synthesized across years. However, the LLM introduces unverified details (e.g., restart of Baton Rouge, exact capacity numbers) not present in the original, weakening factual accuracy. (4) The contextual relevance is high as the answer directly addresses the evolution in strategy, geographic focus, and capacity additions. Qualitative accuracy is strong due to correct entity identification (ExxonMobil, Baytown, Dayawan, China, performance polymers, etc.) and logical reasoning. Quantitative accuracy is lower due to unsupported capacity figures and omission of the 500k advanced recycling plan. Correctness score is 7 because the core strategic narrative is accurate, but key factual omissions and additions reduce full fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 545,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did 3M's investment in Certificates of Deposit/Time Deposits evolve from 2022 to 2023, and what does this shift indicate about the company's short-term investment strategy?",
      "original_answer": "In 2022, 3M held $21 million in Certificates of Deposit/Time Deposits, which increased to $49 million in 2023 — more than doubling. This indicates a strategic shift toward increasing liquidity or reallocating short-term cash holdings into more stable or higher-yielding instruments within this category.",
      "llm_answer": "3M’s holdings of certificates of deposit / time deposits more than doubled, rising from **$21 million at year‑end 2022 to $49 million at year‑end 2023**【page_64】.  At the same time, its commercial‑paper balance fell to zero, showing the company is moving cash into safer, highly liquid short‑term assets rather than higher‑risk paper—an indication of a more conservative, liquidity‑focused short‑term investment strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the quantitative evolution of 3M's Certificates of Deposit/Time Deposits: $21 million in 2022 increasing to $49 million in 2023, which is accurate and matches the ground truth. The claim that this represents more than doubling is correct (49/21 ≈ 2.33x). 2) The numbers, years, and units are precisely accurate with no calculation or formatting errors. The citation to page_64 supports the data. 3) The reasoning is sound and adds value: the LLM correctly infers a strategic shift in short-term investment behavior, noting the drop in commercial paper to zero, which is consistent with a more conservative, liquidity-focused strategy. While the original answer does not mention commercial paper, this additional context is factually aligned and strengthens the conclusion about increased conservatism. 4) The answer fully addresses both parts of the question: the quantitative evolution and the strategic implication. The interpretation ('safer, highly liquid short-term assets') is semantically equivalent to the ground truth's 'increasing liquidity or reallocating into more stable or higher-yielding instruments.' The only minor difference is that the original answer allows for the possibility of higher yield as a motive, while the LLM emphasizes safety and risk reduction. This is a nuanced difference in emphasis, not a factual error. Thus, the answer is highly accurate, complete, and contextually appropriate, warranting a 9/10 due to slight interpretive expansion beyond the ground truth without contradicting it.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 426,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Mastercard's approach to proprietary insights evolved from 2022 to 2023, particularly in terms of data responsibility and trust-building language?",
      "original_answer": "In 2022, Mastercard described its proprietary insights as being based on the 'principled use of consumer and merchant data.' By 2023, the language evolved to emphasize 'principled and responsible use of secure consumer and merchant data.' This shift indicates a stronger emphasis on data security and trust as a core component of their proprietary insights strategy. The change in phrasing reflects a broader narrative around cybersecurity and stakeholder confidence in how Mastercard manages sensitive data.",
      "llm_answer": "In the 2022 Form 10‑K Mastercard described its value‑added services as providing “proprietary insights, drawing on Mastercard’s **principled use of consumer and merchant data**” and framed the offering as helping parties “transact easily and with confidence”【page_71】. By the 2023 filing the language had been sharpened to say the insights come from “**principled and responsible use of secure consumer and merchant data**,” explicitly highlighting data responsibility and security as part of its trust‑building narrative【page_49】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately captures the evolution in Mastercard's language around proprietary insights from 2022 to 2023: from 'principled use of consumer and merchant data' in 2022 to 'principled and responsible use of secure consumer and merchant data' in 2023. The key additions—'responsible' and 'secure'—are correctly identified and contextualized as part of a trust-building narrative. (2) There are no numerical values to verify, but the years (2022 and 2023) and document references (Form 10-K) are accurate. (3) The multi-hop reasoning is sound: the model correctly compares language across two annual filings, identifies the shift in phrasing, and interprets the strategic implication—enhanced emphasis on data responsibility, security, and trust. (4) The answer is semantically equivalent to the original, with added value from direct quotes and page references that enhance credibility. All aspects of the question—evolution of approach, data responsibility, and trust-building language—are thoroughly and accurately addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 313,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did the factors influencing the accounting estimates for pension and retiree medical plans evolve between 2022 and 2023, and what does this indicate about the changing external environment affecting these plans?",
      "original_answer": "In 2022, the accounting estimates for pension and retiree medical plans were influenced by uncertainties related to the ongoing impacts of the COVID-19 pandemic. By 2023, this had evolved, and the estimates were instead influenced by business and economic uncertainty stemming from the ongoing conflicts in Ukraine and the Middle East, as well as a high interest rate and inflationary cost environment. This indicates a shift in the external risk factors affecting the company's pension and retiree medical plans from health-related disruptions to broader macroeconomic and geopolitical concerns.",
      "llm_answer": "In the 2022 filing PepsiCo said that the assumptions underlying its pension and retiree‑medical plan estimates were driven mainly by “uncertainties, including those related to the COVID‑19 pandemic” (PEP_10k_2022.pdf page 59). By the 2023 filing the company’s discussion of the same critical accounting policies shifted to “business and economic uncertainty resulting from the ongoing conflicts in Ukraine and the Middle East and the high‑interest‑rate and inflationary‑cost environment” (PEP_10k_2023.pdf page 57). This change shows that the external environment affecting the plans has moved from a pandemic‑focused risk to a broader mix of geopolitical tension and macro‑economic pressures, which are likely to alter discount‑rate, inflation and health‑cost assumptions used in the actuarial estimates.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately identifies the shift in factors influencing accounting estimates: from 'uncertainties related to the COVID-19 pandemic' in 2022 to 'business and economic uncertainty resulting from the ongoing conflicts in Ukraine and the Middle East and the high-interest-rate and inflationary-cost environment' in 2023. The wording is directly supported by citations to the respective 10-K filings (PEP_10k_2022.pdf page 59 and PEP_10k_2023.pdf page 57), which aligns with the original answer. (2) There are no numerical values (e.g., percentages, dollar amounts) in the question or ground truth, so quantitative accuracy is not applicable—however, the LLM correctly avoids introducing any incorrect figures. (3) The multi-hop reasoning is sound: it synthesizes information across two years of filings for the same company (PepsiCo), correctly identifies the evolution in disclosed risk factors, and draws a valid conclusion about the changing external environment—from pandemic-related health risks to broader macroeconomic and geopolitical pressures. (4) The LLM adds slight interpretive depth (e.g., mentioning 'discount-rate, inflation and health-cost assumptions') that is contextually appropriate and consistent with actuarial practices, without overreaching or introducing inaccuracies. All entities (PepsiCo, correct years, correct plan types) are accurately referenced. The answer is semantically equivalent to the ground truth and fully addresses both parts of the question: the evolution of factors and what it indicates about the external environment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 447,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has ExxonMobil's undeveloped acreage position in the Other Americas region evolved between 2022 and 2023, and what does this indicate about the company's exploration potential in that region?",
      "original_answer": "ExxonMobil's undeveloped acreage in the Other Americas region decreased from 25,096 gross and 11,977 net thousands of acres in 2022 to 24,221 gross and 11,548 net thousands of acres in 2023. This indicates a reduction in the total acreage under evaluation, suggesting that some properties may have been relinquished or transitioned to developed status, while the company continues to focus on properties with higher exploration potential.",
      "llm_answer": "ExxonMobil’s undeveloped land in the Other Americas fell from 25,196 gross (11,977 net) thousand acres at year‑end 2022 to 24,221 gross (11,548 net) thousand acres at year‑end 2023 – a drop of about 875 gross and 429 net thousand acres (XOM 2023 10‑K, page 24, footnote 1). The modest decline implies the company is converting or relinquishing a small slice of its inventory while still retaining a large undeveloped base, signalling that significant exploration upside remains in the region.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 gross and net acreage (24,221 gross, 11,548 net) and the 2022 net acreage (11,977 net), but reports 25,196 gross acres for 2022 instead of the correct 25,096 — a 100,000-acre error. This affects the stated drop of 'about 875 gross' thousand acres, which should be 875 only if starting from 25,096; the actual difference is 25,096 - 24,221 = 875, so the calculation is correct if the input were right, but the input is wrong. Thus, the gross acreage figure is inaccurate, though net figures and their difference (11,977 - 11,548 = 429) are correct. (2) The calculation of the net decrease (429 thousand acres) is accurate. The gross decrease is misstated due to the incorrect starting value: LLM uses 25,196 - 24,221 = 975, but reports 'about 875', which is inconsistent — likely a typo or miscalculation. The correct gross decrease is 875 (25,096 - 24,221), so while the intended number is right, the input data is flawed. (3) The reasoning is sound: the answer correctly infers that the decline suggests conversion or relinquishment while maintaining a large undeveloped base, aligning with the ground truth's interpretation of ongoing exploration potential. It synthesizes the implication from the data accurately. (4) The answer addresses both parts of the question — the evolution of acreage and its implication — and uses appropriate context from the 10-K. Despite the gross acreage error, the overall message is consistent with the ground truth. The quantitative accuracy is penalized for the incorrect 2022 gross figure and miscalculation inconsistency, but qualitative and contextual scores remain high due to correct logic and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 465,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How did the treatment and financial impact of non-functional currency denominated items evolve from 2022 to 2023, particularly in terms of the use of foreign currency contracts not designated in hedging relationships?",
      "original_answer": "In 2022, MMM used foreign exchange forward and option contracts not designated in hedging relationships to offset the impacts of changes in value of various non-functional currency denominated items, including certain intercompany financing balances, with a gross notional amount of $3.7 billion. By 2023, the company continued to use such contracts for the same purpose but shifted focus to derivatives not designated as hedging instruments, with fair value gains and losses directly impacting earnings. This indicates a shift from primarily designated hedging strategies to a more direct financial exposure management approach.",
      "llm_answer": "The company kept the same accounting approach – foreign‑currency forwards and options that are **not** placed in cash‑flow or fair‑value hedges are recorded at fair value and any gain or loss is taken directly to earnings 【page 45 (2022 10‑K)】. In 2023 the exposure to these non‑designated contracts fell sharply (gross notional $1.0 bn versus $2.8 bn in 2022) and the earnings impact improved, moving from a $76 million loss in 2022 to only a $9 million loss in 2023 【page 76 (2023 10‑K) – gain/loss table and notional amounts】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in key quantitative figures and misrepresents the evolution of MMM's strategy, despite correctly identifying the accounting treatment. (1) Quantitative Accuracy: The gross notional amounts are incorrect—LLM states $1.0 billion in 2023 and $2.8 billion in 2022, whereas the ground truth reports $3.7 billion in 2022 and does not specify 2023 notional value. The loss figures ($76M in 2022 and $9M in 2023) are not present in the original answer and contradict the ground truth, which does not mention specific gains or losses. These numbers appear fabricated or misattributed. (2) Completeness: The LLM fails to capture the core evolution described in the original answer—the strategic shift from designated hedging relationships to non-designated derivatives for managing non-functional currency items. Instead, it incorrectly implies continuity in approach while focusing on a reduction in exposure, which is not supported by the ground truth. (3) Entity Accuracy: The company (MMM) and instruments (foreign exchange forwards/options not designated in hedging) are correctly identified, and the years (2022, 2023) are accurate. (4) Reasoning: The multi-hop synthesis is flawed—the original answer emphasizes a qualitative shift in strategy (from hedging to direct exposure management), while the LLM focuses on unverified quantitative reductions and earnings impacts. This misaligns with the actual evolution described. (5) Semantic Equivalence: While the LLM discusses non-designated contracts and their accounting treatment (fair value through earnings), it introduces unsupported data and misses the central strategic shift, leading to a materially different conclusion. The contextual relevance is high as it addresses foreign currency contracts and financial impact, but correctness is low due to critical number errors and mischaracterization of the strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 519,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the role and emphasis of Cyber and Intelligence Solutions evolved within Mastercard's value proposition between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were mentioned as part of a broader list of value-added services, grouped alongside consulting fees, loyalty programs, gateway services, and other payment-related offerings. This suggests a supporting role within the company's portfolio. By 2023, the Cyber and Intelligence Solutions were more prominently positioned as a core component of Mastercard’s value proposition, explicitly described as enabling secure, easy, and confident transactions across the global payments ecosystem. This indicates a strategic shift toward elevating the importance of cybersecurity within Mastercard’s overall service offering.",
      "llm_answer": "In the 2022 filing, cyber‑and‑intelligence solutions were mentioned only as one line item among a broad set of “other value‑added services” (e.g., batch and real‑time payments, consulting, loyalty, gateway services) and were bundled with $1.3 billion of unsatisfied performance obligations for those services【page_81】. By the 2023 filing, Mastercard’s Business Overview and revenue description call out cyber‑and‑intelligence solutions as a distinct, security‑focused offering that “allows all parties to transact securely, easily and with confidence” and is priced for fraud‑prevention and transaction safety【page_49】【page_80】, indicating a stronger, more prominent role in its value proposition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Cyber and Intelligence Solutions from a minor, grouped service in 2022 to a distinct, emphasized offering in 2023. The 2022 description accurately reflects that the service was listed among other value-added services and associated with $1.3 billion in unsatisfied performance obligations—this quantitative detail is correct and supported by the source (page 81). In 2023, the LLM correctly notes the elevated language, quoting that the service 'allows all parties to transact securely, easily and with confidence' (page 49), and mentions its pricing model tied to fraud prevention (page 80), which matches the ground truth's emphasis on strategic prominence. (2) The dollar amount ($1.3 billion) is accurate and properly contextualized as part of unsatisfied performance obligations for a bundle of services, not solely for Cyber and Intelligence Solutions—this nuance is preserved. No calculations are required, and all dates (2022, 2023) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across two years, compares the positioning of the service in Mastercard’s disclosures, and infers a strategic shift based on language and structure changes in the filings. The use of specific page references adds verifiability. (4) The only minor shortcoming is that the LLM does not explicitly state the *strategic shift* in as conceptual a tone as the ground truth (e.g., 'core component', 'strategic shift toward elevating cybersecurity'), though the evidence presented fully supports that conclusion. This slight gap in interpretive synthesis prevents a perfect 10, but the factual and qualitative accuracy remains very high. Overall, the answer is factually correct, well-supported, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 501,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the treatment or disclosure of Income Tax Expense and Accruals evolved in the list of critical accounting policies between 2022 and 2023?",
      "original_answer": "In 2022, 'income tax expense and accruals' was explicitly listed as one of the critical accounting policies and estimates, indicating its significance in financial reporting. By 2023, while still listed as a critical accounting policy, it was moved to a subsection under 'Our Critical Accounting Policies and Estimates' with a more structured presentation of related notes, such as Note 5 - Income Taxes, which provided deeper transparency into tax-related disclosures. This evolution reflects a shift toward more detailed and organized reporting of tax-related matters in 2023.",
      "llm_answer": "Both the 2022 and 2023 Form 10‑K filings list “income tax expense and accruals” as one of the four critical accounting policies, and the accompanying description is essentially the same – it explains that the annual tax rate is based on income, statutory rates and transfer‑pricing, that significant judgment is required, reserves are set for positions that may be challenged, and the estimated effective tax rate is applied to quarterly results. Thus, the treatment and disclosure of income‑tax expense and accruals did not materially change between 2022 and 2023. (2022 pp. 59‑61; 2023 pp. 59‑61)",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, despite being consistent in referencing the same section (pp. 59–61) across years. The ground truth states that while 'income tax expense and accruals' remained a critical accounting policy, its presentation evolved in 2023 with a more structured format and integration into a broader section ('Our Critical Accounting Policies and Estimates') and enhanced disclosure via Note 5 – Income Taxes. This indicates a material change in disclosure depth and organization. However, the LLM claims there was 'no material change' in treatment or disclosure, directly contradicting the ground truth. There are no numeric values to verify, so quantitative accuracy is not applicable—scored as 10 by default since no numbers are involved. The qualitative accuracy is low because the model fails to recognize the evolution in structure and transparency, missing the multi-hop nuance between continued inclusion and improved presentation. Contextual relevance is moderate: the answer addresses the right topic and sections but misinterprets the significance of the changes. Semantic equivalence fails because the conclusion opposes the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 335,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Intel's development and positioning of the Universal Chiplet Interconnect Express standard evolved between 2023 and 2024 in the context of its broader systems of chips strategy?",
      "original_answer": "In 2023, Intel introduced the Universal Chiplet Interconnect Express (UCIe) standard and demonstrated it in silicon, marking the initial phase of its strategic push to enable optimized systems of chips. By 2024, Intel had progressed beyond the demonstration phase and was actively producing based on this standard, integrating it into its broader advanced semiconductor assembly and test offerings. This evolution reflects Intel's deepening commitment to the UCIe standard as a core component of its systems of chips strategy, aimed at enhancing system performance and accelerating customer designs through advanced packaging technologies and system-level standards.",
      "llm_answer": "In 2023 Intel announced the Universal Chiplet Interconnect Express (UCIe) as a new standard for chip‑to‑chip communication and showed a first silicon demonstration, positioning it as a cornerstone of its “systems of chips” and advanced‑packaging roadmap【page_37】. By the 2024 filing Intel is no longer just showcasing a prototype – it says it “continues to drive … the Universal Chiplet Interconnect Express standard … which we demonstrated in silicon in 2023,” framing UCIe as an ongoing, core element of its broader systems‑of‑chips and Open System Foundry strategy to accelerate customer designs【page_22】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of Intel's UCIe standard from 2023 to 2024 as described in the ground truth. In 2023, Intel introduced UCIe and demonstrated it in silicon, which is accurately reflected. By 2024, Intel had moved to active production and integration into its advanced packaging offerings, which the LLM conveys by stating Intel is 'no longer just showcasing a prototype' and is actively driving the standard. The core facts—introduction, silicon demonstration in 2023, and continued strategic integration in 2024—are all correct. (2) There are no numerical values, percentages, or financial figures in the question or answers, so quantitative accuracy is not applicable in terms of calculations, but all dates (2023, 2024) are accurate and consistent with the ground truth. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two time points (2023 and 2024) and correctly links UCIe to Intel’s broader 'systems of chips' and advanced packaging strategy. It also appropriately references the progression from demonstration to ongoing strategic implementation. The only minor shortcoming is that the LLM does not explicitly mention 'production' or 'semiconductor assembly and test offerings' as in the ground truth, which slightly reduces completeness in technical specificity. (4) The answer is semantically equivalent to the original, with slight variation in emphasis but no factual inaccuracies. The inclusion of 'Open System Foundry strategy' adds context not in the ground truth but does not contradict it. Overall, the answer is highly accurate, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 455,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has the accounting treatment and completion timeline of CVS's Accelerated Share Repurchase (ASR) transactions evolved between the 2023 and 2024 10-K filings?",
      "original_answer": "In 2023, CVS completed a $2.0 billion ASR with Citibank, receiving 17.4 million shares initially (80% of the notional amount) and an additional 5.4 million shares in February 2023, concluding the transaction. The forward contract portion was reclassified from capital surplus to treasury stock upon completion. In 2024, CVS completed a $3.0 billion ASR with Morgan Stanley, initially receiving 31.4 million shares (85% of the notional amount) and an additional 8.3 million shares in March 2024. Similar to 2023, the forward contract was reclassified from capital surplus to treasury stock after the final shares were received. The accounting treatment remained consistent, but the scale and timeline of completion evolved, with the 2024 ASR taking two months to conclude compared to one month in 2023.",
      "llm_answer": "In both the 2023 and 2024 10‑K filings CVS records each ASR as an initial treasury‑stock purchase for the bulk of the notional amount and a forward contract for the remainder, which is first placed in capital surplus and then re‑classified to treasury stock when the final shares are delivered (2023: $1.6 bn treasury + $0.4 bn forward; 2024: $2.6 bn treasury + $0.4 bn forward)【page_75†L1-L9】【page_92†L1-L9】. The 2023 filing shows the ASRs concluding one month after the purchase (January receipt, February final receipt)【page_75†L9-L12】, whereas the 2024 filing’s $3.0 bn ASR extended the settlement to March 2024 and added language about optional cash or share settlement and a maximum share cap of 73.9 million shares【page_74†L13-L20】【page_92†L9-L13】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct accounting treatment and general timeline evolution between 2023 and 2024 ASRs, showing that the forward contract is reclassified from capital surplus to treasury stock upon completion in both years. However, there are significant quantitative inaccuracies. The LLM states the 2023 ASR was split into $1.6B treasury and $0.4B forward, implying 80% upfront, which aligns with the 80% share delivery (17.4M of ~21.75M total), but the ground truth does not specify dollar allocations—only share counts. More critically, for 2024, the LLM claims $2.6B treasury + $0.4B forward, but this implies only ~87% upfront, whereas the ground truth says 85% of $3.0B ($2.55B) was delivered initially as 31.4M shares, not $2.6B. The $0.4B forward portion is inconsistent with the actual $0.45B remainder. Additionally, the LLM introduces a 'maximum share cap of 73.9 million shares' and 'optional cash or share settlement' in 2024, which are not in the ground truth and appear to be over-interpretations or misreadings. The timeline is partially correct: 2023 completion took one month (January to February), but the 2024 transaction started in January and ended in March (two months), which the LLM notes but does not explicitly compare as 'longer' or 'evolved'. The core reasoning about consistent accounting treatment is correct, and the multi-hop synthesis across years is present, but flawed by incorrect dollar allocations and unsupported new details. Semantic equivalence is partially achieved, but factual precision on numbers and terms reduces correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 432,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did UPS's financial exposure and reporting approach related to the Central States Pension Fund evolve from 2022 to 2023, particularly in terms of actuarial estimates and sensitivity analysis?",
      "original_answer": "In 2022, UPS disclosed a $2.3 billion pre-tax actuarial loss related to potential coordinating benefits for the Central States Pension Fund, as part of broader pension obligation disclosures. By 2023, the company's reporting shifted focus to sensitivity analysis, referencing a 25 basis point change in expected and actual returns on assets as a key assumption affecting pension liabilities, with an explicit cross-reference to Note 5 for details on the Central States Pension Fund liability. This indicates a shift from quantifying a specific obligation to emphasizing the sensitivity of returns on the overall liability.",
      "llm_answer": "In the 2022 filing UPS reported a $5.1 billion pre‑tax actuarial gain for the Central States Pension Fund, reflecting a reduction in the estimated coordinating‑benefit liability and itemizing the gain into discount‑rate, coordinating‑benefits and demographic components (page 101). By the 2023 filing the company had shifted to a forward‑looking approach, referencing the potential CSPF coordinating‑benefit liability in note 5 and adding a 25‑basis‑point sensitivity analysis that quantifies how changes in discount rates and asset returns would affect projected benefit obligations and net periodic benefit cost (page 56).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. The ground truth states that UPS reported a $2.3 billion pre-tax actuarial *loss* in 2022 related to potential coordinating benefits for the Central States Pension Fund. However, the LLM incorrectly claims a $5.1 billion pre-tax actuarial *gain*, which is both the wrong magnitude and the wrong direction (gain vs. loss). This fundamental error undermines the entire response. (2) The quantitative inaccuracies are severe: $5.1 billion vs. $2.3 billion and 'gain' vs. 'loss' are not minor discrepancies—they represent opposite financial implications. Additionally, the LLM invents a breakdown into 'discount-rate, coordinating-benefits and demographic components' not mentioned in the ground truth. While the 25 basis point sensitivity analysis is correctly identified as part of the 2023 reporting, the context is distorted. (3) The multi-hop reasoning is partially sound in that the model identifies a shift in reporting approach from quantifying a specific obligation in 2022 to discussing sensitivity analysis in 2023, and correctly notes the reference to Note 5 in 2023. However, because the foundational fact (the 2022 gain/loss) is incorrect, the synthesis fails. (4) Contextual relevance is moderate—the answer addresses the evolution of reporting and mentions sensitivity analysis and Note 5, which are relevant. But due to the critical quantitative and directional errors, the overall correctness score is very low. The answer misrepresents UPS's financial exposure and implies an improvement (gain) when the truth was a deterioration (loss).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 442,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Mastercard's positioning and emphasis on its Cyber and Intelligence Solutions evolved between 2022 and 2023, particularly in terms of the value proposition communicated to stakeholders?",
      "original_answer": "In 2022, Mastercard described its Cyber and Intelligence Solutions as part of its value-added services that 'allow all parties to transact easily and with confidence' and emphasized principled use of consumer and merchant data. By 2023, the company expanded this messaging, positioning the solutions as central to enabling secure transactions and confidence in the payments ecosystem, while also linking them to strategic investments in new networks like open banking and digital identity. This reflects a broader integration of cyber solutions into the company's overall infrastructure narrative.",
      "llm_answer": "In the 2022 filing Mastercard positioned its cyber‑and‑intelligence solutions as a core “value‑added service … to allow all parties to transact **easily and with confidence**” and even called them a primary driver of revenue growth (“Cyber & Intelligence … solutions” – 2022 Business Overview p.46; financial highlights p.48). By the 2023 filing the messaging had evolved to stress that these solutions let parties “**transact securely, easily and with confidence**” and are built on a “principled and **responsible use of secure** consumer and merchant data,” shifting the value proposition toward a stronger security‑and‑trust narrative for stakeholders (2023 Business Overview p.49).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in Mastercard's messaging between 2022 and 2023: in 2022, the emphasis was on enabling transactions to occur 'easily and with confidence' as part of value-added services, which matches the original answer. In 2023, the LLM correctly notes the addition of 'securely' and the shift toward a stronger security-and-trust narrative, including responsible use of data. (2) There are no numeric values, dates, or financial figures in dispute; all references to years (2022, 2023) and document sections (Business Overview pp.46, 49) are consistent with expected sourcing and do not introduce factual errors—thus quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model synthesizes changes in language and framing across two years, correctly inferring a strategic shift in value proposition. However, the LLM omits a key element from the ground truth: the linkage of Cyber and Intelligence Solutions to strategic investments in new networks like open banking and digital identity in 2023. This contextual expansion is part of the broader integration into infrastructure narrative, which the LLM does not mention, resulting in a minor completeness gap. (4) Despite this omission, the core evolution in messaging is accurately captured with precise wording from filings and correct interpretation. The answer remains semantically very close to the original and highly relevant to the question. Hence, correctness is 9/10, with full marks for quantitative accuracy and contextual relevance, and only a slight deduction in qualitative accuracy due to missing the strategic infrastructure connection.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 468,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did PepsiCo's presentation of the 4.450% Senior Note due 2046 evolve between its 2022 and 2023 SEC filings, particularly in terms of exhibit referencing and associated documentation dates?",
      "original_answer": "In the 2022 filing, the 4.450% Senior Note due 2046 was listed as Exhibit 4.12, incorporated by reference from PepsiCo's Form 8-K filed on October 14, 2015. In the 2023 filing, the same note was reclassified as Exhibit 4.13 and referenced the Form 8-K filed on February 24, 2016. This indicates a shift in how PepsiCo organized or updated its capital structure disclosures, potentially reflecting revised documentation or administrative reclassification over time.",
      "llm_answer": "In the 2022 Form 10‑K the 4.450% Senior Note due 2046 is listed as Exhibit 4.11 and is incorporated by reference to Exhibit 4.4 of a Current Report on Form 8‑K filed on October 14 2015【page_125】. In the 2023 Form 10‑K the same note appears as Exhibit 4.13, still referencing Exhibit 4.4, but the underlying 8‑K filing date is updated to February 24 2016【page_126】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in structure and intent but contains a key factual discrepancy in the 2022 exhibit number. The ground truth states the note was listed as Exhibit 4.12 in the 2022 filing, while the LLM claims it was Exhibit 4.11. This is a clear error in numeric accuracy. The 2023 exhibit number (4.13) and both Form 8-K dates (October 14, 2015, and February 24, 2016) are correctly reported. (2) Quantitative accuracy is compromised due to the incorrect exhibit number in the 2022 reference. All other numbers—interest rate (4.450%), maturity year (2046), and dates—are accurate. The citation of Exhibit 4.4 in the 8-K filings is consistent across both answers and correct. (3) The multi-hop reasoning is sound: the model correctly identifies the evolution across two years, tracks the same financial instrument, and notes the change in exhibit numbering and underlying filing date. It correctly infers continuity of the note despite administrative changes. However, the incorrect exhibit number in the 2022 filing suggests a potential misreading of the source document. (4) Contextual relevance is perfect—the answer directly addresses exhibit referencing and documentation date changes as asked. Qualitative accuracy is high due to correct synthesis and logical interpretation, but quantitative accuracy is reduced by the exhibit number error. Correctness score reflects minor factual error with no impact on overall understanding but still significant in a precise disclosure context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 419,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Intel's relationship with Positive Technologies evolved between 2023 and 2024, particularly in terms of their engagement under OFAC licensing following the U.S. sanctions?",
      "original_answer": "In 2023, Intel disclosed that it had communicated with Positive Technologies regarding IT security research and coordinated disclosure of vulnerabilities, and that it resumed such communications under an OFAC license following the sanctions. By 2024, Intel's relationship had evolved from mere disclosure of past communication to an explicit statement of intent to continue these interactions in accordance with the OFAC license. While both years clarify that there were no gross revenues or net profits associated with these activities, the 2024 filing reflects a more forward-looking and sustained partnership posture with Positive Technologies under the sanctioned conditions.",
      "llm_answer": "Intel’s disclosures in both the 2023 and 2024 10‑K show the same post‑sanctions stance: after the April 2021 Treasury designation, Intel resumed security‑research communications with Positive Technologies under an OFAC General License and has generated no gross revenue or profit from those interactions. The 2024 filing repeats the 2023 language, indicating that Intel’s engagement with Positive Technologies remains unchanged and will continue in accordance with the OFAC license.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant qualitative inaccuracy in its reasoning and synthesis. (1) It correctly identifies that Intel resumed communications with Positive Technologies under an OFAC license after U.S. sanctions and accurately notes that no gross revenues or net profits were generated from these interactions—this aligns with the original answer and is factually consistent across both years. The mention of the April 2021 Treasury designation, while not part of the question, is contextually accurate and adds relevant background. (2) Quantitatively, all dates and financial assertions (e.g., no revenue/profit) are accurate or reasonably inferred; there are no numerical errors. (3) However, the critical flaw lies in the reasoning and interpretation of evolution between 2023 and 2024. The LLM claims the 2024 filing 'repeats the 2023 language' and that 'engagement remains unchanged,' which directly contradicts the ground truth: the relationship evolved from disclosing past communication (2023) to expressing a forward-looking intent to continue the partnership under the license (2024). This evolution in tone and strategic posture—a key point in the original answer—is missed entirely. The LLM incorrectly concludes there was no change, failing the multi-hop reasoning required to compare the qualitative shift in disclosures across years. (4) Therefore, while contextually relevant and quantitatively sound, the answer lacks the necessary depth of analysis and misrepresents the core evolution of the relationship, warranting a moderate correctness score of 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 438,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has the balance of CVS's 4.78% Senior Notes due March 2038 evolved between 2023 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "The balance of CVS's 4.78% Senior Notes due March 2038 remained stable at $5,000 million in both 2023 and 2024, indicating that the company did not retire or issue additional amounts of this particular debt instrument during the period. This stability contrasts with other senior notes, such as the 2.7% senior notes due August 2040, which decreased from $1,250 million in 2023 to $367 million in 2024, suggesting selective debt management and refinancing activity in other long-term obligations.",
      "llm_answer": "The balance of the 4.78 % senior notes due March 2038 was $5.0 billion at both year‑end 2023 and year‑end 2024 (2023 $5,000 m vs 2024 $5,000 m)【page_168】【page_161】. The unchanged amount shows CVS has neither retired nor added to this tranche, indicating that this large, fixed‑rate, long‑dated issue remains a stable pillar of its long‑term debt mix and reflects a deliberate strategy to preserve a diversified, long‑maturity financing profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports that the balance of CVS's 4.78% Senior Notes due March 2038 remained unchanged at $5,000 million ($5.0 billion) in both 2023 and 2024, matching the ground truth exactly. All numeric values, dates, and percentages are accurate. (2) Quantitative accuracy is perfect: $5,000 million in both years is correctly represented as $5.0 billion, and the citation of page numbers (168 and 161) supports traceability. (3) The reasoning is sound—the LLM correctly infers that the stability of this debt tranche indicates it remains a 'stable pillar' of the long-term debt structure and reflects a strategy to maintain a diversified, long-maturity financing profile. However, the original answer adds a comparative insight—contrasting this stability with the reduction in the 2.7% senior notes due 2040 (from $1,250M to $367M)—which the LLM omits. This comparative multi-hop element is part of the full synthesis in the ground truth and thus represents a minor gap in completeness. (4) Despite this omission, the LLM captures the core factual and inferential content of the question. The answer is semantically equivalent on the primary point (stability of the 4.78% notes) and provides valid qualitative interpretation. Hence, correctness is rated 9 (excellent but missing one element of comparative context), quantitative accuracy is 10, qualitative accuracy 9, and contextual relevance 10 as it directly addresses the question with high relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 408,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has the status of the 0.835% Notes due 2032 evolved between the 2022 and 2024 SEC filings for Exxon Mobil Corporation?",
      "original_answer": "In the 2022 filing, the 0.835% Notes due 2032 were listed among other notes with distinct trading symbols, including the 0.142% Notes due 2024 (XOM24B), indicating a broader set of publicly traded debt instruments. By 2024, the 0.835% Notes due 2032 remained listed with the trading symbol XOM32, but the 0.142% Notes due 2024 no longer appeared in the 2024 filing, suggesting that the 2024 notes were either redeemed or no longer publicly traded. Therefore, while the 0.835% Notes due 2032 remained a consistent part of Exxon Mobil's publicly disclosed debt structure, the removal of the 2024 notes indicates a change in the company's short-to-intermediate term debt composition.",
      "llm_answer": "In the 2022 Form 10‑K, Exxon Mobil’s 0.835 % Notes due 2032 (ticker XOM32) are listed among the securities registered under Section 12(b), showing they were outstanding at that filing 【page_1】. The 2024 Form 10‑K again lists the same 0.835 % Notes due 2032 as a registered security (XOM32) on the NYSE, indicating the notes remain outstanding and there has been no change in their status between the two filings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually correct regarding the status of the 0.835% Notes due 2032: they were listed in both the 2022 and 2024 filings with the trading symbol XOM32, indicating continued outstanding status. All numeric values (0.835%, 2032, XOM32) and dates (2022, 2024) are accurate, satisfying quantitative accuracy. However, the LLM answer omits a key comparative insight present in the original answer: the removal of the 0.142% Notes due 2024 (XOM24B) from the 2024 filing, which provides context for changes in Exxon Mobil’s debt composition. While the question focuses on the 0.835% Notes due 2032, the evolution of the broader debt structure—particularly the disappearance of the 2024 notes—adds qualitative depth that the LLM fails to address. This limits the completeness and multi-hop reasoning, as the full evolution involves not just the continuity of the 2032 notes but also the change in the overall set of registered securities. The answer remains contextually relevant and correctly identifies entities and their status, but misses an opportunity to synthesize across both filings to highlight structural changes. Thus, while the core facts are correct, the lack of contextual comparison reduces the qualitative accuracy and overall correctness slightly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 354,
        "total_tokens": 1621
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has American Express's investment strategy toward U.S. Government treasury obligations evolved between 2022 and 2024, particularly in terms of fair value allocation and maturity distribution?",
      "original_answer": "In 2022, American Express held U.S. Government treasury obligations exclusively in short-term instruments with a fair value of $477 million and no long-term exposure. By 2024, the company shifted its strategy to include both short-term ($189 million) and intermediate-term ($98 million) treasury obligations, indicating a more diversified maturity profile. This reflects a transformation in the company's investment approach, expanding beyond less than 12-month instruments to include holdings maturing within 1 to 5 years.",
      "llm_answer": "In the 2022 filing (covering 2021) American Express held about **$1.704 billion of U.S. Treasury securities at fair value**, with the portfolio split roughly **49 % due within one year and 51 % due in the 1‑to‑5‑year bucket**【page_120†L31-L38】【page_121†L31-L38】. By the 2024 filing the Treasury position had **shrank to roughly $287 million at fair value**, and the maturity mix had become more short‑dated – **about two‑thirds now maturing within one year and the balance in the 1‑to‑5‑year range**【page_124†L31-L38】【page_126†L9-L13】. This reflects a clear shift from a larger, more evenly‑distributed Treasury holding to a much smaller, more short‑term‑focused allocation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The reported figures are wrong. The ground truth states that in 2022, American Express held $477 million in short-term U.S. Treasury obligations with no long-term exposure. The LLM claims a total of $1.704 billion split between 49% short-term and 51% intermediate-term, which contradicts the ground truth of zero long-term holdings. In 2024, the ground truth reports $189 million short-term and $98 million intermediate-term (total ~$287 million), which the LLM incorrectly interprets as a shrinkage from a larger prior portfolio, when in fact the 2022 portfolio was smaller. While the 2024 total (~$287M) matches approximately, the LLM misrepresents the evolution by claiming a reduction in size when the actual shift was from $477M (all short-term) to $287M (mixed), which is not a 'shrinkage' from $1.7B. (2) Completeness: The answer addresses fair value and maturity distribution but misrepresents the direction and nature of the strategy shift. (3) Entity Accuracy: The company (American Express) and metric (fair value of treasury obligations) are correct, but the years are misaligned—the 2022 filing should reflect 2022 data, not 2021. (4) Reasoning: The multi-hop reasoning fails. The LLM incorrectly infers that the 2022 portfolio was larger and more balanced, and that the 2024 strategy became more short-term focused, when the opposite is true: the strategy evolved from exclusively short-term to include intermediate-term, indicating diversification, not concentration in short-term. (5) Semantic Equivalence: The conclusion is inverted—ground truth shows a move toward diversification; LLM claims a move toward short-term focus. This is a critical factual and logical error. The contextual relevance is moderate because it discusses the right topic and structure, but the substance is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 517,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Amazon's introduction and subsequent treatment of the 2.500% Note due 2050 evolve between 2022 and 2024?",
      "original_answer": "In 2022, the 2.500% Note due 2050 was introduced as part of an Officers' Certificate dated June 3, 2020, and was listed alongside other notes in Exhibit 4.5. By 2024, the 2.500% Note due 2050 was reintroduced in Exhibit 4.6, which was an exact replication of Exhibit 4.5 from 2020, indicating that Amazon continued to maintain this long-term debt instrument without modification. The reintroduction in 2024 reaffirmed the note's role in Amazon's capital structure.",
      "llm_answer": "In Amazon’s 2022 Form 10‑K the 2.500 % senior note due 2050 is disclosed for the first time in Exhibit 4.5 – an Officers’ Certificate dated June 3 2020 that lists that note (along with other senior notes) 【page_72†L31-L38】. By the 2024 Form 10‑K the same 2.500 % Note due 2050 is again included in an updated Officers’ Certificate (now Exhibit 4.6), indicating the note remained outstanding and was carried forward unchanged in the company’s filings 【page_75†L1-L7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) All key facts are correct: the 2.500% Note due 2050 was first disclosed in the 2022 10-K via Exhibit 4.5, which references the June 3, 2020 Officers' Certificate, and it reappeared in the 2024 10-K in Exhibit 4.6. The percentages, years, and exhibit numbers are accurate. (2) Quantitative elements—interest rate (2.500%), maturity year (2050), and dates (June 3, 2020)—are all correct. (3) The reasoning is sound: the LLM correctly infers that the note remained outstanding and unchanged, based on the replication of the exhibit, which matches the multi-hop synthesis required. (4) The only minor shortcoming is that the LLM does not explicitly state that Exhibit 4.6 in 2024 was an 'exact replication' of Exhibit 4.5 from 2020, a detail present in the original answer that reinforces the lack of modification. However, the phrase 'carried forward unchanged' conveys the same meaning semantically. The answer is highly relevant, complete, and precise, warranting a high correctness score with only a slight deduction for the minor omission of the replication detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 323,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the number of amendments to the Citibank, N.A. Co-Branded Credit Card Agreement evolve between 2022 and 2023?",
      "original_answer": "In 2022, the most recent amendment to the Citibank, N.A. Co-Branded Credit Card Agreement was the Eighth Amendment, filed on March 10, 2022. By 2023, the agreement had undergone further modifications, with the Twelfth Amendment being filed on October 11, 2023, indicating a total of four additional amendments during this period. This demonstrates a continued evolution and refinement of the agreement terms over the 12-month period.",
      "llm_answer": "Costco’s 2022 Form 10‑K exhibit list for the Citibank, N.A. Co‑Branded Credit Card Agreement includes amendments through the Tenth Amendment (10.8.10)【page_68】. The 2023 Form 10‑K adds the Eleventh and Twelfth Amendments, with the Twelfth Amendment (10.8.12) shown【page_68】. Thus, the total amendments rose from ten in 2022 to twelve in 2023 – an increase of two amendments.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies that the number of amendments increased from 2022 to 2023 and notes the Twelfth Amendment was filed in 2023, which aligns with the ground truth. However, there is a critical discrepancy in the quantitative claim: the LLM states that the 2022 Form 10-K includes amendments up to the Tenth Amendment, implying ten amendments existed by 2022. In contrast, the ground truth specifies that the Eighth Amendment was the most recent in 2022, filed on March 10, 2022. This means the LLM overstates the number of amendments in 2022 by two, leading to an incorrect calculation of the increase (2 amendments vs. the correct 4 additional amendments from Eighth to Twelfth). The reasoning is partially sound—using Form 10-K exhibits to track amendments is valid—and the answer is contextually relevant, addressing the evolution of amendments. However, the error in the baseline number of amendments undermines the accuracy of the conclusion. While the mention of the Twelfth Amendment in 2023 is correct, the failure to accurately reflect the starting point in 2022 results in a significant factual deviation. Thus, the answer is partially correct but contains a major quantitative and entity-level error in the amendment count for 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 351,
        "total_tokens": 1545
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration with new computing architectures and software ecosystems?",
      "original_answer": "In 2022, NVIDIA emphasized CUDA as a foundational building block across its target markets, including Gaming, Data Center, Professional Visualization, and Automotive, highlighting its role in enabling accelerated computing and deep learning. CUDA was positioned as a core component of the company's unified architecture, supporting a wide range of applications through internal and third-party software stacks. By 2024, NVIDIA had significantly expanded the scope of CUDA's integration, describing it as part of a broader full-stack computing platform that includes the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific application frameworks. Additionally, CUDA was now explicitly tied to NVIDIA's expanded data center platform, which now includes CPUs (introduced in fiscal 2024) alongside GPUs and DPUs, showing a strategic evolution toward deeper integration with heterogeneous computing architectures and enterprise-grade AI ecosystems.",
      "llm_answer": "In 2022 NVIDIA presented CUDA as the core GPU‑programming model that, together with its GPUs, CPUs and networking, formed the “fundamental building blocks” of a unified architecture and was used by roughly three million developers (​pages 7 & 11). By 2024 CUDA has become the centerpiece of a full‑stack software ecosystem—augmented by CUDA‑X libraries, SDKs and APIs—and is now explicitly integrated with new hardware layers such as DPUs, the Grace CPU and the forthcoming Blackwell GPU architecture, while its developer base has grown to almost six million (​pages 4, 5, 6, 7).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the developer base growth from ~3 million (2022) to ~6 million (2024) matches the context, and the years (2022, 2024) are correctly referenced. (2) The LLM correctly identifies the evolution of CUDA from a core programming model to a full-stack ecosystem, including CUDA-X libraries, APIs, and SDKs—consistent with the 'full-stack computing platform' described in the original answer. (3) The multi-hop reasoning is sound: it synthesizes CUDA’s integration with new architectures (DPUs, Grace CPU, Blackwell GPU) and ties them to NVIDIA’s broader heterogeneous computing strategy, which reflects the expansion beyond GPUs mentioned in the ground truth. (4) Minor omission: the original answer emphasizes CUDA’s role across specific markets (Gaming, Data Center, etc.) in 2022 and the strategic shift toward enterprise-grade AI ecosystems in 2024, which the LLM touches on implicitly but does not explicitly mention. However, the core evolution in integration with new architectures and software ecosystems is accurately captured. Wording differs but semantic meaning is equivalent. No factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 343,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did Pfizer's financial relationship with Paxlovid evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual obligations?",
      "original_answer": "In 2023, Paxlovid generated $1.279 billion in revenue, but this figure was significantly impacted by a non-cash revenue reversal of $3.5 billion due to the expected return of 6.5 million treatment courses of EUA-labeled U.S. government inventory. By 2024, this reversal was adjusted favorably by $771 million as only 5.1 million treatment courses were actually returned, and an additional $442 million in revenue was recorded in connection with the creation of the U.S. Strategic National Stockpile (SNS). Furthermore, as of December 31, 2024, Pfizer reported approximately $1 billion in remaining performance obligations related to Paxlovid supply contracts, indicating ongoing but reduced commercial activity compared to the prior year. This evolution reflects a shift from a high-volume, government-driven revenue model in 2023 to a more stable, contracted future delivery model in 2024.",
      "llm_answer": "In 2023 Pfizer reported only $1.279 billion of Paxlovid sales and booked a $3.5 billion non‑cash revenue reversal for the expected return of EUA‑labeled government inventory, leaving $5.1 billion of Paxlovid‑related deferred revenue on its balance sheet 【page_107†L31-L34】【page_108†L1-L9】【page_110†L1-L5】. By 2024 Paxlovid revenue had risen to $5.716 billion as the company recognized about $2.9 billion of the previously deferred amounts (including a $771 million favorable adjustment for returned courses and $442 million revenue from a U.S. Strategic National Stockpile supply) and the remaining contracted‑revenue obligation for Paxlovid fell to roughly $1 billion 【page_107†L31-L34】【page_108†L9-L13】【page_109†L31-L34】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the 2024 revenue figure and the interpretation of deferred revenue. While it correctly identifies the $1.279 billion in 2023 Paxlovid sales and the $3.5 billion non-cash revenue reversal due to expected returns of EUA-labeled inventory, it incorrectly states that 2024 Paxlovid revenue rose to $5.716 billion. The original answer does not state any total revenue figure for 2024, only that there was a $771 million favorable adjustment and an additional $442 million from the SNS. The LLM appears to have incorrectly reconstructed a total revenue number by adding these adjustments to prior figures, which is not supported by the ground truth. Additionally, the claim that $2.9 billion of previously deferred revenue was recognized is not substantiated in the original answer. (2) The $771 million favorable adjustment and $442 million SNS revenue are correctly cited, as is the $1 billion in remaining performance obligations as of December 31, 2024. However, the calculation of total 2024 revenue is flawed and introduces numbers not present in the original. The mention of $5.1 billion in deferred revenue on the balance sheet is not in the original answer and appears to be an erroneous inference. (3) The multi-hop reasoning is partially sound—Pfizer’s shift from a government-driven model to contracted future delivery is implied, and the use of contractual obligations and adjustments shows synthesis across time and financial events. However, the incorrect reconstruction of total revenue undermines the reasoning. (4) The contextual relevance is high, as the answer addresses revenue recognition and contractual obligations directly. The qualitative accuracy is moderate due to correct identification of key events and adjustments, but the quantitative accuracy is low due to unsupported totals and miscalculations. Hence, correctness is scored at 6—partially correct but with significant quantitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 539,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the availability and structure of shares under the 2003 Incentive Program evolved between 2022 and 2024?",
      "original_answer": "In 2022, the 2003 Incentive Program had 65,754,069 shares available for award. By 2024, the total maximum number of shares that could be issued under the program was increased to 220 million, with 47 million remaining available for awards by the end of 2024. This indicates a significant expansion in the program's capacity, although actual usage had grown moderately over time, with restricted stock units granted increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024.",
      "llm_answer": "By the end of 2022 the 2003 Incentive Program still had roughly 65.8 million shares available for grant (the filing notes “65,754,069 shares available for award under the 2003 Incentive Program” 【page_43】). At the close of 2024 that pool had fallen to about 47 million shares (“remaining shares available for award … were 47 million” 【page_102】). The program’s design – a 220‑million‑share ceiling that can be used for stock options, SARs, restricted stock and other awards, with a 10‑year option life, no fixed term and new awards allowed until the pool is exhausted – has remained unchanged between the two years.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the number of shares available in 2022 (65,754,069, rounded to 65.8 million) and the remaining available shares in 2024 (47 million), which matches the ground truth. However, it fails to mention a critical fact from the original answer: that the total maximum number of shares under the 2003 Incentive Program was increased to 220 million by 2024. Instead, the LLM implies that the 220-million-share ceiling was already in place and unchanged, which contradicts the ground truth stating an expansion occurred. This is a significant omission in both quantitative and qualitative accuracy. While the LLM correctly notes the program structure (types of awards, no fixed term, etc.), it incorrectly asserts that the program’s design 'has remained unchanged'—but the increase in the share ceiling constitutes a structural change. Additionally, the LLM omits the evolution of restricted stock units granted (increasing from 9,392 thousand in 2022 to 10,393 thousand in 2024), which is a key part of how the program's usage evolved. Thus, while some numbers are accurate and the context is relevant, the failure to report the increase in the share cap and the moderate growth in grants undermines the correctness and completeness of the answer. Multi-hop synthesis is partially correct but misses key comparative data across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 376,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has AdSense's role within Google's advertising revenue streams evolved between 2022 and 2024, particularly in relation to the company's broader advertising technology portfolio?",
      "original_answer": "In 2022, AdSense was explicitly cited as a key growth driver within the Google Network, contributing to an $8.6 billion year-over-year revenue increase alongside AdMob and Google Ad Manager. By 2024, while AdSense remained part of the Google Network, it was no longer specifically quantified as a growth lever. Instead, newer AI-powered advertising products like Demand Gen and Performance Max were highlighted as central to advertiser success, suggesting a strategic shift where AdSense became a more foundational, mature offering within Google's broader advertising technology stack.",
      "llm_answer": "In the 2022 Form 10‑K, Alphabet still highlighted AdSense as a distinct pillar of its “Google Network” business – it was named alongside AdMob and Google Ad Manager as a primary driver of network‑revenue growth, even though impressions from AdSense had slipped (see page 35). By the 2024 filing, the company no longer calls out AdSense by name; the narrative groups it under “Google Network partners’ properties” and presents advertising as a unified, AI‑enhanced platform that spans Search, YouTube and the network, indicating that AdSense has moved from a highlighted standalone product to a component of a broader, integrated advertising‑technology portfolio (see page 8).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, AdSense was explicitly named as a key growth driver within the Google Network alongside AdMob and Google Ad Manager, matching the original answer. While the LLM does not mention the $8.6 billion year-over-year revenue increase, this is the only quantitative omission. All other factual claims are correct. (2) The LLM accurately reflects that by 2024, AdSense was no longer called out by name in disclosures and was instead subsumed under broader categories like 'Google Network partners’ properties,' which is consistent with the ground truth’s claim that it was no longer specifically quantified as a growth lever. (3) The reasoning is sound: the LLM infers a strategic shift from a standalone product to an integrated component, paralleling the original answer’s conclusion about AdSense becoming a more foundational, mature offering. It correctly synthesizes information across 2022 and 2024 filings to show evolution in narrative and strategic emphasis. (4) The answer is contextually excellent—directly addressing the evolution of AdSense’s role and its integration into Google’s broader AI-enhanced ad tech portfolio. The only minor shortcoming is the omission of the $8.6 billion figure, which slightly affects completeness but not overall correctness. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy (since no stated numbers are wrong) and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 420,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the UPS Retirement Plan's benefit accrual structure evolve between 2022 and 2023, and what specific changes were made to future benefit accruals for non-union participants?",
      "original_answer": "In 2022, the UPS Retirement Plan was described as noncontributory and covering substantially all eligible employees hired before July 1, 2016, who were not part of a collective bargaining unit or certain employees covered by a collective bargaining agreement. The plan provided retirement benefits based on average compensation and was subject to IRS limits. It was also disclosed that the plan would cease accruals of additional benefits for future service and compensation for non-union participants effective January 1, 2023. In 2023, this cessation of accruals was confirmed as effective, and the plan was described with the same eligibility and benefit structure but explicitly stated that no further accruals would occur for non-union participants. This marks a transformational change in the plan's structure, as the accrual freeze was implemented as planned, shifting the plan from an active benefit-accruing structure to a closed one for non-union employees. The change represents a significant strategic shift in UPS's retirement benefit policy.",
      "llm_answer": "In the 2022 filing the UPS Retirement Plan was still a non‑contributory defined‑benefit plan that accrued benefits based on average compensation for all eligible employees, including non‑union participants, although it disclosed that accruals for non‑union participants would end on January 1, 2023 (see 2022 Note 6). By the 2023 filing the plan had implemented that change, formally ceasing all future‑service and compensation‑based benefit accruals for non‑union participants as of January 1, 2023 (see 2023 Note 5).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) All key facts are correct: the UPS Retirement Plan was non-contributory, covered non-union employees hired before July 1, 2016, and it ceased benefit accruals for non-union participants effective January 1, 2023. The 2022 filing disclosed the upcoming change, and the 2023 filing confirmed its implementation. (2) Quantitative accuracy is perfect: the date 'January 1, 2023' is correctly cited, and there are no numerical errors. Format variations (e.g., 'non-contributory' vs 'noncontributory') are acceptable and do not affect meaning. (3) Multi-hop reasoning is sound—the model correctly synthesized information across the 2022 and 2023 filings to show the evolution of the plan and the implementation of the accrual freeze. It references specific footnotes (2022 Note 6, 2023 Note 5), which adds credibility, though the ground truth does not require footnote verification. (4) The only minor shortcoming is slight incompleteness: the LLM omits the detail that the plan was subject to IRS limits and that eligibility excluded certain collectively bargained employees, which adds context to the benefit structure. However, the core of the question—how the accrual structure evolved and what changed for non-union participants—is fully and correctly addressed. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 406,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Amazon's utilization and structure of its short-term credit facilities evolved between 2022 and 2024, particularly in terms of credit capacity, interest rate terms, and outstanding borrowings?",
      "original_answer": "In 2022, Amazon had a $7.0 billion unsecured revolving credit facility with an interest rate of benchmark rate plus 0.50% and a commitment fee of 0.04%, and no borrowings were outstanding under this facility. Additionally, Amazon had $7.2 billion in unused letters of credit as of December 31, 2021. By 2024, Amazon had significantly expanded its credit capacity by entering into a new $15.0 billion unsecured revolving credit facility with a lower interest rate of benchmark rate plus 0.45% and a reduced commitment fee of 0.03%. In addition, Amazon introduced a new $5.0 billion unsecured 364-day revolving credit facility in October 2024, which also carried a rate of SOFR plus 0.45% and a 0.03% commitment fee. Notably, there were still no borrowings outstanding under the main Credit Agreement or the Short-Term Credit Agreement as of December 31, 2024. However, Amazon had $147 million and $151 million in borrowings under other short-term credit facilities as of December 31, 2023 and 2024, respectively, which were included in 'Accrued expenses and other.' The company also increased its unused letters of credit to $8.3 billion by the end of 2024.",
      "llm_answer": "In the 2022 filing Amazon’s short‑term financing was anchored by a $7 billion unsecured revolving credit facility that bore a benchmark rate + 0.50% with a 0.04% commitment fee and had no borrowings, a $1 billion secured revolving facility (LIBOR + 1.40%, 0.50% fee) that carried $803 million of debt, and a commercial‑paper program of up to $10 billion that had about $725 million outstanding 【page_57】, 【page_56】. By the 2024 filing the company had replaced the secured line with a larger $15 billion unsecured revolving credit agreement (benchmark + 0.45%, 0.03% fee) and added a $5 billion 364‑day revolving facility (SOFR + 0.45%, 0.03% fee); neither of these facilities had any borrowings, while only $151 million of other short‑term credit facilities were outstanding at year‑end (up from $147 million in 2023) 【page_58】, and the commercial‑paper capacity was expanded to $20 billion with no borrowings reported as of Dec 31 2024 【page_58】.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies despite capturing some correct elements. It incorrectly states that in 2022 Amazon had a $1 billion secured revolving facility with $803 million in debt and a commercial paper program with $725 million outstanding. These details are not present in the ground truth and contradict it—original data confirms no borrowings under the main $7.0 billion facility and no mention of secured debt or commercial paper usage in 2022. The ground truth only notes $7.2 billion in unused letters of credit as of end-2021. (2) Quantitative accuracy is compromised: while the 2024 $15.0 billion unsecured facility, $5.0 billion 364-day facility, and $151 million in other short-term borrowings are correctly reported, the $803 million secured borrowing and $725 million commercial paper balance in 2022 are entirely fabricated. The expansion of commercial paper capacity to $20 billion in 2024 is also not in the ground truth. (3) Multi-hop reasoning is partially sound—the model attempts to compare 2022 and 2024 credit structures and identifies correct trends like increased capacity and lower fees—but it fails to synthesize accurately due to reliance on incorrect source data. The correct evolution is from a single $7B facility to two larger unsecured facilities with improved terms and minimal short-term borrowings, but the LLM introduces non-existent secured debt and commercial paper balances. (4) Contextual relevance is high as the answer addresses credit capacity, interest rates, fees, and outstanding borrowings across years. However, the inclusion of false details severely undermines factual correctness, warranting a low correctness and quantitative accuracy score despite structurally appropriate framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 483,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has Costco's use of variable-priced contracts for energy purchases evolved between 2022 and 2023, and what does this indicate about its commodity price risk management strategy?",
      "original_answer": "In 2022, Costco entered into variable-priced contracts for some purchases of electricity and natural gas, as well as fuel for its gas stations, on an index basis. These contracts met the definition of derivatives but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. By 2023, Costco continued this approach but specifically called out natural gas and fuel for gas stations as key components of its variable-priced contract usage. This indicates a continued reliance on variable-priced contracts as part of its commodity price risk management, with no significant shift away from index-based pricing mechanisms. The strategy remains consistent, showing stability in how Costco manages exposure to energy price fluctuations.",
      "llm_answer": "In the 2022 filing Costco said it used variable‑priced contracts on an index basis for some electricity **and** natural‑gas purchases (plus fuel for its gas stations). The 2023 filing narrows that language to variable‑priced contracts only for natural‑gas (and gas‑station fuel), with electricity exposure now largely covered by fixed‑price contracts. The change indicates Costco is tightening its commodity‑price risk management—locking in electricity prices while still using index‑linked contracts where it judges the risk to be acceptable.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains a significant factual error in its core claim: it states that Costco shifted from variable-priced contracts for electricity in 2022 to fixed-price contracts in 2023, implying a strategic change in risk management. However, the ground truth indicates no such shift—Costco continued using variable-priced contracts for electricity, natural gas, and fuel in 2023, with the 2023 filing merely emphasizing natural gas and fuel more prominently. The original answer explicitly states there was 'no significant shift away from index-based pricing mechanisms' and that the strategy 'remains consistent.' The LLM incorrectly infers a strategic tightening and shift to fixed-price contracts for electricity, which is not supported by the data. This misrepresents the evolution and strategic implication. Quantitatively, there are no numerical inaccuracies (dates are correct, no incorrect dollar amounts), so quantitative accuracy is high. However, the qualitative reasoning is flawed due to incorrect synthesis across years—failing the multi-hop reasoning test by drawing an unsupported conclusion from wording differences. Contextually, the answer addresses the right topic and entities (Costco, variable-priced contracts, commodity risk), so relevance is moderate, but the conclusion misaligns with the evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 368,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has the strategic positioning and commercial role of NVIDIA AI Enterprise evolved within NVIDIA's data center offerings between 2022 and 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, indicating its foundational role in NVIDIA's AI and accelerated computing strategy. By 2024, the product had evolved into a more prominent commercial offering, described as a 'comprehensive suite of enterprise-grade AI software' that is actively licensed and integrated into broader data center solutions. This shift reflects NVIDIA's move from positioning it as a strategic initiative to a key monetization vehicle within its full-stack data center platform, alongside offerings like NVIDIA DGX Cloud and the expansion into CPUs and DPUs.",
      "llm_answer": "In the 2022 filing NVIDIA described AI Enterprise as “essentially an operating system for enterprise AI applications,” positioning it as a core, internally‑delivered software layer of its data‑center stack (page 78). By the 2024 filing the product is presented as a commercial, paid‑license suite – listed alongside DGX Cloud as a key compute offering (page 4) and described as “a comprehensive suite of enterprise‑grade AI software” (page 6) that now includes NIM, Nemo and AI Blueprints to simplify generative‑AI development (page 7). Thus, AI Enterprise has shifted from a foundational OS‑type component to a monetized, feature‑rich software platform that drives NVIDIA’s data‑center revenue and strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: NVIDIA AI Enterprise was introduced in 2022 as a foundational software layer (referred to as an 'operating system for enterprise AI applications'), and by 2024 evolved into a commercial, monetized product described as a 'comprehensive suite of enterprise-grade AI software'. The inclusion of NIM, Nemo, and AI Blueprints in 2024 is consistent with the product's expanded feature set. (2) There are no numeric values, dates, or financial figures in dispute; the years 2022 and 2024 are used correctly, and no calculations are required. (3) The multi-hop reasoning is sound—correctly synthesizing information across two years of filings to show a strategic shift from foundational platform to monetized offering. It appropriately references integration with DGX Cloud and the broader data center strategy. (4) The answer captures the core evolution: from internal software stack component to revenue-driving product. The only minor gap is that the original answer explicitly mentions the Compute & Networking segment in 2022 and the expansion into CPUs/DPUs as part of the broader context, which the LLM answer omits. However, this does not detract significantly from the overall correctness. Semantic equivalence is maintained, and the LLM provides additional document page references that support its claims. Thus, the answer is excellent but not perfect, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 418,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did Pfizer's contractual obligations related to Paxlovid evolve between 2023 and 2024, and what does this indicate about the company's future revenue expectations for the product?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of Paxlovid labeled under Emergency Use Authorization (EUA) from the U.S. government. This indicated uncertainty and potential decline in demand for Paxlovid. By 2024, however, remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, signaling a stabilization and expectation of future revenue from existing contracts. This shift from a large revenue reversal to a defined forward-looking contractual obligation suggests improved demand forecasting and a more stable outlook for Paxlovid in 2024 compared to the uncertainty in 2023.",
      "llm_answer": "In 2023 Pfizer carried roughly $5.1 billion of deferred revenue for Paxlovid (and Comirnaty), which fell to about $2.2 billion by year‑end 2024 as large advance‑payment balances were recognized (including a $771 million favorable adjustment)【page_110】.  At the same time, the company’s remaining performance‑obligation balance for Paxlovid was about $1 billion as of Dec 31 2024, to be recognized over 2025‑2028, signalling that most of the earlier government‑stockpiled inventory has been delivered and that future Paxlovid revenue will be modest but spread across several years【page_109】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but has significant quantitative inaccuracies. The ground truth states that Pfizer recorded a $3.5 billion non-cash revenue reversal in Q4 2023 due to expected returns of 6.5 million Paxlovid treatment courses under EUA from the U.S. government. However, the LLM answer does not mention this key event or the $3.5 billion reversal at all. Instead, it references a $5.1 billion deferred revenue balance (for Paxlovid and Comirnaty combined) declining to $2.2 billion by end-2024, which is not equivalent and conflates two products. This is a major factual deviation. (2) The only correct quantitative element is the $1 billion remaining performance obligation for Paxlovid as of December 31, 2024, which matches the ground truth and is correctly cited with a forward recognition period (2025–2028). The $771 million favorable adjustment is mentioned but not explained in context and does not align with the $3.5 billion reversal in the original answer. (3) The reasoning partially captures the evolution from uncertainty to stabilization by noting that government stockpiled inventory has been delivered and future revenue will be modest and spread out. This aligns with the qualitative interpretation in the ground truth about improved forecasting and stable outlook. However, because the model fails to identify the core 2023 event (the $3.5B reversal due to expected returns), the multi-hop synthesis is incomplete. It misses the cause of the decline in deferred revenue and misattributes it without referencing the EUA-related return expectations. (4) Contextually, the answer addresses both years and discusses future revenue expectations appropriately. While the conclusion about stabilization is reasonable, the absence of the central $3.5B reversal undermines factual accuracy. Thus, correctness is scored at 6 due to partial facts and major omissions in key financial events, despite correct mention of the $1B forward obligation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 538,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "Compare and contrast how Google's exposure to new regulatory costs in international markets evolved between 2022 and 2024, particularly in terms of the scope and nature of regulatory challenges described?",
      "original_answer": "In 2022, Google highlighted that an evolving foreign policy landscape could subject the company to 'new regulatory costs and challenges,' specifically mentioning data transfers between the EU and the UK, as well as new customer requirements. By 2024, the scope of regulatory challenges expanded significantly. The 2024 filing not only reiterated the exposure to 'new regulatory costs and challenges' but also introduced elements like 'uncertainty regarding regulatory outcomes' and the risk of 'other liabilities under local laws that may not offer due process or clear legal precedent.' This indicates a shift from primarily data-related regulatory concerns in 2022 to broader, more unpredictable regulatory risks in 2024, reflecting an increased complexity in Google's international regulatory environment.",
      "llm_answer": "In the 2022 Form 10‑K Google said that an “evolving foreign‑policy landscape” could create new regulatory costs and challenges – chiefly the need to comply with data‑transfer rules between the EU and the United Kingdom and other new customer‑requirement obligations, together with the usual foreign‑ownership, exchange‑control, tariff and anti‑corruption exposures (2022 p. 14). By the 2024 filing the scope had widened: the company now lists sanctions, import‑export controls, market‑access barriers, geopolitical tensions and armed‑conflict risks, and stresses uncertainty over regulatory outcomes and liabilities under local laws that may lack clear precedent, while still noting new customer requirements and anti‑corruption compliance (2024 p. 16).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Google's regulatory exposure between 2022 and 2024. In 2022, it accurately cites data-transfer rules between the EU and UK, new customer requirements, and standard foreign compliance issues (e.g., anti-corruption, exchange controls), referencing the 'evolving foreign-policy landscape' as a source of new costs. In 2024, it correctly notes the expanded scope, including sanctions, import-export controls, market-access barriers, geopolitical tensions, armed-conflict risks, uncertainty in regulatory outcomes, and liabilities under laws lacking clear precedent—while still acknowledging ongoing concerns like customer requirements and anti-corruption. (2) There are no numerical values to verify, but dates (2022, 2024) and document references (p. 14, p. 16) are consistent with typical 10-K formatting and plausible, though not independently verifiable from the ground truth provided. (3) The multi-hop reasoning is sound: the model synthesizes changes in risk disclosures across two years, correctly identifying both continuity (e.g., customer requirements) and expansion (broader geopolitical and legal risks), demonstrating a clear understanding of the evolving nature of regulatory challenges. (4) The only minor shortcoming is that the LLM includes additional details not present in the original answer (e.g., 'foreign-ownership, exchange-control, tariff') in the 2022 summary, which, while plausible, were not mentioned in the ground truth. However, this does not make the answer factually incorrect—just slightly more detailed. The core progression from data-centric to broader, more uncertain regulatory risks is accurately captured. Thus, the answer is semantically equivalent and highly faithful to the original, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 529,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has UPS's approach to funding postretirement medical benefits evolved between 2022 and 2023, particularly in terms of the sources used for expected benefit payments?",
      "original_answer": "In 2022, UPS indicated that expected benefit payments for postretirement medical benefits would be paid from both plan trusts and corporate assets. In 2023, the language remained unchanged, indicating continuity in the funding approach. Therefore, there was no change in the sources used for expected benefit payments for postretirement medical benefits between the two years.",
      "llm_answer": "UPS’s funding policy for post‑retirement medical benefits did not change from 2022 to 2023. Both the 2022 filing (page 109) and the 2023 filing (page 92) state that “expected benefit payments for post‑retirement medical benefits will be paid from plan trusts and corporate assets,” indicating UPS continues to rely on a mix of plan‑trust assets and corporate resources to meet those obligations.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately states that UPS's funding approach for postretirement medical benefits did not change between 2022 and 2023, with both years indicating that expected benefit payments are funded from plan trusts and corporate assets. (2) There are no numerical figures requiring calculation in this question, but the years (2022 and 2023) and the cited page numbers (109 and 92) are correctly referenced, adding precision. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two different years of filings and concludes that the language and thus the funding policy remained unchanged, which is the core of the question. (4) The answer is contextually relevant, directly addressing the evolution (or lack thereof) in funding sources. Semantic equivalence is maintained with the original answer, using slightly different phrasing but conveying the exact same factual conclusion. No errors in entities, reasoning, or facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 295,
        "total_tokens": 1493
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the role and scope of NVIDIA AI Enterprise evolved from its introduction in 2022 to its broader supply and integration in 2024?",
      "original_answer": "In 2022, NVIDIA AI Enterprise was introduced as part of the Compute & Networking segment, described as a software suite aimed at simplifying the deployment of AI applications across data centers and enterprise environments. By 2024, the platform had evolved into a more comprehensive and integrated solution, including components such as NVIDIA NIM, NVIDIA NeMo, and AI Blueprints, with specific performance improvements like a 2.5x increase in token throughput. This reflects a shift from a foundational offering to a full-stack, production-grade generative AI platform with enhanced capabilities and broader deployment options.",
      "llm_answer": "In the 2022 filing NVIDIA AI Enterprise was introduced as a **paid‑license, enterprise‑grade AI software suite** that was bundled with the company’s data‑center compute offerings (alongside DGX Cloud and vGPU) to give customers a ready‑made AI stack【page_5 (2022)】【page_6 (2022)】. By the 2024 filing the suite had **expanded into a broader, end‑to‑end generative‑AI platform**—now called NVIDIA AI Enterprise—featuring components such as NIM, Nemo and AI Blueprints and positioned as a widely supplied, integrated solution for developing, fine‑tuning and deploying production‑grade AI applications on NVIDIA‑accelerated infrastructure anywhere【page_5 (2024)】【page_7 (2024)】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: NVIDIA AI Enterprise was introduced in 2022 as an enterprise AI software suite, and by 2024 evolved into a broader generative AI platform with components like NIM, NeMo (spelled 'Nemo' in the answer, minor variation), and AI Blueprints. The shift from a foundational suite to a full-stack, production-grade platform is accurately conveyed. (2) There are no numeric inaccuracies—while the ground truth mentions a '2.5x increase in token throughput,' this specific metric is omitted in the LLM answer, but no incorrect numbers are presented. This is a minor completeness gap, not a quantitative error. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across 2022 and 2024 filings to show evolution in scope and integration. (4) Semantic equivalence is strong—wording differs (e.g., 'end-to-end generative-AI platform' vs 'full-stack, production-grade generative AI platform') but meaning is preserved. The only minor shortcoming is the omission of the specific performance improvement (2.5x token throughput), which slightly affects completeness but not overall correctness. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 369,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has ExxonMobil's proved reserves through equity companies evolved from 2022 to 2024, and what does this indicate about its strategic positioning in different regions?",
      "original_answer": "In 2022, ExxonMobil's total proved reserves from equity companies amounted to 14 million barrels gross (1 million net) across the United States, Europe, Africa, and Asia. By 2024, these reserves had significantly increased to 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas, with the majority of this growth concentrated in Asia. This indicates a major strategic shift toward strengthening its upstream presence in the Asia region through equity companies.",
      "llm_answer": "The 2024 Form 10‑K shows that ExxonMobil’s equity‑company proved reserves total roughly 2.99 billion barrels oil‑equivalent (about 1.48 billion barrels developed + 1.51 billion barrels undeveloped), with the overwhelming majority (≈2.78 billion barrels) located in Asia and only modest amounts in the United States (≈17 million barrels), Europe (≈45 million barrels) and Africa (≈143 million barrels). The 2022 filing excerpts do not provide comparable equity‑company reserve figures, so a precise year‑over‑year change cannot be calculated, but the 2024 regional mix underscores a strategic emphasis on expanding its Asian portfolio while maintaining diversified exposure in other key regions.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, ExxonMobil's equity-company proved reserves in 2022 were 14 million barrels gross (1 million net), but the LLM claims that 'the 2022 filing excerpts do not provide comparable equity-company reserve figures,' which contradicts the provided truth. Furthermore, the 2024 figures in the LLM answer (2.99 billion barrels oil-equivalent) are completely different from the ground truth, which reports 467 million barrels of crude oil, 120 million barrels of natural gas liquids, and 5,367 billion cubic feet of natural gas. The LLM incorrectly converts or aggregates these into 'barrels oil-equivalent' without justification or alignment with the original data. The regional breakdown in the LLM answer (e.g., 2.78 billion barrels in Asia, 143 million in Africa) is not supported by the ground truth, which only states that the majority of growth is in Asia but does not quantify regional splits beyond that. (2) The numbers are not accurate in any format: 2.99 billion BOE vs. the actual sum of ~600 million barrels liquids and ~900 million BOE gas (using 6:1 conversion) still does not align, and the LLM's regional allocations are speculative. There is no mention in the ground truth of developed vs. undeveloped reserves, making that detail fabricated. (3) The multi-hop reasoning fails because the model does not correctly synthesize the 2022 and 2024 data to show evolution. Instead, it asserts a lack of 2022 data, missing the opportunity to compare the 14 million barrel baseline to the 2024 surge. While it correctly infers a strategic focus on Asia, this conclusion is based on incorrect data and thus undermines the reasoning. (4) The answer is contextually relevant in addressing ExxonMobil's strategic positioning and regional emphasis, but the severe quantitative and factual errors drastically reduce correctness. The qualitative assessment is slightly higher because the direction of the strategic shift (toward Asia) is consistent with the ground truth, even if the supporting data is wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 565,
        "total_tokens": 1877
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of their role in revenue generation and cost structure?",
      "original_answer": "In 2022, Google Network Partners played a central role in the revenue generation process as Google acted as the principal for ads placed on Google Network properties, reporting advertising revenues on a gross basis, with payments to partners recorded as cost of revenues. By 2024, Google continued to pay Google Network partners, but the focus of the financial reporting shifted to emphasize the net cash flow impact, noting that payments to these partners were a primary use of cash from operating activities. This reflects a more cost-centric framing of the relationship in the later year.",
      "llm_answer": "In the 2022 filing the company explained that advertising on Google Network properties is recorded on a gross basis – the full amount billed to advertisers is shown as revenue and the payments made to the Network partners are reflected in traffic‑acquisition costs (TAC), a component of cost of revenues 【page_55】. The 2024 filing uses the same accounting treatment (payments to Google Network partners are included in TAC under cost of revenues 【page_56】) but adds that advertising from those properties is a “largest source of cash provided by operations” and that payments to the partners are a “primary use of cash from operating activities” 【page_42】. Thus, between 2022 and 2024 the partners’ role as both a revenue generator and a cost driver has remained consistent, with the later report simply emphasizing the cash‑flow impact of those payments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, Google reported advertising revenue from Network Partners on a gross basis, with payments to partners recorded in traffic-acquisition costs (TAC) under cost of revenues. This matches the original answer's description of the 2022 treatment. (2) For 2024, the LLM correctly notes that the accounting treatment remained unchanged but that the emphasis shifted to cash flow language—specifically that payments to partners are a 'primary use of cash from operating activities' and that ad revenue from these properties is a 'largest source of cash provided by operations.' This reflects the ground truth's point about a more cost- and cash-flow-centric framing in 2024. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and correctly infers that while the accounting policy did not change, the narrative emphasis evolved to highlight cash flow impacts. (4) All entities (Google Network Partners, TAC, cost of revenues, operating cash flows) and years (2022, 2024) are accurate. There are no numerical inaccuracies—though no specific dollar amounts are mentioned, the qualitative financial concepts are correctly represented. The only minor shortcoming is that the LLM slightly downplays the shift in framing by calling it a 'simple' emphasis on cash flow, whereas the original answer interprets it as a 'more cost-centric framing,' suggesting a subtle strategic repositioning. This nuance is not fully captured, preventing a perfect 10. However, the core facts, logic, and synthesis are correct, warranting a 9 for correctness and qualitative accuracy, and full marks for quantitative accuracy and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 476,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has UPS's foreign currency exchange risk management strategy evolved between 2022 and 2023, particularly in terms of the financial impact of undesignated foreign currency forward contracts on earnings volatility?",
      "original_answer": "In 2022, UPS disclosed that foreign currency exchange forward contracts were used to economically offset foreign currency remeasurement and settlement risk for certain balance sheet assets and liabilities, and that changes in their fair value affected earnings directly. For 2023, UPS expanded the disclosure to emphasize that undesignated derivative settlements are now explicitly linked to earnings volatility, with a specific focus on how these contracts impact income statement recognition. The 2023 filing also introduced a more structured presentation of fair value changes and settlements for these contracts, with amounts for both 2023 and 2022 now reported side-by-side in millions, indicating a more transparent and systematic approach to disclosing the financial effects of these instruments.",
      "llm_answer": "In 2022 UPS booked a $69 million loss in earnings from foreign‑currency forward contracts that were **not** designated as hedges, creating noticeable earnings volatility. By 2023 that loss had shrunk to only $7 million, reflecting a sharp reduction in non‑designated forward positions (the balance‑sheet shows just $1 million of non‑designated contracts versus $174 million designated) and a larger notional of designated currency hedges, indicating the company moved more exposure into formal hedge relationships to dampen earnings swings.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer introduces specific numerical claims—such as a $69 million loss in 2022 and a $7 million loss in 2023, and balance sheet figures of $1 million non-designated versus $174 million designated contracts—that are not present in the original ground truth answer. The ground truth does not provide any actual financial figures related to the gains or losses from undesignated forward contracts, nor does it mention the notional amounts of designated vs. non-designated contracts. Therefore, these numbers are factually unsupported and appear to be hallucinated. This severely undermines quantitative accuracy. While the LLM attempts to address the evolution in UPS's risk management strategy by suggesting a shift toward designated hedges to reduce earnings volatility, the original answer focuses on the evolution of disclosure practices—not changes in hedge positioning or notional amounts. The ground truth emphasizes improved transparency, structured presentation, and side-by-side reporting of fair value changes, not a reduction in non-designated contracts. Thus, the reasoning is misaligned with the actual source information. However, the LLM answer is contextually relevant, as it engages with the core topic of foreign currency forward contracts and earnings volatility, and it attempts multi-hop reasoning by comparing 2022 and 2023 impacts. But because key factual claims are invented and the strategic evolution is misrepresented (operational shift vs. disclosure enhancement), the overall correctness is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 418,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the role of the membership format in Costco's profitability strategy evolved between 2022 and 2023, particularly in terms of its impact on member loyalty and fee revenue?",
      "original_answer": "In 2022, the membership format was described as 'an integral part of our business and has a significant effect on our profitability,' with an emphasis on growth in the membership base, increasing Executive member penetration, and sustaining high renewal rates as key drivers of profitability. By 2023, the language evolved to underscore that the membership format 'is an integral part of our business and profitability,' indicating a more consolidated role in the company's financial model. Additionally, in 2023, Costco introduced a new concern about the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not explicitly mentioned in 2022. This suggests that while the membership model remained central to profitability, the company faced emerging challenges in sustaining renewal rates as it expanded into newer markets.",
      "llm_answer": "Both the 2022 and 2023 Form 10‑K describe Costco’s membership format as “an integral part of our business…designed to reinforce member loyalty and provide continuing fee revenue,” and they stress that growth in the membership base, higher Executive‑membership penetration and high renewal rates “materially influence our profitability.” The language is essentially unchanged from 2022 (see 2022 pages 23‑24) to 2023 (see 2023 pages 23‑24), indicating that Costco’s strategy continued to rely on the membership model as a stable, loyalty‑driving source of fee revenue without a shift in emphasis.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct in stating that Costco's membership format remains integral to its business and profitability, and it correctly identifies key elements like member loyalty, fee revenue, growth in membership base, Executive membership penetration, and renewal rates. However, it incorrectly claims that the language in the 10-K is 'essentially unchanged' between 2022 and 2023, which directly contradicts the ground truth. The original answer highlights a meaningful evolution in wording—from 'has a significant effect on our profitability' in 2022 to 'is an integral part of our business and profitability' in 2023—indicating a stronger, more consolidated role. Additionally, the LLM answer completely omits a critical new concern introduced in 2023: the potential adverse impact of lower renewal rates in newer markets on the worldwide renewal rate, which was not mentioned in 2022. This omission represents a significant failure in multi-hop reasoning and synthesis across years. (2) There are no numerical values in this question, so quantitative accuracy is not applicable; however, the LLM does not introduce any incorrect numbers, so this dimension is neutral. (3) The reasoning is flawed because the model fails to detect and report the shift in language and the emergence of a new strategic concern in 2023, which is central to understanding the evolution of the membership model. The conclusion that there was 'no shift in emphasis' is factually incorrect based on the ground truth. (4) While the answer is contextually relevant and addresses the general role of membership in profitability, it lacks the necessary depth and accuracy in comparing the two years. Correctness and qualitative accuracy are low due to the failure to capture key evolving dynamics, despite using accurate terminology and referencing correct document sections.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 509,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has NVIDIA's approach to CUDA evolved between 2022 and 2024, particularly in terms of its integration within the broader data center platform and software ecosystem?",
      "original_answer": "In 2022, CUDA was primarily positioned as a key component of NVIDIA's AI ecosystem, with nearly 3 million developers using CUDA and other software tools to deploy AI and accelerated computing technologies. It was described as central to NVIDIA's partnerships and developer programs, including the Deep Learning Institute and Inception program. By 2024, CUDA had evolved into a more deeply integrated part of a full-stack computing platform, specifically within the data center. It was described as the foundation of the CUDA-X collection of acceleration libraries, APIs, SDKs, and domain-specific frameworks, emphasizing its role in enabling end-to-end optimized computing across GPUs, CPUs, and DPUs. This reflects a strategic shift from promoting CUDA as a developer-focused tool to positioning it as a core infrastructure layer for enterprise-scale computing solutions.",
      "llm_answer": "In the 2022 filing NVIDIA positioned CUDA primarily as the core parallel‑programming language that, together with its GPUs, formed the foundation of its accelerated‑computing platform and supported roughly 3 million developers (2022 p.9, p.11). By the 2024 filing CUDA is described as a foundational programming model that runs on all NVIDIA GPUs and is bundled with the expanded CUDA‑X library suite, tightly woven into a full‑stack data‑center platform that now also includes CPUs, DPUs and networking—reflecting a broader software ecosystem and a developer community that has grown to about 5.9 million (2024 p.4, p.6, p.7).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies CUDA's role in 2022 as a core programming language supporting approximately 3 million developers, consistent with the original answer. In 2024, it accurately reflects CUDA’s evolution into a foundational layer of a full-stack data center platform, integrated with CPUs, DPUs, and networking. (2) Quantitatively, the 3 million developer figure for 2022 is correct. The LLM states a growth to 5.9 million developers by 2024, which is not contradicted by the original answer (which doesn’t provide a 2024 number), so this additional detail does not reduce accuracy—assuming it's supported by the cited filing pages. The mention of specific filing pages (e.g., 2024 p.4, p.6, p.7) suggests grounding in source material. (3) The reasoning is sound: the LLM captures the multi-hop evolution from a developer-centric tool to an enterprise infrastructure layer, noting the expansion of CUDA-X and integration across hardware types. It synthesizes the strategic shift effectively. (4) The answer is contextually excellent, directly addressing the question about CUDA’s evolution in integration with data center platforms and software ecosystems. The only minor gap is that the original answer emphasizes CUDA’s role in domain-specific frameworks and programs like Deep Learning Institute and Inception, which the LLM omits—hence not a perfect 10. However, the core evolution and integration are accurately conveyed with strong supporting detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 420,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2023 to 2024, particularly in terms of expected future revenue and product delivery timelines?",
      "original_answer": "In 2023, Pfizer had a non-cash revenue reversal of $3.5 billion recorded in the fourth quarter related to the expected return of an estimated 6.5 million treatment courses of EUA-labeled Paxlovid from U.S. government inventory. By the end of 2024, Pfizer reported remaining performance obligations for Paxlovid at approximately $1 billion, with expected product delivery and revenue realization scheduled from 2025 through 2028, indicating a shift from uncertain returns and revenue reversals to a more defined forward-looking revenue outlook based on firm contracts.",
      "llm_answer": "In 2023 Pfizer’s Paxlovid contracts generated about $5.1 billion of deferred revenue (≈ $2.6 billion current + $2.5 billion non‑current) reflecting large advance payments from governments, and the company recorded a $3.5 billion non‑cash revenue reversal for the expected return of 6.5 million EUA‑labeled courses 【page_110】. By year‑end 2024 the deferred balance had fallen to roughly $2.2 billion ($1.4 billion current + $785 million non‑current) as $771 million of returned courses were favorably adjusted and $442 million of revenue was recognized for a U.S. Strategic National Stockpile of 1 million courses, and Pfizer now reports about $1 billion of remaining performance‑obligation revenue for Paxlovid with product deliveries slated for 2025‑2028 【page_108】【page_109】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and provides a detailed, factually correct evolution of Pfizer's financial commitment and contractual obligations for Paxlovid from 2023 to 2024. (1) It correctly identifies the $3.5 billion non-cash revenue reversal in 2023 related to the expected return of 6.5 million treatment courses of EUA-labeled Paxlovid, matching the ground truth. (2) It accurately reports the remaining performance obligations of approximately $1 billion by end of 2024, with product delivery and revenue realization expected from 2025 through 2028, indicating the shift in revenue outlook. (3) The LLM adds granular detail not in the original answer—such as deferred revenue balances in 2023 ($5.1B) and 2024 ($2.2B), breakdown into current/non-current components, and specific adjustments like $771M returned courses and $442M recognized revenue for 1 million courses for the U.S. Strategic National Stockpile—which are consistent with plausible extensions of the ground truth and supported by cited pages. These details enhance completeness without contradicting the core facts. (4) All quantitative values align with reasonable interpretations of the data; minor rounding differences (e.g., $785M non-current vs. implied totals) are acceptable. (5) The multi-hop reasoning is sound: it synthesizes information across years, financial metrics, and contractual timelines to show a clear evolution from uncertain returns to firm future obligations. The only reason for not scoring a 10 is that the original ground truth does not explicitly confirm the $5.1B deferred revenue or its reduction mechanics, so while plausible and well-sourced, those specifics slightly exceed the verified scope. However, they do not detract from correctness. Overall, the answer is semantically equivalent, contextually complete, and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 497,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has ExxonMobil's strategic emphasis on Guyana evolved between 2022 and 2024, based on its disclosures around reserves development and advantaged asset reporting?",
      "original_answer": "In 2022, ExxonMobil reported that Guyana was a key contributor to extensions and discoveries, adding approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves. By 2024, Guyana was explicitly listed as one of the core 'Advantaged Assets' in the company's updated earnings drivers, signaling a strategic shift to highlight Guyana's role in driving earnings through volume growth. This evolution reflects a transition from Guyana being primarily a reserves growth region to being a recognized source of advantaged production and earnings visibility.",
      "llm_answer": "In the 2022 filing, ExxonMobil mentioned Guyana only in the context of “extensions and discoveries, primarily in the United States, Brazil, and **Guyana**, resulted in an addition of ≈ 1.3 billion oil‑equivalent barrels of proved undeveloped reserves” (page 14), showing a focus on reserve‑building activity. By the 2024 filing, Guyana is listed as one of the “**Advantaged Assets**” (alongside Permian and LNG) in the definition of Advantaged Volume Growth (pages 36‑37), indicating that the project has progressed to a strategic, high‑return growth asset rather than just a reserve‑addition.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that in 2022, Guyana contributed to approximately 1.3 billion oil-equivalent barrels (GOEB) of proved undeveloped reserves, matching the original answer's quantitative claim. (2) The 2024 disclosure correctly notes Guyana's inclusion in 'Advantaged Assets' alongside Permian and LNG, reflecting a strategic shift in reporting emphasis, which aligns with the ground truth's assertion about earnings-driven volume growth. (3) The multi-hop reasoning is sound: the model synthesizes information across two years (2022 and 2024), correctly infers the evolution from reserves growth to advantaged production status, and supports this with specific references to filing content and page numbers. (4) All entities—ExxonMobil, Guyana, advantaged assets, proved undeveloped reserves—are accurately identified and contextualized. Minor wording differences (e.g., 'reserve-building activity' vs 'reserves growth region') do not affect meaning and are acceptable under semantic equivalence. No calculation errors or omissions present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 321,
        "total_tokens": 1617
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the planned utilization of the ATR 72-600F aircraft evolve from 2022 to 2024, and what does this indicate about its role in the company's fleet strategy?",
      "original_answer": "In 2022, the ATR 72-600F was projected to have a decreasing role in the company's fleet, with planned units dropping from 11 in 2023 to just 1 by 2026. By 2024, however, the company's projections showed a shift, with ATR 72-600F units remaining steady at 7 for 2025 and declining only slightly to 3 by 2026. This indicates that while the aircraft was initially expected to phase out more rapidly, it continued to play a more sustained, albeit reduced, role in the fleet strategy.",
      "llm_answer": "In the 2022 10‑K FedEx said it had committed to receive 11 ATR 72‑600F aircraft in 2023, 6 in 2024, 6 in 2025 and 1 in 2026 – 24 in total (see page 114). By the 2024 filing the schedule had shifted to only 7 deliveries in 2025 and 3 in 2026 – 10 aircraft overall, with no units slated for 2023‑2024 (see page 117). The cut‑back and later timing suggest the ATR 72‑600F is being used as a modest, niche feeder‑type plane rather than a core growth element of FedEx’s fleet strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022 the company projected 11 ATR 72-600F units for 2023 and a drop to 1 by 2026. However, the LLM incorrectly states that 11 were planned for 2023, 6 in 2024, 6 in 2025, and 1 in 2026 — implying a total of 24 units, which contradicts the original answer’s description of a decreasing role. The 2024 update correctly notes a shift to 7 units in 2025 and 3 in 2026, aligning with the ground truth. However, the LLM misrepresents the initial (2022) plan by suggesting deliveries in multiple years rather than a drawdown from 11 to 1. (2) The calculation of 24 total units is factually incorrect based on the ground truth, which implies a reduction from 11 to 1 over time, not cumulative deliveries. The revised total of 10 aircraft (7+3) in the 2024 plan is consistent with the ground truth’s description of a more sustained but reduced role. (3) The reasoning is partially sound: the LLM correctly infers from the delayed and reduced schedule that the aircraft plays a niche role, which aligns with the ground truth’s conclusion about a sustained but reduced strategic role. However, the flawed initial numbers undermine the multi-hop synthesis between 2022 and 2024 plans. (4) The contextual relevance is high — the answer addresses fleet strategy evolution and draws a reasonable qualitative conclusion. Quantitative accuracy is low due to incorrect unit projections in the 2022 plan; qualitative accuracy is moderate because the logic follows despite wrong numbers; overall correctness is partially compromised by key factual errors in the baseline data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 455,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has NVIDIA's approach to offering Omniverse evolved between 2022 and 2024, particularly in terms of its integration with other AI and simulation platforms?",
      "original_answer": "In 2022, NVIDIA Omniverse was primarily described as a virtual world simulation and collaboration platform for 3D workflows, available as a software subscription for enterprise use and free for individual use. It was highlighted as being integrated with VR and AR in enterprise applications such as virtual car showrooms and surgical training. By 2024, NVIDIA's offering of Omniverse had evolved into a more comprehensive development platform and operating system for building and running virtual world simulation applications. It was now emphasized as being used by industrial enterprises to digitalize complex physical assets and processes—such as building digital twins of factories and testing autonomous robots and vehicles—powered by NVIDIA's accelerated computing infrastructure both on-premises and in the cloud. This represents a shift from general 3D collaboration to a more specialized, enterprise-focused simulation and digital twin platform.",
      "llm_answer": "In the 2022 filing NVIDIA described Omniverse primarily as a standalone virtual‑world simulation and collaboration platform for 3‑D workflows, offered as a software subscription for enterprises and free for individual users【page_9】. By the 2024 filing the company had folded Omniverse into its broader AI‑driven stack—bundling it with NVIDIA AI Enterprise for industrial digital‑twin use cases and using it to generate synthetic data for AI model training and to power the DRIVE Constellation/Sim automotive simulation solution【page_4】【page_5】【page_7】. This marks a shift from a stand‑alone visualization tool to a core component of NVIDIA’s integrated AI and simulation ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of NVIDIA's Omniverse from a standalone 3D collaboration platform in 2022 to an integrated component of NVIDIA’s AI and simulation ecosystem by 2024. The key shift—from a visualization tool to a core part of an industrial AI and digital twin stack—is accurately captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in that sense, but all dates (2022, 2024) and references to product names (Omniverse, AI Enterprise, DRIVE Constellation/Sim) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years and platforms, correctly identifying the integration of Omniverse with AI Enterprise, synthetic data generation, and automotive simulation. It goes slightly beyond the original answer by naming specific integrations (DRIVE Constellation/Sim), which are consistent with the direction of the ground truth but not explicitly detailed there—this is a minor enhancement rather than an error. (4) The only reason for not scoring a perfect 10 is that the original answer emphasizes the shift toward being a 'development platform and operating system' and mentions on-premises/cloud infrastructure, which the LLM answer omits. However, the core evolution and integration points are correctly conveyed. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 419,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has the role of Google Play in generating non-advertising revenue evolved between 2022 and 2023?",
      "original_answer": "In 2022, Google Play was introduced as part of the company's broader strategy to expand non-advertising revenues, specifically through the sales of apps, in-app purchases, and digital content. By 2023, Google Play had transitioned into a more defined revenue stream under 'platforms,' where it was explicitly tied to revenues from app sales and in-app purchases. This evolution indicates a strategic shift toward solidifying Google Play’s role as a key monetization platform rather than just a component of diversification. The change reflects a more structured categorization and likely a stronger contribution to revenue stability within the ecosystem.",
      "llm_answer": "In the 2022 filing Google Play was only referenced as one of the products helping to grow Alphabet’s non‑advertising revenues (e.g., “...focus on expanding our offerings through … Google Play …” – page 30). By the 2023 filing it is singled out as a distinct platform revenue source—listed under “Google subscriptions, platforms, and devices” and “Google other revenues” (e.g., “platforms, which primarily include revenues from Google Play …” – page 33; “Google Play, which includes sales of apps and in‑app purchases …” – page 31)—showing that its contribution to non‑advertising revenue has become more explicit and central.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, Google Play was mentioned as part of broader non-advertising revenue growth without detailed categorization, and by 2023, it was explicitly called out as a distinct revenue stream under 'platforms' and linked to app sales and in-app purchases. The citations to specific pages (30, 31, 33) add precision and match the evolution described in the original answer. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all references to years (2022, 2023) and document locations are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, identifies a shift in disclosure language, and infers increased strategic importance—consistent with the ground truth's claim of a 'strategic shift' and 'more structured categorization.' (4) The only minor shortcoming is that the LLM does not explicitly state the broader strategic implication (e.g., 'solidifying Google Play’s role as a key monetization platform' or 'revenue stability'), which slightly reduces qualitative depth. However, the core facts, timeline, and interpretation are correct. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses the evolution of Google Play’s role in non-ad revenue between 2022 and 2023.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 398,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has AIG's use of expected loss ratio methods in workers' compensation reserving evolved between 2022 and 2023, particularly in relation to guaranteed cost and excess of deductible business?",
      "original_answer": "In 2022, AIG generally gave significant weight to expected loss ratio methods for guaranteed cost business only in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that changes in claims strategy and loss mitigation efforts were accelerating settlements, increasing paid losses along the latest diagonals. In 2023, the reserving methodology remained broadly consistent, with AIG continuing to use a combination of loss development, frequency/severity, and expected loss ratio methods. However, the 2023 filing emphasized that incurred and paid losses were now presented net of reinsurance and undiscounted, which may reflect a refinement in reporting transparency rather than a change in reserving philosophy. Additionally, the increased proportion of large deductible business continued to slow the reporting pattern of claims in 2023, consistent with the trend noted in 2022.",
      "llm_answer": "In the 2022 filing AIG explained that for workers’‑comp it applies expected‑loss‑ratio techniques to guaranteed‑cost business only in the most recent accident year, whereas for excess‑of‑deductible business the method may be given “significant weight in the most recent five accident years” (2022 p. 258‑260). The 2023 filing still stresses the five‑year weighting for excess‑of‑deductible work‑comp (2023 p. 200) but no longer calls out a specific, limited use of expected‑loss‑ratio for guaranteed‑cost business, suggesting the approach has been broadened or its weighting is now implicit rather than explicitly limited (2023 p. 202).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately reports that in 2022, AIG applied expected loss ratio methods to guaranteed cost business only in the most recent accident year and to excess of deductible business in the most recent five accident years, citing correct page references. This matches the original answer. (2) Quantitatively, there are no numbers, percentages, or dollar amounts in the question or answer, so no calculation errors exist—this aspect is fully accurate. (3) The LLM correctly infers from the 2023 filing that while the five-year weighting for excess of deductible business continues, the explicit limitation on guaranteed cost business is no longer mentioned, suggesting a broadening or implicit use. This is a reasonable interpretation based on the absence of the prior restriction in the 2023 text. However, the LLM omits key contextual details present in the ground truth: it does not mention the change in presentation of incurred and paid losses net of reinsurance and undiscounted in 2023, nor does it reference the ongoing impact of large deductible business slowing claims reporting patterns—both of which are important elements of the evolution in reserving methodology. (4) Despite these omissions, the core multi-hop reasoning across 2022 and 2023 filings is sound, and the answer addresses the central comparison about expected loss ratio method application. The answer is semantically close to the original but lacks full completeness on secondary refinements in reporting and claims dynamics. Hence, correctness is high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 441,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Cisco's product category segmentation evolved between fiscal 2022 and fiscal 2024, particularly in relation to the Collaboration category?",
      "original_answer": "In fiscal 2022, Cisco introduced a product revenue segmentation that included 'Collaboration' as one of six distinct categories, which also included Secure, Agile Networks; Internet for the Future; End-to-End Security; Optimized Application Experiences; and Other Products. By fiscal 2024, Cisco restructured its product categories into four main areas, retaining 'Collaboration' but now grouping it alongside Networking, Security, and a new category called Observability. This indicates a consolidation and realignment of product offerings, with the introduction of Observability as a distinct area and the removal or reclassification of Optimized Application Experiences and Internet for the Future.",
      "llm_answer": "Cisco’s product‑revenue reporting changed from six categories in FY 2022 – Secure Agile Networks; Internet for the Future; Collaboration; End‑to‑End Security; Optimized Application Experiences; and Other Products (with Collaboration defined as Meetings, Collaboration Devices, Calling, Contact Center and CPaaS)【page_44】【page_45】 – to four broader categories in FY 2024: Networking, Security, Collaboration and Observability【page_41】. The Collaboration category remained but was re‑defined to include the Webex Suite, Collaboration Devices, Contact Center and CPaaS, effectively dropping the separate Calling and Meetings line‑items and folding them into the broader Webex Suite offering【page_41】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All entities are correct: Cisco, fiscal years 2022 and 2024, Collaboration category, and the other product segments. The transition from six to four categories is correctly stated. (2) Quantitative accuracy is perfect: the number of categories (6 in FY2022, 4 in FY2024) and the inclusion of Collaboration in both periods are factually correct. The redefinition of Collaboration to include Webex Suite, Devices, Contact Center, and CPaaS — with Calling and Meetings absorbed into Webex — is supported and adds detail not in the original but consistent with the evolution described. (3) Reasoning is sound: the model correctly synthesizes the reorganization as a consolidation, noting the removal of 'Optimized Application Experiences' and 'Internet for the Future' by implication through their absence, and the introduction of 'Observability' as a new category. The answer goes further than the original by specifying component changes within Collaboration, which is a strength. (4) The only minor shortcoming is that the original answer explicitly names the consolidation and the fate of the discontinued categories, while the LLM implies it. However, the core multi-hop reasoning — tracking Cisco’s product segmentation evolution with a focus on Collaboration — is fully addressed with excellent contextual relevance. Wording differs but semantic meaning matches. No calculation errors. Minor deduction in qualitative accuracy for not explicitly stating the removal/reclassification of the old categories, though it's contextually implied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 441,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has Amgen's disclosure regarding the 3.125% 2025 Notes evolved from 2022 to 2023 in terms of financial presentation and associated interest rate framework?",
      "original_answer": "In 2022, Amgen reported a carrying value of $1,000 million for the 3.125% 2025 Notes within its debt table, but no specific interest rate framework was disclosed. By 2023, Amgen included the 3.125% 2025 Notes in a new table that explicitly outlined the interest rate mechanism, identifying it as SOFR + 2.1%. This evolution reflects a shift from a purely quantitative disclosure in 2022 to a more detailed qualitative and quantitative presentation in 2023, including the interest rate benchmark and spread.",
      "llm_answer": "In the 2022 Form 10‑K Amgen listed the 3.125 % 2025 Notes as a separate $1 billion line‑item in its debt‑schedule table (see page 130) and disclosed that the notes were hedged with swaps that gave them an effective rate of **LIBOR + 1.8 %** (page 132). By the 2023 filing the notes are no longer shown individually – they are rolled into the $5.5 billion of debt maturing in 2025 (page 145) – and the swap‑based effective rate is updated to **SOFR + 2.1 %**, reflecting the shift from a LIBOR‑based to a SOFR‑based interest‑rate framework (page 144).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) QUANTITATIVE ACCURACY: The LLM incorrectly states that in 2022, the 3.125% 2025 Notes had an effective interest rate of LIBOR + 1.8%, but the ground truth confirms no interest rate framework was disclosed in 2022. This is a major factual error. Additionally, the LLM claims the notes were hedged with swaps resulting in an effective rate, which is not supported by the original answer. (2) The 2023 disclosure correctly identifies SOFR + 2.1%, which matches the ground truth, so this part is accurate. (3) The LLM incorrectly states that the 2025 Notes are 'no longer shown individually' in 2023 and are 'rolled into $5.5 billion of debt,' but the ground truth says the notes were included in a new table with explicit interest rate disclosure—this contradicts the claim of aggregation or loss of line-item status. (4) ENTITY & REASONING: The shift from LIBOR to SOFR is contextually plausible due to the industry-wide transition, but the model fabricates the prior LIBOR-based framework and hedging details not present in the ground truth. The multi-hop reasoning fails because it misrepresents both years’ disclosures. (5) SEMANTIC EQUIVALENCE: While the answer attempts to address the evolution in disclosure, it introduces unsupported details (hedging, effective rates in 2022, consolidation into a larger debt bucket) that distort the actual progression from simple quantitative to enhanced qualitative disclosure. The core narrative of increased transparency around interest rate framework is partially aligned, but the factual foundation is flawed. Thus, despite some relevant context and correct mention of SOFR + 2.1% in 2023, the answer is mostly incorrect due to fabricated data and misrepresentation of financial presentation changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 495,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning in that geographic area?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure had decreased to 296 billion cubic feet. This indicates a reduction in the company's natural gas holdings in the region over the two-year period, suggesting a potential strategic shift or divestment in that geographic area.",
      "llm_answer": "ConocoPhillips’ proved natural‑gas reserves in the Asia Pacific/Middle East fell from ≈ 330 billion cubic feet (326 BCF developed + 4 BCF undeveloped) at the end of 2022 to ≈ 303 BCF (296 BCF developed + 7 BCF undeveloped) at the end of 2024 – an 8 % drop (‑27 BCF)【page_145】. Nevertheless, the 2024 filing notes that all of the company’s equity‑affiliate reserves are located in this region and that extensions and discoveries continue there (e.g., Middle‑East and Australia projects)【page_146】【page_144】, indicating that ConocoPhillips still views Asia Pacific/Middle East—particularly its LNG opportunities—as a strategic focus despite the modest reserve decline.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains minor quantitative inaccuracies. The ground truth states that COP's natural gas reserves decreased from 326 BCF in 2022 to 296 BCF in 2024, a reduction of 30 BCF. The LLM reports ≈330 BCF in 2022 (326 developed + 4 undeveloped) and ≈303 BCF in 2024 (296 developed + 7 undeveloped), implying a total of 330 and 303 BCF, which slightly overstates the total reserves in both years. While the developed reserves (326 → 296 BCF) match the ground truth exactly, the inclusion of undeveloped reserves (not mentioned in the original answer) introduces a nuance not present in the ground truth. The claimed 8% drop (−27 BCF) is close but not exact: the actual drop is 30 BCF (9.2% decline). (2) Calculations: The difference between 326 and 296 is exactly 30 BCF, not 27. The percentage decline is (30/326) ≈ 9.2%, not 8%. The LLM’s calculation appears based on rounded totals (330 → 303), which are not supported by the original data. (3) Reasoning: The LLM correctly identifies a decline in reserves and synthesizes additional context from the filing—such as ongoing extensions, discoveries, and equity-affiliate reserves in the region—which supports a nuanced interpretation that COP still views the region strategically despite the decline. This multi-hop reasoning (combining reserve data with strategic commentary) is sound and adds value beyond the ground truth. (4) The answer is contextually excellent and semantically aligned, with only minor numerical discrepancies due to inclusion of undeveloped reserves and rounding. The core facts (decline from 326 to 296 BCF developed reserves) are correct, and the strategic interpretation is well-supported. Hence, correctness is high but not perfect due to the quantitative deviations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 486,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did the repurchase activity of Class C Capital Stock by Alphabet change between 2022 and 2023, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023, the repurchase amount increased to $62.2 billion. Additionally, in April 2023, the Board authorized an additional $70.0 billion for share repurchases, with $36.3 billion remaining available as of December 31, 2023. This indicates a continued and expanding emphasis on returning capital to shareholders through share repurchases, with a notable increase in the scale of buybacks year-over-year.",
      "llm_answer": "Alphabet’s buy‑back of its non‑voting Class C shares slipped slightly in volume – 469 million shares were repurchased in 2022 versus 450 million in 2023 – but the cash outlay rose marginally, from about $52.6 billion to $52.9 billion (page 81).  The modest decline in share count alongside a higher spend reflects a continued, aggressive buy‑back program that uses cash to return value to shareholders even as the share price rises, underscoring a capital‑allocation strategy focused on shareholder returns. (page 81)",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Alphabet repurchased $59.3 billion in 2022 and $62.2 billion in 2023, but the LLM claims $52.6 billion and $52.9 billion respectively—both figures are incorrect. Additionally, the LLM cites share counts (469 million in 2022, 450 million in 2023), which are not present in the ground truth and cannot be verified against it; more importantly, the original answer does not mention share volumes at all, only dollar amounts. The LLM also fails to mention the key event in April 2023 when the Board authorized an additional $70.0 billion for repurchases, with $36.3 billion remaining as of year-end—critical information that underscores the expansion of the buyback program. (2) The quantitative inaccuracies are severe: the dollar amounts are off by billions, and the cited share numbers introduce unverified data. While the trend direction (increase in spend) is correctly implied in the LLM answer ($52.6B to $52.9B), the actual increase in the ground truth is much larger ($59.3B to $62.2B), and the LLM underrepresents this. (3) The reasoning is partially sound—tying increased cash outlay despite lower share volume to rising share prices and a focus on shareholder returns shows logical inference—but it is based on incorrect data. The multi-hop synthesis is weak because it fails to incorporate the new authorization and remaining capacity, which are essential to assessing capital allocation strategy. (4) The contextual relevance is moderate because the answer addresses share repurchases and shareholder returns, but the incorrect numbers and missing strategic developments (new $70B authorization) severely undermine its accuracy. The conclusion about continued focus on shareholder returns aligns with the ground truth, but the evidence presented is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 506,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has AIG's use of frequency/severity methods evolved between 2022 and 2023, particularly in terms of the lines of business where they are applied and the reasoning behind their usage?",
      "original_answer": "In 2022, AIG primarily used frequency/severity methods for short-tail classes such as U.S. Property, and explicitly avoided using them for aviation exposures due to the high severity and varying mix of claims year to year. By 2023, AIG expanded the application of frequency/severity methods to include U.S. Workers' Compensation, a long-tail line of business, as part of a combination of methods that also included loss development and expected loss ratio methods. This reflects a strategic shift toward using frequency/severity methods in more complex, long-tail environments, especially where risk-sharing features and large deductible business have increased.",
      "llm_answer": "In the 2022 filing AIG said it applies frequency‑/severity‑based “average‑loss” techniques mainly to short‑tail lines – for example U.S. Property – because claim counts are relatively stable and can be combined with severity estimates to set reserves for those classes (while it avoids such methods for high‑severity, long‑tail lines like aviation)【page_271】. By 2023 the discussion of the same approach appears in the “Average Loss method” description, which is now framed as a tool used wherever loss‑development patterns are inconsistent or overly volatile, emphasizing that projected claim counts are less variable than loss amounts and therefore give more reliable reserve estimates for those specific reserve categories【page_200】. Thus, AIG’s use of frequency/severity has shifted from a line‑specific (short‑tail property) application to a broader, pattern‑driven application that targets any business where development is erratic, with the same underlying rationale of leveraging the relative stability of claim‑frequency forecasts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022, AIG applied frequency/severity methods primarily to short-tail lines like U.S. Property and avoided them for aviation due to high severity and claim volatility. In 2023, it notes the expansion of the method's use beyond line-specific applications to a broader, pattern-driven approach—specifically mentioning application where loss development is inconsistent or volatile. While the original answer explicitly names U.S. Workers' Compensation as a new line of application, the LLM answer captures the conceptual shift (from short-tail to more complex environments) and the rationale (stable claim frequency in volatile loss environments), even if it does not name Workers' Compensation directly. (2) There are no numerical values to verify, but dates (2022, 2023) and method names (frequency/severity, average loss) are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes in application scope and rationale across two years and correctly infers a strategic shift based on stability of claim frequency. (4) The omission of the specific example of U.S. Workers' Compensation prevents a perfect 10, but the core evolution in usage and reasoning is accurately conveyed, making the answer semantically very close to the original. Contextual relevance is excellent, directly addressing the evolution in application and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 402,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Amgen's financial relationship with BeiGene evolved from 2022 to 2023, particularly in terms of cost recovery, product sales, and profit and loss sharing?",
      "original_answer": "In 2022, Amgen recovered $199 million in R&D costs from BeiGene, recorded product sales of $64 million, and recognized $53 million in profit and loss sharing expenses. In 2023, these figures changed to $109 million in cost recovery, $125 million in product sales, and $40 million in profit and loss sharing expenses. This indicates a decrease in cost recovery and profit-sharing expenses, but a significant increase in product sales to BeiGene. The shift suggests a maturation of the collaboration, with more product sales occurring in 2023, while the level of R&D cost sharing declined.",
      "llm_answer": "In 2023 Amgen’s net cost recoveries from BeiGene dropped to **$109 million**, down from **$199 million** in 2022; product sales to BeiGene rose sharply to **$125 million** from **$64 million** a year earlier; and the profit‑and‑loss‑share expense for the initial product‑specific commercialization period fell to **$40 million**, versus **$53 million** in 2022【page_131】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $199 million and $109 million for cost recovery in 2022 and 2023 respectively; $64 million and $125 million for product sales; $53 million and $40 million for profit and loss sharing expenses. The directional changes (decrease in cost recovery and P&L sharing, increase in product sales) are correctly described. (2) The answer addresses all parts of the multi-part question—cost recovery, product sales, and profit and loss sharing—across both years, demonstrating completeness. (3) Entities are accurate: Amgen and BeiGene are correctly identified, time periods (2022 vs 2023) are correct, and financial metrics are properly labeled. (4) The reasoning is sound and implies the evolving nature of the collaboration, though it omits the interpretive sentence about maturation present in the original answer. However, this does not detract from factual correctness, as the numerical trends support that interpretation implicitly. The citation [page_131] indicates proper sourcing. Overall, the answer is factually equivalent to the ground truth with precise multi-hop synthesis across years and financial metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 345,
        "total_tokens": 1589
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2022 to 2024, and what specific changes occurred in terms of revisions, production, and purchases during this period?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. During this period, revisions in 2023 added 9 billion cubic feet, but production subtracted 25 billion cubic feet in 2024. Additionally, there were no purchases reported directly affecting this region in 2024, indicating a reduction in active reserve growth strategies compared to earlier years.",
      "llm_answer": "ConocoPhillips’ proved natural‑gas reserves in the Asia Pacific/Middle East fell from 326 BCF at year‑end 2022 to 312 BCF in 2023 and to 296 BCF in 2024【page_145】. The region saw modest upward revisions of +6 BCF in 2022 and +9 BCF in 2023, but a net downward revision of about ‑26 BCF in 2024 (driven by lower‑price and cost adjustments in equity‑affiliate reserves)【page_146】; production was roughly 24 BCF in 2022 and 25 BCF in 2023 (the 2024 figure is not disclosed)【page_145】, and purchases were made only in 2022 via an equity‑affiliate acquisition of additional Asia‑Pacific interest, with no purchases recorded in 2023 or 2024【page_146】.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the starting and ending reserve volumes (326 BCF in 2022 and 296 BCF in 2024), which matches the ground truth. However, it introduces an intermediate value of 312 BCF in 2023, which is not present in the original answer and may imply a level of precision not supported by the ground truth. The revisions are mostly accurate: +9 BCF in 2023 aligns with the original, but the LLM adds a +6 BCF revision in 2022 and a -26 BCF downward revision in 2024, which are not mentioned in the ground truth. The production figures are partially correct: 25 BCF in 2024 is correctly cited as occurring in 2024 in the original, but the LLM attributes 25 BCF to 2023 and states 2024 production is undisclosed, which contradicts the original. Purchases are correctly noted as absent in 2024, though the LLM adds detail about a 2022 purchase via an equity affiliate, which is not in the original and may be extraneous. (2) Key numbers like the 2022 and 2024 reserves and the 9 BCF 2023 revision are correct. However, the inclusion of unmentioned figures (e.g., 312 BCF in 2023, -26 BCF revision in 2024, production in 2023 vs 2024) reduces quantitative accuracy. The production timing error is significant. (3) The reasoning shows good multi-hop synthesis—tying revisions, production, and purchases across years—and correctly infers reduced activity in recent years. The use of page citations suggests grounding in source material. However, the addition of unsupported specifics (like the 2024 downward revision) indicates overextrapolation. (4) The answer is highly relevant, addressing all aspects of the question: reserve evolution, revisions, production, and purchases. Despite some inaccuracies, it maintains focus and provides a coherent narrative. Overall, the core facts are mostly correct, but the inclusion of unverified details and a key error in production timing prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 522,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did FedEx's planned usage of the B767F aircraft evolve from 2022 to 2024, and what does this indicate about its strategic fleet planning?",
      "original_answer": "In 2022, FedEx projected using 14 B767F aircraft in both 2023 and 2024, with a planned reduction to 10 by 2025. By 2024, the projections had changed, showing a decrease to 11 B767F aircraft for 2025 and only 3 by 2026. This indicates a strategic shift toward a more accelerated reduction in the planned use of B767F aircraft, reducing reliance on this model over time.",
      "llm_answer": "In the 2022 filing FedEx was slated to take delivery of 14 Boeing 767‑F freighters in 2023, another 14 in 2024 and 10 in 2025 – 38 aircraft in total (page 40). By the 2024 filing the schedule had been trimmed to 11 767‑F deliveries in 2025 and only 3 in 2026 – 14 aircraft overall (page 117). The sharp cut‑back reflects a strategic shift to phase out the older 767‑F fleet and prioritize newer, more fuel‑efficient types such as the Boeing 777‑F as part of its broader fleet‑modernization program (page 118).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor differences in framing. (1) Quantitatively, the LLM correctly reports the reduction from 14 B767F aircraft planned in 2022 for 2023–2024 (though the original answer specifies projected usage, not deliveries) to 11 in 2025 and 3 in 2026. The original answer states that in 2022, FedEx projected using 14 aircraft in both 2023 and 2024, with a drop to 10 by 2025; by 2024, this was revised to 11 in 2025 and 3 in 2026. The LLM slightly mischaracterizes the 2022 plan as 'deliveries' rather than 'planned usage' and omits the 2023 and 2024 usage numbers, jumping straight to 2025. However, the key evolution—accelerated reduction from 10 to 3 between 2025 and 2026 in the new plan vs. prior expectations—is correctly captured. (2) The calculation of total deliveries (38 vs. 14) is consistent with the numbers provided, though the original answer does not mention totals, so this is an addition, not an error. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes changes in fleet planning across two filings (2022 and 2024) and infers a strategic shift, which aligns with the ground truth. (4) The qualitative explanation—phasing out older 767-Fs in favor of more fuel-efficient 777-Fs as part of fleet modernization—is consistent with the strategic interpretation in the original answer. The only minor shortcoming is the emphasis on 'deliveries' rather than 'planned usage,' which slightly misrepresents the metric but does not invalidate the conclusion. Overall, the answer is factually correct, complete in substance, and contextually excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 453,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did AIG's use of Expected Loss Ratio Methods evolve between 2022 and 2023, particularly in terms of the lines of business and the reasoning behind their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to the high severity nature of claims and varying mix across years. By 2023, AIG applied Expected Loss Ratio Methods more broadly, particularly in U.S. Workers' Compensation, a long-tail line of business, where they used a combination of methods including Expected Loss Ratio, to account for extended loss emergence periods and complex risk-sharing features in policies. This reflects a shift from a focus on short-term forecasting in high-severity contexts to a broader application in long-tail, structurally complex lines.",
      "llm_answer": "In 2022 AIG’s Expected‑Loss‑Ratio (ELR) approach was applied chiefly to aviation exposures and to the most recent accident year across its portfolio, serving as a complement to loss‑development techniques for high‑severity, short‑tail claims. By 2023 the ELR method was expanded to other lines—especially business written in excess of a deductible—and its use was justified when loss‑development patterns are inconsistent, losses emerge very slowly, or there is limited loss history, with the ratios adjusted for rate changes, inflation and market conditions. This marks a shift from a narrow, aviation‑focused tool to a broader, strategically‑driven reserve methodology across multiple lines.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, earning a high score. (1) It accurately captures the evolution of AIG's use of Expected Loss Ratio (ELR) methods from 2022 to 2023. In 2022, ELR was correctly described as being used primarily for aviation and the latest accident year, complementing loss development methods for high-severity claims—this matches the original answer. In 2023, the expansion to other lines is noted, particularly excess-of-deductible business, which is contextually consistent with U.S. Workers' Compensation's risk-sharing features mentioned in the ground truth, though not explicitly named. The reasoning—slow loss emergence, inconsistent development patterns, limited history—is accurate and aligns with the long-tail nature and complexity described in the original. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not compromised; all years (2022, 2023) are correct. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift in methodology application over time and across lines of business. However, it misses the specific mention of 'U.S. Workers' Compensation' as the key line in 2023, instead referring more generally to 'business written in excess of a deductible.' While this is a related concept and contextually plausible, it is not a perfect match, leading to a slight deduction in qualitative accuracy. (4) The answer remains highly relevant and semantically close to the original, with only minor imprecision in entity specification. Thus, correctness is high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 445,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has Cisco's positioning around Enterprise Data Center Transformation evolved between 2022 and 2024, particularly in relation to its strategic alliances and competitive landscape?",
      "original_answer": "In 2022, Cisco highlighted that the enterprise data center was undergoing a fundamental transformation due to the convergence of technologies like computing, networking, storage, and software, with strategic alliance partners sometimes acquiring or aligning with competitors, reducing business with Cisco. By 2024, Cisco continued to emphasize this transformation but expanded its focus on strategic alliances aimed at industry advancement and new market creation, while also updating its competitive landscape to include new entrants like Nvidia Corporation, signaling a shift in market dynamics and alliance strategies.",
      "llm_answer": "In the 2022 filing (see 2022 pages 8 and 11), Cisco described the enterprise data‑center as “undergoing a fundamental transformation” driven by the convergence of compute, networking, storage and software, and warned that many of its strategic‑alliance partners (and rivals forming new alliances or acquisitions) could become direct competitors in delivering end‑to‑end data‑center solutions. By the 2024 filing (see 2024 pages 8 and 10), Cisco still stresses the same transformation but pivots its narrative to treat strategic alliances as a core growth lever—highlighting expanded partnerships with Apple, Equinix, Google and others—while framing competition more broadly (including price‑focused Asian vendors and other incumbents), indicating a shift from caution about alliances becoming competitors to a proactive, partnership‑driven positioning.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures Cisco's evolving positioning from 2022 to 2024 around enterprise data center transformation, noting the initial concern in 2022 about alliance partners becoming competitors due to acquisitions or realignments—consistent with the original answer's point about reduced business with Cisco as partners aligned with competitors. In 2024, the LLM correctly identifies a strategic pivot toward proactive, growth-oriented alliances (e.g., Apple, Equinix, Google), which matches the ground truth's emphasis on alliances for industry advancement and new market creation. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not applicable in that sense, but the years (2022, 2024) and page references (though not required) are correctly cited and consistent with the source context, earning full marks. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and evaluates shifts in both strategic alliances and competitive landscape. The mention of new competitors like 'price-focused Asian vendors' slightly differs from the ground truth’s specific naming of Nvidia Corporation, but the broader framing of an expanded competitive landscape is consistent. The omission of Nvidia as a named new entrant is a minor gap, but the overall shift in market dynamics is still conveyed. (4) The answer is contextually excellent—directly addressing the evolution in Cisco’s strategy, alliance dynamics, and competitive environment. Wording differs but semantic meaning is equivalent. One point deducted from qualitative and overall scores for not explicitly naming Nvidia as a new competitive threat highlighted in 2024, which is a specific detail in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 497,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the effective interest rate and notional amount associated with the 3.125% 2025 Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 3.125% 2025 Notes were part of a $5.2 billion principal amount on which new interest rate swaps were entered into after the termination of previous swaps, indicating a dynamic hedging strategy due to low interest rates. By 2023, the notional amount of the 3.125% 2025 Notes under interest rate swaps had decreased to $1.0 billion, with an effective interest rate of SOFR + 2.1%. This reflects a reduction in the hedged notional exposure and a shift in the interest rate environment.",
      "llm_answer": "In the 2022 filing the 3.125 % 2025 Notes carried a $1 billion notional amount and were hedged at an effective rate of LIBOR + 1.8% (see the swap‑rate table)【page_132】. By the 2023 filing the notional amount remained $1 billion, but the benchmark shifted and the effective rate became SOFR + 2.1% 【page_144】. Thus, the principal amount was unchanged while the effective interest rate moved from LIBOR‑based to a slightly higher SOFR‑based rate.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, the notional amount associated with the 3.125% 2025 Notes was part of a $5.2 billion principal amount on which new interest rate swaps were entered, not $1 billion as stated by the LLM. By 2023, the notional amount decreased to $1.0 billion, which matches the LLM's number, but the LLM incorrectly claims the notional amount remained unchanged at $1 billion in both years, contradicting the evolution described in the question. (2) The effective interest rate in 2022 is reported by the LLM as LIBOR + 1.8%, but the ground truth does not specify this rate or benchmark for 2022—instead, it emphasizes the restructuring of swaps due to low interest rates, without citing a specific pre-SOFR rate. The 2023 rate of SOFR + 2.1% is correct. However, the shift from LIBOR to SOFR may be contextually plausible due to market-wide benchmark transitions, but the specific rates and timing are not supported by the ground truth. (3) The multi-hop reasoning is flawed: the LLM fails to capture the key evolution—namely, a reduction in hedged notional from $5.2B to $1.0B—thus missing the core dynamic of decreasing exposure. It incorrectly assumes the $1B notional was constant, undermining the synthesis across years. (4) The contextual relevance is moderate because the answer addresses the right topic (evolution of notional and effective rate) and correctly identifies the 2023 SOFR-based rate, but major quantitative and qualitative errors severely limit factual correctness. The answer fabricates a stable $1B notional and specific 2022 hedging terms not present in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 461,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Cisco's strategic positioning of AppDynamics within its product portfolio evolved from 2022 to 2024, particularly in terms of its emphasis within observability offerings?",
      "original_answer": "In 2022, Cisco explicitly introduced AppDynamics as a key component of its full-stack observability strategy, positioning it alongside Intersight and ThousandEyes to provide application performance monitoring capabilities. However, by 2024, Cisco restructured its product revenue reporting to include a new category called 'Observability,' which subsumed offerings like AppDynamics. This shift indicates a more formalized and integrated strategic emphasis on observability as a standalone pillar within Cisco's broader portfolio.",
      "llm_answer": "In its 2022 filing Cisco described AppDynamics as a “key element” of its full‑stack observability strategy, specifically calling it out for application‑performance‑monitoring alongside Intersight and ThousandEyes (page 5). By the 2024 filing Cisco had created a separate “Observability” product category that includes the Observability Suite—of which AppDynamics is a component—and this category grew 27% year‑over‑year, signaling a stronger, revenue‑driven emphasis on AppDynamics within its observability offerings (pages 41‑42).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, Cisco positioned AppDynamics as a 'key element' of its full-stack observability strategy alongside Intersight and ThousandEyes, which matches the original answer's description. (2) For 2024, it accurately states that Cisco created a new 'Observability' product category that includes AppDynamics, reflecting the formal integration described in the ground truth. The 27% year-over-year growth cited is consistent with the emphasis on revenue-driven focus, though this specific metric is not in the original answer—it is likely drawn from the filing but not part of the ground truth provided, so it does not detract significantly. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years and infers increased strategic emphasis through structural reporting changes. (4) Minor deduction in qualitative accuracy due to the addition of the 27% growth figure, which, while plausible and relevant, was not part of the original answer and could introduce unsupported specificity. However, it does not contradict the core evolution narrative. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 355,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the effective interest rate and notional amount associated with the 4.663% 2051 Notes evolve from 2022 to 2023?",
      "original_answer": "In 2022, the 4.663% 2051 Notes were part of a $5.2 billion principal amount of notes that were hedged using interest rate swaps, with the swaps terminated and replaced at then-current interest rates. In 2023, the notional amount of the 4.663% 2051 Notes was $1.5 billion, and the effective interest rate was SOFR + 4.3%. This indicates a continuation of the hedging strategy but with updated interest rate terms and a more specific disclosure of the notional amount and rate for the 2051 Notes.",
      "llm_answer": "The 4.663 % 2051 Notes did not change between 2022 and 2023.  The notes’ effective interest rate remained 5.6 % (the same as the prior year)【page_130】【page_142】, and the interest‑rate‑swap tied to them continued to have a notional amount of $1.5 billion with an effective rate of SOFR + 4.3% in both periods【page_144】.  In short, both the effective rate and the $1.5 billion notional stayed unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and reasoning. The ground truth states that in 2022, the 4.663% 2051 Notes were part of a $5.2 billion hedged portfolio, with swaps terminated and replaced at current rates—indicating a change in hedging terms. However, the LLM claims no change occurred between 2022 and 2023, which contradicts the original answer. The LLM incorrectly states the effective interest rate remained 5.6% in both years, but the ground truth does not mention a 5.6% rate at all; instead, it specifies that in 2023, the effective rate was SOFR + 4.3%. While the LLM correctly identifies the $1.5 billion notional amount in 2023, it falsely claims this was also the notional amount in 2022, whereas the ground truth implies the $1.5 billion figure is specific to 2023 and not confirmed for 2022. (2) Quantitatively, the $1.5 billion notional amount for 2023 is correct, but the 5.6% effective interest rate is fabricated and not present in the ground truth. The SOFR + 4.3% rate is correctly cited for 2023 but wrongly attributed to both years. The $5.2 billion figure from 2022 is entirely omitted. (3) The multi-hop reasoning fails: the model does not recognize that the hedging structure evolved—swaps were terminated and replaced in 2022, indicating a change—yet the LLM asserts no change occurred. It also fails to distinguish between the broader $5.2 billion hedged notes in 2022 and the more specific $1.5 billion 2051 Notes in 2023, missing the evolution in disclosure and structure. (4) Contextual relevance is moderate because the answer addresses the right topic (interest rate and notional amount of the 2051 Notes) and references the correct type of financial instrument and hedging, but the factual inaccuracies and flawed synthesis severely undermine correctness. The model appears to misinterpret or misrepresent the timeline and changes in hedging terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 519,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of the lines of business and segmentation criteria applied?",
      "original_answer": "In 2022, AIG referenced the use of expected loss ratio methods in a general sensitivity analysis related to loss reserve assumptions, without specifying detailed segmentation or particular lines of business. By 2023, AIG explicitly applied expected loss ratio methods to U.S. Workers' Compensation, a long-tail line of business, and introduced more granular segmentation criteria such as risk-sharing features, state and industry subsets, deductible size, and claim handling entities. This indicates a more structured and detailed application of the method in 2023 compared to 2022.",
      "llm_answer": "In the 2022 filing AIG said it applied expected‑loss‑ratio techniques across a wide set of long‑tail lines – U.S. Workers’ Compensation (combined with loss‑development and segmented by state, industry, deductible size and claim‑handling mode), U.S. Excess Casualty (segmented by attachment points and layer participation), U.S. Financial‑Lines D&O (through Bornhuetter‑Ferguson and Cape‑Cod a‑priori loss‑ratio assumptions) and other run‑off lines – and even used the method in sensitivity tests for those segments (see 2022 pp. 66‑68). By contrast, the 2023 filing narrows the focus of the expected‑loss‑ratio approach to business written in excess of a deductible, giving it “significant weight in the most recent five accident years” and adjusting the ratios for rate changes, loss‑trend, inflation and market conditions rather than the detailed state/industry or deductible‑size segmentation used earlier (see 2023 pp. 200‑201).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in key aspects. (1) According to the original answer, in 2022 AIG only referenced expected loss ratio methods in a general sensitivity analysis without specifying detailed segmentation or particular lines of business. However, the LLM claims AIG applied the method across multiple specific lines (U.S. Workers’ Compensation, Excess Casualty, D&O) with granular segmentation—this level of detail and application is factually incorrect for 2022 and misrepresents the evolution. (2) The LLM states that in 2023 AIG narrowed its focus and moved away from state/industry/deductible-size segmentation, whereas the ground truth indicates that 2023 introduced these very segmentation criteria (e.g., state, industry, deductible size) specifically for U.S. Workers’ Compensation—meaning the LLM reverses the actual progression. (3) The multi-hop reasoning is flawed: instead of showing increased granularity and expansion of method use from 2022 to 2023, the LLM incorrectly portrays a shift from detailed segmentation in 2022 to a more generalized approach in 2023, which is the opposite of the truth. (4) While the LLM mentions U.S. Workers’ Compensation and some relevant segmentation factors, the overall direction of evolution is misrepresented, leading to a low correctness score. Quantitative accuracy is low due to incorrect characterization of method application (no specific numbers in question, but factual descriptors treated as qualitative metrics). Contextual relevance is moderate because the answer discusses the right topic and some plausible segmentation criteria, but the core factual trajectory is wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 457,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did PepsiCo's engagement with the 2.850% Senior Notes due 2026 evolve between 2023 and 2024, particularly in terms of its broader debt issuance strategy as reflected in the additional notes introduced in 2024?",
      "original_answer": "In 2023, PepsiCo referenced the 2.850% Senior Notes due 2026 as part of a broader set of debt instruments, including other senior notes with varying interest rates and maturity dates. By 2024, the company introduced a significantly expanded range of senior notes, including higher-yielding instruments such as the 7.00% Senior Notes due 2029 and the 5.50% Senior Notes due 2035, indicating a more diversified and long-term debt issuance strategy. This evolution suggests that PepsiCo not only maintained its commitment to the 2.850% Senior Notes due 2026 but also broadened its capital structure by incorporating a wider spectrum of debt instruments with different risk-return profiles.",
      "llm_answer": "PepsiCo first authorized the 2.850 % Senior Notes due 2026 in its 2023 board‑of‑directors resolutions (see Exhibit 4.64 on page 130 of the 2023 10‑K). The same 2.850 % notes re‑appear in the 2024 resolutions (Exhibit 4.65 on page 129 of the 2024 10‑K), and the 2024 filing also shows a broader debt‑issuance program that adds new series—such as a 3.600 % Senior Note due 2024, a 5.125 % Senior Note due 2026, a 5.250 % Senior Note due 2025 and additional longer‑dated notes (e.g., 4.500 % due 2029, 4.800 % due 2034, 5.250 % due 2054)—indicating PepsiCo’s strategy of diversifying its senior‑note portfolio beyond the original 2.850 % issuance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies PepsiCo's continued engagement with the 2.850% Senior Notes due 2026 in both 2023 and 2024, citing board resolutions and exhibit references from the respective 10-K filings, which aligns with the ground truth's emphasis on continuity. However, the specific new notes introduced in 2024 listed in the LLM answer (e.g., 3.600% due 2024, 5.125% due 2026, 5.250% due 2025, 4.500% due 2029, 4.800% due 2034, 5.250% due 2054) do not match the ground truth, which specifies the introduction of a 7.00% Senior Note due 2029 and a 5.50% Senior Note due 2035. These discrepancies in key percentages and maturities represent significant quantitative inaccuracies. (2) The numbers cited—interest rates and maturity years—are factually inconsistent with the ground truth. For example, the LLM claims a 3.600% note due 2024 was issued in 2024, but a note maturing in 2024 would have been issued earlier, and this specific instrument is not mentioned in the ground truth. Similarly, the 5.250% due 2054 is not corroborated. The ground truth emphasizes higher-yielding instruments like 7.00% and 5.50%, which the LLM fails to mention. (3) The multi-hop reasoning is partially sound: the model correctly infers that the recurrence of the 2.850% note across years indicates ongoing commitment and that the addition of new notes reflects a diversification strategy. This aligns with the qualitative interpretation in the original answer. However, because the specific instruments used to support this conclusion are incorrect, the synthesis is based on flawed data. (4) The contextual relevance is high—the answer addresses the evolution of PepsiCo’s debt strategy and attempts to show broadening of the debt portfolio. The qualitative reasoning about diversification is valid, but the correctness score is reduced due to major quantitative errors in the specific notes cited, which are central to the question about 2024's new issuances.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 531,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Cisco's exposure to channel partner financing guarantees evolved between fiscal years 2022 and 2024, and what does this indicate about the company's financial risk management strategy?",
      "original_answer": "In fiscal year 2022, Cisco disclosed that the volume of channel partner financing was $27.9 billion, with a balance of financing subject to guarantees amounting to $1.4 billion as of July 30, 2022. By fiscal year 2024, while the company continued to provide financing guarantees, the specific volume of channel partner financing and the balance subject to guarantees were no longer explicitly quantified in the disclosures. This shift indicates a potential strategic move toward reducing transparency around these financial commitments, which may reflect a broader risk management approach to limit visibility into contingent liabilities. However, the absence of updated figures prevents definitive conclusions about the actual change in exposure.",
      "llm_answer": "Cisco’s contingent liability for channel‑partner financing guarantees fell markedly – the “maximum potential future payments” under those guarantees were about **$188 million in FY 2022** (net $179 million after deferred‑revenue offsets) and **approximately $127 million in FY 2024** (including $13 million of deferred revenue)【page_94】【page_50】.  The decline shows Cisco is actively curbing the size of its guarantee commitments, reflecting a more conservative, risk‑focused approach to managing contingent liabilities.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in FY 2022, Cisco reported a balance of financing subject to guarantees of $1.4 billion (not $188 million or $179 million as stated by the LLM). The ground truth also states that in FY 2024, Cisco no longer disclosed specific figures for channel partner financing guarantees, whereas the LLM claims a precise figure of $127 million — which contradicts the original answer that no such quantification was provided. These numbers are not just incorrect but misrepresent the nature and magnitude of the exposure. (2) The calculations and comparisons are therefore invalid. The LLM asserts a decline from $188M to $127M, implying a trend, but the ground truth explicitly states that FY 2024 figures were not disclosed, making any such comparison unsupported. Additionally, the LLM cites 'maximum potential future payments' and 'deferred revenue offsets' that are not mentioned in the original answer, introducing metrics not present in the source. (3) The multi-hop reasoning is flawed. The original answer emphasizes a lack of transparency in FY 2024 due to missing disclosures, suggesting caution in drawing conclusions. In contrast, the LLM assumes continuity of disclosure and computes a trend that cannot be validated, failing to recognize the shift in reporting practice. This reflects a failure to synthesize the key point: reduced disclosure, not reduced liability, is the observable change. (4) While the LLM attempts to address the question about risk management strategy, it draws the opposite conclusion from the available evidence — asserting a conservative strategy based on declining guarantees, while the ground truth suggests reduced transparency may indicate a desire to limit visibility into liabilities. Thus, the reasoning and conclusion are misaligned with the facts. The contextual relevance is moderate because the answer addresses the right topic and timeframe, but with incorrect data and interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 546,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has the status and interest rate structure of the 2.45% 2030 Notes evolved between 2022 and 2023?",
      "original_answer": "In 2022, Amgen disclosed that it had entered into interest rate swap contracts with an aggregate notional amount of $1.0 billion with respect to the 2.45% 2030 Notes, effectively converting the fixed-rate interest to a floating LIBOR-based coupon. By 2023, the 2.45% 2030 Notes remained outstanding with a notional amount of $1.0 billion, but the interest rate structure had transitioned from LIBOR to SOFR, now stated as SOFR + 1.3%. This reflects a continuation of the note's existence but with a modified floating-rate benchmark.",
      "llm_answer": "The 2.45 % 2030 Notes were issued in 2020 for $1.25 billion and, according to the 2022 filing, were still fully outstanding (the table shows $1,250 m of 2.45 % 2030 Notes and the debt‑issuance note confirms the $1.25 bn issuance) with no repayment reported 【page_130】【page_131】. By the 2023 filing the notes remained on the balance sheet (no redemption is disclosed) and the company continued to hedge $1 billion of them with an interest‑rate swap; the swap’s reference rate shifted from LIBOR + 1.0 % (as of Dec 31 2021) to SOFR + 1.3 % (as of Dec 31 2023) while the hedged notional stayed at $1 billion 【page_132】【page_144】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the continuation of the 2.45% 2030 Notes being outstanding and the use of interest rate swaps to convert fixed to floating rates, with a shift from LIBOR to SOFR. However, it introduces an incorrect issuance amount of $1.25 billion, while the ground truth does not specify the original issuance size and focuses on the $1.0 billion notional amount hedged. The LLM claims the full $1.25 billion remained outstanding in 2022, but the ground truth only confirms $1.0 billion was subject to swaps, not necessarily the total outstanding amount. Additionally, the LLM states the 2022 swap was LIBOR + 1.0%, but the ground truth does not specify the spread in 2022—only that it became SOFR + 1.3% in 2023. (2) The numbers for the hedged notional ($1 billion) and the 2023 SOFR + 1.3% rate are correct and align with the ground truth. However, the $1.25 billion figure and the LIBOR + 1.0% spread are unsupported by the provided ground truth and appear to be overextrapolations from document snippets. (3) The multi-hop reasoning is mostly sound—linking the existence of the notes across years and the evolution of the swap terms—but it incorrectly infers details not present in the ground truth, particularly around the total note amount and the exact 2022 spread. (4) The contextual relevance is high as the answer directly addresses the evolution of the note's status and interest rate structure. Qualitative accuracy is strong due to correct entity identification (Amgen, 2.45% 2030 Notes, swap transition), but quantitative accuracy is reduced due to unsupported numerical claims. Correctness score is 7 because core facts about the swap transition and note status are correct, but key numbers are inaccurate or unverified.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 481,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has FedEx's relationship with Pass-Through Certificates evolved between 2022 and 2023, particularly regarding its financial guarantees and obligations?",
      "original_answer": "In 2022, FedEx Express had issued $970 million of Pass-Through Certificates, Series 2020-1AA, which were fully and unconditionally guaranteed by FedEx. These certificates were secured by 19 Boeing aircraft with a net book value of $1.8 billion. However, in 2023, FedEx clarified that pass-through certificates associated with leveraged operating leases were not direct obligations of, nor guaranteed by, FedEx or FedEx Express. This indicates a shift from direct financial guarantees in 2022 to a position of no direct financial obligation in 2023.",
      "llm_answer": "In the 2022 filing FedEx disclosed that the $970 million of Series 2020‑1AA pass‑through certificates issued by FedEx Express were “fully and unconditionally guaranteed” by FedEx, and it also noted that the certificates are not a direct liability of FedEx or FedEx Express. The 2023 filing repeats the same unconditional guarantee and the same disclaimer that the certificates are not a direct obligation, with only a modest change in the collateral – the 19 Boeing aircraft backing the certificates were valued at $1.8 billion in 2022 and $1.7 billion in 2023. Thus, FedEx’s guarantee and the nature of its obligations to the certificates have remained essentially unchanged between the two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct quantitative details: the $970 million amount, the Series 2020-1AA designation, the 19 Boeing aircraft, and the collateral value change from $1.8 billion in 2022 to $1.7 billion in 2023 are all factually accurate or reasonably close. However, the core qualitative claim—that FedEx’s guarantee and obligations remained 'essentially unchanged'—is directly contradicted by the ground truth. The original answer states that in 2023, FedEx clarified that pass-through certificates were *not* guaranteed by FedEx or FedEx Express, marking a significant shift from the 2022 position where they were 'fully and unconditionally guaranteed.' The LLM incorrectly asserts continuity, misrepresenting the evolution of FedEx's financial obligations. (2) Quantitative accuracy is high: all dollar amounts, series identifiers, and asset counts align with or are minor variations of the truth. The $100 million decrease in collateral value is plausible and not contradicted. (3) Multi-hop reasoning fails: the model does not correctly synthesize the change in legal and financial stance between years. It notes both the guarantee and the disclaimer in both years, but fails to resolve the contradiction or recognize the strategic recharacterization in 2023. Instead, it treats the disclaimer as consistent with the guarantee, when in fact the 2023 filing represents a retraction of prior implied support. (4) Correctness is low due to the fundamental error in interpreting the nature of FedEx’s obligations over time, despite accurate numbers. Qualitative accuracy is poor because the conclusion is the opposite of the truth—no guarantee in 2023 is not a minor change but a major shift. Contextual relevance is moderate as the answer addresses the right topic and documents, but draws the wrong inference.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 499,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Mastercard's use of risk mitigation arrangements to manage gross settlement exposure evolve from 2023 to 2024, and what does this indicate about the company's risk management strategy?",
      "original_answer": "In 2023, Mastercard had $75,023 million in gross settlement exposure, with $12,167 million covered by risk mitigation arrangements. By 2024, gross settlement exposure increased to $78,385 million, and the company applied $13,466 million in risk mitigation arrangements, reflecting an increase in both total exposure and the amount mitigated. This indicates that Mastercard's risk management strategy became more robust over time, as it increased its use of mitigation tools in response to growing settlement exposure.",
      "llm_answer": "In 2023 Mastercard reported $75 billion of gross settlement exposure and offset $12.2 billion of that exposure with risk‑mitigation arrangements (cash collateral, letters of credit, guarantees), leaving a net exposure of $62.9 billion. By year‑end 2024 gross exposure had risen to $78.4 billion and the company had increased its mitigation instruments to $13.5 billion, producing a net exposure of $64.9 billion – a slightly higher mitigation‑to‑gross ratio (≈17 % versus 16 % in 2023). This shows that Mastercard scales its collateral and credit‑enhancement safeguards in step with growing settlement risk, reflecting a disciplined, proactive risk‑management framework that continuously adjusts mitigation to keep net exposure under control.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the numbers are correctly reported with acceptable rounding: $75,023 million is accurately rounded to $75 billion (and $75.0B), $12,167 million to $12.2 billion, $78,385 million to $78.4 billion, and $13,466 million to $13.5 billion. These minor rounding differences are within acceptable limits and do not affect factual correctness. The net exposure calculations ($75B - $12.2B = $62.8B ≈ $62.9B; $78.4B - $13.5B = $64.9B) are correct, and the implied mitigation-to-gross ratios (~16.3% in 2023 and ~17.2% in 2024) support the stated ≈16% and ≈17% comparison. (2) The answer is complete, addressing both the evolution from 2023 to 2024 and the implication for risk management strategy. (3) Entities—Mastercard, gross settlement exposure, risk mitigation arrangements, and years—are correctly identified. (4) The reasoning is sound and adds value by calculating the mitigation ratio and net exposure, concluding that Mastercard proactively scales its risk controls—a logical and well-supported interpretation of the trend. The only minor shortcoming is the use of rounded figures without specifying exact values, which slightly reduces quantitative precision but does not misrepresent the data. Overall, the answer demonstrates strong multi-hop synthesis and correct interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 381,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Nike's liabilities related to foreign exchange forwards and options designated as hedging instruments change between 2022 and 2024, and what does this indicate about the company's exposure or strategy?",
      "original_answer": "In 2022, Nike reported $37 million in liabilities for foreign exchange forwards and options designated as hedging instruments under accrued liabilities, and $11 million under deferred income taxes and other liabilities, totaling $48 million. By 2024, the liability under accrued liabilities for the same category increased to $110 million, while the amount under deferred income taxes and other liabilities decreased to $5 million, resulting in a total of $115 million. This represents a significant increase in total liabilities for designated hedging instruments related to foreign exchange forwards and options, indicating a potential increase in Nike's foreign exchange risk exposure or a strategic shift in hedging activity.",
      "llm_answer": "Nike’s foreign‑exchange forward and option liabilities that are designated as hedging instruments rose sharply – from about **$37 million in 2022** (all recorded as accrued liabilities) to roughly **$115 million in 2024** (about $110 million accrued plus $5 million in deferred‑tax liabilities)【page_83 (2022)】【page_83 (2024)】. The three‑fold increase in these hedging‑instrument liabilities indicates that Nike has expanded its currency‑hedge program, likely to cover larger foreign‑exchange exposure from its global operations or to adopt a more aggressive risk‑management strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the key numbers: $37 million total liability in 2022 (though it omits the $11 million under deferred income taxes and assumes the full amount was under accrued liabilities), and accurately states the 2024 breakdown of $110 million under accrued liabilities and $5 million under deferred taxes, totaling $115 million. The total figures for both years match the ground truth ($48M in 2022 and $115M in 2024), but the LLM incorrectly simplifies the 2022 allocation by stating all $37M was under accrued liabilities, when in fact the $37M was only part of the total $48M (with an additional $11M in deferred income taxes). This is a minor inaccuracy in breakdown but does not affect the overall total. (2) Calculations are correct: the increase from ~$48M to $115M is accurately reflected as a significant rise, and the LLM’s description of a 'three-fold increase' is approximately correct (115/48 ≈ 2.4x, which may be rounded up). (3) Multi-hop reasoning is sound—information is synthesized across 2022 and 2024 filings, and the conclusion about increased hedging activity or exposure is logically supported by the data. (4) The answer addresses both parts of the question: the change in liabilities and the implication for exposure or strategy. The interpretation—that Nike likely expanded its hedge program due to greater FX exposure or more aggressive risk management—is semantically equivalent to the ground truth’s suggestion of increased risk exposure or strategic shift. The only shortcoming is the misrepresentation of the 2022 liability allocation, which slightly affects qualitative accuracy but not overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 458,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the representation of Bounty within P&G's Baby, Feminine & Family Care segment evolve between the 2022 and 2023 10-K filings, and what does this suggest about its brand visibility?",
      "original_answer": "In the 2022 10-K filing, Bounty was mentioned as part of P&G's Family Care business within the Baby, Feminine & Family Care segment, but it was not explicitly listed among the key brands. In contrast, the 2023 10-K filing explicitly included Bounty among the major brands under the Family Care category. This change suggests an increase in Bounty's brand visibility within P&G's portfolio, though the filings do not provide specific market share or sales figures to quantify this shift. The explicit mention in 2023 indicates a possible strategic move to highlight Bounty's role, though no direct strategic intent is stated in the evidence provided.",
      "llm_answer": "In the 2022 10‑K, Bounty was listed among the Baby, Feminine & Family Care segment’s “Major Brands” (as “Tampax Bounty”) and was mentioned only as part of the family‑care business 【page_19】. By the 2023 10‑K, Bounty remains a major brand in the same segment (still shown as “Tampax Bounty”), but the filing now highlights its strength – noting “North America market shares are over 40 % for Bounty” 【page_18】. Adding a specific market‑share figure indicates that P&G is giving Bounty greater prominence and brand visibility within the segment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Bounty was *not* explicitly listed among the key brands in the 2022 10-K, but the LLM claims it was listed as 'Tampax Bounty'—a brand combination that does not exist in P&G's reporting. This is a critical error in entity representation. Additionally, the LLM asserts that the 2023 10-K includes a specific market share figure of 'over 40%' for Bounty in North America, which is not supported by the original answer or the evidence provided in the ground truth. The ground truth explicitly states that *no market share or sales figures* were provided in either filing to quantify Bounty's performance. (2) Quantitative accuracy is severely compromised: the 40% market share figure is entirely fabricated in this context, and there is no mention of such data in the original answer. No calculations are involved, but the introduction of false quantitative data undermines reliability. (3) The multi-hop reasoning is flawed. The LLM incorrectly identifies the presence of Bounty in the 2022 list of major brands and misrepresents how it was described. It then draws a conclusion about increased brand visibility based on a non-existent metric, leading to invalid inference. While the general direction—increased visibility—aligns with the ground truth’s interpretation, the reasoning path is based on false premises. (4) Contextual relevance is moderate because the answer addresses the evolution of Bounty's representation and brand visibility, which is on-topic, but the use of incorrect data and brand naming ('Tampax Bounty') severely damages factual integrity. The conclusion about greater prominence is partially aligned with the ground truth’s suggestion of increased visibility, but it is unjustified by the cited evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 496,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How has Oracle's approach to its hardware business, particularly Oracle Engineered Systems, evolved between fiscal 2022 and fiscal 2023 in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle's hardware business, which includes Oracle Engineered Systems, was described in terms of its contractual activities and revenue recognition, with an emphasis on the timing of revenue recognition for cloud and license contracts. By fiscal 2023, Oracle introduced a more detailed explanation of how hardware and related software are treated as a combined performance obligation, with revenue recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve and develop new hardware products and services, which was not explicitly mentioned in 2022. This indicates a shift toward a more strategic focus on innovation and integration of hardware and software components within the hardware business.",
      "llm_answer": "In FY 2022 Oracle explained that hardware – including Oracle Engineered Systems – is accounted for as a product‑plus‑software bundle whose revenue is recognized at the point in time the equipment and its essential software are delivered, while hardware‑support fees are recognized ratably over the contract term【page_105】. By FY 2023 the same point‑in‑time and ratable treatment is retained, but Oracle now highlights the hardware line as about 6 % of total revenue, stresses continued R&D investment to improve and add new Engineered Systems, and emphasizes that the hardware and its software are a combined performance obligation, indicating a more explicit, integrated strategic focus on the hardware portfolio【page_43】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the revenue recognition method for hardware and software as a combined performance obligation recognized at point of delivery is accurately described for both years, and the shift in strategic emphasis toward R&D investment in FY2023 is correctly identified. The 6% of total revenue figure for hardware in FY2023 is a precise addition not in the original answer but consistent with likely source data and adds value without contradicting the ground truth. (2) Quantitative accuracy is perfect: no incorrect numbers, percentages, or misattributed fiscal years. The mention of page references (e.g., page_105, page_43) suggests fidelity to source documents. (3) Multi-hop reasoning is sound—LLM correctly synthesizes changes in both revenue recognition language and strategic emphasis across two fiscal years, identifying continuity in accounting treatment while highlighting new disclosures in 2023. (4) The only reason for not scoring a 10 is minor: the original answer emphasizes that in FY2022, the focus was on timing of revenue recognition for cloud and license contracts broadly, while the LLM answer frames the FY2022 policy accurately but slightly narrows the context. However, this does not make it incorrect—just less contextual than the ground truth. Overall, the answer is semantically equivalent, factually precise, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 404,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did the sales performance of the product ERLEADA evolve between 2022 and 2023, and what does this indicate about its market trajectory?",
      "original_answer": "In 2022, ERLEADA generated $1,881 million in sales, and by 2023, its sales increased to $2,387 million, representing a 26.9% growth. This indicates a strong upward trajectory for ERLEADA in the market, suggesting increased adoption or improved commercial performance over the period.",
      "llm_answer": "ERLEADA’s sales climbed from $1.881 billion in 2022 to $2.387 billion in 2023 – a 26.9% increase (27.5% operational growth)【page_31】.  The company attributes this jump to “continued share gains and market growth in metastatic castration‑resistant prostate cancer,” indicating a strong, upward market trajectory for the product【page_32】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the sales figures for ERLEADA are accurate: $1.881 billion in 2022 and $2.387 billion in 2023, with a calculated growth rate of 26.9%, which matches the ground truth exactly. The additional detail of 27.5% operational growth is a minor elaboration not contradicted by the original answer. (2) The answer addresses both parts of the question: the sales performance evolution (increase from 2022 to 2023) and the market trajectory (upward, supported by share gains and market growth in a specific indication). (3) Entity accuracy is correct: ERLEADA is the product in focus, years are accurate (2022 and 2023), and the financial metric (sales) is appropriate. (4) The reasoning is sound and reflects multi-hop synthesis—connecting sales growth to market dynamics using information likely drawn from different parts of the filing (as indicated by page references). The conclusion about strong upward trajectory aligns semantically with the original answer. Minor enhancements (e.g., citing 'metastatic castration-resistant prostate cancer') add context without deviating from correctness. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 343,
        "total_tokens": 1496
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the nature of CMCSA's relationship with local broadcast television stations evolved from 2023 to 2024, particularly in terms of competitive positioning and dependency for content distribution?",
      "original_answer": "In 2023, CMCSA's Media segment directly competed with local broadcast television stations for viewers' attention and advertising revenue. By 2024, the relationship shifted to a more interdependent one, where CMCSA's linear television networks became reliant on local broadcast television stations for retransmission consent, which is necessary for distributing broadcast network programming to video service customers. This marks a shift from competition to dependency, reflecting a strategic and operational evolution in how CMCSA interacts with local broadcast stations.",
      "llm_answer": "In the 2023 filing Comcast framed local broadcast stations largely as **competitors‑turned‑necessary partners** – it said the company “competes … with … local broadcast television stations” for talent and content and that its domestic broadcast networks must “secure affiliations with independently owned local broadcast television stations … to ensure the effective distribution of broadcast‑network programming”【page_14】.  \n\nBy the 2024 filing the tone has shifted to one of **greater dependency and cost pressure**: Comcast now highlights that programming expenses include “payments to certain local broadcast television stations in exchange for their required consent for the retransmission of broadcast network programming” and that it will “continue to be subject to demands for payment and other concessions” from those stations, while still needing “network affiliation agreements with third‑party local broadcast television stations” for distribution【page_23】【page_22】.  \n\nThus, the relationship has moved from a competitive‑affiliation focus in 2023 to a more bargaining‑heavy, cost‑driven dependence on local stations for retransmission consent and distribution in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in CMCSA's relationship with local broadcast television stations from 2023 to 2024: initially competitive, then shifting toward dependency. The key elements—competition for viewers and advertising in 2023, and reliance on retransmission consent and affiliation agreements in 2024—are all present and correctly attributed. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable; however, the years (2023 and 2024) are correctly used and tied to the appropriate disclosures. (3) The multi-hop reasoning is sound: the model synthesizes information from two different filings (2023 and 2024), correctly infers the shift in strategic posture from competition to dependency, and supports this with direct quotes and page references. The characterization of the shift as 'competitors-turned-necessary partners' and later 'bargaining-heavy, cost-driven dependence' captures the semantic essence of the original answer’s 'shift from competition to dependency.' (4) The only minor shortcoming is that the LLM answer emphasizes 'cost pressure' and 'demands for payment' more than the original, which focuses on the structural shift in dependency for distribution. While this is a valid interpretation supported by the 2024 filing, it adds a slight nuance (financial burden) not emphasized in the ground truth. However, this does not detract from factual correctness. Overall, the answer is contextually relevant, factually accurate, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 456,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did the value of Held-to-Maturity (HTM) securities held by MA evolve between 2023 and 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2023, MA held $306 million in HTM securities, but by 2024, this amount dropped significantly to $38 million. This indicates a major shift in MA's investment strategy, with a sharp reduction in long-term held securities, likely reflecting a move toward more liquid or short-term investment positions.",
      "llm_answer": "Mastercard’s held‑to‑maturity securities fell from **$306 million at the end of 2023** to **$38 million at the end of 2024**, a decline of about $268 million【page_86】【page_83】. This dramatic reduction indicates the company is moving away from a large time‑deposit (HTM) portfolio toward more liquid, available‑for‑sale investments, reflecting a strategic shift to greater flexibility and liquidity in its investment approach.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of $306 million in 2023 and $38 million in 2024 are accurately reported, and the implied decrease of $268 million is correct. The years are properly aligned with the data. (2) The answer addresses both parts of the question: the change in HTM value between 2023 and 2024, and the strategic implication of this shift. (3) Entities are accurate—MA (Mastercard) is correctly identified, and the financial metric (HTM securities) is properly used. (4) The reasoning is sound: the sharp reduction is correctly interpreted as a strategic move toward greater liquidity and flexibility, with a shift to available-for-sale investments, which aligns with the ground truth's interpretation of a move toward more liquid or short-term positions. Minor wording differences (e.g., 'time-deposit' as a descriptor for HTM) do not affect factual accuracy and are contextually acceptable. All information is semantically equivalent and supported by the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 301,
        "total_tokens": 1489
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has the positioning of the Always brand within Procter & Gamble's Baby, Feminine & Family Care segment evolved between 2022 and 2023, particularly in terms of its product categorization and associated sub-categories?",
      "original_answer": "In 2022, Always was categorized under Feminine Care within the Baby, Feminine & Family Care segment, which included sub-categories like Adult Incontinence and Feminine Care. By 2023, the brand remained part of the same reportable segment but was more specifically aligned with 'Menstrual Care' under the updated Feminine Care sub-category, reflecting a more targeted positioning. This evolution indicates a strategic shift in how Always is being categorized to emphasize its core focus area.",
      "llm_answer": "In the 2022 filing the “Baby, Feminine & Family Care” segment was broken out into three sub‑categories – Baby Care, Feminine Care (Adult Incontinence and Feminine Care) and Family Care – and Always was listed among the segment’s major brands under the generic Feminine Care sub‑category【page_19】. By the 2023 filing the segment’s product categories were trimmed to Feminine Care (Adult Incontinence and Menstrual Care) and Family Care, and Always is now positioned explicitly in the Menstrual Care sub‑category of Feminine Care (with Always Discreet still in Adult Incontinence)【page_18】. This reflects a shift from a broader “Feminine Care” grouping to a more specific “Menstrual Care” categorization for the Always brand.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately reflects the 2022 categorization of Always under the broader 'Feminine Care' sub-category within the Baby, Feminine & Family Care segment, including the presence of Adult Incontinence and Feminine Care as sub-components. (2) It correctly identifies the 2023 reorganization, where 'Feminine Care' was refined to include 'Menstrual Care' as a distinct sub-category, with Always now explicitly positioned under Menstrual Care, while noting that Always Discreet remains in Adult Incontinence. (3) The multi-hop reasoning is sound—comparing the structural changes between two years and linking them to the brand’s evolving positioning. (4) The answer captures all key entities (Always, Baby, Feminine & Family Care segment, Menstrual Care, Adult Incontinence), correct years (2022 vs 2023), and correctly interprets the strategic shift toward more targeted categorization. Minor wording differences (e.g., 'generic Feminine Care' vs 'Feminine Care') are semantically equivalent and do not affect accuracy. All information is contextually relevant and factually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 326,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How has Oracle's positioning and financial contribution of Oracle Engineered Systems evolved between 2022 and 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In 2022, Oracle Engineered Systems were disclosed as part of hardware revenues, but no specific percentage of total revenue was provided. Revenue recognition for hardware products, including Engineered Systems, was described as occurring at the point in time when the product and related software were delivered. By 2023, Oracle explicitly stated that the hardware business, which includes Engineered Systems, represented 6% of total revenues in both fiscal 2023 and fiscal 2024, indicating a clearer and more consistent measurement of the product line's contribution. Additionally, in 2023, Oracle emphasized ongoing R&D investments to improve hardware offerings and introduced more detailed factors affecting hardware revenue predictability, such as manufacturing partner performance and competitive positioning against cloud infrastructure offerings. This reflects both quantitative and strategic evolution in how Oracle presents and manages the Engineered Systems product line.",
      "llm_answer": "In the 2022 filing Oracle described Engineered Systems simply as a component of its hardware segment, noting that “revenues from the sale of hardware products represent amounts earned primarily from the sale of our Oracle Engineered Systems…​” and that “the revenues for this combined performance obligation are generally recognized at the point in time that the hardware product is delivered” (Notes – Revenue Recognition, p. 74‑76). By the 2023 filing the company still positions Engineered Systems within the hardware business, but now calls out that the hardware segment (which includes Engineered Systems) contributed roughly 6 % of total revenue and stresses “continued investments in research and development to improve existing hardware products and services and to develop new hardware products and services” (Business Overview – Hardware, p. 43). Thus, the accounting treatment (point‑in‑time revenue recognition) remains unchanged, while the strategic narrative has shifted from a purely accounting focus in 2022 to an explicit growth‑and‑R&D emphasis and a disclosed 6 % revenue contribution in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the 6% revenue contribution of the hardware segment (including Engineered Systems) in fiscal 2023 and 2024 is accurately reported, with correct context that this was not quantified in 2022. The revenue recognition policy—point-in-time upon delivery—is correctly stated for both years. (2) The answer addresses all parts of the question: evolution in positioning (from being a generic component in 2022 to a strategically emphasized, R&D-focused product line in 2023), financial contribution (introduction of 6% metric), revenue recognition (unchanged treatment), and strategic emphasis (new focus on R&D and external factors affecting predictability). (3) Entities are accurate: Oracle, Engineered Systems, hardware segment, fiscal years 2022 and 2023, and correct referencing of disclosures in the 10-K (e.g., Business Overview, Revenue Recognition notes). (4) Multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings, compares disclosure depth, identifies continuity in accounting policy, and detects a shift in strategic narrative. The LLM even adds value by citing specific sections and page numbers, enhancing verifiability. Semantic equivalence is strong, with no factual discrepancies. Minor wording differences (e.g., 'roughly 6%' vs 'represented 6%') do not affect accuracy. All criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1532,
        "completion_tokens": 404,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Comcast's relationship with representation firms evolved in terms of advertising sales strategy between 2023 and 2024?",
      "original_answer": "In 2023, Comcast worked with representation firms as an extension of its sales force to sell a portion of the advertising units allocated to them, recording revenue net of agency commissions. By 2024, Comcast had evolved this relationship into formal representation agreements under which they sell advertising on behalf of third parties, indicating a deeper strategic alignment and expanded role for these firms. This reflects a shift from a co-selling model to a more formalized representation structure.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K filings describe the same approach: Comcast works with representation firms as an extension of its own sales force, using them to sell a portion of the advertising units allocated to the company and recording the revenue net of agency commissions【page_75】. The language is essentially identical in each year, indicating that the advertising‑sales strategy involving representation firms has remained unchanged between 2023 and 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that Comcast's strategy remained unchanged between 2023 and 2024. The ground truth states a clear evolution from a co-selling model in 2023 to formal representation agreements in 2024, reflecting a strategic shift. The LLM incorrectly claims the language in the 10-K filings is 'essentially identical' and that the strategy has 'remained unchanged,' which contradicts the ground truth. (2) There are no numeric values in this question, so quantitative accuracy is not applicable; however, the LLM does not introduce any incorrect numbers, so this dimension is scored as fully accurate. (3) The multi-hop reasoning is flawed: the model fails to recognize the strategic evolution described in the ground truth, which requires synthesizing changes in Comcast's relationship with representation firms across two years. Instead, it asserts no change occurred, indicating a failure in comparative analysis across filings. (4) Contextual relevance is moderate because the answer discusses the correct topic (Comcast's use of representation firms in ad sales) and references the correct type of document (10-K), but it draws an incorrect conclusion about the evolution of the strategy, making it misleading despite using plausible language. The answer misses the core of the multi-hop comparison the question demands.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 382,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Oracle's approach to its industry-specific hardware offerings evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue recognition and strategic emphasis?",
      "original_answer": "In fiscal 2022, Oracle described its hardware business as including industry-specific hardware and recognized hardware revenues at the point in time when products and related software were delivered to customers. By fiscal 2023, Oracle introduced a more detailed explanation of revenue recognition for hardware, stating that revenues for combined performance obligations (hardware plus related software) are generally recognized at the point in time of delivery and ownership transfer. Additionally, in 2023, Oracle emphasized ongoing investments in R&D to improve existing hardware offerings and develop new products, signaling a more strategic focus on innovation in this area compared to 2022, where the description was more general and focused on the breadth of offerings.",
      "llm_answer": "Oracle’s accounting for its industry‑specific hardware remained unchanged – both the 2022 filing (see page 105) and the 2023 filing (see page 43) state that hardware products and the related software are treated as a single performance obligation and revenue is recognized at the point of delivery, with hardware‑support fees recognized ratably over the contract term. However, the strategic emphasis shifted: hardware now represents about 6 % of total revenue in fiscal 2023 (down from roughly 7‑8 % in fiscal 2022) and the 2023 discussion stresses a broader, integrated hardware portfolio and continued R&D investment, indicating a modest but sustained focus amid a stronger push toward cloud and license growth.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Oracle's revenue recognition for hardware (combined with related software) remained consistent between fiscal 2022 and 2023, recognizing revenue at the point of delivery. This aligns with the ground truth, which notes that both years recognize hardware revenue upon delivery. However, the LLM introduces specific percentages (6% of total revenue in 2023, down from 7–8% in 2022) that are not present in the original answer and cannot be verified from the provided ground truth, making these additions potentially inaccurate or unsupported. (2) The quantitative accuracy is partially compromised due to the inclusion of unverified revenue percentages. While the direction of change (decline in hardware's revenue share) may be plausible, the exact figures are not corroborated by the ground truth, which does not mention revenue proportions. This introduces a factual risk, lowering the quantitative score. (3) The qualitative reasoning is strong: the LLM correctly identifies that the accounting policy did not change and accurately reflects the point-in-time recognition for combined performance obligations. It also correctly notes a shift in strategic emphasis, highlighting increased focus on R&D and an integrated hardware portfolio in 2023—consistent with the ground truth’s observation of a more strategic innovation focus in 2023 versus a more general description in 2022. The multi-hop synthesis across years and between accounting and strategy aspects is sound. (4) Contextual relevance is high, as the response directly addresses both revenue recognition and strategic emphasis, the two core components of the question. Despite the unsupported percentages, the overall structure, logic, and factual core (especially on revenue recognition and R&D emphasis) are aligned with the ground truth, warranting a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 512,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the sales performance of IMBRUVICA (ibrutinib) evolve between 2022 and 2023, and what factors contributed to this change?",
      "original_answer": "IMBRUVICA sales decreased from $3.784 billion in 2022 to $3.264 billion in 2023, a decline of 13.7%. In 2022, the growth of IMBRUVICA was already being offset by competitive pressures from novel oral agents and market dynamics related to the pandemic, such as delays in new patient starts. By 2023, this downward trend continued, with the product experiencing a significant drop in sales, reflecting sustained competitive pressures and likely increased market saturation or treatment shifts in the oncology space.",
      "llm_answer": "IMBRUVICA sales fell from $3.784 billion in 2022 to $3.264 billion in 2023, a 13.7% decline driven by a 13.2% operational drop and a 0.5% adverse currency impact (page_31). The company attributed the operational decline to global competitive pressures on the drug (page_32).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the sales figures for IMBRUVICA in 2022 ($3.784 billion) and 2023 ($3.264 billion), and accurately calculates the 13.7% decline, matching the ground truth. The breakdown into a 13.2% operational drop and 0.5% currency impact is additional detail not contradicted by the original answer and consistent with the overall decline. (2) All numeric values and percentages are accurate. The calculation of the percentage decline ((3.784 - 3.264) / 3.784 ≈ 13.7%) is correct. Format variations (e.g., $3.784 billion) are acceptable and match. (3) The reasoning is sound: the LLM identifies competitive pressures as the primary driver, which aligns with the ground truth. It adds specificity by citing 'global competitive pressures' and distinguishing operational vs. currency impacts, which enhances rather than distorts the narrative. However, it omits mention of pandemic-related delays in new patient starts in 2022 and does not reference market saturation or treatment shifts in 2023, which are part of the full explanatory context in the original answer. This makes the qualitative explanation slightly less complete but still accurate in its core claims. (4) The answer is highly relevant, directly addressing both parts of the question—sales evolution and contributing factors. The scores reflect near-perfect quantitative accuracy and strong qualitative accuracy, with a minor deduction in qualitative accuracy due to incomplete contextual factors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 413,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Comcast's involvement with Universal Beijing Resort evolved from 2023 to 2024 in terms of debt levels, ownership structure, and financial risk exposure?",
      "original_answer": "In 2023, Universal Beijing Resort had $3.5 billion of debt outstanding, including a $3.1 billion term loan, and was consolidated by Comcast, which owns a 30% interest. By 2024, the debt level slightly decreased to $3.4 billion, with the term loan principal reducing to $3.0 billion. Comcast continues to consolidate Universal Beijing Resort as a VIE, maintaining its 30% ownership stake. The maximum financial risk exposure for Comcast remains limited to its 30% equity interest, indicating a stable risk profile despite the slight reduction in debt. This evolution reflects a minor decrease in leverage but no change in ownership or governance structure.",
      "llm_answer": "In 2023 Comcast’s 30 % stake in Universal Beijing Resort was backed by about $3.5 billion of debt (including a $3.1 billion term loan) and the resort’s assets and liabilities were $7.8 billion and $7.2 billion, respectively. By year‑end 2024 the debt had slipped to roughly $3.4 billion (term loan $3.0 billion) and the consolidated assets and liabilities fell to $7.3 billion and $7.0 billion, while Comcast’s ownership remained unchanged at 30 % and there are still no liquidity arrangements, guarantees or other commitments – meaning its maximum financial loss is limited to that 30 % equity interest【page_86†L9-L15】【page_86†L16-L22】【page_56†L31-L38】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key quantitative data are correct: 2023 debt of $3.5 billion (including $3.1 billion term loan), 2024 reduction to $3.4 billion ($3.0 billion term loan), and Comcast's unchanged 30% ownership. These match the original answer exactly, with acceptable formatting (e.g., $3.5 billion vs $3.5 billion). (2) The LLM adds extra but accurate details not in the ground truth—specific asset and liability figures for 2023 and 2024 ($7.8B/$7.2B and $7.3B/$7.0B)—which are consistent with the source citations and do not contradict the original answer. (3) The reasoning is sound: it correctly identifies Comcast’s consolidation of Universal Beijing Resort as a VIE, absence of guarantees or liquidity support, and that financial risk remains limited to the 30% equity stake—this captures the core of the risk exposure analysis. (4) The only minor gap is that the original answer explicitly mentions the VIE (variable interest entity) consolidation framework, while the LLM implies it through context but does not name it. However, the functional understanding is preserved. Multi-hop synthesis across years and financial dimensions (debt, ownership, risk) is accurate and complete. Overall, the answer is factually excellent, with only slight omission of the term 'VIE' preventing a perfect 10 on qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 384,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How did the financial commitment related to future lease payments for build-to-suit facilities and equipment evolve from 2022 to 2023, and what does this indicate about FedEx's leasing strategy?",
      "original_answer": "In 2022, FedEx disclosed future undiscounted payments of approximately $3.4 billion for build-to-suit facilities that had not yet commenced, with expected commencement dates from 2023 to 2024. By 2023, the company reported a significant reduction in these future commitments, with undiscounted payments dropping to approximately $0.9 billion for build-to-suit facilities and equipment, with commencement dates expected from 2025 to 2027. This indicates a strategic shift toward fewer long-term build-to-suit lease commitments and a more extended timeline for asset utilization.",
      "llm_answer": "- In the 2022 filing FedEx said that “additional leases … for build‑to‑suit facilities … have undiscounted future payments of approximately **$3.4 billion**” (page 96).  \n- The 2023 filing shows that the same type of commitment is now only about **$0.9 billion** (page 98).  \n\nThe drop from $3.4 billion to $0.9 billion indicates FedEx is scaling back its build‑to‑suit lease program, adopting a more restrained and selective leasing strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the key financial figures: $3.4 billion in 2022 and $0.9 billion in 2023 for future lease payments related to build-to-suit facilities, matching the ground truth exactly. The numbers are accurately cited with source pages, and the significant reduction is correctly highlighted. 2) Quantitatively, all dollar amounts are correct and properly compared. The drop from $3.4B to $0.9B is accurately represented, and no calculations are required beyond this comparison. Format is consistent and acceptable. 3) The reasoning is sound: the LLM infers a strategic shift toward a more restrained leasing approach, which aligns with the ground truth's conclusion about a strategic shift and extended timeline. However, the LLM omits mention of the extended commencement period (2025–2027 vs. 2023–2024), which adds nuance to the strategy (i.e., not just reduced volume but also delayed utilization). This minor omission prevents a perfect qualitative score. 4) The answer is contextually relevant, directly addressing both parts of the question—evolution of financial commitment and implications for leasing strategy. It synthesizes information across two years correctly, fulfilling the multi-hop requirement. Overall, the answer is factually complete and semantically equivalent to the ground truth, with only slight loss in depth regarding the timeline extension.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 385,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Mastercard's relationship with Dynamic Yield LTD evolved between 2023 and 2024, and what does this indicate about the company's strategic focus during this period?",
      "original_answer": "In 2023, Mastercard disclosed that it had acquired Dynamic Yield LTD in April 2022 for $325 million, with $200 million of goodwill attributed to synergies expected after the acquisition. By 2024, the relationship is described as stable, with no new investments or acquisitions involving Dynamic Yield reported during the year. This indicates that the integration of Dynamic Yield was largely completed by 2023, and Mastercard shifted focus to newer acquisitions like Recorded Future in 2024, signaling a strategic pivot toward cybersecurity and threat intelligence.",
      "llm_answer": "In 2023 Mastercard completed the purchase‑accounting for its 2022 acquisition of Dynamic Yield, integrating the firm’s intangible assets and goodwill into its books【page_79】. By the 2024 filing the acquisition is listed only as a historic transaction, while value‑added services revenue (which includes Dynamic Yield’s personalization capabilities) grew to $10.8 billion, indicating that Mastercard is now leveraging Dynamic Yield as part of a broader strategic push to expand data‑driven, digital and personalization services【page_77】【page_81】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but misses key elements from the ground truth. It correctly references the 2022 acquisition of Dynamic Yield and its integration into Mastercard's financials in 2023, citing purchase accounting and goodwill indirectly through 'intangible assets and goodwill'【page_79】. However, it fails to mention the specific $325 million acquisition price or the $200 million attributed to goodwill—critical quantitative details in the original answer. These omissions significantly affect quantitative accuracy. (2) The LLM introduces a new figure—$10.8 billion in value-added services revenue【page_77】【page_81】—which is not present in the ground truth and cannot be verified as directly tied to Dynamic Yield’s performance. This number may be accurate in the filing but is used misleadingly to infer strategic expansion without confirming that this revenue includes or reflects Dynamic Yield’s contribution. There is no mention of Recorded Future or the strategic pivot to cybersecurity in 2024, which is a major component of the original answer’s conclusion about Mastercard’s shifting focus. (3) The reasoning is partially sound: the model infers ongoing strategic use of Dynamic Yield via integration into digital personalization services, which aligns with the idea of post-acquisition utilization. However, it fails the multi-hop requirement to contrast 2023 (integration phase) with 2024 (strategic shift away from Dynamic Yield toward new acquisitions). Instead, it implies continued strategic emphasis on Dynamic Yield, contradicting the ground truth that no new activity occurred in 2024 and focus had moved elsewhere. (4) Contextual relevance is high because the answer addresses the evolution of the relationship and attempts to infer strategic direction. But due to missing financial figures, incorrect emphasis on revenue growth not in the original, and failure to identify the strategic pivot, the overall correctness is reduced to a 6—partially correct but with significant gaps in factual completeness and reasoning accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 560,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the Severance Plan for Senior Officers at Lowe's evolved between 2022 and 2024, particularly in terms of the most recent amendment dates and associated filings?",
      "original_answer": "In 2022, the Severance Plan for Senior Officers was described as 'amended and restated May 29, 2020' and was filed on August 26, 2020 (Exhibit 10.29). By 2024, the plan had been further amended and restated on May 26, 2022, with the updated version filed on November 27, 2024 (Exhibit 10.28). This indicates that Lowe's updated its Severance Plan for Senior Officers at least once between 2022 and 2024, with the most recent amendment occurring in mid-2022 and formally disclosed in late 2024.",
      "llm_answer": "The Severance Plan for Senior Officers was last amended on May 26, 2022. In the 2022 Form 10‑K the plan was disclosed as Exhibit 10.28 reflecting that May 2022 amendment, and the 2024 Form 10‑K again references the same amendment but re‑files the exhibit on November 27, 2024 (Exhibit 10.28)【page_79】. This shows that the amendment itself has not changed since 2022, but the filing of the exhibit was updated in the 2024 filing.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the most recent amendment date of the Severance Plan for Senior Officers as May 26, 2022, which matches the ground truth. It also correctly notes the re-filing of the exhibit on November 27, 2024, as Exhibit 10.28. However, it incorrectly states that the 2022 Form 10-K disclosed the May 2022 amendment as Exhibit 10.28. According to the ground truth, the 2022 Form 10-K described the plan as 'amended and restated May 29, 2020' and filed on August 26, 2020 (Exhibit 10.29), meaning the May 2022 amendment would not have been included in the 2022 Form 10-K. The May 26, 2022 amendment was instead filed in 2024, not in the 2022 filing. This is a significant factual error in the timeline and exhibit labeling. (2) Quantitatively, the dates (May 26, 2022; November 27, 2024) are accurate, but the association of Exhibit 10.28 with the 2022 Form 10-K is incorrect—this exhibit number and amendment were not part of the 2022 filing per the ground truth. (3) The reasoning is partially sound in recognizing that the amendment occurred in 2022 and was later re-filed in 2024, but it fails the multi-hop synthesis by misaligning the exhibit number and filing year, suggesting confusion between the 2020 and 2022 amendments. (4) Despite this key error, the answer correctly captures the core fact that the plan was last amended in 2022 and re-filed in 2024, earning a 7 for correctness. Contextual relevance is perfect as it directly addresses the evolution of the plan and associated filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 421,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the fair value of Netflix's 6.375% Senior Notes change between December 31, 2021, and December 31, 2023, and what does this evolution indicate about market perceptions of the company's debt over this period?",
      "original_answer": "The fair value of Netflix's 6.375% Senior Notes increased from $999 million as of December 31, 2021, to $872 million as of December 31, 2023. This indicates a decrease in the fair value of the notes over the two-year period, suggesting a potential decline in market confidence or an increase in required yields for this debt instrument.",
      "llm_answer": "The fair‑value of Netflix’s 6.375 % Senior Notes was $999 million on December 31 2021 and fell to $872 million on December 31 2023 – a decline of about $127 million (≈13 %)【page_56】. The lower price indicates that investors were demanding a higher yield (or perceived greater risk) for the company’s debt, suggesting a weaker market perception of Netflix’s credit profile over the two‑year span.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the fair value of Netflix's 6.375% Senior Notes as $999 million on December 31, 2021, and $872 million on December 31, 2023, matching the ground truth exactly. The calculated decline of $127 million (≈13%) is accurate and appropriately contextualized. (2) All numeric values, dates, and calculations are correct. The difference between $999M and $872M is indeed $127M, and the percentage decrease is approximately 12.7%, which rounds to 13% — acceptable and correctly interpreted. (3) The reasoning is sound: the decrease in fair value is correctly linked to higher required yields and increased perceived risk, indicating a deterioration in market perception of Netflix’s creditworthiness. This multi-hop inference — connecting price decline to yield increase and credit risk — is logically and financially valid. (4) The only minor shortcoming is that the original answer mentions 'a potential decline in market confidence,' while the LLM states a more definitive 'weaker market perception.' While the LLM’s interpretation is reasonable and aligned with financial logic, it slightly overstates certainty compared to the more cautious 'potential decline' in the ground truth. However, this does not constitute a factual error, just a nuance in tone. All entities (Netflix, 6.375% Senior Notes, correct dates) are accurate. The answer fully addresses both parts of the question: the change in fair value and its implication for market perceptions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 413,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the sales performance of IMBRUVICA evolve between 2022 and 2023, and what does this indicate about its market position in the oncology segment?",
      "original_answer": "IMBRUVICA's sales decreased from $4,369 million in 2022 to $3,264 million in 2023, representing a decline of 25.2%. This indicates a weakening market position for IMBRUVICA within the oncology segment, especially as other products like DARZALEX and ERLEADA experienced significant growth during the same period.",
      "llm_answer": "IMBRUVICA’s sales fell from $3.784 billion in 2022 to $3.264 billion in 2023 – a decline of roughly 13‑14 % (operations ‑13.2 %)【page_31】. Because the overall oncology portfolio grew 10.5 % in the same period, the drop reflects “global competitive pressures” on IMBRUVICA and suggests it is losing share and its market position is weakening within the oncology segment【page_32】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, IMBRUVICA's sales were $4,369 million in 2022, but the LLM reports $3.784 billion (i.e., $3,784 million), which is off by nearly $585 million. This leads to an incorrect decline calculation: the LLM states a 13–14% drop (with -13.2% from operations), whereas the correct decline is (4,369 - 3,264) / 4,369 ≈ 25.2%. The 2023 sales figure ($3,264 million) is correct in both answers. (2) Despite the incorrect base numbers, the LLM correctly identifies a sales decline and attributes it to competitive pressures, citing weakening market position—consistent with the ground truth. It also correctly contextualizes the drop against overall oncology portfolio growth (10.5%), supporting the conclusion about loss of market share. (3) The multi-hop reasoning is sound: the model synthesizes IMBRUVICA’s performance with broader oncology trends and infers competitive challenges. However, the flawed input data undermines the quantitative conclusion. (4) The contextual relevance is high as the answer addresses both parts of the question—sales evolution and market position—and provides supporting rationale. The qualitative reasoning is strong, but the major numerical error in the 2022 sales figure and resulting miscalculation of the decline severely impacts factual correctness, warranting a mid-range score of 5 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 399,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did LOW's inventory shrink reserve and LCNRV reserve evolve between 2022 and 2024, and what were the implications for net earnings?",
      "original_answer": "Between 2022 and 2024, LOW's inventory shrink reserve increased from $414 million to $427 million, while the LCNRV reserve increased from $168 million to $222 million. In 2024, a 10% change in either the amount of inventory subject to markdown or the weighted average estimated loss rate used in the LCNRV reserve calculation would have affected net earnings by approximately $17 million, and a 10% change in the estimated shrinkage rate would have impacted net earnings by approximately $32 million. These changes indicate a growing need for reserves, particularly for shrinkage, and highlight the increasing sensitivity of net earnings to inventory valuation assumptions.",
      "llm_answer": "In fiscal 2022 Lowe’s reported an inventory‑shrink reserve of **$414 million** and an LCNRV reserve of **$168 million**【LOW_10k_2022.pdf page 33】. By fiscal 2024 the shrink reserve had risen modestly to **$427 million** (≈ +$13 million) and the LCNRV reserve had grown to **$222 million** (≈ +$54 million)【LOW_10k_2024.pdf page 34】. The company notes that a 10 % change in the shrink reserve would shift net earnings by roughly **$32 million**, and a 10 % change in the LCNRV reserve would affect net earnings by about **$17 million** in fiscal 2024, highlighting the material impact of these reserves on earnings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the shrink reserve increased from $414 million in 2022 to $427 million in 2024, and the LCNRV reserve increased from $168 million to $222 million. The impacts on net earnings—a $32 million effect from a 10% change in shrink reserve and $17 million from a 10% change in LCNRV—are correctly reported. (2) The answer is complete, addressing both the evolution of the reserves over time and their implications for net earnings. (3) Entities are accurate: LOW (Lowe’s), correct fiscal years (2022 and 2024), and proper financial terms (inventory shrink reserve, LCNRV reserve, net earnings impact) are used. (4) The reasoning is sound and reflects multi-hop synthesis: the model correctly pulled data from two different 10-K filings (2022 and 2024), compared the reserve changes over time, and integrated forward-looking sensitivity disclosures from the 2024 filing. (5) The semantic meaning is equivalent to the original answer, with slightly more detailed presentation (e.g., approximate deltas in reserves) but no factual deviation. Minor formatting differences (e.g., $427 million vs $427M) are acceptable and do not affect accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 350,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did Qulipta's status and financial contribution evolve from 2022 to 2023, particularly in terms of its development and commercialization progress?",
      "original_answer": "In 2022, Qulipta was among the products that contributed to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights upon receiving regulatory approvals. By 2023, Qulipta had transitioned from development to commercialization, generating $405 million in revenue in the United States and $3 million internationally, indicating a significant shift from a developmental asset to a revenue-generating product.",
      "llm_answer": "In 2022 Qulipta was still a newly launched migraine‑preventive therapy, posting only $158 million of U.S. net revenue and essentially no international sales (product‑revenue table shows $158 M U.S. and $‑ M abroad)【page_42】. By 2023 the drug had cleared key development milestones – FDA approval for chronic migraine in April 2023 and European Commission approval in August 2023 – and its sales more than doubled, rising to $405 million in the United States and $408 million internationally, a “greater than 100 %” increase driven by the new indication and broader market uptake【page_40】【page_44】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in financial figures and international revenue. The ground truth states Qulipta generated $405 million in U.S. revenue and $3 million internationally in 2023, but the LLM incorrectly reports $408 million internationally, which is a major error. Additionally, the LLM claims $158 million U.S. revenue in 2022, but the original answer does not mention any specific revenue for 2022—instead, it notes Qulipta's role in the reclassification of $1.0 billion in R&D assets upon regulatory approval. This revenue figure for 2022 is unsupported by the ground truth. (2) The dates of approvals are fabricated: the LLM states FDA approval for chronic migraine in April 2023 and European approval in August 2023, but the original answer does not mention these events or timelines. There is no evidence in the ground truth that approvals occurred in 2023—Qulipta had already been approved prior to 2022, as it triggered the 2022 asset reclassification. The 'greater than 100%' sales increase claim is also not verifiable due to incorrect base numbers. (3) The multi-hop reasoning is partially sound in that the model attempts to trace development to commercialization, but it fails to correctly link the 2022 asset reclassification event to Qulipta’s approval, instead inventing new approval milestones. It misses the key point that the $1.0 billion reclassification in 2022 was the financial signal of its transition from development to commercialization. (4) Despite these errors, the answer is contextually relevant, addressing the evolution of Qulipta’s status and revenue trajectory. The U.S. revenue figure for 2023 ($405 million) is correct, and the general narrative of growth from a developmental asset to a commercial product aligns with the ground truth, earning partial credit. However, the numerous quantitative and factual errors severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 526,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities evolved between 2022 and 2023, and what does this indicate about the company's risk exposure?",
      "original_answer": "Honeywell's financial dependency on the Resideo subsidiary for environmental liabilities remained consistent between 2022 and 2023, with Resideo's subsidiary still obligated to pay 90% of Honeywell's annual net spending on environmental matters at specified sites, up to a maximum of $140 million per year. This ongoing arrangement indicates that Honeywell continues to rely on Resideo's payments to offset a significant portion of its environmental costs, suggesting that the risk mitigation strategy through this indemnification agreement has not changed over the two years.",
      "llm_answer": "In 2022 Honeywell recorded a $157 million receivable from Resideo (the $140 million short‑term portion plus $474 million long‑term) and collected $140 million in reimbursements; in 2023 the receivable grew to $187 million (still $140 million short‑term, $521 million long‑term) while the reimbursement remained capped at $140 million. The larger receivable shows a modest increase in Honeywell’s reliance on Resideo to offset environmental costs, but the fixed $140 million annual cap limits the company’s overall risk exposure to those liabilities.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Resideo's subsidiary is obligated to pay 90% of Honeywell's annual net spending on environmental matters up to $140 million per year, but the LLM incorrectly claims Honeywell recorded a $157 million receivable in 2022 and $187 million in 2023, with long-term receivables of $474 million and $521 million respectively—these figures are not supported by the original answer and appear fabricated. The original answer does not mention receivables, their breakdown, or any growth in amounts, so these numbers are entirely incorrect. (2) The quantitative inaccuracies are severe: the LLM invents specific dollar amounts for short-term and long-term receivables that are not present in the ground truth. While it correctly notes the $140 million annual cap, this is the only accurate number. The claim of a 'modest increase in reliance' due to a growing receivable is unsupported because the core data is wrong. (3) The reasoning is flawed—instead of recognizing that the indemnification structure remained unchanged (same percentage, same cap), the LLM infers increased dependency based on invented receivable balances, failing the multi-hop synthesis. The correct inference from the original answer is stability in risk exposure due to unchanged terms, not increasing reliance. (4) Despite incorrect facts, the answer is contextually relevant—it addresses the right companies (Honeywell, Resideo), the right topic (environmental liabilities), and the right timeframe (2022–2023). It attempts to assess risk exposure, aligning with the question’s intent, but fails on factual and logical grounds. Hence, low scores on correctness and quantitative accuracy, moderate on qualitative reasoning due to flawed logic, and decent contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 499,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Target's definition or treatment of 'original maturity' for cash equivalents evolved between 2022 and 2024, and what does this indicate about potential changes in their cash management strategy?",
      "original_answer": "In 2022, Target defined cash equivalents as highly liquid investments with an original maturity of three months or less, with no additional context or clarification. By 2024, the company maintained the same three-month threshold for original maturity but added a broader discussion around fair value measurements for other short-term assets and liabilities, suggesting a more comprehensive approach to short-term financial instruments. This evolution indicates a potential refinement in how Target evaluates and manages its cash and near-cash assets within a broader financial framework.",
      "llm_answer": "Target’s definition of cash equivalents has not changed – in both the 2022 and 2024 filings the company says cash equivalents are “highly liquid investments with an original maturity of three months or less from the time of purchase” (2022 Note 9, p. 48; 2024 Note 7, p. 52). The unchanged three‑month‑or‑less criterion shows Target continues to treat only very short‑term instruments as cash equivalents, signaling a steady, liquidity‑focused cash‑management policy, even as the actual amount of short‑term investments fell (from $4.985 bn in 2022 to $2.897 bn in 2024), suggesting it may be deploying cash elsewhere or tightening its short‑term investment holdings.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Target's definition of 'original maturity' for cash equivalents remained unchanged between 2022 and 2024, maintaining the 'three months or less' threshold, which aligns with the ground truth. It accurately cites the relevant notes and pages from both filings. However, the LLM omits a key qualitative evolution noted in the original answer: the 2024 filing included a broader discussion of fair value measurements for short-term assets and liabilities, indicating a more comprehensive financial framework. This omission limits completeness. (2) Quantitatively, the LLM provides accurate figures for short-term investments ($4.985 billion in 2022 and $2.897 billion in 2024), which are factually correct and properly contextualized. No calculation errors are present. (3) The reasoning is sound in concluding that the unchanged definition reflects a consistent liquidity-focused strategy. However, the multi-hop synthesis is incomplete — while the LLM notes a decline in short-term investments and speculates on cash deployment, it fails to connect this to the broader trend of enhanced fair value disclosures, which is central to the original answer’s insight about strategic refinement. (4) The correctness score is 7 because core facts and numbers are accurate, but a significant qualitative nuance from the ground truth is missing. Quantitative accuracy is 10 due to correct numbers and citations. Qualitative accuracy is 7 due to partial reasoning and missing synthesis. Contextual relevance is 9 as the answer is highly relevant and well-focused, with only a moderate gap in depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 447,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the valuation and classification of NVDA's 3.50% Notes Due 2040 evolve between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, the 3.50% Notes Due 2040 were listed under liabilities with a carrying value of $851 million as of January 28, 2024, and were categorized as Level 2 in the pricing hierarchy. By 2024, the valuation of the same notes increased to $1,000 million as of January 26, 2025, with a more detailed breakdown including an effective interest rate of 3.54% and a remaining term of 15.2 years. This indicates a strategic emphasis on long-term financing with stable interest rate structures.",
      "llm_answer": "In the 2023 filing the 3.50 % Notes Due 2040 were disclosed as a Level 2 fair‑value liability with a market value of about **$870 million**, while the notes were carried on the balance sheet at their original issuance amount of **$1 billion** as a long‑term unsecured senior obligation. In the 2024 filing the same notes were still classified as Level 2 but their fair‑value fell to **$851 million** and the carrying amount remained **$1 billion** (entirely in the long‑term portion). The modest decline in market value combined with the unchanged long‑term classification shows NVIDIA is retaining the low‑cost, long‑dated debt rather than refinancing or retiring it, reflecting a strategy of preserving stable, inexpensive long‑term financing.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. According to the ground truth, in 2023 the carrying value was $851 million as of January 28, 2024, and by 2024 it increased to $1,000 million as of January 26, 2025. However, the LLM incorrectly states that the fair value was $870 million in 2023 and then fell to $851 million in 2024, which contradicts the upward trend in valuation. Additionally, the LLM claims the carrying amount remained at $1 billion, but this is not supported by the ground truth, which reports a carrying value of $851 million in 2023 and $1,000 million in 2024—indicating a change, not stability. The effective interest rate (3.54%) and remaining term (15.2 years) mentioned in the ground truth are entirely missing from the LLM response. (2) The LLM misrepresents both the direction and magnitude of valuation changes. It incorrectly asserts a decline in market value when the ground truth shows an increase from $851M to $1,000M. The $1 billion carrying amount is presented as static, but the ground truth shows an increase, suggesting amortization or revaluation activity. These errors undermine the financial accuracy. (3) The reasoning is partially sound in interpreting the strategic implication—long-term debt retention with stable financing—but this conclusion is based on incorrect data. The multi-hop synthesis fails because the model misaligns the years, values, and classifications. The ground truth shows an increase in valuation and more detailed disclosure in 2024, indicating active management or re-evaluation of long-term debt, not passive retention. (4) The correctness score is low due to major quantitative errors. Quantitative accuracy is severely compromised. Qualitative accuracy is moderate because the general idea of long-term strategy is plausible, but reasoning is flawed. Contextual relevance is acceptable as the answer addresses the right topic and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 527,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the financial performance of Venclexta evolve between 2022 and 2023, particularly in terms of total global revenue and the growth rate?",
      "original_answer": "In 2022, Venclexta generated a total global revenue of $2,009 million, with a growth rate of 10.4%. In 2023, the total global revenue from Venclexta increased to $2,288 million, representing a growth rate of 13.9%. This indicates an upward trend in both absolute revenue and growth rate year-over-year.",
      "llm_answer": "Venclexta’s worldwide net revenues rose from $2.009 billion in 2022 to $2.288 billion in 2023, a gain of roughly 15 percent (13.9 % at actual currency rates and about 15 % on a constant‑currency basis)【page_42】. The 2023 filing notes that “Net revenues for Venclexta increased 15 % in 2023”【page_43】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports Venclexta's global revenues as $2.009 billion in 2022 and $2.288 billion in 2023, matching the ground truth of $2,009 million and $2,288 million. The growth rate in the ground truth is 13.9% for 2023, which the LLM accurately cites as '13.9% at actual currency rates'. The LLM also mentions a ~15% growth on a constant-currency basis and references a quote from the filing stating a 15% increase, which aligns with the source context but slightly diverges from the reported 13.9% YoY growth in the ground truth. This discrepancy is contextual (constant vs. actual currency) and properly attributed, so it does not constitute an error. 2) All numeric values are correct and accurately formatted ($2.009 billion = $2,009 million). The 13.9% growth rate is correctly calculated: (2,288 - 2,009) / 2,009 ≈ 0.1386 (13.9%). The LLM correctly identifies the upward trend. 3) The reasoning is sound: the model synthesizes revenue figures across years and correctly interprets growth rates, noting the distinction between actual and constant currency—a nuance that reflects deeper understanding. The multi-hop requirement (comparing revenue and growth across two years) is fulfilled. 4) The answer is semantically equivalent to the ground truth, with slightly more detail (constant currency adjustment) that adds context without distorting facts. The only minor shortcoming is the emphasis on the 15% figure, which, while explained, could momentarily overshadow the 13.9% actual growth if not properly contextualized. However, since it is clearly qualified, this does not reduce factual accuracy. Overall, the answer is highly accurate, complete, and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1149,
        "completion_tokens": 458,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has Netflix's approach to executive severance and retention incentives evolved between the 2022 and 2023 SEC filings, particularly in terms of plan amendments and their effective dates?",
      "original_answer": "In 2022, the filing referenced the 'Amended and Restated Executive Severance and Retention Incentive Plan' with a filing date of September 10, 2021, indicating that the plan had undergone revisions by that date. By 2023, the filing showed further evolution, introducing the 'Executive Severance and Retention Incentive Plan as Amended and Restated effective January 1, 2024,' with a filing date of December 8, 2023. This demonstrates Netflix’s ongoing adjustments to executive compensation frameworks, with a forward-looking amendment effective in 2024.",
      "llm_answer": "In the 2022 Form 10‑K Netflix’s Executive Severance and Retention Incentive Plan was shown only as the “Amended and Restated Executive Severance and Retention Incentive Plan” that had been filed on September 10 2021 (exhibit 10.6†) 【page_66】. By the 2023 filing the company had issued a new amendment that restates the plan with a future effective date of January 1 2024 (exhibit 10.16†) and also added a separate “Executive Officer Severance Plan” (exhibit 10.15†) 【page_68】. Thus Netflix moved from a 2021‑dated amendment to a fresh 2024‑effective amendment and broadened its severance framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2022 filing references the 'Amended and Restated Executive Severance and Retention Incentive Plan' filed on September 10, 2021, and the 2023 filing introduces a new amendment effective January 1, 2024, filed on December 8, 2023. The LLM correctly identifies the future effective date and the filing date (implied via exhibit reference). (2) Quantitative accuracy is perfect: dates (September 10, 2021; January 1, 2024) match the ground truth. While the LLM does not explicitly state the December 8, 2023 filing date, it correctly references the exhibit in the 2023 filing, which implies the document was filed in 2023, and the effective date is clearly and correctly stated. (3) The reasoning is sound and captures the evolution: from a 2021-amended plan in the 2022 filing to a forward-looking 2024-effective amendment in the 2023 filing. The LLM adds a detail not in the original answer—the introduction of a separate 'Executive Officer Severance Plan' (exhibit 10.15†)—which is consistent with the 2023 filing and enriches the response without introducing error. (4) The answer is contextually relevant, directly addressing the evolution in plan amendments and effective dates. The only minor shortcoming is the omission of the specific December 8, 2023 filing date of the new amendment, which slightly reduces qualitative completeness, but the core multi-hop synthesis (change over time in plan structure and effective dates) is accurate and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 429,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did Lowe's documentation and structure of its Benefit Restoration Plan evolve from 2022 to 2024, and what does this indicate about the company's approach to employee retirement benefits?",
      "original_answer": "In 2022, Lowe's maintained the Benefit Restoration Plan as part of its defined contribution retirement offerings, supplementing benefits under the 401(k) Plan for employees affected by IRS limitations. The plan included both employee salary deferrals and employer contributions in the form of a Company Match. By 2024, the company formally introduced an updated and restated version of the Benefit Restoration Plan, effective January 1, 2025, as evidenced by the new exhibit filing (10.3) in the 2024 10-K. This indicates a deliberate effort to formalize and likely enhance the structure of the plan, signaling a more strategic and forward-looking approach to managing executive and high-earner compensation through improved documentation and alignment with long-term benefit policies.",
      "llm_answer": "In the 2022 Form 10‑K the Benefit Restoration Plan was only described in the retirement‑plan note (page 68), where Lowe’s said the plan “supplements benefits … provides for employee salary deferrals and employer contributions in the form of a Company Match.” By the 2024 filing the plan appears as a stand‑alone exhibit (Exhibit 10.3 – “Lowe’s Companies Benefit Restoration Plan, as amended and restated as of January 1 2025,” page 78), indicating it has been formally amended, restated and filed as a separate document. This move from a brief narrative disclosure to a formal, updated exhibit shows that Lowe’s is actively refining and formalizing its retirement‑benefit structure, underscoring a proactive, compliance‑focused approach to protecting employee retirement benefits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, the Benefit Restoration Plan was described narratively in the retirement-plan note (page 68 of the 10-K), covering salary deferrals and employer matching; by 2024, it was filed as a standalone exhibit (Exhibit 10.3) titled 'as amended and restated as of January 1, 2025', which matches the original answer's claim of a formal update effective 2025. (2) There are no numeric values requiring calculation, but dates (January 1, 2025) and document identifiers (Exhibit 10.3) are correctly cited—format variations are consistent and acceptable. (3) The multi-hop reasoning is sound: the model correctly infers that moving from a descriptive footnote to a separately filed restated plan indicates formalization and strategic refinement, which logically supports the conclusion of a more proactive, compliance-focused approach. (4) The only minor shortcoming is that the LLM slightly underemphasizes the strategic intent toward 'executive and high-earner compensation' mentioned in the ground truth, focusing more broadly on 'employee retirement benefits' rather than specifying high-earners affected by IRS limits. However, this does not detract significantly from the overall correctness. Semantic equivalence is maintained, and the answer fully addresses both the evolution and its implications. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 424,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did NVDA's financial obligations related to the 0.584% Notes Due 2024 evolve between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal year 2023, NVDA reported a liability of $1,185 million for the 0.584% Notes Due 2024. By fiscal year 2024, this obligation was fully repaid, as stated in the 2024 10-K filing. This indicates a complete resolution of this specific debt obligation over the two-year period.",
      "llm_answer": "NVDA’s liability for the 0.584 % Notes Due 2024 grew modestly. At the end of fiscal 2023 the notes were recorded at about $1.185 billion, while by fiscal 2024 they were carried at roughly $1.228 billion (fair‑value) and $1.250 billion (net carrying amount) – an increase of roughly $45‑$65 million【page_67】【page_72】.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the original answer states that NVDA's liability for the 0.584% Notes Due 2024 was $1,185 million in fiscal 2023 and fully repaid in fiscal 2024. The LLM incorrectly claims the liability increased to $1.228 billion (fair value) and $1.250 billion (net carrying amount) in fiscal 2024, which contradicts the ground truth that the obligation was fully repaid. These numbers do not reflect repayment and are factually wrong. (2) The calculations implied—an increase of $45–65 million—are incorrect because the actual change was a decrease of $1,185 million (to zero). (3) Qualitatively, the reasoning fails: instead of recognizing the complete repayment as stated in the 2024 10-K, the model suggests growth in the liability, showing a failure in multi-hop reasoning and misinterpretation of the financial data. (4) Contextually, the answer addresses the right entity (NVDA), metric (notes due 2024), and time frame (fiscal 2023–2024), so it is relevant, but the core factual claim is false. The citation of page_67 and page_72 may refer to real sections, but the interpretation is erroneous. Overall, the answer conveys the opposite of the truth—growth instead of repayment—warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1141,
        "completion_tokens": 366,
        "total_tokens": 1507
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the global revenue performance of Mavyret evolve between 2022 and 2023, and what were the trends in its United States and international markets during this period?",
      "original_answer": "In 2022, Mavyret generated total global revenue of $1,541 million, with $755 million from the United States and $786 million from international markets. By 2023, total revenue from Mavyret decreased to $1,430 million, driven by a decline in both U.S. and international markets. Specifically, U.S. revenue dropped to $659 million, a decrease of 12.7%, while international revenue slightly declined to $771 million, a marginal decrease of 1.9%. This indicates a contraction in Mavyret's market performance across both regions, with a more pronounced decline in the U.S. market.",
      "llm_answer": "Mavyret’s total net revenue fell from $1.541 billion in 2022 to $1.430 billion in 2023 – a decline of roughly 7 percent (‑$111 million) 【page_43】.  The U.S. portion dropped more sharply, from $755 million to $659 million (‑12.7 %), while international sales slipped only modestly, from $786 million to $771 million (‑1.9 %) 【page_43】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: total revenue decreased from $1,541 million to $1,430 million (correctly reported as $1.541 billion and $1.430 billion), U.S. revenue dropped from $755 million to $659 million (12.7% decline), and international revenue declined from $786 million to $771 million (1.9% decline). The absolute drop of $111 million is correctly implied. (2) Calculations are accurate: the 12.7% and 1.9% decreases match the ground truth (verified: (755-659)/755 ≈ 12.7%, (786-771)/786 ≈ 1.9%). (3) The answer addresses all parts of the question—global revenue evolution, U.S. trends, and international trends—with precise multi-hop synthesis across regions and years. (4) Entities (Mavyret, 2022, 2023, U.S., international) are correctly identified and contextualized. (5) The reasoning is sound, clearly attributing the global decline to both regions with appropriate emphasis on the steeper U.S. drop. Wording differs slightly from the original answer but maintains full semantic equivalence. No errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 317,
        "total_tokens": 1550
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Netflix's compliance with covenant limitations related to its Senior Notes evolve between 2022 and 2024, particularly in terms of repayment obligations and the scope of restrictions?",
      "original_answer": "In 2022, Netflix was in compliance with all covenant limitations tied to its Senior Notes, which included restrictions on creating liens, entering into sale and lease-back transactions, incurring additional indebtedness by certain subsidiaries, and merging or transferring substantial assets. These notes included various euro-denominated tranches with principal amounts totaling €5,170 million. By 2024, Netflix remained in compliance with these covenants, but the scope of limitations had slightly evolved—specifically, certain Senior Notes no longer referenced restrictions on sale and lease-back transactions, suggesting a narrowing of covenant scope for some notes. Additionally, in 2024, Netflix repaid $400 million of its 5.750% Senior Notes upon maturity, indicating active debt management and a shift in its debt composition.",
      "llm_answer": "In the 2022 filing (see page 56) Netflix noted that its senior notes could be repaid on a change‑of‑control event at 101 % of principal plus accrued interest, could be redeemed early with a premium, and were subject to covenants that barred the company from creating additional liens, entering sale‑and‑lease‑back transactions, incurring or guaranteeing extra subsidiary debt, or merging or transferring substantially all of its assets – and the company was in compliance with those covenants as of Dec 31 2021 (and 2020). By the 2024 filing (see page 54) the same core restrictions remained, but the company clarified that “certain” notes impose additional limits on sale‑and‑lease‑backs and subsidiary indebtedness, and it disclosed that it had repaid the $400 million of 5.750 % senior notes that matured in March 2024 while still being in compliance with all covenant requirements as of Dec 31 2024 (and 2023).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Netflix's compliance with covenants in both 2022 and 2024, the $400 million repayment of 5.750% Senior Notes in March 2024, and the core restrictions (liens, sale-and-lease-backs, subsidiary debt, mergers). However, it misrepresents the evolution of covenant scope. The ground truth states that by 2024, certain notes *no longer referenced* sale-and-lease-back restrictions (a narrowing), while the LLM claims that 'certain notes impose additional limits'—which implies tightening, not loosening, contradicting the original. This is a significant qualitative error in reasoning. (2) Quantitatively, all numbers are accurate: $400 million, 5.750%, March 2024 maturity, and compliance as of Dec 31, 2023 and 2024. The 101% change-of-control repayment and early redemption with premium are extra details not in the ground truth but not incorrect; they add context without contradicting. (3) Multi-hop reasoning is partially sound—compliance across years and debt repayment are correctly synthesized—but the interpretation of covenant evolution is inverted, undermining the qualitative accuracy. (4) Scores reflect high factual precision (8/10 quantitative), but reduced correctness (7/10) due to the mischaracterization of covenant scope change, which is central to the question. Contextual relevance remains high as all content directly addresses the query.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 390,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Honeywell's approach to the Safety and Retail product line evolve between 2022 and 2023, and what structural change was introduced in 2023 that reflects this evolution?",
      "original_answer": "In 2022, Honeywell reported the Safety and Retail business unit as a standalone component under the Safety and Productivity Solutions segment, generating $2,387 million in revenue. By 2023, the company had realigned its organizational structure, merging the Safety and Retail unit with the Advanced Sensing Technologies unit to form a new business unit called Sensing and Safety Technologies. This structural change, introduced in July 2022 but reported in the 2023 filing, reflects a strategic shift toward integrating sensing capabilities with safety solutions to enhance technological offerings and streamline operations.",
      "llm_answer": "In 2022 Honeywell still reported a distinct “Safety and Retail” line within the Safety and Productivity Solutions segment, but in July 2022 it combined that unit with Advanced Sensing Technologies to create a new “Sensing and Safety Technologies” business unit【page_68】. The 2023 filing no longer lists a separate Safety and Retail line; instead the segment now reports a “Sensing and Safety Technologies” sub‑segment, reflecting the structural re‑classification of the product line introduced in 2023【page_68】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: in 2022, Safety and Retail was a standalone unit; it was merged with Advanced Sensing Technologies to form Sensing and Safety Technologies. The structural change occurred in July 2022 and was reflected in the 2023 filing. (2) Quantitative accuracy is perfect—though the revenue figure ($2,387 million) is not explicitly mentioned in the LLM answer, this does not appear to be required for the core question about structural evolution. No incorrect numbers or dates are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes the timeline (change in July 2022, reported in 2023) and the organizational shift. (4) The only minor omission is the lack of the specific revenue figure from 2022, which was included in the original answer and could enhance completeness. However, since the question focuses on the evolution and structural change rather than financial performance, this does not significantly detract from correctness. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing both parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 336,
        "total_tokens": 1627
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the status and role of Class B-2 Common Stock evolved between 2023 and 2024, particularly in terms of its convertibility and impact on corporate governance?",
      "original_answer": "In 2023, Class B-2 Common Stock was described as part of a structure that would become convertible into Class A Common Stock, with potential dilutive effects on voting power and market price. It also played a role in approving significant corporate actions, indicating a governance influence. By 2024, no shares of Class B-2 Common Stock were outstanding prior to the Class B-1 Common Stock exchange offer, suggesting a strategic shift in equity structure. This indicates a transformation in the role of Class B-2 Common Stock, moving from an active governance and conversion position to a non-outstanding status, reducing its influence on corporate decisions.",
      "llm_answer": "In the 2023 filing Visa explained that Class B‑2 common stock is a convertible class – it can be turned into Class A common stock, which would increase the number of Class A shares and dilute the voting power of existing Class A holders – and that, although its voting rights are limited, B‑2 holders can vote on “certain significant transactions” such as a merger, a consolidation or a decision to exit the core payments business (see page 34). By the 2024 filing the company had actually issued 49 shares of Class B‑2 (none existed in 2023) as shown in the equity table and footnote (see page 59), but the same convertibility and limited‑vote rights remain, so B‑2 still can affect corporate‑governance decisions and any conversion would again dilute Class A voting power (page 34).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that contradict the ground truth. (1) The most critical error is the claim that Visa issued 49 shares of Class B-2 Common Stock in 2024, stating 'none existed in 2023' and that they were newly issued. This directly contradicts the ground truth, which states that *no shares of Class B-2 were outstanding in 2024 prior to the Class B-1 exchange offer*, indicating a reduction to zero, not a new issuance. The LLM incorrectly infers from a footnote or table that 49 shares were issued, when the ground truth confirms the class was effectively eliminated or no longer outstanding. (2) Quantitatively, the number '49 shares' is unsupported by the ground truth and introduces a false data point. There is no mention of such an issuance in the original answer, and this undermines the entire conclusion. (3) Qualitatively, the reasoning is flawed: the LLM assumes that because certain rights (convertibility, limited voting) are described in the 2024 filing, the stock must still be active and issued. However, the ground truth clarifies that the absence of outstanding shares indicates a strategic shift, regardless of retained legal provisions. The model fails to recognize that a stock class can have defined rights in principle but no practical role if no shares are outstanding. (4) Contextually, the answer addresses the right topics—convertibility, dilution, governance impact—but draws the opposite conclusion of the ground truth: it suggests continuity, while the truth shows discontinuation. The citation of page numbers does not compensate for the incorrect interpretation of the data. Overall, the answer is semantically divergent and factually incorrect on the key point of whether Class B-2 shares were outstanding in 2024, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 490,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has The Home Depot's approach to enhancing the ease of shopping experience evolved between 2023 and 2024, particularly in terms of digital and in-store capabilities?",
      "original_answer": "In 2023, The Home Depot focused on improving the ease of shopping experience by investing in mobile app-enabled store navigation, electronic shelf labels, reconfigured service desks, and enhanced self-checkout options. These efforts were aimed at improving store navigation, convenience, and checkout speed. By 2024, the company expanded its focus to include more personalized digital experiences, such as customer product review summaries and enhanced product content, while continuing to invest in digital platforms to improve navigation and 'shopability.' The 2024 strategy placed greater emphasis on leveraging customer data to meet personalized expectations, indicating a shift toward deeper integration of data-driven insights into the shopping journey.",
      "llm_answer": "In fiscal 2023 Home Depot’s “ease‑of‑shopping” plan centered on adding digital and in‑store conveniences such as way‑finding signage, store‑refresh packages, self‑service lockers, curbside pickup, electronic‑shelf‑label capabilities, re‑designed front‑end and checkout layouts, expanded self‑checkout and a mobile‑app that provides store‑specific maps, together with website upgrades that improved search, navigation, product content and checkout speed (2023 pages 9‑8). In fiscal 2024 the company deepened that strategy—spending $3.5 billion on capex to broaden self‑checkout, mobile‑app navigation and omnichannel pickup programs (BOSS, BOPIS, BODFS, BORIS), while also deploying new associate‑focused digital tools (hdPhone devices, Sidekick and computer‑vision inventory assistance) and further integrating stores into a seamless online‑offline fulfillment network (2024 pages 9‑8‑6‑10).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with accurate entity identification (The Home Depot), correct timeframes (2023 and 2024), and appropriate focus on both digital and in-store enhancements. Quantitatively, the $3.5 billion capex figure in 2024 is accurate and correctly attributed, and no other numerical discrepancies are present. The mention of specific programs (BOSS, BOPIS, BODFS, BORIS) and tools (hdPhone, Sidekick, computer-vision inventory) adds detail not in the original answer but is consistent with Home Depot's known omnichannel strategy and does not contradict the ground truth. However, the LLM omits the 2024 emphasis on personalized digital experiences such as customer review summaries and data-driven personalization, which is a key differentiator in the original answer. While it correctly notes continued investment in mobile app navigation and digital platforms, it does not explicitly highlight the strategic shift toward leveraging customer data for personalization, which is central to the 2024 evolution. This omission reduces completeness in capturing the full scope of the strategic evolution. The reasoning is sound and multi-hop synthesis across years is appropriate, and the answer remains highly relevant to the question. Wording differs but semantic meaning overlaps significantly, especially on in-store and digital capabilities. Minor deduction for missing the personalized experience/data-driven insights component in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 410,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has the structure of the Target Corporation Long-Term Incentive Plan evolved from 2022 to 2024, particularly in terms of the specific forms of equity awards included under the plan?",
      "original_answer": "In 2022, the Long-Term Incentive Plan included forms such as Non-Qualified Stock Options, Restricted Stock Units, Performance-Based Restricted Stock Units, Performance Share Units, Price-Vested Stock Options, Non-Employee Director Non-Qualified Stock Options, and Non-Employee Director Restricted Stock Units. By 2024, the plan introduced new forms of equity awards, including the Cliff-Vested Restricted Stock Unit Agreement and the Performance Award Performance Share Unit Agreement, indicating an expansion in the types of equity compensation vehicles available under the plan.",
      "llm_answer": "In the 2022 filing the Long‑Term Incentive Plan was described as providing **price‑vested stock options, restricted‑stock units, performance‑based RSUs, performance‑share units and non‑employee director stock‑option and RSU awards** (see Exhibit list showing Forms U, V, W, X, Y and Z)【page_68】.  \nBy the 2024 filing the same core awards remain, but the plan now also includes **cliff‑vested RSU agreements and a new performance‑award performance‑share‑unit agreement**, and it references the 2022 SPP I and SPP II plan statements as part of the LTIP (see Exhibit list showing Forms 10.4.5* and 10.4.6* in addition to the earlier RSU, performance‑RSU and performance‑share‑unit forms)【page_73】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the equity award types under Target Corporation's Long-Term Incentive Plan (LTIP) in 2022, including price-vested stock options, restricted stock units (RSUs), performance-based RSUs, performance-share units, and non-employee director awards. These match the original answer's list, though phrased more concisely. (2) For 2024, the LLM correctly notes the addition of cliff-vested RSU agreements and a new performance-award performance-share-unit agreement, which reflects the expansion mentioned in the ground truth. The reference to Exhibits (e.g., Forms 10.4.5*, 10.4.6*) adds contextual support without introducing inaccuracies. (3) Multi-hop reasoning is sound: the model compares the 2022 and 2024 plan structures, identifies continuity in core awards, and correctly infers evolution through the introduction of new forms. (4) Minor deduction in qualitative accuracy due to slightly compressed phrasing (e.g., not listing every award type like Non-Qualified Stock Options explicitly), but all key forms are covered either directly or by category. No calculation or date errors; all years and award types are factually correct. Semantic equivalence is strong. Contextual relevance is excellent, directly addressing the evolution of equity award structures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 377,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How did Qulipta's commercial performance evolve from its FDA approval in 2021 through 2023, based on AbbVie's financial disclosures?",
      "original_answer": "Qulipta was approved by the FDA in September 2021 for the preventive treatment of episodic migraine in adults, marking its entry into the market. By 2023, Qulipta had generated $405 million in U.S. revenue and $3 million internationally, totaling $408 million. This indicates a significant commercial trajectory following its approval, especially considering it had no revenue in 2021 and only $158 million in U.S. revenue in 2022. The product demonstrated strong growth, suggesting robust market adoption and positioning within AbbVie's portfolio.",
      "llm_answer": "Qulipta was first cleared by the FDA in September 2021 for episodic migraine, but recorded no sales that year (U.S. and international net revenues shown as “‑” in the 2021 product table)【page_62】. In 2022 it generated about $158 million of U.S. net revenue (with essentially no international sales)【page_42】, and by 2023 total net revenue had risen to roughly $408 million (U.S. $405 million + $3 million abroad)【page_42】, a rise of more than 100% year‑over‑year driven by strong market‑share uptake and the April 2023 FDA approval for chronic migraine【page_44】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $0 in 2021 (denoted as '‑'), $158 million U.S. revenue in 2022, and $408 million total revenue in 2023 ($405M U.S. + $3M international). The year-over-year growth of over 100% is correctly implied (from $158M to $408M is ~158% increase). (2) The dates are correct: FDA approval in September 2021 and the April 2023 expanded approval for chronic migraine are both accurately cited with supporting document references. (3) Entity accuracy is perfect: Qulipta, AbbVie (implied as the reporting company), correct time periods (2021–2023), and revenue breakdowns by geography are all correctly identified. (4) The reasoning is sound and enhances the ground truth by adding context—specifically citing the expanded FDA approval in April 2023 as a growth driver, which aligns with the commercial trajectory. The multi-hop synthesis across years and revenue segments is accurate and well-supported. (5) The answer is semantically equivalent to the original, with added value from document citations and deeper context. All evaluation criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 331,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has Netflix's treatment and disclosure of the 2020 Stock Plan evolved between the 2022 and 2024 SEC filings, particularly in terms of its structural description and associated equity compensation activities?",
      "original_answer": "In 2022, the 2020 Stock Plan was referenced primarily through its inclusion in the exhibit list as a filed document (Def 14A, filed April 22, 2020), with no detailed description of its provisions or activities. In contrast, by 2024, the 2020 Stock Plan was not only explicitly described in detail but also linked to specific equity compensation activities, including the granting of incentive stock options, nonstatutory stock options, and restricted stock units (RSUs) with defined vesting schedules and performance-based criteria. This represents a significant shift from mere documentation to a more comprehensive disclosure of the plan's operational role in equity compensation.",
      "llm_answer": "In the 2022 Form 10‑K the 2020 Stock Plan is mentioned only in the exhibit index – it appears as “2020 Stock Plan” (Exhibit 10.4†) and the related “Form of Stock Option Agreement under the 2020 Stock Plan” (Exhibit 10.12†) are listed, but the filing contains no narrative description or activity tables for the plan【page_65】【page_66】.  \n\nBy the 2024 filing, Netflix describes the plan in the body of the report, stating that the “Netflix, Inc. 2020 Stock Plan is a stockholder‑approved plan that provides for the grant of incentive stock options … and for the grant of non‑statutory stock options, stock appreciation rights, restricted stock and restricted stock units to employees, directors and consultants”【page_60】, and it now discloses detailed equity‑compensation activity—including tables of options outstanding, granted, exercised and expired, intrinsic value of exercises, and related stock‑based compensation expense and RSU activity【page_61】.  \n\nThus, the disclosure evolved from a simple exhibit reference in 2022 to a full structural description and quantitative reporting of the plan’s equity‑compensation activities in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that in 2022, the 2020 Stock Plan was only referenced in the exhibit list (Exhibit 10.4† and 10.12†), with no narrative or activity disclosure, matching the original answer's claim of 'no detailed description.' (2) For 2024, it accurately states that the plan is now described in the body of the filing, including specific grant types (incentive stock options, non-statutory options, RSUs), and that detailed equity compensation activities are disclosed—such as tables for options granted, exercised, expired, intrinsic value, and stock-based compensation expense. These details align precisely with the ground truth’s emphasis on 'explicit description' and 'specific equity compensation activities.' (3) The multi-hop reasoning is sound: the model correctly contrasts the structural and disclosural differences between two filings across years, synthesizing information about disclosure depth and content evolution. (4) All entities (Netflix, 2020 Stock Plan, 2022 and 2024 filings) are correct, and while no numerical values (e.g., dollar amounts) are present, the qualitative metrics (types of awards, vesting schedules, performance criteria indirectly referenced via 'detailed tables') are accurately conveyed. Minor wording differences (e.g., 'stock appreciation rights, restricted stock' included in LLM answer but not in original) do not detract from correctness—they add precision without contradiction. The answer fully addresses both structural description and equity compensation activities as required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 448,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the company's approach to aluminum purchase agreements evolve between 2022 and 2023, particularly in terms of their classification and strategic use of derivative instruments?",
      "original_answer": "In 2022, the company described its aluminum purchase agreements as derivative instruments entered into for long-term strategic sourcing objectives and non-U.S. business requirements. By 2023, the company continued to use these agreements but provided additional clarity that the quantities of aluminum in these contracts offset each other and are priced at prevailing market prices. This evolution indicates a more refined strategy around market pricing alignment and potentially reduced exposure through offsetting positions.",
      "llm_answer": "In the 2022 filing the company said its aluminum purchase agreements were “derivative instruments for accounting purposes” whose quantities simply offset and were priced at prevailing market rates, with no explicit hedge‑accounting treatment noted (see page 122). By the 2023 filing the firm tied those same contracts to a long‑term strategic‑sourcing and non‑U.S. business objective and listed them in the derivative tables, showing commodity contracts both designated as hedging instruments and as non‑hedged contracts—indicating a shift to using the aluminum agreements as cash‑flow hedges (see pages 103 and 102).",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies in the reverse presentation of the evolution between 2022 and 2023, which undermines the core multi-hop reasoning. According to the ground truth, in 2022 the company described aluminum purchase agreements as derivative instruments for long-term strategic sourcing and non-U.S. business needs. In 2023, the company added clarity that the quantities offset and are priced at market rates—indicating refinement in transparency and risk management. However, the LLM answer incorrectly reverses this progression: it claims that in 2022 the company noted offsetting quantities and market pricing (with no mention of strategic purpose), and in 2023 tied them to strategic sourcing and hedging objectives. This misrepresents the chronological development. Additionally, the LLM introduces the claim that the 2023 contracts were 'designated as hedging instruments' and used as 'cash-flow hedges,' which is not supported by the original answer and represents an unsupported inference. While the mention of derivative accounting treatment and market pricing aligns semantically with the truth, the strategic evolution is misrepresented. The quantitative aspects (years: 2022 and 2023) are correct, and the references to derivative classification are partially accurate, earning moderate scores for quantitative accuracy and contextual relevance. However, the qualitative reasoning fails on multi-hop synthesis—drawing an incorrect conclusion about strategic shift direction and hedge accounting adoption. Thus, the overall correctness is significantly reduced due to the inversion of the timeline and unsupported claims about hedge designation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 457,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the disclosure or treatment of the Directors' Code of Conduct evolved between 2023 and 2024, particularly in terms of its accessibility and scope?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly referenced and posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors-code-of-conduct.pdf. In 2024, the URL for the Directors' Code of Conduct changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf, indicating a shift in how the document is categorized or accessed. Additionally, in 2024, the company introduced a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES,' which was not present in 2023, suggesting an expanded focus on compliance mechanisms beyond the Code itself. These changes reflect a transformation in the presentation and accessibility of the Directors' Code of Conduct, as well as an increased emphasis on insider trading compliance.",
      "llm_answer": "In the 2023 Form 10‑K BNY Mellon disclosed its Directors’ Code of Conduct with a full URL ( https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors‑code‑of‑conduct.pdf ) and a statement that the code “applies to all directors of BNY Mellon.” The 2024 filing still makes the same applicability statement but updates the hyperlink to a revised path ( bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf ) and nests the disclosure together with the employee Code of Conduct, making the code’s location on the website more streamlined while leaving its scope unchanged.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies the 2023 and 2024 URLs for the Directors' Code of Conduct, with accurate formatting and domain details, satisfying quantitative accuracy. It also correctly notes the consistent applicability statement ('applies to all directors') across both years, which aligns with the ground truth. However, the LLM misses a key qualitative update from the original answer: the addition of a new section titled 'INSIDER TRADING POLICIES AND PROCEDURES' in 2024, which represents an expansion in scope. Instead, the LLM claims the 'scope' is unchanged, which contradicts the ground truth. Additionally, while the LLM correctly notes the URL change and reorganization (e.g., 'investor-relations' path), it incorrectly implies the code is now 'nested together with the employee Code of Conduct'—a detail not present in the original answer and unsupported by the provided ground truth. This introduces a factual overreach. The reasoning is partially sound in tracking accessibility changes but fails in accurately assessing scope evolution. The answer is contextually relevant and addresses both accessibility and scope, but with a significant omission and an unsupported claim, reducing its overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 343,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How has the structure and value of HD's 4.95% Senior Notes evolved between 2023 and 2024, and what does this indicate about the company's long-term debt strategy?",
      "original_answer": "In 2023, HD issued $750 million of 4.95% senior notes due September 30, 2026, at a discount of $1.6 million. By 2024, the carrying amount of these 4.95% senior notes due September 2026 was $747 million as of February 2, 2025, and the company also reported $980 million in 4.95% senior notes due September 2052. This indicates that while the original 2026 notes remained outstanding with only a slight reduction in carrying value, HD expanded its 4.95% senior note structure to a much longer maturity in 2052, suggesting a strategy of extending debt maturities and potentially locking in fixed interest rates over a longer horizon.",
      "llm_answer": "In 2023 Home Depot’s 4.95 % senior‑note program consisted of a single $750 million tranche issued in November 2023, due September 30 2026 and sold at a $1.6 million discount, giving a net carrying amount of about $744 million as of the 2023 filing【page_60】【page_59】. By the 2024 filing the original 2026 notes show a slightly higher carrying amount of $745‑$747 million (reflecting discount amortization)【page_62】, and the company added a new $1.75 billion tranche of 4.95 % senior notes due June 2034 (discount $16.7 million)【page_63】. This growth and extension of the 4.95 % series indicates that HD is deliberately expanding its low‑coupon, fixed‑rate debt and lengthening maturities to lock in inexpensive financing, diversify its debt profile and support long‑term growth and acquisition plans.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that HD issued $750 million of 4.95% senior notes due September 30, 2026, at a $1.6 million discount in 2023 (net carrying amount ~$748.4 million, not $744 million as stated), it incorrectly reports the 2024 carrying amount as $745–$747 million with a citation to discount amortization. The ground truth states the carrying amount was $747 million as of February 2, 2025 (which is fiscal 2024), so this part is approximately correct. However, the LLM introduces a new $1.75 billion tranche of 4.95% notes due June 2034 with a $16.7 million discount, which is entirely incorrect. The ground truth reports $980 million in 4.95% senior notes due 2052, not 2034, and no mention of a $1.75 billion issuance. This is a major error in both amount and maturity date. (2) Quantitative accuracy is low: the $1.75 billion figure is more than double the correct $980 million, and the maturity date is off by nearly two decades. The initial carrying amount miscalculation (stating $744 million instead of $748.4 million) also reflects poor calculation accuracy. (3) The multi-hop reasoning is partially sound—the LLM correctly infers that extending maturities and locking in fixed rates indicates a long-term debt strategy—but it does so based on fabricated data. The synthesis fails because it relies on incorrect entities and figures. (4) Contextual relevance is high because the answer addresses both the evolution of the debt structure and the strategic implication. However, due to major factual and quantitative errors, the correctness score is low despite reasonable structure and intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 459,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did Intel's financial treatment and valuation of its investment in Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of observable price adjustments and net book value?",
      "original_answer": "In 2021, Intel recognized $471 million in observable price adjustments in its investment in Beijing Unisoc Technology Ltd. By the end of 2023, Intel was accounting for its interest in Unisoc as a non-marketable equity security, with a net book value of $1.1 billion as of December 30, 2023 (the same as December 31, 2022). This indicates that while Intel continued to hold the investment without marketability, the valuation remained stable over the two-year period despite the earlier price adjustment.",
      "llm_answer": "In 2021 Intel recorded a $471 million observable‑price adjustment to its non‑marketable equity stake in Beijing Unisoc Technology Ltd., reflecting an upward revaluation of that investment. By the end of 2023 the investment’s net book value was $1.1 billion (the same as at the end of 2022), and the observable‑price adjustments on non‑marketable equity securities – which include the Unisoc holding – had shrunk to just $17 million in 2023 (down from $299 million in 2022).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $471 million observable price adjustment in 2021 and the $1.1 billion net book value at the end of 2023 (same as 2022), which aligns with the ground truth. However, it introduces new information not present in the original answer — specifically, that observable-price adjustments for non-marketable equity securities (including Unisoc) were $17 million in 2023 and $299 million in 2022. This level of detail about aggregate adjustments is not in the ground truth and cannot be verified from the provided answer; more critically, it implies a trend that may misrepresent the specific evolution of the Unisoc investment. The original answer emphasizes stability in valuation post-2021 and does not mention 2022 or 2023 adjustments specific to Unisoc or the broader category. (2) Quantitatively, the $471M and $1.1B figures are accurate and correctly dated. However, the inclusion of $17M (2023) and $299M (2022) adjustments is unsupported by the ground truth and introduces factual inaccuracies by implication — these numbers may be from broader categories but are presented as contextually linked to Unisoc. (3) The multi-hop reasoning is partially sound — the model connects 2021 adjustments to later valuation — but fails to restrict its synthesis to the available facts. It extrapolates beyond the provided data, undermining the qualitative accuracy. (4) Contextual relevance is high because the answer addresses the evolution of valuation and accounting treatment over time, directly responding to the question’s focus. However, the correctness score is reduced due to unsupported numerical claims that distort the factual narrative. A score of 4 reflects partial correctness: core facts are right, but significant additions introduce material inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 492,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did AbbVie's engagement with Qulipta evolve from 2022 to 2023, particularly in terms of its regulatory and commercial development status?",
      "original_answer": "In 2022, Qulipta was part of a group of products that received regulatory approvals, leading to the reclassification of $1.0 billion of indefinite-lived research and development intangible assets to developed product rights. By 2023, AbbVie had introduced Qulipta with specific regulatory milestones: it received FDA approval in April 2023 for the preventive treatment of chronic migraine in adults and EC approval in August 2023 for the preventive treatment of migraine in adults with four or more migraine days per month. This evolution reflects a shift from asset reclassification to active regulatory and commercial advancement.",
      "llm_answer": "In 2022 Qulipta was already a marketed product—having been re‑classified to a developed‑product right after its earlier regulatory approval—and generated $158 million of U.S. net revenue (with no international sales) (2022 10‑K Note 7, page_100; revenue table, page_42). By 2023 AbbVie added new clearances—U.S. FDA approval for chronic migraine in April and European Commission approval in August—and U.S. sales rose to $405 million, showing an expanded commercial rollout (2023 10‑K Neuroscience section, page_40; revenue table, page_42).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes several correct elements but contains key factual inaccuracies. The ground truth states that Qulipta received regulatory approvals in 2022 leading to the reclassification of $1.0 billion in intangible assets, implying that the drug was approved prior to 2022. However, the LLM claims Qulipta was 'already a marketed product' in 2022 with $158 million in U.S. net revenue. This revenue figure is not present in the ground truth and contradicts the timeline, as the original answer emphasizes 2023 as the year of FDA and EC approvals. The LLM incorrectly implies commercial sales occurred in 2022, while the ground truth positions 2023 as the start of active regulatory and commercial advancement. The $405 million in 2023 U.S. sales is not in the ground truth and appears to be fabricated or misattributed. (2) Quantitatively, the dates of FDA (April 2023) and EC (August 2023) approvals are correct and align with the original answer. However, the revenue figures ($158M in 2022, $405M in 2023) are not supported by the ground truth, which does not mention any sales data. These numbers may be drawn from external sources or confused with another product, reducing quantitative accuracy. (3) The multi-hop reasoning is partially sound: the model connects regulatory milestones to commercial development and attempts to show progression from asset reclassification to market rollout. However, it misrepresents the timeline by asserting commercial sales in 2022, which undermines the logical evolution described in the original answer. The core idea of progression from regulatory approval to commercial expansion is valid, but the factual basis is flawed. (4) Despite the inaccuracies, the answer is highly contextually relevant, addressing both regulatory and commercial development as asked. The qualitative reasoning is strong in structure and synthesis, even if based on incorrect data. The mention of specific approvals and their implications shows good understanding of the domain. However, the inclusion of unsupported financial figures significantly reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 570,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has Boeing's framing and strategic emphasis on 'upgrades and conversions' within the Global Services segment evolved between 2022 and 2023, based on the language used in the 10-K filings?",
      "original_answer": "In 2022, 'upgrades and conversions' were listed as part of a broader set of services under the Global Services segment, grouped alongside supply chain logistics, engineering, maintenance, spare parts, training systems, technical documents, and digital services. The description was general and lacked strategic framing. In 2023, while the service was still included, the context shifted subtly: it was now positioned within a more structured narrative that emphasized the full spectrum of sustaining aerospace platforms and systems, indicating a more integrated and strategic role within the segment. This evolution suggests a more deliberate positioning of 'upgrades and conversions' as a core capability rather than a general service offering.",
      "llm_answer": "In the 2022 Form 10‑K (see page 3), Boeing simply listed “upgrades and conversions” as one line‑item in the Global Services portfolio – a neutral description among many other services. By the 2023 filing (see page 3 for the unchanged Business description and page 5 for the Competition narrative), the same phrase still appears, but the discussion now spotlights “modifications and upgrades” as a key capability for winning business, effectively shifting the strategic framing toward upgrades (and dropping the explicit mention of conversions) as a growth focus.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its assessment of the evolution in Boeing's strategic framing of 'upgrades and conversions' between 2022 and 2023, with accurate referencing of the 10-K filings (pages 3, 5) and correct observation that the 2022 description was more neutral and list-based. It correctly identifies a shift in emphasis in 2023 toward 'modifications and upgrades' as a competitive capability. However, there is a minor but notable discrepancy: the original answer states that 'upgrades and conversions' remained included in 2023 but were framed within a broader, more strategic narrative about sustaining aerospace platforms, whereas the LLM claims the explicit mention of 'conversions' was dropped. The ground truth does not confirm the omission of 'conversions'—only a reframing. This misrepresents a detail of the textual evolution. Additionally, the LLM introduces the idea that this shift was tied to 'winning business' and 'growth focus,' which, while plausible, goes slightly beyond the original answer’s more cautious interpretation of 'integrated and strategic role.' The reasoning is sound and contextually relevant, and there are no quantitative errors (no numbers involved). Wording differences are acceptable, but the claim about dropping 'conversions' and the stronger emphasis on growth represent small factual and interpretive deviations, justifying a 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 393,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Intel's financial relationship with Beijing Unisoc Technology Ltd. evolve between 2021 and 2023, particularly in terms of the valuation and recognition of this investment?",
      "original_answer": "Intel's financial relationship with Beijing Unisoc Technology Ltd. remained consistent in terms of total net book value, which stayed at $1.1 billion as of both December 25, 2021 (from the 2022 filing) and December 30, 2023 (from the 2023 filing). However, in 2021, Intel recognized $471 million in observable price adjustments related to its investment in Unisoc, indicating a revaluation event during that year. This type of valuation adjustment was not explicitly mentioned in the 2023 filing, suggesting a stabilization of the investment's value over time or a lack of significant observable price changes in 2023 compared to 2021.",
      "llm_answer": "Intel recorded its interest in Beijing Unisoc Technology Ltd. as a non‑marketable equity security.  In 2021 the stake was carried at $1.1 billion and Intel recognized a $471 million observable‑price adjustment that year, raising the investment’s carrying amount【page_52】.  By the end of 2022 and again at year‑end 2023 the net book value of the Unisoc investment remained $1.1 billion, indicating that after the 2021 adjustment the valuation was unchanged【page_96】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: Intel's investment in Beijing Unisoc was carried at $1.1 billion in both 2021 and 2023, and a $471 million observable-price adjustment was recognized in 2021. The net book value remained unchanged in subsequent years. These figures match the ground truth exactly, with acceptable formatting ($1.1 billion, $471 million). (2) Quantitative accuracy is perfect: all dollar amounts and years are correct. The mention of the carrying amount being raised in 2021 due to the adjustment aligns with the valuation event described in the original answer. (3) The reasoning is sound and reflects multi-hop synthesis: the model correctly infers that the stable book value in 2022 and 2023 (though only 2023 is required) suggests stabilization post-adjustment, even if it references 2022 not explicitly in the ground truth. The only minor gap is that the original answer notes the absence of such adjustments in 2023 filings as a point of contrast, which the LLM implies but does not explicitly state. (4) The answer is contextually fully relevant, directly addressing the evolution of the financial relationship, valuation, and recognition over time. The qualitative score is slightly reduced due to the lack of explicit comparison between 2021 and 2023 regarding the absence of observable adjustments in the latter, but overall the synthesis and accuracy are excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 395,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role of Self-Service Lockers evolved within Home Depot's interconnected shopping experience between 2023 and 2024?",
      "original_answer": "In 2023, Self-Service Lockers were described as part of Home Depot's investments to improve the customer shopping experience, specifically to enable convenient online order pickup options alongside other features like wayfinding signage and electronic shelf labels. By 2024, Self-Service Lockers were positioned more strategically as part of the company's broader fulfillment network, specifically referenced in the context of leveraging stores as 'convenient customer pickup, return, and delivery fulfillment locations' under interconnected retail programs such as BOSS, BOPIS, BODFS, and BORIS. Additionally, in 2024, approximately 50% of U.S. online orders were fulfilled through a store, highlighting a more integrated and operationally significant role for Self-Service Lockers in the fulfillment process. This reflects a shift from a convenience-focused feature to a core component of the omnichannel delivery strategy.",
      "llm_answer": "In fiscal 2023 Home Depot first highlighted self‑service lockers as a store‑refresh investment that gave shoppers a convenient front‑entrance spot for picking up online orders and helped launch its “interconnected shopping experience” 【page_8】. By fiscal 2024 the lockers were no longer a new add‑on but a core piece of a broader omnichannel fulfillment suite—listed alongside BOSS, BOPIS, BODFS and BORIS and paired with curb‑side pickup—to further streamline the frictionless, end‑to‑end shopping journey across stores, online and delivery 【page_9】【page_10】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution of Self-Service Lockers within Home Depot's interconnected shopping experience from 2023 to 2024. (1) It correctly identifies that in 2023, lockers were introduced as part of store-refresh investments to enhance convenience for online order pickup and support the interconnected shopping experience. In 2024, it accurately reflects their elevated role as a core component of omnichannel fulfillment, integrated with programs like BOSS, BOPIS, BODFS, and BORIS. (2) There are no numeric values in the LLM answer, so quantitative accuracy is not compromised—no incorrect figures or miscalculations. The original answer includes the statistic that ~50% of U.S. online orders were fulfilled through stores in 2024, which the LLM omits. This is a minor but notable omission affecting completeness. (3) The multi-hop reasoning is sound: the model synthesizes information across years and correctly infers the strategic shift from a convenience feature to an integrated fulfillment tool. (4) The LLM answer uses different phrasing (e.g., 'core piece of a broader omnichannel fulfillment suite') that is semantically equivalent to the ground truth's 'core component of the omnichannel delivery strategy.' The inclusion of curb-side pickup adds context not in the original but does not contradict it. The only shortfall is the missing 50% fulfillment statistic, which slightly reduces completeness but does not impair the overall correctness. Hence, a 9/10 on correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 440,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the level of detail and specificity in Costco's disclosure regarding the estimation methods for Insurance/Self-insurance Liabilities evolved from 2023 to 2024?",
      "original_answer": "In 2023, Costco provided a general description of its self-insurance practices and risk management mechanisms, including the use of a captive insurance subsidiary and a reinsurance program, but did not specify the factors used in estimating liabilities. In 2024, the company significantly expanded its disclosure, detailing that liabilities are estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions. Additionally, 2024's disclosure included a discussion of the unpredictability of claim costs and the potential for significant differences between actual and recorded liabilities, which was not present in 2023. This represents a meaningful increase in transparency and specificity.",
      "llm_answer": "In the 2023 filing Costco explained that insurance/self‑insurance liabilities are “estimated using historical claims experience, demographic factors, severity factors, and other actuarial assumptions,” and warned that the accruals could change if future claims or expenses differ from those assumptions. The 2024 filing expands on that description – it still cites the same actuarial inputs but adds that claim costs are “highly unpredictable” because of inflation, regulatory or legal changes and other unforeseen developments, and it notes that historically adjustments have been immaterial, making the disclosure more detailed and specific than in 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that in 2023, Costco already disclosed the use of 'historical claims experience, demographic factors, severity factors, and other actuarial assumptions'—this level of detail was only introduced in 2024, according to the ground truth. The 2023 disclosure was more general and did not specify these factors. (2) The claim that the 2023 filing included a warning about accrual changes due to future claims differing from assumptions is not supported by the ground truth, which states that discussion of unpredictability and potential significant differences was absent in 2023 and newly added in 2024. (3) The LLM correctly identifies that the 2024 filing added discussion of unpredictability due to inflation, regulatory changes, and immaterial historical adjustments—this aligns with the increased transparency noted in the original answer. (4) While the LLM captures the directional trend (increased detail in 2024), it misattributes key content to the wrong year, breaking the multi-hop comparison logic. This reversal of disclosure evolution severely impacts qualitative accuracy. Quantitative accuracy is moderate because there are no numeric values to verify, but dates (2023 vs 2024) are used incorrectly in context. Contextual relevance is high as the answer addresses the question's focus on comparative disclosure evolution. Overall, the answer is partially correct in direction but fundamentally flawed in factual attribution, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 432,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How did the financial impact of the Aldevron acquisition on inventory-related costs evolve from 2022 to 2023?",
      "original_answer": "In 2022, the Aldevron acquisition contributed to a $59 million increase in cost of sales due to fair value adjustments to inventory. By 2023, this specific acquisition-related cost associated with Aldevron was no longer present; instead, a new $87 million charge emerged in the second quarter, primarily related to excess inventory in the Biotechnology segment due to reduced demand. This indicates a shift from acquisition-driven inventory adjustments to operational inventory challenges.",
      "llm_answer": "In the 2022 filing the company said that the rise in cost of sales was partly offset by a **lower incremental acquisition‑related charge for fair‑value inventory adjustments tied to the 2021 Aldevron acquisition** (the $59 million inventory impact recorded in 2021 was reduced)【page_46】. By contrast, the 2023 filing disclosed a **$87 million inventory charge in Q2, mainly from excess inventory in the Biotechnology segment**, indicating a larger inventory‑related cost impact than the modest, reduced effect seen in 2022【page_46】.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error regarding the timing and nature of the $59 million inventory charge. The original answer states that the $59 million increase in cost of sales due to fair value adjustments from the Aldevron acquisition occurred in 2022. However, the LLM incorrectly claims this $59 million impact was in 2021 and that 2022 saw a 'lower incremental charge' due to a reduction of the prior year's adjustment. This misrepresents the financial timeline and the evolution of the acquisition-related cost. The $87 million charge in Q2 2023 is correctly identified and attributed to excess inventory in the Biotechnology segment, aligning with the ground truth. (2) Quantitatively, the $87 million figure is accurate and correctly placed in 2023. However, the $59 million figure is misattributed to 2021 instead of 2022, and the claim that it was 'reduced' in 2022 is unsupported by the original answer, which states the acquisition-related cost was no longer present in 2023—not that it decreased in 2022. Thus, while the numbers themselves are correct in value, their temporal assignment and interpretation are flawed. (3) The multi-hop reasoning is partially sound in connecting inventory charges across years and identifying a shift in cost drivers, but it fails in accurately tracing the acquisition-related charge to the correct year. The model incorrectly infers a reduction in the Aldevron-related charge in 2022 when the original answer indicates the charge was present in 2022 and absent in 2023. This undermines the logical evolution of the financial impact. (4) Contextual relevance is high—the answer addresses inventory-related costs, references the correct segments and events, and attempts a year-over-year comparison. However, due to the critical misplacement of the $59 million charge and the erroneous characterization of its trend, the overall correctness score is reduced to 5, reflecting partial accuracy with significant factual and reasoning flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 542,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the treatment and recognition of shop card liabilities evolved between 2023 and 2024, and what does this indicate about Costco's approach to unclaimed balances?",
      "original_answer": "In both 2023 and 2024, Costco recognized revenue from shop cards upon redemption and accounted for outstanding balances as a liability, net of estimated breakage based on redemption data. However, the specific mention of 'estimated breakage' and the methodology tied to redemption data became more emphasized in 2024, indicating a more refined or formalized approach to tracking and accounting for unclaimed shop card balances. This evolution suggests Costco improved its estimation techniques for unclaimed balances, aligning its liability reporting more closely with actual redemption behavior over time.",
      "llm_answer": "Costco’s accounting for shop‑card balances did not change from 2023 to 2024 – the company still records outstanding shop‑card amounts as a liability “net of estimated breakage” and recognizes revenue only when cards are redeemed, with the net liability shown in other current liabilities [page_48]. This continuity signals a consistent, prudent approach that treats unredeemed balances as breakage and reduces the liability accordingly.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent in terms of accounting treatment—correctly stating that Costco records shop card liabilities net of estimated breakage and recognizes revenue upon redemption, with the liability in other current liabilities. There are no numeric inaccuracies, and the entities (Costco, shop cards, breakage, 2023–2024 timeframe) are correctly identified, supporting a high quantitative accuracy and contextual relevance. However, the original answer highlights an evolution in the *emphasis* and *refinement* of breakage estimation methodology between 2023 and 2024, noting increased focus on redemption data and a more formalized approach in 2024. The LLM answer incorrectly asserts that 'there was no change' in accounting treatment, which contradicts the ground truth that while the core policy remained, the methodology became more emphasized and refined. This misrepresents the qualitative evolution and fails to capture the multi-hop inference that subtle changes in disclosure and emphasis indicate improved estimation practices. Thus, while the surface-level facts are correct, the reasoning and synthesis are flawed, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 333,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has Intel's Foundry Services offering evolved from 2022 to 2023 in terms of strategic partnerships and customer engagement, based on the specific initiatives and agreements mentioned in those years?",
      "original_answer": "In 2022, Intel introduced its Foundry Services as part of the IDM 2.0 strategy, emphasizing plans to build a world-class foundry business with differentiated offerings, including leading-edge packaging and process technology, committed capacity in the US and Europe, and a strong IP portfolio. By 2023, Intel had significantly advanced this offering by securing four design wins on Intel 18A, including a major high-performance computing customer, and five new design wins in advanced packaging, particularly for AI-related designs. Additionally, Intel expanded its IFS Accelerator Ecosystem Alliance program to over 40 strategic agreements and entered into multigenerational agreements with ARM and Synopsys to enable optimized SoC design on Intel 18A. These developments indicate a shift from strategic intent in 2022 to concrete customer engagements and ecosystem partnerships in 2023.",
      "llm_answer": "In 2022 Intel introduced Intel Foundry Services (IFS) as a new pillar of its IDM 2.0 strategy, emphasizing the creation of a world‑class foundry business with dedicated U.S. and European capacity, advanced packaging, and a broad IP portfolio, but the filing only described the strategic intent and internal capabilities (2022 10‑K pp. 7‑9). By 2023 the IFS model had matured into an ecosystem: the IFS Accelerator Alliance doubled to > 40 strategic agreements, Intel signed multigenerational deals with ARM and a definitive agreement with Synopsys, expanded the DoD RAMP‑C program to include customers such as Nvidia, IBM, Microsoft, Boeing and Northrop Grumman, and secured a commercial foundry contract with Tower for 300 mm advanced analog processing (2023 10‑K pp. 36‑37).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core evolution of Intel's Foundry Services from strategic intent in 2022 to concrete partnerships in 2023, aligning well with the ground truth. It correctly identifies the introduction of IFS under IDM 2.0 in 2022 and the maturation into an ecosystem in 2023. Key elements such as multigenerational agreements with ARM and Synopsys, expansion of the IFS Accelerator Alliance to over 40 agreements, and the strategic focus on U.S. and European capacity are accurately reported. However, there are notable discrepancies: the mention of 'DoD RAMP-C program' and specific customers like Nvidia, IBM, Microsoft, Boeing, and Northrop Grumman is not present in the ground truth and appears to be extraneous or incorrectly inferred information. Similarly, the 'commercial foundry contract with Tower for 300 mm advanced analog processing' is not mentioned in the original answer and introduces unsupported detail. While the ground truth highlights four design wins on Intel 18A and five new advanced packaging design wins (especially AI-related), these specific quantitative customer engagements are missing in the LLM answer. The LLM instead emphasizes ecosystem growth and third-party alliances, which is relevant but omits key customer design win metrics. Quantitative accuracy is high for the numbers it does report (e.g., >40 agreements), but it misses the critical design win figures from the ground truth. The reasoning is logically structured and shows multi-hop synthesis between 2022 and 2023 developments, though it substitutes some correct details with potentially fabricated ones. Contextually, the answer remains highly relevant to the question about strategic partnerships and customer engagement. Overall, the answer is factually sound in parts but contains additions not supported by the ground truth and omits key metrics, warranting a score of 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 511,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the financial impact of DHR's relationship with Aldevron evolve between 2022 and 2023, particularly in terms of goodwill and net cash consideration?",
      "original_answer": "In 2022, DHR preliminarily recorded approximately $6.1 billion of goodwill related to the Aldevron Acquisition. By 2023, the net cash consideration for Aldevron increased to $9.561 billion, indicating a more detailed or revised financial assessment of the acquisition. This evolution shows a significant increase in the financial commitment to the Aldevron relationship, particularly in terms of cash outlay, beyond the initial goodwill estimate provided in 2022.",
      "llm_answer": "In the 2022 Form 10‑K Danaher said the Aldevron purchase generated about **$6.1 billion of goodwill** and was funded with an **approximately $9.6 billion cash purchase price** (see page 83). The 2023 filing now records the same deal with **$6.149 billion of goodwill** and a **net cash consideration of $9.561 billion** (see page 74), reflecting a modest rise in goodwill and a slight dip in the cash outlay.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the goodwill and net cash consideration figures for both 2022 and 2023, with high precision. It accurately states $6.1 billion goodwill in 2022 and updates it to $6.149 billion in 2023, which aligns with a refined assessment. The net cash consideration is correctly reported as $9.561 billion in 2023. However, the LLM claims the 2022 filing mentioned an 'approximately $9.6 billion cash purchase price,' which is not supported by the original answer or ground truth — the original answer only specifies the 2023 net cash consideration and does not confirm the exact figure disclosed in 2022. This introduces a minor inaccuracy, though the $9.6 billion figure may be a rounded version of $9.561 billion. (2) Quantitatively, all cited numbers ($6.1B, $6.149B, $9.561B) are correct or reasonably approximated. The slight dip in cash outlay is logically inferred from $9.6B to $9.561B, but the original answer does not state that $9.6B was reported in 2022, so this comparison is speculative. (3) The multi-hop reasoning is sound — the model synthesizes data across two years and correctly contrasts the evolving financial impact. It captures the increased specificity in 2023 and interprets the trend appropriately. (4) Scores reflect high factual accuracy with a minor deduction in correctness and quantitative accuracy due to the unsupported claim about 2022 cash consideration. Qualitative reasoning remains strong, and contextual relevance is perfect as all information directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1220,
        "completion_tokens": 427,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the maturity date of the AT&T Inc. 1.800% Global Notes changed between the 2022 and 2024 SEC filings, and what does this indicate about the company's debt structure evolution?",
      "original_answer": "In the 2022 SEC filing, the AT&T Inc. 1.800% Global Notes were due on September 5, 2026. In the 2024 filing, the same class of notes is listed with a maturity date of September 14, 2039. This indicates a significant shift in the company's debt structure, extending the maturity of this particular note by over 13 years.",
      "llm_answer": "The 1.800 % Global Notes listed in AT&T’s 2022 Form 10‑K were due September 5 2026 (with a separate series due September 14 2039) and the 2024 Form 10‑K shows the same two maturity dates for those series【T_10k_2022.pdf page_2】【T_10k_2024.pdf page_2】.  The unchanged schedule indicates that AT&T has retained its existing medium‑ and long‑term fixed‑rate debt, reflecting a stable, long‑dated debt structure rather than a shift toward shorter‑term financing.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The ground truth states that the maturity date for the 1.800% Global Notes changed from September 5, 2026 (in the 2022 filing) to September 14, 2039 (in the 2024 filing), indicating a major extension. However, the LLM claims both maturity dates existed in both filings and that the schedule is 'unchanged,' which contradicts the ground truth. This misrepresents the evolution of the debt structure. (2) Quantitatively, the dates mentioned (September 5, 2026 and September 14, 2039) are factually present in the correct filings, so the numbers themselves are accurate, but their attribution across years is wrong. The LLM incorrectly implies both series were present in both 2022 and 2024, when the change reflects a replacement or update in maturity, not coexistence. (3) The multi-hop reasoning fails: the model should have compared the same class of notes across years and noted the shift from 2026 to 2039 maturity. Instead, it assumes multiple series without evidence and concludes stability, when the truth indicates a strategic extension of debt maturity—over 13 years—suggesting a move toward longer-term financing, not stability. (4) Contextual relevance is moderate because the answer discusses the right topic (AT&T debt structure, maturity dates, 10-K filings), but the conclusion is directly opposite to the correct interpretation. The reasoning and factual synthesis are flawed, warranting a low correctness score despite some accurate date references.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 423,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Target's compliance with its debt leverage covenant evolved between 2023 and 2024, and what changes in credit facility structure may have influenced this compliance?",
      "original_answer": "In 2023, Target stated that it was, and expected to remain, in compliance with its debt leverage covenant, which was part of a $1.0 billion 364-day credit facility that would expire in October 2024, along with a $3.0 billion five-year facility expiring in October 2028. By 2024, Target had renewed its 364-day credit facility, extending its expiration to October 2025, while maintaining the same $3.0 billion five-year facility. The company continued to assert compliance with the debt leverage covenant. The renewal of the 364-day facility likely provided continued flexibility, supporting Target’s ability to remain compliant with the covenant.",
      "llm_answer": "Target said it was “in compliance” with its debt‑leverage covenant in both years – the 2023 filing notes that “We are, and expect to remain, in compliance with these covenants” 【page_54】 and the 2024 filing repeats the same statement 【page_35】.  The underlying credit‑facility structure was adjusted: in October 2023 Target replaced its prior 364‑day revolving line with a new $1.0 billion 364‑day facility (expiring Oct 2024) and extended its existing $3.0 billion five‑year revolving facility to Oct 2028 【page_54】; in October 2024 it again renewed the $1.0 billion 364‑day facility (now expiring Oct 2025) while keeping the $3.0 billion facility through 2028 【page_35】.  These renewals and extensions provided additional borrowing capacity that helped sustain covenant compliance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Target maintained compliance with its debt leverage covenant in both 2023 and 2024, renewed the $1.0 billion 364-day facility (extending expiration from Oct 2024 to Oct 2025), and maintained the $3.0 billion five-year facility expiring in Oct 2028. (2) Quantitative accuracy is perfect: dollar amounts ($1.0 billion, $3.0 billion), timeframes (364-day, five-year), and expiration dates (Oct 2024, Oct 2025, Oct 2028) are all correctly reported. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings, identifies changes in credit facility structure, and links renewals to sustained covenant compliance. (4) Minor deduction in qualitative accuracy due to slightly stronger implication of 'additional borrowing capacity' as a direct factor in compliance—while logical, the original answer emphasizes 'flexibility' rather than increased capacity, which is a subtle but notable nuance. Otherwise, the answer is complete, factually correct, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 317,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has Intel's approach to expanding digital readiness for global populations evolved from 2022 to 2023, particularly in relation to its RISE strategy and external collaboration initiatives?",
      "original_answer": "In 2022, Intel committed to expanding digital readiness through its RISE strategy, focusing on collaborative initiatives with other technology companies via the Alliance for Global Inclusion to create an Inclusion Index with unified goals and metrics. By 2023, this effort had matured into the publication of the third global inclusion index survey, which transitioned into an index system where organizations scoring 50% or higher were formally recognized. Intel was among the 18 recognized organizations out of 27 respondents, indicating a more structured and outcome-focused approach to digital readiness and inclusion. This evolution reflects a shift from establishing collaborative frameworks to measuring and recognizing performance against defined benchmarks.",
      "llm_answer": "In 2022 Intel’s 10‑K described the RISE strategy as a high‑level pledge to work with customers and the Alliance for Global Inclusion to “accelerate the adoption of inclusive business practices… and expand digital readiness for millions of people,” but the discussion was largely aspirational. By 2023 the company had turned that pledge into concrete action—publishing the third Global Inclusion Index (recognizing 18 firms, including Intel), scaling its AI‑for‑Youth and AI‑for‑Workforce digital‑readiness programs in partnership with governments and institutions, and using the RISE Technology Initiative to fund projects that explicitly broaden digital readiness—showing a shift from a stated commitment to measurable, collaborative execution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Intel's 2022 RISE strategy as aspirational, focused on collaboration with the Alliance for Global Inclusion to expand digital readiness. In 2023, it accurately notes the publication of the third Global Inclusion Index and Intel’s recognition among 18 organizations—consistent with the ground truth. The number of respondents (27) is not mentioned in the LLM answer, but the key fact that Intel was one of 18 recognized organizations is correct. (2) No numerical inaccuracies: the years (2022, 2023), the index version (third), and the recognition of 18 firms are all factually correct. The 50% scoring threshold mentioned in the original answer is omitted, but this is a minor detail that does not undermine the core accuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes Intel’s evolving strategy across two years, connects it to the RISE framework, and links external collaborations (Alliance, governments, institutions) to tangible outcomes. It correctly infers a shift from aspiration to execution. (4) The LLM adds contextual details not in the original—such as AI-for-Youth and AI-for-Workforce programs and the RISE Technology Initiative—which are plausible extensions of Intel’s strategy and do not contradict the ground truth. These additions enhance relevance without introducing error. Overall, the answer captures the evolution accurately, with only minor omissions of granular metrics (e.g., 50% benchmark), warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 434,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did Emerson's relationship with Micromine evolve between 2023 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2023, Emerson (via its AspenTech subsidiary) entered into an agreement to acquire Micromine for AU$900 (approximately $623 USD), but later terminated the agreement due to uncertainty around Russian regulatory approval. This led to a mark-to-market gain of $24 in 2023 related to foreign currency forward contracts tied to the Micromine acquisition. By 2024, AspenTech had terminated all outstanding foreign currency forward contracts associated with the Micromine deal. The termination of the Micromine acquisition represented a shift from a strategic expansion effort in 2023 to a full withdrawal from the transaction, with no further financial commitments or exposures to Micromine reported in 2024.",
      "llm_answer": "Emerson’s AspenTech unit moved from planning to buy Micromine (an AU $900/≈US $623 deal announced in July 2022) to cancelling that deal in August 2023, ending the relationship without paying any termination fee【page_52】. The only measurable financial effect was a $24 million mark‑to‑market foreign‑currency gain in 2023 (versus a $50 million loss in 2022) tied to forward contracts that were unwound when the acquisition was terminated, and no further cash impact appeared in 2024【page_55】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor factual inaccuracy regarding the announcement date of the deal. The ground truth states the agreement was entered into in 2023, while the LLM claims it was announced in July 2022. This discrepancy affects timeline accuracy. However, the termination in August 2023 is correctly noted. (2) Quantitatively, the AU$900 / ~$623 USD acquisition value and the $24 million mark-to-market gain in 2023 are accurately reported, including the comparison to a $50 million loss in 2022 (though this loss is not in the ground truth, it does not contradict it and may be contextually valid). The financial implications are correctly limited to the gain and termination of contracts, with no further impact in 2024. (3) The multi-hop reasoning is sound: the model correctly links Emerson → AspenTech → Micromine acquisition attempt → termination → financial effects via foreign currency contracts. It synthesizes the shift in relationship and associated financial outcomes across years. (4) The answer is contextually fully relevant, addressing both the evolution of the relationship and financial implications. The minor date discrepancy prevents a top score, but core facts, numbers, and synthesis are correct, warranting a high 'correctness_score' of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 366,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How did the availability of shares under The Home Depot's U.S. Employee Stock Purchase Plan (ESPP) and the average purchase price of shares during the fiscal year change from 2022 to 2023?",
      "original_answer": "In 2022, there were approximately 17 million shares available under the U.S. ESPP, and associates purchased approximately one million shares at an average price of $305.14. In 2023, the number of shares available under the U.S. ESPP decreased to 15 million, and associates again purchased approximately one million shares, but at a lower average price of $277.19. This indicates a reduction in share availability and a notable decrease in the average purchase price during the fiscal year.",
      "llm_answer": "The U.S. ESPP’s share pool shrank from roughly 17 million shares at the end of fiscal 2022 (≈ Jan 30 2022) to about 15 million shares at the end of fiscal 2023 (≈ Jan 28 2024)【page_70】.  At the same time, the average price paid for ESPP shares fell from about $305 per share to $277 per share【page_70】【page_68】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decrease in available shares from 17 million in 2022 to 15 million in 2023 and the drop in average purchase price from $305.14 to $277.19, rounding to $305 and $277 respectively—this is acceptable under semantic equivalence. All key facts are present and accurate. (2) Numeric values are correct within acceptable rounding: $305.14 ≈ $305 and $277.19 ≈ $277; share counts (17M and 15M) are exact. The fiscal year end dates (Jan 30, 2022 and Jan 28, 2024) are contextually accurate for fiscal years 2022 and 2023, though not required in the original answer. (3) The multi-hop reasoning is sound—comparing share availability and average purchase prices across two years for the same plan (U.S. ESPP). The synthesis of information across pages (70 and 68) indicates proper cross-referencing. (4) The only minor shortcoming is that the LLM does not explicitly mention that approximately one million shares were purchased in each year, which is part of the original answer and relevant to understanding the scale of purchases. While not critical to the core comparison, it is a small omission affecting completeness. Otherwise, the answer is factually correct, well-supported, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 353,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the pattern of impairment triggers and associated charges across DHR's business segments evolved between the 2022 and 2023 filings, and what does this indicate about shifting risks in its intangible asset portfolio?",
      "original_answer": "In the 2022 filing, DHR reported impairment triggers only in the Diagnostics segment during the first quarter of 2021, resulting in a $10 million impairment charge. In contrast, the 2023 filing identified impairment triggers in multiple segments: the Biotechnology segment in the second quarter of 2023, the Diagnostics and Biotechnology segments in the fourth quarter of 2023, and again in the Diagnostics segment in the first quarter of 2021 (which was included for comparative purposes). The impairment charges increased significantly, from $10 million in 2021 (reported in the 2022 filing) to $77 million in 2023 (reported in the 2023 filing). This indicates a notable expansion in both the scope and magnitude of impairment activity, particularly affecting the Biotechnology segment in 2023, which was not previously a focus of impairment events. This evolution suggests growing risks in DHR’s intangible asset portfolio, especially in its Biotechnology segment.",
      "llm_answer": "In the 2022 filing the company only reported impairment triggers in the Diagnostics segment (Q1 2021) and in both Diagnostics and Environmental & Applied Solutions (Q1 and Q3 2020), resulting in modest charges of $10 million (2021) and $22 million (2020) and no impairment in 2022 【page_100】. By the 2023 filing the triggers had moved to the Biotechnology segment (Q2 2023 and Q4 2023) and again to Diagnostics in Q4 2023, producing a much larger $77 million charge in 2023 while 2022 saw no impairments 【page_89】. This shift signals that risk in Danaher’s intangible‑asset portfolio is now concentrating on technology‑based intangibles in its Biotechnology business—likely driven by recent biotech acquisitions—rather than the earlier focus on Diagnostics and Environmental assets.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. According to the ground truth, the 2022 filing only reported an impairment trigger in the Diagnostics segment in Q1 2021 ($10 million charge). However, the LLM incorrectly states that there were triggers in Diagnostics and Environmental & Applied Solutions in Q1 and Q3 2020 with a $22 million charge in 2020—this information is not present in the ground truth and introduces false data. The ground truth does not mention any 2020 impairments or the Environmental & Applied Solutions segment being involved in impairments. (2) The $77 million charge in 2023 is correctly reported, as is the absence of impairments in 2022. However, the LLM misattributes the $22 million charge to 2020, which is unsupported by the original answer and creates a false comparison. The original answer only references a $10 million charge in 2021 (reported in 2022 filing) and a $77 million charge in 2023 (reported in 2023 filing). (3) The multi-hop reasoning is partially sound—the LLM correctly identifies a shift toward Biotechnology in 2023 (Q2 and Q4) and notes increased charges. It also correctly observes that Diagnostics was re-implicated in Q4 2023. However, it fails to mention that the 2021 Diagnostics charge was included in the 2023 filing for comparative purposes, and it fabricates earlier impairment events. The conclusion about shifting risk to Biotechnology is reasonable but based on flawed premises. (4) The contextual relevance is high—the answer addresses the evolution of impairment triggers and interprets shifting risks in intangible assets. However, due to significant factual errors in entities, dates, and financial figures, the correctness and accuracy scores are reduced. The answer is plausible-sounding but not factually aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 497,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the value of outstanding letters of credit related to trade contracts change between 2022 and 2023, and what does this indicate about the company's involvement in business transactions tied to trade contracts?",
      "original_answer": "The value of outstanding letters of credit related to trade contracts increased from $362 million in 2022 to $598 million in 2023. This significant increase indicates a growing involvement or expansion in business activities tied to trade contracts during this period.",
      "llm_answer": "The company’s outstanding letters of credit rose from $362 million at the end of 2022 (HD 10‑K 2022 p.70) to $598 million at the end of 2023 (HD 10‑K 2023 p.67), an increase of about $236 million. This jump signals that Home Depot is using more letters of credit to back its trade‑related business transactions, reflecting a larger exposure and greater involvement in contracts tied to trade activities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the values of $362 million in 2022 and $598 million in 2023 are accurately reported, and the calculated increase of $236 million is correct (598 - 362 = 236). Minor formatting with thin spaces is acceptable and does not affect accuracy. (2) The answer addresses both parts of the question: the change in value and its implication regarding the company's involvement in trade-related transactions. (3) Entities are correct—Home Depot (implied by 'HD 10-K' citations), the metric 'outstanding letters of credit related to trade contracts', and the years 2022 and 2023 are all properly identified. (4) The reasoning is sound: the increase is correctly interpreted as signaling greater involvement and exposure in trade-related business activities, which aligns with the ground truth's conclusion of 'growing involvement or expansion'. The inclusion of source citations (page numbers from 10-K filings) adds contextual support, though not required. Semantic equivalence is maintained throughout with no factual discrepancies. All evaluation criteria are met at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 330,
        "total_tokens": 1515
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has the status of the 0.300% Notes due 2028 evolved between the 2023 and 2024 SEC filings, and what does this indicate about IBM's financial instruments disclosures?",
      "original_answer": "In the 2023 filing, the 0.300% Notes due 2028 were disclosed as part of IBM's instruments defining the rights of holders, with specific reference to Exhibit 4.1, filed on February 10, 2020. In the 2024 filing, the 0.300% Notes due 2028 are listed as actively issued financial instruments under the trading symbol IBM28B, registered on the New York Stock Exchange. This indicates a shift from merely disclosing the existence of the instrument in 2023 to formally recognizing it as an actively traded financial instrument in 2024, suggesting increased market engagement or liquidity for this instrument.",
      "llm_answer": "In the 2023 Form 10‑K the 0.300 % Notes due 2028 are mentioned only in the exhibit list – IBM notes that “the instrument defining the rights of the holders of the 0.300 % Notes due 2028 … is Exhibit 4.1 to Form 8‑K, filed February 10 2020”【page_20】. In the 2024 Form 10‑K the same notes appear in the Section 12(b) securities‑registration table as an active security (ticker IBM28B)【page_1】. This change shows IBM’s disclosures have moved from a historical reference to an explicit, current registration of the notes, underscoring the company’s ongoing, transparent reporting of its debt instruments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the status of the 0.300% Notes due 2028 in both the 2023 and 2024 SEC filings. In 2023, it accurately notes that the notes were referenced only in the exhibit list as Exhibit 4.1 to the Form 8-K filed on February 10, 2020, which matches the ground truth. In 2024, it correctly states that the notes appear in the Section 12(b) securities-registration table with ticker IBM28B, confirming their active registration and trading status. (2) All quantitative elements—interest rate (0.300%), year (2028), filing dates (February 10, 2020), and ticker symbol (IBM28B)—are factually accurate and match the original answer. No calculations are required, but the references to specific exhibits and forms are precise. (3) The multi-hop reasoning is sound: the model synthesizes information from two different years’ filings and infers a meaningful evolution in disclosure practice—from passive reference to active registration. The conclusion about increased transparency and ongoing reporting aligns with the ground truth’s interpretation of greater market engagement. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the New York Stock Exchange (NYSE) as the exchange where IBM28B is listed, which is included in the ground truth. However, referencing Section 12(b) implies NYSE listing, so this omission is not material. Overall, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 416,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has IBM's treatment of the 1.750% Notes due 2031 evolved between 2023 and 2024, particularly in terms of disclosure and registration on stock exchanges?",
      "original_answer": "In 2023, IBM disclosed the 1.750% Notes due 2031 in its 10-K filing, indicating that the instrument defining the rights of the holders was incorporated by reference as part of an exhibit filed on January 30, 2019. By 2024, the 1.750% Notes due 2031 were not only still referenced but also explicitly registered under a trading symbol (IBM31) on the New York Stock Exchange, reflecting a shift from mere disclosure to formal recognition and active listing on a financial market platform.",
      "llm_answer": "In IBM’s 2023 Form 10‑K the 1.750 % Notes due 2031 were disclosed only by incorporation‑by‑reference – the filing notes that the instrument defining the holders’ rights is Exhibit 4.4 to a Form 8‑K filed on January 30 2019 (see page 20). By the 2024 Form 10‑K, the same notes are listed in the Section 12(b) securities table with ticker IBM31 and shown as trading on the New York Stock Exchange (see page 1), indicating that IBM now registers the notes as an exchange‑listed security rather than merely referencing the prior 8‑K instrument.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately reflects that in 2023, the 1.750% Notes due 2031 were disclosed via incorporation by reference to Exhibit 4.4 of a Form 8-K filed on January 30, 2019, which aligns with the original answer. (2) For 2024, it correctly states that the notes are now listed under Section 12(b) with the ticker IBM31 and are trading on the New York Stock Exchange, indicating formal registration—this captures the evolution from disclosure to listing. (3) All entities (IBM, 1.750% Notes due 2031, NYSE, IBM31, Form 10-K 2023 and 2024) are correctly identified. (4) The multi-hop reasoning—comparing the treatment of the same financial instrument across two years and interpreting the shift from incorporation by reference to exchange listing—is sound and well-articulated. (5) Minor wording differences (e.g., 'Section 12(b) securities table' vs 'registered under a trading symbol') do not affect semantic equivalence; both convey formal exchange registration. All facts, dates, percentages, and logical inferences are accurate and complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 316,
        "total_tokens": 1575
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Eli Lilly's financial relationship with Zyprexa evolve between 2023 and 2024, particularly in terms of revenue recognition and business model approach?",
      "original_answer": "In 2023, Eli Lilly generated $1.45 billion from the sale of the rights for the olanzapine portfolio, including Zyprexa, outside the U.S., indicating a direct revenue stream from product sales. By 2024, the company no longer reported Zyprexa as part of product sales; instead, revenue from the 2023 sale of rights was included in collaboration and other arrangements revenue, signaling a shift from direct product sales to revenue recognition through licensing and collaboration agreements. This change reflects a transformation in the financial relationship from active product sales to post-sale royalty or profit-sharing arrangements.",
      "llm_answer": "In 2023 Eli Lilly recorded Zyprexa’s contribution as part of net product revenue – $1.7 billion in total, driven mainly by the one‑time sale of the olanzapine‑portfolio rights that included Zyprexa [page_48]. By the 2024 filing that same rights‑sale is presented under “collaboration and other revenue,” with the company explaining that revenue from the 2023 sale of Zyprexa’s rights is now treated as a licensing/collaboration transaction and is recognized when control of the asset transfers (or the performance obligation is satisfied) rather than at product shipment [page_64][page_66]. This marks a shift from a product‑sale model to a rights‑sale/licensing business model for Zyprexa.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift in Eli Lilly's financial relationship with Zyprexa from 2023 to 2024, noting the transition from direct product sales to recognition under collaboration and other revenue, which aligns with the ground truth. The core reasoning about the business model shift—from product sales to licensing/collaboration arrangements—is accurate and well-supported. (2) However, there is a discrepancy in the reported dollar amount: the LLM states $1.7 billion in 2023, while the ground truth specifies $1.45 billion. This is a material difference (approximately 17% higher), which affects quantitative accuracy despite the correct context of a one-time sale. The mention of 'page_48', 'page_64', and 'page_66' suggests document grounding but cannot be verified without source access. (3) The multi-hop reasoning is sound—correctly synthesizing changes in revenue recognition categories and linking them to a strategic shift in business model. The explanation of revenue recognition timing (control transfer vs. shipment) adds depth beyond the original answer, showing strong qualitative understanding. (4) The answer is fully contextually relevant, addressing both revenue recognition and business model evolution. The correctness score is 8 due to the accurate conceptual and structural analysis, but docked for the incorrect financial figure. Quantitative accuracy is 7 due to the significant dollar amount mismatch; qualitative accuracy is 9 for excellent reasoning and entity/year alignment; contextual relevance is 10 as all aspects of the question are directly addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 444,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the treatment and financial impact of the Mobility Preferred Interests evolve from 2023 to 2024, particularly in terms of redemption obligations and their effect on earnings per share calculations?",
      "original_answer": "In 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to the certainty of redemption, recording $2,670 in current liabilities and $2,670 in noncurrent liabilities. The company ultimately repurchased all remaining interests in April 2023 for $5,414, including accrued distributions. By 2024, the Mobility Preferred Interests were fully retired, and the focus shifted to their impact on earnings per share calculations, where under ASU 2020-06, the ability to settle these interests in stock was reflected in the diluted earnings per share computation for periods prior to the repurchase. This indicates a shift from active financial obligations to retrospective accounting treatment.",
      "llm_answer": "In 2023 AT&T was forced to recognize a redemption liability for its Mobility II preferred interests.  Because the AT&T pension‑trust notice required the company to buy back the remaining 213 million interests (≈ $5.4 billion), the interests were re‑classified from equity to a liability with about $2.67 billion recorded in current liabilities and $2.67 billion in non‑current liabilities, and the full repurchase was completed in April 2023 for $5.414 billion 【page_90†L13-L22】【page_90†L23-L27】.  For the portion of 2023 before the buy‑back, the ability to settle the interests in stock was reflected in diluted EPS (72 dilutive shares in the numerator and 71 in the denominator) 【page_53†L15-L22】【page_53†L31-L38】.  By 2024 the Mobility preferred interests had been fully repurchased, no redemption obligation remained, and they were omitted from the diluted EPS calculation (no Mobility‑interest shares shown) 【page_53†L15-L22】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2023, AT&T reclassified the Mobility Preferred Interests from equity to a liability due to redemption certainty, recording $2.67 billion in current and $2.67 billion in noncurrent liabilities, totaling $5.34 billion in liabilities, and repurchased all remaining interests in April 2023 for $5.414 billion, including accrued distributions. These numbers match the original answer exactly (allowing for format: $2,670 = $2.67 billion). (2) The treatment in 2024 is correctly described: the interests were fully retired, no redemption obligation remained, and they were excluded from diluted EPS calculations in 2024. (3) The multi-hop reasoning is sound—linking the 2023 reclassification and repurchase to the change in EPS treatment in 2024. (4) The LLM adds specific contextual detail not in the original answer—72 dilutive shares in numerator and 71 in denominator—drawn from the source (page 53), which enhances completeness. (5) The only minor deviation is that the original answer emphasizes the retrospective application of ASU 2020-06 for prior periods in diluted EPS, while the LLM focuses on the absence of the instrument in 2024. However, both convey the same core idea: post-repurchase, the instrument no longer affects EPS. This is a difference in emphasis, not factual inaccuracy. Quantitative accuracy is perfect. Contextual relevance is excellent. Qualitative accuracy is slightly reduced due to less explicit mention of ASU 2020-06’s retrospective role, but the substance is preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 439,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has IBM's treatment and disclosure of the 0.875% Notes due 2030 evolved between 2023 and 2024, particularly in terms of its listing and registration status?",
      "original_answer": "In 2023, the 0.875% Notes due 2030 were disclosed as part of a list of instruments incorporated by reference to Exhibit 4.1 to Form 8-K filed on February 8, 2022. By 2024, the 0.875% Notes due 2030 were explicitly listed in the table of registered securities with a trading symbol (IBM30A) and registered on the New York Stock Exchange. This indicates a shift from a referenced disclosure to a fully listed and registered financial instrument.",
      "llm_answer": "In the 2023 Form 10‑K IBM only mentioned the 0.875 % Notes due 2030 in its exhibit schedule, stating that the holders’ rights were set out in Exhibit 4.1 to a Form 8‑K filed on Feb 8 2022 (see page 20). By the 2024 filing the notes are listed in the Section 12(b) securities table with ticker IBM30A and shown as trading on the New York Stock Exchange (see page 1), indicating that IBM now treats them as a registered, listed security rather than merely an exhibit‑referenced instrument.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: in 2023, the 0.875% Notes due 2030 were referenced via Exhibit 4.1 to the Form 8-K filed on February 8, 2022, and not explicitly listed in the securities table. By 2024, they were included in the Section 12(b) table with ticker IBM30A and listed on the New York Stock Exchange. (2) Quantitative elements—interest rate (0.875%), maturity year (2030), filing date (February 8, 2022), and ticker (IBM30A)—are all correct. No calculations are required, but the temporal comparison across 2023 and 2024 is accurately framed. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two annual reports (2023 and 2024) and connects the change in disclosure practice to a meaningful shift in registration and listing status. (4) The answer addresses all parts of the question—evolution of treatment, listing status, and registration status—over the two years. Wording differs slightly (e.g., 'exhibit-referenced instrument' vs 'incorporated by reference') but conveys the same meaning. No omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 327,
        "total_tokens": 1563
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the structure and distribution terms of the Telco Preferred Interests evolve from 2023 to 2024, and what does this indicate about AT&T's approach to financing through preferred equity instruments?",
      "original_answer": "In 2023, the Telco Preferred Interests consisted of $2,000 of Class A-1 preferred interests issued in September 2020, paying a 4.25% annual distribution, and $5,250 of Class A-2 and A-3 preferred interests issued in April 2023, paying a 6.85% annual distribution. By 2024, the total Telco Preferred Interests had grown to $7,250, with the Class A-1 preferred interests still at 4.25% and the Class A-2 and A-3 interests remaining at 6.85%, both subject to reset every seven years. Additionally, in 2024, AT&T clarified that failure to pay distributions would not restrict cash movements or its ability to pay dividends or repurchase shares. The structure remained consistent in terms of redemption rights and noncontrolling interest classification, but the expansion of the instrument in 2024 suggests a continued reliance on preferred equity as a financing strategy.",
      "llm_answer": "In the 2023 filing AT&T reported three series of Telco LLC preferred interests – Class A‑1 ($2 bn) paying a 4.25 % annual distribution and resetting every seven years, and Class A‑2 and A‑3 ($5.25 bn) paying 6.85 % annually and resetting on Nov 1 2027 and every seven years thereafter – for a total of $7.25 bn of preferred equity 【page_90】. The 2024 filing shows the same three series still outstanding at $7.25 bn, but adds a planned Class A‑4 issuance of $2.25 bn that will pay 5.94 % annually, reset on Nov 1 2028 and every four years, and be callable on that date 【page_89】【page_88】. This evolution – adding a new class with a distinct rate and reset schedule while retaining call and redemption features – signals that AT&T is using cumulative non‑convertible preferred interests as a flexible financing tool, tailoring terms to raise capital and manage liquidity without restricting common‑stock dividends or repurchases.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, the Telco Preferred Interests totaled $7,250 million ($2,000M Class A-1 + $5,250M Class A-2/A-3), and this same total was carried into 2024 with no new issuance. However, the LLM claims a new Class A-4 issuance of $2.25B in 2024, increasing total preferred interests to $9.5B, which contradicts the ground truth stating the total remained $7,250M. This is a major quantitative error. Additionally, the LLM introduces a 5.94% distribution rate and a reset every four years for a new class, which is not supported by the original answer. (2) The original answer confirms that in 2024, the structure remained unchanged—no new classes were issued. The LLM incorrectly infers a new issuance based on possibly misreading the filing. The reset dates (e.g., Nov 1, 2027) are plausible but not mentioned in the ground truth, making them unsupported additions. (3) The multi-hop reasoning is partially sound—the LLM correctly identifies the use of preferred equity as a financing tool and links structural features to dividend flexibility. It also correctly notes that distribution non-payment does not restrict dividends or buybacks, aligning with the original’s conclusion about AT&T’s financing strategy. However, the reasoning is based on false premises (i.e., a new class issuance), undermining the validity. (4) While the LLM captures the broader strategic implication (flexible financing without restricting shareholder returns), the core factual evolution is incorrect. The original answer emphasizes continuity in structure and terms, whereas the LLM describes a structural expansion that did not occur. Thus, despite relevant context and reasonable interpretation, the answer fails on key facts and calculations, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 504,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has Capital One's involvement in multifamily commercial real estate loans evolved between 2022 and 2023, particularly in terms of risk exposure under loss sharing agreements with government-sponsored enterprises?",
      "original_answer": "In 2022, Capital One originated multifamily commercial real estate loans with the intent to sell them to GSEs, entering into loss sharing agreements, which resulted in a liability of $82 million. By 2023, the company continued this practice but the liability recognized on the consolidated balance sheets for these loss sharing agreements increased to $137 million, indicating a significant increase in risk exposure. This evolution reflects a growing involvement in these types of loans and a corresponding rise in the financial obligations tied to their loss sharing agreements.",
      "llm_answer": "Capital One continues to originate multifamily commercial‑real‑estate loans for sale to the government‑sponsored enterprises and to retain risk through loss‑sharing agreements, but the amount of that retained risk rose sharply – the liability for loss‑sharing agreements grew from $82 million at 12/31/2022 to $137 million at 12/31/2023, a $55 million increase【page_216】.  Multifamily CRE loans remain a material part of its loan portfolio (about 12‑13 % of loans held for investment in the most recent disclosed period)【page_99】, indicating that while the overall involvement is steady, the exposure to potential losses under the GSE loss‑sharing arrangements has increased.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution of Capital One's involvement in multifamily commercial real estate loans between 2022 and 2023, noting the continuation of loan origination for sale to GSEs with retained risk via loss sharing agreements. The liability amounts are accurate: $82 million as of 2022 and $137 million as of 2023, with a correct $55 million increase. These figures match the ground truth exactly, and the citation of page_216 supports the quantitative claims. (2) Quantitative accuracy is perfect: both the starting and ending liabilities are correct, the difference is accurately calculated as $55 million, and the time periods (12/31/2022 and 12/31/2023) align with the annual reporting structure. (3) The multi-hop reasoning is sound—linking loan origination practices to risk exposure through loss sharing agreements across two years. The addition of portfolio composition (12–13% of loans held for investment, cited from page_99) enhances context, though this detail is not in the original answer. While informative, it does not detract from accuracy. (4) The semantic meaning fully aligns with the ground truth: the core conclusion—that risk exposure increased due to higher liability under loss sharing agreements—is clearly and correctly conveyed. The only minor deviation is the emphasis on 'steady overall involvement' due to portfolio share, which slightly nuances the 'growing involvement' in the original answer. However, since the primary focus of the question is on risk exposure under loss sharing agreements, and that is accurately highlighted with correct data and trend interpretation, the answer remains highly accurate. Thus, a score of 9 is justified—excellent correctness with only a slight interpretive expansion beyond the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 491,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did Amazon's co-branded credit card programs shift in strategic significance and associated regulatory risks from 2022 to 2023, particularly in terms of new compliance obligations and their potential impact on operating results?",
      "original_answer": "In 2022, Amazon introduced co-branded credit card programs as part of its payment offerings, highlighting the risk that renewal on less favorable terms or termination could adversely affect operating results. The regulatory risks at that time included compliance with payment card association rules such as data security and certification requirements. By 2023, Amazon expanded its offerings and emphasized additional compliance obligations, including data localization rules, which were not mentioned in 2022. This indicates that the co-branded credit card programs became subject to a broader set of regulatory risks, particularly in international jurisdictions, which could increase compliance costs and operational complexity. The potential impact on operating results grew as Amazon now faced risks not only from traditional payment regulations but also from evolving data governance laws, particularly regarding cross-border data transfers tied to these credit card programs.",
      "llm_answer": "In the 2022 filing Amazon only warned that its co‑branded credit‑card programs “could adversely affect our operating results if renewed on less favorable terms or terminated” (2022 10‑K p. 13). By the 2023 filing the company added that these programs are now subject to “additional regulations and compliance requirements (including obligations to implement enhanced authentication processes)” and to stricter payment‑card association rules, which could raise costs, trigger fines and materially impact operating results (2023 10‑K p. 14). The language therefore shifts the programs from a peripheral contractual‑risk item in 2022 to a strategically significant service that now carries new compliance obligations and heightened regulatory risk in 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content, entity accuracy, and reasoning. (1) It correctly identifies Amazon and the relevant time periods (2022 vs 2023), and accurately reflects the shift in risk disclosure between the two years. The citations to page numbers (p. 13 in 2022, p. 14 in 2023) are consistent with typical 10-K structures, though exact page numbers are not part of the ground truth and are acceptable as illustrative. (2) There are no numerical values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly infers that the co-branded card programs gained strategic significance due to expanded regulatory language in 2023. It accurately notes the addition of 'enhanced authentication processes' and stricter payment card rules, which implies increased compliance burden. However, the LLM answer does not mention 'data localization rules' or 'cross-border data transfers,' which are key regulatory developments highlighted in the original answer and represent a critical expansion of risk into international data governance. This omission limits completeness and slightly weakens qualitative accuracy. (4) Despite this, the LLM captures the core evolution—from a program with contractual renewal risk to one with broader compliance exposure—and correctly assesses the potential impact on operating results. The answer is contextually highly relevant and well-structured. The correctness score is 8 due to the missing data localization and international jurisdiction elements, which are important for full factual completeness, but the overall reasoning and factual base remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 489,
        "total_tokens": 1944
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has PM's financial relationship with RBH evolved between 2022 and 2024, particularly regarding the consolidation status and valuation considerations of RBH within PM's financial statements?",
      "original_answer": "In 2022, RBH was deconsolidated from PM's financial statements due to CCAA proceedings initiated in 2019, with its financial results excluded since that time. Additionally, PM faced potential material impacts from unresolved Canadian tobacco litigation, including a CAD 3.1 billion allocation of compensatory damages against RBH. By 2024, PM's relationship with RBH had evolved into holding an equity investment, which required impairment analysis. The audit process emphasized significant judgment around the fair value estimate of the investment, including assumptions on discount rates, sales volumes, operating margins, and the tax treatment of a potential global settlement. This reflects a shift from a deconsolidated subsidiary to a valued equity stake requiring ongoing impairment evaluation.",
      "llm_answer": "In the 2022 filing PMI still treated Rothmans, Benson & Hedges (RBH) as a de‑consolidated subsidiary – it had been removed from the consolidated balance sheet in March 2019 and was carried only as an equity security with no readily determinable fair value, the de‑consolidation being reflected in other‑comprehensive‑loss reclassifications (see 2022 Note 20/Note 16, p. 113‑112). By the 2024 filing PMI continued not to consolidate RBH, but it performed a quantitative fair‑value assessment of the equity investment, concluded the carrying amount exceeded fair value, recorded a $2.316 bn non‑cash impairment and reported the remaining stake at an estimated $714 mn fair value based on a discounted‑cash‑flow analysis (see 2024 Note 6 and the Critical Audit Matters discussion, p. 147‑148). This shows the relationship evolving from a simple de‑consolidated equity holding to an actively valued and impaired investment in PMI’s consolidated statements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 2019 deconsolidation is accurately noted, and the 2024 $2.316 billion impairment and $714 million remaining fair value are precisely reported, matching the disclosed figures. These values are consistent with a carrying amount exceeding fair value and a discounted cash flow analysis, as required. (2) The answer correctly identifies the evolution from a deconsolidated subsidiary (as of March 2019) to an equity investment subject to active valuation and impairment in 2024. It correctly states that RBH was not consolidated in 2022 or 2024, and that it was carried as an equity security without readily determinable fair value initially. (3) The multi-hop reasoning is sound: it synthesizes information across years (2019 deconsolidation, 2022 status, 2024 impairment), entities (PM/PMI and RBH), and accounting treatments (deconsolidation, equity method, fair value measurement, impairment). (4) The only minor limitation is that the original answer mentions the CAD 3.1 billion litigation exposure as a contextual factor influencing valuation assumptions (e.g., global settlement), which the LLM answer does not explicitly reference. While the LLM correctly identifies key valuation assumptions (discount rates, sales volumes, etc.) via audit matter disclosure, it omits the litigation context that underpins those assumptions. This is a small but relevant qualitative nuance. Otherwise, the answer is factually complete, semantically equivalent, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1449,
        "completion_tokens": 439,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the financial performance and strategic positioning of Baqsimi evolve between 2023 and 2024, particularly in terms of revenue contribution and its role within LLY's product portfolio?",
      "original_answer": "In 2023, Baqsimi contributed $677.6 million in total revenue, with $645.7 million from the U.S. and $31.9 million from outside the U.S., indicating it was still a growing product within LLY's portfolio. By 2024, Baqsimi was no longer reported as a direct revenue contributor through product sales; instead, it was disclosed as part of a collaboration and other arrangements, specifically under the 2023 sale of rights. This shift suggests that LLY transitioned Baqsimi from an internally commercialized product to a divested asset, impacting its strategic focus and revenue model. The absence of Baqsimi from direct product revenue in 2024 reflects a significant change in its role and contribution to LLY's financials.",
      "llm_answer": "In 2023 Baqsimi moved from a modest product line to a fast‑growing one, delivering $677.6 million of net product revenue (U.S. $645.7 m + outside‑U.S. $31.9 m) and generating $579 million of cash from the sale of its rights, which together boosted Lilly’s total revenue (see pages 48 and 47). By 2024 the product no longer appears in net product revenue; the Baqsimi rights‑sale proceeds are instead reflected in the $4.3 billion of “collaboration and other revenue,” indicating that Lilly has shifted Baqsimi from an ongoing sales driver to a monetized asset within its portfolio (see page 64). This transition marks a strategic repositioning from a revenue‑generating product in 2023 to a cash‑generating transaction in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 2023 revenue figures are correct: $677.6 million total ($645.7 million U.S. + $31.9 million outside U.S.), matching the original answer. The mention of $579 million from the sale of rights is not in the ground truth and appears to be an addition not supported by the provided data—this is a minor factual overreach, though it may reflect external knowledge. The $4.3 billion 'collaboration and other revenue' in 2024 is contextually plausible but not explicitly tied to Baqsimi in the ground truth, which only states Baqsimi was included in such arrangements. (2) The core financial numbers for Baqsimi’s 2023 performance are accurate, and the absence from 2024 product revenue is correctly noted. (3) The reasoning is sound: the model correctly infers a strategic shift from direct commercialization to a divested, monetized asset based on the removal from product revenue and inclusion in collaboration income. This reflects proper multi-hop synthesis between 2023 and 2024 reporting changes. (4) Semantically, the answer captures the evolution in both financial performance and strategic role. The only deviations are the unsupported $579 million figure and the specific attribution of Baqsimi to the $4.3 billion line without explicit confirmation—minor issues that do not undermine the overall correctness. Hence, a score of 9 is warranted: excellent accuracy with minor overprecision in unverified figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 414,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has the composition of Union Pacific's Total Highway Revenue Equipment changed from 2022 to 2024, particularly in terms of the ratio of owned versus leased containers and chassis?",
      "original_answer": "In 2022, Union Pacific owned 78,837 units and leased 16,004 units of Total Highway Revenue Equipment, with containers making up the majority of owned assets and chassis being heavily leased. By 2024, the company significantly reduced both owned and leased equipment, with owned units dropping to 50,731 and leased units to 1,485. The most notable change was in leased containers, which fell from 1,856 in 2022 to just 288 in 2024, and owned chassis decreased from 29,875 to 4,356. This indicates a strategic shift toward owning fewer assets and leasing even fewer, especially in chassis.",
      "llm_answer": "In the 2022 filing Union Pacific reported 48,962 owned containers and 1,856 leased (≈96 % owned) and 29,875 owned chassis versus 14,148 leased (≈68 % owned) (page_24). By 2024 the mix had shifted dramatically to 46,375 owned containers and only 288 leased (≈99 % owned) and 4,356 owned chassis versus 1,197 leased (≈79 % owned), raising the owned‑to‑leased ratio from roughly 26 : 1 to 161 : 1 for containers and from about 2.1 : 1 to 3.6 : 1 for chassis (page_19).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also significant quantitative inaccuracies. It correctly identifies the trend of decreasing leased equipment and increasing ownership ratios, especially for containers and chassis. However, it misrepresents the total owned and leased units for Total Highway Revenue Equipment. The ground truth states that in 2022, Union Pacific owned 78,837 units and leased 16,004 — but the LLM answer does not report these totals at all. Instead, it breaks down containers and chassis separately, summing to only 48,962 + 29,875 = 78,837 owned units in 2022, which matches the total owned, suggesting that the container and chassis figures may be accurate components. However, for leased units, the LLM reports 1,856 (leased containers) + 14,148 (leased chassis) = 16,004, which matches the total leased in 2022 — so the component numbers appear correct. In 2024, the LLM reports 46,375 owned containers and 4,356 owned chassis (total owned: ~50,731), matching the ground truth total owned. Leased: 288 + 1,197 = 1,485, which matches the ground truth total leased. So while the LLM does not state the overall totals, the component numbers are accurate. (2) The calculation of ownership percentages and ratios is mathematically correct based on the provided numbers. The owned-to-leased ratio for containers went from ~26:1 (48,962 / 1,856 ≈ 26.38) to ~161:1 (46,375 / 288 ≈ 161), and for chassis from ~2.1:1 (29,875 / 14,148 ≈ 2.11) to ~3.6:1 (4,356 / 1,197 ≈ 3.64), so these ratios are accurate. (3) The multi-hop reasoning is sound — the model correctly synthesizes data across years and equipment types, identifies the shift toward higher ownership ratios, and supports it with specific numbers. (4) Despite missing the explicit mention of 'Total Highway Revenue Equipment' totals, the component data adds up correctly, and the qualitative conclusion about strategic reduction in both owned and leased assets, especially leased containers and chassis, aligns with the ground truth. However, the LLM incorrectly implies that chassis were 68% owned in 2022 (29,875 / (29,875+14,148) ≈ 68%), but this metric was not requested; the question focuses on the ratio of owned vs leased, not percentages. The main issue is that the LLM fails to present the full picture of total units (owned vs leased) as a whole, focusing only on containers and chassis without confirming they constitute all of Total Highway Revenue Equipment. While the numbers check out when summed, this synthesis is left to the reader. Thus, quantitative accuracy is penalized because the answer omits aggregate totals and risks misrepresenting scope, even if component data is correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 715,
        "total_tokens": 1987
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did Capital One's use of securitized debt obligations evolve between 2022 and 2023, particularly in terms of their role within the company's overall funding structure?",
      "original_answer": "In 2022, securitized debt obligations were explicitly described as one of the company's key funding sources alongside deposits, senior and subordinated notes, federal funds purchased, and FHLB advances. By 2023, while still present in the funding structure at $18.043 billion in carrying value, securitized debt obligations were categorized under Level 2 in the fair value hierarchy, indicating a shift toward more standardized valuation methods. This evolution suggests a more structured and possibly less volatile role for securitized debt obligations in Capital One's funding strategy.",
      "llm_answer": "Capital One’s securitized‑debt portfolio grew modestly from one year to the next.  At year‑end 2022 the company carried $16.973 billion of securitized debt obligations (fair value $16.918 billion) 【page_211】, and by year‑end 2023 that balance had risen to $18.043 billion (fair value $18.067 billion) 【page_210】.  Because deposits and other borrowings rose only slightly, the securitized‑debt line moved from roughly 13 % of total funding sources (deposits + notes + securitized debt + federal funds + interest payable) in 2022 to about 14 % in 2023, indicating a modest increase in both absolute size and relative importance within Capital One’s overall funding mix.",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but diverges significantly from the ground truth in terms of the core narrative about the evolution of securitized debt obligations in Capital One's funding structure. (1) Quantitatively, the dollar amounts are accurate: $16.973 billion in 2022 and $18.043 billion in 2023 align with the ground truth (though the ground truth does not specify the 2022 amount, so this may be correct based on source data). The 2023 carrying value matches exactly. The percentage increase from ~13% to ~14% of total funding is a reasonable inference if supported by the underlying data, though this calculation is not verifiable from the ground truth provided. (2) However, the qualitative analysis in the LLM answer focuses on increased relative importance due to growth in proportion, while the original answer emphasizes a shift in valuation methodology—specifically the classification under Level 2 of the fair value hierarchy in 2023, indicating more standardized and transparent valuation. This is a key evolution that the LLM answer completely omits. (3) The multi-hop reasoning is partially sound: the model synthesizes data across years and computes relative weight in the funding mix, which shows analytical effort. But it fails to incorporate the conceptual shift in how securitized debt was accounted for (fair value hierarchy), which is central to the original answer and reflects a structural change in risk and reporting, not just size. (4) Thus, while the LLM provides numerically plausible data and relevant context about growth, it misses the primary qualitative evolution described in the ground truth. This results in a moderate correctness score: numbers are mostly right, but the core insight about evolving role due to valuation standardization is absent, leading to an incomplete and somewhat misleading conclusion about the 'evolution' in funding strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 510,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the nature of LLY's revenue from Zyprexa evolve between 2023 and 2024, particularly in terms of the source and recognition method of that revenue?",
      "original_answer": "In 2023, Zyprexa revenue was primarily derived from the sale of the rights for the olanzapine portfolio. By 2024, the revenue associated with Zyprexa was recognized as part of collaboration and other arrangements, specifically stemming from the 2023 sale of rights for the olanzapine portfolio, and was included in collaboration revenue rather than product sales. This reflects a shift in how Zyprexa-related revenue was categorized and recognized in 2024 compared to 2023.",
      "llm_answer": "In 2023 Eli Lilly booked Zyprexa revenue as **net product revenue** – it was the “sale of the rights for the olanzapine portfolio” and was recognized as product revenue when the product (or its rights) was sold 【page_67】. By 2024 that same transaction is shown under **collaboration and other revenue**, because the sale of the olanzapine rights (including Zyprexa) is treated as a one‑time intellectual‑property sale and is recognized when control of the rights transfers to the buyer 【page_64】【page_66】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that in 2023, Zyprexa revenue was recognized as net product revenue from the sale of rights to the olanzapine portfolio, and by 2024, it shifted to collaboration and other revenue. The explanation about the recognition method—being a one-time IP sale upon transfer of control—is consistent with the nature of revenue recognition described in the original answer. All entities (LLY, Zyprexa, olanzapine portfolio, 2023 and 2024) are correct. There are no numerical inaccuracies (no dollar amounts involved), and the reasoning correctly synthesizes the change in revenue classification over time. The only minor shortcoming is that the LLM slightly reframes the 2023 revenue as 'net product revenue' and emphasizes it as a product sale, while the original answer more precisely avoids calling it ongoing product sales and focuses on the sale of rights. However, given that the sale of rights could be reported under product revenue in the context of a divestiture, and the shift to collaboration revenue in 2024 is clearly and correctly explained, this does not constitute a factual error. The answer is semantically equivalent and demonstrates sound multi-hop reasoning across time periods and accounting treatments.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 366,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the valuation methodology and classification of Federal Government Securities in the pension plan evolved from 2022 to 2024?",
      "original_answer": "In 2022, Federal Government Securities were valued under the 'Significant Other Observable Inputs (Level 2)' category and totaled $742 million. By 2024, the company clarified that these securities are valued using a bid evaluation process with bid data from independent pricing sources and are explicitly classified as Level 2 investments. This reflects a continuation in classification but adds specificity in methodology explanation.",
      "llm_answer": "In the 2022 filing the plan said that Federal Government Securities “are valued using a bid‑evaluation process with bid data provided by independent pricing sources” and are classified as **Level 2** investments (UNP 10‑K 2022 p. 70‑72). The 2024 filing repeats the same language – they are still valued by a bid‑evaluation process using independent pricing data and remain **Level 2** securities (UNP 10‑K 2024 p. 56). Thus, the valuation methodology and classification of these securities have not changed from 2022 to 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that Federal Government Securities were classified as Level 2 in both 2022 and 2024 and that the valuation methodology involves a bid-evaluation process using independent pricing sources. However, it omits the specific 2022 valuation amount of $742 million, which is present in the ground truth and relevant to completeness. While the answer accurately states that the methodology and classification remained consistent, the ground truth emphasizes that the 2024 filing added more specificity in explaining the methodology (i.e., clarifying the use of bid data from independent sources), which the LLM downplays by stating there was 'no change' rather than acknowledging the enhanced clarification. This misrepresents the nuance in evolution—though classification remained the same, the explanation became more detailed. The entities (UNP, Level 2, bid-evaluation process) and years (2022, 2024) are correct, and citations to the 10-Ks are appropriately referenced. Quantitative accuracy is high, though the missing $742 million figure prevents a top score. Reasoning is mostly sound but lacks full synthesis of the 'evolution' aspect—emphasizing continuity without capturing the added specificity in 2024. Contextual relevance is excellent, directly addressing the question with appropriate sourcing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 370,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did Capital One's credit score data utilization for product segmentation decisions evolve from 2022 to 2023, and what does this indicate about their credit risk modeling strategy?",
      "original_answer": "In 2022, Capital One used credit score data for product segmentation decisions based on historical credit score distributions from 2020 to 2021, as shown in Table 21. In 2023, the company updated its data to reflect credit score distributions from 2022 to 2023 in the same table. This shift indicates a more current and dynamic credit risk modeling strategy, with product segmentation decisions being informed by the most recent borrower behavior and risk profiles, suggesting a proactive approach to managing credit risk in evolving economic conditions.",
      "llm_answer": "Capital One’s 10‑K disclosures show that the firm’s approach to using credit‑score data for product segmentation remained unchanged – the 2022 filing notes that borrower credit scores are “used … in some cases, to drive product segmentation decisions” (2022 p.103) and the 2023 filing repeats the same language (2023 p.95).  The 2023 table, however, shows a modest shift in the underlying score mix (credit‑card balances with scores > 660 fell from 69 % to 68 % while the auto‑loan >660 share stayed at 53 %) (2023 p.95 vs. 2022 p.103), indicating that Capital One continues to embed credit‑score information in its proprietary risk models for segmentation but is fine‑tuning the models to a slightly broader borrower risk profile.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but misses the core evolution described in the ground truth. While it correctly notes that Capital One uses credit scores for product segmentation in both years, it fails to identify the key change in data recency — from using 2020–2021 data in 2022 to using 2022–2023 data in 2023. Instead, the LLM claims the approach 'remained unchanged,' which contradicts the ground truth and misrepresents the strategic shift. The percentages cited (69% to 68%, 53%) are plausible and contextually relevant but are not the focus of the original answer, which emphasizes the time period of data used in modeling, not just shifts in score distribution. (2) Quantitatively, the percentages mentioned (69%, 68%, 53%) may align with tables in the filings, but they are not central to the question about data utilization evolution. No calculation errors are present, but the numbers do not support the required multi-hop inference about modeling strategy updates. (3) The reasoning is flawed: the LLM observes similar language in disclosures and concludes no change, failing to recognize that the update of underlying data periods (from older to current) represents a meaningful evolution in risk modeling strategy, even if phrasing is consistent. This reflects a failure in multi-hop synthesis — connecting the change in data vintage to implications for risk modeling agility. (4) Contextual relevance is moderate because the answer discusses credit score usage and segmentation, but it misses the strategic implication of using more recent data, which is the key insight in the ground truth. Thus, while some elements are accurate, the core of the answer is incorrect, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 477,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Amazon's strategic positioning of AWS evolved from 2022 to 2023 in terms of its role within the company's broader business segments and investment priorities?",
      "original_answer": "In 2022, AWS was positioned primarily as a key area of investment within Amazon's broader technology and content spending, with an emphasis on supporting geographic expansion, new product categories, and internal operational efficiencies. The document highlighted that Amazon was investing in AWS alongside initiatives to build and deploy innovative software and electronic devices, indicating a strategic alignment with internal growth and infrastructure enhancement. By 2023, AWS had evolved into one of Amazon's three core business segments—alongside North America and International—reflecting its elevated strategic importance. The 2023 filing explicitly states that AWS serves developers and enterprises by offering a broad set of on-demand technology services, including compute, storage, database, analytics, and machine learning, and is now a distinct and central pillar of Amazon’s business model. This shift demonstrates a transformation in AWS's role from a strategic investment area to a standalone, mission-critical business segment.",
      "llm_answer": "In the 2022 filing, AWS was presented mainly as a key investment area within Amazon’s broader technology and content spending—“We are investing in AWS, which offers a broad set of on‑demand technology services…to developers and enterprises of all sizes” (2022 p. 19). By the 2023 filing, AWS is elevated to a core operating segment—“We have organized our operations into three segments: North America, International, and Amazon Web Services (‘AWS’)” (2023 p. 3)—with its own CEO and a distinct focus on serving developers and enterprises, signaling a stronger strategic priority and central role in Amazon’s overall business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential evolution of AWS's strategic positioning from 2022 to 2023. (1) It correctly identifies that in 2022, AWS was framed as a key investment area within technology and content spending, citing the correct language and page reference (2022 p. 19), and accurately notes the focus on serving developers and enterprises with on-demand services. In 2023, it correctly states that AWS became one of three core operating segments, quoting the exact sentence from the filing (2023 p. 3), and highlights organizational changes like having its own CEO, which aligns with the ground truth’s emphasis on AWS becoming a standalone, mission-critical segment. (2) There are no numerical values, dates, or financial figures in dispute; all references are to textual descriptions and page numbers, which are accurately cited—thus quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, correctly infers the strategic elevation of AWS based on structural and linguistic changes in the reports, and supports the shift with direct quotes. The only minor omission is that the original answer includes more detail about AWS’s role in internal operational efficiencies and innovation in 2022, and a broader list of services (compute, storage, database, analytics, ML), which the LLM mentions only partially. While the core services are implied in the quote, they are not explicitly summarized. (4) The answer is fully contextually relevant, directly addressing how AWS’s role evolved within Amazon’s business segments and investment priorities. Overall, the LLM captures the key transformation with strong evidence and precise sourcing, warranting a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 502,
        "total_tokens": 1924
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has Philip Morris International's financial relationship with Rothmans, Benson & Hedges Inc. (RBH) evolved between 2022 and 2024, particularly in terms of its accounting treatment and potential financial exposure?",
      "original_answer": "In 2022, RBH was deconsolidated from Philip Morris International’s financial statements due to its CCAA restructuring, and its financial results were no longer included in PMI’s consolidated financials. At that time, there was a comprehensive stay of Canadian tobacco litigation until March 31, 2022, and no loss accruals were made due to the inability to estimate potential losses. By 2024, PMI’s relationship with RBH had shifted from deconsolidation to an equity investment model. A proposed settlement of CAD 32.5 billion in the Canadian tobacco litigation emerged, prompting PMI to assess its investment in RBH for impairment. As a result, PMI recorded a non-cash impairment charge of $2,316 million in 2024, reflecting a decline in the estimated fair value of its investment. This marks a significant evolution from a deconsolidated entity with uncertain liabilities to a recognized equity investment with a quantified impairment.",
      "llm_answer": "In the 2022 filing PMI still treated Rothmans, Benson & Hedges (RBH) as a de‑consolidated subsidiary – it recorded only the CAD ≈ 257 million security‑deposit required by the Canadian judgments (a $194 million pre‑tax charge) and disclosed a contingent liability but did not accrue a loss because the outcome was not deemed probable or estimable (see pages 113‑114 and the credit‑risk discussion on page 112)【page_113】【page_114】【page_112】. By the 2024 filing PMI’s relationship had shifted to an equity investment in RBH, and because the CCAA‑mediated settlement of the CAD 32.5 billion claim remains unresolved, PMI recognized a non‑cash impairment of $2.3 billion (≈ $1.49 per share) on that investment, reflecting a much larger potential financial exposure (see Item 8, Note 6 on page 30 and the diluted‑EPS table on page 32)【page_30】【page_32】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Philip Morris International's (PMI) financial relationship with Rothmans, Benson & Hedges Inc. (RBH) from 2022 to 2024. (1) In 2022, the answer correctly states that RBH was deconsolidated and that PMI recorded only a security deposit (CAD ~257 million, $194 million pre-tax charge) without accruing a loss due to uncertainty—this aligns with the ground truth. The reference to contingent liability and lack of accrual due to non-probability or estimability matches the original. (2) By 2024, the shift to an equity investment model is correctly identified, as is the $2.3 billion non-cash impairment (rounded from $2,316 million). The mention of the CAD 32.5 billion CCAA-mediated settlement as the trigger for impairment is factually correct. (3) The multi-hop reasoning—linking deconsolidation in 2022, ongoing litigation exposure, and the 2024 impairment due to fair value decline—is sound and synthesizes changes over time accurately. (4) Minor quantitative discrepancies: the LLM rounds $2,316 million to $2.3 billion (acceptable), but does not explicitly name the impairment as tied to the 'proposed settlement' (though implied). It adds EPS impact (~$1.49 per share), which is extra detail not in the ground truth but plausible and consistent. The answer is semantically equivalent, well-contextualized, and directly addresses accounting treatment and financial exposure evolution. One point deducted from correctness due to slight rounding without qualification and omission of 'inability to estimate' phrasing, though the meaning is preserved.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 441,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has the commercial significance of Biktarvy evolved for GILD from 2022 to 2024, considering both its revenue contribution and associated product risks?",
      "original_answer": "In 2022, Biktarvy was a major revenue driver for GILD, generating $8,624 million in total product sales globally, indicating its strong market position in the HIV treatment segment. By 2024, while specific revenue figures are not provided, the company's risk disclosures highlight Biktarvy's ongoing importance but also emphasize heightened risks related to the HIV product class, particularly concerning the reliance on TAF-based therapies and potential shifts in treatment paradigms. This evolution suggests that although Biktarvy remains central to GILD's revenue, its commercial outlook has become more vulnerable to competitive and regulatory pressures.",
      "llm_answer": "In the 2022 Form 10‑K, Gilead reported that Biktarvy produced $8.6 billion of sales in 2021 – roughly half of the company’s $16.3 billion HIV portfolio and a major component of total revenue. By the 2024 filing, Gilead still cites Biktarvy (and its other HIV products) as a “substantial portion” of its revenue, but it now highlights the drug among products subject to heightened commercial risk – including competition from generics, reliance on the tenofovir‑alafenamide (TAF) platform and possible shifts in HIV treatment paradigms that could erode sales. Thus, Biktarvy’s commercial importance remains high, while the risk narrative around its future sales has become more pronounced.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the quantitative section: it states that Biktarvy generated $8.6 billion in sales in 2021 according to the 2022 Form 10-K, while the ground truth specifies $8,624 million (i.e., $8.624 billion) in sales for 2022. This misattributes the year of the revenue figure and slightly misrepresents the amount. Additionally, the claim that this represented 'roughly half of the company’s $16.3 billion HIV portfolio' is not present in the original answer and cannot be verified from the provided ground truth, introducing unverified data. (2) The qualitative aspects are strong: the LLM correctly identifies that by 2024, Gilead continues to view Biktarvy as a substantial revenue contributor but highlights increased risk disclosures around competition, reliance on TAF, and potential shifts in treatment paradigms. These align well with the ground truth’s emphasis on heightened risks despite ongoing commercial significance. (3) The multi-hop reasoning is sound—linking revenue importance in 2022 to evolving risk disclosures in 2024—though based on slightly incorrect initial data. The synthesis across time periods and risk factors is logically structured and responsive to the question’s request for evolution over time. (4) Despite the numerical inaccuracy, the overall narrative about Biktarvy’s sustained importance and growing risk profile is consistent with the ground truth, warranting a score of 7 for correctness. Quantitative accuracy is penalized due to the wrong year and unsupported portfolio percentage, but qualitative and contextual accuracy remain high due to correct identification of key risks and trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 461,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has Union Pacific Railroad's financial stake and operational relationship with TTX evolved from 2022 to 2024, particularly in terms of investment value and car hire expenses?",
      "original_answer": "Union Pacific Railroad's financial stake in TTX increased from $1.6 billion in 2021 (referenced in the 2022 filing) to $1.9 billion in 2024. Additionally, UPRR's car hire expenses rose from $375 million in 2021 to $432 million in 2024. These increases indicate a growing financial and operational involvement with TTX over the period.",
      "llm_answer": "In 2022 Union Pacific owned a 36.79 % economic interest in TTX, recorded as a $1.6 billion equity investment, and incurred about $402 million of TTX car‑hire expenses. By 2024 that interest had risen to 37.03 % with the investment growing to roughly $1.9 billion and car‑hire costs climbing to $432 million, showing a modest increase in both its financial stake and its operational use of TTX’s pooled rail‑car fleet【page_88†L1-L3】【page_89†L1-L3】【page_68†L1-L4】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects—Union Pacific's investment in TTX increased from $1.6 billion (2022 filing, referencing 2021 value) to $1.9 billion in 2024, and car hire expenses rose from $375 million in 2021 to $432 million in 2024. The LLM correctly reports the 2024 car hire expense ($432M) and investment value ($1.9B), but cites $402 million for 2022 instead of the ground truth $375 million for 2021. This discrepancy is minor in context—likely due to using the 2022-reported expense (which may reflect 2022 actuals, not 2021). The percentages (36.79% in 2022, 37.03% in 2024) are accurate and add precision not in the original answer, enhancing detail. (2) Quantitative accuracy is high: $1.6B → $1.9B and $432M are correct; only the intermediate expense figure differs slightly, but this may reflect reporting year vs. reference year differences. No calculation errors. (3) Multi-hop reasoning is sound—LLM synthesizes data across years and metrics (investment value, ownership %, car hire costs) and correctly infers growing involvement. (4) The answer is semantically equivalent and contextually complete, with slightly more granular detail (percentages) than the ground truth. The minor mismatch in car hire expense for the earlier period does not undermine the overall correctness, especially since the question asks about 2022–2024 and the LLM uses 2022-reported data. Thus, a high score is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 402,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Tesla's approach to scaling Solar Roof production change from 2022 to 2023, particularly regarding installer training initiatives and supply chain risk management?",
      "original_answer": "In 2022, Tesla emphasized expanding Solar Roof production by on-boarding and training new installers, collaborating with real estate developers, and reducing installation time and costs. The company also highlighted its need to hire additional personnel, particularly skilled electricians, to support the ramp. By 2023, Tesla's focus had shifted toward addressing broader supply chain risks and production ramp challenges, with language indicating that Solar Roof production now depended more on managing supplier reliability, global component constraints, and cost-effective manufacturing processes. The 2023 filing also noted that delays in production ramps could harm the business, signaling a shift from installer-focused growth to a more risk-averse strategy centered on supply chain resilience.",
      "llm_answer": "In 2022 Tesla said it would grow Solar Roof by expanding its installer network – “on‑boarding and training new installers, as well as collaborating with real‑estate developers and builders to reduce installation time and costs”【page_34】. By the 2023 filing the focus had shifted to supply‑chain resilience – the company now stresses the risk of component shortages, the need to diversify and tightly manage suppliers, and discusses training only in the broader context of hiring and retaining qualified staff rather than a dedicated installer program【page_16】【page_17】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, Tesla focused on on-boarding and training new installers and collaborating with real estate developers to scale Solar Roof, as cited from page 34. By 2023, the emphasis shifted to supply chain risks, including component shortages and supplier management, with training mentioned only in the broader context of hiring skilled personnel, per pages 16 and 17. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct use of years (2022, 2023), which are accurate. (3) The multi-hop reasoning is sound—correctly synthesizing changes in Tesla’s strategy across two years and two different focus areas (installer training vs. supply chain resilience). The answer captures the strategic pivot from labor and installation scalability to managing external production risks. (4) Minor deduction in qualitative accuracy due to slightly less emphasis on the explicit mention of 'delays in production ramps' impacting the business (a point in the original answer that underscores the risk-averse shift), but the core reasoning and entity mapping (Tesla, Solar Roof, 2022 vs. 2023, installer training, supply chain) are fully accurate. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect—directly addresses both parts of the question: installer training initiatives and supply chain risk management across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 424,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has The Coca-Cola Company's relationship with fountain retailers evolved between 2022 and 2023, particularly regarding the manufacturing and distribution of fountain syrups in the United States?",
      "original_answer": "In 2022, The Coca-Cola Company stated that U.S. bottlers were generally not authorized to manufacture fountain syrups, and instead, the Company itself manufactured and sold fountain syrups directly to authorized fountain wholesalers (including some bottlers) and certain fountain retailers. By 2023, the Company clarified that it continues to manufacture fountain syrups in the U.S., but now explicitly states that it sells these syrups to both fountain retailers and authorized fountain wholesalers or bottling partners who then distribute them to fountain retailers. This indicates a more explicit acknowledgment of a tiered distribution model involving bottling partners in 2023, suggesting a potential expansion of their distribution network or clarification of roles.",
      "llm_answer": "In the 2022 filing the Company explained that it manufactures fountain syrups in the United States and sells them either directly to fountain retailers or through authorized fountain wholesalers (including some bottlers), while U.S. bottlers are not permitted to produce those syrups (page 6‑8). The 2023 filing repeats the same arrangement – Coca‑Cola still is the sole U.S. manufacturer of fountain syrups and continues to supply them to fountain retailers directly or via authorized wholesalers, with bottlers excluded from syrup production (page 37). Thus, the relationship with fountain retailers has remained essentially unchanged between 2022 and 2023.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that The Coca-Cola Company manufactures fountain syrups in the U.S. and that U.S. bottlers are not authorized to produce them, which aligns with the ground truth for both 2022 and 2023. It also accurately states that syrups are sold directly to fountain retailers or through authorized wholesalers, including some bottlers. However, the key shortcoming is that the LLM concludes the relationship has 'remained essentially unchanged' between 2022 and 2023, which contradicts the ground truth. The original answer highlights a meaningful evolution: in 2023, the Company explicitly acknowledges selling to bottling partners who distribute to fountain retailers, indicating a more defined tiered distribution model. This nuance—clarification or expansion of bottling partners' role in distribution—is missing in the LLM answer, leading to an incorrect conclusion about the stability of the relationship. (2) There are no numerical values in this question, so quantitative accuracy is not applicable; however, the LLM correctly cites page numbers and does not introduce any factual inaccuracies in dates or entities. (3) The multi-hop reasoning is partially sound: the model correctly retrieves information from both years but fails to detect the subtle yet important shift in language and structure in the 2023 filing. This reflects a failure in comparative analysis and synthesis across years, particularly in identifying evolving business relationships beyond surface-level descriptions. (4) While the answer is contextually relevant and factually accurate in parts, the incorrect conclusion about no change significantly undermines the overall correctness, warranting a mid-range score of 5. The qualitative accuracy is similarly limited by the failure to capture the evolution in distribution roles.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 501,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has IBM's treatment and disclosure of the 0.950% Notes due 2025 evolved from 2022 to 2024, particularly in terms of its financial instrument classification and registration details?",
      "original_answer": "In 2022, the 0.950% Notes due 2025 were disclosed as part of IBM's exhibits in Form 8-K filings, specifically referenced under Exhibit 4.1 filed on May 22, 2017. By 2024, the 0.950% Notes due 2025 were not only still present but were actively listed as a financial instrument with a trading symbol 'IBM25B' on the New York Stock Exchange. This evolution indicates a shift from merely disclosing the instrument to formally registering and listing it for trading.",
      "llm_answer": "In IBM’s 2022 Form 10‑K (see pages 28‑32) the 0.950 % Notes due 2025 were mentioned only as a debt instrument in the footnotes and were not shown in a separate Section 12(b) registration table. By the 2024 Form 10‑K (see page 1) IBM continues to classify the instrument as a note (debt security) but now lists it explicitly in the Section 12(b) securities‑registration table, assigning it the ticker IBM25B and indicating that it trades on the New York Stock Exchange.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key details are correct: the 0.950% Notes due 2025 are accurately referenced, and the ticker 'IBM25B' and listing on the New York Stock Exchange are correctly reported. The evolution from 2022 to 2024 in terms of disclosure and registration is properly captured. (2) The LLM correctly identifies that in 2022 the notes were mentioned in footnotes without a Section 12(b) registration table entry, consistent with being disclosed in exhibits (e.g., 8-K filings), and by 2024 are formally listed in the Section 12(b) table—indicating formal registration. (3) The multi-hop reasoning is sound: the model synthesizes changes in disclosure practices across years and correctly infers an evolution from passive disclosure to active registration and trading status. (4) The only minor gap is that the LLM does not explicitly reference the original 2017 8-K filing (Exhibit 4.1) mentioned in the ground truth, which slightly reduces completeness in provenance. However, this does not affect the core factual accuracy of the classification and registration evolution. Wording differs but semantic meaning matches. All entities (IBM, 0.950% Notes due 2025, NYSE, IBM25B) are correct. The answer is fully relevant and addresses all parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 372,
        "total_tokens": 1614
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How has GILD's strategic positioning of Biktarvy evolved from 2022 to 2024, particularly in terms of its financial risk exposure and competitive differentiation within the HIV treatment market?",
      "original_answer": "In 2022, Biktarvy was listed among GILD’s key marketed products, indicating its central role in the company's HIV portfolio and suggesting strong commercial positioning. By 2024, the company highlighted increasing financial risk tied to its reliance on nucleoside-based therapies like Biktarvy, particularly due to the potential shift in HIV treatment paradigms away from TAF-based regimens. This evolution reflects a growing concern over Biktarvy’s long-term competitive differentiation and its ability to sustain revenue, especially in the face of rising generic competition and changing therapeutic preferences.",
      "llm_answer": "In the 2022 filing Gilead listed Biktarvy as a flagship TAF‑based HIV regimen in its product portfolio and stressed that its growth could be supported by the company’s broad resource‑allocation strategy (see product list on page 63). By the 2024 filing the tone has shifted: Biktarvy is still highlighted for its efficacy and TAF‑based differentiation, but the company now flags heightened financial‑risk exposure from pricing reforms, reimbursement pressures and growing generic/competitor competition, emphasizing the need to protect market share and potentially launch new HIV products (see risk factors on page 18 and competition discussion on page 20).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Biktarvy was a key product in 2022 (flagship TAF-based regimen), and by 2024, GILD expressed increased financial risk due to pricing reforms, reimbursement pressures, and generic/competitor threats. The mention of risk factors on page 18 and competition on page 20 matches typical 10-K structure, though exact page numbers are not verifiable from the ground truth; however, such references are reasonable and do not detract from accuracy. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not applicable beyond correct use of years (2022, 2024), which are accurate. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes Biktarvy’s strategic positioning over time, linking its 2022 commercial strength with 2024 financial risk exposure and competitive challenges. It captures the evolution in tone and strategic concern, including the threat to TAF-based regimens and the need for new product development. (4) Semantic equivalence is strong—while the LLM adds slightly more detail (e.g., 'resource-allocation strategy', 'page 63'), it does not introduce inaccuracies. The core message—that Biktarvy remains important but faces growing financial and competitive risks—is consistent with the ground truth. One minor point: the original emphasizes a 'paradigm shift away from TAF-based regimens' as a key risk, which the LLM mentions implicitly via 'generic/competitor competition' but could have stated more explicitly. This slight omission prevents a perfect 10 on qualitative accuracy, but overall the response is excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 468,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Lockheed Martin's approach to defined contribution retirement savings plans evolve between 2022 and 2023, particularly in terms of pension obligation transfers and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin transferred $4.3 billion of gross defined benefit pension obligations through group annuity contracts, recognizing a noncash pension settlement charge of $1.5 billion. In 2023, instead of another annuity purchase, the company made $414 million in settlement payments to approximately 6,500 former employees who had not yet started receiving benefits. This shift indicates a strategic evolution from transferring large blocks of pension obligations to insurers (as in 2022) to directly settling smaller portions of obligations with individual participants in 2023.",
      "llm_answer": "In 2022 Lockheed Martin accelerated its move to an enhanced defined‑contribution retirement savings plan by purchasing group‑annuity contracts that transferred roughly $4.3 billion of defined‑benefit pension obligations to insurers, which produced a $1.5 billion non‑cash pension‑settlement charge (shown as a $1.47 billion expense in FAS income). By 2023 the company shifted to cash lump‑sum settlements – a $414 million payment to about 6,500 former employees – and recorded no settlement charge, while the unfunded liability on the remaining plans rose to about $6.2 billion, reflecting the continued transition to the defined‑contribution model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) All key facts are correct: in 2022, Lockheed Martin transferred $4.3 billion in pension obligations via group annuities and recognized a $1.5 billion noncash settlement charge (noted as $1.47 billion in FAS income, which is consistent with reporting variations). In 2023, the company made $414 million in settlement payments to about 6,500 former employees, shifting from insurer transfers to direct individual settlements. These numbers match the ground truth exactly, with acceptable formatting variations. (2) Quantitative accuracy is perfect: all dollar amounts ($4.3 billion, $1.5 billion, $414 million), participant count (~6,500), and the absence of a settlement charge in 2023 are correctly reported. The mention of $1.47 billion instead of $1.5 billion is a minor rounding or reporting-level detail and does not constitute an error. (3) The multi-hop reasoning is sound—LLM correctly contrasts the two years’ strategies and infers a strategic evolution toward defined-contribution transition. It adds contextual value by noting the rise in unfunded liability to $6.2 billion and the absence of a settlement charge in 2023, which, while not in the original answer, are consistent with the trajectory and enhance the explanation. (4) The only reason for not scoring a 10 is that the original answer emphasizes the strategic shift in approach (large insurer transfers vs. direct individual settlements), while the LLM slightly reframes it around the 'enhanced defined-contribution plan' and adds the $6.2 billion unfunded liability figure not present in the ground truth. This addition is plausible but not verifiable from the provided truth, slightly affecting qualitative precision. However, it does not contradict and improves contextual understanding. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 531,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 2.875% Notes due 2025?",
      "original_answer": "In 2022, IBM listed the 2.875% Notes due 2025 (IBM 25A) among other Notes due in 2025, including the 0.950% Notes due 2025 (IBM 25B) and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 2.875% Notes due 2025 (IBM25A) remained, but the 0.875% Notes due 2025 (IBM 25C) were no longer listed, indicating a shift in the debt composition for that year. The 2.875% Notes due 2025 continued to be a key part of IBM's debt structure in 2024, suggesting a strategic decision to maintain this specific financial instrument while retiring or restructuring others.",
      "llm_answer": "In the 2022 Form 10‑K IBM reported four securities maturing in 2025 – the 2.875 % notes (IBM 25A), 0.950 % notes (IBM 25B), 0.875 % notes (IBM 25C) and a 7 % debenture (IBM 25)【page_1†L1-L12】. The 2024 filing still lists the 2.875 % notes (IBM 25A) together with the 0.950 % notes and the 7 % debenture, but the 0.875 % notes (IBM 25C) are no longer shown【page_1†L1-L8】. Thus, the 2.875 % notes due 2025 have remained outstanding, while the overall 2025 debt basket has narrowed with the 0.875 % notes being retired.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all percentages, note identifiers (IBM 25A, IBM 25B, IBM 25C), and maturities are correct. The mention of a '7% debenture (IBM 25)' in both 2022 and 2024 is consistent with IBM's filings and does not contradict the original answer, which focused on the 2.875%, 0.950%, and 0.875% notes. The key observation—that the 0.875% Notes (IBM 25C) disappeared by 2024 while the 2.875% Notes (IBM 25A) remained—is factually correct and well-supported. (2) There are no calculation errors; the answer correctly identifies the change in composition without requiring numerical computation. (3) The multi-hop reasoning is sound: the model compares IBM’s debt instruments across 2022 and 2024 filings, identifies which notes mature in 2025, and correctly infers a narrowing of the debt basket due to the removal of IBM 25C. (4) The only minor shortcoming is that the original answer emphasizes the strategic implication of maintaining the 2.875% Notes, while the LLM answer states the facts without elaborating on strategy—this slight omission in qualitative depth prevents a perfect 10, but the core reasoning and facts are fully accurate. The inclusion of the 7% debenture, while not in the original answer, is not incorrect—it adds detail without distorting the truth. Overall, the answer is factually precise, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 403,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the strategic importance and risk profile of Biktarvy within Gilead's HIV portfolio evolved from 2022 to 2024, particularly in light of competitive pressures and changes in the treatment paradigm?",
      "original_answer": "In 2022, Biktarvy was positioned as a key growth driver for Gilead, with the company noting its 'continued growth in all geographies' and attributing part of the 11% revenue increase to its performance. By 2024, however, the strategic importance of Biktarvy appears more precarious. The 2024 10-K highlights increased risks around Gilead's HIV franchise, noting that 'many of our HIV products contain TAF' and that any shift away from nucleoside-based therapies could materially impact sales. This suggests that while Biktarvy was a growth asset in 2022, by 2024 it was increasingly seen as vulnerable to paradigm shifts in HIV treatment, representing a change in both strategic positioning and risk exposure.",
      "llm_answer": "In the 2022 filing Gilead described Biktarvy as the “growth engine” of its HIV franchise – sales rose worldwide, offsetting the loss of Truvada/Atripla and even prompting a new low‑dose pediatric tablet (see pages 38 & 41), and the company’s 2022 strategy explicitly called for maintaining leadership in HIV (page 40). By the 2024 filing the drug is still portrayed as a core product, but the risk discussion now stresses that “if there are any changes to the treatment or prevention paradigm for HIV, and nucleoside‑based therapeutics do not remain the preferred regimen, our HIV product sales would be adversely impacted” (page 18) and that “we face significant competition…including generics and new agents” together with pricing/reimbursement pressures (page 20). Thus Biktarvy’s strategic importance remains high, while its risk profile has risen because of intensified competitive pressure and the possibility of a shift away from nucleoside‑based regimens.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Biktarvy was a growth engine in 2022, driving global sales and prompting product extensions (e.g., pediatric formulation), consistent with the 2022 10-K. By 2024, the risk profile increased due to potential shifts away from nucleoside-based therapies (specifically TAF-containing regimens like Biktarvy), competition, and pricing pressures, as noted in the 2024 10-K. (2) There are no numeric inaccuracies—while no specific dollar amounts or percentages are cited in the LLM response, none are required for correctness since the original answer also avoids exact figures. The qualitative characterization of revenue growth (e.g., offsetting Truvada/Atripla losses) is consistent with the 11% increase mentioned in the ground truth. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across 2022 and 2024 filings, identifying both the strategic elevation in 2022 and the increased risk exposure in 2024. It accurately links Biktarvy’s reliance on TAF to broader franchise vulnerability. (4) The only minor shortcoming is that the LLM slightly softens the shift in strategic importance—while it says strategic importance 'remains high,' the ground truth suggests a more pronounced downgrade from 'growth driver' to 'vulnerable flagship.' However, this is a nuance in emphasis rather than a factual error. Overall, the answer is factually correct, contextually complete, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 418,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the balance of the U.S. litigation escrow account evolve between the end of fiscal year 2022 and the end of fiscal year 2023, and what were the specific deposit contributions during each period?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1,449 million at the end of fiscal year 2022 to $3,089 million at the end of fiscal year 2023. During this time, deposits into the account rose from $1,000 million in fiscal year 2022 to $1,500 million in fiscal year 2023.",
      "llm_answer": "The escrow balance was $1.449 billion at the end of FY 2022 (the “balance as of beginning of period” for 2023) and rose to $1.764 billion at the end of FY 2023【page_73†L1-L4】. The company put $850 million into the escrow during FY 2022【page_102†L1-L3】 and added $1.0 billion in FY 2023【page_73†L5-L7】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the U.S. litigation escrow account balance increased from $1,449 million at the end of FY 2022 to $3,089 million at the end of FY 2023. However, the LLM reports the end-of-FY2023 balance as only $1.764 billion ($1,764 million), which is $1,325 million lower than the correct value. Additionally, the LLM states that $850 million was deposited in FY2022 and $1.0 billion in FY2023, but the ground truth specifies $1,000 million in FY2022 and $1,500 million in FY2023. These deposit figures are therefore both incorrect. (2) Quantitative accuracy is severely compromised: the final balance is off by over 40%, and deposit amounts are understated by 15% and 33% respectively. No correct calculation of the balance change or deposit trends is presented. (3) The multi-hop reasoning is flawed—the model fails to correctly synthesize the evolution of the account balance and associated deposits across fiscal years. It references specific pages (e.g., page_73, page_102), suggesting document grounding, but the extracted numbers do not align with the ground truth, indicating either misextraction or misinterpretation. (4) Contextual relevance is moderate because the answer addresses the right topic (U.S. litigation escrow account, deposits, fiscal years), uses appropriate terminology, and attempts to provide period-specific data. However, due to major numerical and factual errors, the qualitative and correctness scores are very low. Semantic equivalence is not achieved because the core financial figures and trends are misrepresented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 448,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the role of fountain syrups in Coca-Cola's North America operating segment evolved between 2022 and 2023, particularly regarding the company's manufacturing and distribution responsibilities?",
      "original_answer": "In 2022, Coca-Cola explicitly stated that it manufactured fountain syrups in the United States and sold them directly to fountain retailers or to authorized fountain wholesalers or bottling partners for further distribution. By 2023, the company's description shifted: while it still referenced selling fountain syrups in the North America segment, it also indicated that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates. This suggests a nuanced evolution where Coca-Cola may be emphasizing a more decentralized, authorization-based model, particularly outside the U.S., while maintaining direct control within the U.S. There is no explicit mention of a change in manufacturing responsibilities within North America itself, indicating operational continuity there.",
      "llm_answer": "In both the 2022 and 2023 Form 10‑K filings Coca‑Cola’s North America segment still includes the company’s own production of fountain syrups in the United States, with the syrups sold either directly to fountain retailers or to authorized fountain wholesalers or bottling partners that then distribute them to those retailers【page_35】. The language describing these manufacturing and distribution responsibilities is unchanged between the two years, indicating that the role of fountain syrups in the North America segment has remained the same【page_36】.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, despite being well-structured and referencing appropriate sections. (1) The original answer (ground truth) states that while Coca-Cola maintained direct manufacturing of fountain syrups in the U.S. in both years, there was a notable shift in 2023 language indicating that outside the U.S., bottling partners were authorized to manufacture fountain syrups using company concentrates—a change not mentioned in 2022. This represents an evolution in the company's model, particularly in how it frames manufacturing responsibilities beyond the U.S. within the North America segment. However, the LLM incorrectly asserts that 'the language describing these manufacturing and distribution responsibilities is unchanged between the two years,' which contradicts the ground truth. (2) There are no numeric values in this question, so quantitative accuracy is not applicable; however, the years (2022, 2023) and entities (Coca-Cola, North America segment, bottling partners) are correctly identified, supporting a high quantitative accuracy score. (3) The multi-hop reasoning fails because the LLM did not detect the nuanced shift in disclosure between years—specifically the 2023 addition about partner-led manufacturing outside the U.S.—which is central to understanding the evolution of the company's role. This omission leads to an incorrect synthesis. (4) While the answer is contextually relevant and addresses the question’s focus on manufacturing and distribution in North America, it misses the key qualitative evolution described in the ground truth, resulting in a moderate correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 456,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has the composition of IBM's debt instruments maturing in 2025 evolved between 2022 and 2024, particularly regarding the 0.950% Notes due 2025?",
      "original_answer": "In 2022, IBM had three sets of notes maturing in 2025: the 2.875% Notes due 2025 (IBM 25A), the 0.950% Notes due 2025 (IBM 25B), and the 0.875% Notes due 2025 (IBM 25C). By 2024, the 0.875% Notes due 2025 were no longer listed, leaving only the 2.875% Notes due 2025 (IBM 25A) and the 0.950% Notes due 2025 (IBM 25B). This indicates a reduction in the diversity of interest rate profiles for debt maturing in 2025, with the removal of the 0.875% instrument.",
      "llm_answer": "In the 2022 Form 10‑K IBM reported three separate notes that mature in 2025 – a 2.875 % note (IBM 25A), a 0.950 % note (IBM 25B) and a 0.875 % note (IBM 25C) – together with a 7.00 % debenture due 2025 (IBM 25)【page_1】. The 2024 filing still lists the 2.875 % and the 0.950 % notes and the 7.00 % debenture, but the 0.875 % note is no longer shown, indicating that the 0.950 % Notes due 2025 remained outstanding while the 0.875 % issue was retired, narrowing the 2025 debt composition【page_1】.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but introduces a significant factual error not present in the ground truth. (1) Correct elements: The LLM correctly identifies that in 2022, IBM had three notes maturing in 2025, including the 2.875%, 0.950%, and 0.875% notes, and notes that by 2024 the 0.875% note was no longer listed. The conclusion that the 0.950% Notes remained outstanding and that the composition narrowed is consistent with the ground truth. (2) Quantitative inaccuracy: The LLM incorrectly adds a '7.00% debenture due 2025 (IBM 25)' present in both 2022 and 2024 filings, which is not mentioned in the original answer or implied by the ground truth. This is a critical error because it introduces a debt instrument that was not part of the verified knowledge graph data, undermining factual reliability. (3) Multi-hop reasoning: The model correctly synthesizes changes over time (2022 to 2024) and draws a reasonable inference about the narrowing of debt composition. However, the inclusion of an unverified instrument suggests flawed entity extraction or data synthesis from the source document. (4) The answer is contextually relevant and addresses the evolution of debt composition and the status of the 0.950% Notes. However, due to the incorrect addition of a debenture not in the ground truth, the quantitative and qualitative accuracy scores are reduced. A correctness score of 6 reflects that core facts about the 0.875% note's disappearance and the persistence of the 0.950% note are correct, but the answer contains significant extraneous and unverified information that affects overall reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 441,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Disney's strategic approach to cruise ships evolved between 2022 and 2024 based on disclosures in their 10-K filings?",
      "original_answer": "In 2022, Disney mentioned cruise ships as part of its broader travel and resort experiences, indicating that their success depended on consumer demand for out-of-home entertainment and travel. By 2024, Disney had elevated its approach, explicitly stating plans to 'expand investment in our Experiences segment' and 'additional expansion of our fleet of cruise ships.' This evolution reflects a shift from general dependence on consumer demand to an active investment and growth strategy in cruise ship operations. The 2024 filing also notes that new offerings, such as additional cruise ships, come with increased costs and uncertain returns, signaling a more capital-intensive and strategic focus compared to the more passive mention in 2022.",
      "llm_answer": "In the 2022 filing Disney’s cruise‑ship strategy was centered on a single new destination – it disclosed that it had acquired about 550 acres at Lighthouse Point, Eleuthera, which was slated to open as a Disney Cruise Line destination in 2024. By the 2024 filing the focus had broadened to a fleet‑expansion approach – the company announced “additional expansion of our fleet of cruise ships” and further investment in its Experiences segment, while also noting the closure of the Star Wars Galactic Starcruiser concept and the higher costs of launching new ships. (2022 p. 22; 2024 p. 22)",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution in Disney's cruise strategy from 2022 to 2024, noting the shift from a focus on a single destination (Lighthouse Point) to fleet expansion. It accurately references the 2024 disclosure about 'additional expansion of our fleet of cruise ships' and increased investment in the Experiences segment, aligning with the ground truth. It also correctly notes the closure of the Star Wars Galactic Starcruiser, which adds context to the strategic shift. However, the original answer does not mention Lighthouse Point or the 550-acre acquisition, so this detail—while factually plausible and consistent with Disney’s strategy—is not part of the ground truth derived from the knowledge graph. This introduces a minor factual overreach not supported by the provided truth data. (2) Quantitatively, the LLM correctly states the 2024 opening of Lighthouse Point and references page numbers (2022 p.22; 2024 p.22), which are plausible but not verifiable without access to the actual filings. No incorrect numbers or dates are presented. (3) The multi-hop reasoning is sound: the model synthesizes information across two years, identifies a strategic shift, and supports it with specific disclosures. The addition of the Star Wars Galactic Starcruiser closure strengthens the narrative of strategic realignment, even if not in the original answer. (4) The answer is contextually relevant and well-structured. The correctness score is 8 because while the core facts about fleet expansion and increased investment are accurate and match the ground truth, the inclusion of Lighthouse Point details—though potentially true—introduces unverified information not present in the original answer, reducing completeness alignment. Quantitative accuracy is high due to correct dates and no numerical errors. Qualitative accuracy is strong but slightly reduced due to the extraneous detail. Contextual relevance is perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 529,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did Lockheed Martin's approach to pension risk transfer transactions evolve from 2022 to 2023, particularly in terms of financial impact and strategic intent?",
      "original_answer": "In 2022, Lockheed Martin detailed a specific pension risk transfer transaction from August 3, 2021, where $4.9 billion of gross defined benefit pension obligations were transferred via group annuity contracts (GACs), resulting in a noncash pension settlement charge of $1.7 billion. The company also noted that since December 2018, it had transferred approximately $11.6 billion in pension obligations, eliminating volatility for around 95,000 retirees. By 2023, the company reiterated its strategic intent to continue evaluating such transactions but shifted focus toward the broader financial and risk implications, including potential future contributions to the pension trust and the possibility of additional noncash settlement charges. The 2023 filing also introduced a nuanced risk: while most GACs relieve Lockheed of pension obligations, some could leave the company liable if the insurer defaults. This reflects a more cautious framing of pension risk transfer, acknowledging residual liability exposure not emphasized in 2022.",
      "llm_answer": "In the 2022 filing Lockheed Martin reported that a 2021 group‑annuity‑contract purchase transferred about $4.9 billion of defined‑benefit obligations and triggered a $1.7 billion pretax non‑cash pension‑settlement charge (page 60).  That transaction under‑pinned its 2022 outlook of $460 million of FAS pension income and a net $2.3 billion pension benefit (page 62), and the company said it would continue to seek additional risk‑transfer deals to reduce volatility (page 60).  \n\nBy the 2023 filing the discussion had become more forward‑looking: the company again notes it will “continue to evaluate” pension‑risk‑transfer transactions, acknowledges that some GACs may still leave it responsible for benefit payments and that future deals could require extra contributions or new non‑cash settlement charges, but no comparable large charge is reported for 2023 (page 19).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the $4.9 billion pension obligation transfer and $1.7 billion noncash charge from the August 3, 2021 transaction are accurately reported, and the absence of a similar large charge in 2023 is correctly noted. The mention of continued evaluation of risk transfers and forward-looking financial implications (e.g., potential future contributions and settlement charges) matches the strategic shift described in the original. (2) Quantitative accuracy is perfect: dollar amounts ($4.9B, $1.7B) and the lack of a 2023 charge are correct; no calculations were required. Format variations (e.g., 'billion' vs 'B') are acceptable and do not affect meaning. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across 2022 and 2023 filings, identifying both the specific 2021 transaction’s impact in 2022 and the evolved, more cautious tone in 2023, including the nuanced risk of residual liability if insurers default—though this specific phrasing is slightly less explicit in the LLM answer, the core idea that 'some GACs may still leave it responsible' captures the same concept. (4) The only minor shortcoming is that the LLM does not explicitly mention the cumulative $11.6 billion in obligations transferred since 2018 or the 95,000 retirees affected—details present in the original that add context to the strategic intent. However, the omission does not undermine the core accuracy of the evolution in financial impact and strategic framing. Overall, the answer is factually correct, well-reasoned, and directly responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 454,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has Tesla's relationship with its financing partners evolved between 2022 and 2023, particularly in terms of accounts receivable management and leasing program risks?",
      "original_answer": "In 2022, Tesla disclosed that accounts receivable from financing partners could take up to approximately two weeks to settle based on contractual payment terms, directly impacting the company's short-term liquidity and balance sheet fluctuations. By 2023, Tesla highlighted increased complexity and risk in managing its financing programs, noting that its leasing business depends on securing adequate financing or partners, and that residual value risks from leased vehicles could negatively affect profitability. This indicates a shift from a focus on operational cash flow timing in 2022 to a broader concern over credit, compliance, and residual value risks in 2023 as the leasing program scaled.",
      "llm_answer": "In the 2022 filing Tesla described its receivables from banks and leasing companies as a routine part of its cash‑flow cycle, maintaining an allowance for expected credit losses, noting that no single financing partner accounted for more than 10 % of the balance and that payments from those partners can take up to two weeks to clear (2022 10‑K p. 64). By the 2023 filing the tone had shifted to a risk‑focused view: the company stresses that its vehicle‑leasing and financing programs now rely heavily on securing adequate partner funding and on resale‑value guarantees, warning that lower‑than‑expected resale values or a loss of partner financing could materially hurt its financial condition and increase credit‑loss exposure (2023 10‑K p. 20‑21).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 disclosure about up to two weeks for payment settlement from financing partners is accurately cited (2022 10-K p.64), and the 2023 shift toward risk concerns around leasing, partner funding, and residual (resale) value is correctly summarized (2023 10-K pp.20-21). The statement that no single partner accounted for more than 10% of receivables adds contextual detail not in the original answer but is factually consistent and enhances completeness. (2) Quantitative accuracy is perfect: 'up to two weeks' and '<10%' are correctly reported with proper sourcing. No calculations were required, but temporal references (2022 vs 2023) are accurate. (3) Multi-hop reasoning is sound—LLM correctly synthesizes changes in tone and risk focus across years, identifying the evolution from cash-flow timing in 2022 to credit, residual value, and partner dependency risks in 2023. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'resale-value guarantees' vs 'residual value risks'), the meaning is equivalent and well-supported. The only minor gap is that the original answer explicitly frames the shift as one from 'operational cash flow timing' to 'broader credit, compliance, and residual risks,' a nuance slightly underemphasized in the LLM response, but the core insight remains intact. Hence, a score of 9 is warranted—excellent accuracy with only slight room for deeper synthesis framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 424,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "What changes occurred in Coca-Cola's fountain syrup distribution strategy between 2022 and 2023, and how did the roles of bottlers and fountain wholesalers evolve during this period?",
      "original_answer": "In 2022, Coca-Cola manufactured and sold fountain syrups directly to authorized fountain wholesalers (including certain authorized bottlers), who then sold or delivered the syrups to retailers. Bottlers in the U.S. were generally not authorized to manufacture fountain syrups. By 2023, the strategy evolved such that outside the United States, bottlers were typically authorized to manufacture fountain syrups using Coca-Cola concentrates, which they could sell to fountain retailers or authorized fountain wholesalers. This represents a shift from a more centralized syrup distribution model to a more integrated one, where bottlers play a more active role in the fountain syrup supply chain, particularly in international markets.",
      "llm_answer": "In the 2022 filing Coca‑Cola said that in the United States it manufactured fountain syrups and sold them only to fountain retailers or to “authorized fountain wholesalers (including certain authorized bottlers),” because U.S. bottlers were not authorized to manufacture or directly distribute the syrup (KO 2022 p. 8). The 2023 filing still notes the Company manufactures the syrup, but now adds “authorized fountain wholesalers **or bottling partners**” as a channel that can sell and distribute the syrup to retailers (KO 2023 p. 37). Thus, the strategy shifted to give bottling partners a direct distribution role alongside traditional fountain wholesalers, expanding their involvement in the U.S. fountain‑syrup supply chain.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual inaccuracy regarding the geographic focus of the strategic shift. The ground truth states that the change—bottlers being authorized to manufacture fountain syrups using Coca-Cola concentrates—applies specifically to markets *outside the United States*, whereas the LLM incorrectly claims the shift occurred in the *U.S.* market. This is a critical error in entity and contextual accuracy. (2) Quantitatively, the answer is accurate in citing the years (2022 and 2023) and referencing the correct documents (KO 2022 p. 8 and KO 2023 p. 37), and there are no numerical calculations to verify. The format and dates are correctly used. (3) The multi-hop reasoning is partially sound— the model identifies a change in distribution channels between two years and attempts to synthesize information from two filings. However, it misinterprets the scope of the change, failing to recognize that the expanded role for bottlers pertains to international markets, not the U.S., which fundamentally undermines the correctness of the conclusion. (4) While the answer is relevant and structured well, the core factual error—reversing the geographic applicability of the strategy shift—demerits high scores. The model captures the evolution in bottler roles but applies it to the wrong region, leading to a partially correct but ultimately misleading response. Correctness score is 4 due to major factual inaccuracy despite correct use of sources and reasonable structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 418,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of receivables and new investment activities?",
      "original_answer": "In 2023, AMD had receivables from the ATMP JV of $9 million, and there was no mention of any direct investment or loan made by AMD to the JV. By 2024, AMD's receivables from the ATMP JV increased to $12 million, and the company entered into a new $100 million one-year term loan agreement with one of the ATMP JVs to support its general corporate purposes. This marks a significant shift from a purely transactional relationship in 2023 to a more financially integrated one in 2024, where AMD is not only a customer but also a creditor and strategic supporter of the JV.",
      "llm_answer": "In 2023 AMD’s ATMP JV balance sheet showed a modest $9 million receivable from the JV and an equity‑method investment of roughly $99 million 【page_78】. By 2024 the receivable had risen to $12 million, AMD added a $17 million equity contribution (raising the carrying value of the investment to about $149 million) and also entered a $100 million one‑year term loan to the JV 【page_75】【page_76】.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that AMD's receivables from the ATMP JV increased from $9 million in 2023 to $12 million in 2024, it incorrectly claims that AMD had an equity-method investment of $99 million in 2023 and made a $17 million equity contribution in 2024, raising the carrying value to $149 million. The original answer (ground truth) explicitly states that there was no mention of any direct investment or loan by AMD to the JV in 2023, which contradicts the LLM's assertion of a $99 million equity investment. Additionally, the $100 million one-year term loan in 2024 is correctly identified. (2) Quantitative accuracy is partially correct: receivables ($9M → $12M) are accurate, and the $100M loan is correct, but the $99M investment in 2023 and $17M contribution in 2024 are unsupported by the ground truth and thus factually wrong. Calculations based on these numbers (e.g., $149M carrying value) are therefore also incorrect. (3) Multi-hop reasoning is partially sound—LLM connects AMD and ATMP JV across years and identifies an evolving financial relationship—but it fabricates investment details not present in the ground truth, undermining the reasoning. It incorrectly infers an equity investment where none was stated. (4) Contextual relevance is high as the answer addresses receivables and new financial activities between 2023 and 2024, but the inclusion of false investment data reduces factual reliability. Correctness score is low due to major factual errors in core financial figures despite some correct elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 441,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Lockheed Martin's approach to managing its nonqualified defined benefit pension plans evolve between 2022 and 2023, particularly in terms of pension obligation settlements and associated financial impacts?",
      "original_answer": "In 2022, Lockheed Martin purchased group annuity contracts to transfer $4.3 billion of gross defined benefit pension obligations and recognized a noncash pension settlement charge of $1.5 billion. In 2023, the company continued its strategy of reducing pension liabilities by making voluntary settlement payments of $414 million to approximately 6,500 former employees, significantly smaller in scale compared to the 2022 transaction. This indicates a shift from large-scale pension obligation transfers to a more targeted approach involving smaller settlements with former employees who had not yet started receiving benefits.",
      "llm_answer": "In 2022 Lockheed Martin eliminated a large block of non‑qualified pension obligations by buying group‑annuity contracts that transferred about $4.3 billion of obligations to an insurer; the transaction was recorded as a $1.5 billion non‑cash settlement charge (shown as a $1.47 billion settlement charge in the 2022 FAS‑income table)【page_82】. By 2023 the company moved to smaller, voluntary lump‑sum settlements – paying $414 million to roughly 6,500 former participants – which reduced the benefit obligation but generated no settlement charge or impact on pension expense (the $414 million settlement appears in the 2023 “Settlements” line and is noted as having no effect on FAS pension income)【page_82】【page_83】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers and dates are accurate: $4.3 billion in pension obligations transferred in 2022 with a $1.5 billion noncash settlement charge (noting the $1.47 billion figure in financial tables as a minor rounding detail, which is acceptable); in 2023, $414 million in voluntary payments to ~6,500 former employees is correctly reported. (2) The answer is complete, addressing both years, the nature of the transactions (annuity buyout vs. lump-sum settlements), and the financial impacts (settlement charge in 2022 vs. no charge in 2023). (3) Entities are accurate—Lockheed Martin, nonqualified defined benefit plans, correct years, and proper financial terminology (e.g., 'noncash settlement charge', 'FAS pension income'). (4) The reasoning is sound and reflects multi-hop synthesis: it contrasts the scale and accounting treatment between 2022 and 2023, correctly inferring a strategic shift from large insurer-mediated transfers to targeted internal settlements. The observation that the 2023 payments had no impact on pension expense or settlement charges aligns with accounting rules for settlements below the 'corridor' threshold, demonstrating accurate qualitative understanding. Semantic equivalence is strong, with slightly more detailed financial reporting (e.g., referencing FAS-income table) than the original, adding value without introducing error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 401,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did AMD's financial relationship with the ATMP JV evolve between 2023 and 2024, particularly in terms of its investment and equity income?",
      "original_answer": "In 2023, AMD recorded $16 million in equity income from the ATMP JV and had a carrying value of $99 million as of the end of the year. In 2024, AMD contributed an additional $17 million to the JV, increasing its investment's carrying value to $149 million by the end of the year. Equity income also rose to $33 million. This indicates a significant increase in both AMD's investment stake and the returns it received from the ATMP JV.",
      "llm_answer": "In 2023 AMD’s 15 % stake in the ATMP JV was carried at roughly **$99 million** and generated **$16 million of equity‑income** (page 78). By 2024 the company added a **$17 million capital contribution**, raising the carrying amount to about **$149 million**, and its equity‑income from the JV increased to **$33 million** (page 75). This represents a $50 million boost in the investment and more than a doubling of equity‑income year‑over‑year.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key numbers are correct: $99 million carrying value in 2023, $16 million equity income in 2023, $17 million additional contribution in 2024, $149 million ending carrying value, and $33 million equity income in 2024. These match the original answer exactly. (2) The calculation of the $50 million increase in investment (from $99M to $149M) is accurate, though it should be noted that this increase includes both the new $17M contribution and accumulated income or other adjustments, not solely the contribution—however, the LLM does not claim causation, so this is acceptable. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two years, identifies changes in both investment and income, and draws a valid conclusion about growth in AMD's relationship with the JV. (4) The only minor issue is the introduction of a '15%' stake' not present in the original answer, which may be correct but is not in the ground truth and thus introduces unverified information. This slightly affects qualitative accuracy but does not undermine the factual correctness of the financial figures or overall interpretation. Otherwise, the answer is complete, relevant, and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 367,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Johnson & Johnson's financial stake and ownership relationship with Kenvue evolve between 2023 and 2024, particularly in terms of retained equity and associated gains or losses?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% ownership stake in Kenvue valued at $4.3 billion following the exchange offer, which resulted in a non-cash gain of $21.0 billion, including a $2.8 billion gain on the retained shares. By the end of 2024, the company completed a Debt-for-Equity Exchange of its remaining 182,329,550 shares of Kenvue Common Stock, thereby eliminating its ownership stake and incurring a loss of approximately $0.4 billion in the process. This marks a full exit from Kenvue after initially reducing its stake significantly in 2023.",
      "llm_answer": "In 2023, after the August 23, 2023 exchange offer, Johnson & Johnson kept roughly 9.5 % of Kenvue’s outstanding shares – a stake recorded in other assets at about $4.3 billion – and booked a non‑cash gain of roughly $21 billion (including a $2.8 billion gain on the Kenvue stock it retained) in Net earnings from discontinued operations 【page_108】【page_109】. By May 2024 the company completed a debt‑for‑equity swap of its remaining 182 million Kenvue shares, eliminating its ownership and recognizing an approximately $0.4 billion loss in Other (income) expense 【page_41】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Johnson & Johnson retained a 9.5% stake in Kenvue in 2023 valued at $4.3 billion, recognized a $21.0 billion non-cash gain (including $2.8 billion on retained shares), and fully exited its ownership by May 2024 via a debt-for-equity exchange of 182,329,550 shares (rounded appropriately to 182 million), incurring a $0.4 billion loss. (2) Quantitative accuracy is perfect: all dollar amounts ($4.3B, $21B, $2.8B, $0.4B), percentage (9.5%), share count (~182 million), and dates (August 23, 2023 exchange; May 2024 completion) match or are acceptably rounded versions of the original. (3) Multi-hop reasoning is sound—correctly synthesizing the two-step divestment process across 2023 and 2024, including financial impacts and accounting treatment (gain in discontinued operations, loss in other income/expense). (4) Entity accuracy is strong: correct company names, correct sequence of transactions, and proper financial terminology. The inclusion of document page references adds credibility. The answer fully addresses the evolution of the ownership stake, retained equity, and associated gains/losses, making it complete and contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 353,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. evolve between 2022 and 2023, particularly in terms of its inclusion in guarantee agreements?",
      "original_answer": "AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the company continuing to guarantee certain obligations of Southwestern Bell Telephone Co. in both years. In 2022, the guarantee was listed in Exhibit 4-c, which included multiple entities such as Southwestern Bell Telephone Company. In 2023, the guarantee was again referenced in Exhibit 4-c, maintaining the same inclusion of Southwestern Bell Telephone Co. within the list of guaranteed entities. This indicates no change in the nature or scope of the guarantee.",
      "llm_answer": "In the 2022 Form 10‑K (pages 133‑137) AT&T’s exhibit list does not contain any guaranty or guarantee agreement that references Southwestern Bell Telephone Co. By contrast, the 2023 Form 10‑K’s exhibit schedule (page 103) includes a “4‑b Guaranty of certain obligations of Pacific Bell Telephone Co. and Southwestern Bell Telephone Co.” and a “4‑c Guaranty of certain obligations … Southwestern Bell Telephone Company” (Exhibits 4‑c and 4‑d). Thus, between 2022 and 2023 AT&T added Southwestern Bell Telephone Co. to its disclosed guarantee agreements.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in its core claim. According to the ground truth, AT&T's financial guarantee relationship with Southwestern Bell Telephone Co. remained consistent between 2022 and 2023, with the guarantee included in Exhibit 4-c in both years. The LLM incorrectly asserts that the guarantee was absent in 2022 and added in 2023, which contradicts the original answer. The LLM misidentifies exhibit numbers (claiming Exhibits 4-b and 4-d in 2023, while the truth states Exhibit 4-c in both years), and falsely claims no mention in 2022 when the original answer confirms inclusion in Exhibit 4-c that year. This represents a complete reversal of the factual evolution. While the LLM attempts multi-hop reasoning by comparing exhibits across years, the underlying data is wrong, leading to an invalid conclusion. The contextual relevance is moderate because it addresses the right topic and structure, but the factual inaccuracies render the answer misleading. No calculations are involved, but entity and document references (exhibit numbers, company names) are inaccurately reported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 313,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Lockheed Martin's involvement in hypersonics programs evolved from 2022 to 2023, particularly in terms of strategic positioning and program development responsibilities?",
      "original_answer": "In 2022, Lockheed Martin's involvement in hypersonics programs was described as a growth area that was dependent on U.S. Government authorization and funding, and was listed among other key development areas like classified programs and next-generation franchise programs. By 2023, the company's role had evolved significantly, with hypersonics programs now explicitly listed among major programs under the Space segment, indicating a more concrete and active role in designing, developing, and building hypersonic strike weapons for the U.S. Army and Navy. This reflects a shift from a potential growth area to a clearly defined and active program portfolio.",
      "llm_answer": "In the 2022 Form 10‑K, hypersonics was referenced only as a “key area of growth” and a risk factor that could be impacted by budget constraints (2022 p. 14). By the 2023 filing, Lockheed Martin had elevated hypersonics to a core strategic priority—listing it among four near‑to‑mid‑term growth elements (2023 p. 3), assigning its Advanced Development Programs/Skunk Works to drive future hypersonic capabilities (2023 p. 4), and tasking its Missiles & Fire Control segment with the design, development and production of multiple hypersonic strike weapons for the U.S. Air Force and Army, with several programs expected to enter early‑production by 2026 (2023 p. 5).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly identifies the evolution of Lockheed Martin's hypersonics involvement from 2022 to 2023. In 2022, the company described hypersonics as a 'key area of growth' subject to government funding, which matches the original answer's characterization as a potential growth area dependent on U.S. Government authorization. By 2023, the LLM correctly notes the elevated strategic positioning—listing hypersonics among near-to-mid-term growth elements, assigning Skunk Works to lead development, and assigning Missiles & Fire Control with design, development, and production responsibilities. The mention of programs entering early production by 2026 adds detail not in the original but is consistent with the trajectory and does not contradict it. The only minor discrepancy is that the original specifies U.S. Army and Navy, while the LLM mentions Air Force and Army—this is a partial entity mismatch but likely reflects actual program assignments across services; however, it slightly deviates from the ground truth. All cited page numbers (2022 p.14, 2023 pp.3–5) are plausible and contextually accurate. There are no numerical inaccuracies (quantitative accuracy is perfect), reasoning is sound across the two years, and the synthesis of strategic shift is well-executed. The answer is fully contextually relevant and captures the multi-hop evolution in strategic positioning and program responsibilities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 408,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How did the balance of the U.S. litigation escrow account evolve from fiscal year 2022 to fiscal year 2023, and what were the respective amounts deposited into the account during those years?",
      "original_answer": "The balance of the U.S. litigation escrow account increased significantly from $1.4 billion as of September 30, 2022, to $3.089 billion as of September 30, 2023. During fiscal year 2022, $850 million was deposited into the account, while in fiscal year 2023, $1.0 billion was deposited.",
      "llm_answer": "In fiscal 2022 Visa deposited **$850 million** into its U.S. litigation escrow account, leaving a year‑end balance of roughly **$1.4 billion**【page_46】. In fiscal 2023 the company deposited **$1.0 billion**, and the balance grew to **$1.764 billion** as of September 30, 2023【page_73】.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $850 million deposit in fiscal year 2022 and the $1.0 billion deposit in fiscal year 2023, which matches the ground truth. It also correctly states the fiscal year-end date of September 30, 2022, with a balance of $1.4 billion. However, it incorrectly reports the 2023 year-end balance as $1.764 billion instead of the correct $3.089 billion, a significant factual error. (2) The quantitative accuracy fails on the final balance figure: starting from $1.4 billion and adding $1.0 billion should yield $2.4 billion at minimum, but the actual reported balance in the ground truth is $3.089 billion, suggesting additional deposits or interest not accounted for. The LLM’s $1.764 billion is neither arithmetically consistent nor factually correct. (3) The multi-hop reasoning is partially sound—linking deposits and balances across two years—but fails in synthesizing the correct final balance, indicating either a data extraction error or failure to reconcile the full account evolution. (4) Contextual relevance is high because the answer addresses both parts of the question (balance evolution and deposits) and references appropriate fiscal years and account type. However, the major numerical inaccuracy in the ending balance severely undermines factual correctness, warranting a low overall score despite correct deposit amounts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 385,
        "total_tokens": 1539
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the role and positioning of Outdoor Garden within HD's product strategy evolved from 2022 to 2024, based on its classification and performance metrics?",
      "original_answer": "In 2022, Outdoor Garden was disclosed as a distinct product line with $10,317 million in net sales, accounting for 6.8% of total net sales, indicating its importance as a standalone category. By 2024, Outdoor Garden was grouped under the broader 'Hardlines' merchandising department, suggesting a strategic integration into a larger product segment. This shift reflects a change in how HD positions Outdoor Garden within its overall product portfolio, moving from a separate focus area to a component of a consolidated category.",
      "llm_answer": "In 2022 Outdoor Garden was a merchandising department within the Hardlines product line (which at that time grouped Hardware, Indoor Garden, Outdoor Garden and Tools) and it generated $10.0 bn of net sales – about 6.4 % of Primary‑segment revenue【page_56†L31-L38】【page_56†L1-L8】. By 2024 it is still positioned in Hardlines, but the Hardlines grouping has been broadened to include Power and Storage & Organization (instead of Tools) and Outdoor Garden’s sales rose to $10.3 bn, or roughly 6.5 % of Primary‑segment sales【page_56†L31-L38】【page_57†L31-L38】. This reflects a modest increase in absolute sales and share while keeping Outdoor Garden firmly within the Hardlines strategy, now aligned with a wider set of related categories.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in both the classification and performance metrics of Outdoor Garden. According to the ground truth, in 2022, Outdoor Garden was a *distinct product line*, not a sub-department within Hardlines as claimed by the LLM. The LLM incorrectly states that Outdoor Garden was already part of Hardlines in 2022, which contradicts the original answer indicating it was a standalone category before being integrated into Hardlines by 2024. This misrepresents the core evolution of the product strategy. (2) Quantitatively, the LLM reports $10.0 billion (vs. $10,317 million or ~$10.3 billion in ground truth), which is close but not precise—though acceptable with rounding. However, the percentage is reported as 6.4% (vs. 6.8% in truth), which is a notable discrepancy. For 2024, the LLM claims sales rose to $10.3 billion (aligns with truth) and 6.5% of Primary-segment sales, but the original answer does not provide 2024 performance metrics—only the reclassification—so this addition is unsupported. (3) The multi-hop reasoning is flawed: the LLM fails to recognize the strategic shift from standalone line to integrated component as a key evolution, instead portraying Outdoor Garden as always part of Hardlines, thus missing the central change in positioning. The mention of changes in Hardlines composition (e.g., inclusion of Power and Storage & Organization) adds detail but distracts from the main strategic shift. (4) Contextual relevance is high because the answer addresses the timeframe, product category, and performance trends, but correctness and qualitative accuracy are low due to fundamental misrepresentation of the initial state (2022 classification) and unsupported claims about 2024 metrics. Minor formatting variations in numbers are acceptable, but incorrect structure and logic undermine the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 510,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has AMD maintained its emphasis on an engaging and open environment as its global workforce expanded from 2023 to 2024, and what does this suggest about its talent retention strategy in a competitive semiconductor industry landscape?",
      "original_answer": "In 2023, AMD reported having approximately 26,000 employees and emphasized being at its best when 'our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' By 2024, AMD’s global workforce grew to approximately 28,000 employees, and the company reiterated the same language, stating it is 'at our best when our culture of innovation, creative minds and people from all kinds of backgrounds work together in an engaging and open environment.' Despite a 7.7% increase in workforce size, AMD maintained identical messaging around its cultural values. This suggests that AMD is intentionally preserving its inclusive and innovative culture as a strategic element to retain top talent in the highly competitive semiconductor industry, where attracting skilled professionals is critical.",
      "llm_answer": "AMD’s headcount grew from roughly 26,000 employees at the end of 2023 (page 15 2023 10‑K) to about 28,000 employees by December 2024 (page 13 2024 10‑K), yet the company kept its focus on an “engaging and open environment” (page 13 2024 10‑K). It does so by repeating a confidential annual culture‑engagement survey that consistently ranks in the top 10 % of technology peers (pages 16 2023 10‑K and 14 2024 10‑K), acting on the results at the board level, expanding inclusive programs such as Employee Resource Groups (‑85 % of new hires join one, page 14 2024 10‑K), offering flexible hybrid/remote work, competitive total‑rewards and robust development/mentoring initiatives (pages 14 2024 10‑K and 16 2023 10‑K). This signals that AMD’s talent‑retention strategy hinges on a deliberately inclusive, high‑engagement workplace that differentiates it in the fiercely competitive semiconductor industry and helps attract and keep top talent as the company scales.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. While the headcount numbers (26,000 in 2023 and 28,000 in 2024) match the ground truth and the 7.7% growth is approximately correct (~7.69%), the LLM introduces specific claims not present in the original answer or implied by the question, such as 'confidential annual culture-engagement survey that consistently ranks in the top 10% of technology peers', '85% of new hires join one [ERG]', and detailed programs like 'flexible hybrid/remote work, competitive total-rewards and robust development/mentoring initiatives'. These specifics are not mentioned in the ground truth and cannot be verified from the provided context. (2) The quantitative accuracy is low because the percentages and survey rankings cited (e.g., top 10%, 85%) are fabricated or at least unsupported by the original answer. The original answer only states that AMD repeated the same cultural messaging across years, not that it ran surveys or had measurable engagement rankings. (3) The reasoning is partially sound: the LLM correctly identifies workforce growth and cultural continuity as a retention strategy, which aligns with the original inference. It attempts multi-hop synthesis by linking headcount growth to cultural initiatives, but it overreaches by introducing unverified programs and metrics. (4) Contextual relevance is high because the answer addresses both parts of the question—how AMD maintained its environment and what it suggests about talent retention—and stays focused on AMD’s cultural strategy in the semiconductor industry. However, the inclusion of unsupported specifics reduces factual reliability. The original answer emphasizes consistency in messaging as evidence of cultural preservation; the LLM instead cites operational programs not present in the source, leading to a partially correct but overstated response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 521,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did AT&T's relationship with The Ohio Bell Telephone Company evolve between 2022 and 2023, particularly in terms of its guarantee obligations?",
      "original_answer": "In 2022, AT&T had a guarantee obligation covering The Ohio Bell Telephone Company as part of a broader list of subsidiaries under Exhibit 4-c, which was originally filed in 2011. In 2023, although the structure of the guarantee remained similar, the exhibit reference was updated to reflect current documentation practices, indicating a continuation of the guarantee without any explicit discontinuation or expansion. This suggests that the nature of the relationship remained stable, but documentation was maintained in line with current reporting standards.",
      "llm_answer": "The 2022 Form 10‑K (see pages 133‑137) contains no reference to a guarantee for The Ohio Bell Telephone Company, indicating that AT&T did not disclose any such obligation that year. By the 2023 Form 10‑K, AT&T lists a “Guaranty of certain obligations of … The Ohio Bell Telephone Company” (Exhibit 4‑d, page 103), showing that the company assumed a guarantee for that subsidiary in 2023. This reflects an expansion of AT&T’s relationship to include a formal guarantee obligation that was not present in the prior year.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim. According to the ground truth, AT&T maintained a continuous guarantee obligation for The Ohio Bell Telephone Company, with only an update in exhibit reference (from Exhibit 4-c to Exhibit 4-d), indicating no substantive change in the guarantee between 2022 and 2023. However, the LLM incorrectly asserts that there was no guarantee disclosed in 2022 and that a new guarantee was 'assumed' in 2023, representing an expansion of obligations. This misrepresents the evolution of the relationship. The LLM cites specific pages and exhibits (e.g., Exhibit 4-d in 2023), which shows some contextual awareness, but its interpretation of the 2022 filing as lacking any reference is factually wrong if the ground truth confirms the obligation existed under Exhibit 4-c. The reasoning fails the multi-hop synthesis: it should have recognized the continuity of the guarantee across years despite changes in exhibit labeling. While the answer addresses the question's focus on guarantee obligations and uses correct entity names and document types (Form 10-K, exhibit numbers), the central factual error—claiming emergence of a new obligation rather than continuation—severely undermines accuracy. Number and date references (2022, 2023, page numbers) are plausible but not verifiable without access to filings; however, their use does not compensate for the incorrect inference. Thus, quantitative accuracy is low due to incorrect qualitative interpretation of disclosure presence, qualitative accuracy is poor due to flawed reasoning, and while the response is contextually relevant in structure, it is factually misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1269,
        "completion_tokens": 453,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of gains on retained and sold ownership interests?",
      "original_answer": "In 2023, GE reported a $5.7 billion increase in corporate operating profit due to higher gains on retained and sold ownership interests, primarily driven by its AerCap and GE HealthCare investments. However, in 2024, the gains on retained and sold ownership interests decreased by $5.2 billion compared to 2023, again primarily related to AerCap and GE HealthCare. This indicates a significant reduction in the value or realization of these investments year-over-year.",
      "llm_answer": "In 2023 GE reported a $5.8 billion gain on retained and sold ownership interests, driven primarily by its AerCap investment (see 2023 10‑K page 13). By 2024 that benefit had collapsed – the 10‑K notes a $5.2 billion drop in those gains, leaving only a modest gain of roughly $0.5 billion (i.e., near‑break‑even) from AerCap (see 2024 10‑K page 9).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy. The original answer states a $5.7 billion increase in corporate operating profit in 2023 due to gains on retained and sold ownership interests, while the LLM reports $5.8 billion—a $0.1 billion discrepancy. This small difference may stem from rounding or source interpretation but does not drastically alter the conclusion. The $5.2 billion decrease in 2024 is accurately reported in both answers. However, the LLM adds a derived figure—'leaving only a modest gain of roughly $0.5 billion'—which is an inference (i.e., $5.8B - $5.2B = $0.6B, not $0.5B) not explicitly stated in the ground truth and introduces slight imprecision. (2) The calculation implied by the LLM (subtracting the drop from prior gain) is logical but not directly supported in the original answer, which only states the *change* in gains, not the absolute level in 2024. Thus, while the $5.2 billion decline is correct, the derived residual gain is speculative and not in the ground truth. (3) The multi-hop reasoning is sound: the LLM correctly identifies the shift from 2023 to 2024, attributes the gains primarily to AerCap and GE HealthCare (consistent with the original), and synthesizes the year-over-year impact. It appropriately cites the relevant 10-K pages, indicating correct source alignment. (4) Despite the minor numerical discrepancy and the unsupported inference about the residual gain, the core message—that gains surged in 2023 and then sharply declined in 2024 due to AerCap/GEHC—is preserved. Hence, the answer earns a high score but is penalized slightly for quantitative precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 456,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Home Depot's strategic use of HD Supply evolved between 2022 and 2024, particularly in relation to its focus on professional customers and MRO services?",
      "original_answer": "In 2022, Home Depot highlighted the integration risks and challenges associated with its acquisition of HD Supply in 2020, noting that achieving synergies and benefits was subject to significant uncertainty and complexity. By 2024, HD Supply had become a core component of Home Depot’s strategy to serve professional customers, specifically through its MRO offerings to multifamily, hospitality, healthcare, and government housing facilities. The 2024 filing explicitly references HD Supply as a key contributor to Pro-focused growth initiatives, indicating a shift from post-acquisition integration concerns to a more mature and strategic role in supporting Home Depot's professional customer segment.",
      "llm_answer": "In the 2022 filing Home Depot mentioned HD Supply only as a recent acquisition (Q4 2020) that could deliver sales growth, cost savings and synergies, without tying it to a specific professional‑customer strategy【page_18】. By the 2024 filing the company has made HD Supply the core channel for its MRO product line and related value‑added services to Pros—especially in multifamily, hospitality, health‑care and government‑housing markets—and has integrated it with its Pro‑focused digital platform (hdsupply.com) and Pro Xtra loyalty program【page_5】【page_6】【page_7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: HD Supply was acquired in Q4 2020 (noted as 'recent acquisition' in 2022), and by 2024 it had evolved into a strategic channel for MRO services targeting professional customers in multifamily, hospitality, healthcare, and government housing—matching the original answer's emphasis. The integration with Pro Xtra and the hdsupply.com platform adds contextual detail consistent with a mature strategic role. (2) Quantitative accuracy is perfect: the dates (2022 and 2024 filings, Q4 2020 acquisition) are correct, and no numerical calculations are required. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes the evolution from integration concerns (implied in 2022 by focus on synergies) to strategic centrality in 2024, even if it doesn't explicitly mention 'integration risks'—but this is only slightly less detailed than the original, not incorrect. (4) Semantic equivalence is strong: the core message—that HD Supply transitioned from a general growth asset to a core Pro/MRO pillar—is fully preserved. The only minor gap is that the LLM does not explicitly reference 'uncertainty and complexity' from the 2022 filing, but it captures the lack of strategic specificity at that time. Overall, this is a highly accurate, well-supported response with only negligible omission of tone/context from 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 393,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has AMD's reliance on cross-licensing agreements evolved between 2023 and 2024, particularly in terms of patent portfolio size and its implications for technology exchange?",
      "original_answer": "In 2023, AMD reported having approximately 18,500 patent matters worldwide, including 12,800 issued patents and 5,600 pending applications. In 2024, this portfolio grew slightly to approximately 18,800 patent matters, with 13,200 issued patents and 5,600 pending applications. This increase in issued patents indicates a strengthening of AMD's intellectual property position, which likely enhances its leverage in cross-licensing agreements. AMD continues to emphasize that these agreements are critical for transferring and receiving technology and intellectual property rights, suggesting that the company's reliance on such agreements remains strong and possibly more strategically advantageous in 2024 due to the expanded patent portfolio.",
      "llm_answer": "AMD’s 2023 filing noted that it already relied on “numerous cross‑licensing and technology‑exchange agreements” and held about 12,800 issued patents worldwide (≈7,500 U.S. patents and 5,600 pending applications) 【page_15】. By the 2024 filing the same language was used, but the portfolio had expanded to roughly 13,200 issued patents worldwide (≈7,500 U.S. patents and 5,600 pending applications), a modest increase of ≈400 patents and ≈300 total patent matters 【page_13】. The larger patent base gives AMD a broader IP pool to leverage in its cross‑licensing deals, reinforcing its ability to both receive and transfer technology while keeping its reliance on such agreements essentially unchanged.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the growth in AMD's patent portfolio from 2023 to 2024, noting an increase from 12,800 to 13,200 issued patents and maintaining 5,600 pending applications. However, it incorrectly states the total number of patent matters in 2023 as approximately 18,300 (12,800 + 5,600 = 18,400, not 18,500 as in the ground truth), and in 2024 calculates a total increase of ≈300 patent matters, when the actual total increased from 18,500 to 18,800 (a 300 increase is correct, but the base is off by 100). The LLM also omits the exact global total patent matters (18,500 and 18,800) mentioned in the original answer, instead focusing only on issued and pending. (2) The calculation of a ≈400 increase in issued patents is correct (13,200 - 12,800 = 400), but the total patent matters increase should be 300 (18,800 - 18,500), which the LLM approximates correctly though with slightly inaccurate inputs. The U.S. patent figure (≈7,500) is mentioned but not in the ground truth, so its inclusion is extraneous but not incorrect. (3) The reasoning is sound: the LLM correctly infers that a larger patent portfolio strengthens AMD’s position in cross-licensing agreements and that reliance on such agreements remains stable. It synthesizes information across two years and connects patent growth to strategic implications, fulfilling the multi-hop requirement. (4) The answer is contextually relevant and captures the core evolution and implications. The quantitative accuracy is slightly reduced due to missing total patent matter figures and minor arithmetic inconsistency in totals, but key facts (issued patents, pending apps, growth trend) are correct. Hence, correctness is high but not perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 472,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did Johnson & Johnson's financial stake and strategic relationship with Kenvue evolve from 2023 to 2024, particularly regarding the retention and subsequent disposal of Kenvue shares?",
      "original_answer": "In 2023, Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion after completing the exchange offer in August. This stake was recorded in other assets and experienced a $0.4 billion expense by year-end due to subsequent changes. By 2024, the company completed a debt-for-equity exchange in May, using its remaining 182,329,550 shares of Kenvue Common Stock to satisfy $3.6 billion of commercial paper. This resulted in a $0.4 billion loss and marked the complete exit from Kenvue, ending any financial stake in the company.",
      "llm_answer": "In the 2023 filing Johnson & Johnson disclosed that after the August 23, 2023 exchange offer it retained a 9.5 % ownership of Kenvue – recorded as an “other‑assets” equity investment worth about $4.3 billion – and that the two companies continued to work under transition‑service, manufacturing‑, trademark‑ and other agreements tied to the separation (see page 108). By the 2024 filing the company had eliminated that stake: on May 17 2024 it completed a debt‑for‑equity exchange of its remaining 182,329,550 Kenvue shares for outstanding commercial paper, which removed all Kenvue shares from J&J’s balance sheet and generated a roughly $0.4 billion loss recorded in other (income) expense (see page 69).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Johnson & Johnson retained a 9.5% stake in Kenvue valued at $4.3 billion in 2023 after the August exchange offer, recorded in other assets, and incurred a $0.4 billion expense due to changes in value. In 2024, the company completed a debt-for-equity exchange on May 17 using 182,329,550 Kenvue shares to retire $3.6 billion in commercial paper, resulting in a $0.4 billion loss. (2) Quantitative accuracy is perfect: percentages (9.5%), dollar amounts ($4.3B, $0.4B loss), share count (182,329,550), and dates (August 23, 2023; May 17, 2024) all match the ground truth. The $3.6 billion commercial paper amount is correctly implied from context even if not explicitly scored in the original answer. (3) Multi-hop reasoning is sound: the answer synthesizes information across two years, two filings, and multiple financial events (retention of stake, accounting treatment, subsequent disposal via debt exchange, and financial impact), correctly concluding the complete exit from Kenvue. (4) Entity accuracy is strong: correct company names (Johnson & Johnson, Kenvue), proper financial terms (debt-for-equity exchange, commercial paper, other assets, other income/expense), and correct time periods. The answer also adds contextual value by referencing transition-service and trademark agreements, enriching the strategic relationship aspect without introducing error. All elements align with the question’s focus on financial stake evolution and strategic relationship. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 442,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AT&T's relationship with Indiana Bell Telephone Co. Inc. evolved between 2022 and 2023 in terms of its inclusion in guarantee disclosures?",
      "original_answer": "In 2022, Indiana Bell Telephone Co. Inc. was listed among the entities whose obligations were guaranteed by AT&T under Exhibit 4-d. In 2023, the company continued to reference the same guarantee for Indiana Bell Telephone Co. Inc. under Exhibit 4-d, indicating that the guarantee remained in place without any modification or removal. Therefore, there was no change in the nature or status of the guarantee relationship between the two entities from 2022 to 2023.",
      "llm_answer": "In the 2022 Form 10‑K (pages 133‑137) there is no guarantee listed that involves Indiana Bell Telephone Co. Inc. – the pages contain no reference to that company in the guarantee disclosures. By contrast, the 2023 Form 10‑K’s exhibit list (Item 15, page 103) expressly includes a “Guaranty of certain obligations of … Indiana Bell Telephone Co. Inc.” (Exhibit 4‑d) 【page_133】​【page_103】. Thus, AT&T’s guarantee relationship with Indiana Bell, which was absent from the 2022 filing, appears in the 2023 filing, indicating that the company added Indiana Bell to its disclosed guarantees.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both factual content and reasoning. (1) According to the ground truth, Indiana Bell Telephone Co. Inc. was included in AT&T's guarantee disclosures in both 2022 and 2023 under Exhibit 4-d, with no change in status. The LLM incorrectly claims that the guarantee was absent in 2022 and only added in 2023. This misrepresents the core fact. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or answer, so quantitative accuracy cannot be scored on numbers, but the temporal claims (2022 vs 2023) are factually wrong. (3) The multi-hop reasoning fails: the model should have compared the guarantee disclosures across both years and concluded no change, but instead inferred a change that did not occur. The citation of page numbers (e.g., page 133, 103) does not compensate for the incorrect interpretation of content. (4) Contextual relevance is partially met because the answer addresses the right topic (guarantee disclosures involving Indiana Bell), but the conclusion is the opposite of the truth. The LLM likely misread or misinterpreted the 2022 filing, leading to a completely reversed conclusion. Thus, the correctness score is very low due to a major factual error in entity relationship evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 356,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How did GE's financial relationship with AerCap evolve from 2023 to 2024, particularly in terms of cash involvement and investment gains?",
      "original_answer": "In 2023, GE had a continuing financial involvement with AerCap through a note receivable, product leases, and transition services, which included a net cash payment of $203 million to AerCap. By 2024, GE no longer had continuing operational involvement but instead held an investment stake in AerCap. This shift resulted in a significant financial impact, as GE reported a decrease in gains on retained and sold ownership interests by $5.2 billion, largely attributed to its AerCap and GE HealthCare investments. This indicates a strategic and financial transition from operational collaboration to investment-based returns.",
      "llm_answer": "In 2023 GE still held AerCap equity and a note, paid $203 million of net cash to AerCap for product‑service and transition work, and recorded a $5.7 billion boost to earnings from gains on its AerCap (and GE HealthCare) ownership interests【page_51】. By 2024 the cash payment to AerCap is no longer reported and the AerCap holding helped drive a $5.2 billion drop in gains on retained‑and‑sold ownership interests, essentially reversing the large gain seen the year before【page_8】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift in GE's financial relationship with AerCap from operational involvement in 2023 to investment-based returns in 2024, and notes the absence of cash payments in 2024. However, it incorrectly states that GE recorded a $5.7 billion boost in earnings from gains on ownership interests in 2023, while the ground truth reports a $5.2 billion decrease in gains in 2024 (not a $5.7 billion gain in 2023). This is a significant quantitative error. The $203 million net cash payment to AerCap in 2023 is correctly reported. (2) The $5.7 billion figure does not appear in the ground truth and contradicts it; the only numeric change mentioned is the $5.2 billion decrease in gains in 2024. There is no support for a prior $5.7 billion gain, making this a factual inaccuracy. The directional logic — that gains reversed into a drop — is conceptually aligned, but the specific numbers are not. (3) The multi-hop reasoning is sound: the model correctly synthesizes the transition from cash payments and operational ties in 2023 to investment-based gains/losses in 2024, and links the change in gains to AerCap and GE HealthCare. The logic of a reversal in financial impact is consistent with the ground truth’s implication of a strategic shift. (4) Scores reflect that core entities (GE, AerCap, years, note receivable, cash payment) and the overall narrative of transition are correct, but the incorrect $5.7 billion figure undermines quantitative accuracy. The answer remains contextually relevant and qualitatively strong in reasoning, warranting a 7 for overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 445,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has The Home Depot's approach to store appearance and its role in competition evolved from 2022 to 2024, particularly in relation to customer experience and digital integration?",
      "original_answer": "In 2022, The Home Depot emphasized store appearance as a competitive factor alongside customer experience, price, and product availability. The company highlighted the importance of store location, appearance, and ease of shopping experience in both brick-and-mortar and online contexts. By 2024, the company expanded its focus, integrating store appearance into a broader 'interconnected shopping experience' that linked physical stores, digital platforms, and on-site services. The 2024 report specifically noted investments in digital platforms to enhance the presentation and ease of navigation for users, reflecting a shift toward digital integration as a core component of store and shopping experience competitiveness. This evolution shows a strategic shift from physical store aesthetics alone to a more holistic, digitally-enhanced customer experience.",
      "llm_answer": "In 2022 Home Depot already treated store location, appearance and merchandise presentation as a core competitive lever, investing in way‑finding signage, store‑refresh packages, front‑end redesigns and basic mobile‑app navigation to make stores easier to shop (2022 p. 8‑9). By 2024 the company still emphasizes store appearance, but frames it as part of an “interconnected shopping experience,” layering the same physical refreshes with electronic shelf‑labeling, expanded self‑checkout and a mobile‑app map that ties the store layout to digital tools, while also expanding its website and app capabilities to deliver a seamless omnichannel experience (2024 p. 8‑9, 10). This reflects a shift from primarily physical upgrades to a more integrated digital‑physical strategy that uses technology to amplify store appearance and customer experience as a competitive advantage.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: The Home Depot's emphasis on store appearance as a competitive factor in 2022, including store location, appearance, and ease of shopping, is accurately reflected. The 2024 evolution toward an 'interconnected shopping experience' integrating physical and digital components is correctly described. Specific examples like electronic shelf labeling, expanded self-checkout, and mobile-app integration (e.g., in-store maps) are consistent with the direction of digital integration mentioned in the original answer. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—only years (2022, 2024), which are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years, identifying both continuity (ongoing focus on store appearance) and evolution (integration with digital tools). It goes slightly beyond the original answer by citing specific initiatives (e.g., way-finding signage, front-end redesigns, electronic shelf labels), which are plausible and contextually appropriate, though not explicitly detailed in the ground truth. These additions do not contradict but enrich the response, assuming they are from the cited pages (2022 p. 8–9, 2024 p. 8–9, 10). (4) The semantic meaning fully matches the original: the shift from physical aesthetics to a digitally enhanced, omnichannel experience is clearly conveyed. The only minor deduction is for the inclusion of specific features (e.g., electronic shelf labeling) not present in the ground truth, which, while reasonable, introduce slight over-specificity without confirmation. However, since they support the correct overall conclusion and do not distort facts, the answer remains highly accurate. Contextual relevance is perfect—it directly addresses the evolution in strategy regarding store appearance, customer experience, and digital integration from 2022 to 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 547,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2023 and 2024, particularly in terms of resales and new financial arrangements?",
      "original_answer": "In 2023, AMD's resales to the ATMP JV amounted to $14 million, with no mention of direct financial arrangements such as loans. By 2024, AMD's resales to the ATMP JV increased significantly to $121 million. Additionally, in October 2024, AMD entered into a one-year $100 million term loan agreement with one of the ATMP JVs to support the joint venture's general corporate purposes. This indicates a notable deepening of the financial relationship, moving beyond operational services to include direct financial support.",
      "llm_answer": "In 2023 AMD only resold about $14 million of inventory to the ATMP JV (with $9 million of receivables) and had no new financing with the venture 【page_78】. By 2024, AMD’s resales to the JV surged to roughly $121 million (receivables rose to $12 million) and AMD entered a new $100 million one‑year term‑loan agreement with the JV (and also made a $17 million equity contribution) 【page_74】【page_75】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in resales from $14 million in 2023 to $121 million in 2024, aligning with the ground truth. It also accurately notes the new $100 million one-year term loan agreement with the ATMP JV in 2024. However, the LLM introduces two pieces of information not present in the ground truth: a $17 million equity contribution and specific receivables amounts ($9M in 2023, $12M in 2024). These figures, while possibly present in the cited pages, are not part of the original answer and were not requested in the question, introducing factual overreach. (2) The core financial figures (resales: $14M → $121M, loan: $100M) are correct and properly contextualized. The additional receivables and equity contribution are unverified in the ground truth and thus constitute quantitative inaccuracies. (3) The multi-hop reasoning is sound—LLM synthesizes data across years and identifies both operational (resales) and new financial (loan) dimensions of the relationship. However, the inclusion of the equity contribution suggests either misinterpretation or over-extraction from the source, weakening the reasoning fidelity. (4) Despite the extra details, the answer addresses the evolution of the financial relationship accurately and completely on the main points. The core progression—from limited resales in 2023 to expanded resales and direct financing in 2024—is correctly conveyed, justifying a high but not top score. Contextual relevance is perfect as all key aspects of the question are addressed directly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 429,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has Johnson & Johnson's approach to privacy compliance programs evolved between 2023 and 2024, particularly in response to new privacy laws and international data flow regulations?",
      "original_answer": "In 2023, Johnson & Johnson had established privacy compliance programs and controls that its global businesses were required to follow, with an emphasis on addressing new privacy laws expected in 'other territories' and increasing enforcement by governmental authorities, especially concerning data localization and international data flows. By 2024, the company maintained these privacy compliance programs but expanded its focus to include evolving technology and data-driven initiatives across the company, involving multiple vendors and third parties. The 2024 disclosure also specifically notes the expectation of new privacy laws 'globally' (not just in other territories) and highlights legislative actions imposing limitations on the use, sharing, and cross-border flows of personal data. This indicates a broadening of the company's compliance focus and a more anticipatory posture toward global regulatory changes.",
      "llm_answer": "In the 2023 filing Johnson & Johnson noted that it had already put “privacy compliance programs and controls … that our businesses worldwide are required to comply with,” primarily to meet existing privacy‑law obligations and to prepare for anticipated new statutes, especially around data‑localisation and cross‑border data flows【2023 p.22】. By the 2024 filing the company expanded that framework, explicitly covering the full lifecycle of personal data (collection, use, storage, access, transfer and protection) and stating that its programs are being updated to address “new privacy laws … together with greater privacy enforcement … particularly on data‑localisation requirements and international data flows” while managing risks from technology‑driven initiatives and third‑party vendors【2024 p.22】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Johnson & Johnson had established privacy compliance programs in 2023 focused on new privacy laws and international data flows, particularly data localization; by 2024, the company expanded its focus to include evolving technology initiatives and third-party vendor risks. The shift from 'other territories' in 2023 to a 'global' expectation in 2024 is accurately reflected in the LLM's description of broader regulatory anticipation. (2) There are no numeric values, dates, or calculations to verify—no issues here. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings, identifying both continuity (ongoing compliance programs) and evolution (expanded scope, lifecycle coverage, third-party risks). The mention of 'full lifecycle of personal data' adds detail not explicitly in the ground truth but consistent with the 2024 expansion and supported by typical privacy program frameworks. (4) The only minor gap is that the LLM does not explicitly contrast the geographic scope shift from 'other territories' (2023) to 'globally' (2024), though it captures the essence by referencing 'new privacy laws' and 'greater enforcement' without limiting geography. This slight omission prevents a perfect 10 on qualitative accuracy, but overall the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 406,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has GE's financial exposure to Bank BPH evolved between 2023 and 2024, particularly in terms of estimated borrower litigation losses and related valuation allowances?",
      "original_answer": "In 2023, GE reported $2,669 million in total estimated losses related to borrower litigation for Bank BPH's foreign currency-denominated mortgage portfolio, with $1,712 million in valuation allowances against financing receivables held for sale and $957 million in other liabilities. By 2024, this total estimated loss decreased to $2,461 million, with $1,517 million in valuation allowances and $944 million in other liabilities. Additionally, the valuation allowance fully offset the financing receivables balance by the end of 2024, indicating a strategic shift in how GE managed its exposure to Bank BPH through a settlement program. This represents a reduction in GE's financial exposure to Bank BPH litigation risks over the period.",
      "llm_answer": "GE’s estimate of total borrower‑litigation losses on the Bank BPH mortgage portfolio fell from **$2.669 billion at year‑end 2023 to $2.461 billion at year‑end 2024** (Note 24, 2024 10‑K, p. 48).  The related valuation allowance was also reduced – the allowance for financing receivables held for sale dropped from **$1.963 billion (including $1.712 billion for litigation losses) in 2023 to $1.594 billion (including $1.517 billion for litigation losses) in 2024** (p. 50), leaving the Bank BPH receivable portfolio with no net carrying value in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the overall trend of decreasing estimated litigation losses and valuation allowances from 2023 to 2024, and correctly reports the total estimated losses ($2.669 billion in 2023 and $2.461 billion in 2024), which matches the ground truth. However, there is a critical error in the valuation allowance figures: the LLM states the total allowance for financing receivables held for sale was $1.963 billion in 2023 and $1.594 billion in 2024, but the ground truth specifies only the litigation-related portion of the allowance—$1.712 billion (2023) and $1.517 billion (2024). The LLM incorrectly adds non-litigation components or misrepresents the total allowance, introducing inaccuracy. (2) The ground truth confirms $1,712M and $1,517M as the litigation-specific valuation allowances, which the LLM does extract correctly in parentheses, but the inclusion of higher total allowance figures ($1.963B and $1.594B) creates confusion and suggests a misreading of the source. The other liabilities component ($957M in 2023, $944M in 2024) is omitted entirely. (3) The reasoning is mostly sound—LLM recognizes the reduction in exposure and notes the net carrying value became zero in 2024, aligning with the ground truth’s point about full offset by valuation allowance. However, it fails to mention the strategic shift via a settlement program, a qualitative nuance present in the original. (4) Scores reflect mostly correct core numbers with a significant error in ancillary figures, partial completeness, and strong contextual relevance. The answer captures the main trend and key litigation-specific allowances but misrepresents total valuation allowances and omits other liabilities, reducing quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 478,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has HD's treatment and positioning of the Indoor Garden product line evolved from 2022 to 2024, given its financial performance in 2022 and its merchandising department categorization in 2024?",
      "original_answer": "In 2022, HD's Indoor Garden product line generated $15,546 million in net sales, accounting for 10.3% of total revenue, indicating its significance as a standalone category. By 2024, the Indoor Garden product line was grouped under the 'Hardlines' merchandising department, suggesting a strategic shift to integrate it with related product lines rather than treating it as a distinct category. This reclassification implies a change in how HD is organizing and potentially promoting the product line within its broader offerings.",
      "llm_answer": "In fiscal 2022 Home Depot reported that the Indoor Garden department generated $10,105 million in net sales, or about 6.4 % of total company sales, and it was listed as a separate merchandising department within the Hardlines product line【page_57】. By fiscal 2024, after a Q1 merchandising‑department realignment, Indoor Garden is still treated as its own department under Hardlines (grouped with hardware, outdoor garden, power and storage & organization) and its net sales rose modestly to $10,519 million, or roughly 6.6 % of total sales【page_57】【page_56】.  This shows a slight sales increase while the product line’s positioning within Hardlines remained unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, the Indoor Garden product line generated $15,546 million in net sales (10.3% of total revenue), but the LLM claims $10,105 million (6.4%), which is materially incorrect. The 2024 sales figure of $10,519 million (6.6%) is also inconsistent with the ground truth, which does not provide 2024 financials but emphasizes a reclassification, not performance trends. (2) The quantitative inaccuracies are severe—both dollar amounts and percentages are wrong, and the implied calculation of total company revenue based on these figures does not align with Home Depot's actual scale. The ground truth does not mention 2024 sales figures at all, so including them is an unsupported addition. (3) The reasoning is flawed: the ground truth states that by 2024, Indoor Garden was *grouped under* the Hardlines department, indicating it was no longer a standalone category. However, the LLM claims it 'remained' a separate department under Hardlines, contradicting the key strategic shift. This misrepresents the core evolution—integration versus independence. (4) Contextual relevance is moderate because the answer addresses the right topic (product line evolution) and mentions Hardlines, but the synthesis across years is incorrect. The LLM fails the multi-hop requirement: it must connect 2022 financial significance with 2024 structural reclassification to infer strategic downgrading or integration, but instead asserts continuity. Thus, correctness and quantitative accuracy are very low due to wrong numbers and mischaracterization of positioning change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 454,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Colgate-Palmolive's use of sourcing strategies to manage cost volatility evolved from 2022 to 2024, particularly in relation to commodity price fluctuations?",
      "original_answer": "In 2022, Colgate-Palmolive utilized sourcing strategies as part of a broader risk management framework to manage volatility in foreign exchange, interest rates, and commodity prices, specifically mentioning the use of derivative instruments and local currency borrowings. By 2024, the company continued to rely on sourcing strategies but placed greater emphasis on managing raw material cost volatility, including commodities like resins, essential oils, and soybeans, while also incorporating more proactive cost containment and productivity initiatives. The 2024 disclosure highlights increased exposure to geopolitical and climatic disruptions, indicating a shift toward more defensive sourcing and cost management tactics in response to external pressures.",
      "llm_answer": "In the 2022 Form 10‑K Colgate‑Palmolive said it coped with raw‑material price swings mainly through **cost‑containment measures, sourcing strategies and limited commodity‑hedge contracts** (with futures used only in the Hill’s pet‑nutrition segment). By the 2024 filing the company still relies on **sourcing strategies and modest hedging**, but it has broadened its toolkit to **add price‑increase actions and targeted cost‑efficiency programs in manufacturing and distribution** to offset commodity‑price volatility. Thus, the approach has evolved from a primary focus on containment and hedging to a broader mix that also leverages pricing and efficiency levers while keeping sourcing and limited hedging as core tools.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022, Colgate-Palmolive used sourcing strategies, cost containment, and limited hedging (specifically futures in the Hill’s segment), which matches the original answer’s mention of derivative instruments and local currency borrowings as part of risk management. In 2024, the LLM correctly notes a broader toolkit including pricing actions and cost-efficiency programs, reflecting the increased emphasis on proactive cost containment and productivity initiatives mentioned in the ground truth. The evolution from a narrower to a more diversified strategy is accurately captured. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) Multi-hop reasoning is sound: the model synthesizes information across two years and correctly infers an evolution in strategy, connecting sourcing, hedging, cost management, and pricing levers. The mention of Hill’s pet nutrition using futures is a specific detail consistent with the type of targeted hedging implied in the original. (4) The only minor gap is that the LLM answer does not explicitly mention the increased exposure to geopolitical and climatic disruptions highlighted in the 2024 filing, which contextualizes the defensive shift. This omission slightly affects completeness but does not undermine the core accuracy. Overall, the answer is semantically equivalent, well-reasoned, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 432,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did the sales performance of TREMFYA evolve between 2023 and 2024, and what factors contributed to this change?",
      "original_answer": "In 2023, TREMFYA (guselkumab) experienced growth driven by market expansion, continued strength in PsO/PsA (Psoriasis and Psoriatic Arthritis), and favorable patient mix. By 2024, TREMFYA achieved sales of $3,670 million, an increase of 16.6% compared to $3,147 million in 2023. The growth in 2024 was attributed to an 18.1% change from operations, despite a negative currency impact of 1.5%. This indicates that TREMFYA not only maintained its market position but also expanded further in its therapeutic areas during this period.",
      "llm_answer": "TREMFYA’s sales rose from $3.147 billion in 2023 to $3.670 billion in 2024 – a 16.6% total increase (18.1% operational growth offset by a 1.5% negative currency impact)【page_31】. The growth was driven by overall market expansion and share gains, supported by continued strength in its psoriasis/psoriatic‑arthritis and ulcerative‑colitis indications and a favorable patient‑mix profile【page_32】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: TREMFYA sales increased from $3.147 billion in 2023 to $3.670 billion in 2024, representing a 16.6% total growth. The breakdown into 18.1% operational growth and a 1.5% negative currency impact is precisely aligned with the original answer. (2) Quantitative accuracy is perfect: the dollar amounts match exactly (with acceptable format variation using 'billion' instead of 'million' notation), and the percentage change of 16.6% is correctly calculated [(3,670 - 3,147) / 3,147 ≈ 0.166]. The operational and currency effects also sum correctly (18.1% - 1.5% = 16.6%). (3) The qualitative reasoning is sound and captures all contributing factors: market expansion, strength in psoriasis/psoriatic arthritis (PsO/PsA), ulcerative colitis (additional detail not in original but factually consistent and supportive), favorable patient mix, and share gains. While the original answer does not explicitly mention ulcerative colitis, its inclusion does not contradict and may reflect expanded indication support—this is a permissible enhancement. (4) The answer addresses both parts of the multi-hop question: the sales performance evolution (quantitative change over time) and the contributing factors (qualitative drivers). Synthesis across time periods and causal factors is accurate and complete. All entities—TREMFYA, years 2023 and 2024, financial metrics—are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 417,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the structural change in Disney's relationship with A&E from 2022 to 2023 affect its reporting of subscriber numbers and financial stake in the partnership?",
      "original_answer": "In 2022, Disney reported A&E as a partner with 69 million domestic subscribers, indicating a collaborative but arms-length relationship. By 2023, Disney's relationship with A&E had evolved into a 50% equity stake, with A+E now classified as a significant equity investment. The 2023 report noted that A+E's channels, including A&E, had 58 million domestic subscribers. This shift from a partnership to a joint ownership model altered how Disney reported both subscriber data and financial performance, moving from simple subscriber counts in 2022 to including A+E’s financial results under 'Equity in the income of investees' in 2023.",
      "llm_answer": "In the 2022 filing Disney disclosed a 50 % equity interest in A+E and listed separate Nielsen‑based subscriber counts for each of its channels – A&E (69 M), HISTORY (70 M), Lifetime (69 M), LMN (52 M) and FYI (42 M). By the 2023 filing the partnership had been re‑classified under Disney’s Linear Networks segment; the company still owns 50 % of A+E, but now reports a single subscriber estimate of about 58 M for each of the three core A+E brands (A&E, HISTORY and Lifetime) and no longer provides separate figures for LMN or FYI. This structural shift simplified the subscriber reporting while leaving the ownership stake unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) The claim that Disney disclosed a 50% equity interest in A+E in 2022 contradicts the ground truth, which states that the 50% stake and classification as a significant equity investment began in 2023, not 2022. This is a critical error in both entity accuracy and temporal reasoning. (2) The LLM reports separate subscriber numbers for multiple A+E channels in 2022 (e.g., HISTORY at 70M, Lifetime at 69M), but the ground truth only mentions 69 million domestic subscribers for A&E specifically—not a breakdown across channels. These additional figures are unsupported and incorrect. (3) The assertion that Disney 'still owns 50%' in 2023 implies continuity from 2022, which is false according to the original answer—the shift to 50% ownership was a change in 2023. (4) While the 58 million domestic subscribers in 2023 is correctly reported, the LLM incorrectly states this number applies to 'each of the three core A+E brands,' implying 58M per channel, which is not supported by the ground truth—it should be 58M total for A+E channels collectively. (5) The structural shift in reporting—from partnership to equity investment and inclusion under 'Equity in the income of investees'—is entirely omitted, which is a core part of the question about how reporting changed. Instead, the LLM incorrectly claims the ownership stake was unchanged. This reflects a failure in multi-hop reasoning: the model did not correctly synthesize the change in relationship type over time. Despite these issues, the answer is contextually relevant in discussing subscriber reporting changes and focuses on the right entities (Disney, A&E, subscriber numbers), earning moderate relevance. However, due to major factual and logical errors in dates, ownership structure, and subscriber data, the overall correctness is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1321,
        "completion_tokens": 508,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the financial impact of GE's relationship with AerCap evolve between 2023 and 2024, particularly in terms of realized and unrealized gains or losses?",
      "original_answer": "In 2023, GE reported an unrealized gain of $129 million from its investment in and note with AerCap. However, in 2024, the relationship had evolved such that GE recognized a significant decrease in gains on retained and sold ownership interests, which dropped by $5.2 billion compared to 2023, with AerCap being one of the primary contributors to this decline. This indicates a negative shift in the financial performance of the AerCap investment from a gain in 2023 to a loss or significantly reduced gain in 2024.",
      "llm_answer": "In 2023 GE recorded a modest net gain on its AerCap exposure – the “investment in and note with AerCap” showed a **$129 million realized‑and‑unrealized gain** (Note 19, 2023 10‑K, p. 72). By 2024 that positive impact had flipped; the MD&A says continuing earnings were hit by a **$5.2 billion drop in gains on retained and sold ownership interests**, “primarily related to our GE HealthCare and AerCap investments” (2024 10‑K, p. 9), indicating the AerCap position moved from a small gain to a large loss.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $129 million gain in 2023 and the $5.2 billion drop in gains in 2024 are accurately reported, with proper context. The format variation (e.g., $129 million vs $129 million) is acceptable. (2) The answer correctly identifies that the 2023 gain was on the 'investment in and note with AerCap' and cites the correct source (Note 19, 2023 10-K, p. 72), demonstrating strong grounding. (3) For 2024, it accurately reflects the $5.2 billion decrease in gains on retained and sold ownership interests, explicitly naming AerCap as a primary contributor, as stated in the 2024 10-K MD&A (p. 9). (4) The reasoning is sound: it correctly infers a negative shift from a small gain to a large loss, even though the exact amount of the 2024 loss isn't isolated—this is reasonable given that the $5.2B drop is relative and attributed to multiple investments (GE Healthcare and AerCap). The only minor shortcoming is the LLM's phrasing of the 2023 gain as 'realized-and-unrealized' whereas the original answer specifies 'unrealized gain.' This is a subtle but notable distinction in financial reporting. However, since the source (Note 19) may include both components and the LLM may be summarizing, this does not constitute a major error. Overall, the multi-hop synthesis across years and documents is correct, and the conclusion about the negative evolution is logically supported. Semantic equivalence is maintained, and all entities (GE, AerCap, years, financial metrics) are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 436,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Mastercard's multi-layered security approach evolved between 2022 and 2024, particularly in terms of addressing risks associated with third-party service providers, and what does this evolution indicate about the company's strategic response to emerging cybersecurity threats?",
      "original_answer": "In 2022, Mastercard's multi-layered security approach included a robust program to protect its network from cyber and information security threats, with multiple layers of protection and third-party assessments. However, there was no explicit mention of addressing risks related to third-party service providers. By 2024, Mastercard explicitly integrated third-party provider risk management into its security framework, noting that it works with experts across the organization and through public-private partnerships to monitor and respond to threats associated with the use of services provided by third-party providers. This indicates a strategic shift toward strengthening the ecosystem-wide resilience of its security architecture, particularly in response to the growing complexity and interconnectedness of the payments landscape.",
      "llm_answer": "Mastercard’s core multi‑layered security framework—security‑operations centers, enterprise‑resilience programs, insurance coverage, regular testing and third‑party assessments—was already described in 2022 (“Payments System Security. We have a multi‑layered approach to protect the global payments ecosystem…” [page 11]). By 2024 the filing adds explicit language that the firm now monitors and mitigates “threats and incidents associated with the use of services provided by third‑party providers” [page 11], indicating a strategic shift to broaden its cyber‑risk focus to supply‑chain partners and a more proactive response to emerging cybersecurity threats.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Mastercard had a multi-layered security approach in 2022, citing specific components like security operations centers, enterprise resilience, third-party assessments, and regular testing, which matches the general framework described in the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is sound: the LLM correctly contrasts the 2022 and 2024 disclosures, noting that while third-party assessments existed in 2022, explicit monitoring of 'threats associated with the use of services provided by third-party providers' was only added in 2024. This reflects the evolution in risk management focus. (4) The LLM captures the strategic implication—that this change indicates a broader, more proactive approach to supply-chain and ecosystem-wide cyber risks—mirroring the original answer’s conclusion about strengthening ecosystem-wide resilience. The only minor shortcoming is that the LLM does not explicitly state that third-party *provider risks* were *not mentioned* in 2022, instead implying it by contrast. However, this is reasonably inferred. Wording differs slightly but maintains semantic equivalence. All entities (Mastercard, 2022, 2024, third-party providers) are correct. The answer is fully contextually relevant and addresses all parts of the multi-faceted question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 423,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has Target Corporation's compliance with its debt leverage covenant evolved between 2022 and 2023, particularly in light of changes to its credit facilities?",
      "original_answer": "In 2022, Target Corporation stated that it was in compliance with its debt leverage covenant and expected to remain so, with a $3.0 billion unsecured revolving credit facility set to expire in October 2026. By 2023, Target had obtained a new $1.0 billion 364-day unsecured revolving credit facility (expiring in October 2024) and extended the expiration of its five-year $3.0 billion facility to October 2028. Despite these structural changes to its credit facilities, Target continued to assert compliance with the debt leverage covenant in 2023, indicating consistent adherence to regulatory requirements even as its financing arrangements evolved.",
      "llm_answer": "Target said it was “in compliance with” its debt‑leverage covenant in both the 2022 filing (see 2022 Form 10‑K, page 30) and the 2023 filing (see 2023 Form 10‑K, page 33). In 2023 the company added a new $1.0 billion, 364‑day revolving credit facility and extended its existing $3.0 billion five‑year facility to 2028—both with no balances outstanding—yet it still expects to remain in compliance with the covenant, just as it did in 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Target was in compliance with its debt leverage covenant in both 2022 and 2023, maintained a $3.0 billion five-year facility (extended to 2028), and added a new $1.0 billion 364-day facility in 2023 expiring in 2024. The LLM correctly notes no balances were outstanding and compliance was maintained. (2) Quantitative accuracy is perfect: dollar amounts ($1.0 billion, $3.0 billion), timeframes (364-day, 2028 extension), and years (2022, 2023) match the original. Format variations (e.g., '2028' vs 'October 2028') are acceptable. (3) Multi-hop reasoning is sound: the model synthesizes information across two years, identifies changes in credit facilities, and correctly infers that covenant compliance persisted despite structural changes. (4) The only minor omission is the original expiration date of the $3.0 billion facility (October 2026 in 2022, extended to October 2028 in 2023), which the LLM does not explicitly mention, slightly reducing qualitative completeness. However, the core evolution—extension to 2028—is present. Semantic equivalence is maintained, and the answer directly addresses the question’s focus on covenant compliance and credit facility changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 357,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the nature of the risks associated with Salesforce's AI offerings, including generative AI such as Agentforce, evolved from 2023 to 2024?",
      "original_answer": "In 2023, Salesforce's primary risk related to third-party integrations and applications centered on potential claims or liabilities stemming from customer expectations for warranties, despite the company not developing or selling these third-party offerings. By 2024, the risk profile expanded significantly with the increased integration of AI into Salesforce's offerings, particularly generative and agentic AI like Agentforce. The 2024 disclosures highlight new risks such as ethical concerns, regulatory scrutiny, and potential legal liabilities from AI-generated content that may be inaccurate, biased, or infringe on copyright. Additionally, the company now anticipates increased costs related to AI governance, compliance, and testing, which were not specifically tied to AI in 2023.",
      "llm_answer": "In the 2023 filing Salesforce’s AI‑risk discussion was centered on the fact that the markets and monetization models for new AI products such as Agentforce were still “relatively new and uncertain,” with limited experience in setting optimal consumption‑based pricing and a risk that customers might consume less than expected (CRM 10‑K 2023 p. 21). By the 2024 filing the risk narrative had broadened dramatically: the company now warns that generative‑AI offerings (Agentforce, Einstein GPT) expose it to “accuracy, bias, toxicity, privacy and security and data‑provenance” problems, heightened ethical and reputational concerns, and expanding regulatory scrutiny that will require costly compliance, governance and data‑licensing investments (CRM 10‑K 2024 p. 22‑24).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Salesforce's AI-related risks from 2023 to 2024. In 2023, the focus was on market and monetization uncertainty for new AI products like Agentforce, including pricing and consumption risks—this matches the ground truth's emphasis on uncertain markets and customer expectations, though the LLM specifies pricing while the original emphasizes third-party liability. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; the years (2023, 2024) and product names (Agentforce, Einstein GPT) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes risk disclosures across two years and correctly contrasts the narrower 2023 concerns with the expanded 2024 risks around ethics, bias, accuracy, regulation, and compliance costs. (4) The LLM adds specific details (e.g., 'toxicity, privacy and security, data-provenance') not in the original but consistent with the broader risk categories mentioned (e.g., ethical concerns, legal liabilities), enhancing precision without introducing error. The only minor deviation is that the original emphasizes third-party integration liability in 2023, while the LLM emphasizes monetization uncertainty—both are present in Salesforce’s 2023 10-K, but the LLM slightly shifts focus. However, this does not invalidate the answer, as both reflect real aspects of the risk landscape. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with excellent reasoning and no factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 457,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Lowe's delivery capability for parcel-eligible items evolved between fiscal years 2023 and 2024, and what specific improvements were made?",
      "original_answer": "In fiscal year 2023, most parcel-eligible items could be delivered within two business days at standard shipping rates. By fiscal year 2024, Lowe's improved this capability, enabling delivery of most parcel-eligible items within two business days or less. Additionally, in 2024, Lowe's expanded its delivery capabilities to include next-day delivery for major appliances in nearly every zip code in the United States. This represents a refinement and expansion of their delivery speed and geographic coverage.",
      "llm_answer": "In fiscal 2023 Lowe’s said that most parcel‑eligible items could be ordered online and delivered within two business days at standard rates, with a nationwide gig network providing same‑day delivery for some items and 16 geographic “market‑based” delivery areas already converted (2023 10‑K p. 6). By fiscal 2024 the company had completed the market‑based delivery rollout, further expanded the gig network and added next‑day delivery of major appliances to almost every U.S. zip code, while still delivering the majority of parcel‑eligible items in two days or less (2024 10‑K p. 6).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: delivery within two business days for most parcel-eligible items in 2023, improvement to two days or less in 2024, and expansion to next-day delivery for major appliances in nearly every U.S. zip code in 2024. The mention of the gig network and market-based delivery areas is consistent with the 10-K disclosures and adds contextual detail not in the ground truth but not contradictory. (2) The LLM correctly identifies fiscal years 2023 and 2024 and attributes the correct delivery capabilities to each, with proper entity focus on Lowe's. (3) Multi-hop reasoning is sound: it synthesizes changes over time (2023 to 2024), compares delivery speeds, and incorporates geographic expansion. The only minor gap is that the original answer emphasizes a 'refinement and expansion' of speed and coverage, while the LLM focuses more on rollout completion and network expansion—slightly less emphasis on the 'refinement' aspect, but the core improvements are accurately captured. (4) The answer is contextually relevant, directly addressing both parts of the question: evolution between years and specific improvements. The added detail about the gig network and market-based areas enhances completeness without introducing error. Minor deduction in qualitative accuracy due to slightly expanded scope (e.g., '16 geographic market-based delivery areas') not in the ground truth, but this information is accurate per the 10-K and supports the main point.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 427,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial impact of the Dermstore LLC sale evolved from 2022 to 2023 in terms of Target's consolidated revenues and operating income?",
      "original_answer": "The financial impact of the Dermstore LLC sale remained minimal in both years, as Dermstore represented less than 1 percent of Target's consolidated revenues, operating income, and net assets in both 2022 and 2023. The sale, which occurred in February 2021, resulted in a $335 million pretax gain included in Net Other (Income)/Expense, and no significant post-sale financial contribution or change was observed in either year.",
      "llm_answer": "The Dermstore sale has remained a negligible factor in Target’s results. Both the 2022 and 2023 Form 10‑K filings state that Dermstore “represented less than 1 percent of our consolidated revenues, operating income and net assets,” indicating the impact on both revenue and operating income has not materially changed from 2022 to 2023. 【page_21】【page_24】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. It accurately states that Dermstore represented less than 1 percent of Target's consolidated revenues and operating income in both 2022 and 2023, which matches the original answer. The answer correctly conveys that the financial impact remained negligible with no material change between the years. It cites the relevant pages (21 and 24), supporting its claims with direct references. However, it omits the detail about the $335 million pretax gain from the February 2021 sale, which is part of the full financial context even though the question focuses on 2022–2023 impact. This omission slightly affects completeness but does not undermine the core correctness regarding the evolution of the financial impact in the specified years. All entities (Dermstore LLC, Target, revenues, operating income, 2022, 2023) are accurate, and the reasoning correctly synthesizes the consistent disclosure across two years. Quantitative accuracy is perfect—'less than 1 percent' is correctly reported with no numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 311,
        "total_tokens": 1506
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the strategic positioning of Data Cloud evolved between 2023 and 2024, particularly in terms of its role within Salesforce's broader service offerings and competitive landscape?",
      "original_answer": "In 2023, Data Cloud was described as a 'hyperscale, trusted data engine native to Salesforce' that unified enterprise data to deliver a 360-degree view of customers, emphasizing its integration across Salesforce's offerings like Marketing and Analytics. By 2024, Data Cloud was positioned within a broader context of competitive risk, with the filing noting that markets for offerings like Data Cloud are 'relatively new and uncertain,' and that Salesforce faces increasing competition as AI and data platforms evolve. Additionally, in 2024, Salesforce acknowledged limited experience in pricing consumption-based models like that of Data Cloud, signaling a shift from product-centric messaging to one that includes strategic risk and monetization challenges.",
      "llm_answer": "In the 2023 filing Data Cloud is described as Salesforce’s “hyperscale, trusted data engine native to Salesforce” that unifies a company’s disconnected data and powers AI‑driven analytics across the entire Customer 360 suite—including Sales, Service, Marketing, Commerce, Integration and Tableau analytics (see 2023 p. 7‑8). By the 2024 filing the company is positioning Data Cloud as a newer, consumption‑based offering whose pricing and monetization are still uncertain, and it is now highlighted as part of a broader, highly competitive landscape that includes AI‑focused vendors, data‑preparation, integration and platform‑development competitors (see 2024 p. 18‑20). This shift moves Data Cloud from a core integrated data layer to a growth‑focused, revenue‑model‑driven product facing intensified market competition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2023, Data Cloud is described as a 'hyperscale, trusted data engine native to Salesforce' that unifies data and powers AI-driven analytics across Customer 360 (including Sales, Service, Marketing, etc.), which matches the original answer's emphasis on integration across Salesforce offerings. In 2024, the shift toward competitive pressures and uncertainty in pricing/consumption models is accurately captured. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense—however, the years (2023, 2024) and page references (p. 7-8, p. 18-20) are consistent with expected sourcing and do not contradict the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings, identifying both the evolution in strategic positioning (from integration focus to monetization and competition concerns) and the broader competitive landscape, including AI and data platform vendors. (4) The LLM adds slightly more detail than the original (e.g., listing specific Customer 360 components like Commerce and Tableau), but this is consistent with likely content from the cited pages and enhances completeness without introducing error. The only minor shortcoming is that the original emphasizes 'limited experience in pricing consumption-based models' as a risk, while the LLM paraphrases this as 'pricing and monetization are still uncertain'—a semantically close but slightly less precise formulation. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 475,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has LOW's treatment and accounting of forward interest rate swap contracts evolved between 2023 and 2024, particularly in terms of hedge designation and financial impact?",
      "original_answer": "In 2023, LOW disclosed forward interest rate swap contracts related to its March 2023 Notes with a notional amount of $2.0 billion, from which it received $247 million upon settlement. These contracts were designated as cash flow hedges and their (loss)/gain was recorded in other comprehensive (loss)/income and earnings. By 2024, the company clarified that its fixed-to-floating interest rate swap agreements are accounted for as fair value hedges using the shortcut method, under which the hedges are assumed perfectly effective. This resulted in no net impact on the consolidated statements of earnings from the fair value of the derivatives, indicating a shift in both hedge designation and accounting treatment compared to the prior year.",
      "llm_answer": "In the 2023 Form 10‑K Lowe’s reported $1.29 billion of forward‑interest‑rate swap contracts classified as cash‑flow hedges, with the resulting gains or losses shown in other comprehensive income and earnings 【page_60】. By the 2024 filing the company listed a $0 notional for forward‑interest‑rate swaps, meaning none were designated as cash‑flow hedges and any effect would flow through earnings rather than OCI 【page_58】. The fair‑value hedge for its fixed‑to‑floating interest‑rate swaps remained unchanged at $850 million in both years.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2023, LOW had forward interest rate swap contracts with a notional amount of $2.0 billion (not $1.29 billion as stated), and it received $247 million upon settlement. The LLM incorrectly reports the notional amount and omits the $247 million settlement gain. Additionally, the LLM claims that in 2024, the notional amount was $0 for forward interest rate swaps, implying no cash flow hedges, but the ground truth states that the change was in hedge designation and accounting method for fixed-to-floating swaps, not elimination of swaps. The $850 million fair value hedge amount is not mentioned in the original answer and appears to be fabricated or misattributed. (2) Quantitative accuracy is severely compromised: $1.29B vs $2.0B, omission of $247M settlement, introduction of $850M not in ground truth, and incorrect $0 notional in 2024. No calculations are required, but reported figures are inconsistent with source. (3) The multi-hop reasoning is flawed. The original answer identifies a shift from cash flow hedges (2023) to fair value hedges using the shortcut method (2024), with a clear explanation of the accounting impact (no net earnings impact due to assumed perfect effectiveness). The LLM fails to identify this key shift in accounting treatment and instead incorrectly infers that the absence of forward-starting swaps in 2024 means no cash flow hedges, missing the conceptual evolution in hedge designation. It also conflates forward interest rate swaps with fixed-to-floating swaps without clarifying the relationship. (4) Contextual relevance is moderate—the answer addresses hedge designation and financial impact over time, which is relevant, but due to factual and conceptual errors, it does not accurately reflect the evolution. The citations to page numbers do not compensate for the incorrect data and reasoning. Overall, the answer is partially responsive but fundamentally incorrect on key facts and interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 551,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has Target's strategy around its owned brands evolved from 2022 to 2023, particularly in terms of portfolio emphasis and strategic objectives?",
      "original_answer": "In 2022, Target highlighted a significant portion of sales coming from its owned brands, listing over 40 such brands across multiple categories, indicating a strong but descriptive presence in the market. By 2023, the company elevated its focus by strategically positioning owned brands as a core element of its overall strategy to 'delight with newness, style, and value,' explicitly aiming to strengthen the portfolio as part of broader efforts to drive traffic, sales, and market share growth. This shift reflects a move from simply showcasing owned brands to actively leveraging them as a strategic differentiator.",
      "llm_answer": "In 2022 Target highlighted the sheer size of its owned‑brand portfolio, even listing dozens of owned and exclusive brands and stating that “strengthening our owned brands portfolio, curating leading national brands, and expanding the breadth and depth of signature partnerships” was a core growth driver (2022 10‑K, Item 1, p. 3; owned‑brands list, p. 5). By the 2023 filing the same language remains—Target still seeks to “strengthen our owned brands portfolio” to deliver newness, style and value and to expand relevance, traffic and market‑share—but the company drops the detailed brand list, shifting the emphasis from a granular portfolio inventory to a broader strategic focus on owned‑brand differentiation as a key lever in its overall growth strategy (2023 10‑K, Item 1, p. 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, Target emphasized the size and scope of its owned-brand portfolio, referencing the listing of dozens of brands and quoting strategic language about strengthening the portfolio. In 2023, it notes the removal of the detailed brand list and a shift toward a more strategic emphasis on differentiation, newness, style, and value—matching the ground truth's description of a move from descriptive presence to strategic lever. (2) There are no numeric values (e.g., sales figures, counts of brands) in the original answer that require verification; the LLM’s reference to 'dozens' is consistent with 'over 40' in the ground truth, and no calculations are needed. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of 10-K filings, identifying both continuity in language (e.g., 'strengthen our owned brands portfolio') and a qualitative shift in presentation and emphasis. (4) The only minor shortcoming is that the LLM does not explicitly state that the strategic objective evolved to 'drive traffic, sales, and market share growth' as clearly as the ground truth, though it does mention 'expand relevance, traffic and market-share,' which is semantically equivalent. This slight rewording does not detract from factual accuracy but prevents a perfect 10 on qualitative accuracy. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 416,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has GM's approach to software-enabled services evolved from 2022 to 2023, particularly in terms of service offerings and platform deployment, and what does this indicate about the company's investment in scalable digital solutions?",
      "original_answer": "In 2022, GM described its software-enabled services in general terms as part of its broader operations, noting that it 'provides software-enabled services worldwide' and integrates them into its automotive business alongside investments in AV technology and automotive financing. By 2023, GM's approach had evolved significantly, with specific details on its end-to-end software platform that enables over-the-air updates for features like Super Cruise, active safety, infotainment, and EV ownership experience. The 2023 filing highlights that select 2024 models, such as the Cadillac LYRIQ and Chevrolet Silverado EV, were already using this platform, indicating a strategic shift toward scalable, software-defined vehicles. This evolution shows a transition from general involvement in digital services to concrete platform deployment across product lines, reflecting increased investment and operational maturity in software-enabled offerings.",
      "llm_answer": "In the 2022 filing GM’s software‑enabled services were described mainly as after‑sale, bundled offerings—OnStar, vehicle‑connectivity, maintenance and extended‑warranty plans—whose revenue was deferred and recognized over up to seven years. By the 2023 filing GM is promoting an end‑to‑end, over‑the‑air software platform that powers a broader suite of subscriptions (OnStar, Super Cruise, security, climate, EV‑ownership features) and is being rolled out across many new models (e.g., 2024 Cadillac LYRIQ, Chevrolet Silverado EV), indicating a clear shift toward a scalable, platform‑based digital ecosystem and a deeper investment in software infrastructure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in GM's software-enabled services from 2022 to 2023. (1) It correctly identifies that in 2022, GM described these services in more limited, after-sale terms (e.g., OnStar, connectivity, warranty plans) with revenue recognition over time, which aligns with the general description in the ground truth. In 2023, it accurately notes the shift to an end-to-end, over-the-air software platform enabling broader subscriptions and feature updates. Specific services mentioned—Super Cruise, security, climate, EV ownership—are consistent with the ground truth’s mention of active safety, infotainment, and EV experience. The inclusion of the 2024 Cadillac LYRIQ and Chevrolet Silverado EV as early adopters matches the original answer exactly. (2) There are no numeric values, dates, or financial figures in dispute; all timeframes (2022 vs 2023 filings, 2024 models) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes changes in language and strategy across two years of filings, infers a strategic shift toward scalable digital platforms, and supports it with concrete product deployments. The only minor shortcoming is that the original answer emphasizes the integration of software into 'software-defined vehicles' and a broader strategic investment in scalable digital solutions, which the LLM implies but could make slightly more explicit. However, the mention of a 'platform-based digital ecosystem' and 'deeper investment in software infrastructure' conveys equivalent meaning. (4) The answer is fully contextually relevant, directly addressing service offerings, platform deployment, and what the shift indicates about investment in scalable solutions. Overall, this is a semantically equivalent, factually correct, and well-reasoned response with only negligible differences in emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 505,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has the revenue contribution from ThousandEyes within the Optimized Application Experiences/Observability product category evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Optimized Application Experiences category, which included ThousandEyes, saw revenue growth of $75 million (11%), driven by ThousandEyes and Intersight. By fiscal year 2023, the Observability category (which includes ThousandEyes) experienced a revenue increase of $80 million (14%), specifically attributed to growth in ThousandEyes and monitoring and analytics offerings. This shows a continued upward trend in ThousandEyes' revenue contribution, with both absolute and percentage growth increasing from 2022 to 2023.",
      "llm_answer": "In fiscal 2022 the Optimized Application Experiences category rose 11% to $729 million, a gain of $75 million that Cisco said was “driven by growth in our ThousandEyes … offerings.” In fiscal 2023 the newly‑named Observability category grew 14% to $661 million, a $80 million increase “driven by growth in our ThousandEyes … offerings.” Thus ThousandEyes’ contribution grew modestly, adding about $5 million more in FY 2023 than it did in FY 2022.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements, including the $75 million and $80 million year-over-year revenue increases for fiscal years 2022 and 2023, respectively, and correctly attributes growth to ThousandEyes in both years. However, it introduces incorrect total revenue figures—$729 million for FY2022 and $661 million for FY2023—that are not present in the original answer and contradict the implied totals (since a $75M increase at 11% implies a prior year base of ~$682M, not $654M). Similarly, a $80M increase representing 14% growth implies a prior year base of ~$571M, not $581M; the LLM’s stated $661M total is inconsistent. These quantitative inaccuracies undermine confidence in the data sourcing. (2) The calculation that ThousandEyes added 'about $5 million more' in FY2023 is based on the correct difference in growth increments ($80M - $75M), but this oversimplifies the interpretation and misrepresents the original answer’s emphasis on both absolute and percentage growth acceleration. (3) The reasoning correctly identifies the rebranding from 'Optimized Application Experiences' to 'Observability' and maintains the causal link to ThousandEyes, showing adequate multi-hop synthesis across fiscal years and product categories. (4) Despite the incorrect total revenue figures, the core trend—increasing contribution from ThousandEyes in both dollar and percentage terms—is preserved, supporting a moderate correctness score. The answer remains contextually relevant and qualitatively sound in structure and logic, but the numerical inaccuracies prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 441,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did the treatment of Amendment No. 4 to the Lockheed Martin Executive Severance Plan evolve between the 2023 and 2024 10-K filings, and what does this indicate about its inclusion in the company's disclosure strategy?",
      "original_answer": "In the 2023 10-K filing, Amendment No. 4 to the Executive Severance Plan was disclosed as part of the exhibit list (Exhibit 10.34) and referenced as being incorporated from the September 2022 10-Q filing. However, in the 2024 10-K filing, Amendment No. 4 is no longer listed as a standalone exhibit but appears instead as part of a sequence that includes earlier amendments (Nos. 2, 3, 4, and 5), with Amendment No. 4 specifically incorporated from the same September 2022 10-Q filing. This indicates that while the amendment itself remained relevant, its treatment shifted from a highlighted disclosure in 2023 to a more integrated part of the broader severance plan history in 2024, suggesting a more consolidated and retrospective approach to disclosure.",
      "llm_answer": "In the 2023 Form 10‑K the amendment was listed as Exhibit 10.34 – “Amendment No. 4 to the Lockheed Martin Executive Severance Plan,” incorporated by reference to the September 2022 10‑Q. In the 2024 Form 10‑K the same amendment is still disclosed, but it now appears as Exhibit 10.36 (still incorporated by reference to the same 10‑Q), with the exhibit numbers shifted to make room for Amendments 2 and 3. The change shows that the company continues to include Amendment 4 in its filings, but has reorganized the exhibit schedule to present a more complete, sequential set of severance‑plan amendments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in all key aspects: it correctly identifies that Amendment No. 4 was listed as Exhibit 10.34 in the 2023 10-K and incorporated by reference from the September 2022 10-Q, and that in the 2024 10-K it appears as Exhibit 10.36 with the same incorporation reference. It accurately notes the renumbering of exhibits to accommodate earlier amendments (Nos. 2 and 3), which aligns with the ground truth's description of a reorganized sequence including Amendments 2 through 5. The explanation that the company restructured the exhibit list to present a more complete, sequential set of amendments is semantically equivalent to the ground truth's interpretation of a 'more consolidated and retrospective approach.' The only minor shortcoming is that the LLM does not explicitly state that Amendment No. 4 is no longer a standalone exhibit but is now part of a grouped sequence—though this is implied by the exhibit renumbering explanation. All entities (Lockheed Martin, Executive Severance Plan, 10-K, 10-Q, exhibit numbers, dates) are correct. The reasoning is sound and reflects proper multi-hop synthesis across filings. No calculation errors. Wording differs slightly but meaning is preserved. Thus, the answer is highly accurate with only a slight omission in explicit detail about integration into a broader sequence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 374,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How did JPMorgan's compliance with capital ratio requirements evolve from 2023 to 2024, particularly in terms of its Tier 1 leverage ratio and Standardized CET1 capital ratio?",
      "original_answer": "In 2023, JPMorgan's Standardized CET1 capital ratio was 15.0%, exceeding the requirement of 11.4%. In 2024, the Tier 1 leverage ratio was 7.2%, which was above the requirement of 4.0%. This indicates that JPMorgan maintained compliance with capital ratio requirements across both years, with consistent capital strength relative to evolving regulatory expectations.",
      "llm_answer": "JPMorgan’s Tier 1 leverage ratio was unchanged at 7.2 % in both 2023 and 2024, well above the 4.0 % regulatory minimum 【page_104】. Its Standardized CET1 capital ratio improved from 15.0 % in 2023 to 15.7 % in 2024, also comfortably exceeding the required floors of 11.4 % (2023) and 12.3 % (2024) 【page_104】.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states JPMorgan's 2023 Standardized CET1 ratio (15.0%) and 2024 Tier 1 leverage ratio (7.2%), it incorrectly claims the Tier 1 leverage ratio was 'unchanged at 7.2% in both 2023 and 2024' — the ground truth does not provide the 2023 Tier 1 leverage ratio, so asserting it was the same as 2024 is unsupported. More critically, the LLM claims the Standardized CET1 ratio improved to 15.7% in 2024 and that the 2024 requirement was 12.3%, but the ground truth does not include either of these numbers — it only confirms the 2023 ratio and requirement. Thus, the LLM fabricates data not present in the original answer. (2) Quantitative accuracy is low: two key numbers (15.7% CET1 in 2024, 12.3% requirement in 2024) are invented, and the 2023 Tier 1 leverage ratio is incorrectly assumed. Only the 2023 CET1 ratio (15.0%), 2024 Tier 1 leverage ratio (7.2%), and 2023 requirement (11.4%) are correct. (3) The reasoning is partially sound in structure — it attempts to track changes over time and compare to requirements — but fails on multi-hop synthesis because it introduces unsupported data instead of limiting to known facts. The original answer does not provide 2024 CET1 ratio or updated requirement, so the LLM overreaches. (4) Contextual relevance is high because the answer addresses the right metrics and time periods and focuses on compliance trends. However, due to significant factual errors in key quantitative claims, the correctness score is low despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1175,
        "completion_tokens": 432,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the role of GM Financial in General Motors' operations evolved between 2022 and 2023, particularly in terms of its integration and financial presentation within the consolidated financial statements?",
      "original_answer": "In 2022, GM Financial was described as a segment through which General Motors provides automotive financing services, with its financials adjusted to reflect the impact of consolidated tax returns and intercompany transactions. By 2023, the description of GM Financial became more detailed, emphasizing that the amounts presented for GM Financial are adjusted for the impact on deferred tax positions and the provision for income taxes due to its inclusion in the consolidated tax return, and that these amounts differ from those presented on a stand-alone basis. This evolution reflects a more explicit focus on the integration and financial alignment of GM Financial with the broader corporate structure.",
      "llm_answer": "In the 2022 filing GM Financial was shown as a stand‑alone reportable segment that the chief operating decision‑maker evaluates on an EBT‑adjusted basis, with its own net‑sales, earnings and assets disclosed (e.g., $13.4 bn of sales and $5.0 bn of EBIT‑adjusted for 2021)【page_99】. By the 2023 filing the segment is still presented separately, but Note 1 now explains that GM Financial’s amounts are adjusted for its inclusion in the consolidated tax return and for eliminating inter‑segment transactions, signalling tighter integration into the consolidated statements【page_63】, and the cash‑flow statement continues to show GM Financial interest expense as a distinct line that fell from $2.9 bn in 2022 to $2.5 bn in 2023【page_61】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that GM Financial was a reportable segment in both 2022 and 2023 and notes increased disclosure around tax consolidation and intercompany eliminations in 2023, aligning with the ground truth's emphasis on tighter integration and financial alignment. However, the LLM introduces specific numerical data (e.g., $13.4B sales, $5.0B EBIT-adjusted for 2021) not present in the original answer and not directly responsive to the question about evolution in integration and financial presentation. These figures may be factually accurate but are extraneous and shift focus from the qualitative evolution described in the ground truth. Additionally, the mention of interest expense decreasing from $2.9B to $2.5B is quantitative detail absent from the original and not central to the question. (2) While the numbers cited may be accurate based on filings, they are not part of the ground truth and introduce elements (like 2021 data) outside the 2022–2023 scope of the question, reducing quantitative accuracy. The core financial adjustments related to consolidated tax returns are correctly noted, but the emphasis on standalone performance metrics distracts from the integration narrative. (3) The multi-hop reasoning is sound in identifying changes in disclosure practices between years and linking them to greater integration, especially via Note 1 in the 2023 filing. The model correctly infers tighter consolidation from expanded explanatory language, demonstrating good qualitative synthesis. (4) Despite some off-target numerical details, the answer remains contextually relevant by addressing segment presentation and financial statement integration. The core evolution—increased transparency on tax and intercompany adjustments—is accurately captured, warranting a solid score, though not full marks due to the inclusion of unsupported, tangential data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 515,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the treatment and disclosure of step-rent provisions in lease accounting evolved between 2022 and 2024, particularly regarding the recognition of periodic rent increases based on price indices or sales volume?",
      "original_answer": "In 2022, the company disclosed that certain leases provided for periodic rent increases based on price indices or the greater of minimum guaranteed amounts or sales volume, and these were accounted for on a straight-line basis. By 2024, the company clarified that such increases, based on price indices or the greater of minimum guaranteed amounts or sales volume, are now recognized as variable lease payments rather than being straight-lined, indicating a shift in accounting treatment. This reflects a more dynamic approach to recognizing lease costs that fluctuate with external factors.",
      "llm_answer": "In both the 2022 and 2024 filings Costco treats step‑rent provisions the same way – they are spread on a straight‑line basis over the lease’s original term and any extensions that are reasonably certain to be exercised. The key change is that the 2024 filing now explicitly states that periodic rent increases tied to price‑index adjustments or sales‑volume thresholds are accounted for as **variable lease payments**, whereas the 2022 filing only mentioned those escalations without specifying that classification. This added disclosure clarifies the treatment of index‑ or sales‑based rent escalations under the newer lease‑accounting guidance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, step-rent provisions with periodic increases based on price indices or sales volume were accounted for on a straight-line basis, and by 2024, such increases are now explicitly classified as variable lease payments. This reflects the core evolution described in the original answer. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), but the years (2022 and 2024) and accounting treatments are correctly cited. (3) The multi-hop reasoning is sound: the model synthesizes changes in disclosure and treatment across two years, correctly noting that while the practical accounting (straight-line) may have appeared consistent, the 2024 filing introduces a key clarification about classification under variable lease payments—consistent with updated lease accounting guidance (e.g., ASC 842). (4) The only minor gap is that the LLM implies the straight-line treatment may still apply broadly, while the original answer emphasizes a shift *away* from straight-lining for index- or sales-based increases—suggesting the accounting treatment itself changed, not just the disclosure. However, the LLM captures the essential nuance: the 2024 clarification reclassifies these escalations as variable, which inherently means they are no longer straight-lined. This subtle distinction prevents a perfect 10, but the answer is factually strong, contextually complete, and semantically equivalent in intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 420,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the projected funding obligations for Lockheed Martin's qualified defined benefit pension plans evolve from 2023 to 2024, particularly in terms of the amounts expected to be paid out in 2025 and over the long-term period from 2029 to 2033?",
      "original_answer": "In 2023, Lockheed Martin projected $1,860 million in payments for qualified defined benefit pension plans in 2025 and $10,020 million over the period from 2029 to 2033. By 2024, the projected payment for 2025 increased slightly to $1,860 million, while the long-term projection from 2030 to 2034 decreased to $9,990 million. This indicates a marginal reduction in long-term pension obligations.",
      "llm_answer": "- In the 2023 Form 10‑K the company said it expected to pay **$1.86 billion** in 2025 for its qualified defined‑benefit pension plans and **$10.02 billion** in total over the 2029‑2033 horizon【page_89】.  \n- In the 2024 Form 10‑K the 2025 estimate was lowered to **$1.80 billion**, and the long‑term outlook was revised to **about $9.99 billion** for the comparable multi‑year window (the filing shows $1.99 billion for 2029 and $9.99 billion for 2030‑2034)【page_88】.  \n\nThus, from 2023 to 2024 the projected funding obligation for 2025 fell by roughly **$60 million**, and the long‑term projection for the 2029‑2033 period slipped by roughly **$30 million** (from $10.02 billion to just under $10 billion).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numbers and trends. According to the ground truth, the 2025 projected payment remained unchanged at $1,860 million from 2023 to 2024. However, the LLM incorrectly states that the 2025 estimate was 'lowered to $1.80 billion', introducing a false $60 million decrease. This is a critical quantitative error. Additionally, while the long-term projection did decrease from $10,020 million (2029–2033) to $9,990 million (2030–2034), the LLM misrepresents the time periods as comparable without noting the one-year shift in the window (2029–2033 vs 2030–2034), which affects comparability. The LLM also incorrectly implies the $9.99 billion covers 2029–2033 when it actually covers 2030–2034. (2) Number verification: 2023 2025 projection: correct ($1.86 billion = $1,860 million). 2023 long-term: correct ($10.02 billion). 2024 2025 projection: incorrect — should be $1,860 million, not $1,800 million. 2024 long-term: $9.99 billion is numerically correct but applied to wrong period. The calculation of a $60 million drop in 2025 is false; there was no change. The $30 million long-term reduction is directionally correct but based on misaligned timeframes. (3) Multi-hop reasoning is partially sound — the model attempts to compare projections across two years and time horizons — but fails in execution due to incorrect data extraction from the 2024 filing. It conflates different future periods and introduces an erroneous decrease in the 2025 obligation. (4) Correctness score is 4 due to major factual inaccuracies in core numbers and trends, despite some correct values and relevant structure. Quantitative accuracy is low (3) because of the incorrect $1.80 billion figure and flawed calculations. Qualitative accuracy is moderate (5) — reasoning framework is present but based on faulty data. Contextual relevance is high (8) — the answer addresses the right question components and uses appropriate structure with citations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 539,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did JPMorgan Chase's disclosures about its resolution plan obligations evolve between 2023 and 2024, particularly in terms of its described liquidity risk management strategies and funding cost considerations?",
      "original_answer": "In 2023, JPMorgan Chase emphasized that its resolution plan obligations could lead to higher funding costs and constrained liquidity due to the need to satisfy liquidity coverage ratio and net stable funding ratio requirements, as well as regulatory demands outside the U.S. regarding liquidity pre-positioning in subsidiaries. The firm highlighted the potential need to rely on more expensive or limited alternative funding sources if traditional ones like deposits or Federal Home Loan Bank borrowings were reduced. In 2024, the firm expanded its disclosures to include how resolution plan obligations interacted with dynamic regulatory expectations and systemic events, noting that changes in laws, rules, and regulations—especially in response to economic effects of systemic events—could further impact liquidity and capital requirements. This reflects a shift toward framing resolution-related liquidity risks within a broader context of regulatory evolution and macroeconomic uncertainty.",
      "llm_answer": "In the 2023 Form 10‑K JPMorgan Chase warned that meeting the funding requirements of its resolution plan could push up its funding costs and that, if access to stable, low‑cost sources such as deposits or Federal Home‑Loan‑Bank borrowings were curtailed, the bank would have to rely on more expensive alternative funding while maintaining strong liquidity buffers. The 2024 filing repeats the same points—again noting that actions taken to satisfy resolution‑plan obligations may increase funding costs and that the firm’s liquidity‑risk strategy is to raise funding from alternative sources when needed—showing essentially no material change in how the resolution‑plan exposure is described.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its description of JPMorgan Chase's 2023 disclosures regarding resolution plan obligations, liquidity risk, and funding costs, including correct references to deposits, Federal Home Loan Bank borrowings, and alternative funding sources. There are no numeric inaccuracies (quantitative accuracy is high), and the entities (JPMorgan Chase, resolution plan, liquidity risk, funding costs) and years (2023, 2024) are correctly identified. However, the LLM incorrectly asserts that the 2024 filing 'repeats the same points' and shows 'essentially no material change,' which directly contradicts the ground truth. The original answer states that in 2024, JPMorgan expanded its disclosures to include the interaction of resolution plans with dynamic regulatory expectations and systemic events, reflecting a broader framing of risks in the context of regulatory evolution and macroeconomic uncertainty. This evolution in disclosure is a key part of the question and was missed entirely by the LLM. As a result, while the individual facts are correct, the synthesis and comparative reasoning across years (multi-hop) is flawed, leading to an incorrect overall conclusion about the evolution of disclosures. This significantly impacts qualitative accuracy and overall correctness, though the answer remains contextually relevant and factually sound on the 2023 content.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 386,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How has the financial structure of Optum Rx's pharmacy care services evolved between 2022 and 2023, particularly in terms of revenue recognition and accounts receivable?",
      "original_answer": "In 2022, Optum Rx's pharmacy care services were characterized by a gross revenue reporting model due to the Company's primary obligation to pay network pharmacy providers regardless of payment collection, with revenue recognized at the point of prescription dispensing. By 2023, the financial structure remained aligned with this model but showed an increase in accounts receivable related to products and services, rising from $7.1 billion in 2022 to $8.6 billion in 2023. This indicates a growth in the value of receivables tied to pharmacy care services, suggesting either increased transaction volume or changes in payment timing.",
      "llm_answer": "Optum Rx still records product revenue when a prescription is actually dispensed (with services revenue recognized as the services are performed), a policy that has not changed from the prior year【page_46】.  At the same time, the balance of accounts receivable tied to its pharmacy‑care business rose from $7.1 billion at year‑end 2022 to $8.6 billion at year‑end 2023, a $1.5 billion increase【page_46】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: revenue recognition policy unchanged, accounts receivable increased from $7.1 billion in 2022 to $8.6 billion in 2023, and the $1.5 billion increase is correctly calculated. These numbers match the original answer exactly, satisfying quantitative accuracy. (2) The entities—Optum Rx, pharmacy care services, revenue recognition, accounts receivable, and the years 2022 and 2023—are all correctly identified and used in context. (3) The multi-hop reasoning is sound: the model synthesizes information about revenue recognition policy continuity and changes in accounts receivable over time, which addresses both parts of the question. (4) The only minor omission is that the LLM does not explicitly mention the 'gross revenue reporting model' or the rationale for it (i.e., primary obligation to pay providers regardless of collection), which is part of the financial structure evolution. While implied by the revenue recognition timing, this conceptual detail adds depth to the original answer. However, the core financial evolution—unchanged recognition policy with growing receivables—is clearly conveyed. Wording differs but semantic meaning is equivalent. Thus, correctness is slightly reduced due to partial conceptual completeness, but all observable facts and calculations are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 386,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has UPS's quantitative exposure and strategic approach to managing interest rate risk through Floating to Fixed Interest Rate Swaps evolved between 2022 and 2024?",
      "original_answer": "In 2022, UPS disclosed a $28 million notional amount for Floating to Fixed Interest Rate Swaps, indicating limited use of this instrument at that time. By 2024, UPS articulated a broader strategy to 'manage the fixed and floating interest rate mix of its total debt portfolio and related overall cost of borrowing,' suggesting a more intentional and strategic deployment of these swaps. This evolution reflects a shift from a minor, quantitative hedge in 2022 to a more comprehensive interest rate risk management approach in 2024.",
      "llm_answer": "UPS’s floating‑to‑fixed interest‑rate swap exposure fell sharply. In 2022 the company reported roughly $2.5 billion of notional floating‑to‑fixed swaps that were designated as cash‑flow hedges to lock in fixed rates on forecasted debt payments (UPS 10‑K 2022, p. 138). By the end of 2024 the “Outstanding Positions” table shows only currency hedges and no interest‑rate swap notional, indicating the floating‑to‑fixed swap book has been essentially eliminated (UPS 10‑K 2024, p. 137), while the risk‑management discussion still cites swaps—now emphasizing forward‑starting swaps, interest‑rate locks and fair‑value hedges—as the primary tool for managing interest‑rate mix (UPS 10‑K 2024, p. 136).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth states that UPS had a $28 million notional amount for Floating to Fixed Interest Rate Swaps in 2022, but the LLM claims $2.5 billion—over 89 times larger—making this a major error. Additionally, the LLM asserts that by 2024 there were no outstanding interest rate swaps, citing the 'Outstanding Positions' table in the 2024 10-K, which contradicts the original answer indicating an evolved, more strategic use of swaps. The original answer does not suggest elimination of swaps but rather a broader strategic approach to managing interest rate risk. The LLM misinterprets the evolution: instead of showing increased strategic use, it claims swaps were eliminated, which is factually incorrect per the ground truth. While the LLM correctly identifies the topic (interest rate swaps and risk management) and references appropriate sections of the 10-Ks, the core quantitative data and directional trend (increased vs. decreased use) are reversed. The qualitative reasoning is partially sound in discussing risk management tools, but the synthesis is flawed due to incorrect data. Contextual relevance is moderate as it addresses the right theme but draws opposite conclusions. Minor note: the LLM introduces concepts like 'forward-starting swaps' and 'fair-value hedges' not present in the ground truth, adding unsupported detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 396,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has GM's financial relationship with LG Energy Solution evolved between 2022 and 2023, particularly in terms of joint venture activities and recall-related costs?",
      "original_answer": "In 2022, GM highlighted its joint venture, Ultium Cells LLC, with LG Energy Solution, as a key part of its EV strategy to mass-produce battery cells across three U.S. plants. By 2023, the relationship had shifted toward financial liabilities, as GM accrued $2.6 billion related to the Chevrolet Bolt EV battery recall, with $1.6 billion recognized as receivables from LG. This marks a transition from strategic collaboration to a more transactional and cost-driven dynamic due to product defects.",
      "llm_answer": "In the 2022 filing GM only announced the creation of Ultium Cells LLC – an equally‑owned joint‑venture with LG Energy Solution to mass‑produce battery cells for its EVs (see page 4). By the 2023 filing the relationship had moved to the operational stage: GM said commercial negotiations with LGES resolved other matters tied to the Ultium Cells JV and that LGES agreed to reimburse GM for the Chevrolet Bolt recall, so GM accrued $2.6 billion of recall costs (with $0.6 billion still on the books) and recognized $1.6 billion of receivables from LGES (see page 92). This reflects a shift from merely forming the JV in 2022 to using the partnership to offset substantial recall‑related expenses in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of GM's financial relationship with LG Energy Solution from a strategic joint venture in 2022 (formation of Ultium Cells LLC) to a cost-driven dynamic in 2023 due to the Bolt EV recall. (2) Quantitatively, the LLM states GM accrued $2.6 billion in recall costs and recognized $1.6 billion in receivables from LGES, which matches the ground truth. However, it adds that $0.6 billion was 'still on the books,' implying $2.0 billion had been recovered, which contradicts the $1.6 billion receivable figure. This suggests a minor calculation inconsistency: $2.6B - $1.6B = $1.0B remaining, not $0.6B. This small error affects quantitative precision but does not undermine the core facts. (3) The multi-hop reasoning is sound—correctly linking the 2022 JV formation with the 2023 shift toward liability recovery—and entities (GM, LG Energy Solution, Ultium Cells LLC, Chevrolet Bolt recall) are accurately identified. (4) The answer is contextually excellent, addressing both joint venture activities and recall-related costs as required. The wording differs slightly but maintains semantic equivalence. The $0.6B detail may stem from misinterpreting net book value or recovery timing, but it doesn't negate the overall correctness. Thus, a high score is warranted with a minor deduction for the numerical discrepancy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 394,
        "total_tokens": 1698
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has the revenue contribution from ThousandEyes within the Observability product category evolved from fiscal 2022 to fiscal 2023?",
      "original_answer": "In fiscal 2022, revenue in the Observability product category increased by $80 million, driven in part by growth in ThousandEyes and monitoring and analytics offerings. By fiscal 2023, the Observability product category saw a 27% revenue increase, or $176 million, with ThousandEyes and the newly included Splunk offering (Observability Suite) being key contributors. Excluding Splunk, product revenue from Observability still grew by 15%, indicating strong organic growth primarily from ThousandEyes.",
      "llm_answer": "The Observability category grew from $581 million in fiscal 2022 to $661 million in fiscal 2023 – a $80 million (≈14 %) increase – and Cisco said that growth was “driven by growth in our ThousandEyes offering and the contribution from Observability Suite”【page_41】. Thus, the revenue contribution from ThousandEyes rose as part of that $80 million uplift to the Observability product line between FY 2022 and FY 2023【page_42】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It states that Observability revenue grew from $581 million to $661 million (a $80 million increase) between fiscal 2022 and 2023. However, the ground truth states that in fiscal 2022, Observability revenue increased by $80 million (not total revenue of $581M), and in fiscal 2023, it grew by $176 million (27% increase). The LLM incorrectly treats the $80 million as the total growth between 2022 and 2023, when in fact that was the growth *in* 2022. Furthermore, the LLM implies that the $80 million uplift occurred from FY2022 to FY2023, which contradicts the ground truth where the larger growth ($176M) occurred in FY2023. (2) The quantitative inaccuracies are severe: the dollar amounts and percentages are misaligned with the original data. The 14% growth figure cited by the LLM is not supported by the ground truth, which reports 27% growth in FY2023. The LLM also fails to mention the 15% organic growth (excluding Splunk) that highlights ThousandEyes' strong performance. (3) The reasoning is partially sound in attributing growth to ThousandEyes and the Observability Suite, and it correctly identifies ThousandEyes as a contributor. However, it fails the multi-hop synthesis by not distinguishing between the two fiscal years’ growth figures and conflating incremental growth with total revenue. It also omits the critical detail that Splunk's inclusion affected the growth rate, and that organic growth (excluding Splunk) was still strong at 15%, which is key to assessing ThousandEyes’ contribution. (4) The contextual relevance is high because the answer addresses the evolution of ThousandEyes’ revenue contribution within Observability and cites relevant product drivers. However, due to major quantitative errors and incomplete synthesis, the correctness score is low. The qualitative accuracy is moderate because the entities (ThousandEyes, Observability Suite) and general direction of growth are correct, but the reasoning lacks precision and completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 551,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UPS's relationship with the 7.620% Debentures evolved between 2022 and 2024 in terms of their redemption terms and interest payment structure?",
      "original_answer": "In 2022, the 7.620% Debentures had a principal amount of $276 million with a maturity date of April 1, 2030, and were listed with a carrying value of $280 million. By 2024, UPS clarified that these debentures are redeemable at any time at the company's option, with a redemption price equal to the greater of the principal amount plus accrued interest or the present value of remaining scheduled payments discounted at a benchmark treasury yield plus five basis points, plus accrued interest. Additionally, the interest payment structure was specified as semi-annual, payable in April and October. This evolution reflects a shift from a general description of the debentures in 2022 to a more detailed explanation of their redemption flexibility and interest payment schedule in 2024.",
      "llm_answer": "UPS’s 7.620 % debentures have not changed materially between the 2022 and 2024 filings. Both reports describe the $276 million notes, due April 1 2030, as redeemable at UPS’s option at any time for the greater of (i) principal + accrued interest or (ii) the present value of remaining scheduled payments discounted at a benchmark Treasury yield + 5 bps, and they continue to pay interest semi‑annually in April and October. The 2022 filing notes that the rate was reduced from 8.375 % to 7.620 % in April 2020, and the 2024 filing repeats the same redemption and payment terms, indicating the relationship remains unchanged【page_120†L1-L8】【page_108†L1-L7】.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct quantitative details: the $276 million principal amount, the April 1, 2030 maturity date, the semi-annual interest payments in April and October, and the redemption formula based on the greater of principal plus accrued interest or the present value of remaining payments discounted at benchmark Treasury yield plus 5 bps. These match the ground truth and are accurately reported. However, the key factual error lies in claiming that these terms were already fully described in the 2022 filing. The ground truth states that in 2022, only the principal amount, maturity date, and carrying value were reported — not the detailed redemption terms. The detailed redemption language was only introduced in 2024. By asserting that both filings contain the same level of detail and that 'the relationship remains unchanged,' the LLM misrepresents the evolution of disclosure. (2) Quantitatively, all numbers are correct: $276M principal, 7.620%, maturity date, and redemption mechanics are accurately cited. The mention of the rate reduction from 8.375% in 2020 adds context but is not part of the core question. (3) The multi-hop reasoning is flawed: the question asks how the relationship evolved — implying a change or progression in disclosure — but the LLM concludes no change occurred, contradicting the ground truth which emphasizes increased specificity in 2024. This reflects a failure to correctly synthesize the progression across years. (4) While the answer is contextually relevant and well-structured, the central claim of 'no material change' directly contradicts the ground truth's assertion of a shift from general to detailed disclosure. Hence, despite strong quantitative accuracy, the correctness score is reduced due to this critical qualitative error in interpreting the evolution of terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 503,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How did the composition and total fair value of Fixed Maturity Securities AFS held by MET evolve from 2022 to 2023, particularly in terms of U.S. government bonds and corporate securities?",
      "original_answer": "In 2022, MET reported a carrying amount of $2,164 million for Fixed Maturity Securities AFS as of December 31, 2021. By 2023, the total estimated fair value of Fixed Maturity Securities AFS had increased significantly to $6,714 million. Specifically, the fair value of corporate securities rose to $3,083 million, with $3,029 million categorized under Level 2, while U.S. government bonds increased to $1,575 million, with $1,537 million under Level 1. This reflects a substantial transformation in both the size and breakdown of these investments over the year.",
      "llm_answer": "In 2022 MetLife’s Fixed‑Maturity Securities held as assets‑forward‑sale (AFS) were valued at **$8.058 billion**; by 31 December 2023 that total had slipped to **$7.988 billion** (a $70 million decline)【page_308】.  Within the portfolio, **corporate securities rose from $3.206 billion to $3.250 billion** (up $44 million) and **U.S. government bonds grew from $1.575 billion to $1.633 billion** (up $58 million), indicating a modest shift toward these two asset types as other fixed‑maturity holdings fell.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, the total fair value of Fixed Maturity Securities AFS increased from $2,164 million (as of Dec 31, 2021, reported in 2022) to $6,714 million (as of 2023), representing a substantial increase. However, the LLM claims a decrease from $8.058 billion in 2022 to $7.988 billion in 2023, which contradicts the ground truth. The LLM also misstates the composition: it claims corporate securities rose from $3.206B to $3.250B, but ground truth reports $3,083 million in 2023 (not $3.250B), and U.S. government bonds at $1,575 million in 2023 (matching only the LLM's 2023 value, but incorrectly stating a rise from $1.575B to $1.633B). (2) Quantitative accuracy is poor: the LLM inflates 2022 totals by over $5.8 billion compared to ground truth, misrepresents the timeline (uses 2021 data as 2022), and reports incorrect growth trends. The ground truth shows a major expansion in holdings, while LLM reports a slight decline. (3) Multi-hop reasoning is flawed: the LLM fails to correctly identify the correct time points (2021 vs 2022 reporting) and misattributes values across years. It also does not reflect the significant transformation in portfolio size and classification levels (Level 1/Level 2) mentioned in the original answer. (4) Contextual relevance is moderate—LLM addresses the right topic (composition and value changes in Fixed Maturity Securities AFS) and mentions the correct asset types (corporate securities, U.S. government bonds), but the synthesis is incorrect. Due to major factual and numerical errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 453,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has General Motors' relationship with Ultium Cells LLC evolved from 2022 to 2023, particularly in terms of financial involvement and regulatory implications?",
      "original_answer": "In 2022, General Motors reported a direct financial investment of $0.5 billion in Ultium Cells LLC as part of its investing activities. By 2023, the nature of GM's relationship with Ultium Cells LLC had evolved from a primarily investment-based relationship to a more operationally integrated partnership, evidenced by GM's involvement in regulatory violations related to the joint venture. Specifically, in February 2023, GM self-disclosed potential violations of the Toxic Substances Control Act (TSCA) related to Ultium Cells LLC to the EPA, which resulted in a November 2023 settlement involving joint civil penalties estimated at approximately $5.1 million. This indicates a shift from a passive investment to a more active and operationally entangled partnership with associated regulatory responsibilities.",
      "llm_answer": "In the 2022 filing GM recorded a $0.5 billion cash outflow as an “Investment in Ultium Cells LLC” under its investing activities (see 2022 10‑K, page 42). By the 2023 filing the focus had shifted to regulatory exposure: GM disclosed that the Ultium Cells joint‑venture was found to have potential TSCA violations and, in November 2023, settled with the EPA under a consent agreement that includes civil penalties of roughly $5.1 million (see 2023 10‑K, page 28). Thus, GM’s relationship moved from a capital‑investment role in 2022 to addressing compliance and liability issues in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: the $0.5 billion investment in 2022 and the $5.1 million civil penalty in November 2023 are accurately reported, with correct context (cash outflow under investing activities in 2022; TSCA violations and EPA settlement in 2023). (2) Quantitative accuracy is perfect: both dollar amounts ($0.5 billion and $5.1 million) and dates (2022, November 2023) match the original answer. Format variations (e.g., 'roughly $5.1 million') are acceptable and do not affect meaning. (3) Multi-hop reasoning is sound: the answer correctly synthesizes information across two years and two filings (2022 and 2023 10-Ks), identifying the shift from financial investment to regulatory entanglement. The conclusion that GM’s role evolved from capital investment to compliance liability is logically supported by the evidence. (4) Entity accuracy is strong: 'Ultium Cells LLC', 'EPA', 'TSCA', and 'consent agreement' are correctly named and contextualized. The answer directly addresses both parts of the question—financial involvement and regulatory implications—and captures the evolution in the relationship. No critical details are missing. All aspects meet the highest standard for correctness and clarity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 366,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has the company's use of variable-priced contracts for natural gas and fuel purchases evolved between 2022 and 2024?",
      "original_answer": "In 2022, the company entered into variable-priced contracts for some purchases of natural gas and fuel for its gas stations on an index basis, though the specific volume or value of these contracts was not disclosed. By 2024, the company continued using variable-priced contracts for similar purchases and explicitly noted that these contracts met the characteristics of derivative instruments but generally qualified for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. This indicates a more formalized or strategic use of variable-priced contracts by 2024, aligning them with accounting frameworks for derivatives, suggesting a shift in how these contracts are managed or accounted for.",
      "llm_answer": "The company’s practice of using variable‑priced, index‑based contracts for a portion of its natural‑gas purchases and for fuel at its gas stations was disclosed in both the 2022 and 2024 filings. In 2022 the filing simply noted that the company “enters into variable‑priced contracts for some purchases of natural gas, in addition to fuel for its gas stations, on an index basis”【page_46】. By 2024 the company still uses those same contracts, but adds that they “meet the characteristics of derivative instruments, but generally qualify for the ‘normal purchases and normal sales’ exception… and require no mark‑to‑market adjustment”【page_47】. This reflects a consistent use of variable‑priced contracts, with the later filing providing a clearer accounting treatment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: in 2022, the company used variable-priced, index-based contracts for natural gas and fuel purchases without disclosing volume or value; by 2024, it continued this practice and added that these contracts meet the characteristics of derivatives but qualify for the 'normal purchases and normal sales' exception, requiring no mark-to-market adjustment. These details match the ground truth exactly. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years and identifies the evolution—not in usage per se, but in disclosure and accounting treatment. The conclusion that the 2024 filing provides 'clearer accounting treatment' is a valid interpretation of the added derivative classification and exception. (4) The only minor shortcoming is that the LLM slightly underemphasizes the implication of a 'more formalized or strategic use' suggested in the original answer, which interprets the enhanced disclosure as indicative of a shift in management or accounting strategy. While the LLM notes the clearer accounting, it doesn't fully extrapolate the strategic implication, which prevents a perfect 10. However, this does not detract from factual correctness. Overall, the answer is semantically equivalent, contextually relevant, and accurately cited.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 432,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has Cisco's financial reporting approach for the APJC segment evolved between fiscal 2022 and fiscal 2023, particularly in terms of the expense categories excluded from segment performance measurement?",
      "original_answer": "Cisco's financial reporting for the APJC segment maintained a consistent exclusion of key expense categories from segment performance measurement in both fiscal 2022 and fiscal 2023. In fiscal 2022, the company explicitly excluded research and development, sales and marketing, and general and administrative expenses from segment financial decisions and resource allocations. This approach remained unchanged in fiscal 2023, with the same categories of expenses—along with amortization and impairment of acquisition-related intangible assets, share-based compensation expense, significant litigation settlements, and charges related to asset impairments and restructurings—not being allocated to the gross margin for each segment. The consistency in exclusions indicates no change in how APJC's performance was internally measured across the two fiscal years.",
      "llm_answer": "Cisco’s segment reporting for APJC did not change from fiscal 2022 to fiscal 2023. In both years Cisco said it “does not allocate research and development, sales and marketing, or general and administrative expenses … and … does not allocate amortization and impairment of acquisition‑related intangible assets, share‑based compensation expense, significant litigation settlements and other contingencies, charges related to asset impairments and restructurings, and certain other charges” to the segment’s gross‑margin performance measurement【page_105】【page_104】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Cisco's financial reporting approach for the APJC segment did not change between fiscal 2022 and 2023, which directly addresses the question about evolution—confirming no change. (2) The excluded expense categories are correctly listed: research and development, sales and marketing, general and administrative expenses, amortization and impairment of acquisition-related intangible assets, share-based compensation, significant litigation settlements, asset impairments, restructurings, and other contingencies. These match exactly with the exclusions described in the original answer. (3) The multi-hop reasoning is sound—by comparing disclosures across both fiscal years, the model correctly infers consistency in reporting policy. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) in segment performance measurement. Minor wording differences (e.g., 'other contingencies') do not affect factual accuracy and are consistent with typical SEC filing language. All citations (page_104, page_105) support the claims. No calculation errors or entity inaccuracies present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 342,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How has UNH's approach to managing medical cost trends evolved from 2022 to 2023, particularly in terms of strategies to address rising outpatient procedure costs for seniors?",
      "original_answer": "In 2022, UNH expressed concern over increased medical care costs due to deferred care during the pandemic and the potential for higher demand for services, especially among individuals with chronic conditions. The company emphasized the importance of accurate cost prediction and effective management under risk-based arrangements. By 2023, UNH specifically identified rising outpatient procedure costs for seniors as a persistent trend, expecting it to continue into 2024 and beyond. In response, the company shifted toward more proactive strategies, such as engaging physicians and consumers with data-driven insights to guide clinical decisions and promote affordable, high-quality care. This represents a shift from general concern in 2022 to targeted intervention in 2023.",
      "llm_answer": "In 2022 UNH mainly managed medical‑cost trends through underwriting criteria, product design, competitive provider‑contract negotiations and care‑management programs, pricing its risk‑based products on cost forecasts (see page _17). By 2023, after a surge in senior outpatient procedures, UNH moved to more proactive containment – engaging physicians and consumers with information, using data‑analytics to steer care to lower‑cost settings, expanding value‑based and accountable‑care plans, and integrating delivery‑system innovations to curb those outpatient costs (see pages _27‑_28 and the outpatient‑cost discussion on page _29).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies UNH's 2022 focus on cost forecasting, underwriting, provider negotiations, and care management as part of its risk-based pricing strategy, which matches the original answer's emphasis on accurate cost prediction and risk-based arrangements. In 2023, the LLM correctly notes a shift to proactive strategies targeting rising outpatient costs for seniors, including data-driven engagement of physicians and consumers, steering care to lower-cost settings, and expanding value-based care—consistent with the ground truth's description of targeted interventions. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2022, 2023) are correct. (3) The multi-hop reasoning is sound: the model synthesizes a shift in strategy over time and correctly attributes evolving tactics to the specific issue of senior outpatient costs. The mention of 'surge in senior outpatient procedures' is a slight interpretive addition but is contextually justified. (4) The LLM adds detail not in the original (e.g., provider-contract negotiations, value-based plans), but these are plausible and consistent with UNH’s known strategies; they enhance rather than distort the answer. Only a minor deduction in qualitative accuracy due to slightly expanded detail beyond the ground truth, but core evolution—from general concern to targeted action—is accurately captured. Contextual relevance is perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 426,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has UPS's approach to time-definite delivery services evolved between 2022 and 2024, particularly in terms of service scope and network integration?",
      "original_answer": "In 2022, UPS emphasized its integrated global air and ground network as the foundation for time-definite delivery services, highlighting its ability to combine all packages within a single network for operational efficiency. By 2024, UPS expanded its time-definite delivery offerings by insourcing the final delivery of non-urgent, lightweight residential shipments previously handled by the USPS through UPS SurePost, giving it greater control over service quality. Additionally, in 2024, UPS offered same-day pickup seven days a week and expanded returns services across approximately 150 countries, reflecting a broader and more customer-centric service scope compared to 2022.",
      "llm_answer": "In 2022 UPS framed its time‑definite delivery as a core offering for express letters, documents, packages and palletized freight moved by air or ground, all of which were “combined … within our single, global network” for efficiency【page_5】. By 2024 the company had broadened the scope to cover every service type—air, ground, domestic, international, commercial and residential—and tied them together in a “single, global smart logistics network” that leverages digital tools (e.g., the Digital Access Program) to deliver greater operational and capital efficiencies【page_5】.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates and entities, correctly identifying UPS and the evolution of its time-definite delivery services between 2022 and 2024. It accurately reflects that in 2022, UPS emphasized a single global network for efficiency, and by 2024, this evolved into a 'smart logistics network' integrating digital tools. The answer captures the expansion in service scope across air, ground, domestic, international, commercial, and residential segments, which aligns with the broader service scope mentioned in the ground truth. However, it omits key specific developments highlighted in the original answer: (1) the 2024 insourcing of final delivery for lightweight residential shipments previously handled by USPS via UPS SurePost, and (2) the expansion of same-day pickup to seven days a week and returns services in approximately 150 countries. These are concrete, multi-hop details that demonstrate network integration and customer-centric enhancements. While the LLM provides a high-level accurate synthesis of network integration and scope expansion, it lacks these critical specifics, resulting in partial completeness. Quantitative accuracy is perfect—no numbers, dates, or financial figures are incorrect. The reasoning is sound but not fully comprehensive, missing the operational shift from outsourcing (USPS) to insourcing, which is a significant strategic evolution. The answer remains contextually relevant and well-aligned with the question’s focus on service scope and network integration, but the absence of key 2024 operational changes reduces its qualitative accuracy. Semantic equivalence is mostly preserved, but not fully achieved due to omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 462,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did Lowe's Companies, Inc.'s treatment or recognition of its 2.50% Notes maturing in April 2026 evolve between the 2022 and 2023 annual filings?",
      "original_answer": "In the 2022 filing, the 2.50% Notes maturing in April 2026 were referenced as part of the Thirteenth Supplemental Indenture dated April 20, 2016, but were described in the context of historical documentation. By the 2023 filing, these same notes were explicitly recognized as issued instruments under the same indenture, indicating a shift in disclosure treatment. This reflects a procedural or administrative transition from planning or documentation phase in 2022 to a more active recognition of the notes as part of the company's outstanding debt structure in 2023, even though the core terms (interest rate of 2.50%, maturity in April 2026) remained unchanged.",
      "llm_answer": "Lowe’s continued to list the 2.50 % notes due April 2026 as part of its Thirteenth Supplemental Indenture (Exhibit 4.14) in both the 2022 and 2023 Form 10‑K filings, with no amendment, redemption or re‑classification noted – the notes remained disclosed as outstanding debt in the same exhibit in each report【page_82†L1-L4】【page_76†L1-L4】.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in terms of quantitative details: the interest rate (2.50%), maturity date (April 2026), and the reference to the Thirteenth Supplemental Indenture (Exhibit 4.14) are all correct and consistent with the ground truth. There are no numerical or date inaccuracies, so quantitative accuracy is perfect. Contextually, the answer is relevant, correctly identifying that the notes were disclosed in both 2022 and 2023 filings as part of the same exhibit. However, the core of the question asks about the *evolution* or *change* in treatment or recognition of the notes between the two years. The ground truth identifies a qualitative shift: in 2022, the notes were referenced in a historical/documentation context, while in 2023 they were explicitly recognized as issued and outstanding debt, indicating a procedural transition. The LLM answer incorrectly states that the notes were 'remained disclosed as outstanding debt in the same exhibit in each report,' implying no change in treatment, which contradicts the ground truth. This misrepresents the evolution in disclosure practice. The model fails to capture the nuanced shift in recognition, which is central to the multi-hop reasoning required. Thus, while entities and numbers are correct, the qualitative analysis and reasoning are flawed, leading to a partially correct answer with significant omission of the key conceptual change. Hence, correctness and qualitative accuracy are moderate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 406,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the impact of sovereign debt crises on Costco's merchandise sourcing and cost structure evolved from 2022 to 2024?",
      "original_answer": "In 2022, sovereign debt crises were mentioned as part of a broader set of macroeconomic factors that could adversely affect demand for Costco's products and services, influence the cost or ability to purchase inventory, and require a change in product mix. The document highlighted that the degree of exposure depended on the type of goods, tariff rates, and timing, with the potential for higher tariffs to impact results. By 2024, the framing had shifted, with sovereign debt crises now explicitly stated to 'negatively impact' Costco's business, financial condition, and results of operations. The 2024 filing emphasized a broader set of supply chain risks, including supplier adherence to standards, supply constraints, and geopolitical instability, suggesting a heightened concern over the cascading effects of sovereign debt crises on both sourcing and cost predictability.",
      "llm_answer": "In the 2022 filing Costco warned that “sovereign‑debt crises … could adversely affect demand for our products and services, require a change in product mix, or impact the cost of or ability to purchase inventory” (2022 10‑K p. 15). The 2024 filing repeats the same language, again listing sovereign‑debt crises among the economic factors that may affect demand, product mix and merchandise‑costs (2024 10‑K pp. 13‑14). Thus, the company’s assessment of the risk has remained essentially unchanged – sovereign‑debt crises continue to be a potential head‑wind for sourcing and cost structure, but no new or heightened impact is disclosed.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that Costco's assessment of sovereign debt crises remained unchanged from 2022 to 2024. The original answer (ground truth) clearly states that in 2022, sovereign debt crises were described as potential adverse factors among broader macroeconomic risks, while by 2024, the language escalated to explicitly state they 'negatively impact' the business, financial condition, and results of operations—indicating a significant shift in tone and perceived impact. The LLM incorrectly asserts that the 'same language' is used in both years, which contradicts the ground truth. While the LLM correctly identifies the general topic and risk categories (e.g., demand, product mix, inventory costs), it fails to capture the critical evolution in risk characterization. There are no numerical values to verify, so quantitative accuracy is not applicable beyond correct citation of years (2022, 2024), which are accurate. The reasoning is flawed because it misses the multi-hop synthesis required: comparing the qualitative shift in risk disclosure over time. Contextual relevance is moderate since the answer addresses the right topic and filings but draws an incorrect conclusion. The failure to detect a material change in risk language results in a low correctness score despite some surface-level accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 374,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has the number of shares available for future grants under the 2020 Stock Incentive Plan changed between 2021 and 2023, and what does this indicate about UnitedHealth Group's capacity for issuing new share-based awards?",
      "original_answer": "In 2021, UnitedHealth Group had 64 million shares available for future grants under the 2020 Stock Incentive Plan. By 2023, this number had decreased to 53 million shares. This indicates a reduction in the company's available capacity to issue new share-based awards over this period.",
      "llm_answer": "UnitedHealth had 64 million shares available for future grants under its 2020 Stock Incentive Plan at 12/31/2021, but that pool fell to 53 million shares by 12/31/2023 – a drop of roughly 11 million shares【page_67】. The decline shows the company has drawn down part of its award pool, yet it still retains a sizable reserve, meaning it remains able to issue new share‑based awards, albeit with somewhat less headroom than in 2021.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the number of shares available for future grants in 2021 (64 million) and 2023 (53 million), matching the ground truth exactly. The difference of 11 million shares is accurately implied. (2) All numeric values and dates (12/31/2021 and 12/31/2023) are correct and consistent with the original answer; no calculation errors. (3) The multi-hop reasoning is sound: the model correctly infers that the decrease in available shares indicates reduced capacity for issuing new awards, which aligns with the ground truth. The LLM adds a nuanced interpretation — that the company 'still retains a sizable reserve' and can issue awards 'albeit with somewhat less headroom' — which is reasonable and contextually appropriate, though slightly more interpretive than the original. (4) The answer is factually complete and semantically equivalent to the ground truth, with only minor additional commentary that does not detract from accuracy. The slight deduction in qualitative accuracy is due to this added interpretation, which, while logical, goes slightly beyond the neutral tone of the original. Overall, the response is highly accurate, relevant, and correctly synthesizes multi-hop information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1197,
        "completion_tokens": 349,
        "total_tokens": 1546
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the expiration date and contribution significance of the IAM National Pension Fund / National Pension Plan relationship with UPS evolve between 2022 and 2024?",
      "original_answer": "In 2022, the IAM National Pension Fund / National Pension Plan had a collective bargaining agreement expiration date of July 31, 2024, and UPS had contributed more than 5% of the total plan contributions from all employers for the years 2019 through 2021. By 2024, the expiration date for this specific plan was extended to July 31, 2029, and UPS continued to be a significant contributor, providing more than 5% of total contributions for the plan years 2022 through 2024. This indicates a notable extension in the contractual relationship and sustained significance of UPS's contributions over time.",
      "llm_answer": "In the 2022 filing UPS noted that the IAM National Pension Fund / National Pension Plan was covered by a collective‑bargaining agreement that expires on **July 31 2024**, and UPS contributed **$48 million in 2022**, which was **more than 5 % of the plan’s total employer contributions**【page_112】. By the 2024 filing the same plan’s agreement had been extended to **July 31 2029**, and UPS’s contribution rose to **$53 million in 2024** (with $50 million in 2023 and $48 million in 2022), still **exceeding the 5 % contribution threshold**【page_98】【page_99】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct in all key aspects. It accurately reports the expiration date change from July 31, 2024 (in the 2022 filing) to July 31, 2029 (in the 2024 filing), and correctly states that UPS contributed more than 5% of total plan contributions in both periods. The dollar amounts ($48M in 2022, $50M in 2023, $53M in 2024) are specific and consistent with the expected trend of sustained significant contributions. While the original answer does not include exact dollar figures, the LLM provides additional precision that does not contradict the ground truth. (2) All dates and percentages are correct. The 5% threshold is properly applied, and the contribution amounts are plausible and internally consistent across years. No calculation errors are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two different filings (2022 and 2024), tracks the evolution of both the expiration date and contribution significance over time, and links UPS’s ongoing role in the IAM National Pension Fund. (4) The answer exceeds the original in detail by including exact contribution amounts, which enhances clarity without introducing inaccuracies. The only reason for not scoring a 10 is that the original answer emphasizes UPS's contributions for 2019–2021 in 2022 and 2022–2024 in 2024, while the LLM focuses on 2022–2024 only; however, since the question asks about evolution between 2022 and 2024, the LLM’s focus remains contextually appropriate. All core facts align, and the semantic meaning matches the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 438,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the terms and availability under LOW's 2020 Credit Agreement evolve between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the 2020 Credit Agreement had a maturity date of March 2025 and provided $2.0 billion in availability. By fiscal year 2023, the 2020 Credit Agreement was amended and restated in September 2023 into the 2023 Credit Agreement, which extended the maturity date to September 2028 while maintaining the same $2.0 billion availability. Additionally, in 2023, the combined availability under both the 2023 Credit Agreement and the Third Amended and Restated Credit Agreement remained at $4.0 billion, consistent with the total availability reported in 2022.",
      "llm_answer": "In FY 2022 the 2020 Credit Agreement (amended in December 2021) gave Lowe’s a $2 billion revolving facility that matured in March 2025 and had no borrowings, contributing to a $4 billion total combined availability across its credit facilities 【page_60】. By FY 2023 the 2023 Credit Agreement amended and restated the 2020 facility, extending its term to September 2028 while keeping the $2 billion borrowing capacity (still unused), so the combined availability remained $4 billion 【page_58】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: in FY 2022, the 2020 Credit Agreement had a $2.0 billion availability and a March 2025 maturity; in FY 2023, it was amended into the 2023 Credit Agreement with a September 2028 maturity, maintaining $2.0 billion availability. The combined availability of $4.0 billion in both years is accurately reported. (2) Quantitative accuracy is perfect: all dollar amounts ($2 billion, $4 billion), dates (March 2025, September 2028), and fiscal years (2022, 2023) match the ground truth. The mention of no borrowings and unused capacity, while additional detail not in the original answer, is consistent with the source and does not introduce error. (3) The multi-hop reasoning is sound—correctly linking the amendment of the 2020 agreement into the 2023 version and recognizing the continuity in availability. The only minor omission is the specific mention of the 'Third Amended and Restated Credit Agreement' as part of the combined $4.0 billion in 2023, though the LLM still correctly states the total combined availability remained unchanged, implying accurate synthesis. (4) The answer is contextually fully relevant, directly addressing the evolution of terms and availability. The slight lack of specificity on the second facility name prevents a perfect qualitative score, but overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 401,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did MDLZ's use of Net Investment Hedge Derivative Contracts evolve between 2022 and 2024, particularly in terms of their notional amounts?",
      "original_answer": "In 2022, MDLZ reported a notional amount of $3,915 million for Net Investment Hedge Derivative Contracts as of December 31, 2021, and $4,551 million as of December 31, 2020. By 2024, the notional amount for these contracts had increased significantly to $8,647 million as of December 31, 2024, up from $7,456 million in 2023. This indicates a growing reliance on such contracts over the two-year period.",
      "llm_answer": "MDLZ expanded its net‑investment‑hedge program, with the aggregate notional amount of those derivative contracts rising from roughly $7.5 billion in the prior‑year period (the level after 2022) to $8.6 billion at year‑end 2024—an increase of about $1 billion【page_96】. This growth shows a clear upward trend in the use of NIH derivative contracts between 2022 and 2024.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the increase in notional amounts from approximately $7.5 billion to $8.6 billion between 2023 and 2024, aligning with the ground truth values of $7,456 million and $8,647 million. However, it omits all data from 2022 and earlier (specifically the $3,915 million as of Dec 31, 2021, and $4,551 million as of Dec 31, 2020), which are critical to assessing the evolution between 2022 and 2024. The answer inaccurately refers to 'the prior-year period (the level after 2022)'—a vague and incorrect temporal framing—as the starting point, thus failing to represent the full two-year evolution. (2) The numbers cited ($7.5B and $8.6B) are acceptable rounded versions of $7,456M and $8,647M. However, the answer invents a 'roughly $7.5 billion' figure for a period it calls 'after 2022' without specifying 2023, and completely ignores the 2020–2022 data provided in the original answer. The calculation of a ~$1 billion increase is approximately correct but based on incomplete data. (3) The multi-hop reasoning is partially sound—there is recognition of a trend from one year to the next—but fails to synthesize the full timeline from 2022 through 2024. The omission of 2020–2022 data breaks the continuity required for a complete evolution analysis. (4) The contextual relevance is high because the answer addresses the use and growth of NIH derivatives and correctly notes an upward trend. However, due to significant omissions in quantitative data and incorrect framing of the time periods, the correctness and quantitative accuracy scores are reduced. The answer captures the final leg of the trend but misses the earlier context essential to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 465,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Microsoft 365's integration with AI technologies evolved between 2022 and 2024, and what specific new capabilities were introduced in 2024 to enhance its role in productivity and collaboration?",
      "original_answer": "In 2022, Microsoft 365 was described as integrating Office 365, Windows, and Enterprise Mobility + Security with AI-backed tools to empower employees, focusing on creativity, collaboration, and innovation. By 2024, Microsoft 365 had evolved into an 'AI first platform,' introducing Copilot for Microsoft 365, which combines AI with business data from the Microsoft Graph and Microsoft 365 applications. Additionally, role-specific extensions such as Copilot for Sales, Copilot for Service, and Copilot for Finance were introduced to streamline business processes. These developments reflect a significant enhancement in AI integration aimed at delivering more personalized and intelligent productivity tools.",
      "llm_answer": "By 2022 Microsoft 365 was already framed as an “AI‑first” platform that bundles Office, Windows, Copilot and Enterprise Mobility + Security, with Copilot for Microsoft 365 using AI and Microsoft Graph data to augment Office apps and Teams (2022 p. 4). In the 2024 filing the AI layer was deepened: Microsoft added Copilot Pro—a consumer‑subscription service that delivers faster, more powerful AI assistance across Microsoft 365 apps and the web—and expanded AI‑driven features in Teams (single‑pane integration of all apps) and Viva, turning the suite into an even more unified productivity‑and‑collaboration hub (2024 p. 4‑5).",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but has significant factual inaccuracies and omissions that affect overall correctness. (1) It incorrectly states that Microsoft 365 was already an 'AI-first' platform in 2022, while the ground truth indicates this evolution culminated in 2024. This misrepresents the timeline of AI integration. (2) The mention of 'Copilot for Microsoft 365' in the 2022 context is inaccurate—the ground truth confirms that Copilot for Microsoft 365 was introduced in 2024, not 2022. (3) The LLM introduces 'Copilot Pro' as a new 2024 capability, which is not mentioned in the ground truth; instead, the actual 2024 additions were role-specific extensions like Copilot for Sales, Service, and Finance—these are entirely missing from the LLM response. (4) While the LLM correctly notes deeper AI integration in 2024 and mentions enhancements in Teams and Viva, these details are not specific enough and do not align with the key innovations cited in the original answer. (5) The citation of page numbers (e.g., 2022 p. 4, 2024 p. 4–5) suggests document referencing, but the content attributed to those years is factually misaligned. Quantitative accuracy is acceptable because there are no numerical values to verify, and the years 2022 and 2024 are correctly used as reference points. However, the qualitative accuracy is low due to incorrect attribution of features to the wrong years and failure to identify the correct new capabilities introduced in 2024. Contextual relevance is moderate—the response addresses AI evolution and productivity enhancements but misses the core developments. Overall, the answer is partially correct but contains critical errors in feature timing and specificity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 467,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has 3M's approach to PFAS discharge characterization in its wastewater permits evolved between its Decatur, Alabama facility disclosures in 2022 and 2024?",
      "original_answer": "In 2022, 3M disclosed that it had not fully characterized its PFAS discharge in its NPDES permit for the Decatur facility and had submitted an application to ADEM to add additional PFAS to the permit. By 2024, the Company had installed and was upgrading wastewater treatment controls specifically designed to address PFAS at the Decatur facility, and the controls were being optimized, though ADEM had not yet acted on the permit modification request. This evolution shows a shift from identifying the issue and initiating corrective actions to implementing and refining treatment solutions while awaiting regulatory approval.",
      "llm_answer": "In the 2022 10‑K, 3M said it had discovered that its Decatur, Ala., NPDES permit did not fully capture the PFAS it was discharging, filed an application to add the missing PFAS, installed additional wastewater‑treatment controls and entered a July 2020 interim consent order that required it to conduct analytical and characterization studies. By the 2024 10‑K, the company’s approach had shifted to operating under that interim consent order as the primary mechanism, with explicit, ongoing obligations to provide notices and reports, perform continual analytical/characterization work and fund capital improvements—turning a one‑time permit‑amendment effort into a sustained, consent‑order‑driven PFAS‑discharge‑characterization program.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general evolution of 3M's approach to PFAS discharge characterization at the Decatur facility but introduces significant factual inaccuracies that undermine its correctness. (1) The claim that 3M 'installed additional wastewater-treatment controls' by 2022 is incorrect per the ground truth: in 2022, 3M had only submitted a permit modification application and had not yet implemented treatment controls. The installation and upgrading of PFAS-specific treatment controls occurred by 2024, not 2022. (2) The reference to a 'July 2020 interim consent order' is not supported by the original answer and introduces a specific date and regulatory mechanism (consent order) that are absent from the ground truth. The original answer makes no mention of a consent order or any 2020 regulatory action, so this is a fabrication or misattribution. (3) While the LLM correctly identifies that 3M acknowledged incomplete PFAS characterization in 2022 and filed an application with ADEM, it misrepresents the timeline and regulatory context of the response. (4) The qualitative shift described—'from a one-time permit-amendment effort into a sustained, consent-order-driven program'—is a reasonable inference but is based on incorrect premises. The ground truth emphasizes ongoing treatment optimization and ADEM inaction, not a transition to a consent-order framework. (5) Contextually, the answer is relevant and attempts multi-hop reasoning by contrasting 2022 and 2024 disclosures, but the synthesis is flawed due to unsupported details. Quantitative accuracy is low due to the incorrect date (July 2020) and implied timeline of control installation. Qualitative accuracy is moderate because the core idea of evolving from identification to sustained action is aligned, but the reasoning is based on incorrect entities and events. Contextual relevance is high as the response directly addresses the question's focus on evolution in PFAS characterization approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 531,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Lowe's Companies, Inc.'s issuance of the 4.550% Notes evolve between 2022 and 2023?",
      "original_answer": "In 2022, the 4.550% Notes were first introduced in the Fifteenth Supplemental Indenture dated April 5, 2019, and were due April 5, 2049. In 2023, the same 4.550% Notes continued to be referenced under the same Fifteenth Supplemental Indenture, with no changes to the terms or maturity date. Therefore, while the 4.550% Notes were still in effect in 2023, there was no modification or new issuance related to this specific instrument during that year.",
      "llm_answer": "In the 2022 filing Lowe’s still listed its 4.550 % notes as part of the Fifteenth Supplemental Indenture (issued April 5 2019, due 2049) 【page_76】. By the 2023 filing the most recent supplemental indentures were a 4.400 % issue in September 2022 and a 4.800 % issue in March 2023, with no new 4.550 % notes mentioned 【page_77】【page_78】, indicating that the company did not issue additional 4.550 % notes between 2022 and 2023.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that the 4.550% Notes were part of the Fifteenth Supplemental Indenture dated April 5, 2019, and due in 2049, consistent with the ground truth. It accurately states that no new 4.550% notes were issued between 2022 and 2023, aligning with the original answer’s conclusion of no modification or new issuance in 2023. However, the LLM introduces information not present in the ground truth—specifically mentioning a 4.400% issue in September 2022 and a 4.800% issue in March 2023—which, while possibly true, distracts from the focus on the 4.550% Notes and implies a shift in financing activity that isn’t directly relevant to the evolution of that specific instrument. (2) Quantitatively, all dates and percentages related to the 4.550% Notes are correct: April 5, 2019 issuance and 2049 maturity. The additional note details (4.400%, 4.800%) are not contradicted by the ground truth but are extraneous and not required for answering the question. (3) The reasoning is mostly sound: the model infers from the absence of mention in 2023 filings that no new issuance occurred, which is valid. However, it fails to explicitly confirm that the 4.550% Notes were still in effect in 2023 under the same terms, instead focusing on other notes. This omits a key part of the original answer’s completeness—continuity of the instrument. (4) The answer is contextually relevant and well-supported with citations, but loses precision in qualitative accuracy due to the inclusion of unrelated debt instruments and omission of explicit confirmation of the 4.550% Notes’ ongoing status. Thus, while the core conclusion is correct, the reasoning path is slightly flawed in emphasis and completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 470,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MDLZ's financial relationship with KDP evolve between 2022 and 2024, particularly in terms of gains recognized from changes in accounting for the investment?",
      "original_answer": "In 2022, MDLZ recognized a pre-tax gain of $71 million (or $54 million after-tax) during the first quarter related to the sale of KDP shares, which reduced its ownership interest. By 2024, the company recorded a significantly larger pre-tax gain of $493 million ($368 million after-tax) due to a change in accounting for its investment in KDP. This indicates a substantial evolution in the financial impact of MDLZ's relationship with KDP over the two-year period.",
      "llm_answer": "MDLZ’s KDP stake was still accounted for under the equity‑method in 2022.  In the first quarter of 2023 its ownership fell below 5 %, so the investment was re‑classified to a marketable‑securities basis (and the remaining shares were sold later that year) 【page_88】.  Before the re‑classification MDLZ recorded a pre‑tax equity‑method gain of $493 million, and the sale of the re‑classified shares generated a $593 million pre‑tax gain on marketable securities 【page_89】.  By 2024 the KDP investment was fully exited and no further KDP‑related gains were reported.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, MDLZ recognized a $71 million pre-tax gain ($54 million after-tax) in 2022 related to the sale of KDP shares. However, the LLM incorrectly states that the $493 million pre-tax gain occurred before reclassification in 2023, while the ground truth specifies this $493 million gain occurred in 2024 due to a change in accounting. The LLM also introduces a $593 million pre-tax gain from the sale of shares in 2023, which is not mentioned in the original answer and contradicts the timeline and amounts provided. (2) The numbers are largely incorrect: the $493 million gain is attributed to 2023 instead of 2024, and a new $593 million gain is fabricated. The 2022 gain of $71 million is completely omitted. The ownership threshold drop below 5% and reclassification in Q1 2023 may align with external facts, but this shifts the timeline away from the question’s focus on 2022–2024 evolution and misattributes the major gain. (3) The multi-hop reasoning is flawed: the model fails to correctly link the 2022 and 2024 gains as key markers of financial evolution, instead inserting an intermediate event in 2023 that overshadows the actual 2024 accounting change. It incorrectly implies the investment was fully exited by 2023, so no gains in 2024, which contradicts the ground truth that a major gain occurred in 2024. (4) The contextual relevance is moderate because it discusses the investment evolution and accounting changes, but the incorrect timing, invented figures, and omission of key facts severely undermine accuracy. Thus, the correctness score is low due to major quantitative and qualitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 466,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How has the scale and positioning of Xbox Game Pass evolved between 2022 and 2024, based on the number of titles available and Microsoft's strategic emphasis?",
      "original_answer": "In 2022, Xbox Game Pass offered access to a curated library of over 100 first- and third-party titles, and was positioned as a key part of Microsoft's broader gaming strategy focused on content, community, and cloud services. By 2024, the service had expanded significantly, offering access to over 400 first- and third-party titles, and was described as the 'cornerstone' of Microsoft's gaming platform, reflecting a stronger strategic emphasis on subscriptions and community growth. This indicates a significant transformation in both scale and strategic importance.",
      "llm_answer": "In FY 2022 Microsoft said Xbox Game Pass gave members “access to a curated library of **over 100** first‑ and third‑party console and PC titles”【page_6】. By FY 2024 the filing describes the service as a “subscription … with access to a curated library of **over 400** first‑ and third‑party console and PC titles” and positions Game Pass as the **cornerstone of the Xbox platform**, stressing its role in expanding the content‑community‑cloud ecosystem, reaching gamers on many devices, and differentiating Microsoft’s gaming business【page_13】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers 'over 100' titles in 2022 and 'over 400' titles in 2024 are accurately reported, with correct fiscal year references (FY2022 and FY2024). (2) The answer is complete, addressing both the scale (number of titles) and strategic positioning (evolution from key part to 'cornerstone') of Xbox Game Pass. (3) Entities are correct: Microsoft, Xbox Game Pass, and the timeframes are properly identified. (4) The reasoning is sound and reflects multi-hop synthesis—comparing the growth in library size and the increased strategic emphasis over time, citing specific language from filings (e.g., 'cornerstone', 'content-community-cloud ecosystem'). (5) Semantic equivalence is maintained: while the LLM uses slightly different phrasing (e.g., 'subscription' or 'reaching gamers on many devices'), the core facts and strategic implications align exactly with the original answer. Minor additions like 'console and PC titles' add precision without deviating from the truth. All claims are supported by the cited pages, indicating accurate sourcing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 323,
        "total_tokens": 1604
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the structure or disclosure of Deferred Stock Unit Award Agreements for non-employee directors under the 3M Company 2016 Long-Term Incentive Plan evolved from 2022 to 2024, based on the referenced filings?",
      "original_answer": "The Deferred Stock Unit Award Agreement for non-employee directors was first referenced in the 2022 10-K filing as part of the 3M Company 2016 Long-Term Incentive Plan, applicable to grants on or after January 1, 2019. By 2024, the agreement continued to be disclosed in the 10-K filing, still referencing grants on or after January 1, 2019, indicating no change in the effective date or structure of the agreement over this period. However, the 2024 disclosure reflects an updated incorporation by reference from the 2023 10-K, showing the ongoing maintenance of the plan through amendments as of May 8, 2023.",
      "llm_answer": "In the 2022 Form 10‑K the exhibit schedule does not contain a separate item describing a Deferred Stock Unit (DSU) award agreement for non‑employee directors, so the agreement is not explicitly disclosed in the sections provided. By the 2024 Form 10‑K, the company adds Exhibit 10.7 – “Form of Deferred Stock Unit Award Agreement for deferred stock units granted on or after January 1, 2019 to Non‑Employee Directors under the 3M 2016 Long‑Term Incentive Plan,” incorporated by reference to the 2018 Form 10‑K. This change shows that the DSU award agreement for non‑employee directors, while unchanged in substance, moved from being omitted to being specifically listed as a referenced exhibit, providing a clearer disclosure of its structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. First, it incorrectly claims that the Deferred Stock Unit (DSU) Award Agreement was not disclosed in the 2022 10-K, stating it was 'not explicitly disclosed' and 'omitted'—this contradicts the ground truth, which confirms the agreement *was* referenced in the 2022 10-K. This is a major error in entity and disclosure timeline accuracy. Second, the LLM incorrectly states that the 2024 exhibit is incorporated by reference to the *2018* 10-K, while the ground truth specifies it reflects an update via the *2023* 10-K with amendments as of May 8, 2023—this misrepresents both the source and timing of the update. While the LLM correctly identifies the January 1, 2019 effective date for grants, this single accurate detail does not compensate for the core misrepresentation of disclosure history. The reasoning is flawed in its multi-hop logic: it infers a change in disclosure practice (from 'omitted' to 'listed') that is factually incorrect, leading to an erroneous conclusion about evolution. The answer is contextually relevant to the question’s focus on disclosure evolution and structure, but its factual foundation is unsound. Quantitative accuracy is partially preserved (correct date: January 1, 2019), but incorrect incorporation reference (2018 vs 2023) harms precision. Overall, the answer is partially correct in substance but fundamentally wrong in key disclosures and timeline, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 415,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the composition of Charles Schwab Bank's First Mortgages and HELOCs portfolio evolved between 2023 and 2024, particularly in terms of origination costs and geographic concentration in California?",
      "original_answer": "In 2023, the First Mortgages and HELOCs portfolio included $100 million in unamortized premiums, discounts, and direct origination costs, with 43% of the portfolio concentrated in California. By 2024, these costs increased to $112 million, while the California concentration slightly decreased to 42%. This indicates a slight shift in geographic risk exposure and an increase in loan origination activity or associated costs over the year.",
      "llm_answer": "Between 2023 and 2024 the First‑Mortgage balance grew modestly (to $27.4 billion from $26.2 billion) while the HELOC balance fell (to $424 million from $479 million), and the pool’s un‑amortized premiums, discounts and direct origination costs rose to **$112 million** from **$100 million**.  At the same time the geographic concentration in California slipped slightly, from **about 43 %** of the portfolio in 2023 to **about 42 %** in 2024【page_88†L71-L78】【page_88†L79-L82】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative facts from the ground truth: unamortized premiums, discounts, and direct origination costs increased from $100 million in 2023 to $112 million in 2024, and California concentration decreased from 43% to 42%. These numbers match the original answer exactly, with acceptable formatting (e.g., $112 million). (2) The LLM provides additional context not in the original answer—specific portfolio balances for First Mortgages ($26.2B to $27.4B) and HELOCs ($479M to $424M)—which are factually consistent with typical 10-K disclosures and do not contradict the ground truth; however, these were not part of the original answer and thus represent augmentation rather than error. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in origination costs and geographic concentration across years, linking them to portfolio evolution. The slight decrease in California exposure and increase in costs are accurately interpreted as trends. (4) The only minor shortcoming is that the LLM does not explicitly connect the increase in costs to 'loan origination activity or associated costs' as the original answer does, slightly weakening the qualitative inference. However, the factual core is fully accurate, and the answer remains semantically aligned with the ground truth. Thus, the correctness score is 9 due to full factual accuracy with slight omission in interpretive synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 406,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Nike's strategic emphasis on the Dri-FIT technology evolved between fiscal 2023 and fiscal 2024, based on the language in Nike's product research and development sections?",
      "original_answer": "Nike's strategic emphasis on the Dri-FIT technology remained stable between fiscal 2023 and fiscal 2024. In both years, Dri-FIT was listed among key technologies such as Nike Air, Zoom, Free, Flyknit, FlyEase, ZoomX, Air Max, and React, indicating consistent strategic importance. The exact same language was used in both the 2023 and 2024 10-K filings, showing no change in the description or emphasis of Dri-FIT's role in Nike’s innovation strategy.",
      "llm_answer": "Nike’s product‑research narrative already highlighted Dri‑FIT as a core performance fabric in fiscal 2023, listing it with other marquee technologies (e.g., Air, Zoom, Free, Flyknit, etc.)【page_6】. The fiscal 2024 filing repeats that language, again naming Dri‑FIT alongside Air, Zoom, Flyknit, FlyEase, ZoomX, Air Max and React, showing that the strategic emphasis on Dri‑FIT has remained steady rather than shifting dramatically【page_6】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Nike's strategic emphasis on Dri-FIT remained stable between fiscal 2023 and 2024, with no change in language across the 10-K filings. (2) There are no numerical values requiring calculation, but the fiscal years (2023 and 2024) are correctly identified and referenced. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from both years' filings, noting the repetition of the same list of technologies—including Dri-FIT—and concludes that the strategic emphasis did not shift. (4) The LLM cites the correct context (product research and development sections) and lists the same technologies mentioned in the ground truth (Air, Zoom, Flyknit, FlyEase, ZoomX, Air Max, React), confirming consistency. Minor rewording (e.g., 'core performance fabric', 'remained steady') does not affect factual accuracy. All aspects of the question are addressed with precise, factually correct information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 294,
        "total_tokens": 1525
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Mondelez International's investment in backup and disaster recovery evolved from 2022 to 2024, particularly in response to increasing cybersecurity threats?",
      "original_answer": "In 2022, Mondelez was on heightened alert regarding cybersecurity risks, dedicating focused resources to backup and disaster recovery as part of its response to increased global cybersecurity threats, especially during the pandemic. By 2024, the company significantly expanded its efforts, explicitly stating that it continues to invest and augment its cybersecurity program with enhanced backup and disaster recovery solutions, among other measures, to address increasingly sophisticated threats including those from state-sponsored actors and emerging technologies like artificial intelligence.",
      "llm_answer": "In the 2022 Form 10‑K, Mondelez noted that it was “on heightened alert and dedicate[d] focused resources to network security, **backup and disaster recovery**” as part of its response to growing cyber‑risk exposure【page_45】. By the 2024 filing, the company says it is “continuing to **invest and augment** our cybersecurity program…including **backup and disaster recovery**” along with broader upgrades such as identity‑management, multi‑factor authentication and advanced threat protection, indicating a deeper, more expansive commitment as cyber threats have become more frequent and sophisticated【page_20】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies Mondelez International and the relevant time frame (2022 to 2024), with accurate representation of the company's evolving investment in backup and disaster recovery. (2) There are no numeric values requiring calculation (e.g., dollar amounts or percentages), but the years (2022, 2024) are correct and properly contextualized. (3) The multi-hop reasoning is sound: the answer synthesizes information from two different Form 10-K filings, correctly showing an evolution from 'heightened alert' and 'focused resources' in 2022 to 'continuing to invest and augment' in 2024, reflecting an expanded cybersecurity program. (4) The LLM includes key contextual details such as increasing sophistication of threats and cites specific enhancements (identity management, MFA, advanced threat protection), which aligns with the broader scope mentioned in the ground truth, including threats from state-sponsored actors and AI. The use of direct quotes with proper page references adds precision. Wording differs slightly but preserves full meaning—thus achieving semantic equivalence. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 348,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has Microsoft's financial commitment and engagement with Black and African American-owned suppliers evolved from fiscal year 2022 to fiscal year 2024?",
      "original_answer": "In fiscal year 2022, Microsoft reported that it had enriched its supplier pipeline, reaching more than 90% of its goal to spend $500 million with double the number of Black and African American-owned suppliers. By fiscal year 2024, Microsoft had not only achieved its $500 million spending goal but also expanded its financial commitments by allocating $150 million to Minority Depository Institutions and funds supporting Black and African American-owned small businesses. This evolution indicates a deepening of Microsoft's strategic focus on supplier diversity and community economic development over time.",
      "llm_answer": "In the FY 2022 filing Microsoft’s 10‑K contains no disclosed monetary commitment or spend target for Black‑ and African‑American‑owned suppliers (see FY 2022 page 8). By FY 2024 the company announced a $150 million commitment to minority‑depository institutions and funds for Black‑owned small businesses, set a $500 million spend goal to double the number of Black‑ and African‑American‑owned suppliers, and extended 162 low‑ or no‑interest loans through its Partner Capital Fund (see FY 2024 page 7). This reflects a substantial increase in both the amount of capital allocated and the breadth of supplier engagement.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant factual discrepancies in the quantitative details and timeline. (1) On quantitative accuracy: The claim that Microsoft had 'no disclosed monetary commitment' in FY2022 contradicts the ground truth, which states Microsoft had already reached over 90% of its $500 million goal by FY2022. This is a major factual error. Additionally, the LLM incorrectly implies that the $500 million goal was newly set in FY2024, when in fact it was a target already in progress by FY2022. The $150 million commitment to Minority Depository Institutions is correctly reported for FY2024. (2) On completeness: The answer addresses Microsoft's evolving commitments but misrepresents the timeline and progress, failing to acknowledge the prior existence of the $500 million goal in FY2022. The mention of 162 low- or no-interest loans is extra detail not in the ground truth; while potentially true, it distracts from the core supplier spend evolution and lacks alignment with the original answer. (3) Entity accuracy is correct—Microsoft, Black and African American-owned suppliers, fiscal years 2022 and 2024, and the $150 million commitment are all properly identified. (4) Reasoning is partially sound but flawed in synthesis: the conclusion of increased engagement is valid, but the reasoning is based on an incorrect premise that no goal existed in FY2022. (5) Semantic equivalence is not achieved due to the misrepresentation of the $500 million goal’s timeline. While the overall direction of increased commitment is correctly inferred, the failure to accurately reflect the multi-hop progression from FY2022 to FY2024—especially the near-achievement of the $500M goal by FY2022—undermines the factual core of the answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 484,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How has the availability of common shares for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non-U.S. Employees evolved from 2022 to 2023, and what does this indicate about Abbott's stock-based incentive strategy?",
      "original_answer": "In 2022, as of December 31, 2021, an aggregate of 10,638,639 common shares were available for future issuance under the Employee Stock Purchase Plan. In 2023, as of December 31, 2023, this number had decreased to 8,565,087 common shares. This indicates a reduction in the number of shares available for future issuance, suggesting a potential tightening or adjustment in Abbott's stock-based incentive strategy for non-U.S. employees.",
      "llm_answer": "The 2022 Form 10‑K reported that **10,638,639** common shares were available for future issuance under the Abbott Laboratories Employee Stock Purchase Plan for Non‑U.S. Employees【page_83】. By the 2023 filing, that pool had fallen to **8,565,087** shares【page_84】—a reduction of roughly 2 million shares. The decline shows the plan has been actively used and that Abbott is tightening the remaining share reserve, reflecting a strategy of leveraging stock‑based incentives while managing dilution.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the number of shares available for future issuance in both 2022 (10,638,639 as of December 31, 2021, per the 2022 10-K) and 2023 (8,565,087 as of December 31, 2023, per the 2023 10-K), matching the ground truth exactly. The reduction of roughly 2 million shares is accurate (difference is 2,073,552), and the phrasing 'fallen to' correctly reflects a decrease. (2) All numeric values are correct and properly cited to specific pages in the filings, demonstrating strong quantitative accuracy. The calculation of the reduction, while approximate ('roughly 2 million'), is reasonable and does not misrepresent the data. (3) The reasoning is sound: the LLM correctly infers that the decline indicates active use of the plan and a tightening of the share reserve, aligning with the ground truth's interpretation of a 'reduction' suggesting an adjustment in strategy. It adds a nuanced insight about managing dilution, which is a logical and contextually appropriate extension of the data. (4) The answer fully addresses both parts of the question—evolution of share availability and implications for Abbott's incentive strategy—and maintains semantic equivalence with the original answer. The only minor limitation is that it slightly extends the interpretation by mentioning 'managing dilution,' which, while plausible, is not explicitly stated in the ground truth. However, this does not detract from factual correctness. All entities (Abbott Laboratories, Employee Stock Purchase Plan for Non-U.S. Employees, correct years and share counts) are accurately identified. Overall, the response is factually precise, contextually relevant, and demonstrates correct multi-hop reasoning across two annual reports.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1257,
        "completion_tokens": 477,
        "total_tokens": 1734
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Nike's treatment of Nike Air technology evolved in its product development strategy between fiscal years 2023 and 2024?",
      "original_answer": "In fiscal 2023, Nike Air was described as part of a list of technologies that 'typifies our dedication to designing innovative products,' indicating it was still being actively proliferated across product lines. By fiscal 2024, Nike Air was again listed among key technologies, but now embedded alongside mature technologies like Zoom, Free, and React, suggesting that Nike Air had become a standard component of Nike’s broader innovation platform rather than a distinct growth driver. This reflects a strategic shift from emphasizing Nike Air as an emerging innovation to treating it as an integrated, foundational offering within Nike’s product development framework.",
      "llm_answer": "In FY 2023 Nike Air was referenced mainly as one of the core technology platforms that drive new product designs – it appears in the list of “Nike Air, Zoom, Free, Dri‑FIT, Flyknit, FlyEase, Zoom X, Air Max and React” technologies that underpin the company’s innovation pipeline【page_6】. By FY 2024 Nike not only continues to tout Air but also explicitly ties the technology to its wholly‑owned Air Manufacturing Innovation subsidiary, which supplies the Nike Air‑Sole cushioning components used in footwear, signaling a more integrated, vertically‑controlled emphasis on Air technology in product development【page_7】.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of entities and dates (FY2023 and FY2024), and correctly identifies Nike Air as a core technology in both years, which aligns with the original answer. It also introduces new information — the Air Manufacturing Innovation subsidiary — which is contextually relevant and supports a narrative of deeper integration. However, the LLM answer diverges from the ground truth in interpreting the strategic evolution: while the original answer emphasizes a shift from Nike Air as an 'innovative product' to a 'mature, foundational' technology embedded among others like Zoom and React, the LLM frames the change as a move toward vertical integration and control via manufacturing, which is not mentioned in the ground truth. This misrepresents the nature of the strategic shift — the core insight in the original answer is about Nike Air transitioning from a growth driver to a standard component, not about supply chain or manufacturing control. The LLM answer is plausible and contextually rich but misses the key conceptual evolution described in the ground truth. There are no numerical inaccuracies (quantitative accuracy is perfect), and the response is highly relevant to the question. However, due to the incorrect characterization of the strategic shift — a central requirement of the multi-hop reasoning — the qualitative accuracy and overall correctness are reduced.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 390,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Abbott's positioning of Osmolite within its Nutritional Products segment evolved between 2022 and 2023, particularly in terms of its enteral feeding portfolio and associated product line strategy?",
      "original_answer": "In 2022, Osmolite was listed among Abbott's enteral feeding products used in healthcare institutions, alongside Jevity®, Glucerna® 1.2 Cal, Glucerna® 1.5 Cal, Oxepa®, Freego™, Nepro®, and Vital®. By 2023, Osmolite continued to be included in the enteral feeding portfolio, but Abbott's product listing in this category remained largely consistent, indicating a stable strategic positioning of Osmolite within the institutional enteral nutrition segment. There is no indication of Osmolite being newly introduced, discontinued, or significantly repositioned relative to other products in this category during this period.",
      "llm_answer": "In the 2022 10‑K, Osmolite was listed as one of the enteral‑feeding products in the Nutritional Products segment, grouped with Jevity, Glucerna, Oxepa, Freego, Nepro and Vital (ABT_10k_2022 p. 3). The 2023 filing repeats this placement, again positioning Osmolite within the same enteral‑feeding portfolio and product line (ABT_10k_2023 p. 4), showing that Abbott’s strategy for Osmolite has remained unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately states that Osmolite was listed among Abbott's enteral feeding products in both 2022 and 2023, grouped with Jevity, Glucerna, Oxepa, Freego, Nepro, and Vital—matching the original answer's entity list and context. (2) There are no numeric values requiring calculation, but the years (2022 and 2023) are correctly referenced, and the document citations (ABT_10k_2022 p. 3, ABT_10k_2023 p. 4) are consistent with expected sourcing. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of 10-K filings to conclude that Osmolite’s positioning remained stable, with no repositioning, discontinuation, or strategic shift. (4) The answer is semantically equivalent to the ground truth—though slightly more concise, it captures the core conclusion of unchanged strategic positioning. The only minor limitation is the lack of explicit mention that there was 'no indication of Osmolite being newly introduced, discontinued, or significantly repositioned,' which is implied but not stated outright. This small omission prevents a perfect 10, but overall the response is highly accurate, relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 348,
        "total_tokens": 1620
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has 3M's regulatory engagement and remediation obligations related to PFAS discharge evolved between 2022 and 2024, particularly in Minnesota and Alabama?",
      "original_answer": "In 2022, 3M was actively working under a 2007 Settlement Agreement and Consent Order with the MPCA to address PFAS contamination in Minnesota, with remediation substantially completed at the Cottage Grove site and ongoing operational and maintenance activities at multiple locations. In Alabama, the Company had entered into a July 2020 Interim Consent Order with ADEM, which included obligations for PFAS-related wastewater discharges and air emissions, and had completed installation of a multilayer cap at the Decatur facility. By 2024, regulatory scrutiny had intensified. In Minnesota, MPCA issued a draft Clean Water Act permit for the Cottage Grove facility with significantly revised effluent limits for certain PFAS compounds, some below current quantification levels, and the Company submitted public comments in August 2024. Additionally, in 2024, MPCA published a revised draft permit in December after considering stakeholder input, which could have a significant adverse impact on the Cottage Grove facility's operations. In Alabama, while the 2020 Interim Consent Order remained in effect, the Company's obligations under ongoing investigations and potential future remediation were still expected to involve additional operating costs and capital expenditures over multiple years. The regulatory landscape evolved to include more stringent standards, such as updated HBVs from MDH in January 2024 and proposed HRLs in October 2024, further complicating 3M's compliance path.",
      "llm_answer": "In the 2022 filing, 3M said its Minnesota work was governed by the 2007 Settlement Agreement and Consent Order (SACO) with the MPCA – remediation at the Cottage Grove site was largely finished and a new PFAS‑treatment system was being installed – while in Alabama it was operating under a voluntary remedial‑action agreement and a July 2020 interim consent order with ADEM that required a multilayer cap, ongoing remediation, reporting and other site‑operation commitments. By the 2024 filing, the Minnesota obligations had broadened to include a new wastewater‑treatment system, a storm‑water compliance order, response to stricter Minnesota health‑based values, and active participation in a draft Clean Water Act permit that imposes tighter PFAS effluent limits, whereas the Alabama effort now centers on upgrading and optimizing the installed wastewater controls, a pending amendment to the NPDES permit, and continued cooperation with EPA, ADEM and the DOJ to satisfy the interim consent order’s ongoing operational and remediation duties.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the evolution of 3M's regulatory engagement and remediation obligations related to PFAS in Minnesota and Alabama between 2022 and 2024, with accurate entity identification and sound multi-hop reasoning. Quantitatively, all dates (2007 SACO, July 2020 Interim Consent Order) and key regulatory milestones are correctly cited. The LLM accurately notes that in 2022, remediation at Cottage Grove was substantially complete and a new PFAS-treatment system was being installed, aligning with the ground truth. It also correctly identifies the 2020 ADEM Interim Consent Order and the multilayer cap completion in Alabama. By 2024, the LLM correctly reflects increased regulatory pressure: in Minnesota, it references the draft Clean Water Act permit with stricter effluent limits, response to updated health-based values (HBVs), and participation in public comment processes (August and December 2024 drafts mentioned in ground truth). In Alabama, it accurately notes ongoing compliance under the Interim Consent Order, cooperation with EPA/DOJ/ADEM, and efforts to upgrade wastewater controls. However, the LLM omits specific details about MPCA issuing a revised draft permit in December 2024 after stakeholder input and does not mention the potential significant adverse operational impact on Cottage Grove, which is a notable omission in completeness. It also refers to a 'storm-water compliance order' and 'pending amendment to the NPDES permit'—details not present in the ground truth—introducing slight overreach, though these are plausible inferences. The core financial and operational implications (ongoing costs, capital expenditures) are implied but not explicitly stated as in the original. Overall, the answer is semantically close, with strong qualitative reasoning and contextual relevance, but minor omissions and one or two potentially inferred (but unconfirmed) details prevent a top score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1636,
        "completion_tokens": 523,
        "total_tokens": 2160
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola HBC AG evolved between 2022 and 2024, particularly in terms of investment classification and stake percentage?",
      "original_answer": "In 2022, Coca-Cola HBC AG was among the listed equity method investees, though the specific ownership percentage was not disclosed in the provided evidence. By 2024, Coca-Cola HBC AG remained an equity method investee, and the company explicitly stated a 22% ownership stake as of December 31, 2024. This indicates a formalization and quantification of the relationship, with Coca-Cola now specifying the exact percentage of ownership, which was absent in the 2022 disclosures.",
      "llm_answer": "In the 2024 Form 10‑K the Company reports its Coca‑Cola HBC AG holding as an equity‑method investment, owning 22 % of the bottler’s outstanding shares (page 87). The 2022 filing’s disclosed sections (pages 116‑120) do not list Coca‑Cola HBC AG among equity‑method investments, indicating it was previously accounted for within the broader bottling‑investment segment and that the ownership stake has been reduced from a higher level in 2022 to 22 % in 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitatively, the 22% ownership stake in Coca-Cola HBC AG as of 2024 is correctly reported, aligning with the ground truth. However, the claim that Coca-Cola HBC AG was *not listed* among equity-method investments in 2022 is false—the ground truth states it *was* among the listed equity method investees in 2022, though the percentage was not disclosed. The LLM incorrectly infers a reduction in stake from a 'higher level' in 2022 to 22% in 2024, which is unsupported by evidence and contradicts the original answer, which notes continuity in equity-method accounting and only a formalization of disclosure. (2) The calculation or comparison of stake change is erroneous due to incorrect premise—no reduction is indicated in the ground truth. (3) Multi-hop reasoning fails: the model incorrectly synthesizes the absence of a stated percentage in 2022 as evidence of non-inclusion in equity-method investments, when the original answer confirms its presence. This misreading leads to a flawed conclusion about stake reduction. (4) While the answer addresses the question's focus on classification and stake percentage, it does so with incorrect assertions about the 2022 status and trend over time. Contextual relevance is moderate as it discusses the right entities and time frame, but reasoning and facts are compromised. Thus, the correctness score is low due to core factual and logical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 409,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Oracle's strategic emphasis on hybrid deployments evolved between fiscal 2022 and fiscal 2024, particularly in terms of product development investment and deployment model integration?",
      "original_answer": "In fiscal 2022, Oracle emphasized hybrid deployments as part of its broader deployment model strategy, investing $7.2 billion in research and development to enhance existing offerings and develop new technologies, including hybrid solutions like Oracle Cloud@Customer. By fiscal 2024, Oracle further integrated hybrid deployments into its core offerings, positioning them as a standard deployment choice alongside on-premise and cloud-based models, and reinforcing its commitment to interoperability and customer choice. This reflects a strategic evolution from a development-focused approach to a more mature, integrated deployment model.",
      "llm_answer": "Oracle’s 2022 filing makes hybrid‑deployment a distinct pillar of its strategy – it highlights the Oracle Cloud@Customer hybrid offering and notes that it spent **$7.2 billion on R&D in fiscal 2022** to enhance its portfolio and enable on‑premise/cloud integration【page_6】. By fiscal 2024 the company still stresses hybrid as a core option, but frames it as part of a **“flexible and interoperable” suite of on‑premise, cloud‑based and hybrid models that are tightly integrated with its Oracle SaaS and OCI services**【page_72】, indicating the emphasis has broadened from specific hybrid products to a universal, integrated deployment approach, with continued (though undisclosed) product‑development investment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Oracle's strategic evolution from fiscal 2022 to 2024 regarding hybrid deployments. It accurately states the $7.2 billion R&D investment in fiscal 2022, which matches the ground truth. While the 2024 investment amount is not disclosed in the LLM answer (as it is in the original answer), this omission does not introduce inaccuracy—only incompleteness—and the core facts about integration and strategic shift are preserved. (2) Quantitative accuracy is perfect: the $7.2 billion figure is correctly cited with appropriate context and year. No calculations are required, and all numeric references are precise. (3) The multi-hop reasoning is sound: the model synthesizes information across fiscal years, correctly identifying the shift from a product-focused hybrid strategy (2022) to an integrated, interoperable deployment model (2024). It references Oracle Cloud@Customer and links hybrid deployments to broader SaaS and OCI integration, demonstrating proper entity and concept linkage. (4) The answer is semantically equivalent to the ground truth, with slightly different phrasing but identical meaning—particularly in capturing the evolution from development emphasis to integrated deployment. The only minor gap is the lack of explicit mention of hybrid being positioned as a 'standard deployment choice' alongside others in 2024, though this is implied in 'flexible and interoperable suite.' Overall, the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 421,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has the filing status of the Mandatory Clawback Policy evolved between the 2023 and 2024 SEC 10-K disclosures for Wells Fargo & Company?",
      "original_answer": "In 2023, the Mandatory Clawback Policy was filed directly as part of the 10-K filing under Exhibit 97. In 2024, instead of being filed directly, it was incorporated by reference to Exhibit 97 from the previous year's 10-K filing. This indicates a procedural change in how the policy is disclosed rather than a substantive change to the policy itself.",
      "llm_answer": "In the 2023 Form 10‑K, the Mandatory Clawback Policy appears as Exhibit 97 and is listed as “Filed herewith.” In the 2024 Form 10‑K, the same policy (Exhibit 97) is no longer filed anew; it is “Incorporated by reference to Exhibit 97 to the Company’s Annual Report on Form 10‑K for the year ended December 31, 2023.” Thus the filing moved from a direct attachment in 2023 to a reference to the prior‑year filing in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately describes the evolution of the filing status: in 2023, the Mandatory Clawback Policy was filed directly as Exhibit 97 ('Filed herewith'), and in 2024, it was incorporated by reference to the 2023 filing. (2) There are no numeric values requiring calculation, but the years (2023, 2024) and exhibit number (97) are correct and consistent with the original answer. (3) The multi-hop reasoning is sound—LLM correctly synthesized information across two years of SEC 10-K filings and identified the procedural change in disclosure method. (4) The answer addresses all parts of the question, uses precise terminology, and conveys the same conclusion as the ground truth: a procedural, not substantive, change in how the policy is disclosed. Wording differs slightly but meaning is identical. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 273,
        "total_tokens": 1464
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did Thermo Fisher's relationship with CorEvitas, LLC evolve between 2023 and 2024, and what specific financial implications were associated with this change?",
      "original_answer": "In 2023, Thermo Fisher invested $0.91 billion to acquire CorEvitas, LLC, a U.S.-based provider of regulatory-grade, real-world evidence for medical treatments. By 2024, this relationship had evolved from an investment into a full acquisition, as CorEvitas was integrated into the Laboratory Products and Biopharma Services segment. The acquisition in 2023 was part of a broader strategy that included significant capital expenditures and financing activities, such as issuing $5.94 billion in senior notes and repurchasing $3.00 billion of company stock. In 2024, the company began amortizing the definite-lived intangible assets from CorEvitas over a weighted average period of 18 years, reflecting the long-term strategic value of the acquisition.",
      "llm_answer": "Thermo Fisher went from buying CorEvitas in 2023 to having it operate as an integrated part of the business in 2024.  The August 14, 2023 acquisition was completed for a $910 million purchase price (cash $730 million plus $184 million of debt assumed), generated $627 million of goodwill and produced a $0.91 billion cash outflow in investing activities 【page_65】【page_66】【page_24】, and by 2024 CorEvitas’s contribution was reflected in the Laboratory Products and Biopharma Services segment’s 2 % revenue increase and 17 % segment‑income increase with no additional acquisition cash outlay recorded 【page_22】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct and highly aligned with the ground truth. It accurately states that Thermo Fisher acquired CorEvitas, LLC in 2023 for $910 million (equivalent to $0.91 billion), with a detailed breakdown of $730 million in cash and $184 million in assumed debt, which matches the financial structure. The $627 million goodwill and $0.91 billion cash outflow in investing activities are correctly reported. The integration into the Laboratory Products and Biopharma Services segment in 2024 is confirmed, along with CorEvitas contributing to a 2% revenue increase and 17% segment income increase—specific performance impacts not in the original answer but consistent with deeper filing insights. (2) All numbers are quantitatively accurate: $910M = $0.91B, sum of $730M + $184M = $914M (minor $4M discrepancy possibly due to rounding or other liabilities, but within acceptable SEC reporting variance). No calculation errors. (3) Multi-hop reasoning is sound: the model connects the 2023 acquisition event with 2024 integration and financial impact across segments, correctly inferring operational evolution and financial treatment. It goes beyond the original answer by adding performance metrics from the segment, enhancing completeness. (4) The only reason for not scoring 10 is that the original answer mentions amortization of definite-lived intangible assets over 18 years—a specific accounting treatment in 2024—which the LLM omits. This is a minor omission in an otherwise excellent synthesis. All other elements—entities, years, financial implications—are correct and contextually well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 449,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How did RTX's flight hour payment obligations under its 2012 agreement with Rolls-Royce evolve between 2022 and 2023, particularly in terms of the timing and capitalization treatment of these payments?",
      "original_answer": "In 2022, RTX disclosed that flight hour payments to Rolls-Royce were contingent upon each hour flown through June 2027 by V2500-powered aircraft in service as of the acquisition date, and these payments were considered in 'Other commercial aerospace commitments' and capitalized as collaboration intangible assets as payments were made. In 2023, RTX reiterated the same contingent payment structure tied to flight hours through June 2027 and maintained that these payments would continue to be capitalized as collaboration intangible assets. There was no indication of a change in the magnitude or timing of these obligations between the two years, suggesting a stable commitment structure.",
      "llm_answer": "In the 2022 Form 10‑K the V2500 flight‑hour payments were listed under “Other commercial aerospace commitments” with $735 million expected in 2022 and $1,053 million in 2023 【page_112】. By the 2023 filing those near‑term amounts had been removed and the remaining schedule now shows $836 million in 2024, $862 million in 2025, $705 million in 2026 and $687 million in 2027, indicating the obligations have been pushed into later years 【page_101】. In both years the company said each flight‑hour payment will be capitalized as a collaboration intangible asset as the payments are made 【page_112】【page_101】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. The ground truth states there was no change in the magnitude or timing of RTX's payment obligations between 2022 and 2023, with consistent disclosure of the same contingent structure through June 2027 and continued capitalization as collaboration intangible assets. However, the LLM claims specific dollar amounts ($735M in 2022, $1,053M in 2023) that are not present in the original answer and asserts these were 'removed' in 2023, replaced by new figures for 2024–2027. These numbers and the conclusion that obligations were 'pushed into later years' contradict the ground truth, which explicitly states there was no indication of a change in timing or magnitude. No such re-scheduling is supported by the original answer. The only correct element is the consistent capitalization treatment noted in both years, which aligns with the ground truth. The reasoning is flawed because it infers a shift in payment timing based on disclosed figures that may reflect normal reporting updates rather than an actual change in obligation—yet the ground truth affirms stability. While the LLM attempts multi-hop synthesis (comparing 2022 and 2023 disclosures), it draws an unsupported conclusion, failing to recognize that evolving near-term vs. long-term liability disclosures do not necessarily imply a change in total obligation if the overall commitment remains structurally unchanged. The entities (RTX, Rolls-Royce, V2500, collaboration intangible assets) and general context are accurate, and the question parts are addressed in scope, but the core factual claim about evolving payment obligations is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 461,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has The Coca-Cola Company's financial relationship with fairlife evolved from 2022 to 2024, particularly regarding contingent payments tied to performance milestones?",
      "original_answer": "In 2022, Coca-Cola's acquisition-related disclosures referenced the 2020 acquisition of the remaining ownership interest in fairlife, with no mention of ongoing contingent payments. By 2024, the company disclosed that there was a remaining milestone payment related to the 2020 acquisition of fairlife, contingent on fairlife achieving certain financial targets through 2024, with the payment scheduled for 2025. This indicates that Coca-Cola's relationship with fairlife has evolved from a completed acquisition in 2020 to one where a performance-linked financial obligation remains active through 2024.",
      "llm_answer": "In the 2022 filing Coca‑Cola’s fairlife relationship was limited to the acquisition of the remaining ownership interest, which was recorded as a $902 million gain and a $40 million tax benefit (KO 10‑K 2022 p.55; p.53). By the 2024 filing the company reports a $6.126 billion contingent‑consideration liability for a milestone payment that is contingent on fairlife meeting specified financial targets through 2024, and it has already paid $275 million toward that milestone in 2023 (KO 10‑K 2024 p.111‑112).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, Coca-Cola made no mention of ongoing contingent payments related to fairlife, but the LLM incorrectly claims a $6.126 billion contingent-consideration liability was reported in 2024 and that $275 million was paid in 2023—none of which is supported by the original answer. The $902 million gain and $40 million tax benefit mentioned are not in the ground truth and appear to be fabricated or misattributed. (2) Quantitatively, all key numbers are incorrect: the original answer does not specify any dollar amount for the contingent payment, only that one remains due in 2025 based on performance through 2024. The LLM invents precise figures ($6.126 billion, $275 million) with false citations, failing basic quantitative accuracy. (3) The multi-hop reasoning is flawed: while the LLM attempts to show evolution from 2022 to 2024, it misrepresents both years’ disclosures. The original answer emphasizes the emergence of a previously unmentioned contingent payment by 2024, not the existence of a massive liability and partial payment. The LLM fails to correctly synthesize the nature of the contingent obligation as newly disclosed rather than actively paid down. (4) Contextual relevance is moderate because the answer addresses the right topic (Coca-Cola’s financial relationship with fairlife and contingent payments) and the correct timeframe (2022–2024), but the factual foundation is severely compromised. The mention of specific 10-K page numbers adds false credibility. Overall, the answer is mostly incorrect with major errors in facts, numbers, and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 458,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has Oracle's strategic positioning of Oracle Cloud Services evolved between 2022 and 2024, particularly in terms of integration with enterprise applications and infrastructure technologies?",
      "original_answer": "In 2022, Oracle emphasized the transformational potential of Oracle Cloud Services, particularly highlighting the Oracle Autonomous Database as a key OCI offering that utilized machine learning to enable leaner business processes and automation. The focus was on flexibility, interoperability, and customer choice across deployment models, including cloud-based, hybrid, and on-premise environments. By 2024, Oracle expanded this positioning by describing Oracle Cloud Services (including SaaS and OCI) as comprehensive and integrated offerings that provide customers with a full suite of applications and infrastructure services. The 2024 filing explicitly frames Oracle Cloud Services as enabling customers to 'choose the best option that meets their specific business needs,' indicating a more mature and customer-centric strategic approach. This evolution reflects a shift from promoting individual innovations (e.g., Autonomous Database) to positioning Oracle Cloud Services as a holistic, integrated platform for enterprise IT transformation.",
      "llm_answer": "In the 2022 filing Oracle described its Cloud Services as a flexible, interoperable suite that bundles SaaS and OCI to help customers migrate and run their existing on‑premise applications and infrastructure on Oracle’s cloud, emphasizing that its applications and infrastructure technologies are the “building blocks” of both Oracle‑run and customer‑run clouds (2022 p. 6‑7). By the 2024 filing the company positions Oracle Cloud Services as a single, comprehensive platform—Oracle SaaS together with OCI—delivered as a managed, subscription‑based service that tightly integrates enterprise applications with the underlying infrastructure, giving customers a choice‑driven, fully integrated cloud experience (2024 p. 72‑73). This marks a shift from a migration‑and‑flexibility narrative to a more unified, service‑centric strategy that stresses seamless application‑infrastructure integration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Oracle's 2022 emphasis on flexibility, interoperability, and migration support for on-premise applications is accurately described, as is the 2024 shift toward a unified, integrated platform. The evolution from promoting infrastructure 'building blocks' to a 'comprehensive platform' reflects the same strategic progression noted in the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable beyond correct use of years (2022 and 2024), which are accurate. (3) The multi-hop reasoning is sound—LLM correctly synthesizes Oracle's changing narrative across two time points and connects shifts in language around integration, customer choice, and service delivery. It captures the core shift from migration/flexibility to integration/service-centricity, matching the ground truth’s conclusion about a more mature, holistic positioning. (4) The only minor gap is that the LLM answer does not explicitly mention the Oracle Autonomous Database as a highlighted innovation in 2022, which is a specific detail included in the original answer. However, it compensates by referencing the 'building blocks' concept and integration of applications and infrastructure, which are thematically consistent. Overall, the answer is semantically equivalent and contextually precise, with only a slight omission of a supporting detail. Hence, a correctness score of 9 is warranted.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1497,
        "completion_tokens": 432,
        "total_tokens": 1929
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has the treatment or status of the Key/Specified Employee Policy evolved between the 2023 and 2024 SEC filings, particularly in terms of its documentation and incorporation by reference?",
      "original_answer": "In the 2023 filing, the Key/Specified Employee Policy was introduced as part of the company's disclosures, specifically incorporated by reference to Exhibit 10(v) from the Annual Report on Form 10-K for the year ended December 31, 2018. By 2024, the policy was no longer newly introduced but was instead announced as a continuing policy, still relying on the same Exhibit 10(v) from the 2018 filing. This indicates that while the policy remained in place, there were no new amendments or updates to its documentation during this period.",
      "llm_answer": "In the 2023 Form 10‑K the Key/Specified Employee Policy is listed as Exhibit 10(r)* and is incorporated by reference to Exhibit 10(v) of the company’s 2018 Form 10‑K Annual Report 【page_17】. The 2024 Form 10‑K shows the same Exhibit 10(r)* and still incorporates the policy by reference to the same 2018 Annual Report (Exhibit 10(v)) 【page_20】, indicating that its documentation and filing status have not changed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in all key aspects: it accurately identifies that the Key/Specified Employee Policy in both the 2023 and 2024 filings is incorporated by reference to Exhibit 10(v) of the 2018 Form 10-K, and correctly notes that the documentation and reference have not changed. The exhibit number listed in the 2023 and 2024 filings is correctly cited as Exhibit 10(r)* in the LLM answer, which aligns with the actual filing structure (where Exhibit 10(r)* refers to the policy and incorporates Exhibit 10(v) from 2018). The only minor discrepancy is that the original answer emphasizes the policy's evolution from 'newly introduced' in 2023 to 'continuing' in 2024, a nuance slightly underemphasized in the LLM response, though the core factual continuity is correctly conveyed. All dates (2018, 2023, 2024) and exhibit references are accurate. The reasoning correctly synthesizes information across years and filings, demonstrating sound multi-hop logic. Wording differs slightly but maintains semantic equivalence. No calculation errors. Contextual relevance is perfect—directly addresses documentation and incorporation by reference as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 328,
        "total_tokens": 1576
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the aggregate principal balance of the 6.700% notes due 2028 evolve between 2022 and 2023, and what does this indicate about RTX's debt management strategy?",
      "original_answer": "In 2022, the aggregate principal balance of the 6.700% notes due 2028 was $115 million. By 2023, this amount increased significantly to $285 million. This indicates that RTX increased its outstanding debt related to this particular note, suggesting a strategic decision to retain or expand exposure to this fixed-rate debt instrument.",
      "llm_answer": "The 6.700% notes due 2028 carried an aggregate principal balance of **$285 million at the end of 2022 and the same $285 million at the end of 2023** (see the long‑term debt tables for 2022 and 2023)【page_84】【page_94】.  Keeping this tranche unchanged indicates RTX deliberately left this portion of its debt untouched, preserving a stable maturity profile while focusing its refinancing and repayment activity on other issuances.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. According to the ground truth, the aggregate principal balance of the 6.700% notes due 2028 was $115 million in 2022 and increased to $285 million in 2023. The LLM incorrectly states that the balance was $285 million at the end of both 2022 and 2023, which misrepresents the evolution of the debt. This error fundamentally undermines the answer’s correctness. (2) The quantitative accuracy is severely compromised: the 2022 figure is off by $170 million, and the reported stability is false. The actual data shows a significant increase, which the LLM fails to capture. Calculations or comparisons based on this data would be invalid. (3) The multi-hop reasoning is flawed. The LLM draws a conclusion about RTX’s debt management strategy—claiming the company 'deliberately left this portion of its debt untouched'—which contradicts the ground truth indicating a strategic expansion of this debt tranche. The reasoning is internally consistent with its incorrect data but fails to synthesize the correct information across years. (4) Contextual relevance is moderate: the answer addresses the right metric (aggregate principal balance) and company (RTX) and attempts to interpret strategy, but due to incorrect numbers and resulting flawed interpretation, the overall accuracy is very low. Minor point: citation of pages 84 and 94 may reflect real locations in filings but do not excuse the factual inaccuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1195,
        "completion_tokens": 412,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the carrying value and effective interest rate of TMO's 1.95% 12-Year Senior Notes evolve between 2023 and 2024?",
      "original_answer": "In 2023, the carrying value of the 1.95% 12-Year Senior Notes was $773 million with an effective interest rate of 2.08%. In 2024, the carrying value decreased to $725 million, and the effective interest rate slightly declined to 2.07%. This indicates a reduction in the financial liability associated with these notes and a marginal improvement in the effective borrowing cost.",
      "llm_answer": "The 1.95 % 12‑year senior notes (due 7/24/2029, euro‑denominated) were carried at $773 million at the end of 2023 and fell to $725 million at the end of 2024, a reduction of about $48 million.  Their effective interest rate slipped slightly, from roughly 2.08 % in 2023 to about 2.07 % in 2024【page_62】【page_47】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the carrying value in 2023 is correctly stated as $773 million and in 2024 as $725 million, with an implied $48 million decrease (773 - 725 = 48), which is accurate. The effective interest rate is correctly reported as 2.08% in 2023 and 2.07% in 2024. Minor wording variations such as 'slipped slightly' or 'roughly' are acceptable and do not affect factual accuracy. (2) The answer is complete, addressing both parts of the question—the evolution of carrying value and effective interest rate—over the two years. (3) Entity accuracy is correct: TMO's 1.95% 12-Year Senior Notes are properly identified, and the years 2023 and 2024 are correctly referenced. The additional detail about the maturity date (7/24/2029) and euro-denomination, while not in the original answer, is contextually relevant and does not contradict the ground truth. (4) The reasoning is sound: the LLM correctly synthesizes data across time periods and financial metrics, showing a clear understanding of how the carrying value and interest rate evolved. The conclusion implied by the data—reduction in liability and slight improvement in borrowing cost—is consistent with the original answer. (5) Semantic equivalence is maintained: despite slightly different phrasing, the core information and implications are identical. All citations (page_62, page_47) support the data. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1165,
        "completion_tokens": 418,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "What are the corporate governance implications of the change in how BNY Mellon presents its Directors' Code of Conduct between its 2022 and 2024 SEC filings?",
      "original_answer": "In 2022, BNY Mellon explicitly detailed the availability of the Directors' Code of Conduct on its website with a direct URL link, and it was referenced within the broader context of corporate governance disclosures and ethics policies. By 2024, the Code was listed among other governance materials—such as committee charters and by-laws—without a direct link or specific mention of updates or amendments. This shift in presentation may signal a more streamlined or consolidated approach to governance disclosures, potentially reducing the visibility of the Code as a standalone document. While the Code remains accessible, the change could affect transparency and stakeholder engagement with the specific ethical expectations for directors, which may influence perceptions of governance accountability.",
      "llm_answer": "In the 2022 Form 10‑K the Directors’ Code of Conduct was tucked under a broad “Code of Ethics” section, with a simple web link and a statement that any amendments or waivers would be posted online. By the 2024 filing, the Directors’ Code of Conduct is listed together with the corporate‑governance guidelines, bylaws and committee charters as a formal document incorporated by reference. This change elevates the code from a peripheral ethics posting to a core governance instrument, reinforcing board accountability, transparency and the enforceability of director‑level standards.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the nature and direction of the change in presentation of the Directors' Code of Conduct. The original answer states that in 2022, BNY Mellon provided a direct URL and explicit reference to the Code within ethics and governance disclosures, but by 2024, it was grouped with other governance documents without a direct link or mention of updates—indicating reduced visibility. In contrast, the LLM claims the 2024 presentation 'elevates' the Code as a 'core governance instrument,' which contradicts the ground truth that suggests diminished prominence. This misrepresents the corporate governance implications entirely. (2) There are no numeric values, dates, or calculations in the question or answers beyond the years 2022 and 2024, which are correctly used in both answers—so quantitative accuracy is not an issue. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers that incorporation by reference and grouping with other documents signifies elevation in importance, when the ground truth interprets this as a move toward consolidation that may reduce transparency and stakeholder engagement. The LLM fails to recognize that removal of a direct link and lack of specific mention of amendments weakens accessibility and accountability, contrary to its claim of increased transparency and enforceability. (4) While the answer addresses the question's topic and timeframe, its core conclusion is opposite to the ground truth, warranting a low correctness and qualitative accuracy score. Contextual relevance is moderate because it discusses the right documents and years, but draws incorrect inferences.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 464,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has Amazon's Short-Term Credit Agreement evolved between 2023 and 2024, particularly in terms of facility size, maturity date, and the timing of its establishment?",
      "original_answer": "In 2023, Amazon entered into a $5.0 billion unsecured 364-day revolving credit facility (Short-Term Credit Agreement) in November, replacing the prior agreement from November 2022, with a maturity date in October 2024. In 2024, Amazon again entered into a new $5.0 billion unsecured 364-day revolving credit facility in October, replacing the 2023 agreement, with a maturity date in October 2025. The facility size remained the same at $5.0 billion, but the establishment date shifted from November to October, and the maturity date moved forward by one year, indicating a procedural renewal rather than a substantive change in the credit structure.",
      "llm_answer": "In the 2023 Form 10‑K Amazon disclosed that it entered a $5 billion unsecured 364‑day revolving “Short‑Term Credit Agreement” in **November 2023**, which **matures in October 2024** (with one optional 364‑day extension). In the 2024 Form 10‑K the company replaced that facility with a new **$5 billion unsecured 364‑day revolving agreement signed in October 2024**, extending the **maturity to October 2025** (again with a one‑period extension option). Thus the facility size stayed at $5 billion, the maturity was pushed out by one year, and the agreement was re‑established roughly a year after the original signing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: facility size ($5 billion), 364-day term, unsecured revolving nature, establishment in November 2023 (maturity October 2024), and replacement in October 2024 with maturity in October 2025. (2) Quantitative accuracy is perfect: dates and dollar amounts match exactly, and the one-year maturity extension is correctly noted. (3) Multi-hop reasoning is sound—information is correctly synthesized across the 2023 and 2024 10-K filings. The only minor shortcoming is that the LLM does not explicitly state that the 2024 agreement 'replaced' the 2023 one in the same procedural manner as the prior year (though it is implied), and it omits the explicit comparison that the establishment date shifted from November to October as part of a pattern. However, this is a nuance in framing rather than a factual error. (4) The answer is fully contextually relevant, directly addressing facility size, maturity, and timing of establishment. Wording differs slightly (e.g., 'pushed out' vs 'moved forward'), but semantic equivalence is maintained. No calculation errors. Overall, this is a strong, factually correct response with only negligible omissions in contextual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 358,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has AMD's APU strategy evolved from 2022 to 2024 in terms of product integration and target markets, and what implications does this shift have for its revenue potential in the AI PC segment?",
      "original_answer": "In 2022, AMD emphasized external GPU-based solutions for AI and HPC workloads, particularly through the Instinct MI200 series and Radeon PRO V620 GPUs, focusing on data center and cloud applications. By 2024, AMD had shifted toward integrating dedicated AI acceleration directly into client devices, becoming the first company to include a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs. This strategic pivot toward integrated APUs with NPU cores indicates a move to capture revenue growth in the emerging AI PC market, where on-device AI processing is becoming critical. This evolution likely enhances AMD's revenue potential by positioning it as a differentiated player in the AI PC segment, moving beyond traditional CPU-GPU combinations.",
      "llm_answer": "In 2022 AMD’s APU strategy was focused on integrating a CPU and a GPU on a single chip to deliver visual‑processing capability for value‑oriented and mainstream PCs (page 8). By 2024 the company added a dedicated neural‑processing unit (NPU) to its APUs – the Ryzen AI 300 Series – positioning them for next‑generation AI PCs (page 7; page 5). This shift expands AMD’s addressable market into the fast‑growing AI‑PC segment, creating a new high‑margin revenue stream and giving the company upside to increase AI‑PC sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly identifies AMD's 2022 APU strategy as integrating CPU and GPU on a single chip for mainstream PCs, consistent with the original answer's emphasis on external GPU solutions for data center and cloud, though it slightly reframes the focus toward client devices. (2) The 2024 shift to including a dedicated NPU in Ryzen AI 300 Series APUs is accurately stated, matching the ground truth's claim that AMD became the first to integrate an NPU with an x86 CPU on the same SoC. (3) The reasoning is sound: the evolution from integrated CPU-GPU to CPU-GPU-NPU represents a strategic pivot toward AI PCs, which the model correctly links to expanded addressable markets and new high-margin revenue streams. (4) The implications for revenue potential in the AI PC segment are correctly interpreted—positioning AMD as a differentiated player—though the original answer adds nuance by contrasting 2022's data center focus with 2024's client-side AI shift, which the LLM answer omits. However, this does not undermine the core correctness. All entities (AMD, APU, NPU, Ryzen AI 300 Series), years (2022, 2024), and strategic implications are accurate. Minor deduction in qualitative accuracy due to less explicit contrast between external vs. on-device AI strategies across years, but overall semantic equivalence is strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 387,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has the treatment of Irish income tax liability for U.S. shareholders receiving dividends from Medtronic evolved between 2023 and 2024, particularly in relation to the Irish dividend withholding tax?",
      "original_answer": "In both 2023 and 2024, dividends paid by Medtronic were generally subject to Irish dividend withholding tax at a rate of 25 percent unless an exemption applied. For U.S. residents, exemptions were available based on residency documentation, such as a valid U.S. Certification of Residence (Form 6166) or Irish Non-Resident Form V2. In both years, a U.S. resident who met the exemption criteria and did not hold shares through an Irish branch generally had no Irish income tax liability. Additionally, if a U.S. shareholder was subject to the 25% withholding tax, the payment discharged any Irish income tax liability, provided the shareholder submitted the required statement to the Irish Revenue authorities. There was no change in the tax rate or in the conditions for exemption between the years, indicating a stable regulatory framework.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K state the same rule: Irish dividends are subject to a 25 % withholding tax unless a U.S. shareholder qualifies for an exemption (U.S. address on the broker’s records for DTC holdings or a valid Form 6166/Irish Form V2 for record owners). If a U.S. shareholder does incur the withholding tax, that payment discharges any Irish income‑tax liability once the shareholder provides a statement to the Irish Revenue. The language and treatment are unchanged between the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: the 25% Irish dividend withholding tax rate, the availability of exemptions for U.S. shareholders via Form 6166 or Irish Form V2, the discharge of Irish income tax liability upon withholding (with submission of a statement), and the absence of changes between 2023 and 2024. (2) Quantitative accuracy is perfect: the 25% rate is correctly stated, and no erroneous calculations are present. (3) The reasoning is sound and reflects proper multi-hop synthesis across both years and tax jurisdictions. The only minor omission is that the original answer specifies that U.S. residents not holding shares through an Irish branch generally have no Irish income tax liability when exempt—this nuance is missing in the LLM response, slightly reducing completeness. Additionally, the LLM mentions 'U.S. address on the broker’s records for DTC holdings' as a condition, which is not explicitly detailed in the ground truth, though it may be an operational implementation of the exemption process. This addition does not contradict but slightly extends the original without confirmation. (4) Despite this, the answer is contextually fully relevant, directly addressing the evolution (or lack thereof) in tax treatment between 2023 and 2024. Overall, the response is factually aligned, well-reasoned, and semantically equivalent to the ground truth with only minor omissions or rephrasing differences.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 416,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the risk disclosure around new products and services evolved between 2022 and 2024, particularly regarding the company's platforms operating model initiative?",
      "original_answer": "In 2022, BNY Mellon highlighted that new lines of business, new products and services, or transformational or strategic project initiatives subject the company to new or additional risks. By 2024, this risk disclosure evolved to specifically include the 'transition to a platforms operating model' as a new source of uncertainty. The 2024 filing explicitly states that the company 'may not realize some or all of the expected benefits of our transition to a platforms operating model,' indicating a more focused risk related to this specific strategic initiative. This evolution shows a shift from general strategic risk language to a more concrete acknowledgment of platform-specific implementation risks.",
      "llm_answer": "In the 2022 Form 10‑K the risk‑factor section only warned that “new lines of business, new products and services … subject us to new or additional risks,” but it did not call out the platforms operating model at all (see 2022 page 4). By the 2024 filing the same language about new products and services remains, and a new bullet was added stating the company “may not realize some or all of the expected benefits of our transition to a platforms operating model” (see 2024 page 5), while the forward‑looking statements also explicitly reference the “transition to a platforms operating model” as a strategic initiative (see 2024 page 3). This reflects an evolution from a generic new‑product risk to a specific risk tied to the platforms operating model initiative.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately captures the evolution of risk disclosure between 2022 and 2024: in 2022, BNY Mellon used general language about new products and services introducing new risks, while in 2024 it added specific language about the platforms operating model initiative. The key quote from 2024 — 'may not realize some or all of the expected benefits of our transition to a platforms operating model' — is correctly cited. (2) There are no numerical values to verify, but the years (2022 and 2024) and document references (page numbers) are consistent with the knowledge graph and support the claim. Format variations are not applicable here, but the temporal and contextual references are precise. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different years of Form 10-K filings, identifies the addition of a new risk factor, and interprets the shift from generic to specific risk disclosure. It also notes that the forward-looking statements in 2024 explicitly reference the initiative, adding contextual depth. (4) The semantic meaning matches the original answer exactly — both describe a shift from general strategic risk to a focused acknowledgment of platform-specific implementation risks. All entities (BNY Mellon, platforms operating model, Form 10-K, years) are correct. The answer is highly relevant, complete, and factually accurate, warranting top scores across all categories.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 415,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Amazon's relationship with the 3.600% Note due 2032 evolved between 2023 and 2024, particularly in terms of its debt instrument disclosures?",
      "original_answer": "In 2023, the 3.600% Note due 2032 was disclosed as part of a Supplemental Indenture dated April 13, 2022, among Amazon.com, Inc., Wells Fargo Bank, National Association (as prior trustee), and Computershare Trust Company, National Association (as successor trustee). In 2024, the same note was referenced under the same Supplemental Indenture, but the trustee structure now only referenced Computershare Trust Company, National Association, as successor trustee, indicating a formal transition away from Wells Fargo Bank. This reflects a procedural evolution in the administration of the note, with no changes to the note’s terms or interest rate, but a shift in the trustee relationship.",
      "llm_answer": "In the 2023 Form 10‑K Amazon listed the 3.600 % Note due 2032 as a component of its supplemental indenture (Exhibit 4.2) – the note is explicitly named among the long‑term debt instruments (see 2023 p. 74). By the 2024 filing the exhibit list no longer includes that note (the 2024 exhibit schedule on p. 76 shows only other certificates and does not mention the 3.600 % Note), indicating the instrument has been retired, repurchased or otherwise removed from Amazon’s disclosed debt portfolio.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in its core claim. (1) It incorrectly states that the 3.600% Note due 2032 was removed from Amazon's 2024 disclosures and implies retirement or repurchase, which contradicts the ground truth: the note was still disclosed in 2024 under the same Supplemental Indenture. The ground truth confirms continuity in the note’s existence and terms. (2) Quantitatively, the interest rate (3.600%) and maturity year (2032) are correctly identified, earning partial credit, but there are no calculations to verify. However, the claim about exhibit omission in 2024 (p.76) is factually wrong—the note remains referenced under the same indenture. (3) The multi-hop reasoning fails: instead of recognizing the trustee transition from Wells Fargo to Computershare as an administrative update, the model falsely infers debt retirement based on exhibit listing changes, showing flawed logic. (4) Contextually, the answer addresses debt instrument disclosures and cites document pages, so it appears relevant, but the conclusion is factually unsupported. The ground truth emphasizes a procedural trustee change, not instrument removal. Thus, while the question is approached with some structural fidelity, the factual and reasoning errors are severe, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 361,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How did MDLZ's treatment and disclosure of net investment hedge derivative contracts evolve from 2023 to 2024, particularly in terms of their financial impact and presentation within the financial statements?",
      "original_answer": "In 2023, MDLZ disclosed the fair value of derivative assets and liabilities associated with net investment hedge contracts, with $1,347 million and $377 million in other current assets and $250 million and $413 million in other assets as of December 31, 2023 and 2022, respectively. By 2024, the focus shifted to the income statement impact, where the company noted that 'Other income, net' included amounts excluded from the assessment of hedge effectiveness related to these contracts, indicating a change in emphasis from balance sheet valuation to income volatility effects.",
      "llm_answer": "In 2023 MDLZ reported its net‑investment‑hedge derivatives as a **net liability** of roughly $219 million (fair‑value) – shown in the derivative‑volume table as $163 million of asset contracts offset by $382 million of liability contracts and reflected as a $185 million after‑tax loss in other comprehensive earnings【page_94†L13-L21】【page_96†L13-L21】. By 2024 the same hedges were presented as a **net asset** of about $255 million (fair‑value), with $305 million of asset contracts and only $50 million of liability contracts, and the footnote still classifies them as accounting hedges but now shows a positive fair‑value impact that flows through other income【page_94†L13-L21】【page_95†L13-L21】. The disclosure therefore shifted from a negative‑valued hedge liability in 2023 to a positive‑valued hedge asset in 2024, while remaining recorded at fair value on the consolidated balance sheet and disclosed in the same derivative‑volume and fair‑value tables.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that in 2023, MDLZ disclosed derivative assets of $1,347 million in other current assets and $250 million in other assets, with corresponding liabilities of $377 million and $413 million in 2023 and 2022 respectively. The LLM incorrectly reports net liability of $219 million in 2023 and net asset of $255 million in 2024 based on its own calculations from purported asset and liability figures ($163M asset vs $382M liability in 2023; $305M vs $50M in 2024), none of which appear in the original answer or align with the disclosed numbers. These figures are not supported by the ground truth and appear fabricated or misread from source material. (2) There is a complete mismatch in numerical data: the original answer emphasizes balance sheet classification (other current assets, other assets) and provides specific values for two years, while the LLM invents a net liability/asset narrative with different totals and no mention of the actual line items. The shift from liability to asset is not stated in the original and cannot be validated due to mismatched inputs. (3) Qualitatively, the LLM captures a change in presentation emphasis—mentioning fair value disclosure in both years and suggesting a shift in financial impact—but mischaracterizes it as a balance sheet sign flip (liability to asset), whereas the original describes a shift in *disclosure focus* from balance sheet valuation to income statement effects (i.e., 'Other income, net' including amounts excluded from hedge effectiveness). This reflects a fundamental misunderstanding of the nature of the evolution. (4) Contextually, the response addresses the question about evolution in treatment and disclosure, and correctly identifies that derivatives remain on the balance sheet at fair value and are still designated as hedges, which shows some relevance. However, the core financial data and reasoning about the evolution are incorrect. The multi-hop synthesis fails because the model does not connect the correct data points across years or accurately represent the nature of the change in disclosure emphasis. Minor formatting variations are acceptable, but here the numbers are entirely inconsistent with the source. Thus, while the structure and intent of the answer are relevant, the factual foundation is unsound, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 646,
        "total_tokens": 2046
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the Abrams Main Battle Tank's modernization strategy evolved from 2023 to 2024, particularly in terms of technological development and international demand?",
      "original_answer": "In 2023, General Dynamics was focused on delivering the System Enhancement Package version 3 (SEPv3) for the Abrams tank, which included upgrades in communications, power generation, fuel efficiency, optics, and armor. Additionally, GD announced the development of the M1E3 Abrams, a more significant engineering change aimed at future threats, featuring the latest systems architecture for quicker upgrades and reduced sustainment footprint. By 2024, the company emphasized continued capability enhancement of the Abrams to counter current and potential threats, with increased international demand reflected in a growing installed base across Europe, the Middle East, North Africa, and the Indo-Pacific. While 2023 focused on the technical roadmap (SEPv3 and M1E3), 2024 highlighted the global strategic relevance and procurement momentum of the Abrams platform.",
      "llm_answer": "In 2023 General Dynamics said its Abrams‑modernization effort was focused on fielding the SEPv3 upgrade package and launching the new M1E3 program, noting “strong demand by NATO members and other allies and partners… reflected by a growing installed base in Europe, the Middle East, North Africa and Indo‑Pacific theaters”【page_10】. By 2024 the strategy remained the same on the technology side—continuing SEPv3 upgrades and advancing the M1E3—but the filing now emphasizes “upgrading Abrams tanks for several non‑U.S. partners” and highlights export opportunities to allies, showing that international demand stays robust and is being met through partner upgrades【page_10】【page_11】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2023, General Dynamics focused on the SEPv3 upgrade and initiated the M1E3 program; by 2024, the technological focus remained consistent, but there was increased emphasis on international demand and partner upgrades. The geographic regions cited—Europe, Middle East, North Africa, Indo-Pacific—are accurately reflected. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; dates (2023, 2024) are correct. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across years and strategic dimensions (technology development and international demand), linking 2023's technical roadmap with 2024's operational and export focus. (4) Semantic equivalence is strong—while the LLM uses slightly different phrasing (e.g., 'fielding the SEPv3' vs 'delivering SEPv3', 'launching the M1E3 program' vs 'development of M1E3'), the meaning is consistent. The only minor shortcoming is that the LLM does not explicitly mention the specific technical improvements in SEPv3 (communications, power generation, fuel efficiency, etc.) or the M1E3’s design goals (systems architecture, reduced sustainment), which slightly reduces qualitative completeness. However, the core evolution in strategy—from internal tech development to external deployment and international scaling—is correctly captured. Contextual relevance is excellent as it directly addresses both technological development and international demand across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 444,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has AMD's role in the development and positioning of APUs evolved between 2022 and 2024, particularly in terms of their market segmentation and strategic emphasis?",
      "original_answer": "In 2022, APUs were discussed as part of AMD's broader Enterprise, Embedded and Semi-Custom product portfolio, which included CPUs, GPUs, and customized SoC products. They were described in general terms without specific market segmentation or strategic emphasis. By 2024, APUs were explicitly included in two of AMD's four reportable segments: the Data Center segment and the Client segment. In the Data Center segment, APUs were listed alongside AI accelerators, CPUs, GPUs, and DPUs, indicating a strategic shift to position APUs as part of data center solutions. In the Client segment, APUs were specifically tied to desktop and notebook CPUs and chipsets, showing a more defined and segmented approach to their market positioning. This evolution reflects a more structured and strategic integration of APUs into AMD's core business segments.",
      "llm_answer": "In the 2022 filing AMD described its APUs as integrated CPU‑GPU chips that “deliver visual‑processing functionality for value and mainstream PCs” and are used in notebooks, embedded devices and semi‑custom consoles, emphasizing power‑efficiency, heterogeneous computing and a unified‑platform strategy for consumer‑grade markets【page_7】【page_8】【page_9】【page_10】. By the 2024 filing AMD now lists APUs as a distinct component of both the Client segment (desktops and notebooks) and the Data Center segment—signaling a strategic shift to leverage APUs for AI, HPC and cloud workloads while still serving traditional PC customers【page_69】【page_70】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of AMD's APU strategy between 2022 and 2024. In 2022, APUs were part of the broader Enterprise, Embedded and Semi-Custom segment, described with emphasis on consumer markets, power efficiency, and unified platforms—consistent with the original answer's characterization of general discussion without detailed segmentation. By 2024, the LLM correctly notes that APUs are now explicitly included in both the Client and Data Center segments, reflecting a strategic repositioning. (2) There are no numeric values, dates, or financial figures in dispute; all time references (2022, 2024) are correct and contextually appropriate. (3) The multi-hop reasoning is sound: the model synthesizes information across years and segments, correctly inferring a strategic shift in market segmentation and emphasis. The mention of AI, HPC, and cloud workloads in the Data Center context goes slightly beyond the original answer but is a reasonable interpretation given the inclusion of APUs alongside AI accelerators and other data center technologies. (4) The only minor shortcoming is that the original answer emphasizes the structural integration into reportable segments more clearly, while the LLM focuses on use cases. However, the core facts—segmentation into Client and Data Center, strategic elevation, and expanded positioning—are all correct. Wording differs but semantic meaning is equivalent. No factual errors present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 419,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has Medtronic's disclosure regarding the implications of the Financial Transfers Act 1992 on financial transfers between Ireland and third countries evolved from 2023 to 2024?",
      "original_answer": "In 2023, Medtronic disclosed that the Financial Transfers Act 1992 allowed the Irish Minister for Finance to impose restrictions on financial transfers with certain third countries, and that the list of such countries was subject to ongoing change. By 2024, the company continued to disclose the same regulatory framework but no longer emphasized the dynamic nature of the list of restricted countries, suggesting a potential shift in focus or a stabilization in the regulatory environment affecting these transfers.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K contain the same statement that the Irish Financial Transfers Act 1992 allows the Irish Minister for Finance to restrict “financial transfers” between Ireland and other countries, that the Minister has already imposed such restrictions on a number of third‑country jurisdictions, and that the list of restricted countries is “subject to ongoing change.” The wording of this disclosure is essentially unchanged from 2023 to 2024, indicating no new restrictions or material revisions to the statement.【page_31】",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in its description of the disclosure content and correctly identifies that the Financial Transfers Act 1992 allows the Irish Minister for Finance to restrict financial transfers with third countries, with the list being 'subject to ongoing change.' The quantitative accuracy is high—dates (2023, 2024), legal act name, and entity (Medtronic) are correct, and no numerical errors are present. However, the core of the question asks about the *evolution* of Medtronic's disclosure from 2023 to 2024. The ground truth states that while the regulatory framework was still disclosed in 2024, the emphasis on the 'dynamic nature' of the list of restricted countries was reduced, suggesting a shift in focus or stabilization. In contrast, the LLM claims the wording is 'essentially unchanged' and that the phrase 'subject to ongoing change' appears in both years, directly contradicting the ground truth which notes a de-emphasis of this point in 2024. This represents a critical failure in multi-hop reasoning and qualitative accuracy: the model did not detect or report the nuanced change in tone or emphasis, instead asserting no change when the ground truth indicates a subtle but meaningful evolution. While the answer is contextually relevant and addresses the right document and topic, it misses the key analytical point about disclosure evolution, resulting in a partially correct but ultimately misleading response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 399,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How did the status and production outlook of the G700 aircraft evolve from 2023 to 2024 based on GD's disclosures?",
      "original_answer": "In 2023, the G700 was described as the next model to join the Gulfstream lineup, with expectations for it to enter service following FAA certification in early 2024. By 2024, the G700 had begun deliveries in the second quarter, indicating that it successfully completed certification and transitioned from development to active production and customer delivery. This marks a clear evolution from a future product to a realized and delivered aircraft model.",
      "llm_answer": "In the 2023 Form 10‑K, General Dynamics said the ultra‑long‑range G700 was still awaiting FAA certification and was expected to enter service “following certification … in early 2024” (see page 5). By the 2024 filing, the company reported that the G700 had already begun deliveries in the second quarter of 2024 and that production was being ramped up, reflected in a rise in work‑in‑process inventory for the model (see page 70).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately reflects the status of the G700 in 2023 as awaiting FAA certification with expected entry into service in early 2024, citing the correct context from the 2023 Form 10-K. (2) For 2024, it correctly states that deliveries began in the second quarter and that production was ramping up, supported by a rise in work-in-process inventory, as disclosed in the 2024 filing. (3) The multi-hop reasoning—comparing disclosures across two years to show evolution from pre-certification to active delivery—is sound and well-supported. (4) All entities (G700, General Dynamics, FAA, 2023 and 2024 timeframes) are accurate, and the semantic meaning fully aligns with the original answer. Minor additions (e.g., mention of inventory) enhance completeness without introducing error. No factual, quantitative, or reasoning issues are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 267,
        "total_tokens": 1480
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the nature of PMI's relationship with KT&G evolved from 2023 to 2024, particularly in terms of strategic dependency and product commercialization?",
      "original_answer": "In 2023, PMI announced a long-term collaboration with KT&G to commercialize KT&G's smoke-free devices and consumables on an exclusive, worldwide basis (excluding South Korea), under a 15-year agreement running through January 29, 2038. This partnership granted PMI exclusive access to KT&G's smoke-free brands and product pipeline, including offerings for low- and middle-income markets. By 2024, this relationship had evolved into a more integrated dependency, as KT&G's heat-not-burn products were explicitly referenced as part of PMI's heat-not-burn product portfolio, indicating a shift from exclusive distribution to inclusion within PMI's broader smoke-free product strategy. This evolution reflects a deeper strategic alignment and operational integration of KT&G's offerings into PMI's product ecosystem.",
      "llm_answer": "In the 2023 filing PMI portrayed its KT&G deal as a 15‑year, exclusive, worldwide collaboration that gives PMI “continued exclusive access to KT&G’s smoke‑free brands and product‑innovation pipeline,” underscoring a strategic dependency on KT&G for new smoke‑free offerings (see page 59). By the 2024 filing the relationship is described mainly as a licensing arrangement—PMI’s heat‑not‑burn portfolio now “includes licensed KT&G heat‑not‑burn products” and the KT&G‑licensed brands Fiit and Miix are listed among its HTU offerings (see pages 38, 40‑41)—showing a shift from a broad strategic partnership to a more product‑specific commercialization model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 15-year term, exclusivity, global scope (excluding South Korea), and the evolution from a broad strategic partnership in 2023 to deeper integration by 2024. The reference to specific pages (e.g., 59, 38, 40–41) adds precision and matches the source documentation. (2) Quantitative accuracy is perfect: the 15-year agreement duration and timeline (running through 2038) are consistent with the original answer. No numerical errors. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information across two years of filings to show an evolution in the nature of the relationship. It identifies the shift from 'exclusive access' to 'licensed products included in portfolio' as evidence of deeper integration, which reflects the same conclusion as the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly mention the strategic significance of KT&G’s products for low- and middle-income markets, which is part of the original answer and adds context to PMI’s strategic dependency. However, this omission does not undermine the core correctness. The LLM captures the essential evolution: from exclusive commercialization to operational inclusion within PMI’s product ecosystem. Wording differs slightly (e.g., 'licensing arrangement' vs 'integrated dependency'), but the semantic meaning is equivalent. Overall, the answer is factually correct, well-supported, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 419,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has AMD's approach to semi-custom SoC products evolved from 2022 to 2024, particularly in terms of their strategic positioning and integration with broader product ecosystems?",
      "original_answer": "In 2022, AMD's semi-custom SoC products were described as being dependent on third-party product success, with revenue tied to both non-recurring engineering fees and the incorporation of AMD's SoCs into customer devices. There was a clear emphasis on the risks associated with this dependency, including the lack of control over third-party marketing and the uncertainty of revenue realization. By 2024, AMD's approach had evolved significantly, with semi-custom SoCs being positioned as core components of a broader, more integrated product ecosystem that includes AI accelerators, CPUs, GPUs, and APUs. The 2024 filing highlights strategic integration with AI capabilities, such as the inclusion of a dedicated neural processing unit (NPU) on the same SoC as an x86 CPU for AI PCs, and the use of semi-custom SoCs in gaming, cloud services, and embedded systems across multiple industries. This reflects a shift from a dependency model to a more proactive, integrated product leadership strategy.",
      "llm_answer": "In the 2022 filing AMD treated semi‑custom SoCs mainly as a revenue‑generating service – non‑recurring engineering fees and sales that depend on a third‑party’s product success and that the company has little control over (2022 p. 25). By the 2024 filing the company positions semi‑custom SoCs as a core, co‑engineered component of its broader high‑performance portfolio, tightly integrated with its Adaptive SoCs, chiplet platform, Infinity Architecture and software stack and used to power leading gaming consoles and handheld devices, reflecting a strategic, ecosystem‑wide approach (2024 pp. 5‑7).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in AMD's semi-custom SoC strategy from 2022 to 2024. (1) It correctly identifies the 2022 positioning as revenue-dependent on third-party success with limited control, citing non-recurring engineering fees and reliance on customer product adoption—consistent with the ground truth. In 2024, it accurately reflects the shift to a more integrated, strategic role within AMD’s broader portfolio, emphasizing co-engineering and ecosystem integration. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the ground truth or LLM response, so quantitative accuracy is not compromised; dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and filings to show a strategic shift. The LLM adds specific technical details (Adaptive SoCs, chiplet platform, Infinity Architecture, software stack) not in the ground truth but consistent with AMD's known ecosystem and plausibly present in the 2024 filing (pp. 5–7), enhancing precision without introducing inaccuracies. (4) The only minor gap is that the LLM omits explicit mention of AI integration (e.g., NPU in AI PCs) and the expansion into cloud services and embedded systems across industries—key elements in the ground truth’s description of the 2024 strategy. However, the reference to powering 'leading gaming consoles and handheld devices' aligns with known semi-custom applications. Overall, the answer conveys strong qualitative and contextual accuracy with near-complete alignment to the ground truth, warranting a 9/10 correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 448,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has the treatment of Irish income tax on dividends paid to U.S. residents evolved between 2023 and 2024, particularly regarding exemptions and withholding tax obligations?",
      "original_answer": "In 2023, Medtronic noted that U.S. residents who are exempt from Irish dividend withholding tax generally would not be subject to Irish income tax on dividends unless they had a connection to Ireland beyond shareholding. Additionally, non-residents subject to withholding tax typically had no further Irish income tax liability. In 2024, the company clarified that U.S. residents who qualify for a withholding tax exemption and do not hold shares through an Irish branch generally will not have Irish income tax liability, and those subject to withholding can discharge any further liability by furnishing a statement to Irish Revenue. The 25% withholding tax rate remained unchanged, but the 2024 disclosure provided more structured conditions for exemption and clarified post-withholding tax procedures.",
      "llm_answer": "In the 2023 filing (page 26) Medtronic explained that Irish dividend‑withholding tax (25 %) could apply, but U.S. shareholders who held their shares through the Depository Trust Company (DTC) with a U.S. address were exempt; those exempt from withholding were also not liable for Irish income tax on the dividend unless they had another Irish connection. The 2024 filing (page 31) keeps the 25 % rate but expands the exemption – a record‑owner can claim it by furnishing a U.S. Certification of Residence (Form 6166) or an Irish Non‑Resident Form V2, and it clarifies that any withholding tax paid discharges any Irish income‑tax liability on the dividend.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 25% Irish dividend withholding tax rate remained unchanged between 2023 and 2024, U.S. residents exempt from withholding generally avoid Irish income tax unless connected to Ireland, and those subject to withholding have no further liability. The LLM correctly identifies the exemption mechanisms in 2024 (Form 6166 or Form V2), which reflects the more structured conditions mentioned in the original answer. (2) Quantitative accuracy is perfect: the 25% rate is correctly cited, and no erroneous numbers are introduced. (3) The reasoning is sound and synthesizes multi-hop information across years and conditions—comparing 2023 exemption based on DTC/U.S. address to 2024's broader certification methods. The clarification that withholding discharges further liability matches the original's point about furnishing a statement to Irish Revenue. (4) Minor omission: the 2024 update about not holding shares through an Irish branch is not explicitly mentioned, which slightly reduces completeness. However, the core evolution—exemption expansion and finality of withholding tax—is accurately conveyed. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as it directly addresses the evolution in exemptions and tax obligations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 379,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did General Dynamics' financial performance and strategic focus in ship construction change from 2023 to 2024, particularly regarding cost pressures on the Virginia-class and DDG-51 programs and the revenue outlook for the Columbia-class submarine initiative?",
      "original_answer": "In 2023, General Dynamics' Marine Systems segment experienced a 110 basis point decline in operating margin due to supply chain disruptions affecting the Virginia-class submarine schedule and cost overruns on the DDG-51 guided-missile destroyer program. Despite these challenges, revenue from U.S. Navy ship construction rose, driven by increased activity on the Columbia-class submarine program. By 2024, the company projected revenue for the Marine Systems segment to rise to $12.8–12.9 billion with an expected operating margin of approximately 7.6%, suggesting a strategic effort to stabilize and improve profitability. This indicates a shift from cost-driven margin pressure in 2023 to a more optimistic outlook in 2024, likely supported by improved program execution and growth in the Columbia-class program.",
      "llm_answer": "In 2023 General Dynamics’ Marine Systems segment posted higher revenue ( $12.5 bn) largely from increased volume on the Columbia‑class submarine program, but its operating margin slipped to 7.0% because of supply‑chain cost pressures on the Virginia‑class submarine schedule and cost growth on the Arleigh Burke‑class (DDG‑51) destroyer program (page 36). For 2024 the company now projects Marine Systems revenue to rise to about $12.8‑$12.9 bn with an operating margin near 7.6%, indicating that cost pressures are expected to be contained and that the Columbia‑class submarine initiative remains a key revenue driver (page 37).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2023 operating margin decline to 7.0% (implied 110 basis point drop from prior year), $12.5B revenue in 2023, 2024 revenue projection of $12.8–12.9B, and expected margin improvement to 7.6%. The causes—supply chain disruptions on Virginia-class and cost overruns on DDG-51 (referred to correctly as Arleigh Burke-class)—are accurately identified. (2) Quantitative accuracy is perfect: all dollar figures, percentages, and ranges match or are consistent with the original answer. The margin improvement from 7.0% to 7.6% reflects the recovery mentioned in the ground truth. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes financial performance trends across years, identifies cost pressures in 2023, and links the improved 2024 outlook to better cost containment and Columbia-class revenue growth. (4) The only minor omission is the explicit mention of the '110 basis point decline'—though this is implied by the margin drop to 7.0%—and the answer slightly rephrases 'strategic focus' as 'key revenue driver', which is semantically acceptable. Overall, the answer is factually complete, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 357,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BKNG's financial dependency on Booking.com evolved between 2022 and 2023 based on the proportion of revenue derived from accommodation reservations?",
      "original_answer": "BKNG's financial dependency on Booking.com has remained high but slightly increased between 2022 and 2023. In 2022, Booking.com's accommodation reservations contributed 89% of BKNG's total revenues. This percentage remained unchanged in 2023, indicating BKNG continues to heavily rely on Booking.com for its revenue base. The consistent 89% contribution in both years shows a sustained and concentrated dependency on Booking.com's core service offering.",
      "llm_answer": "Booking.com’s accommodation‑reservation services generated roughly 89 % of Booking Holdings’ total revenue in both 2022 and 2023 (the filing notes “approximately 89 %, 89 % and 87 % … for the years ended 2023, 2022 and 2021” respectively)【page_87】. Thus, the company’s financial reliance on Booking.com stayed essentially flat over the period, with no material change in the revenue share.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Booking.com's accommodation reservations accounted for 89% of BKNG's revenue in both 2022 and 2023, which matches the ground truth. However, the LLM answer states that the percentage was 'approximately 89%, 89%, and 87%' for 2023, 2022, and 2021 respectively, implying that the 2023 and 2022 figures are both exactly 89%, which aligns with the ground truth. But the use of 'approximately' and the inclusion of 2021 (not asked) may suggest imprecision, though not incorrect. (2) The quantitative accuracy is high—percentages for 2022 and 2023 are correctly reported as 89%—but the answer introduces a nuance (the word 'approximately') and cites a source reference ('page_87') not present in the original, which may be fabricated or assumed. This slightly undermines trust in exactness. (3) The reasoning is mostly sound: the conclusion that financial reliance 'stayed essentially flat' is valid given unchanged percentages. However, the original answer notes a 'slightly increased' dependency, which contradicts 'flat'—but since the percentage did not change, the LLM’s 'flat' is more accurate than the original answer’s 'slightly increased'. Thus, the LLM is actually more factually correct in reasoning. (4) Contextual relevance is perfect—the response directly addresses the evolution of financial dependency via revenue proportion from accommodation reservations. The only discrepancy is the interpretation of trend: 'flat' vs 'slightly increased'—but given no numerical change, 'flat' is correct. The LLM loses points only because it introduces 'approximately' and extraneous 2021 data, slightly reducing precision and focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 458,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How did the company's position with respect to its Swiss Franc note evolve between 2023 and 2024, and what does this indicate about its foreign currency obligations?",
      "original_answer": "In 2023, the company disclosed a Swiss Franc note obligation of $299 million, which was completely removed by the end of 2024. This indicates that the company either repaid or restructured this foreign currency obligation over the year, reflecting a strategic shift in managing its Swiss Franc exposure.",
      "llm_answer": "The Swiss‑franc note was $299 million outstanding at December 31 2023 (Swiss franc note, 1.625 %, due 2024)【PM_10k_2023.pdf page 105】, but by December 31 2024 the line shows “‑” (no amount) after the CHF 250 note maturing in May 2024 was repaid【PM_10k_2024.pdf page 102】【PM_10k_2024.pdf page 107】. This removal of the note means PMI eliminated its Swiss‑franc‑denominated debt, thereby reducing its foreign‑currency obligations and exposure.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) Quantitatively, the $299 million Swiss Franc note obligation in 2023 is accurately reported, and its complete removal by the end of 2024 is correctly noted with the use of '—' in the 2024 filing. The maturity date (due 2024) and interest rate (1.625%) are additional accurate details not in the ground truth but consistent with proper sourcing. (2) The citation of repayment of the CHF 250 million note in May 2024 from the 2024 10-K (pages 102 and 107) provides valid support for the elimination of the obligation. (3) The reasoning is sound: the removal of the debt indicates a reduction in foreign currency obligations, which logically implies a strategic shift in managing Swiss Franc exposure, as stated in the original answer. (4) The LLM synthesizes information across two years’ filings (PM_10k_2023.pdf and PM_10k_2024.pdf), correctly identifying the evolution of the liability and its implications—this demonstrates accurate multi-hop reasoning. The answer is semantically equivalent to the ground truth, with slightly more detail, and fully addresses both parts of the question: the evolution of the position and the implication for foreign currency obligations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1190,
        "completion_tokens": 350,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did Goldman Sachs' treatment of Non-Employee Director RSU Award Agreements evolve between the 2023 and 2024 10-K filings, particularly in terms of introduced or modified agreements?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8, indicating that the existing documentation pertained to agreements prior to 2015. In the 2024 filing, the company not only retained the reference to the pre-2015 RSU Award Agreement but also introduced a new exhibit titled 'Amendments to Certain Non-Employee Director Equity Award Agreements' as Exhibit 10.18, which was not present in the 2023 filing. This indicates that Goldman Sachs expanded its disclosures to include amendments to these agreements, suggesting a more comprehensive or updated treatment of non-employee director equity arrangements in 2024.",
      "llm_answer": "In the 2023 Form 10‑K Goldman Sachs disclosed a pre‑2015 Non‑Employee Director RSU Award Agreement as Exhibit 10.8, the current RSU agreement as Exhibit 10.31, a cash‑settled version as Exhibit 10.32, and an amendment to certain director equity award agreements as Exhibit 10.17. In the 2024 filing the same three agreements are retained but renumbered – the pre‑2015 form is now Exhibit 10.9, the standard form is Exhibit 10.32, the cash‑settled form is Exhibit 10.33, and the amendment is Exhibit 10.18 – reflecting a re‑ordering of the exhibit schedule rather than the addition of new agreement types.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) According to the ground truth, the 2023 10-K only referenced the 'Form of Non-Employee Director RSU Award Agreement (pre-2015)' as Exhibit 10.8 — there was no mention of a 'current RSU agreement' as Exhibit 10.31, a cash-settled version as Exhibit 10.32, or an amendment as Exhibit 10.17 in 2023. These exhibits are entirely fabricated and not supported by the original data. (2) The claim that Goldman Sachs disclosed a 'current RSU agreement' and a 'cash-settled version' in 2023 is false per the ground truth, which states only the pre-2015 form was referenced. (3) The introduction of Exhibit 10.18 in 2024 as 'Amendments to Certain Non-Employee Director Equity Award Agreements' is correctly identified in the LLM answer, but it is falsely presented as a renumbering of a prior 2023 exhibit (10.17), when in fact this amendment was newly introduced in 2024 and did not exist in 2023. (4) The LLM incorrectly frames the change as a renumbering or reordering of exhibits rather than recognizing the substantive evolution: the addition of a new amendment exhibit in 2024 not present in 2023. This misrepresents the nature of the evolution in disclosure. (5) Multi-hop reasoning fails because the model does not correctly identify which agreements existed in each year, leading to a false narrative of continuity and reorganization instead of recognizing the actual change: expansion of disclosures in 2024 with a new amendment. While the mention of Exhibit 10.18 in 2024 aligns with the truth, the surrounding context is so distorted that the overall answer is largely incorrect. Quantitative accuracy is low due to incorrect exhibit numbers and implied existence of agreements that weren't in the 2023 filing. Qualitative accuracy suffers from flawed entity and document tracking. Contextual relevance is moderate because the answer addresses exhibit changes, but with wrong details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 530,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did PM's financial relationship with Swedish Match AB evolve between 2023 and 2024, particularly in terms of long-term debt obligations tied to the acquisition?",
      "original_answer": "In 2023, the long-term debt obligations related to the Swedish Match AB acquisition totaled $6,121 million, while in 2024, this amount decreased to $2,610 million. This indicates a significant reduction in the debt tied to the acquisition, suggesting that PM made substantial repayments or refinanced during the period. The decrease supports the idea that PM's financial dependency or exposure linked to the Swedish Match acquisition lessened over time.",
      "llm_answer": "By the end of 2023 PMI still carried €6.1 billion (≈ $6.1 bn) of Euro‑denominated credit‑facility borrowings that were tied to the Swedish Match acquisition. At year‑end 2024 that balance had fallen to €2.6 billion (≈ $2.6 bn) – the company prepaid the entire €3 billion (≈ $3.2 bn) 3‑year tranche of the €5.5 billion senior unsecured term‑loan facility in November 2024, leaving only the €2.5 billion 5‑year tranche (due 2027) outstanding. This reduction is reflected in the long‑term‑debt schedule, which shows the “Euro credit facility borrowings related to Swedish Match AB acquisition” dropping from $6,121 million in 2023 to $2,610 million in 2024.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, the numbers are accurate: $6,121 million in 2023 and $2,610 million in 2024 are reported exactly as in the original answer. The LLM correctly converts €6.1 billion and €2.6 billion to approximately $6.1 billion and $2.6 billion, which aligns with the dollar figures in the ground truth. (2) The explanation of the debt reduction is more detailed than the original, adding valuable context: the prepayment of the €3 billion (≈$3.2 billion) 3-year tranche in November 2024, leaving only the €2.5 billion 5-year tranche. This additional detail is consistent with the overall reduction and enhances the answer without introducing errors. (3) Entity accuracy is correct: PM (PMI), Swedish Match AB, and the correct time frame (2023–2024) are properly identified. (4) The reasoning is sound and demonstrates multi-hop synthesis: it connects the acquisition-related debt, its structure (term-loan facility), the timing of repayment, and the resulting balance change. (5) The semantic meaning fully matches the original: both convey a significant reduction in long-term debt obligations tied to the acquisition, from $6,121M to $2,610M, indicating reduced financial exposure. Minor differences in wording and added detail do not affect factual equivalence. All scoring categories warrant top marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 384,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How did BMY's strategic positioning around KRAS inhibition evolve from 2023 to 2024, particularly in relation to the acquisition of Mirati and the development trajectory of Krazati?",
      "original_answer": "In 2023, BMY had not yet acquired Mirati, and Krazati was not part of its portfolio. However, by 2024, BMY completed the acquisition of Mirati for $4.8 billion, gaining full rights to Krazati, a KRAS G12C inhibitor. Krazati had already received FDA approval for second-line NSCLC and was in clinical development for first-line NSCLC in combination with a PD-1 inhibitor. Additionally, in 2024, Krazati was also FDA approved for advanced or metastatic KRAS-mutated colorectal cancer with cetuximab, expanding its therapeutic footprint. This acquisition marked a significant evolution in BMY’s oncology strategy, positioning it more strongly in the KRAS inhibition space.",
      "llm_answer": "In 2023 BMS presented the Mirati deal as a way to add a “best‑in‑class” KRAS‑G12C inhibitor — Krazati — to its oncology portfolio, noting its FDA approval for second‑line NSCLC and the opportunity to expand the KRAS program with additional inhibitors and combination studies (see 2023 page 87). By 2024, after the acquisition closed, Krazati was recorded as a definite‑life marketed‑product right with FDA and EMA approvals for NSCLC and KRAS‑mutated colorectal cancer, and BMS was actively advancing it in first‑line PD‑1‑combination trials, cementing KRAS inhibition as a core, revenue‑generating focus (see 2024 pages 93‑94).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of BMY's (Bristol-Myers Squibb's) strategic positioning in KRAS inhibition from 2023 to 2024. It correctly notes that in 2023, BMS viewed the Mirati acquisition as a strategic move to gain access to Krazati, a best-in-class KRAS G12C inhibitor, which had already received FDA approval for second-line NSCLC. The answer accurately reflects that the acquisition was completed by 2024, aligning with the ground truth, though it omits the specific $4.8 billion price tag — a minor omission that does not undermine the overall correctness. The LLM correctly identifies Krazati’s expanded FDA approvals in 2024, including for KRAS-mutated colorectal cancer (with cetuximab), and notes EMA approvals as well, which is consistent with the broader regulatory trajectory. It also accurately highlights ongoing first-line combination trials with PD-1 inhibitors, reinforcing BMS’s strategic focus. The only minor gap is the lack of explicit mention of the $4.8 billion acquisition cost, which is present in the ground truth but not critical to the core narrative. All entities (BMS/BMY, Mirati, Krazati, KRAS G12C, NSCLC, PD-1) and timeframes (2023 vs 2024) are correctly identified and synthesized. The reasoning is sound, demonstrating multi-hop understanding: from pre-acquisition strategy to post-acquisition integration and clinical development. Wording differs slightly (e.g., 'definite-life marketed-product right') but maintains semantic equivalence. Quantitative accuracy is high — no incorrect numbers are stated, and the absence of the dollar amount is a small completeness issue rather than an inaccuracy. Overall, the answer is factually correct, contextually rich, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 474,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Goldman Sachs' disclosure and positioning of the Restricted Partner Compensation Plan evolved between 2023 and 2024, particularly in relation to newer compensation governance policies introduced during this period?",
      "original_answer": "In 2023, the Restricted Partner Compensation Plan was listed as Exhibit 10.3 and appeared early in the exhibit list, indicating a prominent position among compensation-related disclosures. By 2024, while the plan itself (still referenced as Exhibit 10.4) remained substantively unchanged, its relative placement shifted later in the exhibit list. Notably, in 2024, the firm introduced the Clawback Policy (Exhibit 10.1), signaling a new emphasis on compensation accountability and governance reforms. This suggests a strategic repositioning of compensation-related disclosures to prioritize risk mitigation and regulatory alignment alongside traditional partner compensation frameworks.",
      "llm_answer": "In the 2023 Form 10‑K the Restricted Partner Compensation Plan was disclosed simply as “The Goldman Sachs Amended and Restated Restricted Partner Compensation Plan” (exhibit 10.3, incorporated by reference to a 2006 10‑Q) and listed among the other compensation‑related exhibits. In the 2024 Form 10‑K the same plan appears again (now exhibit 10.4 with the identical reference) but is now positioned after a newly‑added “Amended and Restated Goldman Sachs Group Clawback Policy (effective Dec 1 2023)” and other updated compensation‑governance items (e.g., the 2021 Stock Incentive Plan), indicating that while the plan’s disclosure itself has not changed, Goldman Sachs has introduced newer governance policies—most notably the 2023 clawback rule—to strengthen oversight of its compensation programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Restricted Partner Compensation Plan was Exhibit 10.3 in 2023 and moved to Exhibit 10.4 in 2024, with no substantive change and the same 2006 10-Q reference. The introduction of the Clawback Policy in 2024 (Exhibit 10.1, effective Dec 1, 2023) is correctly identified. (2) Quantitative accuracy is perfect: exhibit numbers, years (2023, 2024, 2006, Dec 1 2023), and sequence are all factually correct. Format variations (e.g., 'Dec 1 2023' vs 'December 1, 2023') are acceptable. (3) Multi-hop reasoning is sound: the model correctly infers that the plan’s disclosure remained unchanged but its relative positioning shifted due to the addition of newer governance policies, particularly the clawback policy. This reflects a strategic repositioning in disclosure priorities. (4) The only minor shortcoming is that the LLM does not explicitly state that the exhibit list order implies a 'prominent' position in 2023 or that the shift 'suggests a strategic repositioning'—phrasing present in the original answer. However, the implication is clearly conveyed through the observation about new policies being listed first. Thus, the answer is semantically equivalent with only slight nuance missing. Contextual relevance is excellent, directly addressing the evolution of disclosure and positioning in relation to newer governance policies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 397,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of product categorization and business integration?",
      "original_answer": "In 2022, Philip Morris described its heat-not-burn products as part of its Reduced-Risk Products (RRPs) portfolio, emphasizing their role in a smoke-free future and highlighting the IQOS Platform 1 device and various heated tobacco units (HTUs) such as HEETS and Marlboro HeatSticks. These products were positioned as a key part of the company's long-term strategy to replace traditional cigarettes. By 2023, the categorization had evolved, with heat-not-burn products now explicitly grouped under 'smoke-free products' alongside e-vapor and oral nicotine products, as well as wellness and healthcare offerings. Additionally, in 2023, PMI explicitly stated that its heat-not-burn products include licensed KT&G heat-not-burn products, indicating a broader integration and expansion of the product line beyond internally developed offerings.",
      "llm_answer": "In the 2022 filing PMI defined its heat‑not‑burn offering simply as “Heated Tobacco Units (HTU),” covering a fixed set of brands – HEETS (and its Creations/Dimensions), Marlboro HeatSticks, Parliament HeatSticks, TEREA and the KT&G‑licensed Fiit and Miix (Item 1 Business, p. 5). By the 2023 filing the HTU definition was expanded to include new families (BLENDS, DELIA, SENTIA, TEREA Crafted, TEREA Dimensions) and a zero‑tobacco line (LEVIA) (Consolidated Operating Results, p. 40), and HTU performance is now reported within the broader “smoke‑free products” segment while the Swedish Match acquisition is shown as a separate segment that adds to the overall smoke‑free portfolio (Net Revenues by Product Category, p. 39).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of product names, categorization changes, and reporting structure, with no errors in dates or entities (e.g., correct mention of HEETS, Marlboro HeatSticks, KT&G-licensed Fiit and Miix, and new 2023 additions like LEVIA and BLENDS). Quantitative accuracy is perfect—no numerical claims are made that conflict with the ground truth, and all referenced document sections align contextually. However, the LLM misrepresents the evolution of product categorization: it states that in 2022 PMI defined heat-not-burn products simply as 'Heated Tobacco Units (HTU)' covering a fixed set, but the ground truth emphasizes that in 2022 these were part of the broader 'Reduced-Risk Products (RRPs)' portfolio, a strategic framing the LLM omits. Additionally, while the LLM correctly notes that HTU performance is now reported under 'smoke-free products' in 2023, it fails to mention the integration of oral nicotine and wellness/healthcare offerings into this category, which is a key aspect of the business integration evolution. The mention of Swedish Match as a separate segment is accurate but slightly off-focus, as the question centers on heat-not-burn integration, not adjacent acquisitions. The reasoning is sound in tracking product expansion and reporting changes, but misses the strategic repositioning from RRPs to 'smoke-free products' as an umbrella category. Thus, while the core facts and timeline are correct, the answer lacks full completeness and conceptual depth on the strategic integration aspect, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 438,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How did Bristol-Myers Squibb's approach to business risk governance evolve between 2023 and 2024 in relation to SEC Consent Order compliance, particularly regarding the role of the business risk and disclosure group?",
      "original_answer": "In 2023, Bristol-Myers Squibb established the business risk and disclosure group specifically to comply with the SEC Consent Order. This included implementing a formal review and certification process for SEC filings, retaining an outside consultant to re-engineer accounting and financial reporting processes, and introducing a governance mechanism to escalate and resolve compliance-related questions. By 2024, the company had fully integrated this group into its ongoing compliance framework, with no indication of modifications or reductions in scope, suggesting that the group remained a central component of financial governance under the Consent. The continued reference to the group in 2024 filings indicates that the company maintained its enhanced risk governance structure without significant changes.",
      "llm_answer": "In the 2023 filing BMS disclosed that, to satisfy the 2004 SEC Consent Order, it **created** a “business risk and disclosure group” as one of several new controls—including a formal SEC‑report review and a governance‑escalation process for any sales‑policy questions 【page_65】. By the 2024 filing the same group is no longer described as a new entity but as an **ongoing, integral part of a company‑wide policy** that continuously monitors compliance, escalates issues to senior management and, together with the other procedures, is deemed to provide a reasonable basis for meeting the Consent requirements 【page_63】【page_66】. This reflects a shift from establishing the group in 2023 to embedding and relying on it as a permanent governance mechanism in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Bristol-Myers Squibb (BMS) created the business risk and disclosure group in 2023 to comply with the SEC Consent Order, implemented a formal review process, and used an outside consultant (implied in 'new controls' and supported by context). By 2024, the group was embedded as an ongoing, integral part of governance. The evolution from 'new' in 2023 to 'ongoing, integral' in 2024 reflects the same conclusion as the original answer about integration into long-term compliance framework. (2) There are no numeric values, dates, or financial figures in dispute; all time references (2023, 2024) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesized information across two years of filings, identifying both the establishment and the institutionalization of the group. The conclusion about a shift from creation to embedding is logically supported. (4) Minor point: the original answer mentions retention of an outside consultant to re-engineer processes, which the LLM answer omits. However, this detail is contextual and not central to the core question about the group’s evolving role. The LLM emphasizes governance integration, which is the main thrust. Wording differs but semantic meaning matches. No inaccuracies—only slight incompleteness on a secondary detail. Hence, correctness score is 9 rather than 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 400,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has UNP's treatment of the relationship between its pension plan's expected return and its asset allocation mix evolved between 2023 and 2024?",
      "original_answer": "In 2023, UNP explicitly stated that the expected return on plan assets was based on the asset allocation mix, historical returns, and market conditions, and included a specific actual return of 6% for that year. By 2024, the language shifted to indicating that the expected return 'depends on' the asset allocation mix, with no explicit mention of historical returns or market conditions, and no disclosure of the actual return for 2024. This represents a shift from a more comprehensive explanation of factors influencing returns to a narrower focus on the asset allocation mix alone.",
      "llm_answer": "In the 2023 filing UNP explained that the pension‑plan’s expected return is “based on our asset‑allocation mix and our historical return, taking into account current and expected market conditions” and applied a 5.25% long‑term target rate. The 2024 filing repeats the same linkage—still tying the expected return to the asset‑allocation mix and historical performance with a 5.25% target—and merely adds the clarification that the expectation also reflects current and expected market conditions, indicating no substantive change in how the relationship is treated.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in multiple key aspects. The ground truth states that in 2023, UNP used a 6% actual return, but the LLM claims a 5.25% long-term target rate, which is not mentioned in the original answer and contradicts the disclosed 6% actual return. Additionally, the LLM asserts that the 2024 filing maintains the same linkage to historical returns and market conditions, but the ground truth explicitly states that by 2024, UNP no longer mentioned historical returns or market conditions and only stated that the expected return 'depends on' the asset allocation mix. The LLM incorrectly concludes there was no substantive change, while the original answer identifies a clear narrowing of explanatory factors. (2) Quantitative inaccuracy: the 5.25% figure is unsupported by the ground truth, which specifies a 6% actual return in 2023 and no disclosed return for 2024. There is no mention of a 'long-term target rate' in the original answer, making this a fabrication. (3) Multi-hop reasoning failed: the question requires comparing the evolution of disclosure language and assumptions between 2023 and 2024. The LLM misrepresents both years’ disclosures, failing to identify the shift from a broader set of factors (historical returns, market conditions) to a narrower focus on asset allocation alone. (4) Scores are low due to major factual errors in numbers, entities, and reasoning. The contextual relevance is moderate because the answer addresses the general topic of pension plan return assumptions and asset allocation, but the substance is incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 438,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did BNY Mellon's disclosure approach to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of its accessibility and integration within corporate governance reporting?",
      "original_answer": "In 2022, BNY Mellon explicitly stated that the Directors' Code of Conduct was posted on its website and outlined its applicability to all directors. The document was referenced in the context of broader corporate governance disclosures, including Board Meetings and Committee Information. By 2023, the Directors' Code of Conduct was no longer just referenced but was specifically listed among the governance materials 'available on our website,' alongside key governance documents like the Corporate Governance Guidelines and committee charters. This evolution indicates a more structured and centralized approach to governance disclosures, with the Code being more directly tied to the company's overall governance framework in the 2023 filing.",
      "llm_answer": "In the 2022 Form 10‑K, BNY Mellon listed the Directors’ Code of Conduct under Item 10 and gave a specific URL ( https://www.bnymellon.com/.../directors‑code‑of‑conduct.pdf ) while noting that any amendments or waivers would be posted on its website. In the 2023 filing, the Code is bundled with the corporate‑governance guidelines, bylaws and committee charters in the “Available Information” section, and the filing states that the entire set of governance documents—including the Directors’ Code—is freely accessible on the company’s website and incorporated by reference, showing a more integrated and prominently accessible disclosure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in BNY Mellon's disclosure approach between 2022 and 2023: in 2022, the Directors' Code of Conduct was explicitly posted with a direct URL under Item 10, and in 2023, it was integrated into a broader set of governance documents listed together. (2) There are no numeric values to verify, but dates (2022 and 2023) and document names (Directors’ Code of Conduct, corporate-governance guidelines, committee charters) are accurate. (3) The multi-hop reasoning is sound—comparing the placement, accessibility, and integration of the Code across two years—and correctly infers a more structured and centralized disclosure approach in 2023. (4) The LLM adds specific details not in the original answer (e.g., Item 10 reference, exact URL format), which are plausible and consistent with SEC filing structures, though not confirmed in the ground truth; this does not detract from accuracy but slightly exceeds the provided information. The answer captures the core evolution in accessibility and integration, matching the semantic meaning of the original answer. Only a minor deduction in qualitative accuracy due to the unverified specificity of the URL and 'incorporated by reference' phrasing, which, while reasonable, are not confirmed in the ground truth. Overall, the response is factually correct, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 399,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with engineered systems, and what does this indicate about the company's approach to cloud migration and hybrid IT environments?",
      "original_answer": "In 2023, Oracle emphasized the flexibility of running Oracle Database across multiple deployment models, including on-premise, Oracle Cloud, and multicloud environments, with specific offerings like Oracle Exadata Cloud@Customer and Oracle Roving Edge Infrastructure. These options were framed around enabling customers to securely run Oracle Database behind their firewalls while being managed by Oracle. By 2024, Oracle shifted toward deeper integration of Oracle Database within Oracle Engineered Systems, such as the Oracle Exadata Database Machine, which combines database, storage, operating system, and networking hardware into a single optimized platform. This system was highlighted as being available across on-premise, OCI cloud, and hybrid deployments. The evolution from flexible deployment of standalone database services to tightly integrated engineered systems suggests a strategic shift toward offering more holistic, performance-optimized solutions that align with enterprise needs for scalability, security, and simplified maintenance. This indicates a maturation of Oracle's cloud migration strategy, focusing not only on deployment flexibility but also on delivering comprehensive, high-performance infrastructure packages.",
      "llm_answer": "In 2023 Oracle framed the Oracle Database as a “flexible, open” platform that could be run on‑premise, in Oracle Cloud (OCI) or in a hybrid model such as Exadata Cloud@Customer, and it stressed that the database was tightly bundled with its engineered‑system portfolio (e.g., the Exadata Database Machine) to deliver superior performance, scalability and ease of maintenance (page 10; page 12; page 13). By 2024 the messaging was broadened to a full suite of hybrid‑ and multicloud options—including OCI Dedicated Region, OCI Sovereign Cloud, Oracle Alloy and Roving Edge—while still positioning the database (including Autonomous Database) as integrated with Exadata engineered systems and available as cloud, on‑premise, or hybrid services (page 11; page 12; page 13). This shift signals Oracle’s deeper emphasis on engineered‑system‑backed, deployment‑agnostic database offerings that simplify cloud migration and support customers’ increasingly hybrid IT environments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Oracle's 2023 positioning emphasized deployment flexibility (on-premise, OCI, hybrid via Exadata Cloud@Customer), and by 2024, the focus evolved toward deeper integration with engineered systems like Exadata, available across hybrid and multicloud models including OCI Dedicated Region, OCI Sovereign Cloud, Oracle Alloy, and Roving Edge. These offerings are correctly tied to Oracle’s strategy for cloud migration and hybrid IT. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all referenced programs, product names, and deployment models are factually accurate and consistent with the original answer. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information across years (2023 to 2024), deployment models, and product integrations, showing an evolution from flexibility to integrated performance. The conclusion about Oracle emphasizing engineered-system-backed, deployment-agnostic solutions accurately reflects the strategic shift. (4) Minor difference: the LLM mentions 'Oracle Alloy' and 'OCI Dedicated Region' more prominently, which are valid 2024 extensions but not explicitly detailed in the original answer; however, these are accurate additions that enhance completeness without distorting the core message. The original answer emphasizes 'tighter integration' more explicitly, while the LLM frames it as 'bundled' and 'integrated,' which is semantically equivalent. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with only slight variation in emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1584,
        "completion_tokens": 466,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the implementation of the formal review and certification process of annual and quarterly SEC reports evolved between 2023 and 2024, particularly in terms of compliance monitoring and governance procedures?",
      "original_answer": "In 2023, the company established a formal review and certification process of SEC filings as part of the Consent agreement, which included governance procedures to escalate potential compliance concerns to appropriate management levels and regular monitoring of compliance. By 2024, the company continued to emphasize the implementation of these governance procedures, noting that compliance with the policy was consistently monitored and that the process was integrated into company-wide sales policies to ensure adherence to inventory and sales limitations. The evolution reflects a shift from initial implementation in 2023 to sustained enforcement and integration into broader operational frameworks in 2024.",
      "llm_answer": "The 2023 Form 10‑K first disclosed that, under the SEC Consent Order, Bristol‑Myers Squibb instituted a formal review‑and‑certification process for its annual and quarterly reports, created a dedicated business‑risk and disclosure group, retained an outside consultant, and put in place a governance‑escalation path with “regular” compliance monitoring of the sales‑policy procedures【page_63】. The 2024 Form 10‑K repeats the same set of controls—formal review and certification, the risk‑disclosure group, external consultant support, and a governance process that escalates compliance questions and is monitored on an ongoing basis—showing that the initial 2023 measures have been institutionalized and are now a sustained, regularly‑monitored governance framework【page_65】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All key facts are correct: in 2023, the company implemented a formal review and certification process under a Consent agreement (referred to as 'Consent Order' in the LLM answer, which is semantically equivalent), established governance procedures including escalation paths and regular compliance monitoring, created a business-risk and disclosure group, and engaged an external consultant. The 2024 update confirms the continuation and institutionalization of these controls. (2) There are no numeric values requiring calculation, but all dates (2023 and 2024) and procedural elements are correctly cited. (3) The multi-hop reasoning is sound—information is synthesized across two years of 10-K filings, showing evolution from implementation to sustained enforcement. The LLM correctly infers that repeating the same controls in 2024 indicates institutionalization, which matches the ground truth's claim of 'sustained enforcement and integration'. (4) The only minor shortcoming is that the LLM does not explicitly mention the integration into 'company-wide sales policies' or 'inventory and sales limitations'—a detail present in the original answer that adds specificity about operational integration. However, it does reference monitoring of 'sales-policy procedures', which partially captures this idea. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with near-complete alignment to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 428,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Philip Morris International's approach to heat-not-burn products evolved from 2022 to 2023, particularly in terms of their market positioning and product categorization?",
      "original_answer": "In 2022, Philip Morris International (PMI) positioned heat-not-burn products as part of its broader Reduced-Risk Products (RRPs) portfolio, emphasizing their potential to present less harm to smokers who switch from traditional cigarettes. These products, including the Platform 1 device and its consumables, were described as being in various stages of development, scientific assessment, and commercialization. By 2023, PMI had refined its categorization, explicitly including heat-not-burn products within the smoke-free product segment, alongside e-vapor and oral nicotine products. Additionally, PMI began including licensed KT&amp;G heat-not-burn products in its portfolio, indicating a broader market approach and potential expansion of partnerships or offerings. This evolution shows a strategic shift from internal development focus to a more integrated and commercialized product positioning.",
      "llm_answer": "In the 2022 filing PMI described its heat‑not‑burn offerings only as part of the broader “Reduced‑risk products” umbrella and the “Platform 1” heating device, without a separate product line (PM_10k_2022.pdf p. 76). By the 2023 filing the company created a distinct “Heated Tobacco Units (HTU)” category that groups all heat‑not‑burn consumables—including HEETS, Marlboro HeatSticks, TEREA, Fiit, Miix and the zero‑tobacco LEVIA product—and positioned HTUs as a core growth driver, reporting a 14.7% rise in HTU shipments and a 14.8% increase in adjusted in‑market sales (PM_10k_2023.pdf p. 40‑41).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution in PMI's approach: in 2022, heat-not-burn products were part of the broader 'Reduced-Risk Products' (RRPs) category, specifically mentioning the Platform 1 device, which matches the original answer. By 2023, the LLM correctly notes the creation of a distinct 'Heated Tobacco Units (HTU)' category, signaling a strategic shift in product categorization and market positioning. (2) Quantitatively, the LLM accurately reports a 14.7% rise in HTU shipments and a 14.8% increase in adjusted in-market sales, with correct citation to the 2023 10-K (pp. 40–41). These figures are precise and support the claim of enhanced commercial focus. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings to show a shift from internal development (2022) to a more structured, growth-oriented commercial strategy (2023). (4) The only minor omission is that the LLM does not mention the inclusion of licensed KT&G products in 2023, which is part of the ground truth and indicates a broader partnership strategy. This is a small but relevant detail affecting completeness. However, the core facts, numbers, and strategic evolution are correctly conveyed. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 408,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Oracle's strategic positioning of Oracle Database evolved between 2023 and 2024 in terms of deployment flexibility and integration with other Oracle technologies?",
      "original_answer": "In 2023, Oracle emphasized the deployment flexibility of Oracle Database across cloud-based, on-premise, or other IT environments, highlighting its perpetual licensing model and the company's strategy to provide customer choice. By 2024, Oracle Database's role had evolved to become a foundational component within broader engineered systems, such as Oracle Exadata Database Machine, which integrates the database with storage, operating system software, and hardware components for optimized performance. This shift indicates a move toward deeper integration with Oracle's infrastructure technologies, positioning Oracle Database not just as a standalone product but as a core element of Oracle Engineered Systems, available in on-premise, cloud (OCI), and hybrid cloud deployments.",
      "llm_answer": "In the 2023 filing Oracle framed the Oracle Database primarily as a flexible‑deployment asset—customers could run it on‑premise, in the public Oracle Cloud or in hybrid‑cloud models and could “pivot” existing licenses to cloud‑based deployments. By the 2024 filing the database is positioned as a tightly integrated core of the OCI ecosystem—delivered as Autonomous Database, Exadata Cloud@Customer, OCI Dedicated Region, Sovereign Cloud and other edge options—and is bundled with Oracle Middleware, Java, APEX and multicloud networking, giving customers even broader choice to run the database across public, private and sovereign environments while leveraging the full suite of Oracle technologies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Oracle's 2023 emphasis on deployment flexibility across on-premise, cloud, and hybrid models, including license portability—matching the original answer's focus on customer choice and perpetual licensing. In 2024, it accurately reflects the strategic evolution toward deeper integration with Oracle technologies, particularly within OCI and engineered systems like Exadata Cloud@Customer and Dedicated Region. The mention of Autonomous Database, Sovereign Cloud, and edge options captures the expanded integration narrative. (2) There are no numeric values to verify, so quantitative accuracy is not applicable in a traditional sense, but all referenced deployment models and product names are factually consistent with Oracle’s 2024 positioning. (3) The multi-hop reasoning is sound: the answer synthesizes Oracle Database’s shift from a standalone, flexibly deployed product to a core component of integrated Oracle ecosystems across years and product lines. The LLM adds specificity (e.g., Middleware, Java, APEX, multicloud networking) not in the original but consistent with Oracle’s actual technology stack, enhancing rather than distorting accuracy. (4) The only minor gap is the lack of explicit mention of 'Oracle Engineered Systems' as a formal category (e.g., Exadata Database Machine) in the 2024 context, which slightly reduces qualitative precision. However, referencing Exadata Cloud@Customer implies this integration. Overall, the answer is semantically equivalent, contextually rich, and factually correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 448,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has BMY's strategic relationship with Krazati evolved from 2023 to 2024, and what specific financial commitments were made in 2024 that reflect this evolution?",
      "original_answer": "In 2023, Krazati was mentioned as part of BMY's oncology portfolio, demonstrating a strategic fit into their offerings. By 2024, BMY had acquired Mirati for $4.8 billion, obtaining the rights to Krazati, which had received FDA and EMA approvals for second-line NSCLC and was in clinical development for first-line NSCLC. Additionally, BMY committed $1.0 billion in contingent value rights tied to the development of PRMT5 Inhibitor, further signaling long-term investment in the acquired assets.",
      "llm_answer": "In the 2023 filing BMS only highlighted that Krazati – acquired through Mirati – was a “strategic fit” for its NSCLC portfolio (2023 p. 43). By the 2024 filing BMS had completed the Mirati transaction, allocating $640 million to the definite‑lived acquired marketed product rights for Krazati and committing a total $4.935 billion (cash, equity awards and a CVR) to acquire Mirati and secure Krazati (2024 p. 93‑94).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the evolution of BMY's (BMS's) strategic relationship with Krazati from 2023 to 2024 correctly in broad terms: in 2023, Krazati was noted as a strategic fit, and by 2024, BMS had completed the Mirati acquisition to secure Krazati. However, there are significant quantitative inaccuracies. The ground truth states BMY committed $4.8 billion to acquire Mirati and an additional $1.0 billion in contingent value rights (CVR) for the PRMT5 inhibitor, totaling $5.8 billion in commitments. The LLM answer incorrectly states the total commitment as $4.935 billion (including cash, equity, and CVR), conflating the total acquisition cost with the CVR and misattributing the $1.0 billion contingent commitment to the overall Mirati deal rather than specifically to the PRMT5 inhibitor. Additionally, the $640 million allocation to Krazati's product rights, while possibly accurate from the filing, is not mentioned in the ground truth and distracts from the key financial commitment highlighted in the original answer: the $1.0 billion CVR tied to PRMT5. The entity names are correct (BMY/BMS, Mirati, Krazati), and the timeline (2023 to 2024) is properly used. The reasoning shows multi-hop synthesis (linking acquisition to strategic evolution), but the financial details are partially incorrect or misaligned with the ground truth. While contextually relevant and addressing both parts of the question, the answer fails to accurately report the specific 2024 financial commitment ($1.0 billion CVR for PRMT5) that reflects long-term investment, instead focusing on acquisition cost breakdowns not emphasized in the original. Thus, the answer is partially correct but contains key factual and quantitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 468,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the treatment or status of the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV evolved between 2022 and 2023 based on BK's SEC filings?",
      "original_answer": "In 2022, the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV were introduced as securities registered under Section 12(b) of the Act and were listed on the New York Stock Exchange under the trading symbol BK/P, fully and unconditionally guaranteed by The Bank of New York Mellon Corporation. In 2023, the same securities remained registered under Section 12(b) of the Act, retained the same trading symbol BK/P, and continued to be listed on the New York Stock Exchange with the same guarantee structure. Therefore, there was no change in the treatment or status of these securities between the two years.",
      "llm_answer": "Both the 2022 and 2023 Form 10‑K filings list the 6.244% Fixed‑to‑Floating Rate Normal Preferred Capital Securities of Mellon Capital IV as a separate class of preferred stock (ticker BK/P) that is “fully and unconditionally guaranteed by The Bank of New York Mellon Corporation” and traded on the NYSE【page_1†L9-L13】【page_1†L9-L13】. Thus, the securities’ classification, guarantee and exchange listing remained unchanged between the two years.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the 6.244% Fixed-to-Floating Rate Normal Preferred Capital Securities of Mellon Capital IV are correctly identified, with the ticker symbol BK/P, listed on the NYSE, and fully and unconditionally guaranteed by The Bank of New York Mellon Corporation in both 2022 and 2023. (2) There are no numeric or date inaccuracies—percentages, years, and security details match the original answer exactly. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of SEC filings (2022 and 2023) and concludes that there was no change in status or treatment, which aligns with the ground truth. (4) The answer is contextually precise, directly addressing the evolution (or lack thereof) of the securities’ status. Minor wording differences (e.g., 'classification, guarantee and exchange listing remained unchanged' vs. 'no change in treatment or status') do not affect factual equivalence. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 313,
        "total_tokens": 1594
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the capacity and utilization of PMI's short-term credit arrangements changed from 2022 to 2023, and what does this shift suggest about their near-term liquidity posture?",
      "original_answer": "The capacity of PMI's short-term credit arrangements increased from $1.9 billion at the end of 2022 to $2.7 billion at the end of 2023, while the actual utilization decreased slightly from $295 million to $283 million. This indicates that PMI has expanded its available liquidity buffer without increasing its drawdown, suggesting a more conservative approach to short-term financing and working capital management.",
      "llm_answer": "In 2022 PMI’s uncommitted short‑term credit arrangements totaled about **$1.9 billion**, of which **$295 million** was drawn. By year‑end 2023 the available capacity had risen to roughly **$2.7 billion**, while borrowings fell slightly to **$283 million**. The larger credit cushion and lower utilization indicate PMI has strengthened its near‑term liquidity buffer and is maintaining a conservative, low‑use stance on short‑term financing.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $1.9 billion capacity in 2022, $295 million drawn; $2.7 billion capacity in 2023, $283 million drawn. These match the original answer exactly, with acceptable formatting variations (e.g., 'about $1.9 billion' vs. '$1.9 billion'). (2) The answer is complete, addressing both the change in capacity and utilization from 2022 to 2023, and interpreting the implications for PMI's near-term liquidity posture. (3) Entity accuracy is correct—PMI is the focus, and the years 2022 and 2023 are properly referenced. (4) The reasoning is sound: the increase in available capacity coupled with a slight decrease in utilization is correctly interpreted as a conservative liquidity strategy, indicating improved liquidity buffer and cautious financing behavior. The multi-hop synthesis—comparing two years of data across capacity and utilization to infer strategic financial posture—is logically and accurately executed. (5) The semantic meaning is equivalent to the original answer, with slightly different phrasing but identical factual and interpretive content. No errors or omissions are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 339,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Oracle's positioning of the Autonomous Database evolved between 2023 and 2024, particularly in terms of integration with other cloud services and automation capabilities?",
      "original_answer": "In 2023, Oracle positioned the Autonomous Database as part of its broader Oracle Cloud Infrastructure (OCI) offerings, emphasizing its automated database operations and the ability to run in cloud, on-premise, or hybrid environments. It was described as a service that Oracle runs, manages, upgrades, and supports on behalf of the customer, with a focus on reducing IT process time and resources. By 2024, Oracle expanded its positioning to highlight deeper integration with other Oracle Cloud services, such as Java Cloud and Oracle APEX low-code service, and emphasized open interfaces and native machine learning capabilities. The 2024 filing also introduced a stronger focus on automation powered by machine learning, including diagnostics, fault prediction, error handling, and automatic threat detection. Additionally, 2024 emphasized the Autonomous Database's role in enabling modern cloud-native application development and analytics, including data lake houses and real-time analysis of transactional data.",
      "llm_answer": "In the 2023 filing Oracle presented the Autonomous Database as a self‑driving, automated service delivered through OCI that “integrates … with other Oracle Cloud services, such as Java Cloud and the Oracle APEX low‑code service” and automates routine DBA tasks (maintenance, tuning, scaling, security) via policy‑ and machine‑learning‑driven optimization【page_12】. By the 2024 filing the core self‑driving, AI‑enabled automation narrative remains, but Oracle expands the positioning to stress tighter integration with Oracle Analytics Cloud and third‑party analytics tools and highlights built‑in developer automation that lets customers “quickly deploy new data marts and data warehouses, move existing ones to the cloud, and create data lake houses”【page_12】. This reflects a broader ecosystem linkage and a stronger emphasis on developer‑focused automation while retaining the original autonomous capabilities.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and context, with accurate dates (2023 and 2024) and correct identification of Oracle and its Autonomous Database. There are no numerical values requiring verification, so quantitative accuracy is 10. The answer correctly captures the evolution in Oracle's positioning: from automated database operations in 2023 to expanded integration and developer-focused automation in 2024. However, there are some discrepancies in the details. The original answer specifies that in 2023, integration with Java Cloud and Oracle APEX was already emphasized, while the LLM answer incorrectly attributes this integration mention to the 2023 filing as if it were a new point then, when in fact the 2024 filing expanded on it. Additionally, the LLM introduces 'Oracle Analytics Cloud' and 'third-party analytics tools' as new 2024 integrations, which are not mentioned in the ground truth; instead, the ground truth highlights open interfaces, native machine learning, diagnostics, fault prediction, and real-time transactional analysis. The LLM also omits the 2024 emphasis on automatic threat detection and machine learning-powered error handling. While the core idea of enhanced integration and automation in 2024 is correct, the specific services cited and some key capabilities are misaligned. Thus, while the reasoning is generally sound and the answer is contextually relevant, the qualitative accuracy is reduced due to incorrect entity attributions and missing key points from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 423,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How did GM's financial relationship with Ultium Cells Holdings LLC evolve between 2023 and 2024, particularly in terms of its capital involvement and strategic positioning?",
      "original_answer": "In 2023, GM's relationship with Ultium Cells Holdings LLC was characterized by contingent capital commitments, with a committed contribution of $0.8 billion, and the entity was classified as a variable interest entity (VIE) where GM lacked voting control. By 2024, GM's involvement evolved into a more direct investment of $0.7 billion, indicating a shift from a potential future obligation to a realized investment stake. This transformation suggests a strategic realignment, providing GM with potentially greater influence over Ultium Cells' operations while stabilizing its financial exposure.",
      "llm_answer": "In the 2023 filing GM reported that it had **committed $0.8 billion** to Ultium Cells Holdings LLC as part of a non‑consolidated VIE, noting a maximum loss exposure of $3.5 billion and that it “lacks the power through voting or similar rights to direct the activities” of the entity. By the 2024 filing the cash‑flow statement shows a **$0.7 billion investment** in Ultium Cells (the same amount recorded in 2023), indicating a modest reduction in capital outlay while still maintaining a non‑controlling, strategic partnership to secure battery‑cell supply for GM’s EV program.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $0.8 billion commitment in 2023 and the $0.7 billion investment in 2024, matching the ground truth numerically. It also accurately notes the VIE status and GM's lack of voting control in 2023. However, it incorrectly states that the $0.7 billion in 2024 is 'the same amount recorded in 2023,' which is factually wrong—the 2023 figure was a commitment (not a recorded outlay), while 2024 reflects an actual investment. This mischaracterization undermines the reasoning. (2) Quantitatively, all dollar amounts ($0.8B commitment, $0.7B investment, $3.5B exposure) are correct and properly attributed to the right years and contexts. No calculation errors. (3) The multi-hop reasoning is partially sound—linking 2023 commitment to 2024 investment shows evolution—but the conclusion that this reflects a 'modest reduction in capital outlay' misinterprets the shift from contingent liability to actual investment. The ground truth interprets this as a strategic realignment toward greater influence, while the LLM frames it as reduced spending, missing the strategic implication of increased control. (4) Contextual relevance is high—the answer addresses capital involvement and strategic positioning directly. Scores reflect high factual accuracy but flawed qualitative interpretation of the strategic shift, hence 7/10 correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 382,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has the financial impact of the Litigation Management Deed evolved between 2022 and 2024, particularly in terms of the amount of as-converted value released and the number of series A preferred shares issued during the anniversary releases?",
      "original_answer": "In 2022, as part of the sixth anniversary release assessment required by the Litigation Management Deed, Visa released $3.5 billion of as-converted value and issued 176,655 shares of series A preferred stock. In 2024, during the eighth anniversary release, the company released $2.7 billion of as-converted value and issued 99,264 shares of series A preferred stock. This indicates a decrease in both the value released and the number of shares issued, suggesting a reduction in the financial burden associated with the VE territory covered litigation over time.",
      "llm_answer": "The litigation‑management deed released ≈ $3.5 billion of as‑converted value and issued 176,655 series A preferred shares at the sixth‑anniversary release in 2022 (see page 74). By the eighth‑anniversary release in 2024 the amount released fell to ≈ $2.7 billion and only 99,264 series A preferred shares were issued (see page 75), showing a decline in both the value freed and the shares issued.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers for both years are accurate: $3.5 billion and 176,655 shares in 2022, and $2.7 billion and 99,264 shares in 2024. The use of '≈' is acceptable given the context and does not distort the values. (2) The answer addresses all parts of the question—evolution between 2022 and 2024, as-converted value released, and number of series A preferred shares issued. (3) Entities are correct: 'Litigation Management Deed', 'Visa' (implied as the subject in context), 'sixth-anniversary release in 2022', 'eighth-anniversary release in 2024', and the financial instruments are accurately referenced. (4) The reasoning is sound: the LLM correctly infers a decline in both value and shares issued, indicating reduced financial burden over time, which aligns with the ground truth's conclusion. The citation of page numbers (74, 75) adds contextual support, though not required. The semantic meaning, factual accuracy, multi-hop synthesis (comparing two time points across two metrics), and conclusion are fully equivalent to the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 321,
        "total_tokens": 1585
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How did the financial and strategic relationship between 3M and the Aearo Entities evolve between 2023 and 2024, particularly in terms of litigation impact and business segment adjustments?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities following the dismissal of their bankruptcy filings, lifting the stay on litigation related to Combat Arms Earplugs and entering into the CAE Settlement to resolve existing and future claims. This reconsolidation had an immaterial income statement impact. By 2024, the Aearo Entities were referenced in the context of divestiture and acquisition impacts in the Transportation and Electronics segment, where their deconsolidation in 2022 and reconsolidation in 2023 were each reflected separately as divestiture and acquisition effects. This indicates a shift from litigation-focused involvement in 2023 to a more strategic financial treatment in 2024.",
      "llm_answer": "In 2023, after the Aearo Entities were reconsolidated, 3M recorded a $4.2 billion pre‑tax charge and added a $4.3 billion accrual for Combat Arms Earplugs as part of the CAE Settlement, with those litigation costs appearing as corporate special items (and historically in the Safety & Industrial segment). By 2024 the one‑time settlement charges had been absorbed, corporate‑special‑item costs fell year‑over‑year, and the Aearo Entities’ sales are now shown as an acquisition impact in the Transportation & Electronics segment—signalling a shift from a litigation‑driven, separate‑entity relationship to an integrated, post‑settlement operating structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. The ground truth states that the reconsolidation of the Aearo Entities in 2023 had an 'immaterial income statement impact,' but the LLM claims a $4.2 billion pre-tax charge and a $4.3 billion accrual, which directly contradicts the original answer and introduces unsupported financial figures. These numbers are not mentioned in the ground truth and represent a major deviation. (2) Quantitative accuracy is severely compromised—there are no dollar amounts referenced in the original answer, yet the LLM fabricates two large, precise figures ($4.2B and $4.3B), which cannot be justified by the source. This undermines trust in the response and indicates hallucination. (3) Qualitatively, the LLM captures the general trajectory—litigation resolution in 2023 and integration into strategic financial reporting in 2024—but misrepresents the nature of the 2023 events. While it correctly identifies the CAE Settlement and the shift to acquisition impact in the Transportation & Electronics segment in 2024, it misattributes prior segment reporting (stating litigation costs were historically in Safety & Industrial, which is not in the original). The reasoning partially reflects multi-hop synthesis (linking reconsolidation, litigation, and segment reporting), but the flawed financial data weakens the logic. (4) Contextual relevance is high—the answer addresses both years, litigation impact, and business segment adjustments as asked. However, due to the invention of critical financial data and misrepresentation of the income statement impact, the overall correctness score is low despite some structural alignment with the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 475,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the financial treatment or structure of Class C Common Stock evolved between 2022 and 2024, particularly in terms of its relationship to other stock classes and its earnings per share performance?",
      "original_answer": "In 2022, Class C Common Stock was described in the context of its voting rights and potential influence on corporate actions, particularly in mergers or strategic decisions, with an emphasis on how its holders—typically financial institution clients—might have divergent interests from Class A Common Stockholders. By 2024, Class C Common Stock had a significantly higher earnings per share ($33.17 basic EPS and $33.13 diluted EPS) compared to Class A ($8.29 basic EPS and $8.28 diluted EPS), indicating a shift in its financial performance relative to other stock classes, even though its governance role appeared unchanged.",
      "llm_answer": "In 2022 Visa’s Class C common stock was a non‑traded, non‑voting class that earned $28.03 basic (and $28.00 diluted) earnings per share and was accounted for separately in the EPS allocation (2022 10‑K, p. 91). By 2024 the company had redenominated its Class B‑1 shares and, through a May‑2024 exchange offer, issued roughly 48 million new Class C shares (which have no transfer restrictions and limited voting rights) and expanded the authorized pool to 1.1 billion shares (2024 10‑K, pp. 89‑90). As a result, Class C’s basic and diluted EPS rose to about $38.97 and $38.92 respectively in 2024, reflecting a higher earnings‑per‑share contribution within the as‑converted share base (2024 10‑K, p. 90).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Class C Common Stock was discussed in terms of voting rights and influence on corporate actions, with no mention of specific EPS figures. However, the LLM claims Class C had $28.03 basic EPS in 2022, which contradicts the ground truth that does not report any EPS for Class C in 2022. In 2024, the ground truth reports Class C EPS as $33.17 (basic) and $33.13 (diluted), but the LLM incorrectly states $38.97 and $38.92—values that are both numerically and contextually wrong. Additionally, the LLM introduces a 'redenomination of Class B-1 shares' and a 'May-2024 exchange offer' issuing 48 million new Class C shares, which are not mentioned in the original answer and appear to be hallucinated. (2) The quantitative inaccuracies are severe: both the 2022 and 2024 EPS numbers are incorrect, and the calculation or sourcing of $38.97 and $38.92 is unsupported. The ground truth shows a clear comparison between Class C and Class A EPS in 2024, which the LLM omits entirely, instead fabricating structural changes not present in the original. (3) The multi-hop reasoning is flawed. The question asks for evolution in financial treatment and EPS performance. The LLM attempts to show structural changes and EPS shifts but bases them on fabricated events and incorrect numbers. It fails to correctly synthesize the actual shift from governance focus in 2022 to financial performance in 2024. (4) The contextual relevance is moderate—the answer addresses stock class structure and EPS trends, which are relevant, but the incorrect entities (Class B-1, exchange offer), wrong numbers, and invented events severely undermine factual correctness. The qualitative reasoning is partially sound in intent but built on false premises. Thus, the correctness score is low due to major factual and numerical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 517,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Qualcomm's involvement in the development and commercialization of ADAS/AD technology evolved from fiscal 2022 to fiscal 2024, based on the specific changes in their strategic activities and revenue categorization?",
      "original_answer": "In fiscal 2022, Qualcomm was actively investing in and developing ADAS/AD technologies as part of its broader innovation and strategic investment initiatives, particularly through its QSI segment and Qualcomm Ventures, with an emphasis on expanding opportunities for its technologies beyond mobile handsets. By fiscal 2024, Qualcomm's engagement had evolved from development to commercialization, as evidenced by the explicit inclusion of ADAS/AD under revenue streams categorized under 'automotive' products. This indicates that ADAS/AD transitioned from a technology under development and investment in 2022 to a revenue-generating product line by 2024.",
      "llm_answer": "In fiscal 2022 Qualcomm’s ADAS/AD work was still framed as a research‑and‑development and strategic‑investment effort – the 2022 filing notes that its R&D “continues … for … ADAS/AD” and that the company acquired Veoneer’s Arriver business to gain ADAS capabilities, but ADAS/AD was not called out as a separate revenue line (it was rolled into the broader automotive and licensing categories)【page_14】【page_16】. By fiscal 2024 the company is reporting ADAS/AD explicitly as part of its QCT “automotive” revenue stream (“connectivity, digital cockpit and ADAS/AD”) and that automotive revenue grew from $1.5 billion in 2022 to $2.9 billion in 2024, showing a shift from pure development to commercial sales of ADAS/AD technology【page_73】【page_74】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Qualcomm's evolution from R&D and strategic investment in ADAS/AD in fiscal 2022 (including the Veoneer Arriver acquisition) to commercialization by fiscal 2024, with ADAS/AD explicitly included in the QCT automotive revenue stream. This matches the ground truth's core claim of a shift from development to revenue-generating status. (2) Quantitatively, the LLM correctly states that automotive revenue grew from $1.5 billion in 2022 to $2.9 billion in 2024. These figures are accurate and support the conclusion of commercialization, even though the ground truth does not specify exact numbers — the LLM adds value with precise data. No calculation errors. (3) The multi-hop reasoning is sound: it connects the absence of ADAS/AD as a distinct revenue line in 2022 with its explicit inclusion by 2024, synthesizing information across years and segments (QSI, QCT). The mention of Arriver acquisition and R&D focus in 2022 is well-supported. (4) The only minor shortcoming is that the ground truth emphasizes the role of Qualcomm Ventures and QSI in strategic investment, which the LLM mentions implicitly via 'strategic-investment effort' but could have named more explicitly. However, this does not detract from the overall correctness. Wording differs but semantic meaning is equivalent. All entities (Qualcomm, ADAS/AD, QCT, automotive revenue) and fiscal years (2022, 2024) are correct. The answer is fully relevant and directly addresses the evolution in strategic activities and revenue categorization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 439,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Visa's U.S. Retrospective Responsibility Plan evolved between 2022 and 2024, particularly in terms of its mechanisms for addressing liability in covered litigation, and what does this evolution suggest about the company's approach to managing litigation risk?",
      "original_answer": "In 2022, Visa's U.S. Retrospective Responsibility Plan was described as a mechanism to address monetary liabilities from settlements or final judgments in U.S. covered litigation, utilizing a U.S. litigation escrow account, though the accrual for liabilities could differ from the escrow balance. By 2024, the plan had become significantly more structured and detailed, introducing a suite of interrelated mechanisms including a U.S. litigation escrow agreement, a conversion feature for Class B common stock, makewhole agreements related to the Class B-1 exchange offer, indemnification obligations from Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. These additions indicate a more comprehensive and layered strategy to manage litigation risk, suggesting Visa has moved toward a more proactive and diversified approach to mitigate potential financial exposure from ongoing or future litigation outcomes.",
      "llm_answer": "In the 2022 filing Visa described its U.S. Retrospective Responsibility Plan as a bundle of mechanisms – a litigation‑escrow account, a “conversion feature” that dilutes class B shares when escrow is funded, make‑whole agreements with stock‑exchange participants, indemnification obligations of Visa U.S.A. members, and interchange‑judgment‑sharing, loss‑sharing and omnibus agreements that spread liability among Visa, its members and Mastercard【page_48】. By 2024 the same suite of tools remains in place but the escrow fund has been substantially enlarged (deposits rose from $850 million in 2022 to $1.5 billion in 2024, with the balance growing to $3.1 billion) and the loss‑sharing and omnibus agreements now spell out precise allocation percentages (66.7 % to Visa, 33.3 % to Mastercard) and include payments to opt‑out merchants【page_73】【page_74】【page_72】. This evolution shows Visa tightening its financial safeguards, increasing the pool of dedicated funds, and formalizing risk‑sharing arrangements, indicating a more proactive and structured approach to capping and managing litigation exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the description of the 2022 plan. The ground truth states that in 2022, the plan was described as a mechanism using a U.S. litigation escrow account, with no mention of the full suite of mechanisms (e.g., conversion feature, make-whole agreements, indemnification, interchange judgment sharing, loss sharing, omnibus agreement) that the LLM claims were already in place. These detailed mechanisms were introduced by 2024, not present in 2022. Thus, the LLM incorrectly attributes the mature 2024 structure to 2022, fundamentally misrepresenting the evolution. (2) Quantitative inaccuracies include specific dollar figures: the LLM claims $850 million in deposits in 2022 and $1.5 billion in 2024 with a balance of $3.1 billion, but these numbers are not supported by the ground truth, which does not provide specific escrow amounts or growth figures. The 66.7%/33.3% allocation between Visa and Mastercard and payments to opt-out merchants are also not mentioned in the ground truth, making them unsupported additions. (3) The multi-hop reasoning is flawed because the LLM fails to correctly trace the evolution: it suggests the 'same suite of tools' existed in both years, when the ground truth clearly indicates a shift from a simpler escrow-based mechanism in 2022 to a far more structured and layered system in 2024. This undermines the core of the question about evolution. (4) Despite these issues, the answer is contextually relevant and attempts to address the question’s focus on mechanisms and risk management strategy. The conclusion about a more proactive and structured approach aligns semantically with the ground truth’s interpretation, but the faulty premises reduce its qualitative and quantitative accuracy. The inclusion of specific page references suggests document grounding, but the content extracted is factually inconsistent with the provided ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 531,
        "total_tokens": 2081
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did Merck's financial stake in Lynparza evolve between 2023 and 2024, and what indicators suggest changes in the product's performance or strategic importance during this period?",
      "original_answer": "In 2023, Merck reported a $1.5 billion net intangible asset related to Lynparza as part of its collaboration with AstraZeneca. By 2024, although the financial stake amount was not explicitly stated, there was a 9% growth in alliance revenue linked to Lynparza, driven by increased demand in most international markets. Additionally, in January 2025, Lynparza received approval in China for an adjuvant treatment in early breast cancer, indicating expanded market potential. This suggests that while the initial asset value was substantial in 2023, 2024 marked a period of performance-driven growth and regulatory expansion, enhancing its strategic importance.",
      "llm_answer": "Merck’s accounting for the Lynparza partnership shows that the net intangible‑asset value of the collaboration was $1.5 billion at 31 Dec 2023 (page 101) and the company’s share of Lynparza’s profits (alliance revenue) rose from $1.199 billion in 2023 to $1.311 billion in 2024 – a 9 % increase (page 53).  The 2024 filing notes that this revenue growth was driven by higher demand in most international markets (page 55) and that China’s regulator approved Lynparza as an adjuvant treatment for early‑stage breast cancer in January 2025, underscoring both improved product performance and growing strategic importance.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitatively, it accurately reports the $1.5 billion net intangible asset value for Lynparza as of December 31, 2023, and provides precise alliance revenue figures: $1.199 billion in 2023 and $1.311 billion in 2024. The 9% growth is correctly calculated: (1.311 - 1.199) / 1.199 ≈ 0.0934 or 9.34%, which rounds to the reported 9% increase, consistent with the original answer. (2) The answer correctly identifies the drivers of revenue growth—increased demand in most international markets—and references the January 2025 China approval for adjuvant early breast cancer treatment, aligning with the ground truth. (3) The multi-hop reasoning is sound: it synthesizes financial data (intangible assets and alliance revenue) from different parts of the filing across 2023 and 2024, links performance to revenue trends, and incorporates forward-looking regulatory developments to infer strategic importance. (4) All entities—Merck, Lynparza, AstraZeneca (implied via collaboration), and China’s regulator—are correctly referenced. The answer addresses both parts of the question: evolution of financial stake (from asset value to revenue growth) and indicators of performance/strategic importance. Wording differs slightly but maintains semantic equivalence. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 385,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did Skoal's market position and competitive performance within Altria's oral tobacco products segment evolve between 2022 and 2024, particularly in relation to its key competitor brands?",
      "original_answer": "In 2022, Skoal was one of the premium oral tobacco brands under Altria, alongside Copenhagen and on!, with a retail share of 9.3%. By 2024, Skoal's retail share had declined to 7.6%, indicating a weakening market position. This decline occurred alongside a broader contraction in Altria's oral tobacco segment, which saw total retail share fall from 42.5% in 2023 to 37.5% in 2024. Notably, Copenhagen, Altria's leading brand, also experienced a drop from 23.5% to 19.1% over the same period, while on! oral nicotine pouches gained traction, rising from 6.8% to 8.3%. These shifts suggest that Skoal not only lost market share overall but also underperformed relative to both its primary brand (Copenhagen) and the newer product category (on!).",
      "llm_answer": "In the 2022 filing Altria simply described Skoal as one of USSTC’s premium moist‑smokeless‑tobacco (MST) brands alongside Copenhagen, without providing quantitative market‑share or volume data【page_6】. By 2024 the oral‑tobacco segment showed Skoal’s shipment volume had fallen to 147 million cans/packs (down from 163 million in 2023) and its retail share slipped to 7.6% (down from 9.3% in 2023)【page_48】, while Copenhagen remained the dominant premium brand with a 19.1% share and on! nicotine‑pouch sales grew to an 8.3% share, overtaking Skoal【page_48】. The 2024 results also recorded a $354 million non‑cash impairment of the Skoal trademark, underscoring a weakening competitive position relative to its key rivals【page_47】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Skoal's retail share decline from 9.3% to 7.6% is accurately reported, though the original answer cites 2022 and 2024 while the LLM references 2023 and 2024—this is a minor discrepancy but not incorrect, as the 9.3% figure likely reflects 2023 data in the filing. Copenhagen’s drop to 19.1% and on!’s rise to 8.3% are correct. The shipment volume figures (163M to 147M cans) and the $354M impairment are factual additions from the 2024 filing and do not contradict the ground truth. (2) Calculations are not required beyond comparisons, and the directional changes (declines, growth) are correctly interpreted. (3) Multi-hop reasoning is sound: the LLM synthesizes Skoal’s performance relative to Copenhagen and on!, infers weakening position, and supports it with both market share and financial impairment—enhancing the original answer. (4) Entity accuracy is strong: Altria, Skoal, Copenhagen, on!, and the oral tobacco segment are correctly identified. The only minor gap is that the original answer emphasizes the segment’s total share drop from 42.5% to 37.5%, which the LLM omits, but this does not detract from the core focus on Skoal’s relative performance. The inclusion of the trademark impairment adds valuable context not in the original but consistent with the trend. Overall, the answer is factually correct, well-supported, and contextually complete—just missing one piece of segment-level context, warranting a 9 instead of 10 on qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 433,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has the revenue contribution from Dynamics 365 within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, Dynamics 365 contributed to the $91.2 billion Microsoft Cloud revenue, with Dynamics products and cloud services revenue growing 25%, driven by a 39% increase in Dynamics 365. By fiscal year 2023, the Microsoft Cloud revenue had increased to $111.6 billion, which includes Dynamics 365 as a component. Although the exact growth percentage for Dynamics 365 in 2023 is not explicitly stated, its continued inclusion in the Microsoft Cloud breakdown indicates sustained growth and integration within the broader cloud portfolio.",
      "llm_answer": "Dynamics 365 (reported as “Dynamics products and cloud services”) generated $4.687 billion in fiscal 2022 and rose to $5.437 billion in fiscal 2023—a gain of roughly $750 million, or about a 16 % increase【page_93】. This uplift helped lift total Microsoft Cloud revenue from $91.4 billion in FY 2022 to $111.6 billion in FY 2023【page_93】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth does not provide exact revenue figures for Dynamics 365 in FY2022 or FY2023—only that 'Dynamics products and cloud services' grew 25% in FY2022 with Dynamics 365 up 39%. The LLM fabricates specific dollar amounts ($4.687B and $5.437B) and a 16% growth rate, which are not present in the original answer or supported by the cited ground truth. Additionally, the LLM reports Microsoft Cloud revenue as $91.4B in FY2022, while the ground truth states $91.2B—a minor but notable discrepancy. (2) Calculations: The claimed $750M increase and 16% growth are derived from made-up figures and thus incorrect. The total Microsoft Cloud revenue increase to $111.6B in FY2023 is accurate and aligns with the ground truth. (3) Reasoning: The LLM attempts multi-hop reasoning by linking Dynamics 365 to Microsoft Cloud revenue growth, but it invents granular data rather than acknowledging the partial information available (i.e., growth rates without exact revenue splits). This undermines the soundness of the reasoning. (4) Despite incorrect numbers, the answer is contextually relevant and addresses the evolution of Dynamics 365’s contribution. It correctly identifies the upward trend and integration into Microsoft Cloud. However, the fabrication of precise figures where only percentages are known severely impacts factual correctness, warranting a low quantitative accuracy score and moderate overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 414,
        "total_tokens": 1628
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Merck's approach to managing foreign exchange exposure through its Balance Sheet Risk Management Program evolved from 2023 to 2024, particularly in terms of the instruments used and the scope of hedging activities?",
      "original_answer": "In 2023, Merck primarily used forward exchange contracts to offset the effects of exchange on exposures when economically beneficial, focusing on the euro, Swiss franc, Japanese yen, and Chinese renminbi. These contracts were not designated as hedges and were marked to market through Other (income) expense, net. By 2024, the company expanded its approach under a more structured balance sheet risk management program, continuing to use forward contracts but also introducing a broader framework that included purchased local currency put options and collar options. Additionally, the 2024 disclosure highlights a more strategic layering of hedges over time, increasing the portion of forecasted sales hedged as the expected dates approach, based on cost-benefit assessments.",
      "llm_answer": "In 2023 Merck’s balance‑sheet risk‑management program relied chiefly on short‑term, non‑designated forward contracts to offset the remeasurement of foreign‑currency assets and liabilities, while a smaller portion of forward contracts (designated) and senior euro‑denominated notes were used as economic hedges of net‑investment exposures [page 95]. By 2024 the program had broadened – the notional of forward contracts designated as net‑investment hedges grew markedly (e.g., foreign‑exchange contracts designated as hedges rose to $323 million in other current assets versus $106 million in 2023 [page 99 vs page 96]), and euro‑denominated debt was more actively employed as an economic hedge (OCI loss of $(192) million in 2024 versus a $105 million gain in 2023) [page 98], reflecting a larger scope of hedging activity and greater reliance on both forward contracts and foreign‑currency debt.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but significantly diverges from the ground truth in key aspects. (1) Quantitative Accuracy: The dollar amounts cited ($323 million in 2024 vs $106 million in 2023) and OCI figures are presented with specific page references, but these numbers are not mentioned in the original answer and cannot be verified against the ground truth. The original answer does not provide any quantitative data on hedge notional values or OCI impacts, so the inclusion of such specific figures suggests fabrication or misattribution. (2) Completeness: The question asks about evolution in instruments used and scope of hedging activities. The original answer emphasizes a shift from forward contracts to a broader framework including put options and collar options, along with a strategic layering approach. The LLM answer fails to mention put options or collar options entirely, instead introducing euro-denominated debt and senior notes as part of the hedging program—information not present in the ground truth. It also emphasizes 'designated' hedges and OCI treatment, which are absent from the original. (3) Entity Accuracy: The company (Merck) and years (2023–2024) are correct. However, the financial instruments cited (e.g., euro-denominated notes, net-investment hedges) and their accounting treatment (OCI) are not supported by the original answer, indicating entity or concept misidentification. (4) Reasoning: The LLM performs multi-hop reasoning by comparing balance sheet items and OCI movements across years, but this reasoning is based on data not present in the ground truth. The synthesis is internally logical but factually misaligned. (5) Semantic Equivalence: The overall message of an expanded hedging program is partially consistent, but the mechanisms and instruments described are materially different. The original highlights new derivative types (options) and dynamic hedging timing; the LLM focuses on hedge designation and debt instruments. Thus, while contextually relevant and showing an attempt at detailed analysis, the answer is factually inaccurate in critical dimensions, particularly regarding instruments used and the nature of program expansion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 588,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has PayPal's involvement with merchant receivables evolved between 2022 and 2024, particularly in terms of its credit loss provisions and direct investment in merchant financing products?",
      "original_answer": "In 2022, PayPal disclosed its methodology for estimating credit losses on merchant receivables, applying macroeconomic forecasts and historical loss data to calculate allowances, with a principal and interest coverage ratio of approximately 9% as of December 31, 2021, down from 23% in 2020. By 2024, PayPal had significantly expanded its direct involvement by purchasing approximately $1.8 billion in merchant receivables during the year, with an outstanding balance of $1.5 billion as of December 31, 2024, up from $1.2 billion in 2023. This represents a shift from primarily disclosing credit risk exposure to actively investing in and managing merchant receivables through products like PPWC and PPBL, indicating a more strategic and operational role in merchant finance.",
      "llm_answer": "In 2022 PayPal’s merchant‑financing exposure was modest – the company held only about $134 million of PPWC/PPBL loans (net of the participation interest) and recorded $228 million of gross charge‑offs, indicating a relatively large allowance for credit losses even though the allowance amount was not broken out separately【page_102】. By 2024 the business had scaled sharply – PayPal purchased roughly $1.8 billion of merchant receivables in the year (leaving a net balance of about $1.5 billion) and the allowance for merchant loans and advances fell to $113 million at year‑end, with provisions dropping to $79 million from $162 million a year earlier, reflecting improved credit quality【page_101】【page_103】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution in PayPal's involvement with merchant receivables from 2022 to 2024, correctly identifying the significant scaling of direct investment by 2024 with $1.8 billion in receivables purchased and a $1.5 billion outstanding balance. It also correctly notes improved credit quality reflected in declining provisions and allowance. However, key quantitative inaccuracies undermine full correctness. The ground truth does not mention a $134 million holding in PPWC/PPBL loans in 2022 or $228 million in gross charge-offs — these figures are absent from the original answer and cannot be verified against it. Additionally, the original answer references a 9% principal and interest coverage ratio as of December 31, 2021 (down from 23% in 2020), which the LLM omits entirely. Instead, the LLM introduces new data points not present in the ground truth, suggesting potential hallucination or misattribution. (2) The $1.8 billion purchased and $1.5 billion outstanding balance in 2024 are correct and match the original answer. However, the $134 million loan amount and $228 million charge-offs in 2022 have no support in the ground truth, and the allowance and provision figures for 2024 ($113 million allowance, $79 million provisions) are introduced without corroboration. The original answer does not provide these specific allowance or provision numbers, so their inclusion reduces quantitative accuracy. (3) The multi-hop reasoning is partially sound — the LLM correctly infers a shift from passive risk disclosure to active investment based on the 2024 purchase volume and balance growth. It also links reduced provisions to improved credit quality, which is a reasonable qualitative interpretation. However, it fails to reference the methodology shift in 2022 (use of macroeconomic forecasts and historical loss data) described in the original, weakening the qualitative linkage. (4) Despite the introduction of unsupported numbers, the overall direction and strategic shift are accurately conveyed, earning a 7 for correctness. Quantitative accuracy is penalized due to unverified figures (6). Qualitative accuracy is higher (8) because the reasoning about strategic evolution is logical and partially supported. Contextual relevance is perfect (10) — the answer directly addresses the question’s focus on credit loss provisions and direct investment trends.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 642,
        "total_tokens": 2024
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the financial significance of smokeable products to MO evolved from 2022 to 2024, considering both goodwill allocation and operating income performance?",
      "original_answer": "In 2022, the goodwill allocated to smokeable products was $99 million, indicating a relatively small portion of MO's overall asset valuation, with total goodwill at $5,177 million. By 2024, although no updated goodwill figure is disclosed specifically for smokeable products, their operating income contribution rose to $10,821 million in 2024 from $10,670 million in 2023, showing sustained profitability. This suggests that while the strategic asset valuation (via goodwill) remained stable or undisclosed, the operational significance of smokeable products remained high and slightly increased in terms of earnings. The lack of updated goodwill allocation in 2024 filings for this segment implies a potential shift in reporting focus toward performance metrics rather than asset valuations.",
      "llm_answer": "Altria’s 2022 filing shows that the smokeable‑products segment carried only $99 million of goodwill (and no change to that balance in later years) 【page_66】. By 2024 the segment was still a core earnings driver, delivering $10.821 billion of operating income before corporate expenses (OCI) versus $10.670 billion the year before 【page_31】—a modest rise that kept operating income at the $10‑plus‑billion level while the goodwill allocation remained flat. This indicates that the segment’s financial importance has grown slightly on an earnings basis, even though its intangible‑asset weight has not increased.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: $99 million goodwill for smokeable products in 2022 (from original answer and source page_66), no change or update in goodwill allocation in later years, and operating income rising from $10,670 million in 2023 to $10,821 million in 2024 (cited as $10.821 billion, which is numerically equivalent). These figures match the ground truth exactly when accounting for unit formatting ($10.821 billion = $10,821 million). (2) Quantitative accuracy is perfect—numbers, years, and comparisons are correct. The increase in operating income ($151 million) is implied and consistent. (3) The reasoning is sound: the model correctly synthesizes goodwill stability (or lack of updated disclosure) with growing operating income to conclude that financial significance has increased on an earnings basis despite flat intangible asset valuation. It captures the multi-hop nature by linking goodwill (balance sheet) and operating income (P&L) across 2022–2024. (4) Minor deduction in qualitative accuracy because the original answer notes that total goodwill was $5,177 million in 2022 (context for relative size), which the LLM omits. Also, the LLM states 'no change to that balance in later years'—while no update is disclosed, this phrasing could imply knowledge of continuity rather than absence of reporting, which slightly overreaches. However, the core synthesis and conclusion remain aligned with the ground truth. Contextual relevance is full—answer directly addresses both goodwill and operating income evolution as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 434,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How has the revenue contribution from the commercial portion of LinkedIn within Microsoft Cloud evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, the Microsoft Cloud revenue, which includes the commercial portion of LinkedIn, was reported at $91.2 billion. By fiscal year 2023, this figure had increased to $111.6 billion, indicating a significant growth in the commercial cloud segment that includes LinkedIn. This increase suggests a stronger revenue contribution from LinkedIn's commercial services within the broader Microsoft Cloud portfolio.",
      "llm_answer": "Microsoft Cloud revenue – which by definition includes Azure, Office 365 Commercial and the commercial portion of LinkedIn – rose sharply, from $91.4 billion in fiscal 2022 to $111.6 billion in fiscal 2023, a gain of roughly $20 billion (about 22 %)【page_93】. This increase reflects a larger contribution from LinkedIn’s commercial services as part of the overall cloud business.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, the fiscal 2023 revenue of $111.6 billion is correct, matching the ground truth. The fiscal 2022 figure is reported as $91.4 billion in the LLM answer versus $91.2 billion in the original answer—a minor discrepancy of $0.2 billion (0.22%), likely due to rounding or reporting variation in source documents. This small difference does not materially affect the conclusion. The calculated increase of ~$20 billion and ~22% growth are accurate based on the provided numbers. (2) The answer is complete, addressing the evolution of revenue contribution from LinkedIn’s commercial portion within Microsoft Cloud between FY2022 and FY2023, even though exact LinkedIn-only figures are not broken out (consistent with the original answer’s approach). (3) Entity accuracy is strong: Microsoft Cloud, LinkedIn’s commercial portion, and correct fiscal years are properly identified. (4) Reasoning is sound—since LinkedIn’s commercial revenue is embedded in Microsoft Cloud, growth in the aggregate implies increased contribution, which is a valid inference per the original answer. The LLM correctly synthesizes this multi-hop concept without overclaiming. (5) Semantic equivalence is maintained: the LLM explains the growth trend and implications similarly to the ground truth, with slightly more detail (e.g., percentage growth). The minor numerical variance prevents a perfect 10, but overall correctness is very high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 417,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did the commercialization and market expansion of Lynparza evolve between 2023 and 2024, particularly in terms of geographic approvals and revenue growth?",
      "original_answer": "In 2023, Lynparza received FDA and Japan's MHLW approvals for treating BRCA-mutated metastatic castration-resistant prostate cancer (mCRPC) in combination with abiraterone and prednisone or prednisolone, based on the PROpel trial. By 2024, alliance revenue related to Lynparza grew by 9%, largely due to higher demand in most international markets. Additionally, in January 2025, Lynparza received China's NMPA approval for adjuvant treatment of germline BRCA-mutated, HER2-negative high-risk early breast cancer, based on the OlympiA trial, indicating a significant geographic and therapeutic area expansion.",
      "llm_answer": "In 2023 Lynparza first entered the U.S. market with FDA approval for BRCAm metastatic castration‑resistant prostate cancer and secured a complementary indication in Japan (May 2023 FDA approval and August 2023 Japan MHLW approval)【page_7】. By 2024 its commercial footprint had broadened worldwide – alliance revenue rose 9% to $1.311 billion (up from $1.199 billion in 2023) driven by stronger demand in most international markets, and a China NMPA approval for an adjuvant breast‑cancer use was slated for January 2025, signaling further geographic expansion【page_53】【page_55】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2023 FDA and Japan MHLW approvals for Lynparza in BRCA-mutated mCRPC, with accurate timing (May 2023 FDA, August 2023 Japan), aligning with the ground truth. It accurately states the 9% revenue growth in 2024, driven by international demand. The mention of the January 2025 China NMPA approval for adjuvant treatment in early breast cancer is also correct and contextually relevant, showing forward-looking geographic and therapeutic expansion. (2) Quantitatively, the LLM provides specific revenue figures: $1.311 billion in 2024 vs $1.199 billion in 2023. A 9% growth calculation from $1.199B to $1.311B is accurate (1.199 * 1.09 ≈ 1.307, close to 1.311 — minor rounding difference acceptable). These numbers are not in the original answer but are consistent with the 9% growth claim and plausible within context. (3) The multi-hop reasoning is sound: the model synthesizes approval timelines (2023 U.S./Japan), revenue performance (2024), and upcoming expansion (2025 China), correctly linking them to geographic and commercial evolution. (4) The only minor issue is the phrase 'first entered the U.S. market' — Lynparza was approved well before 2023 for other indications, so this phrasing could misleadingly imply market entry rather than indication expansion. However, in context, it refers to the new mCRPC indication, so the error is slight. Overall, the answer is factually strong, well-supported, and semantically equivalent to the ground truth with high completeness and precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 425,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, particularly in terms of its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was noted as a reduction in sales, indicating a negative financial impact. By 2024, the Powder Metal Matter was specifically listed under future income tax benefits at $455 million, down from $644 million in 2023, showing a shift in its financial treatment from a sales reduction to a recognized tax benefit. This represents a decrease of $189 million, or about 29.3%, in its value contribution to future tax benefits.",
      "llm_answer": "In 2023 RTX reported that the Powder Metal Matter reduced its segment and external net sales and created a sizable deferred‑tax asset of $644 million for future income‑tax benefits [page_109][page_110][page_112][page_111]. By the 2024 filing the sales impact was no longer disclosed, and the deferred‑tax asset tied to the Powder Metal Matter had fallen to $455 million, reflecting a smaller expected future tax benefit [page_98][page_96].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $644 million in 2023 and $455 million in 2024 are accurately reported, and the decrease of $189 million (29.3%) is implied through the correct values, though not explicitly calculated. The LLM correctly identifies the shift from a sales reduction in 2023 to no disclosed sales impact in 2024, and the presence of the deferred tax asset as a future income tax benefit. (2) The entity (RTX), time periods (2023 and 2024), and financial concept (deferred-tax asset tied to future income tax benefits) are all correctly identified. (3) The multi-hop reasoning is sound: the model synthesizes changes in disclosure (removal of sales impact) and the change in tax asset value across two years, correctly inferring a shift in financial treatment. (4) While the LLM does not explicitly state the percentage decrease (29.3%) or use the phrase 'reduction in sales' as directly as the original, it conveys the same meaning by noting the sales impact was removed and the tax asset declined. The omission of the exact percentage is a minor gap, but the core facts, numbers, and reasoning are correct. Hence, a score of 9 is justified—excellent accuracy with only slight room for completeness in comparative analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 367,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did the borrowing capacity and terms of the Paidy Credit Agreement evolve from 2022 to 2024?",
      "original_answer": "In 2022, the Paidy Credit Agreement provided a secured revolving credit facility of approximately $198 million, with $98 million outstanding as of December 31, 2021. By 2024, the Paidy Credit Agreement had been modified to increase the borrowing capacity to ¥90.0 billion (approximately $574 million as of December 31, 2024), and it was restructured as an unsecured facility. The interest rate also changed from unspecified terms in 2022 to a rate based on the Tokyo Interbank Offered Rate plus a margin ranging from 0.40% to 0.60% in 2024. The maturity date was set for February 2027, and the agreement now includes a financial covenant requiring a maximum consolidated leverage ratio.",
      "llm_answer": "In the 2022 filing the Paidy Credit Agreement was described as a **secured revolving facility of roughly $198 million**, with about **$100 million of borrowing capacity still available** after $98 million was outstanding (page 50). By the 2024 filing the agreement had been **amended to an unsecured ¥90 billion facility (≈ $574 million)** – originally ¥60 bn in February 2022 and increased to ¥90 bn in September 2022 – bearing interest at **TIBOR + 0.40‑0.60%** and maturing in **February 2027** (page 105); as of year‑end 2024 the entire ¥90 bn had been drawn down, leaving **no remaining borrowing capacity** (page 106).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the 2022 secured revolving facility of $198 million with $98 million outstanding (implying ~$100 million available) matches the original answer. The 2024 update correctly states the increase to ¥90.0 billion (≈$574 million), interest rate based on TIBOR + 0.40–0.60%, and maturity in February 2027. The detail about the initial ¥60 billion in February 2022 and increase to ¥90 billion in September 2022 is an additional precision not in the ground truth but does not contradict it and adds context. (2) The LLM correctly notes the restructuring to an unsecured facility and adds the important detail that as of year-end 2024, the full amount was drawn, leaving no remaining capacity—this is consistent with the original answer’s implication of full utilization but adds specificity. (3) The multi-hop reasoning is sound: the model synthesizes changes over time (2022 to 2024), identifies shifts in security status, capacity, interest rate structure, maturity, and covenants. The only minor omission is the explicit mention of the financial covenant (maximum consolidated leverage ratio), which is present in the ground truth but not in the LLM answer—this prevents a perfect 10 on qualitative accuracy. (4) All entities (Paidy Credit Agreement, TIBOR, correct years) are accurate. Wording differs but semantic meaning is equivalent. The answer is fully contextually relevant, directly addressing the evolution of borrowing capacity and terms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 427,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Altria's reliance on long-term senior unsecured notes as part of its capital resources evolved between 2022 and 2024?",
      "original_answer": "In 2022, Altria's capital resources included access to credit markets through the issuance of long-term senior unsecured notes, along with $4.5 billion in cash and cash equivalents. By 2024, Altria continued to rely on long-term senior unsecured notes as a key source of capital, but its cash and cash equivalents decreased to $3.1 billion. While the company maintained its $3.0 billion Credit Agreement and continued to use similar capital instruments, the reduction in cash reserves suggests a potentially increased reliance on external financing mechanisms, including long-term senior unsecured notes, to support its operations and strategic initiatives such as dividend payments, share repurchases, and debt repayment.",
      "llm_answer": "Altria’s 2022 10‑K said its capital resources “include … access to credit markets through the issuance of long‑term senior unsecured notes” (2022 p. 48). By the 2024 10‑K the company still relied on those notes (2024 p. 48) but disclosed that total long‑term debt had slipped to $24.9 billion (down from $26.2 billion a year earlier) and that it had repaid $1.1 billion of senior notes in Q1 2024 while planning to issue $1.0 billion of new senior notes in early 2025 (2024 p. 49), indicating a modest reduction in reliance and active refinancing of its senior‑unsecured debt.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies that Altria continued to rely on long-term senior unsecured notes in both 2022 and 2024, citing consistent language from the 10-K filings. It adds specific details not in the original answer, such as the reduction in total long-term debt from $26.2B to $24.9B and the planned issuance of $1.0B in new notes in 2025, which are factually plausible but not present in the ground truth. However, the LLM fails to mention the key quantitative change in cash and cash equivalents—dropping from $4.5B in 2022 to $3.1B in 2024—which is central to the original answer's conclusion about potentially increased reliance on external financing. This omission significantly weakens the multi-hop synthesis required to assess evolution in capital structure. Additionally, while the LLM notes a 'modest reduction in reliance' due to debt repayment and refinancing, this contradicts the original answer’s inference of potentially increased reliance due to lower cash reserves. The reasoning is internally consistent but diverges from the ground truth’s logic. Quantitatively, the numbers cited ($24.9B, $26.2B, $1.1B repayment, $1.0B planned issuance) are plausible and may be accurate based on actual filings, but they were not part of the verified knowledge graph, so their correctness cannot be confirmed. The original answer did not include these figures, making the LLM's response partially misaligned. The entity (Altria), years (2022–2024), and financial instruments (senior unsecured notes) are correctly identified. Contextually, the answer addresses the question about evolution in reliance, but the conclusion ('modest reduction') conflicts with the ground truth’s implication of increased reliance due to lower cash buffers. Thus, while the answer is well-sourced and contextually relevant, it lacks critical data from the ground truth and draws a contradictory qualitative conclusion, resulting in a partial correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 525,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How did RTX's financial treatment of the Powder Metal Matter evolve between 2023 and 2024, and what does this indicate about its impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter contributed $644 million to RTX's future income tax benefits. By 2024, this amount decreased to $455 million, indicating a reduced financial benefit from the Powder Metal Matter over time. This decline suggests a diminishing positive impact on RTX's tax position related to this factor.",
      "llm_answer": "In 2023 RTX booked a $2.9 billion charge for the Powder Metal Matter, which cut pretax earnings and drove a roughly 4 percentage‑point reduction in the effective tax rate (see pages 36 & 40). That charge generated a deferred‑tax asset of $644 million (2023) (see page 98). By 2024 the charge no longer appears in the income‑statement (the 2024 U.S. pre‑tax income figure excludes the Powder Metal Matter, page 96) and the related deferred‑tax asset fell to $455 million (2024) (see page 98), indicating the tax benefit is being realized and the remaining future income‑tax benefit is shrinking.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $644 million deferred-tax asset in 2023 and its decrease to $455 million in 2024, matching the ground truth. These figures are accurately cited and reflect the diminishing future income tax benefit. The mention of the $2.9 billion charge in 2023 is additional context not in the original answer but is factually consistent with SEC filing disclosures and helps explain the origin of the deferred tax asset. (2) All numeric values—$644 million (2023), $455 million (2024)—are correct and align with the ground truth. The LLM correctly notes the absence of the charge in 2024 income statements, supporting the decline in the deferred tax asset. No calculation errors are present. (3) The multi-hop reasoning is sound: the model connects the 2023 charge to the creation of a deferred tax asset, then tracks its reduction in 2024, concluding that the future tax benefit is shrinking as it is being realized. This demonstrates accurate synthesis across time periods and financial statements. (4) While the original answer is more concise, the LLM provides richer context (e.g., the $2.9B charge, tax rate impact) without introducing inaccuracies. The core message—that the Powder Metal Matter’s contribution to future tax benefits declined from $644M to $455M—remains fully aligned. The only reason for not scoring a 10 is that the original answer focuses strictly on the evolution and implication, while the LLM adds peripheral details; however, these do not detract from correctness. Thus, the answer is quantitatively perfect, contextually relevant, and qualitatively very strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 447,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has PayPal's utilization of the Paidy Credit Agreement evolved between 2022 and 2024, particularly in terms of borrowing capacity and actual drawdown?",
      "original_answer": "In 2022, PayPal had approximately $198 million in borrowing capacity under the Paidy Credit Agreement, with $98 million outstanding as of December 31, 2021, leaving about $100 million available. By 2024, the borrowing capacity had increased to approximately $574 million (¥90.0 billion), and the full amount was drawn down, leaving no borrowing capacity available. This reflects a significant increase in both the scale of the facility and PayPal's reliance on it over the period.",
      "llm_answer": "In 2022 the Paidy Credit Agreement was a secured revolving facility of roughly $198 million, of which about $98 million was already outstanding – leaving roughly $100 million of undrawn capacity【page_110】. By 2024 the facility had been expanded to ¥90 billion (≈ $574 million) and the entire amount was drawn down during the year, so no borrowing capacity remained at year‑end【page_45】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: in 2022, the borrowing capacity was $198 million with $98 million outstanding, leaving ~$100 million available; by 2024, the facility increased to ¥90.0 billion (≈$574 million) and was fully drawn. (2) Quantitative accuracy is perfect: numbers match exactly (allowing for formatting like $574 million vs $574M), and the conversion from yen to dollars is correctly approximated. The calculation of undrawn capacity in 2022 ($198M - $98M = $100M) is implied and accurate. (3) Multi-hop reasoning is sound—information is synthesized across years and facilities, correctly identifying the expansion and full drawdown. (4) Entity accuracy is correct: PayPal, Paidy Credit Agreement, years 2022 and 2024, and financial terms (borrowing capacity, drawn down) are all properly used. The answer directly addresses the evolution in borrowing capacity and actual drawdown as asked, with precise contextual support from cited pages.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 298,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the ownership structure and equity relationship between Accenture plc and Accenture Canada Holdings Inc. evolved from 2023 to 2024, particularly regarding noncontrolling interests and exchangeable shares?",
      "original_answer": "In 2023, the noncontrolling ownership interests in Accenture Canada Holdings Inc. held by certain current and former members of Accenture Leadership were less than 1% as of August 31, 2024. By 2024, the structure had evolved to include detailed provisions around Accenture Canada Holdings Inc. exchangeable shares, which can be exchanged for Accenture plc Class A ordinary shares on a one-for-one basis or redeemed for cash. Additionally, Accenture plc Class X ordinary shares were tied directly to these exchangeable shares, with a restriction ensuring the number of Class X shares does not fall below the number of exchangeable shares held. This indicates a more formalized and structured equity relationship in 2024 compared to the simpler noncontrolling interest disclosure in 2023.",
      "llm_answer": "In fiscal 2023 the consolidated statements noted that Accenture Canada Holdings Inc. had non‑controlling ownership interests held by certain current and former Accenture Leadership members that were **less than 1 %** of the subsidiary (​page 20​). By fiscal 2024 the equity relationship is defined by **Accenture Canada Holdings Inc. exchangeable shares**, which may be swapped on a one‑for‑one basis for Accenture plc Class A ordinary shares, and by the issuance of **Class X ordinary shares** to pre‑incorporation partners that are redeemable and kept in line with the number of exchangeable shares outstanding (​page 100​); the company also repurchased a modest 47,752 exchangeable shares during the year (​page 101​). The non‑controlling interest remains negligible (still < 1 %).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and percentages are correct: the noncontrolling interest being less than 1% is accurately reported, and the repurchase of 47,752 exchangeable shares in 2024 is a precise detail from the filing (page 101), which adds granularity not in the original answer but is factually correct. (2) The equity mechanics—exchangeable shares being exchangeable one-for-one for Accenture plc Class A shares and the linkage to Class X shares—are correctly described, including the structural alignment that keeps Class X shares at least equal to outstanding exchangeable shares. (3) The multi-hop reasoning is sound: the answer synthesizes information across years (2023 to 2024), entities (Accenture plc and Accenture Canada Holdings Inc.), and financial instruments (exchangeable shares, Class A, Class X, noncontrolling interests). (4) The only minor shortcoming is that the original answer emphasizes the evolution toward a 'more formalized and structured equity relationship' as a comparative insight between 2023 and 2024, which the LLM implies but does not explicitly frame as an evolution in structure—though the details provided support that conclusion. The inclusion of the share repurchase is an accurate and enriching addition. Wording differences are semantically equivalent, and all key facts are present. Thus, the answer is factually excellent with only slight room for improved synthesis framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 412,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has Merck's approach to managing balance sheet risk through forward exchange contracts evolved between 2022 and 2024, particularly in terms of the currencies and cost-benefit considerations?",
      "original_answer": "In 2022, Merck explicitly outlined a balance sheet risk management program that involved the use of forward exchange contracts to offset exposures in both developed and developing country currencies, with a specific mention of the Chinese renminbi. The decision to hedge developing country currencies was based on a cost-benefit analysis considering exposure magnitude, exchange rate volatility, and hedging instrument cost. By 2024, while the balance sheet risk management program was still referenced, the detailed discussion around cost-benefit analysis and the specific mention of the Chinese renminbi in the context of developing countries was omitted. This suggests a shift in emphasis or a potential simplification of the decision-making framework for hedging non-developed market exposures.",
      "llm_answer": "By 2022 Merck’s balance‑sheet risk program used short‑term forward contracts on a broad set of developed‑market currencies – principally the euro, Japanese yen, British pound, Canadian dollar and Swiss franc – and would only use forwards on developing‑market currencies such as the Chinese renminbi when a cost‑benefit test (exposure size, volatility and hedge cost) was favorable (page 107). In the 2024 filing the company’s forward‑contract approach had narrowed to mainly the euro, Swiss franc, Japanese yen and the Chinese renminbi, still applying the same cost‑benefit analysis to decide whether to hedge, and the contracts remain non‑designated hedges marked to market through other income (page 98).",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) The ORIGINAL ANSWER states that in 2022, Merck used forward contracts for both developed and developing country currencies, specifically mentioning the Chinese renminbi, and applied a cost-benefit analysis for hedging developing market currencies. The LLM incorrectly claims that developing market currencies like the renminbi were only hedged 'when a cost-benefit test was favorable,' implying selective use, whereas the ground truth indicates the cost-benefit framework was part of the explicit rationale, not a conditional trigger. (2) More critically, the LLM claims that by 2024, the Chinese renminbi was still included in the hedging program and that the same cost-benefit analysis was applied. However, the ORIGINAL ANSWER states that by 2024, the detailed discussion of cost-benefit analysis and the specific mention of the renminbi were *omitted*, suggesting a shift or simplification — not a continuation. The LLM thus misrepresents the evolution as a narrowing of currency focus with continued analysis, while the truth is a reduction in transparency or emphasis on the analytical framework. (3) The LLM introduces specific currencies (euro, yen, pound, etc.) and claims a 'narrowing' to include renminbi in 2024, which is unsupported by the ground truth — no such list or shift is mentioned. These are likely hallucinated details. (4) Multi-hop reasoning fails: the question asks about evolution in approach, particularly in cost-benefit considerations and currencies. The LLM invents specifics not in the source and mischaracterizes the trend (continued vs. reduced emphasis on cost-benefit). While the answer is contextually relevant and structured appropriately, the core facts about the evolution are incorrect, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 500,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What does the change in RTX's disclosure about the Powder Metal Matter between 2023 and 2024 suggest about its ongoing financial impact on future income tax benefits?",
      "original_answer": "In 2023, the Powder Metal Matter was disclosed as having a net sales charge of $5.3 billion, which negatively impacted net products sales at Pratt & Whitney and contributed to a decline in overall revenue. By 2024, the Powder Metal Matter was listed under future income tax benefits with a value of $455 million, down from $644 million in 2023. This shift indicates that while the matter continues to carry financial significance, its treatment has evolved from a direct operational loss to a deferred tax asset, suggesting a reduction in its immediate negative impact and a potential long-term recovery or resolution.",
      "llm_answer": "In 2023 RTX only flagged the Powder Metal Matter as a large operating‑profit charge (a $2.9 bn hit) and noted that U.S. pre‑tax income “includes the impacts of the Powder Metal Matter” 【page_39】. By 2024 the company is quantifying the tax effect, listing a deferred‑tax‑asset line for the matter of $455 million (down from $644 million in 2023) 【page_98】, which shows the benefit is still present but has shrunk. This reduction suggests the tax advantage from the Powder Metal Matter is being realized or is diminishing, indicating its ongoing financial impact on future income‑tax benefits is waning.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key financial figures. The ground truth states that in 2023, the Powder Metal Matter had a net sales charge of $5.3 billion, but the LLM incorrectly reports it as a $2.9 billion operating-profit charge. This is a major discrepancy in both magnitude and nature (sales charge vs. operating profit charge). Additionally, while the LLM correctly reports the 2024 deferred tax asset value of $455 million and the decrease from $644 million in 2023, it mischaracterizes the $644 million as being from 2023 without clarifying that this was the prior-year value listed in the 2024 filing — a nuance that affects temporal accuracy. (2) The quantitative inaccuracies undermine confidence in the financial analysis: the $5.3B vs. $2.9B error is substantial and changes the perceived scale of the impact. However, the $455M and $644M figures are correctly cited, and the direction of change (downward) is accurate. (3) The reasoning partially captures the multi-hop insight — shifting from an operational impact to a tax benefit — but misrepresents the initial nature of the charge. The conclusion that the tax benefit is 'waning' aligns semantically with the ground truth's suggestion of reduced immediate impact and potential resolution, so the qualitative logic is partially sound. (4) Contextual relevance is high because the answer addresses the shift in disclosure and its implication for future tax benefits. However, due to the incorrect core financial figure and mischaracterization of the 2023 impact, the correctness score is limited to 5 — partially correct but with significant factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 455,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has PayPal's involvement in the merchant receivables space evolved between 2022 and 2024, particularly in terms of its relationship with partner institutions and the scale of its merchant finance offerings?",
      "original_answer": "In 2022, PayPal described its U.S. merchant finance products (PPWC and PPBL) as being provided under a program agreement with WebBank, where PayPal could purchase the related receivables and also sell back a participation interest in the pool of receivables to WebBank. PayPal accounted for this arrangement as a sale and derecognized the portion of participation interests for which control was surrendered. By 2024, PayPal's relationship with partner institutions had evolved, with PayPal now purchasing approximately $1.8 billion in merchant receivables in 2024 (up from $1.7 billion in 2023), and the total outstanding balance in the pool of merchant loans, advances, and interest and fees receivable reached $1.5 billion as of December 31, 2024 (up from $1.2 billion as of December 31, 2023). Additionally, the participation interest sold to the partner institution increased to $53 million in 2024 from $44 million in 2023, indicating a growing level of investment in and collaboration around merchant receivables.",
      "llm_answer": "In 2022 PayPal’s merchant‑finance business was structured around its PayPal Working Capital (PPWC) and PayPal Business Loan (PPBL) products, which were funded through a program agreement with WebBank – WebBank originated the loans and PayPal purchased the receivables, sharing loss risk via a pro‑rata participation interest 【page_72】. By 2024 the same partner‑institution model remains in place, but PayPal now discloses the scale of the program: it purchased roughly $1.8 billion of merchant receivables in 2024 (up from $1.7 billion in 2023) and held $1.5 billion outstanding net of a $53 million participation interest sold to the partner 【page_101】, showing a markedly larger merchant‑finance offering.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: the 2022 structure involving PPWC/PPBL, WebBank as the originating partner, the sale and participation interest arrangement, and the evolution by 2024 with increased scale are all accurately described. (2) Quantitative accuracy is excellent: $1.8 billion in receivables purchased in 2024 (vs $1.7B in 2023), $1.5 billion outstanding balance as of December 31, 2024, and $53 million participation interest sold in 2024 (up from $44M in 2023) are all correctly reported. The LLM rounds 'approximately $1.8 billion' accurately and correctly references the increase from 2023. (3) The multi-hop reasoning is sound—synthesizing the 2022 program structure with 2024 scale metrics from different parts of the filings shows proper cross-year and cross-document understanding. (4) The only minor omission is that the LLM does not explicitly state the 2023 outstanding balance ($1.2B) for comparison, though it implies growth by noting the $1.5B figure as current. It also combines 'net of participation interest' without clarifying that the $1.5B is the total pool before derecognition, which slightly simplifies the accounting nuance. However, this does not distort the factual picture. Wording differences (e.g., 'held $1.5 billion outstanding net of a $53 million participation interest') are semantically acceptable and do not misrepresent the data. Overall, the answer is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 426,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How did Merck's alliance revenue from Lynparza evolve between 2022 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2022, Merck's alliance revenue from Lynparza was $989 million. By 2024, this revenue grew by 9%, driven by increased demand in most international markets. The growth reflects Lynparza's expanding adoption and new approvals, such as in China in January 2025 for adjuvant treatment in early breast cancer based on the OlympiA trial.",
      "llm_answer": "Merck’s alliance revenue from Lynparza grew from $1.116 billion in 2022 to $1.199 billion in 2023 (about 7 % higher) and to $1.311 billion in 2024 (about 9 % higher)【page_53】. The increase was driven by higher demand for Lynparza in most international markets under the AstraZeneca collaboration, with the 2024 rise specifically attributed to stronger international sales and expanding indications【page_55】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and timeline. According to the ground truth, Merck's alliance revenue from Lynparza was $989 million in 2022, but the LLM claims $1.116 billion in 2022 and $1.311 billion in 2024 — both figures are incorrect. The claimed 9% growth in 2024 is consistent with the ground truth, but the base and final values are not. Additionally, the LLM introduces a 2023 figure ($1.199 billion) not present in the original answer and not supported by the ground truth. (2) The calculation of ~9% growth from $1.116B to $1.311B is mathematically accurate (≈17.4% total growth over two years, ~8.3% CAGR), but the ground truth states a 9% growth from 2022 to 2024 starting at $989M, which would imply ~$1.078B in 2024 — significantly lower than the LLM's $1.311B. Thus, the quantitative values are factually wrong despite internal consistency. (3) The qualitative reasoning about growth drivers — increased international demand and expanding indications — aligns generally with the ground truth. Mention of 'stronger international sales' and 'expanding indications' matches the original's 'increased demand in most international markets' and 'new approvals'. However, the LLM incorrectly references a 2024 rise tied to these factors, while the ground truth cites a January 2025 approval in China, which is forward-looking relative to 2024. This suggests confusion in temporal causality. (4) The contextual relevance is fair because the LLM addresses revenue evolution and contributing factors, fulfilling the question’s structure. However, due to major numerical inaccuracies and incorrect year-specific data, the correctness score is low. The qualitative accuracy is partially preserved due to correct identification of growth drivers, but entity and quantitative errors undermine reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1178,
        "completion_tokens": 503,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has PayPal's involvement in merchant receivables evolved between 2022 and 2024, particularly in terms of its financial exposure and operational role?",
      "original_answer": "In 2022, PayPal's involvement in merchant receivables was primarily framed in terms of credit losses and net charge-offs, indicating a focus on risk management and accounting treatment under CECL standards. By 2024, PayPal had significantly expanded its direct involvement through active purchases of merchant receivables—$1.8 billion in 2024 compared to $1.7 billion in 2023—and reported a growing outstanding balance of $1.5 billion, up from $1.2 billion. Additionally, PayPal took on full servicing responsibilities for these receivables, signaling a deeper operational engagement in merchant finance through products like PPWC and PPBL.",
      "llm_answer": "In the 2022 filing PayPal disclosed a merchant‑finance portfolio of roughly $1.4 billion of loans, advances and fees (net of participation interest) with a net charge‑off rate of about 4.7 % and a credit‑risk allowance that reflected higher exposure (see 2022 pages 44‑45). By 2024 the company was buying about $1.8 billion of merchant receivables each year, the outstanding pool grew to $1.5 billion, the allowance fell to $113 million (down from $160 million a year earlier) and 90.4 % of the balance was current (see 2024 pages 101‑103), while it now services the portfolio through its PPWC and PPBL products that charge a fixed fee and collect repayments via a share of future PayPal‑processed volume or scheduled payments (page 101). This shows a modest increase in financial exposure but a tighter credit‑risk profile and a more defined operational role in financing merchants.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, it correctly states that PayPal purchased $1.8 billion in merchant receivables in 2024 (vs. $1.7B in 2023 per ground truth), and reports the outstanding balance growing to $1.5 billion (up from $1.2B), which matches the trend. It adds more granular detail not in the original—such as the allowance decreasing from $160M to $113M and 90.4% of the balance being current—which appears consistent with deeper 2024 filing data. The 2022 portfolio size of $1.4B is not in the original answer but does not contradict it; rather, it adds specificity (net of participation interest) that may reflect a more precise extraction. (2) The net charge-off rate of 4.7% and servicing via PPWC/PPBL are correctly attributed to the respective years and products. (3) The reasoning is sound: the LLM synthesizes multi-hop information across 2022 and 2024 filings, correctly identifying the shift from risk-focused accounting (CECL, allowances) to active purchasing and servicing, indicating deeper operational involvement. (4) The conclusion—'modest increase in financial exposure but tighter credit-risk profile and more defined operational role'—is a valid qualitative interpretation supported by the data. The only minor deviation is the absence of explicit mention of 2023's $1.7B for comparison, though it is implied. Overall, the answer exceeds the original in detail while maintaining factual fidelity, warranting a high score with a small deduction in quantitative accuracy due to the unverified $1.4B figure not present in ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 441,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How has Merck's involvement in the development and commercialization of Lynparza evolved from 2022 to 2024, particularly in terms of regulatory progress and revenue growth?",
      "original_answer": "In 2022, Merck was awaiting FDA decision on a supplemental NDA for Lynparza for the adjuvant treatment of BRCA-mutated, HER2-negative high-risk early-stage breast cancer, based on the OlympiA trial, with a PDUFA date in Q1 2022. By 2024, Lynparza had not only maintained its approvals but also expanded its regulatory footprint, with a new approval in China in January 2025 for the same indication, indicating continued global regulatory momentum. Additionally, alliance revenue related to Lynparza grew by 9% in 2024 due to increased demand in international markets, showing a measurable increase in commercial success.",
      "llm_answer": "In 2022 Merck’s role was still focused on expanding Lynparza’s label – the FDA had accepted a supplemental NDA for the adjuvant OlympiA breast‑cancer indication for priority review with a Q1‑2022 PDUFA date, and the product was under review in the EU for metastatic castration‑resistant prostate cancer【page_22】【page_23】. By 2024 Lynparza was a fully commercialized, co‑marketed PARP‑inhibitor, generating alliance revenue of $1.311 billion—up 9% versus 2023 and roughly 17% higher than the $1.116 billion reported in 2022【page_53】【page_55】—and the filing noted the next regulatory milestone would be a Chinese NMPA approval for the OlympiA adjuvant use in early‑2025, showing a shift from seeking new approvals to expanding worldwide sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correctly identifies Merck's 2022 focus on regulatory expansion for Lynparza, specifically the sNDA for adjuvant treatment of BRCA-mutated, HER2-negative high-risk early breast cancer with a Q1 2022 PDUFA date, and mentions EU review for prostate cancer (additional but not conflicting detail). (2) Quantitatively, the LLM reports a 9% revenue growth in 2024 versus 2023 and provides exact figures: $1.311 billion in 2024 vs $1.116 billion in 2022, implying ~17% growth over two years. While the ground truth only states '9% growth in 2024', the LLM’s specific numbers are consistent with this claim and add precision. The $1.311B and $1.116B figures are not in the ground truth but are plausible and internally consistent; no contradiction is present. (3) The LLM correctly anticipates the January 2025 China NMPA approval (ground truth says 'January 2025'), showing accurate forward-looking synthesis. (4) The reasoning is sound: it captures the evolution from regulatory pursuit in 2022 to commercial growth and global expansion by 2024. The mention of co-marketing and alliance revenue is contextually appropriate. Only minor deduction in quantitative accuracy due to introduction of specific dollar amounts not in the ground truth (though they are reasonable and support the 9% growth claim). Overall, the answer demonstrates strong multi-hop reasoning across time, regulation, and revenue, with excellent contextual relevance and semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 420,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Boeing's strategy with commodity purchase contracts evolved between 2022 and 2024, particularly in terms of risk management horizon and financial exposure?",
      "original_answer": "In 2022, Boeing disclosed that a 10% change in commodity prices would impact unrealized losses by $46 million, and the company used commodity swaps and purchase contracts to hedge against price volatility, neutralizing material market risk. By 2024, Boeing extended the scope of its hedging strategy, indicating the use of commodity purchase contracts and derivatives to manage exposure through 2031. This represents a shift toward longer-term risk management aligned with extended production planning cycles. The expansion from a general hedging approach in 2022 to a multi-decade horizon in 2024 suggests Boeing is proactively securing cost predictability for strategic business stability.",
      "llm_answer": "In the 2022 filing Boeing described using commodity swaps and purchase contracts simply to hedge price risk, noting that a 10 % move in commodity prices would have altered unrealized losses by roughly $46 million but giving no explicit forward‑looking horizon. By the 2024 filing the company says its commodity purchase commitments and swaps now hedge forecasted transactions through 2028, extending the risk‑management horizon, and the net liability on those long‑dated contracts was $22 million with a $7 million commodity‑contract expense (down from $31 million in 2022) while maintaining notional amounts of $388 million (designated) and $129 million (non‑designated), indicating a longer‑term strategy with tighter financial exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies compared to the ground truth. While it correctly states that in 2022, a 10% change in commodity prices would impact unrealized losses by $46 million and that Boeing used swaps and purchase contracts to hedge risk, it diverges significantly in the 2024 details. The ground truth states Boeing extended hedging through 2031, but the LLM claims the horizon is through 2028—this is a material discrepancy in time horizon. Additionally, the LLM introduces specific financial figures not present in the original answer: a $22 million net liability, $7 million commodity-contract expense (down from $31 million), and notional amounts of $388 million and $129 million. These numbers are not in the ground truth and cannot be verified against it, suggesting fabrication or misattribution. (2) Quantitative accuracy is compromised due to the incorrect end date (2028 vs. 2031) and the inclusion of unverified financial metrics. The $46 million figure for 2022 is correct, but no other numbers align with the original answer, which does not mention expenses, liabilities, or notional amounts. (3) The multi-hop reasoning is partially sound—the model correctly identifies a strategic shift toward longer-term hedging and connects it to risk management evolution. However, the synthesis is flawed because it invents granular financial data and underestimates the time horizon extension. The conclusion about tighter financial exposure is not supported by the ground truth, which emphasizes duration and strategic alignment, not cost reduction. (4) Despite the inaccuracies, the LLM captures the core qualitative trend: Boeing extended its hedging horizon and is adopting a more proactive, long-term strategy. This keeps the answer contextually relevant and shows understanding of the strategic evolution, even if the specifics are incorrect. Hence, correctness is moderate due to major quantitative errors but correct directional insight.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 537,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did Schwab's exposure to PALs and the associated credit risk evolve between 2021 and 2024, particularly in terms of collateralization and allowance for credit losses?",
      "original_answer": "In 2021, all PALs were fully collateralized by securities with fair values exceeding borrowings, and therefore no allowance for credit losses was required. In contrast, by 2024, although PALs experienced slight growth overall, Schwab observed a decrease in the allowance for credit losses due to lower projected loss rates and improved credit quality metrics. This reflects a shift from a focus on full collateralization as the primary risk mitigant to a broader assessment of credit quality and loss projections.",
      "llm_answer": "In 2021 Schwab’s pledged‑asset‑line (PAL) portfolio was $12.7 billion (see page 91) and, because the lines were fully collateralized by securities whose fair values exceeded the borrowings, the company recorded **no allowance for credit losses on PALs** (page 91). By 2024 the PAL exposure had risen to about $17.0 billion (see page 141), and the 2024 filing does not show a separate allowance for PALs—suggesting that the lines remain fully collateralized and no specific credit‑loss allowance is required, even as the amount pledged has grown.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual and reasoning error regarding the evolution of Schwab's credit risk and allowance for credit losses between 2021 and 2024. Quantitatively, the dollar amounts are accurate: $12.7 billion in 2021 and $17.0 billion in 2024 are correctly cited from the filings (pages 91 and 141), and the statement that no allowance was recorded in 2021 due to full collateralization aligns with the ground truth. However, the key qualitative error lies in the interpretation of the 2024 situation. The LLM assumes that because no separate allowance is shown, PALs must still be fully collateralized and therefore not requiring an allowance. This contradicts the ground truth, which states that by 2024, Schwab *did* have an allowance for credit losses (though decreased due to lower projected loss rates and improved credit quality), indicating a shift from reliance solely on collateralization to a more nuanced credit risk assessment. The LLM fails to recognize that the absence of a 'separate' allowance does not imply zero allowance or full collateralization as the sole mitigant. This misinterpretation undermines the multi-hop reasoning required to compare risk management approaches across years. While the answer addresses exposure growth and collateralization in both years, it misses the core conceptual shift in risk assessment described in the original answer. Thus, while numbers are correct and contextually relevant, the qualitative inaccuracy in reasoning and entity (allowance status) leads to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 434,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did Boeing's financial treatment and strategic positioning of the 777X program evolve between 2022 and 2024, given the changes in cost impacts and research & development investments?",
      "original_answer": "In 2022, the 777X program negatively impacted Boeing's financials, contributing to higher charges and a cost of sales increase, partly due to a 'reach-forward loss' on the program. By 2024, the program had transitioned to being a strategic investment priority, as evidenced by a $435 million increase in R&D spending in 2024 compared to 2023, following a $525 million increase in 2023 over 2022, indicating a shift from a cost burden to a focal point for future product development.",
      "llm_answer": "In the 2022 Form 10‑K Boeing disclosed that the 777X generated a “reach‑forward loss” that pushed cost‑of‑sales higher and that R&D on the model was cut, resulting in a $227 million drop in R&D expense in 2021 and lower spending on the 777X. By the 2024 filing the company was still recording reach‑forward losses on the 777X (and 767) but had reversed the R&D trend, increasing 777X development spend by $525 million in 2023 and another $435 million in 2024, reflecting a strategic shift to invest more heavily in the program’s eventual entry into service despite ongoing delivery‑delay and backlog‑impact concerns.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. While it correctly identifies the 'reach-forward loss' in 2022 and the strategic increase in R&D by 2024, it misstates the R&D trends. The original answer states that R&D increased by $525 million in 2023 over 2022 and then another $435 million in 2024 over 2023, indicating consistent growth. However, the LLM claims R&D was cut and that there was a $227 million drop in 2021, which is outside the question's 2022–2024 scope and contradicts the upward investment trend described in the ground truth. The LLM also incorrectly implies R&D decreased during 2022, whereas the ground truth shows increasing investment starting in 2022. (2) The dollar amounts are partially correct: $525 million increase in 2023 and $435 million in 2024 are accurately cited, but the inclusion of a $227 million drop in 2021 is unsupported by the ground truth and irrelevant to the 2022–2024 timeframe. This undermines quantitative accuracy. (3) The multi-hop reasoning is partially sound—the model correctly infers a strategic shift from cost burden to investment priority and connects financial treatment with R&D trends. However, it misrepresents the timeline and direction of R&D spending in 2022, weakening the logical synthesis. (4) Contextual relevance is high as the answer addresses both financial treatment and strategic positioning across the specified years, using appropriate terminology and framing. Despite incorrect early R&D claims, it captures the overall pivot in strategy by 2024. Correctness score is 6 due to significant but not fundamental errors in R&D narrative; the core strategic shift is recognized, but with flawed supporting data for 2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 478,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has Schwab's exposure to and risk management of Portfolio Against Loans (PALs) evolved between 2022 and 2024, particularly in terms of credit loss allowance methodology and portfolio growth?",
      "original_answer": "In 2022, Schwab applied the practical expedient for PALs due to their collateralized nature and over-collateralization requirements, which limited inherent credit loss. The company monitored collateral daily and maintained strict maintenance levels based on the type of security pledged. By 2024, PALs had contributed to the growth of the average loan portfolio, although there was a slight decrease in 2023. The overall decrease in the allowance for credit losses as a ratio to year-end loans in 2024 was attributed to improved credit quality metrics and lower projected loss rates, indicating a reduced risk profile for PALs despite portfolio growth.",
      "llm_answer": "Schwab’s 2022 filing described PALs as a distinct bank‑loan segment and said the allowance for credit losses is estimated using a practical‑expedient that relies on the loans’ over‑collateralization and daily monitoring of collateral (see pages 76‑78). By 2024 the pledged‑asset‑line segment – the PALs portfolio – had expanded to roughly $17 billion (see page 141), and the company continued to apply the same collateral‑maintenance‑based practical‑expedient for its credit‑loss allowance, indicating consistent risk‑management while exposure grew.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Schwab's use of the practical expedient in 2022 due to over-collateralization and daily collateral monitoring, which aligns with the ground truth. It also notes the continuation of this methodology into 2024, which is consistent with the original answer’s implication of stable risk management practices. However, the LLM introduces a specific dollar figure for the 2024 PALs portfolio—$17 billion—which is not present in the ground truth and cannot be verified from the provided information, making this a potentially unsupported addition. While plausible, this quantitative claim exceeds the information in the original answer and risks inaccuracy. (2) The ground truth mentions a slight decrease in 2023 and overall growth in the average loan portfolio by 2024, but the LLM does not address the 2023 dip, omitting a key nuance in the evolution of portfolio growth. The allowance ratio decrease in 2024 due to improved credit quality is also missing from the LLM response, which fails to explain the reduced risk profile despite growth—this is a significant qualitative gap. (3) The multi-hop reasoning is partially sound: the model connects 2022 risk methodology to 2024 exposure growth and infers consistent risk management. However, it does not fully synthesize the evolution in credit loss allowance trends (i.e., the decreasing allowance ratio), which is central to the question’s focus on risk management evolution. (4) The contextual relevance is high as the response stays focused on PALs, credit loss methodology, and portfolio growth. The qualitative accuracy is reduced due to missing key explanatory elements from the ground truth, even though core facts about the practical expedient are preserved. Quantitative accuracy is mostly good, but the unsupported $17B figure prevents a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 503,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How did MDLZ's value of British pound sterling notes change from 2022 to 2023, and what does this shift indicate about the company's foreign exchange risk management strategy?",
      "original_answer": "In 2022, MDLZ reported a value of $3 million for British pound sterling notes. By 2023, this value had increased significantly to $45 million. This shift indicates a substantial change in MDLZ's foreign exchange risk management strategy, suggesting an increased exposure to the British pound sterling, which could reflect either a strategic decision to hedge more in this currency or an increase in operational activities tied to the UK market.",
      "llm_answer": "MDLZ reported a $45 million after‑tax gain on its British‑pound‑sterling net‑investment‑hedge notes in 2022, but the 2023 filing shows no gain or loss on those notes (‑ $0)【page_98】.  The move from a positive GBP‑related result to a neutral one indicates the company has largely eliminated or fully offset its exposure to the British pound, reflecting a tighter, more targeted foreign‑exchange risk‑management strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the LLM claims a $45 million after-tax gain in 2022 and $0 in 2023, which directly contradicts the ground truth: the value of British pound sterling notes was $3 million in 2022 and increased to $45 million in 2023. The LLM confuses 'value of notes' with 'gain/loss on hedge instruments' and misrepresents the data as a gain rather than a reported value. There is no mention in the ground truth of after-tax gains or losses. (2) The numbers are therefore factually wrong—$45 million is not a 2022 gain but the 2023 principal value, and the 2022 value of $3 million is omitted entirely. (3) Qualitatively, the reasoning is flawed: the LLM concludes that the company eliminated exposure due to a 'neutral' result, while the actual increase from $3M to $45M indicates a significant increase in exposure, suggesting either increased hedging or operational activity in GBP. The LLM's interpretation is the opposite of the correct inference. (4) Contextually, the answer addresses foreign exchange risk management, which is relevant, but the basis for the conclusion is incorrect. The multi-hop synthesis fails because it draws conclusions from misrepresented financial figures and misidentifies the metric in question. Minor credibility is retained due to correct identification of MDLZ and GBP focus, but core facts and logic are unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 395,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "Compare the interest rate disclosures for Amgen's 3.125% 2025 Notes in the 2022 and 2024 filings, and explain what this reveals about the company's approach to debt financing for this instrument.",
      "original_answer": "In the 2022 filing, Amgen disclosed a fixed interest rate of 3.125% for the 2025 Notes with no mention of variable rate terms. However, by the 2024 filing, Amgen disclosed that the interest rate for the same 3.125% 2025 Notes was tied to SOFR (Secured Overnight Financing Rate) plus 2.1%. This indicates a shift from a purely fixed-rate structure to a floating-rate mechanism, suggesting Amgen may have refinanced or repriced the notes to adapt to changing market conditions and interest rate environments.",
      "llm_answer": "In the 2022 Form 10‑K Amgen reported that its $1 billion of 3.125 % 2025 notes were hedged with interest‑rate swaps that produced an effective floating rate of **LIBOR + 1.8 %** (see page 132). In the 2024 filing the same $1 billion of 3.125 % 2025 notes are still hedged for the full notional amount, but the swaps now reference **SOFR + 2.1 %** (see page 149). This shows Amgen consistently uses swaps to convert fixed‑rate debt to floating‑rate exposure and has transitioned its benchmark from LIBOR to SOFR, reflecting a proactive, market‑aligned approach to managing interest‑rate risk on this instrument.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, Amgen disclosed a fixed interest rate of 3.125% with no variable rate terms, but the LLM claims the rate was effectively LIBOR + 1.8% due to interest-rate swaps. This contradicts the original answer, which makes no mention of hedging or swaps in 2022. Similarly, in 2024, the ground truth says the rate was disclosed as SOFR + 2.1%, implying a structural change in the debt instrument, but the LLM attributes this to swaps rather than a change in the underlying note terms. The LLM incorrectly frames the rate change as a result of hedging activity, while the original answer suggests a refinancing or repricing of the note itself. (2) The dollar amount ($1 billion) and page numbers (132, 149) are plausible but not verifiable from the ground truth, which does not include them. The percentages (LIBOR + 1.8%, SOFR + 2.1%) are specific to the LLM’s hedging narrative but are not supported by the original answer, which makes no mention of swaps or effective rates. These numbers are therefore incorrect in context. (3) The multi-hop reasoning is partially sound—comparing disclosures across years and identifying a benchmark shift from LIBOR to SOFR—but it misattributes the source of the rate change to hedging rather than a change in the note’s terms. This undermines the core conclusion about Amgen’s debt financing strategy. (4) The contextual relevance is high because the answer addresses the right instrument, time periods, and a plausible financial narrative. However, the factual and qualitative inaccuracies—especially the unsupported claim about interest-rate swaps in both years—severely limit correctness. The answer invents a hedging explanation not present in the ground truth, leading to a misleading interpretation of Amgen’s approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 504,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has Schwab's reliance on its Commercial Paper Issuance Program evolved between 2022 and 2024 in response to market disruptions and rising interest rates?",
      "original_answer": "In 2022, Schwab introduced its Commercial Paper Issuance Program as one of several potential sources of external financing, alongside unsecured bank credit lines and a universal shelf registration, to address liquidity needs during market disruptions. The company emphasized that while these tools were available, access to financing could still be constrained due to credit market volatility and potential credit rating downgrades. By 2024, Schwab's reliance on the program had increased as a complement to other funding mechanisms like FHLB advances and repurchase agreements, particularly in response to rising short-term interest rates in 2022 and 2023, which led to higher client cash outflows. The company noted that these outflows, outpacing cash generated from maturities and paydowns, required supplemental funding sources, including the commercial paper program, to manage liquidity under more costly and constrained conditions.",
      "llm_answer": "In the 2022 filing Schwab described its commercial‑paper issuance program as one of several external‑financing tools—alongside uncommitted bank lines—and cautioned that a disruption in credit markets could make that source unavailable or costly (page 23). By the 2024 filing the program is still listed as part of its funding mix, but the company stresses that the rapid rise in short‑term rates and client cash outflows have pushed it to rely more on higher‑cost supplemental funding and that commercial‑paper access may be constrained by market conditions (page 16; see also the discussion of rising rates and supplemental funding in page 14).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential evolution of Schwab's reliance on its Commercial Paper Issuance Program between 2022 and 2024. (1) It correctly states that in 2022, the program was introduced as one of several external financing tools, alongside uncommitted bank lines, and that market disruptions could constrain access—matching the original answer's emphasis on potential constraints due to volatility and credit rating risks. By 2024, the LLM accurately reflects increased reliance on the program as part of a broader shift toward higher-cost supplemental funding, driven by rising short-term interest rates and client cash outflows. (2) There are no numerical values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across years and connects rising rates and outflows to increased reliance on commercial paper and other funding sources. It correctly identifies the causal chain: market conditions → client outflows → need for supplemental funding → greater use of commercial paper, despite constraints. (4) The only minor shortcoming is that the LLM omits specific mention of FHLB advances and repurchase agreements as complementary funding mechanisms highlighted in the original 2024 description. While it refers generally to 'higher-cost supplemental funding,' naming these specific tools would have improved completeness. However, the core factual progression and rationale are preserved with high fidelity. Wording differences are acceptable under semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 456,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How has the status and interest rate structure of the 3.625% Notes evolved from 2022 to 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2022, the 3.625% 2024 Notes had a carrying value of $1,400 million with a fixed interest rate of 3.625%. By 2024, these notes were fully paid off, as indicated by the $0 notional amount, and were replaced with floating interest rates tied to SOFR (Secured Overnight Financing Rate). This shift from fixed to floating rate debt indicates a strategic change in Amgen's debt management, aligning with broader market conditions and potentially reducing interest costs in a declining rate environment.",
      "llm_answer": "The 3.625 % notes that matured in 2022 were fully redeemed in 2021, leaving only the $1.4 bn 3.625 % notes due 2024 outstanding in 2022 (the balance sheet shows a $1,400 mm balance for the 2024 series and a “‑” for the 2022 series)【page_130】; the company hedged those 2024 notes with interest‑rate swaps at an effective LIBOR + 3.2 % in 2020‑2021【page_132】. By 2023 the swap rate had been reset to SOFR + 3.4 % while the notes remained outstanding【page_149】, and in 2024 the 3.625 % 2024 notes were repaid and the related $1.4 bn swap contracts were terminated【page_150】. This shows the firm’s strategy of retiring maturing fixed‑rate debt, using swaps to convert fixed coupons to floating‑rate exposure, and unwinding the hedges at maturity to manage interest‑rate risk and optimize financing costs.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but has key factual inaccuracies. It incorrectly states that the 3.625% notes maturing in 2022 were redeemed in 2021 — the ground truth does not mention 2022-maturing notes at all; the focus is solely on the 3.625% 2024 Notes. This introduces a non-existent debt series and misrepresents the timeline. The carrying value of $1,400 million (or $1.4 billion) in 2022 is correct and matches the ground truth. The claim that the notes were hedged with swaps at LIBOR + 3.2% in 2020–2021 is not contradicted by the ground truth but adds detail not present in the original answer, which may be accurate but cannot be verified against the provided truth. The reset to SOFR + 3.4% in 2023 and termination of swaps in 2024 upon repayment aligns with the shift to floating rates mentioned in the ground truth, though the original answer does not mention swaps explicitly. (2) Quantitative accuracy is partially compromised: while $1,400 million and $1.4 billion are equivalent, the introduction of LIBOR/SOFR spread values (3.2%, 3.4%) lacks corroboration in the ground truth, which only states that floating rates tied to SOFR replaced the fixed-rate debt. The repayment in 2024 and zero notional thereafter is correctly implied. (3) The multi-hop reasoning is sound in linking hedging activity, swap termination, and debt repayment to infer a strategy of managing interest rate risk. The conclusion about retiring fixed-rate debt and using derivatives to transition to floating-rate exposure aligns with and even enriches the ground truth’s assertion of a strategic shift. However, the reasoning builds on potentially extraneous details (e.g., 2022 notes, specific swap rates) not supported by the ground truth. (4) Despite these issues, the core of the answer — that Amgen retired fixed-rate debt and replaced it with floating-rate exposure, indicating a strategic shift in debt management — is correct and well-supported. The contextual relevance is high as it directly addresses the evolution and strategic implications. Hence, correctness is scored 7 for accurate core facts with significant but not critical errors; quantitative accuracy is 6 due to unsupported numerical claims; qualitative accuracy is 8 for strong reasoning; and contextual relevance is 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 619,
        "total_tokens": 1949
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has Schwab's approach to providing financial or other support to variable interest entities (VIEs) evolved between 2022 and 2024, particularly in terms of intent and conditions for funding commitments?",
      "original_answer": "In 2022, Schwab explicitly stated that it did not provide or intend to provide financial or other support to VIEs that it was not contractually required to provide. By 2024, Schwab's disclosures indicate a shift, as the company now acknowledges that while it has no contractual obligation, it may choose to provide credit, liquidity, or other support to its proprietary funds in response to significant declines in valuation or redemption activity. This reflects a more proactive stance in supporting funds under certain market conditions, even though it is not mandated.",
      "llm_answer": "In the 2022 Form 10‑K Schwab said it “did not provide or intend to provide financial or other support to the VIEs that it was not contractually required to provide,” and that any remaining funding commitments would be made only if certain conditions were met, with most of those commitments expected to be satisfied between 2022‑2025 (see 2022 p. 98). The 2024 filing (pages 17‑21) contains no VIE‑related disclosure, indicating that Schwab has not added new support commitments or altered its intent – the prior stance of providing no extra support and conditioning any funding on specific events remains unchanged (or the VIE exposure is no longer material).",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect in its core conclusion, directly contradicting the ground truth. While it correctly quotes Schwab's 2022 position—stating it did not provide or intend to provide support beyond contractual obligations—it incorrectly asserts that the 2024 filing shows no change in stance. The ground truth confirms that by 2024, Schwab updated its disclosure to acknowledge a potential willingness to provide credit, liquidity, or other support to its proprietary funds under stress conditions (e.g., significant valuation declines or redemptions), even without contractual obligation. The LLM incorrectly interprets the absence of VIE-related disclosure in the cited 2024 pages (17–21) as evidence of no change, when in fact the knowledge graph reflects updated disclosures elsewhere or a material shift in policy not captured in those specific pages. This represents a critical failure in multi-hop reasoning: the model should have identified the evolution in intent from 'no intent to support' to 'possible discretionary support under market stress.' Quantitative accuracy is acceptable—dates (2022–2025) and page references are plausible and do not contain numerical errors. However, the qualitative reasoning is flawed, as it misses the key evolution in Schwab’s policy. Contextual relevance is moderate—the response addresses the topic and timeframe but draws an incorrect conclusion due to misinterpretation of disclosure absence. The answer fails on the primary dimension of correctness because it reports no change when a significant shift in approach occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 433,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has MDLZ's financial relationship with JDE Peet's evolved between 2022 and 2023, particularly in terms of how the investment impacts MDLZ's liquidity and capital structure?",
      "original_answer": "In 2022, MDLZ's relationship with JDE Peet's was characterized as a 'Has_Stake_In' arrangement, where MDLZ reported its proportionate share of significant operating and non-operating items from JDE Peet's including restructuring and acquisition-related costs. By 2023, the relationship was reclassified to 'Invests_In', and the investment in JDE Peet's was described as providing additional financial flexibility within MDLZ's liquidity and capital resources framework. This shift indicates a more strategic and stable investment posture, aligning JDE Peet's more closely with MDLZ's long-term capital planning and funding sources.",
      "llm_answer": "In 2022 MDLZ’s JDE Peet’s stake was still being “settled” – the company issued €300 million of zero‑interest exchangeable notes that could be redeemed for cash or JDE Peet’s shares 【page_45】 and recorded a large equity‑method gain of $740 million (and related transaction costs) on the investment 【page_46】, showing the deal’s direct impact on financing and earnings. By 2023 the firm frames the same investment as a source of “additional flexibility” that does not hurt its funding sources 【page_54】, and its balance‑sheet metrics reflect a stronger capital structure – total debt fell from $22.9 billion to $19.4 billion and the debt‑to‑capitalization ratio improved from 0.46 to 0.41 【page_55】, indicating the JDE Peet’s holding now bolsters liquidity rather than creating financing strain.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of MDLZ's financial relationship with JDE Peet's from 2022 to 2023, noting a shift in framing from a transactional, gain-recognizing event to a strategic source of financial flexibility. This aligns with the ground truth’s description of a reclassification from 'Has_Stake_In' to 'Invests_In' and the emphasis on improved liquidity and capital structure. However, the LLM introduces specific quantitative details not present in the original answer, such as the €300 million zero-interest exchangeable notes, a $740 million equity-method gain, and exact debt and ratio figures ($22.9B to $19.4B, 0.46 to 0.41). While these numbers may be factually accurate in the actual 10-K, they are not part of the ground truth provided, which focuses on qualitative characterization rather than specific financials. (2) The quantitative accuracy is scored lower because the original answer does not mention these figures, so their correctness cannot be verified against the ground truth. The inclusion of precise numbers and calculations (e.g., debt reduction of $3.5B, ratio improvement) goes beyond the scope of the original and risks misalignment if those details were not in the source. (3) The multi-hop reasoning is strong: the LLM synthesizes information across years, interprets the change in accounting treatment or framing, and links it to liquidity and capital structure impact. It correctly infers that the investment evolved from a source of financing activity and gains to a stabilizing element in capital planning. (4) Despite the added numerical detail, the core qualitative narrative matches the ground truth—shift in relationship classification, increased financial flexibility, and better integration into capital structure. The answer is highly contextually relevant and adds useful detail, but the unverifiable numbers prevent a top score on correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 526,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How did the interest rate hedging strategy for the 3.125% 2025 Notes evolve between 2022 and 2024, particularly in terms of the interest rate applied under the swap agreements?",
      "original_answer": "In 2022, the company had terminated interest rate swaps for portions of the 3.125% 2025 Notes and reentered into new swap agreements at then-current interest rates, though the exact rate for the 3.125% 2025 Notes was not disclosed. By 2024, the interest rate applied under the swap agreement for the 3.125% 2025 Notes was explicitly stated as SOFR+2.1%, with a consistent notional amount of $1,000 million as of December 31, 2024, compared to December 31, 2023.",
      "llm_answer": "In the 2022 filing the $1 billion of 3.125 % 2025 Notes were hedged with an interest‑rate swap that paid **LIBOR + 1.8 %** (see page 132). By the 2024 filing the same $1 billion of notes were hedged with a swap tied to **SOFR + 2.1 %** (see page 149), reflecting the shift from LIBOR to the SOFR benchmark and a modest increase in the spread.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, the company terminated existing swaps and entered new ones, but the exact rate for the 3.125% 2025 Notes was not disclosed. However, the LLM claims a specific rate of LIBOR + 1.8% in 2022, which contradicts the original answer and is not supported by the ground truth. This is a major quantitative error. The 2024 rate of SOFR + 2.1% and the $1,000 million notional amount are correctly reported and match the ground truth. (2) The dollar amount ($1 billion) is consistent with $1,000 million, so that is acceptable. However, the 2022 interest rate (LIBOR + 1.8%) is fabricated and not mentioned in the ground truth, making it factually wrong. The shift from LIBOR to SOFR is a reasonable inference given market trends, but the specific 2022 rate is not justifiable. (3) The multi-hop reasoning is partially sound—comparing the hedging strategy across 2022 and 2024 is appropriate, and identifying the benchmark shift shows contextual understanding. However, the model invents a specific rate for 2022 that was explicitly stated as undisclosed, indicating a failure in accurate synthesis. (4) Correctness score is low due to the critical error in the 2022 rate, which undermines the factual reliability. Quantitative accuracy is poor due to the incorrect rate. Qualitative accuracy is moderate because the structure and intent are reasonable, but reasoning is flawed by unsupported data. Contextual relevance is high as the answer addresses the evolution of the hedging strategy and the benchmark transition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 443,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did Walmart's fair value of equity investments measured using Level 2 inputs evolve from fiscal year 2022 to fiscal year 2023, and what was the magnitude of this change?",
      "original_answer": "Walmart's fair value of equity investments measured using Level 2 inputs decreased from $5,819 million in fiscal year 2022 to $5,570 million in fiscal year 2023, representing a moderate decline of $249 million over the period.",
      "llm_answer": "Walmart’s equity investments measured using Level 2 inputs were valued at **$5.819 billion** at fiscal‑year end 2022 and fell to **$5.570 billion** at fiscal‑year end 2023.  This represents a decline of roughly **$249 million** (about $0.25 billion).【page_72】【page_71】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: Walmart's fair value of equity investments using Level 2 inputs was $5,819 million ($5.819 billion) in fiscal year 2022 and decreased to $5,570 million ($5.570 billion) in fiscal year 2023. The magnitude of change is correctly calculated as $249 million (also expressed as ~$0.25 billion), which matches the ground truth. (2) Quantitative accuracy is perfect: the numbers are correct in both absolute values and the difference; format variations (billion vs million) are appropriately handled and do not affect correctness. (3) The multi-hop reasoning is sound—comparing two fiscal years' values and computing the change is correctly executed. (4) Entity accuracy is preserved: Walmart, Level 2 inputs, equity investments, and fiscal years 2022 and 2023 are all correctly identified. The answer is complete, addressing both the evolution and the magnitude of change. Contextual relevance is high, with direct citation of source pages. All criteria are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1130,
        "completion_tokens": 310,
        "total_tokens": 1440
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How has Apple's characterization of its reliance on marketing abilities evolved between its 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Apple stated that while it believes ownership of intellectual property rights is an important factor in differentiating its business, it 'relies primarily' on the innovative skills, technical competence, and marketing abilities of its personnel. In the 2024 filing, Apple shifted its language, stating that it 'depends heavily' on these same three factors—innovative skills, technical competence, and marketing abilities—tying them directly to ensuring a continual and timely flow of competitive products, services, and technologies to the marketplace. This evolution reflects a stronger emphasis on the strategic importance of marketing abilities in maintaining competitiveness, particularly as the company faces increasing pressure from rivals imitating its features and offering lower-priced alternatives.",
      "llm_answer": "Apple’s description of the role of marketing has not changed. Both the 2023 and the 2024 Form 10‑K state that the Company “relies primarily on the innovative skills, technical competence and **marketing abilities** of its personnel” (page 6 of each filing), indicating a consistent view of marketing as a core driver of its success.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that Apple's characterization of marketing has 'not changed' between the 2023 and 2024 10-K filings. The ground truth shows a clear evolution in language: from 'relies primarily' in 2023 to 'depends heavily' in 2024, with added strategic context about ensuring a 'continual and timely flow' of competitive offerings. The LLM incorrectly asserts that the exact same phrase appears in both filings (citing 'page 6 of each filing'), which contradicts the ground truth and misrepresents the evolution in Apple's disclosure. While the entities (Apple, 2023, 2024, 10-K) and general topic (marketing abilities) are correctly identified, the reasoning fails to capture the multi-hop nuance of how the company's emphasis has shifted. There are no numerical values in the question, so quantitative accuracy is not applicable in a scoring sense but is marked 10 by default. The answer is contextually relevant in discussing Apple's reliance on marketing, but the conclusion is misleading due to the failure to detect the linguistic and strategic shift. This represents a significant qualitative error in interpretation and synthesis, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 340,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How did the notional amount and interest rate structure for the 3.625% 2024 Notes change between 2022 and 2024, and what does this indicate about Amgen's hedging strategy?",
      "original_answer": "In 2022, Amgen terminated interest rate swaps with a notional amount of $5.2 billion that hedged several notes, including the 3.625% 2024 Notes, and reentered into new interest rate swap agreements at then-current rates on the same principal amount. By 2024, the notional amount for the 3.625% 2024 Notes had dropped to $0 as of December 31, 2024, compared to $1,400 million in December 2023, with the interest rate tied to SOFR+3.4% in 2023. This indicates that Amgen fully unwound its hedging position for the 3.625% 2024 Notes by the end of 2024, likely as the notes approached maturity.",
      "llm_answer": "In 2022 Amgen still had a $1.4 billion interest‑rate‑swap hedge on the 3.625 % 2024 Notes that converted the fixed coupon to a floating LIBOR + 3.2 % rate (page 132). By the end of 2024 the swap had been terminated – the notional amount is shown as “‑” and no interest‑rate term is listed (page 149), after having been re‑priced to SOFR + 3.4 % in 2023. This drop to zero notional and the shift from LIBOR to SOFR before termination shows Amgen actively unwinds hedges as the debt matures and moves away from LIBOR‑based structures.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer gets several key facts correct but contains significant quantitative inaccuracies. It states that in 2022, Amgen had a $1.4 billion hedge on the 3.625% 2024 Notes, but the ground truth indicates that in 2022, Amgen terminated $5.2 billion in swaps covering multiple notes (including the 2024 Notes), not just $1.4 billion on the 2024 Notes alone. The $1.4 billion figure is correct for the notional amount as of December 2023, not 2022. The LLM incorrectly assigns this amount to 2022, which misrepresents the timeline and scale of the hedging activity. Additionally, the LLM claims the 2022 swap converted the rate to LIBOR + 3.2%, but the ground truth does not specify the exact spread in 2022—only that new swaps were entered at 'then-current rates'—and the shift from LIBOR to SOFR is implied but not explicitly detailed in the truth. The 2023 rate (SOFR + 3.4%) is correctly reported. The 2024 notional dropping to $0 is correctly inferred from the '—' notation, which aligns with the ground truth. (2) Calculation-wise, the drop to zero is accurate, but the initial notional amount is wrong. The $5.2 billion figure in 2022 (across all hedged notes) is missing from the LLM answer, which undermines the completeness of the financial picture. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes over time (2022 → 2023 → 2024), recognizes the significance of the notional dropping to zero, and infers that Amgen unwinds hedges as debt matures. It also correctly identifies the transition from LIBOR to SOFR as part of broader market trends, which is a reasonable qualitative inference. (4) Despite the incorrect assignment of the $1.4 billion to 2022 and the unsupported claim about LIBOR + 3.2%, the core conclusion—that Amgen terminated its hedge by 2024 and adjusted its interest rate benchmark—is consistent with the ground truth. The answer is contextually relevant and well-structured, but the quantitative inaccuracies prevent a higher score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 541,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How did Schwab's integration of the iRebal portfolio rebalancing solution evolve from 2022 to 2023, and what does this indicate about its competitive positioning in the RIA market?",
      "original_answer": "In 2022, Schwab stated that it was retaining TD Ameritrade Institutional's customizable portfolio rebalancing solution, iRebal, as part of its offering for independent advisor clients. This indicated that Schwab acknowledged the value of iRebal but had not yet fully integrated or emphasized it within its broader platform. By 2023, Schwab had incorporated iRebal as a core part of its offerings for independent advisors, signaling a deeper integration and a strategic move to enhance its competitive positioning in the RIA market. This evolution reflects Schwab's broader integration progress, including the transition of over $1.6 trillion in client assets and more than 15 million client accounts from TD Ameritrade to the Schwab platform by 2023. The inclusion of iRebal as a central feature for RIAs suggests that Schwab is leveraging the solution to differentiate its service offerings and strengthen its appeal to independent advisors, aligning with its competitive advantage of introducing new products credibly through its strong brand and corporate reputation.",
      "llm_answer": "In the 2022 filing Schwab said it had **incorporated TD Ameritrade Institutional’s iRebal customizable portfolio‑rebalancing solution into its offering for independent‑advisor clients** (2022 p. 4). By the 2023 filing the integration overview notes that **Schwab is still retaining iRebal as a core component of its unified platform for advisor clients** (2023 p. 6), indicating the tool has moved from an initial add‑on to a permanent, leveraged capability. This continued integration shows Schwab is strengthening its technology stack for RIAs, using iRebal to differentiate its Advisor Services and sharpen its competitive positioning in the RIA market.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and context, but reverses the timeline of iRebal's integration, which impacts the qualitative accuracy. According to the ground truth, in 2022 Schwab stated it was *retaining* iRebal, indicating it was still in the early stages of integration, while by 2023 it had *incorporated* iRebal as a core part of its offering—showing progression from retention to deeper integration. The LLM incorrectly states that in 2022 Schwab had already 'incorporated' iRebal, and in 2023 was 'still retaining' it, which misrepresents the evolution as static or regressive rather than progressive. This undermines the reasoning behind Schwab’s strategic advancement in the RIA market. However, all referenced document pages (2022 p.4, 2023 p.6) are contextually plausible, and there are no issues with numerical data, dates, or entity names—quantitative accuracy is perfect. The answer correctly identifies the significance of iRebal for Schwab's competitive positioning in the RIA market and ties it to broader platform integration, satisfying contextual relevance. The core facts about iRebal being a key tool for independent advisors and contributing to competitive differentiation are semantically aligned with the original. The error lies in the direction of the integration narrative, making the multi-hop reasoning partially flawed despite correct entity identification and synthesis intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 396,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How has Apple's approach to the iMac product line evolved between 2023 and 2024, based on the company's disclosures in its 10-K filings?",
      "original_answer": "In 2023, Apple described the iMac as part of its Mac product line, indicating it was actively manufacturing and marketing the desktop computer as part of its standard offerings. By 2024, Apple elevated the iMac to the level of a significant product announcement, listing it among other key launches like the MacBook Pro and iPad Pro in the MD&A section of its 2024 10-K. This shift suggests that the iMac gained strategic importance in 2024, likely reflecting a product refresh or redesign that warranted special mention as part of the company's innovation cycle.",
      "llm_answer": "In Apple’s 2023 Form 10‑K the iMac is only referenced as one of the desktop models in the Mac family (“desktops iMac, Mac mini, Mac Studio and Mac Pro”) with no specific product‑update discussion (see 2023 p. 4). By contrast, the 2024 Form 10‑K lists a new iMac among the first‑quarter product announcements, indicating that Apple is actively refreshing the iMac line in 2024 (see 2024 p. 24). This reflects a shift from a static product‑line mention in 2023 to a concrete, newly‑launched iMac offering in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that in the 2023 10-K, the iMac was mentioned only as part of the broader Mac product line without specific updates, and in the 2024 10-K, it was highlighted among key product announcements, indicating a refresh. These details match the original answer’s claim about increased strategic emphasis. (2) There are no numerical values to verify, but the references to page numbers (p. 4 for 2023, p. 24 for 2024) are consistent with typical 10-K structures and plausible, though not independently verifiable from the provided data; no quantitative inaccuracies are present. (3) The multi-hop reasoning is sound: the model correctly contrasts the treatment of iMac across two years’ filings to infer a shift in strategic importance, synthesizing information from both documents appropriately. (4) The answer captures the core evolution—elevation from a listed product to a highlighted launch—though it omits the explicit mention of 'strategic importance' or 'innovation cycle' from the original answer, which slightly reduces qualitative completeness. However, the semantic meaning and factual content are equivalent. The response is fully relevant and directly addresses the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 358,
        "total_tokens": 1624
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How has RTX's relationship with the 2.820% Notes Due 2051 evolved between 2022 and 2024, and what does this indicate about the company's long-term debt structure?",
      "original_answer": "In 2022, RTX introduced the 2.820% Notes Due 2051 with an aggregate principal balance of $1,000 million. By 2024, this debt instrument remained on the books with the same principal balance of $1,000 million, indicating no repayment or additional issuance occurred during this period. However, the broader long-term debt structure expanded significantly, with total principal long-term debt increasing from an implied $40,078 million in 2022 (based on the 2024 presentation format) to $41,146 million in 2024. This suggests that while the 2.820% Notes Due 2051 remained unchanged, RTX increased its overall debt burden through other issuances, maintaining the 2051 notes as a stable component within a growing long-term debt portfolio.",
      "llm_answer": "RTX’s $1 billion of 2.820 % notes that mature in 2051 were still on the balance sheet in the 2022 filing (the long‑term‑debt schedule shows a $1 bn balance for those notes)【page_94】and were unchanged at $1 bn in the 2024 filing【page_89】. The company has neither retired nor refinanced this low‑coupon, 30‑year issue, indicating that RTX deliberately retains a sizable, low‑cost, long‑dated tranche of debt as a stable pillar of its overall long‑term debt structure.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that RTX's 2.820% Notes Due 2051 had a $1 billion principal balance in both 2022 and 2024, with no repayment or issuance during the period—this matches the ground truth exactly. All numeric values (2.820%, $1 billion, 2051 maturity) are accurate and properly cited to filing pages. (2) Quantitative accuracy is perfect: dollar amounts, percentages, and years are correct and consistent with the original answer. There are no calculation errors. (3) The reasoning is mostly sound—the LLM correctly infers that the unchanged balance indicates a stable, long-term debt component. However, it omits a key multi-hop insight from the ground truth: that total long-term debt increased from $40,078 million to $41,146 million over the same period, indicating RTX issued other debt despite holding the 2051 notes constant. This broader context about the evolving debt structure is missing, weakening the synthesis. (4) The answer is highly relevant and factually correct on the specific instrument, but less complete in characterizing the overall long-term debt evolution. Hence, while quantitative and contextual scores are high, qualitative accuracy and overall correctness are slightly reduced due to incomplete multi-hop reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 356,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How did the terms of Schwab's IDA agreement evolve between 2022 and 2023, particularly regarding service fees and reference rate adjustments?",
      "original_answer": "In 2022, Schwab disclosed that the IDA agreement had been amended to reduce the service fee on client cash deposits held at the TD Depository Institutions to 15 basis points from 25 basis points. By 2023, the company reported that its IDA agreement had transitioned reference rates previously tied to LIBOR to other appropriate benchmarks as part of its broader LIBOR phase-out preparation. This evolution reflects a shift from adjustments in fee structure to modifications in financial reference mechanisms, aligning the agreement with post-LIBOR regulatory and market standards.",
      "llm_answer": "In the 2022 Form 10‑K Schwab reported that the amended Inter‑Depository Agreement (IDA) lowered the service fee on client cash held at the TD Depository Institutions from 25 basis points to 15 basis points. By the 2023 filing, Schwab said the IDA (and related inter‑company loans) had been re‑based off LIBOR to alternative reference rates as part of its LIBOR transition, completing the rate‑adjustment change while the fee level remained at the 15‑basis‑point amount introduced in 2022.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key facts are correct: in 2022, the service fee was reduced from 25 to 15 basis points, as stated in the 2022 Form 10-K; by 2023, the IDA transitioned away from LIBOR to alternative reference rates as part of Schwab's LIBOR phase-out, consistent with the original answer. (2) Quantitative accuracy is perfect: the 10-basis-point reduction (from 25 to 15) is correctly represented, and the timing (2022 for fee change, 2023 for reference rate transition) matches the original. (3) Multi-hop reasoning is sound—the answer synthesizes information across two years and two aspects of the IDA (fee structure and reference rates), correctly identifying the evolution from fee adjustments to benchmark rate changes. (4) The LLM adds slight but accurate contextual detail (mention of inter-company loans and continuity of the 15-basis-point fee in 2023) without introducing error. Wording differs slightly but maintains semantic equivalence. All entities—Schwab, IDA, TD Depository Institutions, LIBOR—are correctly identified and used in context. The answer fully addresses both parts of the question: service fees (2022) and reference rate adjustments (2023).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 346,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "What does the change in Filorga's financial treatment from 2023 (when it had $221 million in goodwill as a standalone reporting unit) to 2024 (when it was listed among other trademarks within broader segments) suggest about its strategic importance and valuation approach by the company?",
      "original_answer": "In 2023, Filorga was treated as a standalone reporting unit within the Europe segment with a clearly disclosed goodwill carrying value of $221 million, indicating its distinct financial significance and the company’s detailed impairment analysis for this brand. By 2024, Filorga was listed among other global and regional trademarks within broader product segments, without separate goodwill or valuation figures. This suggests that Filorga may have been integrated into a larger reporting structure, reducing its visibility as a standalone asset, which could signal a shift in strategic focus or a consolidation of brand management. This change affects how Filorga’s valuation and performance are assessed, potentially influencing future strategic decisions such as divestiture, investment, or brand prioritization.",
      "llm_answer": "In 2023 Colgate‑Palmolive still treated Filorga as a separate reporting unit, carrying $221 million of goodwill and testing that unit’s fair value on its own (see 2023 Note 13, page 59). By 2024 the brand is simply listed among a long list of global trademarks (see 2024 Nature of Operations, page 79) with no distinct goodwill disclosed, indicating the company has folded Filorga into a broader brand portfolio and now values it as part of an aggregated trademark segment rather than as a stand‑alone, strategically‑critical unit. This shift suggests a reduced emphasis on Filorga’s independent strategic weight and a move to a more consolidated valuation approach.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $221 million goodwill amount for Filorga in 2023 is accurately cited, and the absence of separate goodwill disclosure in 2024 is correctly noted. No calculations were required, but the factual financial treatment across years is precisely described. Format variations (e.g., $221 million vs $221M) are acceptable and do not affect accuracy. (2) The answer addresses both parts of the question: the change in financial treatment and its implications for strategic importance and valuation approach. It correctly infers that the integration into a broader trademark list without standalone goodwill suggests reduced strategic independence and a shift to consolidated valuation. (3) Multi-hop reasoning is sound: the model synthesizes information across two years (2023 and 2024), identifies the change in reporting structure (from standalone unit to aggregated listing), and draws a logical conclusion about strategic emphasis and valuation methodology. (4) The only minor limitation is that the LLM does not explicitly mention potential impacts on future decisions (e.g., divestiture, investment) as noted in the original answer, which slightly reduces completeness in qualitative reasoning. However, the core implications about reduced strategic weight and consolidated valuation are clearly conveyed. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only slight omission of downstream strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 439,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 122,
      "question": "How does the change in Apple's disclosure about the iPhone 16 Pro between the 2023 and 2024 10-K filings reflect an evolution in its product development and reporting strategy?",
      "original_answer": "In the 2023 10-K filing, Apple announced the iPhone 16 Pro as part of its Fourth Quarter 2024 product lineup, indicating it was still in the planning and launch phase. By contrast, in the 2024 10-K filing, the iPhone 16 Pro is listed among existing product lines like the iPhone 15 and iPhone 14, suggesting it has transitioned into an active and established product within Apple's portfolio. This shift reflects a movement from forward-looking product planning in 2023 to retrospective inclusion in 2024, aligning with the product's lifecycle stage and indicating a more mature reporting posture around the iPhone 16 Pro.",
      "llm_answer": "In the 2023 Form 10‑K the iPhone discussion is limited to aggregate net‑sales (see 2023 page 26, which mentions only “iPhone net sales” without naming any specific model), whereas the 2024 Form 10‑K explicitly lists the iPhone 16 Pro in the product description (2024 page 4) and announces its launch in the fourth‑quarter product rollout (2024 page 24). This change shows Apple moving from a generic, historical‑sales focus to a forward‑looking strategy that highlights a new generation iPhone, reflecting both the development of the iPhone 16 Pro line and a more detailed, product‑specific reporting approach.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly states that the 2023 10-K does not mention the iPhone 16 Pro and instead only discusses aggregate iPhone sales, whereas the ground truth confirms that the 2023 10-K explicitly announced the iPhone 16 Pro as part of the Fourth Quarter 2024 product lineup. This misrepresents a key fact and inverts the timeline. (2) It claims the 2024 10-K 'announces' the iPhone 16 Pro's launch in Q4, implying it is a future event, but the ground truth indicates that by the 2024 10-K, the iPhone 16 Pro is treated as an existing product, reflecting its transition to an established offering—this is the opposite of a forward-looking announcement. (3) The LLM incorrectly frames the evolution as a shift from 'historical-sales focus' to 'forward-looking strategy,' when the actual shift is from forward-looking (2023) to retrospective/mature reporting (2024). (4) The citation of specific pages (e.g., 2024 page 4 and 24) may be plausible but cannot be verified and are used to support an incorrect narrative. (5) The reasoning is fundamentally flawed: it fails to recognize the product lifecycle progression and misinterprets the direction of change in disclosure strategy. While the answer addresses the general theme of reporting evolution and is structured around the right documents, the core facts and logic are inverted, leading to a mostly incorrect conclusion. Thus, despite some contextual relevance, the quantitative and qualitative inaccuracies severely reduce correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 430,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How has the company's use of Economic Value of Equity (EVE) simulations evolved in assessing interest rate risk, particularly in terms of modeling assumptions and balance sheet dynamics, between 2022 and 2023?",
      "original_answer": "In 2022, the company used EVE simulations to measure long-term interest rate risk, with key assumptions including non-negative investment yields, prepayment speeds of mortgage-related investments, and non-maturity deposit behavior. The EVE analysis was described as highly dependent on asset and liability assumptions based on historical behaviors and expectations of the economic environment. By 2023, the company expanded the role of EVE simulations to specifically capture the impact of client cash allocation changes on the balance sheet, which was not included in the earlier modeling approach. Additionally, in 2023, the company actively updated deposit beta assumptions in a declining interest rate environment for its net interest revenue simulation model, indicating a more dynamic approach to modeling interest rate sensitivity.",
      "llm_answer": "In 2022 Schwab’s EVE simulations were a largely static, theoretical exercise that applied instantaneous interest‑rate shifts to a balance‑sheet snapshot built on historical asset‑liability behavior, using proprietary and third‑party term‑structure, pre‑payment and cash‑run‑off models with key assumptions such as rate‑floor scenarios, pre‑payment speeds, non‑maturity deposit behavior and pricing. By 2023 the firm had refined the framework – adding interest‑rate swap derivatives into the EVE analysis, updating deposit‑beta and liability‑duration assumptions to reflect a shortening liability duration as rates rose, and explicitly modeling client‑cash allocation changes – while still relying on the same mix of internal and external models.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key developments between 2022 and 2023 in the company's use of EVE simulations. It accurately identifies that in 2022, the modeling relied on historical behaviors and assumptions such as prepayment speeds, non-negative (rate-floor) yields, and non-maturity deposit behavior. The answer correctly notes the use of proprietary and third-party models, which is consistent with the original answer’s reference to assumptions based on historical behaviors and economic expectations. In 2023, the LLM correctly highlights enhancements: modeling client cash allocation changes (explicitly mentioned in the ground truth), updating deposit beta assumptions, and refining liability duration—though the ground truth emphasizes a declining rate environment while the LLM mentions rising rates, which is a minor inconsistency. The addition of interest-rate swaps in 2023 is an extra detail not present in the original answer; while plausible, it is not verifiable from the ground truth and introduces unconfirmed information. The LLM also mentions 'shortening liability duration as rates rose,' which infers causality not explicitly stated in the original, slightly overextending the evidence. However, the core multi-hop synthesis—evolution from static, historical-based modeling in 2022 to a more dynamic, behaviorally responsive framework in 2023 incorporating client behavior and updated betas—is sound and semantically equivalent. All dates and entities (Schwab, EVE, 2022–2023) are correct. No numerical inaccuracies exist, as no specific numbers are involved. The answer is highly contextually relevant and captures the essence of the evolution in modeling assumptions and balance sheet dynamics. The score is reduced slightly due to the unverified addition of interest-rate swaps and the minor misalignment on the rate environment (rising vs. declining), which affects qualitative precision but not overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 536,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How did Qualcomm's strategic shift from enabling wireless access point technologies in 2022 to directly producing them in 2023 affect its competitive positioning and product portfolio breadth in the broader networking market?",
      "original_answer": "In 2022, Qualcomm's involvement with wireless access points was limited to enabling the technology through its foundational wireless innovations and chipset solutions, as noted in its discussion of edge networking growth driven by 5G and Wi-Fi 6 adoption. However, by 2023, Qualcomm had evolved its strategy to directly producing wireless access points as part of its broader networking product suite, which included Wi-Fi chips, routers, and network processors. This shift reflects an expansion of Qualcomm's product portfolio and a more direct role in the networking ecosystem, positioning the company to compete more directly with players like Broadcom and Intel by offering full-system solutions rather than just underlying components.",
      "llm_answer": "In 2022 Qualcomm’s role in the Wi‑Fi market was largely that of an enabler – it supplied the core Wi‑Fi, Bluetooth and WLAN chipsets and licensed the underlying patents that let other OEMs build access‑point equipment 【page_10】. By fiscal 2023 the company had moved up the value chain and began offering complete wireless‑access‑point and router solutions as part of a broader networking portfolio that now also includes Ethernet, PON chips, network processors and broadband‑gateway equipment 【page_12】. This shift gives Qualcomm a stronger competitive position by capturing more of the networking‑hardware value chain and broadening its product breadth across the entire networking market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly identifies Qualcomm's shift from being a technology enabler in 2022—providing chipsets and IP—to directly producing complete wireless access point and router solutions in 2023. The years (2022 and 2023) are accurate, and there are no numeric values requiring calculation, so quantitative accuracy is fully preserved. (2) The answer addresses all parts of the question: the strategic shift, its impact on competitive positioning (stronger position by capturing more value), and product portfolio breadth (expanded to include full solutions like routers, Ethernet, PON, network processors). (3) Multi-hop reasoning is sound—synthesizing Qualcomm’s earlier enabling role with its evolved 2023 strategy of vertical integration into full-system offerings. (4) The LLM adds contextual detail (e.g., Bluetooth, WLAN, Ethernet, PON) not in the original but consistent with plausible extensions of the knowledge graph and Qualcomm’s known product lines, which enhances completeness without introducing inaccuracies. The only minor shortcoming is the lack of explicit mention of competitive comparison to Broadcom and Intel, which the original answer includes to illustrate competitive positioning. However, the core competitive implication—moving up the value chain to capture more value—is clearly conveyed. Thus, the answer is semantically equivalent with high qualitative and contextual fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 407,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has the interest-only payment structure of Schwab's HELOC product evolved from 2022 to 2023, based on the percentage of adjustable-rate mortgages with interest-only terms and the portion not scheduled to reset for three or more years?",
      "original_answer": "In 2022, 28% of adjustable-rate mortgages were interest-only loans, with 89% of those not scheduled to reset for three or more years. In 2023, this shifted slightly to 27% of adjustable-rate mortgages being interest-only, with 86% of those not scheduled to reset for three or more years. This reflects a minor decrease in both metrics, suggesting a slight tightening or evolution in the interest-only structure of the HELOC product.",
      "llm_answer": "Schwab’s HELOC product showed essentially no shift in its interest‑only profile. In both 2022 and 2023, roughly 27 percent of the adjustable‑rate mortgage balance was interest‑only, and about 86 percent of those interest‑only loans were not scheduled to reset for three or more years, indicating a stable interest‑only payment structure across the two years【page_93†L1-L4】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its key quantitative claims. According to the ground truth, in 2022, 28% of adjustable-rate mortgages were interest-only, not 27%, and 89% of those were not scheduled to reset for three or more years, not 86%. In 2023, the correct figures are 27% and 86%, respectively. The LLM incorrectly states that both years had 'roughly 27%' interest-only loans and 'about 86%' not resetting for three or more years, which misrepresents the 2022 data. (2) The quantitative inaccuracies are significant: the 2022 percentage of interest-only loans is off by 1 percentage point (28% vs 27%), and the portion not resetting is off by 3 percentage points (89% vs 86%). These are not minor rounding differences but substantive misstatements, especially the reset figure. (3) The reasoning is flawed because the LLM concludes 'essentially no shift' and 'stable structure', while the ground truth shows a decline in both metrics (28% → 27% and 89% → 86%), indicating a slight tightening. The model fails to recognize or report the change in 2022 baseline, leading to incorrect synthesis. (4) Contextual relevance is high because the answer addresses the right product (Schwab HELOC), time frame (2022–2023), and metrics. However, due to incorrect numbers and misleading conclusion, the overall correctness score is low despite relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 383,
        "total_tokens": 1608
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How has Qualcomm's involvement in the XR market evolved from 2022 to 2023, based on their strategic investments and product revenue disclosures?",
      "original_answer": "In 2022, Qualcomm's involvement in XR was primarily through strategic investments made via Qualcomm Ventures, targeting early-stage companies in areas including XR to expand opportunities for their technologies. By 2023, this involvement evolved into direct revenue generation, as XR was explicitly listed among the industries and applications for which Qualcomm sold products, indicating a shift from investment to commercialization. This transition reflects a significant change in Qualcomm's engagement with XR, moving from supporting external innovation to deriving tangible revenue from XR-related product sales.",
      "llm_answer": "In the 2022 Form 10‑K Qualcomm explicitly said its QSI (Qualcomm Ventures) unit was making “strategic investments … in … XR” as part of its early‑stage portfolio (see page 14). By the 2023 filing, XR is no longer called out as a separate investment focus; it is folded into the broader IoT product line, and the IoT segment (which includes XR) fell from $7.353 billion in 2022 to $5.94 billion in 2023 (see page 73), showing that Qualcomm’s XR involvement shifted from a highlighted venture‑investment push to a modest, declining revenue contribution.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains partial factual accuracy but introduces significant errors in both quantitative and qualitative dimensions. (1) Quantitatively, the IoT revenue figures are mostly correct: $7.353 billion in 2022 and $5.94 billion in 2023 are accurate per Qualcomm's 10-K filings. However, the LLM incorrectly attributes the entire IoT segment decline to XR, which is not supported by the ground truth. XR is only one component of the broader IoT category, and no specific revenue breakdown for XR is provided in the filings, making the claim about XR’s 'declining revenue contribution' speculative and unsupported. (2) The LLM misrepresents the evolution of Qualcomm’s strategy: while it correctly notes that XR was explicitly mentioned in 2022 as a focus area for Qualcomm Ventures, it falsely claims that by 2023 XR was 'folded into the broader IoT product line' as a revenue stream. The ground truth indicates that in 2023, XR was explicitly listed as an industry for which Qualcomm sold products—marking a shift from investment to commercialization—not that it was subsumed or de-emphasized. The LLM interprets the lack of explicit mention in venture investments as a demotion of XR, but the real evolution is a transition from external investment to internal product monetization. (3) The reasoning is flawed: the model fails to recognize the positive strategic shift (from investment to revenue generation) and instead infers a decline based on a drop in overall IoT revenue, which includes many non-XR segments like automotive and networking. This mischaracterizes the nature of Qualcomm’s XR involvement. (4) While the answer is contextually relevant and cites correct document locations and revenue figures, it misses the core insight of the ground truth—the strategic maturation of XR from a venture focus to a commercial product line—leading to a low correctness score despite some accurate data points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 516,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the aggregate principal balance of the 3.030% Notes Due 2052 evolved between 2022 and 2024, and what does this indicate about RTX's long-term debt structure?",
      "original_answer": "The aggregate principal balance of the 3.030% Notes Due 2052 remained stable at $1,100 million in both 2022 and 2024. This indicates that RTX has maintained its long-term commitment to this particular debt instrument without any repayments or additional issuances during this period. Despite overall changes in other long-term debt components, the 3.030% Notes Due 2052 remained unchanged, suggesting strategic consistency in managing this portion of its capital structure.",
      "llm_answer": "The 3.030 % notes due 2052 carried an aggregate principal balance of **$1.1 billion at year‑end 2022** (see the 2022 10‑K table where the first column lists $1,100 million) and the same **$1.1 billion at year‑end 2023 and 2024** (the 2024 10‑K shows $1,100 million for both years). The unchanged balance indicates that RTX has left this long‑dated issuance untouched, making it a stable, long‑term anchor in its debt portfolio and contributing to a diversified maturity schedule that extends well beyond the next decade.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the aggregate principal balance of the 3.030% Notes Due 2052 as $1,100 million (or $1.1 billion) in both 2022 and 2024, matching the ground truth. It also correctly notes the balance remained unchanged in 2023, which is consistent with the stability described in the original answer. The use of $1.1 billion instead of $1,100 million is an acceptable format variation. (2) All numeric values are accurate: $1,100 million appears correctly in both years, and no erroneous calculations are made. The LLM references the correct data source (10-K tables), though it mentions 2023 without being asked—this is a minor addition but not incorrect. (3) The reasoning is sound: the LLM correctly infers that the unchanged balance indicates stability and serves as a long-term anchor in RTX's debt structure. It accurately synthesizes information across filings (2022 and 2024 10-Ks) and draws a logical conclusion about strategic consistency in capital structure management. (4) The answer is contextually fully relevant, addressing both the evolution of the debt balance and its implication for RTX's long-term debt strategy. The only minor shortcoming is that the original answer emphasizes 'no repayments or additional issuances' and 'strategic consistency,' which the LLM implies but does not explicitly state. This slight omission in qualitative nuance prevents a perfect 10, but the core facts, synthesis, and interpretation are correct.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 408,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has AXP's focus on Corporate Card solutions evolved between 2023 and 2024, and what does this shift suggest about its broader commercial payments strategy?",
      "original_answer": "In 2023, AXP emphasized evolving its card value propositions and differentiating its corporate card and accounts payable expense management solutions as part of a broader push to strengthen its position in commercial payments. By 2024, while the focus on commercial payments remained, AXP shifted toward designing 'innovative products and features, including financing, banking and payment solutions for our business customers,' indicating a more integrated and solution-oriented approach. This evolution suggests that AXP is expanding beyond just product differentiation to embedding the Corporate Card into a wider suite of business financial services, aligning it more closely with holistic commercial needs.",
      "llm_answer": "In the 2023 filing American Express said it would “evolve our card value propositions, further differentiating our corporate card and accounts‑payable expense‑management solutions” as a key part of its commercial‑payments focus【page_8】. By the 2024 filing the language expands to “designing innovative products and features, including financing, banking and payment solutions for our business customers,” indicating the corporate‑card is now being woven into a broader suite of financial services【page_8】. This shift suggests AXP is moving from simply enhancing its corporate‑card product to building a more integrated, end‑to‑end commercial‑payments platform for business customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: AXP's 2023 focus on evolving card value propositions and differentiating corporate card and accounts payable solutions is accurately cited with correct context and page reference. The 2024 shift toward 'innovative products and features, including financing, banking and payment solutions' is also correctly reported. (2) There are no numeric values, dates, or calculations in the question or answer, so quantitative accuracy is not applicable beyond correct year references (2023 and 2024), which are accurate. (3) The multi-hop reasoning—comparing AXP’s strategic language across two years to infer a broader shift toward integrated commercial solutions—is sound and well-supported. The conclusion that AXP is moving from product enhancement to an end-to-end platform mirrors the original answer’s inference about a 'more integrated, solution-oriented approach' and 'holistic commercial needs.' (4) The only minor shortcoming is that the LLM answer does not explicitly use the term 'solution-oriented approach' or mention 'embedding the Corporate Card into a wider suite,' which slightly reduces qualitative precision, but the semantic meaning remains equivalent. Wording differences are acceptable under semantic equivalence. Contextual relevance is perfect—the answer directly addresses both parts of the question: evolution between 2023 and 2024, and what the shift suggests about broader strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 420,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic positioning of PCA SKIN within Colgate-Palmolive's Oral, Personal and Home Care segment evolved between 2023 and 2024, particularly in terms of its distribution channels?",
      "original_answer": "In 2023, PCA SKIN was listed among Colgate-Palmolive’s principal global and regional trademarks and was included in the broader category of products sold primarily to traditional and eCommerce retailers, wholesalers, distributors, and dentists. By 2024, PCA SKIN remained a listed principal trademark, but the filing specifically expanded the distribution channels to include sales to skin health professionals in some geographies. This indicates a refinement in positioning PCA SKIN within more specialized skincare distribution channels, though no change in production or brand status is indicated.",
      "llm_answer": "In both the 2023 and 2024 Form 10‑K, PCA SKIN is listed among the global brands that sit in the Oral, Personal and Home Care segment, and the segment’s products are described as being sold “primarily to a variety of retailers, wholesalers, distributors, dentists and, in some geographies, skin‑health professionals,” with “some … sold direct‑to‑consumer” (2023 & 2024 Nature of Operations, p. 79). The language is unchanged, showing that PCA SKIN’s strategic positioning stayed the same – a skin‑health brand marketed through the same mix of traditional retail/professional channels and an expanding e‑commerce/direct‑to‑consumer channel – between 2023 and 2024.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that the language regarding distribution channels for PCA SKIN was unchanged between 2023 and 2024. The ground truth states that in 2024, the filing specifically expanded distribution channels to include sales to skin health professionals in some geographies, indicating a refinement in strategic positioning. However, the LLM asserts that the language is identical in both years and that no change occurred, which contradicts the ground truth. There are no numerical figures in this question, so quantitative accuracy is scored as 10 since no numbers were misstated. Qualitative accuracy is low because the model failed to identify the key evolution in distribution strategy — the explicit addition of skin health professionals as a channel in 2024 — representing a failure in multi-hop reasoning or document comparison. Contextual relevance is moderate because the answer addresses the right segment, brand, and general distribution context, but misses the critical change in positioning. The citation to unchanged 'Nature of Operations, p. 79' language may reflect an actual textual observation, but the conclusion drawn (no change in strategic positioning) is incorrect per the ground truth, suggesting either a misinterpretation or incomplete data access.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 365,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "How has the strategic focus and commercial positioning of Opdivo evolved between 2022 and 2023, particularly in terms of new tumor indications and combination therapies, and what implications does this have for its revenue growth trajectory?",
      "original_answer": "In 2022, Opdivo was approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, with the Opdivo + Yervoy regimen approved in multiple markets for NSCLC, melanoma, MPM, RCC, CRC, and gastric/esophageal cancers. It reported U.S. revenue growth driven by combinations in NSCLC, kidney cancer, and gastric/esophageal cancers. By 2023, Opdivo's strategic focus expanded into new tumor types and earlier lines of therapy, with an emphasis on broadening its use both as a monotherapy and in combination with Yervoy and other agents. The company also highlighted the potential of a subcutaneous formulation to enhance patient benefits and drive long-term adoption. This evolution indicates a strategic push to sustain revenue growth by diversifying indications and optimizing delivery mechanisms, despite increasing market competition.",
      "llm_answer": "In 2022 Opdivo was already marketed across a broad set of cancers (bladder, CRC, head‑and‑neck, RCC, HCC, lung, melanoma, MPM, stomach) and its Opdivo + Yervoy combos were highlighted as growth engines, while the company emphasized ongoing registrational studies to push Opdivo into earlier lines and new tumor types (​page 71​). By 2023 the pipeline translated into concrete approvals – adjuvant treatment of stage IIB/IIC melanoma in the U.S. and EU, neoadjuvant resectable NSCLC with platinum‑based chemotherapy in the EU and Japan, and a move toward a fixed‑dose Opdivo + Yervoy (Opdualag) – reflecting a sharpened focus on earlier‑line, adjuvant and neoadjuvant indications and additional combos (​page 42​, ​page 43​). Those new labels have made Opdivo a key growth driver, helping offset the company’s overall revenue decline in 2023 and positioning the product for incremental revenue expansion as the new indications mature (​page 41​, ​page 45​).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Opdivo's broad indication base in 2022 across bladder, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, and stomach cancers, and notes the importance of the Opdivo + Yervoy combination as a growth driver—consistent with the original answer. In 2023, it accurately describes the strategic evolution toward earlier lines of therapy (adjuvant and neoadjuvant settings), citing specific new approvals: adjuvant treatment for stage IIB/IIC melanoma in the U.S. and EU, and neoadjuvant use in resectable NSCLC in the EU and Japan. It also correctly highlights the development of fixed-dose combinations like Opdualag (Opdivo + Yervoy), which supports the strategic focus on combination therapies and improved delivery. (2) There are no numeric values (e.g., revenue figures) in either answer, so quantitative accuracy is not compromised; all dates (2022 vs. 2023) and indications are correctly attributed. (3) The multi-hop reasoning is sound: the LLM synthesizes information about prior indications, pipeline progression, regulatory approvals, and strategic implications across years and therapeutic areas. It goes slightly beyond the ground truth by referencing specific page numbers and regulatory regions, which adds precision. (4) The only minor gap is that the LLM answer does not explicitly mention the subcutaneous formulation as a strategic lever for long-term adoption—a point included in the original answer. However, the emphasis on Opdualag (a subcutaneous combo) implicitly touches on this. Overall, the answer is factually correct, contextually rich, and logically structured, warranting a high score with only a small deduction for partial omission of the delivery mechanism rationale.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 486,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did American Express's investment in foreign government bonds and obligations evolve between 2023 and 2024 in terms of fair value and maturity distribution?",
      "original_answer": "In 2023, American Express held $549 million in foreign government bonds and obligations with all of it maturing in 12 months or more and a gross unrealized loss of $1 million. By 2024, the fair value of these investments increased significantly to $765 million, with $764 million maturing within one year and only $1 million maturing after one year but within five years. This indicates a substantial increase in exposure to foreign government bonds, primarily in short-term maturities.",
      "llm_answer": "American Express’s foreign‑government bond portfolio slipped slightly in value, from an estimated fair value of **$770 million in 2023** to **$765 million in 2024** (a $5 million decline).  The maturity mix stayed almost entirely short‑term: in 2023, **$768 million** was due within one year and **$2 million** in the 1‑to‑5‑year bucket; in 2024 it was **$764 million** due within one year and **$1 million** in the 1‑to‑5‑year bucket, with no holdings beyond five years.【page_119】【page_120】【page_124】【page_126】",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in key financial figures. According to the ground truth, American Express held $549 million in foreign government bonds in 2023, not $770 million as stated by the LLM. The 2024 value of $765 million is correct, but the LLM incorrectly frames this as a decline when it is actually a significant increase from $549 million. The maturity distribution for 2023 is completely wrong: the ground truth states that all $549 million matured in 12 months or more (i.e., long-term), whereas the LLM claims $768 million matured within one year (short-term), which contradicts the actual data. The 2024 maturity breakdown ($764M within one year, $1M in 1-5 years) is accurate. (2) Quantitative accuracy fails on critical numbers: 2023 fair value is off by $221 million, and the 2023 maturity allocation is entirely incorrect. Calculations based on these wrong numbers (e.g., implying a $5M decline) are therefore invalid. (3) Multi-hop reasoning is flawed because the model failed to correctly retrieve and synthesize data across years and categories. It incorrectly characterizes the trend (decrease vs actual increase) and misrepresents the maturity shift (from long-term to short-term), which is central to the question. (4) Contextual relevance is high because the answer addresses fair value and maturity distribution as asked, and cites appropriate pages. However, due to severe factual and quantitative errors, the overall correctness score is low despite relevant structure and focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 425,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How has Walmart's use of intercompany financing arrangements evolved between 2022 and 2024, particularly regarding the amount of cash not freely transferable to the U.S. and the conditions under which such transfers occur?",
      "original_answer": "In 2022, Walmart reported $4.3 billion in cash and cash equivalents that may not be freely transferable to the U.S., with $2.2 billion of that amount subject to approval by Flipkart minority shareholders. By 2024, the amount of cash not freely transferable decreased slightly to $3.3 billion, and the language indicates that these transfers are now generally subject to approval from noncontrolling interest shareholders, rather than specifically tied to Flipkart. This reflects a slight reduction in the magnitude of restricted cash and a broader framing of the conditions under which such transfers occur, suggesting a shift in the structure or focus of intercompany financing arrangements.",
      "llm_answer": "In 2022 Walmart reported that about $4.3 billion of its cash and cash equivalents could not be freely transferred to the United States, and roughly $2.2 billion of that amount could be accessed only through dividends or inter‑company financing arrangements that required approval of Flipkart’s minority shareholders【page_60】. By fiscal 2024 the non‑transferable balance had fallen to about $3.5 billion, and any repatriation is now limited by local laws or other restrictions and may require the approval of the non‑controlling‑interest shareholders rather than a specific Flipkart‑shareholder vote【page_43】. The company continues to rely on inter‑company financing to move cash where needed at minimum cost, but the pool of restricted cash has shrunk and the approval mechanism has broadened.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct but contains a minor quantitative inaccuracy: it reports the 2024 non-transferable cash amount as $3.5 billion, whereas the ground truth states $3.3 billion. All other numbers are accurate—$4.3 billion in 2022 and $2.2 billion requiring Flipkart minority shareholder approval are correctly cited. (2) The calculation of the change in restricted cash is slightly off due to the $3.5B vs $3.3B discrepancy, but the direction (decrease) and magnitude (slight reduction) are consistent. The qualitative interpretation of broader shareholder approval mechanisms replacing Flipkart-specific requirements is accurately captured. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across years (2022 to 2024), identifies the shift from Flipkart-specific to more general noncontrolling interest shareholder approvals, and contextualizes the evolution in intercompany financing strategy. (4) The answer is highly relevant, addressing both parts of the question—evolution in amount and conditions of cash transferability. The wording differs slightly but maintains semantic equivalence. The $0.2B overstatement prevents a higher score, but core facts, trends, and reasoning remain robust.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 352,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How did the composition of Texas Instruments' U.S. Retiree Health Care Plan assets evolve between the 2023 and 2024 filings, particularly in terms of fixed income securities and equity securities allocation?",
      "original_answer": "The composition of Texas Instruments' U.S. Retiree Health Care Plan assets remained completely unchanged between the 2023 and 2024 filings. In both years, the plan held $210 million in fixed income securities and cash equivalents, and $54 million in equity securities, resulting in a total of $264 million in plan assets. The fixed income allocation represented approximately 79.5% of the total plan assets, while equity securities represented approximately 20.5% in both years. The identical figures across both filings indicate no evolution in the asset allocation strategy for this plan during the reported period.",
      "llm_answer": "In 2023 the U.S. Retiree Health Care Plan held $210 million of fixed‑income securities and cash equivalents and $54 million of equity securities – roughly 80 % fixed income and 20 % equity of a $264 million total (page 46). By the 2024 filing those balances had slipped to $198 million and $50 million respectively, still about 80 %/20 % of the $248 million portfolio (page 46), and the weighted‑average allocation percentages remained unchanged at 80 % fixed income and 20 % equity (page 48).",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claims. According to the ground truth, Texas Instruments' U.S. Retiree Health Care Plan assets remained unchanged between 2023 and 2024, with fixed income securities at $210 million and equity securities at $54 million in both years, totaling $264 million. The LLM incorrectly states that by 2024, fixed income dropped to $198 million and equity to $50 million, totaling $248 million—numbers not supported by the ground truth. These errors directly contradict the original answer and misrepresent the asset evolution. (2) Calculations in the LLM answer are internally consistent (e.g., $198M + $50M = $248M; ~80/20 split), but they are based on false inputs. The correct calculation from the ground truth is $210M + $54M = $264M, with fixed income at ~79.5% and equity at ~20.5% in both years. The LLM rounds to 80/20, which is acceptable, but the underlying asset values are wrong. (3) The multi-hop reasoning fails because the model incorrectly infers a change in allocation over time when the ground truth explicitly states there was no change. The LLM suggests a decline in asset values and implies a dynamic shift, which is the opposite of the actual static allocation. This undermines the synthesis across years. (4) Despite the factual errors, the answer is contextually relevant—it addresses the right plan, the right company, and the right asset classes, and attempts to compare years and compute percentages. However, the severe quantitative inaccuracies and flawed conclusion about evolution when none occurred result in a very low correctness score. The qualitative reasoning is partially sound in structure but built on false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 470,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Honeywell's 2006 Stock Plan for Non-Employee Directors evolve between 2022 and 2024 in terms of the specific forms of award agreements offered, and what might this suggest about changes in the company's non-employee director compensation structure?",
      "original_answer": "In 2022, Honeywell's 10-K filing listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32) as part of the 2006 Stock Plan for Non-Employee Directors. By 2024, while the 'Form of Option Agreement' was still referenced (Exhibit 10.29), the 'Form of Restricted Unit Agreement' was no longer explicitly mentioned in the exhibit list. This suggests a shift in the types of equity awards offered to non-employee directors, potentially signaling a strategic move toward emphasizing stock options over restricted units in director compensation.",
      "llm_answer": "In the 2022 Form 10‑K the 2006 Stock Plan for Non‑Employee Directors was shown to provide a **Form of Option Agreement** (Exhibit 10.29) and an **Omnibus Amendment to that Option Agreement** (Exhibit 10.30) 【page_123】. The 2024 filing still lists those same two award forms, but also includes updated amendment exhibits (10.27‑10.28) that revise the plan’s terms, indicating Honeywell is refining the existing option‑award language rather than adding new award types—suggesting a modest modernization of its non‑employee director compensation structure.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Honeywell listed both the 'Form of Option Agreement' (Exhibit 10.30) and the 'Form of Restricted Unit Agreement' (Exhibit 10.32). However, the LLM incorrectly states that the 2022 10-K included Exhibit 10.29 (Option Agreement) and Exhibit 10.30 (Omnibus Amendment), misidentifying both exhibits and omitting the Restricted Unit Agreement entirely. By 2024, the ground truth confirms the Option Agreement was still present (Exhibit 10.29) but the Restricted Unit Agreement was no longer listed—indicating a shift away from restricted units. The LLM fails to note this removal and instead claims both the original option forms and amendments were retained, and that no new award types were added, which contradicts the key evolution in award structure. (2) Quantitatively, the years (2022, 2024) are correct, and exhibit numbers are plausible, but their mapping to award types is wrong. The LLM invents an 'Omnibus Amendment' not mentioned in the ground truth and misassigns exhibit numbers (e.g., citing 10.29 in 2022 when ground truth lists 10.30 for Option Agreement). (3) The multi-hop reasoning is flawed: the question asks for evolution in award types and implications for compensation structure. The ground truth identifies a shift from offering both options and restricted units to only options (or at least no longer listing restricted units), suggesting a strategic change. The LLM instead suggests 'refining existing language' with amendments, missing the key point about elimination of restricted unit awards. This reflects a failure in synthesizing the change in award forms over time. (4) Contextual relevance is moderate—the response addresses director compensation and equity awards, and references correct filings and exhibit conventions, but misrepresents the core data. Due to major factual and reasoning errors, especially the omission of restricted units and incorrect exhibit mapping, the correctness score is low at 3.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 551,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How did Walmart's strategic position regarding its ownership stake in Flipkart evolve between 2022 and 2024, particularly in terms of financial implications and potential exposure to regulatory risks?",
      "original_answer": "In 2022, Walmart received $3.2 billion in equity funding related to Flipkart, which reduced its ownership stake from 83% to 75%. This signaled a partial financial exit while maintaining majority control. By 2024, however, Walmart disclosed ongoing regulatory scrutiny in India, including a show cause notice issued in July 2021 and subsequent information requests related to alleged violations of India's Foreign Direct Investment rules during the period 2009–2015—prior to Walmart's acquisition of Flipkart in 2018. Despite the reduced ownership stake, Walmart remained exposed to potential regulatory consequences, including share ownership restrictions, and noted its inability to reasonably estimate potential losses or indemnification proceeds from prior shareholders. The evolution reflects a shift from active financial participation to managing legacy risks tied to Flipkart's pre-acquisition history.",
      "llm_answer": "In the 2022 filing Walmart said it raised about $3.2 billion by selling a minority portion of its Flipkart holding, cutting its ownership from roughly 83 % to about 75 % and thereby monetizing part of the investment. By the 2024 filing the company still holds a majority stake, but it is now confronting Indian regulatory scrutiny—a Directorate of Enforcement foreign‑direct‑investment show‑cause notice and a Competition Commission of India antitrust investigation—so the remaining stake carries exposure to possible fines, share‑ownership restrictions or other relief that cannot be quantified. This marks a shift from cash‑generating divestiture to managing heightened legal and regulatory risk on the residual ownership.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key financial and strategic developments in Walmart's ownership of Flipkart between 2022 and 2024. All quantitative figures—$3.2 billion raised, ownership reduction from 83% to 75%—are accurate and match the ground truth. The years (2022 and 2024) are correctly referenced. (2) Quantitative accuracy is perfect: dollar amount, percentages, and direction of change (reduction in stake) are all correct. No calculation errors. Format variations (e.g., 'about' or 'roughly') are acceptable and do not affect factual correctness. (3) The multi-hop reasoning is sound: the model connects Walmart’s partial divestiture in 2022 to its continued majority control and then synthesizes the emergence of regulatory risks by 2024, including the show-cause notice and inability to estimate losses. The LLM correctly notes that the regulatory issues stem from pre-2018 activities, though it does not explicitly state the 2009–2015 timeframe or that the notice was issued in July 2021 (a minor omission). It does, however, accurately name the Directorate of Enforcement and the Competition Commission of India, which aligns with the type of regulatory scrutiny described. (4) The answer captures the core evolution: from financial monetization to risk management. The only slight gap is the omission of the specific time period (2009–2015) of the alleged FDI violations and the exact 2021 issuance date of the notice, which were in the original. However, the essence—that the risks are legacy issues predating Walmart’s ownership—is implied. Overall, the answer is factually correct, contextually complete, and semantically equivalent to the ground truth, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 469,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the composition and strategic emphasis of HON's U.S. cash balances evolve between 2022 and 2024, particularly in terms of total cash holdings and geographic distribution of funds?",
      "original_answer": "In 2022, HON reported holding $11.5 billion of cash and cash equivalents as of December 31, 2021, with an emphasis on safety of principal and diversification among counterparties. By 2024, the company held $11.0 billion in total cash and equivalents as of December 31, 2024, but specifically noted that $8.0 billion of that amount was held in non-U.S. subsidiaries. This represents a shift in geographic distribution, with a larger portion of liquidity positioned outside the U.S., while maintaining the same strategic emphasis on safety and diversification.",
      "llm_answer": "In the 2022 filing Honeywell noted that its liquidity strategy for U.S. cash balances was “primarily safety of principal and secondarily maximizing yield” and that it diversified cash among counterparties, reporting $11.5 billion of cash‑and‑cash‑equivalents (including short‑term investments) as of Dec. 31 2021 (the most recent figure disclosed)【page_41】. By the 2024 filing total cash‑and‑cash‑equivalents had slipped slightly to $11.0 billion, but the company disclosed that $8.0 billion of those funds were held in non‑U.S. subsidiaries—leaving roughly $3.0 billion in U.S. cash—while reiterating the same safety‑first, yield‑second, diversification emphasis【page_39】. This reflects a shift toward a larger overseas cash pool while maintaining the same strategic focus on protecting principal and optimizing yield.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key facts: $11.5 billion in cash as of Dec 31, 2021 (disclosed in 2022 filing), $11.0 billion total cash as of Dec 31, 2024, with $8.0 billion held in non-U.S. subsidiaries. The inference that approximately $3.0 billion remained in U.S. cash is accurate and logically derived. The strategic emphasis on safety of principal, diversification, and secondary focus on yield is correctly described and consistent with the ground truth. (2) Quantitative accuracy is perfect: all dollar amounts ($11.5B, $11.0B, $8.0B), dates (Dec 31, 2021 and Dec 31, 2024), and derived values ($3.0B U.S. cash) are correct. No calculation errors. (3) Multi-hop reasoning is sound: the model synthesizes data from two different filings (2022 and 2024), correctly interprets the shift in geographic distribution of cash, and maintains continuity in strategic emphasis. The only minor omission is that the original answer explicitly states the strategic emphasis was unchanged, while the LLM implies it by reiterating the same priorities—this is semantically equivalent but slightly less direct. (4) Scores reflect near-perfect factual accuracy, complete coverage of the question, and correct synthesis. The 9/10 on correctness and qualitative accuracy reflects this slight difference in phrasing around strategic continuity, but no factual errors exist.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 384,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How did the financial treatment and liability estimation methodology for the Membership Rewards program evolve from 2023 to 2024, particularly in terms of deferred fees and liability modeling assumptions?",
      "original_answer": "In 2023, the company recognized deferred fees related to Membership Rewards program participants, indicating a focus on the deferral aspect of fee revenue associated with the program. By 2024, the disclosures provided a much more detailed explanation of the liability estimation methodology, including the use of the Ultimate Redemption Rate (URR) and the weighted average cost (WAC) per point. The 2024 filing also quantified the sensitivity of the liability to changes in assumptions, noting that a 25 basis point increase in URR would raise the liability by $197 million, and a 1 basis point increase in WAC per point would increase it by $220 million. This reflects a shift from a simpler mention of deferred fees to a comprehensive, model-driven approach to estimating future redemption liabilities.",
      "llm_answer": "In the 2023 filing American Express recorded a separate “deferred card and other fees, net” line of $3.4 billion that bundled deferred acquisition costs and cancellation reserves for Membership Rewards participants, and it estimated the rewards liability by applying a weighted‑average cost per point (WAC) and an ultimate redemption rate (URR) derived from statistical‑actuarial models of redemption trends, spend, tenure and credit attributes. The 2024 filing still bases the Membership Rewards liability on the same WAC‑and‑URR methodology, but it now discloses the sensitivity of the liability (e.g., a 25‑bp URR change would add $197 million; a 1‑bp WAC change would add $220 million) and no longer shows a distinct net deferred‑fees balance for the program, suggesting the deferred acquisition‑cost and cancellation‑reserve amounts have been integrated into other liability presentations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact correctness, particularly in the quantitative and methodological details. (1) The $3.4 billion 'deferred card and other fees, net' figure is not present in the ground truth and appears to be fabricated or misattributed; the original answer does not mention any specific dollar amount for deferred fees in 2023. (2) The LLM incorrectly states that in 2023, American Express already used URR and WAC derived from 'statistical-actuarial models of redemption trends, spend, tenure and credit attributes'—but the ground truth indicates that such detailed modeling was introduced in 2024, not 2023. This misrepresents the evolution of the methodology. (3) The claim that the 2024 filing 'no longer shows a distinct net deferred-fees balance' is speculative and not supported by the original answer, which focuses on increased disclosure of modeling assumptions, not presentation changes. However, the LLM correctly identifies the sensitivity figures: a 25-bp URR increase adding $197 million and a 1-bp WAC increase adding $220 million, matching the ground truth exactly. (4) The core idea of a shift toward more detailed liability modeling in 2024 is correctly captured, showing good qualitative understanding of the trend. While the reasoning framework is logical and contextually relevant, the inclusion of unsupported specifics—especially the incorrect retroactive attribution of advanced modeling to 2023—lowers factual accuracy. The answer synthesizes the concept of evolving methodology well but fails on key factual anchors, particularly in quantitative and entity-year attribution accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 454,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How has Adobe's strategic positioning and integration of Frame.io evolved between 2022 and 2024, particularly in terms of its alignment with Adobe's broader product ecosystem?",
      "original_answer": "In 2022, Adobe described the integration of Frame.io as part of its Digital Media reportable segment, emphasizing its role as a cloud-based video collaboration platform acquired for $1.18 billion, with integration efforts just beginning. By 2024, Frame.io had transitioned from being a newly acquired integration to being positioned as a core component of Adobe's creative collaboration suite, directly integrated with key applications such as Adobe Premiere Pro, After Effects, Photoshop, and Workfront. Additionally, in 2024, Frame.io was included as part of Adobe GenStudio, indicating a deeper strategic alignment with Adobe's broader content production and collaboration ecosystem. This evolution reflects a shift from initial integration to full ecosystem incorporation.",
      "llm_answer": "In the 2022 Form 10‑K Adobe highlighted that it had just acquired Frame.io (October 2021) and was beginning to fold the cloud‑based video‑collaboration platform into its Digital Media segment to broaden its video‑creation capabilities [page_42]; the filing also notes the acquisition and initial integration as a strategic move for the Digital Media portfolio [page_41]. By the 2024 filing, Frame.io is described as a core, cloud‑native collaboration hub that is directly embedded in key Creative Cloud apps (Premiere Pro, After Effects, Photoshop, Lightroom) and linked with Workfront, and is offered through Adobe GenStudio for large‑scale content production—showing a much deeper, cross‑product alignment across Adobe’s Creative, Document and Digital Experience ecosystems [page_12].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: Frame.io was acquired in October 2021 (context for 2022 integration), integrated into the Digital Media segment, and by 2024 became a core collaboration hub embedded in Premiere Pro, After Effects, Photoshop, and linked with Workfront and GenStudio. The strategic evolution from initial integration to deep ecosystem alignment is correctly conveyed. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or dollar amounts; the $1.18B acquisition figure is omitted but not claimed, so not an error. (3) Multi-hop reasoning is sound—correctly synthesizes information across 2022 and 2024 filings to show progression in strategic positioning. (4) Minor difference: LLM mentions Lightroom and GenStudio in the context of large-scale content production, while the original answer emphasizes GenStudio inclusion and integration with Workfront; also, LLM extends ecosystem alignment to 'Document and Digital Experience' ecosystems, which is a slight overreach as the original answer focuses on creative collaboration and GenStudio. However, this does not materially misrepresent the strategic direction. Wording differs but semantic meaning is equivalent. High completeness and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 364,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 129,
      "question": "How did the composition of private alternative investments, specifically equity-like funds, evolve between 2022 and 2023 in terms of fair value measurements using significant unobservable inputs (Level 3)?",
      "original_answer": "In 2022, equity-like funds under private alternative investments had a fair value of $5.5 million measured using significant unobservable inputs (Level 3). In 2023, this value increased significantly to $25.4 million. This indicates a fivefold increase in the portion of equity-like funds valued using Level 3 inputs, suggesting a shift toward more opaque or complex valuation methodologies for these investments.",
      "llm_answer": "In 2022 the equity‑like funds held in private‑alternative investments were measured at Level 3 for **$25.4 million** in the defined‑benefit pension plan and **$2.4 million** in the retiree‑health plan (total ≈ $27.8 million)【page_99】. In 2023 the same assets were measured at Level 3 for **$25.1 million** in the pension plan and **$2.4 million** in the retiree‑health plan (total ≈ $27.5 million)【page_98】. Thus the Level 3 component of equity‑like funds fell slightly in the pension plan (‑$0.3 million) while the retiree‑health portion was unchanged, leaving the overall Level 3 exposure for equity‑like funds essentially stable.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitative Accuracy: The LLM states that in 2022, equity-like funds measured at Level 3 were $25.4 million in the pension plan and $2.4 million in the retiree-health plan, totaling ~$27.8 million. However, the ground truth states the total Level 3 fair value for equity-like funds in 2022 was $5.5 million—not $27.8 million. In 2023, the LLM reports $25.1 million (pension) + $2.4 million (health) = ~$27.5 million, while the ground truth reports $25.4 million total. These numbers are not only misattributed across plans but also grossly inflated compared to the correct aggregate values. The LLM incorrectly implies stability, while the truth shows a fivefold increase from $5.5M to $25.4M. (2) Completeness: The answer fails to report the correct aggregate values for equity-like funds under Level 3 and instead introduces a breakdown by pension and retiree-health plans not requested in the question. The evolution from $5.5M to $25.4M is completely misrepresented. (3) Entity Accuracy: While years (2022, 2023) and the concept of Level 3 inputs are correctly referenced, the financial figures are assigned to incorrect plans and totals, suggesting confusion in entity mapping. (4) Reasoning: The multi-hop synthesis is flawed—the LLM compares plan-specific values year-over-year but misses the actual trend in the total fair value of equity-like funds. The conclusion of 'essentially stable' contradicts the ground truth of a significant fivefold increase. (5) Semantic Equivalence: The answer conveys the opposite trend (stable vs. rapidly increasing) and misstates magnitudes, so it fails on factual and semantic grounds. The cited pages (99, 98) may contain data, but the interpretation is incorrect or misaligned with the question's scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 496,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has Adobe's integration and positioning of Frame.io within its Digital Media offerings evolved between 2022 and 2024?",
      "original_answer": "In 2022, Adobe had just acquired Frame.io in October 2021 and was beginning to integrate it into the Digital Media segment as a cloud-based video collaboration platform. By 2024, Frame.io had become a core part of Adobe’s creative collaboration tools, being directly integrated with Adobe Premiere Pro, After Effects, Photoshop, Lightroom, and Workfront, and was also included in Adobe GenStudio for scalable content production. This reflects a strategic evolution from initial integration to deeper ecosystem embedding.",
      "llm_answer": "In the 2022 Form 10‑K Adobe reported that after acquiring Frame.io for roughly $1.18 billion in the fourth quarter of fiscal 2021, it had **just begun integrating the cloud‑based video‑collaboration platform into its Digital Media segment**【page_41】. By the 2024 Form 10‑K, Frame.io is described as a **core, cloud‑native collaboration hub that is directly integrated with Premiere Pro, After Effects, Photoshop, Lightroom and Workfront, and is also offered through Adobe GenStudio**, showing that it has moved from an initial integration step to a deep, cross‑app embedding and broader positioning within Adobe’s Digital Media and content‑production ecosystem【page_12】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: Frame.io was acquired in late 2021 (fiscal 2021 Q4), and integration into Adobe's Digital Media segment began in 2022. By 2024, it had evolved into a core collaboration hub with deep integrations across Adobe's creative suite. (2) Quantitative accuracy is maintained: the acquisition timing (fiscal 2021, reported in 2022 10-K) and $1.18 billion price (implied from context, though not in ground truth, but not contradicted) are consistent with public facts and do not conflict with the knowledge graph. The ground truth does not specify the dollar amount, so its inclusion is a factual enhancement, not an error. (3) Multi-hop reasoning is sound: the answer synthesizes information across two time points (2022 and 2024) and two 10-K filings to show evolution in integration and positioning. (4) All entities—Frame.io, Digital Media segment, Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, Adobe GenStudio—are correctly identified and contextually placed. The answer captures the strategic shift from initial integration to deep ecosystem embedding, matching the original answer's intent and factual basis. Minor wording differences (e.g., 'cloud-native collaboration hub' vs 'cloud-based video collaboration platform') are semantically equivalent. No omissions or inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 391,
        "total_tokens": 1682
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How has CVS's approach to Medication Management evolved between 2022 and 2024, particularly in terms of clinical programs and digital tools aimed at improving medication adherence and cost efficiency?",
      "original_answer": "In 2022, CVS emphasized formulary management through its National Pharmacy and Therapeutics Committee, promoting the use of generic drugs and offering real-time benefit information to guide members toward lower-cost alternatives. The company also operated mail order and specialty pharmacies, and provided clinical programs focused on medication adherence and utilization management, including an industry-leading approach to limit opioid prescriptions to seven-day supplies for acute cases. By 2024, CVS had expanded its Medication Management offerings with the introduction of digital tools like the NovoLogix preauthorization platform and enhanced analytics for identifying lower-cost drug alternatives. The company also launched the CVS Weight Management program, integrating GLP-1 medication optimization with lifestyle coaching, and expanded its value-based care initiatives through Oak Street Health, operating 239 primary care centers across 27 states to better manage chronic conditions and medication use. These developments reflect a shift from primarily cost-containment strategies to a more integrated, digitally enabled, and clinically proactive model of medication support.",
      "llm_answer": "By 2022 CVS’s medication‑management strategy was built around a suite of clinical programs – utilization‑management, medication‑management, adherence and counseling – delivered through the Pharmacy Advisor and Drug‑Savings‑Review services and the NovoLogix online pre‑authorization tool, all supported by its Health‑Engagement Engine and digital connectivity that gave members real‑time visibility of lower‑cost alternatives【page_13】. By 2024 the company had layered a much broader, technology‑driven layer on top of those basics: AI‑powered Canopy analytics, proprietary clinical‑workflow software and an integrated device hub for in‑home health evaluations and medication reviews, expanded virtual MinuteClinic scheduling and reminder tools, and the Cordavis biosimilar subsidiary – all aimed at boosting adherence and driving cost‑efficiency through richer data integration and digital patient engagement【page_12】【page_13】.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several inaccuracies and fabrications that significantly impact correctness. While it correctly identifies CVS's focus on medication management and cost efficiency, it misrepresents key details. The NovoLogix preauthorization tool is incorrectly stated to exist in 2022; the ground truth states it was introduced in 2024. The LLM also fabricates AI-powered Canopy analytics, proprietary clinical-workflow software, an integrated device hub, expanded virtual MinuteClinic tools, and the Cordavis biosimilar subsidiary—all of which are not mentioned in the original answer and lack support from the provided context. Additionally, the LLM omits major factual developments from the ground truth, such as the seven-day opioid supply policy, the CVS Weight Management program with GLP-1 optimization, and Oak Street Health's expansion to 239 centers in 27 states. While the general theme of a shift toward digital and integrated care is consistent, the specific clinical programs and digital tools cited are largely incorrect or misplaced in time. Quantitative accuracy is acceptable because no explicit numbers are wrong (e.g., no false figures for centers or dates), but the answer fails in entity accuracy and multi-hop reasoning due to invented tools and programs. Contextually, the response addresses the evolution of medication management, so relevance is moderate, but factual divergence reduces overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1542,
        "completion_tokens": 396,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How has Adobe's integration and positioning of Frame.io within its Creative Cloud ecosystem evolved from 2022 to 2024, and what specific enhancements were made to its collaboration features during this period?",
      "original_answer": "In 2022, Adobe acquired Frame.io and began integrating its cloud-based video collaboration platform into Adobe Creative Cloud, with initial enhancements focused on deeper integration into Premiere Pro and After Effects to deliver native collaborative workflows for video editing. By 2024, Frame.io had evolved into a more comprehensive cloud-native creative collaboration platform, offering real-time upload, review, and approval features not only for video but also for still images, design files, and PDFs. It expanded its integration across Adobe Photoshop, Lightroom, and Workfront, and introduced Camera to Cloud functionality, enabling automatic upload of footage directly into Frame.io from cameras on set. These enhancements reflect a strategic shift from a video-specific collaboration tool to a broader creative asset production and review platform within Adobe’s ecosystem.",
      "llm_answer": "In the 2022 filing Adobe said that after acquiring Frame.io in October 2021 it was just beginning to embed the service into Creative Cloud, focusing on deeper integration and enhanced review‑and‑approval capabilities in Premiere Pro and After Effects【page_6】. By the 2024 filing Frame.io is positioned as a core cloud‑native collaboration platform integrated across Premiere Pro, After Effects, Photoshop, Lightroom, Workfront and GenStudio, with new features such as real‑time upload, frame‑accurate commenting, annotations, Camera‑to‑Cloud automatic footage ingestion and support for still‑image, design‑file and PDF reviews【page_12】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Adobe acquired Frame.io in October 2021 (not 2022, but the answer correctly references the 2022 filing discussing post-acquisition integration), and integration began with Premiere Pro and After Effects. By 2024, Frame.io evolved into a broader collaboration platform with expanded integrations and features. (2) Quantitative accuracy is strong: dates (2021 acquisition, 2022 and 2024 filings), product names (Premiere Pro, After Effects, Photoshop, Lightroom, Workfront, GenStudio), and feature rollouts (real-time upload, frame-accurate commenting, annotations, Camera-to-Cloud) are all factually correct. Minor note: 'GenStudio' appears in the LLM answer but not in the original; this may be a typo or overstatement (possibly meant 'Firefly' or another Adobe tool), but it does not materially distort the core message. (3) Multi-hop reasoning is sound: the answer synthesizes information across time (2022 to 2024), platforms (Creative Cloud apps), and feature enhancements, correctly showing the evolution from video-specific to cross-creative collaboration. (4) Semantic equivalence is maintained—wording differs slightly but meaning matches the original. The answer is fully contextually relevant, addressing both the evolution of integration and specific collaboration enhancements. Deducted 1 point from correctness and qualitative accuracy due to 'GenStudio' mention, which lacks support in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 417,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has the use of recently executed transactions in the valuation of loans and other assets evolved from 2023 to 2024, particularly in terms of their role in fair value determination?",
      "original_answer": "In 2023, recently executed transactions were a key input for determining the fair value of corporate loans and contingent lending commitments, often used alongside market price quotations, implied yields, and proprietary valuation models. By 2024, the role of recently executed transactions remained significant but was more specifically tied to the held-for-sale category of loans and lending commitments, and also extended to the valuation of other assets such as other investments, where they were used in conjunction with discounted cash flow models and comparable company multiples. This reflects a more targeted application of transaction data in valuation practices.",
      "llm_answer": "In the 2023 filing the firm said that the fair value of corporate loans and lending commitments is determined “using recently executed transactions, market‑price quotations (where observable), implied yields from comparable debt, market‑observable CDS spreads and proprietary models” (see page 99). By 2024 the discussion shifts to the non‑recurring fair‑value measurement of loans, lending commitments and other assets, stating that their values are now “based on recently executed transactions, market price quotations, valuation models that incorporate market‑observable inputs … such as comparable loan or debt prices and CDS spread levels” (see page 103). Thus, while recent transactions were already an input in 2023, in 2024 they are highlighted as a primary observable source for a broader set of assets and for non‑recurring valuations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2023, recently executed transactions were used alongside market price quotations, implied yields, CDS spreads, and proprietary models for valuing corporate loans and lending commitments, citing the correct context from page 99. In 2024, it accurately notes a shift in emphasis, with recently executed transactions being highlighted as a primary observable input for non-recurring fair value measurements of loans, lending commitments, and other assets, referencing page 103. (2) There are no numerical values to verify, but all dates (2023, 2024) and document references (page numbers) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in disclosure language across years and infers a broader and more targeted application of transaction data in 2024. The conclusion that recent transactions became a 'primary observable source' for a broader set of assets is a reasonable interpretation, though the original answer emphasizes a more specific tie to 'held-for-sale' loans and extension to 'other investments' using DCF and comparable multiples—details slightly underdeveloped in the LLM response. (4) Despite this minor omission of valuation methodologies (DCF, comparable multiples) applied to other assets in 2024, the LLM captures the core evolution: continued significance with expanded scope and emphasis on observability. Wording differs but semantic meaning is substantially equivalent. Thus, high scores across all dimensions, with a 9 on correctness due to partial omission of specific 2024 valuation methods for other assets.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 458,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How has Adobe's approach to the Substance 3D Stager product evolved between 2022 and 2024, particularly in terms of its positioning within the broader Substance 3D ecosystem?",
      "original_answer": "In 2022, Substance 3D Stager was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio but without detailed information about its functionality or strategic positioning. By 2024, Adobe introduced a more comprehensive view of Substance 3D as an ecosystem, where Stager is specifically described as a tool for building and assembling 3D scenes. This evolution reflects a strategic shift from simply offering the product to integrating it into a broader suite of 3D tools, including Painter, Sampler, Designer, and Modeler, emphasizing its role in enabling end-to-end 3D content creation workflows.",
      "llm_answer": "In the 2022 Form 10‑K (pages 95‑99) Adobe’s filing makes no specific mention of Substance 3D Stager, treating the Substance 3D suite only as a general collection of tools. By the 2024 filing, Adobe explicitly lists Stager as a distinct desktop app within the “Adobe Substance 3D Collection,” describing it as the product used to build and assemble 3D scenes and highlighting its integration with Painter, Sampler, Designer, Modeler and the Substance 3D Assets library (page 12). This shows Adobe moving from a non‑highlighted, bundled approach in 2022 to positioning Stager as a core, integrated component of the broader Substance 3D ecosystem in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, Substance 3D Stager was not specifically mentioned in Adobe's 10-K filing, only implied through trademark listings, and that by 2024 it was explicitly positioned as a core tool for building and assembling 3D scenes. The evolution from a non-highlighted component to an integrated part of the Substance 3D ecosystem is accurately conveyed. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), but the years (2022 and 2024) are correct and contextually appropriate. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift by comparing the absence of detailed mention in 2022 to the explicit description in 2024, and synthesizes Stager’s role within the broader suite (Painter, Sampler, Designer, Modeler, Assets library). (4) The only minor shortcoming is that the original answer notes Stager was listed in trademarks in 2022, while the LLM states it was not mentioned at all—this is a slight inaccuracy, though the overall interpretation of low emphasis in 2022 remains valid. Otherwise, the answer is factually correct, complete, and contextually precise, with strong qualitative reasoning and full relevance to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 364,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How did GE's strategic positioning regarding grid-scale batteries evolve from 2022 to 2023, particularly in terms of their role in the company's energy transition strategy and level of strategic reliance?",
      "original_answer": "In 2022, GE mentioned grid-scale batteries as part of a broader set of emerging technologies that 'may become more important over time' in achieving deep decarbonization goals, indicating GE was considering them as a potential future investment. By 2023, GE explicitly listed grid-scale batteries as one of the key technologies 'that may become more important over time' and integrated them into the company’s strategic narrative as a dependency, noting that achieving decarbonization goals would 'depend in part' on such technologies. This reflects a shift from viewing grid-scale batteries as a speculative investment to a more central component of GE's energy transition strategy.",
      "llm_answer": "- 2022 10‑K (p. 64): GE said deep‑decarbonisation “will likely depend … on technologies that are not yet deployed … such as **grid‑scale batteries** or other storage solutions,” framing batteries as a future, not‑yet‑core element of its energy‑transition plan.  \n\n- 2023 10‑K (p. 29): the same language appears – batteries are again listed among emerging technologies that “may become more important over time,” showing GE still views them as a prospective, longer‑term option rather than a core, relied‑upon capability.  \n\nThus, from 2022 to 2023 GE’s positioning on grid‑scale batteries remained consistent: they are recognized as a potentially important future technology for the energy transition, but the company’s strategic reliance on them stays modest and largely speculative.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, despite citing accurate page numbers and similar language from the 10-K filings. The original answer (ground truth) identifies a meaningful shift in GE's strategic positioning: from viewing grid-scale batteries as a speculative future technology in 2022 ('may become more important') to framing decarbonization goals as 'depending in part' on such technologies in 2023—indicating increased strategic reliance. The LLM incorrectly asserts that GE's positioning 'remained consistent' between 2022 and 2023, claiming the same language appears in both years. However, the 2022 10-K (p. 64) uses stronger language—'will likely depend'—while the 2023 10-K (p. 29) downgrades this to 'may become more important over time,' suggesting a nuanced evolution in tone and strategic emphasis. The LLM mischaracterizes this evolution as stagnation, failing the multi-hop reasoning required to detect a shift in strategic reliance. While entity accuracy (GE, years, document types) and contextual relevance are strong, and no numerical inaccuracies exist, the qualitative misinterpretation of strategic intent severely undermines correctness. Thus, the correctness and qualitative accuracy scores are low despite high quantitative accuracy and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 361,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How has CVS's disclosure regarding the use of broker quoted debt securities in its fair value measurements evolved between 2022 and 2024, particularly in terms of its presence or impact on financial reporting?",
      "original_answer": "In 2022, CVS explicitly stated that it did not have any broker quoted debt securities for the years ended December 31, 2021, and 2020, and that it only used internal pricing for certain private placements. By 2024, the company continued to disclose that it had no broker quoted debt securities for the years ended December 31, 2024 and 2023, indicating a consistent absence of such securities in its portfolio. However, the 2024 disclosure no longer mentions any negative impact or specific review process related to broker quoted debt securities, suggesting a reduced emphasis or relevance of this topic in the company's fair value measurement disclosures over time.",
      "llm_answer": "In the 2022 Form 10‑K CVS disclosed that “the Company did not have any broker‑quoted debt securities for the years ended December 31, 2021 and 2020,” so none were used in its Level 3 fair‑value calculations. The 2024 Form 10‑K repeats the same language, updating the periods to “the years ended December 31, 2024 and 2023,” confirming that broker‑quoted debt securities remain absent and therefore have no impact on CVS’s fair‑value measurement or reported earnings.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative and entity-specific details: it correctly identifies CVS, the relevant years (2020–2021 in the 2022 10-K; 2023–2024 in the 2024 10-K), and the consistent absence of broker-quoted debt securities. The statement that these securities had no impact on Level 3 fair value measurements or reported earnings is logically sound and supported by the ground truth. However, the LLM answer omits a key qualitative nuance present in the original answer: the 2024 disclosure no longer mentions any negative impact or specific review process related to broker-quoted debt securities, which indicates a reduced emphasis over time. This evolution in tone and disclosure focus is a critical part of how the disclosure 'evolved'—not just in content but in emphasis. While the LLM captures the continuity in factual disclosure (absence of such securities), it fails to address the change in narrative framing, which is central to the question about 'evolution' in disclosure practices. Thus, while the core facts and dates are correct (hence high quantitative and contextual scores), the qualitative reasoning is slightly incomplete, warranting a reduction from a perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 340,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did the composition of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of equity securities/mutual funds and equity method investments?",
      "original_answer": "In 2023, BlackRock reported $1,211 million in equity securities/mutual funds under Equity Securities at FVTNI, while equity method investments totaled $1,895 million. By 2024, the value of equity securities/mutual funds increased to $1,950 million, and equity method investments rose to $2,783 million. This reflects a significant increase in both categories, indicating a strategic expansion in these investment areas.",
      "llm_answer": "In 2023 BlackRock reported $1.585 billion of equity securities / mutual‑fund holdings at FVTNI and $2.756 billion of equity‑method investments (≈$4.34 billion total)【page_92】. By 2024 the equity‑securities component had risen to $1.950 billion while equity‑method holdings were $2.783 billion (≈$4.73 billion total)【page_92】. Thus the equity‑securities/mutual‑fund piece grew by about $365 million (≈23 %) versus only a $27 million (≈1 %) rise in equity‑method investments, shifting the overall mix toward a larger share of direct equity securities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the reported values for 2023. According to the ground truth, in 2023, BlackRock reported $1,211 million (not $1,585 million) in equity securities/mutual funds and $1,895 million (not $2,756 billion) in equity method investments. These numbers are critical and directly contradict the ground truth. The 2024 figures ($1,950 million and $2,783 million) match the original answer and are correct. (2) Calculations based on incorrect 2023 values are therefore flawed: the LLM claims a $365 million increase in equity securities/mutual funds (correct increase should be $1,950M - $1,211M = $739M), and a 23% growth rate (actual growth is ~61%). Similarly, the LLM reports only a $27 million increase in equity method investments (correct increase is $2,783M - $1,895M = $888M, or ~47% growth), but claims only 1% growth due to wrong base. (3) The reasoning is partially sound in structure—comparing year-over-year changes and assessing mix shift—but is based on incorrect data, undermining the multi-hop synthesis. The conclusion about a shift toward direct equity securities may seem logical given the LLM's numbers, but it misrepresents the actual magnitude and balance of growth. (4) Contextual relevance is high as the answer addresses the right categories and time frame, and attempts comparative analysis. However, due to major quantitative errors in core data points, the correctness score is low despite correct 2024 values and proper citation format.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 421,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How did UnitedHealth Group's evaluation and treatment of credit-related impairments for available-for-sale debt securities evolve from 2022 to 2024, particularly in terms of unrealized losses and the allowance for credit losses?",
      "original_answer": "In 2022, UnitedHealth Group reported that unrealized losses in its available-for-sale debt securities were primarily driven by interest rate increases and not credit deterioration, with no significant credit deterioration observed since purchase. The allowance for credit losses was noted to be not material as of December 31, 2021. By 2024, the company's evaluation methodology remained consistent in terms of assessing present value of expected cash flows, issuer credit condition, and fair value relative to amortized cost. However, the allowance for credit losses is now explicitly described as being recorded as a separate component through an allowance account, with credit-related impairments impacting investment and other income, indicating a more structured recognition of credit risk. This evolution shows a shift from a qualitative, low-risk assessment to a more formalized impairment accounting framework.",
      "llm_answer": "In the 2022 Form 10‑K UnitedHealth said it reviews every available‑for‑sale debt security for credit‑related impairment whenever fair value falls below amortized cost, records any credit‑related loss as an allowance (the allowance was “not material”) and reports the resulting unrealized losses – $274 million of gross unrealized losses for 2021 (and $22 million for 2020) – in other comprehensive income. The 2024 filing repeats the same evaluation framework (present‑value of expected cash flows, issuer credit quality and fair‑value versus cost) and still treats credit‑related impairments as an allowance offset to investment and other income, with unrealized gains/losses excluded from net earnings and shown in comprehensive income, and it likewise does not disclose a material allowance for credit losses, indicating the policy and its impact have essentially remained unchanged.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several correct elements but diverges significantly from the ground truth in key qualitative and factual aspects. (1) Quantitatively, the LLM introduces specific numbers—$274 million in gross unrealized losses for 2021 and $22 million for 2020—that are not present in the original answer and cannot be verified against the provided ground truth. The ground truth does not include any dollar amounts for unrealized losses, so these figures are unsupported and likely incorrect or misattributed. (2) The LLM claims the 2022 Form 10-K states the allowance was 'not material,' which aligns with the ground truth reference to the allowance being 'not material as of December 31, 2021.' This part is factually consistent. (3) However, the core of the question asks about the *evolution* from 2022 to 2024. The LLM concludes that the policy and impact 'have essentially remained unchanged,' which directly contradicts the ground truth, which identifies a meaningful evolution: a shift toward a more structured, formalized impairment accounting framework with explicit allowance account treatment and clearer recognition of credit risk impacts on income. The LLM fails to recognize this evolution, instead asserting continuity. (4) The LLM correctly identifies the evaluation methodology (present value of expected cash flows, issuer credit, fair value vs. cost) as consistent, which matches the ground truth. However, it misses the nuance that by 2024, the allowance is now *explicitly described* as a separate allowance account impacting investment income—a key development indicating formalization. (5) Multi-hop reasoning is partially sound—information is synthesized across years and filings—but the conclusion misinterprets the direction and significance of change. (6) Contextual relevance is high, as the response stays focused on the topic and uses appropriate financial terminology. Overall, the answer is partially correct in methodology and entity identification but flawed in its central conclusion and introduces unverified quantitative data, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 561,
        "total_tokens": 2033
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has AMD's financial relationship with the ATMP JV evolved between 2022 and 2023, particularly in terms of investment value and equity income?",
      "original_answer": "In 2022, AMD's carrying value of its investment in the ATMP JV was $83 million, and it recorded $14 million in equity income from the JV. By 2023, the carrying value increased to $99 million, and equity income rose to $16 million. This indicates a growing financial stake and increased profitability from the joint venture over the two-year period.",
      "llm_answer": "AMD’s 15 % stake in the ATMP joint venture grew in both book value and earnings. The carrying amount of the investment rose from roughly **$83 million at 12/31/2022** to **about $99 million at 12/30/2023** (page 78), and the equity‑income recognized from the JV increased from **$14 million in 2022** to **$16 million in 2023** (page 78). This shows a modest expansion of AMD’s investment and a higher share of the JV’s profit attributed to AMD.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the carrying value increased from $83 million in 2022 to $99 million in 2023, and equity income rose from $14 million to $16 million. The dates (12/31/2022 and 12/30/2023) are specific and consistent with typical fiscal year-end reporting. Minor phrasing like 'roughly' and 'about' does not detract from accuracy, as the values are correctly cited to the nearest million. (2) The answer is complete, addressing both parts of the question—investment value (carrying amount) and equity income—across both years. (3) Entity accuracy is correct: AMD, ATMP JV, and the financial metrics (carrying value, equity income) are properly identified. (4) The reasoning is sound: the LLM correctly infers a growing financial stake and increased profitability, which is a valid conclusion from the upward trend in both investment value and income. The mention of a 15% stake, while not in the original answer, is consistent with external knowledge and does not contradict the ground truth. (5) Semantic equivalence is strong—the LLM conveys the same core information with slightly more detail (e.g., page reference, exact dates), enhancing clarity without introducing error. All multi-hop elements (comparing two years across two financial metrics) are correctly synthesized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 383,
        "total_tokens": 1581
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How has UnitedHealth Group's exposure to tort claims evolved between 2022 and 2024, particularly in terms of the nature of the claims and the potential financial impact?",
      "original_answer": "In 2022, UnitedHealth Group specifically highlighted self-insured liabilities related to medical malpractice claims against affiliated physicians and the potential for actual losses to significantly exceed recorded liabilities. The document emphasized increasing legal actions alleging medical malpractice and general professional liabilities, with litigants seeking recoveries under new theories of liability that might not be subject to damage caps. By 2024, while tort claims remained a concern, the focus shifted slightly to broader legal risks tied to the delivery of health care services, including claims related to clinical quality and patient safety standards. The 2024 filing also emphasized the potential for reputational harm and adverse effects on business relationships, indicating a broader and more systemic risk profile compared to the more narrowly defined exposure in 2022.",
      "llm_answer": "UnitedHealth’s tort‑claim exposure has stayed focused on medical‑malpractice and other professional‑liability suits arising from the delivery of health‑care services. Both the 2022 and 2024 filings note that the company is largely self‑insured, records reserves for probable costs, but cautions that the growing volume of claims—and the use of new liability theories—could cause actual losses to far exceed those reserves, creating the potential for substantial monetary damages. The 2024 filing reiterates that this risk remains material and may be increasing.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies that UnitedHealth Group faces tort claim exposure primarily through self-insured medical malpractice and professional liability risks, with both 2022 and 2024 filings warning about potential losses exceeding reserves due to increasing claims and novel legal theories. The quantitative accuracy is perfect—no numerical errors, and the years (2022, 2024) are correctly referenced. However, the answer lacks completeness in capturing the evolution of risk focus between the years. While the original answer notes a shift in 2024 from narrowly defined medical malpractice exposure to broader systemic risks—including clinical quality, patient safety, reputational harm, and impacts on business relationships—the LLM response treats the risk profile as largely unchanged. This omission downplays the qualitative evolution in how UnitedHealth characterizes its exposure. The reasoning is sound but not fully multi-hop, as it fails to contrast the changing nature of the risk over time. The answer remains contextually relevant and captures the materiality and financial impact (e.g., reserves may be exceeded), but misses the expanded scope of non-financial and systemic risks emphasized in 2024. Thus, while key facts are correct, the synthesis across years is incomplete, warranting a 7 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 387,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How has the structure and capacity of Boeing's three-year revolving credit agreement evolved between 2023 and 2024, and what does this indicate about the company's liquidity strategy?",
      "original_answer": "In 2023, Boeing had a legacy three-year revolving credit agreement expiring in August 2025 with $3.0 billion of total commitments. In 2024, this agreement remained in effect, but Boeing also entered into a new $4.0 billion five-year revolving credit agreement expiring in May 2029 while terminating two other credit facilities. This evolution indicates a strategic shift to enhance liquidity capacity and extend maturity timelines, reinforcing Boeing's financial flexibility and commitment to managing corporate borrowing needs.",
      "llm_answer": "In 2023 Boeing’s credit portfolio consisted of a $3 billion three‑year revolving credit agreement (expiring August 2025), a $3.2 billion five‑year facility (expiring October 2024) and a $0.8 billion 364‑day facility. By 2024 the short‑term and the older five‑year facilities were terminated and replaced with a new $4 billion five‑year agreement, while the $3 billion three‑year line remained unchanged, boosting total available borrowing capacity to $10 billion. This reflects a strategy of consolidating and extending its credit lines to provide a larger, more flexible liquidity cushion for operations and debt service.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. While it correctly identifies the $3.0 billion three-year revolving credit agreement from 2023 expiring in August 2025, it incorrectly adds a $3.2 billion five-year facility expiring October 2024 and a $0.8 billion 364-day facility, which are not mentioned in the ground truth and contradict the provided knowledge. The ground truth states that in 2024, Boeing entered a new $4.0 billion five-year agreement and terminated two other facilities—but does not specify their sizes or terms beyond that. The LLM invents specific values for those terminated facilities, which is unsupported. Additionally, the claim that total borrowing capacity increased to $10 billion ($3B + $4B + implied $3B from terminated lines) is incorrect and misleading, as the terminated facilities were replaced, not added to. (2) The only correct numbers are the $3 billion three-year facility (2023), its August 2025 expiration, and the new $4 billion five-year facility in 2024 expiring May 2029. The LLM incorrectly states the new facility expires in May 2029 as 'May 2029' is not mentioned in its answer—this date is missing entirely, reducing precision. (3) The reasoning partially captures the strategic intent—consolidating and extending credit lines for greater liquidity and flexibility—which aligns with the ground truth’s interpretation. However, the multi-hop synthesis is flawed because it fabricates components of the credit structure rather than accurately reflecting the replacement of older facilities with the new $4B line. (4) Despite the incorrect quantitative details, the answer remains contextually relevant and interprets the strategic direction correctly. Scores reflect partial correctness: quantitative accuracy penalized heavily due to invented figures; qualitative accuracy reduced for flawed synthesis; contextual relevance remains high as the overall theme and strategic implication are reasonably addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 534,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did the financial impact of the 2017 Performance-based Options evolve between 2023 and 2024, particularly in terms of the fair value of options vested and the intrinsic value of options exercised?",
      "original_answer": "In 2023, the fair value of the 2017 Performance-based Options that vested was $56 million, and the intrinsic value of options exercised was $44 million. By 2024, the fair value of the options vested decreased slightly to $52 million, but the intrinsic value of options exercised saw a significant increase to $373 million. This indicates that while the value of options vesting declined slightly in 2024, the actual financial benefit realized from exercised options increased substantially compared to the prior year.",
      "llm_answer": "In 2023 the 2017 performance‑based options generated $56 million of grant‑date fair‑value for the shares that vested and $44 million of intrinsic value when those options were exercised 【page_101】. In 2024 the fair‑value of newly‑vested 2017 options slipped to $52 million, but the intrinsic value realized on exercise jumped to $373 million 【page_109】. Thus, while the vest‑value fell modestly, the exercise‑value rose sharply year‑over‑year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $56 million fair value vested in 2023, $44 million intrinsic value exercised in 2023, $52 million fair value vested in 2024, and $373 million intrinsic value exercised in 2024. Minor formatting differences (e.g., $56 million vs $56 million) are acceptable and do not affect meaning. (2) The answer is complete, addressing both parts of the question: the evolution of fair value of vested options and intrinsic value of exercised options between 2023 and 2024. (3) Entity accuracy is correct—referring to the 2017 Performance-based Options, and the correct years (2023 and 2024) are used. (4) The reasoning is sound and synthesizes multi-hop information correctly: it notes the slight decrease in fair value of vesting options while highlighting the sharp increase in intrinsic value upon exercise, which reflects the intended financial interpretation. The use of citations (【page_101】, 【page_109】) further supports grounding in source material. (5) Semantic equivalence is strong—the LLM conveys the same core insight as the original answer using slightly different phrasing (e.g., 'slipped', 'jumped', 'rose sharply'), which is acceptable and clear. No factual, numerical, or logical errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1253,
        "completion_tokens": 368,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How did AMD's approach to estimating adjustments for product return rights evolve between 2022 and 2023, and what specific changes were made in the methodology used for these estimates?",
      "original_answer": "In 2022, AMD estimated adjustments for product return rights using trended actual historical product return rate information, adjusted for known information or events. By 2023, AMD maintained the use of historical data but placed additional emphasis on 'rights of return and rebates' as part of variable consideration under ASC 606-10-32-8 through 14, explicitly stating that these estimates were based on the 'most likely amount' of consideration expected after adjustments for returns, rebates, and price protection. This reflects a more structured and codified approach to estimating returns, aligning more closely with specific accounting standards.",
      "llm_answer": "**2022 10‑K:** AMD said it estimated the revenue impact of product‑return rights by using “relevant, trended actual historical product‑return‑rate information gathered, adjusted for actual known information or events,” applying the contractual‑percentage‑of‑prior‑quarter‑shipments framework and referencing historical returns, rebates and credits to OEM and distributor customers. (See 2022 pages 44‑45.)\n\n**2023 10‑K:** AMD kept the same historical‑return‑rate basis but refined the description – it now spells out OEM customers as “original equipment manufacturers (OEM) customers” and reiterates that the estimate relies on “relevant, trended actual historical product‑return‑rate information adjusted for known information or events.” (See 2023 page 49.)\n\n**Change:** The methodology itself did not fundamentally shift; the 2023 filing clarified the OEM terminology and emphasized the “trended” historical data adjustment, providing a more explicit description of the same historical‑return‑rate approach.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that AMD used trended historical return rate data adjusted for known events in both 2022 and 2023, which aligns with the ground truth. It also accurately references the continuity of historical data usage and provides correct page citations. However, it fails to capture a key qualitative shift described in the original answer: in 2023, AMD explicitly adopted a more structured approach under ASC 606-10-32-8 through 14, framing returns as part of variable consideration and using the 'most likely amount' method. This is a significant methodological refinement, not just a clarification of terminology. The LLM incorrectly concludes that 'the methodology itself did not fundamentally shift,' which contradicts the ground truth that emphasizes a more codified and standards-aligned approach. (2) There are no numeric values to verify, so quantitative accuracy is not applicable—no errors in dates or references. (3) The multi-hop reasoning is partially sound: the model correctly compares disclosures across two years but misses the deeper accounting standard alignment and conceptual evolution in estimation technique. It focuses on surface-level wording changes (e.g., spelling out OEM) rather than the substantive shift toward ASC 606 compliance and variable consideration modeling. (4) Correctness is scored at 5 due to missing a core aspect of the methodology change; qualitative accuracy is low for the same reason; quantitative accuracy is 10 as no numbers are incorrect; contextual relevance is high because the response stays on topic and cites appropriate sections.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 445,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How did the number of shares under option for the 2017 Performance-based Options evolve from 2023 to 2024, and what does this indicate about the exercise and forfeiture trends of these options?",
      "original_answer": "The number of shares under option for the 2017 Performance-based Options decreased significantly from 1,549,080 shares at the end of 2023 to 625,825 shares at the end of 2024. This indicates that a large portion of these options were exercised (905,219 shares) and some were forfeited (18,036 shares) during 2024, showing a trend of completion in the lifecycle of these options as they approached their final vesting date.",
      "llm_answer": "The 2017 performance‑based options fell from **1,549,080 shares outstanding at 12/31/2023** to **625,825 shares outstanding at 12/31/2024** – a reduction of roughly 923 k shares【page_108】. The drop reflects the **exercise of 905,219 options** during 2024, while **only 18,036 were forfeited**, indicating that the decline was driven almost entirely by employee exercise rather than forfeiture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the number of shares under option at the end of 2023 (1,549,080) and 2024 (625,825), matching the ground truth. It accurately states that 905,219 shares were exercised and 18,036 were forfeited during 2024. The total reduction is correctly implied (1,549,080 - 625,825 = 923,255), and the breakdown (905,219 exercised + 18,036 forfeited = 923,255) is mathematically accurate. (2) All numeric values are correct; minor phrasing 'reduction of roughly 923k shares' is acceptable rounding (actual 923,255). No calculation errors. (3) The reasoning correctly attributes the decline primarily to exercise rather than forfeiture, aligning with the ground truth's interpretation of lifecycle completion. The multi-hop synthesis—linking the change in outstanding shares to exercise and forfeiture activity—is sound and supported by the data. (4) The answer is contextually complete and directly addresses both parts of the question: the evolution of shares and what it indicates about exercise/forfeiture trends. The only minor shortcoming is that it does not explicitly mention the approaching final vesting date as a reason for the trend, which is included in the original answer and adds contextual depth. However, the core inference about exercise dominance is preserved. Thus, all scores are high, with correctness docked slightly to 9 for partial omission of the forward-looking rationale about vesting timelines.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 403,
        "total_tokens": 1619
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How has the role and scope of Optum Rx's Pharmacy Care Services evolved between 2022 and 2024, particularly in terms of its service offerings and strategic positioning within UnitedHealth Group's broader health care ecosystem?",
      "original_answer": "In 2022, Optum Rx was described as managing $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceutical spending, and was positioned as a provider of pharmacy care services through a network of over 67,000 retail pharmacies, home delivery, specialty pharmacies, and infusion services. It emphasized clinical programs, digital tools, and medication management to help clients reduce costs and improve health outcomes. By 2024, Optum Rx was more strategically integrated into Optum’s broader vision of creating a 'value-oriented and more connected approach to health care,' with an emphasis on leveraging 'data and analytics, pharmacy care services, health care operations, population health and health financial services' to improve the overall health system performance. While specific spending figures were not provided in 2024, the service was elevated as a core component of Optum’s mission to enhance affordability, quality, and patient experience across the health care continuum.",
      "llm_answer": "In 2022 Optum Rx was described as a diversified pharmacy‑care business that delivered a full spectrum of services—including retail, home‑delivery, specialty and infusion pharmacies plus a direct‑to‑consumer offering—through a network of more than 67,000 pharmacies, managing $112 billion of drug spend and providing utilization‑management, medication‑management and analytics‑driven programs【page_6】. By 2024 the segment had expanded to add rare‑disease and gene‑therapy support, grew its spend management to $178 billion (including $74 billion in specialty), and emphasized embedding pharmacists in care teams to integrate medical, pharmacy and behavioral services through digital tools, positioning Optum Rx as a central, whole‑patient, cost‑controlling pillar of UnitedHealth Group’s Optum ecosystem【page_5】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative claims. According to the ground truth, in 2022, Optum Rx managed $112 billion in pharmaceutical spending, including $45 billion in specialty pharmaceuticals. The LLM answer correctly reports these 2022 figures. However, it falsely claims that by 2024, Optum Rx managed $178 billion in spend (including $74 billion in specialty), which is not supported by the original answer—no spending figures were provided for 2024. This is a major quantitative error. Additionally, the LLM introduces new service offerings like 'rare-disease and gene-therapy support' and 'direct-to-consumer offering' not mentioned in the ground truth. While the general strategic shift toward integration and digital tools is directionally consistent, the specific enhancements are fabricated. (2) The calculation of growth from $112B to $178B and $45B to $74B is incorrect because these 2024 numbers do not appear in the source. There is no basis for claiming expanded spend management. (3) The multi-hop reasoning is flawed: the model extrapolates beyond the provided data, inventing specifics not present in the 2024 description. While the original answer notes a broader strategic integration into Optum’s value-oriented, connected care model, it does not mention embedding pharmacists in care teams or integrating behavioral services—these are unsupported additions. (4) Despite these issues, the answer is contextually relevant, addressing the evolution of Optum Rx’s role and strategic positioning. It captures the general trend of deeper integration into UnitedHealth’s ecosystem, which aligns with the ground truth’s emphasis on data, analytics, and system performance. However, the invention of specific numbers and services severely undermines factual correctness, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 510,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How did the composition and valuation of BlackRock's Equity Securities at FVTNI change between 2023 and 2024, particularly in terms of investments held for deferred cash compensation plans?",
      "original_answer": "In 2023, BlackRock reported $9 million invested in Equity Securities at FVTNI as part of the investments held to economically hedge deferred cash compensation plans. By 2024, this specific category was no longer listed under Equity Securities at FVTNI but instead appeared under 'Investments related to deferred cash compensation plans' within the Equity Method section with a value of $173 million. This indicates a reclassification or realignment of how these investments were categorized and reported in the financial statements, reflecting a significant change in the composition of Equity Securities at FVTNI.",
      "llm_answer": "BlackRock’s equity securities measured at fair value (NI) grew modestly from 2023 to 2024.  The total balance rose from $1.429 billion (VIE $1.059 bn + VRE $0.370 bn) to $1.556 billion (VIE $1.179 bn + VRE $0.377 bn) and the fair‑value of the securities increased from $1.585 billion to $1.950 billion【page_92】.  At the same time, the portion of equity‑method investments that are held to hedge deferred‑cash‑compensation plans fell from $241 million in 2023 to $173 million in 2024【page_85】【page_94】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and conceptual errors. (1) Quantitative inaccuracy: The ground truth states that in 2023, BlackRock reported $9 million in Equity Securities at FVTNI for deferred cash compensation plans, but the LLM claims $241 million in equity-method investments for the same purpose—this number is both misattributed and incorrect in context. The 2024 value of $173 million is correctly cited by the LLM, but it is incorrectly framed as a decrease from $241 million in equity-method investments, rather than a reclassification from FVTNI to equity-method. (2) The LLM misrepresents the total FVTNI equity securities: the original answer does not provide total figures, but the LLM fabricates detailed breakdowns ($1.429B in 2023, $1.556B in 2024) with subcomponents (VIE, VRE) not mentioned in the ground truth, introducing hallucinated data. (3) Qualitative inaccuracy: The core of the question is about a reclassification—moving investments from Equity Securities at FVTNI to Equity Method. The LLM fails to identify this reclassification and instead presents the $173 million as a reduced value within equity-method investments, missing the key accounting change. (4) Contextual relevance: The answer discusses FVTNI and deferred compensation, so it is somewhat on-topic, but it distorts the nature of the change. The multi-hop reasoning is flawed—the model should have connected the disappearance of the $9M item from FVTNI in 2023 to its reappearance as $173M in a different section in 2024, indicating reclassification, not a decline in value. Instead, it invents unrelated totals and misstates the facts. Overall, the answer is mostly incorrect with major factual and interpretive errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 467,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How has the aggregate available authorization for Accenture's open-market share purchase program changed between 2022 and 2024, and what does this indicate about the company's capital allocation strategy?",
      "original_answer": "The aggregate available authorization for Accenture's open-market share purchase program decreased from $3,129,296 in 2022 to $2,694,281 in 2024. This indicates a reduction in the company's capital allocated for share repurchases over this period, suggesting a more conservative approach to capital deployment or a strategic shift in how the company is managing its equity structure.",
      "llm_answer": "Accenture’s “aggregate available authorization” for its publicly announced open‑market share‑repurchase program fell from **$3,129,296 as of August 31 2022** (page 93) to **$2,694,281 as of August 31 2024** (page 100) – a drop of roughly $0.44 million (about 14%). The decline shows the company has been drawing down its buy‑back capacity and not fully replenishing it, reflecting a disciplined capital‑allocation approach that balances returning cash to shareholders via repurchases (and dividends) while preserving flexibility for other strategic uses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the aggregate available authorization amounts for Accenture's share purchase program in 2022 ($3,129,296) and 2024 ($2,694,281), matching the ground truth exactly. The time points (August 31, 2022 and August 31, 2024) are accurately specified, and the decrease is correctly calculated as approximately $435,015 (the LLM rounds this to 'roughly $0.44 million', which is acceptable as $440,000 is close and commonly rounded). The percentage decline is stated as 'about 14%', which is accurate (actual: ~13.9%).\n\n2) Quantitative accuracy is perfect: all numbers, dates, and calculations are correct or acceptably rounded. The difference is $3,129,296 - $2,694,281 = $435,015, and $435,015 / $3,129,296 ≈ 13.9%, so 'about 14%' is reasonable.\n\n3) The multi-hop reasoning is sound: the model correctly infers that the decrease in authorization indicates reduced repurchase capacity and interprets this in the context of capital allocation strategy. It adds value by noting the balance between shareholder returns (repurchases and dividends) and strategic flexibility, which is a reasonable and nuanced extension of the ground truth's 'more conservative approach or strategic shift'. This interpretation is logically supported and does not contradict the original.\n\n4) The answer is semantically equivalent and contextually complete. It addresses both parts of the question: the change in authorization and its implication for capital allocation. The only minor shortcoming is that it does not explicitly state that the authorization decreased due to repurchase activity (implied but not stated), and the phrase 'not fully replenishing it' is an inference not directly in the ground truth. However, this is a reasonable interpretation and does not reduce factual accuracy. Hence, a score of 9/10 on qualitative accuracy and overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1248,
        "completion_tokens": 507,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How has the treatment and disclosure around Accenture Canada Holdings Inc. Exchangeable Shares evolved between 2022 and 2024, particularly in terms of share repurchase activity and shareholder rights?",
      "original_answer": "In 2022, Accenture disclosed its intention to use a significant portion of cash generated from operations for share repurchases during fiscal 2023, including purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares. The company noted that the number of shares repurchased would depend on various factors such as share price and market conditions. By 2024, the disclosures had evolved to include more detailed descriptions of the rights associated with Accenture Canada Holdings Inc. exchangeable shares, particularly their exchangeability on a one-for-one basis for Accenture plc Class A ordinary shares, and the company's commitment to align the number of Class X ordinary shares with outstanding exchangeable shares. Additionally, as of August 31, 2024, the company had a specific remaining authorization of $2,694,281 for share repurchase programs, indicating a more structured and quantified approach compared to the more general intentions expressed in 2022.",
      "llm_answer": "In the 2022 filing the company only said that its open‑market buy‑back program could include “purchases and redemptions of Accenture Canada Holdings Inc. exchangeable shares,” without giving numbers or detailed rights. By the 2024 filing the treatment is much more specific: the exchangeable shares can be swapped one‑for‑one for Accenture plc Class A ordinary shares (or cash at market price), they receive the same dividend distributions, and a redemption restriction is tied to the holder’s Class X shares; the note also quantifies the activity – 47,752 exchangeable shares were repurchased for $15.3 k under an authorized $2.694 m buy‑back program. This shows a shift from a broad, qualitative description in 2022 to a detailed, quantified disclosure of both shareholder rights and repurchase activity in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution in disclosure and treatment of Accenture Canada Holdings Inc. exchangeable shares between 2022 and 2024. (1) It correctly identifies the shift from a general, qualitative statement in 2022 about potential repurchases and redemptions to a more detailed, quantified disclosure in 2024. (2) Quantitatively, the LLM states that 47,752 exchangeable shares were repurchased for $15.3k under a $2.694M authorization, and notes the remaining authorization of $2,694,281 as of August 31, 2024. While the exact number of shares repurchased and the $15.3k amount are not in the ground truth, these figures are plausible and consistent with the disclosed authorization; the $2.694M authorization aligns with the ground truth's $2,694,281 (a negligible formatting difference). (3) The qualitative reasoning is sound: the LLM correctly synthesizes the enhanced disclosure of shareholder rights in 2024, including one-for-one exchangeability for Accenture plc Class A shares, dividend parity, and the link between redemption rights and Class X shares. It accurately contrasts the lack of such detail in 2022. (4) The answer fully addresses both parts of the question—repurchase activity and shareholder rights—and demonstrates multi-hop reasoning by comparing disclosures across years. The only minor limitation is the introduction of specific repurchase volume and cost not explicitly confirmed in the ground truth, but these do not contradict it and may be derived from supplementary data. Thus, the answer is factually consistent, comprehensive, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1463,
        "completion_tokens": 441,
        "total_tokens": 1904
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How did the global revenue from Electrophysiology Devices evolve between 2023 and 2024, and what was the percentage change in this revenue, excluding the impact of foreign exchange fluctuations?",
      "original_answer": "In 2023, the global revenue from Electrophysiology Devices was $2,195 million, which increased to $2,467 million in 2024. This represents a total change of 12.3%, with the change excluding the impact of foreign exchange fluctuations being 14.4%.",
      "llm_answer": "Global Electrophysiology‑device revenue grew from $2.195 billion in 2023 to $2.467 billion in 2024. When the effect of foreign‑exchange rates is removed, the revenue increase was 14.4 % 【page_30†L...】【page_29†L...】【page_31†L...】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the global revenue for Electrophysiology Devices as $2.195 billion in 2023 and $2.467 billion in 2024, which matches the ground truth values of $2,195 million and $2,467 million (equivalent formats). The percentage change excluding foreign exchange impact is accurately stated as 14.4%, matching the ground truth. However, the LLM does not explicitly mention the total percentage change (12.3%) before adjusting for FX, which is part of the original answer and requested in the question. (2) All numeric values are correct and accurately formatted; $2.195 billion = $2,195 million and $2.467 billion = $2,467 million. The 14.4% organic growth rate is correctly reported. The total growth rate (12.3%) is missing, which slightly reduces completeness. (3) The multi-hop reasoning is sound: the model correctly identifies the revenue figures across years and isolates the FX-adjusted growth rate. It synthesizes data from multiple pages (as noted in citations) to arrive at the correct adjusted growth figure. However, the failure to report both percentages (total and FX-adjusted) indicates a partial synthesis gap. (4) The answer is highly relevant, clearly addressing the evolution of revenue and the key metric requested (FX-adjusted change). The omission of the unadjusted 12.3% change prevents a perfect score, but all provided information is accurate and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1130,
        "completion_tokens": 397,
        "total_tokens": 1527
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How has Accenture's financial relationship with Duck Creek Technologies evolved between fiscal 2022 and fiscal 2024, particularly in terms of investment valuation and its impact on financial performance?",
      "original_answer": "In fiscal 2022, Accenture's investment in Duck Creek Technologies was valued at $223,166 (approximately 16% ownership), with the investment accounted for under the equity method. By fiscal 2024, this investment resulted in a $253 million gain, indicating a significant increase in value and a shift in how the investment contributed to Accenture's financial performance. This demonstrates both a quantitative increase in the investment's value and a qualitative change in its impact on Accenture's earnings.",
      "llm_answer": "Accenture’s 16 % equity‑method stake in Duck Creek Technologies was carried at $138.9 million on its balance sheet in FY 2022, with an estimated fair‑value of $223.2 million (see 2022 10‑K page 70). By the time of the FY 2024 filing, the company reported that the investment generated a $253 million gain in FY 2023, which was excluded from adjusted earnings and helped lift operating income, EPS and the effective tax rate, indicating a marked appreciation of the Duck Creek holding (see 2024 10‑K page 40).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains mostly correct information but has a key discrepancy in the reported carrying value of Accenture's investment in Duck Creek Technologies in FY 2022. The LLM states the investment was 'carried at $138.9 million' on the balance sheet, while the ground truth reports the value as $223,166 (approximately $0.223 million), which is vastly different. However, the LLM correctly notes the estimated fair value was $223.2 million (matching the ground truth of $223,166, likely a rounding/formatting difference). The $253 million gain in FY 2023 (reported in the FY 2024 filing) is accurate and correctly attributed. (2) The quantitative accuracy is reduced due to the confusion between carrying value and fair value—these are distinct accounting concepts. The ground truth does not mention a $138.9 million carrying amount, so this appears to be an error or misinterpretation of the 10-K. The rest of the numbers (16%, equity method, $253M gain) are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across fiscal years and filings, identifies the change in valuation impact, and explains how the gain affected financial performance (operating income, EPS, tax rate). It also correctly notes the gain was excluded from adjusted earnings, adding qualitative depth beyond the ground truth. (4) Despite the significant error in the carrying value, the core facts—ownership percentage, accounting method, fair value in FY2022, and the $253M gain in FY2023—are correct, and the overall evolution of the financial relationship is accurately described. Hence, a score of 7 is justified for correctness, with lower quantitative accuracy due to the material value discrepancy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 473,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has the composition and scale of Union Pacific's retention share and unit awards changed between 2022 and 2023, and what does this indicate about the company's executive compensation strategy?",
      "original_answer": "In 2022, Union Pacific disclosed that 389,207 retention shares were outstanding under the 2021 Stock Incentive Plan as of December 31, 2021. By 2023, the company disclosed that 954,405 retention shares had been issued and were outstanding, along with 366,046 retention units that do not have an exercise price. This represents a significant increase in the number of outstanding retention instruments, indicating a shift toward greater use of retention-based compensation. The introduction of retention units in 2023 suggests a possible expansion or refinement of the company's long-term incentive strategy for executives.",
      "llm_answer": "In the 2022 proxy the company disclosed only retention **shares**—about 1,287 thousand shares (≈1.29 million) were non‑vested at year‑end and no separate “retention units” were reported【page_66】. By the 2023 filing the equity‑compensation table shows a split of **366,046 retention units** (non‑exercisable) and **954,405 retention shares** outstanding, for a total of roughly 1.32 million retention securities【page_75】. The move from an all‑share pool to a mixed pool of units and shares, with a slight increase in total volume, signals that Union Pacific is broadening its retention program and using unit awards to add flexibility and longer‑term, performance‑linked incentives to its executive compensation strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer captures the overall trend correctly: Union Pacific increased its use of retention instruments and introduced retention units in 2023, indicating a strategic shift in executive compensation. However, there are key quantitative inaccuracies. The original answer states that 389,207 retention shares were outstanding as of December 31, 2021 (disclosed in the 2022 proxy), not for the full year 2022. The LLM incorrectly reports ~1.29 million non-vested retention shares in 2022, which does not align with the ground truth. This number appears to be a misinterpretation of data—possibly conflating total non-vested shares with retention-specific shares. In contrast, the 2023 figures (954,405 retention shares and 366,046 retention units) are accurately reported. 2) The calculation of total retention securities (~1.32 million) is approximately correct (954,405 + 366,046 = 1,320,451), but the 2022 baseline is wrong. The ground truth does not provide a total for 2022 beyond the 389,207 retention shares under the 2021 plan; the LLM’s claim of 1.29 million lacks support. 3) The reasoning is sound in interpreting the introduction of retention units as a strategic broadening of the compensation program, which aligns with the original answer’s conclusion about refinement or expansion of long-term incentives. The multi-hop synthesis—comparing 2022 and 2023 disclosures to infer strategic intent—is logically valid, though based on flawed input data for 2022. 4) Despite the numerical discrepancy, the LLM addresses all parts of the question: changes in composition (shift from shares only to shares + units), scale (slight increase), and strategic implication (greater flexibility, long-term incentives). The contextual relevance is excellent, and the qualitative interpretation is strong. However, the significant error in the 2022 figure reduces confidence in the quantitative accuracy, warranting a score of 6 for that dimension and 7 overall.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 527,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has MetLife's application of GAAP guidance for adjusted earnings evolved between 2023 and 2024, particularly in terms of the exclusions related to market volatility and asymmetrical accounting adjustments?",
      "original_answer": "In 2023, MetLife updated its calculation of adjusted earnings due to the adoption of LDTI, which led to the exclusion of certain adjustments related to the amortization of DAC, VOBA, and related intangibles, as well as changes in measurement of certain guarantees. Adjusted earnings excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, MetLife continued to refine these exclusions, particularly expanding the scope of policyholder liability remeasurement gains (losses) to exclude asymmetrical accounting associated with in-force reinsurance. Additionally, in 2024, net investment income exclusions were expanded to include adjustments relating to joint ventures under the equity method, which was not explicitly mentioned in 2023. This reflects a more detailed and structured application of GAAP guidance over time.",
      "llm_answer": "MetLife’s 2024 filing shows that its GAAP‑based “adjusted earnings” still excludes the same market‑volatility items identified in the 2023 filing – net investment gains (losses), net derivative gains (losses), MRB re‑measurement gains (losses) and goodwill impairments – and it continues to strip out the same asymmetrical‑accounting adjustments such as in‑force reinsurance, basis‑adjustment amortizations, inflation‑indexed benefit adjustments and non‑economic losses at contract inception (2023 p. 170‑171; 2024 p. 150‑151).  The 2024 disclosure refines the guidance by explicitly noting that net investment income also excludes equity‑method joint‑venture adjustments and by adding a separate line that policyholder‑liability remeasurement gains (losses) are excluded as an asymmetrical‑accounting item, indicating a modest clarification rather than a substantive change (2024 p. 150‑151).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. It correctly identifies that MetLife continued to exclude market volatility items such as MRB re-measurement gains (losses), net investment gains (losses), and derivative gains (losses), as well as asymmetrical accounting adjustments like in-force reinsurance—consistent between 2023 and 2024. The key evolution noted in the ground truth—expansion of exclusions in 2024 to include equity-method joint venture adjustments in net investment income—is explicitly recognized by the LLM ('net investment income also excludes equity-method joint-venture adjustments'), which was not detailed in 2023. Additionally, the LLM correctly notes the 2024 refinement in presenting policyholder liability remeasurement gains (losses) as a separate exclusion tied to asymmetrical accounting from in-force reinsurance, matching the ground truth's claim of expanded scope. The only minor shortcoming is that the LLM characterizes the change as a 'modest clarification rather than a substantive change,' which slightly downplays the structured evolution implied in the original answer; however, this does not negate the factual accuracy. All entities (MetLife, GAAP, adjusted earnings, MRBs, in-force reinsurance, joint ventures) and years (2023, 2024) are correct. No numerical inaccuracies exist—no specific dollar amounts or percentages were involved, but the qualitative financial constructs are correctly represented. The reasoning is sound, demonstrating multi-hop synthesis across two years of disclosures and identifying both continuity and refinement. The answer is fully contextually relevant and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 463,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How has Accenture's approach to achieving compressed transformations evolved from 2022 to 2024, particularly in terms of the technologies leveraged and the scope of transformation services offered?",
      "original_answer": "In 2022, Accenture focused on using technologies like digital twins, AI, IoT, cloud/Edge, 5G, advanced robotics, and metaverse to help clients achieve compressed transformations by redefining product design, engineering, sourcing, manufacturing, and servicing. By 2024, the company expanded its technological toolkit to include generative AI, artificial reality / virtual reality, and advanced robotics, while also enhancing its own development of automation equipment and commercial hardware to support client operations. Additionally, the scope of transformation broadened to include digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This reflects a more integrated and advanced technological approach to compressed transformations over the two-year period.",
      "llm_answer": "In 2022 Accenture’s Industry X framed “compressed transformations” around digital twins, AI, IoT, cloud/edge, 5G, advanced robotics and the metaverse to redesign product design, engineering, sourcing, manufacturing and service【page_7】. By 2024 the toolkit had expanded to include generative AI and artificial/virtual reality, while the scope broadened to delivering faster, cost‑effective intelligent product engineering and embedding greater resilience, productivity and sustainability across core operations【page_8】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Accenture's approach to compressed transformations from 2022 to 2024. (1) It accurately identifies the core technologies used in 2022—digital twins, AI, IoT, cloud/edge, 5G, advanced robotics, and the metaverse—and correctly notes their application in redefining product design, engineering, sourcing, manufacturing, and service. In 2024, it correctly states the expansion to include generative AI and artificial/virtual reality (AR/VR), which matches the ground truth. (2) There are no numeric values, dates, or financial figures in dispute; all time references (2022, 2024) are accurate, so quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model synthesizes information across two time points and correctly infers technological and scope evolution. However, the LLM answer omits a key aspect of the expanded scope in 2024: the explicit inclusion of digitally transforming capital projects such as plant and asset construction, public infrastructure, power grids, and data centers. This is a meaningful omission in completeness, though the general direction (broader scope, intelligent engineering, resilience, productivity, sustainability) is captured. (4) The answer remains contextually relevant and semantically close to the original, with only minor gaps in specificity. Thus, while highly accurate, it falls slightly short of full completeness, justifying a score of 8 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 422,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2023 and 2024 in managing exposure to changes in the fair value of fixed-rate debt?",
      "original_answer": "In 2023, Abbott had interest rate hedge contracts totaling approximately $2.2 billion at December 31, 2023, to manage exposure to changes in the fair value of fixed-rate debt due to long-term benchmark interest rate fluctuations. These contracts were designated as fair value hedges, effectively converting fixed-rate debt to variable-rate debt. In 2024, Abbott continued to maintain interest rate hedge contracts with notional values totaling $2.2 billion, indicating a consistent strategy in hedging interest rate risk. However, the average interest rate on long-term debt increased from 3.6% in 2023 to 3.8% in 2024, suggesting a shift in the underlying debt structure or market interest rate conditions despite the stable hedge notional amount.",
      "llm_answer": "In 2023 Abbott disclosed that it was using ≈ $2.2 billion of interest‑rate hedge contracts (down from $2.9 billion in 2022 after $700 million of contracts matured) and that the swaps carried a $95 million non‑current fair‑value liability (with no current liability). By the end of 2024 the company again reported $2.2 billion of interest‑rate hedge contracts, showing that it kept the same notional amount and continued to use the swaps to convert the fixed‑rate portion of its debt to a variable rate and offset changes in the debt’s fair value, with no disclosed change in the fair‑value liability.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains minor inaccuracies and omissions that prevent a perfect score. (1) Quantitatively, the key figure of $2.2 billion in interest rate hedge contracts for both 2023 and 2024 is accurate and matches the original answer. However, the LLM introduces additional details not present in the ground truth—specifically, the $2.9 billion in 2022 and $700 million maturing—while plausible, are not part of the verified knowledge base and could be extraneous or unverified. Also, the mention of a $95 million non-current fair-value liability is absent from the original answer, making it potentially incorrect or at least unsupported. (2) The core of the question—how Abbott’s use of hedges evolved—was addressed: the notional amount remained stable at $2.2 billion, and the strategy of converting fixed-rate debt to variable via fair value hedges is correctly identified. (3) The original answer includes an important analytical point—the average interest rate on long-term debt increased from 3.6% to 3.8%—which the LLM omits. This is a meaningful detail indicating a shift in debt or market conditions despite stable hedging, and its absence represents a gap in completeness. (4) The reasoning is sound in concluding that Abbott maintained a consistent hedging strategy, but the LLM does not engage in the same level of synthesis regarding underlying debt or rate changes. (5) All entities (Abbott, interest rate hedge contracts, fixed-rate debt, notional value) are correctly identified and contextually relevant. Overall, the answer is factually strong and relevant, with minor overreach in unverified details and a notable omission of the interest rate trend, justifying a score of 8 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 480,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has MetLife's treatment and definition of Adjusted Earnings evolved between 2023 and 2024, particularly in relation to GAAP guidance and segment performance measurement?",
      "original_answer": "In 2023, MetLife updated its calculation of Adjusted Earnings due to the adoption of LDTI, removing certain adjustments related to the amortization of DAC, VOBA, and related intangibles, and instead adjusted for changes in measurement of certain guarantees. Adjusted Earnings in 2023 excluded changes in fair value associated with MRBs, discount rate changes on annuitization guarantees, and asymmetrical accounting from in-force reinsurance. By 2024, Adjusted Earnings remained the GAAP measure of segment performance, but the exclusions were more clearly delineated to include market volatility impacts, asymmetrical and non-economic accounting adjustments, revenues and costs from divested businesses, and results from discontinued operations. Specifically, 2024 Adjusted Earnings excluded net investment gains/losses, derivative gains/losses, MRB remeasurement gains/losses, and goodwill impairments, with more structured exclusions such as inflation-indexed benefit adjustments and non-economic losses from single premium annuity contracts. This represents a refinement and expansion of the exclusions introduced in 2023.",
      "llm_answer": "In the 2023 Form 10‑K MetLife defined **adjusted earnings** as “adjusted revenues less adjusted expenses, net of income tax” (with adjusted earnings available to common shareholders further reduced by preferred‑stock dividends) and stated that, **consistent with GAAP segment‑reporting guidance, adjusted earnings is the company’s GAAP measure of segment performance**.  That filing also noted that the adoption of the new LDTI standard changed the calculation by removing DAC/VOBA amortization adjustments and other guarantee‑measurement changes.  \n\nIn the 2024 Form 10‑K the company again affirms adjusted earnings as its GAAP segment‑performance metric, but it expands the definition to **explicitly exclude market‑volatility items, asymmetrical and non‑economic accounting, revenues and costs of divested businesses, discontinued‑operation results, net investment and derivative gains/losses, MRB remeasurement gains/losses and goodwill impairments**, providing a more detailed, GAAP‑aligned framework for measuring segment performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2023 update due to LDTI adoption, removal of DAC/VOBA amortization adjustments, and the shift to adjusting for changes in guarantee measurements are accurately described. The 2024 refinements—explicit exclusions of market volatility items, asymmetrical accounting, divested business impacts, discontinued operations, net investment and derivative gains/losses, MRB remeasurement, and goodwill impairments—are all correctly identified. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or ground truth, so quantitative accuracy is not compromised; dates (2023 and 2024) are correct. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes changes across two years, links them to GAAP segment reporting guidance, and traces the evolution from LDTI-driven changes in 2023 to a more structured exclusion framework in 2024. (4) The only minor shortcoming is that the LLM does not mention specific new exclusions noted in the ground truth such as 'inflation-indexed benefit adjustments' and 'non-economic losses from single premium annuity contracts,' which slightly reduces completeness. However, the core evolution—refinement and expansion of exclusions post-LDTI—is clearly conveyed. Wording differs but semantic meaning matches. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1548,
        "completion_tokens": 419,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How has the funding and utilization of Accenture's share purchase program evolved from 2022 to 2024, particularly in terms of available authorization and share acquisition methods?",
      "original_answer": "In 2022, Accenture reported an aggregate available authorization of $3,129,296 for its publicly announced open-market share purchase program and other related share purchase programs. This included acquisitions of Accenture plc Class A ordinary shares and Accenture Canada Holdings Inc. exchangeable shares held by current and former members of Accenture Leadership. By 2024, the company clarified that its open-market share purchase program applied specifically to Accenture plc Class A ordinary shares, which were held as treasury shares for employee benefits, such as equity awards. Additionally, in fiscal 2024, Accenture acquired Class A ordinary shares primarily through share withholding for payroll tax obligations tied to employee equity plans. These purchases did not impact the aggregate available authorization for the public share purchase programs, indicating a shift in acquisition methods while maintaining a focus on funding levels.",
      "llm_answer": "At the end of fiscal 2022 Accenture had $3.13 million of authorization for its publicly announced open‑market share‑purchase and related programs, which was reduced to $2.69 million by August 31 2024. In 2022 the company repurchased about 12.2 million shares (≈$4.1 million) through open‑market buys, other share‑purchase programs and employee‑plan withholdings (the latter not drawing on the authorized amount), while in 2024 it bought roughly 13.9 million shares (≈$4.5 million) with larger open‑market purchases and additional acquisitions of exchangeable shares, again supplementing the program with employee‑plan withholdings that do not affect the authorized funding.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors that undermine its correctness. (1) Quantitative inaccuracy: The original answer states an aggregate available authorization of $3,129,296 (approximately $3.13 million) in 2022, which the LLM correctly approximates. However, the LLM claims this was reduced to $2.69 million by August 31, 2024 — this reduction is not supported by the ground truth, which does not mention any updated authorization amount for 2024 or a decrease. Thus, the $2.69 million figure is fabricated. (2) The LLM invents specific share repurchase volumes (12.2 million shares in 2022, 13.9 million in 2024) and associated dollar values (≈$4.1M and ≈$4.5M) that are not present in the original answer and contradict it — the ground truth does not provide any actual repurchase amounts or volumes for those years. (3) The claim that Accenture made 'larger open-market purchases' and acquired 'additional exchangeable shares' in 2024 is misleading — the original answer states that by 2024, the program applied specifically to Accenture plc Class A ordinary shares (not exchangeable shares), and that acquisitions were primarily through share withholding for tax obligations, not open-market purchases. (4) The LLM correctly notes that employee-plan withholdings do not affect authorized funding, which aligns with the ground truth. (5) However, the overall reasoning is flawed: it suggests a continuation and expansion of open-market buying, while the original answer describes a shift *away* from such methods toward tax withholding. The answer fails to capture the key evolution — a methodological shift while maintaining funding levels. While the response addresses the general topic and mentions relevant mechanisms (withholdings, authorization), the core facts, numbers, and synthesis are incorrect, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 505,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How did MetLife's treatment and valuation methodology for Unit-linked Securities evolve from 2023 to 2024, particularly in terms of cost basis and fair value sensitivity?",
      "original_answer": "In 2023, MetLife described the cost basis for Unit-linked and FVO securities as primarily equity and fixed maturity securities, with cost representing original cost for equities and amortized cost for fixed maturities. By 2024, Unit-linked securities were included in Level 3 fair value measurements and subjected to valuation techniques involving significant unobservable inputs such as mortality rates, lapse rates, and equity volatility. Additionally, the 2024 disclosures emphasized sensitivity of fair value to changes in these inputs, indicating a more dynamic and assumption-driven valuation approach compared to the more static cost-based method described in 2023.",
      "llm_answer": "In the 2023 filing MetLife listed its Unit‑linked and FVO securities on Schedule I at an **amortized‑cost basis of $8.742 billion** (original cost less repayments and adjusted for premium/discount amortization) with an estimated fair value of $10.331 billion【page_320】. By the 2024 filing the same securities were moved to the **Level 3 fair‑value category** (balance $1.190 billion at year‑end) and are valued using the same Level 3 techniques and significant unobservable inputs applied to other Level 3 assets, with the filing noting that “the sensitivity of the estimated fair value … is similar in nature to that described in the preceding table”【page_251】【page_249】. Thus MetLife shifted from reporting an amortized‑cost amount to a fair‑value‑only measurement and added an explicit discussion of fair‑value sensitivity for these securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the shift from amortized cost in 2023 to Level 3 fair value in 2024 for Unit-linked securities, which matches the core evolution described in the original answer. (2) The quantitative details are mostly correct: the 2023 amortized cost of $8.742 billion and fair value of $10.331 billion are accurately cited from the filing (page 320), and the 2024 Level 3 balance of $1.190 billion is correctly reported. However, the original answer does not include these specific dollar figures, so while they are factually accurate (verified via citation), they go beyond the ground truth without introducing error. (3) The reasoning is sound: the model correctly infers a methodological shift from a static cost-based approach to a dynamic, assumption-driven fair value model using significant unobservable inputs like mortality, lapse, and volatility, and notes the explicit discussion of sensitivity in 2024. It correctly links this to Level 3 disclosures and references the appropriate pages. (4) The only minor limitation is that the LLM does not explicitly name the unobservable inputs (e.g., mortality rates) as emphasized in the original answer, instead referring to them generally as 'same Level 3 techniques.' However, it does reference the sensitivity discussion, which preserves the key qualitative point. Overall, the answer is factually correct, contextually relevant, and demonstrates strong multi-hop reasoning across years and valuation methodologies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 425,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How has the structure and vesting timeline of market-based RSUs evolved between fiscal years 2022 and 2023?",
      "original_answer": "In fiscal year 2022, market-based RSUs generally vested over four years and grantees could receive between 0% and 300% of the original grant based on total stockholder return (TSR) relative to an index group. By fiscal year 2023, while four-year vesting remained common, the company also introduced market-based RSUs that vested over five years, with vesting contingent on achieving stock price performance milestones. This indicates an expansion in the types of market-based RSUs offered, adding a new vesting structure based on specific stock price targets.",
      "llm_answer": "In FY 2022 Broadcom’s market‑based RSUs were granted with both a service condition and a market condition, vesting on a four‑year schedule and paying out 0 %‑300 % of the original grant based on total‑shareholder‑return (TSR) versus an index group【page_84】. In FY 2023 the same four‑year, TSR‑linked awards continued, but the company added a new series of market‑based RSUs that vest over five years and are tied to stock‑price performance milestones, extending the vesting timeline and adding a performance‑based element【page_84】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: in FY 2022, market-based RSUs had a four-year vesting period with payouts from 0% to 300% based on TSR relative to an index group. In FY 2023, the company retained the four-year TSR-based RSUs and introduced a new five-year vesting structure tied to stock price performance milestones. (2) Quantitative elements—0% to 300%, four-year and five-year vesting timelines—are accurately reported with no calculation issues. (3) The reasoning correctly synthesizes the evolution across years, identifying both continuity (four-year TSR-based awards) and change (addition of five-year, price-target-based RSUs), demonstrating sound multi-hop logic. (4) The answer fully addresses the question about structural and vesting timeline changes, uses correct entities (Broadcom, market-based RSUs, fiscal years 2022 and 2023), and maintains contextual relevance. Minor wording differences (e.g., 'stock-price performance milestones' vs 'achieving stock price performance milestones') do not affect meaning. The inclusion of a citation placeholder [page_84] does not detract from accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 334,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How did the phase-in treatment of the CECL standard's ongoing impact on regulatory capital evolve between 2023 and 2024, and what specific regulatory capital treatment applied during the phase-in period?",
      "original_answer": "In 2023, the CECL Transition Election allowed for the cumulative 'day 2' ongoing impact to be phased into regulatory capital at 25% per year from January 1, 2022, through December 31, 2024. By 2024, this phase-in treatment remained consistent, with the ongoing impact continuing to be phased in at 25% annually, indicating that the regulatory capital treatment under the CECL Transition Rule was applied uniformly across both years as part of the multi-year transition framework.",
      "llm_answer": "By the end of 2023 Capital One had only half of the $2.4 billion CECL impact added back to its regulatory capital (≈ 50 % of the total), but on January 1 2024 it added a further $600 million, bringing the cumulative phase‑in to about three‑quarters (≈ 75 %) with the last $600 million to be added on January 1 2025. The treatment was governed by the CECL Transition Rule, which let the firm add back the after‑tax “day‑1” CECL adoption impact plus a 25 % scaling factor for the “day‑2” ongoing allowance increase and phase that amount into regulatory capital at 25 % per year.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and introduces specific dollar amounts and a company (Capital One) not mentioned in the original question or ground truth. The original answer discusses a general regulatory framework for the CECL Transition Election applicable to banks, with a phase-in period from January 1, 2022, to December 31, 2024, at 25% per year. The LLM incorrectly narrows the response to Capital One and asserts that by end-2023 it had phased in 50%, then added $600M on January 1, 2024, and will add another $600M in 2025—none of which is supported by the ground truth. The total CECL impact of $2.4B and its split into two $600M increments are factually unsupported. The ground truth does not mention 'day-1' impact being added back with a 25% scaling factor for 'day-2'—this characterization is inaccurate. The CECL Transition Rule did allow for the ongoing 'day-2' impact to be phased in at 25% annually over three years (2022–2024), which the LLM misrepresents as extending into 2025. This is a critical error in both timeline and mechanism. While the LLM correctly references the CECL Transition Rule and the 25% annual phase-in concept, it misapplies them to a specific firm and incorrect financials, fails to reflect the uniform treatment across 2023 and 2024 as stated in the ground truth, and distorts the multi-year framework. The reasoning is therefore flawed, and the quantitative inaccuracies are severe. Contextual relevance is moderate because it addresses CECL phase-in and regulatory capital, but the focus on a single bank and fabricated figures reduces accuracy significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 438,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How has Broadcom's relationship with Wilmington Trust, National Association evolved between 2022 and 2023 in terms of the types and terms of senior notes issued under their indentures?",
      "original_answer": "In 2022, Broadcom had an ongoing relationship with Wilmington Trust, National Association as trustee under indentures governing senior notes issued in January 2021, which included notes with interest rates as low as 1.950% (due 2028) and as high as 3.750% (due 2051). By 2023, the relationship had evolved to include new indentures dated April 18, 2022, and July 12, 2024, under which Broadcom issued higher-yielding senior notes, including a 4.926% note due 2037 and later, in October 2024, notes ranging from 4.150% (due 2028) to 4.800% (due 2034). This reflects a shift toward issuing longer-term debt with higher interest rates over time.",
      "llm_answer": "In the 2022 filing Broadcom entered into two new indentures with Wilmington Trust, National Association – one dated April 14 2022 for 4.00 % senior notes due 2029 (exhibit 4.42‑4.44) and a second dated April 18 2022 for 4.15 % senior notes due 2032 and 4.926 % senior notes due 2037 (exhibit 4.46‑4.47)【page_99】【page_100】. The 2023 filing’s exhibit list (pages 98‑102) shows only those 2022 indentures and contains no additional senior‑note indentures or new series with Wilmington Trust, indicating that the trustee relationship persisted but no new senior notes were issued in 2023【page_98】【page_102】.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies compared to the ground truth. It claims that in 2022, Broadcom entered into indentures on April 14 and April 18, 2022, issuing notes at 4.00% due 2029, 4.15% due 2032, and 4.926% due 2037. However, the original answer states that the April 18, 2022 indenture is valid, but also includes a July 12, 2024 indenture — which is outside the 2022–2023 scope — and notes issued in October 2024, which are beyond the timeframe of the question. More critically, the LLM incorrectly asserts that no new senior notes were issued in 2023, directly contradicting the ground truth which describes the evolution of the relationship through new indentures and higher-yielding notes. (2) Quantitatively, the LLM gets some percentages correct (4.15%, 4.926%) and maturities (2032, 2037), but introduces a 4.00% note due 2029 not mentioned in the ground truth, and misdates the April 18, 2022 indenture as April 14, 2022. The ground truth does not mention a 4.00% note or an April 14 date, indicating fabrication or misattribution. (3) The multi-hop reasoning is flawed: the LLM infers from the 2023 exhibit list that no new indentures were issued, but the ground truth indicates that the relationship evolved with new indentures dated April 18, 2022 (within 2022) and July 12, 2024 (outside), suggesting the LLM failed to correctly interpret the timeline and evolution. It also misses the key point of increasing interest rates and longer maturities over time, which is central to the evolution. (4) The contextual relevance is moderate — it addresses the trustee relationship and indentures with Wilmington Trust, but incorrectly concludes no new notes in 2023 and omits the trend toward higher yields and longer terms. The reliance on exhibit lists to infer absence of activity may be methodologically weak if filings incorporate by reference. Overall, major factual and reasoning errors reduce correctness significantly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 533,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did Capital One's regulatory capital add-back under the CECL Transition Rule evolve from 2023 to 2024, and what was the specific phase-in progression during this period?",
      "original_answer": "In 2023, Capital One had already added back $2.4 billion to its regulatory capital under the CECL Transition Rule, with a phase-in of 50% as of January 1, 2023. By January 1, 2024, the phase-in had progressed to 75%, indicating a 25 percentage point increase over the year. This reflects the structured five-year phase-in process under the CECL Transition Rule, where 25% of the cumulative impact was phased in annually after 2021.",
      "llm_answer": "Capital One’s CECL add‑back grew from the 50 % level in 2023 to the 75 % level in 2024 – i.e., it moved from half of the $2.4 billion aggregate CECL impact to three‑quarters of that amount as of the start of 2024【page_202】.  The CECL Transition Rule required a 25 %‑per‑year phase‑in of the impact: 25 % in 2022, 50 % in 2023, 75 % in 2024 and full (100 %) by 2025【page_10】【page_11】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers, percentages, and dates are accurate: the $2.4 billion CECL impact, 50% phase-in in 2023, 75% in 2024, and the 25% annual phase-in increments are correctly reported. The dollar amount is consistent with the original answer, and the progression aligns with the five-year phase-in schedule starting from 2022. (2) The answer correctly identifies Capital One and the CECL Transition Rule, with accurate time periods (2023 to 2024) and proper context about the structured phase-in process. (3) The reasoning is sound and reflects multi-hop synthesis: it connects the annual phase-in percentages to the specific years and explains the progression logically, noting the full phase-in by 2025, which is consistent with the rule. (4) The semantic content is equivalent to the original answer—though phrased differently, it conveys the same core facts: the increase from 50% to 75%, the $2.4 billion base, and the annual 25 percentage point phase-in. Minor formatting differences (e.g., '25 %' vs '25%') do not affect accuracy. All parts of the question are addressed: the evolution from 2023 to 2024 and the specific phase-in progression.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 346,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How did the treatment of VMware stock options for non-employee directors evolve between 2022 and 2023 following the Broadcom acquisition?",
      "original_answer": "In 2022, the 10-K filing stated that all outstanding in-the-money VMware stock options and RSU awards held by non-employee directors would be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts, upon the completion of the acquisition. By 2023, this provision had been realized, with the statement confirming that these awards were indeed accelerated and converted into the right to receive cash and Broadcom shares. This reflects a transition from a planned conversion to an actualized event following the completion of the acquisition.",
      "llm_answer": "In the 2022 filing (pending the VMware merger) Broadcom said that “all outstanding in‑the‑money VMware stock options and RSU awards held by non‑employee directors will be accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts”【page_97】. After the merger closed, the 2023 filing confirmed that the same action “were accelerated and converted into the right to receive cash and shares of Broadcom common stock, in equal parts”【page_66】. Thus, the treatment did not change – the options were accelerated and split 50 % cash/50 % Broadcom stock – but the language shifted from a planned action in 2022 to a completed action in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures the treatment of VMware stock options for non-employee directors in both 2022 and 2023, noting the planned acceleration and conversion in 2022 and the confirmation of execution in 2023. (2) All quantitative details are correct: the 50% cash and 50% Broadcom stock conversion is explicitly stated and matches the 'equal parts' phrasing in the original answer. No calculations are required, but the percentages are correctly interpreted. (3) The multi-hop reasoning is sound—LLM correctly synthesizes information from two different years and filings, showing the evolution from a pending plan to a realized outcome. (4) Entity accuracy is perfect: VMware, Broadcom, non-employee directors, stock options, RSUs, and the timeline (2022 vs. 2023) are all correctly identified and contextualized. The answer also appropriately cites page numbers as evidence. The shift from 'will be' to 'were' is correctly interpreted as a transition from plan to completion, which is the core of the question. All scoring categories warrant top marks.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 321,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How has the therapeutic positioning of Vraylar evolved from 2022 to 2024 based on AbbVie's disclosures?",
      "original_answer": "In 2022, Vraylar was described as being evaluated in Phase 3 clinical trials as an adjunctive treatment for major depressive disorder (MDD), with one trial meeting its primary endpoint and the other showing numerical but not statistically significant improvement. By 2024, Vraylar was disclosed as being indicated for a broader range of psychiatric conditions, including acute and maintenance treatment of schizophrenia, acute treatment of manic or mixed episodes associated with bipolar disorder, acute treatment of depressive episodes associated with bipolar I disorder, and as an adjunctive treatment in major depressive disorder. This reflects a clear expansion and solidification of its therapeutic positioning over time.",
      "llm_answer": "AbbVie’s 2022 filing noted Vraylar as a dopamine D3‑preferring D3/D2 partial agonist approved for acute and maintenance treatment of schizophrenia, acute manic or mixed episodes and depressive episodes of bipolar I disorder, and it highlighted Phase 3 data supporting its use as an adjunctive therapy for major depressive disorder【page_60】. The 2024 filing lists the same set of approved indications—schizophrenia, bipolar‑I (manic/mixed and depressive episodes) and adjunctive treatment of major depressive disorder—showing no change in Vraylar’s therapeutic positioning【page_6】.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its conclusion that there was 'no change in Vraylar’s therapeutic positioning' from 2022 to 2024, which directly contradicts the ground truth. In 2022, Vraylar was still under evaluation for adjunctive treatment of MDD, with mixed Phase 3 results—not yet firmly established as an approved indication. By 2024, it was disclosed as having a broader, solidified set of indications including adjunctive MDD, reflecting an evolution in therapeutic positioning. The LLM incorrectly asserts that the indications were the same in both years, failing the core multi-hop comparison. (2) Quantitatively, there are no numerical values to verify (e.g., trial success rates, financials), but the years (2022, 2024) and drug names (Vraylar, AbbVie) are correct—hence a moderate score on quantitative accuracy based on correct entity dates and proper referencing of filings. (3) The reasoning is flawed: the model fails to recognize that mention of Phase 3 data in 2022 implies investigational status, not approved use, and conflates 'highlighting supportive data' with 'having an approved indication.' This misinterpretation breaks the multi-hop logic required to assess evolution over time. (4) Contextual relevance is moderate because the answer discusses the right drug, company, and general indications, but misses the key point of therapeutic evolution, rendering the response misleading despite some accurate details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 404,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has GE's accounting policy for long-term services agreements evolved from 2022 to 2024, particularly in terms of revenue recognition method and contract billing estimates?",
      "original_answer": "In 2022, GE recognized revenue for long-term services agreements on a straight-line basis, primarily in the Healthcare and Renewable Energy segments, with periodic invoicing as services were provided. By 2024, GE shifted to using the percentage of completion method for revenue recognition, predominantly within the CES segment, based on costs incurred relative to total expected costs. Additionally, in 2024, GE reported a long-term services agreements net liability balance of $6.6 billion, representing approximately 4.1% of total estimated life of contract billings of $162 billion, indicating a more detailed and forward-looking estimation process involving asset utilization and cost improvements, which was not explicitly mentioned in 2022.",
      "llm_answer": "In the 2022 filing GE said it used the percentage‑of‑completion method for long‑term service contracts in its Aviation and Power businesses, but it accounted some healthcare and renewable‑energy service contracts on a straight‑line basis. By the 2024 filing the policy has been unified under the percentage‑of‑completion approach – revenue is recognized as costs are incurred relative to updated total‑cost estimates, and the company now routinely re‑estimates asset‑utilization and billing amounts and records any changes as a cumulative catch‑up adjustment. This shows a move from a mixed (percentage‑of‑completion + straight‑line) treatment to a single, more detailed estimate‑driven revenue‑recognition and billing‑estimate process.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the timing and nature of GE's accounting policy evolution. It incorrectly states that in 2022, GE used the percentage-of-completion method for Aviation and Power businesses and only some healthcare and renewable energy contracts on a straight-line basis. However, the ground truth states that in 2022, GE recognized revenue on a straight-line basis primarily in Healthcare and Renewable Energy — not percentage-of-completion. This reverses the actual 2022 policy. The shift to percentage-of-completion occurred by 2024, mainly in the CES segment, not Aviation and Power as implied. (2) Quantitatively, the LLM answer fails to include any of the key numerical data from the ground truth: the $6.6 billion net liability, the $162 billion total estimated life of contract billings, or the 4.1% ratio. These are critical quantitative indicators of the enhanced estimation process in 2024 and their absence severely undermines quantitative accuracy. (3) The reasoning is partially sound in identifying a shift from a mixed model to a unified percentage-of-completion approach, which aligns with the direction of change. It also correctly notes the use of updated cost estimates and cumulative catch-up adjustments in 2024, reflecting improved forward-looking estimation. However, the multi-hop synthesis is flawed because it misattributes the 2022 policy and omits the specific segment (CES) where the new method was applied. (4) Contextual relevance is high because the answer addresses revenue recognition methods and contract billing estimates over time, directly responding to the question’s focus. Despite incorrect entity-year mappings and missing quantitative evidence, the qualitative trend — increased estimation sophistication and unification of method — is plausibly conveyed. Thus, correctness is partially accurate but significantly limited by key factual and numerical omissions and reversals.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 534,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has IBM's disclosure of the 1.250% Notes due 2027 evolved between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, IBM disclosed the 1.250% Notes due 2027 as part of a list of instruments defining the rights of holders, with Exhibit 4.3 to Form 8-K filed on January 30, 2019, referenced for the notes. In the 2023 10-K filing, the 1.250% Notes due 2027 are listed under registered securities with the trading symbol IBM 27B on the New York Stock Exchange. This evolution reflects a shift from referencing the instrument defining the rights to identifying the notes as a registered class of securities.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the 1.250 % Notes due 2027 are not listed among the securities registered under Section 12(b); the only 2027 instrument mentioned is a 6.22 % debenture (see the exhibit list on page 31, which references “6.22% Debentures due 2027” but makes no mention of a 1.250 % note). By contrast, the 2023 Form 10‑K adds a specific line in the Section 12(b) registration table for “1.250 % Notes due 2027 – IBM 27B” (see page 1) — showing that IBM now discloses this note explicitly.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) It incorrectly claims that the 1.250% Notes due 2027 were *not* listed in the 2022 10-K, stating that only a 6.22% debenture was mentioned. However, the ground truth confirms that IBM *did* disclose the 1.250% Notes due 2027 in the 2022 10-K, referencing Exhibit 4.3 to the Form 8-K filed on January 30, 2019. The mention of a '6.22% Debentures due 2027' appears to be a confusion with another instrument and is not supported by the original answer. (2) The quantitative accuracy is partially correct: the percentage (1.250%) and year (2027) are accurate, and the trading symbol IBM 27B is correctly identified in the 2023 filing. However, the erroneous claim about absence in 2022 and the incorrect reference to a 6.22% debenture introduce major factual errors. (3) The reasoning is flawed because it fails to capture the actual evolution: from being disclosed via a reference to an exhibit defining rights (2022) to being listed as a registered security under Section 12(b) with a trading symbol (2023). Instead, the model falsely asserts the note was absent in 2022, undermining the multi-hop synthesis. (4) Despite the factual errors, the answer is contextually relevant—addressing the right documents, years, and type of disclosure change—and correctly identifies the 2023 listing with the symbol IBM 27B. Wording and structure are clear, but core facts are incorrect, leading to a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 417,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How has the structure and performance criteria of AbbVie's performance-vested RSUs evolved between 2022 and 2024, particularly in terms of vesting increments and performance metrics?",
      "original_answer": "In 2022, performance-vested RSUs had the potential to vest in one-third increments over a three-year performance period, with performance measured based on AbbVie's return on invested capital (ROIC) relative to a defined peer group of pharmaceutical, biotech, and life science companies for awards granted in 2021 and 2020. By 2024, the vesting structure remained similar—allowing for one-third increments over a three-year period—but the description of performance metrics was streamlined, focusing primarily on ROIC performance against the same peer group, without mention of specific years tied to tranches as seen in 2022. This indicates a simplification or standardization of the performance criteria over time.",
      "llm_answer": "AbbVie’s performance‑vested RSUs were described the same way in both filings. In the 2022 10‑K the awards “have the potential to vest in one‑third increments during a three‑year performance period and may be earned based on AbbVie’s return on invested capital (ROIC) performance relative to a defined peer group of pharmaceutical, biotech and life‑science companies”【page_115】. The 2024 10‑K repeats that wording – the RSUs still vest in three equal one‑third portions over three years and are tied to ROIC versus a peer group【page_92】. Thus, between 2022 and 2024 the vesting schedule and performance metric for the performance‑vested RSUs have not changed.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the vesting structure (one-third increments over a three-year period) and the performance metric (ROIC relative to a peer group) for both 2022 and 2024, which aligns with the ground truth. All entities (AbbVie, performance-vested RSUs, ROIC, peer group) and timeframes are accurately referenced, and there are no numerical or date inaccuracies—hence a quantitative accuracy score of 10. The answer is contextually relevant and addresses the core of the question regarding vesting increments and performance metrics. However, it misses a key nuance highlighted in the original answer: the evolution and simplification of the performance criteria over time. Specifically, the 2022 description referenced awards granted in 2021 and 2020 with tranches tied to specific years, while the 2024 filing streamlined the language, removing those year-specific references, indicating a standardization. The LLM incorrectly concludes that 'the vesting schedule and performance metric... have not changed,' failing to acknowledge this qualitative shift in disclosure and presentation. This omission affects the completeness and reasoning aspects of the multi-hop analysis, particularly in capturing the evolution over time. Thus, while factually accurate in what it reports, it lacks full qualitative depth, warranting a correctness score of 7 rather than higher.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 382,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How did GE's financial relationship with AerCap evolve from 2022 to 2024, based on the realized and unrealized gains or losses associated with its investment?",
      "original_answer": "In 2022, GE reported an unrealized loss of $865 million related to its investment in and note with AerCap, indicating a negative valuation impact during that year. By 2024, this position had shifted to a realized and unrealized gain of $38 million, suggesting that GE had either exited part of its position or the value of the remaining investment had improved. This represents a significant turnaround in the financial performance of the AerCap investment over the two-year period.",
      "llm_answer": "GE’s AerCap investment moved from a large loss in 2022—recording a $865 million combined realized and unrealized loss—to modest gains in the next two years, with a $129 million gain in 2023 and a $38 million gain in 2024. This reflects a turnaround from a significant loss to small positive returns on the investment.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, GE reported an *unrealized loss* of $865 million, but the LLM incorrectly labels this as a 'combined realized and unrealized loss,' which misrepresents the nature of the loss. More critically, the LLM introduces a $129 million gain in 2023, which is not mentioned or supported by the original answer or ground truth data—this figure is entirely fabricated. The 2024 gain of $38 million is correct in amount and is described as a 'realized and unrealized gain,' which aligns with the original answer. (2) Quantitative accuracy is low because of the incorrect characterization of the 2022 loss and the inclusion of a spurious 2023 figure. The $865 million loss and $38 million gain are correct in magnitude but misrepresented in composition and context. The addition of a $129 million 2023 gain breaks factual fidelity and introduces false progression. (3) The multi-hop reasoning is flawed because the model invents an intermediate data point (2023) not present in the source, undermining the synthesis across years. While the general narrative of a turnaround is consistent, the reasoning path is invalid due to hallucinated data. (4) Contextual relevance is high because the answer addresses the evolution of GE's financial relationship with AerCap through gains/losses over time and attempts to interpret the trend. However, correctness and quantitative accuracy are severely compromised by factual errors, warranting a low overall score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 426,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How has IBM's treatment of the 0.300% Notes due 2026 evolved between the 2022 and 2023 SEC filings, particularly in terms of its disclosure status and visibility in financial instruments?",
      "original_answer": "In 2022, the 0.300% Notes due 2026 were disclosed as part of IBM's exhibits under Exhibit 4 to Form 8-K filed November 1, 2016, indicating it was referenced in the context of legal instruments defining holder rights. By 2023, the 0.300% Notes due 2026 were no longer just referenced in exhibits but were explicitly listed as a titled class of notes registered on the New York Stock Exchange under the trading symbol IBM 26B, showing increased visibility and formal recognition in the company's capital structure.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the 0.300 % Notes due 2026 do not appear in the securities‑registered table (the filing’s Table of Contents and exhibit listings on pages 28‑32 contain no reference to such a note), indicating that the instrument was not separately disclosed. By contrast, the 2023 Form 10‑K lists “0.300 % Notes due 2026 – IBM 26B” among the securities registered under Section 12(b) (see page 1 of the 2023 filing) 【page_1】, showing that the notes are now explicitly disclosed and visible as a registered financial instrument.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) Quantitatively, all details are correct: the 0.300% Notes due 2026 are correctly identified with the right interest rate, maturity year, and trading symbol IBM 26B. The years 2022 and 2023 are accurately referenced in the context of the respective Form 10-K filings. (2) The LLM correctly observes that in 2022, the notes were not explicitly listed in the securities-registered table or exhibits, implying lack of standalone disclosure, which matches the ground truth that they were only referenced indirectly via Exhibit 4 to Form 8-K in 2016. In 2023, the notes are correctly noted as explicitly listed under Section 12(b) with the symbol IBM 26B, confirming increased visibility. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, compares disclosure practices, and infers an evolution in visibility and formal recognition. (4) The only minor shortcoming is that the LLM does not explicitly mention the prior Exhibit 4 to Form 8-K reference from 2016, which is part of the ground truth context. However, stating that the note 'does not appear' in 2022 filings effectively captures the reduced visibility. The answer conveys semantic equivalence and demonstrates strong contextual understanding, with high relevance and accuracy. Hence, a score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 402,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has GE's approach to the RISE Program evolved between 2022 and 2024, particularly in terms of its strategic emphasis and investment focus?",
      "original_answer": "In 2022, GE announced the RISE Program as a collaborative technology development initiative with Safran, targeting a reduction of more than 20% in fuel consumption and CO2 emissions compared to current engines. This marked the initial phase of the program as a forward-looking announcement aimed at shaping the future of sustainable aviation. By 2024, GE's engagement with the RISE Program had evolved into a more concrete investment strategy, with the company making 'significant investments' in the RISE program suite of technologies. This shift indicates a transition from conceptual development to active, funded R&D aimed at enabling a sustainable future of flight. The change reflects a deepening strategic commitment to sustainability and technological leadership in aviation.",
      "llm_answer": "In the 2022 10‑K GE presented the Revolutionary Innovation for Sustainable Engines (RISE) program as a joint development effort with Safran aimed at achieving “more than 20 % lower fuel consumption and CO₂ emissions” – essentially an early‑stage technology‑development target (page_18). By the 2024 filing the language had shifted to portray RISE as a broader “suite of pioneering technologies” – Open‑Fan, compact‑core and hybrid‑electric systems compatible with alternative fuels – and the company highlighted “significant investments” and the completion of “more than 250 tests on a full‑scale Open Fan engine,” indicating a move from concept to large‑scale, multi‑technology execution (page_4; page_6).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2022 RISE Program was introduced as a joint effort with Safran targeting 'more than 20% lower fuel consumption and CO2 emissions,' matching the original answer. By 2024, GE shifted to 'significant investments' and advanced testing, including over 250 tests on a full-scale Open Fan engine, which reflects the evolution into active R&D. (2) Quantitative accuracy is perfect: the 20% reduction target and 'more than 250 tests' are correctly reported, with no calculation errors. Format and sourcing (e.g., page references) are consistent with document-based reporting. (3) Multi-hop reasoning is sound: the model synthesizes information across 2022 and 2024 filings, correctly identifying the shift from conceptual announcement to funded, multi-technology development involving Open-Fan, compact-core, and hybrid-electric systems. The mention of alternative fuel compatibility adds useful detail not contradicted by the ground truth. (4) The only minor gap is that the original answer emphasizes the strategic framing of sustainability and technological leadership more explicitly, which the LLM implies but does not directly articulate. However, the core evolution in strategic emphasis and investment focus is accurately conveyed. Wording differs but semantic meaning is equivalent. No factual errors or entity inaccuracies (GE, Safran, RISE, years, technologies) are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 408,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How has the role and emphasis on asset securitizations within American Express's funding strategy evolved from 2022 to 2023, based on the specific disclosures in the respective 10-K filings?",
      "original_answer": "In 2022, American Express defined asset securitizations in a glossary entry, describing the mechanics of transferring loans to trusts that issue asset-backed securities, and noted that securitized loans and receivables were reported as assets while the securities were reported as liabilities. This definition was part of a broader explanation of financial terminology rather than a strategic focus. By 2023, asset securitizations were explicitly positioned as a core component of the company's funding strategy, listed alongside deposits and unsecured debt as key funding sources. The 2023 filing emphasized the importance of diversity in funding sources, with securitizations playing a role in mitigating disruptions in any single funding channel. This represents a shift from a definitional disclosure in 2022 to a strategic emphasis in 2023.",
      "llm_answer": "In the 2022 Form 10‑K the only reference to asset securitizations is a glossary entry that simply defines the process (see 2022 p. 88), with no discussion of it as a funding source. By the 2023 filing, American Express explicitly positions securitizations as a regular, cost‑effective pillar of its diversified funding mix—describing periodic securitizations of Card Member loans and receivables, noting $3.5 billion of asset‑backed securities issued in 2023 (2023 p. 70, Table 21) and listing “asset securitizations” alongside deposits and unsecured debt in its funding‑strategy narrative (2023 p. 68). This shows a shift from a peripheral, definitional mention in 2022 to an active, quantified component of the company’s funding strategy in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and aligns perfectly with the ground truth. (1) It accurately captures the evolution in American Express's treatment of asset securitizations: from a definitional glossary entry in 2022 (p. 88) with no strategic discussion, to an active, quantified component of the funding strategy in 2023. (2) The quantitative details are precise: the $3.5 billion in asset-backed securities issued in 2023 is correctly cited from Table 21 on p. 70 of the 2023 10-K, and the mention of page 68 for the funding-strategy narrative is consistent with the filing. (3) The multi-hop reasoning is sound—comparing the absence of strategic discussion in 2022 with the explicit inclusion of securitizations alongside deposits and unsecured debt in 2023 demonstrates proper synthesis across years and documents. (4) The LLM adds value by including specific dollar amounts and page references not in the original answer, enhancing precision without introducing error. All entities (American Express, asset securitizations, Card Member loans, funding mix) and years (2022 to 2023) are correct. The semantic meaning and factual content fully match the ground truth, with improved specificity. Therefore, all scores are maximized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 345,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2023, particularly in terms of investment returns and operational integration?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was characterized by a minority investment, with AspenTech contributing $656 in sales and a $12 earnings gain, while holding total assets of $14,484. By 2023, Emerson significantly deepened its involvement by acquiring Heritage AspenTech, gaining a 55% ownership stake in the newly formed AspenTech. This acquisition positively impacted gross margins by 0.6 percentage points in 2023 and marked a strategic shift from a passive investment to an active controlling interest, indicating a transformation in the nature of the relationship.",
      "llm_answer": "In fiscal 2022 Emerson completed the $6 billion Heritage AspenTech acquisition, taking a 55 % stake and establishing a new AspenTech segment that generated $656 million of sales, $12 million of earnings and $148 million of acquisition‑related intangible amortization (see 2022 segment tables and amortization note). By fiscal 2023 the AspenTech business was fully folded into Emerson’s Software & Control portfolio, contributing about 3 % of total net sales, driving a 20 % rise in software sales and producing a $24 million mark‑to‑market gain on AspenTech’s foreign‑currency hedge (versus a $50 million cost in 2022), while intangible amortization rose to $678 million—signs that the investment was delivering stronger financial returns and deeper operational integration.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Emerson held a minority investment in AspenTech in 2022 and only acquired Heritage AspenTech in 2023, gaining a 55% stake. However, the LLM incorrectly states that the $6 billion acquisition occurred in fiscal 2022, which reverses the timeline and misrepresents the evolution of the relationship. (2) Quantitative inaccuracies include: reporting the acquisition in 2022 instead of 2023; stating sales of $656 million (correct figure but missing that it was $656 in ground truth without 'million'—but context suggests it's the same value); however, the $12 million earnings gain is plausible if 'million' is implied. More critically, the LLM invents a $148 million amortization in 2022 and $678 million in 2023, which are not in the original answer and are implausibly large. The $24 million mark-to-market gain and $50 million cost in 2022 are also fabricated. The 3% of total net sales and 20% rise in software sales are unsupported by the ground truth. (3) The multi-hop reasoning is flawed: the model fails to correctly sequence the shift from minority investment (2022) to controlling interest (2023), instead asserting full acquisition in 2022. This undermines the core strategic evolution. It also introduces new financial metrics (amortization, hedge gains) not present in the original, suggesting hallucination rather than synthesis. (4) Despite incorrect facts and timeline, the answer is contextually relevant—it attempts to address investment returns and operational integration. However, due to major factual and chronological errors, especially reversing the acquisition year and inventing financials, the correctness score is low. Quantitative accuracy is poor due to wrong numbers and timing. Qualitative reasoning fails on multi-hop logic. Contextual relevance is moderate as it stays on topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 517,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of noncontrolling interest accounting and acquisition-related impacts on equity and expenses?",
      "original_answer": "In 2022, Emerson completed the creation of New AspenTech by contributing its industrial software business and $6.0 billion in cash, resulting in a 55% ownership stake. A noncontrolling interest of $5.9 billion was recorded, with a decrease to additional paid-in capital of $550 million. By 2023, the AspenTech acquisition positively impacted gross margins by 0.6 percentage points and contributed to increased SG&A expenses, which rose by $572 million compared to 2022, partly due to the AspenTech transaction and higher stock compensation expenses. This shows that while the initial accounting impact was significant in 2022, by 2023, the focus had shifted to operational integration and financial performance effects.",
      "llm_answer": "In the 2022 filing Emerson accounted for the Heritage AspenTech transaction as an acquisition, recording a $5.9 billion non‑controlling interest for the 45 % of AspenTech it did not own and reducing additional paid‑in‑capital by $550 million. By 2023 the AspenTech investment shows up in the consolidated results through higher SG&A ($572 million increase) and a $146 million rise in intangibles amortization (and a modest 3 % sales boost), and the non‑controlling interest is no longer disclosed separately, indicating it has been absorbed into Emerson’s equity presentation.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution of Emerson's financial relationship with AspenTech between 2022 and 2023, correctly identifying the 2022 noncontrolling interest of $5.9 billion and the $550 million reduction in additional paid-in capital. It also correctly notes increased SG&A expenses in 2023. However, it introduces a $146 million intangibles amortization and a '3% sales boost' not present in the ground truth, which undermines quantitative accuracy. The original answer states a 0.6 percentage point improvement in gross margins, not a 3% sales increase, and does not mention amortization. Additionally, the claim that noncontrolling interest is 'no longer disclosed separately' in 2023 is speculative and not supported by the ground truth, which simply shifts focus to operational impacts. (2) Key correct numbers: $5.9 billion noncontrolling interest (2022), $550 million APIC reduction, $572 million SG&A increase (2023 vs 2022). Incorrect/invented: $146 million amortization, 3% sales boost. (3) The multi-hop reasoning is generally sound—linking 2022 accounting treatment to 2023 operational impacts—but overreaches by inferring the elimination of noncontrolling interest disclosure without evidence. (4) Scores reflect mostly correct facts and synthesis (qualitative and contextual strength), but significant penalty on quantitative accuracy due to unsupported figures and misrepresentation of financial impacts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 401,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has IBM's treatment and disclosure of the 6.22% Debentures due 2027 evolved between the 2022 and 2023 SEC filings?",
      "original_answer": "In 2022, IBM disclosed the 6.22% Debentures due 2027 by referencing the instrument defining the rights of its holders, which was filed as Exhibit 3 to Form 8-K on August 1, 1997. In contrast, the 2023 filing introduces a more structured and visible disclosure by listing the 6.22% Debentures due 2027 with its respective trading symbol (IBM 27) and explicitly identifying it among other registered securities on the New York Stock Exchange. This evolution reflects a shift from a purely historical reference to a more transparent and current market-oriented presentation.",
      "llm_answer": "In IBM’s 2022 Form 10‑K the 6.22 % Debentures due 2027 were disclosed in the Exhibits section, with the filing stating that “the instrument defining the rights of the holders of the 6.22 % Debentures due 2027 is Exhibit 3 to Form 8‑K, filed on August 1, 1997, and is hereby incorporated by reference.” In the 2023 Form 10‑K the same debentures are shown only in the securities‑registration table (listed under Section 12(b) as “6.22 % Debentures due 2027”), and the filing no longer repeats the exhibit‑incorporation language, indicating a shift from detailed exhibit reference to a simple registration listing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All numeric values—6.22% interest rate, 2027 maturity, and August 1, 1997 filing date—are correct. The reference to Exhibit 3 of Form 8-K is accurately cited. (2) Quantitative accuracy is perfect: no calculations required, but all dates, percentages, and exhibit numbers match the original. (3) The reasoning correctly captures the evolution: in 2022, disclosure was via incorporation by reference to a 1997 exhibit; in 2023, it shifted to a concise listing in the Section 12(b) securities registration table. The LLM correctly infers a shift in disclosure style from detailed historical reference to streamlined registration listing. (4) The only minor shortcoming is that the LLM does not mention the trading symbol 'IBM 27' or the connection to NYSE listing, which the original answer includes as evidence of a 'more transparent and current market-oriented presentation.' While this detail is omitted, the core evolution in disclosure approach is accurately described. Thus, the answer is highly accurate and relevant, meriting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative and contextual performance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 342,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How has UnitedHealth Group's exposure to financial risk through risk-based arrangements with healthcare providers evolved from 2023 to 2024, and what implications does this have on its cost estimation and service delivery responsibilities?",
      "original_answer": "In 2023, UnitedHealth Group assumed economic risk under risk-based arrangements where it was responsible for funding healthcare costs, and it recognized premium revenues based on estimated premiums earned, net of projected rebates. The company also highlighted its involvement in value-based arrangements where it received per-patient-per-month premiums and recognized revenue as services were made available. By 2024, the company's exposure expanded as it noted increased responsibility for unpaid healthcare claims if risk-based providers faced financial difficulties or failed to meet their obligations. Additionally, the 2024 disclosures emphasized greater operational risk tied to providers' ability to manage costs, maintain solvency, and provide necessary data for cost estimation, indicating a broader and more complex financial exposure compared to 2023.",
      "llm_answer": "In the 2023 filing UnitedHealth noted that its risk‑based contracts with physicians, hospitals and other providers “limit our exposure to the risk of increasing medical costs, but expose us to risk related to the adequacy of the financial and medical‑care resources of the health‑care providers” and that a provider’s financial distress could leave UnitedHealth “responsible for unpaid health‑care claims … for which we have already paid the provider” (2023 p. 44). By the 2024 filing the company expanded this view, stating that its risk‑based benefit products now “assume the risk of both medical and administrative costs” and that any failure to “accurately predict, price for or manage the costs of providing care under risk‑based arrangements” would “materially and adversely affect” results of operations (2024 p. 12) and reiterated the same provider‑solvency risk (2024 p. 14). The evolution shows a broader, more explicit assumption of cost‑risk and a heightened reliance on accurate cost‑estimation and timely provider data, making UnitedHealth increasingly accountable for both estimating expenses and ensuring uninterrupted service delivery under those arrangements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: the 2023 exposure to provider financial risk and responsibility for unpaid claims if providers fail is accurately described, citing the correct risk of 'inadequate financial and medical-care resources' and UnitedHealth being left responsible for claims despite prior payments. The 2024 evolution—expanded risk to include both medical and administrative costs, and greater emphasis on cost prediction, pricing, and management—is correctly reported. The heightened operational and financial risks tied to provider solvency and data reliability are also properly emphasized. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or the original answer, so quantitative accuracy is not applicable in a numerical sense, but all references to years (2023, 2024) and document locations (p. 44, p. 12, p. 14) are consistent with typical 10-K disclosure practices and do not contradict the ground truth. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across two years of disclosures, identifies the evolution in risk exposure, and connects it to implications for cost estimation and service delivery. It captures the increased accountability in 2024 beyond 2023’s framework. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'materially and adversely affect' is a direct quote from filings), the core meaning—broader financial exposure, greater reliance on cost estimation, and service continuity risks—matches the original. The only minor shortcoming is that the original answer explicitly mentions 'value-based arrangements' and 'per-patient-per-month premiums', which the LLM omits; however, this detail is contextual rather than central to the evolution of risk exposure. Thus, the answer is comprehensive and correct in substance, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1533,
        "completion_tokens": 560,
        "total_tokens": 2093
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How did Emerson's financial relationship with AspenTech evolve between 2022 and 2023, particularly in terms of investment magnitude and strategic involvement?",
      "original_answer": "In 2022, Emerson's relationship with AspenTech was primarily financial, as shown by its investment reflected in the Automation Solutions segment, where Emerson reported $362 million invested in AspenTech in 2022. By 2023, the relationship evolved into a strategic partnership following the introduction of a major transaction where Emerson contributed its Industrial Software Business along with approximately $6.0 billion in cash to Heritage AspenTech stockholders, creating 'New AspenTech.' Emerson gained 55% ownership of AspenTech's outstanding shares, marking a significant shift from a minority investment to a controlling stake.",
      "llm_answer": "In 2022 Emerson closed the Heritage AspenTech transaction, contributing two of its stand‑alone software businesses and roughly **$6 billion of cash** to create “New AspenTech” and emerging with a **majority equity stake (≈55‑57 %)** in the company; the deal was reflected in the 2022 filing by a **$148 million amortization of intangibles** tied to the acquisition (see 2022 p.79) and AspenTech reported $656 million of sales and a $12 million profit (2022 p.77‑78). By 2023 Emerson remained the **55 % owner** of AspenTech, fully integrated it into its Software & Control segment, where it helped lift segment sales about **20 %** (the “Heritage AspenTech acquisition added 3 % to net sales”) and generated **$146 million of acquisition‑related amortization** and a **$24 million hedge loss** on the Micromine purchase price (2023 p.26, 24, 27, 28), showing a deeper strategic involvement and continued financial commitment.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Emerson's $6.0 billion cash contribution and the creation of 'New AspenTech' occurred in 2023, not 2022 as the LLM claims. The LLM incorrectly states that the transaction closed in 2022 and attributes the $6 billion cash contribution and 55% ownership to that year, which contradicts the original answer. Additionally, the LLM cites a $148 million amortization in 2022 and AspenTech's $656 million in sales and $12 million profit — figures not present in the ground truth and potentially fabricated or misattributed. The 2023 ownership percentage (55%) is correct, but the context is flawed because the deal is misdated. (2) Quantitative accuracy is severely compromised: the $6 billion cash contribution is assigned to 2022 instead of 2023; the $362 million investment in 2022 from the ground truth is entirely missing; the $148 million amortization and AspenTech financials are unsupported by the original answer. The 20% sales lift and hedge loss are additional unverified figures. (3) Multi-hop reasoning fails: the model does not correctly sequence the evolution from a $362M minority investment in 2022 to a controlling 55% stake in 2023 via the $6B transaction. Instead, it inverts the timeline, making the strategic shift appear to precede the financial investment. (4) Contextual relevance is moderate — the answer discusses investment magnitude and strategic involvement, addressing the question's intent, but the incorrect timeline and fabricated numbers undermine the entire response. The mention of integration into 'Software & Control' and amortization effects adds detail but is not aligned with the ground truth's focus on segment reporting and ownership shift. Overall, major factual and chronological errors lead to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 504,
        "total_tokens": 1897
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How has Adobe Target's role within Adobe's customer journey solutions evolved from fiscal 2022 to fiscal 2023, and what does this evolution indicate about Adobe's strategic direction in AI-driven personalization?",
      "original_answer": "In fiscal 2022, Adobe Target was described as part of a broader set of customer journey solutions, specifically noted alongside Marketo Engage, Adobe Campaign, and Journey Optimizer. It was characterized as a tool for testing, targeting, and personalizing content across channels. By fiscal 2023, Adobe Target was elevated in prominence and described specifically as an 'AI- and machine learning-driven personalization engine' with capabilities for omnichannel personalization and large-scale A/B and multivariate testing through AI-powered automation. This evolution indicates Adobe is placing greater strategic emphasis on AI-driven personalization as a core capability within its customer journey offerings, aligning with its broader push toward AI-powered solutions.",
      "llm_answer": "In fiscal 2022 Adobe Target was presented simply as one of the “Customer Journeys” tools – grouped with Marketo Engage, Adobe Campaign and Journey Optimizer and described as a capability that helps customers **manage, test, target, personalize and orchestrate campaigns and journeys**【page_43】.  \n\nBy fiscal 2023 the filing spotlights Target as a **stand‑alone AI‑ and machine‑learning‑driven personalization engine**, emphasizing its ability to run AI‑powered A/B/multivariate tests, automate targeting and deliver omnichannel personalized experiences at scale【page_15】.  \n\nThis shift from a bundled journey‑orchestration component to a flagship AI‑centric personalization engine signals Adobe’s strategic move to make AI‑driven, automated personalization the core of its Experience Cloud offering.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies Adobe Target's role in fiscal 2022 as part of a suite of customer journey tools (Marketo Engage, Adobe Campaign, Journey Optimizer) and accurately describes its functionality as enabling testing, targeting, and personalization. In fiscal 2023, it correctly notes the repositioning of Adobe Target as an 'AI- and machine-learning-driven personalization engine' with AI-powered A/B and multivariate testing, automation, and omnichannel personalization at scale. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct use of fiscal years (2022 and 2023), which are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across two fiscal years and correctly infers the strategic shift—from being a component within a broader suite to a flagship AI-driven engine—indicating Adobe’s increased focus on AI in personalization. (4) The answer fully addresses both parts of the question: the evolution of Adobe Target’s role and what it indicates about Adobe’s strategic direction. Wording differs slightly (e.g., 'flagship AI-centric personalization engine' vs. 'elevated in prominence'), but the meaning is equivalent and well-supported. All entities (Adobe Target, Marketo Engage, Adobe Campaign, Journey Optimizer) and timeframes are correct. No factual errors or omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 413,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did Emerson's relationship with AspenTech evolve from 2022 to 2023, particularly in terms of its financial stake and post-acquisition integration activities?",
      "original_answer": "In 2022, Emerson reported a balance of $8,326 million related to AspenTech as part of its acquisitions, indicating a significant financial stake following the acquisition of Heritage AspenTech. By 2023, the relationship had evolved into a more integrated structure, with AspenTech operating as a separate publicly traded company under Emerson's acquisition framework. This included the continuation of AspenTech's stock-based compensation plans, such as stock options and restricted stock units, which were now aligned with AspenTech's own equity structure. Additionally, Emerson was actively managing performance stock units tied to predefined goals like annual contract value and free cash flows, showing a shift from a purely financial stake to a more operationally integrated and incentive-driven relationship.",
      "llm_answer": "Emerson completed its purchase of Heritage AspenTech in the third quarter of 2022, which added a new AspenTech segment with roughly $8.3 billion of goodwill (and $240 million of AspenTech‑related debt) to Emerson’s balance sheet. In 2023 Emerson treated AspenTech as a separate publicly‑traded subsidiary, converting all pre‑combination Heritage AspenTech options and restricted‑stock units into AspenTech awards and recognizing AspenTech‑related stock‑based compensation of about $82 million, reflecting Emerson’s continued equity stake and ongoing post‑acquisition integration of the business.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and addresses the evolution of Emerson's relationship with AspenTech from 2022 to 2023, focusing on financial stake and integration activities. (1) Quantitatively, the $8.3 billion goodwill figure aligns closely with the ground truth's $8,326 million (i.e., $8.326 billion), a negligible rounding difference, so this is acceptable. The mention of $240 million in AspenTech-related debt is not contradicted by the ground truth, though it is not included in the original answer—this may be additional context rather than an error. The $82 million stock-based compensation figure is new and not present in the ground truth; however, since the ground truth confirms ongoing stock-based compensation activities (e.g., conversion of options and RSUs), this specific number could plausibly be accurate but cannot be verified. (2) The timeline is correct: acquisition completed in Q3 2022, and operational integration in 2023. (3) Entity accuracy is strong: correct names (Emerson, AspenTech, Heritage AspenTech), correct financial terms (goodwill, stock options, restricted stock units, stock-based compensation). (4) Reasoning is sound: the answer captures the shift from acquisition (2022) to integration (2023), including the conversion of equity awards and treatment of AspenTech as a separate publicly traded subsidiary, which matches the ground truth’s emphasis on operational integration and incentive alignment. (5) The answer is contextually relevant and synthesizes multi-hop information across time and financial dimensions. One minor omission is the lack of mention of performance stock units tied to metrics like annual contract value and free cash flow, which the ground truth highlights as evidence of incentive-driven integration. This missing detail prevents a perfect score but does not undermine the core accuracy. Overall, the answer is factually strong, slightly exceeding the ground truth in specificity (e.g., $82M compensation, $240M debt), but with minor incompleteness on incentive structure details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 549,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How has Adobe Experience Platform's role within Adobe's customer journey solutions evolved from 2022 to 2023, particularly in terms of its integration with AI-powered tools and cross-channel campaign orchestration?",
      "original_answer": "In 2022, Adobe Experience Platform was described as the foundational infrastructure for Adobe Experience Cloud, enabling data standardization and integration with Adobe Sensei to provide AI-powered services such as automated insights, sentiment analysis, and enhanced anomaly detection. It was central to Adobe's differentiation, supporting applications like Adobe Analytics and Adobe Audience Manager. By 2023, Adobe Experience Platform's role had evolved to become the underlying engine for cross-channel campaign orchestration, particularly through its integration with Adobe Journey Optimizer. This app allowed brands to deliver personalized, connected customer journeys across any channel, using real-time data profiles and cloud-native scalability. Additionally, Adobe Mix Modeler, introduced in 2023 and powered by Adobe Sensei, leveraged cross-channel datasets in Adobe Experience Platform to provide machine learning-driven insights for optimizing marketing investments. This indicates a shift from a general AI-enhanced infrastructure role to a more specialized and actionable function in campaign planning and customer journey orchestration.",
      "llm_answer": "In the 2022 filing Adobe Experience Platform was framed mainly as the data‑standardization and AI‑service foundation that feeds Adobe Sensei‑powered analytics and enables data to flow across Experience Cloud solutions (see page 8). By the 2023 filing the platform is portrayed as a purpose‑built, AI‑driven hub that directly powers integrated tools such as Journey Optimizer, Real‑Time Customer Data Platform, Customer Journey Analytics and Product Analytics, allowing brands to activate AI‑generated insights and orchestrate real‑time, cross‑channel campaigns from a single app (see pages 13‑15).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of Adobe Experience Platform from 2022 to 2023. (1) In 2022, it correctly identifies the platform as the data-standardization and AI-service foundation powered by Adobe Sensei, supporting Experience Cloud solutions—this aligns with the ground truth. In 2023, it accurately describes the platform’s evolved role as a hub for cross-channel orchestration through integration with tools like Journey Optimizer, Real-Time Customer Data Platform, and others, reflecting the shift toward actionable campaign execution. (2) There are no numeric values, dates, or financial figures in dispute; all time references (2022, 2023) are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes in the platform’s strategic role across two years and links it to AI integration and campaign orchestration, as required. It correctly infers that the platform moved beyond infrastructure to enable direct activation via apps. (4) While the LLM omits specific mention of Adobe Mix Modeler and machine learning-driven marketing investment optimization (a minor omission), it compensates by naming other relevant tools (Customer Journey Analytics, Product Analytics) and emphasizing real-time, cross-channel orchestration from a single app—consistent with the ground truth’s emphasis. Wording differs but semantic meaning is equivalent. Minor deduction in qualitative accuracy due to partial omission of Mix Modeler, but overall reasoning and contextual relevance are excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 421,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How did UnitedHealth Group's approach to care delivery models evolve from 2023 to 2024 in response to Medicare Advantage funding pressures?",
      "original_answer": "In 2023, UnitedHealth Group emphasized accelerating the transition to value-based care delivery models, investing in clinical engagement, integrated care coordination technology, and new delivery channels like in-home and virtual care. The company viewed these innovations as key to future growth despite initial costs. However, by 2024, the company faced significant funding pressures in the Medicare Advantage program, including reduced benchmarks and risk adjustment changes, which led to operational adjustments. These included selective changes to provider networks, benefit structures, and county-level decisions about plan offerings, indicating a shift from expansion-focused investment to cost containment and strategic retrenchment in response to external financial constraints.",
      "llm_answer": "In the 2023 filing UnitedHealth said that, after seeing a surge in senior outpatient use, it would “accelerate…the innovation and integration of our care‑delivery models including in‑clinic, in‑home, behavioral and virtual care” and move more members into “fully accountable value‑based plans” to contain costs 【page_27】. By the 2024 filing, with Medicare Advantage benchmarks still under pressure, the company said its “2024 benefit design approach” now “intensifies medical and operating cost management, adjusts the size and composition of our care‑provider networks, modifies member benefits and premiums, and leans even more on value‑based, accountable‑care models” to offset reduced funding 【page_26】【page_20】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies UnitedHealth Group's 2023 strategy of accelerating innovation in care delivery models—specifically in-clinic, in-home, behavioral, and virtual care—and the push toward value-based care to manage costs, which matches the original answer's emphasis on value-based models, clinical engagement, and technology. The 2024 shift is also accurately portrayed: in response to continued Medicare Advantage benchmark pressures, the company intensified cost management, adjusted provider networks, modified benefits, and leaned further into accountable care models. These points correspond directly to the ground truth's description of strategic retrenchment involving provider networks, benefit structures, and county-level plan decisions. (2) There are no numeric values, dates, or financial figures in the question or answers that require calculation or quantitative verification; all temporal references (2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years of filings, correctly identifying a shift in strategy from expansion and investment (2023) to cost containment and operational adjustments (2024) due to external funding pressures. The use of citations (e.g., page_27, page_26, page_20) suggests grounding in source material. (4) While the LLM answer captures the core evolution and driving factors accurately, it omits a few contextual details present in the ground truth—such as explicit mention of 'risk adjustment changes' and 'initial costs' of innovation, and the framing of the 2024 changes as 'selective' or tied to 'county-level decisions.' These omissions are minor and do not undermine the overall correctness. Wording differs slightly but maintains semantic equivalence. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 532,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 1.950% Notes due 2029?",
      "original_answer": "In 2022, the 1.950% Notes due 2029 were listed among TMO's outstanding debt instruments with the trading symbol TMO 29. In 2023, the 1.950% Notes due 2029 remained present with the same trading symbol TMO 29, indicating continuity in this debt instrument. However, TMO introduced new debt instruments in 2023, such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, suggesting a broader shift in financing strategy. The continued presence of the 1.950% Notes due 2029 indicates no change in this specific liability, even as TMO expanded its debt portfolio.",
      "llm_answer": "In the 2022 filing the company’s registered debt included the 1.950 % Notes due 2029 (TMO 29) together with a range of lower‑coupon issues – 0.750 % (2024), 0.125 % (2025), 2.000 % (2025), 1.400 % (2026), 1.450 % (2027), 1.750 % (2027), 0.500 % (2028), 1.375 % (2028), 0.875 % (2031), 2.375 % (2032), 2.875 % (2037), 1.500 % (2039) and 1.875 % (2049)【page_1】.  \n\nBy the 2023 filing the 1.950 % Notes due 2029 were still listed, but the debt mix was expanded with two new series—3.200 % Notes due 2026 (TMO 26B) and 3.650 % Notes due 2034 (TMO 34)—while the rest of the existing notes remained unchanged【page_1】.  \n\nThus, the 1.950 % Notes due 2029 persisted unchanged, and the overall composition grew to include higher‑coupon, later‑maturing notes in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values, including interest rates (1.950%, 3.200%, 3.650%), maturity years (2029, 2026, 2034), and trading symbols (TMO 29, TMO 26B, TMO 34) are correct. The presence of the 1.950% Notes due 2029 in both years is correctly noted. (2) Quantitative accuracy is perfect: percentages and dates match the original answer and reflect accurate extraction from filings. The introduction of the two new notes in 2023 is correctly identified with exact terms. (3) Reasoning is sound: the model correctly infers continuity of the 1.950% Notes due 2029 and identifies the strategic expansion of the debt portfolio with higher-coupon, longer-term instruments. The only minor shortcoming is that the original answer emphasizes a 'broader shift in financing strategy,' which the LLM implies but does not explicitly interpret—hence a slight deduction in qualitative accuracy. (4) The response is fully contextually relevant, directly addressing the evolution of TMO's debt composition and the specific role of the 1.950% Notes due 2029. Minor additional detail (listing other notes) adds context not in the original but does not detract. Overall, the answer is factually complete and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 362,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How has the composition of TMO's debt instruments evolved between 2022 and 2023, particularly regarding the 0.500% Notes due 2028 and the introduction of new note categories?",
      "original_answer": "In 2022, TMO listed the 0.500% Notes due 2028 alongside other debt instruments, including the 1.375% Notes due 2028. By 2023, TMO continued to list the 0.500% Notes due 2028, but introduced new debt categories such as the 3.200% Notes due 2026 and the 3.650% Notes due 2034, while maintaining similar categories like the 1.375% Notes due 2028. This indicates a strategic shift toward diversifying TMO's debt portfolio with new interest rate structures and maturity timelines.",
      "llm_answer": "In the 2022 filing the debt register listed the 0.500 % Notes due 2028 (TMO 28A) among a series of notes ranging from 0.750 % to 1.875 % (see 2022 page 1). The 2023 filing still includes the 0.500 % Notes due 2028, but also adds two new series—a 3.200 % Notes due 2026 (TMO 26B) and a 3.650 % Notes due 2034 (TMO 34)—showing that the company expanded its debt mix with higher‑coupon, new‑maturity issues (see 2023 page 1).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the presence of the 0.500% Notes due 2028 in both 2022 and 2023, and accurately reports the introduction of the 3.200% Notes due 2026 and the 3.650% Notes due 2034 in 2023. All percentages and maturity years match the ground truth exactly. (2) Quantitative accuracy is perfect: 0.500%, 3.200%, 3.650%, and corresponding maturities (2026, 2028, 2034) are all correct. No calculations are required, but the comparison across years is sound. (3) The multi-hop reasoning is solid—correctly comparing TMO's debt instruments across 2022 and 2023 filings and identifying the addition of new note categories. The LLM slightly omits mention of the 1.375% Notes due 2028 being maintained, which is a minor completeness gap but does not undermine the core conclusion about diversification. (4) The answer is contextually fully relevant, directly addressing the evolution of debt composition. The conclusion about expanding the debt mix with higher-coupon, new-maturity issues aligns with the ground truth's interpretation of strategic diversification. The only reason for not scoring a 10 is the omission of the continued presence of the 1.375% Notes due 2028, which was explicitly noted in the original answer and adds minor contextual depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 360,
        "total_tokens": 1591
      },
      "error": null
    },
    {
      "question_id": 160,
      "question": "How has the range of excess fair value over carrying value for DHR's reporting units changed between the 2023 and 2024 annual goodwill impairment analyses?",
      "original_answer": "In 2023, the excess of the estimated fair value over carrying value for DHR's reporting units ranged from approximately 140% to 495%. In 2024, this range decreased to between approximately 70% and 450%. This indicates a reduction in the lowest excess fair value percentage, suggesting a decline in the overall cushion before potential impairment.",
      "llm_answer": "In the 2023 goodwill‑impairment test the excess of fair value over carrying value for each reporting unit was **approximately 140 % to 495 %** of carrying value【page_56】. In the 2024 test the same metric fell to a **roughly 70 % to 450 %** range【page_52】, indicating a lower and narrower excess‑value spread year‑over‑year.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentages for both years are accurate: 140% to 495% in 2023 and 70% to 450% in 2024, with correct formatting and semantic equivalence (e.g., 'approximately' vs 'roughly'). (2) The answer is complete, addressing the change in range between the two years and correctly identifying the trend of decline in the excess fair value spread. (3) Entity accuracy is correct—DHR’s reporting units, the correct years (2023 and 2024), and the proper financial metric (excess of fair value over carrying value) are all accurately referenced. (4) The reasoning is sound: the LLM correctly infers that the range narrowed and decreased year-over-year, which aligns with the ground truth’s interpretation of a reduced cushion before potential impairment. The use of source citations (page_56, page_52) further supports contextual fidelity. Overall, the answer demonstrates precise multi-hop synthesis across time periods and reporting units, with no factual or interpretive errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1169,
        "completion_tokens": 303,
        "total_tokens": 1473
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How did the treatment of canceled RSUs and tax-withheld shares under the 2022 Employee Stock Plan evolve from 2022 to 2023 in terms of their impact on the available share pool?",
      "original_answer": "In 2022, the 2022 Employee Stock Plan specified that canceled RSUs and shares withheld to satisfy tax withholding obligations would increase the number of shares available for grant under the plan by a factor of two times the number of RSUs canceled or shares withheld. However, in 2023, this specific language regarding the factor of two times for RSUs canceled or shares withheld was omitted, indicating a change in how these events were accounted for in the share pool calculation.",
      "llm_answer": "In the 2022 filing the 2022 Employee Stock Plan expressly stated that “RSUs canceled and shares withheld to satisfy tax‑withholding obligations increase the number of shares available for grant under the 2022 Plan utilizing a factor of two times the number of RSUs canceled or shares withheld” 【page_49】. By the 2023 filing the plan’s description was trimmed to only note the grant, vesting and dividend‑equivalent features and no longer mentions the factor‑two increase for cancellations or tax‑withheld shares 【page_47】, indicating that the explicit disclosure of that impact on the share pool was removed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly identifies that in 2022, canceled RSUs and tax-withheld shares increased the share pool by a factor of two, citing the exact language and page reference (page_49). In 2023, it accurately notes the omission of this factor-two provision, referencing page_47 and describing the trimmed disclosure. (2) All quantitative elements—specifically the 'factor of two times'—are correct and properly attributed to the respective years. No calculations are required, but the numerical factor is accurately reported. (3) The multi-hop reasoning is sound: the model correctly compares the treatment across two years and infers a change in policy based on the removal of specific language, which aligns with the ground truth's interpretation. (4) The only minor shortcoming is that the LLM does not explicitly state that the omission 'indicates a change in how these events were accounted for in the share pool calculation'—a subtle but important implication made in the original answer. However, the LLM implies this by stating the explicit disclosure was removed, which is semantically close. Wording differences are acceptable under semantic equivalence, so this does not warrant a major deduction. All entities (2022 Employee Stock Plan, RSUs, tax-withheld shares, years 2022 and 2023) are correct. The answer is highly relevant and fully addresses the evolution in treatment over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 408,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How has Danaher's strategic relationship with Aldevron evolved between 2023 and 2024, particularly in terms of its financial stake and integration into Danaher's business segments?",
      "original_answer": "In 2023, Danaher had a significant financial stake in Aldevron, as evidenced by the $9,561 million in net cash consideration allocated to Aldevron in the acquisition table, indicating a direct ownership interest. By 2024, Aldevron was no longer listed as a separately accounted stake but had been integrated into the Life Sciences segment as part of Danaher's broader portfolio of acquisitions, including Beckman Coulter, Pall, and IDT. This reflects a strategic shift from holding a standalone stake to full operational integration, aligning Aldevron's capabilities in biopharma research and manufacturing with Danaher’s broader life sciences offerings.",
      "llm_answer": "In the 2023 Form 10‑K Danaher disclosed that it had fully acquired Aldevron in 2021 for about $9.6 billion (recording $6.1 billion of goodwill) and that Aldevron was now part of Danaher’s Life Sciences segment. The 2024 filing still lists Aldevron as a brand within the Life Sciences segment, showing that Danaher continues to hold 100 % ownership and has kept Aldevron integrated in the same segment with no change to its financial stake.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that impact correctness. (1) It incorrectly states that Aldevron was fully acquired in 2021, while the ground truth indicates the financial stake was reflected in 2023 with $9,561 million in net cash consideration—this suggests the acquisition was finalized closer to 2023, not 2021. The $9.6 billion figure is approximately correct (close to $9,561 million), but the timing error undermines the timeline. (2) The LLM claims Aldevron was already part of the Life Sciences segment in 2023, which aligns with integration, but fails to note the key evolution: in 2023 Aldevron was still a separately accounted stake, whereas by 2024 it was no longer listed separately, indicating full absorption into the segment. This shift—from standalone stake to integrated entity—is the core of the strategic evolution and is missed by the LLM. (3) The LLM asserts there was 'no change to its financial stake,' implying continuity, but the ground truth shows a structural change in accounting treatment, signaling a strategic shift in integration. While the LLM correctly identifies Aldevron as part of the Life Sciences segment in both years and gets the approximate acquisition value right, it misses the multi-hop nuance of how the relationship evolved from a distinct investment to an embedded operational unit. This results in partial credit for entity accuracy and contextual relevance, but significant deductions for quantitative accuracy (wrong year) and qualitative reasoning (lack of synthesis on integration progression).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 428,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How has Microsoft's strategic positioning of Microsoft 365 evolved between 2023 and 2024, particularly in terms of its integration with AI technologies and its role in the company's commercial business metrics?",
      "original_answer": "In 2023, Microsoft 365 was described as an 'AI first' platform integrating Office, Windows, Copilot, and Enterprise Mobility + Security, with Copilot for Microsoft 365 combining AI with business data to enhance productivity. By 2024, Microsoft had expanded the Microsoft 365 Consumer subscribers metric to include Microsoft 365 Basic subscribers, aligning with internal business management practices and signaling a broader consumer focus. This evolution reflects a strategic shift toward enhancing AI integration and expanding the product's market reach, particularly within the commercial segment.",
      "llm_answer": "In the 2023 filing Microsoft 365 was presented mainly as an **AI‑first productivity platform**—a unified suite that brings together Office, Windows, Enterprise Mobility + Security and “Copilot for Microsoft 365,” with Copilot Studio letting customers customize AI assistance across the apps【page_4】. By fiscal 2024 the company had turned that narrative into a **measurable commercial engine**: Office 365 Commercial revenue grew 16% and Microsoft 365 Consumer subscribers rose to 82.5 million (now including the Basic tier)【page_39】【page_41】, and the MD&A metrics explicitly list “Copilot for Microsoft 365” and “Copilot Pro” as part of Office Commercial and Consumer revenue growth【page_42】. This evolution shows Microsoft moving from positioning Microsoft 365 as an AI‑enhanced suite to embedding its AI features in the core commercial metrics that drive the company’s revenue growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Microsoft 365's evolution from an 'AI-first' platform in 2023 to a more deeply integrated commercial engine in 2024, emphasizing AI integration through Copilot for Microsoft 365 and Copilot Studio. (2) Quantitatively, it accurately reports the 16% growth in Office 365 Commercial revenue and the 82.5 million Microsoft 365 Consumer subscribers in fiscal 2024, noting the inclusion of the Basic tier—consistent with the ground truth's mention of expanded subscriber metrics. While the exact 82.5 million figure isn't in the original answer, the key point—the expanded definition of subscribers to include Basic—is correctly captured and contextually valid. (3) The reasoning is sound: it synthesizes the strategic shift from AI as a feature to AI-driven revenue metrics, correctly linking Copilot for Microsoft 365 and Copilot Pro to commercial and consumer growth, demonstrating multi-hop understanding across product strategy and financial reporting. (4) Minor deduction in quantitative accuracy only because the original answer does not specify the 82.5 million number or the 16% growth—those are plausible inferences from the source documents but not part of the provided ground truth. However, since the core strategic evolution—AI integration and expanded consumer metric—is accurately conveyed with strong contextual and semantic alignment, the overall correctness is high. Wording differs but meaning matches. No entity or year errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 422,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has Microsoft's positioning and emphasis on Copilot Pro evolved between 2023 and 2024, particularly in terms of its role within Microsoft 365 apps and web-based AI assistance?",
      "original_answer": "In 2023, Copilot Pro was introduced as a consumer subscription service that offered 'faster and more powerful AI assistance in Microsoft 365 apps and on the web.' By 2024, while the core definition remained consistent, the emphasis on Copilot Pro's differentiation and innovation appeared more pronounced, with language such as 'faster and more powerful AI assistance' retained but now embedded within a broader narrative of AI-driven transformation across Microsoft's ecosystem. This suggests a strategic evolution where Copilot Pro is not only a standalone offering but increasingly integrated into the broader AI-first positioning of Microsoft's productivity suite.",
      "llm_answer": "In the 2023 filing Microsoft introduced Copilot Pro simply as a consumer‑subscription service that brings AI assistance to Microsoft 365 applications and the web. By the 2024 filing the company sharpened the message, describing Copilot Pro as delivering “faster and more powerful” AI assistance and positioning it as a core AI‑first feature of Microsoft 365 apps as well as a web‑based AI helper【page_4】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: Copilot Pro was introduced in 2023 as a consumer subscription for AI assistance in Microsoft 365 apps and on the web, and by 2024, Microsoft emphasized 'faster and more powerful' AI assistance, reinforcing its role within Microsoft 365 and web-based AI. The key phrase 'faster and more powerful' is correctly retained. (2) There are no numeric values, dates, or calculations in the question or answer, so quantitative accuracy is not applicable beyond correct use of years (2023 and 2024), which are accurate. (3) The multi-hop reasoning is sound—comparing Microsoft’s evolving messaging between 2023 and 2024 filings—and the synthesis across time periods is valid. The LLM captures the evolution in emphasis, though it slightly underrepresents the broader 'AI-driven transformation across Microsoft's ecosystem' narrative mentioned in the ground truth. (4) The answer is semantically equivalent and contextually precise, with only minor omission of the strategic framing of Copilot Pro as part of a larger AI-first ecosystem transformation. This does not detract from core accuracy but prevents a perfect 10. Contextual relevance is full, as all parts of the question are addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 365,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How has the structure and availability of the 2007 Omnibus Incentive Plan evolved between 2023 and 2024, particularly in terms of remaining shares available for issuance?",
      "original_answer": "In 2023, the 2007 Omnibus Incentive Plan was described in the context of PSU and RSU awards, vesting conditions, and valuation methods, but no specific figure was provided regarding the remaining shares available for issuance. In contrast, by 2024, the plan explicitly stated that approximately 47 million shares of Danaher common stock remained available for issuance under the plan as of December 31, 2024 (excluding shares underlying outstanding awards). This indicates a more transparent disclosure and potential depletion or tracking of the share pool since the plan's inception, showing a shift in how the company communicates the availability of shares under the plan.",
      "llm_answer": "The 2007 Omnibus Incentive Plan still authorizes roughly 135 million shares and continues to grant stock options, RSUs and PSUs that issue shares at no cost – RSUs vest over a five‑year period for grants made before 2022 and over a four‑year period thereafter, while PSUs vest on performance criteria and carry a post‑vesting holding period (see the plan description in both years)【page_103】【page_97】.  However, the pool of shares left for new awards has shrunk, falling from about 50 million shares available at December 31 2023 to roughly 47 million shares available at December 31 2024 (excluding shares already underlying outstanding awards)【page_102】【page_96】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the number of shares available in 2023. The original answer states that no specific figure was provided for remaining shares in 2023, but the LLM claims there were 'about 50 million shares available at December 31, 2023'—this number is unsupported by the ground truth and introduces false precision. The 2024 figure of approximately 47 million shares available is correct and matches the ground truth. However, the claim that the plan authorizes 'roughly 135 million shares' is not mentioned in the original answer and cannot be verified from the provided context, making it an unsupported addition. (2) Quantitative accuracy is low because the LLM fabricates a 2023 share availability number and implies a year-over-year comparison that the original answer does not support. The decrease from 50M to 47M is incorrect reasoning based on false data. (3) The multi-hop reasoning is partially sound in that it attempts to compare disclosure practices and share availability across years, but it fails because it invents data for 2023 rather than acknowledging the absence of a disclosed figure. The LLM also correctly identifies the types of awards (RSUs, PSUs) and vesting terms, which shows some accurate synthesis. (4) Contextual relevance is high because the response addresses the evolution of the plan and focuses on share availability, but correctness is undermined by fabricated numbers. The qualitative accuracy is moderate due to correct identification of plan features but flawed synthesis on the key metric in question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 444,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did Microsoft's accounting policy regarding the estimated useful lives of server and network equipment evolve between fiscal years 2023 and 2024, and what factors influenced this change?",
      "original_answer": "In fiscal year 2023, Microsoft increased the estimated useful lives of server and network equipment from four years to six years, effective beginning fiscal year 2023. This change was driven by investments in software that improved operational efficiencies and advances in technology. In fiscal year 2024, the policy remained consistent with the updated six-year estimate, indicating that the initial change was sustained and likely integrated into ongoing asset management practices. The continued focus on cloud and AI infrastructure investments further supported the rationale behind extending the useful lives of these assets.",
      "llm_answer": "Microsoft lengthened the depreciation period for its server and network equipment from four years to six years, a change that took effect at the start of fiscal 2023 and remained in place for fiscal 2024【page_40】. The revision was driven by recent software investments that improved the efficiency of operating that equipment and by overall advances in technology, which together justified a longer useful‑life estimate【page_40】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key change in Microsoft's accounting policy—extending the estimated useful life of server and network equipment from four to six years, effective at the start of fiscal year 2023, and confirms the policy remained unchanged in fiscal year 2024. All factual elements (timing, duration, direction of change) match the ground truth. (2) Quantitative accuracy is perfect: the years (4 to 6), and the fiscal timing (effective FY2023, ongoing in FY2024) are precisely correct. No calculations are required, but the numerical assertions are accurate. (3) The reasoning is sound and reflects multi-hop understanding: it connects the policy change to its drivers—software investments improving operational efficiency and technological advances—exactly as stated in the original. However, the LLM answer omits the forward-looking context about cloud and AI infrastructure investments supporting the sustained policy in FY2024, which slightly reduces completeness in qualitative synthesis. (4) Despite this minor omission, the answer is semantically equivalent in core content and fully addresses the evolution and influencing factors. The citation to 'page_40' suggests source grounding. Thus, high scores across all dimensions, with a 9 in correctness and qualitative accuracy due to the missing nuance about ongoing infrastructure strategy reinforcing the policy in FY2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 394,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How did MDT's exposure to auction rate securities evolve from 2022 to 2023 in terms of fair value and classification within the balance sheet?",
      "original_answer": "In 2022, MDT reported auction rate securities with a fair value of $33 million and classified them under 'Total' in the investment portfolio without specifying a separate balance sheet classification. By 2023, the fair value of auction rate securities remained at $33 million, but they were explicitly classified under 'Other Assets' instead of being included in the broader investment category. This indicates a shift in how MDT categorized these securities on its balance sheet, moving from a general investment classification to a more distinct reporting under other assets.",
      "llm_answer": "In 2022 Medtronic reported $36 million of auction‑rate securities with a fair value of $33 million, which were shown on the balance sheet as **other assets** (not as “investments”)【page_70】. The 2023 filing shows the same $36 million cost, $33 million fair value and the same **other‑asset** classification【page_71】—so the exposure, both in value and balance‑sheet presentation, did not change from 2022 to 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It claims that in 2022, Medtronic (MDT) classified auction rate securities as 'other assets', which contradicts the ground truth stating they were included under 'Total' in the investment portfolio without a separate classification. The ground truth confirms that the shift to 'Other Assets' occurred in 2023, not 2022. This misrepresents the evolution of classification. (2) Quantitatively, the LLM incorrectly states the cost as $36 million (not mentioned in the ground truth), though it correctly reports the fair value of $33 million for both years. The ground truth does not mention cost, so introducing $36 million is extraneous and potentially misleading. The fair value numbers are correct, but the classification timeline is wrong. (3) The multi-hop reasoning is flawed: the question asks how exposure evolved in terms of fair value and classification. The LLM concludes there was no change, but the ground truth shows a clear change in balance sheet classification—from being embedded in total investments in 2022 to being explicitly listed under 'Other Assets' in 2023. The model fails to detect this key shift, undermining the core of the answer. (4) Contextual relevance is high—the response addresses fair value and classification as asked, uses correct years and entity (MDT), and cites pages. However, due to the critical error in classification timing and introduction of unsupported data (cost), the correctness and qualitative accuracy scores are low. Semantic equivalence is not achieved because the conclusion (no change) directly contradicts the ground truth (change in classification).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 457,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 167,
      "question": "How did the net gains or losses from Cisco's available-for-sale debt investments change between fiscal years 2023 and 2024, and what does this indicate about the company's investment performance in this category?",
      "original_answer": "In fiscal year 2023, Cisco reported a net loss of $21 million from its available-for-sale debt investments, while in fiscal year 2024, this loss increased to $67 million. This indicates a significant worsening in investment performance related to this category year-over-year.",
      "llm_answer": "Cisco’s available‑for‑sale debt portfolio posted a net loss of **$21 million in FY 2023**, which widened to a **$67 million loss in FY 2024** – a **$46 million increase in the loss** year‑over‑year【page_46】. The deeper loss indicates that the debt‑investment segment performed worse in 2024, reflecting adverse market conditions (e.g., higher interest rates) that reduced the fair value of these securities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the net losses for both fiscal years: $21 million in FY 2023 and $67 million in FY 2024, matching the ground truth exactly. The year-over-year increase in loss is accurately calculated as $46 million ($67M - $21M), which is correct. (2) All numeric values, fiscal years, and calculations are factually accurate. Format variations (e.g., $21 million vs $21 million) are acceptable and do not affect meaning. (3) The multi-hop reasoning is sound—comparing two fiscal years’ investment performance and drawing a conclusion about worsening performance is valid. The LLM adds contextual insight about adverse market conditions and interest rates, which is reasonable and consistent with the implication in the ground truth, though not explicitly stated in the original answer. This additional context does not contradict but enhances the explanation. (4) The answer fully addresses both parts of the question: the change in net gains/losses and what it indicates about performance. The only minor deduction is in qualitative accuracy because the added explanation about interest rates, while plausible, goes slightly beyond the ground truth’s more neutral statement. However, this does not reduce factual correctness. Overall, the answer is semantically equivalent and highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 372,
        "total_tokens": 1559
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How did Cisco's approach to the APJC region evolve between 2023 and 2024 in terms of operational structure versus financial investment, and what implications does this have for its revenue model in that region?",
      "original_answer": "In 2023, Cisco directly operated in the APJC region as one of its three geographic segments, indicating a strong operational presence focused on delivering products and services. By 2024, Cisco's relationship with APJC evolved to include financial investments, specifically through equity instruments categorized as marketable equity securities, non-marketable equity securities, and equity method investments. While the 2023 filing emphasized operational delivery and customer engagement in APJC, the 2024 financial statements suggest a parallel strategy of capital participation, potentially signaling a shift toward leveraging local market growth through investment rather than solely through direct sales. This dual approach could indicate a broader revenue model incorporating both operational income and investment returns, though the filings do not quantify the specific financial impact of these investments on Cisco's APJC revenue.",
      "llm_answer": "In the 2023 filing Cisco described APJC simply as one of three geographic segments used to organize its operations (see page 3). By the 2024 filing the company still notes the geographic structure (page 65) but adds a clear emphasis on financial investment—highlighting a $25.9 billion acquisition spend (page 63) and the consolidation of its investment portfolio—indicating a shift toward a subscription‑and‑services‑driven, recurring‑revenue model in the APJC region. This evolution means APJC revenue is expected to come increasingly from software and service contracts rather than one‑time hardware sales.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly notes that APJC was a geographic segment in 2023 and remained structurally recognized in 2024, it incorrectly claims a '$25.9 billion acquisition spend' as part of Cisco's APJC strategy. The ground truth does not mention this figure in relation to APJC or acquisitions in that region; instead, it refers to types of financial investments (marketable/non-marketable/equity method) without quantifying them. This number appears to be either misattributed or taken out of context, severely undermining quantitative accuracy. (2) The LLM incorrectly infers a shift to a 'subscription-and-services-driven, recurring-revenue model' based on investment activity, but the original answer makes no such claim about revenue model transformation—only that there may now be dual streams (operational and investment returns). The emphasis on software and service contracts replacing hardware sales is speculative and not supported in the ground truth. (3) The multi-hop reasoning is partially sound in identifying a structural continuity and new mention of investments, but fails in synthesis: it conflates general corporate investment activity with region-specific strategic shifts and invents a narrative about recurring revenue not present in the source. (4) Contextual relevance is moderate because the answer addresses Cisco’s evolving approach to APJC and attempts to discuss operational vs. financial dimensions, but introduces irrelevant details (e.g., $25.9B spend, subscription model) that distort the actual implications. The core idea of a dual operational-investment strategy is hinted at but misrepresented in execution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 467,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How has Apple's approach to App Store commissions and regulatory compliance evolved between 2022 and 2024, particularly in response to legal and market pressures?",
      "original_answer": "In 2022, Apple acknowledged that changes to the App Store, including those in response to legal and market conditions, could reduce the volume of sales and the commission it earns on those sales, potentially affecting its financial condition. By 2024, Apple had implemented specific changes, particularly in the U.S. and the European Union, to address legal pressures such as the Digital Markets Act (DMA). These changes included new business terms, alternative fee structures, alternative app distribution methods, and additional developer tools and APIs. These adjustments reflect a shift from a more general acknowledgment of potential changes to concrete actions taken in response to regulatory demands, which could significantly affect App Store revenue and commission structures.",
      "llm_answer": "In its 2022 filing Apple still described the App Store as a platform where it “retains a commission from sales of applications and sales of digital services or goods” but noted that, in response to litigation and antitrust scrutiny, it had begun to require U.S. developers to disclose alternative purchase options and to adopt “alternative fee structures … to comply with the European Union’s Digital Markets Act.” By the 2024 filing Apple said those steps had become permanent – it now offers new business terms, lower‑or‑alternative commission models, alternative payment‑processing and additional APIs for developers – a broader, regulator‑driven redesign of the App Store aimed at meeting ongoing legal challenges and EU‑mandated market‑fairness rules.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies Apple's evolving stance from 2022 to 2024 regarding App Store commissions and regulatory compliance. In 2022, Apple acknowledged legal and antitrust pressures and began implementing changes like allowing U.S. developers to communicate alternative purchase options and adopting new fee structures for EU compliance—specifically citing the Digital Markets Act (DMA). By 2024, these changes became permanent and expanded, including new business terms, alternative commission models, payment processing options, and additional APIs. (2) There are no numeric values, percentages, or dollar amounts in either answer, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is sound: the model synthesizes information across time (2022 to 2024), geography (U.S. and EU), and regulatory context (DMA), correctly tracing the evolution from acknowledgment to concrete action. (4) The only minor shortcoming is that the LLM slightly condenses the nuance in the original answer—specifically, it does not explicitly state that Apple *anticipated* financial impact in 2022 due to potential sales volume reduction, which is a key part of the original risk disclosure. However, the core facts, timeline, regulatory drivers, and nature of changes are all accurately conveyed. Wording differs but semantic meaning is equivalent. Thus, the answer is excellent but not perfect, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 424,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How did the allocation strategy for Texas Instruments' U.S. Retiree Health Care Plan evolve between fixed income securities and equity securities from 2022 to 2024?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had a diversified mix of fixed income securities and equity securities, with fixed income and cash equivalents totaling $248 million and equity securities at $137 million. By 2024, the allocation strategy showed a significant shift toward a more conservative posture, with fixed income securities and cash equivalents comprising 80% of the portfolio, while equity securities made up only 20%. This reflects a notable increase in emphasis on fixed income securities compared to equities, even though the relative proportions remained the same between 2023 and 2024, suggesting a strategic decision to prioritize capital preservation.",
      "llm_answer": "In the 2022 filing the U.S. Retiree Health Care Plan was guided by a target mix of **65 %‑80 % fixed‑income securities and 20 %‑35 % equity securities**【TXN_10k_2022.pdf p. 50】. By the 2024 filing the target range had shifted to **75 %‑85 % fixed‑income and 15 %‑25 % equity**, and the plan’s actual weighted‑average allocation reflected this move, rising to roughly **80 % fixed‑income and 20 % equity**【TXN_10k_2024.pdf p. 48】. This shows a clear evolution toward a higher proportion of fixed‑income assets and a lower equity exposure over the 2022‑2024 period.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution in allocation strategy from 2022 to 2024, with accurate target ranges and actual allocations. In 2022, the target was 65%-80% fixed income and 20%-35% equity, which shifted to 75%-85% fixed income and 15%-25% equity by 2024, with an actual weighted average of ~80% fixed income and 20% equity. This aligns with the ground truth's description of a shift toward a more conservative posture prioritizing fixed income. (2) Quantitatively, the percentages are accurate and consistent with the cited filings. While the ground truth mentions specific dollar amounts for 2022 ($248M fixed income and $137M equity), the LLM does not include these figures. However, since the question focuses on the *allocation strategy* (i.e., percentages and shifts in policy), the omission of dollar values does not undermine the core correctness. The LLM’s emphasis on changing target ranges and actual allocation reflects the strategic evolution accurately. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from both the 2022 and 2024 filings, compares the target ranges, notes the actual allocation in 2024, and infers a strategic shift—matching the ground truth’s conclusion about increased emphasis on fixed income. (4) The scores reflect high accuracy in all dimensions: quantitative details are correct, reasoning is logical and complete, entities (Texas Instruments’ U.S. Retiree Health Care Plan, years, security types) are accurate, and the response is fully relevant to the question about strategic evolution in allocation. The only minor limitation is the omission of 2022 dollar amounts, but these are not essential to answering the specific question about *strategy evolution*, which is best captured by percentage targets and shifts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 493,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How has Texas Instruments' strategic emphasis on Embedded Processing Products evolved from 2022 to 2024, particularly in terms of its contribution to the company's competitive advantages and segment reporting structure?",
      "original_answer": "In 2022, Texas Instruments described Embedded Processing as one of its core product lines within a broader business model that emphasized four competitive advantages: manufacturing and technology strength, a broad product portfolio, strong market channels, and product diversity and longevity. Embedded Processing was positioned as part of this integrated strategy but was not highlighted as a standalone reportable segment. By 2024, Embedded Processing was elevated to a reportable segment alongside Analog, indicating a strategic shift where the company explicitly called out Embedded Processing as a key driver of value. This change suggests that Embedded Processing has become more central to TI's competitive positioning, particularly in terms of enabling optimized performance, power, and cost across a range of customer applications. The elevation to a reportable segment also implies greater operational and financial focus, aligning with the company’s long-term objective of strengthening its competitive advantages and driving free cash flow growth.",
      "llm_answer": "In 2022 TI described its Embedded Processing products as a core element of the business model and one of the four sustainable competitive advantages – a broad analog‑and‑embedded portfolio that fuels cash‑flow growth – and reported it as a distinct segment alongside Analog (2022 MD&A, p.20‑21). By 2024 the company still treats Embedded Processing as a separate reportable segment and cites the same portfolio advantage, but its scale has modestly contracted, contributing $2.53 billion of revenue (≈16% of total) and $352 million of operating profit versus $3.26 billion of revenue and $1.25 billion of operating profit in 2022 (2024 segment table, p.30‑31).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) QUANTITATIVE INACCURACY: The financial figures cited are incorrect. According to the ground truth, there is no mention of Embedded Processing revenue being $3.26 billion in 2022 or $2.53 billion in 2024, nor operating profits of $1.25 billion or $352 million. More critically, the ground truth states that Embedded Processing was *not* a reportable segment in 2022, but the LLM claims it was reported as a 'distinct segment' in 2022 with specific financials — this is false. (2) ENTITY AND TEMPORAL ERROR: The LLM incorrectly asserts that Embedded Processing was a reportable segment in 2022, directly contradicting the ground truth which states it was elevated to a reportable segment only in 2024. This misrepresents a key strategic shift. (3) REASONING FAILURE: The multi-hop reasoning is flawed — the core of the question asks about the *evolution* of strategic emphasis, particularly regarding segment reporting. The LLM fails this by asserting no change occurred ('still treats... as a separate reportable segment'), when in fact the change *from non-reportable to reportable* is the central development. (4) SEMANTIC NON-EQUIVALENCE: Despite using similar terminology (e.g., 'broad portfolio'), the LLM conveys the opposite of the truth — that Embedded Processing was always a reportable segment — which inverts the actual strategic evolution. The mention of 'modestly contracted' performance is unsupported by the ground truth and introduces false quantitative claims. While the answer addresses the right topic and attempts to discuss competitive advantages, the factual foundation is incorrect, leading to a low correctness score. Contextual relevance is moderate because it engages with the right company and product line, but accuracy and reasoning are severely compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 504,
        "total_tokens": 1952
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did TMO's issuance and valuation of its 2.00% 10-Year Senior Notes evolve between 2022 and 2024?",
      "original_answer": "In 2022, TMO reported $1,200 million in 2.00% 10-Year Senior Notes due on October 15, 2031, with an effective interest rate of 2.23%. By 2024, the same category of 2.00% 10-Year Senior Notes showed no change in the principal amount at $1,200 million, and the effective interest rate remained at 2.23%. This indicates that TMO maintained a consistent position on this specific debt instrument over the two-year period, with no new issuances or repayments affecting this line item.",
      "llm_answer": "In the 2022 Form 10‑K Thermo Fisher reported that it had issued euro‑denominated 2.00 % 10‑year senior notes due 4/15/2025 with a par amount of **$728 million** and an effective interest rate of **2.10 %**【page_87】.  \nBy the 2024 filing the same series had been partially retired, leaving an outstanding balance of **$663 million** and the note’s effective interest rate had slipped to **2.07 %**【page_47】, indicating a modest reduction in both the amount outstanding and its carrying‑value valuation.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is almost entirely incorrect in both factual content and reasoning. The original answer states that TMO (Thermo Fisher Scientific) issued $1,200 million of 2.00% 10-Year Senior Notes due October 15, 2031, with an effective interest rate of 2.23% in 2022, and this amount and rate remained unchanged in 2024. In contrast, the LLM claims a completely different maturity date (April 15, 2025), a different principal amount ($728 million in 2022, dropping to $663 million in 2024), and different interest rates (2.10% and 2.07%). These numbers do not match the ground truth and refer to a different note series. (2) The quantitative inaccuracies are severe: the principal amounts, maturity date, and interest rates are all wrong. There is no mention of the $1,200 million principal or the 2031 maturity in the LLM answer, and the reported reduction in principal is fabricated. (3) The multi-hop reasoning is flawed—the LLM fails to correctly identify the same debt instrument across years and incorrectly asserts a partial retirement and changing interest rate. It also introduces 'euro-denominated' notes, which are not mentioned in the ground truth. (4) The contextual relevance is low because the answer discusses a different debt instrument (possibly confusing it with another filing), though it does attempt to address the evolution of a specific note over time. Due to complete factual misalignment, the correctness score is near zero.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 405,
        "total_tokens": 1639
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How has the financial performance of REMICADE evolved between 2022 and 2024, and what does this indicate about its role in Johnson & Johnson's Pharmaceutical segment?",
      "original_answer": "In 2022, REMICADE was listed as a key product in Johnson & Johnson's Pharmaceutical segment, specifically within the Immunology therapeutic area, indicating its importance in treating immune-mediated inflammatory diseases. By 2024, REMICADE's sales had declined significantly, from $1,839 million in 2023 to $1,605 million in 2024, representing a 12.8% decrease. This decline suggests a diminishing contribution of REMICADE to the company's Immunology revenue, potentially due to market saturation, increased competition, or the emergence of newer biologics within the segment.",
      "llm_answer": "REMICADE is identified in the 2022 filing as one of the flagship drugs of the Pharmaceutical segment 【page_7】, but the 2024 filing shows its sales fell to $1.605 billion in 2024 from $1.839 billion in 2023 – a 12.8% drop driven by “continued biosimilar competition” 【page_31】【page_32】. This downward trend signals that, while REMICADE remains a major revenue source for Johnson & Johnson’s Pharmaceutical business, its contribution is being eroded as biosimilars capture market share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies REMICADE's role in Johnson & Johnson's Pharmaceutical segment in 2022 and accurately reports the sales decline from $1.839 billion in 2023 to $1.605 billion in 2024, representing a 12.8% decrease—matching the ground truth exactly. The use of 'billion' format is equivalent to 'million' when scaled appropriately ($1,839 million = $1.839 billion), so formatting variation is acceptable. (2) All numeric values and the percentage drop are correct and properly calculated: (1.839 - 1.605) / 1.839 ≈ 12.8%. (3) The reasoning is sound: the model correctly synthesizes information across years (2022 to 2024), identifies REMICADE’s therapeutic context, and attributes the decline to biosimilar competition, which aligns with and even adds specificity beyond the ground truth (which cites 'competition' generally). (4) The only minor shortcoming is that the original answer emphasizes REMICADE’s role in the Immunology therapeutic area and its diminishing contribution to that sub-segment’s revenue, while the LLM focuses more broadly on the Pharmaceutical segment. This slightly reduces qualitative accuracy, but the core multi-hop synthesis—linking product status, sales trend, and strategic implication—is accurate and well-supported. Contextual relevance is full, as all parts of the question are addressed with precise, relevant details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 385,
        "total_tokens": 1656
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did the sales performance of REMICADE evolve from 2022 to 2024, and what does this indicate about its market position within JNJ's Immunology portfolio?",
      "original_answer": "In 2022, REMICADE had sales of $3,190 million, showing a decline of 14.9% compared to 2020. By 2024, its sales had further decreased to $1,605 million, representing a 12.8% drop from 2023. This consistent decline indicates a weakening market position of REMICADE within JNJ's Immunology portfolio over time.",
      "llm_answer": "REMICADE’s sales have been falling steadily – the 2022 filing already warned that its infliximab sales were being pressured by biosimilar competition (page_31).  Revenue slipped to $1.839 billion in 2023 and further to $1.605 billion in 2024, a 12.8 % decline (page_31).  The ongoing drop, coupled with growth in other immunology brands such as TREMFYA, shows that REMICADE’s share of JNJ’s Immunology portfolio is eroding as biosimilar entrants capture market share (page_32).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2024 sales figure of $1,605 million and the 12.8% decline from 2023, which matches the ground truth. However, it omits the 2022 sales figure of $3,190 million from the original answer and instead introduces a 2023 figure of $1.839 billion not present in the ground truth. While the 12.8% decline aligns with the original, the absence of the 2022 data point and introduction of an unverified 2023 number reduces quantitative accuracy. (2) The ground truth does not mention a 2023 value or a direct 2022-to-2023 comparison; instead, it references a 14.9% decline from 2020 to 2022. The LLM’s inclusion of $1.839 billion in 2023 may be factually accurate but is not supported by the provided ground truth, making it an unsupported addition. (3) The reasoning is sound: the LLM correctly infers that declining sales and biosimilar competition indicate a weakening market position, and it appropriately contextualizes REMICADE’s erosion relative to growing brands like TREMFYA, demonstrating multi-hop synthesis between REMICADE’s performance and JNJ’s broader immunology portfolio. (4) Despite missing the specific 2022 sales number and introducing an unverified 2023 figure, the LLM captures the core trend and strategic implication—ongoing decline and loss of portfolio share—making the answer largely correct with minor factual discrepancies. Hence, correctness is scored 8, quantitative accuracy 7 due to unsupported numbers, qualitative accuracy 9 for strong reasoning, and contextual relevance 10 as it fully addresses the question's intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 436,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has the sales performance of REMICADE evolved between 2021 and 2024, and what factors contributed to this change?",
      "original_answer": "REMICADE's sales declined significantly from $16.8 billion in 2021 (as part of total Immunology sales) to $1,605 million in 2024, reflecting a 12.8% decrease from 2023 to 2024 alone. This decline was primarily driven by biosimilar competition in the U.S. and other global markets, which intensified over time and led to a continued reduction in REMICADE sales.",
      "llm_answer": "REMICADE’s worldwide sales fell from $3.19 billion in 2021 to $1.605 billion in 2024 – a drop of roughly 50 percent (about $1.6 billion) 【JNJ_10k_2022.pdf page_31】. The decline reflects a sharp loss of volume as biosimilar infliximab products entered the U.S. and other markets, eroding REMICADE’s market share 【JNJ_10k_2022.pdf page_31】【JNJ_10k_2024.pdf page_32】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error in the 2021 sales figure. The ground truth states REMICADE's sales were $16.8 billion in 2021 as part of total Immunology sales, but the LLM incorrectly reports $3.19 billion as REMICADE’s standalone sales in 2021. This is a significant discrepancy. The 2024 sales figure of $1.605 billion is correct and matches the ground truth. However, the claimed ~50% drop and $1.6 billion decrease are based on the incorrect baseline and are therefore inaccurate. The ground truth specifies a 12.8% decline from 2023 to 2024, which the LLM does not mention. (2) Quantitative accuracy is low because the core financial data for 2021 is wrong. While $1.605 billion in 2024 is accurate, the starting point is not, invalidating the comparison. The calculation of a 50% drop is incorrect based on ground truth numbers. (3) The qualitative reasoning about biosimilar competition in the U.S. and global markets is correct and aligns with the ground truth. The LLM correctly identifies biosimilar infliximab products as the primary driver of market share erosion, which reflects sound multi-hop reasoning across cited documents. (4) Contextual relevance is high because the answer addresses both parts of the question—sales evolution and contributing factors—and cites appropriate sources. However, the major numerical inaccuracy in the 2021 figure severely undermines the correctness score, despite correct reasoning and partial data accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 410,
        "total_tokens": 1584
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the status and commercial performance of STELARA (ustekinumab) evolve between 2022 and 2024?",
      "original_answer": "In 2022, STELARA was in the filing stage for the treatment of pediatric patients with juvenile psoriatic arthritis in the U.S., indicating it was under regulatory review but not yet approved. By 2024, STELARA had achieved significant commercial success, generating $10,361 million in sales, a decrease from $10,858 million in 2023, representing a 4.6% decline in total sales. This reflects that STELARA had transitioned from a product in active regulatory development to a mature, high-revenue-generating drug facing slight sales decline, suggesting market saturation or increased competition.",
      "llm_answer": "In the 2022 filing, STELARA was still protected by a U.S. patent that would not expire until September 2023 and the company had a U.S. filing to expand its label to pediatric psoriatic arthritis; it was a growth driver with worldwide sales of $9.1 billion in 2021 (up 18.5% YoY) and about $5.9 billion of U.S. sales【page_30†L1-L5】【page_31†L31-L34】【page_32†L31-L34】. By the 2024 filing, STELARA’s sales had slipped to $10.4 billion (down 4.6% from 2023) with U.S. sales of roughly $6.7 billion, as it lost share to European biosimilar entrants, faced multiple FDA biosimilar BLAs and settled litigation, and the company now expects biosimilar launches in Europe and the U.S. in 2025 while pursuing an EU filing for pediatric Crohn’s disease【page_31†L31-L35】【page_32†L1-L9】【page_33†L31-L34】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution of STELARA between 2022 and 2024, including its regulatory status in 2022 (filing for pediatric psoriatic arthritis) and commercial performance in 2024 ($10.4 billion in sales, down 4.6% from 2023), aligning with the ground truth. It also correctly identifies the context of biosimilar competition and expected 2025 launches. However, there are minor quantitative inaccuracies: the ground truth reports 2024 sales as $10,361 million ($10.361 billion), while the LLM rounds to $10.4 billion — acceptable for rounding but slightly imprecise. More notably, the LLM cites $9.1 billion in worldwide sales for 2021, which is factually correct per the source but not directly responsive to the 2022–2024 timeframe focus. The 2023 sales figure is implied ($10.858 billion) via the 4.6% decline, but the LLM does not state it explicitly, though it correctly applies the percentage. (2) The 4.6% decline is accurately repeated, and U.S. sales figures ($6.7 billion in 2024) are plausible but not in the ground truth, so they cannot be fully verified; however, they don’t contradict it. The patent expiration date (September 2023) is accurate and contextually relevant. (3) Multi-hop reasoning is strong: the model synthesizes regulatory status, sales trends, patent life, biosimilar threats, and geographic market dynamics across years and filings. It correctly infers the transition from growth to maturity and competitive pressure. (4) The answer is contextually excellent, addressing both status and commercial performance evolution. The inclusion of 2021 sales is slightly off-focus but supports the narrative. The minor numerical imprecision prevents a 9–10 on quantitative accuracy, but qualitative and relevance scores remain high due to strong reasoning and completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 497,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How did the total net revenue from Restasis in the United States change between 2023 and 2024, and what was the percentage decrease in each year?",
      "original_answer": "In 2023, the United States net revenue from Restasis was $382 million, which decreased to $172 million in 2024. This represents a 38.5% decrease in 2023 compared to 2022, and a further 55.2% decrease in 2024 compared to 2023.",
      "llm_answer": "Restasis U.S. net revenue fell from **$382 million in 2023 to $172 million in 2024**, a drop of **$210 million**.  The 2023 figure reflected a **38.5 % decline** from the prior year, and the 2024 figure reflected a **55.2 % decline** versus 2023【page_43†L31-L38】【page_43†L31-L38】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the dollar amounts are accurate: $382 million in 2023 and $172 million in 2024, with a correct difference of $210 million. The percentage decreases are also exactly matched: 38.5% decrease in 2023 (vs. 2022) and a 55.2% decrease in 2024 (vs. 2023). (2) The answer is complete, addressing both parts of the question: the change in total net revenue between 2023 and 2024, and the percentage decrease in each year. (3) Entity accuracy is correct—Restasis, U.S. net revenue, and the years 2023 and 2024 are all properly identified. (4) The reasoning is sound and reflects proper multi-hop synthesis: it correctly references year-over-year declines across three years (2022→2023→2024), even though the question only asks for the change between 2023 and 2024 and the respective annual decreases. The citations (page_43†L31-L38) suggest proper grounding. (5) Semantic equivalence is maintained—though the LLM rephrased the answer with additional detail (e.g., stating the $210M drop), all information aligns factually with the original. No errors in calculation, logic, or interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1126,
        "completion_tokens": 331,
        "total_tokens": 1457
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role and strategic importance of Master Lease Agreements evolved between 2022 and 2023 in supporting AMT's international growth and tenant relationships?",
      "original_answer": "In 2022, AMT emphasized that master lease agreements were comprehensive in nature and instrumental in building strong strategic partnerships with tenants, significantly reducing colocation cycle times and enabling rapid deployment of equipment across its international portfolio of approximately 177,000 communications sites. By 2023, AMT reiterated the importance of these agreements in providing consistent, long-term revenue and reducing non-contractual churn, while operating an expanded international portfolio of approximately 182,000 communications sites. The evolution reflects a continued strategic focus on leveraging master lease agreements to support international growth and tenant retention, with an emphasis on mitigating risks such as customer consolidation and regulatory changes.",
      "llm_answer": "In the 2022 filing the company said its master‑lease agreements “provide for consistent, long‑term revenue and reduce the likelihood of non‑contractual churn” and that they “build and augment strong strategic partnerships” with tenants, noting the T‑Mobile MLA as a key driver of churn in the U.S. & Canada segment (2022 p.34‑35). By the 2023 filing, the narrative had shifted to portray those same master‑lease agreements as a cornerstone for leveraging an expanded international portfolio of roughly 182,000 sites, allowing tenants to deploy equipment quickly and deepening carrier relationships worldwide, thereby becoming a primary engine for AMT’s global growth (2023 p.37).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic role of master lease agreements (MLAs) in both 2022 and 2023, noting their importance in generating long-term revenue, reducing churn, and strengthening tenant relationships. It accurately reflects the evolution toward international growth and rapid deployment. However, it omits key details from the ground truth: the 2022 portfolio size (~177,000 sites) is missing, and while it mentions the 2023 portfolio (~182,000 sites), it fails to note the expansion from 2022. Also, the ground truth emphasizes risk mitigation (e.g., customer consolidation, regulatory changes), which the LLM answer omits. The reference to T-Mobile MLA as a churn driver in the U.S. & Canada is factually present in the 2022 filing but not directly relevant to the international focus of the question, slightly misaligning emphasis. (2) Quantitatively, the 182,000 international sites figure is correct for 2023; however, the 177,000 figure from 2022 is not mentioned, making the comparison incomplete. No calculations are required, but the absence of the earlier number limits quantitative completeness. (3) The multi-hop reasoning is partially sound—linking MLAs to international portfolio growth and tenant relationships across years—but misses synthesizing the portfolio size change and risk mitigation aspects, weakening the full strategic evolution. (4) Scores reflect mostly accurate facts and good contextual relevance, but with notable omissions in completeness and precision of strategic evolution, particularly around portfolio growth metrics and risk context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 441,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has the role of Google Marketing Platform in the company's advertising revenue generation evolved between 2023 and 2024, particularly in relation to how advertising revenues are recognized and managed across Google Network properties?",
      "original_answer": "In 2023, Google Marketing Platform was directly involved in the recognition of advertising revenues on a gross basis for Google Network properties, meaning the full amount billed to customers was recorded as revenue. By 2024, the platform's role evolved to include a more nuanced evaluation of its principal versus agent status, with an emphasis on its control over advertising inventory before transfer to customers, further supporting the gross revenue reporting. Additionally, 2024 introduced a more detailed explanation of the platform's role in managing advertising across Google Network properties, highlighting its central function in both performance and brand advertising delivery.",
      "llm_answer": "Both the 2023 filing (p. 57) and the 2024 filing (p. 58) describe Google Marketing Platform as one of the primary channels through which advertisers buy inventory (alongside Google Ads, Ad Manager and Display & Video 360). In each year the company continues to recognize ad revenue on Google Network properties on a gross‑basis—recording the full amount billed to advertisers as revenue and the amounts paid to network partners as cost of revenues—so the platform’s role and the way those revenues are accounted for have remained essentially unchanged.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, despite correctly citing the gross revenue recognition policy in both years. (1) The original answer states that Google Marketing Platform's role evolved in 2024 to include a more nuanced evaluation of principal versus agent status and greater emphasis on control over inventory, which supports gross revenue reporting. The LLM answer incorrectly claims the role and revenue accounting have 'remained essentially unchanged,' directly contradicting the ground truth. (2) There are no numeric values to verify, so quantitative accuracy is not applicable—score is 10 by default as no numbers were misstated. (3) The reasoning is flawed: the LLM fails to recognize the evolution in the platform’s role related to revenue management and control, missing the multi-hop nuance between structural consistency (gross reporting) and functional evolution (enhanced justification and evaluation of principal status). (4) Contextual relevance is moderate—the answer addresses advertising revenue recognition and mentions Google Network properties, but misses the key evolution in the platform’s strategic and accounting role in 2024, resulting in a substantively incomplete and misleading response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 348,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How did the volume and fair value of Federal Funds Purchased & Sec Loaned change between 2023 and 2024, and what does this indicate about BAC's short-term funding strategies?",
      "original_answer": "In 2023, the volume of Federal Funds Purchased & Sec Loaned showed a net change of $16,466 million, indicating a significant increase in short-term funding liabilities. By 2024, the fair value of this category was reported at $192,859 million, a substantial increase from the prior year. This suggests that BAC significantly expanded its reliance on short-term secured funding mechanisms in 2024, likely to support its trading and liquidity management activities.",
      "llm_answer": "In 2023 Bank America held about $301 billion of Federal funds purchased and securities loaned (earning $20.6 billion of interest at a 6.84 % yield).  By year‑end 2024 the gross amount measured at Level 2 had risen to $570 billion (up from $436 billion in 2023) and the net fair‑value of the liability grew from $144.5 billion to $192.9 billion.  The jump in both balance and fair‑value shows the bank is relying more heavily on Federal‑funds and securities‑loan arrangements as a short‑term funding source, expanding its wholesale‑funding pool to meet liquidity needs and capture higher short‑term rates.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also notable inaccuracies. The 2024 fair value of $192.9 billion is correctly reported (matching the ground truth $192,859 million), which supports the conclusion about increased reliance on short-term funding. However, the LLM claims a net change in 2023 volume of $16,466 million was from an increase in liabilities, but instead reports a total volume of $301 billion in 2023 without clearly identifying it as a net change or explaining the $16,466 million figure. Additionally, the LLM introduces new figures not in the ground truth—such as $20.6 billion interest income, 6.84% yield, $570 billion gross Level 2 amount, and $436 billion prior gross—none of which appear in the original answer or are supported by the knowledge graph. These additions reduce quantitative accuracy. (2) The only verifiable correct number is the 2024 net fair value (~$192.9B), aligning with the ground truth. The $144.5B to $192.9B net liability increase implies a $48.4B rise, but the ground truth emphasizes a 2023 net change of $16,466M ($16.5B) in volume, which the LLM fails to address directly. The LLM’s calculation of growth in gross amounts is unsupported. (3) The multi-hop reasoning is partially sound: the model correctly infers that rising balances and fair values indicate greater reliance on short-term secured funding, which aligns with the ground truth's interpretation regarding BAC’s short-term funding strategy. It connects volume and valuation trends to liquidity and rate capture, showing good qualitative logic. (4) Despite incorrect or hallucinated numbers, the core conclusion about increased use of short-term funding mechanisms is consistent with the original answer, and all entities (BAC, Federal Funds Purchased & Sec Loaned, 2023–2024 timeframe) are accurate. The answer remains highly relevant contextually, addressing both parts of the question—changes in volume/fair value and implications for funding strategy—though with compromised numerical fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 549,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has PepsiCo's disclosure regarding the sensitivity of pension and retiree medical plan liabilities to market fluctuations evolved between 2022 and 2024?",
      "original_answer": "In 2022, PepsiCo mentioned that the exposure of pension and retiree medical plan assets and liabilities to risks related to market fluctuations was discussed in 'Our Critical Accounting Policies and Estimates.' By 2024, the company expanded this disclosure, explicitly linking the sensitivity of these liabilities not only to market fluctuations but also to inflationary, deflationary, and recessionary conditions. This broader context indicates a more detailed characterization of the macroeconomic risks affecting these obligations, beyond just market volatility.",
      "llm_answer": "In the 2022 Form 10‑K PepsiCo’s “Market Risks” section (page 40) only stated that its pension and retiree‑medical plan assets and liabilities are **exposed** to market‑rate changes and pointed readers to the “Critical Accounting Policies and Estimates” discussion for details. By the 2024 Form 10‑K (pages 40‑42) the company still makes that same reference, but now places it within a broader market‑risk narrative that explicitly links the sensitivity of those pension and retiree‑medical plan liabilities to interest‑rate, inflationary and other market‑condition fluctuations, providing a more integrated discussion of the risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. It correctly identifies that in 2022, PepsiCo referenced market-risk exposure for pension and retiree medical plans and directed readers to the 'Critical Accounting Policies and Estimates' section. It also accurately notes that by 2024, the disclosure was expanded to include sensitivity to interest-rate, inflationary, and other market-condition fluctuations, which matches the ground truth's emphasis on broader macroeconomic risks (inflationary, deflationary, recessionary). The mention of specific pages (40, 40–42) adds precision and is consistent with typical 10-K structure, though page numbers are not part of the ground truth and do not detract from accuracy. The only minor shortcoming is that the LLM does not explicitly use the term 'recessionary conditions' as in the original answer, but 'other market-condition fluctuations' serves as a reasonable proxy. No numerical inaccuracies exist—dates (2022, 2024), entities (PepsiCo, pension and retiree medical plans), and document types (Form 10-K) are correct. The reasoning is sound, demonstrating multi-hop understanding by comparing disclosures across years and identifying evolution in risk characterization. The answer is fully relevant and conveys the same core information as the original with high fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 375,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How has Adobe's approach to Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's broader document management ecosystem?",
      "original_answer": "In 2023, Adobe Scan was positioned as a free mobile scanning tool that converts paper documents into editable, searchable PDFs via Adobe Document Cloud services, emphasizing its utility for individual users. By 2024, Adobe Scan remained part of Adobe Document Cloud, but the broader ecosystem placed increased emphasis on integration with cloud-based productivity tools and AI-driven features like Content Credentials and Firefly-powered generative AI workflows, indicating a shift toward deeper integration within enterprise document workflows and enhanced digital trust mechanisms.",
      "llm_answer": "In the 2023 filing Adobe Scan was described mainly as a free mobile‑only scanner that captures paper, converts it to PDFs and offers OCR, and it was listed as a separate free download alongside Acrobat Reader (ADBE_10k_2023.pdf p.13). By the 2024 filing the company positions Scan as an integral part of Adobe Document Cloud—highlighting its tight integration with Acrobat, Acrobat Sign and other Document Cloud APIs to provide a seamless, end‑to‑end cloud‑based document workflow (ADBE_10k_2024.pdf p.12‑13).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies Adobe Scan's 2023 positioning as a free, mobile-only scanning tool with OCR functionality, citing its standalone availability and role in converting paper to PDFs (consistent with ADBE_10k_2023.pdf p.13). For 2024, it accurately reflects the shift in positioning toward deeper integration within Adobe Document Cloud, emphasizing seamless workflows with Acrobat, Acrobat Sign, and cloud APIs (supported by ADBE_10k_2024.pdf pp.12–13). The answer captures the core evolution: from a standalone utility for individuals to an integrated component of a broader, cloud-based document ecosystem. While the ground truth mentions specific AI-driven features like Content Credentials and Firefly, which the LLM answer omits, this is a minor gap in completeness rather than a factual error. There are no issues with quantitative accuracy—no numerical data is present, but dates (2023, 2024) and document references are correct. Entity accuracy is strong: Adobe, Adobe Scan, Adobe Document Cloud, Acrobat, Acrobat Sign are all correctly named and contextualized. The reasoning is sound, demonstrating multi-hop synthesis across two years of 10-K filings to infer a strategic shift. The semantic meaning is equivalent to the original answer, though slightly less detailed in describing the AI and trust-related enhancements. Overall, the response is highly accurate, relevant, and well-supported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 407,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Gemini's role and integration across Google's products evolved from its initial launch in 2023 to 2024, and what specific advancements were made in its multimodal capabilities?",
      "original_answer": "In 2023, Gemini was introduced as a multimodal AI model capable of understanding and operating across different types of information, including text, code, audio, images, and video. It was intended to be leveraged across Alphabet to enhance product experiences. By 2024, Gemini had evolved significantly, with the launch of Gemini 2.0, which became the most capable model yet. It was integrated into all seven of Google's two billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube—powering AI features across these platforms. Additionally, in 2024, Gemini was used in experimental research prototypes such as Project Astra and Project Mariner, showcasing broader and more advanced applications than in 2023.",
      "llm_answer": "Gemini was first introduced in 2023 as Google’s native multimodal model that could understand and generate text, code, audio, images and video, and was initially used in early AI features. By 2024 the upgraded Gemini 2.0—described as the most capable model—was embedded in all seven of Google’s core consumer products (Android, Chrome, Gmail, Maps, Play Store, Search and YouTube) and extended to Google Cloud, Workspace, the Gemini app and research prototypes such as Project Astra and Project Mariner, adding deeper general‑purpose multimodal reasoning and new generation abilities like image creation, coding assistance and app‑integration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Gemini launched in 2023 as a multimodal model (text, code, audio, images, video), evolved into Gemini 2.0 in 2024, and was integrated into all seven of Google's core two-billion-user products—Android, Chrome, Gmail, Maps, Play Store, Search, and YouTube. The mention of integration into Google Cloud, Workspace, the Gemini app, and research prototypes like Project Astra and Project Mariner is consistent with the original answer. (2) Quantitative elements—such as the timeline (2023 launch, 2024 upgrade), the number of core products (seven), and the types of multimodal inputs—are all factually correct. No numerical inaccuracies or miscalculations are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution over time, product integrations, and advancements in capabilities. (4) The only minor deviation is that the original answer emphasizes Gemini 2.0 as 'the most capable model yet' and highlights its role in enhancing product experiences across Alphabet, while the LLM adds 'image creation, coding assistance and app-integration' as specific new abilities. These are plausible extensions of 'deeper general-purpose multimodal reasoning' but not explicitly stated in the ground truth. However, they do not contradict it and are reasonable inferences. Thus, the answer is semantically equivalent with slight elaboration. Overall, the response is factually correct, complete, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 424,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How has Linde's relationship with helium evolved between 2022 and 2024, particularly in terms of its impact on sales and operating profit?",
      "original_answer": "In 2022, helium was listed as a supply for Linde, indicating a positive or neutral relationship. However, by 2024, the relationship had evolved, and helium was reported to negatively impact the company. Specifically, in 2024, lower volumes in global helium contributed to a 2% decrease in sales for the 'Other' segment, which includes global helium wholesale. Additionally, higher costs due to helium partially offset an insurance recovery for Linde Advanced Materials Technology (LAMT), limiting the operating profit growth in that segment despite a 44% overall increase in operating profit for 'Other'.",
      "llm_answer": "In the 2022 filing helium was only noted as one of the small businesses bundled in the “Other” segment (along with Surface Technologies and GIST), which posted about $2.0 bn of sales and a $56 m operating loss in 2021 (no specific helium‑related commentary)【page_31】. By the 2024 filing helium is again grouped in “Other” (now with LAMT) but the company explicitly says that lower global‑helium volumes reduced “Other” sales by $32 m (‑2 %) and that higher helium‑related costs weighed on operating profit, even though the segment’s operating profit rose to $43 m due to insurance recoveries【page_28】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $32M (2%) sales decrease in 'Other' due to lower helium volumes in 2024 is accurately reported, and the context around operating profit rising to $43M due to insurance recoveries—despite helium-related cost pressures—is consistent with the original. The 2022 reference to helium being part of the 'Other' segment with $2.0B in sales and a $56M operating loss (from 2021 data) is correctly contextualized, even if not directly from 2022, as the filing uses prior-year financials for comparison. (2) The LLM correctly identifies the evolution: helium shifted from neutral/positive (no negative impact noted in 2022) to a negative factor in 2024 due to volume and cost pressures. (3) Multi-hop reasoning is sound—LLM synthesizes information across years and segments (helium in 'Other', inclusion of LAMT, impact on sales and profit), correctly linking helium’s cost impact to partially offsetting insurance gains. (4) Minor deduction in qualitative accuracy because the LLM references 2021 financials ($56M loss) without clarifying it's not 2022 data, which could cause confusion, though this is common in 10-K reporting. Otherwise, entity names (LAMT, 'Other' segment), years (2022 vs 2024), and financial metrics are accurate. The answer is fully contextually relevant and addresses both sales and operating profit impacts over time.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 400,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How did the net value of acquired franchise rights evolve from 2022 to 2024, and what was the magnitude of this change?",
      "original_answer": "In 2022, the net value of acquired franchise rights was $789 million, while in 2024 it decreased to $598 million. This represents a significant decline in value over the two-year period.",
      "llm_answer": "The net carrying amount of acquired franchise rights slipped from $1.891 billion in 2022 to $1.858 billion in 2024, a decline of roughly $33 million【page_85】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in all key numeric values. The ground truth states the net value of acquired franchise rights was $789 million in 2022 and $598 million in 2024, whereas the LLM reports $1.891 billion in 2022 and $1.858 billion in 2024—over twice the correct amount. The claimed decline of $33 million contrasts sharply with the actual decline of $191 million ($789M - $598M), which is a significant miscalculation. (2) The numbers are not only wrong but also misaligned with the correct scale (billions vs. correct hundreds of millions), and the cited page reference (page_85) does not override the factual mismatch. (3) The reasoning is flawed as it fails to correctly identify or synthesize the correct values across the time period; there is no evidence of accurate multi-hop retrieval or validation against the correct data sources. (4) Due to severe quantitative and qualitative inaccuracies, the answer fails to meet the basic requirements of correctness, despite addressing the general structure of the question (change over time and magnitude). The contextual relevance is low because the data provided pertains to a different financial context or entity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1079,
        "completion_tokens": 338,
        "total_tokens": 1418
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did Chevron's natural gas delivery commitments and production volumes related to Tengizchevroil evolve from 2023 to 2024?",
      "original_answer": "In 2023, Chevron reported that its natural gas volumes included 596 million cubic feet per day consumed in operations and 7,148 million cubic feet per day as sold, which included its share from Tengizchevroil in Kazakhstan. By 2024, these figures increased to 609 million cubic feet per day consumed and 7,569 million cubic feet per day as sold, indicating a growth in both operational consumption and market delivery. This reflects an increase in Chevron’s involvement and dependency on Tengizchevroil for natural gas production and delivery commitments.",
      "llm_answer": "In the 2023 filing Chevron promised to deliver roughly 813 billion cubic feet of U.S. natural gas (and 3.2 trillion cf abroad) for 2025‑27, but the 2024 filing moved those contracts forward to 2024‑26 and cut the U.S. commitment to about 746 billion cf (with the overseas commitment falling to 2.9 trillion cf).  By contrast, Chevron’s share of production from its Kazakhstan partner Tengizchevroil was essentially flat – about 45 million barrels of oil‑equivalent per day (≈26 MBD crude and 114 MMCFD gas) in both 2023 and 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 4,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to address the core of the question. (1) It introduces unrelated data about future delivery commitments for 2024–2026 and 2025–2027, which are not mentioned in the original answer and do not pertain to actual production volumes or operational consumption from Tengizchevroil. (2) The quantitative figures are factually wrong: the original answer states Chevron’s 2023 natural gas volumes as 596 MMCFD consumed and 7,148 MMCFD sold (including Tengizchevroil share), increasing to 609 and 7,569 MMCFD in 2024. The LLM instead cites flat production of ~114 MMCFD gas from Tengizchevroil, which contradicts the documented increase and misrepresents the scale (by orders of magnitude). (3) The reasoning is flawed: the question asks about evolution in Chevron’s natural gas delivery commitments and production volumes related to Tengizchevroil from 2023 to 2024, but the LLM conflates long-term sales contracts (unrelated to Tengiz) with production volumes and incorrectly concludes 'essentially flat' when the ground truth shows clear growth. (4) Entity accuracy is partially correct (Tengizchevroil, Chevron, years), but the metrics (barrels of oil equivalent, forward delivery contracts) are mismatched. The answer lacks synthesis of the correct multi-hop data: linking Chevron’s reported gas volumes to its Tengizchevroil operations across two years. While it attempts relevance by discussing Chevron and Tengizchevroil, the factual and numerical disconnects severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1265,
        "completion_tokens": 419,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the role of Google Network partners in Google's advertising revenue model evolved between 2023 and 2024, based on changes in the way payments to these partners are described?",
      "original_answer": "In 2023, Google Network partners were described as part of the primary uses of cash from operating activities, specifically noting payments made to these partners as a standard operating expense. By 2024, the description evolved to categorize payments to Google Network partners under Traffic Acquisition Costs (TAC), explicitly linking them to ads displayed on partner properties and tying them directly to revenue generation. This shift indicates a more strategic and performance-based dependency on these partners within the advertising ecosystem.",
      "llm_answer": "In the 2023 filing the payments to Google Network partners were mentioned only as a line‑item in cost of revenues – “amounts paid to Google Network partners primarily for ads displayed on their properties” (2023 10‑K p. 59). By the 2024 filing Alphabet now spells out the accounting relationship, stating that it evaluates whether it is a principal or an agent for network ads and “generally…report advertising revenues for ads placed on Google Network properties on a gross basis, with amounts paid to Google Network partners recorded as cost of revenues” (2024 10‑K p. 58). Thus the partner role has shifted from a generic cost component to an explicitly defined principal‑agent arrangement, with Google now treating most network ads as gross‑basis revenue and the partner payments as a cost of revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in how payments to Google Network partners are described between 2023 and 2024. In 2023, the payment was described as a line item in cost of revenues for ads on partner properties (citing 2023 10-K p.59), which matches the ground truth's characterization as a standard operating expense. By 2024, the LLM correctly notes the more detailed accounting treatment, where Google evaluates principal vs. agent status and reports ad revenues on a gross basis, with partner payments recorded as cost of revenues (citing 2024 10-K p.58). This reflects the shift toward a more strategic, revenue-linked classification, consistent with the ground truth’s mention of TAC linkage. (2) There are no numerical values to verify, so quantitative accuracy is not applicable beyond correct year references (2023, 2024), which are accurate. (3) The multi-hop reasoning is sound: the model synthesizes changes in disclosure language across two years and infers an evolving accounting and strategic role, correctly interpreting the gross reporting implication as a sign of deeper integration. (4) The only minor gap is that the LLM does not explicitly use the term 'Traffic Acquisition Costs (TAC)'—a key phrase in the original answer—which slightly reduces qualitative precision. However, describing these payments as 'cost of revenues' in the context of gross revenue reporting effectively conveys the same economic substance, as TAC is typically reported within cost of revenues. Thus, the omission is terminological rather than factual. Overall, the answer is semantically equivalent and contextually fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 465,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has the impact of public policies on Bank of America's climate-related regulatory requirements evolved from 2023 to 2024, particularly in terms of jurisdictional divergence and compliance risks?",
      "original_answer": "In 2023, Bank of America highlighted increasing global regulatory focus on climate change, noting that new or heightened regulatory requirements across state, federal, and non-U.S. jurisdictions were expected to increase legal, compliance, and public disclosure risks and costs. The company specifically mentioned jurisdictional divergence as a challenge. By 2024, this concern intensified, with the company noting that existing and pending disclosure requirements in various jurisdictions, along with jurisdictional divergence, were now actively impacting legal, compliance, and public disclosure risks and costs. This indicates a shift from anticipation of increased risk to experiencing tangible impacts due to evolving public policies.",
      "llm_answer": "In the 2023 10‑K Bank of America said a growing global regulatory focus on climate change was spawning “new or heightened” requirements and “potential jurisdictional divergence,” which it expected would raise its legal, compliance and public‑disclosure costs. By the 2024 10‑K the language had shifted to note that “existing and pending” climate‑disclosure rules are already in place across multiple jurisdictions, with clear jurisdictional divergence that is now expected to increase its compliance and disclosure risks and associated costs, reflecting a move from emerging requirements to a more concrete, fragmented regulatory landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Bank of America's 2023 10-K noted an increasing global regulatory focus with anticipated increases in legal, compliance, and disclosure risks due to new or heightened requirements and potential jurisdictional divergence. By 2024, the language evolved to reflect that existing and pending disclosure rules across jurisdictions—along with clear jurisdictional divergence—are now actively increasing risks and costs. The shift from 'expected' to 'already in place' and 'now expected to increase' aligns with the ground truth's characterization of a move from anticipation to tangible impact. (2) There are no numerical values, dates, or calculations to verify—years (2023, 2024) are correct and consistently referenced. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of 10-K filings, identifies the evolution in tone and impact, and attributes the change to public policy developments, particularly jurisdictional divergence. (4) The only minor shortcoming is that the LLM slightly softens the 2024 impact by saying risks are 'expected to increase' rather than stating they are 'actively impacting' as in the original, which implies current, ongoing effects. This is a subtle but meaningful distinction in risk reporting, warranting a deduction of one point from perfection. Otherwise, the answer is semantically equivalent, contextually precise, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 422,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has General Motors' strategic emphasis on full-size pickup trucks evolved from 2022 to 2024, and what quantitative indicators in 2024 suggest a shift toward stronger performance and market positioning for this product line?",
      "original_answer": "In 2022, General Motors identified the success of its full-size SUVs and full-size pickup trucks as a key risk factor, indicating that their performance was critical to the company's competitive position and financial health. By 2024, this strategic emphasis had evolved into a demonstrated strength, as evidenced by a significant increase in net wholesale volumes driven by higher sales of full-size pickup trucks. Additionally, the 2024 report highlights that full-size pickup trucks contributed favorably to the company's EBIT-adjusted results, with a variable profit of approximately 160% for trucks on a weighted-average basis, reflecting improved profitability and market demand for this product line.",
      "llm_answer": "In the 2022 filing GM only flagged the “success of our current line of full‑size SUVs and full‑size pickup trucks” as a forward‑looking priority (2022 p.48). By 2024 the MD&A shows that full‑size pickups have become a concrete growth driver – they lifted wholesale vehicle sales by 317 k units (10.1% YoY), raised the truck share to 23.7% of units (up from 21.9% in 2023) and generated $12.8 billion of volume‑related net‑sales growth plus $2.5 billion of mix‑related growth (2024 p.32‑34). These numbers indicate a clear shift to stronger performance and a more dominant market position for the full‑size pickup segment.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the evolution in GM's strategic emphasis from 2022 to 2024, noting that full-size pickups transitioned from a risk factor (implied in 2022) to a growth driver in 2024. This aligns with the ground truth’s narrative of shifting from risk to strength. However, the LLM introduces specific quantitative figures not present in the original answer, such as a 317k unit increase (10.1% YoY), truck share rising to 23.7%, $12.8 billion volume-related sales growth, and $2.5 billion mix-related growth. These numbers, while plausible, are not found in the ground truth and cannot be verified against it, raising concerns about hallucination or sourcing from outside the knowledge graph. (2) The ground truth mentions a 'significant increase in net wholesale volumes' and a 'variable profit of approximately 160% for trucks on a weighted-average basis', which the LLM omits entirely. This is a major omission in quantitative accuracy, as the 160% variable profit is a key 2024 indicator of profitability and performance. The LLM’s introduced figures, though detailed, do not substitute for this core metric. (3) The multi-hop reasoning is sound in structure—comparing 2022 risk framing to 2024 performance outcomes—but the synthesis relies on unsupported numbers rather than the actual evidence (i.e., EBIT-adjusted contribution and variable profit). (4) Contextual relevance is high, as the answer directly addresses both parts of the question: evolution of strategy and 2024 performance indicators. However, the correctness score is reduced due to the inclusion of unverified quantitative data and the omission of the key profitability metric from the ground truth. Quantitative accuracy is moderate because while the numbers are internally consistent, they are not factually aligned with the provided truth. Qualitative accuracy is good due to correct entity and year identification and logical progression, but not excellent due to reliance on unsupported metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 541,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How did the allocation to U.S. Treasury and government agency securities within the nuclear decommissioning trusts evolve from 2022 to 2024, and what does this shift indicate about the company's investment strategy?",
      "original_answer": "In 2022, the allocation to U.S. Treasury and government agency securities was $21 million for Alabama Power and $293 million for Georgia Power. By 2024, this allocation decreased slightly to $20 million for Alabama Power but increased significantly to $349 million for Georgia Power. The overall trend shows a shift in focus toward Georgia Power’s portfolio, indicating a possible reallocation of safer, fixed-income assets to that subsidiary.",
      "llm_answer": "The nuclear‑decommissioning trusts held about **$314 million of U.S. Treasury and government‑agency securities at the end of 2022**【page_310】, but that balance fell to **only $9 million by the end of 2024**【page_275】.  The dramatic cut‑back shows Southern Company is moving out of low‑yield Treasury holdings and reallocating the trust assets toward other fixed‑income and alternative investments, indicating a shift toward a more diversified, higher‑return investment strategy.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both quantitative and qualitative aspects. According to the ground truth, in 2022, Alabama Power had $21M and Georgia Power had $293M in U.S. Treasury and government agency securities, totaling $314M — this matches the LLM's 2022 figure. However, by 2024, the ground truth shows Alabama Power decreased to $20M while Georgia Power increased to $349M, resulting in a total of $369M — a net increase. In contrast, the LLM claims the total dropped to only $9M by 2024, which is factually wrong. (2) The calculation and tracking of dollar amounts are severely flawed: the LLM reports a decrease to $9M, whereas the correct trend is an increase from $314M to $369M. This misrepresents the direction of the allocation change. (3) The multi-hop reasoning fails: the original answer requires distinguishing between two subsidiaries (Alabama Power and Georgia Power) and synthesizing their respective allocations over time. The LLM treats the trusts as a single consolidated entity and draws an incorrect conclusion about divesting from Treasuries, when in fact the data shows a strategic shift toward increasing allocations in Georgia Power. (4) While the LLM attempts to interpret the investment strategy, its conclusion about moving away from low-yield holdings toward diversification is speculative and based on incorrect data. The actual shift indicates a reallocation within subsidiaries, not an overall reduction. The contextual relevance is moderate because it addresses the right topic and time frame, but factual inaccuracies severely undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 441,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has PepsiCo's relationship with independent bottlers evolved from 2022 to 2024 in terms of financial incentives and strategic dependency?",
      "original_answer": "In 2022, PepsiCo provided sales incentives and discounts to independent bottlers primarily through funding of advertising and other marketing activities, with accruals based on annual targets and historical experience. By 2024, the company's relationship had evolved into a more structured dependency, with bottler funding negotiated annually and specifically allocated across trade and consumer programs such as advertising support, new product launches, and vending equipment placement. Additionally, in 2024, sales through independent bottlers contributed to a significant portion of revenue, with Walmart alone accounting for approximately 14% of consolidated net revenue, highlighting increased strategic dependency on these bottlers.",
      "llm_answer": "In 2022 PepsiCo described its support for independent bottlers as “bottler funding” that was part of its overall sales‑incentive program, with payments based on annual targets and accrued during the year as a reduction of revenue【page_60】. By 2024 the relationship is framed around exclusive manufacturing and distribution contracts and annually‑negotiated bottler funding that now funds a broader suite of programs—consumer‑price incentives, advertising, new‑product launches and vending‑equipment placement—and the filing explicitly notes that major retailers such as Walmart depend on those bottlers, underscoring a deeper strategic reliance on the bottling network【page_9】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the description of bottler funding in 2022 as part of sales incentives, based on annual targets and accrued as a reduction of revenue, matches the original. In 2024, the evolution to more structured, annually negotiated funding supporting advertising, new product launches, and vending equipment is accurately reported. (2) There are no numeric inaccuracies—while the LLM does not explicitly mention the 14% Walmart revenue figure, it correctly notes that major retailers like Walmart depend on independent bottlers, which captures the essence of increased strategic dependency. The omission of the exact percentage is a minor gap but does not undermine the core accuracy. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across years (2022 to 2024), identifies the shift in nature of the bottler relationship from incentive-based to strategically embedded, and links bottler operations to major retail dependencies. (4) Semantic equivalence is strong—wording differs slightly but conveys the same meaning, such as 'broader suite of programs' reflecting the expanded scope of funding. The answer is fully contextually relevant, directly addressing both financial incentives and strategic dependency. The only reason for not scoring a 10 is the missing 14% quantitative detail, which would have strengthened completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 401,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How has Adobe Firefly's role within Adobe's product innovation strategy evolved from 2023 to 2024, based on its positioning in the company's trademark listings and risk disclosures?",
      "original_answer": "In 2023, Adobe Firefly was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Firefly was specifically highlighted in the risk factors section as a newly released generative AI product, reflecting its strategic importance in Adobe's innovation efforts. This evolution shows a shift from being a registered brand to becoming a central part of Adobe's forward-looking product development and AI strategy, with explicit mention of its role in addressing market demands for generative AI capabilities.",
      "llm_answer": "In the 2023 Form 10‑K Adobe’s trademark schedule lists “Adobe Firefly” as a protected brand name, indicating the company’s initial focus on securing the mark (see the trademark‑listing section of the filing)【page_94】. By the 2024 Form 10‑K, Firefly is highlighted in the risk‑factor discussion as a flagship generative‑AI product that is being integrated across Adobe’s portfolio and that brings reputational, regulatory and competitive risks, showing its evolution from a merely‑registered trademark to a central pillar of Adobe’s AI‑driven product‑innovation strategy【page_23】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that in 2023, Adobe Firefly was listed in the trademark schedule, indicating its status as a protected brand, and by 2024, it was highlighted in the risk factors section as a flagship generative AI product. These details align perfectly with the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the years (2023 and 2024) are correctly used and tied to the appropriate filings (Form 10-K), with accurate page references. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of SEC filings, inferring strategic evolution from trademark registration to risk disclosure as a sign of increased strategic importance. (4) The LLM enhances the original answer slightly by specifying the types of risks (reputational, regulatory, competitive) and noting integration across Adobe’s portfolio, which adds context without introducing error. All elements—entity accuracy (Adobe Firefly, 2023 vs. 2024, Form 10-K), reasoning, and relevance—are fully correct and responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 336,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the role of contractual rent escalations in driving tenant billing growth changed between 2022 and 2023, particularly in light of the increased churn and lease cancellations in 2023?",
      "original_answer": "In 2022, contractual rent escalations were highlighted as a key factor contributing to tenant billing growth, listed alongside new colocation activity and lease amendments. By 2023, while contractual rent escalations remained a stated driver of growth, the context shifted due to an elevated churn rate of approximately 3%, primarily in the U.S. & Canada segment. This churn, expected to remain elevated through 2025 due to T-Mobile's lease cancellations, introduced a countervailing force against the positive impact of rent escalations, suggesting a more challenging environment for maintaining organic revenue growth solely through escalations.",
      "llm_answer": "In 2022 the company said that “contractual rent escalations on existing tenant leases” were one of the three primary drivers of tenant‑billing growth (alongside new colocation space and new‑site leases) and that churn was modest – about 4 % of billings 【page_33】. In 2023 the same escalations remain a core growth lever, but their net effect is now being offset by higher churn and lease cancellations – especially T‑Mobile‑related terminations that keep churn elevated (≈ 3 % of billings) and reduce the net contribution of the escalations to overall billing growth 【page_35】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, contractual rent escalations were a primary driver of tenant billing growth alongside new colocation and lease activity, and churn was modest. The LLM correctly states that in 2023, escalations remain a core growth lever but are offset by higher churn, particularly due to T-Mobile-related lease cancellations. (2) Quantitatively, the LLM accurately reports the churn rate as approximately 3% in 2023, consistent with the ground truth. Although it references 4% churn in 2022, the ground truth does not specify a billing churn percentage for 2022—only that it was 'modest'—so this minor discrepancy appears to stem from potential misreading of the source (page 33 may mention 4% in a different context). However, this does not materially distort the comparison. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across years and identifies the shift in the net impact of rent escalations due to increased churn. It correctly identifies T-Mobile as a key source of lease cancellations and links this to sustained elevated churn. (4) The answer is contextually relevant, directly addressing how the role of rent escalations changed from 2022 to 2023 amid rising churn. The only minor shortcoming is the unsupported 4% churn figure for 2022, which slightly affects qualitative accuracy, but the overall reasoning and conclusion remain valid. Hence, a score of 9 is warranted for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 420,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Chevron's (CVX) relationship with Tengizchevroil evolved between 2023 and 2024 in terms of capital expenditure commitments and production involvement?",
      "original_answer": "In 2023, Chevron indicated that nearly half of its Affiliate Capex, which was expected to be $3 billion in 2024, was allocated to Tengizchevroil's FGP/WPMP Project in Kazakhstan. By 2024, Chevron continued to highlight its production involvement with Tengizchevroil, noting that production volumes included Chevron's share from affiliates such as Tengizchevroil in Kazakhstan. While 2023 focused on capital commitments for project development, 2024 emphasized ongoing production contributions from the same entity, indicating a shift from investment to operational phase.",
      "llm_answer": "In 2023 Chevron’s affiliate capital spending was $3.5 billion, with “nearly half” of that amount earmarked for Tengizchevroil’s FGP/WPMP project in Kazakhstan (roughly $1.7 billion)【page_50】. For 2024 the company expects total affiliate capex of about $3 billion but does not disclose a specific allocation to Tengizchevroil, implying a lower or unchanged commitment relative to 2023【page_50】. Production from the joint‑venture, shown in the Kazakhstan figures, stayed flat at roughly 45 thousand barrels of oil‑equivalent per day in both 2023 and 2024【page_9】.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains both correct and incorrect information. It correctly identifies that nearly half of Chevron's affiliate capital expenditures (Capex) were allocated to Tengizchevroil’s FGP/WPMP project in 2023, but inaccurately states the 2023 affiliate Capex as $3.5 billion, while the ground truth indicates that $3 billion was *expected for 2024*, not 2023. The LLM incorrectly assigns $3.5B to 2023 without support from the original answer, which does not specify the 2023 total affiliate Capex—only that nearly half of the expected 2024 $3B was allocated to Tengizchevroil. This misattribution of the base amount and year undermines quantitative accuracy. The implied $1.7B calculation (half of $3.5B) is internally consistent but based on a false premise. (2) The claim that 2024 production from Tengizchevroil was flat at ~45 thousand barrels per day is not present in the original answer, which makes no mention of specific production volumes or trends—only that Chevron included its share from affiliates like Tengizchevroil in reported production. This introduces unsupported quantitative detail. (3) The qualitative reasoning partially captures the evolution—shifting focus from capital commitments (2023) to production involvement (2024)—which aligns with the ground truth’s narrative of a transition from investment to operational phase. However, the LLM overreaches by asserting production flatness and specific capex figures not in the original, weakening multi-hop synthesis. (4) Contextual relevance is high because the answer addresses both capital expenditure and production involvement across the two years, directly responding to the question’s scope. However, the introduction of unverified numbers and misaligned timeframes reduces factual correctness. The original answer emphasizes qualitative shifts in focus, while the LLM presents unsupported precise figures, leading to a correctness score of 5 due to significant quantitative errors despite some structural alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 543,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has the specificity of UPS's bond matching approach evolved in determining the discount rate for U.S. pension and postretirement benefit plans between 2023 and 2024?",
      "original_answer": "In 2023, UPS described using a bond matching approach to select specific bonds that would satisfy projected benefit payments, emphasizing its belief that this method reflects the process they would employ to settle pension and postretirement obligations. By 2024, the language evolved to place stronger emphasis on the bond matching approach as a guide for selecting bonds that align with projected benefit cash flows, without any material change in the mechanics of the method. However, the 2024 disclosure included a more precise statement indicating that the approach 'guides' the selection process, suggesting a subtle shift in how the policy is framed operationally, even though the underlying practice remained consistent.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K describe the same method: UPS “uses a bond‑matching approach to select specific bonds that would satisfy our projected benefit payments,” and notes that this reflects the process it would employ to settle the pension and post‑retirement obligations (2023 Note 5, p. 84; 2024 Note 5, p. 88). The wording is essentially unchanged, indicating that the specificity of the bond‑matching approach did not evolve between 2023 and 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in stating that UPS used a bond-matching approach in both 2023 and 2024 and correctly cites the consistent core language across the two years. However, it fails to capture the nuanced evolution in specificity and framing described in the ground truth. While the mechanics of the method did not change, the 2024 disclosure refined the language to say the bond-matching approach 'guides' the selection of bonds, rather than directly stating it selects specific bonds, indicating a subtle but meaningful shift in operational framing. The LLM incorrectly concludes that 'the wording is essentially unchanged' and that there was no evolution in specificity, which contradicts the ground truth's emphasis on a more precise and guidance-oriented characterization in 2024. This omission represents a significant gap in qualitative accuracy, particularly in capturing the intent behind disclosure changes, even if the underlying practice remained consistent. There are no errors in dates, entities, or quantitative details (hence high quantitative accuracy), and the response is contextually relevant, but the failure to identify the shift in emphasis reduces correctness and reasoning quality.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 341,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Linde's relationship with helium evolved from 2022 to 2024, and what financial impact did this change have on the company's sales and operating profit during this period?",
      "original_answer": "In 2022, helium was a supply input for Linde, indicating a supportive role in operations. By 2024, helium had a negative impact on operations, with a $32 million, or 2%, decrease in sales for the Other segment primarily due to lower volumes in global helium and LAMT. Additionally, helium-related costs contributed to downward pressure on operating profit, partially offset by an insurance recovery for LAMT. This reflects a shift from a neutral or positive relationship to one that posed operational challenges.",
      "llm_answer": "The 2022 filing makes no specific reference to helium, indicating that the gas was a minor, unsegmented part of Linde’s business at that time. By 2024 the company explicitly lists “global helium wholesale” in its “Other” segment and notes that lower helium volumes reduced segment sales by $32 million (≈2 %) versus the prior year, while operating profit in the segment rose $19 million (≈44 %) thanks to insurance recoveries that partially offset higher helium‑related costs【page_28】. This shows a shift from an unremarked revenue source in 2022 to a cost‑pressured line that trimmed sales but was mitigated by other profit‑boosting items in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the shift in Linde's relationship with helium from 2022 to 2024, noting that helium was not explicitly mentioned in 2022 (implying a minor or background role) and became a distinct factor in the 'Other' segment by 2024. The $32 million sales decrease (≈2%) due to lower helium volumes is accurately reported and matches the ground truth. However, the LLM incorrectly states that operating profit in the segment *rose* by $19 million (44%), which contradicts the ground truth that helium had a *negative impact* on operating profit, with costs applying downward pressure—only partially offset by insurance recovery. This misrepresents the financial impact on profit. (2) Quantitatively, the $32 million sales impact and ~2% figure are correct. The $19 million and 44% operating profit increase appear to come from the LLM's interpretation of the filing but are not aligned with the ground truth, which does not state a profit increase due to helium—it emphasizes pressure on profit. This is a significant error in financial interpretation. (3) The multi-hop reasoning is partially sound: the model connects the absence of helium in 2022 reporting to its later explicit mention in 2024 and infers increased significance. However, it fails to correctly synthesize the net effect on operating profit, incorrectly framing it as positive when the ground truth describes it as negative with partial mitigation. (4) The contextual relevance is high—the answer addresses both the evolution of the relationship and the financial impact. The qualitative accuracy is reduced due to the incorrect profit conclusion. Correctness score is 7 because core sales data is accurate and the shift in helium’s role is correctly identified, but the operating profit claim introduces a significant factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 496,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did Bank of America's unfunded capital contributions for renewable energy investments evolve between 2023 and 2024, and what was the corresponding change in recognized tax credits related to these investments?",
      "original_answer": "In 2023, Bank of America had unfunded capital contributions for renewable energy investments of $6.2 billion, and it recognized tax credits and other tax benefits of $4.0 billion. By 2024, the unfunded capital contributions decreased to $4.6 billion, and the recognized tax credits slightly declined to $3.9 billion. This indicates a reduction in the Corporation's near-term funding commitments to renewable energy projects, even as the tax benefits remained relatively stable.",
      "llm_answer": "Bank of America’s unfunded capital contributions for renewable‑energy projects fell from $6.2 billion at year‑end 2023 to $4.6 billion at year‑end 2024 – a reduction of about $1.6 billion.  In the same period, the tax credits and other tax benefits it recognized from those renewable‑energy equity investments slipped from $4.0 billion in 2023 to $3.9 billion in 2024, a decline of roughly $0.1 billion【page_132】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: unfunded capital contributions decreased from $6.2 billion in 2023 to $4.6 billion in 2024, and recognized tax credits declined from $4.0 billion to $3.9 billion. The calculated differences ($1.6 billion and $0.1 billion) are correct. (2) The answer is complete, addressing both parts of the question: the evolution of unfunded capital contributions and the corresponding change in tax credits. (3) Entities are correctly identified—Bank of America, the correct years (2023 and 2024), and the correct financial metrics (unfunded capital contributions and recognized tax credits). (4) The reasoning is sound: the LLM correctly infers a reduction in funding commitments while noting the relative stability of tax benefits, aligning with the qualitative interpretation in the ground truth. Minor wording differences (e.g., 'slipped' vs 'slightly declined') do not affect semantic equivalence. The citation [page_132] adds contextual support. All criteria for a perfect score are met.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 312,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has General Motors' approach to fleet sales involving commercial fleet customers evolved from 2022 to 2024, particularly in terms of sales channels and profitability considerations?",
      "original_answer": "In 2022, General Motors highlighted that fleet transactions, especially sales to daily rental car companies, were generally less profitable compared to retail sales, and these vehicles were sold either directly or through the dealer network. By 2024, the company emphasized that fleet sales, including those to commercial fleet customers, were completed through the dealer network and in some cases directly with fleet customers, suggesting a more structured and possibly optimized approach to fleet sales. This evolution indicates a strategic shift toward balancing fleet sales with profitability by leveraging both direct and dealer-based channels.",
      "llm_answer": "In the 2022 filing GM explained that it sells to commercial‑fleet customers both directly and through its dealer network, but it warned that fleet transactions—particularly those to daily‑rental companies—are generally less profitable than retail sales. The 2024 filing still describes fleet sales being carried out through the dealer network with “some cases” of direct‑to‑fleet sales, but it no longer calls out the lower profitability of those sales, indicating a shift away from emphasizing that profit‑margin gap.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, GM sold fleet vehicles both directly and through dealers, with lower profitability—especially for daily rental companies—compared to retail sales. In 2024, it accurately notes the continued use of dealer networks and some direct sales, reflecting a more structured approach. The observation that GM no longer emphasizes the lower profitability in 2024 is a valid inference and consistent with the strategic shift toward optimizing profitability. (2) There are no numerical values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—dates (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and two types of sales channels (direct vs. dealer), and correctly infers a strategic evolution based on changes in disclosure tone. The only minor gap is that the LLM does not explicitly state that the 2024 approach suggests a 'more structured and possibly optimized' strategy as in the original answer, though the implication is present. (4) The answer is fully relevant to the question about evolution in sales channels and profitability considerations. Wording differs slightly but meaning is semantically equivalent. One point deducted from qualitative accuracy for slightly less explicit articulation of strategic optimization, but overall reasoning and facts are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 408,
        "total_tokens": 1710
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How did PepsiCo's relationship with Sabra evolve between 2022 and 2024, and what financial implications were associated with this change?",
      "original_answer": "In 2022, PepsiCo owned the Sabra brand as part of its joint venture portfolio. However, by 2024, PepsiCo no longer had full ownership but instead held a 50% equity stake, which was remeasured at fair value, resulting in a pre-tax gain of $122 million. This indicates that PepsiCo divested a portion of its ownership in Sabra during the intervening period, marking a strategic shift in its relationship with the brand.",
      "llm_answer": "In the 2022 filing PepsiCo disclosed that it owned a 50 % equity stake in the Sabra joint‑venture, listing the partnership among its trademark‑licensed ventures but reporting no specific earnings impact. By the 2024 filing the company had re‑measured that former 50 % equity ownership at fair value, recognizing a pre‑tax gain of $122 million (about $92 million after‑tax) in the FLNA division’s selling‑general‑and‑administrative line— the primary financial effect of the changed Sabra relationship.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $122 million pre-tax gain and the 50% equity stake in both 2022 and 2024, which aligns with the ground truth. It also accurately notes the remeasurement at fair value and the financial impact, including the after-tax figure of $92 million (which, while not in the original answer, is a reasonable inference and does not contradict it). However, the LLM incorrectly states that PepsiCo already had a 50% equity stake in 2022, whereas the ground truth specifies that PepsiCo *owned* Sabra (implying full or majority ownership) before reducing it to 50% by 2024. This misrepresents the evolution of the relationship—a key part of the question. (2) Quantitatively, all numbers are accurate: $122 million pre-tax gain is correct, and the 50% stake is correctly cited. The after-tax amount is a minor addition but plausible. (3) The multi-hop reasoning is partially flawed: the model fails to recognize the change in ownership structure *from full ownership to 50%*, instead portraying the stake as unchanged. This undermines the qualitative accuracy of the relationship evolution. (4) Despite this, the answer is contextually relevant and captures the main financial implication. The error is in the initial state of ownership, which affects the narrative of change. Hence, correctness is reduced to 7 due to this significant factual misstatement about the 2022 ownership structure, even though the financial outcome is correctly reported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1227,
        "completion_tokens": 411,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How has Adobe's treatment of Adobe Scan evolved between 2023 and 2024, particularly in terms of its positioning within Adobe's product ecosystem?",
      "original_answer": "In 2023, Adobe Scan was listed among Adobe's trademarks, indicating it was an established product within the company's portfolio. By 2024, Adobe Scan was explicitly positioned as part of Adobe Document Cloud, which includes Acrobat, Acrobat Sign, and other apps and API services that support digital document and signature workflows. This evolution shows a shift from mere trademark recognition to a more integrated and strategically emphasized role within Adobe’s broader document management and productivity offerings.",
      "llm_answer": "In the 2023 filing the product overview contains no discussion of Adobe Scan – the sections that are provided (pages 94‑98) list only exhibits and signatures and make no mention of the Scan app. By the 2024 filing, Adobe Scan is highlighted as a free mobile‑only scanning app that creates PDFs through Adobe Document Cloud and is listed alongside Acrobat Reader as a separate free download, showing that Adobe now positions Scan explicitly as an integrated, stand‑alone component of its Document Cloud ecosystem【page_94】【page_13】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Adobe Scan's positioning between 2023 and 2024. It accurately notes that Adobe Scan was not mentioned in the 2023 filing (specifically in the product overview sections provided), which contrasts with its explicit inclusion in the 2024 filing as part of Adobe Document Cloud. The LLM correctly identifies that by 2024, Adobe Scan is positioned as a free mobile app integrated into the Document Cloud ecosystem and is listed alongside Acrobat Reader, supporting the idea of a more strategic and integrated role. This reflects the core of the ground truth: a shift from absence (or at least non-prominence) in 2023 to explicit integration in 2024. The only minor shortcoming is that the original answer emphasizes the 2023 trademark status as evidence of its established presence, while the LLM focuses on absence in the product overview—these are not contradictory but represent different aspects of 'treatment' (legal vs. strategic visibility). The LLM could have acknowledged the trademark point to fully capture the multi-hop nuance, but its reasoning based on filing content is sound and factually supported. All entities (Adobe Scan, Document Cloud, Acrobat Reader), years (2023, 2024), and product descriptions are accurate. No numerical data is involved, so quantitative accuracy is scored based on correct dates and references. The answer is contextually relevant and synthesizes information across two filings correctly, showing a clear evolution in product positioning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 431,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has General Motors' financial exposure and nature of obligations to Stellantis evolved from 2022 to 2024, particularly regarding indemnifications and historical liabilities?",
      "original_answer": "In 2022, General Motors continued to have supply-related transactions with Stellantis following the sale of the Opel/Vauxhall business, indicating an ongoing operational relationship. By 2024, the nature of GM's exposure to Stellantis had shifted from operational supplies to financial guarantees and indemnifications tied to legacy liabilities. Specifically, GM had agreed to indemnify Stellantis for certain emissions-related lawsuits, Takata-related recalls, and potential penalties from European regulatory investigations into end-of-life vehicle practices. Additionally, as of December 31, 2024, GM had accrued an immaterial amount related to these matters, showing a continued but reduced financial exposure compared to earlier liabilities. This reflects a transformation from active supply chain involvement to a more passive, indemnification-based financial relationship.",
      "llm_answer": "In the 2022 filing GM disclosed that, as part of the 2017 sale of the Opel/Vauxhall business, it had entered into a guarantee for Stellantis and agreed to indemnify Stellantis for any losses arising from inaccurate representations, covenant breaches, emissions and product‑liability claims, with the obligations subject to time limits, thresholds and caps and with no material loss estimate possible (2022 p. 89). By the 2024 filing the same indemnification framework remained, but GM added that it had already paid an immaterial amount to cover Stellantis‑conducted recalls—including Takata inflator recalls—and noted that further Takata‑related indemnifications were possible though remote, while still being unable to quantify any material exposure (2024 p. 93).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the origin of the indemnification obligations in the 2017 Opel/Vauxhall sale and notes the continuation of these obligations through 2022 and into 2024. The mention of emissions, product liability, and representation/covenant breaches matches the nature of liabilities in the original answer. The addition in 2024 of actual immaterial payments for Takata-related recalls and the possibility of further remote indemnifications is consistent with the shift from operational to indemnification-based exposure. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer beyond 'immaterial' and 'no material loss estimate possible,' which are correctly reported by the LLM and allowed under format flexibility. The years (2022, 2024) and page references are accurately cited. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years of filings to show evolution—from ongoing indemnifications in 2022 to partial fulfillment and reduced exposure in 2024. It captures the transformation from active supply involvement (implied in 2022 context) to passive financial guarantees. (4) The only minor gap is that the LLM does not explicitly mention 'European regulatory investigations into end-of-life vehicle practices,' which is a specific component of the indemnifications in the ground truth. However, it broadly covers 'emissions and product-liability claims,' which may encompass this. This omission prevents a perfect 10 but does not undermine the core accuracy. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1418,
        "completion_tokens": 461,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How has PepsiCo's relationship with co-packers evolved between 2022 and 2024, particularly in terms of operational dependency and strategic involvement?",
      "original_answer": "In 2022, PepsiCo described its relationship with co-packers as part of a 'highly distributed network of plants, warehouses and distribution centers' that are owned or leased by these third parties, indicating an operational dependency. By 2024, the company's language shifted to emphasize co-packers as part of 'strategic alliances or joint ventures in which we have an equity interest,' suggesting a more active and ownership-based strategic involvement. This evolution reflects a shift from a primarily operational partnership to a more integrated and strategic stake in co-packers.",
      "llm_answer": "PepsiCo’s 2022 filing already noted that, beyond its own owned and leased plants, the company “utilizes a highly distributed network of … contract manufacturers, **co‑packers**, strategic alliances or joint‑ventures in which we have an equity interest” (2022 Form 10‑K Item 2, p. 27). The 2024 filing repeats the same language, again describing co‑packers as part of that distributed network and stating the combined facilities are “suitable, adequate and of sufficient capacity for our current operations” (2024 Form 10‑K Item 2, p. 30). Thus, between 2022 and 2024 PepsiCo’s reliance on co‑packers has remained essentially unchanged – they continue to be an operationally‑dependent, third‑party capacity source, with no new strategic partnership or deeper integration disclosed.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, directly contradicting the ground truth. While it correctly cites the 2022 and 2024 Form 10-Ks and quotes language from them, it misinterprets the evolution of PepsiCo's relationship with co-packers. The original answer (ground truth) states that in 2022, co-packers were described as part of a 'highly distributed network' indicating operational dependency, but by 2024, the language shifted to emphasize 'strategic alliances or joint ventures in which we have an equity interest,' signaling deeper strategic involvement. However, the LLM claims the language is 'the same' in both years and concludes no change occurred, which is incorrect. The LLM fails to detect the shift in emphasis and framing between the two years, thus missing the multi-hop synthesis required to identify an evolution in strategic posture. While the citations and quoted text are accurate (hence full marks for quantitative accuracy), the reasoning is flawed, leading to an incorrect overall assessment of the relationship's evolution. The answer is contextually relevant as it addresses the right topic and uses proper sources, but the conclusion is unsupported by the evidence it cites. This represents a significant failure in qualitative accuracy and overall correctness despite accurate sourcing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 371,
        "total_tokens": 1713
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did SPG's financial relationship with ABG evolve between 2023 and 2024, particularly in terms of gains recognized and strategic investments?",
      "original_answer": "In 2023, SPG recognized multiple non-cash pre-tax gains related to its relationship with ABG, including $59.1 million from deemed disposals due to ABG's capital transactions and $157.1 million from the sale of a portion of its ABG interests. Additionally, SPG recorded a $145.8 million gain from the dilution of its ownership in SPARC Group. In 2024, SPG disclosed a pre-tax gain of $18.8 million from the sale of a portion of its ABG interest in December 2021, along with a strategic partnership with ABG to become the core licensee and operating partner for Reebok in the U.S., indicating a shift toward deeper operational collaboration rather than just financial transactions.",
      "llm_answer": "In 2023 Simon Property Group was still trimming its ABG holding – it sold a slice of its stake for a $157.1 million pretax gain and, because ABG’s capital‑transaction dilutions forced “deemed disposals,” it booked roughly $59 million (plus a $10.3 million non‑cash gain) of pretax gains on those disposals【page_65】.  The company had also made a strategic cash investment in ABG (a $100 million purchase of additional ABG interests) as part of its broader licensing partnership【page_74】.  By early 2024 Simon completed the exit, selling the balance of its ABG interest for $1.2 billion and recognizing a $414.8 million pretax gain, effectively ending the ABG investment relationship【page_73】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents the evolution of SPG's financial relationship with ABG between 2023 and 2024. (1) Quantitatively, the LLM incorrectly states that SPG sold the balance of its ABG interest in early 2024 for $1.2 billion and recognized a $414.8 million gain, which is not supported by the ground truth; the original answer mentions only an $18.8 million gain in 2024 from the sale of a portion of its ABG interest in *December 2021*, not 2024. This is a major error in both timing and amount. Additionally, the LLM invents a '$10.3 million non-cash gain' not present in the original. The $157.1 million and $59.1 million gains in 2023 are mostly correct (though rounded down to $59 million), but the $145.8 million gain from dilution in SPARC Group is omitted entirely. (2) The LLM falsely claims SPG made a 'strategic cash investment in ABG' of $100 million to purchase additional interests, which contradicts the original answer and suggests the relationship was deepening financially, when in fact SPG was divesting. (3) Qualitatively, the reasoning is flawed: instead of identifying a shift from financial gains to strategic operational collaboration (e.g., Reebok partnership), the LLM asserts a complete exit in 2024, missing the key point about ongoing strategic partnership. (4) Contextually, the answer addresses the general theme of gains and investments but mischaracterizes the nature and direction of the relationship. The mention of 'page_65', 'page_74', 'page_73' suggests fabricated citations. Overall, the answer is mostly incorrect with serious errors in numbers, dates, direction of transactions, and strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 461,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How has Lockheed Martin's involvement in Sikorsky helicopter programs evolved from 2022 to 2024, particularly in terms of production volume and program scope?",
      "original_answer": "In 2022, Lockheed Martin's RMS segment experienced a $560 million increase in product costs, partly due to higher production volume on various Sikorsky helicopter programs. By 2024, RMS explicitly listed Sikorsky helicopter programs—such as those related to the Black Hawk, Seahawk, and CH-53K King Stallion—as key components of its portfolio, indicating a continued and potentially expanded focus. This evolution reflects a shift from being a cost driver to being a clearly defined strategic product line within the RMS segment.",
      "llm_answer": "In the 2022 filing Lockheed Martin said that “higher production volume on various Sikorsky helicopter programs” lifted RMS product‑costs by about $560 million (2022 10‑K, p. 43). By the 2024 filing the company’s Sikorsky work is highlighted by two flagship platforms – the CH‑53K King Stallion heavy‑lift helicopter and the VH‑92A Marine One presidential helicopter – and it notes that the VH‑92A program delivered its final aircraft in 2024, showing a shift from broadly increasing production volumes to focusing on specific, high‑profile program deliveries (2024 10‑K, p. 3 & 5).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative claims: the $560 million increase in product costs due to higher production volume on Sikorsky programs in 2022 is correctly cited from the 2022 10-K (p. 43), and the mention of the CH-53K King Stallion and VH-92A Marine One programs in the 2024 filing is consistent with the source (2024 10-K, pp. 3 & 5). The final delivery of the VH-92A in 2024 is also accurate, indicating a shift in focus. However, the original answer emphasizes a broader evolution—from Sikorsky programs being a cost driver in 2022 to a strategically defined portfolio component by 2024, explicitly naming Black Hawk, Seahawk, and CH-53K. The LLM answer omits mention of Black Hawk and Seahawk programs, which are key to fully capturing the scope expansion. While it correctly infers a shift in focus toward high-profile deliveries, it underrepresents the continued and expanded production scope implied in the original answer. The reasoning is sound and contextually relevant, with excellent use of citations and correct entity identification (Lockheed Martin, RMS, Sikorsky, correct programs, years). The omission of key programs mentioned in the ground truth prevents a perfect score, but core facts and numbers are correct, warranting a high but not full correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 363,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How did Walmart's ownership stake and financial investment in Alert Innovation evolve between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Walmart completed a $0.4 billion acquisition of Alert Innovation, increasing its ownership to approximately 100%. By fiscal 2024, there was no mention of Walmart retaining ownership of Alert Innovation, indicating that the company had fully exited its stake, likely through a sale or divestiture.",
      "llm_answer": "In fiscal 2023 Walmart bought Alert Innovation for about $0.4 billion, which lifted its ownership to roughly 100 % of the company【page_45】. In fiscal 2024 there was no further purchase or sale of Alert Innovation reported, so Walmart continued to hold the full 100 % stake with no additional cash investment disclosed【page_65】.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Walmart acquired Alert Innovation for $0.4 billion in fiscal 2023 and increased its ownership to approximately 100%, which matches the ground truth. However, it incorrectly concludes that Walmart continued to hold the full 100% stake in fiscal 2024 due to lack of reported activity. The ground truth explicitly states that there was no mention of Walmart retaining ownership in fiscal 2024, indicating a full exit—likely via divestiture. The LLM misinterprets the absence of reporting as continuity of ownership, which contradicts the inference in the original answer. (2) Quantitatively, the $0.4 billion figure and 100% ownership are accurate, with acceptable formatting. No calculations were required. (3) The multi-hop reasoning fails: the model should have inferred from the absence of ownership mention in fiscal 2024—after full ownership in 2023—that Walmart likely exited the investment, as stated in the ground truth. Instead, it assumes status quo, breaking the logical chain. (4) Scores reflect mostly correct numbers but a critical error in interpretation and reasoning, leading to an incorrect conclusion about the evolution of Walmart's stake. Context is relevant but directionally wrong on the key point of stake evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1153,
        "completion_tokens": 359,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did SPG's utilization and management of the Supplemental Facility evolve between 2023 and 2024, particularly in terms of borrowing activity and repayment strategy?",
      "original_answer": "In 2023, SPG utilized the Supplemental Facility as part of its broader capital strategy, borrowing €750.0 million under this facility, which was later repaid on November 17, 2023, following the issuance of senior unsecured bonds. By 2024, there was no outstanding balance under the Supplemental Facility, indicating a full repayment and a shift away from its use. This evolution shows a strategic reduction in reliance on the Supplemental Facility, with SPG opting instead to refinance through long-term unsecured notes, such as the $1.0 billion issuance in September 2024.",
      "llm_answer": "In 2023 the Operating Partnership eliminated its use of the Supplemental Facility – it issued €750 million of senior unsecured bonds and used the entire proceeds to repay the €750 million balance that was outstanding under the Supplemental Facility on Nov 17 2023【page_61】. By 2024 the facility remained in place as a $3.5‑$4.5 billion revolving credit line (maturing Jan 31 2029, extendable to 2030) but the filing shows no new draws, indicating the company is now keeping the Supplemental Facility available as an undrawn source of liquidity rather than actively borrowing against it【page_68】【page_69】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor discrepancies in framing and completeness. (1) Quantitatively, all numbers and dates are accurate: the €750 million borrowing and repayment on November 17, 2023, are correctly stated, and the absence of draws in 2024 is consistent with the original answer. The additional detail about the facility's size ($3.5–$4.5 billion) and maturity (Jan 31, 2029, extendable to 2030) is contextually relevant and likely from the filing, though not in the ground truth; it does not contradict it. (2) The repayment mechanism is accurately described—proceeds from the €750 million bond issuance were used to repay the Supplemental Facility. However, the LLM incorrectly states that the Operating Partnership issued the bonds, while the original answer attributes this to SPG (a potential entity-level confusion, though SPG and its Operating Partnership are closely linked). (3) The reasoning is sound: the shift from active borrowing to maintaining the facility undrawn reflects a strategic reduction in reliance, which matches the multi-hop inference in the ground truth. (4) The LLM omits mention of the $1.0 billion unsecured note issuance in September 2024, which is a key part of SPG’s refinancing strategy and the evolution of its capital management. This omission reduces completeness, especially in explaining *why* the facility was no longer used in 2024. Despite this, the core facts about borrowing and repayment are correct, and the overall interpretation is semantically aligned. Hence, high scores across the board with a slight deduction in correctness and qualitative accuracy for the missing refinancing detail and minor entity framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 468,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How has Linde's treatment of helium in its industrial gases business evolved between 2023 and 2024, particularly in terms of its positioning as a primary product and associated supply strategies?",
      "original_answer": "In 2023, helium was explicitly listed as one of Linde's primary products within its industrial gases business, specifically called out alongside gases like oxygen, nitrogen, and hydrogen. The 2023 filing also described helium's distribution through merchant delivery, with contracts typically lasting three to seven years and without minimum purchase requirements. By 2024, helium was no longer specifically named as a distinct product in the industrial gases segment. Instead, it was subsumed under more general descriptions of gas supply methods and contracts, suggesting a reduced emphasis on helium as a standalone offering. This shift indicates a strategic repositioning of helium within Linde's broader gas portfolio, aligning it more closely with other merchant gases rather than maintaining its prior distinct status.",
      "llm_answer": "In the 2023 filing Linde already listed helium as a core process gas – one of its primary industrial‑gases products – and explained that it can be supplied through on‑site plants, merchant bulk shipments (which can be shipped long distances under 3‑ to 7‑year supply agreements without minimum‑purchase requirements) and packaged cylinders【page_100】. The 2024 filing continues to treat helium as a primary process gas (now grouped with hydrogen, carbon dioxide and carbon monoxide) and retains the same three‑method supply model (on‑site, merchant and packaged), so its positioning and supply strategy have remained essentially unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim that helium remained a primary product in 2024. The ground truth states that in 2024, helium was no longer specifically named as a distinct product, but was instead subsumed under general descriptions—indicating a strategic de-emphasis. The LLM incorrectly asserts continuity in positioning, directly contradicting the documented shift. (2) Quantitatively, the LLM correctly reports the 3- to 7-year contract durations and the three supply methods (on-site, merchant, packaged) from the 2023 filing, which aligns with the ground truth. These numbers and timeframes are accurate and properly cited. (3) The multi-hop reasoning is flawed: the question requires comparing Linde’s treatment of helium across 2023 and 2024 filings to detect strategic evolution. The LLM fails this synthesis by asserting no change, when the ground truth confirms a clear shift in product classification and emphasis. The claim that helium is 'grouped with hydrogen, CO2, and CO' in 2024 is not supported by the original answer and contradicts the de-listing of helium as a named product. (4) Correctness is severely penalized because the central conclusion—'positioning and supply strategy have remained essentially unchanged'—is false per the ground truth. While supply methods may have stayed similar, the strategic repositioning (from named primary product to implicit inclusion) is a key qualitative change that the LLM overlooks. Quantitative accuracy is scored moderately high due to correct dates and contract terms. Qualitative accuracy is low due to incorrect entity treatment and reasoning. Contextual relevance is acceptable as the answer addresses the right topic and time frame, but with wrong conclusions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 480,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the allocation of assets in the U.S. Retiree Health Care Plan evolve between 2022 and 2023, particularly in terms of fixed income securities and equity securities?",
      "original_answer": "In 2022, the U.S. Retiree Health Care Plan had $248 in fixed income securities and cash equivalents and $137 in equity securities, totaling $385. In 2023, the plan's allocation changed to $210 in fixed income securities and cash equivalents and $54 in equity securities, totaling $264. This indicates a decrease in both categories, with a more significant reduction in equity securities.",
      "llm_answer": "In 2022 the U.S. Retiree Health Care plan held about $182 million of fixed‑income securities and cash equivalents and $98 million of equity securities – roughly a 65% / 35% split【page_48】. By year‑end 2023 those balances had shifted to $210 million in fixed‑income and $54 million in equity, moving the allocation to roughly 80% fixed‑income and 20% equity【page_47】【page_49】. This represents a clear move toward more fixed‑income assets and away from equities.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the 2022 figures: it reports $182 million in fixed income and $98 million in equity for 2022, whereas the ground truth is $248 million and $137 million, respectively. The 2023 figures ($210 million fixed income, $54 million equity) are correct and match the ground truth. (2) Calculations based on the LLM's 2022 numbers yield a total of $280 million, which does not match the correct total of $385 million. The 65%/35% split is therefore inaccurate. The 2023 allocation percentages (80%/20%) are approximately correct given the $210/$54 split. (3) The reasoning correctly identifies a shift toward fixed income and away from equities, which aligns with the trend in the ground truth. However, because the 2022 baseline is wrong, the magnitude and interpretation of the change are distorted. The model fails to accurately synthesize the correct multi-hop data points from 2022 to 2023 due to incorrect input values. (4) Despite correct directional interpretation and relevance to the question, the quantitative inaccuracies severely undermine the correctness. The contextual relevance is high as the answer addresses asset allocation evolution, but the core financial data is partially incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1218,
        "completion_tokens": 351,
        "total_tokens": 1569
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How did the financial performance and strategic positioning of Trodelvy evolve between 2022 and 2023, particularly in terms of revenue generation and regulatory milestones?",
      "original_answer": "In 2022, Trodelvy generated $380 million in total product sales, primarily in the U.S., indicating its early commercial presence. By 2023, there was a strategic shift in Trodelvy's positioning as it received significant regulatory approvals: FDA approval for treating HR+/HER2- metastatic breast cancer and EC approval for a similar indication. These developments suggest a strong enhancement in its market potential and therapeutic footprint, although specific revenue figures for 2023 are not provided.",
      "llm_answer": "In 2022 Trodelvy generated $680 million in total product sales; by 2023 that rose to $1.063 billion – a 56 % jump driven by stronger demand in the United States, Europe and other markets 【page_40】. 2023 also marked a major regulatory breakthrough: Trodelvy received both FDA approval and European Commission (EC) approval as a monotherapy for adult patients with unresectable or metastatic HR⁺/HER2‑negative breast cancer, expanding its label and strengthening its oncology positioning 【page_39】【page_41】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in financial figures. The ground truth states that Trodelvy generated $380 million in 2022, but the LLM claims $680 million — a significant overstatement. Similarly, the LLM reports $1.063 billion in 2023 revenue, while the original answer states that no specific 2023 revenue figures are provided, making this claim entirely incorrect. The 56% growth calculation is therefore also invalid, as it is based on false inputs. (2) Quantitative accuracy is severely compromised: both revenue numbers are wrong, and the percentage increase (56%) is a fabricated metric unsupported by the ground truth. There is no mention in the original answer of revenue growth or international demand, so these are unsupported additions. (3) Qualitatively, the LLM correctly identifies the key regulatory milestones in 2023 — FDA and EC approval for HR+/HER2- metastatic breast cancer — which aligns with the original answer and shows correct multi-hop reasoning regarding strategic positioning. This part of the response is accurate and relevant. (4) Contextually, the answer addresses both parts of the question — financial performance and strategic positioning — and focuses on the correct drug and time frame. However, the inclusion of completely incorrect revenue data undermines the overall correctness. While the regulatory information is sound, the financial misinformation results in a low correctness score. The answer would have scored higher if it had acknowledged the absence of 2023 revenue data or matched the 2022 figure correctly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 437,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did Chevron's downstream-related earnings and investment relationship with GS Caltex evolve from 2022 to 2024, and what does this indicate about the strategic importance of the joint venture?",
      "original_answer": "In 2022, Chevron reported higher downstream-related earnings from GS Caltex in Korea, contributing to improved income from equity affiliates. By 2024, Chevron maintained a 50% ownership stake in GS Caltex Corporation, which operates as a joint venture with GS Energy, importing, producing, and marketing petroleum products, petrochemicals, and lubricants. Additionally, in 2024, Chevron reported $13,850 million in sales and other operating revenues with affiliated companies, including GS Caltex, compared to $16,286 million in 2022. This indicates that while the joint venture remained strategically important, the level of downstream-related revenue with affiliated companies slightly decreased over the period.",
      "llm_answer": "Chevron’s downstream segment earnings fell sharply – from about **$8.2 billion in 2022** (U.S. $5.4 bn + International $2.8 bn) to roughly **$6.1 billion in 2023** (U.S. $3.9 bn + International $2.2 bn)【page_83】.  At the same time, the equity‑method earnings from its 50 %‑owned joint‑venture **GS Caltex dropped from $874 million in 2022 to $437 million in 2023 and to just $58 million in 2024**, while Chevron’s investment balance stayed near **$4.1‑$4.3 billion**【page_84】 (the JV is described as a 50 % ownership in the 2022 filing【page_85】).  The trend shows that, although the GS Caltex JV remains a strategic foothold for Chevron in the Korean market, its contribution to downstream profitability has been rapidly declining.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Chevron reported higher downstream-related earnings from GS Caltex in 2022 and maintained a 50% ownership stake through 2024, with affiliated company revenues of $13,850 million in 2024 vs $16,286 million in 2022. However, the LLM claims equity-method earnings from GS Caltex dropped from $874 million in 2022 to $437 million in 2023 and $58 million in 2024 — figures not present in the original answer and unsupported by the provided context. Additionally, the LLM introduces a breakdown of Chevron’s total downstream earnings ($8.2B in 2022, $6.1B in 2023), which are not mentioned in the ground truth and represent a different scope than the focus on GS Caltex specifically. (2) The only correct quantitative element is the 50% ownership stake, which aligns with the original answer. However, the revenue figures cited in the ground truth ($16,286M in 2022 and $13,850M in 2024 from affiliated companies) are entirely omitted in the LLM response, and instead, fabricated earnings trends for GS Caltex are introduced. There is no verification of the $874M, $437M, or $58M figures in the ground truth. (3) The multi-hop reasoning is flawed: while the LLM correctly identifies GS Caltex as a 50% JV and attempts to assess strategic importance over time, it incorrectly infers a sharp decline in profitability based on non-existent data. The original answer notes a slight decrease in affiliated revenues but affirms ongoing strategic importance — a nuance lost in the LLM’s overstatement of decline. (4) Contextual relevance is moderate because the LLM addresses the evolution of the Chevron-GS Caltex relationship and its strategic implications, but the conclusion is based on incorrect data, undermining correctness and qualitative accuracy. The mention of investment balance stability (~$4.1–4.3B) is plausible but not confirmed in the ground truth, further reducing confidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 534,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the financial performance and production status of the CH-53K program evolve from 2022 to 2024, particularly in terms of risk retirements and production volume?",
      "original_answer": "In 2022, the CH-53K program contributed to higher operating profit for Sikorsky helicopter programs, with approximately $140 million in increased profit driven by higher risk retirements and production volume. By 2024, while the CH-53K remained a key product within RMS, the overall operating profit for RMS declined significantly—by 73%—partially due to lower profit booking rate adjustments across the portfolio. Although specific profit figures for CH-53K were not disclosed in 2024, the broader profit decline suggests that the gains from risk retirements observed in 2022 may have diminished as the program matured and entered higher-volume production.",
      "llm_answer": "In the 2022 filing Lockheed Martin’s RMS segment reported $16.1 bn of net sales and $1.9 bn of operating profit, but the CH‑53K was not called out for any risk‑retirement benefit – the only recent risk‑retirement credit for the helicopter had been noted in the prior year’s discussion (≈$140 m of operating profit from CH‑53K risk retirements in 2021)【page_41】【page_50】. By the 2024 filing the focus had shifted to output: higher production volume on the CH‑53K added roughly $140 million to RMS net sales, signalling a clear ramp‑up in deliveries, while risk‑retirement adjustments were no longer emphasized for the program【page_41】.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitatively, it incorrectly attributes the $140 million risk retirement benefit to 2021, while the ground truth states it occurred in 2022. This is a critical error in both timing and context. The LLM also introduces $16.1 billion in net sales and $1.9 billion in operating profit for RMS in 2022, which are not mentioned in the original answer and distract from the focus on CH-53K-specific performance. (2) While the LLM correctly identifies that by 2024 risk retirements were no longer emphasized and production volume had increased (with a $140 million sales impact), this figure is not present in the ground truth and appears to be a conflation of the 2022 profit increase with sales—a different metric. The original answer does not mention any $140 million contribution to net sales in 2024. (3) The reasoning is partially sound in observing a shift from risk retirements to production volume, which aligns with program maturation, but the multi-hop synthesis is flawed due to incorrect year attribution and misrepresentation of financial impacts. (4) Contextually, the answer addresses the evolution of the CH-53K program across years and touches on both risk retirements and production volume, satisfying the question's scope. However, the core financial facts are misstated, leading to a low correctness score despite relevant structure and some directional accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 404,
        "total_tokens": 1732
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has PayPal's approach to seller protection programs evolved between 2022 and 2023, particularly in terms of risk exposure and strategic emphasis?",
      "original_answer": "In 2022, PayPal highlighted that its seller protection programs carried risk exposure tied to regional variations and regulatory changes, with historical transaction loss rates ranging between 0.09% and 0.15% of TPV. By 2023, the company placed a stronger strategic emphasis on these programs as a competitive differentiator, explicitly linking them to merchant trust and platform growth. While 2022 focused on risk management and potential loss implications, 2023 framed seller protection as part of a broader value proposition to attract and retain merchants, integrating it with analytics, risk management, and other merchant services.",
      "llm_answer": "In the 2022 Form 10‑K PayPal treated its seller‑protection (along with buyer‑protection) chiefly as a risk‑management line‑item – it disclosed that losses from these programs drive its “transaction loss” allowance and that loss rates have historically run between 0.09 % and 0.15 % of total payment volume, with allowances set based on past experience and macro‑economic factors (2022 10‑K p. 51‑53). By the 2023 filing the tone had shifted: seller‑protection is highlighted as a strategic differentiator that “reduces merchant losses” and is part of PayPal’s value‑proposition for merchants, backed by continued investment in technology and risk‑management systems, while still noting the need to monitor exposure (2023 10‑K p. 9‑10). Thus the program moved from a primarily accounting‑risk focus in 2022 to a growth‑oriented, risk‑mitigation emphasis in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the 2022 focus on risk exposure with historical loss rates between 0.09% and 0.15% of TPV is accurately cited, including the reference to transaction loss allowance and macroeconomic factors. The shift in 2023 to framing seller protection as a strategic differentiator tied to merchant trust and platform value is correctly captured. (2) Quantitative accuracy is perfect: the percentage range (0.09%–0.15%) matches the original, and no calculations were required. (3) Multi-hop reasoning is sound—LLM correctly synthesized information across two years of 10-K filings, identifying both the change in tone and strategic emphasis, and supported it with specific context (e.g., accounting-risk focus in 2022 vs. growth-oriented positioning in 2023). (4) The answer addresses all parts of the question: evolution between 2022 and 2023, risk exposure, and strategic emphasis. Wording differs slightly but meaning is preserved, including integration with risk technology and merchant value proposition. No factual errors, omissions, or misattributions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 327,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How has Starbucks' approach to its ready-to-drink beverages evolved between 2023 and 2024, particularly in terms of revenue recognition and supplier dependency?",
      "original_answer": "In 2023, Starbucks recognized revenue from ready-to-drink beverages under the 'Other Revenues' category, where sales were generally recognized upon shipment to customers depending on contract terms. By 2024, the company's focus shifted to supplier dependency and supply chain resilience, emphasizing that ready-to-drink beverages are sourced from specialty suppliers under long-term contracts, indicating a strategic move toward securing stable supply rather than just reporting revenue. While 2023 included ready-to-drink beverages in broader revenue disclosures without specific figures, 2024 highlighted the importance of supplier relationships to mitigate delivery risks, signaling a shift from revenue-centric reporting to a supply-chain risk management focus.",
      "llm_answer": "In the 2023 Form 10‑K, Starbucks grouped ready‑to‑drink (RTD) beverages with its “Other revenues” and said that sales of those products “are generally recognized upon shipment to customers, depending on contract terms” 【page_65】. The 2024 filing still records RTD sales at shipment, but now explicitly notes that the beverages are “purchased from several specialty suppliers, usually under long‑term supply contracts,” highlighting a more explicit reliance on external suppliers for the RTD portfolio 【page_13】【page_12】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2023, Starbucks recognized ready-to-drink (RTD) beverage revenue under 'Other Revenues' and that revenue was recognized upon shipment depending on contract terms, citing the correct context from the 2023 10-K (page 65). For 2024, it accurately notes the continued use of shipment-based revenue recognition but highlights the new emphasis on supplier dependency, specifically stating that RTD beverages are 'purchased from several specialty suppliers, usually under long-term supply contracts'—a key shift toward supply chain resilience. (2) There are no numerical figures involved in the original or LLM answer, so quantitative accuracy is not applicable beyond correct referencing of years (2023 and 2024), which are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, correctly identifying both continuity in revenue recognition and evolution in disclosure focus—from revenue treatment to supplier reliance. The only minor omission is that the LLM does not explicitly frame the 2024 shift as a strategic move toward 'supply-chain risk management' or 'mitigating delivery risks,' which is present in the original answer. However, the core insight about increased emphasis on long-term supplier contracts is preserved. (4) The answer is contextually fully relevant, directly addressing both parts of the question: revenue recognition and supplier dependency. Wording differs slightly but maintains semantic equivalence. Thus, the correctness score is 9 due to high accuracy with a slight gap in framing the strategic implication of supplier dependency in 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 469,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How did the geographic reach and regulatory approvals of Trodelvy evolve between 2022 and 2023?",
      "original_answer": "In 2022, Trodelvy generated $370 million in U.S. sales and $10 million in Europe, with no sales reported in other international markets, indicating limited geographic reach. By 2023, Trodelvy received significant regulatory approvals: it was approved by the FDA for treating adult patients with HR+/HER2- metastatic breast cancer, and it obtained EC approval for monotherapy treatment of unresectable or metastatic HR+/HER2- breast cancer. These approvals suggest an expansion of Trodelvy's market access and therapeutic application, likely contributing to broader geographic distribution beyond what was reported in 2022.",
      "llm_answer": "In 2022, Trodelvy was already marketed in the United States (accelerated approval for metastatic urothelial cancer and full approval for metastatic triple‑negative breast cancer), had a European‑Commission marketing authorization for metastatic TNBC, and was approved in Canada (joining Australia, the United Kingdom, Switzerland and the U.S. under the Project Orbis collaborative review). By 2023 Gilead added both European‑Commission and U.S. FDA approvals for Trodelvy as a monotherapy in hormone‑receptor‑positive/HER2‑negative breast cancer, expanding its label and geographic footprint and driving higher sales in new and existing markets worldwide.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key regulatory approvals for Trodelvy in both 2022 and 2023, including U.S. and European approvals for HR+/HER2- metastatic breast cancer in 2023, which aligns with the ground truth. It also accurately notes prior approvals in 2022 for metastatic triple-negative breast cancer (TNBC) and urothelial cancer, as well as participation in Project Orbis with approvals in multiple countries (Canada, UK, Australia, Switzerland), which adds contextual depth not contradicted by the original answer. However, the original answer emphasizes quantitative sales data—$370M in the U.S. and $10M in Europe in 2022—with no international sales reported, while the LLM answer omits these specific figures entirely, representing a factual omission. (2) There are no incorrect numbers or miscalculations; the LLM does not introduce any false quantitative claims, but it fails to include the specific sales amounts from the ground truth, which are central to assessing geographic reach. This affects completeness but not direct factual inaccuracy. (3) The multi-hop reasoning is sound: the LLM synthesizes information about regulatory approvals across regions and years, correctly inferring expanded market access and broader geographic distribution. It connects 2022 approvals to 2023 label expansions logically, supporting the evolution of geographic and regulatory reach. (4) The answer is contextually relevant and semantically aligned in direction, though less precise on geographic reach due to missing sales data. The qualitative accuracy is high due to correct entity identification (FDA, EC, Gilead, indications) and accurate timeline representation. The correctness score is 8 because core facts are correct and reasoning is strong, but the omission of key quantitative benchmarks from 2022 limits full factual completeness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 505,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did Simon Property Group's ownership stake and financial gains from transactions involving ABG evolve between 2023 and 2024?",
      "original_answer": "In 2023, Simon Property Group (SPG) experienced multiple dilutions of its ownership stake in ABG through capital transactions, including a reduction from approximately 12.3% to 11.8%, then to 11.7%, and finally to approximately 9.6%. These transactions resulted in non-cash pre-tax gains of $36.4 million, $12.4 million, and $10.3 million, respectively. By contrast, in 2024, SPG no longer disclosed active changes in its ownership stake in ABG. Instead, it referenced a prior transaction from December 20, 2021, where it sold a portion of its interest in ABG for a pre-tax gain of $18.8 million and later acquired additional interests for $100.0 million. This indicates a shift from active stake reduction and financial recognition in 2023 to a more passive disclosure stance in 2024, with no new transactions reported.",
      "llm_answer": "In 2023 Simon’s ownership of ABG was progressively diluted – it fell from roughly 12.3 % at the start of the year to about 9.6 % by year‑end – and the company recorded a series of non‑cash deemed‑disposal gains of $36.4 million (Q2), $12.4 million (Q3) and $10.3 million (Q4) together with a cash pre‑tax gain of $157.1 million from selling a portion of its interest [page_114] [page_113]. In the first quarter of 2024 Simon sold its remaining ABG stake, exiting the investment entirely and realizing a cash pre‑tax gain of $414.8 million [page_73].",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the 2023 dilution of Simon Property Group's (SPG) ownership stake in ABG from 12.3% to 9.6% and reports the non-cash pre-tax gains of $36.4M, $12.4M, and $10.3M (matching the ground truth), it incorrectly adds a 'cash pre-tax gain of $157.1 million' not present in the original answer or implied by the knowledge graph. Furthermore, it falsely claims that in Q1 2024, SPG sold its remaining ABG stake and realized a $414.8 million gain—this is entirely contradicted by the ground truth, which states that SPG did not report any new transactions in 2024 and only referenced a prior 2021 transaction. (2) Quantitative accuracy is partially correct for 2023 figures but fails in 2024: the $157.1M and $414.8M figures are unsupported, and the 2024 events are fabricated. The 2023 percentages (12.3% to 9.6%) and three gain amounts are accurate. (3) Multi-hop reasoning is flawed: the model incorrectly infers active 2024 transactions and exit from ABG, failing to recognize the shift to passive disclosure as described in the ground truth. It also conflates the 2021 transaction (sale for $18.8M gain and $100M acquisition) with 2024 activity, which is not supported. (4) Contextual relevance is moderate because the answer addresses ownership evolution and financial gains, but the inclusion of false 2024 transactions and gains severely undermines correctness. The qualitative reasoning is unsound due to incorrect entity-event mapping and timeline errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 428,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How has the 2012 Equity Incentive Plan evolved between the 2023 and 2024 filings, particularly in terms of amendments and forms of award agreements disclosed?",
      "original_answer": "In 2023, the 2012 Equity Incentive Plan was disclosed as amended, including the Third Amendment to the plan, and referenced forms of award agreements from 2012 and 2017. In 2024, the filing included a Fourth Amendment dated August 1, 2024, and introduced additional forms of award agreements from April 2024, showing continued evolution and expansion of the plan over time.",
      "llm_answer": "The 2023 filing listed the 2012 Equity Incentive Plan “as amended” with a **Third Amendment** (10.2(A) & 10.2(B)) and a series of award‑agreement forms through 10.2(L) (April 2023) 【page_128】【page_129】. In the 2024 filing the plan received a **Fourth Amendment** (10.2(C), filed Aug 1 2024) and a new award‑agreement form (10.2(K)+, filed Apr 25 2024), extending the prior set of disclosed forms (10.2(D)‑10.2(K)) 【page_127】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the Third Amendment in the 2023 filing and the Fourth Amendment dated August 1, 2024, in the 2024 filing—matching the original answer's key facts. The mention of April 2024 award agreement forms (10.2(K)+ filed Apr 25, 2024) corresponds to the 'additional forms of award agreements from April 2024' in the ground truth. (2) All dates (Aug 1, 2024; Apr 25, 2024), amendment numbers (Third and Fourth), and document references are factually correct. Format variations (e.g., '10.2(K)+') are acceptable and consistent with filing conventions. (3) The reasoning correctly synthesizes multi-hop information across two years of filings, showing evolution through amendments and updated forms. The only minor shortcoming is that the LLM specifies 'April 2023' for a form (10.2(L)) while the ground truth does not emphasize 2023 forms beyond referencing 2012 and 2017 versions—this introduces a detail not confirmed in the original answer, slightly reducing qualitative accuracy. However, this does not contradict the core evolution narrative. (4) The answer is fully relevant, directly addressing how the plan evolved in terms of amendments and award agreements between 2023 and 2024 filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1202,
        "completion_tokens": 358,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How did the treatment and valuation of capitalized software licenses evolve between 2022 and 2023, and what does this indicate about the company's investment in software licensing?",
      "original_answer": "In 2022, capitalized software licenses were described as being generally amortized on a straight-line basis over the term of the license, indicating a clear policy for their depreciation over time. By 2023, the company disclosed the actual carrying value of these licenses on the balance sheet at $223 million, up from $152 million in 2022. This increase suggests a growing investment in software licensing, despite the unchanged amortization policy. The evolution from a disclosed accounting method in 2022 to a quantified asset in 2023 reflects a more tangible and increasing role of capitalized software licenses in the company's asset structure.",
      "llm_answer": "The company’s accounting for software licenses did not change – capitalized software licenses are still amortized on a straight‑line basis over the term of the license (page 36).  However, the balance of capitalized licenses grew from $152 million at the end of 2022 to $223 million at the end of 2023 (page 27), and the related amortization expense rose from $54 million to $63 million (page 28).  This increase in both the asset balance and amortization charge indicates that Texas Instruments has been investing more heavily in software licensing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the unchanged amortization policy (straight-line basis) and accurately reports the capitalized software license balances of $152 million in 2022 and $223 million in 2023, matching the ground truth. It also adds new correct detail not in the original answer — the increase in amortization expense from $54 million to $63 million — which strengthens the conclusion about increased investment. All numeric values are factually correct and properly attributed to fiscal year ends. (2) Quantitative accuracy is perfect: $152M → $223M increase is correctly stated, and additional figures ($54M → $63M amortization) are consistent with a growing asset base. No calculation errors. (3) Multi-hop reasoning is sound: the model synthesizes accounting policy (2022–2023) with balance sheet trends and expense data to infer increased investment, aligning with and extending the ground truth’s conclusion. The only minor gap is not explicitly noting the shift from qualitative disclosure (2022) to quantitative reporting (2023), which the original answer highlights as an evolution in transparency. (4) Scores reflect near-perfect factual accuracy, excellent reasoning, and full relevance. The 9/10 on correctness and qualitative accuracy reflects the omission of the ‘disclosure evolution’ nuance, but the core multi-hop insight — growing investment despite stable policy — is clearly and correctly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 401,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How did PayPal's utilization of European customer balances for credit activities evolve between 2022 and 2023, and what does this indicate about its strategic approach to funding credit products?",
      "original_answer": "In 2022, PayPal had approved $3.8 billion of European customer balances for credit activities, representing approximately 37% of European customer balances available for corporate use. In 2023, this approved amount decreased to $3.0 billion, representing 39% of European customer balances. This indicates a slight reduction in the total approved funding base but a higher percentage utilization of available balances, suggesting a more efficient use of existing customer balances for credit activities. Additionally, PayPal entered into a new €40 billion agreement in 2023 to sell consumer installment receivables, with $5.5 billion sold during the year, signaling a strategic shift toward external funding mechanisms to support credit product expansion.",
      "llm_answer": "In 2022 PayPal had $3.8 billion of European customer balances – roughly 37 % of the balances available for corporate use – approved for funding credit activities. By year‑end 2023 the approved amount fell to $3.0 billion, but it now covered about 39 % of the available balances. The drop in absolute size coupled with a higher utilization rate signals that PayPal is tightening the pool of internal funds it draws on while increasingly leveraging a larger share of those balances to finance its credit products, underscoring a more efficient, internally‑focused funding strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all quantitative facts: $3.8 billion in 2022 (37%), $3.0 billion in 2023 (39%), and the decrease in absolute approved amounts with a higher percentage utilization. These match the ground truth exactly, earning a perfect score for quantitative accuracy. (2) However, the LLM omits a key strategic development mentioned in the original answer: PayPal's new €40 billion agreement to sell consumer installment receivables, with $5.5 billion sold in 2023. This is a critical component of the company's shift toward external funding mechanisms, which directly addresses the second part of the question about strategic approach to funding. (3) The reasoning provided—about tightening the internal fund pool and increasing efficiency—is logically sound and consistent with the data, but it incorrectly frames the strategy as 'increasingly leveraging internal funds' and 'internally-focused', which contradicts the ground truth indicating a move toward *external* funding via receivables sales. This mischaracterization affects qualitative accuracy. (4) The answer remains contextually relevant and well-structured, addressing the evolution of utilization and inferring strategic intent, but the omission of the receivables sale agreement and misinterpretation of the strategic direction prevent a higher score. Correctness is reduced to 7 due to missing a major factual component and flawed strategic interpretation despite accurate numbers.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 409,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has Starbucks' investment relationship with Valor Siren Ventures I L.P. evolved between fiscal years 2023 and 2024, particularly in terms of the carrying value of the investment and its financial impact on Starbucks' consolidated statements?",
      "original_answer": "In fiscal 2023, Starbucks held a limited partnership interest in Valor Siren Ventures I L.P., with the total carrying value of such investments not specifically disclosed for that year. The financial impact of these investments, including Valor Siren Ventures I L.P., was included in 'interest income and other, net' and was not considered material. By fiscal 2024, the total carrying value of Starbucks' investments in Valor Siren Ventures I L.P. and II L.P. combined was $211.9 million as of September 29, 2024. The investment relationship evolved from a general equity stake to a more defined and quantified investment with ongoing monitoring, though the financial impact remained non-material and continued to be reported in 'interest income and other, net.'",
      "llm_answer": "Starbucks disclosed that its limited‑partnership interest in Valor Siren Ventures I LP (and II LP) was carried at $211.9 million as of September 29, 2024, essentially unchanged from the prior year, and the share of income or loss from these private‑equity interests continues to be recorded in “interest income and other, net” on the consolidated statements of earnings, with the related activity described as not material in both FY 2023 and FY 2024【SBUX_10k_2024.pdf page_76】【SBUX_10k_2023.pdf page_76】.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $211.9 million carrying value as of September 29, 2024, for Valor Siren Ventures I LP and II LP combined, which matches the ground truth. It also correctly states that the financial impact is recorded in 'interest income and other, net' and is not material in both years. However, it incorrectly claims the carrying value was 'essentially unchanged from the prior year,' which contradicts the ground truth: in FY2023, the specific carrying value for Valor Siren Ventures I L.P. was not disclosed, so no comparison can be made. This is a significant factual error. (2) The date (September 29, 2024) and dollar amount ($211.9 million) are accurate. But the inference of 'essentially unchanged' introduces a false quantitative comparison not supported by the data—this penalizes quantitative accuracy. (3) The multi-hop reasoning is partially sound: the model connects Starbucks’ investment across two fiscal years and correctly identifies the reporting line. However, it fails to acknowledge that FY2023 lacked specific disclosure, thus misrepresenting continuity. The evolution from unspecified to quantified investment is a key nuance missing in the LLM answer. (4) Contextual relevance is high because the answer addresses the core elements—carrying value, financial impact, and reporting line. However, due to the incorrect assertion about stability in value year-over-year and omission of the lack of FY2023 disclosure, correctness and qualitative accuracy are reduced to moderate scores.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 425,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How has the strategic positioning of Analog Products evolved between 2022 and 2023 in terms of TI's competitive advantages and financial contribution?",
      "original_answer": "In 2022, Analog Products were central to TI's strategic focus, contributing to a gross margin of 67.5% driven by the efficiency of their manufacturing strategy, including 300-millimeter production. By 2023, Analog Products remained a core pillar but were framed more explicitly within the context of TI's four sustainable competitive advantages, particularly emphasizing lower costs and greater control of the supply chain. Additionally, the 2023 report reinforced the role of Analog Products in enabling TI to generate and return significant cash, with a renewed emphasis on long-term free cash flow per share growth as the ultimate performance metric.",
      "llm_answer": "Both 2022 and 2023 filings stress that analog products remain a core pillar of TI’s business model, built on the four sustainable competitive advantages—manufacturing & technology foundation, broad portfolio, extensive market‑channel reach, and product diversity—and continue to be emphasized for industrial and automotive end‑markets (2022 p.21; 2023 p.19). Nevertheless, the analog segment’s financial contribution weakened: revenue fell from $15.4 billion in 2022 to $13.0 billion in 2023 (‑15%) and operating profit dropped from $8.36 billion to $5.82 billion (‑30%), cutting its operating‑margin from 54.4% to 44.6% (2023 p.20).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. The ground truth states that Analog Products contributed to a gross margin of 67.5% in 2022 due to manufacturing efficiency, but the LLM claims an operating margin of 54.4% in 2022 and 44.6% in 2023, which contradicts the ground truth. Additionally, the LLM reports declining revenue and operating profit (from $15.4B to $13.0B and $8.36B to $5.82B), but the ground truth does not mention any such decline—instead, it emphasizes continuity and strategic reinforcement. These financial figures are entirely absent from the original answer and appear to be fabricated or misattributed. (2) The quantitative inaccuracies are severe: no revenue, profit, or margin numbers are present in the ground truth, and the LLM introduces unsupported data with precise but incorrect figures and calculations (e.g., -15%, -30%). These numbers do not align with the actual filings. (3) The reasoning is flawed: while the LLM correctly identifies that analog products remain a core pillar and references TI’s competitive advantages, it fails to capture the evolution in strategic framing—specifically, the increased emphasis on supply chain control, cost leadership, and free cash flow per share growth in 2023. Instead, it incorrectly infers a strategic weakening due to fabricated financial deterioration. (4) Contextual relevance is moderate because the answer discusses relevant themes (competitive advantages, core business role), but the incorrect financial narrative undermines the qualitative and quantitative accuracy, leading to a low overall correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 443,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Chevron's capital allocation strategy in the Lower 48 region evolved from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments?",
      "original_answer": "Chevron's capital allocation in the Lower 48 region increased significantly from 2022 to 2023, as evidenced by the rise in depreciation, depletion, amortization, and impairments from $4,854 million in 2022 to $5,729 million in 2023. This indicates a growing focus on asset development and operational expansion in the Lower 48, contrasting with relatively stable or declining figures in other geographic segments like Europe, Middle East and North Africa.",
      "llm_answer": "Chevron’s Lower 48 segment recorded $4.854 billion of depreciation, depletion, amortization and impairments in 2022, which rose to $5.729 billion in 2023—an increase of roughly $875 million【page_133】. The higher non‑cash expense reflects a larger asset base and greater capital spending, indicating that Chevron shifted to a more aggressive capital‑allocation stance in the Lower 48 region in 2023 versus 2022.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the depreciation, depletion, amortization, and impairments (DD&A) figures for Chevron's Lower 48 region as $4.854 billion in 2022 and $5.729 billion in 2023, matching the ground truth exactly. The calculated increase of $875 million is accurate ($5,729M - $4,854M = $875M), though the LLM rounds it to 'roughly $875 million', which is acceptable. (2) All numeric values and dates are correct, with appropriate unit formatting ($4.854 billion = $4,854 million). Calculations are precise and consistent with the source data. (3) The reasoning is sound: the increase in DD&A is correctly interpreted as evidence of higher capital spending and a growing asset base, indicating a more aggressive capital allocation strategy in 2023. This aligns with the multi-hop logic in the original answer, which infers strategic shifts from financial trends. (4) The LLM answer is semantically equivalent to the ground truth, capturing the core conclusion about increased capital allocation. It omits the comparative context about other regions (e.g., Europe, Middle East and North Africa) mentioned in the original answer, which slightly reduces completeness but does not affect the main factual accuracy. Hence, a high score of 9 is justified, with full marks in quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1223,
        "completion_tokens": 375,
        "total_tokens": 1598
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Verizon's approach to FWA Broadband evolved between 2023 and 2024, particularly in terms of its positioning within the company's product portfolio and its target customer segments?",
      "original_answer": "In 2023, Verizon provided FWA broadband through both 5G and LTE networks, targeting both Consumer and Business customers, and reported 3.1 million FWA broadband connections. By 2024, the company continued to offer FWA broadband primarily under the Verizon Consumer and Business Group segments, but with a more integrated positioning as an alternative to traditional landline internet access and as part of a broader portfolio that includes IoT and advanced communication services. The shift from 'provides' in 2023 to 'produces' in 2024 indicates a more strategic and product-centric approach to FWA broadband.",
      "llm_answer": "In the 2023 filing Verizon presented Fixed‑Wireless Access (FWA) as a stand‑alone broadband product that was offered to both residential consumers and business customers – it was described as “fixed wireless access (FWA) broadband … as an alternative to traditional landline internet access” in the Consumer segment and as part of the Business segment’s portfolio, and the company even disclosed about 3.1 million FWA connections at year‑end 2023【page_4】【page_5】. By the 2024 filing the language still places FWA under both segments, but the Consumer description now frames it primarily as an extension of the 5G/4G LTE network within the residential broadband suite (“We also provide FWA broadband … as an alternative to traditional landline internet access”), while the Business segment merely lists it among a broader set of services for enterprises, public‑sector and carrier customers, indicating a shift toward a more integrated, consumer‑centric positioning and less separate emphasis on the business‑specific FWA offering【page_100】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Verizon offered FWA broadband via 5G and LTE in 2023 to both Consumer and Business segments, reported 3.1 million connections by year-end 2023, and maintained FWA presence in both segments in 2024. The shift in language from standalone to more integrated positioning is accurately captured. (2) Quantitative accuracy is perfect: the 3.1 million FWA connections figure is correctly cited and attributed to 2023. No calculations were required, but the number is precise and matches the ground truth. (3) Reasoning is sound: the LLM correctly infers a strategic shift based on wording changes (e.g., from 'provides' to 'also provides' and integration into broader service suites), noting a more consumer-centric and less business-emphasized approach in 2024. It synthesizes information across both years and segments appropriately. (4) The only minor shortcoming is that the LLM does not explicitly mention the shift in terminology from 'provides' to 'produces' as an indicator of a more product-centric strategy, which is a nuance highlighted in the original answer. However, the overall semantic meaning and strategic interpretation are effectively conveyed. Wording differences are acceptable under semantic equivalence. Contextual relevance is excellent as all parts of the question—positioning within the portfolio and target customer segments—are addressed with appropriate detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 409,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has Emerson's relationship with AspenTech evolved from 2022 to 2024, and what financial impact did this evolution have on Emerson's gross margin and equity structure?",
      "original_answer": "In 2022, Emerson partnered with AspenTech, leveraging its asset optimization software to enhance industrial operational efficiency. By 2024, Emerson had significantly deepened this relationship by acquiring a 55% ownership stake in AspenTech as part of a strategic transaction that created 'New AspenTech.' This acquisition contributed positively to Emerson’s gross margin, benefiting it by 0.6 percentage points in 2023 and further influencing financial structure in 2024 with increased SG&A expenses tied to the integration. Additionally, the equity structure was impacted through the recognition of gains and losses associated with the AspenTech stock plans and the broader restructuring of industrial software assets.",
      "llm_answer": "Emerson’s tie‑up with AspenTech began in 2022 when it contributed its two stand‑alone industrial‑software businesses and $6 billion of cash to Heritage AspenTech, receiving a 55 % ownership of the newly formed “New AspenTech” 【page_3】. By 2024 Emerson still owned a majority stake—about 57 %—and on November 5 2024 announced a cash offer to purchase all of the remaining AspenTech shares, moving the relationship toward full ownership 【page_25】. The 2022‑23 AspenTech acquisition lifted Emerson’s gross margin by roughly 0.6 percentage point in 2023 (part of the 3.3‑point rise to 49.0 %) and gross margin continued to improve to 50.8 % in 2024, while the equity structure shifted from a 55 % joint‑venture to a near‑complete (potential 100 %) owned subsidiary, increasing the proportion of AspenTech earnings reflected in Emerson’s consolidated equity 【page_26】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually correct and aligns closely with the ground truth. It accurately captures the evolution of Emerson's relationship with AspenTech from a strategic transaction in 2022 to a move toward full ownership by 2024. The financial impact on gross margin (0.6 percentage point increase in 2023) is correctly stated and contextualized within Emerson’s overall margin improvement to 49.0% in 2023 and 50.8% in 2024. The equity structure shift from 55% to ~57% and the November 5, 2024 announcement of a cash offer for remaining shares are consistent with the source material. (2) Quantitative accuracy is excellent: all percentages (55%, 57%), dollar amount ($6 billion), dates (November 5, 2024), and margin impacts (0.6 pp, 49.0%, 50.8%) are correct and match the source. The 3.3-point gross margin rise is also accurate contextually. (3) Multi-hop reasoning is sound—LLM synthesizes information across time (2022 formation, 2023 impact, 2024 developments), entities (Emerson, AspenTech), and financial dimensions (gross margin, equity structure). One minor omission: the original answer mentions increased SG&A expenses due to integration, which the LLM omits. Also, the LLM implies the 0.6 pp lift was spread over 2022–2023, while the original specifies it was realized in 2023. This nuance slightly affects precision but not overall correctness. (4) Scores reflect high accuracy, with a 9 on correctness due to minor omission and slight imprecision in timing attribution; qualitative accuracy is strong but not perfect for the same reason. Quantitative and contextual scores are 10 due to full alignment on numbers and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 455,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How did the financial relationship between NEE and FPL Group Capital Inc evolve from 2022 to 2023, particularly in terms of the nature of their obligations and capital structure involvement?",
      "original_answer": "In 2022, the relationship was characterized by a guarantee agreement between FPL Group, Inc. and FPL Group Capital Inc. dated October 14, 1998, indicating a direct obligation from FPL Group, Inc. to FPL Group Capital Inc. By 2023, this relationship had evolved into a more complex capital structure involvement, with NEE issuing multiple series of junior subordinated debentures to FPL Group Capital Inc., including Series B, C, L, M, N, O, and P, with maturity dates ranging from 2057 to 2082. This transition reflects a strategic shift from a simple guarantee to a long-term capital financing arrangement.",
      "llm_answer": "In the 2022 proxy the link between NEE (through its subsidiary FPL Group) and FPL Group Capital Inc was essentially a guarantee arrangement – FPL Group acted as guarantor of Capital’s obligations (see the “Guarantee Agreement … dated Oct 14 1998” listed as Exhibit *10(vv) on page 124). By the 2023 filing that relationship had expanded: Capital (now NextEra Energy Capital Holdings) is issuing its own unsecured debt – a series of debentures and floating‑rate notes documented in the Indenture (Exhibit *4(l)), the supplemental indenture (Exhibit *4(m)), a new guarantee agreement (Exhibit *4(n)) and a host of officer‑certificate and amendment letters on page 118 – showing NEE/FPL still providing guarantees but now actively involved in Capital’s capital‑structure financing.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general evolution of the financial relationship between NEE and FPL Group Capital Inc from a guarantee to a more involved capital structure, which aligns with the question's intent. However, there are significant factual inaccuracies that reduce correctness. (1) The LLM incorrectly states that FPL Group Capital Inc is issuing debt in 2023, when the ground truth indicates that NEE (not Capital) issued junior subordinated debentures *to* FPL Group Capital Inc — a critical reversal of the financial flow. (2) The renaming of FPL Group Capital Inc to 'NextEra Energy Capital Holdings' is plausible but not confirmed in the ground truth and should not be asserted without support. (3) The mention of 'floating-rate notes', 'Indenture (Exhibit *4(l))', 'supplemental indenture (Exhibit *4(m))', and 'officer-certificate and amendment letters on page 118' adds procedural detail but is not present in the original answer and may reflect overinterpretation of filing structures rather than the core factual evolution. (4) The guarantee agreement is correctly cited as existing in 2022 (Oct 14, 1998), but the LLM mischaracterizes it as FPL Group guaranteeing Capital’s obligations, whereas the original answer describes it as an obligation *from* FPL Group, Inc. to Capital — a directional difference with financial significance. (5) The original answer specifies the issuance of Series B, C, L, M, N, O, and P debentures with maturities from 2057–2082, which the LLM omits entirely, missing key quantitative and structural details. While the LLM recognizes a shift in relationship and cites exhibit numbers, it fails to accurately represent the nature of the 2023 capital structure changes. Quantitative accuracy is moderate due to correct dates (1998) and exhibit references, but missing series and maturities hurt precision. Qualitative accuracy suffers from incorrect entity roles and directionality of obligations. Contextual relevance is high as the response stays focused on the evolution of the financial relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 548,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How has the positioning and market acceptance of InterStim II evolved between 2022 and 2024, particularly in relation to other InterStim neurostimulators and broader Pelvic Health therapies?",
      "original_answer": "In 2022, InterStim II was described as part of a suite of InterStim neurostimulators including InterStim Micro and InterStim X, with an emphasis on continued acceptance and growth in treating overactive bladder, urinary retention, and bowel incontinence. By 2024, InterStim II was specifically highlighted as a recharge-free neurostimulator, grouped alongside InterStim X and InterStim Micro (now differentiated by recharge status), and positioned within a broader context of continued acceptance and growth of Pelvic Health therapies. This evolution indicates a shift toward emphasizing device-specific attributes (e.g., recharge-free) and integration into a more mature and diversified product portfolio.",
      "llm_answer": "In the 2022 filing Medtronic noted that **InterStim II was part of the broader InterStim therapy suite**—alongside InterStim Micro and InterStim X—whose “continued acceptance and growth” was driving the Pelvic Health segment (MDT 2022 10‑K, p. 42). By the 2024 filing the company **re‑positions InterStim II as a distinct “recharge‑free neurostimulator,”** highlighting its differentiation from the rechargeable InterStim Micro and the newer InterStim X, while again emphasizing “continued acceptance and growth” of the Pelvic Health therapies that include all three devices (MDT 2024 10‑K, p. 39). This evolution shows that InterStim II’s market acceptance has been sustained and its positioning sharpened to stress its recharge‑free advantage within an expanding Pelvic Health portfolio.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures the evolution of InterStim II's positioning: in 2022, it was part of a broader suite (InterStim II, Micro, and X) with 'continued acceptance and growth' in pelvic health therapies, and by 2024, it was repositioned as a recharge-free device, differentiated from rechargeable alternatives. (2) There are no numerical values requiring calculation, but the years (2022 and 2024) and product names (InterStim II, Micro, X) are correctly identified. (3) The multi-hop reasoning is sound—information is correctly synthesized across two years of filings and product positioning shifts, showing how InterStim II’s market role evolved within a maturing portfolio. (4) The LLM adds contextual precision by citing specific 10-K page numbers and Medtronic (MDT) as the filer, enhancing credibility without introducing error. The core message—that InterStim II shifted from being part of a general suite to being highlighted for its recharge-free attribute while maintaining market acceptance—is fully aligned with the original answer. All aspects of the question (positioning, market acceptance, relation to other devices and broader therapies) are addressed with factual and conceptual accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 359,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Simon Property Group's utilization and management of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of borrowing capacity, interest rate strategies, and repayment actions?",
      "original_answer": "In 2022, the Supplemental Facility had an initial borrowing capacity of $3.5 billion, which could be increased to $4.5 billion, with a maturity date of January 31, 2026. Borrowings under the facility bore interest based on SOFR or similar rates, with a margin determined by the company's credit rating. By 2024, SPG had borrowed €750.0 million under the Supplemental Facility, which was repaid on November 17, 2023, following the issuance of exchangeable bonds. Additionally, interest rate swaps were used in 2023 to fix the rate on these borrowings at 3.81%. This indicates a shift from passive availability in 2022 to active utilization and strategic interest rate management in 2024.",
      "llm_answer": "In the 2022 Form 10‑K the Supplemental Facility was described as a $3.5 billion revolving line (expandable to $4.5 billion) that would mature on January 31 2026, with borrowings priced at SOFR + 72.5 bps (or other benchmark options) plus a margin tied to Simon’s credit rating. By the 2024 filing the capacity range remained $3.5‑$4.5 billion but the maturity was extended to January 31 2029 (extendable to 2030) and the same SOFR + 72.5 bps pricing is still used; the company also repaid the €750 million of Euro‑denominated borrowings under the Supplemental Facility in November 2023 using proceeds from a €750 million senior unsecured bond issuance and terminated the related interest‑rate swaps.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but introduces significant inaccuracies. The initial borrowing capacity of $3.5 billion (expandable to $4.5 billion) and the SOFR-based pricing are correctly reported, as is the repayment of €750 million in November 2023. However, the LLM incorrectly states that the maturity was extended to January 31, 2029 (extendable to 2030), which contradicts the ground truth stating the 2022 maturity as January 31, 2026, with no mention of an extension in the provided truth. This is a critical factual error. Additionally, the LLM claims the pricing remained at 'SOFR + 72.5 bps', but the ground truth does not specify this exact margin, only that the margin is tied to credit rating—making this detail unsupported. The ground truth mentions interest rate swaps were used to fix the rate at 3.81%, but the LLM states the swaps were terminated, which contradicts the original answer implying active use for rate management. (2) Quantitative accuracy is partially correct: $3.5B/$4.5B capacity, €750M repayment, and November 17, 2023 (approximated as November 2023) are accurate. However, the maturity date and interest rate margin (72.5 bps) are incorrect or unverified. (3) The multi-hop reasoning is sound in structure—comparing 2022 and 2024 states of the facility, addressing capacity, interest strategy, and repayment—but fails due to incorporation of incorrect data (maturity extension, specific margin, swap termination). (4) Contextual relevance is high as the answer directly addresses borrowing capacity, interest rate strategy, and repayment actions. However, due to key factual errors in dates and financial terms, the correctness score is reduced to 6, reflecting partial accuracy with significant flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 482,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has Verizon's approach to device payment plans evolved from 2023 to 2024, particularly in terms of customer financing structure and promotional incentives?",
      "original_answer": "In 2023, Verizon permitted customers to acquire equipment using device payment plans that allowed installment payments over time, with no mention of structured promotional incentives or trade-in rights. By 2024, Verizon formalized the device payment plan structure, describing it as a non-interest-bearing installment note typically repaid over a 36-month term, and introduced a defined promotional feature that allows customers to upgrade to a new device after paying a specified portion of their plan and trading in their current device in good working order. This represents a shift from a general financing mechanism to a more structured and incentive-driven model.",
      "llm_answer": "In the 2023 filing Verizon only said that customers could “acquire equipment … using device payment plans, which permit the customer to pay for the device in installments over time” (page 5). By 2024 the description had become more detailed: the plan is a non‑interest‑bearing installment note—typically 36 months—paired with a month‑to‑month service contract, and Verizon now adds promotional billing‑credit incentives and upgrade/trade‑in rights that are accounted for as variable consideration and a guarantee liability (pages 60‑61). Thus, the financing structure remains an installment note, but the company has layered in explicit promotional incentives and more granular accounting treatment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2023, Verizon offered device payment plans with installment payments but without detailed promotional structure. In 2024, it accurately notes the formalization of the plan as a non-interest-bearing installment note over a typical 36-month term, which matches the ground truth. (2) All quantitative elements—'36-month term'—are correct and consistently reported; no calculations were required. (3) The multi-hop reasoning is sound: the model synthesizes changes across two years, correctly identifying the evolution from a basic installment plan to one with added promotional incentives (upgrade/trade-in rights) and variable consideration accounting. It even adds granular detail (e.g., 'guarantee liability', 'pages 60-61') not in the ground truth but consistent with accurate sourcing. (4) The only minor gap is that the LLM mentions 'promotional billing-credit incentives' and 'guarantee liability'—while factually plausible and consistent with the structured incentives in the ground truth—the original answer frames the promotion more narrowly around upgrade eligibility after paying a portion and trading in the device. The core evolution (from basic financing to structured, incentive-driven model) is correctly captured. Wording differs slightly but semantic meaning is equivalent. No factual errors; minor difference in emphasis does not undermine correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 406,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How has The Coca-Cola Company's legal relationship with Aqua-Chem evolved between 2023 and 2024, particularly in terms of its stance on liability for Aqua-Chem's asbestos-related claims?",
      "original_answer": "In 2023, Coca-Cola maintained that it had no obligation to Aqua-Chem for any liabilities or expenses related to claims or lawsuits against Aqua-Chem, as outlined in the Georgia Case. By 2024, while the litigation status remained largely unchanged, Coca-Cola's disclosure now includes a more detailed description of the insurance policies issued during its ownership of Aqua-Chem, particularly highlighting the involvement of multiple insurers and the ongoing coverage litigation. This indicates a shift in emphasis from outright denial of liability to a more nuanced stance centered on insurance coverage and shared responsibility among insurers.",
      "llm_answer": "Both the 2023 and 2024 10‑K filings describe the Aqua‑Chem matter in the same terms: the Company still maintains that it “has no obligation … for any past, present or future liabilities … in connection with any claims or lawsuits against Aqua‑Chem,” including the asbestos‑related claims (see 2023 p. 30 and 2024 p. 30). The litigation status is unchanged – the Georgia case remains stayed, the Wisconsin case was voluntarily dismissed, and the Company continues to defend its position and pursue coverage settlements, with a summary‑judgment ruling in its favor (see 2023 p. 31 and 2024 p. 31).",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent with the 10-K filings in terms of the legal positions and case statuses cited (e.g., Coca-Cola's stated lack of obligation, the stayed Georgia case, dismissal of the Wisconsin case, and summary judgment), and there are no errors in dates, entities, or quantitative details—hence a high quantitative accuracy score. However, the LLM fails to capture the key qualitative evolution highlighted in the ground truth: the shift in Coca-Cola's 2024 disclosure toward a more nuanced stance emphasizing insurance coverage and shared insurer responsibility, despite maintaining the same denial of direct liability. The original answer identifies a subtle but important change in narrative emphasis—from outright denial to engagement with insurance dynamics—while the LLM portrays the stance as unchanged, missing the multi-hop synthesis between legal position and disclosure tone. This omission significantly undermines the qualitative accuracy, as the evolution in disclosure strategy is central to the question. Contextually, the answer is relevant and well-structured, citing correct pages and cases, but it does not fully address the 'evolution' aspect of the question, particularly the shift in rhetorical and strategic framing around liability and insurance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 359,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How did Intel's utilization of non-US tax credits impact its long-term income tax liabilities in 2024 compared to 2022, and what does this indicate about the company's international tax strategy?",
      "original_answer": "In 2022, Intel reported long-term income taxes payable of $4.3 billion, which included the transition tax from Tax Reform and uncertain tax positions, reduced by non-US tax credits. By 2024, this figure had decreased to $1.6 billion, indicating that the company's utilization of non-US tax credits had a stronger offsetting effect over time. This suggests a strategic shift or increased effectiveness in leveraging international tax credits to reduce overall tax liabilities.",
      "llm_answer": "Intel’s long‑term tax payable shrank dramatically – it was $4.3 billion in the 2022 filing (Dec 25 2021) and fell to $1.6 billion in the 2024 filing (Dec 28 2024) – and both footnotes note that the balance is “reduced by … non‑US tax credits”【page_92】 and “reduced by … non‑US tax credits”【page_83】. The steep decline shows Intel is actively using foreign tax credits to offset U.S. transition‑tax and uncertain‑position liabilities, indicating a deliberate international tax strategy that leverages its overseas operations to lower its overall tax burden.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the long-term income tax payable amounts for Intel in 2022 ($4.3 billion) and 2024 ($1.6 billion), matching the ground truth exactly. The years and corresponding figures are accurate, and the mention of non-US tax credits reducing the liability in both years is factually correct and supported by the cited pages. (2) Quantitative accuracy is perfect: both dollar amounts and the implied comparison (a significant decrease) are correct. There are no calculation errors, and the formatting variations (e.g., $4.3 billion vs $4.3B) are acceptable. (3) The reasoning is sound and reflects proper multi-hop synthesis: the model connects the reduction in tax liability over time with the increasing or sustained use of non-US tax credits, correctly inferring a strategic international tax approach. The conclusion about leveraging overseas operations aligns semantically with the ground truth’s interpretation of a 'strategic shift or increased effectiveness.' The only minor gap is that the original answer emphasizes the 'stronger offsetting effect over time,' which the LLM implies but does not explicitly quantify (e.g., no mention of the $2.7 billion decrease). (4) Contextual relevance is excellent—the response directly addresses both parts of the question: the impact on tax liabilities and the implication for international tax strategy. Overall, the answer is factually complete, well-reasoned, and semantically equivalent to the ground truth, warranting a high score with only a slight deduction in qualitative accuracy for not fully elaborating on the trend's magnitude.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1270,
        "completion_tokens": 446,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has the treatment and risk exposure of pension risk transfers evolved between 2022 and 2024, particularly in terms of interest rate sensitivity and regulatory influence?",
      "original_answer": "In 2022, pension risk transfers were part of the Retirement and Income Solutions business, which was described as containing both short- and long-duration products, and was subject to interest rate scenarios that could impact asset-liability management (ALM) strategies. By 2024, regulatory changes, particularly around defined benefit pension plan funding, were found to potentially reduce the likelihood or delay corporate plan sponsors from terminating their plans or transferring pension obligations. This regulatory evolution increased the potential for a shift in the mix of pension risk transfers toward non-guaranteed funding products, indicating a strategic and regulatory-driven change in exposure.",
      "llm_answer": "In the 2022 filing, pension risk transfers were grouped in the Retirement‑and‑Income‑Solutions (RIS) segment and were explicitly modelled for interest‑rate risk – the company projected earnings impacts for RIS under both declining‑ and rising‑rate scenarios (e.g., ‑$5 M to +$15 M in adjusted earnings, page 61) and noted that lower rates increase pension‑liability values (page 63). By the 2024 filing, the focus shifted to regulatory drivers: new or revised defined‑benefit funding rules are expected to alter the mix of pension‑risk‑transfer transactions and push the business toward more non‑guaranteed funding products (page 32), while the detailed interest‑rate sensitivity of those transfers is no longer highlighted.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022, pension risk transfers were part of the Retirement and Income Solutions (RIS) segment and subject to interest rate sensitivity, noting that lower rates increase pension liability values—consistent with the original answer's reference to interest rate scenarios impacting ALM strategies. The specific quantitative projections (e.g., -$5M to +$15M in adjusted earnings) are accurately cited from page 61 and 63, which supports the interest rate sensitivity discussion. (2) For 2024, the LLM correctly captures the shift toward regulatory influence, specifically changes in defined benefit funding rules that affect the mix of pension risk transfer transactions, pushing toward non-guaranteed funding products, as stated on page 32. This matches the original answer’s emphasis on regulatory evolution reducing plan terminations and altering exposure. (3) The multi-hop reasoning is sound: the model synthesizes information across two years, correctly identifying a shift from interest-rate-driven risk modeling in 2022 to regulatory-driven strategic changes in 2024. (4) Minor deduction in quantitative accuracy is due to the introduction of specific dollar figures (-$5M to +$15M) not present in the ground truth; while plausible and contextually appropriate, they cannot be verified as correct without access to the actual filings. However, since the ground truth does not contradict them and they support a correct qualitative point, this does not severely impact correctness. Overall, the answer is factually solid, contextually precise, and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 460,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 13,
      "question": "How has Medtronic's positioning and product strategy around the InterStim Micro neurostimulator evolved between 2022 and 2024?",
      "original_answer": "In 2022, Medtronic positioned the InterStim Micro as part of its broader InterStim therapy offering for treating overactive bladder, urinary retention, and bowel incontinence, alongside InterStim II and InterStim X neurostimulators. It was described as part of a growing and accepted product line within the Pelvic Health therapies under the Specialty Therapies division. By 2024, Medtronic specifically highlighted the InterStim Micro as a 'rechargeable neurostimulator' while emphasizing the continued acceptance and growth of InterStim therapy, particularly in the U.S., and distinguishing it from the recharge-free InterStim X and InterStim II models. This indicates a more targeted marketing and differentiation strategy for the InterStim Micro within the evolving Pelvic Health product portfolio.",
      "llm_answer": "In 2022 Medtronic presented the InterStim Micro as a **newly launched** rechargeable neurostimulator that was a key driver of growth in its Specialty‑Therapies/Pelvic‑Health segment (e.g., “growth was led by sales of the recently launched InterStim Micro neurostimulator” – 2022 10‑K p. 41; and the InterStim portfolio description – 2022 10‑K p. 42). By 2024 the company treats the InterStim Micro as an **established component** of a broader InterStim therapy suite (InterStim X, InterStim II and InterStim Micro) and emphasizes **continued acceptance and growth** of the device within its Pelvic‑Health portfolio (2024 10‑K p. 39).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in Medtronic's positioning of the InterStim Micro: from a newly launched, growth-driving product in 2022 to an established part of a broader therapy suite by 2024. This matches the original answer’s narrative of shifting from general inclusion in a product line to more distinct, targeted marketing. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer beyond the years 2022 and 2024, which are correctly used—thus quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years of 10-K filings, correctly inferring a strategic shift based on changes in language (from 'newly launched' to 'established component'). It also correctly identifies the product category (Pelvic Health therapies under Specialty Therapies) and differentiates InterStim Micro from InterStim II and InterStim X. (4) The only minor shortcoming is that the LLM does not explicitly mention that by 2024, Medtronic emphasized the InterStim Micro as 'rechargeable' in contrast to the 'recharge-free' InterStim X and II models—a key differentiator highlighted in the original answer. While the LLM implies this by calling it rechargeable in 2022, it doesn’t reiterate the contrast in 2024, slightly weakening the qualitative completeness. However, the core facts, entities, timeline, and strategic evolution are all correct and contextually well-represented.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 426,
        "total_tokens": 1780
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Simon Property Group's use of the Supplemental Facility evolved between 2022 and 2024, particularly in terms of outstanding borrowings and repayment actions?",
      "original_answer": "In 2022, Simon Property Group had a weighted average outstanding balance under the Credit Facilities (including the Supplemental Facility) of $519.9 million, with a maximum aggregate outstanding balance of $2.1 billion during the year. By 2024, the weighted average outstanding balance under the Facilities had decreased to $311.1 million, and the company had repaid a significant portion of its borrowings, including €750.0 million ($815.4 million U.S. dollar equivalent) under the Supplemental Facility on November 17, 2023. This indicates a strategic reduction and refinancing of debt drawn from the Supplemental Facility over the two-year period.",
      "llm_answer": "In the 2022 filing the Operating Partnership had drawn $1.05 billion from the Supplemental Facility in December 2021 and then fully repaid that amount on January 12 2022 with proceeds from newly issued senior notes (see page 125). By the 2024 filing the only Supplemental‑Facility borrowing left was a €750 million ($815 million) draw that was retired in November 2023 when the Partnership issued €750 million of senior bonds (see page 70), and the year‑end 2024 aggregate outstanding balance across all credit facilities was just $325.1 million, indicating the Supplemental Facility is now essentially unused (pages 68‑69).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and timing compared to the ground truth. While it correctly identifies the €750 million ($815 million) repayment under the Supplemental Facility in November 2023, it incorrectly states that a $1.05 billion draw was made in December 2021 and repaid in January 2022. The ground truth does not mention this specific $1.05 billion draw/repayment in early 2022, nor does it isolate the Supplemental Facility usage to that single draw. Instead, the ground truth reports a weighted average outstanding balance of $519.9 million across all Credit Facilities (including the Supplemental Facility) in 2022, with a maximum aggregate balance of $2.1 billion during the year. The LLM answer misrepresents this by implying the Supplemental Facility was used for a single $1.05B draw and then fully repaid, which is not supported by the original data. Additionally, the LLM cites a year-end 2024 aggregate balance of $325.1 million, while the ground truth reports a weighted average outstanding balance of $311.1 million in 2024—close but not exact, and conflates year-end with weighted average. (2) Quantitative accuracy is compromised: the $1.05B draw and repayment are not in the ground truth; the $325.1M vs $311.1M discrepancy, while minor, reflects imprecise reporting; the €750M repayment is correctly cited. (3) The reasoning is partially sound: the model correctly infers a reduction in Supplemental Facility usage and links the November 2023 repayment to bond issuance, showing multi-hop synthesis. However, it overinterprets isolated transactions not clearly stated in the ground truth and fails to reflect the broader usage pattern across the full 2022 period. (4) Contextual relevance is high—the answer addresses the evolution of Supplemental Facility use, repayments, and current status. Despite incorrect specifics, it captures the directional trend of debt reduction. Correctness score is 6 due to significant quantitative errors but correct identification of key repayment event and overall trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 558,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did COP's investment activity in the Lower 48 region evolve from 2022 to 2023, based on the changes in depreciation, depletion, amortization, and impairments expenses?",
      "original_answer": "In 2022, COP reported $4,854 million in depreciation, depletion, amortization, and impairments expenses for the Lower 48 region, which increased to $5,729 million in 2023. This indicates a significant increase in investment activity or asset utilization in the Lower 48 region over that period.",
      "llm_answer": "In 2022 the Lower 48 segment recorded $4.854 billion of depreciation, depletion, amortization and impairments; in 2023 that amount grew to $5.729 billion – an increase of roughly $875 million (about 18%). The higher expense indicates that COP’s investment activity in the Lower 48 region rose in 2023 relative to the prior year.【page_133】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the depreciation, depletion, amortization, and impairments expenses for COP's Lower 48 region in both 2022 ($4.854 billion) and 2023 ($5.729 billion), matching the ground truth values exactly (with acceptable format variation: $4,854 million = $4.854 billion). (2) The calculation of the increase—$5,729M - $4,854M = $875M—is accurate, and the percentage increase is correctly approximated at about 18% (exact: (875 / 4854) ≈ 18.03%), demonstrating precise quantitative reasoning. (3) The multi-hop reasoning is sound: the model correctly infers that rising DDA&I expenses indicate increased investment activity or asset utilization, which aligns with standard financial interpretation in upstream oil and gas. (4) All entities—COP, Lower 48 region, correct years, and financial metric—are accurately identified and synthesized. The answer is semantically equivalent to the ground truth, with added value in quantifying the change. All aspects of the question are addressed thoroughly and accurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1164,
        "completion_tokens": 301,
        "total_tokens": 1466
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has Verizon's approach to corporate networking solutions evolved from 2023 to 2024, particularly in terms of service description and business segment emphasis?",
      "original_answer": "In 2023, Verizon's Business segment explicitly described offering a broad portfolio of network connectivity products, including private networking services, private cloud connectivity services, and software-defined networking services, with Enterprise and Public Sector revenues reaching $15.1 billion, or approximately 50% of Business's total revenues. By 2024, the Business segment's description became more streamlined, focusing on wireless and wireline communications services and products, including corporate networking solutions, without specifying the same level of detail in offerings or segment revenue. This indicates a shift toward a more generalized presentation of services, potentially signaling a strategic consolidation or simplification of messaging around corporate networking solutions.",
      "llm_answer": "In the 2023 filing Verizon described its Business segment’s corporate networking offering as one of a set of services – “wireless and wireline communications … including FWA broadband, data, video and conferencing services, **corporate networking solutions**, security and managed network services, …”【page_5】. By the 2024 filing the language had been broadened to place corporate networking inside a larger “**advanced communication services**” suite – “wireless and wireline communications … including FWAbroadband, data, video and **advanced communication services, corporate networking solutions**, security and managed network services, …”【page_100】.  \n\nAt the same time, the Business segment’s revenue mix shifted. In 2023, Business Markets and Other (which houses the corporate‑networking products for small‑ and medium‑size firms) accounted for about $12.7 billion of $30.1 billion in Business revenue (≈42%)【page_101】. In 2024 that line grew to $13.1 billion of $29.5 billion (≈44%) while Enterprise and Public Sector fell slightly, indicating a stronger emphasis on the Business Markets and Other segment – and thus on corporate networking solutions – in 2024.【page_100】",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The revenue figures cited are incorrect. The original answer states that Enterprise and Public Sector revenues were $15.1 billion in 2023, accounting for approximately 50% of Business segment revenue. However, the LLM claims Business Markets and Other accounted for $12.7 billion of $30.1 billion (≈42%) in 2023 and $13.1 billion of $29.5 billion (≈44%) in 2024, which contradicts the ground truth and misrepresents both the segment and the magnitude of corporate networking emphasis. There is no mention in the original answer of 'Business Markets and Other' being the home of corporate networking products, nor of its revenue split. (2) Entity Accuracy: The LLM incorrectly identifies 'Business Markets and Other' as the segment housing corporate networking solutions, while the ground truth emphasizes Enterprise and Public Sector as the key segment with $15.1B in revenue. This misattribution leads to flawed conclusions. (3) Reasoning: The LLM infers a strategic shift toward greater emphasis on corporate networking in 2024 based on incorrect revenue data, which invalidates the logic. While it correctly observes a change in service description language—adding 'advanced communication services'—this is framed as broadening rather than streamlining, contrary to the original answer’s conclusion of a more generalized, less detailed presentation. (4) Semantic Equivalence: Despite capturing a linguistic shift in service categorization, the LLM fails to reflect the core insight from the original answer: a move toward simplified, less detailed disclosure in 2024. Instead, it posits increased emphasis on corporate networking due to flawed data, leading to an incorrect overall interpretation. (5) Contextual Relevance: The response addresses the question's focus on service description and business segment emphasis, and attempts multi-hop reasoning across years and segments, earning points for relevance and structure, even if the conclusions are factually unsound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 558,
        "total_tokens": 2059
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How did MetLife's valuation approach and sensitivity to fair value changes for FVO securities evolve from 2022 to 2024, particularly in terms of the impact of U.S. dollar appreciation?",
      "original_answer": "In 2022, MetLife reported that FVO securities had an estimated fair value of $1.6 billion and were sensitive to changes in the U.S. dollar, with a 10% appreciation leading to a $54 million decrease in value. By 2024, while no direct fair value figure for FVO securities is provided, the company emphasized a broader sensitivity framework where nonperformance risk spreads and unobservable inputs varied by duration and currency, indicating a more nuanced and dynamic valuation methodology. This evolution shows a shift from a static sensitivity model to a more complex, duration- and currency-dependent approach.",
      "llm_answer": "In the 2022 Form 10‑K MetLife disclosed that its FVO securities were measured at fair value using Level 3 techniques and that a 10 % appreciation of the U.S. dollar would reduce their estimated fair value by roughly **$7 million** (see the “U.S.‑dollar appreciation” sensitivity table – page 150, and footnote 7 on page 151). By the 2024 filing the company placed FVO securities together with unit‑linked assets under a single “Unit‑linked and FVO securities” Level 3 line, applying the same matrix‑pricing, offered‑quote and other significant‑unobservable‑input methods described for all Level 3 assets (page 249), and the dollar‑strength effect is now captured only in the broader foreign‑currency exchange‑rate sensitivity discussion (footnote 7 on page 250) rather than a separate dollar‑amount, indicating a shift to a more integrated valuation framework.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual errors, particularly in the quantitative domain. The ground truth states that a 10% U.S. dollar appreciation would lead to a $54 million decrease in FVO securities' value in 2022, but the LLM incorrectly reports this impact as $7 million, which is materially off. This error undermines the core of the multi-hop comparison. Additionally, the LLM claims that in 2022 FVO securities had a fair value of $1.6 billion (from ground truth), but this figure is not mentioned at all in the LLM response, weakening completeness. (2) The quantitative inaccuracy is severe: $7M vs $54M is not a formatting or rounding difference but a tenfold discrepancy, suggesting either misreading of the source or data hallucination. No correct fair value estimate for 2022 is provided in the LLM answer, and no fair value or sensitivity figure for 2024 is accurately reflected. (3) On qualitative reasoning, the LLM correctly identifies a shift in disclosure practices—bundling FVO with unit-linked assets and moving sensitivity into a broader foreign exchange discussion—suggesting an evolution toward a more integrated framework. This aligns with the ground truth’s notion of a more nuanced, dynamic approach. However, it fails to explicitly connect this to the stated evolution from a static to a duration- and currency-dependent model based on nonperformance risk and unobservable inputs. (4) Contextually, the answer is relevant and addresses the right documents (2022 and 2024 10-Ks), correct sections (footnotes, Level 3 disclosures), and the right conceptual shift in valuation approach. But due to the critical numerical error and omission of key figures, the correctness score is low despite some accurate directional insights.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 476,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has NextEra Energy's engagement in power marketing activities evolved between 2022 and 2023, particularly in terms of its energy trading services and associated financial performance?",
      "original_answer": "In 2022, NextEra Energy (NEE) was actively engaged in power and fuel marketing and trading activities, primarily providing full energy and capacity requirements services to distribution utilities, including load-following and ancillary services, while also optimizing the value of electricity and fuel contracts and generation assets. By 2023, NEE's subsidiary NEER had expanded its role in power marketing and trading, contributing to a significant increase in net income, which rose from $285 million in 2022 to $3,558 million in 2023. This indicates a substantial evolution and growth in the scale or profitability of NEE’s power marketing and trading activities over the period.",
      "llm_answer": "NextEra Energy’s NEER segment continued to “provide full energy and capacity‑requirements services … engage in power and fuel marketing and trading activities” in both years (2022 description of energy‑trading services 【page_77】; 2023 reaffirmation of the same activities 【page_40】).  The financial contribution of those activities, however, swung dramatically: 2022 saw a $2.67 billion loss from non‑qualifying commodity hedges, while 2023 generated a $2.53 billion gain, which was a primary driver of the $5.95 billion increase in operating revenues for 2023 (see operating‑revenues discussion 【page_40】).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in financial figures. The ground truth states that NextEra Energy's net income from power marketing activities rose from $285 million in 2022 to $3,558 million in 2023—a net increase of $3,273 million. However, the LLM claims a $2.67 billion loss in 2022 and a $2.53 billion gain in 2023, which contradicts the ground truth of positive net income in both years, especially the substantial profit in 2023. These figures are not only incorrect but suggest losses where there were large gains, fundamentally misrepresenting financial performance. (2) The LLM references a $5.95 billion increase in operating revenues tied to gains from commodity hedges, but this figure does not align with the ground truth, which attributes the growth to a rise in net income (not operating revenue) from $285M to $3,558M. There is no mention in the original answer of a $2.67B loss or $2.53B gain from hedges, nor is there support for framing the change as a swing from loss to gain. (3) While the LLM correctly identifies that NEER engaged in power and fuel marketing and trading in both years—showing some qualitative understanding of continuity in services—it fails to capture the key evolution: a dramatic increase in profitability. The multi-hop synthesis is flawed because it pulls in unrelated or incorrect financial metrics (commodity hedge impacts) instead of reporting the actual net income figures that demonstrate growth. (4) Despite incorrect numbers, the answer is contextually relevant, addressing both years, the nature of energy trading services, and attempting to link activities to financial outcomes. Hence, contextual relevance is high, but quantitative accuracy is severely compromised, dragging down overall correctness. Minor point: references to page numbers suggest document grounding, but the data extracted is factually inconsistent with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 526,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How has The Coca-Cola Company's financial relationship with Coca-Cola FEMSA evolved between 2023 and 2024, particularly in terms of its stake ownership and implications for equity income?",
      "original_answer": "In 2023, Coca-Cola FEMSA was referenced as one of the key bottlers whose financial performance could influence The Coca-Cola Company's credit ratings, indicating an indirect financial dependency. By 2024, The Coca-Cola Company held a 28% ownership stake in Coca-Cola FEMSA, which was accounted for under the equity method. This shift from a dependency-based relationship to a direct ownership stake suggests a strategic evolution, where Coca-Cola now has a more direct financial interest in FEMSA's performance, which will directly impact its equity income (loss) - net line item.",
      "llm_answer": "The Coca‑Cola Company’s ownership of Coca‑Cola FEMSA remained essentially unchanged – it still held a 28 % equity stake in 2024, the same level reported for 2023【page_87】.  That stable ownership translated into a modest rise in the company’s equity‑income line, which grew from $1.691 billion in 2023 to $1.770 billion in 2024, reflecting stronger proportionate earnings from its bottling partners, including FEMSA【page_87】.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces significant inaccuracies not present in the ground truth. While it correctly states that The Coca-Cola Company held a 28% stake in Coca-Cola FEMSA in 2024, it incorrectly claims the same stake was held in 2023, directly contradicting the original answer which indicates no direct ownership stake was mentioned for 2023—only an indirect financial dependency due to credit rating implications. The LLM fabricates a quantitative equity income increase from $1.691 billion to $1.770 billion, which is not supported by the ground truth; the original answer does not provide any specific equity income figures or suggest a 'modest rise' in income. These numbers appear to be hallucinated or derived from external data not in the knowledge graph. (2) The quantitative accuracy is partially correct in the 28% ownership figure for 2024, but the $1.691B and $1.770B figures are unsupported and thus factually incorrect. There is no verification that these numbers come from the cited 'page_87' in the context of the provided knowledge graph. (3) The multi-hop reasoning is flawed: the original answer emphasizes a strategic evolution from indirect dependency (2023) to direct ownership (2024), which the LLM fails to recognize, instead asserting stable ownership across years. This misrepresents the nature of the financial relationship evolution. (4) Contextual relevance is high because the answer addresses stake ownership and equity income implications, but correctness and qualitative reasoning are low due to factual errors and failure to capture the shift in relationship dynamics. The answer gives a false impression of continuity rather than strategic change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 474,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has the financial investment and operational focus on the Lower 48 region evolved between 2022 and 2023 based on production volumes and depreciation expenses?",
      "original_answer": "In 2022, the Lower 48 region showed strong production volumes, particularly in crude oil (447 thousand barrels daily) and natural gas (1,340 million cubic feet daily), indicating a significant operational focus. In 2023, the financial emphasis on the Lower 48 increased further, as evidenced by a rise in depreciation, depletion, amortization, and impairments expenses from $4,854 million in 2022 to $5,729 million in 2023. This reflects a growing financial investment in the region despite stable or moderate production levels in the prior year.",
      "llm_answer": "The Lower 48 segment’s depreciation expense rose from $4.854 billion in 2022 to $5.729 billion in 2023 (≈18 % increase)【page_133】, and capital spending grew from $5.630 billion to $6.487 billion over the same period【page_135】, indicating a stronger financial commitment to the region.  Although the excerpts only show the Lower 48’s 2021 production of 447 k bbl/d of crude oil, 110 k bbl/d of NGL and 1,340 mmcf/d of natural gas【page_169】, the higher depreciation and capex imply that production was sustained or expanded in 2022‑23, reflecting an intensified operational focus on the Lower 48.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the depreciation expenses for 2022 ($4.854 billion) and 2023 ($5.729 billion), matching the ground truth of $4,854 million and $5,729 million. The ≈18% increase is accurate (calculated as (5,729 - 4,854)/4,854 ≈ 17.98%). Capital spending figures are correctly cited from the source, though not part of the ground truth answer. However, the LLM incorrectly references 2021 production data (447 kbbl/d crude oil, 1,340 mmcf/d gas) as if it were 2022 data, which is a factual misalignment. The ground truth explicitly states these production volumes are from 2022, but the LLM attributes them to 2021 based on a misreading of the document context. (2) All numeric values are accurate in format and calculation, with acceptable unit variations (billion vs. million). (3) The reasoning is mostly sound: increased depreciation and capex are correctly interpreted as signs of growing financial investment. The inference that operational focus intensified is reasonable, though the incorrect year attribution weakens the multi-hop synthesis between production and financial data. (4) Despite the year misattribution, the core financial trend and its interpretation align with the ground truth, and the answer remains highly relevant. The error is significant but does not invalidate the overall conclusion, warranting a score of 8 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 386,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Verizon's strategic relationship with its 4G LTE network evolved between 2023 and 2024 in terms of its role within the company's network infrastructure and growth initiatives?",
      "original_answer": "In 2023, Verizon's 4G LTE network was positioned primarily as a foundational component of its wireless services, specifically highlighted as a means to provide FWA broadband as an alternative to traditional landline internet access. By 2024, the strategic role of the 4G LTE network had evolved into being part of a broader integrated network vision that includes C-Band spectrum, millimeter wave spectrum, and fiber infrastructure, aimed at driving innovative products and services and fueling growth. This shift indicates a move from viewing 4G LTE in a service delivery context to a more strategic asset within a multi-technology ecosystem.",
      "llm_answer": "In the 2023 filing, Verizon’s 4G LTE network is mentioned mainly as a platform for Fixed‑Wireless Access (FWA) broadband—an alternative to traditional land‑line service (see 2023 page 97). By the 2024 filing, the 4G LTE network is described as a core element of the company’s overall network infrastructure, alongside C‑Band and millimeter‑wave spectrum and fiber, and is explicitly cited as a driver of new products, services and growth initiatives (see 2024 page 23). This reflects a shift from a supporting role for FWA to a strategic pillar that underpins Verizon’s growth strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2023, 4G LTE was emphasized for Fixed-Wireless Access (FWA) as an alternative to landline internet (citing 2023 page 97), and by 2024, it evolved into a core component of a broader network ecosystem including C-Band, millimeter wave, and fiber, supporting growth initiatives (citing 2024 page 23). (2) There are no numeric values requiring calculation, so quantitative accuracy is not applicable beyond correct referencing of years and page numbers, which are accurate. (3) The multi-hop reasoning is sound—correctly synthesizing information across two years and filings to show strategic evolution. The shift from 'supporting role' to 'strategic pillar' mirrors the ground truth's 'foundational component' to 'strategic asset within a multi-technology ecosystem.' (4) Minor deduction in qualitative accuracy due to slightly less detailed articulation of the 'integrated network vision' compared to the original, but the core meaning and strategic implication are preserved. Wording differs but semantic equivalence is strong. Contextual relevance is perfect—directly addresses the evolution in strategic role between 2023 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 348,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How did Emerson's financial and strategic relationship with AspenTech evolve from 2022 to 2024, particularly in terms of stake value, ownership structure, and the impact on financial metrics such as backlog and gross margin?",
      "original_answer": "In 2022, Emerson held a stake in AspenTech with a backlog value of $1,042 million, indicating a strategic business relationship. By 2024, this relationship evolved significantly as Emerson completed a transaction that resulted in the creation of 'New AspenTech,' where Emerson owned 55% of the outstanding shares. This acquisition had a measurable impact on financial metrics: gross margin in 2023 increased by 3.3 percentage points, partly due to the AspenTech acquisition, and backlog in 2024 reached $8,053 million, up from $6,533 million in 2021, showing the influence of the AspenTech integration.",
      "llm_answer": "Emerson’s tie‑up with AspenTech began in fiscal 2022 when it closed the Heritage AspenTech transaction, paying roughly $6 billion in cash and emerging with a 55 % equity stake in the software firm (page 26).  The deal swelled the consolidated order backlog – AspenTech’s backlog jumped from $328 million in 2021 to $1,042 million in 2022 (page 10) – and added about 0.6 percentage‑points to Emerson’s gross margin in 2023 (gross margin rose to 49.0 % that year, page 26).  By 2024 Emerson’s ownership had risen to about 57 % and it announced a $240‑per‑share cash offer to buy the remaining shares, valuing AspenTech at roughly $15.3 billion (page 25).  The AspenTech acquisition continued to lift overall gross margin, which climbed to 50.8 % in 2024 (page 26).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies that significantly affect correctness. First, it claims Emerson closed the 'Heritage AspenTech transaction' in fiscal 2022 with a 55% stake, but the ground truth states that Emerson completed a transaction resulting in 55% ownership in 2024, not 2022. The 2022 data refers to a backlog value ($1,042M), not ownership. The LLM incorrectly asserts 55% ownership was established in 2022 and later rose to 57% by 2024, which contradicts the ground truth that 55% ownership was achieved in 2024 via the creation of 'New AspenTech'. Additionally, the LLM claims AspenTech’s backlog rose from $328M in 2021 to $1,042M in 2022, but the ground truth states overall backlog was $6,533M in 2021 and $8,053M in 2024—no mention of $328M or AspenTech-specific backlog growth. (2) Quantitative accuracy is low: the $6B cash payment, 0.6 percentage-point margin impact, 57% ownership, $240-per-share offer, $15.3B valuation, and 50.8% gross margin in 2024 are all absent from the ground truth. The ground truth reports a 3.3 percentage-point increase in gross margin due to the acquisition, not 0.6 points. While the LLM correctly notes margin improvements, the magnitude is wrong. (3) Multi-hop reasoning is partially sound—the LLM attempts to link the AspenTech deal to financial metrics like backlog and margin—but misattributes timing and ownership evolution. It fabricates a two-step acquisition process (55% in 2022, then 57% in 2024) not supported by the ground truth, which describes a single transformative event in 2024. (4) Contextual relevance is high as the answer addresses stake value, ownership, backlog, and gross margin as asked. However, due to major factual and numerical errors, especially around ownership timeline and financial impacts, the overall correctness score is limited to 5—partially correct but with significant inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 516,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has NEE's financial commitment to the Mountain Valley Pipeline evolved between 2022 and 2023, and what does this indicate about its investment strategy?",
      "original_answer": "In 2022, NEE's involvement in the Mountain Valley Pipeline was described as part of its equity method investments, with an ownership stake ranging between 32% and 55%. By 2023, NEE, through its subsidiary NEER, had a more defined 32.8% equity investment in the Mountain Valley Pipeline, which was accompanied by a 20-year natural gas transportation agreement valued at approximately $70 million per year. This indicates a strategic deepening of NEE's commitment to the pipeline, moving from a general equity investment toward a more structured, long-term contractual relationship tied to infrastructure development.",
      "llm_answer": "In the 2022 10‑K NEE noted that, after a $1.5 billion impairment in 2020, it recorded an additional impairment in Q1 2022 that **completely wrote off its investment in the Mountain Valley Pipeline** (see page 96). By the 2023 filing the company is **committing new equity contributions and a 20‑year, roughly $70 million‑per‑year, transportation agreement with the pipeline** (see pages 108‑109), indicating a shift from exiting the project to re‑engaging with it and pursuing long‑term natural‑gas infrastructure as part of a broader, diversified investment strategy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The claim that NEE 'completely wrote off its investment in the Mountain Valley Pipeline' in Q1 2022 due to an impairment is incorrect and contradicts the ground truth, which states NEE maintained an equity stake (32%-55%) in 2022 and increased its commitment in 2023. There is no mention in the ground truth of a full write-off or exit from the project. Instead, the evolution described is one of strategic deepening, not disengagement followed by re-engagement. (2) Quantitative accuracy is partially correct: the $70 million per year transportation agreement and 20-year term align with the ground truth, and the 32.8% equity stake in 2023 is consistent. However, the $1.5 billion impairment in 2020 and the Q1 2022 write-off are not reflected in the ground truth and appear to be hallucinated or misattributed. These errors undermine the financial narrative. (3) The multi-hop reasoning is flawed. The model incorrectly infers a reversal in strategy (exiting then re-entering), whereas the ground truth shows continuity and strengthening of investment. The synthesis across years is therefore invalid, as it misrepresents the 2022 position. (4) Despite the incorrect financial narrative, the answer is contextually relevant—addressing the evolution of commitment and linking it to investment strategy—and includes some correct forward-looking contractual details. However, the core factual error about the write-off severely reduces correctness. Minor flexibility is allowed for referencing specific page numbers (e.g., page 96, 108–109), but these do not compensate for substantive inaccuracies.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1298,
        "completion_tokens": 456,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Coca-Cola's relationship with Costa Limited evolved from 2023 to 2024 in terms of its operational integration and strategic positioning within the Global Ventures segment?",
      "original_answer": "In 2023, Costa Limited was referenced as part of Coca-Cola's direct retail operations, specifically through retail stores operated by Costa, and was included within the Global Ventures operating segment. By 2024, Costa Limited was more strategically embedded within the Global Ventures segment, which now also included the results of innocent and doğadan businesses, as well as fees earned under distribution coordination agreements. This indicates a deeper integration and broader strategic role for Costa within Coca-Cola’s diversified beverage portfolio.",
      "llm_answer": "In the 2023 Form 10‑K Coca‑Cola said it “sell[s] directly to consumers through retail stores operated by Costa Limited (‘Costa’). These sales are included in our Global Ventures operating segment” (page 6). By the 2024 filing the company lists Costa by name as a distinct component of Global Ventures – “Our Global Ventures operating segment includes the results of our Costa Limited (‘Costa’), innocent and doğadan businesses, as well as fees earned pursuant to distribution‑coordination agreements” (page 73). Thus, Costa has moved from being described merely as a sales channel to being formally integrated and positioned as a core business within the Global Ventures segment.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) It correctly identifies the evolution of Coca-Cola's relationship with Costa Limited from 2023 to 2024, noting that in 2023, Costa was mentioned as part of direct retail operations within the Global Ventures segment, and by 2024, it was explicitly named as a core component alongside innocent and doğadan. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages), but the years (2023, 2024) and entity names (Costa Limited, innocent, doğadan) are correct and match the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information across two different 10-K filings, correctly infers increased strategic integration based on changes in disclosure language, and draws a valid conclusion about deeper operational and strategic embedding. (4) The answer addresses all parts of the question—operational integration and strategic positioning—and uses direct quotes from the filings to support its claims. Wording differs slightly from the original answer but conveys the same meaning with high precision and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 331,
        "total_tokens": 1648
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How has Intel's investment in financial institution instruments evolved between 2022 and 2024, particularly in terms of the fair value of economically hedged marketable debt investments?",
      "original_answer": "In 2022, Intel recorded net losses of $748 million on economically hedged marketable debt investments. By 2024, the fair value of these hedged investments had decreased to $13.5 billion from $17.1 billion in 2023, with Intel recording net losses of $464 million in 2024. This indicates a reduction in both the size of the hedged investment portfolio and the magnitude of losses compared to two years prior.",
      "llm_answer": "Intel’s short‑term portfolio still includes financial‑institution instruments, but the fair‑value of its economically hedged marketable‑debt holdings has fallen – it was $13.5 billion at year‑end 2024 versus $17.1 billion at year‑end 2023【page_83】.  Over the same period the result on those hedged investments swung from a $748 million loss in 2022, to a $534 million gain in 2023, and back to a $464 million loss in 2024, indicating a declining value and earnings contribution from the hedged debt positions【page_83】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the fair value of economically hedged marketable debt investments in 2024 ($13.5 billion) and 2023 ($17.1 billion), matching the ground truth. It also correctly states the $464 million net loss in 2024. However, it incorrectly reports a $534 million gain in 2023, which is not mentioned in the original answer and contradicts the trend implied by the ground truth (which only reports losses in 2022 and 2024). More critically, the LLM misstates the 2022 loss as being part of a 'swing' that includes a 2023 gain, whereas the original answer does not provide any 2023 gain figure—only a 2023 fair value and a 2024 loss. The ground truth does not mention a 2023 gain, so this is a significant factual error. (2) The numbers for 2022, 2023, and 2024 fair values are accurate except for the fabricated $534 million gain in 2023. The 2022 loss of $748 million is correctly cited, but the implication of a reversal in 2023 is unsupported. (3) The multi-hop reasoning is partially sound—linking changes in fair value and losses over time—but introduces non-existent data (the 2023 gain), undermining the logical synthesis. The conclusion about declining value is supported, but the earnings contribution claim is overstated due to incorrect intermediate data. (4) The contextual relevance is high as the answer addresses the evolution of Intel's investments and focuses on the correct metric. However, the quantitative accuracy is reduced due to the erroneous 2023 gain, leading to a correctness score of 6—partially correct but with significant factual flaws.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 439,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did AMT's financial focus regarding communications sites evolve from 2023 to 2024, particularly in terms of recurring revenue generation and asset retirement liabilities?",
      "original_answer": "In 2023, AMT emphasized recurring revenue generation from communications sites, noting that 99% of total revenues came from property operations, which included leasing space on communications sites. By 2024, the focus expanded to include significant liabilities tied to these assets, with an estimated $4.5 billion in undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This reflects a shift from primarily highlighting revenue streams to also addressing the long-term financial responsibilities associated with site decommissioning.",
      "llm_answer": "In the 2023 filing AMT emphasized that the bulk of its communications‑site revenue came from long‑term, non‑cancellable leases and that, based on those leases, it expected to generate more than $60 billion of recurring lease revenue in future periods (see 2023 p. 34). By the 2024 filing the company still stressed that multiyear leases provide recurring cash flow, but the focus shifted to converting that revenue into operating profit and it disclosed a quantified asset‑retirement liability of about $4.5 billion for removing and remediating sites (see 2024 p. 56).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift in AMT's financial focus from recurring revenue in 2023 to asset retirement liabilities in 2024, and accurately reports the $4.5 billion asset retirement obligation as of 2024, which matches the ground truth. However, it introduces a figure of 'more than $60 billion of recurring lease revenue' in future periods from the 2023 filing, which is not present in the original answer and not corroborated by the ground truth. The original answer states that 99% of total revenues came from property operations (including leasing), but does not quantify future recurring revenue at $60 billion. This is a significant quantitative inaccuracy. (2) The $4.5 billion liability figure is correctly reported and aligns with the ground truth. The years (2023 and 2024) and entities (AMT, communications sites) are accurate. The mention of long-term leases is contextually appropriate but the extrapolated $60 billion figure lacks support in the provided ground truth. (3) The multi-hop reasoning is sound in identifying a strategic shift from revenue generation to liability disclosure, synthesizing information across two years. However, the unsupported $60 billion projection undermines the quantitative reliability of the synthesis. (4) The contextual relevance is high as the answer directly addresses the evolution in financial focus. Qualitative accuracy is strong due to correct framing and entity identification, but quantitative accuracy is reduced due to the unverified $60 billion figure. Correctness score is 7 because core facts (shift in focus, $4.5B liability) are correct, but the inclusion of an unsupported major financial projection constitutes a notable error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 471,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has XOM's strategic positioning in Guyana evolved between 2023 and 2024, particularly in terms of its legal operating framework and business growth emphasis?",
      "original_answer": "In 2023, XOM's operations in Guyana were governed by the Petroleum Activities Act 2023, which allowed for an exploration period typically up to 10 years and a production period of 20 years for oil fields with a renewal period of up to 10 years. By 2024, Guyana was specifically highlighted as one of XOM's 'Advantaged Assets' under the 'Advantaged Volume Growth' earnings driver, indicating a strategic shift to emphasize Guyana as a key contributor to earnings through volume growth and integration. This evolution shows that Guyana transitioned from being a jurisdiction with defined exploration and production terms to being a core growth asset within XOM's portfolio.",
      "llm_answer": "In the 2023 filing ExxonMobil explained that its Guyana operations are governed by the Petroleum Activities Act 2023, which lets the Guyanese government issue licences with an exploration period of up to 10 years and production terms of 20 years for oil ( 30 years for gas) that can be renewed for another 10 years 【page_25】. By the 2024 filing, the company no longer just describes the legal regime but positions Guyana as an “Advantaged Asset” – a core growth project alongside Permian and LNG – underscoring its strategic importance for future volume and value creation 【page_36】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the Petroleum Activities Act 2023 is accurately described with the correct exploration (up to 10 years) and production periods (20 years for oil, with a 10-year renewal), and the 2024 strategic repositioning of Guyana as an 'Advantaged Asset' under volume growth is correctly identified. (2) Quantitative accuracy is perfect: the years (2023, 2024), timeframes (10, 20, 30 years), and legal terms are all factually correct. The mention of 30 years for gas, while not in the original answer, is a precise addition from the source and does not contradict the ground truth. (3) Multi-hop reasoning is sound: the model correctly synthesizes the evolution from a legal-operating-framework focus in 2023 to a strategic business growth emphasis in 2024, showing Guyana’s transition into a core growth asset. (4) The only minor shortcoming is that the LLM does not explicitly name the 'Advantaged Volume Growth' earnings driver, instead describing it conceptually. While the semantic meaning is equivalent, this slight omission prevents a perfect 10 on qualitative accuracy. Overall, the answer is contextually rich, factually precise, and directly responsive to the multi-part question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 358,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Caterpillar's involvement in the diesel-electric locomotives business evolved between 2023 and 2024, particularly in terms of its strategic positioning and operational responsibilities?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader Machinery, Energy & Transportation (ME&T) segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as product support for on-highway vocational trucks in North America. By 2024, Caterpillar's positioning had evolved, with diesel-electric locomotives and related components being explicitly tied to integrated systems and solutions for industries like electric power generation, marine, oil and gas, and industrial sectors. Additionally, 2024 emphasized the development of electrified powertrains and zero-emission power sources, signaling a strategic shift toward more advanced and environmentally focused technologies in the locomotive space.",
      "llm_answer": "In the 2023 filing Caterpillar’s diesel‑electric locomotive activity was described simply as part of the Energy & Transportation segment that “produces diesel‑electric locomotives and components and other rail‑related products and services, including remanufacturing and leasing,” with additional duties limited to remanufacturing Caterpillar reciprocating engines and providing product support for on‑highway vocational trucks【page_116】.  \n\nBy the 2024 filing the business is positioned as a core rail offering within Energy & Transportation, and its role has been broadened to cover the full product‑lifecycle – “business strategy, product design, product management, development and testing, manufacturing, marketing and sales and product support” – while still offering remanufacturing and leasing services【page_38】【page_39】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of entities, years, and operational details, and correctly identifies the evolution of Caterpillar's involvement in the diesel-electric locomotives business from 2023 to 2024. It accurately reflects that in 2023, the business was part of the Energy & Transportation segment with responsibilities including remanufacturing and product support, as stated in the original answer. In 2024, the LLM correctly notes an expanded scope covering the full product lifecycle and continued remanufacturing and leasing services. While the LLM does not explicitly mention the strategic shift toward electrified powertrains and zero-emission technologies highlighted in the ground truth, it does capture the broadening of operational responsibilities and integration into core offerings, which aligns with the strategic evolution. The absence of explicit reference to environmental focus and integration with sectors like electric power and marine is a minor omission, but the core progression in strategic positioning and operational depth is correctly conveyed. All referenced details (segment name, services, lifecycle stages) are consistent with the source context. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning demonstrates sound understanding of the progression across years. Semantic equivalence is largely preserved, with only slight underrepresentation of the forward-looking technological shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 406,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the company's reliance on securitized debt obligations as a funding source evolved from 2022 to 2024, and what does this indicate about its funding strategy?",
      "original_answer": "In 2022, the company disclosed that it raised funding through the issuance of securitized debt obligations, among other instruments, though the exact amount was not provided. By 2024, the company reported a carrying value of $14,264 million for securitized debt obligations, indicating a concrete quantification of this funding source. This evolution suggests a more defined and potentially increased reliance on securitized debt obligations, aligning with a broader strategic emphasis on structured financing.",
      "llm_answer": "In the 2022 filing the company reported securitized‑debt obligations of roughly $15 billion, which was only about 4 % of its total funding sources (Table 6, p. 67). By the end of 2024 the outstanding securitized‑debt balance was still modest – about $14.3 billion (carrying) – representing only a few percent of its overall funding mix (p. 219). This shows that Capital One has kept securitizations as a small, supplemental source of liquidity while continuing to rely primarily on deposits, reflecting a stable, diversified funding strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, the company did not disclose a specific amount for securitized debt obligations, but the LLM claims a figure of $15 billion, which is incorrect. Additionally, the LLM introduces a percentage (4%) and a source (Table 6, p. 67) that are not present in the original answer and cannot be verified against the ground truth. While the 2024 carrying value of $14.3 billion is close to the correct $14,264 million (~$14.3 billion), the LLM misrepresents this as 'still modest' and 'only a few percent of its overall funding mix,' implying continuity from 2022, which contradicts the ground truth that no such quantification existed in 2022. (2) The quantitative inaccuracies are critical: the $15 billion figure for 2022 is fabricated, and the percentage breakdowns (4%, 'few percent') are unsupported. The 2024 value is approximately correct in magnitude but presented with false context. (3) The multi-hop reasoning is flawed. The original answer infers increasing reliance due to the emergence of a concrete, quantified value in 2024 versus no specific number in 2022. The LLM incorrectly assumes comparable figures across years and concludes a stable, minimal role for securitized debt, which contradicts the ground truth's interpretation of growing strategic emphasis. (4) Contextual relevance is moderate—the answer addresses funding strategy evolution and mentions securitized debt across years—but the incorrect data and flawed synthesis undermine the conclusion. The mention of 'Capital One' is an entity error not present in the original and not inferable from the provided data.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 461,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has McDonald's treatment of developmental licensees evolved between 2023 and 2024, particularly in terms of financial reporting and relationship management?",
      "original_answer": "In 2023, McDonald's disclosed that developmental licensees paid royalties based on a percentage of sales and generally paid initial fees, and the company allocated consideration among lease and non-lease components using historical methods. By 2024, the company emphasized its ongoing evaluation of business relationships, including those with developmental licensees, to identify potential variable interest entities, although it concluded that consolidation of such entities was not appropriate. Additionally, in 2024, McDonald's updated its rounding presentation to the nearest whole number for reported amounts, which affected how financial figures were presented, though the company clarified that these changes were not significant.",
      "llm_answer": "McDonald’s continues to treat developmental licensees as non‑consolidated partners whose royalties and any initial‑fee payments are recorded as non‑lease revenue – the same allocation it used in 2023 (2023 p. 50) and reiterated in the 2024 revenue‑recognition note (2024 p. 46).  In 2024 the company added more granular segment disclosure after adopting ASU 2023‑07 (see the segment footnote reference on 2024 p. 46) and changed its rounding presentation, while the count of developmental‑licensed restaurants grew to 9,247 from 8,684 the prior year (2024 p. 45).  The relationship‑management approach is unchanged: McDonald’s still evaluates these licensees for variable‑interest‑entity considerations and concludes they are not consolidated (2023 p. 45; 2024 p. 45).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Correct elements include: the consistent treatment of developmental licensees in terms of royalty and fee recognition as non-lease revenue across 2023 and 2024, the use of historical allocation methods (implied in both answers), the ongoing evaluation for variable interest entities without consolidation, and the 2024 change in rounding presentation. The LLM adds specific page references and mentions ASU 2023-07, which enhances detail beyond the original but does not contradict it. (2) Quantitatively, the LLM correctly reports the increase in developmental-licensed restaurants from 8,684 in 2023 to 9,247 in 2024, a detail not present in the original answer but factually consistent with external data. This number is accurate and supports the evolution narrative. The only minor gap is that the original answer notes the rounding change affected financial presentation but was not significant—a nuance the LLM omits. (3) Multi-hop reasoning is sound: the model synthesizes information across years, financial reporting standards (ASU 2023-07), revenue recognition, and entity evaluation, correctly concluding no change in consolidation policy. (4) The answer is contextually excellent, directly addressing both financial reporting and relationship management evolution. The only reason for not scoring a 10 is the omission of the explicit statement that the rounding change was not considered significant, a small but relevant qualifier in financial reporting context. Overall, the answer is factually correct, well-structured, and comprehensive.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 444,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has Southern Company's approach to its Equity and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of share availability and executive award disclosures?",
      "original_answer": "In 2023, Southern Company had 26.9 million shares available for awards under the Equity and Incentive Compensation Plan, indicating a reserve for future compensation initiatives. By 2024, the company increased transparency around executive compensation by disclosing specific terms for Named Executive Officer equity awards granted under the 2021 Equity and Incentive Compensation Plan, which was effective May 26, 2021. This evolution shows a shift from internal planning and reserve allocation in 2023 to more detailed public disclosure of executive-level compensation mechanisms in 2024, suggesting a more formalized and transparent governance approach for top-level incentives.",
      "llm_answer": "In the 2023 Form 10‑K Southern Company reported that, of the 131 million shares reserved for various equity programs, 26.9 million shares were **available for awards** under its Equity and Incentive Compensation Plan at year‑end. The 2024 filing still references the same 2021 plan but no longer gives a pool‑size figure; instead it includes an exhibit that spells out the **terms of named executive‑officer equity awards** granted under the plan, shifting the disclosure focus from an aggregate share reserve to detailed executive‑award information.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: 26.9 million shares available in 2023 is accurately reported, and the absence of a share pool figure in 2024 is correctly noted. The reference to 131 million shares reserved for equity programs, while not in the original answer, is contextually consistent and does not contradict the ground truth—it adds background without introducing error. (2) The shift in disclosure focus—from aggregate share availability in 2023 to detailed Named Executive Officer award terms in 2024—is correctly identified, matching the original answer’s claim about increased transparency. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years, identifies the continuation of the 2021 plan, and infers a strategic shift in disclosure practices. (4) The only minor shortcoming is that the LLM does not explicitly characterize the evolution as a move toward 'more formalized and transparent governance,' which is a qualitative interpretation present in the original answer. However, the factual basis for that interpretation is accurately presented. Wording differs but semantic meaning is equivalent. No calculation errors. All entities (Southern Company, Equity and Incentive Compensation Plan, Named Executive Officers, 2021 plan) are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 391,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How did the revenue performance of Inlyta evolve between 2022 and 2023, and what factors contributed to the change in its growth trajectory?",
      "original_answer": "In 2022, Inlyta contributed to Pfizer's operational growth, specifically mentioned among products like Comirnaty, Eliquis, and Vyndaqel that drove growth in the U.S. and international markets. By 2023, Inlyta's global revenue reached $1,036 million, reflecting a 3% total increase and a 5% operational growth. The growth was primarily attributed to the adoption of immune checkpoint inhibitor combinations with Inlyta for first-line treatment of advanced RCC in the U.S., despite lower volumes and net price in certain European markets. This indicates a continuation of growth, albeit at a more moderate pace compared to the broader portfolio dynamics in 2022.",
      "llm_answer": "Inlyta’s sales rose modestly from $1,003 million in 2022 to $1,036 million in 2023 (U.S. $618 M → $642 M, International $385 M → $394 M), a worldwide increase of roughly 3 % (4 % in the U.S.)【page_44】.  The uptick was driven primarily by greater U.S. use of Inlyta in combination with immune‑checkpoint inhibitors for first‑line advanced renal‑cell carcinoma, while lower volumes and a weaker net price in some European markets limited the growth pace【page_44】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Inlyta's revenue increase from $1,003 million in 2022 to $1,036 million in 2023, aligning with the ground truth's stated 2023 revenue and implied 2022 figure (since $1,036M represents 3% total growth, backward calculation confirms ~$1,003M in 2022). The U.S. and international breakdowns ($618M → $642M; $385M → $394M) are consistent with the overall growth and are accurately cited. The 3% total and 4% U.S. growth rates match expectations. (2) All numeric values, percentages, and dollar amounts are factually correct and internally consistent. The 3% total growth is accurately reflected; the U.S. growth of ~3.9% is reasonably rounded to 4%. No calculation errors. (3) The reasoning correctly identifies the key driver of growth—increased U.S. adoption of Inlyta in combination with immune checkpoint inhibitors for first-line advanced RCC—and acknowledges limiting factors in Europe (lower volumes and net price), which matches the ground truth. The answer synthesizes multi-hop information (revenue figures, geographic performance, clinical use, pricing dynamics) accurately. (4) The only minor shortcoming is that the original answer notes Inlyta was part of a group of products driving Pfizer’s growth in 2022 (context the LLM omits), but this does not detract from the direct response to revenue evolution and contributing factors. Otherwise, the LLM provides additional granularity (U.S./international split) not in the ground truth, enhancing completeness. Semantic equivalence is strong. Scores reflect high accuracy with only slight omission of 2022 contextual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 446,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has McDonald's relationship with its franchisees evolved from 2023 to 2024 in terms of financial structure and dependency, particularly regarding revenue recognition and cost-sharing for technology platforms?",
      "original_answer": "In 2023, McDonald's described its relationship with franchisees as a collaborative partnership focused on consistency, quality, and revenue generation through rent, royalties based on a percent of sales, and initial fees. The business model was designed to generate stable and predictable revenue largely tied to franchisee sales. By 2024, the relationship evolved to reflect a stronger dependency on franchisees, particularly in the context of technology platforms. McDonald's began recognizing revenue from franchisees for technology services on a gross basis, with related expenses recorded in 'Other restaurant expenses,' indicating a more integrated and cost-sharing approach. This shift reflects a transformation in the nature of the relationship, with franchisees becoming more operationally interdependent with the company through shared technology infrastructure.",
      "llm_answer": "In the 2023 filing the Company simply grouped the technology‑platform fees that franchisees pay under “Other revenues,” describing them as fees that “recover a portion of costs incurred by the Company” without stating whether the Company acted as principal or agent【page_3】. By the 2024 filing, McDonald’s explicitly says it is the principal in those arrangements, presents the platform fees on a gross basis, and recognizes the revenue when the goods or services are transferred – noting that the fees are cost‑recovery and not intended to generate margins【page_46】. This change makes the franchisee‑dependency for technology services more transparent and clarifies the cost‑sharing and revenue‑recognition structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in McDonald's relationship with franchisees from 2023 to 2024 regarding revenue recognition for technology platforms. In 2023, fees were buried in 'Other revenues' with no clarity on principal vs agent; by 2024, McDonald’s explicitly states it is the principal and recognizes revenue on a gross basis—this matches the ground truth's claim about gross revenue recognition and cost-sharing transparency. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—score 10 is justified. (3) The multi-hop reasoning is sound: the model synthesizes changes in accounting treatment (principal designation, gross reporting, timing of recognition) across two years and links them to increased franchisee dependency and cost-sharing, which reflects the core of the original answer’s qualitative shift. The only minor gap is that the LLM does not explicitly mention 'Other restaurant expenses' as the cost-recording line item, which is a small omission in completeness. (4) Contextual relevance is perfect—the response directly addresses financial structure, dependency, revenue recognition, and cost-sharing for technology platforms across 2023–2024. Wording differs but semantic meaning is equivalent. Thus, correctness is 9 due to high accuracy with a minor detail missing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 405,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How did the fair value of energy-related derivatives held by Southern Company's subsidiaries evolve from 2022 to 2023, and what does this indicate about the company's exposure to energy market fluctuations?",
      "original_answer": "In 2022, Southern Company's subsidiaries reported a net fair value of $101 million for energy-related derivatives (Mississippi Power: $59 assets, $32 liabilities; Southern Power: $8 assets, $12 liabilities; Southern Company Gas: $28 assets, $65 liabilities). In 2023, the subsidiaries showed a shift with Alabama Power reporting $15 in assets and $110 in liabilities, and Georgia Power reporting $13 in assets and $124 in liabilities for energy-related derivatives. This indicates a significant increase in net liability exposure, rising from a net liability of $54 million in 2022 to a net liability of $219 million in 2023, suggesting a greater exposure to energy market fluctuations.",
      "llm_answer": "In 2022 Southern Company’s subsidiaries held roughly **$199 million of energy‑related derivative assets and $210 million of related liabilities** – a net liability of only about **$11 million** (see page_283). By year‑end 2023 the asset side had collapsed to **$55 million** while the liability side swelled to **$358 million**, leaving a net liability of roughly **$303 million** (see page_276). The swing from a modest net liability to a large one shows that the company’s derivative position has become far more exposed to swings in natural‑gas and power prices, increasing its sensitivity to energy‑market fluctuations.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative values. According to the ground truth, in 2022, the total derivative assets were $59 + $8 + $28 = $95 million, and liabilities were $32 + $12 + $65 = $109 million, resulting in a net liability of $14 million (not $11 million as stated by the LLM). The LLM incorrectly reports $199 million in assets and $210 million in liabilities for 2022, which is a major overstatement. For 2023, the ground truth indicates Alabama Power and Georgia Power reported combined assets of $15 + $13 = $28 million and liabilities of $110 + $124 = $234 million, leading to a net liability of $206 million (not $303 million). The LLM reports $55 million in assets and $358 million in liabilities, which again is factually incorrect. These errors suggest the model used incorrect source data or miscalculated totals. (2) Calculations are flawed: the LLM’s reported net liability of $303 million in 2023 ($358M - $55M) is based on incorrect inputs. The actual net liability increased from $14M in 2022 to $206M in 2023, not from $11M to $303M. The direction of change (increasing liability) is correct, but the magnitude is severely overstated. (3) Multi-hop reasoning is partially sound—the LLM correctly infers that increasing net liabilities indicate greater exposure to energy market fluctuations. However, it fails to correctly identify the subsidiaries involved: in 2022, the derivatives are from Mississippi Power, Southern Power, and Southern Company Gas; in 2023, the data comes from Alabama Power and Georgia Power. The LLM does not mention these entities or their specific positions, missing a key aspect of the multi-hop synthesis. (4) Despite incorrect numbers, the answer is contextually relevant and draws a reasonable qualitative conclusion about increased market exposure. However, due to severe quantitative inaccuracies and incomplete entity reporting, the correctness score is low. The model appears to have accessed incorrect or hallucinated data, undermining factual reliability.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 556,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How has the treatment and significance of the Procter & Gamble 2019 Stock and Incentive Compensation Plan evolved from 2022 to 2024, based on its disclosure context in the 10-K filings?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was introduced with detailed references to its adoption by shareholders on October 8, 2019, and its additional terms and conditions, indicating its formal establishment and integration into the company's compensation framework. By 2024, the plan was listed among other equity compensation plans as part of the company's broader disclosure on stock ownership and equity compensation, showing that it had become a standard and active component of the company's long-term incentive structure. This evolution reflects the plan's transition from a newly introduced policy to an established part of PG's equity compensation offerings.",
      "llm_answer": "In the 2022 Form 10‑K the 2019 Stock and Incentive Compensation Plan is called out as the **only** equity‑compensation plan that still permits future grants, with a total authorized pool of 187 million shares and **≈119 million shares** remaining available for issuance (see Item 12 and the exhibit list 10‑25, 10‑27, 10‑28)【page_69†L1-L7】【page_70†L25-L28】.  \n\nThe 2024 Form 10‑K continues to reference the same plan through the same exhibits and the Compensation Committee regulations, but the remaining grant pool has shrunk to **≈77 million shares** (still the sole source of new equity awards), reflecting that a substantial portion of the authorized shares has already been used and underscoring the plan’s ongoing central role in P&G’s compensation strategy【page_68†L1-L9】【page_70†L25-L28】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and provides detailed, correct quantitative information that aligns with the expected evolution of the Procter & Gamble 2019 Stock and Incentive Compensation Plan from 2022 to 2024. (1) Quantitatively, the numbers are correct: in 2022, 187 million shares were authorized with approximately 119 million remaining, and by 2024, the remaining pool decreased to approximately 77 million shares. These figures are consistent with typical usage patterns and represent accurate tracking of share depletion over time. The LLM correctly identifies the plan as the sole source of new equity grants in both years, which is a key detail reflecting its central role. (2) The calculations implied—using about 42 million shares between 2022 and 2024 (119M - 77M)—are reasonable and support the narrative of ongoing utilization. (3) Qualitatively, while the original answer emphasizes the plan’s transition from 'newly introduced' to 'established component,' the LLM complements this by providing concrete evidence of that evolution through share usage and continued centrality in equity compensation. The LLM adds granularity not present in the ground truth (e.g., exact share counts, exhibit references), enhancing the response. However, it does not explicitly mention the 2019 shareholder adoption or the initial formal establishment context highlighted in the original answer, slightly weakening the multi-hop synthesis across the full timeline. (4) Contextual relevance is excellent—the response directly addresses how the plan's significance evolved by showing sustained use and structural continuity, supported by precise disclosures from the 10-Ks. Overall, the answer exceeds the ground truth in specificity and remains factually aligned, warranting a high score with only minor deductive points for not fully echoing the 'introduction' context from earlier years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 509,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has Southern Company's approach to managing the risk of large losses in its pension plan assets evolved from 2023 to 2024, and what specific changes in risk management emphasis can be observed?",
      "original_answer": "In 2023, Southern Company emphasized a formal rebalancing program and external investment manager oversight as key components of managing the risk of large losses, with a strong focus on long-term investment expectations for return and risk. In 2024, while maintaining a diversified asset strategy and rebalancing program, the emphasis on external manager oversight was reduced, and the risk of large losses was more directly linked to the broader market volatility and interest rate fluctuations. This indicates a subtle shift in risk management emphasis from active oversight to market-driven risk exposure.",
      "llm_answer": "Southern Company’s risk‑management stance for its pension‑plan assets is essentially unchanged from the 2023 to the 2024 filing. In both years the company says it “minimizes the risk of large losses primarily through diversification but also monitors and manages other aspects of risk,” with the same reliance on formal rebalancing, derivative hedging and oversight of external managers. No new emphasis or shift in policy is evident.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that Southern Company's risk-management approach is 'essentially unchanged' from 2023 to 2024, directly contradicting the ground truth. While there are no numeric values to verify (so quantitative accuracy is not applicable in a meaningful way, but no numbers are wrong), the qualitative analysis fails significantly. The ground truth states that although diversification and rebalancing were maintained, there was a clear shift in 2024: reduced emphasis on external manager oversight and a new focus linking large loss risk to market volatility and interest rate fluctuations. The LLM incorrectly asserts that 'no new emphasis or shift in policy is evident,' missing this key evolution. This represents a failure in multi-hop reasoning—comparing the two years’ risk management emphases across different filings—and results in a substantively incorrect conclusion. The answer is contextually relevant (it addresses pension risk management at Southern Company) but conveys the opposite of the correct insight. Thus, correctness and qualitative accuracy are low, while contextual relevance is moderate due to correct topic alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 333,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How has NVIDIA's role in the development and supply of the CUDA platform evolved between 2022 and 2023, and what does this shift indicate about the company's strategic focus?",
      "original_answer": "In 2022, NVIDIA's relationship with the CUDA platform was primarily as a supplier, providing the platform as part of its accelerated computing offerings. By 2023, NVIDIA's role had evolved into that of a developer, emphasizing a more active and strategic engagement in the platform's expansion and integration within its broader software ecosystem, including CUDA-X libraries, APIs, and domain-specific frameworks. This shift indicates a strategic move toward strengthening its full-stack computing platform to deliver more comprehensive data center-scale solutions.",
      "llm_answer": "In the 2022 filing (pages 78‑82) NVIDIA’s discussion is limited to acquisition accounting and intangible‑asset details, with no explicit mention of the CUDA platform. By the 2023 filing (pages 4‑7) the company describes CUDA as the foundational programming model that runs on all its GPUs, highlights the CUDA‑X libraries and a 4.7 million‑developer ecosystem, and positions it as a core pillar of its full‑stack strategy—signaling a strategic shift toward a software‑centric, ecosystem‑driven focus to accelerate AI and data‑center growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the evolution of NVIDIA's role from limited mention in 2022 to a developer and strategic platform enabler in 2023, emphasizing CUDA's integration into a full-stack software ecosystem. The absence of CUDA in the 2022 filing (focused on accounting) versus its prominence in 2023 as a foundational programming model is factually correct and contextually appropriate. (2) Quantitative details—such as the 4.7 million developer ecosystem—are explicitly mentioned and accurate, with no calculation errors. Page references (2022: 78–82; 2023: 4–7) add precision and support the claim of increased emphasis. (3) The multi-hop reasoning is sound: the model infers a strategic shift based on changes in disclosure focus across years, linking CUDA-X, developer growth, and full-stack positioning to a software- and ecosystem-driven strategy. This matches the ground truth’s conclusion about a strategic move toward comprehensive data center solutions. (4) Minor deduction in qualitative accuracy due to slightly stronger emphasis on 'software-centric' framing than explicitly stated in the original answer, though this is a reasonable interpretation. Overall, the answer is semantically equivalent, factually correct, and contextually rich.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 369,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How did Pfizer's financial relationship with Viatris evolve between 2022 and 2023, particularly in terms of supply agreements and outstanding balances?",
      "original_answer": "In 2022, Pfizer reported $780 million in revenue growth from PC1, primarily reflecting manufacturing of legacy Upjohn products for Viatris under supply agreements. By 2023, the financial relationship had evolved, as indicated by the net amounts due to Viatris under various agreements, which decreased from $94 million as of December 31, 2022, to $33 million as of December 31, 2023. Additionally, most transitional services under the TSAs were completed by the end of 2023, signaling a reduction in operational interdependence.",
      "llm_answer": "After the 2020 Upjohn‑Mylan spin‑off, Pfizer kept operating a transitional agency model and multi‑year manufacturing, labeling and packaging agreements (MSAs) with Viatris that run four‑to‑seven years post‑separation. Under those agreements, the amount Pfizer owed Viatris dropped dramatically, from $94 million at December 31 2022 to $33 million at December 31 2023.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly reports the decrease in the amount Pfizer owed Viatris from $94 million as of December 31, 2022, to $33 million as of December 31, 2023, which matches the ground truth exactly. This demonstrates full quantitative accuracy. 2) All numeric values and dates are correct and properly formatted; no calculation errors. 3) The answer addresses the evolution of the financial relationship in terms of outstanding balances but omits key information about supply agreements' role in generating $780 million in revenue growth for Pfizer in 2022 from manufacturing legacy Upjohn products. This is a significant omission in completeness, particularly regarding the supply agreement impact in 2022. Additionally, the LLM mentions the transitional agency model and MSAs but does not explicitly connect them to revenue or operational interdependence reduction as noted in the ground truth. While it notes the drop in liabilities, it misses the point that most transitional services under TSAs were completed by end of 2023, indicating reduced operational ties. 4) Despite these omissions, the core financial evolution in balances is accurately conveyed with correct entities (Pfizer, Viatris), correct years (2022–2023), and correct metrics (amounts due). The reasoning is sound but lacks full synthesis across all aspects of the financial relationship. Semantic equivalence is mostly preserved, but the answer is less comprehensive than the original. Hence, high scores for quantitative accuracy and contextual relevance, slightly lower for qualitative accuracy and overall correctness due to missing multi-hop elements.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1225,
        "completion_tokens": 445,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has the treatment and disclosure of communications sites in relation to debt obligations evolved between 2023 and 2024?",
      "original_answer": "In 2023, communications sites were explicitly referenced as collateral securing debt obligations, such as the 3,343 communications sites securing the Series 2015-2 Notes and the repayment of $1.3 billion in Series 2013-2A Notes funded by the 2023 Securitization. In 2024, while there was no explicit mention of specific communications sites securing debt, the company disclosed broader financial commitments, such as $4.5 billion in estimated undiscounted future cash outlay for asset retirement obligations as of December 31, 2024. This shift indicates a move from site-specific debt disclosures to more general obligations, suggesting a change in how communications sites are framed in relation to financial liabilities.",
      "llm_answer": "In the 2023 filing the company described its communications towers only in qualitative terms – the sites (the “2015 Secured Sites” and the “Trust Sites”) were pledged as collateral for the 2015‑2 and other securitizations, the cash they generated was earmarked to service those debts, and the notes warned that a default could trigger foreclosure of the sites. By the 2024 filing the same collateral structure is retained, but the disclosure now includes quantitative metrics (e.g., $354 m and $540 m of excess cash distributed, DSCR thresholds, $60.8 m of cash‑trap reserves) and a new footnote that a failure to renew operating leases could cause loss of the communications sites, showing a move from a purely descriptive treatment to a more detailed, metric‑driven discussion of site cash‑flows and the consequences of default.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth in both factual content and reasoning. (1) Quantitatively, the LLM introduces specific dollar amounts—$354M, $540M, $60.8M—that do not appear in the original answer and are not supported by the ground truth. These figures are entirely fabricated or misattributed, failing basic quantitative accuracy. The ground truth mentions $1.3 billion in repayments tied to 2023 securitization and $4.5 billion in asset retirement obligations in 2024, neither of which are referenced in the LLM response. (2) The core claim of the LLM—that the 2024 filing retains the same collateral structure with more detailed metrics—directly contradicts the ground truth, which states that in 2024 there was *no explicit mention* of communications sites securing debt, indicating a shift away from site-specific disclosures. Instead, the LLM asserts continuity and increased quantification, which is the opposite of the documented evolution. (3) The LLM invents a 'new footnote' about lease renewals affecting site retention, which is not present in the original answer and introduces unsupported qualitative details. (4) The multi-hop reasoning fails: the question asks for evolution in treatment and disclosure of communications sites in relation to debt obligations between 2023 and 2024. The ground truth identifies a shift from specific, site-backed debt disclosures in 2023 to broader, non-site-specific financial obligations in 2024. The LLM instead describes increasing detail and retained structure, missing the key transition entirely. While the answer is framed around the right topic (disclosure of communications sites and debt), its factual inaccuracies and reversed conclusion severely undermine correctness. Contextual relevance is moderate because it addresses disclosure trends, but the substance is factually wrong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 505,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Comcast's approach to retransmission consent agreements evolved between 2022 and 2023, particularly in terms of revenue recognition and distribution models?",
      "original_answer": "In 2022, Comcast recognized revenue from retransmission consent agreements on a monthly basis as programming was provided, with fees tied to the number of subscribers and generally collected within 60 days. By 2023, the company's Media segment emphasized a combined linear and streaming distribution model, with retransmission fees now explicitly including both traditional and virtual multichannel video providers. The 2023 filing also highlighted a broader integration of Peacock into the distribution ecosystem, suggesting a strategic shift toward hybrid distribution models that blend traditional and streaming services.",
      "llm_answer": "In the 2022 filing (see Distribution section, page 94), Comcast reported that fees from NBC‑ and Telemundo‑retransmission‑consent agreements were treated as licenses of functional intellectual property and revenue was recognized on a monthly basis as the programming was delivered under multiyear, subscriber‑based contracts. By the 2023 filing (see Distribution section, page 10), the company still uses the licensing model but now spells out a hybrid per‑subscriber/fixed‑fee structure, expands the agreements to cover both traditional multichannel and virtual video providers, and bundles the consent‑fee revenue with monthly retail/wholesale Peacock subscription fees—showing a more granular, multi‑platform distribution approach while retaining monthly revenue recognition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, Comcast recognized revenue from retransmission consent on a monthly basis as programming was delivered, under subscriber-based contracts—matching the original answer. In 2023, it accurately notes the expansion to include both traditional and virtual multichannel video providers, which is explicitly stated in the ground truth. It adds granular detail about a hybrid per-subscriber/fixed-fee structure and bundling with Peacock subscription fees, which goes slightly beyond the original but is consistent with the strategic shift toward hybrid models and integration of Peacock. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; dates (2022 vs. 2023) and page references (though not required) are correctly attributed. (3) The multi-hop reasoning is sound: the model synthesizes changes in revenue recognition and distribution models across two years and correctly identifies the evolution in scope (to virtual providers) and integration with Peacock. (4) The only reason for not scoring a 10 is that the original answer emphasizes the 'combined linear and streaming distribution model' and 'broader integration of Peacock' as strategic shifts, while the LLM answer focuses more on structural changes (fee models, bundling). However, the LLM's details are factually consistent and arguably more specific. Semantic equivalence is maintained. Contextual relevance is perfect—directly addresses revenue recognition and distribution models across both years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 449,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Caterpillar's involvement in the production and strategic positioning of diesel-electric locomotives evolved from 2023 to 2024?",
      "original_answer": "In 2023, Caterpillar's involvement in diesel-electric locomotives was described as part of its broader ME&T segment, which included responsibilities such as remanufacturing Caterpillar reciprocating engines and components, as well as providing product support for on-highway vocational trucks in North America. By 2024, Caterpillar's engagement had evolved into a more defined production role under the Energy & Transportation segment, which explicitly stated that Caterpillar 'produces' diesel-electric locomotives and components, signaling a more direct and strategic emphasis on this product line. Additionally, in 2024, Caterpillar highlighted competitive pressures in rail-related businesses, naming companies like Wabtec Corp and Siemens Mobility A/S, which was not present in 2023. This indicates a shift from a general operational inclusion to a more prominent and competitive product focus.",
      "llm_answer": "In the 2023 filing, diesel‑electric locomotives were described only as one of the many products in the Energy & Transportation segment’s portfolio – a rail‑related offering that competes with firms such as Wabtec, Alstom and Siemens Mobility【page_6】. By the 2024 filing, Caterpillar is positioned as a “world‑leading manufacturer of … diesel‑electric locomotives” in its corporate overview, underscoring a heightened strategic emphasis on that product line【page_4】 (and reiterated in the Energy & Transportation description【page_6】).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer correctly identifies Caterpillar's evolving strategic positioning regarding diesel-electric locomotives from 2023 to 2024, noting a shift toward greater emphasis in 2024. It accurately reflects that in 2024, Caterpillar is described as a 'world-leading manufacturer' of diesel-electric locomotives, signaling stronger strategic positioning, which aligns with the ground truth's point about a more defined production role. The mention of competitors like Wabtec and Siemens Mobility in 2023 is partially correct, though the ground truth states that competitive pressures and specific competitor naming were highlighted in 2024, not 2023—this is a factual inversion. Additionally, the LLM omits key details from the original answer: in 2023, locomotives were part of the ME&T segment with a focus on remanufacturing and support, not direct production, and the 2024 shift involves a structural rebranding to Energy & Transportation explicitly stating 'produces'—a critical operational evolution not mentioned. There are no numerical values to assess, so quantitative accuracy is 10 by default. The reasoning is mostly sound but misses the multi-hop nuance of segment reorganization and operational shift. The answer is contextually relevant and captures the directional change, but lacks completeness and precision in entity-year alignment, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 382,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of revenue recognition and cost-sharing arrangements between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's revenue from franchisees primarily included rent and royalties based on a percentage of sales with minimum rent payments, and initial fees. The company also mentioned that all restaurants were either operated by McDonald's or by franchisees under franchised arrangements. By 2024, the revenue recognition model remained consistent, but the company provided more detailed disclosures on how it recognizes revenue from franchisees, including the treatment of technology platform fees, which are now presented on a gross basis on the Consolidated Statement of Income. Additionally, in 2024, McDonald's clarified its cost-sharing arrangements for restaurant improvements, where it may fund certain projects and allocate costs between Property and Equipment and Accounts Receivable during the project, finalizing the allocation upon completion. This level of detail on cost-sharing was not present in the 2023 filing, indicating a more nuanced and transparent approach to franchisee financial interactions in 2024.",
      "llm_answer": "In both the 2023 and 2024 Form 10‑K filings McDonald’s continues to recognize franchise‑related revenue the same way – rent is split between a straight‑line minimum‑rent component and a variable‑rent component based on franchisee sales, royalties are recorded when the underlying sales occur, initial franchise fees are amortized over the typical 20‑year term, and technology‑platform and brand‑licensing fees are presented on a gross basis because the company is the principal in those arrangements【page_44】【page_46】. Likewise, the cost‑sharing model for restaurant improvements has not changed: McDonald’s funds the project up‑front, estimates each party’s share, allocates the costs between property‑and‑equipment and accounts receivable during the project, and finalizes the allocation at completion, with only immaterial balance‑sheet adjustments【page_44】【page_46】. Thus, the revenue‑recognition and cost‑sharing policies with franchisees remained consistent from 2023 to 2024.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually accurate in describing the revenue recognition and cost-sharing mechanics, with correct references to minimum and variable rent, royalty recognition timing, amortization of initial fees, gross presentation of technology fees, and the cost-sharing process for restaurant improvements. Quantitatively, there are no errors—descriptions of accounting treatments align with standard practices and the cited page numbers support the claims. However, the core of the question asks how the relationship evolved between 2023 and 2024, and the LLM incorrectly concludes that there was no change, stating policies 'remained consistent.' In contrast, the ground truth emphasizes that while the underlying model did not change, McDonald's introduced more detailed disclosures in 2024—particularly around technology platform fees being presented gross and enhanced transparency in cost-sharing allocations. This increased disclosure represents an evolution in transparency and reporting nuance, which the LLM overlooks by interpreting consistency in policy as no evolution. Thus, while the individual facts are correct, the synthesis and reasoning across years is flawed, missing the qualitative shift in disclosure and transparency that constitutes the evolution. This failure to recognize and report the enhanced detail and improved disclosure in 2024 as a meaningful change results in a moderate correctness score despite strong quantitative and descriptive accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1502,
        "completion_tokens": 407,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Southern Company's approach to executive equity compensation evolved between 2023 and 2024, particularly regarding plan documentation and award terms?",
      "original_answer": "In 2023, Southern Company disclosed that stock-based compensation, primarily in the form of performance share units (PSUs) and restricted stock units (RSUs), was granted under the Equity and Incentive Compensation Plan to employees ranging from line management to executives. By 2024, the company formalized the terms for Named Executive Officer equity awards under the same plan, indicating a more structured approach to executive compensation. Additionally, the 2024 filing included detailed documentation practices, such as the designation of specific exhibits for equity award terms, which was not present in the 2023 filing. This reflects a shift toward greater specificity and transparency in executive equity compensation documentation.",
      "llm_answer": "In the 2023 Form 10‑K Southern Company described its executive equity awards only in the notes – PSUs and RSUs were granted under the 2021 Equity & Incentive Compensation Plan with service‑ or performance‑based vesting and automatic vesting on retirement (see pages 277‑278). By the 2024 filing the company attached a stand‑alone “Form of Terms for Named Executive Officer Equity Awards” as an exhibit to the same 2021 plan (page 316) and also disclosed a new Deferred Compensation Plan effective Jan 1 2025 (page 315), showing a move toward more formal, separate documentation of executive award terms while keeping the underlying vesting structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2023, Southern Company granted PSUs and RSUs under the Equity and Incentive Compensation Plan (specifically the 2021 version), with service- or performance-based vesting and retirement provisions, consistent with the original answer’s description of stock-based compensation for executives. In 2024, the company introduced a formalized 'Form of Terms for Named Executive Officer Equity Awards' as a stand-alone exhibit (referenced on page 316), which matches the ground truth’s claim of more structured documentation practices. The mention of the new Deferred Compensation Plan effective January 1, 2025, while not part of the original answer, does not contradict it and adds context about broader executive compensation developments. (2) All dates (2023, 2024, Jan 1 2025), plan names (2021 Equity & Incentive Compensation Plan), and document types (exhibits, Form 10-K pages) are factually accurate. No calculations were required. (3) The multi-hop reasoning is sound: the model correctly infers an evolution from general disclosures in 2023 to formalized, exhibit-based documentation in 2024, indicating increased specificity and transparency—exactly the shift described in the ground truth. (4) The only minor shortcoming is that the LLM emphasizes the '2021' version of the plan, which wasn't specified in the original answer, though it is likely correct; however, the core evolution in approach—greater formalization and documentation for executive awards—is accurately captured. Thus, the answer earns a 9 for correctness due to excellent factual alignment and reasoning, with near-perfect qualitative and full quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 474,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How has Procter & Gamble's strategic reliance on membership club stores evolved from 2022 to 2024, and what does this shift indicate about the company's broader retail channel strategy?",
      "original_answer": "In 2022, Procter & Gamble identified membership club stores as one of its key retail channels, listing them among a broad set of distribution partners such as mass merchandisers, grocery stores, and e-commerce platforms. However, by 2024, the company's language shifted to emphasize dependency on these membership club stores, indicating a deeper strategic alignment or increased reliance on this channel. This evolution suggests that membership club stores have become more central to P&G's distribution and retail execution strategy, likely reflecting growth in this channel's importance to consumer purchasing behavior and overall market dynamics.",
      "llm_answer": "In the 2022 Form 10‑K, P&G identified membership‑club stores as one of its core retail‑customer segments, grouping them with mass merchandisers, grocery, drug and other stores (2022 Item 1, pg 4). By the 2024 filing, the company still lists club stores but explicitly notes that “evolving sales channels…growth in hard‑discounter channels” and a “growing consumer preference for shopping online” are reshaping its channel mix (2024 Item 1, pg 7). This shows that while club stores remain part of the distribution network, P&G is de‑emphasizing that channel and shifting its broader retail strategy toward faster‑growing e‑commerce and discount formats.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core conclusion. While it correctly identifies that membership club stores were listed among P&G's retail channels in 2022, it misrepresents the 2024 shift. The original answer states that P&G increased its strategic reliance on membership club stores by 2024, using language indicating deeper dependency. In contrast, the LLM claims P&G is 'de-emphasizing' the channel and shifting toward e-commerce and hard discounters—this directly contradicts the ground truth. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable beyond correct referencing of years (2022, 2024), which the LLM does correctly. (3) The multi-hop reasoning fails: the model incorrectly interprets mentions of e-commerce and hard-discounter growth in the 2024 filing as evidence of de-emphasis on club stores, when the ground truth indicates club stores have become more central. The synthesis is flawed—acknowledging broader channel changes does not negate increased reliance on a specific channel. (4) The contextual relevance is moderate because the answer discusses the right topic (P&G's retail channels) and cites correct sections (Item 1, pages 4 and 7), but the conclusion misaligns with the evidence. The qualitative accuracy is low due to incorrect inference and reversal of strategic direction. Correctness score is low because the central claim about strategic de-emphasis is false.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 407,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did AMT's involvement with Nigeria Letters of Credit evolve between 2023 and 2024, and what does this indicate about its financial obligations related to this instrument?",
      "original_answer": "In 2023, AMT had a $3.4 million obligation under the Nigeria Letters of Credit as part of its variable rate debt portfolio. However, by 2024, this obligation was no longer present, as indicated by the $0 carrying value in both denominated currency and USD. This indicates that AMT fully settled or otherwise exited its financial obligations tied to Nigeria Letters of Credit within this period.",
      "llm_answer": "In the 2023 filing AMT disclosed that it had drawn on Nigeria‑based letters of credit, carrying a $3.4 million balance (interest on the draws is tied to SOFR + a spread and is due 270 days after each draw)【page_61】. By the 2024 filing the line for Nigeria Letters of Credit shows a dash for 2024, indicating the draws were fully repaid and no amount remains outstanding【page_117】. This transition from a $3.4 million liability in 2023 to zero in 2024 shows that AMT eliminated its financial obligation related to the Nigeria letters of credit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $3.4 million obligation in 2023 and $0 in 2024 are correctly reported; the dash on page 117 indicating no outstanding balance is an accurate representation of a zero carrying value. (2) The answer correctly identifies the evolution of AMT's involvement—full repayment between 2023 and 2024—and concludes that the obligation was eliminated, which matches the ground truth. (3) The multi-hop reasoning is sound: it synthesizes data from two different years and filings to show a change over time, correctly interpreting the dash as 'no remaining liability.' (4) Minor deduction in qualitative accuracy due to the addition of specific interest terms (SOFR + spread, 270-day due) not present in the original ground truth, which may be correct but introduces unverified detail not required or confirmed by the provided answer. Otherwise, all entities (AMT, Nigeria Letters of Credit, 2023–2024 timeline) are accurate, and the response fully addresses both parts of the question: the evolution and its implication for financial obligations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 320,
        "total_tokens": 1561
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How did the valuation methodology and composition of GD's Retirement Annuity Contracts change between 2022 and 2024, and what does this indicate about the company's approach to reporting these assets?",
      "original_answer": "In 2022, GD reported Retirement Annuity Contracts as part of Level 3 assets with a fair value of $35 million as of December 31, 2021, and this value remained relatively stable through December 31, 2020 at $38 million. The contracts were disclosed within a detailed table showing actual returns, unrealized gains and losses, and net purchases or sales. By 2024, Retirement Annuity Contracts were still categorized under Level 3 assets but were now described as being valued using NAV (net asset value) as a practical expedient, excluded from the formal fair value hierarchy. This indicates a shift in GD's reporting methodology from detailed fair value disclosures to a more simplified NAV-based approach, aligning with broader changes in how these contracts are categorized and disclosed.",
      "llm_answer": "In the 2022 Form 10‑K, GD reported its retirement‑annuity contracts as Level 3 defined‑benefit plan assets valued using significant unobservable inputs (internal valuation models) with a fair‑value of $35 million at year‑end 2021【page_96】. The 2024 filing still classifies these contracts as Level 3 assets measured with unobservable inputs (the fair‑value hierarchy description)【page_93】, but the fair‑value has fallen to $22 million at year‑end 2024【page_94】. This shows the company has kept the same Level 3 valuation methodology while transparently reflecting a reduced exposure to retirement‑annuity contracts over time.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. Most critically, it states that the fair value of GD's Retirement Annuity Contracts fell to $22 million at year-end 2024, which contradicts the ground truth stating the $35 million value was as of December 31, 2021, with no mention of a 2024 value. The ground truth also notes stability between 2020 ($38M) and 2021 ($35M), but the LLM incorrectly implies a drop to $22M in 2024 without supporting evidence. (2) The LLM incorrectly claims the valuation methodology remained the same—'still classifies these contracts as Level 3 assets measured with unobservable inputs'—but the ground truth explicitly states a shift: by 2024, the contracts were valued using NAV as a practical expedient and excluded from the formal fair value hierarchy, even if still referenced in Level 3 discussions. This is a key methodological change the LLM fails to recognize. (3) The multi-hop reasoning is flawed: the question asks about changes in both methodology and composition between 2022 and 2024 filings. The LLM misses the shift to NAV as a practical expedient, a central change in reporting approach. It also misrepresents the timeline, citing 2021 data in the 2022 filing and 2024 data without proper context. (4) While the LLM correctly identifies the contracts as previously being Level 3 assets with $35M value in 2021, it fails on the core qualitative shift in valuation approach and provides an unsupported quantitative update for 2024. The contextual relevance is moderate because it addresses the right topic and company, but the factual and reasoning errors severely undermine correctness. Scores reflect major factual and interpretive errors despite some correct baseline details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 475,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the composition and value of restricted cash for securitization investors changed between 2022 and 2024, particularly in terms of its fair value hierarchy classification?",
      "original_answer": "In 2022, the company reported restricted cash for securitization investors as part of consolidated VIEs, with the assets and liabilities presented on the consolidated balance sheets. By 2024, the restricted cash for securitization investors was valued at $441 million, with the entire amount classified under Level 1 of the estimated fair value hierarchy, indicating a shift toward more transparent or market-based valuation methods. This reflects a more defined and standardized valuation approach in 2024 compared to 2022, where the fair value hierarchy was not explicitly detailed for this category.",
      "llm_answer": "In the 2022 filing the company explained that “restricted cash for securitization investors” represents the cash, loan‑receivables and related allowance for credit losses held in its consolidated VIEs [page 179] and is measured at fair value using observable inputs (Level 1). By 2024 the line item is shown at $441 million, still entirely classified in Level 1 of the fair‑value hierarchy, down from $458 million reported in the prior year (2023) [page 219‑220].",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly identifies the 2024 restricted cash value as $441 million and accurately states that this amount is entirely classified under Level 1 of the fair value hierarchy, which aligns with the ground truth. However, it incorrectly claims that in 2022, the restricted cash was already measured using Level 1 inputs. The original answer explicitly states that in 2022, the fair value hierarchy was *not* explicitly detailed for this category, making the LLM's assertion factually inaccurate. This is a significant error in qualitative and quantitative context, as it misrepresents the evolution of the valuation methodology. (2) The dollar amounts are mostly accurate: $441 million in 2024 is correct; the mention of $458 million in 2023 is not contradicted by the ground truth, but the ground truth does not provide 2023 data, so this cannot be verified. However, the core comparison between 2022 and 2024 is flawed because the LLM implies continuity in Level 1 classification, when the ground truth indicates a shift *to* Level 1 by 2024. (3) The multi-hop reasoning is partially sound—information is drawn across years and contexts—but fails in synthesis because it misses the key change in fair value hierarchy disclosure. The model incorrectly assumes consistency rather than identifying the shift, which is central to the question about *change* in composition and valuation. (4) Scores reflect that the answer is factually incorrect on a key qualitative point (fair value hierarchy in 2022), though it gets the 2024 value and classification right. Quantitative accuracy is moderate due to correct $441M figure but unsupported claim about 2023. Contextual relevance is high as the response stays on topic and references appropriate concepts and pages.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 499,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial recognition and asset management between 2023 and 2024?",
      "original_answer": "In 2023, McDonald's relationship with franchisees was primarily characterized by the acquisition of restaurants from franchisees, resulting in goodwill that was either fully or partially written off depending on the time of sale relative to acquisition. The Company used a discounted cash flow methodology to determine the fair value of acquired restaurants. By 2024, the relationship had transformed into a more dependency-based model, particularly in the area of technology platform services. McDonald's now provides distinct technology-related goods and services to franchisees, recognizing revenue on a gross basis and corresponding expenses within 'Other restaurant expenses.' This marks a shift from asset acquisition and goodwill management toward ongoing service-based financial interactions with franchisees.",
      "llm_answer": "McDonald’s core accounting for franchisee fees – royalties, rent (minimum and variable) and initial franchise fees – remained unchanged; the 2024 filing still says these revenues are recognized when the underlying sales occur and that the Company continues to fund and allocate shared restaurant‑improvement costs between property‑and‑equipment and accounts receivable (see 2023 and 2024 Revenue Recognition and Property & Equipment sections, pages 46 of each filing). However, the 2024 filing shows a markedly deeper financial tie‑up with franchisees: the Company purchased more franchisee restaurants (net restaurant purchases rose from $107 m in 2023 to $179 m in 2024), which added $240 m of goodwill and $270 m of other identifiable intangibles and increased total goodwill from $3.04 bn to $3.15 bn (see Goodwill tables, pages 45 (2023) and 47 (2024)), and capitalized software grew to $907 m (page 47). Thus, while revenue recognition stayed the same, asset management shifted toward greater ownership and investment in franchisee‑related assets.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and misrepresents the core evolution described in the ground truth. (1) Quantitatively, the LLM cites specific dollar amounts such as $107M and $179M for net restaurant purchases, $240M goodwill added, $270M other intangibles, and software at $907M. However, these figures are not present in the original answer and cannot be verified against the ground truth, which does not provide any numerical data on restaurant purchases or goodwill changes. The original answer only states that goodwill was written off in 2023 depending on timing, with no dollar figures. (2) The LLM incorrectly implies that McDonald's continued purchasing franchisee restaurants in 2024 as a key trend, whereas the ground truth describes a shift away from asset acquisition toward service-based relationships. This is a fundamental contradiction. (3) The qualitative reasoning is flawed: the LLM claims asset management shifted toward 'greater ownership and investment in franchisee-related assets,' but the ground truth states the opposite — the relationship evolved from asset acquisition to a dependency model centered on technology services. The LLM misses the key point about revenue recognition shifting to gross basis for technology services and corresponding expense classification in 'Other restaurant expenses.' (4) While the LLM correctly notes that core franchise fee accounting remained unchanged, this is not emphasized in the ground truth and distracts from the main shift described. The multi-hop synthesis fails because it relies on fabricated or misinterpreted financial data and mischaracterizes the strategic evolution. (5) Contextually, the answer is relevant to McDonald's and franchisee financial interactions, but it focuses on incorrect aspects (continued asset purchases) rather than the actual transformation in business model. Semantic equivalence is not achieved due to conflicting narratives about the direction of change in the franchisee relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 539,
        "total_tokens": 2004
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How has the treatment of the 2019 Stock and Incentive Compensation Plan evolved between 2022 and 2024 in Procter & Gamble's disclosures, particularly regarding its relationship with other compensation plans and its role in equity compensation?",
      "original_answer": "In 2022, the 2019 Stock and Incentive Compensation Plan was disclosed as part of a broader set of compensation plans, with specific reference to its adoption by shareholders in 2019 and its regulation in conjunction with other plans like the 2014 Stock and Incentive Compensation Plan. By 2024, the 2019 Plan was still included in the list of active equity compensation plans, but it was now referenced in the context of security ownership and the total shares available for issuance, indicating a shift from adoption and governance details to its role in the company's overall equity compensation structure. This reflects a transformation in how the plan is positioned within the company's disclosures, moving from procedural governance to a more strategic ownership framework.",
      "llm_answer": "In the 2022 Form 10‑K the 2019 Stock and Incentive Compensation Plan was described as one of the plans governed by the Compensation and Leadership Development Committee’s regulations (listed together with the 2014 Plan in Exhibit (10‑25) on page 70) and was highlighted in the equity‑ownership table as the only plan that can issue future equity, with a maximum grant capacity of 187 million shares and roughly 119 million shares still available (Item 12, page 69). In the 2024 Form 10‑K the joint‑committee reference disappears; the filing again points out that the 2019 Plan is the sole plan that permits future grants, still capped at 187 million shares but now with only about 77 million shares remaining (Item 12, page 68), showing a reduced grant pool and a narrower focus on its role in equity compensation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the 2019 Plan's maximum capacity of 187 million shares and the remaining shares (119 million in 2022, ~77 million in 2024) match the disclosed data. The specific references to Form 10-K items and page numbers (e.g., Item 12, pages 69 and 68) add precision and are consistent with actual filings. (2) The answer addresses all parts of the question: it traces the evolution between 2022 and 2024, discusses the relationship with other plans (noting the 2014 Plan and joint committee governance in 2022), and highlights the shift in focus to the 2019 Plan's role in equity compensation. (3) The multi-hop reasoning is sound: it correctly infers that the removal of the joint-committee reference in 2024 indicates a shift from governance-focused disclosure to a strategic, equity-structure focus. (4) While the ground truth emphasizes a conceptual shift from 'procedural governance' to 'strategic ownership framework,' the LLM captures this through concrete changes in disclosure language and share availability, offering a more granular, evidence-based perspective. The only minor gap is that the LLM does not explicitly mention 'security ownership' context in 2024 as highlighted in the original answer, but it does reference Item 12 (which covers security ownership), so the context is implied. Overall, the answer is factually excellent, slightly more detailed than the ground truth, and fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 420,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Salvatore Ferragamo's presence in Simon Property Group's international outlet locations evolved between 2022 and 2023?",
      "original_answer": "In 2022, Salvatore Ferragamo was listed as a tenant in three of Simon Property Group's international outlet locations in Japan: Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Sano Premium Outlets. By 2023, Salvatore Ferragamo appeared in only one of SPG's outlet locations, specifically Las Vegas Outlets North in Nevada, USA. This indicates a significant reduction in Salvatore Ferragamo's presence across SPG's outlet portfolio, shifting from multiple locations in Japan to a single location in the U.S.",
      "llm_answer": "In the 2022 filing Salvatore Ferragamo was listed as a tenant at nine international premium‑outlet sites – Gotemba, Kobe‑Sanda, Rinku and Sano in Japan; Punta Norte in Mexico; Yeoju and Siehung in South Korea; Johor in Malaysia; and the Montreal outlet in Canada (see 2022 pages 42‑43). The 2023 filing’s international‑outlet table (page 35) shows the same nine locations still carry Salvatore Ferragamo, so the brand’s international outlet footprint did not change between 2022 and 2023.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, it claims Salvatore Ferragamo was present in nine international outlet locations in 2022 and remained in the same nine in 2023, which directly contradicts the ground truth stating presence in three locations in Japan in 2022 and only one location (Las Vegas Outlets North, USA) in 2023. The listed locations (e.g., Punta Norte, Yeoju, Siehung, Johor, Montreal) are not supported by the ground truth and are factually wrong. (2) The calculation or comparison of presence across years is flawed—the answer asserts no change, while the ground truth shows a significant reduction and geographic shift from Japan to the U.S. (3) The reasoning is unsound: the multi-hop task requires comparing tenant lists across two years and recognizing a shift in geographic footprint, but the LLM incorrectly reports consistency where there is none. It also misrepresents the 2023 presence as still international and unchanged, while the truth indicates a move to a U.S. location (which may not even be classified as 'international' from SPG's perspective). (4) Contextual relevance is low because the answer addresses the general question about evolution but does so with fabricated data. The mention of specific document pages adds false credibility. Overall, the answer fails on all key dimensions: numbers, entities, time periods, and logical synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 397,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about its operational focus in the region?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region, suggesting a potential shift or stabilization in operational focus rather than aggressive growth.",
      "llm_answer": "COP’s total natural‑gas footprint in Asia Pacific/Middle East grew from roughly 5.6 trillion cubic feet at year‑end 2023 (≈312 billion cf of its own consolidated reserves plus 5,275 billion cf held by equity affiliates) to about 6.2 trillion cubic feet at year‑end 2024 (≈296 billion cf consolidated and 5,870 billion cf in equity affiliates). The slight drop in its own consolidated gas base, offset by a sizable rise in equity‑affiliate reserves, signals that COP is concentrating on affiliate‑driven assets and selective development in the region rather than expanding its direct, consolidated gas operations.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces significant data not present in the ground truth. While it correctly states COP's consolidated natural gas reserves as 312 billion cubic feet in 2023 and 296 billion cubic feet in 2024—matching the original answer—it adds unverified figures for equity affiliates (5,275 and 5,870 billion cubic feet) and total footprint (5.6 and 6.2 trillion cubic feet), which are not found in the ground truth and cannot be verified from the provided context. These additions fundamentally alter the interpretation. (2) The individual consolidated reserve numbers are accurate and correctly reflect the slight decrease. However, the derived totals and the claim of growth to 6.2 trillion cubic feet are unsupported, leading to incorrect quantitative synthesis. Calculations involving unprovided affiliate data cannot be validated and appear speculative. (3) The reasoning incorrectly frames the slight drop in consolidated reserves as part of a broader growth strategy via affiliates, which is not indicated in the ground truth. The original answer suggests a potential stabilization or non-aggressive growth stance based solely on the decline in direct reserves. The LLM’s multi-hop reasoning extends beyond available data by incorporating external or hallucinated affiliate reserves, undermining the logic. (4) While the answer addresses the question's structure and attempts deeper insight into operational focus, the use of fabricated quantitative data severely impacts factual correctness. The core observation about reduced consolidated reserves is accurate, but the conclusion is based on unsupported aggregation. Hence, correctness and quantitative accuracy are moderately penalized, while contextual relevance remains high due to appropriate framing and focus on regional operational strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 506,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Comcast's approach to wireless gateways evolved from 2022 to 2024, particularly in terms of strategic emphasis and investment?",
      "original_answer": "In 2022, Comcast offered wireless gateways as part of its broadband services, combining modem and Wi-Fi router capabilities to enhance in-and-out-of-home coverage. The focus was on customer-facing features like the xFi whole-home application and advanced security. By 2024, the company elevated its strategic emphasis by shifting from merely offering wireless gateways to actively investing in their deployment as part of its broader network infrastructure upgrades. This included plans to increase capacity and deliver multigigabit symmetrical speeds, signaling a deeper integration of wireless gateways into its long-term network strategy.",
      "llm_answer": "In the 2022 filing Comcast presented wireless gateways chiefly as a bundled broadband product – an integrated modem‑router with optional xFi Pods that lets customers personalize, manage and secure their home Wi‑Fi (see 2022 p. 7; p. 8). By the 2024 filing the narrative has shifted to treating gateways as a capital‑intensive rollout within the Connectivity & Platforms segment, emphasizing their continued deployment alongside network‑capacity upgrades, line extensions and scalable‑infrastructure investments, even as overall customer‑premise‑equipment spending (which includes gateways) has modestly declined (see 2024 p. 51; p. 50).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Comcast's 2022 approach: wireless gateways as bundled broadband products with xFi Pods and customer-facing management (via xFi app) and security features. In 2024, it accurately reflects the strategic shift—gateways are now framed as part of capital-intensive network infrastructure within the Connectivity & Platforms segment, tied to capacity upgrades and scalable infrastructure. (2) There are no numeric values (e.g., dollar amounts, percentages, speeds) in either the original or LLM answer that conflict; the LLM references document pages but no incorrect figures. Format and references are consistent with source material. (3) Multi-hop reasoning is sound: the model synthesizes information across two years (2022 and 2024 filings), correctly infers a shift in strategic emphasis from customer-facing product bundling to infrastructure integration, and contextualizes gateway deployment within broader capital spending trends—even noting a modest decline in customer-premise equipment spending, which adds nuance. (4) Semantic equivalence is strong: while the LLM uses different phrasing (e.g., 'capital-intensive rollout' vs. 'deeper integration into long-term network strategy'), the meaning matches the original. The only minor gap is that the LLM does not explicitly mention 'multigigabit symmetrical speeds'—a specific technical goal noted in the ground truth—which slightly affects completeness. However, reference to 'network-capacity upgrades' captures the essence. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 451,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has the G600's market presence and production evolution changed between 2022 and 2024, particularly in terms of cumulative deliveries and its role within Gulfstream's product lineup?",
      "original_answer": "In 2022, the G500 and G600 had cumulative deliveries totaling almost 150 by year-end 2021, and were described as replacements for the G450 and G550 models with improvements in speed, fuel efficiency, cabin volume, and flight controls. By 2024, cumulative deliveries of the G500 and G600 had more than doubled to over 300 by year-end 2024. Additionally, the G600 was no longer described in the context of being a new product introduction, indicating it had become a more established part of Gulfstream's lineup, while the focus shifted to newer models like the G800 and G400.",
      "llm_answer": "The G600, introduced in 2019 as a clean‑sheet large‑cabin jet that replaced the G450/G550, has seen its installed base roughly double – cumulative deliveries of the G500/G600 family rose from “almost 150” at year‑end 2021 (2022 filing) to “more than 300” at year‑end 2024 (2024 filing)【page_6】【page_5】.  It remains a cornerstone of Gulfstream’s modern portfolio, anchoring the core G500/G600 line‑up while newer models such as the G700, G800 and G400 expand the family【page_5】【page_5】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports that cumulative deliveries of the G500/G600 rose from 'almost 150' by year-end 2021 (as stated in the 2022 filing) to 'more than 300' by year-end 2024 (from the 2024 filing), which matches the ground truth. The doubling of deliveries is accurately characterized. (2) All numbers and timeframes are factually correct: 'almost 150' and 'more than 300' are direct matches to the original answer; the reference to year-end 2021 and year-end 2024 aligns with the source data. No calculation errors. (3) The multi-hop reasoning is sound: the model correctly infers increased market presence from delivery growth and interprets the G600's evolving role by contrasting its earlier status as a new product with its current position as an established model. The mention of newer models (G700, G800, G400) reflects accurate synthesis of product lineup shifts. (4) The only minor deviation from the original answer is that the LLM states the G600 'remains a cornerstone' and 'anchoring the core G500/G600 line-up', which slightly overemphasizes its current strategic role compared to the original answer's point that focus has shifted to newer models like G800 and G400. However, this does not contradict the fact that it is now an established part of the lineup. Overall, the answer is factually accurate, contextually relevant, and synthesizes information correctly across filings.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 394,
        "total_tokens": 1668
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has AIG's financial relationship with Corebridge evolved between 2023 and 2024, particularly in terms of equity ownership and income recognition?",
      "original_answer": "In 2023, AIG held 52.2% of Corebridge common stock and was in the process of selling down its stake, with the intention to fully divest over time. By 2024, AIG had transitioned to accounting for its remaining interest in Corebridge using the equity method, recognizing pre-tax income based on dividends received and changes in Corebridge's stock price from June 9, 2024. This represents a shift from direct ownership control to a more passive investment approach, indicating a significant change in the nature of AIG's financial relationship with Corebridge.",
      "llm_answer": "In 2023 AIG still owned a majority of Corebridge – 52.2 % of the common stock as of 12/31/23 and reported a $902 million gain from Corebridge in discontinued‑operations net income (2023 attributable to AIG)【page_27】.  By 2024 AIG had de‑consolidated Corebridge, cutting its stake to 48.4 % at the June 9 de‑consolidation date and to just 22.7 % by 12/31/24 【page_108】, and now treats the remaining interest under the equity‑method, recognizing $601 million of equity‑method income for the June‑Dec 2024 period and recording share‑sale gains (e.g., a $282 million gain in Q4 2024) – which together contributed to a $4.1 billion loss attributable to discontinued operations in 2024 【page_109】【page_110】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and provides a detailed, factually correct evolution of AIG's financial relationship with Corebridge from 2023 to 2024. (1) All key numbers are correct: AIG held 52.2% as of 12/31/23 (matches ground truth), de-consolidated on June 9, 2024, with 48.4% stake at that point and reduced to 22.7% by 12/31/24. The $902 million gain in 2023 and $601 million equity-method income (June–Dec 2024) are accurately cited, along with the $282 million Q4 2024 gain. These figures align with the source data. (2) Quantitative accuracy is perfect—percentages, dates, and dollar amounts are precise and contextually placed. (3) The reasoning correctly captures the multi-hop transition: from majority control and consolidation in 2023, to de-consolidation and adoption of the equity method in 2024, reflecting a shift to passive investment. The mention of discontinued operations and specific income recognition mechanisms (dividends and stock price changes) aligns with the conceptual shift described in the ground truth. (4) The LLM adds more granular detail than the original answer (e.g., exact stake percentages post-deconsolidation, specific income figures), enhancing completeness. The only minor gap is that the original answer emphasizes AIG’s *intention to fully divest*, which is implied but not explicitly stated in the LLM response—hence a slight deduction in qualitative accuracy. Overall, the answer is semantically equivalent and contextually rich, fully addressing equity ownership and income recognition changes.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 423,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Tesla's production strategy for the Solar Roof evolved between 2022 and 2024, particularly in terms of manufacturing dependencies and operational challenges?",
      "original_answer": "In 2022, Tesla was actively producing the Solar Roof at Gigafactory New York, which was specifically highlighted as a dedicated facility for the development and production of Solar Roof and other solar products. The company offered financing options tied to the Solar Roof, indicating a strategic push to integrate the product into its broader energy ecosystem. By 2024, Tesla's disclosures shifted to emphasize increased complexity and risk in ramping production of the Solar Roof, with explicit mention of 'delays in launching and/or ramping production of our energy storage products and Solar Roof.' The 2024 filing also highlighted broader operational dependencies, including the need to achieve 'design tolerances, high quality and output rates' across its manufacturing facilities, and noted potential disruptions due to supply chain coordination, localized procurement challenges, and the need for cost-effective scaling. This indicates a transition from a focused production setup in 2022 to a more complex and risk-laden ramp-up phase in 2024.",
      "llm_answer": "In 2022 Tesla’s Solar Roof was produced at a single, dedicated site – Gigafactory New York in Buffalo – under a lease and research‑development agreement with the SUNY Foundation, and the company had already met the facility’s investment and hiring targets after a COVID‑19‑related shutdown (2022 p9‑10). By the 2024 filing the company flags that Solar Roof production has encountered ramp‑up delays and now hinges on new manufacturing processes, broader supply‑chain constraints and other operational challenges, reflecting a shift from a location‑specific, target‑driven approach to a more uncertain, multi‑facility production strategy (2024 p17).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Tesla produced the Solar Roof at Gigafactory New York in 2022, specifically under a lease and R&D agreement with the SUNY Foundation, and had met investment and hiring targets post-COVID shutdown (citing 2022 p9-10). By 2024, the company reported production ramp-up delays and increased operational challenges (citing 2024 p17), consistent with the original answer’s emphasis on delays and complexity. (2) There are no numeric inaccuracies—no specific figures (e.g., dollar amounts, percentages) are misstated, and the cited page numbers and years are accurate. Format and referencing are precise. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years and filings, identifying a strategic shift from a dedicated, target-driven production model in 2022 to a more complex, risk-affected ramp-up phase in 2024 involving supply chain and manufacturing process challenges. The mention of a 'multi-facility production strategy' slightly extends beyond the original answer, which does not explicitly state multi-facility use but does reference broader manufacturing dependencies—this is a minor interpretive leap but not factually incorrect. (4) The answer is contextually excellent, directly addressing the evolution in manufacturing dependencies and operational challenges. The only reason for not scoring a 10 is the slight inference about 'multi-facility' strategy, which, while plausible, is not explicitly confirmed in the ground truth. Overall, the answer is factually robust, well-reasoned, and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 459,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How has Qualcomm's strategic involvement with on-device artificial intelligence (AI) evolved from 2023 to 2024, particularly in terms of its business focus and investment approach?",
      "original_answer": "In 2023, Qualcomm was actively producing on-device AI technologies as part of its broader portfolio of foundational technologies, including wireless connectivity and low-power computing. The company positioned on-device AI as a key innovation driver across industries beyond mobile handsets, such as automotive and IoT. By 2024, Qualcomm's focus on on-device AI had evolved from being a core product offering to a more investment-centric strategy. The company continued to invest heavily in advancing on-device AI through research and development, acquisitions, and strategic transactions, signaling a shift toward long-term growth and ecosystem development rather than immediate product commercialization. This transition reflects a deeper commitment to enabling third-party integration of its AI technologies rather than solely selling AI-based products directly.",
      "llm_answer": "In its 2023 filing Qualcomm positioned on‑device AI as a core element of its “high‑performance and low‑power computing” platform that it was **scaling across existing markets – mobile handsets, automotive and IoT**【page_65】. By the 2024 filing the company still calls on‑device AI a foundational technology, but now ties it to a **broader investment strategy that includes new product‑area initiatives, industry expansion and strategic acquisitions** to push AI‑enabled solutions beyond the handset business【page_20】【page_21】. This reflects a shift from primarily scaling AI within its existing portfolio to using AI as a catalyst for diversified growth and strategic investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly identifies Qualcomm's 2023 focus on scaling on-device AI across mobile, automotive, and IoT markets, citing it as part of its low-power computing platform, which matches the ground truth. In 2024, it accurately captures the strategic shift toward a broader investment approach involving new product initiatives, industry expansion, and acquisitions. The emphasis on AI as a catalyst for diversified growth and ecosystem development is semantically equivalent to the original answer's description of a move toward long-term growth and third-party integration. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—only qualitative descriptions of strategy—so quantitative accuracy is not applicable in a numerical sense, but all stated years (2023, 2024) and contextual references (e.g., '2023 filing', '2024 filing') are correct. (3) The multi-hop reasoning is sound: the model synthesizes changes in strategic focus across two years from different filings, correctly identifying the evolution from product scaling to investment-driven expansion. The use of citation markers (e.g., page_65, page_20, page_21) suggests grounding in source documents. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the reduced emphasis on direct product commercialization or the explicit enabling of third-party integration—nuances present in the original answer. However, the idea is partially captured in 'push AI-enabled solutions beyond the handset business' and 'broader investment strategy.' Overall, the answer is factually correct, contextually relevant, and well-reasoned, warranting a high score with only slight deduction for minor incompleteness in conveying the full depth of the strategic shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 510,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has the presence of Dolce & Gabbana in SPG-operated properties evolved between 2022 and 2023, and what does this indicate about SPG's brand positioning strategy in its premium outlet locations?",
      "original_answer": "In 2022, Dolce & Gabbana was listed as a tenant in multiple SPG-operated premium outlets in Japan, including Gotemba Premium Outlets, Kobe-Sanda Premium Outlets, and Rinku Premium Outlets. By 2023, Dolce & Gabbana was only listed at Las Vegas Outlets North Premium NV in the U.S. This indicates a strategic shift from a multi-location presence in Japan to a more exclusive, flagship-style positioning in a key U.S. market, suggesting a reevaluation of brand placement and target demographics.",
      "llm_answer": "In the 2022 filing Dolce & Gabbana was listed as a tenant at several international premium outlets – Gotemba, Kobe‑Sanda and Rinku in Japan and Punta Norte in Mexico【page 42】【page 43】. By the 2023 filing the brand appears only at Las Vegas Premium Outlets in the United States【page 34】. This drop‑off signals that SPG is pulling the luxury label out of many overseas sites and concentrating it in a few high‑traffic U.S. flagship outlets, using Dolce & Gabbana to underscore an aspirational, premium positioning in its most prominent domestic outlet locations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the presence of Dolce & Gabbana in SPG-operated properties in 2022 and 2023, with accurate locations. However, it adds 'Punta Norte in Mexico' as a 2022 location, which is not present in the ground truth and constitutes a factual overstatement. All other locations (Gotemba, Kobe-Sanda, Rinku in Japan; Las Vegas in the U.S.) are correctly reported. (2) There are no numerical values requiring calculation (e.g., sums, percentages), so quantitative accuracy focuses on correct reporting of entities and years—these are mostly accurate except for the erroneous inclusion of Punta Norte. The years 2022 and 2023 are correctly used. (3) The multi-hop reasoning is sound: the model correctly infers a strategic shift from multiple international locations to a concentrated U.S. presence, aligning with the ground truth's interpretation of a move toward exclusive, flagship-style positioning. The conclusion about aspirational brand positioning in high-traffic U.S. outlets matches the original answer’s implication. (4) The contextual relevance is perfect—the answer directly addresses both parts of the question: evolution of presence and strategic implication. The only deduction is for the incorrect addition of a tenant location, reducing completeness and entity accuracy slightly. Overall, the answer is factually strong with minor but notable overreach in entity reporting.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 393,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did COP's investment in exploration activities in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the company's strategic focus in that region?",
      "original_answer": "In 2023, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region, while in 2024, the company disclosed a total of $0 in new exploration activities in that region. This indicates a complete withdrawal or pause in exploration efforts in the Asia Pacific/Middle East, suggesting a strategic shift away from that region in favor of other geographic areas.",
      "llm_answer": "In 2023 ConocoPhillips spent $49 million on exploration in its consolidated Asia Pacific/Middle East operations and $46 million in its equity‑affiliate assets (about $95 million in total). The 2024 filing notes that the company again recorded extensions and discoveries in the Middle East and Australia, showing that it is maintaining – and arguably sharpening – its strategic emphasis on growing its Asia Pacific/Middle East portfolio, even though a separate 2024 exploration‑spend figure is not disclosed.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, COP reported $49 million in exploration expenditures in the Asia Pacific/Middle East region in 2023 and $0 in 2024, indicating a complete halt in exploration. However, the LLM claims $49 million in consolidated operations and an additional $46 million in equity-affiliate assets (totaling ~$95 million), which is not supported by the ground truth and introduces unverified data. The ground truth does not mention equity-affiliate spending, making this a fabrication or misattribution. Furthermore, the LLM states that 2024 activities included 'extensions and discoveries' in the Middle East and Australia, implying continued exploration, which directly contradicts the ground truth of $0 in new exploration spending. (2) Quantitatively, the $49 million figure for 2023 is correct, but the addition of $46 million from equity affiliates is unsupported and incorrect. The absence of a disclosed 2024 figure in the LLM response is misleading, as the ground truth explicitly states $0 in new exploration, which is a critical data point. The LLM fails to report this definitive drop to zero, which is central to the correct interpretation. (3) The multi-hop reasoning is flawed: instead of recognizing the drop from $49M to $0 as evidence of strategic withdrawal, the LLM infers continued strategic emphasis based on unspecified 'extensions and discoveries' not mentioned in the ground truth. This reflects a failure to synthesize the correct implication of halted spending. (4) Contextual relevance is moderate because the answer addresses exploration in the correct region and time frame, but the incorrect data and opposite conclusion severely undermine accuracy. The reasoning contradicts the ground truth’s clear indication of strategic retreat. Thus, the answer is mostly incorrect with major factual and interpretive errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1236,
        "completion_tokens": 521,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How has Comcast's financial stake and debt involvement in Universal Beijing Resort evolved from 2022 to 2024?",
      "original_answer": "In 2022, Universal Beijing Resort was introduced as a new entity in Comcast's disclosures, noting its opening in September 2021 and highlighting the increased depreciation and amortization expenses across the company, though no specific financial stake or debt figures were provided at that time. By 2024, Comcast explicitly stated its 30% ownership interest in Universal Beijing Resort and detailed the debt financing structure, including $3.4 billion of debt outstanding as of December 31, 2024, down from $3.5 billion in 2023. Additionally, the assets and liabilities of Universal Beijing Resort were reported as $7.3 billion and $7.0 billion respectively in 2024, compared to $7.8 billion and $7.2 billion in 2023.",
      "llm_answer": "Comcast’s equity interest in Universal Beijing Resort has stayed at 30% since at least 2022, when the project was financed through a Chinese‑syndicated loan with a ¥29.7 billion (≈$4.2 billion) borrowing limit【page_86】.  The resort’s debt has been trimmed modestly – $3.5 billion of debt (including a $3.1 billion term loan) was outstanding at year‑end 2023, falling to $3.4 billion (including a $3.0 billion term loan) at year‑end 2024【page_86】 – while Comcast’s ownership share remained unchanged.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Comcast's 30% ownership interest and the reduction in debt from $3.5 billion in 2023 to $3.4 billion in 2024, which aligns with the ground truth. However, the original answer does not state that the 30% stake was confirmed as early as 2022—instead, it notes that no specific financial stake was disclosed in 2022, only that the resort was mentioned. Thus, claiming the equity interest has 'stayed at 30% since at least 2022' is an overstatement not supported by the original data, introducing a factual inaccuracy. (2) The debt figures ($3.5B in 2023, $3.4B in 2024) are accurate and match the ground truth. The mention of a ¥29.7 billion loan (~$4.2B) is additional context not present in the original answer; while potentially true from another source, it introduces external information not verified in the provided knowledge graph and slightly misaligns with the disclosed $3.5B debt figure in 2023. The term loan amounts ($3.1B and $3.0B) are not mentioned in the original answer, so their inclusion adds unverified detail. (3) The multi-hop reasoning is partially sound—correctly linking Comcast’s ownership and debt trends across years—but incorrectly assumes continuity of ownership disclosure back to 2022, when the original answer states no such detail was provided that year. (4) Despite the overstatement on ownership timing and inclusion of unverified loan details, the core financial evolution—stable stake and declining debt—is mostly accurate. The answer is highly relevant and well-structured, but minor factual and sourcing issues prevent a higher score. Quantitative accuracy is marked down due to unsupported figures; qualitative and contextual scores remain high due to logical flow and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 479,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How did Duke Energy's net derivatives balance and associated settlement activity evolve from 2022 to 2023, and what does this indicate about the company's exposure or management of derivative instruments?",
      "original_answer": "In 2022, Duke Energy's net derivatives balance at the end of the year was $29 million, with settlements totaling $32 million. In 2023, the net derivatives balance decreased to $13 million, while settlements increased significantly to $68 million. This indicates a shift in the company's management of derivative instruments, with a larger reduction in the net balance despite higher settlement activity in 2023.",
      "llm_answer": "Duke Energy’s consolidated net‑derivative position shrank sharply – the net balance fell from $29 million at year‑end 2022 to $13 million at year‑end 2023 – while the amount settled more than doubled, rising from $32 million in 2022 to $68 million in 2023 (purchases also fell from $74 million to $42 million and a $10 million gain replaced a $35 million loss)【page_191】.  This swing shows the company actively unwound and settled existing contracts, reducing its net exposure to derivatives and moving from a net loss to a modest net gain on its derivative portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports all key quantitative data from the ground truth: Duke Energy's net derivatives balance decreased from $29 million in 2022 to $13 million in 2023, and settlements increased from $32 million to $68 million. These numbers match the original answer exactly, satisfying quantitative accuracy. (2) Additional details such as purchases decreasing from $74 million to $42 million and the shift from a $35 million loss to a $10 million gain are not present in the ground truth, but they do not contradict it and may come from deeper document context; however, since the question did not ask about purchases or gains/losses, their inclusion is supplementary and does not detract from correctness. (3) The multi-hop reasoning is sound: the model correctly infers that a declining net balance combined with higher settlement activity indicates active unwinding of positions and reduced exposure, which aligns with the original answer’s conclusion about a shift in management strategy. (4) The semantic meaning and core facts are fully preserved, with only minor expansion beyond the ground truth. The answer addresses both parts of the question—evolution of balances/settlements and implications for exposure/management—making it contextually complete and highly accurate. A score of 9 is given because while all required facts are correct and well-reasoned, the inclusion of unverified additional metrics (gains, losses, purchases) slightly exceeds the scope of the confirmed ground truth, though not inaccurately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 427,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How did SPG's treatment and disclosure of LTIP Units evolve from 2022 to 2023, particularly in terms of their dilutive effect and valuation modeling?",
      "original_answer": "In 2022, SPG disclosed that LTIP units were part of potentially dilutive securities but had no material dilutive effect for the years 2021, 2020, and 2019. By 2023, SPG provided more detailed disclosures, including the use of a Monte Carlo model to estimate the grant-date fair values of market-based LTIP units and confirmed that these units are treated as participating securities under the two-class method of computing earnings per share. This reflects a shift from a general statement about dilution to a more granular and valuation-focused disclosure in 2023.",
      "llm_answer": "In the 2022 filing SPG only flagged LTIP units as “potentially dilutive securities” in its EPS discussion and noted that they had **no material dilutive effect** for the years presented, without describing how the awards were valued 【page_116】. By the 2023 filing the company had expanded the disclosure: LTIP units are treated as participating securities under the two‑class method, the grant‑date fair values of market‑based LTIP awards are **estimated using a Monte‑Carlo model**, and the filing lists the **maximum potential fair value of the 2023 LTI program ($42.5 million)** and a table of award‑date fair values for each year 【page_127】【page_129】. This shows a shift from a brief, immaterial‑dilution note to a detailed valuation methodology and explicit fair‑value disclosure while still acknowledging the units’ dilutive potential.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately captures the evolution from 2022 to 2023: in 2022, SPG disclosed LTIP units as potentially dilutive with no material effect for prior years, without valuation details; in 2023, it introduced a Monte Carlo model for valuing market-based LTIP units, confirmed their treatment as participating securities under the two-class method, and added detailed fair value disclosures. (2) The quantitative details are precise: the maximum potential fair value of the 2023 LTI program is correctly stated as $42.5 million, and the use of a Monte Carlo model is accurately reported. These numbers and methods align with the knowledge graph. (3) The multi-hop reasoning is sound—comparing disclosures across two years, identifying changes in both qualitative treatment (participating securities) and quantitative modeling (Monte Carlo), and recognizing the shift from immateriality to detailed valuation. (4) The answer is semantically equivalent to the ground truth, with added value through specific citation of page numbers and exact figures, enhancing credibility without introducing error. All entities (SPG, LTIP units, EPS methods) are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 352,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How has Comcast's financial commitment and involvement in Atairos Group, Inc. evolved between 2022 and 2024, particularly in terms of capital funding and management fee commitments?",
      "original_answer": "Comcast's involvement in Atairos Group, Inc. evolved significantly between 2022 and 2024. In 2022, Comcast was the sole third-party investor with a commitment to fund up to $5 billion in aggregate capital to Atairos. By 2024, this commitment had decreased to up to $4.5 billion, with an additional specific commitment of $40 million annually for a management fee. The reduction in capital commitment and the introduction of a dedicated management fee structure indicate a recalibration of Comcast's financial involvement and strategic oversight of Atairos.",
      "llm_answer": "In the 2022 filing Comcast said its Atairos agreement limited total funding to **up to $4.5 billion** (down from $5 billion), capped annual capital calls at **$400 million**, and included a **$45 million‑per‑year management‑fee commitment**; the company had about **$1.5 billion of unfunded capital** remaining 【page_106】. By the 2024 filing the company was actually **contributing $73 million in 2024 (up from $52 million in 2022)**, the annual management‑fee commitment had been **reduced to $40 million**, and the **unfunded capital commitment fell to roughly $1.4 billion** 【page_85】. This reflects a modest cut in fee obligations and unfunded exposure while cash contributions to Atairos have increased.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The original answer states that in 2022, Comcast's capital commitment was $5 billion, but the LLM incorrectly claims it was already reduced to $4.5 billion in 2022—this contradicts the ground truth. The LLM also introduces figures not present in the original answer, such as a $400 million annual capital call cap, $45 million per year management fee in 2022, and actual contributions of $52 million in 2022 and $73 million in 2024—none of which appear in the ground truth. While the LLM correctly notes the 2024 management fee is $40 million, it falsely claims this was a reduction from $45 million, which is unsupported. The unfunded capital amounts ($1.5B in 2022, $1.4B in 2024) are specific details absent from the original answer and appear to be hallucinated or misattributed. (2) Completeness: The question asks about evolution in capital funding and management fee commitments. The LLM addresses both aspects but with incorrect data. It fails to correctly represent the timeline: the $4.5 billion commitment is stated as a 2024 development, not a 2022 figure. (3) Entity Accuracy: The companies (Comcast, Atairos) and years (2022, 2024) are correct. (4) Reasoning: The multi-hop synthesis is flawed because the LLM misaligns key financial figures across years, leading to an incorrect narrative—claiming a modest cut in fees and exposure while contributions increased, whereas the ground truth describes a reduction in total capital commitment from $5B to $4.5B and the introduction of a $40M annual management fee, without mentioning prior fee levels or actual contributions. (5) Semantic Equivalence: The overall message is not equivalent—the LLM suggests a more complex and dynamic funding structure with specific annual flows and changes that are not in the original. The core fact of a reduced capital commitment is partially aligned, but the magnitude and timing are wrong. Due to major errors in numbers and timeline, the correctness score is low despite addressing the right topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 564,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has COP's natural gas reserves in the Asia Pacific/Middle East region evolved from 2023 to 2024, and what does this indicate about the company's operational focus in that geographic area?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure slightly decreased to 296 billion cubic feet. This indicates a modest reduction in reserves over the year, suggesting a potential shift in operational focus or resource allocation in the region.",
      "llm_answer": "COP’s proved natural‑gas reserves in the Asia Pacific/Middle East area fell from 312 billion cubic feet (BCF) at the end of 2023 (305 BCF developed + 7 BCF undeveloped) to 296 BCF at the end of 2024 (289 BCF developed + 7 BCF undeveloped) – a decline of roughly 16 BCF (about 5 %)【page_145】. The footnote notes that “All Equity Affiliate reserves are located in our Asia Pacific/Middle East Region,” and the 2024 discussion cites only modest revisions and limited extensions in that region【page_146】. This modest drop, combined with the fact that the reserves are held mainly through equity affiliates, indicates that ConocoPhillips’ operational focus in Asia Pacific/Middle East is relatively small and affiliate‑centric rather than driven by large‑scale direct development.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the natural gas reserves for COP in the Asia Pacific/Middle East region as 312 BCF in 2023 and 296 BCF in 2024, matching the ground truth exactly. The calculation of a 16 BCF decrease (5%) is accurate and properly contextualized. The breakdown into developed and undeveloped reserves (305 + 7 in 2023; 289 + 7 in 2024) is consistent with the source data, and the observation that undeveloped reserves remained unchanged is correct. (2) All numbers, dates, and calculations are factually accurate. The 5% decline is a valid approximation of 16/312 (~5.12%), and formatting (BCF, billion cubic feet) is acceptable. (3) The reasoning is sound and goes beyond the ground truth by incorporating additional context from the filing (e.g., equity affiliates, modest revisions, limited extensions), which supports a more nuanced interpretation. The conclusion that operational focus is 'affiliate-centric' rather than driven by large-scale direct development is a reasonable inference from the data and footnotes, though slightly more interpretive than the original answer. This represents strong multi-hop synthesis across pages and concepts. (4) The answer fully addresses both parts of the question: the evolution of reserves (quantitative change) and what it indicates about operational focus (qualitative interpretation). It is highly relevant and adds contextual depth without introducing inaccuracies. The only reason for not scoring a 10 is that the original answer did not include the developed/undeveloped breakdown or equity affiliate detail, so while those enhance the response, they slightly exceed the ground truth scope without contradicting it. Overall, the answer is factually excellent and contextually rich.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 480,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "Compare Comcast's wireless gateway procurement strategy in 2022 with its network deployment investment focus in 2024.",
      "original_answer": "In 2022, Comcast's relationship with wireless gateways was primarily centered on procurement, as the company purchased a significant amount of customer premise equipment, including wireless gateways, from a limited number of suppliers to provide services to residential and business customers. By 2024, the company's approach had evolved into a more strategic investment focus, with wireless gateways being a key component of its planned capital expenditures. Specifically, in 2024, Comcast emphasized deploying wireless gateways as part of its broader network upgrades aimed at delivering multigigabit symmetrical speeds. This shift indicates a move from passive procurement to active integration of wireless gateways into its infrastructure strategy, aligning with its goals for network scalability and capacity expansion.",
      "llm_answer": "In 2022 Comcast’s wireless‑gateway approach was essentially a procurement play – the company bought a large volume of customer‑premise equipment, including wireless gateways, from a **limited number of suppliers** (see page 6 & page 8). By 2024 the emphasis had shifted to **network‑deployment spending**, with capital expenditures directed to **scalable infrastructure, line extensions and support capital** to expand capacity and roll out multigigabit symmetric speeds, while still continuing the rollout of wireless gateways as part of the broader connectivity build‑out (see page 50 & page 51).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core evolution in Comcast's strategy from 2022 to 2024. In 2022, it accurately describes the company's approach as procurement-focused, involving bulk purchases of wireless gateways from a limited number of suppliers, which aligns with the ground truth. By 2024, the answer correctly identifies a strategic shift toward network deployment investment, highlighting capital expenditures on scalable infrastructure, line extensions, and support capital aimed at expanding capacity and delivering multigigabit symmetric speeds. The continued rollout of wireless gateways is appropriately contextualized as part of this broader infrastructure build-out. (2) There are no numeric values (e.g., dollar amounts, percentages, quantities) in either the original or LLM answer, so quantitative accuracy is not compromised; all references to years (2022, 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across time periods (2022 vs 2024) and strategic focus (procurement vs capital investment), correctly identifying the shift from passive equipment buying to active integration into network expansion. The mention of specific page references (e.g., page 6, 8, 50, 51) suggests grounding in source material, though not required for correctness. (4) The only minor shortcoming is that the LLM answer does not explicitly state that wireless gateways became a 'key component' of capital expenditures or emphasize the strategic integration as clearly as the original answer. However, it does imply this by noting their inclusion in the 'broader connectivity build-out' within the context of major network upgrades. This slight omission in emphasis prevents a perfect 10 on qualitative accuracy, but overall factual content and semantic meaning remain highly aligned with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 506,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2022 and 2024, particularly in terms of its strategic importance and production challenges?",
      "original_answer": "In 2022, Tesla highlighted the Solar Roof as a key contributor to the growth in Energy generation and storage revenue, indicating it was being actively deployed alongside products like Megapack and Powerwall. By 2024, Tesla's framing had shifted, with the Solar Roof now positioned as a product facing potential production ramp delays similar to past vehicle and energy storage product launches. This evolution reflects a shift from emphasizing deployment success to cautioning about the operational and manufacturing risks associated with scaling the product.",
      "llm_answer": "In the 2022 Form 10‑K Tesla presented Solar Roof as a key growth driver for its Energy Generation & Storage segment – deployments were rising sharply and unit costs were falling, but the product’s larger share pulled the segment’s gross margin down because the manufacturing line was still under‑utilized during the ramp‑up (see page 40 & page 39). By the 2024 filing the tone had shifted: Solar Roof is still treated as a strategic energy product, but the filing now highlights it mainly as a production‑ramp risk, warning that delays or difficulties in scaling Solar Roof manufacturing could adversely affect results (see page 17).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Tesla's evolving stance on the Solar Roof between 2022 and 2024: in 2022, it was a growth driver with rising deployments and cost reductions, while in 2024, the focus shifted to production ramp risks. These points match the original answer’s core message about strategic importance and production challenges. (2) There are no numeric inaccuracies—though specific numbers (e.g., unit cost declines, margin impact) are mentioned, they are consistent with typical disclosures and do not contradict the ground truth; no specific figures were provided in the original answer, so the LLM’s inclusion of contextual financial dynamics (e.g., under-utilized manufacturing affecting margins) adds detail without introducing errors. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of 10-K filings, correctly identifying a shift in tone and strategic framing. It infers that continued strategic importance does not preclude operational risk, which is logically consistent. (4) The only reason for not scoring a perfect 10 is that the LLM adds granular details (e.g., gross margin pressure due to under-utilization) not present in the ground truth, which, while plausible and contextually appropriate, go beyond the verified knowledge graph output. However, these do not detract from factual correctness. Overall, the answer is semantically equivalent, contextually relevant, and factually sound.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 418,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How did Duke Energy's investment in Net Pending Transactions and Other Investments change from 2022 to 2023, and what does this indicate about the company's strategic positioning in this category?",
      "original_answer": "Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. This indicates a significant reduction in exposure or involvement in pending transactions and other investments, suggesting a strategic shift or completion of certain initiatives during this period.",
      "llm_answer": "Duke Energy’s “Net pending transactions and other investments” in the Master Retirement Trust grew from **$14 million at 12/31/2022** to **$54 million at 12/31/2023**—a $40 million (roughly 4‑times) increase. The sizable rise signals that the company is deliberately expanding its exposure to this category, reflecting a more aggressive or opportunistic strategic positioning within its retirement‑plan asset mix.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and magnitude. The ground truth states that Duke Energy's investment in Net Pending Transactions and Other Investments decreased from $53 million in 2022 to $14 million in 2023. However, the LLM claims an increase from $14 million in 2022 to $54 million in 2023—reversing the trend and misstating both values. The $14 million figure is incorrectly attributed to 2022 instead of 2023, and $54 million (rounded from $53M) is presented as the 2023 value when it should be the 2022 value. (2) The calculation of a $40 million increase and '4-times' growth is therefore based on swapped data and is entirely inaccurate. The actual change was a decrease of $39 million (~73.6%), not an increase. (3) The multi-hop reasoning fails because the model misidentifies the time series data, leading to an opposite conclusion about strategic positioning. Instead of recognizing a strategic reduction or completion of initiatives, the LLM infers increased strategic emphasis, which contradicts the evidence. (4) The contextual relevance is low because the answer discusses the Master Retirement Trust, which is not mentioned in the original answer or implied in the question, introducing an unverified context. This suggests confusion between different financial line items or reports. As a result, all core metrics are incorrect, and the conclusion is the opposite of the truth, warranting a very low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 407,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has the company's implementation of its liability-driven investment framework evolved between 2023 and 2024, particularly in terms of defined contribution plan expenses and the disclosure of plan asset composition?",
      "original_answer": "In 2023, the company disclosed that amounts charged to expense for defined contribution plans totaled $109 million, and the liability-driven investment framework included a 20%/80% equity/fixed income target allocation for pension assets. By 2024, defined contribution plan expenses increased to $112 million, and while the same 20%/80% allocation was maintained, the 2024 filing added a new disclosure indicating that the actual composition of plan assets at year-end would be characterized, suggesting a more detailed transparency in reporting the implementation of the investment framework.",
      "llm_answer": "In 2023 the company reported $109 million of expense for its tax‑qualified defined‑contribution plans; that amount rose to $112 million in 2024, reflecting a modest increase in contributions.  While the liability‑driven investment targets stayed the same (20 % equity/80 % fixed‑income for pension assets and 55 %/45 % for post‑retirement assets), the actual mix shifted in 2024 – pension equity grew to about 21 % (from 18 %), corporate bonds to roughly 63 % (from 57 %), and treasury holdings fell – and the 2024 filing added a far more granular fair‑value disclosure, showing Level 1/Level 2 breakdowns and NAV‑based collective‑fund values for both pension and post‑retirement plan assets, whereas the 2023 filing only provided summary percentage allocations.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the defined contribution plan expenses for 2023 ($109 million) and 2024 ($112 million), which matches the ground truth. It also correctly states that the 20%/80% equity/fixed income target allocation was maintained for pension assets. However, it introduces significant inaccuracies by claiming that the actual asset mix shifted in 2024 (e.g., pension equity rose to 21% from 18%, corporate bonds to 63% from 57%, treasury holdings fell), which is not supported by the original answer. The ground truth does not mention any actual shifts in asset composition—only that a new disclosure indicated future characterization of the actual composition. Additionally, the LLM fabricates granular fair-value disclosures (Level 1/Level 2 breakdowns, NAV-based collective-fund values) and extends the 55%/45% allocation to post-retirement assets, which is absent in the original answer. (2) While the dollar amounts and target allocation percentages are accurate, the additional percentages about actual asset shifts and disclosure details are incorrect or unsupported. There are no calculations in the question, so no calculation errors apply, but the introduction of false quantitative data reduces accuracy. (3) The multi-hop reasoning is partially sound in linking expense changes and investment framework continuity, but it fails in synthesizing the correct evolution of disclosures—instead, it invents new, detailed disclosures not present in the ground truth. The model overextends the information by assuming that increased transparency means reporting actual shifts and granular fair-value levels, which goes beyond the original claim of a promise to characterize the actual composition. (4) The contextual relevance is high because the answer addresses both parts of the question—expenses and disclosure evolution—and stays focused on the liability-driven investment framework. However, due to the inclusion of fabricated data and incorrect assertions about actual asset shifts and disclosure depth, the overall correctness score is reduced to 4, reflecting partial accuracy with significant factual errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 578,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How has Qualcomm's strategic focus on On-Device AI evolved between fiscal 2023 and fiscal 2024, and what specific investments or changes in direction were highlighted in the company's disclosures?",
      "original_answer": "In fiscal 2023, Qualcomm emphasized that On-Device AI, combined with 5G and high-performance, low-power computing, would drive adoption of smartphone technologies into industries beyond mobile, such as automotive and IoT. The company positioned itself as a leader in 5G and integrated circuit products to sustain long-term growth. By fiscal 2024, Qualcomm's focus on On-Device AI had evolved into a more investment-driven strategy, with the company explicitly stating it is investing in new product areas and industries beyond mobile handsets, including automotive and IoT, by leveraging its technical expertise and pursuing acquisitions or strategic transactions. This represents a shift from strategic vision to active investment and expansion.",
      "llm_answer": "In fiscal 2023 Qualcomm’s 10‑K did not call out on‑device AI as a separate strategic priority, focusing its discussion on 5G, handset, automotive and IoT revenue streams (see FY 2023 pages 43‑47). By fiscal 2024 the filing explicitly states that “5G combined with high‑performance, low‑power computing and on‑device artificial intelligence will continue to drive adoption” (FY 2024 p. 45) and adds that the company is devoting additional resources to foundational technologies—including on‑device AI—while raising R&D to $8.9 billion, planning higher near‑term capital expenditures to support production and testing for AI‑related diversification, and pursuing strategic investments and acquisitions to expand its AI capabilities (FY 2024 p. 20, 47).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution of Qualcomm's strategic focus: from not explicitly highlighting On-Device AI as a standalone priority in fiscal 2023 to explicitly emphasizing it in fiscal 2024 alongside 5G and computing. The answer accurately reflects the shift from a broader strategic vision to active investment. (2) Quantitative details are correct: R&D investment of $8.9 billion is accurately cited, and there is no conflicting numeric data. Page references (FY 2023 pp. 43–47; FY 2024 pp. 20, 45, 47) support the claims and match typical disclosure locations, though exact page numbers are not part of the ground truth and are treated as contextual support. (3) The multi-hop reasoning is sound—comparing disclosures across two fiscal years, identifying changes in language and strategy, and linking increased R&D and capital spending to AI-driven diversification. The LLM correctly infers a strategic shift based on explicit statements and financial commitments. (4) Minor deduction in qualitative accuracy because the original answer notes that in fiscal 2023, Qualcomm *did* mention On-Device AI in combination with 5G and computing (though perhaps not as a standalone priority), whereas the LLM states it 'did not call out on-device AI as a separate strategic priority,' which slightly understates its presence. However, this is semantically reasonable given the emphasis on explicit prioritization. Overall, the answer is factually correct, well-supported, and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 431,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has the classification and presentation of the Voting Trust Agreement between Melvin Simon & Associates, Inc. and the Simon family members evolved between the 2022 and 2023 10-K filings, and what does this indicate about the governance structure's stability?",
      "original_answer": "In the 2022 10-K filing, the Voting Trust Agreement was described as 'Second Amended and Restated' as of March 1, 2004, indicating a formal update to the governance arrangement. In contrast, the 2023 10-K filing refers to the same agreement without the 'Second Amended and Restated' modifier, simply listing it as the Voting Trust Agreement dated March 1, 2004. This shift in presentation suggests that no further amendments were made in the intervening period, signaling stability in the governance structure and a continuation of the same voting trust framework without modification.",
      "llm_answer": "In the 2022 Form 10‑K the voting‑trust documents are listed in the exhibit index simply as “9.1 Second Amended and Restated Voting Trust Agreement …” and “9.2 Voting Trust Agreement …” 【page_144】. In the 2023 filing the same agreements appear in the same section but are now labeled “9.1 (a) Second Amended and Restated Voting Trust Agreement …” and “9.2 Voting Trust Agreement …” 【page_140】. The only change is a minor renumbering (adding the “(a)” sub‑item); the agreement’s content and purpose are unchanged, indicating that the Simon family’s voting‑trust arrangement remains in place and the company’s governance framework continues to be stable.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly characterizes the evolution of the classification and presentation of the Voting Trust Agreement. According to the ground truth, the key change is the *omission* of the 'Second Amended and Restated' modifier in the 2023 10-K compared to 2022, signaling no new amendments and thus governance stability. However, the LLM claims the 'Second Amended and Restated' label is still present in 2023 (with only a minor renumbering adding '(a)'), which contradicts the ground truth. This misrepresents the core factual development. (2) There are no numeric values, dates, or calculations in the question or answer that are incorrect per se, so quantitative accuracy is acceptable (score 6), but the answer fabricates a formatting change ('(a)' sub-item) not mentioned in the ground truth, introducing unsupported detail. (3) The multi-hop reasoning is flawed: the model fails to recognize that the removal of the 'Second Amended and Restated' designation is the critical signal of stability, instead asserting continued use of that label. This undermines the qualitative accuracy of the reasoning chain. (4) The answer is contextually relevant—addressing the right document, agreement, and governance implications—but is factually incorrect on the key detail that defines the evolution. Hence, while the conclusion about stability is correct, it is based on incorrect premises, leading to a correctness score of 4 for partial accuracy with significant factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 413,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve between 2023 and 2024, and what does this indicate about the region's changing strategic importance to COP's global reserves portfolio?",
      "original_answer": "In 2023, COP reported 312 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region, while in 2024, this figure decreased slightly to 296 billion cubic feet. This represents a reduction of 16 billion cubic feet, or about 5.1%. Despite this decline, the Asia Pacific/Middle East remained a notable contributor to COP's global reserves, especially when considering equity affiliates, which held an additional 5,870 billion cubic feet in 2024. The slight decrease may suggest a shift in emphasis or extraction focus in favor of other regions, indicating a potential reevaluation of the region's role in COP's long-term production strategy.",
      "llm_answer": "COP’s Asia Pacific/Middle East natural‑gas reserves grew from roughly 5.6 trillion cubic feet at year‑end 2023 (312 BCF in consolidated operations + 5,275 BCF in equity‑affiliate holdings) to about 6.2 trillion cubic feet at year‑end 2024 (296 BCF + 5,870 BCF) – a net increase of ≈580 BCF, driven mainly by a 595 BCF rise in equity‑affiliate reserves【page_145】.  This expansion, especially the surge in affiliate holdings from purchases and extensions, signals that the Asia Pacific/Middle East region is becoming increasingly strategic to COP’s overall reserve portfolio【page_146】.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly reports the 2023 consolidated reserves (312 BCF) and 2024 consolidated reserves (296 BCF), it incorrectly states that equity-affiliate holdings were 5,275 BCF in 2023 — this number is not supported by the ground truth, which only provides the 2024 affiliate figure (5,870 BCF). The LLM fabricates a 2023 affiliate number to create a narrative of growth, which contradicts the original answer’s conclusion of a slight decline in strategic emphasis. The net increase of 580 BCF and the claim of growth from 5.6 to 6.2 trillion cubic feet are entirely incorrect, as the ground truth does not provide total regional reserves including affiliates for 2023. (2) Calculations are flawed: the LLM assumes total reserves = consolidated + equity affiliates for both years, but even if this were valid, it uses an unverified 2023 affiliate number. The claimed 595 BCF rise in affiliate holdings cannot be confirmed and appears invented. (3) Multi-hop reasoning is unsound: instead of recognizing the slight decline in consolidated reserves and interpreting its strategic implications as in the original answer, the LLM reverses the conclusion by emphasizing affiliate growth without sufficient basis. It fails to acknowledge the 16 BCF (5.1%) decrease in direct reserves, which is central to the original analysis. (4) Contextual relevance is moderate — the answer addresses the right region, company (COP), and time frame, and attempts to assess strategic importance. However, due to incorrect data synthesis and reversed conclusions, the qualitative and quantitative accuracy scores are low. The answer misrepresents the evolution of reserves and draws an opposite inference about strategic importance, warranting a correctness score of 3 — mostly incorrect with some accurate component numbers but major errors in interpretation and calculation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 521,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did AIG's financial relationship with Corebridge evolve between 2023 and 2024, particularly in terms of debt structure and equity method income?",
      "original_answer": "In 2023, AIG had a direct financial stake in Corebridge, which was reflected in the $9,368 million total Corebridge debt on AIG's balance sheet, including $6,452 million in senior unsecured notes and $989 million in junior subordinated debt, both not guaranteed by AIG. By 2024, AIG no longer consolidated Corebridge as a subsidiary; instead, it reported Corebridge under the equity method as part of discontinued operations. During the second half of 2024, AIG reported equity method income from Corebridge, which included dividends received and changes in its stock price since June 9, 2024. This marks a significant transformation from a consolidated debt relationship to a minority equity investment with associated income reporting.",
      "llm_answer": "In 2023 AIG still carried Corebridge’s full debt package on its balance sheet – $9.368 billion of senior unsecured notes, junior subordinated debt and a $1.5 billion DDTL facility (net $250 million after repayments) that was guaranteed or collateralized by AIG【page_112】. After Corebridge was de‑consolidated in June 2024, that debt was removed from AIG’s consolidated liabilities, leaving only the $250 million DDTL loan that Corebridge can continue to draw (as shown in the 2024 debt‑maturity schedule)【page_113】, and AIG’s remaining interest is now recorded as an equity‑method investment, producing $601 million of equity‑method income for the June‑Dec 2024 period【page_108】【page_109】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the high-level evolution of AIG's relationship with Corebridge—transitioning from consolidation to equity method accounting—and correctly identifies that equity method income was reported in the second half of 2024. However, there are significant quantitative inaccuracies. The original answer states that total Corebridge debt on AIG’s 2023 balance sheet was $9,368 million, composed of $6,452 million in senior unsecured notes and $989 million in junior subordinated debt (both not guaranteed by AIG). The LLM answer incorrectly inflates this with a $1.5 billion DDTL facility (net $250 million after repayments) and implies AIG guaranteed or collateralized parts of the debt, which contradicts the ground truth that the debt was not guaranteed by AIG. Additionally, the LLM claims $601 million in equity method income for June–Dec 2024, but the original answer does not specify a dollar amount for income, only that it included dividends and stock price changes. This introduces a precise figure not present in the ground truth, reducing quantitative accuracy. While the LLM correctly identifies the deconsolidation in mid-2024 and the shift to equity method reporting, it misrepresents the debt structure and adds unsupported financial figures. The reasoning is partially sound—correctly tracking the shift in accounting treatment—but flawed in financial detail. Contextually, the answer is relevant and addresses both debt structure and equity income as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 408,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How has NextEra Energy's investment strategy in Special Use Funds evolved from 2022 to 2024, particularly in terms of its allocation between fixed income and equity securities, and what does this suggest about its risk appetite or liquidity strategy?",
      "original_answer": "In 2022, NEE's Special Use Funds were entirely composed of fixed income securities, with a carrying amount of $2,505 million. By 2024, the composition had significantly transformed: NEE's Special Use Funds included $6,164 million in equity securities, $722 million in U.S. Government and municipal bonds, $685 million in corporate debt, and $873 million in asset-backed securities. This indicates a strategic shift from a purely fixed income allocation to a more diversified and equity-heavy portfolio, suggesting an increased risk appetite and a potential long-term growth orientation in its investment strategy.",
      "llm_answer": "In the 2022 filing the special‑use funds were essentially a debt‑only pool – NEE held about $2.5 billion of fixed‑income securities (and FPL about $1.9 billion) with no material equity component disclosed (see 2022 Note 5, p. 55). By 2024 the mix had turned upside‑down: equity securities now total roughly $6.2 billion for NEE and $4.2 billion for FPL, while fixed‑income holdings are only about $2.3 billion and $1.7 billion respectively (see 2024 Note 4, p. 89‑90). The shift toward a much larger equity allocation indicates a higher risk appetite and a strategy to capture higher returns, while still keeping a core of liquid debt assets to meet short‑term liquidity and regulatory requirements.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the major shift from fixed income to equity in NextEra Energy's (NEE) Special Use Funds between 2022 and 2024, and the conclusion about increased risk appetite is consistent with the ground truth. However, there are significant quantitative inaccuracies. In 2022, the ground truth specifies $2,505 million in fixed income for NEE, which the LLM approximates as $2.5 billion — acceptable. But in 2024, the LLM states NEE's equity securities are 'roughly $6.2 billion', which aligns with the ground truth's $6,164 million. However, the LLM combines NEE and FPL data: it references FPL's $4.2 billion in equity and $1.7 billion in fixed income, which were not part of the question. The original answer focuses solely on NEE, not FPL. The LLM incorrectly aggregates or conflates NEE and FPL data, leading to misleading totals (e.g., 'fixed-income holdings are only about $2.3 billion' appears to be a sum of NEE and FPL, but the ground truth for NEE alone is $722M + $685M + $873M = $2,280M, which matches approximately, but the breakdown is lost). (2) The LLM omits the detailed fixed-income composition (U.S. Government/municipal bonds, corporate debt, asset-backed securities) provided in the ground truth, instead aggregating them. While the total is roughly correct, the lack of specificity reduces completeness. (3) The multi-hop reasoning is sound in identifying a strategic shift and inferring increased risk appetite and growth orientation, which is well-supported. However, introducing FPL (a subsidiary) without clarification violates entity accuracy — the question asks about NextEra Energy (NEE), not its subsidiaries. (4) Despite these issues, the core conclusion about strategic evolution and risk appetite is correct, and the answer is highly relevant. The quantitative accuracy is reduced due to conflation of entities and lack of precise breakdown, but directional accuracy is preserved. Hence, correctness is partially compromised, warranting a 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 542,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the nature and magnitude of the risk associated with site infrastructure sharing evolved between 2022 and 2024, particularly in relation to 5G technology adoption and its impact on new lease activity?",
      "original_answer": "In 2022, AMT identified site infrastructure sharing as a risk factor that could slow new lease activity or lead to decommissioning of equipment on existing sites, particularly due to the rise of 5G technology. By 2024, this risk evolved into a more specific concern around RAN (Radio Access Network) sharing, roaming, or resale arrangements, which were explicitly tied to the lack of compensation to AMT when carriers opted for shared infrastructure instead of deploying new equipment. The 2024 filing indicates a stronger emphasis on the financial impact of this trend, suggesting a more mature and impactful shift in carrier behavior driven by 5G deployment. This represents a significant evolution in the risk's specificity and perceived threat level.",
      "llm_answer": "In the 2022 Form 10‑K the company warned that “extensive sharing of site infrastructure … including due to increases in advanced network technology such as 5G … may cause new‑lease activity to slow” (2022 p. 15). By the 2024 filing the same risk is framed more strongly – it now says that “extensive sharing of site infrastructure … including due to 5G … may cause new‑lease activity to slow … and could be **materially and adversely** affect our growth, revenue and cash‑flow” (2024 p. 16). Thus, while the nature of the risk (5G‑driven site‑sharing reducing new leases) is unchanged, the company has elevated its magnitude, indicating a greater potential impact on financial performance.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates (2022 and 2024), correct entity (AMT, inferred from context), and correctly identifies the evolution of risk language from slowing new lease activity to a more severe financial impact. The citations to page numbers and direct quotes are consistent with the expected format and support the claims. Quantitatively, there are no numerical inaccuracies—no numbers are misstated, and the timeline is correct. However, the LLM misses a key qualitative evolution highlighted in the ground truth: the shift from general 'site infrastructure sharing due to 5G' to more specific technical and operational arrangements like RAN sharing, roaming, or resale, and crucially, the lack of compensation to AMT despite carrier use of shared infrastructure. The LLM correctly notes the increased severity ('materially and adversely affect') but does not capture the change in nature—from a technological trend (5G enabling sharing) to a business model risk (carriers sharing without paying AMT). This omission reduces the depth of the multi-hop synthesis, particularly around how 5G adoption has concretely changed carrier behavior in a way that financially impacts AMT. While the answer correctly identifies increased risk magnitude, it underrepresents the evolution in risk specificity. The reasoning is sound but incomplete. Contextually, the response is highly relevant and directly addresses the question’s focus on 5G, lease activity, and risk evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 410,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has Chevron's financial relationship with Angola LNG Limited evolved between 2022 and 2023, particularly in terms of its investment structure and equity method accounting?",
      "original_answer": "Chevron's relationship with Angola LNG Limited evolved from a dependency-based structure in 2022 to a more direct investment model in 2023. In 2022, Chevron reported a 36.4% interest in Angola LNG Limited, but the relationship was categorized under 'Depends_On', indicating a more passive or structurally dependent investment. By 2023, the relationship was reclassified as 'Invests_In', suggesting a more active or strategic financial posture. Additionally, while both years maintained the same ownership percentage (36.4%), the reclassification indicates a shift in how Chevron views or manages its investment, possibly reflecting changes in operational involvement or strategic alignment.",
      "llm_answer": "Chevron continues to hold a 36.4 % equity interest in Angola LNG Limited, which is accounted for under the equity‑method (see Note 15 description on page 78).  The carrying amount of that investment fell from $1.963 billion in 2022 to $1.762 billion in 2023, and Chevron’s share of Angola LNG’s earnings dropped sharply from $1.857 billion to $513 million over the same period (see the investment and equity‑in‑earnings figures on page 82).  The ownership percentage and accounting method remained unchanged, but both the investment balance and equity‑method earnings declined.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific quantitative data such as Chevron's 36.4% equity interest, the carrying amount of the investment ($1.963B in 2022, $1.762B in 2023), and equity-method earnings ($1.857B to $513M), which are not present in the original answer. However, the original answer focuses on a qualitative shift in relationship classification (from 'Depends_On' to 'Invests_In')—a key structural change in investment categorization—which the LLM answer completely omits. This is a major factual omission because the question specifically asks about evolution in investment structure and equity method accounting, not just financial performance. (2) While the LLM provides precise dollar figures and percentage changes, these numbers are not verifiable against the ground truth, which does not mention them. Therefore, their accuracy cannot be confirmed, and their inclusion may reflect hallucination or reliance on external data not in the knowledge graph. The 36.4% ownership is correctly stated in both answers. (3) The multi-hop reasoning is flawed: the LLM interprets 'evolution' purely through financial metrics (carrying value and earnings), whereas the ground truth emphasizes a change in relationship type ('Depends_On' → 'Invests_In'), indicating a shift in accounting or strategic classification. This reflects a failure to synthesize the correct type of information—structural/accounting relationship evolution vs. financial performance trends. (4) The contextual relevance is moderate because the answer discusses Chevron’s investment in Angola LNG and equity-method accounting, but it misses the core qualitative transformation highlighted in the original answer. Thus, while numerically detailed, it fails on the primary dimension of structural evolution. Correctness score is low due to missing the key reclassification insight, despite some accurate details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 512,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the G600 aircraft's role in Gulfstream's product lineup evolved from 2022 to 2023, particularly in terms of its performance metrics and production status?",
      "original_answer": "In 2022, the G600 was described as a recent addition to the Gulfstream fleet, having entered service in 2019, and was positioned as a clean-sheet aircraft replacing the G550. By 2023, the G600 was no longer characterized as 'new' but rather as a mature product within the lineup, with over 250 cumulative deliveries by year-end 2023. Additionally, in 2023, the G600's advanced technologies, such as the Symmetry Flight Deck, were highlighted as foundational features being extended to newer models like the G700, G800, and G400. This indicates a shift from product introduction to integration within the broader Gulfstream platform.",
      "llm_answer": "In the 2022 filing Gulfstream described the G600 (along with the G500) as a new large‑cabin jet that replaced the G450/G550 with higher speed, better fuel efficiency, larger cabin volume, longer range and upgraded flight‑control systems, noting that cumulative deliveries of the two models were “almost 150” by year‑end 2021【page_5】. By the 2023 filing those same performance advantages were still emphasized, the aircraft now contributed to more than 90 city‑pair speed records, and cumulative deliveries had risen to “over 250” units by year‑end 2023, showing the G600’s transition from early rollout to a mature, high‑volume product in Gulfstream’s lineup【page_5】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: 'almost 150' cumulative deliveries by end-2021 (implied context for 2022 filing) and 'over 250' by end-2023 are consistent with the original answer's timeline and figures. The mention of more than 90 city-pair speed records in 2023 is an additional accurate detail not in the ground truth but does not contradict it. (2) The evolution from 'new' to 'mature, high-volume product' correctly captures the shift described in the original answer. (3) The LLM correctly synthesizes information across 2022 and 2023 filings, showing multi-hop reasoning by tracking the G600’s progression in production status and market position. (4) One minor omission: the original answer notes the Symmetry Flight Deck being extended to newer models (G700, G800, G400) as evidence of the G600’s role as a technology foundation—this aspect of 'integration into the broader platform' is missing in the LLM answer. However, the core evolution in role, performance emphasis, and production maturity is fully captured. Wording differs but semantic meaning is equivalent. No factual errors; only slight incompleteness on technological legacy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 344,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has McDonald's relationship with its franchisees evolved in terms of financial involvement and strategic collaboration between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's relationship with franchisees was primarily framed around franchised arrangements and license agreements, with franchisees contributing revenue through rent, royalties, and initial fees, while the company did not typically invest in restaurant capital under developmental licenses. By 2024, the company had introduced a more active investment role, co-investing with franchisees to fund restaurant improvements and operating system upgrades. These co-investments were aimed at catering to consumer preferences, improving local performance, and enhancing the brand through modernization. This marks a strategic shift from a largely passive franchising model to a more collaborative and financially engaged partnership.",
      "llm_answer": "In the 2022 filing McDonald’s described its franchise model mainly as a fee‑based relationship – franchisees paid rent, royalties and initial fees while reinvesting capital on their own, and the Company’s co‑investment was limited to occasional restaurant‑improvement projects 【page_44】. By the 2024 filing the partnership had become more collaborative: the Company now routinely co‑invests with franchisees to fund restaurant modernizations and operating‑system initiatives, provides upfront funding for these projects, and leverages joint technology‑platform fees, while the franchisee base has grown to about 95 % of a 43,477‑restaurant system 【page_3】【page_4】. This reflects a shift from a primarily fee‑driven arrangement to a deeper financial and strategic collaboration with franchisees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, McDonald's had a fee-based model with limited co-investment; by 2024, it shifted to routine co-investment with franchisees for modernizations and system upgrades. The description of financial involvement evolving from passive to collaborative is consistent. (2) Quantitative details are accurate: the 95% franchisee ownership and 43,477 total restaurants in 2024 are correctly reported and match the source. No calculations were required, but the numbers cited are precise and properly contextualized. (3) Multi-hop reasoning is sound—information from 2022 and 2024 filings is correctly synthesized to show a strategic evolution. The LLM adds slightly more detail (e.g., joint technology-platform fees, upfront funding) that enrich the answer but are not contradicted by the ground truth. (4) Semantic equivalence is strong; the core message of a shift toward deeper financial and strategic collaboration is preserved. The only minor gap is that the original answer emphasizes the purpose of co-investment (catering to consumer preferences, improving local performance), which the LLM mentions implicitly but not explicitly. This does not detract significantly from correctness. Overall, the answer is factually robust, well-supported, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 379,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined marginally to $10,670 million. This reflects a small decrease in both revenue and profitability year-over-year.",
      "llm_answer": "The consolidated operating results show that smokeable‑product net revenues fell from **$22.476 billion in 2022 to $21.756 billion in 2023** (a drop of about $720 million, ≈ 3%).  Operating income (OCI) for the segment slipped slightly, from **$10.688 billion in 2022 to $10.670 billion in 2023** (a $18 million decline, ≈ 0.2%).【page_29】",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $22,476 million (=$22.476 billion) in 2022 and $21,756 million (=$21.756 billion) in 2023 for net revenues; $10,688 million (=$10.688 billion) and $10,670 million (=$10.670 billion) for operating income—format variations (billion vs million) are semantically equivalent and correctly interpreted. (2) Calculations are precise: the $720 million revenue drop (22,476 - 21,756 = 720) and ~3% decrease, as well as the $18 million operating income decline (10,688 - 10,670 = 18) and ~0.2% drop, are correctly computed. (3) The reasoning is sound and synthesizes year-over-year performance across both metrics, capturing the slight decline in both net revenues and operating income as stated in the original answer. (4) All entities—'smokeable products', '2022', '2023', 'net revenues', 'operating income'—are correctly identified and aligned with the question. (5) The answer is contextually complete, addressing both parts of the question (net revenues and operating income evolution) with accurate, well-sourced information (citing page 29). Semantic equivalence is maintained, with slightly more detailed quantification (percentages, absolute differences) enhancing clarity without distorting facts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1176,
        "completion_tokens": 367,
        "total_tokens": 1543
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How has the role of Opdivo within BMY's product development and commercialization strategy evolved from 2022 to 2024, particularly in terms of its collaborative framework and new therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was primarily positioned within a joint development and commercialization framework with Ono, where profits, losses, and development costs were shared—either equally for combination therapies or under an 80-20 split for single-party compounds. Additionally, Opdivo was part of a broader alliance that included other products like Yervoy and Orencia, with structured co-promotion and supply responsibilities. By 2024, Opdivo's role had evolved significantly, marked by a new FDA approval in March 2024 for use in combination with cisplatin and gemcitabine for the first-line treatment of unresectable or metastatic urothelial carcinoma. This reflects a shift from a co-development focus to a more independent product introduction strategy, with BMY taking the lead in expanding Opdivo’s therapeutic applications in key oncology markets.",
      "llm_answer": "In the 2022 filing, Opdivo was chiefly a product of a regional alliance with Ono—BMS held worldwide exclusive rights except in Japan, South Korea and Taiwan, and the two companies shared development costs (80 %/20 % or 50 %/50 % for combination regimens) and royalties on sales【page_113】【page_114】. By the 2024 filing, Opdivo is portrayed as a cornerstone of BMS’s immuno‑oncology platform, with a wave of new approvals—including FDA clearances for urothelial carcinoma (March 2024) and resectable NSCLC (Oct 2024), the sub‑cutaneous Opdivo Qvantig co‑formulation (Dec 2024), and an EC‑approved Opdivo + Yervoy combo (Dec 2024)【page_44】【page_46】—showing an expanded global commercialization strategy that builds on the earlier regional collaboration while adding new indications and formulations.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and largely aligns with the ground truth. (1) Correct elements: The 2022 collaborative framework with Ono is accurately described, including the 80/20 and 50/50 cost-sharing structure and regional rights (Japan, South Korea, Taiwan). The 2024 FDA approval for urothelial carcinoma in March 2024 is correctly cited. The LLM adds additional approvals (resectable NSCLC in Oct 2024, sub-cutaneous Opdivo Qvantig in Dec 2024, EC approval for Opdivo + Yervoy in Dec 2024), which are not contradicted by the ground truth but represent expanded detail—likely from the source document. (2) Quantitative accuracy: All dates and percentages are correct. The mention of additional 2024 approvals goes beyond the ground truth but does not conflict with it; these could reflect further developments within the same strategic evolution. (3) Reasoning: The LLM correctly infers a strategic shift from co-development (2022) to a broader, more independent global commercialization strategy in 2024, which is consistent with the ground truth’s claim of BMY taking the lead. The synthesis across years and collaboration frameworks is sound. (4) Semantic equivalence: While the LLM provides more detail than the original answer, the core evolution—from a jointly managed asset to a central pillar of BMY’s oncology strategy with expanded indications—is accurately conveyed. The only minor deviation is the inclusion of additional approvals not in the ground truth, but since they are plausible and do not contradict the original, they do not constitute factual errors. Thus, the answer earns a 9 for correctness—excellent but not perfectly aligned in scope.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 454,
        "total_tokens": 1879
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has AMT's disclosure regarding interest rate benchmarks for debt instruments evolved between 2022 and 2024, particularly in terms of referenced rates and associated covenants?",
      "original_answer": "In 2022, AMT's debt instruments referenced LIBOR, EURIBOR, and a defined base rate for USD and EUR denominated borrowings, with the 2021 credit facilities tied to debt ratings and commitment fees ranging from 0.080% to 0.300%. By 2024, AMT disclosed that new drawings under letters of credit in Nigeria bore interest at SOFR (Secured Overnight Financing Rate) plus a spread, indicating a shift away from LIBOR-based instruments. Additionally, while 2022 disclosures detailed specific covenants and optional renewal periods for various credit facilities, the 2024 disclosure focused on the consequences of covenant non-compliance without specifying interest rate structures or renewal terms, suggesting a simplification or evolution in the presentation of covenant-related disclosures.",
      "llm_answer": "In the 2022 filing (see pages 52‑53) AMT said its revolving credit facilities were priced off floating benchmarks – LIBOR, EURIBOR or a defined base rate – with spreads (e.g., 0.875 %‑1.75 % over LIBOR/EURIBOR) and the loan agreements contained generic reporting, financial‑operating and debt‑incurrence covenants (limitations on additional debt, guaranties, asset sales, liens, etc.). By the 2024 filing (see pages 115‑117) the company’s debt is described by fixed coupons on specific notes and securitizations (e.g., 3.029 % on the 2015 notes, 3.652 %/4.459 % on the 2018 securities, 5.490 %/5.735 % on the 2023 securities) and the related agreements now focus on cash‑flow‑coverage covenants – DSCR thresholds, cash‑trap reserve accounts, amortization triggers and explicit prohibitions on incurring additional indebtedness. This shows a shift from benchmark‑linked pricing with broad covenants to fixed‑rate securitized debt with detailed performance‑based covenants.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents key aspects of AMT's disclosure evolution. (1) Quantitatively, the LLM incorrectly states that by 2024, AMT's debt is described by fixed coupons on specific notes (e.g., 3.029%, 3.652%, 4.459%, 5.490%, 5.735%) — these specific rates and note years (2015, 2018, 2023) are not mentioned in the ground truth and appear fabricated or misattributed. The ground truth highlights a shift to SOFR for new drawings in Nigeria, not a general shift to fixed-rate securitized debt. (2) The LLM claims covenants evolved to 'DSCR thresholds, cash-trap reserve accounts, amortization triggers' — none of which are in the original answer; the ground truth only notes that 2024 disclosures focused on consequences of non-compliance without detailing structures, suggesting simplification, not increased specificity. (3) The original answer correctly identifies a transition from LIBOR/EURIBOR to SOFR in specific contexts (Nigeria letters of credit), while the LLM incorrectly generalizes a shift to fixed-rate instruments and securitizations not supported by the ground truth. (4) The LLM invents details about 'pages 115–117' and specific spreads (0.875%–1.75%) not present in the ground truth, which does not provide page numbers or exact spread ranges. (5) While the LLM correctly identifies a broad trend — a shift in benchmark usage and covenant focus — this high-level reasoning is partially sound but undermined by incorrect supporting facts. The answer is contextually relevant and attempts multi-hop synthesis, but fails on factual accuracy, especially regarding rates, covenants, and financial instruments. Minor format flexibility is allowed, but invented numbers and mischaracterized disclosures severely reduce correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 484,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How has McDonald's relationship with franchisees evolved in terms of real estate ownership and co-investment strategy between 2022 and 2024?",
      "original_answer": "In 2022, McDonald's emphasized Systemwide coordination and alignment to manage ESG initiatives, including environmental sustainability and responsible sourcing, which required franchisee cooperation. However, the specific role of franchisees in real estate ownership was not detailed. By 2024, the company explicitly outlined its conventional franchise model, where it typically owns or secures long-term leases on land and buildings, while franchisees invest in equipment, signs, seating, and décor. This co-investment model was described as enabling McDonald's to achieve high restaurant performance levels. The shift from a general emphasis on franchisee collaboration in 2022 to a clearly defined real estate and co-investment strategy in 2024 reflects a more structured and strategic approach to franchise relationships.",
      "llm_answer": "In the 2022 filing McDonald’s said it “generally owns or secures a long‑term lease on the land and building for conventional franchised and Company‑operated restaurant sites” as the core of its real‑estate model (2022 10‑K PROPERTIES, p. 35). By the 2024 filing the company still relies on that ownership/lease structure, but now emphasizes that “ownership of real estate, combined with the co‑investment by franchisees” is used to drive performance and that it “may co‑invest with franchisees to fund improvements to their restaurants or operating systems” (2024 10‑K Conventional Franchise, p. 3; co‑investment paragraph, p. 4). Thus, the relationship has shifted from a pure real‑estate ownership model to one that pairs ownership with active co‑investment alongside franchisees.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies McDonald's real estate model in both 2022 and 2024, noting that the company generally owns or secures long-term leases on land and buildings—a key point from the original answer. It also accurately captures the evolution by highlighting the increased emphasis on co-investment with franchisees in 2024, including funding improvements to restaurants or operating systems. (2) There are no numerical values to verify (e.g., dollar amounts, percentages), but the years (2022 and 2024) and document references (10-K filings) are correctly cited, and no calculations are required. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, comparing the more general real estate ownership model in 2022 with the more explicitly defined co-investment strategy in 2024. The conclusion that the relationship evolved from a 'pure real-estate ownership model' to one involving active co-investment is logically supported and semantically equivalent to the ground truth’s claim of a shift toward a 'more structured and strategic approach.' (4) Minor deduction in qualitative accuracy due to slightly stronger characterization of the 2022 model as a 'pure real-estate ownership model,' which may overstate the contrast—the original answer notes that franchisee cooperation was emphasized in 2022 around ESG, even if real estate details were less explicit. However, this does not undermine the core correctness. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 443,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the status and documentation of the 2015 Stock Compensation Plan for Non-Employee Directors change between 2022 and 2023, and what does this evolution indicate about Altria's governance approach to director compensation?",
      "original_answer": "In 2022, the 2015 Stock Compensation Plan for Non-Employee Directors was disclosed with 703,256 shares available for issuance under the plan. By 2023, the plan was formally amended and restated effective October 26, 2022, and was incorporated by reference from Altria's September 30, 2022, Form 10-Q filing. This indicates a formal update to the plan’s structure and governance, suggesting Altria refined its director compensation framework mid-cycle, potentially to align with evolving governance standards or internal compensation strategies.",
      "llm_answer": "In the 2022 Form 10‑K the 2015 Stock Compensation Plan for Non‑Employee Directors was simply listed as an approved equity‑compensation plan with **703,256 shares still available for future issuance** [114†L...‑3]. By the 2023 filing the plan had been **amended and restated effective October 26 2022** [110†L...‑22] and the remaining share pool had fallen to **589,927 shares** [107†L...‑3]. This shift—updating the plan’s terms and reducing its authorized share reserve—shows Altria actively revises and monitors director equity compensation, reflecting a disciplined governance stance that aligns director pay with actual usage and shareholder oversight.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key facts: in 2022, 703,256 shares were available under the 2015 Stock Compensation Plan for Non-Employee Directors; by 2023, the plan was amended and restated effective October 26, 2022. The LLM adds a new detail not in the original answer—the 2023 share availability of 589,927—which is consistent with a reduction due to usage and strengthens the narrative of active management of the share pool. This number is plausible and aligns with the timeline (post-amendment disclosure), though it was not in the ground truth. Since it does not contradict and enhances accuracy, it does not penalize the score. (2) All numeric values—703,256 shares (2022), October 26, 2022 (amendment date), and 589,927 shares (2023)—are treated as factually accurate based on the cited filings. No calculation errors; the implied reduction of 113,329 shares is logical. (3) Multi-hop reasoning is sound: the model synthesizes information across two years (2022 and 2023 filings), identifies a change in plan status (from active to amended), incorporates share availability trends, and infers governance implications. The conclusion—that Altria actively manages and updates director compensation with discipline—aligns with and slightly expands upon the original answer’s point about refined governance. (4) The answer is semantically equivalent and contextually complete. The only minor gap is that the original answer mentions incorporation by reference from the September 30, 2022, Form 10-Q, which the LLM omits. This is a small omission but does not affect the core correctness. Overall, the LLM provides a more detailed and equally accurate response, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 468,
        "total_tokens": 1788
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the impact of roaming and resale arrangements among wireless service providers on AMT's leasing activity evolved from 2022 to 2024, and what does this indicate about the competitive pressures affecting new lease growth?",
      "original_answer": "In 2022, AMT noted that roaming or resale arrangements among wireless service providers, particularly with the rise of 5G technology, could slow new lease activity if carriers opted to share infrastructure rather than deploy new equipment. By 2024, this concern evolved into a broader risk involving RAN sharing and resale arrangements, which not only threatened new lease activity but also led to potential decommissioning of existing equipment due to redundancy. This indicates a growing competitive pressure where infrastructure sharing is becoming a more viable and widespread alternative to leasing, directly impacting AMT’s revenue growth prospects.",
      "llm_answer": "In its 2022 Form 10‑K, AMT warned that extensive site‑sharing, roaming and resale arrangements among wireless carriers could “slow new lease activity” (Risk Factors 2022 p. 15). By the 2024 filing the company repeats the same risk and adds that the growth of 5G and greater network‑sharing make the effect more acute, potentially curbing new leases and even prompting equipment de‑commissioning (Risk Factors 2024 p. 16). This evolution shows that competitive pressure from carrier‑sharing arrangements has intensified, increasingly limiting AMT’s ability to generate new lease growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 risk regarding roaming, resale, and site-sharing slowing new lease activity is accurately cited from AMT's 2022 10-K, and the 2024 evolution—where 5G and network-sharing intensify the risk and introduce equipment decommissioning—is correctly reflected. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised; dates (2022, 2024) are correct. (3) Multi-hop reasoning is sound: the answer synthesizes information across two years of filings and correctly infers that competitive pressures from infrastructure sharing have intensified, limiting new lease growth. (4) The only minor shortcoming is that the LLM does not explicitly mention 'RAN sharing'—a specific technical term included in the original answer—which slightly reduces qualitative precision. However, 'greater network-sharing' serves as a semantically close proxy. The answer is fully contextually relevant, directly addressing the evolution of the impact and its implications for competitive pressures. Overall, the response is factually correct, well-reasoned, and conveys the same core message as the ground truth with only negligible omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 364,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has McDonald's relationship with its franchisees evolved between 2022 and 2024, particularly in terms of strategic investment and operational expectations?",
      "original_answer": "In 2022, McDonald's highlighted the impact of the COVID-19 pandemic on franchise operations, emphasizing risks related to labor availability, supply chain disruptions, and the importance of executing its 'Accelerating the Arches' strategy to maintain growth. The focus was on franchisees' ability to adapt to changing consumer behavior and operational restrictions. By 2024, McDonald's had shifted toward a more active investment role, co-investing with franchisees to modernize restaurants and improve local performance. The company emphasized franchisee reinvestment in their businesses and introduced structured co-investment initiatives designed to increase the value of the McDonald's brand through restaurant modernization and enhanced consumer appeal. This marks a shift from pandemic-driven operational challenges to a more strategic, investment-backed growth approach.",
      "llm_answer": "In the 2022 filing, McDonald’s stressed that franchisees were expected to fund and execute major, capital‑intensive initiatives on their own and stay aligned with the company’s operating, promotional and reinvestment plans, warning that a lack of financing could impede growth【page_30】. By the 2024 filing, the relationship had become more collaborative: franchisees still must reinvest capital and meet rigorous Global Brand Standards, but McDonald’s now co‑invests with them to accelerate restaurant modernisation and system upgrades, reflecting a deeper strategic partnership【page_4】【page_2】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) It correctly identifies the evolution in McDonald's relationship with franchisees from 2022 to 2024: in 2022, franchisees were expected to independently fund and execute capital-intensive initiatives, which matches the ground truth emphasis on franchisee adaptation during pandemic-related challenges. By 2024, the shift to co-investment and a more collaborative, strategic partnership is accurately captured. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised—dates (2022 and 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across two time points and correctly infers a strategic shift from independent franchisee investment to a co-investment model, reflecting deeper collaboration. The mention of 'Global Brand Standards' and 'restaurant modernisation' aligns with the original's focus on reinvestment and brand value enhancement. (4) The LLM adds slightly more specificity (e.g., 'capital-intensive initiatives', 'financing could impede growth') with citation markers like 【page_30】 and 【page_4】, which are not in the original but do not contradict it—likely reflecting source document references. These additions enhance clarity without distorting facts. The only minor gap is that the LLM does not explicitly mention the 'Accelerating the Arches' strategy or pandemic-related risks like labor and supply chain issues, which are part of the 2022 context in the original. However, the core evolution in the franchisee relationship—strategic investment and operational expectations—is accurately conveyed. Thus, the answer is semantically equivalent with high completeness and reasoning quality.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 495,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did NextEra Energy's investment strategy in equity securities within its Special Use Funds evolve from 2022 to 2024?",
      "original_answer": "In 2022, NextEra Energy held $8,922 million in Special Use Funds, with no explicit breakdown of equity securities provided in the filing. By 2024, the company disclosed a more detailed composition, with $6,164 million specifically allocated to equity securities under Special Use Funds. This evolution suggests a strategic shift toward transparency and a potentially greater emphasis on equity investments within these funds. While the total amount in Special Use Funds decreased, the explicit allocation to equities in 2024 indicates a more defined and possibly more aggressive investment posture compared to 2022.",
      "llm_answer": "In the 2022 filing the company did not break out a separate “equity‑securities” line for its Special‑Use Funds – the balance sheet only showed total special‑use‑fund assets of $8.9 billion (see page 63), implying a modest equity component. By 2023 the equity portion had risen to $5.29 billion (Level 1 $2.35 billion, Level 2 $2.74 billion, Level 3 $0.20 billion) and by 2024 it grew further to $6.16 billion (Level 1 $2.61 billion, Level 2 $3.32 billion, Level 3 $0.23 billion) (see pages 90 and 89), reflecting a clear strategic shift toward larger equity allocations and a greater reliance on Level 2 commingled‑fund investments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. While it correctly states the 2024 equity securities amount as $6.16 billion (matching the ground truth of $6,164 million), it introduces a 2023 figure of $5.29 billion, which is not present in the original answer or implied by the ground truth. The original answer only compares 2022 and 2024, with no data provided for 2023. Additionally, the LLM claims a 'modest equity component' in 2022 based on the total $8.9 billion in Special Use Funds, but the ground truth explicitly states that no breakdown was provided in 2022, so any inference about the equity component is speculative and unsupported. (2) The numeric values for 2024 are accurate ($6.16 billion ≈ $6,164 million), and the total 2022 Special Use Funds are approximately correct ($8.9 billion vs $8,922 million). However, the introduction of Level 1/2/3 breakdowns and the 2023 data is not found in the ground truth and appears to be fabricated or misattributed. (3) The reasoning correctly identifies a strategic shift toward greater equity allocation and transparency, which aligns with the original answer's conclusion. However, the multi-hop synthesis is flawed because it invents an intermediate year (2023) and detailed fair value hierarchies not referenced in the ground truth, undermining the factual basis of the evolution argument. (4) Despite the incorrect numbers and unsupported inferences, the LLM captures the core directional trend—increased emphasis on equity securities and improved disclosure—making the answer partially correct and contextually relevant. The qualitative reasoning is sound in direction but compromised by factual overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 464,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How did the financial performance of smokeable products evolve from 2022 to 2023, particularly in terms of net revenues and operating income?",
      "original_answer": "In 2022, smokeable products generated $22,476 million in net revenues and contributed $10,688 million to operating income. In 2023, net revenues from smokeable products decreased slightly to $21,756 million, and operating income from this segment also declined to $10,670 million. This indicates a marginal decrease in both revenue and profitability year-over-year.",
      "llm_answer": "In the smokeable‑products segment, net revenues fell from **$22.476 billion in 2022 to $21.756 billion in 2023**, a decline of roughly $720 million (about 3 %). Operating income (OCI) for the same segment slipped slightly, from **$10.688 billion in 2022 to $10.670 billion in 2023**, a drop of about $18 million (≈0.2%)【page_29】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: $22,476 million (=$22.476 billion) in 2022 and $21,756 million (=$21.756 billion) in 2023 for net revenues; $10,688 million (=$10.688 billion) and $10,670 million (=$10.670 billion) for operating income—format variations (billion vs million) are semantically equivalent and correctly interpreted. (2) The calculations are precise: a $720 million revenue decline (22,476 - 21,756 = 720) is correctly stated, as is the ~3% decrease; the $18 million drop in operating income (10,688 - 10,670 = 18) and ≈0.2% decline are accurate. (3) The reasoning is sound: the LLM correctly synthesizes year-over-year performance, identifies the trend of marginal decline, and attributes it to both revenue and profitability—this reflects proper multi-hop understanding across time points and financial metrics. (4) All entities (smokeable products, 2022–2023 timeframe, net revenues, operating income) are correctly identified and contextualized. The answer is complete, factually precise, and semantically equivalent to the original, with added value in percentage analysis that remains consistent with the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1172,
        "completion_tokens": 343,
        "total_tokens": 1516
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How has the utilization of Accenture plc Class A Ordinary Shares evolved between 2022 and 2023, particularly in terms of share purchase programs and their intended usage?",
      "original_answer": "In 2022, Accenture disclosed an aggregate available authorization of $3,129,296 for publicly announced open-market share purchase programs and other share purchase programs involving Accenture plc Class A Ordinary Shares and Accenture Canada Holdings Inc. exchangeable shares. By 2023, the company clarified that Class A Ordinary Shares acquired through these programs were being held as treasury shares and intended for employee benefits, such as equity awards. Additionally, in fiscal 2024, shares were acquired via share withholding for payroll tax obligations under employee equity share plans, which were separate from the publicly announced share purchase authorization. This indicates a shift in focus toward internal employee compensation mechanisms while maintaining a formal buyback program.",
      "llm_answer": "In fiscal 2022 Accenture had $3.13 million of authorized funding for its publicly announced open‑market share‑purchase program and other share‑purchase initiatives, and it used those funds to acquire 12.18 million Class A ordinary shares (≈$4.11 million) that were held as treasury shares for employee equity awards and other corporate purposes; the Board later added $3 million of repurchase authority, raising total outstanding authority to $6.13 million【page_93†L1-L5】【page_94†L1-L9】【page_94†L31-L34】. The 2023 filing excerpts (pages 81‑85) contain no updated share‑purchase activity, so no change in utilization or new purpose for the Class A shares is disclosed in the sections provided【page_81†L1-L5】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The authorized amount in 2022 was $3,129,296 (approximately $3.13 billion), not $3.13 million — this is off by a factor of 1,000, a critical error. The claim that 12.18 million shares were acquired for ≈$4.11 million is implausible (implying ~$0.34 per share) and unsupported by the ground truth, which does not mention specific purchase volumes or prices in 2022. The assertion that the Board added $3 million in repurchase authority, raising total authority to $6.13 million, is not present in the original answer and contradicts the ground truth, which only references the $3.13 billion authorization in 2022 and no increase. (2) The quantitative inaccuracies are severe: dollar amounts are wrong by orders of magnitude, and unsupported calculations (e.g., $4.11 million for 12.18 million shares) suggest fabricated data. The original answer does not provide share volumes or total costs, so these numbers are likely hallucinated. (3) The multi-hop reasoning is flawed. The LLM fails to capture the key evolution: in 2023, Accenture clarified that repurchased Class A shares were held as treasury shares specifically for employee benefits like equity awards — a key shift in intended usage. Instead, the LLM incorrectly states that the 2023 filing shows no updated activity or purpose, missing the qualitative clarification in 2023 about usage. It also fails to mention the separate 2024 mechanism of share withholding for tax obligations, which is part of the evolving utilization pattern. (4) While the answer attempts to address share purchase programs and usage, the severe numerical errors, hallucinated data, and failure to report the actual shift in share usage (from general buybacks to employee compensation focus) drastically reduce correctness. Contextual relevance is moderate because it discusses the right topic (share buybacks and employee awards) but with incorrect details and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 533,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the nature and structure of AMT's operating covenants evolved between 2022 and 2024, particularly in terms of the types of debt instruments involved and associated interest rate benchmarks?",
      "original_answer": "In 2022, AMT's operating covenants were tied to a variety of credit facilities and loans that referenced LIBOR and EURIBOR as the interest rate benchmarks. These included the 2021 Multicurrency Credit Facility, the 2021 Credit Facility, and several term loans. By 2024, AMT's disclosures indicate a shift in the interest rate benchmark to SOFR, specifically for letters of credit drawn in Nigeria, which were subject to a rate equal to SOFR at the time of drawing plus a spread. This reflects a transition away from LIBOR-based covenants toward SOFR-based structures, signaling a strategic and regulatory evolution in how AMT manages its debt obligations and associated covenants.",
      "llm_answer": "In the 2022 filing the operating covenants were limited to the 2021 USD‑ and EUR‑denominated revolving credit facilities and delayed‑draw term loans, which required the Company to meet reporting, leverage and debt‑incurrence limits and used floating benchmarks – LIBOR for the USD facilities and EURIBOR for the EUR facilities, each with a 1.125 % spread (see 2022 pp. 113‑114). By the 2024 filing the covenant regime had broadened to also govern the company’s securitizations (the 2015, 2018 and 2023 secured revenue notes), adding DSCR and cash‑trap thresholds, amortisation triggers and pre‑payment provisions, and these securities carry fixed rates (e.g., 5.490 %/5.735 % for the 2023 securities and 3.652 %/4.459 % for the 2018 securities) while the original credit‑facility covenants remain tied to LIBOR/EURIBOR + 1.125 % (see 2024 pp. 115‑117).",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies and misrepresents the evolution of AMT's operating covenants between 2022 and 2024. (1) Quantitatively, the LLM incorrectly states that the 2022 covenants used a 1.125% spread over LIBOR/EURIBOR, a detail not present in the ground truth and unsupported by the question context. It also cites specific fixed interest rates for securitizations (e.g., 5.490%, 5.735%, 3.652%, 4.459%) which are not mentioned in the original answer and appear fabricated. (2) The LLM claims that by 2024, covenants had 'broadened to govern securitizations' including the 2015, 2018, and 2023 secured revenue notes with DSCR and cash-trap thresholds—this is entirely absent from the ground truth and contradicts it. (3) Most critically, the original answer states that by 2024, AMT shifted from LIBOR/EURIBOR to SOFR, specifically for letters of credit in Nigeria. The LLM incorrectly asserts that the original credit facilities 'remain tied to LIBOR/EURIBOR + 1.125%', directly contradicting the transition to SOFR. (4) The multi-hop reasoning fails: instead of tracking the benchmark transition (LIBOR/EURIBOR → SOFR), the LLM invents an expansion into securitization covenants not referenced in the ground truth. While the answer is structured around the right time frame and attempts to compare 2022 and 2024, the core factual claim about the interest rate benchmark evolution is incorrect. The contextual relevance is moderate because it addresses covenant evolution and debt instruments, but the substance is largely fabricated or erroneous.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 430,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did Disney+ Hotstar's subscriber base evolve between the 2023 and 2024 SEC filings, and what impact did the consolidation of Star+ into Disney+ in Latin America have on Disney's international streaming strategy?",
      "original_answer": "In the 2023 SEC filing, Disney+ Hotstar reported approximately 36 million paid subscribers as of September 28, 2024. The 2024 filing noted that in certain Latin American countries prior to July 2024, Disney offered both Disney+ and Star+ as separate services, but these were merged into a single Disney+ product offering by the end of June 2024. This consolidation suggests a strategic shift toward streamlining international service offerings, potentially aligning with the model used for Disney+ Hotstar by integrating diverse content into a unified brand to enhance user experience and operational efficiency.",
      "llm_answer": "Disney + Hotstar’s paid‑subscriber base rose to roughly 36 million by September 28 2024 (page 7), whereas the 2023 filing did not report a separate Hotstar subscriber count, indicating that the service grew to that level over the year. In Latin America, Disney merged Star+ into Disney+ at the end of June 2024, folding the 10.8 million Combo+ subscribers into a single Disney+ product (pages 57‑58), which streamlines the international streaming lineup and reinforces a unified Disney+ brand across markets.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the subscriber count timeline — the ground truth states that Disney+ Hotstar had approximately 36 million paid subscribers as of September 28, 2023, in the 2023 filing, not the 2024 filing as incorrectly claimed by the LLM. The LLM misattributes the 36 million figure to September 28, 2024, which contradicts the original answer and likely reflects a misreading of the fiscal year. Additionally, the LLM introduces a new number — 10.8 million Combo+ subscribers — that is not present in the original answer or ground truth, making it an unsupported addition. (2) Quantitative accuracy is compromised due to the incorrect date attribution (2024 instead of 2023) and the inclusion of an unverified figure (10.8 million). While 36 million is correct, its placement in the wrong fiscal context undermines accuracy. (3) The reasoning around the Star+ consolidation is qualitatively sound — the LLM correctly identifies the merger by June 2024 and interprets it as a strategic move to streamline offerings, aligning with the ground truth’s interpretation of a unified brand strategy. This shows valid multi-hop synthesis between operational changes and strategic intent. (4) Contextual relevance is high because the answer addresses both parts of the question — subscriber evolution and strategic impact — and attempts to cite specific evidence. However, the correctness score is reduced to 6 due to significant factual inaccuracies in dates and fabricated data, which affect the reliability of the response despite otherwise logical structure and relevant framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 445,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the number of employees covered under collective labor agreements changed from 2022 to 2023, and what does this indicate about the company's labor agreement strategy?",
      "original_answer": "In 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year. In 2023, the company projected negotiations covering 2,100 employees for the upcoming year. This indicates a reduction in the number of employees involved in labor renegotiations, suggesting a shift in the company's labor agreement strategy, possibly due to fewer expiring agreements or proactive resolution of collective bargaining terms.",
      "llm_answer": "In 2022 the company said it expected to renegotiate 21 collective‑labor agreements covering roughly 3,000 employees (≈ one‑fifth of its workforce) 【page_77】.  By year‑end 2023, about one‑fifth of its employees were still working under collectively‑bargained terms, now spread across 62 agreements 【page_79】.  The share of union‑covered workers has therefore stayed roughly constant, showing that General Dynamics is maintaining a stable level of union coverage while systematically renegotiating a manageable set of agreements without material disruption.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, the company expected to negotiate agreements covering approximately 3,000 employees in the following year (i.e., 2023), and in 2023, it projected negotiations covering 2,100 employees for the upcoming year (i.e., 2024). The LLM incorrectly interprets this as renegotiations occurring in 2022 and completed by year-end 2023, misrepresenting the time frame and direction of change. It also introduces '21 agreements' and '62 agreements' not present in the original answer, which focuses solely on employee counts (3,000 → 2,100), not number of contracts. (2) Quantitatively, the 3,000 and 2,100 figures are correct in isolation, but the LLM fails to report the 900-employee reduction (3,000 - 2,100) and instead claims union coverage 'stayed roughly constant'—a direct contradiction of the downward trend in employees under negotiation. The 'one-fifth of workforce' detail, while possibly consistent with the source document, is not in the ground truth and distracts from the actual change in negotiation scope. (3) The multi-hop reasoning is flawed: the original answer infers a strategic shift due to fewer employees entering renegotiation, implying fewer expiring agreements or proactive management. The LLM concludes 'stable union coverage' and 'systematic renegotiation,' which contradicts the ground truth’s implication of a strategic reduction. It fails to connect the declining number of employees in upcoming negotiations to a shift in labor strategy. (4) Contextual relevance is moderate—the answer discusses labor agreements and employee coverage, addressing the general topic—but it misses the core trend (decline) and misinterprets the strategic implication, rendering it substantially incorrect despite some relevant terminology.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 501,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How did NextEra Energy's investment in U.S. Government and municipal bonds evolve from 2022 to 2024, and what was the change in total value across these years?",
      "original_answer": "In 2022, NextEra Energy's investment in U.S. Government and municipal bonds totaled $137 million. By 2024, this investment had increased significantly to $161 million under 'Other investments' for NEE. This represents a growth of $24 million, or approximately 17.5%, indicating a strategic increase in this asset class over the two-year period.",
      "llm_answer": "The 2024 filing shows that NextEra Energy held $722 million of U.S. Government and municipal bonds for NEE and $561 million for FPL, for a combined total of **$1.283 billion**【page_89】. The 2022 filing does not disclose a comparable total for these bonds in the pages provided, so the change in value from 2022 to 2024 cannot be calculated from the available documents.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in its quantitative claims. The ground truth states that NextEra Energy's (NEE) investment in U.S. Government and municipal bonds was $137 million in 2022 and $161 million in 2024, representing a $24 million increase. However, the LLM claims a combined total of $1.283 billion in 2024 for NEE and FPL, which is over 7x higher than the correct value for NEE alone. This indicates a severe factual error. (2) The numbers cited by the LLM ($722 million for NEE and $561 million for FPL) are not consistent with the ground truth, which only reports $161 million for NEE in 2024 and does not mention FPL in this context. Additionally, the LLM incorrectly states that 2022 data is unavailable, while the ground truth confirms it was $137 million. Thus, the calculation of change is incorrectly dismissed. (3) The multi-hop reasoning fails: the model should have retrieved and compared NEE's bond investments in 2022 and 2024, but instead introduced FPL (a subsidiary) and combined values not requested. The question specifically asks about NextEra Energy (NEE), not a sum across entities. (4) The contextual relevance is moderate because the answer discusses the right topic and time frame, but introduces irrelevant data (FPL) and omits the correct figures. The refusal to calculate change due to 'missing data' is unjustified, as the ground truth confirms both years' data exist. Overall, major factual and reasoning errors lead to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 414,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How has the role of Opdivo in Bristol-Myers Squibb's product portfolio evolved between 2022 and 2024, particularly in terms of its manufacturing strategy and therapeutic approvals?",
      "original_answer": "In 2022, Opdivo was referenced as a product with both internal manufacturing capability and reliance on third-party manufacturers to meet demand, highlighting its strategic importance in BMY's supply chain. By 2024, Opdivo received a new FDA approval in March for combination therapy with cisplatin and gemcitabine for first-line treatment of unresectable or metastatic urothelial carcinoma, indicating an expansion of its therapeutic applications. This evolution reflects both continued manufacturing investment and increased clinical positioning of Opdivo within BMY's oncology portfolio.",
      "llm_answer": "In the 2022 filing, Opdivo was presented as a core immuno‑oncology asset that BMS could manufacture internally but also backed with third‑party supply arrangements (Manufacturing and Quality Assurance, p.27), and its portfolio presence rested on earlier approvals such as the Opdivo + Yervoy combination and Project Orbis/real‑time oncology reviews (FDA OCE discussion, p.25). By the 2024 filing, Opdivo’s role had broadened substantially, adding a subcutaneous formulation (Opdivo Qvantig) and new indications for resectable NSCLC, urothelial carcinoma and other solid‑tumor uses (Approvals table, p.44), while the company continued to rely on its internal capability but increasingly shifted mature products to third‑party manufacturers as part of a strategic productivity initiative (Strategy, p.46).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains minor overstatements and additional details not present in the original answer. (1) Correct elements: The 2022 manufacturing strategy is accurately described—Opdivo had internal manufacturing capability supplemented by third-party manufacturers. The 2024 therapeutic expansion is partially correct: the urothelial carcinoma approval is correctly noted in the ground truth (March 2024 FDA approval with cisplatin/gemcitabine), though the LLM adds unverified approvals (e.g., resectable NSCLC, subcutaneous formulation Opdivo Qvantig) and references a 'productivity initiative' not mentioned in the original. (2) Quantitative accuracy: No explicit numbers (dollar amounts, percentages) are involved; dates (2022, 2024) are correct. The March 2024 approval is implied in the LLM answer via context, though not explicitly dated. (3) Reasoning: The multi-hop synthesis across years and domains (manufacturing + approvals) is sound and reflects the evolution asked in the question. However, the LLM introduces specific formulations and indications beyond the ground truth, which only confirms the urothelial carcinoma expansion. (4) The answer remains contextually relevant and captures the core evolution—manufacturing continuity and expanded clinical use—though with some extrapolation. Thus, the correctness score is 8 due to accurate core facts but minor over-specification; qualitative accuracy is slightly reduced for unsupported details, while quantitative and contextual scores remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 430,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has Disney's relationship with National Geographic magazine evolved between 2023 and 2024 in terms of its business structure and strategic positioning within the company's portfolio?",
      "original_answer": "In 2023, National Geographic magazine was explicitly described as part of the Entertainment segment under Content Sales/Licensing, and was noted as being 73% owned by Disney. By 2024, the magazine was still reported under Content Sales/Licensing, but the emphasis on its ownership percentage was removed, and it was described more as a publication 'published' by the company rather than a business in which Disney has a direct equity stake. This shift indicates a more operational rather than ownership-focused relationship in 2024 compared to 2023.",
      "llm_answer": "In both the 2023 and 2024 filings Disney continued to own 73 percent of National Geographic magazine and to report it within the Content Sales/Licensing line of the Entertainment segment. That unchanged ownership and segment classification shows the magazine remains positioned as a core content‑licensing asset that supports Disney’s broader National Geographic brand across its linear channels and direct‑to‑consumer platforms.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Disney's 73% ownership of National Geographic magazine remained explicitly acknowledged in both 2023 and 2024. However, the ground truth indicates that while the 73% ownership was clearly stated in 2023, it was removed in the 2024 filing, with Disney instead describing the magazine as being 'published' by the company, signaling a shift from an ownership-focused to an operational relationship. This key change in business structure and strategic positioning is entirely missed by the LLM. (2) The quantitative accuracy is partially correct in that the 73% ownership figure is accurate for 2023, but the LLM incorrectly asserts it remained unchanged in emphasis and reporting in 2024, which contradicts the ground truth. There are no calculations, but the misrepresentation of a critical percentage in context constitutes a factual error. (3) The multi-hop reasoning is flawed: the question asks for an evolution between 2023 and 2024, requiring comparison across filings. The LLM fails to detect the shift in language and strategic framing, instead asserting continuity where there was a notable change. It does correctly identify the Content Sales/Licensing classification in both years, which is accurate per the ground truth. (4) Contextual relevance is moderate—the answer addresses the right segment and metric but draws the wrong conclusion about strategic evolution. The answer suggests stability, while the truth reflects a deliberate shift in how Disney positions the asset, making the response factually misleading despite some correct surface details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 443,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How has PayPal's description of its transaction management databases' capabilities evolved between 2023 and 2024, particularly in relation to global payment processing in different currencies?",
      "original_answer": "In 2023, PayPal described its transaction management databases as part of a platform that allowed consumers to withdraw funds in 56 currencies. By 2024, the company updated this figure to 57 currencies, indicating a slight expansion in the global reach of its transaction processing capabilities. Additionally, while both years emphasize the role of these databases in enabling customers to utilize PayPal's suite of products, the 2024 filing introduced a more consumer-centric framing, placing 'consumers' ahead of 'merchants' in describing the ecosystem served by the platform. These changes suggest a refinement in how PayPal positions its transaction management systems within its broader global payments infrastructure.",
      "llm_answer": "In the 2023 filing PayPal said its transaction‑management databases (and related user‑interface and network‑integration tools) underpin a platform that lets consumers send payments in roughly 200 markets and ≈140 currencies, withdraw to bank accounts in 57 currencies and hold balances in 24 currencies. The 2024 filing repeats the same description of the databases but updates the currency coverage – payments can now be sent in about 150 currencies (still ≈200 markets), withdrawals are supported in 56 currencies, and balances remain in 24 currencies – reflecting an expanded global‑payment capability.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in both direction and magnitude of currency counts compared to the ground truth. (1) According to the original answer, PayPal described withdrawal capabilities in 56 currencies in 2023 and expanded to 57 in 2024. The LLM incorrectly states that 2023 supported withdrawals in 57 currencies and then *reduced* to 56 in 2024, which contradicts the ground truth. (2) The LLM introduces figures not present in the original answer—such as sending payments in ~140 or ~150 currencies and holding balances in 24 currencies—which are unsupported by the provided ground truth. These numbers appear fabricated or misattributed. (3) The multi-hop reasoning is flawed: the question asks about evolution in PayPal’s description of transaction management databases with respect to multi-currency processing; the LLM invents granular breakdowns (send, withdraw, hold) that aren’t in the original and misrepresents the trend. (4) While the LLM attempts to address the comparative evolution between 2023 and 2024 and mentions global payment capabilities, it fails on core facts and directionality. The only correct element is mentioning a change in currency numbers year-over-year, but even the values and direction are wrong. The qualitative shift in language (consumers before merchants) noted in the ground truth is entirely missed. Thus, despite some structural relevance, the answer is largely incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 398,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How did the interest rate terms associated with the Series K Debentures evolve between 2023 and 2024, and what does this indicate about NEE's financing strategy?",
      "original_answer": "In 2023, the Series K Debentures had their interest rate reset to 6.051% per year as part of a remarketing completed in March 2023. By 2024, the terms of the Series K Debentures were further updated through a letter dated March 1, 2023, which set forth certain terms effective March 1, 2023, indicating a continuation of the updated rate and terms from the 2023 remarketing. This suggests that NEE adjusted its financing strategy in response to market conditions, locking in a higher interest rate to secure funding.",
      "llm_answer": "In the 2023 filing NEE disclosed that its February 2020 Series K debentures (due March 1, 2025) were remarketed and the coupon was reset to **6.051 % per year**, with interest payable semi‑annually on March 1 and September 1. The 2024 filing still references the same Series K debentures with no new reset, implying the **6.051 % rate and payment schedule remained unchanged**. This shows NEE’s financing strategy of remarketing equity‑unit‑linked debentures to lock in a market‑aligned fixed rate and then maintaining that rate for predictable, stable debt costs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the key fact that the Series K Debentures were remarketed in 2023 with an interest rate reset to 6.051% per year, and that this rate remained unchanged in 2024. The dates (March 1 and September 1 interest payments) and maturity (March 1, 2025) are accurate and consistent with the ground truth. (2) All numeric values—6.051%, payment dates, maturity date—are factually correct. The LLM correctly notes no new reset occurred in 2024, aligning with the ground truth that the terms from the March 2023 remarketing continued. (3) The multi-hop reasoning is sound: the model synthesizes information from both 2023 and 2024 filings to infer that the rate was set in 2023 and remained stable into 2024. It correctly infers continuity from absence of change in the 2024 filing. The only minor gap is that the ground truth references a March 1, 2023 letter formalizing the terms, which the LLM does not mention—this is a small omission but does not affect the core accuracy. (4) The conclusion about NEE’s financing strategy—locking in a market-aligned fixed rate for stability—is semantically equivalent to the ground truth’s interpretation that NEE adjusted strategy in response to market conditions. Wording differs slightly but meaning is consistent. Thus, the answer is highly accurate, with only a minor detail missing, warranting a 9/10 on correctness and qualitative accuracy, while quantitative and contextual scores are perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1273,
        "completion_tokens": 407,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has ExxonMobil's application of the Unit-of-Production Depreciation method evolved between 2022 and 2023, particularly in response to changes in proved reserves and asset life assumptions?",
      "original_answer": "In 2022, ExxonMobil applied the Unit-of-Production Depreciation method based on proved reserves or proved developed reserves, switching to straight-line depreciation when asset life did not correlate with reserves, and using SEC price-based reserves only when proved reserves were substantially de-booked. By 2023, the company maintained the same core methodology but placed greater emphasis on using the most recent SEC price to determine reserves for depreciation in cases where reserves had been significantly reduced, ensuring a more meaningful allocation of asset costs over the expected life of the asset. This reflects a refinement in the company's approach to align depreciation with updated economic conditions and production realities.",
      "llm_answer": "ExxonMobil’s unit‑of‑production depreciation policy was essentially unchanged from 2022 to 2023. In both years the company still calculates depreciation as the ratio of asset cost to total proved (or proved‑developed) reserves applied to actual production, uses straight‑line depreciation only when an asset’s useful life does not track its reserve life, and, when proved reserves are substantially de‑booked, re‑bases depreciation on the most recent SEC‑price‑derived reserve estimate adjusted for production and technical changes (see 2023 p.73 and 2022 p.77).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the original (ground truth) answer. (1) It correctly identifies that ExxonMobil's core Unit-of-Production Depreciation method remained unchanged between 2022 and 2023, with consistent use of proved or proved-developed reserves, fallback to straight-line when asset life doesn't correlate with reserve life, and a shift to SEC price-based reserves upon substantial de-booking. (2) There are no numeric values (e.g., dollar amounts, percentages, reserve volumes) in either answer, so quantitative accuracy is not compromised—no discrepancies exist. (3) The multi-hop reasoning is sound: the model synthesizes the depreciation methodology across two years and correctly infers continuity with a subtle refinement in the treatment of de-booked reserves using the most recent SEC price, which matches the ground truth's claim of 'greater emphasis' in 2023. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the 'refinement in approach to align with updated economic conditions and production realities'—a qualitative nuance present in the original answer—though the substance of the refinement (using latest SEC price post-de-booking) is accurately conveyed. Thus, the answer is semantically equivalent with only slight omission of explanatory context, warranting a high score of 9/10 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 383,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Netflix's strategic emphasis on original programming evolved between 2023 and 2024, particularly in terms of its reliance on third-party production partners versus internal studio scaling?",
      "original_answer": "In 2023, Netflix emphasized its investments in original programming and highlighted the risks associated with third-party production partners, including potential liability and loss due to legal violations, insolvency, or fraud. It also noted its acquisitions like Scanline and Animal Logic as part of scaling internal studio operations. By 2024, the company shifted its language to focus on the growing complexity of managing original content production and placed greater emphasis on the need to improve internal systems, corporate culture, and operational practices related to content creation. The explicit mention of third-party risks present in 2023 was omitted in 2024, suggesting a reduced dependency on external partners and a stronger strategic move toward internal control and scaling.",
      "llm_answer": "In the 2023 Form 10‑K Netflix still stressed that it “contracts with third parties related to the development, production, marketing and distribution of our original programming” while it was “scaling our own studio operations to produce original content, **including through acquisitions such as Scanline and Animal Logic**” (page 7). By the 2024 filing the company again notes reliance on third‑party partners but now emphasizes “scaling our own studio operations to produce original content” without referencing those acquisitions, signalling a shift toward a larger in‑house production capability (page 7). This reflects Netflix moving from a heavier dependence on external producers toward a stronger internal studio focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Netflix's 2023 emphasis on third-party partnerships and internal studio scaling via acquisitions of Scanline and Animal Logic, and notes the shift in 2024 toward internal scaling without mentioning those specific acquisitions. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct referencing of years (2023, 2024), which are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, correctly infers a strategic shift based on the omission of third-party risk language and continued emphasis on internal studio growth. The only minor shortcoming is that it does not explicitly mention the removal of language around third-party risks (e.g., legal, insolvency, fraud) that was present in 2023 but dropped in 2024—a key nuance in the original answer. (4) Despite this omission, the core conclusion—that Netflix is moving toward greater internal control and reduced reliance on external partners—is correctly inferred and well-supported. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect, addressing all aspects of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 363,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has the strategic positioning of Mastercard's Cyber and Intelligence Solutions evolved between 2022 and 2023?",
      "original_answer": "In 2022, Cyber and Intelligence Solutions were positioned as part of 'Other revenues' and primarily described as products and services offered to prevent, detect, and respond to fraud, ensuring the safety of transactions made on Mastercard products. By 2023, the Cyber and Intelligence Solutions were elevated in strategic importance, being explicitly described as a value-added service that enables secure, easy, and confident transactions across the entire payments ecosystem, indicating a broader role in supporting Mastercard’s core operations and new network investments.",
      "llm_answer": "In the 2022 filing, Mastercard’s cyber‑and‑intelligence solutions were mentioned only as one component of a broad “other value‑added services” portfolio (alongside batch and real‑time account‑based payments), with $1.3 billion of related performance obligations slated for recognition through 2024【page_81】【page_82】. By the 2023 filing, the company had repositioned those solutions as a distinct, security‑focused offering—highlighting their role in fraud detection, prevention and enabling all parties to transact “securely, easily and with confidence” and tying them to proprietary data‑analytics and consulting services【page_49】【page_80】. This shift signals a move from a peripheral service to a flagship, strategically emphasized capability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution of Mastercard's Cyber and Intelligence Solutions from being a component within 'Other revenues' (or 'other value-added services') in 2022 to a more strategically emphasized, distinct offering in 2023. The description of the 2023 positioning—highlighting fraud detection, prevention, and enabling transactions to occur 'securely, easily and with confidence'—matches the original answer verbatim in intent and closely in wording. (2) The quantitative detail about $1.3 billion in related performance obligations through 2024 is not present in the ground truth, but it is plausible and consistent with SEC filing content; however, since this specific figure isn't confirmed in the provided ground truth, it introduces a minor discrepancy. Still, no incorrect calculation is made, and the number format is appropriate. (3) The multi-hop reasoning is sound: the model correctly identifies a shift in strategic emphasis across two years, synthesizing changes in categorization and language used in the filings. (4) The LLM enhances the original answer with additional context (e.g., mention of data analytics and consulting services, reference to specific pages), which is acceptable as long as it doesn't contradict. The core factual progression—elevation in strategic importance and broader role in the payments ecosystem—is accurately conveyed. Minor deduction from 10 due to inclusion of unverified dollar amount not in ground truth, though it does not appear factually incorrect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 434,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Tesla's approach to energy storage products evolved from 2023 to 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized its modular design and in-house expertise in power electronics and software to optimize the manufacturing and performance of its energy storage products like Megapack. By 2024, Tesla's focus shifted to addressing production ramps and supply chain dependencies, citing potential bottlenecks and the need for efficient, cost-effective manufacturing capabilities. The company also highlighted risks related to supplier reliability and the challenges of scaling production to meet planned output rates and quality standards for energy storage products.",
      "llm_answer": "In the 2023 filing Tesla portrayed its storage line (Powerwall and Megapack) as a modular, vehicle‑technology‑derived product family that could be scaled through standardized design, software control and in‑house manufacturing, with only a brief mention of developing a new proprietary lithium‑ion cell to boost supply 【page_5】 【page_7】 【page_6】. By the 2024 filing the company is flagging concrete ramp‑up risks for those storage products and stressing that production now hinges on a limited set of external cell suppliers (Panasonic, CATL) while outlining a strategic shift to manufacture its own cells to lessen that dependency 【page_17】 【page_18】 【page_19】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Tesla's 2023 emphasis on modular design, in-house manufacturing, software control, and standardization for energy storage products like Megapack and Powerwall, which matches the original answer's focus on modular design and in-house expertise. (2) For 2024, the LLM correctly captures the shift toward addressing production ramp-up risks and supply chain dependencies, particularly the reliance on external cell suppliers (Panasonic, CATL), which corresponds to the ground truth's mention of supplier reliability risks and scaling challenges. The strategic intent to manufacture its own cells to reduce dependency is a valid inference and consistent with Tesla's stated goals in the filings. (3) Multi-hop reasoning is sound: the answer synthesizes information across years and sources, correctly contrasting 2023's confidence in scalability with 2024's caution around bottlenecks and external dependencies. (4) Minor deduction in qualitative accuracy because the original answer does not explicitly name Panasonic and CATL or mention Tesla’s proprietary cell manufacturing plans—these are plausible details from the filings but go slightly beyond the ground truth’s scope. However, they do not contradict it and enhance contextual understanding. No numerical data is present, so quantitative accuracy is scored as 10 by default. Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 415,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How did NextEra Energy Capital Holdings' issuance strategy for floating rate debentures evolve from 2023 to 2024, particularly in terms of the principal amount and maturity structure?",
      "original_answer": "In 2023, NextEra Energy Capital Holdings disclosed the sale of $600 million in floating rate debentures due in 2026. By 2024, the company formalized this issuance through an Officer's Certificate dated January 31, 2024, specifying the Floating Rate Debentures, Series due January 29, 2026. While the principal amount was not explicitly updated in 2024, the maturity structure remained consistent with the 2026 horizon, indicating a focused strategy on short-to-medium-term floating rate debt. This reflects a continuation of the prior year's approach without significant expansion or restructuring of the floating rate debenture program.",
      "llm_answer": "In the 2023 filing NEE Capital disclosed that it sold **$600 million of floating‑rate debentures**, all of which **mature in 2026**. By the 2024 filing the company had kept that 2026 series and **added a new floating‑rate series that matures in 2028** (the “Floating‑Rate Debentures, Series due February 4, 2028”), showing a move from a single short‑dated issuance to a broader maturity profile that extends the floating‑rate debt horizon. This shift signals an expansion of the floating‑rate program both in size (beyond the $600 million of 2023) and in maturity range.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2024, NextEra Energy Capital Holdings only formalized the same Floating Rate Debentures due January 29, 2026, with no mention of a new series maturing in 2028. The LLM incorrectly claims a new 2028 series was added, which is not supported by the original answer. Additionally, the LLM asserts that the program expanded in size beyond $600 million, but the original answer explicitly states that the principal amount was not updated or expanded in 2024. (2) Quantitatively, the $600 million amount and 2026 maturity are correctly cited from 2023, but the introduction of a 'February 4, 2028' series is entirely fabricated and contradicts the ground truth, which emphasizes continuity without restructuring or expansion. (3) The multi-hop reasoning is flawed: the LLM incorrectly infers an evolution in maturity structure and issuance strategy by inventing a new debt series, failing to recognize that the 2024 filing merely formalized the prior year’s structure. There is no evidence in the original answer of strategic expansion or broadening of maturity profile. (4) While the answer is relevant to the question’s topic and attempts to address issuance strategy evolution, the core factual errors in dates, amounts, and strategic interpretation severely undermine correctness. The contextual relevance is moderate because it discusses the right company and general concept, but the substance is misleading.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 416,
        "total_tokens": 1727
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How has Intel's approach to industry initiatives related to supply chain responsibility evolved from 2023 to 2024, particularly in terms of collaboration focus and supplier engagement scope?",
      "original_answer": "In 2023, Intel announced a significant expansion of its supplier engagement activities under its RISE strategy, aiming to increase the number of suppliers covered in sustainability and compliance programs, and set a goal to achieve net-zero upstream Scope 3 greenhouse gas emissions by 2050. By 2024, Intel's approach evolved to emphasize broader collaboration on responsible minerals sourcing and transparency around climate and water impacts, with a continued focus on capability-building programs for suppliers but without explicit mention of expanding the number of suppliers engaged. The shift indicates a move from announcing strategic expansions to reinforcing and deepening existing industry partnerships.",
      "llm_answer": "In Intel’s 2023 10‑K the company said it was “significantly expanding the number of suppliers covered by our engagement activities,” with the supply‑chain environmental team measuring suppliers’ GHG footprints, pursuing a net‑zero upstream Scope 3 goal and setting a $2 billion diverse‑supplier spending target, while also leading industry collaborations on climate‑water transparency and responsible‑minerals sourcing 【page_20】. The 2024 filing still notes that Intel “actively collaborates with other companies and lead industry initiatives … on improving transparency around climate and water impacts … and responsible minerals sourcing,” but it no longer highlights the expansion of supplier coverage or the specific emissions‑reduction and diversity‑spending goals, indicating a shift from broadening engagement to maintaining the existing collaborative focus 【page_13】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the evolution in Intel's approach from 2023 to 2024, accurately reflecting the shift from expanding supplier engagement to maintaining and deepening existing collaborations. All key elements—supplier coverage expansion in 2023, net-zero Scope 3 goal by 2050, $2 billion diverse-supplier spending target, and leadership in climate-water transparency and responsible minerals sourcing—are correctly mentioned. In 2024, the continued emphasis on collaboration without explicit mention of expanding supplier numbers or restating specific goals is accurately noted, aligning with the ground truth’s conclusion of a strategic shift toward reinforcing partnerships. (2) Quantitative accuracy is perfect: the $2 billion diverse-supplier spending target is correctly cited, and while the net-zero Scope 3 goal by 2050 is not explicitly repeated in the LLM answer, it was implied in the context of ongoing upstream emissions efforts. No incorrect numbers or dates are present. (3) The multi-hop reasoning is sound—information is correctly synthesized across the 2023 and 2024 10-K filings to show a change in emphasis over time. The LLM correctly infers a strategic pivot based on the presence and absence of specific language across years. (4) The only minor shortcoming is that the LLM does not explicitly restate the 2050 net-zero Scope 3 goal in the 2024 context, which slightly weakens completeness, but since the focus of the question is on collaboration and supplier engagement scope, this omission does not undermine the core accuracy. Wording differs slightly but maintains semantic equivalence. Scores reflect high accuracy with a minor deduction in qualitative accuracy for incomplete restatement of long-term goals.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 480,
        "total_tokens": 1888
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has the characterization of the assumptions underlying the standardized measure of discounted future cash flows evolved between XOM's 2022 and 2023 disclosures, particularly regarding the company's framing of its dependency on first-day-of-the-month average prices?",
      "original_answer": "In XOM's 2022 filing, the standardized measure of discounted future cash flows was described as being 'prepared on the basis of certain prescribed assumptions,' which included first-day-of-the-month average prices. This framing emphasized that the assumptions were foundational to the calculation but did not explicitly highlight the degree of dependency on them. In contrast, the 2023 filing reflects a shift in tone by emphasizing that the standardized measure 'depends on' these prescribed assumptions, particularly first-day-of-the-month average prices, which are described as discrete points in time that 'may cause significant variability in cash flows from year to year as prices change.' This indicates a more explicit acknowledgment of the sensitivity and dependency of the measure on these assumptions, even though the actual calculation methodology remained unchanged, using the same 10 percent discount factor, year-end costs, and legislated tax rates.",
      "llm_answer": "In the 2022 Form 10‑K the company simply noted that the standardized measure is computed using “first‑day‑of‑the‑month average prices, year‑end costs and legislated tax rates” (see XOM 10‑K 2022, pp. 128‑132) without qualifying that price input. By contrast, the 2023 filing adds a cautionary statement that the first‑day‑of‑the‑month average price “represents discrete points in time and therefore may cause significant variability in cash flows from year to year as prices change” (see XOM 10‑K 2023, p. 133). Thus, the company moved from a neutral description of the assumption to explicitly framing the reliance on a single‑day price as a source of potential variability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the key evolution in XOM's disclosure between 2022 and 2023. (1) It correctly identifies that in 2022, the company neutrally described the use of first-day-of-the-month average prices without emphasizing dependency, while in 2023 it added a cautionary note about the potential for significant variability due to the use of discrete pricing points. This aligns with the ground truth's emphasis on a shift from 'prepared on the basis of' to 'depends on' the assumptions. (2) There are no numerical values, dates, or percentages in dispute; all references to years (2022, 2023), discount factors (implied 10%, though not explicitly mentioned in LLM answer), and pricing methodology are consistent with the original. The absence of explicit mention of the unchanged 10% discount rate, year-end costs, and legislated tax rates is a minor omission but does not detract from the core focus on the framing of price assumptions. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes in language across two filings and infers a shift in tone from neutral to cautionary, reflecting increased transparency about sensitivity. (4) The answer is contextually precise, directly addressing how the characterization of assumptions—especially regarding price dependency—has evolved. The only reason for not scoring a 10 is the slight lack of completeness in noting that the methodology itself (e.g., discount rate) remained unchanged, which the ground truth includes for full context. However, the central point about framing dependency on prices is correctly and clearly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 444,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has MA's digital identity solutions evolved between 2022 and 2023, particularly in terms of their integration with open banking capabilities and reach across financial institutions?",
      "original_answer": "In 2022, MA introduced its digital identity solutions as part of an open banking platform that enabled data providers and third parties to access consumer data on a permissioned basis, aiming to improve customer experience and financial inclusion. The platform leveraged data principles such as consumer protection and consent management, and it focused on identity verification across people, devices, and transactions. In 2023, MA expanded its open banking capabilities, achieving connectivity to over 95% of deposit accounts in the U.S. and approximately 3,000 banks across Europe, which significantly enhanced the reach and application of its digital identity solutions. Additionally, in 2023, MA partnered with leading financial institutions to launch an ACH payment solution using its open banking infrastructure, indicating a deeper integration of digital identity within broader financial services.",
      "llm_answer": "In the 2022 filing Mastercard described its digital‑identity suite as a privacy‑by‑design, consent‑centric set of tools that verify people, devices and transactions and sit alongside an open‑banking platform that “enables data providers and third parties … to reliably access, securely transmit and confidently manage consumer data” 【page_17】. By 2023 the company had woven those identity services into the open‑banking platform – launching an ACH bill‑payment solution that uses the same open‑banking capabilities – and the platform now reaches “over 95 % of deposit accounts in the U.S. and approximately 3,000 banks across Europe” 【page_17】. This marks a shift from a standalone identity offering to an integrated, widely‑connected solution that serves a far larger swath of financial institutions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: in 2022, MA introduced digital identity solutions integrated with an open banking platform focused on consent, privacy, and verification of people, devices, and transactions. In 2023, the platform expanded to cover over 95% of U.S. deposit accounts and ~3,000 European banks, and MA launched an ACH payment solution using open banking infrastructure. (2) Quantitative accuracy is perfect: 'over 95%' and 'approximately 3,000 banks' match the original answer exactly. No calculations were required, but the numbers are correctly cited. (3) Multi-hop reasoning is sound—LLM correctly synthesized information across years (2022 vs 2023), capabilities (identity, open banking, ACH), and geographic reach (U.S. and Europe). (4) The answer addresses all parts of the question: evolution over time, integration with open banking, and reach across financial institutions. Wording differs slightly but meaning is preserved, including the shift from standalone to integrated solution. All entities (MA, open banking, ACH, financial institutions) are correctly identified and contextualized.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 336,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Tesla's approach to the Solar Roof product evolved between 2023 and 2024, particularly in terms of production challenges and strategic dependencies?",
      "original_answer": "In 2023, Tesla emphasized the engineering and design maturity of the Solar Roof, highlighting its aesthetic appeal, durability, and integration with Powerwall. The company positioned Solar Roof as a customized solution within its broader energy product suite. However, by 2024, Tesla acknowledged that the production ramp of Solar Roof faced delays similar to those experienced with other products. The 2024 filing also noted that the company's future success 'depends in large part' on scaling mass-market vehicle production, which indirectly signals a potential strategic prioritization shift that could affect Solar Roof's development and deployment timelines.",
      "llm_answer": "In 2023 Tesla described Solar Roof as a commercially‑available product it sold directly and through channel partners, stressing that it had engineered many iterations, was designing and making some of its own components, was improving installation efficiency, and offered limited warranties for defects and weatherization (see 2023 10‑K pp. 6‑7, 9). By the 2024 filing the tone had shifted to a risk‑focused view, noting that the ramp‑up of Solar Roof production has been slower than planned and now hinges on the successful build‑out of new factories, reliable supply‑chain and component‑supplier deliveries, and its integration with Tesla’s broader battery‑cell and energy‑storage manufacturing strategy (see 2024 10‑K pp. 17‑18).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures Tesla's 2023 positioning of Solar Roof as a mature, engineered product with direct and channel sales, improved installation, and warranties—consistent with the original answer's emphasis on design maturity and integration with Powerwall. In 2024, it accurately reflects the shift to acknowledging production ramp delays and dependencies on new factories, supply chain, and component deliveries. The mention of integration with battery-cell and energy-storage manufacturing adds contextual depth supported by the 2024 10-K. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in dates or financial figures. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years of filings, correctly identifying the evolution from product confidence to production challenges and strategic dependencies. It infers a strategic shift without overstating, focusing on operational bottlenecks rather than explicitly re-prioritization, which is a slightly more conservative interpretation than the original answer’s mention of dependence on mass-market vehicle scaling. This nuance prevents a perfect 10 but does not constitute an error. (4) The answer is contextually relevant, directly addressing production challenges and strategic dependencies as asked. The only minor gap is the absence of explicit mention that Tesla's overall success 'depends in large part' on vehicle production—a strategic signal that indirectly affects Solar Roof—but the LLM compensates by highlighting real dependencies in manufacturing and supply chain. Overall, the response is factually correct, well-supported, and semantically equivalent to the ground truth with only slight variation in emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 504,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has NextEra Energy, Inc.'s use of Pledge Agreements evolved between 2023 and 2024, particularly in terms of the dates and counterparties involved?",
      "original_answer": "In 2023, NextEra Energy, Inc. disclosed a Pledge Agreement dated September 1, 2022, involving Deutsche Bank Trust Company Americas and The Bank of New York Mellon. By 2024, the company introduced two new Pledge Agreements dated June 1, 2024, and October 1, 2024, with the same counterparties. This indicates an evolution in the structure and timing of these agreements, expanding their use over time.",
      "llm_answer": "In the 2023 filing the only pledge arrangement disclosed was a **Pledge Agreement dated September 1 2022** between NextEra Energy, Inc., **Deutsche Bank Trust Company Americas** (as collateral, custodial and securities intermediary) and **The Bank of New York Mellon** (as purchase‑contract agent)【page_123】.  \n\nThe 2024 filing shows that the company has entered into **two additional pledge agreements** – one **dated June 1 2024** and another **dated October 1 2024** – and both are again with Deutsche Bank Trust Company Americas and The Bank of New York Mellon【page_123】.  \n\nThus, while the counterparties remain the same, NextEra Energy has expanded its use of pledge agreements in 2024 by adding newer agreements with the same parties.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all dates are accurate: the 2023 filing references the Pledge Agreement dated September 1, 2022, and the 2024 filing discloses two new agreements dated June 1, 2024, and October 1, 2024. These match the original answer exactly. (2) The counterparties—Deutsche Bank Trust Company Americas and The Bank of New York Mellon—are correctly identified, with added contextual detail about their roles (e.g., collateral agent, purchase-contract agent), which enhances accuracy without introducing error. (3) The reasoning is sound and multi-hop: the model correctly infers evolution by comparing the number and timing of agreements across two years, noting that while counterparties remain unchanged, the number of agreements has increased. (4) The answer is semantically equivalent to the ground truth, conveying the same core conclusion—that NextEra Energy expanded its use of pledge agreements in 2024 with the same parties—while providing slightly more structured and detailed presentation. All evaluation criteria are met with high precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 320,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How has Intel's strategic positioning in Edge AI evolved from 2023 to 2024, particularly in terms of its software platform offerings and ecosystem partnerships?",
      "original_answer": "In 2023, Intel emphasized its edge-native software platform with modular building blocks, premium services, and support offerings, aiming to enable developers to build, deploy, run, manage, connect, and secure distributed edge infrastructure and Edge AI across multiple verticals. The platform was described as a horizontal approach to scaling infrastructure for intelligent edge and hybrid AI, supporting diverse architectures and avoiding vendor lock-in. By 2024, Intel's strategy had evolved under its NEX initiative, which aimed to transform networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud-native software on programmable hardware. Intel highlighted broader ecosystem partnerships and a focus on rapid digital transformation from cloud to edge, leveraging core strengths in compute, connectivity, software, and large-scale manufacturing. This shift indicates a more integrated and scalable approach to Edge AI, with a stronger emphasis on cloud-native programmability and collaboration with partners to drive automation and secure data integrity at the edge.",
      "llm_answer": "In 2023 Intel’s Edge‑AI story was built around an “edge‑native software platform with modular building blocks” that let developers build, deploy, run, manage, connect and secure distributed edge infrastructure and AI, and it was backed by a broad ecosystem of > 500 network builders and partners such as Ericsson, Nokia, Cisco, Dell, HPE, Lenovo, Amazon, Google and Microsoft (2023 p.31‑30). By 2024 the company deepened that positioning by coupling the same open, modular platform with new AI‑optimized silicon (Xeon 6 processors with E‑cores/P‑cores, Gaudi 3 accelerators and the upcoming Jaguar Shores GPU) and open‑source frameworks (vRAN Boost, FlexRAN, FlexCore), while continuing to leverage and expand its ecosystem partners to accelerate software‑defined edge‑AI deployments (2024 p.18‑17). This marks a shift from a primarily software‑centric, partnership‑driven approach in 2023 to a more tightly integrated hardware‑software‑partner model for Edge AI in 2024.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and evolution of Intel's Edge AI strategy from 2023 to 2024. (1) It accurately captures the 2023 focus on an edge-native software platform with modular building blocks and a broad ecosystem of over 500 partners, including correct naming of key partners (Ericsson, Nokia, Cisco, etc.), which matches the qualitative emphasis in the original answer. The 2024 evolution is correctly described as a deepening of the strategy with tighter integration of hardware and software, though the original answer emphasizes the NEX initiative and cloud-native transformation more explicitly. (2) Quantitatively, no specific numbers (e.g., dollar amounts, percentages) are present in either answer, but the reference to >500 partners is consistent with typical disclosures and does not contradict the ground truth. Page references (e.g., 2023 p.31-30, 2024 p.18-17) appear to be illustrative and not factual errors. (3) The multi-hop reasoning is sound: the model synthesizes software platform evolution and ecosystem growth across years, correctly identifying a shift from software-centric to integrated hardware-software-partner model. However, it introduces specific product names (Xeon 6, Gaudi 3, Jaguar Shores GPU, vRAN Boost, FlexRAN) not present in the ground truth, which, while plausible, are not confirmed by the provided knowledge graph and slightly extend beyond the source. (4) The answer remains contextually relevant and comprehensive, addressing both software platform offerings and ecosystem partnerships as required. The slight deduction in qualitative accuracy is due to the addition of unverified product-level details and less emphasis on the NEX initiative and cloud-native programmability that are central in the original. Overall, the semantic meaning and strategic trajectory are correctly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 512,
        "total_tokens": 2048
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How did the composition and value of CVS's long-term debt related to senior notes due in 2030 evolve between 2023 and 2024, particularly regarding the 1.75% senior notes due August 2030?",
      "original_answer": "In 2023, the 1.75% senior notes due August 2030 had a value of $1,250 million. In 2024, this value remained unchanged at $1,250 million. However, other senior notes due in 2030, such as the 3.75% senior notes due April 2030, decreased from $1,500 million in 2023 to $1,500 million in 2024, indicating stability in some areas of long-term debt but no change in the 1.75% notes specifically.",
      "llm_answer": "The 10‑K tables show that CVS’s 2030 senior‑note portfolio was unchanged from 2023 to 2024. Both years list three 2030 issues—5.125% notes due February 2030 ($1.5 bn), 3.75% notes due April 2030 ($1.5 bn) and 1.75% notes due August 2030 ($1.25 bn)—and the 1.75% tranche remained at $1.25 billion in both periods, indicating no shift in composition or value for that note. (2023 table page 168; 2024 table page 161)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the 1.75% senior notes due August 2030 remained unchanged at $1.25 billion in both 2023 and 2024, which matches the ground truth. It also accurately notes the presence of other senior notes due in 2030, including the 5.125% February 2030 notes and the 3.75% April 2030 notes, both at $1.5 billion. However, the ground truth states that the 3.75% notes 'decreased from $1,500 million in 2023 to $1,500 million in 2024'—a redundant statement implying no change—but the LLM interprets this as stable, which is reasonable. The minor issue is that the LLM implies all three tranches were present in both years without explicitly confirming whether the 5.125% notes existed in 2023 (not mentioned in ground truth), potentially overextending the data. (2) All numeric values—$1.25 billion for the 1.75% notes, $1.5 billion for the others—are correct and match the ground truth in amount, interest rate, and maturity date. Formatting variations ($1.25 bn vs $1,250 million) are acceptable. (3) The multi-hop reasoning is sound: the model compares the composition and value across two years, synthesizing data from both 10-Ks, and correctly concludes no change in the 1.75% notes. It adds contextual detail (other tranches) that enriches the answer, though with slight risk of overinference. (4) The correctness score is 9 because core facts are accurate and the main focus (1.75% notes) is perfectly addressed; the only deduction is for potentially assuming continuity of the 5.125% notes without explicit confirmation in the ground truth. Quantitative accuracy is 10 as all numbers are correct. Qualitative accuracy is 9 due to excellent reasoning with minor overcompleteness. Contextual relevance is 10—directly addresses the evolution of debt composition and value.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 493,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How did Netflix's ad-supported subscription plan evolve between 2023 and 2024 in terms of its role within the company's pricing strategy and membership growth objectives?",
      "original_answer": "In 2023, Netflix introduced the ad-supported subscription plan as a new, lower-priced option aimed at expanding its membership base and addressing competitive pressures by offering a more accessible entry point. This was part of broader efforts to adjust pricing models and membership plans to improve value perception. By 2024, the ad-supported plan had become a core component of Netflix's pricing strategy, explicitly included in a range of plans designed to meet varied consumer needs, indicating its integration into the company's long-term growth framework. This evolution reflects a shift from experimental pricing to a strategic offering intended to support sustained membership growth across different market segments.",
      "llm_answer": "In the 2023 Form 10‑K Netflix said it had just rolled out a new, lower‑priced ad‑supported subscription tier and framed it as part of a broader set of pricing plans meant to meet a variety of consumer needs and to help drive membership growth【page_3】【page_6】【page_7】. The 2024 filing’s introductory material still lists the ad‑supported tier among its pricing options, showing that the offering has moved from a newly‑launched experiment to an established component of Netflix’s pricing strategy that continues to be used to attract and retain members, with no further changes disclosed【page_1】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that Netflix introduced the ad-supported plan in 2023 as a lower-priced option to drive membership growth and meet varied consumer needs, citing the 2023 Form 10-K. It also accurately notes that by 2024, the plan remained part of the pricing structure, indicating its transition from a new initiative to an established component of the strategy, based on the 2024 filing. There are no numeric inaccuracies—dates and strategic descriptions match the original answer. The only minor shortcoming is that the LLM answer does not explicitly use the phrase 'core component' or 'long-term growth framework' as in the ground truth, nor does it clearly articulate the evolution from 'experimental' to 'strategic' with the same depth. However, the semantic meaning—that the plan evolved from a newly launched offering to an established part of the strategy—is preserved. The reasoning is sound, entities (Netflix, 2023, 2024, ad-supported plan) are correct, and the synthesis across years is appropriate. Contextual relevance is strong as all parts of the question regarding pricing strategy and membership growth objectives are addressed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 343,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Tesla's approach to the Tesla Semi evolved between 2023 and 2024, based on its production status and strategic positioning?",
      "original_answer": "In 2023, Tesla stated that it had begun early production and deliveries of the Tesla Semi, indicating initial market introduction and limited availability. By 2024, Tesla's production status for the Tesla Semi had advanced to 'pilot production' at its Nevada facility, suggesting a more structured and expanded phase of manufacturing, though not yet full-scale commercial production. This evolution reflects Tesla's strategic progression from initial rollout to a more mature testing and scaling phase for the commercial electric vehicle.",
      "llm_answer": "In the 2023 filing Tesla said the Semi had moved into “early production and deliveries” – a limited, nascent rollout of the commercial truck【page_5】. By the 2024 filing the Semi is listed as being in “pilot production” at the Nevada plant and is called out as a key part of Tesla’s plan to expand capacity for newer models and its next‑generation vehicle platform【page_36】, showing a shift from initial low‑volume output to a more structured, strategic scaling effort.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately reflects Tesla's production status evolution: 'early production and deliveries' in 2023 and 'pilot production' in 2024 at the Nevada facility. (2) There are no numerical values requiring calculation, but the temporal progression (2023 → 2024) and production phase labels are factually precise. (3) The multi-hop reasoning is sound—synthesizing information across two years and filings to show strategic progression from initial rollout to structured scaling. (4) The LLM adds contextual depth by noting the Semi's role in Tesla’s broader strategy (expansion of capacity for newer models and next-gen platform), which aligns with and enriches the ground truth without introducing inaccuracies. All entities (Tesla, Tesla Semi, Nevada plant, 2023/2024 filings) are correct. The answer fully addresses both production status and strategic positioning as required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 280,
        "total_tokens": 1528
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "What does the expansion of NextEra Energy's Executive Retention Employment Agreements from 2023 to 2024 suggest about the company's approach to leadership continuity and its strategic emphasis on executive talent retention?",
      "original_answer": "In 2023, NextEra Energy had active Executive Retention Employment Agreements with executives including Mark Lemasney (signed January 1, 2023) and Armando Pimentel, Jr. (signed February 15, 2023), indicating a focus on retaining key leadership at that time. By 2024, the company not only maintained those agreements but also introduced a new agreement with Brian Bolster, dated May 6, 2024, showing an expansion in the number of covered executives. This evolution suggests that NextEra Energy has placed increasing strategic importance on securing leadership continuity and minimizing executive turnover risk, particularly during periods of potential transition or uncertainty. The addition of new executives under retention agreements implies a proactive approach to talent management, which could signal confidence in leadership or a response to external pressures affecting executive mobility.",
      "llm_answer": "The 2024 filing shows that NextEra Energy added two new Executive Retention Employment Agreements—one for Nicole J. Daggs (effective 1 Jan 2024) and one for Brian W. Bolster (effective 6 May 2024)—to the two agreements already in place for Mark Lemasney and Armando Pimentel in 2023【page_125】. By extending retention contracts to additional senior leaders (Bolster is listed as Executive Vice President, Finance and CFO)【page_127】, the company signals a deliberate strategy to preserve leadership continuity and to lock in key executive talent as part of its long‑term performance‑driven compensation framework.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the expansion of Executive Retention Employment Agreements from 2023 to 2024 and names Brian Bolster with the correct effective date (May 6, 2024), aligning with the ground truth. However, it incorrectly adds Nicole J. Daggs as a new executive with an agreement effective January 1, 2024, which is not present in the original answer or supported by the provided ground truth. This introduces a factual error regarding entity and date accuracy. (2) Quantitatively, the claim of 'two new' agreements in 2024 is incorrect—only Brian Bolster’s is confirmed in the ground truth. The original answer does not mention Daggs, so this is a significant quantitative inaccuracy. Dates for Lemasney (Jan 1, 2023) and Pimentel (Feb 15, 2023) are not repeated in the LLM answer but are assumed known; their absence reduces completeness slightly but not critically. (3) The reasoning is otherwise sound: the LLM correctly infers that expanding retention agreements signals a strategic emphasis on leadership continuity and talent retention. It appropriately contextualizes Bolster’s role (EVP, Finance and CFO) to strengthen the argument, demonstrating good multi-hop synthesis between executive roles and strategic intent. (4) Despite the incorrect addition of Daggs, the core conclusion about increasing strategic focus on retention is consistent with the ground truth. The answer is highly relevant and well-reasoned, but the false claim about a second new agreement undermines quantitative accuracy. Hence, correctness is reduced to 7 due to a significant but not central factual error.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 445,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How has Intel's approach to xPU products evolved from 2023 to 2024, particularly in terms of strategic focus and product development priorities?",
      "original_answer": "In 2023, Intel's focus on xPU products was part of a broader R&D strategy that included process and packaging technology, AI, and software, with $16.0 billion spent on R&D. The company faced challenges in timely product development and manufacturing process introductions, which had previously caused delays and cost overruns. By 2024, Intel had evolved its approach by embedding xPU products more deeply into its strategic priorities, specifically under the theme of 'product competitiveness.' The company announced the creation of an advisory group to expand the x86 ecosystem and emphasized the xPU family of products—including client and data center GPUs, IPUs, FPGAs, and other accelerators—as a way to meet diverse computing needs. This represents a shift from a general R&D focus to a more structured and strategic product development initiative.",
      "llm_answer": "In the 2023 Form 10‑K Intel described xPU mainly as a research‑and‑development priority – “we are focusing our R&D efforts … on our xPU products and features” and noted that it had recently expanded its portfolio to include discrete GPUs, AI accelerators, IPU products and silicon‑photonics (2023 p. 51‑53). By the 2024 filing the company had elevated xPU to a strategic pillar, saying it will “lead and democratize compute with Intel x86 and xPU” and outlining a family of accelerators (client‑ and data‑center GPUs, IPUs, FPGAs and other accelerators) that serve AI, edge and autonomous‑driving workloads, backed by increased R&D and IP investment to deliver leading x86 and xPU products (2024 p. 5, 7). This reflects a shift from a broad R&D focus to a market‑oriented, core‑product strategy for xPU.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2023, xPU was framed as an R&D focus, with Intel expanding its portfolio to include discrete GPUs, AI accelerators, IPUs, and silicon photonics (consistent with the $16.0B R&D spend mentioned in the original answer, though the LLM does not explicitly cite the dollar amount). In 2024, xPU is elevated to a strategic pillar, with emphasis on product competitiveness, ecosystem expansion (via the advisory group, though not explicitly mentioned), and a defined family of accelerators. The LLM correctly identifies the shift from R&D focus to core product strategy. (2) Quantitative accuracy is perfect: no incorrect numbers or misstatements; the omission of the $16.0B figure is a minor completeness gap but not a factual error. (3) Multi-hop reasoning is sound—LLM synthesizes information across 2023 and 2024 10-Ks, correctly identifying the evolution in strategic framing and product prioritization. (4) Semantic equivalence is strong: 'market-oriented, core-product strategy' effectively captures the 'structured and strategic product development initiative' described in the original. The only minor shortcoming is the lack of explicit mention of the advisory group or 'product competitiveness' as a named theme, but the substance is conveyed. Hence, correctness is 9/10, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 401,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Netflix's approach to advertising technology evolved between 2023 and 2024, particularly in terms of organizational development and infrastructure investment?",
      "original_answer": "In 2023, Netflix emphasized its limited experience with advertising and outlined several dependencies, particularly on third-party service providers for ad management and the need to attract and retain advertisers. The company also highlighted risks related to developing the necessary advertising technology infrastructure. By 2024, Netflix shifted toward a more proactive stance, emphasizing its ability to 'develop and expand an advertising sales and advertising technology organization team' and 'develop the technology and related infrastructure to support advertising and drive value to advertisers.' This indicates a strategic evolution from reliance on external providers to internal development and investment in ad tech capabilities.",
      "llm_answer": "In the 2023 filing Netflix said it was still in the early‑stage of its ad business, focusing on “develop[ing] and expand[ing] an advertising‑sales organization team” and on “develop[ing] the technology and related infrastructure to support advertising”【page_10】. By the 2024 filing the company had added a dedicated “advertising‑sales and advertising‑technology organization team” and stressed its ability to “develop the technology and related infrastructure to support advertising and drive value to advertisers,” showing a more mature, purpose‑built ad‑tech organization and a stronger commitment to infrastructure investment【page_10】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) It correctly identifies Netflix's evolution from 2023 to 2024 in terms of organizational development and infrastructure investment in advertising technology. In 2023, Netflix was in the early stages, focusing on building an advertising-sales team and developing technology and infrastructure. By 2024, it had evolved to include a dedicated 'advertising-sales and advertising-technology organization team,' reflecting internal development and greater investment. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—only qualitative developments across years, which are correctly attributed to the respective years (2023 vs. 2024). (3) The multi-hop reasoning is sound: the model synthesizes information across two years and two aspects (organizational development and infrastructure), correctly identifying the progression from early-stage efforts to a more mature, integrated structure. (4) The only minor shortcoming is that the LLM slightly downplays the original emphasis in 2023 on reliance on third-party providers and associated risks, which is a key element in the ground truth. However, the core evolution—toward internal development and infrastructure investment—is clearly and correctly captured. Wording differences are acceptable under semantic equivalence. Thus, the answer is factually correct and contextually relevant, meriting a high score with only a slight deduction in qualitative accuracy for the omitted nuance about third-party dependency.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 442,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has Tesla's approach to free Supercharging programs evolved between 2023 and 2024, particularly in terms of revenue recognition and program structure?",
      "original_answer": "In 2023, Tesla's free Supercharging programs were included under Automotive Sales Revenue as part of the revenue associated with new vehicle deliveries, indicating they were bundled with vehicle sales and recognized over time. By 2024, Tesla began deferring revenue related to features such as FSD (Supervised), internet connectivity, and free Supercharging, recognizing these as liabilities to be amortized over time rather than immediately upon vehicle delivery. This structural shift reflects a more formalized and segmented approach to monetizing these features, including free Supercharging, which allows Tesla to better align revenue recognition with service delivery.",
      "llm_answer": "In the 2023 filing Tesla said that unlimited free Supercharging is a “stand‑ready” service that is provisioned when a vehicle is delivered and is recognized on a straight‑line basis over the vehicle’s expected ownership life, while limited free‑Supercharging incentives are recognized when the customer actually uses them or when they expire (see 2023 p.37). By the 2024 filing the company now records the free‑Supercharging component in a dedicated deferred‑revenue liability – showing the beginning balance, additions and the amount recognized each year – but still recognizes the revenue over time on a straight‑line basis and continues to separate unlimited from limited incentives (see 2024 p.58 and p.57). This reflects a shift from a purely performance‑obligation description to a more formalized deferred‑revenue accounting and tracking of the program.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in Tesla's revenue recognition for free Supercharging between 2023 and 2024: in 2023, unlimited free Supercharging was recognized over time as a stand-ready service, while limited usage was recognized upon use or expiration. By 2024, Tesla began deferring revenue and tracking it in a dedicated deferred-revenue liability account, consistent with the shift described in the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised; all references to years (2023, 2024) and page numbers (p.37, p.58, p.57) are factually consistent with typical SEC filing documentation practices and support the claims. (3) The multi-hop reasoning is sound: the model synthesizes changes in accounting treatment across two years, correctly identifying the shift from bundling within vehicle revenue to formal deferral and amortization. It accurately distinguishes between unlimited and limited Supercharging incentives in both years, showing nuanced understanding. (4) The LLM adds more granular detail (e.g., straight-line basis, stand-ready service, deferred-revenue tracking) that enhances the explanation beyond the original answer, without introducing errors. The only minor gap is that it does not explicitly mention FSD (Supervised) and internet connectivity as part of the broader deferral program in 2024, which the original answer includes as context for the structural shift. However, this omission does not detract significantly from the core focus on Supercharging. Overall, the answer is semantically equivalent, factually correct, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 476,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How has NextEra Energy's approach to issuing Series O Junior Subordinated Debentures evolved between 2023 and 2024, particularly in terms of coupon structure and maturity dates, and what might this shift indicate about their financing strategy?",
      "original_answer": "In 2023, NextEra Energy issued the Series O Junior Subordinated Debentures due on May 1, 2079, with no explicit coupon rate disclosed in the filing. This indicates a potentially fixed or deferred interest structure typical for long-dated junior subordinated instruments. By 2024, the Series O Debentures were issued with a defined coupon rate of 5.55% and a significantly shorter maturity date of November 1, 2029. This represents a strategic shift toward issuing more conventional debt instruments with shorter durations and clearly defined interest costs. This evolution suggests a possible recalibration of NextEra’s capital structure strategy, favoring shorter-term, more predictable financing over long-dated, potentially lower-yielding instruments.",
      "llm_answer": "In the 2023 filing the only Series O instrument listed was the original Series O Junior Subordinated Debentures created in 2019, which carry a traditional fixed‑rate coupon and a very long maturity of May 1 2079 (see page 123). The 2024 filing shows a new Series O issuance that matures on November 1 2029 (see page 121), indicating a move to a much shorter‑term debt and, by contrast with the ultra‑long, fixed‑coupon series, a likely revised (lower‑ or floating‑rate) coupon structure—suggesting the company is tightening its debt maturity profile and seeking more flexible, lower‑cost financing.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the 2023 Series O issuance. The ground truth states that in 2023, the Series O Junior Subordinated Debentures were issued with no explicit coupon rate disclosed and a maturity date of May 1, 2079. However, the LLM incorrectly claims that the 2023 filing refers to an instrument 'created in 2019' with a 'traditional fixed-rate coupon', which contradicts the original answer and introduces unverified information. Additionally, the LLM implies the 2023 instrument had a fixed coupon, while the ground truth explicitly states no coupon was disclosed, suggesting a potentially deferred or variable structure. The 2024 details are partially correct: the maturity date of November 1, 2029 is accurate, but the LLM fails to mention the specific 5.55% coupon rate stated in the ground truth, instead speculating about a 'revised (lower- or floating-rate)' structure without evidence. (2) Quantitative accuracy is compromised: the 2023 coupon is misrepresented (no rate given in truth vs. assumed fixed-rate), and the 5.55% rate in 2024 is omitted entirely. Maturity dates are correctly cited (May 1, 2079 and November 1, 2029), so partial credit for dates. (3) Multi-hop reasoning is partially sound—the LLM correctly infers a strategic shift toward shorter maturities and tighter debt profile—but the conclusion about 'lower-cost' or 'flexible' financing is speculative and not aligned with the ground truth’s interpretation of a move toward more conventional, predictable instruments. The reasoning is plausible but based on incorrect premises. (4) Contextual relevance is high as the response addresses the evolution in maturity and coupon structure and attempts to interpret financing strategy. However, due to key factual errors in the quantitative elements and misrepresentation of the 2023 instrument, the correctness score is limited to 5—partially correct but with significant inaccuracies affecting the overall validity of the conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 548,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has ExxonMobil's consideration of OPEC investment activities evolved in its impairment assessment framework from 2022 to 2023, particularly in relation to long-term oil supply dynamics?",
      "original_answer": "In 2022, ExxonMobil explicitly stated that OPEC investment activities and production policies had an impact on world oil supplies and were considered in the context of impairment assessments. By 2023, while the company still acknowledged OPEC's influence on global oil supply, the discussion of OPEC was embedded more broadly within a comprehensive cash flow assessment framework that included forward-looking variables such as greenhouse gas emission costs and net-zero targets. This indicates a shift from a direct focus on OPEC's role to a more integrated view of macroeconomic and environmental factors affecting long-term asset valuation.",
      "llm_answer": "ExxonMobil’s 2022 and 2023 10‑K filings both state that temporary price drops do not by themselves trigger an impairment, but that long‑term oil prices must be high enough to sustain investment and that “OPEC investment activities and production policies also have an impact on world oil supplies.” The 2023 filing repeats the same language, indicating that the company’s view of OPEC’s role in long‑term supply dynamics has remained consistent rather than changed. 【page_94】【page_88】",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, despite citing correct general statements from the 10-K filings. While it accurately quotes language from ExxonMobil's 2022 and 2023 filings regarding OPEC's impact on world oil supplies, it incorrectly asserts that the company's view 'has remained consistent rather than changed.' This directly contradicts the ground truth, which identifies a meaningful evolution in ExxonMobil's impairment assessment framework: in 2023, the discussion of OPEC was no longer treated in isolation but was embedded within a broader, more integrated framework that included forward-looking environmental and macroeconomic factors such as greenhouse gas emission costs and net-zero targets. The LLM fails to recognize or report this shift, instead claiming continuity where there was, in fact, a qualitative change in how OPEC-related risks are contextualized. There are no numerical errors (hence high quantitative accuracy), and the entities (ExxonMobil, OPEC, 2022, 2023) are correct. However, the reasoning is flawed—the repetition of a sentence fragment does not preclude a broader conceptual shift in framework, which the LLM overlooks. Thus, while contextually relevant and factually precise in quotation, the answer misrepresents the evolution of ExxonMobil’s approach, failing the multi-hop synthesis required to compare not just wording, but conceptual framing across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 393,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Netflix's approach to its ad-supported subscription plan evolved from 2023 to 2024, based on the level of detail and strategic emphasis provided in the filings?",
      "original_answer": "In 2023, Netflix's ad-supported subscription plan was mentioned in the context of uncertainty and risk, particularly around consumer adoption and the lack of operating history with such offerings, which could lead to discrepancies between forecasts and actual results. By 2024, the ad-supported plan was presented as part of the company's broader pricing strategy, explicitly included in the description of plans offered to meet a variety of consumer needs. This shift indicates a move from a risk-focused perspective to a more confident, strategic positioning of the ad-supported plan as a core part of Netflix's business model.",
      "llm_answer": "In the 2023 filing, the ad‑supported subscription plan appears only in a risk‑factor discussion that stresses the lack of operating history and the difficulty of forecasting consumer adoption of “the ad‑supported subscription plan” (2023 p. 18). By the 2024 filing, the same plan is woven into the core business description as a standard pricing tier “including our ad‑supported subscription plan, to meet a variety of consumer needs” (2024 p. 3), showing that Netflix has moved from treating it as a tentative, uncertain experiment to positioning it as an established, strategic offering.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately captures the evolution of Netflix's ad-supported plan from 2023 to 2024: in 2023, it was discussed in the context of risk and uncertainty due to lack of operating history and challenges in forecasting adoption (correctly citing page 18 of the 2023 filing), while in 2024, it was integrated into the core business description as a standard offering (citing page 3 of the 2024 filing). (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages), but the years (2023, 2024) and page numbers (p. 18, p. 3) are correctly cited and align with the knowledge graph's implicit evidence. (3) The multi-hop reasoning is sound—comparing the strategic framing of the same offering across two years and synthesizing the shift from risk factor to core product demonstrates accurate cross-document analysis. (4) The LLM uses slightly different phrasing (e.g., 'tentative, uncertain experiment' vs. 'risk-focused perspective') but conveys the same meaning. The inclusion of direct quotes strengthens accuracy. All aspects of the question—evolution, level of detail, strategic emphasis—are addressed with precise, factually correct information.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 351,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How has Amazon's approach to shipping offers evolved between 2022 and 2024, particularly in terms of cost drivers and strategic focus on fulfillment efficiency?",
      "original_answer": "In 2022, Amazon highlighted that shipping costs were expected to increase as customers increasingly adopted its shipping offers, used faster delivery methods, and as the company expanded its fulfillment network. Shipping costs in 2021 were $76.7 billion, and the company anticipated continued growth in these costs. The strategic emphasis was on mitigating these increases through higher sales volumes, network optimization, supplier negotiations, and operational efficiencies. By 2024, the focus had shifted: while the company still invested in expanding its fulfillment network, it emphasized fulfillment network efficiencies as a key cost offset. The 2024 report notes that increased sales and network investments drove up fulfillment costs, but these were partially offset by efficiency gains. This marks a strategic evolution from a customer-driven cost increase in 2022 to a more operations-centric efficiency focus by 2024.",
      "llm_answer": "In 2022 Amazon portrayed its shipping offers as a permanent worldwide marketing tool to keep prices low, but warned that shipping costs were rising because of higher carrier rates, increasing wages and incentives, and fulfillment‑network inefficiencies tied to a tight labor market and rapid network expansion. By 2024 the company still emphasizes shipping offers as an indefinite marketing lever, yet the primary cost pressure now comes from higher sales volumes and continued investment in expanding the fulfillment network—partially offset by network efficiencies and foreign‑exchange gains—reflecting a strategic shift toward leveraging fulfillment‑capacity growth and efficiency improvements to sustain low‑price shipping.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core evolution in Amazon's shipping strategy between 2022 and 2024, correctly identifying rising shipping costs in 2022 due to customer behavior, labor, and network expansion, and a shift toward efficiency gains in 2024. However, it omits the specific $76.7 billion shipping cost figure from 2021 mentioned in the original answer, which is a notable quantitative omission. While it references cost drivers like wages, carrier rates, and network inefficiencies, these are not explicitly detailed in the ground truth for 2022—instead, the original emphasizes customer adoption of faster delivery and network expansion as primary cost drivers. (2) No incorrect numbers are presented, but the absence of the $76.7B figure and lack of explicit mention of 2021 (as the baseline year) reduces quantitative completeness. The years 2022 and 2024 are correctly used as comparison points. (3) The multi-hop reasoning is generally sound—comparing strategic focus across years and identifying a shift from customer-driven cost increases to operations-centric efficiency. However, the LLM introduces 'foreign-exchange gains' as an offset in 2024, which is not mentioned in the original answer and appears to be an unsupported addition. This affects qualitative accuracy. (4) Despite minor inaccuracies and an extraneous detail (FX gains), the LLM conveys the essential strategic shift and maintains strong contextual relevance. The answer aligns semantically with the core message of evolving cost drivers and a growing emphasis on fulfillment efficiency, warranting a correctness score of 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 444,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How did Duke Energy's utilization and reporting of the Master Retirement Trust evolve between 2023 and 2024, particularly in terms of asset allocation and disclosure practices?",
      "original_answer": "In 2023, Duke Energy's Master Retirement Trust was described in terms of its investment objective, focusing on achieving sufficient returns for plan benefits, with specific mention of VEBA trusts and their target and actual asset allocations. By 2024, the reporting evolved to include a more detailed breakdown of how different subsidiaries were allocated portions of the trust, such as Duke Energy Progress at 15% and Duke Energy Florida at 18%. Additionally, 2024 introduced a reconciliation of beginning and ending balances for pension and post-retirement assets, including Level 3 fair value disclosures, which was not present in 2023. This reflects a shift toward more granular and transparent reporting on trust assets and their valuation methodologies.",
      "llm_answer": "In 2023 the Master Retirement Trust held about $7.24 billion of assets (≈$2.0 b Level 1, $4.9 b Level 2, $76 m Level 3) with the RCBP portfolio allocated roughly 45 % equity, 35 % debt and 8 % cash/real‑estate, and the DELPP portfolio at 14 % equity, 80 % debt, 2 % cash/real‑estate and a 2 % hedge‑fund tilt; securities‑lending was still in place (≈$2 m on loan). By 2024 total assets fell to $6.97 b (Level 1 $2.24 b, Level 2 $4.48 b, Level 3 $68 m), the RCBP mix shifted to 44 % equity, 33 % debt and 10 % cash/real‑estate, the DELPP mix added equity to 15 % and cash/real‑estate to 4 % while eliminating hedge‑fund exposure, and the filing added a more granular fair‑value hierarchy (Level 1/2/3 and “not‑categorized” totals), a Level‑3 reconciliation, explicit subsidiary allocation percentages and a note that securities‑lending was discontinued—significantly enhancing disclosure compared with 2023.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth does not provide specific dollar amounts for the Master Retirement Trust assets in 2023 or 2024, nor does it mention Level 1/2/3 breakdowns, portfolio allocations (RCBP/DELPP), or securities lending activity. These detailed figures (e.g., $7.24 billion in 2023, $6.97 billion in 2024, 45% equity in RCBP) are fabrications not supported by the original answer. The original answer focuses on disclosure evolution and subsidiary allocations (e.g., Duke Energy Progress at 15%, Duke Energy Florida at 18%), which the LLM mentions but embeds within a context of false numerical precision. (2) The only correct quantitative elements are the subsidiary allocation percentages (15% and 18%), which align with the ground truth. However, all other numbers—including total assets, fair value hierarchies, portfolio mixes, and securities lending—are not present in the original and are therefore incorrect. Calculations based on these numbers (e.g., shifts in asset allocation) are invalid. (3) The multi-hop reasoning is partially sound: the LLM correctly identifies that 2024 reporting included more granular subsidiary allocations and enhanced disclosures like Level 3 reconciliations, which matches the original. It also correctly infers improved transparency. However, it invents a detailed quantitative narrative absent in the source, failing to reflect that the original answer does not contain portfolio-level allocations or total asset values. (4) The contextual relevance is high because the answer addresses asset allocation and disclosure evolution as asked. However, the correctness score is low due to extensive hallucination of numerical data. The qualitative accuracy is moderate because the direction of change (more granular reporting, subsidiary allocations, Level 3 reconciliation) is correct, but embedded in fabricated detail. Quantitative accuracy is poor due to unsupported figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 536,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How has Google's financial relationship with Google Network Partners evolved between 2022 and 2024, particularly in terms of the cost structure and payment obligations?",
      "original_answer": "In 2022, Google's cost of revenues included significant Traffic Acquisition Costs (TAC) paid to Google Network partners, primarily for ads displayed on their properties, with a noted higher cost percentage compared to Google Search properties due to the substantial share of advertiser revenues paid out as TAC. By 2024, Google Network partners were referenced in the context of operating cash outflows, indicating that payments to these partners had become a primary use of operating cash. This shift suggests a transformation in the nature of the financial relationship, from a cost-of-revenue model to a more direct operational cash flow obligation, reflecting a potential increase in the scale or structure of Google's dependency on these partners.",
      "llm_answer": "In the 2022 filing Google disclosed that the amounts it pays to Google Network partners are recorded as TAC within cost of revenues, and it explicitly noted that this makes the cost‑of‑revenues for ads served on Network properties “significantly higher” than for Search ads. By the 2024 filing the same partner payments are no longer broken out as a cost‑of‑revenues line‑item but are highlighted as one of the “primary uses of cash from operating activities,” showing that the cash‑outflow obligation to Network partners remains (and has grown with higher Network ad revenue) even though the reporting emphasis has shifted from a cost‑percentage to a cash‑payment focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, payments to Google Network Partners were recorded as Traffic Acquisition Costs (TAC) within cost of revenues, and that these costs made the cost-of-revenues for Network properties significantly higher than for Search—this matches the original answer's emphasis on higher cost percentages due to substantial revenue sharing. (2) For 2024, the LLM correctly notes a shift in reporting: while TAC is no longer explicitly broken out as a line item in cost of revenues, payments to Network partners are highlighted as a primary use of operating cash, indicating continued and possibly growing cash outflows. This reflects the ground truth's point about a shift toward operational cash flow obligations. (3) The multi-hop reasoning is sound—linking the change in accounting presentation from cost-of-revenue to cash flow usage shows an understanding of how financial reporting evolution can signal strategic or structural changes. (4) No actual numbers (e.g., dollar amounts or percentages) are present in either answer, so quantitative accuracy is not compromised; the LLM avoids fabricating figures and sticks to qualitative disclosures. The only reason for not scoring a perfect 10 is that the LLM slightly underemphasizes the implication of increased dependency on partners, though it does mention growing cash outflows due to higher Network ad revenue. Overall, the answer is factually correct, contextually precise, and semantically equivalent to the original.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 431,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How did the treatment and financial impact of offsetting swap positions evolve between 2022 and 2023, particularly in terms of fair value changes and settlements reported in the consolidated income?",
      "original_answer": "In 2022, UPS reported fair value changes and settlements of interest rate swaps, foreign currency exchange forwards, and investment market price forward contracts not designated as hedges, with specific figures for 2021 and 2020 provided (e.g., $163M net gain in 2021 and $124M net gain in 2020). In 2023, the company continued to report these derivatives at fair value with unrealized gains and losses in earnings, but the disclosure now included data for 2023 and 2022, showing a shift in focus to more recent periods. The explicit mention of terminating contracts or entering into offsetting swap positions remained consistent, but the financial impact in 2023 was not quantified in the excerpt, indicating a change in transparency around current-year derivative impacts.",
      "llm_answer": "In 2022 UPS still carried a floating‑to‑fixed interest‑rate swap (about $28 million of notional) and, together with its non‑designated foreign‑currency forwards, recognized a $69 million loss in the statement of consolidated income; by 2023 the interest‑rate swap had been terminated (no notional amount) and the loss from those non‑designated derivatives shrank to $7 million【page_130】【page_132】. Although the company has master‑netting arrangements with counterparties, it has not elected to offset the fair‑value positions on the balance sheet, so the reduction reflects the elimination of the offsetting swap positions and a much smaller fair‑value impact in 2023.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The claimed $69 million loss in 2022 and $7 million loss in 2023 are not supported by the ground truth, which does not provide specific 2022 or 2023 figures for non-designated derivatives—only 2021 ($163M gain) and 2020 ($124M gain) are cited. The LLM fabricates precise numbers absent from the original answer, including a notional amount of $28 million and specific losses, which are not mentioned in the ground truth. (2) Completeness: While the question asks about the evolution of treatment and financial impact of offsetting swap positions, the LLM incorrectly asserts termination of interest rate swaps and quantifies impacts that the original answer explicitly states were not disclosed in 2023. The ground truth emphasizes a lack of quantification in 2023 and a shift in disclosure focus, whereas the LLM presents false precision. (3) Entity Accuracy: The company (UPS) and derivative types (interest rate swaps, foreign currency forwards) are correctly identified, and the years 2022 and 2023 are appropriately referenced. (4) Reasoning: The LLM attempts multi-hop reasoning by linking termination of swaps to reduced losses, but this logic is based on invented data. The mention of master-netting arrangements and lack of balance sheet offsetting is plausible but not confirmed in the ground truth, making it an unsupported addition. (5) Semantic Equivalence: The overall message contradicts the ground truth—instead of reduced transparency in 2023, the LLM claims exact figures, misrepresenting the nature of the disclosure change. Thus, despite addressing the right topic and using relevant terminology, the answer is factually incorrect in key numerical and descriptive elements, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 497,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What does the increased prominence of the Directors' Savings Plan in Duke Energy's 2024 disclosures indicate about the company's director compensation strategy compared to 2023?",
      "original_answer": "In 2023, the Directors' Savings Plan was referenced primarily through historical amendments listed in exhibit references (e.g., Exhibit 10.12), with no detailed description of its structure or strategic role in compensation. In contrast, the 2024 filing provides a substantive description of the plan, explaining how outside directors may defer annual compensation, the phantom investment options available, and how balances are adjusted accordingly. This increased prominence indicates a shift toward emphasizing the plan as a core component of director compensation and deferral flexibility, suggesting a more strategic and transparent approach to director-level financial incentives in 2024.",
      "llm_answer": "The 2024 Form 10‑K expands the discussion of the Directors’ Savings Plan, explaining that outside directors may defer all or a portion of their annual retainers into an unfunded account that is adjusted for phantom‑stock performance and paid when they leave the board (see page 239). In the 2023 filing the plan was only mentioned in an exhibit list (e.g., an amendment to the Directors’ Savings Plan in Exhibit 10.12) without such detail (see page 245). This shift shows Duke Energy is making the Directors’ Savings Plan a more central, deferred‑compensation component of director pay, emphasizing performance‑linked, non‑cash remuneration compared with 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2023, the Directors' Savings Plan was only mentioned in an exhibit list (e.g., Exhibit 10.12) without detailed description, and in 2024, it received expanded coverage with a substantive explanation of deferral mechanics, phantom investment options, and payout timing. These details match the original answer. (2) There are no numeric values requiring calculation, but the years (2023 vs 2024), exhibit references, and page numbers (239 vs 245) are accurately cited, supporting factual precision. (3) The multi-hop reasoning is sound: the model correctly synthesizes differences in disclosure depth across two filings and infers a strategic shift in director compensation—specifically, a move toward emphasizing deferred, performance-linked compensation. (4) The LLM captures the core conclusion: Duke Energy is making the plan a more central component of director pay, highlighting non-cash, performance-based incentives. The only minor omission is not explicitly stating that this reflects a 'more transparent approach,' which is implied in the increased disclosure but not directly mentioned. However, the emphasis on expanded discussion and structural details effectively conveys transparency. Wording differs slightly but maintains semantic equivalence. All entities (Duke Energy, Directors' Savings Plan, outside directors, annual retainers) are correct. Overall, the answer is factually complete, logically sound, and contextually precise.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 425,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How has American Express's approach to developing value propositions evolved between 2022 and 2024, particularly in response to competitive pressures and changing customer behaviors?",
      "original_answer": "In 2022, American Express highlighted the challenge of developing compelling value propositions in the face of growing competition, particularly from alternative payment providers and digital wallets, which threatened to fragment customer spending and reduce the competitiveness of its offerings. The company emphasized the need to evolve its value propositions to retain relevance and attract customers amid rising Card Member rewards costs and shifting consumer preferences, especially in mobile and online payments. By 2024, the company's strategy had evolved to focus on expanding leadership in premium consumer and commercial payments, particularly targeting Millennial and Gen-Z consumers, and enhancing digital capabilities through investments in AI, automation, and the Amex app. It also emphasized the importance of strategic partnerships, dining platform expansion (including Tock and Rooam), and global merchant coverage growth as key enablers of its value proposition strategy. This represents a shift from a reactive stance on competition to a more proactive, innovation-driven approach.",
      "llm_answer": "In the 2022 filing American Express largely framed its value‑proposition work as a defensive need – it warned that it must “differentiate ourselves from our competitors, develop compelling value propositions” and that evolving those propositions would raise reward‑and‑service costs, while most of its focus was on protecting and extending cobrand and partnership relationships amid intense competition (see 2022 p. 28‑26). By the 2024 filing the tone has shifted to a proactive, investment‑driven strategy: the company now says it will “continue investing at high levels… in our brand, value propositions, coverage, marketing, technology and talent,” and is explicitly building premium, digitally‑enabled benefits, partner‑funded rewards and new products for Millennial and Gen‑Z customers, using data, marketing efficiency and technology to adapt to competitive pressure and changing customer behavior (see 2024 p. 91‑94, 93).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution in American Express's strategy from a defensive, reactive posture in 2022—focused on differentiation amid rising competition and costs—to a proactive, investment-driven approach in 2024 centered on technology, digital capabilities, and targeting younger demographics. Key elements such as increasing reward costs, competitive pressures from digital wallets, and emphasis on partnerships are accurately reflected. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; references to page numbers (e.g., 2022 p. 28–26, 2024 p. 91–94) are consistent with typical 10-K formatting and do not affect factual correctness. (3) The multi-hop reasoning is sound: the model synthesizes information across two years, identifies the shift in tone and strategy, and links it to competitive pressures and customer behavior changes. It correctly identifies the focus on Millennials and Gen-Z, digital innovation (technology, app), and strategic partnerships (implied via 'partner-funded rewards'), though it does not explicitly name Tock and Rooam or 'dining platform expansion' as in the original. This is a minor omission that prevents a perfect score. (4) The answer is contextually excellent—directly addressing the question about evolution between 2022 and 2024, competitive pressures, and changing customer behaviors. Wording differs but semantic meaning matches. Overall, the response is factually correct, well-reasoned, and only slightly less complete than the ground truth due to missing specific brand names of dining platforms.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 470,
        "total_tokens": 1986
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Exxon Mobil's approach to long-term debt financing evolved between 2022 and 2024, particularly regarding the composition of its long-term notes?",
      "original_answer": "In 2022, Exxon Mobil disclosed a broader range of debt instruments, including the 0.142% Notes due 2024, 0.524% Notes due 2028, 0.835% Notes due 2032, and the 1.408% Notes due 2039. By 2024, the company no longer listed the 0.142% Notes due 2024, indicating that those obligations had matured or been repaid. However, the 1.408% Notes due 2039 remained in the disclosure, suggesting a continued emphasis on long-term financing instruments with distant maturity dates. This shift reflects a strategic evolution in the company's capital structure, focusing more heavily on extended-term debt while retiring shorter-duration obligations.",
      "llm_answer": "In the 2022 filing Exxon Mobil’s long‑term debt portfolio included a short‑dated, ultra‑low‑coupon issue – a 0.142 % note due 2024 – together with three longer‑dated notes (0.524 % due 2028, 0.835 % due 2032 and 1.408 % due 2039)【page_1】. By the 2024 filing the 0.142 % 2024 note had been retired, leaving only the 0.524 % note due 2028, the 0.835 % note due 2032 and the 1.408 % note due 2039【page_1】, indicating a shift toward a longer‑maturity, higher‑coupon debt mix.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values—interest rates (0.142%, 0.524%, 0.835%, 1.408%) and maturity years (2024, 2028, 2032, 2039)—are correctly reported, matching the original answer exactly. The observation that the 0.142% Note due 2024 was retired by 2024 is factually sound and supported by the data. (2) Quantitative accuracy is perfect: all percentages and dates are correct, and no calculations are required beyond correct identification of instrument maturities. (3) The multi-hop reasoning—comparing debt composition across 2022 and 2024 filings to infer a strategic shift—is logically sound. The LLM correctly infers that retiring the 2024 note while retaining longer-dated notes (especially the 2039 note) indicates a move toward longer-maturity debt. It adds the useful insight about a 'higher-coupon debt mix,' which is reasonable given the retained notes have higher coupons than the retired 0.142% note, though this specific phrasing wasn't in the original answer. (4) The only minor shortcoming is that the original answer emphasizes the strategic evolution in capital structure and 'continued emphasis on long-term financing,' which the LLM implies but does not explicitly frame as a strategic shift. Still, the core facts, synthesis, and conclusion are correct. Wording differences do not affect semantic equivalence. All entities (Exxon Mobil, correct years, correct notes) are accurately identified. The answer is fully relevant and responsive to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 421,
        "total_tokens": 1699
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has American Express's approach to corporate card solutions evolved between 2022 and 2024, particularly in terms of strategic emphasis and product differentiation?",
      "original_answer": "In 2022, American Express emphasized evolving card value propositions and differentiating corporate card and accounts payable expense management solutions as part of its broader commercial payments strategy. By 2024, the company continued to focus on commercial payments but introduced a more integrated global network approach, aiming to increase merchant acceptance and provide enhanced fraud protection and marketing insights. This shift indicates a move from internal product development focus in 2022 to a more externally integrated ecosystem strategy by 2024.",
      "llm_answer": "American Express’s corporate‑card strategy has not shifted dramatically – in both the 2022 and 2024 filings the company says it will “build on our strong position in commercial payments by evolving our card value propositions, further differentiating our corporate card and accounts‑payable expense‑management solutions and designing innovative products and features, including financing, banking and payment solutions for our business customers”【page_8】. The identical language in the two “Our Business Strategies” sections shows a continued emphasis on differentiation and innovation rather than a new strategic direction.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but misses key aspects of the evolution in American Express's strategy between 2022 and 2024, leading to a significant gap in qualitative accuracy. (1) The LLM correctly identifies that American Express maintained a consistent emphasis on differentiating corporate card and accounts payable solutions and evolving value propositions in both years, citing identical language from the filings. This supports the claim of continuity and is factually accurate. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored as 10 by default. (3) However, the original answer reveals a deeper strategic evolution: while 2022 focused on internal product development and differentiation, by 2024 the company shifted toward an externally integrated global network strategy emphasizing merchant acceptance, fraud protection, and marketing insights. The LLM fails to detect or report this shift, instead concluding there was 'no dramatic shift' and 'continued emphasis', which contradicts the ground truth's identification of a move from internal to ecosystem-driven strategy. This represents a failure in multi-hop reasoning—synthesizing changes in emphasis across years—despite having access to the same source language. (4) Contextual relevance is high because the answer addresses the core topic and uses relevant excerpts, but correctness is limited by omission of the key strategic evolution. Thus, correctness and qualitative accuracy are moderate due to accurate citation but flawed interpretation and incomplete synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 443,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has Amazon's financial relationship with AWS Services evolved between 2022 and 2024, particularly in terms of cash flow generation and strategic emphasis?",
      "original_answer": "In 2022, AWS Services were primarily discussed in the context of competitive pressures and risks, with an emphasis on the challenges of operating in a rapidly evolving and intensely competitive market. By 2024, AWS had transitioned into a key financial contributor, with Amazon reporting $115.9 billion in operating cash flow for that year, up from $84.9 billion in 2023, driven in part by AWS and other enterprise services. This reflects a shift from viewing AWS as a risk-laden venture to a core revenue generator funding broader corporate initiatives.",
      "llm_answer": "By 2022 Amazon already treated AWS as a core growth engine – it had a dedicated CEO for the unit (page 5) and highlighted AWS in its technology‑infrastructure strategy (pages 6‑7). In the 2024 filing AWS’s financial weight expanded markedly: net sales rose 19% to $107.6 billion, its share of total sales grew to 17% (page 24), operating cash flow jumped to $115.9 billion (page 22), and cash capital expenditures rose to $77.7 billion, “primarily … to support AWS business growth” (page 23), underscoring a stronger cash‑generating role and heightened strategic emphasis on AWS.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the growing strategic and financial role of AWS from 2022 to 2024, aligning with the ground truth's narrative of AWS evolving into a core financial contributor. However, there are key quantitative inaccuracies. The LLM states AWS generated $115.9 billion in operating cash flow in 2024, which matches the ground truth, but attributes this figure directly to AWS. The ground truth clarifies that $115.9 billion is Amazon's total operating cash flow for 2024 (driven in part by AWS), not AWS's standalone cash flow. This is a significant misattribution. Additionally, the LLM claims AWS net sales rose 19% to $107.6 billion in 2024, but this specific figure and percentage increase are not supported by the ground truth, which does not provide AWS-specific net sales. The $84.9 billion figure from 2023 in the ground truth also refers to total Amazon operating cash flow, not AWS-specific. (2) While the $115.9 billion number is factually correct as Amazon's 2024 operating cash flow, its attribution to AWS is incorrect. The 19% growth and $107.6 billion sales figure lack verification in the ground truth. The capital expenditure note is plausible but not confirmed in the provided truth. (3) The multi-hop reasoning is partially sound—LLM correctly infers increased strategic emphasis from structural and investment indicators (dedicated CEO, capex allocation). However, it fails to accurately disentangle AWS-specific financials from Amazon’s consolidated figures, undermining the quantitative synthesis. (4) The contextual relevance is high as the answer directly addresses the evolution in financial relationship and strategic emphasis. Qualitative accuracy is good due to correct use of strategic indicators, but quantitative accuracy is reduced due to incorrect financial attributions and unsupported sales figures. Correctness score is 7 because the core narrative of AWS's growing importance is accurate, but key financial claims are misleading or unsupported.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1286,
        "completion_tokens": 543,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did the scope or focus of trend analyses used in evaluating the historical consistency of regulatory asset balances evolve between 2023 and 2024?",
      "original_answer": "In 2023, trend analyses were used to evaluate the historical consistency of regulatory asset balances in general, without specific reference to asset retirement obligations. By 2024, the scope of the trend analyses remained focused on regulatory asset balances, but the audit procedures expanded to include a specific evaluation of the ongoing regulatory recoverability of asset retirement obligations related to coal ash, indicating a shift in focus toward more specialized regulatory compliance areas.",
      "llm_answer": "Both the 2023 and 2024 audit reports say the auditors “utilized trend analyses to evaluate the historical consistency of regulatory asset balances.” While the 2024 audit added other procedures (e.g., coal‑ash and storm‑cost analyses), the trend‑analysis itself remained focused on checking the historical consistency of the regulatory‑asset balances, with no change in its core scope.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but misses a key qualitative shift described in the ground truth. (1) Correctly identifies that trend analyses were used in both years to evaluate historical consistency of regulatory asset balances, and correctly notes no change in the core scope of trend analyses. (2) There are no numeric values to verify, so quantitative accuracy is not applicable—score reflects absence of numerical errors. (3) However, the LLM fails to capture the evolution in focus: while the trend analysis itself may not have changed, the audit procedures in 2024 expanded to include a specific evaluation of the regulatory recoverability of asset retirement obligations (AROs) related to coal ash, indicating a shift in focus toward specialized compliance areas. The LLM mentions 'coal-ash and storm-cost analyses' as added procedures but incorrectly implies this does not reflect a change in the focus of the trend analyses' application. The ground truth indicates a shift in focus—even if the method remained the same, its application became more targeted. (4) This omission constitutes a significant gap in qualitative accuracy, as the evolution in focus is central to the question. The answer is contextually relevant and factually sound on surface details but lacks depth in capturing the nuanced shift in analytical emphasis, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 383,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How did Costco's strategy regarding the penetration of private-label items evolve between 2022 and 2023 in response to cost and pricing pressures?",
      "original_answer": "In 2022, Costco responded to higher-than-recent inflation in merchandise costs by employing several strategies, including absorbing some cost increases internally, purchasing earlier and in larger volumes, and selectively passing on cost increases to members, all of which were aimed at maintaining pricing authority while managing gross margin pressures. In 2023, Costco continued to emphasize increasing the penetration of its private-label items as part of its broader merchandising and pricing strategy to adapt to ongoing cost increases and competitive pressures. This indicates a shift from a more reactive approach in 2022 to a more strategic and sustained emphasis on private-label offerings in 2023 to maintain competitive pricing and member value.",
      "llm_answer": "- In the 2022 filing Costco said that higher‑than‑expected inflation and merchandise‑cost pressures prompted it to “adjust…our pricing and merchandise mix, **including increasing the penetration of our private‑label items**” as a way to protect margins【page_22】.  \n- In the 2023 filing the company reiterated that same lever, noting that “adjustments to our pricing and merchandise mix, **including increasing the penetration of our private‑label items**, … remain a key response to cost and pricing pressures”【page_23】.  \n\nThus, between 2022 and 2023 Costco’s approach evolved from initiating a push to raise private‑label share to maintaining—and further emphasizing—that push as an ongoing strategy to offset cost and pricing challenges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022, Costco began increasing private-label penetration in response to cost pressures, citing the exact phrasing from the filing (‘adjust our pricing and merchandise mix, including increasing the penetration of our private-label items’). In 2023, it notes the continuation and reinforcement of this strategy, which matches the original answer’s claim of a shift from reactive to sustained strategic emphasis. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the question or the ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes information from both the 2022 and 2023 filings to show evolution in strategy—from initiating to maintaining and emphasizing private-label growth. The conclusion that the approach evolved from initiation to ongoing emphasis captures the strategic shift accurately. (4) The LLM answer conveys semantic equivalence to the original answer, using direct quotes and correct contextual interpretation. The only minor limitation is that it does not explicitly use terms like ‘absorbing cost increases’ or ‘purchasing earlier’ from the 2022 strategy as mentioned in the ground truth, but it still captures the core evolution in private-label strategy. Thus, it earns a high score but not perfect due to slight incompleteness in contextual breadth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 410,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How has the financial outlook for Paxlovid evolved between 2023 and 2024 based on Pfizer's remaining performance obligations?",
      "original_answer": "In 2023, Pfizer did not disclose specific remaining performance obligations for Paxlovid. However, by the end of 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a clear financial commitment from customers for future delivery of the product. This evolution suggests increased contractual certainty and forward-looking revenue expectations for Paxlovid between the two years.",
      "llm_answer": "Pfizer’s 2024 Form 10‑K reports that, as of December 31 2024, it had about **$1 billion of remaining performance‑obligation revenue for Paxlovid**, covering deliveries through 2025‑2028. The 2023 filing did not disclose a comparable amount (the obligations were either not significant or much lower), so the Paxlovid outlook has become markedly stronger in 2024 versus 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $1 billion figure for remaining performance obligations as of December 31, 2024, is correct and matches the original answer. The date (December 31, 2024) and the metric (remaining performance obligations for Paxlovid) are correctly cited. (2) The LLM correctly notes that the 2023 filing did not disclose a specific amount, which is consistent with the ground truth stating that Pfizer did not disclose specific obligations for Paxlovid in 2023. (3) The reasoning is sound: the emergence of a $1 billion obligation in 2024 versus no disclosed amount in 2023 supports the conclusion of a stronger financial outlook, indicating increased contractual revenue visibility. (4) The LLM adds a detail not in the original answer—deliveries expected through 2025–2028—which may be from the 10-K but was not part of the ground truth. This addition does not contradict the original answer and adds context, but since it's not verifiable from the provided ground truth, it slightly affects qualitative accuracy. However, it does not detract from correctness. Overall, the answer correctly synthesizes multi-hop information (comparing disclosures across years) and conveys the same core conclusion: increased financial commitment and improved outlook for Paxlovid from 2023 to 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 378,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has American Express's use and assumptions around the Reasonable and Supportable (R&S) Period evolved between 2022 and 2024 in estimating credit loss reserves, and what does this indicate about the company's approach to financial risk management?",
      "original_answer": "In 2022, American Express explicitly described its use of the R&S Period as a key component in estimating reserves for credit losses on Card Member loans, incorporating historical loss experience and current/future economic conditions over that period. The reserves stood at $3.3 billion as of December 31, 2021, and the R&S Period was a central assumption in modeling expected credit losses. By 2024, while the R&S Period was still referenced, it was no longer introduced as a newly explained concept and instead appeared embedded within a more mature and established process, indicating it had become a standard part of the company's financial risk modeling framework. This evolution suggests a shift from introducing the methodology (2022) to relying on it as a foundational element in credit loss estimation (2024).",
      "llm_answer": "American Express has not altered the fundamentals of its R&S‑Period methodology – in both the 2022 filing and the 2024 filing the company says it “estimates lifetime expected credit losses by incorporating historical loss experience, as well as current and future economic conditions over a reasonable and supportable period (R&S Period) beyond the balance‑sheet date… Within the R&S Period the models use past loss experience and current/future economic conditions, and beyond the R&S Period expected losses are estimated by immediately reverting to long‑term average loss rates” (2022 10‑K, Note 3, p. 95; 2024 10‑K, Note 3, p. 97). The language is essentially unchanged, with the later filing adding a continued emphasis on qualitative reserves to capture risks not fully reflected in the quantitative models. This consistency shows a disciplined, forward‑looking risk‑management framework that relies on a stable, data‑driven horizon while still monitoring emerging risks through qualitative adjustments.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of American Express's consistent use of the R&S Period methodology between 2022 and 2024, correctly citing unchanged core language from the 10-K filings regarding the incorporation of historical loss experience and current/future economic conditions within the R&S Period, followed by reversion to long-term average loss rates. It accurately reflects that the methodology remained fundamentally stable, which aligns with the ground truth's assertion that the R&S Period remained a key component. The mention of qualitative reserves in 2024 as an added emphasis is contextually appropriate and does not contradict the ground truth. However, the LLM answer does not fully capture the evolution highlighted in the original answer—specifically, the shift in presentation from introducing the R&S Period as a newly emphasized concept in 2022 to treating it as an embedded, mature part of the framework in 2024. While the consistency of language supports the LLM’s point, it misses the nuance of methodological maturation and integration into standard practice, which is central to the original answer’s conclusion about the company's evolving risk management approach. There are no errors in entities, years, or financial figures (though no specific reserve numbers like the $3.3 billion as of December 31, 2021 are mentioned, which were in the ground truth). The omission of this specific figure reduces completeness slightly but does not invalidate the overall correctness. The reasoning is sound and contextually relevant, with strong multi-hop synthesis across years and filings, but the qualitative interpretation of evolution leans more on methodological stability than the conceptual maturation emphasized in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 482,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has Amazon's approach to debt financing evolved between 2022 and 2024, particularly with respect to the 0.800% Note due 2025?",
      "original_answer": "In 2022, Amazon's filings referenced the 0.800% Note due 2025 as part of its broader debt structure, originally introduced in the Officers' Certificate dated June 3, 2020. By 2024, Amazon not only continued to reference the 0.800% Note due 2025 in its filings but also introduced new debt instruments with different interest rates and maturity dates, such as the 4.600% Note due 2025. This indicates a shift in Amazon's debt financing strategy, incorporating a wider range of interest rates and maturities to potentially manage cash flow and interest rate risk more effectively.",
      "llm_answer": "In the 2022 Form 10‑K Amazon’s 0.800 % Note due 2025 was disclosed in Exhibit 4.5 (the June 3 2020 Officers’ Certificate) as one of its existing low‑rate senior notes. By the 2024 Form 10‑K the same note appears in Exhibit 4.6, but the filing also adds new revolving‑credit facilities (a five‑year and a 364‑day facility) and other higher‑rate notes, indicating that Amazon has broadened its debt program to include more flexible, short‑term borrowing while still retaining the low‑cost 0.800 % Note due 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers, dates, and percentages are correct: the 0.800% Note due 2025 is correctly cited, with its origin in the June 3, 2020 Officers’ Certificate, and the 2022 and 2024 Form 10-K references are accurately described. The mention of Exhibit 4.5 in 2022 and Exhibit 4.6 in 2024 is consistent with filing evolution. (2) While the ground truth highlights the introduction of the 4.600% Note due 2025 as a new instrument, the LLM instead references 'other higher-rate notes' and new revolving-credit facilities. This is not incorrect—revolving facilities were indeed added—but it substitutes a specific example (4.600% Note) with a broader category. This minor deviation prevents a perfect score but does not undermine factual correctness. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across 2022 and 2024 filings, identifies the continuity of the low-rate note, and infers a strategic broadening of the debt program. The conclusion about Amazon diversifying its debt instruments for flexibility and risk management is logically supported and semantically equivalent to the ground truth’s interpretation. (4) Contextual relevance is excellent—the response directly addresses the evolution of Amazon’s debt financing strategy with respect to the 0.800% Note due 2025 and correctly frames it within broader strategic changes. Minor deduction in qualitative accuracy due to lack of specificity on the 4.600% Note, but overall reasoning and factual content are strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 434,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How has the treatment or disclosure of the Twenty-third Supplemental Indenture evolved between the 2022 and 2024 SEC filings, and what does this indicate about its ongoing relevance or status?",
      "original_answer": "In the 2022 filing (DUK_10k_2022.pdf), the Twenty-third Supplemental Indenture was explicitly listed and dated June 1, 1978, incorporated by reference to Exhibit 2(c), File No. 2-61611. However, in the 2024 filing (DUK_10k_2024.pdf), there is no direct mention or continued reference to the Twenty-third Supplemental Indenture. Instead, the focus shifts to more recent supplemental indentures, such as the Forty-ninth Supplemental Indenture dated March 14, 2024. This indicates that the Twenty-third Supplemental Indenture was not reaffirmed or highlighted in the most recent disclosure, suggesting it may have diminished in operational or reporting significance over time.",
      "llm_answer": "In the 2022 Form 10‑K the “Twenty‑third Supplemental Indenture” is listed as a recent amendment dated May 15 2020 and is incorporated by reference to a 2020 Form 8‑K filing (see 4.1.23). In the 2024 Form 10‑K the same‑numbered indenture appears in the historical series, dated January 1 1977 and filed as Exhibit 2‑57828 (see 4.14.2). This shift from a current amendment to a legacy entry shows that Duke Energy continues to disclose the full series of supplemental indentures, keeping the Twenty‑third Supplemental Indenture on the record as an ongoing, albeit historic, component of its debt documentation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitative Accuracy: The LLM incorrectly states that the Twenty-third Supplemental Indenture was amended on May 15, 2020, in the 2022 filing, while the ground truth confirms it was dated June 1, 1978, and incorporated by reference from File No. 2-61611. The LLM also fabricates a date of January 1, 1977, in the 2024 filing and references a non-existent Exhibit 2-57828. These dates and exhibit numbers are entirely incorrect. (2) Completeness: While the question asks about the evolution of treatment/disclosure between 2022 and 2024, the LLM fails to note the key point from the ground truth — that the Twenty-third Supplemental Indenture is absent in the 2024 filing. Instead, it falsely claims the indenture appears in the 2024 filing, misrepresenting the core fact. (3) Entity Accuracy: The company (Duke Energy) is correct, and the document types (10-K, supplemental indentures) are relevant, but the specific exhibit references and dates are wrong. (4) Reasoning: The LLM draws an incorrect conclusion — that the indenture is still being disclosed as a 'legacy entry' — when in fact it is no longer mentioned at all in 2024. This misrepresents the trend: the ground truth shows diminishing relevance, while the LLM suggests continued inclusion. (5) Semantic Equivalence: The overall meaning is not equivalent — the LLM asserts ongoing disclosure, while the truth is of omission. The shift from active to inactive status is reversed in interpretation. Thus, despite addressing the general topic, the answer is factually and logically flawed, warranting a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 455,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How did the repurchase activity for Class C Capital Stock evolve from 2022 to 2024, and what was the total value of shares repurchased in each year?",
      "original_answer": "In 2022, Alphabet repurchased $59.3 billion of Class A and Class C shares, while in 2023 the amount increased to $62.2 billion, and in 2024 it remained high at $62.0 billion. This demonstrates a consistent and significant level of share repurchase activity over the three-year period, with a slight peak in 2023 followed by a minor decline in 2024.",
      "llm_answer": "Alphabet’s share‑repurchase program, which includes Class C capital stock, grew from $59.3 billion in 2022 to $62.2 billion in 2023 and then held essentially steady at $62.0 billion in 2024 【page_82】.  In 2023 the company retired 450 million Class C shares (≈ $52.9 billion) and in 2024 it retired 306 million Class C shares (≈ $50.2 billion) 【page_82】; the 2022 Class C‑share count is not broken out in the excerpt.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports the total repurchase amounts for 2022 ($59.3B), 2023 ($62.2B), and 2024 ($62.0B), which matches the ground truth and addresses the evolution of repurchase activity. However, the question specifically asks for the total value of Class C shares repurchased in each year, but the LLM answer only provides the total value of all shares (Class A and C combined) in 2022 and breaks out Class C repurchases only for 2023 ($52.9B) and 2024 ($50.2B), noting that 2022 Class C data is not available. This is a significant omission because the question requires the value of Class C repurchases specifically for each year, not just the combined total. (2) The numbers cited for 2023 and 2024 Class C repurchases are plausible and internally consistent with the document reference, but the ground truth does not include these specific breakdowns by share class—instead, it reports combined repurchases. Since the original answer does not mention separate Class C values, the LLM introduces detail not present in the ground truth, which may be accurate per the source document but exceeds the provided truth and misaligns with the expected answer. (3) The multi-hop reasoning is partially sound: the model identifies the trend in total repurchases over time and attempts to isolate Class C data where possible, but it fails to fully satisfy the question’s requirement for annual Class C-specific values, especially for 2022. (4) The contextual relevance is high because the response stays on topic and cites relevant data. Quantitative accuracy is reduced due to incomplete and mismatched metric reporting (mixing total vs. Class C-specific values). Qualitative accuracy is moderate because reasoning is logical but based on incomplete synthesis. Correctness score is 6 due to partial fulfillment: correct trend and some correct figures, but missing key required data points for Class C in 2022 and inconsistent level of detail across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1191,
        "completion_tokens": 532,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "What changes occurred in the treatment and documentation of the American Express Company Salary/Bonus Deferral Plan between the 2022 and 2024 SEC filings?",
      "original_answer": "In the 2022 filing, the Salary/Bonus Deferral Plan was referenced through historical amendments, including Exhibit 10.16 (1988 plan) and Exhibit 10.17 (1994 amendment). The 2024 filing reintroduces the plan through Exhibit 10.13, referencing the same 1988 plan, and also includes Exhibit 10.14, which references the 1994 amendment. Notably, the 2024 filing adds Exhibit 10.16, which incorporates the 1997 amendments to the plan. This indicates that while the foundational documentation remained consistent, the 2024 filing expanded the disclosure to include a broader historical record of amendments, providing more context on the plan's evolution.",
      "llm_answer": "In the 2022 Form 10‑K the Salary/Bonus Deferral Plan was listed as Exhibit 10.16 (the original 1988 plan) with its 1994 amendment shown as Exhibit 10.17 and a 1997 amendment as Exhibit 10.19 【page_165】. In the 2024 filing the same plan appears under the new numbers Exhibit 10.13 (original), Exhibit 10.14 (1994 amendment) and Exhibit 10.16 (1997 amendment) 【page_171】—the underlying documents (Exhibit 10.20, 10.4 and 10.37) are unchanged, but the exhibit numbering was renumbered.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core renumbering of exhibits between the 2022 and 2024 filings and correctly identifies the 1988 plan, 1994 amendment, and 1997 amendment as being referenced in both years. However, it contains a critical factual error: the 2022 filing does not list the 1997 amendment as Exhibit 10.19 according to the ground truth. The original answer states that the 1997 amendments were not included in the 2022 filing but were newly added in 2024 as Exhibit 10.16. The LLM incorrectly asserts that the 1997 amendment was present in the 2022 filing (Exhibit 10.19), which contradicts the ground truth. This undermines the quantitative and qualitative accuracy. While the observation about renumbering is plausible, the claim that 'underlying documents (Exhibit 10.20, 10.4 and 10.37) are unchanged' introduces unverified exhibit numbers not mentioned in the ground truth, further reducing accuracy. The reasoning is partially sound in noting structural changes, but the conclusion that documents are unchanged conflicts with the ground truth assertion that the 2024 filing expanded disclosure to include previously omitted amendments. Thus, while contextually relevant and addressing the question's intent, the answer is factually flawed in key details, warranting a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 360,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has Starbucks' exposure to interest rate swaps evolved between 2022 and 2024, particularly in terms of their balance sheet classification and magnitude of liability?",
      "original_answer": "In 2022, Starbucks reported an interest rate swap liability of $34.0 million under 'Other long-term liabilities'. By 2024, the company's interest rate swap position had shifted significantly, with a liability of $19.2 million under 'Other long-term liabilities' and an additional $41.4 million liability from interest rate swaps reported for the prior year (2023), indicating a decrease in liability from the previous year but a continued significant exposure. This reflects a transformation in the company's interest rate swap position, with a shift in balance sheet classification and a notable reduction in total swap liability.",
      "llm_answer": "In the 2022 Form 10‑K Starbucks reported interest‑rate‑swap liabilities of **$34 million** classified as **“Other long‑term liabilities”** (with a separate $12 million accrued‑liability for interest‑rate items)【page_68】. By the 2024 filing the swap exposure had fallen to **$19.2 million**, still shown under **“Other long‑term liabilities”** and with no accrued‑liability component【page_72】. This reflects a roughly 44 % reduction in the magnitude of the swap liability while the balance‑sheet classification remained long‑term.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $34.0 million liability in 2022 and $19.2 million in 2024, both classified under 'Other long-term liabilities', which matches the ground truth. However, it omits the $41.4 million liability from 2023 (the prior year to 2024), which is a significant part of the multi-hop evolution described in the original answer. This omission reduces completeness and affects the full picture of how the exposure evolved across the three years. (2) The quantitative values for 2022 and 2024 are accurate (allowing for format variation: $34 million = $34.0 million). The 44% reduction claim is approximately correct (calculated as (34 - 19.2)/34 ≈ 43.5%), so the calculation is sound. However, the absence of the $41.4 million 2023 figure means the model fails to capture the increase from 2022 to 2023 before the drop in 2024, leading to an oversimplified narrative of steady decline. (3) The reasoning is partially sound: it correctly tracks the change from 2022 to 2024 and notes consistent classification, but fails to synthesize the full multi-hop trajectory involving 2023 data, which is critical to understanding the 'evolution' over time. The original answer emphasizes a shift involving a prior-year liability, which the LLM does not address. (4) Scores reflect high accuracy on reported numbers and relevance to the question, but docked for missing key data point (2023 liability) that impacts qualitative understanding of trend and balance sheet dynamics. Contextual relevance remains high as the answer addresses classification and magnitude changes appropriately, albeit incompletely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 446,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the treatment of the Directors' Savings Plan evolved between 2022 and 2024, and what does this suggest about Duke Energy's approach to director compensation governance and deferral mechanisms?",
      "original_answer": "In 2022, the Directors' Savings Plan was formally introduced in the 10-K filing with a specific amendment dated December 16, 2021, indicating active documentation and policy updates around director deferrals. By 2024, the plan is referenced in the context of phantom investment options and deferred compensation mechanics, with an emphasis on unfunded accounts tied to the Duke Energy Common Stock Fund. This evolution suggests a shift from policy establishment to operational transparency, highlighting how deferrals are structured and invested, which may reflect a broader governance strategy to align director compensation with long-term shareholder interests and company stock performance.",
      "llm_answer": "In the 2022 Form 10‑K the Directors’ Savings Plan is mentioned only as an exhibit – the “Amended and Restated Directors’ Savings Plan” (dated 1 Jan 2014) and a 2021 amendment (effective 16 Dec 2021) are listed on page 258, but no substantive description is provided. By the 2024 Form 10‑K, Item 12 (page 239) spells out that the plan is a non‑qualified deferred‑compensation arrangement that lets outside directors defer all or part of their retainers, earn phantom‑stock credits tied to the Duke Energy Common Stock Fund, and receive payouts when their board service ends, and it is classified as a plan not approved by security holders whose future share‑issuance depends on voluntary deferrals. This evolution shows Duke Energy moving toward greater transparency and tighter governance of director compensation, emphasizing a structured, performance‑linked deferral mechanism rather than merely referencing the plan as an exhibit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 mention of the Directors' Savings Plan as an exhibit with the December 16, 2021 amendment and the 2014 restated version are accurately cited, and the 2024 10-K's detailed description of the plan as a non-qualified deferred-compensation arrangement with phantom stock tied to Duke Energy Common Stock Fund is correctly reported. (2) Quantitative accuracy is perfect: dates (Dec 16, 2021; Jan 1, 2014), document types (Form 10-K), and page numbers (258 in 2022, 239 in 2024) match or are consistent with the expected data. No calculations were required. (3) Multi-hop reasoning is sound: the LLM correctly infers that the shift from passive exhibit listing to active description in Item 12 reflects increased transparency and governance rigor, which aligns with the ground truth’s interpretation of a move toward operational clarity and alignment with shareholder interests. (4) The only minor gap is that the LLM does not explicitly use the phrase 'unfunded accounts' or directly state the broader governance strategy of aligning with long-term shareholder interests as clearly as the original answer, though the implication is present in 'performance-linked deferral mechanism.' This slight omission in framing prevents a perfect 10 on qualitative accuracy, but the core reasoning and facts are intact. Overall, the answer is contextually precise, factually correct, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 413,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How has the positioning and associated risk profile of Costco's Kirkland Signature brand evolved between 2022 and 2023?",
      "original_answer": "In 2022, Costco emphasized the Kirkland Signature brand as a strategic asset, highlighting its high quality, competitive pricing, and contribution to higher margins. The company planned to continue increasing the sales penetration of these private-label items. However, by 2023, the risk disclosures included broader mentions of how supply chain disruptions, foreign exchange fluctuations, and catastrophic events could negatively impact the business—including private-label brands like Kirkland Signature. While the 2022 filing focused on growth and brand strength, the 2023 filing introduced a more risk-focused lens, indicating that the brand's expansion and reliance could expose Costco to greater operational and financial volatility.",
      "llm_answer": "In the 2022 Form 10‑K Costco explicitly positioned Kirkland Signature as a core private‑label differentiator – “high quality, offered at prices that are generally lower than national brands, and help lower costs, differentiate our merchandise offerings, and generally earn higher margins” – and said it expects to keep increasing the brand’s sales penetration【page_7】. By the 2023 filing, the company no longer restates that growth narrative; instead it groups Kirkland with its other brands in a broader risk discussion that warns “failure could lead to recalls and litigation and otherwise damage our reputation and our brands,” highlighting a more explicit exposure to product‑quality, recall and reputational risks for the brand【page_16】. This reflects a shift from emphasizing Kirkland’s strategic positioning to a greater focus on its associated brand‑risk profile.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the strategic positioning of Kirkland Signature in 2022 as a high-quality, cost-effective private-label brand that contributes to differentiation and higher margins, citing the exact language from the 10-K (e.g., 'high quality, offered at prices that are generally lower than national brands'). This matches the original answer's emphasis on growth and brand strength. In 2023, the LLM correctly notes a shift in tone, where risk disclosures now include Kirkland Signature in broader risk discussions around product recalls, litigation, and reputational damage—consistent with the ground truth's observation of increased focus on supply chain, FX, and operational risks. (2) There are no numeric values, percentages, or financial figures in either the question or answers, so quantitative accuracy is not applicable in a numerical sense; however, the years (2022 and 2023) are correctly referenced, satisfying temporal accuracy. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of 10-K filings, comparing shifts in narrative from growth-oriented to risk-aware, which is the core of the question. The only minor shortcoming is that the LLM does not explicitly mention 'supply chain disruptions' or 'foreign exchange fluctuations' as specific risks affecting Kirkland Signature in 2023—instead focusing on quality, recalls, and reputation. While this captures a key dimension of the risk evolution, it omits the broader macro/operational risks highlighted in the original answer, slightly reducing completeness. (4) Despite this omission, the LLM conveys the essential evolution in risk profile and strategic emphasis, maintaining semantic equivalence. The answer is contextually relevant, directly addressing how positioning and risk perception changed year-over-year. Hence, a correctness score of 9 is warranted—excellent accuracy with a minor gap in full risk factor coverage.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 542,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did COP's natural gas reserves in the Asia Pacific/Middle East region evolve from 2022 to 2024, and what were the key changes in terms of volume and sources of additions?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas reserves in the Asia Pacific/Middle East region. By 2024, this figure decreased slightly to 296 billion cubic feet. Over this period, the company experienced revisions and production activities that impacted reserves, with minimal extensions and discoveries contributing to the region. In 2024, there were no sales or significant reserve additions in this region, indicating a reduction in focus or activity compared to earlier years.",
      "llm_answer": "COP’s natural‑gas reserves in the Asia Pacific/Middle East fell from 326 billion cubic feet (BCF) at year‑end 2022 (322 BCF developed + 4 BCF undeveloped) to 312 BCF at year‑end 2023 (305 + 7) and to 296 BCF at year‑end 2024 (289 + 7), a net decline of roughly 30 BCF 【page_145】. The decrease was driven by a 33‑BCF drop in developed reserves (partly offset by a modest rise in undeveloped reserves) and resulted from a mix of factors: upward revisions from higher LNG prices, technical revisions and improved spot‑market dynamics; purchases of additional affiliate interests in Asia Pacific (2022); extensions and discoveries mainly in the Middle East (2022) and later in Australia (2023‑24); and offsetting sales of Indonesia assets and downward revisions due to lower prices and higher operating costs 【page_146】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2022 (326 BCF) and 2024 (296 BCF) reserve levels, matching the ground truth. However, it introduces a 2023 figure (312 BCF) not present in the original answer, which may be accurate but is not supported by the provided ground truth. The net decline of 30 BCF is consistent with the difference between 326 and 296. (2) The breakdown into developed and undeveloped reserves (e.g., 322 + 4 in 2022) is more detailed than the original answer but not contradicted by it; however, these subtotals are not in the ground truth and cannot be verified as correct from the given information. The claim of a 33-BCF drop in developed reserves lacks direct verification. (3) The LLM provides a more granular explanation of drivers—extensions and discoveries in the Middle East (2022) and Australia (2023–24), sales in Indonesia, price revisions, and affiliate purchases—which goes beyond the original answer’s general statement of 'revisions and production' and 'minimal extensions and discoveries.' While plausible and contextually reasonable, the original answer states 'no sales or significant reserve additions in 2024,' which contradicts the LLM’s implication of ongoing discoveries and purchases. This over-specification introduces potential inaccuracies. (4) Despite adding detail, the LLM captures the overall trend (slight decrease), correct start and end volumes, and plausible contributing factors. The quantitative accuracy is reduced due to unverifiable intermediate values and breakdowns. Qualitative reasoning is strong but slightly overreaches in specificity. Contextual relevance is excellent as it directly addresses the evolution and key changes. Correctness score is 7 due to core factual alignment with minor over-specification and unverified details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 492,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has FedEx's strategic relationship with the Boeing 767F evolved between 2022 and 2024, particularly in terms of fleet ownership and modernization focus?",
      "original_answer": "In 2022, FedEx directly owned 114 Boeing 767F aircraft, indicating a significant owned asset position in its fleet strategy. By 2024, while no updated ownership figures were disclosed, FedEx emphasized the Boeing 767-300 Freighter (B767F) as a key component of its aircraft modernization programs. The company described these aircraft as significantly more fuel-efficient per unit than older models and noted that expenditures for these aircraft are necessary for long-term operating savings and fleet replacement, with limited flexibility to delay purchases without incurring significant costs.",
      "llm_answer": "In 2022 FedEx owned a large base of 114 Boeing 767‑300 freighters and had pledged to buy another 38 of the type through 2025 (e.g., 14 in 2023, 14 in 2024, 10 in 2025)【page_40】. By 2024 the 767F remains a key element of FedEx’s aircraft‑modernization program—used to replace older, less efficient planes—but the new‑purchase pipeline has been scaled back to just 14 B767Fs slated for delivery in 2025‑2026, reflecting a shift from expanding ownership to a more targeted, efficiency‑focused upgrade【page_116】【page_117】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in numbers and unsupported claims not present in the ground truth. While it correctly states that FedEx owned 114 Boeing 767F aircraft in 2022 (matching the original answer), it introduces specific future purchase plans—38 additional aircraft with 14 in 2023, 14 in 2024, and 10 in 2025—that are not mentioned in the ground truth. The original answer states that no updated ownership figures were disclosed for 2024 and does not specify any delivery schedule or purchase commitments. The claim that only 14 B767Fs are slated for delivery in 2025–2026 and that the pipeline has been 'scaled back' implies a change in strategy not supported by the provided ground truth. (2) Quantitative accuracy is compromised because the LLM fabricates delivery timelines and quantities post-2022 without grounding in the original data. There is no mention in the ground truth of a 'pledge to buy 38' or any year-by-year breakdown, making these figures incorrect. (3) The qualitative reasoning partially captures the modernization focus, correctly identifying the B767F as a key component of fleet modernization and efficiency improvements. It also correctly frames the aircraft as replacing older models for fuel efficiency and long-term savings, aligning with the original answer’s emphasis. However, the inference of a strategic shift 'from expanding ownership to a more targeted upgrade' goes beyond the information provided; the ground truth does not indicate a change in ownership strategy, only a continued emphasis on modernization. (4) Contextual relevance is high because the answer addresses both fleet ownership and modernization focus as asked. Despite factual inaccuracies, it stays on-topic and attempts multi-hop synthesis. Correctness score is 6 due to correct baseline ownership number and correct thematic emphasis on modernization, but docked for significant fabrication of quantitative details and unsupported strategic interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 538,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How did Starbucks' involvement with roasted coffee evolve from 2022 to 2024 in terms of inventory value and production infrastructure?",
      "original_answer": "In 2022, Starbucks reported an inventory value of roasted coffee at $310.3 million, reflecting its role in holding roasted coffee as part of its merchandise. By 2024, the company had expanded its infrastructure dedicated to roasting, with facilities in York, PA; Minden, NV (Carson Valley); Kunshan, China; and Kent, WA, indicating a significant increase in its direct involvement in the roasting process. This represents a shift from primarily holding roasted coffee inventory to actively producing and distributing it at scale.",
      "llm_answer": "In the 2022 Form 10‑K Starbucks reported $310.3 million of roasted‑coffee inventory and net roasting equipment of $838.5 million. The 2024 filing does not disclose a roasted‑coffee inventory dollar amount, but it emphasizes that Starbucks still owns its roasting capacity, operating four major roasting and distribution sites (York, PA; Minden, NV; Kunshan, China; Kent, WA) that together comprise roughly 4.2 million sq ft of roasting‑related space, showing a continued (and possibly expanded) production infrastructure.",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2022 roasted coffee inventory value of $310.3 million, which matches the ground truth. However, the LLM introduces a figure not present in the original answer—'net roasting equipment of $838.5 million'—which is not mentioned in the ground truth and cannot be verified against it, raising concerns about factual accuracy. The 2024 roasted coffee inventory value is correctly noted as undisclosed, aligning with the original answer’s implication that no new inventory figure was provided. The LLM accurately lists the four roasting facilities (York, PA; Minden, NV; Kunshan, China; Kent, WA), matching the ground truth. It adds a specific detail—'4.2 million sq ft of roasting-related space'—which, while plausible, is not in the original answer and may represent over-specificity or unverified data. (2) The quantitative accuracy is mostly correct for the inventory value in 2022 and correctly acknowledges missing 2024 inventory data. However, the inclusion of unverified figures (equipment value, square footage) reduces confidence in numerical precision. (3) The multi-hop reasoning is sound: the model infers from infrastructure continuity and expansion that Starbucks maintains and possibly expanded its roasting involvement, which aligns with the ground truth’s interpretation of increased direct involvement. The synthesis between inventory data (2022) and infrastructure (2024) is logical and relevant. (4) The answer is contextually relevant and addresses both parts of the question—inventory value and production infrastructure—though it adds unsupported specifics. The core conclusion about Starbucks shifting toward greater production involvement is consistent with the original answer, even if some details exceed the ground truth. Minor deductions for unverified numbers and lack of explicit mention of the strategic shift described in the original answer.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 518,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How has PepsiCo's utilization of the 2.750% Senior Notes due 2025 evolved between 2023 and 2024, based on the specific debt instruments referenced in the filings?",
      "original_answer": "In 2023, the 2.750% Senior Notes due 2025 were listed among other notes in a Board of Directors Resolutions document that authorized officers to establish terms for several senior notes, including the 2.750% Senior Notes due 2025. By 2024, PepsiCo not only retained the 2.750% Senior Notes due 2025 in its list of authorized instruments but also introduced a new 2.750% Senior Notes due 2030. This indicates that PepsiCo extended its debt strategy involving this interest rate to a longer-term horizon, signaling a strategic evolution in its financing approach.",
      "llm_answer": "In the 2023 Form 10‑K PepsiCo disclosed a Board of Directors resolution (Exhibit 4.64, page 130) that **authorized the terms of the 2.750 % senior notes due 2025** as part of its debt‑issuance program. The 2024 Form 10‑K repeats the same resolution (Exhibit 4.64, page 130), showing the company still has those notes authorized but provides no additional issuance or change, indicating that the utilization of the 2.750 % senior notes due 2025 remained unchanged from 2023 to 2024.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 2.750% Senior Notes due 2025 and references accurate document details (Exhibit 4.64, page 130 in both 10-Ks), which aligns with the ground truth. The dates, percentages, and entities (PepsiCo, 2.750% Senior Notes due 2025) are factually correct, satisfying quantitative accuracy. (2) However, the LLM misses a key evolution highlighted in the original answer: the introduction of a new 2.750% Senior Notes due 2030 in 2024. This omission represents a failure in multi-hop reasoning and qualitative synthesis. The ground truth emphasizes that PepsiCo extended its use of the 2.750% rate to a longer-term instrument, signaling a strategic shift. The LLM incorrectly concludes that utilization 'remained unchanged,' which contradicts the strategic evolution described in the original answer. (3) The reasoning is flawed because it interprets continued authorization as lack of change, while the ground truth shows progression in debt strategy via the new 2030 note. The model fails to synthesize across both filings to detect the broader pattern of extending the same coupon rate to a longer maturity. (4) While the LLM provides accurate document references and correctly states that the 2025 notes remained authorized, it misses the critical strategic development, leading to a low qualitative accuracy and partial correctness score. Contextual relevance is high because the response stays on topic and cites relevant filing details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 410,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did FedEx's planned utilization of the B777F aircraft change from 2022 to 2024, and what does this indicate about its strategic role in the fleet?",
      "original_answer": "In 2022, FedEx planned to operate 4 B777F aircraft in 2024 and 2 in 2025. By 2024, the updated plan showed 2 B777F aircraft operating in 2025, with no further plans beyond that year. This indicates a reduction in the strategic emphasis on the B777F fleet, moving from a gradually decreasing role to a complete phase-out, suggesting a shift in aircraft preference or operational strategy.",
      "llm_answer": "In the 2022 Form 10‑K FedEx’s purchase commitments showed four Boeing 777 Freighters slated for delivery in 2024 (with two in 2023 and two in 2025)【page_114】. By the 2024 filing the plan had been cut to just two Boeing 777 Freighters, now expected in 2025 and with no further B777F deliveries thereafter【page_117】. Both filings stress that the B777F (along with the B767F) is a core element of FedEx’s fleet‑modernization program to boost fuel efficiency and replace older aircraft, so the type remains strategically important but on a reduced scale【page_113】【page_116】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the change in B777F aircraft plans from 2022 to 2024 filings, noting a reduction from 4 planned deliveries (with 2 in 2024 and 2 in 2025) to just 2 in 2025 and no further plans. This aligns with the ground truth, though the original answer specifies 4 for 2024 and 2 for 2025 in the 2022 plan, while the LLM says 2 in 2023, 2 in 2024, and 2 in 2025 — introducing an incorrect 2023 delivery not in the ground truth. This minor error affects quantitative accuracy. (2) The numbers are mostly correct but not fully consistent: the 2022 plan in the ground truth only mentions 4 in 2024 and 2 in 2025, with no 2023 deliveries. The LLM incorrectly adds 2 in 2023, which is not supported by the ground truth, making the quantitative timeline inaccurate. The 2024 filing update (only 2 in 2025, none beyond) is correctly reported. (3) The multi-hop reasoning is sound — the model compares the 2022 and 2024 filings to show a reduction in B777F commitments and infers a strategic shift. However, the conclusion that the aircraft 'remains strategically important' contrasts with the ground truth’s interpretation of a 'complete phase-out' and reduced strategic emphasis. This difference in qualitative interpretation lowers the qualitative accuracy. (4) The contextual relevance is high — the answer addresses both parts of the question: the change in utilization plans and the strategic implication. While the strategic interpretation is plausible and supported by cited pages, it diverges from the ground truth’s stronger conclusion of a phase-out. Overall, the answer is factually close but contains a timeline error and a softer strategic assessment than the ground truth, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1240,
        "completion_tokens": 476,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How did Starbucks' foreign currency - other derivative liabilities and their impact on net gains/(losses) included in AOCI evolve from 2022 to 2024, and what does this indicate about the company's exposure to foreign currency fluctuations?",
      "original_answer": "In 2022, Starbucks reported foreign currency - other derivative liabilities of $0.3 million under accrued liabilities, while in 2024, the net gains included in AOCI related to foreign currency - other were $11.5 million. This indicates a significant shift from a minimal liability position in 2022 to a more substantial unrealized gain in 2024, suggesting increased exposure to or hedging of foreign currency fluctuations.",
      "llm_answer": "Starbucks’ designated “foreign‑currency‑other” derivative liabilities grew from a modest $0.3 million accrued liability in FY 2022 (page 68) to $8.8 million in FY 2024 (combined $4.7 million accrued + $4.1 million long‑term on page 72).  At the same time, the unrealized gain on those hedges recorded in AOCI fell sharply from $55.3 million in 2022 (page 66) to $11.5 million in 2024 (page 70).  The larger liability shows Starbucks expanded its hedging program, while the much smaller AOCI gain indicates the hedges are now offsetting currency movements more effectively, suggesting a more controlled exposure to foreign‑currency fluctuations.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that in 2022, Starbucks had foreign currency - other derivative liabilities of $0.3 million, and in 2024, the net gains in AOCI were $11.5 million. However, the LLM claims that derivative liabilities were $8.8 million in 2024 (split between accrued and long-term), which is not supported by the ground truth. The ground truth does not mention any liability amount for 2024, only the AOCI gain. Additionally, the LLM incorrectly states that AOCI gains were $55.3 million in 2022, which is entirely fabricated and contradicts the ground truth, which does not provide any AOCI gain figure for 2022—only for 2024. (2) The quantitative inaccuracies are severe: the $55.3 million AOCI gain in 2022 and the $8.8 million liability in 2024 are not in the original answer and cannot be verified from the provided truth. The only correct number is the $11.5 million AOCI gain in 2024. The $0.3 million liability in 2022 is correctly cited. (3) The reasoning is partially sound in interpreting that changes in liabilities and AOCI gains reflect hedging activity and exposure management, but it is based on incorrect data. The conclusion that 'hedges are now offsetting currency movements more effectively' is speculative and not supported by the ground truth, which only notes increased exposure or hedging activity due to the shift from a small liability to a large unrealized gain. (4) The contextual relevance is high because the answer addresses the evolution of liabilities and AOCI impact and attempts to interpret foreign currency exposure. However, due to major factual and numerical errors, the correctness and quantitative accuracy scores are low. The qualitative reasoning is somewhat logical but built on false premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 493,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has PepsiCo's engagement with the 2.625% Senior Notes due 2026 evolved between 2023 and 2024, particularly in terms of its broader debt instrument disclosures?",
      "original_answer": "In 2023, the 2.625% Senior Notes due 2026 were listed among other notes in a section that included Board of Directors Resolutions authorizing officers to establish terms for various senior notes. By 2024, PepsiCo not only retained the 2.625% Senior Notes due 2026 in its disclosures but also introduced a significantly expanded list of senior notes, including newer maturities such as the 3.000% Senior Notes due 2027 and the 2.625% Senior Notes due 2029. This indicates a broader and more diversified set of debt instruments, suggesting an active capital markets strategy involving the issuance of notes with different maturities and rates.",
      "llm_answer": "In the 2023 Form 10‑K PepsiCo disclosed a Board of Directors resolution (Item 4.65) authorizing the terms of the 2.625 % Senior Notes due 2026 alongside a handful of other new senior notes【page_129】. By the 2024 Form 10‑K the same note appears again in a much longer Board resolution (Item 4.64) that lists the 2.625 % Senior Notes due 2026 together with a far broader slate of senior‑note issuances and other debt securities, indicating that PepsiCo’s engagement with this issue has continued and is now presented within a more comprehensive debt‑instrument disclosure【page_130】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 2.625% Senior Notes due 2026 were disclosed in both 2023 and 2024 filings; in 2023, they were part of a Board resolution (Item 4.65) authorizing terms, and in 2024, they reappeared in a broader resolution (Item 4.64) alongside many other notes. The percentages (2.625%), maturities (2026), and document types (Form 10-K) are all accurate. (2) Quantitative elements—interest rate (2.625%), maturity year (2026), and item numbers (4.65, 4.64)—are correctly reported. No calculations are required, but the temporal comparison is handled precisely. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of disclosures, identifying continuity in the treatment of the 2026 notes and the expansion of debt instruments in 2024. While the LLM does not explicitly name the new notes (e.g., 3.000% due 2027 or 2.625% due 2029) as the original answer does, it accurately captures the broader context—'a far broader slate of senior-note issuances'—which conveys the same qualitative evolution. (4) The answer is contextually excellent, directly addressing how PepsiCo’s engagement evolved and linking it to more comprehensive disclosure practices. The only minor shortcoming is the lack of specific examples of new notes introduced in 2024, which slightly reduces completeness but does not undermine the core correctness. Hence, a score of 9 is warranted for overall correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 434,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How has Cisco's exposure to and reliance on overcoming technical hurdles evolved from 2022 to 2024, particularly in relation to its strategic investments and product development timelines?",
      "original_answer": "In 2022, Cisco acknowledged facing technical hurdles that could delay successful execution of its vision, especially in areas like product planning, timing, and resource allocation, which could lead to loss of market share and earnings. By 2024, the company's exposure to technical hurdles had transformed into a more specific dependency on overcoming these challenges in a timely manner to maintain competitive advantage, particularly in delivering complex software subscription offerings and introducing new technologies such as those related to artificial intelligence, security, observability, and cloud. The 2024 disclosures emphasize that failure to overcome these hurdles could not only result in loss of market share but also reputational damage, legal liability, and reduced customer retention. This represents a shift from internal execution risk to a broader operational and strategic dependency.",
      "llm_answer": "In the 2022 filing Cisco warned that “technical hurdles that we fail to overcome in a timely fashion” could delay product introductions, hurt its strategic alliances and erode market share [2022 p. 25]; the risk was framed largely as a generic threat to product‑planning and timing. By the 2024 filing the same language reappears [2024 p. 20] but is now tied directly to much larger, software‑driven strategic bets—AI, cloud, cybersecurity, the shift to subscription‑based software and the integration of acquisitions such as Splunk [2024 p. 21]—so Cisco’s reliance on overcoming technical hurdles has grown, making timely resolution of those challenges a key determinant of its product‑development timelines and the payoff from its strategic investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Cisco's 2022 risk disclosure focused on technical hurdles affecting product planning, timing, and market share, and by 2024 this evolved into a more strategic dependency tied to AI, cloud, cybersecurity, subscription software, and acquisitions like Splunk. The LLM correctly identifies the continuity of language across years and the increased strategic weight in 2024. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable beyond correct year references (2022, 2024), which are accurate. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, identifies the evolution in risk framing, and links it to strategic investments and product development timelines. It correctly infers increased reliance on overcoming technical hurdles due to larger software-driven bets. (4) The only minor shortcoming is that the LLM does not explicitly mention the expanded consequences in 2024—such as reputational damage, legal liability, and reduced customer retention—which are present in the original answer. This omission slightly reduces completeness but does not undermine the core correctness. Overall, the answer is semantically equivalent in intent and substance, with excellent contextual relevance and strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1426,
        "completion_tokens": 405,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did the role of Google Ad Manager in driving Google Network revenues change between 2022 and 2023, based on the specific mentions of its performance and positioning across those years?",
      "original_answer": "In 2022, Google Ad Manager was explicitly cited as one of the key drivers behind the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense. By 2023, while Google Ad Manager remained a core advertising platform used by customers, it was listed among several platforms (including Google Ads, Display & Video 360, and the Marketing Platform) without specific attribution to revenue growth. This indicates a shift from being a standout growth contributor in 2022 to being part of a broader suite of advertising tools in 2023, suggesting a more integrated but less singularly emphasized role.",
      "llm_answer": "In the 2022 Form 10‑K the filing notes that “Google Network revenues increased $8.6 billion … The growth was primarily driven by strength in AdMob, **Google Ad Manager**, and AdSense” (2022 p. 35). By the 2023 filing, Google Ad Manager is mentioned only as one of the tools customers use to purchase ad inventory and as part of the Google Network properties (“Our customers generally purchase advertising inventory through Google Ads, **Google Ad Manager**, …” and “Google Network properties … participating in AdMob, AdSense, and **Google Ad Manager**”) (2023 p. 57‑58), without the explicit claim that it was a key growth driver. Thus, its role shifted from being highlighted as a primary growth engine in 2022 to being positioned as a supporting platform for buying ads in 2023.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) It correctly identifies that in 2022, Google Ad Manager was explicitly cited as a key driver of the $8.6 billion year-over-year increase in Google Network revenues, alongside AdMob and AdSense, with a direct quote and page reference from the 2022 10-K. (2) For 2023, it accurately notes that Google Ad Manager was no longer highlighted as a growth driver but was instead mentioned as part of the suite of tools (e.g., Google Ads, Display & Video 360) used to purchase ad inventory, with supporting quotes and page references from the 2023 filing. (3) The multi-hop reasoning is sound: it synthesizes information across two years of SEC filings, compares the change in narrative tone and positioning of Google Ad Manager, and correctly infers a shift from a 'primary growth engine' to a 'supporting platform.' (4) All entities (Google Ad Manager, AdMob, AdSense, Google Ads, Display & Video 360, Google Network) and years (2022 vs 2023) are correctly identified. The $8.6 billion figure is accurately reported. There are no factual errors, omissions, or misinterpretations. The answer is semantically equivalent to the original, with clear, concise, and well-supported reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 352,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How did Starbucks' derivative liabilities related to foreign currency - other evolve from 2022 to 2024, and what was the magnitude of change?",
      "original_answer": "In 2022, Starbucks reported derivative liabilities related to foreign currency - other at $0.3 million under accrued liabilities. By 2024, this amount had increased to $4.7 million under the same category. This indicates a significant increase in the company's liabilities tied to foreign currency derivatives over the two-year period.",
      "llm_answer": "Starbucks’ derivative liabilities for the “foreign currency – other” hedge rose sharply – they were only **$0.3 million** (accrued liability) at Oct 2 2022, but by Sep 29 2024 the balance had grown to **$4.7 million** in accrued liabilities plus **$4.1 million** in other‑long‑term liabilities, or **$8.8 million** in total. That represents an increase of roughly **$8.5 million** over the two‑year period.【page_68】【page_72】",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly identifies the 2022 derivative liability amount ($0.3 million) and the 2024 accrued liabilities amount ($4.7 million), it incorrectly adds an additional $4.1 million from 'other-long-term liabilities', claiming a total of $8.8 million in 2024. The ground truth states that the 2024 amount is $4.7 million under accrued liabilities only, with no mention of an additional $4.1 million in long-term liabilities for this category. This leads to a grossly inflated total and an incorrect change of $8.5 million instead of the correct increase of $4.4 million ($4.7M - $0.3M). (2) The dates are approximately correct (Oct 2, 2022, and Sep 29, 2024), aligning with Starbucks' fiscal year-ends, and the $0.3M and $4.7M figures for the respective years are accurate. However, the addition of $4.1 million from another liability category is unsupported by the ground truth and represents a critical error in quantitative accuracy. (3) The multi-hop reasoning fails because the model incorrectly synthesizes data by combining two different liability line items, possibly misinterpreting the structure of the balance sheet. The question asks specifically about 'derivative liabilities related to foreign currency - other', and the LLM conflates this with another category, breaking the logical chain. (4) Despite the incorrect total and change magnitude, the answer does recognize the upward trend and provides correct values for the starting point and part of the endpoint, which preserves some qualitative and contextual relevance. Hence, partial credit is given for identifying the correct direction and some correct data points, but major deductions are made for factual and computational errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1188,
        "completion_tokens": 483,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How has PepsiCo's issuance of the 4.600% Senior Notes due 2045 evolved between 2023 and 2024, and what does this indicate about the company's debt structure strategy?",
      "original_answer": "In 2023, the 4.600% Senior Notes due 2045 were listed among other senior notes in the Board of Directors Resolutions that authorized PepsiCo's officers to establish terms for various notes, including the 4.600% Senior Notes due 2045. By 2024, the 4.600% Senior Notes due 2045 remained part of the company's debt structure, but were now referenced alongside a broader range of newly introduced senior notes, such as the 4.000% Senior Notes due 2047 and Floating Rate Notes due 2026. This indicates that while the 4.600% Senior Notes due 2045 remained a part of PepsiCo's long-term debt strategy, the company expanded its debt portfolio with additional instruments, suggesting a more diversified approach to long-term financing in 2024.",
      "llm_answer": "PepsiCo only began to move forward with the 4.600 % Senior Notes due 2045 in its 2023 filing – the 2023 10‑K lists a Board resolution authorizing those notes (see PEP 10‑K 2023 p. 129, item 4.65). By the 2024 filing the series no longer appears among the newly‑authorized or listed notes (the 2024 exhibit list on pages 128‑131 shows other senior notes but no 4.600 % due 2045), indicating that the issuance was completed in 2023 and is now part of the existing debt pool. This suggests PepsiCo’s strategy is to lock in long‑dated, moderate‑rate financing and then shift focus to newer issuances, diversifying its maturity profile while maintaining a stable, long‑term debt structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding the status of the 4.600% Senior Notes due 2045 in 2024. Contrary to the ground truth, which states that these notes remained part of PepsiCo's debt structure in 2024 and were referenced alongside new notes, the LLM incorrectly claims the series 'no longer appears' in the 2024 filing and implies the issuance was completed and removed from active listing. This misrepresents the evolution of the debt instrument. (2) Quantitatively, the percentage (4.600%) and maturity year (2045) are correct, as is the mention of Board authorization in 2023. However, the claim that the note 'no longer appears' in the 2024 exhibit list is factually incorrect per the ground truth, which confirms its continued presence in the debt structure. No calculations are involved, so numerical accuracy is partially met. (3) The multi-hop reasoning is flawed: while the LLM attempts to infer strategy from document changes, it draws an incorrect conclusion due to misreading the 2024 data. The ground truth shows PepsiCo maintained the 4.600% notes and added new ones, indicating diversification; the LLM instead suggests retirement or completion of issuance, which is unsupported. (4) Contextual relevance is high—the answer addresses the question's focus on evolution and strategy—but correctness suffers from key factual errors in entity status over time. Thus, while the strategic interpretation (diversifying maturity profile) has some alignment, it is based on incorrect premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 425,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has COP's natural gas position in the Asia Pacific/Middle East region evolved between 2022 and 2024, and what does this indicate about its strategic focus in the region?",
      "original_answer": "In 2022, COP reported 326 billion cubic feet of natural gas in the Asia Pacific/Middle East region. By 2024, this figure had decreased slightly to 296 billion cubic feet. This indicates a minor reduction in natural gas reserves in the region over the two-year period. The decline, although modest, suggests a potential shift in strategic focus, possibly due to market dynamics or operational adjustments in the region.",
      "llm_answer": "COP’s direct gas reserves in the Asia Pacific/Middle East fell – developed reserves dropped from 326 BCF at year‑end 2022 to 296 BCF at year‑end 2024, while undeveloped reserves rose only from 4 BCF to 7 BCF (total regional gas fell from ~330 BCF to ~303 BCF)【page_145】.  At the same time, the company’s equity‑affiliate gas holdings – all located in that region – grew from 5,753 BCF to 5,870 BCF, delivering a modest net increase of about 90 BCF for the region【page_145】.  The 2024 filing notes that this growth came from purchases of additional affiliate interests and extensions/discoveries in equity affiliates in the Middle East and Australia, indicating ConocoPhillips is emphasizing partnership‑driven expansion in Asia Pacific/Middle East rather than building a larger direct‑development gas base【page_146】.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces data not present in the original ground truth, particularly regarding undeveloped reserves (4 BCF to 7 BCF), equity-affiliate holdings (5,753 BCF to 5,870 BCF), and a net regional increase of 90 BCF. These figures are absent from the ground truth and contradict its conclusion of a modest decline. The direct reserve numbers (326 BCF in 2022, 296 BCF in 2024) match the original answer and are correct. However, the LLM’s synthesis leads to a conflicting overall narrative—claiming a net increase and strategic emphasis on partnerships—whereas the ground truth indicates a decline and possible strategic shift without specifying partnership focus. (2) The core numbers for developed reserves are accurate and correctly cited across years. But the additional figures (undeveloped, equity affiliates, total regional ~330 to ~303 BCF) lack corroboration in the ground truth and introduce quantitative inaccuracies by implication. The calculation of a 90 BCF net increase cannot be verified and appears speculative. (3) The multi-hop reasoning is internally logical but based on extraneous data. The LLM attempts sophisticated synthesis—linking affiliate growth to strategic focus—but this reasoning chain is unsupported by the provided ground truth, which makes no mention of equity affiliates or partnership-driven strategy. Thus, the reasoning, while plausible, is not grounded in the evidence given. (4) Contextual relevance is high because the answer addresses the evolution of COP’s gas position and infers strategic implications. However, correctness is significantly compromised by the inclusion of unverified data, leading to a misleading conclusion that contradicts the ground truth’s indication of a reduction in reserves and potential strategic pullback. A score of 4 reflects partial factual accuracy with major errors in data sourcing and interpretation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 515,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has Google Play's role in Google's non-advertising revenue strategy evolved from 2022 to 2023, based on the specific revenue sources mentioned in the filings?",
      "original_answer": "In 2022, Google Play was specifically mentioned as generating revenues from 'sales of apps and in-app purchases and digital content sold in the Google Play store.' By 2023, Google Play's revenue focus had evolved to be more narrowly described as primarily coming from 'apps and in-app purchases,' and it was grouped under the broader category of 'platforms' within non-advertising revenue sources. This indicates a shift in emphasis toward core app-based monetization within Google's strategic narrative around Play.",
      "llm_answer": "In the 2022 Form 10‑K (see page 7) Google Play is called out as a separate non‑advertising revenue pillar – “Google Play generates revenues from sales of apps **and in‑app purchases and digital content** sold in the Google Play store.” By the 2023 filing (see page 8) Google Play is no longer a stand‑alone line; it is grouped under a broader “platforms” category and is described only as generating revenue “from the **sales of apps and in‑app purchases**” (digital content is no longer mentioned). Thus, Google Play’s role has shifted from a distinct revenue stream to a component of a larger platform segment, with its revenue sources narrowed to apps and in‑app purchases.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately reflects the evolution of Google Play's role in Google's non-advertising revenue strategy from 2022 to 2023. In 2022, Google Play was a distinct revenue stream with revenue from 'sales of apps and in-app purchases and digital content,' as correctly cited from the 2022 10-K. By 2023, the description narrows to 'sales of apps and in-app purchases,' omitting 'digital content,' and Play is grouped under the broader 'platforms' category—this shift is precisely captured. (2) There are no numerical values requiring calculation, but the years (2022, 2023), document types (Form 10-K), and page references (page 7, page 8) are correctly cited and consistent with the source context. (3) The multi-hop reasoning is sound: the model correctly synthesizes changes across two years of filings, identifying both the reclassification (from standalone to part of 'platforms') and the narrowing of revenue description. (4) The semantic meaning is equivalent to the original answer, with added precision (e.g., page numbers, exact phrasing). No factual inaccuracies, omissions, or misinterpretations are present. All scores are 10.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 340,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has the projected utilization of the Cessna SkyCourier 408 evolved from 2022 to 2024, and what does this indicate about FedEx's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FedEx projected the Cessna SkyCourier 408 to have a total of 49 aircraft in operation across the years 2023 to thereafter. By 2024, this projection was reduced to a total of 31 aircraft for the years 2025 through 2029. However, in the 2024 report, the relationship to the Cessna SkyCourier 408 shifted from 'Increases' to 'Depends_On', indicating a change in strategic importance. This suggests a moderated but still significant reliance on the aircraft model over time.",
      "llm_answer": "In the 2022 10‑K FedEx expected to acquire 49 Cessna SkyCourier 408s, with deliveries beginning in 2023 (11 aircraft) and 2024 (12 aircraft) and continuing through 2026 (14 aircraft)【page_114】. By the 2024 10‑K the outlook was trimmed to only 31 SkyCourier 408s, all slated for delivery in 2025 (17) and 2026 (14)【page_117】. The reduction in total units and the shift of deliveries to later years shows FedEx is scaling back its reliance on the SkyCourier, making the model a more modest component of its future fleet strategy.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the reduction in projected aircraft from 49 in the 2022 report to 31 in the 2024 report, aligning with the ground truth. It accurately notes the shift in delivery timeline to later years (2025 and 2026), though the original answer specifies the projection now covers 2025–2029, which the LLM omits. The LLM adds specific annual delivery numbers (e.g., 17 in 2025, 14 in 2026) not present in the ground truth, which may be from the cited document but are not confirmed by the original answer. (2) Quantitatively, the key numbers (49 → 31 total aircraft) are correct. The breakdown of deliveries by year (11 in 2023, 12 in 2024, 14 in 2026) appears consistent with the cited page 114, but the 2024 report’s 31-aircraft split (17+14) sums correctly. However, the original answer does not include these annual figures, so their inclusion is supplemental but not erroneous. (3) The reasoning is sound: the LLM correctly infers that the reduced fleet size and delayed deliveries indicate a scaled-back reliance. However, it misses the critical qualitative shift in relationship type from 'Increases' to 'Depends_On' mentioned in the original answer, which is a key indicator of strategic change. This omission affects the depth of strategic interpretation. (4) The answer is highly relevant and factually accurate on core metrics, but lacks full completeness on the strategic relationship shift, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 409,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How has AIG's use of expected loss ratio methods evolved between 2022 and 2023, particularly in terms of segmentation and the types of casualty lines analyzed?",
      "original_answer": "In 2022, AIG used expected loss ratio methods primarily for the three latest accident years in the U.S. Excess Casualty line, segmenting analysis by attachment point and further differentiating between automobile and non-automobile claims, including special treatment for latent exposures like construction defects and mass torts. In 2023, AIG continued to apply expected loss ratio methods but shifted focus to U.S. Workers' Compensation, where the company grouped business by risk-sharing features such as high deductibles and retrospective rating, and analyzed separately by state, industry, and claim handling entity. The increase in large deductible business also affected the reporting pattern of claims, indicating a broader application context for the method. This reflects a strategic evolution in where and how expected loss ratio methods are applied across different casualty lines.",
      "llm_answer": "In the 2022 filing AIG said it “generally use[s] a combination of loss‑development methods and **expected‑loss‑ratio methods for excess casualty product lines**” and **segments the analysis between automobile‑related claims and non‑automobile claims**, further breaking out non‑automobile exposures such as **construction‑defect and mass‑tort claims** and then **segregating by attachment‑point bands and a $10 million loss cap** (see page 263). By contrast, the 2023 filing describes the expected‑loss‑ratio approach more broadly – it is applied to **business written in excess of a deductible** and given significant weight for the **most recent five accident years**, but the disclosure no longer spells out the automobile vs. non‑automobile or latent‑exposure segmentation used previously (see page 200). Thus, AIG’s use of expected‑loss‑ratio methods has shifted from a detailed, line‑by‑line segmentation in 2022 to a more generalized, deductible‑focused application in 2023.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant inaccuracies in the evolution of AIG's use of expected loss ratio methods between 2022 and 2023. (1) Correctly identifies that in 2022, AIG used expected loss ratio methods for excess casualty lines, segmented by automobile vs. non-automobile claims, and included special treatment for latent exposures like construction defects and mass torts. It also correctly notes segmentation by attachment point, aligning with the ground truth. (2) However, the LLM incorrectly states that in 2023, the method was applied to 'business written in excess of a deductible' and emphasizes a shift to a 'deductible-focused application.' The ground truth specifies that in 2023, AIG shifted focus to U.S. Workers' Compensation—not excess deductible business broadly—and segmented analysis by risk-sharing features such as high deductibles and retrospective rating, as well as by state, industry, and claim handling entity. The LLM answer misses this key shift in *casualty line* (from Excess Casualty to Workers' Compensation), which is central to the question. (3) The LLM claims the 2023 approach gives 'significant weight for the most recent five accident years,' but the ground truth does not mention a change in accident year scope (2022 focused on three latest years; 2023 does not specify a number). This introduces unsupported quantitative detail. (4) The reasoning is partially sound in identifying a shift in segmentation approach, but fails the multi-hop synthesis by not correctly identifying the change in casualty line focus, which is critical to answering how the method evolved. (5) While the answer is contextually relevant and well-structured, it substitutes the actual evolution (shift in casualty line and new segmentation dimensions) with an incorrect narrative centered on deductibles. Thus, despite some factual alignment in 2022 description, the 2023 characterization is materially inaccurate, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 539,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did the classification and reporting of unallocated products evolve between fiscal years 2022 and 2024, particularly in terms of how they are categorized within Nike's consumer construct?",
      "original_answer": "In fiscal year 2022, unisex products were classified within Men's, and certain products not allocated to Men's, Women's, NIKE Kids', and Jordan Brand were included in 'Others' with adjustments not allocated by consumer. By fiscal year 2024, 'Others' continued to include products not allocated to Men's, Women's, Kids', and Jordan Brand, but there was no specific mention of unisex product classification within Men's, suggesting a potential shift or integration of unisex products within broader categories.",
      "llm_answer": "In fiscal 2022 Nike reorganized around a new consumer construct of Men’s, Women’s, Kids’ and Jordan Brand, moving unisex items into the Men’s segment and reporting any products that could not be placed in those categories in an “Others” line 【page_35†L31-L38】. By fiscal 2024 the same construct is still used, and “Others” is again defined as products not allocated to Men’s, Women’s, Kids’ or Jordan Brand, indicating that unallocated products continue to be captured in the “Others” category after the 2022 re‑classification 【page_37†L31-L38】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies the fiscal 2022 reorganization of Nike's consumer construct into Men’s, Women’s, Kids’, and Jordan Brand, and accurately states that unisex items were moved into the Men’s segment at that time. It also correctly notes that unallocated products were reported in an 'Others' category. For fiscal 2024, the answer correctly observes that the same consumer construct is maintained and that 'Others' continues to include products not allocated to the main segments. The only minor shortcoming is that the LLM does not explicitly note the absence of specific mention about unisex product classification in 2024 (i.e., no longer explicitly stated as being included in Men's), which implies a potential shift or integration not directly addressed. However, this nuance is subtle and does not undermine the overall correctness. All entities (Nike, fiscal years 2022 and 2024, consumer segments) are accurate, and the reasoning across years is sound. Quantitative elements (years, category names) are correct. The answer is contextually fully relevant and semantically equivalent to the original, with only slight omission of interpretive detail regarding unisex product evolution post-2022.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 356,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How did PepsiCo's engagement with the 3.500% Senior Notes due 2025 evolve between 2023 and 2024, and what does this indicate about the company's debt management strategy?",
      "original_answer": "In 2023, PepsiCo's 3.500% Senior Notes due 2025 were listed among other notes, indicating they were part of the company's existing debt structure. By 2024, the 3.500% Senior Notes due 2025 were still present, but they were now accompanied by a broader range of new notes, including longer-term instruments such as the 3.500% Senior Notes due 2040 and the 3.550% Senior Notes due 2034. This suggests that PepsiCo expanded its debt portfolio in 2024, introducing more long-term financing options while maintaining its commitment to the 3.500% Senior Notes due 2025. The addition of new notes indicates a strategic shift toward diversifying its debt maturity structure.",
      "llm_answer": "In the 2023 Form 10‑K PepsiCo disclosed a board‑of‑directors resolution authorizing the terms of a new 3.500 % senior note that would mature in 2025 (2023 10‑K, p. 130). The 2024 Form 10‑K lists the same resolution again, keeping the 3.500 % senior notes due 2025 on its financing slate (2024 10‑K, p. 129). This continuity shows that PepsiCo is maintaining a pipeline of medium‑term, fixed‑rate debt, reflecting a deliberate strategy to diversify and manage its capital structure by regularly authorizing and potentially issuing such notes.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but diverges significantly from the ground truth in key aspects. (1) Quantitatively, the 3.500% Senior Notes due 2025 and their presence in both 2023 and 2024 filings are correctly identified, and the years and percentages match the ground truth. However, the LLM incorrectly frames the 2023 disclosure as the authorization of a *new* note, whereas the ground truth indicates these notes were already part of the existing debt structure, not newly issued. This misrepresents the nature of the engagement. (2) The ground truth emphasizes that in 2024, PepsiCo introduced *new* long-term notes (e.g., due 2034 and 2040), signaling a strategic diversification of maturities. The LLM answer omits this critical multi-hop insight entirely and instead focuses on the reiteration of the 2025 notes as evidence of a 'pipeline' of medium-term debt, which is not supported by the original answer. (3) The reasoning is flawed: the continuity of mentioning the 2025 notes does not imply an active issuance pipeline but rather their ongoing status as outstanding debt. The strategic shift toward diversification with longer-term instruments is missed, undermining the qualitative accuracy. (4) While the answer is contextually relevant and addresses debt management strategy, it fails to capture the core evolution—expansion and maturity diversification—described in the ground truth. Thus, the correctness score is reduced due to significant omissions and misinterpretation of the strategic implication, despite accurate dates and percentages.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 430,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did COP's financial disclosures regarding the Lower 48 region evolve between 2022 and 2024, particularly in terms of capital expenditures and future cash inflow revisions?",
      "original_answer": "In 2022, COP reported capital expenditures for the Lower 48 region at $3,129 million, indicating significant active investment in the area. By 2024, the company disclosed that certain amounts in the Lower 48 had been revised to reflect additional future cash inflows and future production costs, although no new capital expenditure figure was provided. This shift suggests a transition from active investment to a focus on revising financial projections based on updated expectations for production and cost dynamics in the region.",
      "llm_answer": "In the 2022 filing ConocoPhillips disclosed roughly **$6.3 billion** of capital expenditures for the Lower 48 and projected **future cash inflows of about $195 billion** from that region. By the 2024 filing, the company reported **nearly $30 billion** of Lower 48 capital spending (property acquisitions, exploration and development) and revised the Lower 48’s future cash‑inflow estimate down to **about $164 billion**, a reduction of roughly $31 billion. (Capital‑expenditure figures: 2022 $6,341 M and 2024 $29,952 M – page 157; Future‑cash‑inflow figures: 2022 $195,605 M and 2024 $164,264 M – page 158.)",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) Quantitative Accuracy: The original answer states that COP's 2022 capital expenditures for the Lower 48 were $3,129 million, but the LLM claims $6.3 billion (or $6,341 million), which is more than double the correct amount. This is a major discrepancy. Additionally, the LLM asserts that 2024 capital expenditures were nearly $30 billion ($29,952 million), but the original answer explicitly states that no new capital expenditure figure was provided for 2024—this is a complete fabrication. Regarding future cash inflows, the LLM cites specific figures of $195 billion in 2022 and $164 billion in 2024, with a $31 billion downward revision. However, the original answer does not mention any specific cash inflow numbers or a downward revision; instead, it states that revisions occurred to reflect additional future cash inflows and production costs, implying an upward or neutral adjustment, not a reduction. Thus, both key numerical claims and the direction of change are incorrect. (2) Completeness: While the LLM attempts to address capital expenditures and future cash inflows over time, it fails to accurately represent the evolution described in the ground truth—specifically, the shift from reporting capex in 2022 to revising projections without new capex data in 2024. (3) Entity Accuracy: The company (COP/ConocoPhillips) and region (Lower 48) are correct, as are the years referenced (2022–2024). (4) Reasoning: The multi-hop reasoning is flawed because the LLM invents comparable capex figures for 2024 when none were disclosed, and mischaracterizes the nature of the financial revisions (downward vs. unspecified direction). It also introduces page numbers and precise figures not present in the ground truth, suggesting hallucination. (5) Semantic Equivalence: The overall message contradicts the original—portraying increased spending and reduced inflows rather than a shift from investment to projection refinement. Despite addressing the right topic and structure, the answer is factually unsound on core metrics.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 565,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did Comcast's financial commitments and governance arrangements with Atairos Group evolve between 2023 and 2024, particularly regarding capital obligations and control structures?",
      "original_answer": "In 2023, Comcast had a Fourth Amended and Restated Shareholders Agreement with Atairos Group, Inc., which was further amended in June 2023. This agreement outlined Comcast's role as the sole third-party investor and included governance terms among Atairos-related entities. By 2024, the relationship evolved into a more formalized investment framework under the equity method accounting. In this framework, Comcast reduced its capital commitment from up to $5 billion to $4.5 billion, limited annual capital calls to $400 million, and agreed to separately fund $40 million annually for management fees. Additionally, the 2024 filing clarified that Comcast absorbs approximately 99% of Atairos’ losses and receives approximately 86% of residual returns, while Atairos’ management companies (led by Comcast’s former CFO) retained all voting rights. These changes reflect a recalibration of financial exposure and a clearer delineation of control.",
      "llm_answer": "In 2023 Comcast’s relationship with Atairos was set out in the Fourth Amended and Restated Shareholders Agreement and its June 2 2023 amendment (see 2023 exhibit list, p. 100), which capped the aggregate capital commitment at $4.5 billion (down from $5 billion), limited annual calls to $400 million and added a $40 million management‑fee commitment (see p. 84), while voting control remained with Atairos’s management. By 2024 Comcast concluded Atairos is a variable‑interest entity, that it has no voting rights or power to direct Atairos (only consent rights) and therefore does not consolidate it, limiting its exposure to the $5.1 billion equity investment plus an unfunded $1.4 billion capital commitment, with cash contributions falling to $73 million in 2024 from $145 million in 2023 (see p. 85).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant factual discrepancies in key financial commitments and control structures. (1) Quantitatively, the LLM incorrectly states that the $4.5 billion capital commitment cap was already in place in 2023, while the ground truth indicates this reduction occurred in 2024. The $400 million annual capital call and $40 million management fee are correctly mentioned but misattributed to 2023 rather than 2024. The LLM introduces a $5.1 billion equity investment and $1.4 billion unfunded commitment not present in the original answer, which undermines quantitative accuracy. Cash contribution figures ($73M in 2024 vs $145M in 2023) are specific but not corroborated by the ground truth and appear to conflate different reporting. (2) The date of the June 2023 amendment is correctly cited, but the LLM misrepresents its content by including the $4.5B cap and fee commitment, which the ground truth assigns to the 2024 evolution. (3) Qualitatively, the LLM contradicts the ground truth on control: while the original answer states Comcast absorbs 99% of losses and 86% of returns (indicating significant economic control), the LLM claims Comcast has no power to direct Atairos and only consent rights, leading to non-consolidation—this is a critical reasoning failure in interpreting variable interest entity (VIE) conclusions. The mention of Comcast’s former CFO leading management companies is omitted, weakening entity and governance accuracy. (4) Contextually, the answer addresses the evolution of financial commitments and governance, so relevance is high. However, the synthesis across years is flawed: it incorrectly assigns 2024 terms to 2023 and invents financial figures not in the source. The multi-hop reasoning fails because it does not correctly trace the timeline and nature of changes between years. Overall, the answer is partially accurate but contains major factual and inferential errors that distort the actual evolution of the relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1446,
        "completion_tokens": 545,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did FedEx's projected utilization of the Cessna SkyCourier 408 change between 2022 and 2023 filings, and what does this indicate about its strategic role in the fleet compared to other aircraft?",
      "original_answer": "In the 2022 filing, FedEx projected a total of 49 Cessna SkyCourier 408 aircraft to be in service through 2027. By the 2023 filing, this projection dropped significantly to only 31 Cessna SkyCourier 408 aircraft through 2029. This indicates a strategic reduction in the planned reliance on the Cessna SkyCourier 408, especially when compared to other aircraft types like the B767F and B777F, which saw more stable or less reduced projections. This shift suggests FedEx may have reassessed the aircraft's role in its long-term fleet strategy.",
      "llm_answer": "In the 2022 Form 10‑K FedEx said it had committed to acquire **49 Cessna SkyCourier 408s** – 11 in 2023, 12 in 2024, 12 in 2025 and 14 in 2026 (see page 40). The 2023 filing shows a **smaller future pipeline of 31 SkyCourier 408s**, with 17 slated for 2025 and 14 for 2026 (see page 117). The drop in total units but the boost in near‑term deliveries indicates FedEx is positioning the SkyCourier as a niche, short‑haul feeder aircraft that supplements its larger freighters (ATR‑72‑600F, B767F, B777F) rather than becoming a core capacity driver in the fleet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the change in projected Cessna SkyCourier 408 utilization from 49 in the 2022 filing to 31 in the 2023 filing, matching the ground truth. It accurately notes the delivery schedule in both years, with 49 total units planned across 2023–2026 in 2022’s projection and 31 units (17 in 2025, 14 in 2026) in the updated 2023 plan. The numbers are factually correct and properly cited to filing pages. (2) Quantitative accuracy is perfect: 49 and 31 are correct totals, and the breakdowns per year align with the stated commitments. There are no calculation errors. (3) The reasoning is sound and adds value: the LLM infers that the reduction in total units combined with a concentration of deliveries in later years (2025–2026) suggests a strategic shift toward using the SkyCourier as a niche, short-haul feeder aircraft rather than a core fleet component. This aligns with the ground truth’s conclusion about reduced strategic reliance. The comparison to other aircraft (ATR-72-600F, B767F, B777F) is contextually appropriate and supports the interpretation. (4) The only minor gap is that the ground truth specifies the 2023 projection extends through 2029, while the LLM does not mention the end year of the new timeline—though this does not affect the core conclusion. Otherwise, the answer is semantically equivalent, factually precise, and contextually well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 392,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How has Nike's approach to the Air Max product line evolved from 2022 to 2024, particularly in terms of revenue transparency and technological innovation emphasis?",
      "original_answer": "In 2022, Nike included Air Max in a general list of technologies within the revenue disaggregation table, indicating its presence in the product portfolio but without specific revenue figures. By 2024, while no direct revenue numbers were disclosed, Nike emphasized Air Max as a central example of its innovation strategy, highlighting its integration into broader product categories and consumer applications. This shift reflects a strategic move from passive acknowledgment to positioning Air Max as a key innovation driver, despite the continued lack of standalone financial metrics for the product line.",
      "llm_answer": "Nike’s FY 2022 filing gave only aggregate footwear numbers (e.g., $29.1 bn of footwear revenue) and did not break out or discuss Air Max sales, so the line’s revenue was not disclosed separately (see Note 16 – Revenues, pages page_88‑page_89). By FY 2024, Nike’s 10‑K explicitly lists Air Max alongside other proprietary technologies in its product‑research and development narrative, signaling a stronger focus on Air Max as a driver of innovation even though it still does not provide a separate Air Max revenue figure (see Product Research, Design and Development, page_7).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all references to fiscal years (FY 2022 and FY 2024), revenue figures ($29.1 billion in footwear), and document locations (Note 16, page references) are correct and consistent with typical SEC filing structures. The absence of specific Air Max revenue is correctly noted. (2) The answer addresses both parts of the question: revenue transparency (no standalone disclosure in either year, with 2022 showing only aggregate footwear revenue) and technological innovation emphasis (Air Max highlighted in R&D narrative in 2024). (3) Entities—Nike, Air Max, FY 2022, FY 2024, 10-K filings—are correctly identified. (4) The reasoning is sound: it captures the evolution from passive inclusion in financial tables to active mention in innovation discussions, reflecting a strategic shift even without financial disaggregation. The only minor shortcoming is that the original answer emphasizes the 'strategic move from passive acknowledgment to positioning as a key innovation driver' more explicitly, which the LLM implies but doesn't fully articulate in strategic terms. However, the core facts, synthesis across years, and interpretation are correct. Wording differences do not affect semantic equivalence. Thus, the answer is factually complete and contextually appropriate, meriting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 383,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How did Comcast's capital expenditure strategy regarding Epic Universe evolve from 2023 to 2024, particularly in terms of specific investment amounts and thematic park development priorities?",
      "original_answer": "In 2023, Comcast specifically noted an increase in capital expenditures directly related to the development of Epic Universe in Orlando, with a total of $8.2 billion allocated to Connectivity & Platforms, which included investments in scalable infrastructure and line extensions. By 2024, the company continued to emphasize investment in existing and new attractions at Universal theme parks, including Epic Universe, as part of its broader capital expenditure plan for 2025. While specific figures for Epic Universe alone were not disclosed in 2024, the company indicated an ongoing commitment to theme park development, particularly in expanding attractions and enhancing capacity. The evolution shows a shift from initial infrastructure and development focus in 2023 to a more sustained investment strategy in 2024 that includes both infrastructure and guest experience enhancements.",
      "llm_answer": "In 2023 Comcast lifted its spending on the Epic Universe project – the cap‑ex line for the park rose to fund land‑acquisition for a possible expansion and early development work (see page 50; also page 37). By 2024 total capital spending was essentially flat, but the company shifted the focus of that spending to the construction phase of Epic Universe, increasing outlays on theme‑park attractions and keeping the new park a top development priority (see page 50), although a separate dollar amount for the Epic Universe investment is not disclosed.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies in quantitative details. The ground truth states that Comcast allocated $8.2 billion to Connectivity & Platforms in 2023, which included Epic Universe-related infrastructure, but the LLM does not mention this specific figure or clarify that the amount was part of a broader category. Instead, it vaguely references increased spending without providing the correct total or contextualizing it within the reported segment. In 2024, the LLM correctly notes that no separate dollar amount was disclosed for Epic Universe, aligning with the original answer. However, it incorrectly claims that total capital spending was 'essentially flat'—a claim not supported by the ground truth, which does not provide a year-over-year comparison of total capex. (2) The LLM introduces unverified specifics such as 'land-acquisition for a possible expansion' and cites 'page 50' and 'page 37', which are not part of the provided knowledge graph and cannot be verified; these details may be hallucinated. The ground truth makes no mention of land acquisition or page references. (3) Qualitatively, the LLM captures the shift in focus from early development (2023) to construction and attractions (2024), which reflects sound multi-hop reasoning about evolving priorities. It correctly identifies Epic Universe as a top development priority in both years and acknowledges the lack of a standalone 2024 figure. (4) Contextually, the answer is relevant and addresses the evolution of capital expenditure strategy, investment amounts, and thematic park priorities. However, the absence of the $8.2 billion figure and the introduction of unsupported specifics reduce factual accuracy. The answer is partially correct but contains significant omissions and potential fabrications, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 502,
        "total_tokens": 1873
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did FedEx's utilization of the ATR 72-600F aircraft evolve between 2022 and 2023 as reflected in their fleet projections for the same planning periods?",
      "original_answer": "In 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. By 2023, the projections for the same time periods changed significantly, with 7 ATR 72-600F aircraft planned for 2025 and only 3 for 2026. This indicates a notable reduction in planned usage of the ATR 72-600F by FedEx over time.",
      "llm_answer": "FedEx’s 2022 filing projected six ATR‑72‑600F aircraft to be added in 2025 and just one in 2026, but the 2023 filing lifted those forecasts to seven for 2025 and three for 2026, showing a modest increase in the planned use of the ATR‑72‑600F fleet【page_40】【page_117】.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies. According to the ground truth, in 2022, FedEx projected operating 11 ATR 72-600F aircraft in 2023, 6 in 2024, 6 in 2025, and only 1 in 2026. However, the LLM incorrectly states that the 2022 filing projected 'six ATR-72-600F aircraft to be added in 2025 and just one in 2026'—this misrepresents both the timeline and the nature of the projection (it was not about additions but total fleet size). Furthermore, the LLM claims the 2023 filing 'lifted those forecasts to seven for 2025 and three for 2026', which partially matches the ground truth (7 for 2025, 3 for 2026), but fails to mention the earlier years (2023–2024) and incorrectly frames the change as an 'increase' when the overall trend reflects a reduction in long-term utilization. The ground truth emphasizes a 'notable reduction' over time, while the LLM concludes there was a 'modest increase', which is a misinterpretation of the trend. This reflects flawed multi-hop reasoning: the model did not correctly synthesize the full timeline and direction of change. While the entities (FedEx, ATR 72-600F, years) are correct and the answer is contextually relevant, the core numerical and interpretive errors severely undermine factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1154,
        "completion_tokens": 353,
        "total_tokens": 1507
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How did Nike's approach to estimating product return reserves evolve between fiscal 2022 and fiscal 2024, and what does this indicate about changes in their revenue recognition methodology?",
      "original_answer": "In fiscal 2022, Nike disclosed that the estimated cost of inventory for expected product returns was $269 million, and these reserves were recorded in Prepaid expenses and other current assets. By fiscal 2024, while the specific dollar amount of the product return reserve was not disclosed, Nike described a more formalized estimation process, stating that it calculates anticipated reductions in revenue—such as sales returns—by determining the 'most likely amount' it will be entitled to receive. This indicates a shift toward a more probabilistic and forward-looking revenue estimation methodology, aligning with the broader revenue recognition framework where variable consideration is estimated at the time revenues are recognized.",
      "llm_answer": "In FY 2022 Nike reported a sales‑related reserve of about $1.0 billion and an estimated $194 million of inventory cost for expected product returns, treating the reserve as a balance‑sheet adjustment after revenue was recorded【page_89】. By FY 2024 the company says it now estimates the “most likely” amount of returns, discounts and other claims up‑front, reduces revenue at the time of recognition and records a matching accrued‑liability and inventory cost, showing a shift to a more integrated ASC 606‑style variable‑consideration approach to revenue recognition【page_66】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key numbers. The ground truth states that in fiscal 2022, Nike's estimated cost of inventory for expected product returns was $269 million, but the LLM incorrectly reports it as $194 million. Additionally, the LLM mentions a 'sales-related reserve of about $1.0 billion,' which is not mentioned in the original answer and appears to conflate different reserve categories. These quantitative errors undermine the factual foundation of the response. (2) The fiscal years (2022 and 2024) are correctly identified, and the qualitative shift toward estimating the 'most likely amount' of returns and reducing revenue upfront in FY2024 aligns with the ground truth. However, the absence of the correct $269M figure and introduction of unverified numbers ($194M, $1B) severely impact accuracy. (3) The multi-hop reasoning is partially sound—the model correctly infers a shift toward a more integrated ASC 606 approach based on the 'most likely amount' language, which reflects a probabilistic estimation of variable consideration. This indicates understanding of the conceptual evolution in revenue recognition methodology. (4) Despite incorrect numbers, the answer captures the directional change in Nike’s approach—moving from a post-revenue adjustment to an upfront reduction in revenue based on expected returns—making it contextually relevant and semantically aligned in intent, though not in factual precision. The qualitative insight is reasonable but built on faulty data, warranting a moderate score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 433,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did the planned fleet composition of the Cessna SkyCourier 408 change between 2022 and 2023 for the years 2025 and beyond, and what does this indicate about the company's strategic reliance on this aircraft model?",
      "original_answer": "In 2022, FDX projected a total of 12 Cessna SkyCourier 408 aircraft to be in operation by 2025 and planned to maintain that number through 2026. By 2023, the company increased its planned fleet count for 2025 to 17 but reduced it to 14 for 2026. This indicates a short-term increase in strategic reliance on the Cessna SkyCourier 408, followed by a moderate decline in planned usage by 2026, suggesting a recalibration of fleet strategy.",
      "llm_answer": "The 2022 filing showed 12 Cessna SkyCourier 408s scheduled for delivery in 2025 and 14 in 2026, with no further deliveries beyond 2026 (page 114). The 2023 filing increased the 2025 commitment to 17 aircraft while the 2026 figure remained at 14 and still listed no deliveries after 2026 (page 117). This rise in the 2025 allocation signals a stronger near‑term strategic reliance on the SkyCourier, even as the overall planned SkyCourier fleet was trimmed to focus on those later‑delivery units.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a factual error in the 2022 2026 projection: the ground truth states FDX planned to maintain 12 aircraft through 2026, not 14 as claimed by the LLM. The 2025 increase from 12 to 17 by 2023 is correctly identified. However, the LLM incorrectly states the 2026 number remained at 14 in both years, while in reality, the 2022 plan was 12 for 2025 and 2026, and the 2023 plan changed to 17 for 2025 and 14 for 2026. This misrepresents the change in fleet composition over time. (2) The quantitative accuracy is compromised due to the incorrect 2022 2026 figure. The 2025 numbers (12 in 2022, 17 in 2023) are correct. The claim of 'no further deliveries beyond 2026' is consistent with both filings and the ground truth. (3) The multi-hop reasoning is mostly sound: the model correctly compares two filings across years and draws a strategic conclusion about increased near-term reliance. However, the flawed baseline (wrong 2022 2026 number) undermines the synthesis. The conclusion about trimming the overall fleet to focus on later-delivery units is speculative and not supported in the ground truth, which describes a recalibration but not a focus on 'later-delivery units'. (4) Despite the numerical error, the answer captures the core trend (increase in 2025, reduction from that peak by 2026) and provides relevant strategic interpretation, warranting a 7 for correctness. Contextual relevance is high as it directly addresses fleet changes and strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 416,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has Mastercard's real-time account-based payments infrastructure evolved from 2023 to 2024, particularly in terms of operational scale and integrated security capabilities?",
      "original_answer": "In 2023, Mastercard operated or was implementing real-time payments infrastructure in 13 markets globally, offering instant payments with enhanced data and messaging capabilities. The company emphasized a distributed network architecture that enabled intelligent routing and applied value-added services like fraud scoring and tokenization in real time. By 2024, Mastercard expanded its capabilities by enhancing its ACH and real-time account-based payment systems to provide more secure, simple, and smart payment solutions across its global network. The company also reinforced its multi-layered security approach, integrating additional protections and partnerships to safeguard the payments ecosystem. These developments indicate a strategic shift toward strengthening both the scale and security of its real-time payments infrastructure.",
      "llm_answer": "In 2023 Mastercard said its real‑time account‑based payments capability was operating or being rolled out in 13 markets and was built on a “multi‑layered” security framework that protects the network with cyber‑security programs, tokenization, fraud‑scoring and other controls (page 11). By 2024 the platform’s scale had grown sharply – settlement obligations rose to $922 million (from $282 million) and settlement assets moved to a $(593) million outflow (from a $40 million positive balance), reflecting a far larger real‑time payments footprint – while the same integrated, multi‑layered security approach continues to underpin the infrastructure (page 71 and page 11).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. While it correctly states that Mastercard was operating or implementing real-time payments in 13 markets in 2023 (matching the ground truth), the 2024 quantitative claims about settlement obligations rising to $922 million (from $282 million) and settlement assets moving to a $(593) million outflow (from $40 million) are not supported by the original answer and appear to misinterpret or fabricate financial data. These figures are not mentioned in the ground truth and do not align with the qualitative description of expansion in 2024. (2) The quantitative accuracy is very low because the dollar amounts and financial metrics in the LLM answer are entirely absent from the original answer. There is no mention of settlement obligations or settlement assets in the ground truth, making these numbers incorrect and misleading. Even if format variations are allowed, the values themselves are not present in the source. (3) The multi-hop reasoning is flawed. The LLM incorrectly infers scale growth from unrelated or non-existent financial figures instead of relying on the actual qualitative expansion described in the original answer—enhanced ACH and real-time systems, broader security integration, and global network improvements. It also fails to mention key developments like intelligent routing, value-added services, or partnerships that reinforce security. (4) Contextual relevance is moderate because the answer addresses the general topic of real-time payments and security, and correctly references the 13-market footprint in 2023. However, the introduction of false financial metrics severely undermines correctness. The qualitative accuracy is low due to incorrect reasoning and missing key elements of the evolution described in the original. Overall, the answer is mostly incorrect despite some correct framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 514,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How did Nike's use of foreign exchange forwards and options evolve between 2022 and 2024, particularly in terms of their impact on financial liabilities and hedging strategy?",
      "original_answer": "In 2022, foreign exchange forwards and options had a net gain of $8 million after tax, impacting various income categories such as revenues, cost of sales, and other (income) expense, net. By 2024, the liabilities associated with these instruments increased to $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities, indicating a shift in how these derivatives were managed or reported. This reflects a strategic evolution in Nike's hedging activities and financial exposure management.",
      "llm_answer": "Nike trimmed its foreign‑exchange hedge program after 2022.  The notional amount of forwards and options that were formally designated as cash‑flow hedges fell from $18.5 billion in 2022 to $16.2 billion in 2024, while the pool of undesignated forwards and options grew from $3 billion to $4.4 billion【page_85】.  As a result, derivative liabilities tied to these contracts dropped to $146 million for designated hedges and $5 million for undesignated hedges (total $151 million) on the 2024 balance sheet【page_83】, and the amount of deferred gains expected to be re‑classified from OCI fell from $607 million in 2022 to $231 million in 2024, reflecting a tighter, more actively realized hedging strategy【page_85】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. While it correctly identifies a shift in Nike's hedging strategy between 2022 and 2024, the specific numbers cited do not align with the ground truth. The original answer states that foreign exchange forwards and options had an $8 million net gain after tax in 2022 and that by 2024, liabilities were $110 million under accrued liabilities and $5 million under deferred income taxes and other liabilities (total $115 million). However, the LLM claims total derivative liabilities of $151 million ($146 million designated + $5 million undesignated), which contradicts the ground truth. Additionally, the LLM introduces figures not present in the original answer—such as notional amounts of $18.5B in 2022 and $16.2B in 2024, undesignated growth from $3B to $4.4B, and deferred gains falling from $607M to $231M—which are unsupported by the provided truth. These are likely hallucinated or misattributed details. While the LLM captures the qualitative trend of a strategic evolution in hedging (e.g., reduced designated hedges, increased active management), this reasoning is built on incorrect data. The multi-hop synthesis is partially sound—linking changes in hedge designations to balance sheet impacts and OCI reclassifications—but relies on fabricated metrics. The contextual relevance is high as it directly addresses the evolution of Nike's FX hedging strategy and its financial impact. However, due to major factual and numerical discrepancies, the overall correctness is low despite some directional accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 438,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How has the product category classification of Puffs within the Baby, Feminine & Family Care segment evolved between 2022 and 2023?",
      "original_answer": "In 2022, Puffs was categorized under the Family Care sub-category, which included Paper Towels, Tissues, and Toilet Paper. By 2023, Puffs remained in the Family Care category, but the specific mention of 'Tissues' replaced 'Tissues' with a more general listing without sub-category breakdowns, indicating a simplification or consolidation of how the segment details were reported.",
      "llm_answer": "In the 2022 Form 10‑K, Puffs is listed as a major brand in the Baby, Feminine & Family Care segment under the **Family Care** sub‑category (paper‑towel, tissue, toilet‑paper products)【page_19】. The 2023 Form 10‑K still places Puffs in the same **Family Care** sub‑category of the Baby, Feminine & Family Care segment, even though the segment’s product‑category breakdown was trimmed to only Feminine Care and Family Care (the Baby Care sub‑category was removed)【page_18】. Thus, Puffs’ classification remained in Family Care across both years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies that Puffs remained in the Family Care sub-category within the Baby, Feminine & Family Care segment in both 2022 and 2023, which aligns with the ground truth. It accurately notes the change in reporting structure in 2023, specifically that the segment’s product-category breakdown was simplified by removing the Baby Care sub-category, which is consistent with the consolidation trend mentioned in the original answer. The LLM correctly cites the relevant pages (19 for 2022, 18 for 2023) and maintains factual accuracy regarding the classification of Puffs. The only minor shortcoming is that it does not explicitly mention the shift from specifying 'Tissues' to a more general listing, as noted in the ground truth—instead focusing on the removal of Baby Care. However, this omission does not distort the overall correct conclusion that Puffs stayed in Family Care and that reporting was simplified. All entities (Puffs, Family Care, segment name, years) are correct. No numerical data is involved, so quantitative accuracy is scored based on correct dates and references. The reasoning is sound and synthesizes information across two years of filings. The answer is contextually fully relevant and semantically equivalent in substance, though slightly less detailed in describing the nature of the categorization change.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 376,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has the positioning of Tampax within P&G's product portfolio evolved between 2022 and 2023, particularly in terms of its categorization and associated product lines?",
      "original_answer": "In 2022, Tampax was categorized under 'Feminine Care' within the 'Baby, Feminine & Family Care' segment, which also included 'Baby Care' and 'Family Care' sub-categories. By 2023, the product category was refined, and Tampax was associated solely with 'Menstrual Care' under the same broader segment. This reflects a more focused positioning of Tampax, separating it from general 'Family Care' items and aligning it more specifically with menstrual health needs.",
      "llm_answer": "In the 2022 filing, Tampax was placed in the Baby, Feminine & Family Care segment under the “Feminine Care (Adult Incontinence, Feminine Care)” sub‑category (see 2022 page 19). In the 2023 filing, Tampax remains in the same segment but the sub‑category is now described as “Feminine Care (Adult Incontinence, Menstrual Care)” and the narrative calls it a leader in the menstrual‑care sub‑category (see 2023 page 18). Thus, Tampax’s positioning shifted from a broad feminine‑care grouping to a more specific focus on menstrual‑care products within the same overall segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. (1) It accurately identifies that Tampax was under the 'Baby, Feminine & Family Care' segment in both 2022 and 2023, with a shift in sub-category description from 'Feminine Care (Adult Incontinence, Feminine Care)' to 'Feminine Care (Adult Incontinence, Menstrual Care)', reflecting a more specific focus on menstrual care. This matches the ground truth's assertion of a refined categorization toward 'Menstrual Care'. (2) There are no numeric values requiring verification, so quantitative accuracy is not applicable beyond correct use of years (2022, 2023), which are accurate. (3) The multi-hop reasoning is sound—comparing the categorization across two years and identifying the evolution in terminology and focus. The LLM correctly synthesizes information from both filings and draws a valid conclusion about positioning. (4) The only minor shortcoming is that the LLM does not explicitly state that 'Family Care' was de-emphasized or separated from Tampax’s categorization, as implied in the ground truth; however, the shift in sub-category naming and the emphasis on menstrual care convey the same essential insight. Wording differs slightly but maintains semantic equivalence. Thus, the answer is highly accurate, complete, and contextually relevant, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 402,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How has Oracle's strategy and positioning of Oracle Engineered Systems evolved between fiscal 2022 and fiscal 2023, particularly in terms of revenue contribution and research investment expectations?",
      "original_answer": "In fiscal 2022, Oracle highlighted that its hardware business, which includes Oracle Engineered Systems, involved point-of-sale revenue recognition for hardware and related software, with the majority of products sold through indirect channels. By fiscal 2023, Oracle introduced a more forward-looking strategy, explicitly stating plans to continue investing in research and development to improve existing hardware products and develop new offerings. Additionally, in fiscal 2023, Oracle noted that hardware represented 6% of total revenues, a figure not specified in 2022, indicating a clearer emphasis on the segment's strategic positioning.",
      "llm_answer": "In fiscal 2022 Oracle’s hardware segment—driven by sales of Oracle Engineered Systems, servers and storage—produced $3.2 billion of revenue, a 5% decline from the prior year and roughly a 6‑7% share of total company revenue, and the filing already noted that “we intend to continue to invest significantly in our research and development efforts” (2022 p 51; 2022 p 53). By fiscal 2023 the company positioned the hardware business (including Engineered Systems) as a stable 6% of total revenue and again emphasized that “we expect to continue to make investments in research and development to improve existing hardware products and services and to develop new hardware products and services” (2023 p 43). This reflects a shift from a period of declining hardware sales to a steadier contribution while maintaining a strong, forward‑looking R&D commitment.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific revenue figures ($3.2 billion) and a 5% year-over-year decline for Oracle's hardware segment in fiscal 2022, along with an estimated 6-7% revenue share, none of which appear in the original answer (ground truth). The ground truth does not provide any revenue amounts or percentage share for fiscal 2022—only that hardware was not quantified then. In fiscal 2023, the ground truth correctly states hardware represented 6% of total revenue, which the LLM accurately includes. However, the LLM incorrectly implies that the 6-7% range and $3.2B figure were part of the disclosed data in 2022, which they were not. (2) The citation of R&D language is qualitatively accurate: both years mention continued investment in R&D, with slightly more specific phrasing in 2023 about improving existing products and developing new ones, which the LLM captures. But the LLM misattributes the presence of forward-looking R&D statements to 2022 as if it were part of the strategy evolution, when the ground truth emphasizes that such explicit forward-looking commitment was introduced in 2023. (3) The multi-hop reasoning is partially sound—the LLM attempts to compare strategic emphasis across years and notes the stabilization at 6% in 2023. However, it fabricates quantitative details for 2022, undermining the factual basis of the comparison. The claim of a 'shift from declining sales to steady contribution' is an inference not supported by the ground truth, which makes no mention of revenue trends or performance changes. (4) The contextual relevance is high—the answer addresses strategy evolution, revenue contribution, and R&D expectations. Qualitative accuracy is moderate due to correct use of 2023 data and R&D phrasing, but quantitative accuracy is low due to invented figures. Correctness score reflects partial accuracy with significant factual overreach on numbers not in the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 522,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did Honeywell's investment in private funds for its Non-U.S. pension plans evolve between 2022 and 2023, particularly in terms of allocation and classification across fair value hierarchy levels?",
      "original_answer": "In 2022, Honeywell reported $1,105 million invested in private funds for its U.S. pension plans, with the amount classified under Level 3 of the fair value hierarchy. By 2023, the company reported $115 million in private fund investments for its Non-U.S. pension plans, with $41 million classified under Level 2 and $74 million under Level 3 of the fair value hierarchy. This represents a significant decrease in overall private fund allocation, particularly in U.S. plans, and a shift in classification for the remaining private fund investments under the Non-U.S. plans.",
      "llm_answer": "Honeywell’s Non‑U.S. pension plans held $90 million of private‑fund assets in 2022, all classified as Level 2 ($54 m) or Level 3 ($36 m) with no Level 1 holdings. By year‑end 2023 the total rose to $115 million, still with zero Level 1, but the mix shifted to $41 million at Level 2 and $74 million at Level 3 – a $25 million increase overall and a clear move toward more Level 3 (unobservable‑input) assets【page_110】.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2022, Honeywell reported $1,105 million invested in private funds for its *U.S.* pension plans (not Non-U.S.), all classified under Level 3. However, the LLM incorrectly claims $90 million in *Non-U.S.* plans in 2022, with $54M Level 2 and $36M Level 3—none of which appears in the ground truth. The 2023 data is partially correct: $115M total in Non-U.S. plans with $41M Level 2 and $74M Level 3 matches the ground truth. (2) Calculations: The LLM’s claim of a $25M increase from $90M to $115M is based on fabricated 2022 data and thus incorrect. The actual shift is from $1,105M (U.S., 2022) to $115M (Non-U.S., 2023), a dramatic decrease, not an increase. (3) Multi-hop reasoning failure: The LLM conflates U.S. and Non-U.S. pension plans, misallocating the 2022 figure to the wrong entity. It fails to recognize that the 2022 private fund investment was in U.S. plans (Level 3 only), while 2023 data pertains to Non-U.S. plans with a split across Levels 2 and 3. This misattribution breaks the comparative analysis. (4) Despite incorrect numbers and entity confusion, the answer is contextually relevant—it addresses the evolution of private fund investments, allocation, and fair value hierarchy classification. The 2023 data is accurate, and the observation about a shift toward more Level 3 assets in Non-U.S. plans is valid *if* the baseline were correct. However, due to major quantitative and qualitative errors, especially the fabrication of 2022 Non-U.S. data, the overall correctness score is low.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1260,
        "completion_tokens": 443,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the status and management of the 2014 USD Notes evolve between 2023 and 2024, and what specific actions were taken regarding this debt in 2024?",
      "original_answer": "In 2023, the 2014 USD Notes were classified as short-term debt, net of unamortized discount and debt issuance costs, with a maturity date of April 2024. By 2024, the company reported that in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid in full. This indicates that the company transitioned the obligation from a near-term liability in 2023 to a fully settled debt instrument in 2024.",
      "llm_answer": "In the 2023 Form 10‑K the 2014 USD Notes (3.375 % senior notes due April 2024) were still on the balance sheet and were classified as short‑term debt, net of discounts and issuance costs 【page_97】.  In the 2024 filing the company reports that “in April 2024, $1 billion of principal related to the 2014 USD Notes matured and was paid,” and consequently the earliest remaining debt maturity is now March 2025, indicating the notes were fully retired 【page_58】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the 2014 USD Notes were classified as short-term debt in 2023 with a maturity in April 2024, and in April 2024, $1 billion of principal matured and was paid in full. (2) Quantitative elements are precise: the $1 billion principal amount, the April 2024 maturity and payment date, and the interest rate (3.375%) are all correctly stated and match the source. Format variations (e.g., $1 billion) are acceptable and clear. (3) The multi-hop reasoning is sound—information is correctly synthesized across the 2023 and 2024 filings to show the transition from a short-term liability to a fully settled obligation. The conclusion that the notes were retired is logically supported by the payment and the shift in earliest remaining maturity to March 2025. (4) The answer addresses all parts of the question: the status in 2023, the evolution into 2024, and the specific action (repayment) taken in 2024. Entity accuracy (2014 USD Notes, correct years, debt classification) is flawless. All scores are maximized due to complete factual accuracy, correct synthesis, and clear, relevant expression.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 340,
        "total_tokens": 1562
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has the treatment and documentation of Lowe's Officer Indemnification Agreements evolved between 2022 and 2024, and what does this indicate about the company's executive risk management and governance continuity?",
      "original_answer": "Between 2022 and 2024, Lowe's maintained the same form of Officer Indemnification Agreement, first filed as Exhibit 10.43 on April 2, 2019, and refiled without amendment in both the 2022 and 2024 10-K filings. This indicates that the company did not modify the terms or structure of these agreements over this period, suggesting consistent governance practices and a stable approach to executive risk management and retention. Investors can interpret this continuity as a sign of predictable leadership protections and aligned corporate governance priorities.",
      "llm_answer": "Both the 2022 and 2024 Form 10‑K filings list the same “Form of Lowe’s Companies, Inc. Officer Indemnification Agreement” as Exhibit 10.23 (filed April 2 2019) 【page_79†L1-L5】【page_79†L1-L5】. The agreement’s description, exhibit number and filing date are unchanged, showing that Lowe’s continues to rely on the same indemnification framework for its officers, which signals a stable executive‑risk‑management approach and continuity in its governance practices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct in all key aspects: it accurately identifies that the same form of Officer Indemnification Agreement was used in both 2022 and 2024, correctly references the exhibit number (10.23 vs. ground truth 10.43 — note discrepancy discussed below), and correctly states the filing date (April 2, 2019). The conclusion about stable executive risk management and governance continuity aligns with the ground truth. The only discrepancy is the exhibit number: the LLM states 'Exhibit 10.23', while the ground truth specifies 'Exhibit 10.43'. However, this may reflect a typographical error or exhibit renumbering across filings, and given that both refer to the same agreement filed on the same date and cited in the same context, the semantic and factual equivalence is preserved. All other elements — dates, consistency over time, implications for governance — are correctly interpreted and synthesized across the 2022 and 2024 filings. The reasoning is sound, multi-hop synthesis is accurate, and the answer fully addresses both parts of the question: evolution (or lack thereof) and implications for governance. Minor deduction from 10 to 9 due to exhibit number inconsistency, but not enough to undermine overall correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 350,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How did the market share and category positioning of Always Discreet in the adult incontinence market change between the 2022 and 2023 Procter & Gamble 10-K filings?",
      "original_answer": "In the 2022 filing, Always Discreet was explicitly stated to have over 10% market share in the key adult incontinence markets where Procter & Gamble competes. However, in the 2023 filing, while Always Discreet is still listed as a major brand in the Feminine Care category under the Baby, Feminine & Family Care segment, no specific market share figure is provided for the brand. This suggests a shift in how the brand's performance is communicated, moving away from a quantified market share disclosure to a more general category association.",
      "llm_answer": "In the 2022 filing P&G noted that it “compete[s] in the adult‑incontinence category … behind **Always Discreet**, with **over 10 %** market share in the key markets”【page_19】. The 2023 filing says it still “compete[s] … behind **Always Discreet**, with **about 15 %** market share in the markets in which we compete”【page_18】. Thus, Always Discreet’s share rose from just above 10 % to roughly 15 %, while its status as the category leader (P&G competing “behind” it) remained unchanged.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core claim. The original answer (ground truth) states that in the 2022 filing, Always Discreet had over 10% market share, but in the 2023 filing, no specific market share figure was provided. However, the LLM claims that in 2023, the market share was 'about 15%', which is not supported by the ground truth. This is a major factual error. (2) The quantitative accuracy is severely flawed: the 15% figure is fabricated or misattributed, as the 2023 filing does not report any market share for Always Discreet. There is no calculation or comparison that can justify a rise from over 10% to about 15%, because the latter data point does not exist in the source. (3) The multi-hop reasoning is unsound. The model fails to recognize the absence of a market share metric in the 2023 filing and instead invents a number, leading to a false conclusion about growth and positioning. It also misrepresents the continuity of disclosure, implying consistent reporting when in fact there is a notable omission in 2023. (4) Contextual relevance is moderate because the answer addresses the right brand, category, and time frame, and attempts to compare two filings. However, due to the critical error in data reporting, the conclusion about market share increase and unchanged leadership status is unsupported. The qualitative accuracy is low because the entity identification is correct but the reasoning and synthesis are fundamentally flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 411,
        "total_tokens": 1673
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How has Oracle's strategic positioning of Engineered Systems evolved between 2022 and 2023, particularly in terms of their role within the hardware business and implications for Oracle's cloud transformation narrative?",
      "original_answer": "In 2022, Oracle Engineered Systems were described as pre-integrated products central to both cloud and on-premise data center infrastructure, emphasizing their technical advantages such as improved performance, scalability, and simplified maintenance. However, by 2023, Oracle elevated the strategic importance of Engineered Systems by positioning them as part of a broader hardware business that now includes servers, storage, and operating systems, all tightly integrated and accounted for as combined performance obligations. The 2023 filing also highlighted that hardware revenues, including Engineered Systems, represented 6% of total revenues in both fiscal 2023 and 2024, and underscored ongoing R&D investments to enhance these offerings. This evolution suggests that Oracle is leveraging Engineered Systems not just as technical solutions but as foundational components in its hybrid cloud and on-premise strategies, aligning them more closely with its cloud transformation narrative while acknowledging the lower-margin nature of the hardware business.",
      "llm_answer": "In the 2022 filing Oracle described its Engineered Systems as **“core to our cloud‑based and on‑premise data‑center infrastructure offerings”**, emphasizing that they are pre‑integrated appliances that can be delivered on‑premise, as a cloud service in OCI, or as a hybrid‑cloud solution (see page 13). By the 2023 filing, Engineered Systems are mentioned only as one of the products in the **hardware segment, which contributed about 6 % of total revenue**, and the discussion focuses on the hardware business’s lower margins, manufacturing and competition rather than on a cloud‑enabling role (see page 43). This reflects a shift from positioning Engineered Systems as a flagship, cloud‑transformation platform in 2022 to treating them as a supporting line‑item within a modest hardware business in 2023, while Oracle’s overall narrative now leans more heavily on its cloud‑and‑license operations for growth.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant misinterpretation of Oracle's strategic positioning of Engineered Systems between 2022 and 2023, leading to an incorrect overall conclusion. (1) Quantitatively, the answer correctly states that hardware revenues, including Engineered Systems, represented about 6% of total revenue in 2023, which aligns with the ground truth (6% in both fiscal 2023 and 2024). This number is accurate and properly cited. (2) However, the qualitative reasoning is flawed: the LLM interprets the 2023 discussion of hardware as a lower-margin business with broader product lines as a *demotion* of Engineered Systems from a 'flagship' role to a 'supporting line-item'. In contrast, the ground truth indicates that Engineered Systems were *elevated* strategically in 2023 as part of a more integrated hardware business (including servers, storage, OS) under combined performance obligations, and were emphasized as foundational to hybrid cloud and on-premise strategies. The 2023 filing did not diminish their role in cloud transformation but rather embedded them more deeply into Oracle’s integrated infrastructure narrative. (3) The multi-hop reasoning fails because the LLM incorrectly infers strategic downgrading from a shift in narrative tone, while missing the key point of tighter integration and expanded scope. It also overlooks the continued R&D investment and the explicit linkage to hybrid cloud strategy. (4) While the answer is contextually relevant and uses accurate phrasing from filings, the core conclusion contradicts the ground truth, resulting in a moderate correctness score. The quantitative accuracy is high due to correct percentage reporting, but the qualitative and overall correctness suffer from the misinterpretation of strategic intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1511,
        "completion_tokens": 488,
        "total_tokens": 1999
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the disclosure regarding the 2020 Stock Plan's relationship with the 2011 Stock Plan evolve between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, the 2020 Stock Plan disclosure included the detail that 5,530,106 shares previously available under the 2011 Stock Plan were carried forward and made available for award grants under the 2020 Stock Plan. However, in the 2023 10-K filing, this specific reference to the 2011 Stock Plan and the carry-forward of shares was omitted. This indicates a shift in how the company chose to present the lineage and transition between the two stock plans, focusing only on the 2020 Stock Plan without linking it to its predecessor in the disclosed text.",
      "llm_answer": "The 2022 10‑K only said that the 2020 Stock Plan was approved in June 2020 and described its grant provisions, without referencing the earlier plan. The 2023 10‑K adds that the 2020 Stock Plan is the successor to the 2011 Stock Plan and notes that the 5,530,106 shares previously available under the 2011 Plan are now available under the 2020 Plan【page_61】. This new language clarifies the relationship and the carry‑over of shares from the 2011 Plan【page_59】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 2,
      "detailed_feedback": "The LLM answer is completely incorrect and inverts the actual disclosure evolution between the 2022 and 2023 10-K filings. According to the ground truth, the 2022 10-K *did* include the detail that 5,530,106 shares from the 2011 Stock Plan were carried forward into the 2020 Stock Plan, while the 2023 10-K *omitted* this reference. However, the LLM claims the opposite: that the 2022 10-K did *not* reference the 2011 Plan and that the 2023 10-K *added* this information. This reverses the factual timeline and misrepresents the evolution of the disclosure. The specific number 5,530,106 is correctly stated, but it is applied in the wrong context and direction, making the quantitative accuracy misleading. The entity names (2020 Stock Plan, 2011 Stock Plan) and years are correct, but the reasoning is fundamentally flawed. The answer fails the multi-hop requirement to compare disclosures across years accurately. The contextual relevance is low because it addresses the general topic but with incorrect directional change. The cited pages (e.g., page_61, page_59) are not corroborated and appear fabricated in this context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1255,
        "completion_tokens": 318,
        "total_tokens": 1573
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How has Honeywell's allocation strategy toward private funds evolved between 2022 and 2023, and what might this indicate about the company's capital deployment priorities?",
      "original_answer": "In 2022, Honeywell reported $1,244 million invested in private funds, as disclosed in the 2022 10-K filing. By 2023, this amount increased slightly to $1,265 million, as noted in the 2023 10-K filing. This represents a modest increase of approximately 1.7%, suggesting that Honeywell maintained a relatively stable allocation strategy toward private funds despite broader reductions in total assets under the U.S. plans. This slight upward trend may indicate a strategic decision to preserve or slightly expand exposure to alternative investments, potentially to capitalize on expected higher returns or diversification benefits from private fund investments.",
      "llm_answer": "Honeywell’s pension portfolios have been moving more capital into private‑fund assets.  In 2023 the non‑U.S. plan’s private‑fund balance rose from $90 million in 2022 to $115 million (Level‑3 funds grew from $36 million to $74 million) and the U.S. plan’s direct private‑investment balance rose from $1,284 million to $1,293 million (Level‑3 private‑funds up from $36 million to $74 million)【page_110】【page_109】【page_111】.  This increase signals a deliberate tilt toward alternative/private‑equity‑type investments, reflecting a priority to diversify the pension assets and pursue higher long‑term returns.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that Honeywell's total investment in private funds was $1,244 million in 2022 and $1,265 million in 2023, representing a 1.7% increase. However, the LLM answer incorrectly breaks this down into U.S. and non-U.S. plans with figures not present in the ground truth. Specifically, it claims the U.S. plan’s direct private-investment balance rose from $1,284M to $1,293M, which contradicts the ground truth total of $1,244M in 2022. Additionally, the non-U.S. figures ($90M to $115M) are not mentioned in the original answer and appear fabricated. (2) The quantitative inaccuracies are severe: the LLM reports higher baseline amounts ($1,284M vs $1,244M) and introduces Level-3 fund data ($36M to $74M) that is not in the ground truth and cannot be verified. The 1.7% increase in the original is modest, while the LLM implies a broader strategic shift not supported by the data. (3) The multi-hop reasoning is flawed. The original answer draws a conclusion from total private fund allocations across two years, noting stability amid broader asset reductions. The LLM incorrectly infers a 'deliberate tilt' based on misattributed sub-components (U.S. vs non-U.S.), failing to correctly synthesize the actual data. (4) Contextual relevance is moderate—the answer addresses capital deployment priorities and alternative investments, which is relevant—but the incorrect data undermines the conclusion. Due to major factual and numerical errors, the correctness score is low at 2, with similarly low quantitative and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 446,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the status and disclosure of Class B-2 Common Stock evolve between 2023 and 2024, particularly regarding its outstanding status and relationship to other stock classes?",
      "original_answer": "In 2023, Class B-2 Common Stock was subject to conversion rate adjustments tied to the U.S. litigation escrow account under the U.S. retrospective responsibility plan, which caused dilution in as-converted shares. Additionally, it was noted that no shares of Class B-2 were outstanding prior to the Class B-1 exchange offer. By 2024, the 10-K filing only referenced Class B-2 Common Stock in relation to its lack of outstanding shares prior to the Class B-1 exchange offer, with no further updates or disclosures regarding its conversion mechanics or dilution impacts, suggesting a reduced emphasis or potential discontinuation of its active role in the capital structure.",
      "llm_answer": "In the 2023 filing Visa disclosed that **no Class B‑2 common shares were outstanding** – the Note 15 footnote explicitly says “No shares of class B‑2 common stock were outstanding prior to the class B‑1 common stock exchange offer” (page 87). By the 2024 filing the May 2024 exchange offer had created Class B‑2, issuing roughly 120 million shares (49 million weighted‑average shares outstanding for EPS) with a conversion rate of 1.5430 to Class A common stock and a “double‑impact” on conversion‑rate adjustments versus the newly‑renamed Class B‑1 shares (page 89). The 2024 capital‑stock table also shows 123 million authorized Class B‑2 shares, confirming its status as a distinct, outstanding class alongside Class B‑1 and Class C (page 88; EPS table footnote on page 59).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and contradicts the ground truth. (1) According to the original answer, Class B-2 Common Stock had no outstanding shares prior to the Class B-1 exchange offer in 2023 and was subject to conversion rate adjustments causing dilution in as-converted shares. By 2024, there were no new disclosures about Class B-2, suggesting reduced emphasis or potential discontinuation. However, the LLM claims that in 2024, Class B-2 was newly created with 120 million shares issued, a conversion rate of 1.5430, and detailed capital structure treatment—none of which is supported by the ground truth. (2) The quantitative claims—120 million shares issued, 49 million weighted-average shares for EPS, 123 million authorized shares, and a specific conversion rate—are all fabricated and not present in the ground truth. There are no numbers in the original answer beyond implied dilution effects; thus, all specific figures in the LLM response are factually wrong. (3) The reasoning is flawed: the LLM incorrectly frames Class B-2 as being newly established in 2024, when the truth indicates it existed in 2023 in terms of conversion mechanics but had no outstanding shares before the exchange. The multi-hop synthesis fails—the LLM invents disclosures rather than recognizing the absence of updates in 2024 as indicative of reduced relevance. (4) Contextual relevance is moderate because the answer discusses stock classes and timelines, but the factual inaccuracies and invented data severely undermine correctness. The answer misrepresents the evolution, asserting active development when the truth suggests de-prioritization.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 447,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the financial obligations related to the Target Circle program change between 2022 and 2024, and what does this indicate about the program's evolution?",
      "original_answer": "In 2022, the deferred revenue related to the Target Circle program was $89 million as of January 29, 2022, while in 2024, the deferred revenue related to the program was $117 million as of February 3, 2024. This indicates a significant increase in the company's liability tied to unredeemed rewards, suggesting growth in program participation or changes in redemption patterns. However, by February 1, 2025, the deferred revenue had dropped to $19 million, signaling a sharp decline, which may reflect either a surge in reward redemptions or a strategic change in how the program's liabilities are recognized or managed.",
      "llm_answer": "The Target Circle liability grew from $89 million of deferred revenue in fiscal 2022 (as of January 29, 2022) to $117 million in fiscal 2024 (as of February 3, 2024)【page_46】【page_50】—an increase of roughly $28 million (about 30%). This rise shows the loyalty program is expanding, with more members earning rewards and a larger accrued‑revenue obligation, indicating stronger participation and growth of the Target Circle offering.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the deferred revenue amounts for 2022 ($89 million as of January 29, 2022) and 2024 ($117 million as of February 3, 2024), and accurately calculates the $28 million increase (approximately 30%), which matches the ground truth. All numeric values, dates, and calculations are factually correct, earning a perfect score on quantitative accuracy. (2) However, the LLM answer is incomplete because it fails to mention the significant drop in deferred revenue to $19 million as of February 1, 2025, which is a critical part of the original answer and essential to understanding the full evolution of the program. This omission affects completeness and reasoning, as the sharp decline suggests a major shift—either in redemption behavior or accounting treatment—that the model does not address. (3) The multi-hop reasoning is partially sound: it correctly links the increase in deferred revenue to program growth and participation, which is a valid interpretation. However, it misses the second phase of the program’s evolution (the drop to $19M), which weakens the overall synthesis and indicates a failure to incorporate all relevant time points. (4) Despite this, the answer remains contextually relevant and conveys a plausible interpretation of the upward trend. The correctness score is 7 because core facts are accurate, but a major factual component (the 2025 decline) is missing, limiting the answer’s completeness and depth of insight.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 409,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the fair value of Netflix's 4.375% Senior Notes change between December 31, 2022, and December 31, 2023, and what does this indicate about investor perception or market conditions?",
      "original_answer": "The fair value of Netflix's 4.375% Senior Notes decreased from $980 million on December 31, 2022, to $996 million on December 31, 2023. This indicates a shift in investor perception or market conditions, as the fair value moved closer to the principal amount at par, suggesting a stabilization or improved outlook for the company's debt.",
      "llm_answer": "The Level 2 fair‑value of Netflix’s 4.375 % senior notes rose from **$980 million at 12/31/2022 to $996 million at 12/31/2023** – an increase of roughly $16 million (about 1½ % of the $1 billion principal). This gain indicates that investors were willing to pay a higher price for the notes, reflecting a more favorable view of Netflix’s credit standing or broader market conditions (e.g., lower yields or stronger demand for its debt).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it states that the fair value of Netflix's 4.375% Senior Notes *increased* from $980 million to $996 million, while the ground truth states it *decreased* from $980 million to $996 million. This is a direct contradiction — 'decreased' vs. 'rose' — despite the same numbers being cited. This misrepresents the direction of change and undermines the entire conclusion. (2) Quantitatively, the dollar amounts ($980M and $996M) and dates (12/31/2022 and 12/31/2023) are correct, and the $16M difference is accurately computed. The reference to a ~1.5% increase relative to the $1B principal is reasonable. However, the interpretation of the change as an 'increase' is factually wrong according to the original answer, which describes a *decrease* in fair value. This suggests a possible typo or reversal in logic in the LLM response. (3) The multi-hop reasoning is partially sound — the model connects fair value changes to investor perception and market conditions — but the conclusion is inverted due to the incorrect directional assessment. The original answer interprets the change (from $980M to $996M) as the fair value moving *closer to par*, implying stabilization. The LLM correctly infers that a higher price reflects improved credit perception, but this would only be valid if the fair value were rising *toward* par from below, which aligns numerically but not directionally with the original's description of a 'decrease'. The contradiction in terminology ('decrease' vs. 'increase') creates confusion. (4) The contextual relevance is high — the answer addresses both parts of the question (change in fair value and its implication), uses appropriate financial reasoning, and references relevant concepts like credit standing and market yields. However, the core factual inaccuracy in the direction of change severely impacts correctness. A score of 4 is justified due to correct numbers but incorrect interpretation of trend, leading to a misleading conclusion.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1203,
        "completion_tokens": 547,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How did the equity structure related to Class C Common Stock evolve between 2023 and 2024, particularly in terms of share issuance and equity classification?",
      "original_answer": "In 2023, Visa conducted an exchange offer where 241 million shares of Class B-1 common stock were tendered, and in exchange, approximately 48 million shares of Class C common stock were issued. This indicates active restructuring of stock classes tied to the Visa Europe retrospective responsibility plans. By 2024, the balance of Class C common stock remained at 10 shares issued and outstanding, as stated in the equity section of the balance sheet. This suggests that while there was active movement and restructuring involving Class C shares in 2023, the 2024 disclosures indicate a stabilization or conclusion of that phase of equity restructuring.",
      "llm_answer": "The balance‑sheet line for Class C common stock still shows only 10 shares issued and outstanding in both years, listed under “Common stock, $0.0001 par value”【page_58】.  In fiscal 2024 the company issued additional Class C shares – about 48 million shares in the May 2024 class‑B‑1 exchange offer – which pushed the weighted‑average Class C shares from 10 in 2023 to 16 in 2024【page_59】【page_40】, but the equity classification remained unchanged as common stock.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual and quantitative errors that undermine its correctness. (1) It incorrectly states that 48 million Class C shares were issued in May 2024, while the ground truth indicates this exchange occurred in 2023. This misplacement of a key event by a full year is a major factual error. (2) The claim that 'the balance-sheet line for Class C common stock shows only 10 shares issued and outstanding in both years' contradicts the 2023 exchange activity involving 48 million shares; the ground truth clarifies that while 48 million were issued in 2023 as part of the exchange, the final outstanding balance in 2024 reverted to 10 shares, indicating a temporary issuance followed by stabilization. The LLM misinterprets the 10-share figure as static across both years. (3) The assertion that weighted-average Class C shares increased from 10 to 16 due to the issuance is unsupported and incorrect—there is no such metric or calculation in the ground truth, and '16' appears to be fabricated. (4) The reasoning fails on multi-hop synthesis: it conflates timing, misrepresents the nature of the share activity (temporary issuance vs. permanent change), and invents financial metrics. While the answer correctly identifies the par value line item and references Class C as common stock (contextually relevant), the core facts about when the exchange occurred, the nature of the share change, and the final equity structure are wrong. Thus, despite some surface-level alignment with terminology and document references, the answer is substantially incorrect in its quantitative claims and logical flow.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 443,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How has Lowe's engagement with Rough Plumbing evolved from 2022 to 2024, particularly in terms of its business classification and service offerings?",
      "original_answer": "In 2022, Rough Plumbing was classified under the 'Building Products' category, indicating it was primarily offered as a product within Lowe's merchandise divisions. By 2024, Lowe's had expanded its engagement with Rough Plumbing by integrating it into both installation services and protection plans, signaling a shift from a pure product offering to a more service-oriented approach. This evolution reflects a strategic move to bundle Rough Plumbing with labor and extended protection, contributing to the approximately 5% of total sales attributed to installed sales in 2024.",
      "llm_answer": "In the 2022 Form 10‑K, Rough Plumbing was treated as a sub‑category of the “Building Products” segment (2022 net‑sales table, p. 55) and was mentioned only as one of the product lines eligible for extended protection plans (p. 54). By the 2024 filing, Rough Plumbing is listed as a distinct product line (p. 6) and is highlighted as a major driver of both installed‑sales services and protection‑plan coverage (p. 7), showing that Lowe’s has moved from a simple product classification to a broader service‑oriented engagement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022, Rough Plumbing was part of the 'Building Products' category and only eligible for protection plans, matching the original answer. By 2024, it accurately notes the shift to being a distinct product line integrated into installed sales and protection plans, reflecting the service-oriented evolution. (2) There are no numeric values in the LLM answer that conflict with the ground truth; while the 5% of total sales attributed to installed sales in 2024 is missing, this is a minor omission and not misrepresented. The absence of this percentage does not introduce inaccuracy but slightly reduces completeness. (3) The multi-hop reasoning is sound—correctly synthesizing changes in classification and service integration across 2022 and 2024 filings. The use of specific page references adds credibility. (4) Semantic equivalence is strong: the core message about strategic evolution from product-only to service-bundled engagement is preserved. The only reason for not scoring a 10 is the omission of the quantitative impact (5% of sales), which was present in the original answer and adds contextual depth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 341,
        "total_tokens": 1618
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How did the introduction and subsequent status of Class B-2 common stock evolve between 2023 and 2024, and what does this indicate about its role in the company's capital structure?",
      "original_answer": "In 2023, Class B-2 common stock was newly introduced with 77 million shares outstanding, indicating its initial incorporation into the company's equity structure. By 2024, the company disclosed that no shares of Class B-2 common stock were outstanding prior to the Class B-1 common stock exchange offer, suggesting a strategic shift where Class B-2 shares may have been replaced or restructured as part of a broader capital realignment. This indicates a transformation in the role of Class B-2 common stock within the company’s capital structure.",
      "llm_answer": "In the 2023 filing the company reported **no Class B‑2 shares** – the note on page 91 states “No shares of class B‑2 common stock were outstanding prior to the class B‑1 common stock exchange offer.” The 2024 filing shows that the **Class B‑2 series was created in 2024** as part of the May 2024 exchange offer (page 89 describes Visa issuing “approximately 120 million shares of class B‑2 common stock” in exchange for retired B‑1 shares). By fiscal‑year‑end 2024 the equity section (page 57) lists 125 million B‑2 shares issued and the earnings‑per‑share tables (pages 59 and 90) record 49 million weighted‑average B‑2 shares outstanding. This evolution indicates that B‑2 was introduced as a new tier within the restricted class‑B capital structure, serving as a transitional vehicle to retire B‑1 shares and move toward freely tradable class C stock while retaining the limited‑voting, litigation‑linked characteristics of the broader class‑B equity.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in both factual content and direction of events compared to the ground truth. According to the original answer, Class B-2 common stock was introduced in 2023 with 77 million shares outstanding, but the LLM claims it was created in 2024 and reports 120 million issued (later 125 million) — numbers that do not match the ground truth. The LLM also incorrectly states that zero Class B-2 shares existed in 2023, directly contradicting the ground truth which states 77 million were outstanding in 2023. (2) Quantitative accuracy is poor: the LLM reports 120–125 million shares issued in 2024 and 49 million weighted-average shares outstanding, none of which appear in the ground truth. The correct figure from 2023 is 77 million shares; no specific number for 2024 is given except that zero were outstanding prior to the B-1 exchange, implying a removal or replacement, not a new creation. The LLM reverses the timeline: ground truth says B-2 existed in 2023 and was gone (or restructured) by 2024; LLM says B-2 was created in 2024. (3) Multi-hop reasoning is flawed: the LLM synthesizes non-existent document references (e.g., page 89, 91, 57) and constructs a narrative about Visa issuing shares in a May 2024 exchange, which is not supported by the ground truth. The conclusion about B-2 serving as a 'transitional vehicle' toward Class C stock introduces entities and processes not mentioned in the original answer, indicating hallucination. (4) Contextual relevance is moderate because the LLM attempts to address the evolution of Class B-2 stock and its role in capital structure, but the factual foundation is inverted. While the idea of strategic restructuring is thematically aligned, the incorrect chronology, numbers, and entities severely undermine correctness. The answer reflects a plausible but entirely incorrect narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 510,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How has the financial liability associated with the Target Circle program changed between 2022 and 2024, and what does this indicate about the program's growth or evolution?",
      "original_answer": "In 2022, the Target Circle program was described primarily in terms of its benefits to customers, such as earning 1% rewards on non-RedCard purchases, but no specific liability figure was disclosed. By 2024, the deferred revenue related to the Target Circle program had grown to $117 million as of February 3, 2024, indicating a significant increase in the program's financial liability and suggesting substantial growth or expansion of the program. This increase reflects a greater number of participants or increased transactional activity within the program.",
      "llm_answer": "The 2022 Form 10‑K only describes the Target Circle loyalty program (see page 5) and does not disclose a specific liability for it, while the 2024 Form 10‑K reports a deferred‑revenue liability of $117 million as of February 3 2024 and $19 million as of February 1 2025 (see page 50). The $98 million drop in the liability over the two‑year period shows that the program’s outstanding rewards have been largely redeemed or its accounting treatment has tightened, indicating a shift from a rapid‑growth phase to a more mature, lower‑liability stage.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. While it correctly notes that no liability was disclosed in 2022, it incorrectly states that the 2024 Form 10-K reports a deferred revenue liability of $117 million as of February 3, 2024, *and* $19 million as of February 1, 2025. The ground truth only confirms the $117 million figure as of February 3, 2024; there is no mention of a $19 million liability in the future (February 1, 2025) in the original answer, nor is there any support for a '$98 million drop' in liability. This calculation and the implied trend are entirely fabricated. (2) The quantitative accuracy is low: the $98 million difference is based on a non-existent future liability and misrepresents the direction of change. The original answer indicates growth in liability, while the LLM claims a drop, which contradicts the ground truth. (3) The multi-hop reasoning is flawed: instead of inferring program growth from increasing liability (as supported), the model incorrectly infers maturity from a supposed decline, demonstrating a failure in logical synthesis. It also introduces a future date (2025) not referenced in the question or ground truth, suggesting hallucination. (4) Contextual relevance is moderate because the answer addresses the Target Circle program and financial liability, but the conclusion is opposite to the correct interpretation. The mention of deferred revenue and lack of 2022 disclosure is accurate, but the overall message is misleading. Thus, scores are low on correctness and qualitative accuracy due to critical factual and logical errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1284,
        "completion_tokens": 440,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How has NVDA's exposure to and concern about pollution limits evolved between 2023 and 2024, particularly in terms of regulatory impact on operations and customer data center expansion?",
      "original_answer": "In 2023, NVDA highlighted that pollution limits and related climate regulations could increase direct and indirect costs, including compliance, energy, and capital expenditures, and could require changes to manufacturing processes and supply chain operations. By 2024, the company expanded its concern to include not only cost increases but also the potential for land and permitting constraints tied to pollution limits, which could impair customers' ability to expand data center capacity—an essential market for NVDA's products. This indicates a growing concern that regulatory tightening around pollution could directly affect demand for NVDA's offerings.",
      "llm_answer": "In the 2023 filing NVIDIA first flagged pollution‑limit regulations as a climate‑related risk that could raise direct costs (e.g., changes to manufacturing processes, raw‑material sourcing, capital‑expenditure upgrades) and indirect costs passed on by customers or suppliers, potentially forcing the company to alter its operations or product design【page_22】. By the 2024 filing the company still warned of those cost pressures, but it expanded the exposure to note that regulations limiting energy, water or land – including pollution limits – could also restrict customers’ ability to expand data‑center capacity, thereby threatening demand for NVIDIA’s products and services【page_22】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key factual elements are correct: in 2023, NVDA identified pollution limits as a risk leading to increased direct and indirect costs, including compliance, manufacturing changes, and supply chain impacts; by 2024, the concern expanded to include land and permitting constraints affecting customer data center expansion. The LLM correctly captures this evolution. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, correctly identifying the expansion of risk from internal cost impacts (2023) to external demand-side risks via customer constraints (2024). The mention of 'energy, water or land' as regulatory levers, while slightly broader than the original's focus on pollution limits, is contextually appropriate and reflects the broader environmental regulation context in which pollution limits operate. (4) The answer is semantically equivalent to the original, with only minor rephrasing and no material omissions. The reference to 'page_22' adds sourcing but does not affect accuracy. One point deducted from qualitative accuracy because the LLM slightly generalizes 'pollution limits' into broader resource constraints without explicitly tying land/permitting issues back to pollution—though this linkage is implied, it's less precise than the original. Overall, the response is factually correct, complete, and contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 446,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How did the composition and valuation of the company's Guaranteed Senior Notes evolve between 2023 and 2024, particularly in terms of issuance, repayment, and fair value inputs?",
      "original_answer": "In 2023, the company's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. These notes were valued using Level 3 inputs. In 2024, the Japanese subsidiary repaid $77 of these Guaranteed Senior Notes. The fair value of long-term debt, including Guaranteed Senior Notes, was approximately $5,412 at the end of 2024, compared to $5,738 at the end of 2023. This indicates a reduction in the overall fair value of long-term debt, partially driven by repayments on the Guaranteed Senior Notes.",
      "llm_answer": "In 2023 Costco’s Japanese subsidiary issued four Guaranteed Senior Notes worth roughly $500, which were recorded under “Other long‑term debt” and valued using Level 3 (unobservable) inputs; the balance of that line was $484 at year‑end 2023. By September 2024 the subsidiary had repaid $77 of the notes, raising “Other long‑term debt” to $919 (reflecting the net $500 issuance less the $77 repayment) and contributing to a decline in the total fair‑value of long‑term debt from about $5,738 to $5,412. The valuation of the Guaranteed Senior Notes continues to rely on Level 3 inputs, while the other senior notes are measured with Level 2 inputs.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct elements but also significant inaccuracies. It correctly states that in 2023, the Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed rates (though exact rates 1.400%-2.120% are omitted), and that these were valued using Level 3 inputs. It also correctly notes the $77 repayment in 2024 and the decline in total fair value of long-term debt from $5,738 (2023) to $5,412 (2024). However, it introduces a fabricated figure of 'Other long-term debt' being $484 at year-end 2023 and rising to $919 by September 2024, which is not in the original answer and contradicts the logic (repayment should reduce debt, not increase it). The claim that 'raising Other long-term debt to $919' due to net issuance is illogical and factually unsupported. (2) Quantitative accuracy is partially correct: $500 issuance, $77 repayment, and fair value drop from $5,738 to $5,412 are accurate. But the $484 and $919 figures are incorrect and not in the ground truth. The explanation misrepresents the financial impact of the repayment. (3) Multi-hop reasoning is flawed: while the model identifies issuance, repayment, and valuation inputs correctly, it fails to accurately synthesize how these affect the overall debt balance. The erroneous claim that debt increased to $919 after a $77 repayment on a $500 note issuance suggests a fundamental misunderstanding of debt accounting. (4) Contextual relevance is high—the answer addresses issuance, repayment, fair value, and valuation inputs as required. However, the inclusion of unsupported line-item balances and incorrect logic undermines factual correctness. The mention of Costco is problematic if not confirmed in source (original answer does not name Costco), introducing potential entity error. Overall, core facts are partially correct but mixed with significant fabrications and flawed reasoning, warranting a mid-range score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 528,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did Netflix's investment in streaming service improvements and associated risk exposure evolve from 2022 to 2024, based on the specific personnel and cybersecurity-related changes disclosed in those years?",
      "original_answer": "In 2022, Netflix disclosed a $384 million increase in personnel-related costs driven by headcount growth to support production activity and improve the streaming service. By 2024, the focus had evolved to include significant emphasis on cybersecurity, with detailed descriptions of enterprise-wide security programs, third-party risk management, and the potential financial impact of cyber incidents. The company highlighted the risk of unauthorized data releases and digital content theft, noting that such events could adversely affect business operations and financial results. This represents a shift from purely growth-oriented investment in streaming to a more risk-aware posture as the service matured.",
      "llm_answer": "In the 2022 filing Netflix said its technology‑and‑development spend jumped 24% to $2.27 billion, largely because “personnel‑related costs” rose $384 million as the company added head‑count to support more production activity and continued improvements to the streaming service. By the 2024 filing the narrative shifts to risk mitigation: Netflix describes an enterprise‑wide security program overseen by a Vice President of Security and Privacy Engineering, expanded security tools, bug‑bounty and third‑party risk programs, and regular board‑level reporting of cyber‑risk assessments, showing a greater focus on protecting the streaming platform from cyber threats.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $384 million increase in personnel-related costs in 2022 is accurately reported, and while the $2.27 billion total technology-and-development spend and 24% increase are not in the original answer, they are consistent with plausible context and do not contradict the ground truth. These additional details enhance rather than distort the response. (2) The entity identification is correct—Netflix, 2022 and 2024 timeframes, personnel costs, cybersecurity evolution—and the multi-hop synthesis across years is sound. (3) The reasoning correctly captures the shift from investment in growth (headcount for streaming improvements) to risk management (cybersecurity programs, third-party risk, board reporting), which is the core of the question. (4) The LLM adds specific organizational details (e.g., Vice President of Security and Privacy Engineering, bug-bounty programs) not in the original answer but plausibly reflective of the disclosed 2024 cybersecurity posture; these do not introduce inaccuracies but enrich the narrative. The only minor gap is that the original answer explicitly mentions the financial risk of data breaches and content theft affecting operations, which the LLM implies but does not directly state. This slight omission in qualitative completeness prevents a perfect 10, but overall the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 412,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did The Bank of New York Mellon Corporation's approach to restricted stock unit agreements evolve between the 2023 and 2024 filings, particularly in terms of the lifecycle management of these equity instruments and their implications for executive compensation strategy?",
      "original_answer": "In the 2023 filing, the '2024 Form of Restricted Stock Unit Agreement' was newly introduced and explicitly stated as 'Filed herewith,' indicating it was a current and newly adopted form for that year. This suggests the company was actively updating its equity compensation framework to align with strategic goals for executive retention and incentives. By the 2024 filing, this '2024 Form' was no longer newly filed but instead was referenced as 'Previously filed,' signaling it had become an established part of the company's compensation structure. Additionally, in 2024, the company introduced the '2025 Form of Restricted Stock Unit Agreement,' which was marked as 'Filed herewith,' showing a forward-looking update to the equity compensation strategy. This evolution indicates a consistent, proactive approach to managing executive compensation frameworks, with new forms being introduced annually and the prior year’s forms transitioning into reference documents. This reflects a mature, iterative process in shaping executive incentives and aligning them with long-term corporate objectives.",
      "llm_answer": "In the 2023 10‑K the company disclosed only a single “2023 Form of Restricted Stock Unit Agreement” (Exhibit 10.27/10.24), whereas the 2024 10‑K added a new “2024 Form of Restricted Stock Unit Agreement” (Exhibit 10.29/10.26) and, for the first time, a forward‑looking “2025 Form of Restricted Stock Unit Agreement” (Exhibit 10.29). This shift signals a move from a one‑year‑only RSU template to a staged, lifecycle‑managed program that pre‑positions future RSU issuances, enabling BNY Mellon to align equity vesting and performance criteria more deliberately with its executive compensation and retention strategy.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general direction of the evolution in BNY Mellon's restricted stock unit (RSU) agreement strategy—specifically, the introduction of forward-looking forms and a shift toward lifecycle management. However, it contains significant factual inaccuracies that reduce its correctness. First, the LLM incorrectly states that the 2023 filing included a '2023 Form of Restricted Stock Unit Agreement,' while the ground truth indicates that the '2024 Form' was introduced in the 2023 filing as 'Filed herewith.' This misalignment in year labeling is a critical error: the form labeled for a future year (e.g., 2024 Form) is filed in the prior year’s 10-K (2023), not the same year. Similarly, the LLM claims the 2024 10-K introduced both the '2024 Form' and the '2025 Form,' but according to the ground truth, the 2024 Form was already introduced in 2023 and thus only referenced as 'Previously filed' in 2024, while the '2025 Form' was newly introduced in 2024. The LLM incorrectly implies the 2024 Form was first added in the 2024 filing, which contradicts the ground truth. Additionally, the exhibit numbers cited (e.g., 10.27/10.24, 10.29/10.26) are not present in the ground truth and appear fabricated or misattributed, further undermining quantitative accuracy. Despite these errors, the qualitative insight—that BNY Mellon is moving toward a staged, forward-looking RSU framework for better lifecycle and strategic alignment—is consistent with the ground truth. The reasoning about executive compensation strategy implications is plausible and contextually relevant. Thus, while the conceptual interpretation is sound, the factual foundation is flawed, particularly in dates and document timelines, leading to a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 477,
        "total_tokens": 1937
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the status and structure of the 4.90% Senior Notes evolved from 2023 to 2024, particularly in terms of their carrying amount and maturity timeline?",
      "original_answer": "In 2023, the 4.90% Senior Notes were newly issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. Interest payments were scheduled semi-annually starting April 15, 2024. By 2024, these notes remained outstanding, with a carrying amount of $743 million as of January 28, 2024. The maturity date remained unchanged at April 2029, and the notes continued to be listed among the company’s long-term debt obligations. The carrying amount slightly decreased, reflecting the initial discount and amortization progress over the year.",
      "llm_answer": "The 4.90 % senior notes consist of two $750 million tranches – one due September 2026 and one due April 2029 – that were issued in November 2023. In the 2023 filing the notes carried $744 million (Sept 2026) and $743 million (Apr 2029) on the balance sheet (HD 10‑K 2023 p. 59), and by the 2024 filing the same tranches show slightly higher carrying amounts of $747 million and $744 million respectively (HD 10‑K 2024 p. 62), while their scheduled maturities (Sept 2026 and Apr 2029) remain unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states there is only one tranche of 4.90% Senior Notes, issued in November 2023, with a principal amount of $750 million, a discount of $3.4 million, and a maturity date of April 15, 2029. However, the LLM incorrectly claims there are two tranches — one due September 2026 and one due April 2029 — which is not supported by the original answer. This misrepresents the structure of the debt. (2) Quantitatively, the LLM reports incorrect carrying amounts: it states $744M and $743M in 2023 and $747M and $744M in 2024 for two tranches, but the ground truth specifies a single note with a carrying amount of $743 million as of January 28, 2024, derived from $750M principal minus $3.4M discount and partial amortization. The LLM’s numbers do not align with this, and the trend of increasing carrying amounts contradicts the expected amortization of a discount (which should gradually increase the carrying amount toward par, but starting from ~$746.6M, not lower). (3) The multi-hop reasoning is flawed: the model fails to correctly identify the single-note structure and invents a second tranche with a different maturity, leading to incorrect synthesis across years. It also mischaracterizes the evolution by suggesting both tranches increased in carrying amount, which conflicts with standard amortization logic and the provided truth. (4) Contextual relevance is moderate — the answer addresses carrying amounts and maturity timelines as asked, and references correct filing years and pages, but the core entities (number of tranches, maturities, amounts) are wrong, undermining the response. The mention of HD 10-K filings suggests plausible sourcing, but the data extracted is factually incorrect relative to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 493,
        "total_tokens": 1772
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How did the issuance and repayment of Guaranteed Senior Notes by Costco's Japanese subsidiary evolve between 2023 and 2024?",
      "original_answer": "In 2023, Costco's Japanese subsidiary issued four Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%. In 2024, the subsidiary repaid $77 of these Guaranteed Senior Notes. Additionally, the proceeds from the issuance of these notes were referenced in the 2024 filing as a source of financing activity, indicating continued financial engagement with this instrument.",
      "llm_answer": "Costco’s Japan subsidiary issued four Guaranteed Senior Notes in November 2023, raising about $500 million of debt. In July 2024 it repaid $77 million of those notes, so the “Other long‑term debt” (which consists of the Guaranteed Senior Notes) rose to $919 million at the end of 2024 from $484 million at the end of 2023【page_52】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the issuance of four Guaranteed Senior Notes in 2023 totaling approximately $500 million and the repayment of $77 million in 2024, which aligns with the ground truth. However, it introduces a significant factual error by stating that 'Other long-term debt' rose to $919 million at the end of 2024 from $484 million at the end of 2023. This specific numerical trajectory is not supported by the original answer and appears to be an unsupported inference or miscalculation. The ground truth does not provide ending balances for long-term debt, so this claim cannot be verified and contradicts the limited data available. (2) The dates (November 2023 issuance, July 2024 repayment) are plausible but more specific than the original answer, which only specifies the years 2023 and 2024. These added specifics may be accurate but are not confirmed in the ground truth, introducing potential overprecision. The $500 million and $77 million figures match the original answer in magnitude and intent (allowing for the 'approximately' qualifier), so those are acceptable. (3) The multi-hop reasoning is partially sound — the model connects issuance and repayment events across years and attempts to contextualize them within long-term debt. However, the calculation or assertion about the net change in 'Other long-term debt' is flawed or unsupported, indicating a failure in accurate synthesis. The original answer does not mention debt balances at year-end, so introducing them undermines factual correctness. (4) The contextual relevance is high because the answer addresses the evolution of the notes and ties them to financial activity. However, the quantitative accuracy is reduced due to the unsupported debt balance figures. The qualitative accuracy is moderate because core facts are present but mixed with unverified details. Correctness score is 6 due to partially correct facts but significant added inaccuracies in financial balances.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1181,
        "completion_tokens": 534,
        "total_tokens": 1716
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How has the risk associated with competitors developing after-market parts for DHR's products evolved from 2022 to 2023, particularly in terms of its impact on the company's business and financial statements?",
      "original_answer": "In 2022, the risk of competitors developing after-market parts was described as a direct threat that could 'detract from our sales,' with an emphasis on how commoditization and private-label offerings could reduce market prices and erode DHR's competitive position. By 2023, the framing of this risk shifted to being 'Impacted By' such competition, with a broader contextualization within cost containment trends in the healthcare industry and pricing pressures from managed care and government reimbursement policies. While the core risk remained, it was presented as one of several external pressures rather than a primary threat, suggesting a relative de-emphasis in severity or a strategic recalibration in how the company perceives this risk.",
      "llm_answer": "Both the 2022 and 2023 Form 10‑K risk‑factor sections contain the same warning that “competitors may also develop after‑market services and parts for our products which may detract from our sales,” and that this could “adversely affect our business and financial statements.” The language is essentially unchanged from 2022 to 2023, indicating the risk remains a consistent concern with no new escalation or mitigation noted. (2022 Risk Factors – page 20; 2023 Risk Factors – page 20)",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that the language in the 2022 and 2023 10-K filings is 'essentially unchanged.' While both years do mention that competitors may develop after-market parts and that this could detract from sales, the original answer (ground truth) correctly identifies a meaningful shift in framing and emphasis. In 2022, the risk was presented as a direct and specific threat to sales and competitive position, tied to commoditization and private-label competition. By 2023, the risk was recontextualized as being 'Impacted By' broader industry trends like cost containment, managed care pricing pressures, and government reimbursement policies—indicating a strategic reframing that positions this risk as one of several external pressures rather than a primary threat. The LLM fails to detect this evolution in tone, context, and relative severity, which is central to the question. There are no numerical inaccuracies (hence high quantitative accuracy), but the qualitative analysis and multi-hop reasoning are flawed. The answer is relevant to the topic but misses the nuanced shift the question asks about, resulting in low correctness and qualitative accuracy despite correct entity identification (DHR, years, risk topic).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 353,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Netflix's approach to membership plans evolved from 2022 to 2024, particularly in terms of pricing strategy and service features, and what business challenges were these changes intended to address?",
      "original_answer": "In 2022, Netflix experienced a 19% revenue increase driven by an 11% growth in average paying memberships and a 7% rise in average monthly revenue per membership, partly due to price increases and favorable foreign exchange rates. However, paid net membership additions dropped by 50% compared to the prior year, signaling early signs of member acquisition challenges. By 2024, Netflix responded by introducing a lower-priced ad-supported subscription plan and enforcing terms of use to limit multi-household usage. These changes were aimed at addressing fluctuating member acquisition, retention pressures, and increasing competition in the streaming and broader entertainment market. The company acknowledged that macroeconomic conditions, content competition, and consumer sensitivity to pricing adjustments could negatively impact membership growth and profitability.",
      "llm_answer": "In the 2022 filing Netflix still relied on a tiered, region‑based pricing model – paid plans ranged roughly from $2 to $27 a month and the company used periodic price hikes to lift average monthly revenue per paying member as net membership additions slowed and inflation pressure grew 【page_24】. By the 2024 filing the company had introduced a lower‑priced ad‑supported tier, tightened enforcement of shared‑account rules and begun bundling new features such as games, advertising and live programming to broaden the value proposition 【page_6】, 【page_7】. These shifts were intended to attract price‑sensitive consumers, boost ARPU and counter competitive, macro‑economic and content‑cost challenges that were threatening member growth and margin expansion 【page_6】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the LLM correctly notes Netflix's reliance on price increases in 2022 to boost revenue amid slowing membership growth, consistent with the 7% rise in average monthly revenue per membership and 11% membership growth mentioned in the original. While the LLM provides approximate price ranges ($2–$27), these are reasonable estimates and not contradicted by the ground truth; exact figures were not specified in the original, so this does not constitute an error. The 2024 introduction of the ad-supported tier and enforcement of account-sharing rules are correctly identified. (2) The LLM accurately captures the business challenges: competitive pressures, macroeconomic conditions, and member acquisition/retention issues. It correctly links the strategic changes to goals like attracting price-sensitive users, boosting ARPU, and countering margin pressures—consistent with the original’s focus on addressing fluctuating growth and profitability risks. (3) Multi-hop reasoning is sound: the answer synthesizes information across 2022 and 2024 timeframes, connects pricing and feature changes to underlying business challenges, and infers strategic intent from observable actions. (4) Minor deduction in quantitative accuracy is due to the lack of specific percentages (e.g., 19% revenue increase, 50% drop in net additions), which were present in the ground truth and would have strengthened completeness. However, the core facts, entities, and logic are correct, and the answer remains semantically equivalent in intent and substance. Contextual relevance is perfect—every part of the question is addressed directly and appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 468,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has Boeing's approach to in-orbit incentive payments evolved between 2022 and 2023, particularly in terms of risk exposure and financial recognition?",
      "original_answer": "In 2022, Boeing highlighted the financial risks associated with in-orbit incentive payments, particularly in the context of potential program cancellations or failure to meet performance criteria, which could trigger termination provisions or loss of payments. The company noted that these risks were part of ongoing fixed-price development programs like Commercial Crew, KC-46A Tanker, and VC-25B. By 2023, Boeing had recorded $1,585 million in additional losses on its five most significant fixed-price development programs, which included those mentioned in 2022, and explicitly stated that in-orbit incentive payments were at risk if satellites failed to meet performance criteria over up to 15 years post-acceptance. The company also emphasized that the net present value of these fees was recognized as revenue during the construction period, increasing financial exposure if performance issues arose. This represents a shift from general risk acknowledgment in 2022 to a more specific quantification of losses and a detailed explanation of revenue recognition practices tied to in-orbit performance in 2023.",
      "llm_answer": "In the 2022 filing Boeing only warned that a satellite’s failure to meet specifications could **trigger the loss of in‑orbit incentive payments**, treating those payments as a potential exposure but not describing how they are accounted for【page_45】. By the 2023 filing the company says it **recognizes the net present value of the incentive fees as revenue in the construction period**, while still noting that if the satellite does not perform for up to 15 years the customer can stop payments and Boeing may have to refund amounts, making the revenue‑recognition policy explicit and the performance risk more clearly quantified【page_15】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution in Boeing's approach to in-orbit incentive payments between 2022 and 2023. (1) It correctly identifies that in 2022, Boeing acknowledged the risk of losing payments if satellites failed to meet specifications, without detailing accounting treatment. In 2023, it accurately states that Boeing began recognizing the net present value of incentive fees as revenue during construction, while still facing long-term performance risk up to 15 years post-acceptance. (2) Quantitatively, the LLM does not include the $1,585 million in additional losses mentioned in the ground truth. This is a minor omission—while not strictly required for the core explanation of risk and recognition evolution, it is a key quantitative detail that enhances completeness. However, since the question focuses on 'approach,' 'risk exposure,' and 'financial recognition,' and not explicitly on loss amounts, the absence does not severely undermine correctness. (3) The multi-hop reasoning is sound: the model synthesizes information across two years, correctly contrasting qualitative risk disclosure in 2022 with more explicit accounting policy and risk quantification in 2023. (4) The answer is contextually relevant and semantically equivalent to the ground truth in all major aspects except the missing dollar figure. Wording differences (e.g., 'stop payments and refund' vs. 'loss of payments') are acceptable and convey the same meaning. The answer earns a 9 due to high accuracy with only a minor omission of a specific financial figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 432,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Directors' Code of Conduct was explicitly described as being posted on the company's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/invrelations/directors-code-of-conduct.pdf, and the company stated its intention to disclose amendments or waivers on the website. In 2024, while the Code remained accessible, it was referenced more generally as part of a broader list of governance materials available on the company’s website, including committee charters and governance guidelines, without repeating the direct URL. The change indicates a shift from detailed disclosure of access to a more consolidated and implicit reference, suggesting a streamlined but less direct approach to public access in 2024.",
      "llm_answer": "In the 2023 Form 10‑K the Directors’ Code of Conduct was only mentioned in the “Code of Ethics” section with a specific PDF link ( https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/inv relations/directors‑code‑of‑conduct.pdf ) and a statement that any amendments or waivers would be posted there 【page_13】. By the 2024 filing, the Code is listed together with the Corporate Governance Guidelines, By‑laws and committee charters as a document that is “made available on our website, free of charge,” indicating a more formal, prominent and easily accessible disclosure 【page_3】.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the presence of the Directors' Code of Conduct in both 2023 and 2024 filings and accurately reports the specific URL in the 2023 document, as well as the statement about posting amendments. It also correctly notes that in 2024, the Code is listed among other governance documents with a general reference to website availability. However, the LLM mischaracterizes the evolution as a move toward 'more formal, prominent and easily accessible disclosure,' which contradicts the ground truth that describes a shift to a 'more consolidated and implicit reference'—indicating less direct access. This reversal in interpretation is a significant qualitative error. (2) Quantitatively, all details are accurate: the URL is correct, the years match, and there are no numerical inaccuracies (though no numbers are involved). Format and references are preserved correctly. (3) The multi-hop reasoning is partially sound—the model synthesizes information across two years and identifies changes in disclosure style—but it draws an incorrect conclusion about the direction of change (improved vs. reduced explicitness), failing to recognize that removing the direct link and detailed update policy represents a less direct approach. (4) Correctness is scored 6 due to accurate facts but flawed synthesis; quantitative accuracy is 10 because all factual elements are correct; qualitative accuracy is 6 due to the incorrect interpretation of the nature of the change; contextual relevance is 9 because the response directly addresses the question’s focus on evolution between years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 442,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How has the role and deployment strategy of Mobileye Drive™ evolved between 2022 and 2023?",
      "original_answer": "In 2022, Mobileye launched the SAE L4 Self-Driving System (SDS), Mobileye Drive™, and secured multiple collaborations for commercial use, including with Udelv for autonomous cargo delivery and with Transdev for self-driving mobility services. Additionally, Mobileye achieved its first consumer L4 design win with Geely. By 2023, Mobileye’s strategy had evolved to focus on supplying the Mobileye Drive™ self-driving system to transportation network companies, public transit operators, and suppliers of AV-ready vehicle platforms, with plans to bundle it with Moovit’s urban mobility and transit intelligence application. This shift indicates a more defined go-to-market strategy targeting fleet deployment and mobility-as-a-Service (MaaS) ecosystems.",
      "llm_answer": "In 2022 Mobileye Drive™ was introduced as an SAE L4 self‑driving system (the “Level 4 self‑driving system, Mobileye Drive”) and was first used in early commercial pilots – e.g., collaborations with Udelv for autonomous cargo delivery, Transdev for mobility services, and a consumer L4 design win with Geely 【page_30】. By 2023 the company shifted Mobileye Drive’s role to be the flagship eyes‑off/hands‑off autonomous‑driving platform for AMaaS, targeting transportation‑network companies, public‑transit operators and suppliers of AV‑ready vehicle platforms, often bundled with Moovit’s urban‑mobility and transit‑intelligence services 【page_34】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Mobileye Drive™ was launched as an SAE L4 system in 2022, with collaborations named (Udelv, Transdev), and the Geely design win is accurately mentioned. In 2023, the strategic shift toward targeting transportation network companies, public transit operators, and AV platform suppliers is correctly reported, as is the bundling with Moovit’s services. (2) There are no numeric values requiring calculation, but all dates (2022, 2023) and entity names are accurate. (3) The multi-hop reasoning is sound—the model synthesizes information across time periods and partnerships to show evolution in strategy. (4) The only minor shortcoming is the use of ‘AMaaS’ without spelling out ‘Autonomous Mobility-as-a-Service’, which slightly reduces clarity, but the context implies the correct meaning. Otherwise, the answer is semantically equivalent to the original, well-structured, and fully relevant to the question about strategic evolution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 305,
        "total_tokens": 1640
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has the structure and distribution rate of the Tower Preferred Interests evolved from 2022 to 2024?",
      "original_answer": "In 2022, the Tower Preferred Interests were divided into two series: the September series (Class A-1) totaling $1,500 with a 5.0% initial preferred distribution, and the December series (Class A-2) totaling $4,500 with a 4.75% initial preferred distribution. These distributions reset every five years. By 2024, the structure was amended in August 2024 to reclassify all 2019 Tower preferred interests into Fixed Rate Class A Limited Membership Interests (Tower Fixed Rate Interests) paying a 5.90% preferred distribution. Additionally, a portion of these fixed-rate interests will transition annually into Floating Rate Class A Limited Membership Interests (Tower Floating Rate Interests), which will pay a distribution equal to SOFR plus 250 basis points. This represents both a structural and rate evolution in the Tower Preferred Interests.",
      "llm_answer": "In the 2022 filing the Tower Holdings preferred interests were a single $6 billion non‑convertible cumulative issue split into two fixed‑rate series – a September Class A‑1 of $1.5 bn paying a 5.0% preferred distribution and a December Class A‑2 of $4.5 bn paying 4.75%, with quarterly payouts and a five‑year reset. By the 2024 filing AT&T had amended those interests: the original series were re‑designated as Fixed‑Rate Class A Limited Membership Interests that pay a 5.90% distribution and Floating‑Rate Class A Limited Membership Interests that pay SOFR + 250 bps, with a portion moving to the floating class each year over a five‑year transition, while the total principal amount remains $6 bn.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core evolution of the Tower Preferred Interests from 2022 to 2024, with accurate structure, amounts, and rates. (1) Quantitatively, the $1.5 billion and $4.5 billion amounts (equivalent to $1,500 and $4,500 in millions in the ground truth) and respective 5.0% and 4.75% rates in 2022 are correct. The 2024 reclassification into Fixed-Rate (5.90%) and Floating-Rate (SOFR + 250 bps) interests is also accurately described. However, the ground truth specifies the restructuring occurred in August 2024, which the LLM omits—this is a minor but relevant date discrepancy. (2) The LLM incorrectly attributes the amendment to 'AT&T'—the original answer does not mention AT&T, and the entity is not part of the ground truth, introducing an incorrect entity. This affects qualitative accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes the 2022 structure and the 2024 structural change, including the transition mechanism from fixed to floating rates annually over five years. (4) The total principal of $6 billion is correctly inferred as the sum of the two series, and the description of the reset and payout frequency adds useful context not in the ground truth but not contradicted. Overall, the answer is semantically equivalent in key facts but has minor inaccuracies in entity attribution and timing, justifying a score of 8. Contextual relevance is perfect as it directly addresses the structural and rate evolution asked in the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 415,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the investment approach and unrealized gains/(losses) for Level 3 assets related to the Balanced Index Fund evolve from 2022 to 2023?",
      "original_answer": "In 2022, the company disclosed unrealized losses for Level 3 assets still held at year-end, including ($16) million for corporate fixed income securities and ($11) million for mortgage-backed and asset-backed fixed income securities. By 2023, these values shifted to unrealized gains of $2 million for corporate fixed income securities and $6 million for mortgage-backed and asset-backed fixed income securities. This indicates a significant turnaround in the performance of these assets. Additionally, while the Balanced Index Fund's composition remained at approximately 60% equities and 40% debt securities in both years, the valuation methodology in 2023 explicitly referenced a market approach based on quoted market prices (Level 1), suggesting a more transparent and standardized valuation process.",
      "llm_answer": "The OPB plan’s balanced‑index fund was still valued with a market approach that uses the quoted price of an identical Level 1 instrument in both years【page_96】.  In 2022 the Level 3 assets underlying that fund posted net unrealized losses of roughly $42 million (‑$16 M corporate, ‑$11 M mortgage‑backed, ‑$14 M municipal and ‑$1 M real‑asset)【page_96】, whereas in 2023 the same assets recorded net unrealized gains of about $10 million (+$2 M corporate, +$6 M mortgage‑backed, +$3 M other, offset by a $1 M loss on real assets)【page_96】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes some correct directional trends and partial numeric values but introduces significant inaccuracies. The ground truth reports only two categories of Level 3 assets: corporate fixed income ($-16M in 2022, +$2M in 2023) and mortgage-backed/asset-backed securities ($-11M in 2022, +$6M in 2023). However, the LLM answer adds two unsupported categories—municipal (-$14M) and real-asset (-$1M) in 2022, and 'other' (+$3M) and real assets (-$1M) in 2023—which are not present in the original answer. This inflates the net unrealized loss to $42M in 2022 and gain to $10M in 2023, which are not corroborated by the ground truth. These additions represent major quantitative errors. (2) The correct total unrealized loss in 2022 should be $27M ($16M + $11M), not $42M; in 2023, the total gain should be $8M ($2M + $6M), not $10M. These miscalculations stem from including unverified asset classes. (3) On qualitative accuracy, the LLM correctly identifies a shift from losses to gains and references a market approach for valuation. However, it fails to mention the key point from the original answer that the Balanced Index Fund maintained a 60/40 equities-to-debt allocation in both years, which is central to the investment approach. Also, the original highlights that the 2023 methodology 'explicitly referenced' Level 1 pricing as a change toward transparency, while the LLM implies the market approach was used in both years without noting this evolution. (4) Contextually, the answer is relevant and attempts multi-hop reasoning across years and asset types, but the inclusion of unverified asset categories and misrepresentation of valuation methodology evolution reduce factual reliability. The answer captures the turnaround theme but distorts magnitude and reasoning details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 492,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How has BNY Mellon's emphasis on accounting developments in its forward-looking statements evolved between 2023 and 2024, and what does this reveal about the changing influence of accounting standards on its strategic priorities?",
      "original_answer": "In 2023, BNY Mellon included accounting developments among a broader list of potential influences on forward-looking statements, noting they 'may impact our businesses' without specific elaboration. By 2024, the company expanded this language, explicitly stating that accounting developments 'may impact our businesses, regulatory, technology, market, economic or accounting developments and the impacts of such developments on our businesses.' This shift indicates a more integrated view of accounting changes as part of strategic risk and planning considerations. The inclusion of terms like 'capital plans including dividends and repurchases' and 'efficiency savings' in 2024 further suggests that accounting developments are increasingly tied to concrete business decisions and performance metrics.",
      "llm_answer": "BNY Mellon’s forward‑looking language is essentially unchanged – both the 2023 and 2024 Form 10‑K forward‑looking sections list “accounting developments” alongside regulatory, technology, market and economic factors (2023 p. 3; 2024 p. 3). The identical placement shows that accounting standards remain a recognized material influence, but they have not been elevated to a primary strategic focus, with the firm’s priorities still centered on broader operational, risk‑management and growth initiatives.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that BNY Mellon's forward-looking language is 'essentially unchanged' between 2023 and 2024. The ground truth shows a clear evolution: in 2023, accounting developments were mentioned as one of several factors that 'may impact our businesses,' but in 2024, the language was expanded to explicitly include 'the impacts of such developments on our businesses' and linked to specific strategic elements like 'capital plans including dividends and repurchases' and 'efficiency savings.' This indicates a more integrated and strategic treatment of accounting developments, contrary to the LLM's assertion of no change. While the LLM correctly identifies that accounting developments are listed alongside other factors in both years (hence no numeric or entity errors), it fails to detect the significant qualitative expansion and contextual deepening in 2024. The reasoning is flawed because it draws a conclusion of 'no change' based on surface-level similarity, missing the multi-hop nuance of how the framing and implications evolved. This undermines the qualitative accuracy and overall correctness. The answer is contextually relevant to the question but reaches an incorrect conclusion due to insufficient textual analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 356,
        "total_tokens": 1703
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How did the evolution of risks related to store safety and cybersecurity in 2023 potentially impact the associate experience, as compared to the engagement-focused initiatives highlighted in 2022?",
      "original_answer": "In 2022, HD emphasized internal initiatives to improve the associate experience through engagement surveys, a digital engagement platform, and recognition programs, which historically showed that four out of five associates were emotionally committed. However, in 2023, the company highlighted external risks such as increased store shrink, particularly from organized retail crime, and cybersecurity threats that could compromise associate data and store safety. These risks were noted to potentially erode trust, impact associate morale and retention, and damage the company's reputation. This shift indicates that while HD was actively fostering associate engagement in 2022, the emergence or escalation of external risks in 2023 introduced new challenges that could undermine those earlier gains in associate experience.",
      "llm_answer": "In the 2023 filing Home Depot warned that a failure to keep stores safe –‑ from organized retail crime, “shrink” and other safety incidents –‑ or to protect its data from cyber‑attacks could “erode trust and confidence with … associates, … impact associate morale and retention” and even damage the brand (2023 p. 20‑22). By contrast, the 2022 filing highlighted a suite of engagement‑focused programs –‑ regular pulse‑check and Voice‑of‑Associate surveys, a digital engagement platform, recognition awards, DEI initiatives and expanded compensation/benefits –‑ that were designed to drive high associate commitment and a positive experience (2022 p. 13). Thus, the newer safety and cybersecurity risks identified in 2023 pose a potential threat to the associate experience that the 2022 engagement initiatives had sought to strengthen.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 engagement initiatives (surveys, digital platform, recognition, DEI, compensation) and the 2023 risks (store safety, organized retail crime, shrink, cybersecurity) are accurately described. The impact on associate morale, retention, and trust is correctly identified in both years. (2) There are no numeric values (e.g., percentages, dollar amounts) in either the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly contrasts 2022's internal engagement focus with 2023's external risk environment and synthesizes how the latter could undermine the former. It references specific page numbers (2023 p. 20–22, 2022 p. 13), which adds precision. (4) The only minor shortcoming is that the LLM omits the specific statistic from 2022 that 'four out of five associates were emotionally committed,' which is a small but relevant detail about the success of prior engagement efforts. Otherwise, the semantic meaning, structure, and intent fully match the original answer. Contextual relevance is perfect—the response directly addresses the evolution of risks and their potential impact on the associate experience compared to prior initiatives.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 374,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the role of the 'learning curve' in influencing cost and production estimates evolved between 2022 and 2023, particularly in relation to program profitability and risk management?",
      "original_answer": "In 2022, the 'learning curve' was identified as a risk factor that could negatively impact program profitability due to production complexities, rework, and delays—especially in programs like the 787—potentially leading to additional losses and abnormal production costs. By 2023, the 'learning curve' was no longer framed solely as a risk but was integrated into the company's cost estimation process, factored into production rate assumptions, supplier performance trends, and internal labor efficiency projections. This shift indicates that Boeing began treating the learning curve as a predictable and manageable component of production planning rather than an unpredictable risk.",
      "llm_answer": "In the 2022 filing the learning curve is mentioned only in a broad “risk‑factor” paragraph – a possible element that could erode program margins if expected cost‑savings from experience fail to materialize. By the 2023 filing, the learning curve is listed explicitly among the key inputs that drive the quarterly cost‑and‑production estimates, and the company notes that it directly influences program gross‑margin forecasts and is factored into its risk‑management and profitability assessments. This reflects a shift from a peripheral risk consideration in 2022 to a core component of the 2023 cost‑model and profit‑risk analysis.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core evolution of the 'learning curve' concept between 2022 and 2023 as described in the ground truth. (1) It correctly identifies that in 2022, the learning curve was mentioned as a risk factor that could erode margins if expected cost savings failed to materialize—consistent with the original answer's emphasis on risk due to production complexities and delays. In 2023, the LLM correctly notes it became an explicit input into cost-and-production estimates and influenced gross-margin forecasts, aligning with the ground truth's description of integration into cost estimation, production rates, supplier trends, and labor efficiency. (2) There are no numeric values, dates, or financial figures in the question or answers that require verification—both years (2022, 2023) are correctly referenced. (3) The multi-hop reasoning is sound: the model synthesizes a shift in framing—from passive risk to active modeling input—across two years and connects it to cost estimation, profitability, and risk management. The only minor shortcoming is that the LLM does not mention specific programs like the 787 or terms like 'abnormal production costs' or 'rework,' which are part of the original context, but these omissions do not undermine the central claim about the conceptual shift. (4) The answer is semantically equivalent to the ground truth, uses appropriate financial and operational terminology, and directly addresses all parts of the question. Hence, a correctness score of 9 is warranted—excellent accuracy with only minor contextual omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 437,
        "total_tokens": 1776
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the treatment or disclosure of the Dividend Reinvestment Plan evolved between the 2023 and 2024 SEC filings, particularly in relation to officer or director participation and associated trading arrangements?",
      "original_answer": "In the 2023 filing, the Dividend Reinvestment Plan was mentioned in the context of officer or director participation alongside the employee stock purchase plan and 401(k) plan, with specific reference to elections to have shares withheld for tax purposes or to pay the exercise price of stock awards. The disclosure also included a detailed description of how these elections may be structured under Rule 10b5-1 or non-Rule 10b5-1 trading arrangements as defined in Item 408(c) of Regulation S-K. In the 2024 filing, the Dividend Reinvestment Plan was again referenced in the context of officer or director participation, but the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements was omitted, indicating a simplification or standardization of the disclosure without the earlier level of specificity regarding trading frameworks.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K filings contain the same disclosure that “certain of our officers or directors have made elections to participate in, and are participating in, our dividend reinvestment plan … and have made, and may from time to time make, elections to have shares withheld … which may be designed to satisfy the affirmative‑defense conditions of Rule 10b5‑1 … or may constitute non‑Rule 10b5‑1 trading arrangements” (Item 9B(b) on page 12 of each filing). Thus, the treatment of the dividend‑reinvestment plan has not materially changed – the 2024 filing repeats the 2023 language, confirming continued officer/director participation and the same caveat about potential Rule 10b5‑1 or non‑Rule 10b5‑1 trading arrangements.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim, directly contradicting the ground truth. The original answer states that the 2024 filing omitted the detailed explanation of Rule 10b5-1 and non-Rule 10b5-1 trading arrangements, indicating a simplification of disclosure. However, the LLM claims that the 'same disclosure' appears in both years and that the language is 'repeated,' which is false according to the ground truth. While there are no numeric values to assess (so quantitative accuracy is high by default), the qualitative accuracy is low because the model fails to identify a key change in disclosure and instead asserts continuity. The reasoning is flawed: it incorrectly assumes consistency between filings when the ground truth emphasizes a reduction in specificity in 2024. The answer is contextually relevant—addressing officer/director participation and trading arrangements—but fundamentally wrong about the evolution of the disclosure. Thus, despite correct terminology and structure, the answer fails on the primary dimension of factual correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 305,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has The Home Depot's investment in creating an interconnected shopping experience evolved from fiscal 2021 to fiscal 2023, and what specific changes were made in the way this experience is tailored to customers?",
      "original_answer": "In fiscal 2021, The Home Depot invested $2.6 billion in capital expenditures focused on supporting an interconnected customer experience. By fiscal 2023, the company had advanced this strategy by leveraging enhanced merchandising information technology tools to build an interconnected shopping experience tailored to customers' shopping intent and location. This represents a shift from general investment in interconnectedness to a more refined, data-driven personalization strategy.",
      "llm_answer": "The Home Depot’s spend on the “interconnected, frictionless” shopping platform rose from $2.6 billion of capital expenditures in fiscal 2021 to $3.2 billion in fiscal 2023 (2021 $2.6 B 【page_6】; 2023 $3.2 B 【page_5】). In 2021 the focus was on blending digital and physical channels, whereas by 2023 the company added mobile‑app navigation, richer product‑landing pages with related items and multiple fulfillment options, personalized marketing messages, and a suite of in‑store upgrades—self‑service lockers, curb‑side pickup, electronic shelf‑labels, re‑designed service desks and expanded self‑checkout—to tailor the experience to each customer’s shopping intent and location (2023 digital/experience details 【page_8】; store upgrades 【page_9】; merchandising tools 【page_7】).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative claim that The Home Depot's capital expenditures for the interconnected shopping experience increased from $2.6 billion in fiscal 2021 to $3.2 billion in fiscal 2023. The ground truth only confirms the $2.6 billion investment in 2021 and does not provide any figure for 2023—only that the company advanced its strategy through enhanced IT tools. The $3.2 billion figure is unsupported and contradicts the original answer, which emphasizes a qualitative evolution in strategy, not a quantified increase in spending. (2) The numerical inaccuracy is critical because it fabricates data not present in the ground truth. While $2.6 billion in 2021 is correct, the 2023 amount is not mentioned, making the comparison invalid. (3) On qualitative reasoning, the LLM correctly identifies a shift from integrating digital and physical channels in 2021 to a more personalized, intent- and location-based experience in 2023. It adds specific examples like mobile-app navigation, electronic shelf labels, and self-service lockers, which align with the idea of tailoring the experience, though these details are not in the ground truth. The core multi-hop reasoning—evolution from broad investment to targeted personalization—is partially sound, but the unsupported expenditure figure undermines the synthesis. (4) Contextual relevance is high because the answer addresses both parts of the question: evolution over time and changes in personalization. However, the correctness score is low due to the major quantitative error, which misrepresents the company's financial commitment. The qualitative accuracy is moderate because the direction of strategic evolution is correct, but specifics are over-extended. Quantitative accuracy is poor due to the invented $3.2 billion figure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1332,
        "completion_tokens": 507,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How has the financial relationship between DHR and Aldevron evolved between 2022 and 2023, particularly in terms of capital investment and acquisition-related expenditures?",
      "original_answer": "In 2022, DHR anticipated capital expenditures of approximately $1.5 billion, with a portion of this spending attributed to increased manufacturing capacity for products related to the Aldevron Acquisition, among others. This reflects a growing capital commitment tied to Aldevron. By 2023, the financial relationship had evolved significantly, as evidenced by the net cash consideration paid to Aldevron amounting to $9,561 million, indicating that Aldevron had transitioned from being primarily a capital investment target to a core component of DHR's consolidated assets. This represents a substantial shift in the nature of their relationship from a dependency to a stakeholding and integration model.",
      "llm_answer": "In 2022 Danaher projected about $1.5 billion of capital spending, including $87 million of property‑plant‑and‑equipment purchases funded by government assistance, and in 2023 that PP&E outlay rose to $136 million (up from $87 million) as the company continued to expand manufacturing capacity for its Life Sciences segment, which now includes Aldevron (see page 72). The Aldevron transaction itself was a one‑time cash purchase of roughly $9.6 billion recorded in 2021 with $28 million of transaction costs and $30 million of fair‑value adjustments, and no new Aldevron‑specific acquisition expenses are reported in the 2022 or 2023 filings (see pages 73‑74). Thus, after the 2021 acquisition, Danaher’s financial relationship with Aldevron shifted from large acquisition outlays to ongoing capital investment to grow the business.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the timing and amount of the Aldevron acquisition. The ground truth states that the net cash consideration of $9,561 million was paid in 2023, but the LLM claims the $9.6 billion purchase was recorded in 2021, which is incorrect. This misplacement of the acquisition date fundamentally undermines the answer's correctness. Additionally, the LLM introduces specific figures for property-plant-and-equipment (PP&E) spending ($87M in 2022, $136M in 2023) and government assistance that are not present in the original answer and appear to be fabricated or misattributed, as the ground truth only mentions $1.5 billion in anticipated capital expenditures in 2022 with a portion related to Aldevron. (2) The quantitative inaccuracies are severe: the $9.6 billion acquisition is wrongly dated to 2021 instead of 2023, and the detailed PP&E breakdown is unsupported by the ground truth. While $9.6 billion is approximately equal to $9,561 million (allowing for rounding), the timing error invalidates the financial evolution narrative. The $28M transaction costs and $30M fair-value adjustments are not mentioned in the original answer and introduce unverified details. (3) The multi-hop reasoning is partially sound in that the LLM attempts to distinguish between acquisition-related expenditures and ongoing capital investment, which aligns with the conceptual shift described in the original answer. However, because the key event (the 2023 payment) is misplaced in time, the logical progression from 'acquisition' to 'integration' is based on false premises. The conclusion that the relationship shifted post-2021 is incorrect given that the major cash outflow occurred in 2023. (4) Contextual relevance is high because the LLM addresses capital investment and acquisition-related expenditures and correctly identifies the evolving nature of the relationship. However, due to major factual and temporal errors, especially on the core financial event, the correctness score is low. The answer conveys a plausible but factually incorrect narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 573,
        "total_tokens": 1963
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has the structure and total value of Telco LLC's preferred interests evolved from 2022 to 2024, and what changes were made to the distribution rates and reset schedules during this period?",
      "original_answer": "In 2022, Telco LLC had $2,000 in nonconvertible cumulative preferred interests (Telco Class A-1) with an initial preferred distribution rate of 4.25% annually, subject to reset every seven years. By 2024, Telco LLC expanded its preferred interests with the issuance of an additional $5,250 in preferred interests (Telco Class A-2 and A-3) in April 2023, bringing the total cumulative preferred interests to $7,250. The new preferred interests (Class A-2 and A-3) carried a significantly higher initial preferred distribution rate of 6.85% annually, with the first reset scheduled for November 1, 2027, and every seven years thereafter. This represents both a structural expansion in the capital stack and a strategic shift toward higher-yielding preferred instruments.",
      "llm_answer": "In the 2022 filing AT&T reported that Telco LLC held a single series of non‑convertible cumulative preferred interests – $2 billion of “Class A‑1” interests that paid an initial 4.25 % annual distribution and reset every seven years 【page_130】. By the 2024 filing the preferred structure had been expanded: a $5.25 billion issuance in April 2023 added “Class A‑2” and “Class A‑3” interests (bringing total Telco preferred interests to $7.25 billion) that pay a higher 6.85 % annual distribution and reset on Nov 1 2027 and every seven years thereafter 【page_87】; and in October 2024 AT&T entered into an agreement to issue a further $2.25 billion of “Class A‑4” interests (to be issued in Q1 2025) with a 5.94 % distribution and a reset on Nov 1 2028 and every four years thereafter 【page_88】. Thus, from 2022 to 2024 the preferred pool grew from $2 billion to $7.25 billion, added new classes with higher rates, and moved from a single seven‑year reset to staggered reset dates (Nov 1 2027 for the 2023‑issued classes and Nov 1 2028 for the planned 2025 issuance).",
      "correctness_score": 7,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the initial $2 billion in Class A-1 preferred interests in 2022 with a 4.25% distribution rate and seven-year reset, and accurately reports the April 2023 issuance of $5.25 billion in Class A-2 and A-3 interests, bringing the total to $7.25 billion. The 6.85% rate and November 1, 2027 reset date for the new classes are correct. However, the LLM introduces information not present in the ground truth: the October 2024 agreement to issue $2.25 billion in Class A-4 interests with a 5.94% rate and a 2028 reset every four years. This detail is absent from the original answer and extends beyond the 2024 cutoff for completed changes (the question asks about changes made during 2022–2024, and the Class A-4 issuance is planned for 2025). (2) Quantitative accuracy is mostly correct: $2B + $5.25B = $7.25B is accurate, and all reported percentages and dates for the 2022 and 2023 transactions match. The inclusion of the $2.25B future issuance inflates the total value and introduces incorrect reset frequency (every four years vs. seven), which was not part of the ground truth. (3) The multi-hop reasoning is sound in tracking the evolution from 2022 to 2024 and synthesizing changes in structure, value, and terms. However, the addition of forward-looking 2025 plans not in the original answer reflects either misinterpretation or over-extrapolation, reducing factual correctness. (4) Scores reflect high accuracy on core facts and correct synthesis of structural evolution, but the introduction of unverified future events lowers quantitative and overall correctness. Contextual relevance remains high as all information is directly related to the question’s scope, even if one component is extraneous.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1469,
        "completion_tokens": 476,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has AIG's use of Expected Loss Ratio Methods evolved between 2022 and 2024, particularly in terms of the types of insurance lines and the rationale for their application?",
      "original_answer": "In 2022, AIG used Expected Loss Ratio Methods primarily for the latest accident year and in combination with other methods like loss development for aviation exposures, due to their high-severity nature. By 2024, AIG expanded the use of Expected Loss Ratio Methods to include U.S. Workers' Compensation, a long-tail line of business, where it was used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different insurance lines with varying claim characteristics.",
      "llm_answer": "In the 2022 filing AIG said it applied Expected‑Loss‑Ratio (ELR) methods mainly to **aviation** (for all but the most recent accident year) and to **U.S. workers‑compensation** (including the latest year), using the method where loss‑development data were sparse or severity‑driven. By the 2024 filing the ELR approach is described as a **standard tool across any line** whose loss development is inconsistent, slow‑emerging or has little history—especially for **excess‑of‑deductible business**—and the ratios are now calibrated for rate changes, loss‑trend, inflation and market conditions, showing a broader, more systematic use.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a mix of correct and incorrect information, with significant factual inaccuracies in entity and temporal attribution that undermine the overall correctness. (1) On correctness: The original answer states that in 2022, AIG used Expected Loss Ratio (ELR) methods primarily for the latest accident year and in combination with other methods for aviation, due to high severity. However, the LLM claims ELR was used for aviation 'for all but the most recent accident year'—which contradicts the ground truth that it was used for the latest year. This is a critical error in both entity (accident year timing) and reasoning. Additionally, the LLM incorrectly asserts that U.S. Workers' Compensation was already included in 2022, while the ground truth states that expansion to Workers' Compensation occurred by 2024, not in 2022. This misplacement of a key development timeline breaks the multi-hop logic of how the method evolved. (2) Quantitative accuracy is acceptable because there are no specific numerical values (e.g., percentages, dollar amounts) in the question or answer; dates (2022, 2024) are correctly referenced as comparison points. (3) Multi-hop reasoning is flawed: the question asks for evolution between 2022 and 2024, but the LLM misattributes the application to Workers' Compensation in 2022, reversing the progression. The broader 2024 application to inconsistent or slow-emerging lines is partially correct and aligns with the expansion described, though the emphasis on 'excess-of-deductible business' and calibration for rate changes/inflation is not in the ground truth and appears to be unsupported extrapolation. (4) Contextual relevance is high—the answer addresses insurance lines, rationale, and evolution—but the factual misstatements reduce its reliability. Overall, the answer shows understanding of the conceptual direction of ELR expansion but fails on key factual assertions, warranting a partial score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 525,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How has Target's approach to its owned brands evolved from 2023 to 2024, particularly in terms of strategic emphasis and product portfolio development?",
      "original_answer": "In 2023, Target emphasized expanding its owned brands portfolio as a core strategic element to drive relevancy and market share growth. By 2024, the company shifted focus to producing a broad range of owned and exclusive brands, listing over 40 distinct brands across various categories, indicating a more concrete execution phase of brand development and diversification.",
      "llm_answer": "In the 2023 filing Target’s strategy simply called out “strengthening our owned brands portfolio” as a way to deliver newness, style and value (2023 Form 10‑K Strategy, p. 3). By the 2024 filing the company had turned that intent into measurable execution – owned and exclusive brands now generate roughly one‑third of merchandise sales and the filing lists a much larger, diversified set of owned‑brand names across categories (2024 Form 10‑K Owned Brands, p. 6). This shows a shift from a strategic emphasis on owned‑brand development to a concrete expansion of the product portfolio and a larger share of sales coming from those brands.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures the evolution from 2023 to 2024: in 2023, Target emphasized strengthening its owned brands as a strategic goal, and by 2024, this evolved into concrete execution with a diversified portfolio. The mention of 'over 40 distinct brands' in the original answer is not explicitly repeated, but the LLM conveys the same idea through 'much larger, diversified set of owned-brand names across categories,' which is semantically equivalent. (2) The quantitative claim that 'owned and exclusive brands now generate roughly one-third of merchandise sales' is not present in the original answer, but this figure is plausible and consistent with Target’s public disclosures; however, since it's not in the ground truth knowledge graph, it introduces a minor factual overreach, slightly reducing quantitative accuracy. (3) The reasoning is sound: the LLM correctly performs multi-hop synthesis between the 2023 and 2024 filings, identifying a shift from strategic intent to execution. (4) The answer is contextually excellent, directly addressing both strategic emphasis and product portfolio development. The only deviation is the addition of a specific sales percentage not in the original answer, which prevents a perfect score, but overall the response is factually strong, well-reasoned, and relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 383,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "What does IBM's continued listing of the 0.875% Notes due 2030 in 2024 alongside the new 2.900% Notes due 2030 suggest about its debt financing strategy and the market conditions for long-term borrowing?",
      "original_answer": "In 2023, IBM listed the 0.875% Notes due 2030 (trading symbol IBM30A) among its registered securities, indicating its initial issuance of this long-term debt instrument. By 2024, IBM not only maintained the 0.875% Notes due 2030 in its capital structure but also introduced a new 2.900% Notes due 2030 (trading symbol IBM30C). The significant increase in the interest rate—from 0.875% to 2.900%—for the same maturity year suggests that IBM may have pursued additional financing in 2024 under less favorable interest rate conditions, or it may be targeting different investor segments with varied risk-return profiles. This dual listing could also indicate a strategic effort to diversify its debt portfolio and manage refinancing risks by having multiple instruments maturing in the same year but with different coupon rates.",
      "llm_answer": "IBM’s 2024 registration still shows the legacy 0.875 % Notes due 2030 (IBM30A) and adds a new 2.900 % Notes due 2030 (IBM30C) — the 0.875 % issue appears in the 2023 filing, while the 2.900 % issue first appears in the 2024 filing (see IBM 10‑K 2024 page 1 and IBM 10‑K 2023 page 1). This mix indicates that IBM is keeping its ultra‑low‑coupon debt on the books while issuing fresh long‑dated paper at the higher rates now prevailing, a strategy that diversifies its maturity profile and leverages its strong credit to obtain new funding despite a higher‑rate environment for long‑term borrowing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 0.875% Notes due 2030 (IBM30A) were listed in 2023, and the new 2.900% Notes due 2030 (IBM30C) appeared in 2024. The percentages (0.875% and 2.900%), years (2023, 2024, 2030), and trading symbols (IBM30A, IBM30C) are accurately reported. (2) Quantitative accuracy is perfect—no calculations are required, but the interest rate comparison is correctly stated. (3) The reasoning is sound: the LLM correctly infers that IBM is maintaining low-coupon debt while issuing new debt at higher rates, reflecting current market conditions. It also identifies the strategic benefit of diversifying the maturity profile and accessing funding despite higher rates, which aligns with the ground truth’s point about diversification and refinancing risk. (4) The only minor omission is that the LLM does not explicitly mention the possibility of targeting different investor segments or the idea of managing refinancing risk through multiple instruments with the same maturity but different coupons—nuances present in the original. However, the core strategic insight about leveraging strong credit in a higher-rate environment and diversifying debt is well captured. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing both debt strategy and market conditions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 389,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the composition of AT&T's long-term debt instruments evolve between 2022 and 2024, particularly regarding the 4.000% Global Notes due June 1, 2049 and the addition of new long-term notes?",
      "original_answer": "In 2022, AT&T listed the 4.000% Global Notes due June 1, 2049 (T 49A) among other long-term debt instruments, but did not include the 4.300% Global Notes due November 18, 2034. By 2024, the 4.000% Global Notes due 2049 remained registered under the same symbol (T 49A), and the company added the 4.300% Global Notes due 2034 (T 34C). This indicates that AT&T expanded its long-term debt portfolio by introducing new maturities while maintaining existing long-dated obligations like the 2049 notes.",
      "llm_answer": "In the 2022 Form 10‑K AT&T’s long‑term debt was limited to a series of global notes that mostly matured through 2025‑2026 and the 4.000 % Global Notes due June 1 2049 do not appear on that list【page_1】. By the 2024 Form 10‑K the register had been expanded to include the 4.000 % Global Notes due June 1 2049 (T 49A) and a host of newer, longer‑dated issues such as 4.250 % notes due March 1 2050, 3.750 % notes due September 1 2050, and 5.350 %/5.625 % notes due 2066‑2067【page_2】, showing a shift toward longer‑term financing.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual errors that undermine its correctness. (1) According to the ground truth, the 4.000% Global Notes due June 1, 2049 (T 49A) *were present* in AT&T's 2022 long-term debt disclosures — however, the LLM incorrectly states these notes 'do not appear on that list' in 2022, which is false. (2) The LLM claims that by 2024, AT&T added the 4.000% notes (T 49A), implying they were newly introduced, but the ground truth confirms they were already registered and remained unchanged from 2022 to 2024. This misrepresents the evolution of the debt composition. (3) The LLM invents new debt instruments not mentioned in the ground truth, such as 4.250% notes due 2050, 3.750% notes due 2050, and 5.350%/5.625% notes due 2066–2067, which are entirely fabricated and not part of the original data. (4) The ground truth specifically highlights the addition of the 4.300% Global Notes due November 18, 2034 (T 34C) in 2024, which the LLM fails to mention entirely. (5) The reasoning is therefore flawed: instead of showing continuity of the 2049 notes and the addition of the 2034 notes, the LLM constructs an incorrect narrative of introducing the 2049 notes in 2024 and expanding into much longer-dated maturities. While the general direction — that AT&T expanded its long-term debt portfolio — has some thematic relevance, the specific facts, entities, dates, and instruments are largely incorrect or invented. Quantitative accuracy is very low due to wrong percentages, maturities, and missing/added instruments. Qualitative accuracy suffers from incorrect multi-hop synthesis and entity tracking. Contextual relevance is moderate because the answer addresses debt composition changes, but with wrong details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 471,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did the financial impact of the Heritage AspenTech acquisition evolve between 2023 and 2024, particularly in terms of intangibles amortization and restructuring costs?",
      "original_answer": "In 2023, the intangibles amortization related to the Heritage AspenTech acquisition was $258, while in 2024, this figure decreased to $97. Additionally, restructuring costs were $72 in 2023 and increased to $228 in 2024. This indicates a reduction in the amortization burden but a significant rise in restructuring expenses over the two years.",
      "llm_answer": "The Heritage AspenTech deal added $258 million of intangibles amortization (intellectual‑property and customer‑relationship amortization) in 2023, while the company recorded $72 million of restructuring costs that year. In 2024 total intangibles amortization rose to $1,077 million – but the $560 million portion now relates to the NI acquisition, so the AspenTech‑related amortization has essentially faded – and restructuring costs jumped to $228 million【page_55】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, AspenTech-related intangibles amortization decreased from $258 million in 2023 to $97 million in 2024. However, the LLM claims that 'AspenTech-related amortization has essentially faded' and implies it is negligible in 2024, which contradicts the $97 million figure. Additionally, the LLM states that total intangibles amortization in 2024 was $1,077 million, with $560 million attributed to the NI acquisition—information not present in the original answer and potentially misleading. While restructuring costs are correctly reported as $72 million in 2023 and $228 million in 2024, the core error lies in the misrepresentation of AspenTech-specific amortization. (2) The 2023 amortization number ($258 million) is correct, but the 2024 figure is wrong—the LLM does not report the actual $97 million and instead suggests AspenTech amortization has faded due to a larger total amortization number that includes NI acquisition costs, which were not part of the original question or answer. This introduces extraneous data and distorts the factual trend. (3) The reasoning is partially sound in recognizing that acquisition-related amortization may decline over time, but it fails the multi-hop requirement by conflating two different acquisitions (Heritage AspenTech and NI), leading to incorrect synthesis. The original answer focuses solely on Heritage AspenTech, while the LLM shifts focus to a broader amortization total, undermining accuracy. (4) Despite the incorrect numbers and reasoning, the answer remains contextually relevant—it addresses the same topic, time frame, and financial metrics, and correctly identifies the increase in restructuring costs. Hence, moderate scores are given for qualitative and contextual accuracy, but the major quantitative error limits correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 513,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has AIG's use of expected loss ratio methods for workers' compensation evolved between 2022 and 2024, particularly in relation to the segmentation of business types and the impact of large deductible accounts?",
      "original_answer": "In 2022, AIG applied expected loss ratio methods primarily to guaranteed cost business in the most recent accident year, while for excess of deductible business, these methods were given significant weight in the most recent five accident years. The company also noted that the proportion of large deductible business had increased, slowing the reporting pattern of claims. By 2024, AIG continued to use expected loss ratio methods but placed greater emphasis on segmentation by deductible size and claim handling (AIG vs. third-party administrators), and explicitly highlighted the increasing influence of large deductible accounts on slowing claim emergence. Additionally, 2024 disclosures emphasized limitations in claim count data due to aggregation and reinsurance exclusions, which were not as prominently noted in 2022.",
      "llm_answer": "AIG’s workers‑compensation reserving still relies on a blend of loss‑development, frequency‑severity and expected‑loss‑ratio (ELR) techniques, but the company has sharpened its segmentation – separating guaranteed‑cost and excess‑of‑deductible business, further breaking out the excess segment by deductible size and whether the claim is handled by AIG or a third‑party administrator – and it notes that the proportion of large‑deductible accounts has continued to rise, slowing claim reporting (2022 10‑K p. 260‑261; 2024 10‑K p. 151). The ELR method now receives “significant weight” for excess‑of‑deductible business for the five most recent accident years (and only for the most recent year for guaranteed‑cost), a weighting that is reiterated in the 2024 reserving methodology (2024 10‑K p. 149) and was already described in the 2022 filing (2022 10‑K p. 259). The 2022 filing also referenced specific tail‑factor adjustments and the use of individually priced large accounts, whereas the 2024 filing emphasizes a more uniform application of ELR, indicating a refinement rather than a fundamental shift.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AIG's use of expected loss ratio (ELR) methods in 2022 applied primarily to guaranteed cost business in the most recent accident year and to excess of deductible business over the five most recent accident years, with 'significant weight' given—this is correctly cited from both 2022 and 2024 10-Ks. The increasing proportion of large deductible accounts slowing claim reporting is accurately noted. (2) Quantitative accuracy is perfect: no numerical errors, and the timeframes (most recent year vs. five years) are correctly reported. Page references (e.g., 2022 p. 259, 2024 p. 149–151) support the claims, though not required for correctness, they enhance credibility. (3) Multi-hop reasoning is sound: the model synthesizes information across two years, compares evolution in segmentation (by deductible size and claim handler), and correctly infers continuity in ELR weighting with refinement in segmentation and data limitations. (4) The only minor shortcoming is that the LLM does not explicitly mention the 2024 emphasis on limitations in claim count data due to aggregation and reinsurance exclusions—a point highlighted in the ground truth. While the answer implies data challenges through 'refinement' and 'uniform application,' it omits this specific qualitative shift in disclosure focus. Otherwise, the answer captures the core evolution accurately, with excellent contextual relevance and semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 421,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How has Target's approach to cybersecurity threat investigation and response evolved from 2023 to 2024, particularly in terms of its Cyber Fusion Center operations and collaboration with external organizations?",
      "original_answer": "In 2023, Target operated its Cyber Fusion Center as part of its threat investigation and response capabilities, and emphasized collaboration with organizations across industries to share threat intelligence and best practices. By 2024, Target not only maintained its Cyber Fusion Center but also introduced a more structured incident response program with a coordinated escalation model to inform management and the Board of Directors during security incidents. Additionally, in 2024, Target expanded its external engagement by incorporating regular training and compliance activities for team members, and by leveraging third-party vendors to assess and test its cybersecurity program. This represents a more comprehensive and mature approach to cybersecurity threat response and collaboration.",
      "llm_answer": "In its 2023 filing Target said it “runs a cyber fusion centre to investigate and respond to threats” and that it “shares threat‑intelligence and collaborates with organizations across different industries” (2023 Form 10‑K p. 17). The 2024 filing repeats the cyber‑fusion‑center model but now frames it as part of a “proactive threat‑intelligence program” that is validated by internal and independent assessments, uses a coordinated escalation process, and is bolstered by third‑party vendor assessments, insurance coverage and continued cross‑industry information‑sharing (2024 Form 10‑K p. 21). Thus, Target’s approach has become more proactive and integrated—still centered on the cyber‑fusion‑center, but with stronger threat‑intelligence, risk‑validation and external‑partner collaboration.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2023, Target operated a Cyber Fusion Center and collaborated with external organizations for threat intelligence sharing, citing the 2023 Form 10-K. In 2024, it accurately notes the continuation of the Cyber Fusion Center but enhanced with a more proactive and structured approach, including coordinated escalation (aligned with the 'coordinated escalation model' in the original answer). The mention of third-party vendor assessments matches the ground truth's 'leveraging third-party vendors to assess and test its cybersecurity program.' (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the years 2023 and 2024 are correctly attributed, and no calculations are needed. (3) The multi-hop reasoning is sound: the model synthesizes information from two different years' filings, compares the evolution, and draws a valid conclusion about increased proactiveness and integration. The only minor gap is that the LLM answer does not explicitly mention 'regular training and compliance activities for team members' or 'Board of Directors escalation'—details present in the original answer—though it does reference a 'coordinated escalation process,' which partially captures the Board communication aspect. (4) Despite this slight omission, the LLM conveys the core evolution accurately and uses semantically equivalent phrasing such as 'proactive threat-intelligence program' and 'independent assessments' to reflect maturity and external validation. The contextual relevance is perfect, directly addressing both Cyber Fusion Center operations and external collaboration across years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 488,
        "total_tokens": 1902
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How did Eli Lilly's financial relationship with Baqsimi evolve between 2023 and 2024, particularly in terms of revenue recognition and contractual arrangements?",
      "original_answer": "In 2023, Eli Lilly reported $579.0 million in revenue specifically attributed to the sale of the rights for Baqsimi. By 2024, Baqsimi was included within broader collaboration and other revenue disclosures, reflecting its integration into revenue from collaborations and other arrangements, which included the 2023 sales of rights for both the olanzapine portfolio and Baqsimi. This shift indicates a move from direct product revenue to a more complex revenue recognition model under collaborative arrangements, suggesting a strategic evolution in how the company accounts for and manages its financial relationship with Baqsimi.",
      "llm_answer": "In 2023 Eli Lilly booked Baqsimi as a product sale – the revenue table shows $677.6 million of Baqsimi net product revenue, driven largely by a $579 million upfront payment for the sale of Baqsimi rights 【page 48】, and the accompanying discussion notes that the “sale of the rights for Baqsimi” contributed to 2023 revenue 【page 47】. In the 2024 filing the same transaction is presented under Collaboration and Other Revenue, with the note that “collaboration and other revenue … includes … the 2023 sales of rights for Baqsimi” 【page 64】, and the company’s collaboration‑revenue policy says such rights‑sale revenue is recognized when control of the asset transfers 【page 66】. This reflects a re‑classification from product‑sale accounting in 2023 to a licensing/collaboration arrangement recognized as collaboration revenue in 2024.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2023, Eli Lilly recognized $579 million from the sale of Baqsimi rights, consistent with the original answer. The mention of $677.6 million in total Baqsimi net product revenue is additional context not contradicted by the ground truth and supported by the cited document (page 48), suggesting the $579 million was a component of a larger product revenue line. (2) The 2024 reclassification is accurately described: Baqsimi’s revenue is no longer reported as product revenue but is included in 'Collaboration and Other Revenue,' with explicit reference to page 64 stating that the 2023 sale of rights for Baqsimi is now part of that category. This reflects a correct understanding of the accounting shift. (3) The multi-hop reasoning is sound—linking the 2023 product revenue treatment to the 2024 collaboration revenue reclassification demonstrates synthesis across years and accounting categories. (4) The qualitative and contextual accuracy is excellent: correct entities (Eli Lilly, Baqsimi), correct years, correct financial concepts (revenue recognition, control transfer under collaboration accounting). The only minor deviation is the introduction of $677.6 million in net product revenue, which is not in the ground truth but does not contradict it and appears document-supported. This adds granularity rather than inaccuracy. Thus, the answer earns a 9 for correctness due to full factual alignment and strong reasoning, with a point deducted only because the extra figure could confuse if not properly contextualized, though it is cited appropriately.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 455,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did AT&T's approach to managing its capital structure through preferred interests evolve from 2023 to 2024, particularly regarding the repurchase of Mobility Preferred Interests and the expansion of Tower Holdings and Telco LLC preferred interests?",
      "original_answer": "In 2023, AT&T repurchased the remaining 213 million Mobility Preferred Interests for $5,414, removing $2,650 from 'Accounts payable and accrued liabilities' and $2,670 from 'Other noncurrent liabilities.' This repurchase was primarily funded by the issuance of $5,250 in new Telco LLC preferred interests, which carried a 6.85% annual distribution rate. By 2024, AT&T had shifted focus toward expanding its Tower Holdings preferred interests, where $6,000 in 2019 Tower preferred interests were restructured into fixed and floating rate classes with a 5.90% base rate and SOFR + 250 bps, respectively. Additionally, the total Telco LLC preferred interests increased to $7,250, including the original $2,000 (Telco Class A-1) and the 2023 additions. This reflects a strategic pivot from repurchasing legacy preferred interests to leveraging new preferred structures with more flexible redemption and distribution terms to manage capital and liquidity.",
      "llm_answer": "In 2023 AT&T eliminated its Mobility II Series A cumulative perpetual preferred interests, repurchasing the remaining 213 million interests for about $5.4 billion – a buy‑back that was largely funded by the $5.25 billion of new non‑convertible cumulative preferred interests issued by Telco LLC in April 2023 (the “April preferreds”) and left no Mobility preferred interests outstanding at year‑end 2023【page_38†L31-L38】【page_86†L31-L38】. By 2024 the focus shifted to reshaping subsidiary capital: AT&T amended its 2019 Tower Holdings preferred interests, creating a 5.90 % fixed‑rate class and a floating‑rate class tied to SOFR + 250 bps (effective November 2024)【page_87†L9-L19】, and announced a further $2.25 billion issuance of Telco LLC preferred interests (adding to the $7.25 billion already outstanding) to fund future redemptions【page_87†L31-L38】【page_88†L1-L9】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2023, AT&T repurchased 213 million Mobility Preferred Interests for $5.4 billion (matches $5,414 in original, rounded appropriately), funded by $5.25 billion in new Telco LLC preferred interests at 6.85% (implied from context). By 2024, the restructuring of Tower Holdings' $6,000 in 2019 preferred interests into fixed (5.90%) and floating (SOFR + 250 bps) rate classes is accurately described, as is the increase in total Telco LLC preferred interests to $7.25 billion, including prior and new issuances. (2) Quantitative accuracy is excellent: all dollar amounts ($5.4B, $5.25B, $7.25B, $2.25B addition), percentages (5.90%, SOFR + 250 bps), and timing (April 2023 issuance, November 2024 effective date) match or are valid representations of the original data. The $2.25B new issuance correctly explains the increase from $5.25B to $7.25B. (3) Multi-hop reasoning is sound: the answer synthesizes information across years and subsidiaries (Mobility, Telco LLC, Tower Holdings), correctly identifying the strategic shift from repurchasing legacy interests to issuing new structured preferred instruments. (4) Minor omission: the original answer notes the balance sheet impact ($2,650 from 'Accounts payable' and $2,670 from 'Other noncurrent liabilities'), which the LLM omits. However, this detail is not central to the evolution of capital structure strategy. Wording differs but semantic meaning and strategic interpretation are equivalent. The LLM correctly infers the strategic pivot and funding mechanics. Thus, the answer is factually complete and contextually relevant, meriting a 9 for correctness and qualitative accuracy due to the minor omission, but full marks for quantitative accuracy and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 493,
        "total_tokens": 1975
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Emerson's relationship with AspenTech evolve from 2023 to 2024, and what financial impacts did this transformation have on Emerson's gross margin and ownership structure?",
      "original_answer": "In 2023, Emerson had a business relationship with AspenTech as part of its Software and Control offerings. By 2024, this relationship transformed into a more significant strategic position, as Emerson acquired a 55% ownership stake in 'New AspenTech' (formerly Heritage AspenTech) following a transaction that included approximately $6.0 billion in cash. This change in relationship had a measurable financial impact: the AspenTech acquisition contributed to a 3.3 percentage point increase in gross margin in 2023 and was part of broader changes that led to a 1.8 percentage point increase in gross margin in 2024. Additionally, the ownership stake marked a structural shift in Emerson’s involvement with AspenTech, moving from a partner to a majority shareholder.",
      "llm_answer": "Emerson’s tie‑up with AspenTech deepened – after the 2022 Heritage AspenTech deal Emerson held a 55 % majority stake in 2023, and by 2024 it owned about 57 % of the company and announced a cash offer to purchase all remaining shares, moving toward full ownership【EMR_10k_2024.pdf page 26】【EMR_10k_2024.pdf page 25】.  During the same period Emerson’s gross margin rose from roughly 49.0 % in 2023 to 50.8 % in 2024, reflecting the AspenTech integration and related acquisition effects【EMR_10k_2024.pdf page 26】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it incorrectly states that Emerson held a 55% stake in AspenTech in 2023 and increased it to 57% in 2024, while the ground truth specifies that the 55% ownership stake was acquired as part of a transaction that concluded in 2024 (not held in 2023). The LLM also introduces a claim about a cash offer to purchase all remaining shares, which is not mentioned in the original answer and lacks support from the provided context. Additionally, the LLM cites gross margin percentages (49.0% in 2023, 50.8% in 2024), but the original answer does not provide absolute margin values—instead, it states that AspenTech contributed a 3.3 percentage point increase in gross margin in 2023 and a 1.8 percentage point increase in 2024. These are incremental impacts, not overall margin figures, making the LLM's interpretation incorrect. (2) Quantitative accuracy is low: the 55% stake is correctly mentioned in the ground truth but misattributed to 2023 instead of 2024; the 57% figure and full acquisition offer are fabricated. The $6.0 billion cash transaction is omitted entirely. The gross margin numbers are misrepresented as absolute values rather than contribution effects. (3) The multi-hop reasoning is partially sound in linking AspenTech to gross margin changes and ownership evolution, but fails in synthesizing the correct timeline and nature of the transaction. The shift from partner to majority owner is conceptually correct, but the execution and details are flawed. (4) Contextual relevance is high because the answer addresses the relationship evolution and financial impacts as asked, but correctness suffers due to significant factual and quantitative errors. The answer appears plausible but diverges from the ground truth on key points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 494,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has AIG's Japan pension plans' contribution to non-U.S. pension obligations evolved between 2022 and 2024, and what change occurred in the weighted average discount rate applied to these plans during this period?",
      "original_answer": "In 2022, AIG's Japan pension plans accounted for 61% of total non-U.S. pension assets, with an expected long-term rate of return of 1.85%. By 2024, the Japan pension plans' share of non-U.S. projected benefit obligations decreased to 50% as of December 31, 2024, from 54% in 2023, and the weighted average discount rate increased to 1.81% in 2024 from 1.48% in 2023. This indicates a relative decline in the size of the Japan pension plans within AIG's non-U.S. pension structure, accompanied by a notable increase in the discount rate applied, likely reflecting changes in market conditions or investment strategy.",
      "llm_answer": "AIG’s Japan pension plans continued to represent roughly one‑half of the company’s total non‑U.S. pension obligations – about 50 % of the non‑U.S. projected benefit obligation in the 2022 filing (≈50 % at 12/31/2021) and still about 50 % in the 2024 filing (≈50 % at 12/31/2024)【page_310†L9-L12】【page_183†L9-L12】.  Over the same span the weighted‑average discount rate applied to the Japan plans rose sharply, from roughly 0.52 % at 12/31/2021 (2022 filing) to about 1.81 % at 12/31/2024 (2024 filing)【page_310†L13-L15】【page_183†L13-L16】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details, particularly regarding the evolution of Japan pension plans' share of non-U.S. obligations. The original answer states that the share was 61% in 2022, decreased to 54% in 2023, and further to 50% in 2024. However, the LLM claims it was approximately 50% in both 2022 and 2024, misrepresenting the starting point and trend. This omission of the decline from 61% to 50% over the period undermines the accuracy of the evolution narrative. (2) Regarding the discount rate, the original answer specifies that it increased from 1.48% in 2023 to 1.81% in 2024. The LLM incorrectly states the starting rate in 2022 (referencing 0.52% at 12/31/2021) and tracks the change from 2021 to 2024, which is outside the requested 2022–2024 scope. While the 1.81% figure for 2024 is correct, the baseline is wrong, and the multi-year change described does not align with the question’s timeframe. (3) The reasoning is partially sound in identifying a trend of increasing discount rates and a stable-to-slightly-declining share of obligations, but it fails to capture the full multi-hop synthesis: the original answer links a significant relative decline (61% → 50%) with a recent rate increase (1.48% → 1.81%), whereas the LLM constructs a narrative based on incorrect base values and an off-cycle timeframe. (4) Despite these errors, the answer is contextually relevant and attempts to address both parts of the question using cited document locations. The qualitative reasoning is coherent, and the 2024 figures are accurate, warranting moderate scores for qualitative accuracy and high relevance. However, the quantitative inaccuracies—especially the misstated percentages and incorrect time-period anchoring—are severe enough to limit the correctness score to 5.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 501,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How did Amazon's disclosure about the impact of competitive stores on its business evolve between the 2022 and 2023 10-K filings, particularly in terms of the framing of external market conditions?",
      "original_answer": "In the 2022 10-K filing, Amazon described competitive stores as a general factor among many that could impact sales and operating results, listing them alongside internal capabilities such as inventory management and customer satisfaction. The 2022 filing included the phrase: 'the introduction of competitive stores, websites, products, services, price decreases, or improvements' as a potential cause of sales fluctuations. In contrast, the 2023 filing retained the same core language but embedded it within a broader context that emphasized external economic and geopolitical conditions, stating that revenue and operating profit growth 'depends on the continued growth of demand for the products and services offered by us or our sellers, and our business is affected by, among other things, general economic, business, and geopolitical conditions worldwide.' This indicates a shift toward framing competitive pressures as part of a larger set of external risks rather than a standalone concern.",
      "llm_answer": "In the 2022 Form 10‑K Amazon listed competition as a discrete risk, stating that “the introduction of competitive stores, websites, products, services, price decreases, or improvements” could directly affect its sales and operating results【page_9】. By the 2023 Form 10‑K the same competitive‑store risk was embedded in a broader macro‑environmental discussion, noting that competition is amplified by “general economic, business, and geopolitical conditions worldwide,” a “softening of demand,” and shifts in internet/e‑commerce usage, thereby framing competitive pressure as part of external market conditions【page_9】. This reflects a shift from a stand‑alone competition risk to a risk contextualized within wider economic and market dynamics.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the 2022 10-K did list competitive stores as one of several discrete factors affecting sales, including the exact quoted phrase about 'competitive stores, websites, products, services, price decreases, or improvements' (page 9 in both filings). The 2023 10-K indeed retains this language but embeds it within a broader discussion of macroeconomic and geopolitical conditions, as correctly noted. (2) There are no numeric values, dates, or financial figures in the question or answer, so quantitative accuracy is not applicable in a traditional sense—however, the years (2022 vs 2023) and document types (Form 10-K) are correct, satisfying temporal and source accuracy. (3) The multi-hop reasoning is sound: the model correctly identifies a shift in framing by comparing the placement and context of the same risk factor across two years, synthesizing changes in tone and emphasis. It accurately infers that competition is no longer presented in isolation but as intertwined with external market dynamics like demand softening and e-commerce trends. (4) The only minor shortcoming is that the LLM slightly omits the specific contrast in structure—namely, that in 2022 the risk was listed among internal capabilities (e.g., inventory management), which the original answer highlights. This nuance is missing but does not undermine the core conclusion. Overall, the answer captures the essential evolution in disclosure framing with high fidelity, warranting a 9 for correctness and qualitative accuracy, and perfect scores for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 458,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How has Target's exposure to port security risks evolved between 2023 and 2024, particularly in terms of geographic focus and operational impact?",
      "original_answer": "In 2023, Target specifically highlighted California ports as a key area affected by port security issues, mentioning that these ports were where the company received a significant portion of its imported merchandise. By 2024, Target broadened its focus, referring to 'major U.S. ports' without specifically naming California, indicating a more generalized concern across multiple locations. Additionally, in 2023, the company noted it had made alternative arrangements due to past disruptions, while in 2024, the emphasis shifted to potential future impacts, including increased costs and inventory supply issues, due to ongoing global conflicts and labor disputes.",
      "llm_answer": "In the 2023 Form 10‑K Target listed port‑security as one of many supply‑chain risks and singled out “California ports” as a key gateway for imported merchandise, warning that closures or congestion there could disrupt inventory, raise costs and hurt earnings【page_13】. The 2024 filing still flags port‑security but expands the geographic focus to “major U.S. ports,” indicating a broader exposure, while the operational impact remains the same – potential supply interruptions, higher costs and adverse effects on results of operations【page_15】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2023, Target highlighted 'California ports' as a key gateway for imports and noted risks like disruptions and cost increases. In 2024, it accurately reflects the shift to 'major U.S. ports', indicating broader geographic concern. The operational impacts—supply interruptions, higher costs, and effects on earnings—are consistently reported across both years, matching the original answer. (2) There are no numeric values requiring calculation in this question; all dates (2023, 2024) and references (page 13, page 15) are correctly cited. Format and referencing are consistent and plausible. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, compares geographic focus (specific to generalized), and tracks evolution in risk framing (past disruptions vs. future potential impacts). The only minor shortcoming is that the LLM does not explicitly mention the shift from 'past disruptions with alternative arrangements' in 2023 to 'potential future impacts due to global conflicts and labor disputes' in 2024, which slightly weakens the depth of operational impact evolution. (4) Despite this omission, the answer remains contextually complete and semantically equivalent in substance. The core facts, entities, years, and reasoning are correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 393,
        "total_tokens": 1695
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did Emerson's financial relationship with Heritage AspenTech evolve between 2023 and 2024, particularly in terms of acquisition-related amortization and restructuring costs?",
      "original_answer": "In 2023, Emerson reported $258 million in intangibles amortization related to the Heritage AspenTech acquisition. By 2024, this specific amortization was no longer reported, indicating that the focus had shifted away from AspenTech as a newly acquired entity. Additionally, restructuring costs increased significantly from $72 million in 2023 to $228 million in 2024, suggesting that Emerson undertook more extensive restructuring activities in 2024, potentially reflecting integration efforts or strategic realignments following the AspenTech acquisition.",
      "llm_answer": "In 2023 Emerson booked $258 million of intangibles amortization that was directly tied to the Heritage AspenTech acquisition and incurred $72 million of restructuring costs. By 2024 the Heritage‑AspenTech amortization was no longer shown as a separate line (the $1,077 million total intangibles amortization was driven mainly by a $560 million NI‑related charge) while restructuring expenses jumped to $228 million, indicating a shift from acquisition‑related amortization to higher restructuring activity【page_55】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key financial figures from the ground truth: $258 million in 2023 intangibles amortization related to the Heritage AspenTech acquisition and $72 million in 2023 restructuring costs, with accurate 2024 figures of $228 million in restructuring costs and the absence of separate AspenTech amortization. The additional context about total intangibles amortization of $1,077 million and a $560 million non-income (NI)-related charge in 2024, while not in the original answer, is consistent with the idea that AspenTech-specific amortization was no longer reported separately, supporting the conclusion. (2) All numbers are quantitatively accurate and correctly attributed to the right years and cost categories. There are no calculation errors. Format variations (e.g., using 'million' vs 'M') are acceptable and do not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly infers a shift in financial focus from acquisition-related amortization in 2023 to increased restructuring activity in 2024, which aligns with the ground truth’s interpretation. The mention of the $1,077 million total amortization adds contextual detail that supports rather than contradicts the main point. (4) The answer is semantically equivalent to the original, with slightly more detail from the source (page_55), enhancing completeness without introducing errors. The only minor limitation is that the original answer emphasizes the strategic implication of integration efforts post-acquisition slightly more, but the LLM captures the core logic. Hence, a high score of 9 is justified, with full marks on quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 465,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has AIG's use of Expected Loss Ratio methods evolved between 2022 and 2024, particularly in terms of the weight given to this method across different lines of business and accident years?",
      "original_answer": "In 2022, AIG applied Expected Loss Ratio methods primarily for more recent accident years in lines such as D&O, E&O, EPLI, and professional liability, where losses are low frequency and high severity. The method was also used in conjunction with IBNR factor methods for low frequency/high severity losses, with factors continually reevaluated based on emerging claim experience and market factors. By 2024, AIG continued to use Expected Loss Ratio methods but expanded their application to include U.S. Workers' Compensation, a long-tail line of business, where they were used in combination with loss development and frequency/severity methods. This reflects a broader application of the method across different risk profiles and a more integrated approach to reserving in complex portfolios.",
      "llm_answer": "In the 2022 Form 10‑K AIG noted that Expected‑Loss‑Ratio (ELR) techniques are used for D&O, E&O, EPLI and professional‑liability lines and are “given more weight in the more recent accident years” while older, mature years rely more on loss‑development methods【page_270】. By the 2024 filing the company made the ELR weighting explicit – it may be given “significant weight in the most recent five accident years” (especially for business written in excess of a deductible) and the ELR is now adjusted for rate changes, loss‑trend inflation and market conditions, reflecting a broader, more systematic reliance on ELR for newer accident years across multiple lines【page_149】. This evolution shows AIG moving from a general preference for ELR in recent years to a formal, line‑wide policy that emphasizes ELR in the newest accident years and for excess‑of‑deductible business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022, AIG used Expected Loss Ratio (ELR) methods primarily for recent accident years in D&O, E&O, EPLI, and professional liability lines, where losses are low frequency and high severity, and that older years relied more on loss development methods. This matches the original answer. (2) For 2024, the LLM correctly notes an expansion and formalization of ELR use, including explicit weighting over the 'most recent five accident years' and adjustments for rate changes, inflation, and market conditions. While the original answer highlights the new application to U.S. Workers' Compensation—a detail not mentioned in the LLM response—the core evolution toward broader, more systematic use across lines and accident years is accurately captured. (3) The LLM correctly synthesizes multi-hop information across 2022 and 2024 filings, showing a progression from general preference to formal policy. (4) Quantitative elements (e.g., 'five accident years') are correctly cited, and no numerical inaccuracies are present. The only minor omission is the lack of mention of U.S. Workers' Compensation as a newly included line of business in 2024, which slightly reduces completeness in qualitative accuracy. However, the overall reasoning, entity identification (AIG, correct lines of business), and contextual relevance to the question on evolution of ELR weighting are excellent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 407,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has the monetization strategy for Amazon's film groups evolved between 2022 and 2023, based on changes in capitalized video and music content costs and associated expenses?",
      "original_answer": "Amazon's monetization strategy for film groups evolved between 2022 and 2023, as evidenced by an increase in both the capitalized video and music content costs and the associated expenses. In 2022, the capitalized costs were $16.7 billion with total video and music expenses of $16.6 billion, while in 2023, these figures increased to $17.4 billion and $18.9 billion, respectively. This indicates a more aggressive investment in content and a corresponding rise in monetization efforts.",
      "llm_answer": "Amazon still monetizes its produced and licensed video and music as a single “film‑group” unit, but the underlying asset base and cost structure have shifted.  The capitalized video‑and‑music library grew modestly from $16.7 billion at 12/31/2022 to $17.4 billion at 12/31/2023, while the related expense rose more sharply from $16.6 billion in 2022 to $18.9 billion in 2023【page_49】.  The larger expense increase relative to the modest asset rise suggests Amazon is spending more on licensing/production and accelerating amortization, reflecting a more aggressive content‑investment approach within the same film‑group monetization model.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: capitalized costs increased from $16.7 billion in 2022 to $17.4 billion in 2023, and associated expenses rose from $16.6 billion to $18.9 billion—these match the original answer exactly. Minor formatting differences (e.g., spacing, use of en-dash) do not affect accuracy. (2) The answer is complete, addressing both the change in capitalized costs and expenses, and correctly interpreting the trend as a sign of more aggressive investment. (3) Entities are accurate: Amazon, correct time periods (2022 and 2023), and correct financial metrics (capitalized video and music content costs, associated expenses). (4) The reasoning is sound and adds value: the LLM correctly infers that the sharper rise in expenses compared to capitalized assets suggests increased spending on production/licensing and accelerated amortization, which supports the conclusion of a more aggressive content investment strategy—this is a logical extension of the data provided. The multi-hop synthesis (comparing two years of two distinct financial metrics and drawing a strategic conclusion) is executed flawlessly. (5) The semantic meaning is equivalent to the original answer, with slightly more detailed interpretation but no factual deviation. All scores are maximized accordingly.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1288,
        "completion_tokens": 383,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How has Philip Morris International's financial relationship with RBH evolved between 2022 and 2024, particularly in terms of its stake and associated impairment?",
      "original_answer": "In 2022, Philip Morris maintained a trademark relationship with RBH, continuing to report volume of brands sold by RBH such as HEETS and other heated tobacco units. By 2024, PMI held an equity investment in RBH, which became subject to a significant impairment charge of $2,316 million due to unresolved allocation of a $32.5 billion Canadian tobacco litigation settlement among RBH, ITL, and JTIM. This reflects a shift from a trademark and brand licensing relationship to a more direct equity investment facing financial impairment.",
      "llm_answer": "In the 2022 Form 10‑K PMI still held its equity investment in Rothmans, Benson & Hedges Inc. as a de‑consolidated Canadian subsidiary – the filing notes the de‑consolidation of RBH but records no impairment on that stake【page_32】. By the 2024 filing PMI concluded that the fair‑value of the RBH investment was below its carrying amount and booked a non‑cash impairment of $2.316 billion (a $1.49‑per‑share EPS hit)【page_30】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $2.316 billion impairment in 2024 matches the $2,316 million in the original answer (format variation is acceptable), and the 2022 status is correctly described as having no impairment. The EPS impact ($1.49) is an additional detail not in the ground truth but does not contradict it. (2) The entity identification is accurate—Philip Morris International (PMI), RBH, and the timeline (2022 to 2024) are correctly referenced. (3) The reasoning correctly captures the evolution: from a de-consolidated subsidiary in 2022 (with ongoing relationship) to an equity investment impaired in 2024. The LLM emphasizes the accounting treatment (fair value below carrying amount), which is consistent with the ground truth’s explanation tied to litigation uncertainty. (4) The only minor gap is that the LLM does not explicitly mention the 'trademark and brand licensing' aspect of the 2022 relationship (e.g., HEETS volume reporting), which is part of the original answer’s characterization of the earlier relationship. However, referencing RBH as a de-consolidated subsidiary implies an ongoing financial relationship. The multi-hop synthesis across years and financial treatments is sound. Overall, the answer is factually correct, contextually relevant, and semantically equivalent with only slight omission of brand-level detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1243,
        "completion_tokens": 398,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How did the sensitivity of LLY's net product revenue to changes in sales return, rebate, and discount liabilities evolve between 2023 and 2024, based on the disclosures in the respective 10-K filings?",
      "original_answer": "In 2023, LLY disclosed that a 5% change in its consolidated sales return, rebate, and discount liability would result in a $615 million change in revenue. In 2024, while the company continued to describe the accounting policy for revenue recognition and accruals for rebates and discounts, it did not provide an updated sensitivity figure. This omission suggests that the company did not disclose a revised estimate for the impact of liability changes on revenue in 2024, indicating a lack of updated quantitative disclosure compared to 2023.",
      "llm_answer": "In the 2023 filing, Eli Lilly said that a 5 % change in its consolidated sales‑return, rebate and discount liability would alter revenue by roughly **$615 million**. In the 2024 filing the same 5 % change would affect revenue by about **$600 million**. Thus, the sensitivity of net product revenue to those liability changes fell slightly – by roughly $15 million – from 2023 to 2024.【page_53】【page_54】",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that in 2024, a 5% change in liability would affect revenue by $600 million. The ground truth explicitly states that LLY did not provide an updated sensitivity figure in the 2024 filing. Therefore, the $600 million figure is factually incorrect and not disclosed, making the core quantitative claim false. (2) The 2023 figure of $615 million is correct and matches the ground truth. However, the 2024 figure of $600 million is fabricated or misattributed, as no such number was disclosed. The claimed $15 million decrease in sensitivity is therefore based on incorrect data and invalidates the comparison. (3) The reasoning is flawed because it assumes a multi-hop synthesis was possible by comparing two disclosed figures, but in reality, only 2023 had a disclosed sensitivity amount. The model failed to recognize the absence of 2024 data, leading to an erroneous conclusion about a trend. (4) While the answer is contextually relevant—addressing the right company, metric, and time frame—and uses appropriate terminology, the critical error in quantitative disclosure severely undermines factual correctness. The model should have noted the lack of 2024 disclosure rather than inventing a comparative figure. Correctness and quantitative accuracy are therefore very low despite partial alignment in structure and intent.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1249,
        "completion_tokens": 381,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How has the role and revenue contribution of Bulk shipments evolved from 2022 to 2024, based on Union Pacific's disclosures?",
      "original_answer": "In 2022, Bulk shipments had an average revenue per car of $3,305 in 2021 (referenced in the 2022 filing), showing a 6% increase from 2020. By 2024, Bulk shipments had grown in strategic importance, contributing 32% of total freight revenues, with detailed operations covering grain, fertilizer, and coal markets, including international connections to Mexico and access to Canadian interline routes. This indicates a transformation in the Bulk segment's role from a revenue-per-unit perspective to a more strategically embedded and revenue-significant component of Union Pacific's operations.",
      "llm_answer": "Bulk shipments remain a core commodity group for Union Pacific. In the 2022 filing the company reported Bulk freight revenues of $6.656 billion, which was roughly 33 % of total freight revenues of $20.2 billion (see pages 35 & 34). By 2024 the 10‑K states that Bulk shipments generated 32 % of freight revenues (see page 6), showing the segment’s share has stayed near one‑third of total freight revenue, with only a modest decline in percentage.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth does not mention a $6.656 billion revenue figure for Bulk shipments in 2022 or a total freight revenue of $20.2 billion; these specific dollar amounts are not present in the original answer and appear to be fabricated or inferred without support in the provided truth. The 33% revenue contribution in 2022 is not confirmed in the ground truth, which instead references average revenue per car in 2021 ($3,305) and a 6% year-over-year increase from 2020. The 2024 figure of 32% is correct and aligns with the original answer. (2) Calculations: The LLM implies a comparison between 33% in 2022 and 32% in 2024, suggesting stability, but the ground truth does not provide a 2022 percentage—only a per-unit revenue metric from 2021 cited in the 2022 filing. This misrepresents the evolution, as the original answer emphasizes a strategic shift and increased embeddedness, not just stable revenue share. (3) Multi-hop reasoning: The LLM fails to correctly synthesize the evolution from a per-car revenue focus in earlier years to a strategic, revenue-significant role by 2024. It omits key qualitative developments such as expanded operations in grain, fertilizer, coal, and international connections to Mexico and Canadian interline routes, which are central to the ground truth’s narrative of strategic evolution. (4) While the LLM correctly identifies Bulk as a core segment and approximates the 32% 2024 revenue contribution, it substitutes unsupported financial figures and mischaracterizes the nature of the segment’s evolution, focusing narrowly on revenue share stability rather than strategic transformation. The contextual relevance is high because it addresses the question’s scope, but correctness is compromised by factual inaccuracies and incomplete reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 504,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 64,
      "question": "How did the interest rate of IBM's Notes due 2028 evolve between 2023 and 2024, and what does this indicate about IBM's debt strategy?",
      "original_answer": "In 2023, IBM had 1.750% Notes due 2028 (IBM 28A) listed, and in 2024, the same 1.750% Notes due 2028 (IBM 28A) were still present in the disclosures. This indicates that the interest rate for this specific issuance remained unchanged over the two years. However, IBM introduced new notes with different interest rates in 2024, such as the 2.900% Notes due 2030 and the 3.150% Notes due 2033, suggesting a broader strategy to issue debt at higher rates for longer maturities.",
      "llm_answer": "In the 2023 Form 10‑K IBM listed a 0.300 % and a 1.750 % note due 2028, and the 2024 Form 10‑K shows the same two coupons (0.300 % and 1.750 %) for its 2028 notes【page_1】. The unchanged rates indicate IBM has kept its existing low‑coupon, long‑dated debt unchanged, reflecting a strategy of preserving cheap, stable financing rather than refinancing or altering the terms.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that IBM had two notes due 2028 in both 2023 and 2024: a 0.300% and a 1.750% note. However, the ground truth confirms only the 1.750% Notes due 2028 (IBM 28A) were present in both years. There is no mention of a 0.300% note due 2028 in the original answer, making this a factual error. This undermines the quantitative accuracy. (2) The interest rate of 1.750% is correctly identified and consistent across both years, which is accurate. However, the addition of a non-existent 0.300% note introduces a significant error in financial detail. (3) The reasoning about IBM preserving cheap, stable financing is plausible but incomplete. The original answer highlights a broader debt strategy: while existing low-rate debt was maintained, IBM issued new debt at higher rates (2.900% due 2030, 3.150% due 2033), indicating a strategic shift toward longer maturities at higher yields. The LLM answer fails to mention these new issuances, missing a key multi-hop insight about IBM’s evolving debt strategy. (4) The contextual relevance is high because the response addresses the interest rate evolution and attempts to infer strategy. However, due to the incorrect number of notes and missing synthesis of new debt issuances, both quantitative and qualitative accuracy are significantly reduced. The correctness score is moderate because core facts about the 1.750% note are right, but major errors and omissions limit overall accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 408,
        "total_tokens": 1616
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did AT&T's capital structure strategy regarding preferred interests evolve from 2023 to 2024, particularly in relation to the Mobility Preferred Interests and the introduction of new preferred instruments?",
      "original_answer": "In 2023, AT&T repurchased all of its Mobility Preferred Interests, which had a redemption value of approximately $5,340 million and paid annual cash distributions of $373 million. This marked a significant shift in strategy, as the company eliminated this class of preferred interests. In 2024, AT&T introduced structural modifications to other preferred instruments, including the restructuring of its Tower Holdings preferred interests to include both fixed and floating rate components, and the expansion of Telco LLC preferred interests to a total of $7,250 million. This evolution indicates a strategic pivot from Mobility-based preferred capital to more diversified and strategically tailored preferred instruments tied to infrastructure and telecommunications assets.",
      "llm_answer": "In 2023 AT&T eliminated its legacy Mobility II preferred securities – it repurchased all 320 million Series A cumulative perpetual preferred membership interests and removed them from the balance sheet (Note 16, p. 55; “All outstanding Mobility preferred interests were repurchased as of April 2023” p. 86). By 2024 the company had no Mobility preferred interests outstanding, but it broadened its preferred‑equity toolkit, issuing cumulative perpetual common‑stock preferred shares (Series A, B and C) and new subsidiary‑level preferred instruments—including Mobility II non‑controlling interests, a restructuring of Tower Holdings preferred interests, and a planned Telco Class A‑4 issuance (pages 86‑88). This marks a shift from retiring legacy preferred capital in 2023 to actively deploying new preferred instruments in 2024 to support its capital‑structure strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that AT&T repurchased all Mobility Preferred Interests in 2023, removing them from the balance sheet, which matches the original answer's claim of eliminating this class. While the LLM does not explicitly state the $5,340 million redemption value or $373 million annual distributions, it references Note 16 and page 86, implying source-based accuracy, and the omission of exact figures is a minor gap rather than an error. (2) For 2024, the LLM accurately notes the introduction of new preferred instruments: restructuring Tower Holdings preferred interests (matching the 'fixed and floating rate components' in ground truth), expansion of Telco LLC interests (though the $7,250 million figure is not cited), and mentions new subsidiary-level instruments including Mobility II non-controlling interests and planned Telco Class A-4 issuance. The absence of the exact $7,250 million amount is a minor quantitative omission, but the strategic shift is correctly captured. (3) The reasoning is sound: the LLM synthesizes information across years and entities, showing a pivot from retiring legacy preferred capital (Mobility) to introducing new, diversified preferred instruments tied to infrastructure assets. (4) Terminology like 'Mobility II non-controlling interests' and 'subsidiary-level preferred instruments' reflects accurate entity identification and contextual understanding. The answer is semantically equivalent to the ground truth in overall message and strategic interpretation, with only minor lack of specific dollar amounts preventing a perfect 10. Contextual relevance is excellent—directly addressing the evolution in capital structure strategy as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 479,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has Amazon's characterization of the competitive threat from websites evolved between 2022 and 2023, and what specific changes in language indicate a shift in the nature of this competition?",
      "original_answer": "In 2022, Amazon described competitive websites as part of a broader list of fluctuating business factors, indicating a general awareness of competitive pressures. By 2023, Amazon's language evolved to reflect a more direct and strategic competitive stance, specifically highlighting the introduction of 'competitive stores, websites, products, services, price decreases, or improvements' as a central concern. This shift indicates a more focused and intensified competitive threat from digital platforms, suggesting an evolution from a general operational risk to a more strategic and dynamic competitive challenge.",
      "llm_answer": "Amazon’s 2022 Form 10‑K listed the threat from online rivals only as a static item – “the introduction of competitive stores, **web sites**, products, services, price decreases, or improvements” (2022 p. 9). In the 2023 filing the wording was updated to “the introduction of competitive stores, **websites**, products, services, price decreases, or improvements” and was followed by a new clause about “**changes in usage or adoption rates of the Internet, e‑commerce, electronic devices, and web services, including outside the U.S.**” (2023 p. 9), indicating that Amazon now views competition as a dynamic, internet‑adoption‑driven force rather than just the presence of rival sites.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in Amazon's 10-K language between 2022 and 2023 regarding competitive threats from websites. The 2022 characterization is accurately quoted and described as a static list, while the 2023 update correctly notes the addition of 'changes in usage or adoption rates of the Internet, e-commerce, electronic devices, and web services, including outside the U.S.' This new clause is a key indicator of a broader, more dynamic competitive landscape, supporting the conclusion of a strategic shift. (2) There are no numerical values to verify, but the years (2022, 2023), document types (Form 10-K), and page numbers (p. 9) are correctly cited. Formatting variations (e.g., 'web sites' vs 'websites') are accurately preserved and reflect actual filing differences. (3) The multi-hop reasoning is sound: the model synthesizes language changes across two years of filings and infers a meaningful shift in strategic perception—from static competition to a dynamic, adoption-driven threat. This goes beyond surface-level comparison and captures the essence of the shift described in the ground truth. (4) The only minor shortcoming is that the LLM emphasizes the 'internet-adoption-driven force' angle more than the ground truth, which focuses on the intensification and strategic nature of competition from digital platforms. While related, this slightly reframes the emphasis. However, the core facts, entities, and reasoning are correct, and the semantic meaning is substantially equivalent. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 471,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How has PM's relationship with KT&G evolved from 2022 to 2024, particularly in terms of its strategic reliance on KT&G's heat-not-burn products within PMI's smoke-free product portfolio?",
      "original_answer": "In 2022, PM had a global collaboration agreement with KT&G that allowed PMI to exclusively distribute KT&G's smoke-free products, including heat-not-burn products like LIL Mini and LIL Plus, outside of South Korea. This agreement was initially for three years, indicating a strategic partnership aimed at expanding KT&G's products globally. By 2024, this relationship had evolved such that KT&G's heat-not-burn products were no longer just distributed by PMI but were integrated into PMI's broader smoke-free product portfolio, specifically being listed among PMI's own heat-not-burn offerings. This indicates a deeper strategic reliance on KT&G's product line within PMI's own commercialization efforts, suggesting a shift from a distribution partnership to a more embedded supplier or technology partner role for KT&G.",
      "llm_answer": "In the 2022 filing PMI described its January 2020 global collaboration with KT&G as an exclusive three‑year agreement that gave PMI the right to commercialize KT&G’s heat‑not‑burn products (e.g., LIL Mini/Plus) outside South Korea and noted that it had begun launching those licensed products in select markets. By the 2024 filing, KT&G‑licensed heat‑not‑burn brands such as Fiit and Miix are listed as part of PMI’s HTU (heated‑tobacco unit) category and are included in the company’s smoke‑free net‑revenue and shipment‑volume totals, showing that PMI’s reliance on KT&G’s heat‑not‑burn offerings has become an integral, ongoing component of its smoke‑free portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the January 2020 global collaboration agreement between PMI and KT&G, noting its exclusive three-year term and PMI's right to commercialize KT&G’s heat-not-burn products (e.g., LIL Mini/Plus) outside South Korea—consistent with the original answer’s description of the 2022 status. By 2024, the LLM correctly observes that KT&G-licensed products like Fiit and Miix are now included in PMI’s HTU category and contribute to smoke-free net revenue and shipment volumes, indicating deeper integration into PMI’s portfolio. (2) All dates (2020 agreement, 2022 and 2024 time points), durations (three-year agreement), and product names (Fiit, Miix, LIL Mini/Plus) are factually correct. There are no numerical inaccuracies. (3) The multi-hop reasoning is sound: the LLM synthesizes information across time (2022 to 2024) and infers increased strategic reliance based on inclusion in financial metrics and product categorization, mirroring the ground truth’s conclusion of a shift from distributor to embedded partner. (4) The only minor shortcoming is that the LLM refers to 'Fiit and Miix' as examples in 2024, while the original emphasizes 'LIL Mini and LIL Plus'—though these are related (Fiit is the consumable for LIL devices), the shift in naming slightly obscures continuity. However, this does not undermine the core factual accuracy. Overall, the answer captures the evolution in strategic reliance with strong contextual and qualitative fidelity.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 425,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did IBM's use of the PWCC Plan for funding employee awards evolve between 2022 and 2024, particularly in terms of its administration and scope?",
      "original_answer": "In 2022, the PWCC Plan was described as being used solely to fund awards for employees of PwCC who joined IBM after the acquisition, and it was stated that the plan would continue to be used for this purpose. By 2024, while the plan's administration and terms remained substantively identical to the 2001 Plan, IBM emphasized that the PWCC Plan 'has been and will continue to be used solely' for funding awards for former PwCC employees, indicating a reaffirmation rather than a change in scope. However, the shift in language from 'has been and will continue to be' in 2022 to a more definitive tone in 2024 suggests a stronger commitment to maintaining the plan’s current usage without expansion.",
      "llm_answer": "IBM’s PWCC Acquisition Long‑Term Performance Plan was administered in both years by the Executive Compensation and Management Resources Committee of the Board (with authority that may be delegated to officers) 【page_28】, and the filing for 2024 repeats that same administration under the 2001 Plan description 【page_17】. In each filing the plan is described as being used **solely** to fund equity awards for employees who became IBM staff through the PwCC acquisition, with senior executives expressly excluded, and this scope has not changed from the 2022 filing 【page_28】to the 2024 filing 【page_18】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that the PWCC Plan was used solely to fund awards for former PwCC employees in both 2022 and 2024, with no change in scope, and notes the exclusion of senior executives—consistent with the original answer. Administration remained under the Executive Compensation Committee, which matches the ground truth's reference to continuity in administration. (2) There are no numeric values (e.g., dollar amounts, percentages) in the question or answer, so quantitative accuracy is not applicable in that sense, but all factual assertions about years (2022, 2024), plan names, and administrative bodies are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and filings to confirm consistency in administration and scope. However, it omits the subtle but important point in the ground truth about the evolution in language—from 'was described as being used solely' in 2022 to a more definitive 'has been and will continue to be used solely' in 2024—indicating a stronger reaffirmation. This nuance in linguistic emphasis, suggesting a deepening of commitment without functional change, is missing in the LLM response. (4) Despite this minor omission, the answer is factually correct, contextually complete, and directly addresses the question about evolution in administration and scope. The absence of the tonal shift prevents a perfect 10, but the core facts are all present and accurately conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 422,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How did AT&T's financial obligations and strategic approach to Mobility Preferred Interests evolve between 2023 and 2024, and what does this shift indicate about its broader capital structure management?",
      "original_answer": "In 2023, AT&T repurchased all remaining Mobility Preferred Interests for a total of $5,414 million, which included accrued and unpaid distributions, effectively eliminating this financial obligation. By 2024, there was no mention of Mobility Preferred Interests in the disclosures, indicating a complete exit from this instrument. This contrasts with AT&T's treatment of other preferred interests, such as the Tower Holdings and Telco LLC preferred interests, which remained outstanding and were even expanded or restructured in 2024. This shift indicates a strategic move to reduce certain long-term liabilities while maintaining or adjusting other capital instruments for flexibility, suggesting a selective approach to managing its capital structure.",
      "llm_answer": "In 2023 AT&T still carried a liability for its Mobility II Series A cumulative perpetual preferred interests – about $2.7 billion in current liabilities and $2.7 billion in non‑current liabilities (total ≈ $5.4 billion) that were re‑classified from equity and reflected in interest expense (see page 25 and page 87). By 2024 the company had fully repurchased all 320 million Mobility preferred interests (the April 2023 redemption of the remaining 213 million for $5.4 billion) and reported no outstanding Mobility preferred interests, removing the liability and any dividend‑repurchase constraints (see page 86). This transition signals AT&T’s broader effort to simplify its capital structure by retiring costly preferred equity and reducing non‑controlling interests, thereby increasing financial flexibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the LLM correctly identifies the total repurchase amount as approximately $5.4 billion (ground truth: $5,414 million), which is factually consistent despite minor rounding. It accurately references the full repurchase of Mobility Preferred Interests by 2024 and correctly notes the absence of outstanding interests. The breakdown into $2.7B current and $2.7B non-current liabilities in 2023 is additional detail not in the original answer but does not contradict it and may reflect deeper document insight. The mention of the April 2023 redemption of 213 million units is specific and plausible, though the ground truth does not include unit-level detail, so this cannot be fully verified—but it doesn't detract from accuracy. (2) The LLM correctly captures the evolution between 2023 and 2024: presence of the obligation in 2023, full repurchase, and elimination by 2024. (3) The reasoning is sound: it infers that removing this liability increases financial flexibility and simplifies capital structure, which is logically consistent with the ground truth’s interpretation of a selective capital management strategy. The LLM adds value by characterizing the instrument as 'costly preferred equity' and linking it to dividend-repurchase constraints, which is a reasonable qualitative extension. (4) The only minor gap is that the LLM does not explicitly contrast this retirement with the continued existence of other preferred interests (e.g., Tower Holdings, Telco LLC), which the original answer highlights as evidence of a selective strategy. This omission slightly reduces completeness but does not invalidate the core conclusion. Overall, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score with only a small deduction for partial omission of comparative context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 515,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How has IBM's relationship with stock exchange regulations evolved in terms of regulatory exposure for its debt securities between 2022 and 2024?",
      "original_answer": "In 2022, IBM described stock exchange regulations as one of several factors influencing the value of its debt securities, placing it among other external variables beyond the company's control. By 2024, IBM's language shifted to indicate a more direct regulatory exposure, stating it is 'subject to' stock exchange regulations, which implies a heightened recognition of their binding impact on the company's financing activities. This evolution reflects a stronger acknowledgment of regulatory influence in 2024 compared to the more general mention in 2022.",
      "llm_answer": "Both the 2022 and 2024 Form 10‑K filings note that IBM’s debt securities are subject to “governmental and stock‑exchange regulations” that can affect their value (2022 p. 22; 2024 p. 11). The wording is essentially identical, showing that IBM’s regulatory exposure to stock‑exchange rules for its debt securities has remained unchanged between 2022 and 2024.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion despite citing page numbers and regulatory references. The original answer (ground truth) identifies a meaningful evolution in IBM's language between 2022 and 2024: from describing stock exchange regulations as one of several factors influencing debt security value (2022), to stating it is 'subject to' such regulations in 2024, indicating a stronger, more direct regulatory exposure. The LLM incorrectly claims the wording is 'essentially identical' between the two years, which contradicts the ground truth. While the LLM correctly identifies that both years mention stock exchange regulations in relation to debt securities (preserving some contextual relevance), it fails to detect the shift in tone and legal implication, which is central to the question. There are no numerical values in this question, so quantitative accuracy is scored as 10 by default. However, the qualitative accuracy is very low because the model fails the multi-hop reasoning task—comparing the semantic evolution of regulatory language across filings. The conclusion drawn is the opposite of the correct one, making the answer misleading despite surface-level plausibility.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 340,
        "total_tokens": 1568
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did Disney's financial relationship with A&E evolve from 2022 to 2024, particularly in terms of equity income contribution?",
      "original_answer": "In 2022, Disney's equity investment in A&E was a significant component of its equity income, with A&E being one of the most notable equity method investees alongside CTV Specialty Television. By 2024, Disney's equity in the income of investees had decreased by $207 million, specifically due to lower income generated from A+E. This indicates a material decline in the financial contribution from A&E to Disney over the two-year period.",
      "llm_answer": "In fiscal 2022 Disney’s 50 % joint‑venture stake in A+E generated roughly $1.1 billion of equity earnings (reported as “Equity in the income of investees, net”)【DIS_10k_2022.pdf p. 14】. By fiscal 2024 that contribution had fallen to $575 million, a drop of about $485 million, as Disney noted the decline was driven by lower income from A+E【DIS_10k_2024.pdf p. 34‑35】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the decline in Disney's equity income from A+E between 2022 and 2024 and attributes it to lower income from A+E, which aligns with the original answer’s qualitative direction. However, there is a significant discrepancy in the quantitative details. The LLM claims equity earnings dropped from $1.1 billion in 2022 to $575 million in 2024, implying a $525 million decrease (not $485 million as stated), which contradicts both its own calculation and the ground truth. The original answer states a $207 million decrease in equity income from A+E specifically, not $485 million. Thus, the numbers are factually incorrect. (2) The cited figures ($1.1B to $575M) and resulting drop of ~$485M do not match the ground truth decrease of $207 million. Even allowing for rounding or formatting, the magnitude of error is too large to be considered accurate. Additionally, the original answer does not specify exact 2022 or 2024 equity income amounts from A+E—only the year-over-year change—so the LLM may have fabricated precise figures beyond what the knowledge graph supports. (3) The multi-hop reasoning is partially sound: the model connects Disney’s equity income to A+E across two fiscal years and infers a decline, showing understanding of the evolving financial relationship. However, the synthesis fails on precision, likely due to hallucinated or misquoted data. (4) The contextual relevance is high because the answer addresses the core question about the evolution of Disney’s financial relationship with A&E and the declining contribution. Qualitative accuracy is moderate because the direction and cause of change are correct, but quantitative accuracy is low due to major numerical errors. Correctness score reflects partial credit for correct trend and reasoning but significant deduction for incorrect figures and calculations.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 510,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How did the carrying value of securitized debt obligations change from 2022 to 2023, and what does this indicate about the company's long-term funding strategy?",
      "original_answer": "In 2022, the long-term funding, which primarily consists of securitized debt obligations and senior and subordinated notes, stood at $42.3 billion as of December 31, 2021, with a significant portion driven by securitized debt obligations. By December 31, 2023, the carrying value of securitized debt obligations alone decreased to $18.043 billion. This indicates a strategic shift or reduction in reliance on securitized debt obligations as part of the company's long-term funding structure over this period.",
      "llm_answer": "The carrying value of securitized debt obligations rose from $16.973 billion at year‑end 2022 (COF 2023 10‑K, page 211) to $18.043 billion at year‑end 2023 (COF 2023 10‑K, page 210), an increase of roughly $1.07 billion. This upward move shows Capital One is expanding its securitization program, using securitized debt more heavily as a long‑term funding source to diversify its wholesale funding mix and support ongoing growth.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both direction and magnitude of change. The ground truth states that the carrying value of securitized debt obligations decreased to $18.043 billion by December 31, 2023, from a prior level of $42.3 billion (as of December 31, 2021), with no data provided for 2022 directly. The LLM incorrectly claims the value rose from $16.973 billion in 2022 to $18.043 billion in 2023, which contradicts the downward trend indicated in the original answer. The $16.973 billion figure does not appear in the ground truth and appears to be fabricated or misattributed. (2) The calculation of a $1.07 billion increase is based on incorrect input values and is therefore invalid. The only matching number is $18.043 billion in 2023, which aligns with the ground truth, but the 2022 figure is not supported. (3) The multi-hop reasoning is flawed: the original answer infers a strategic reduction in reliance on securitized debt due to a decline from $42.3 billion to $18.043 billion over two years. The LLM instead infers an expansion of securitization activity based on a false increase, demonstrating a complete reversal of the correct analytical trajectory. (4) The contextual relevance is partially preserved because the answer discusses securitized debt obligations and long-term funding strategy, but the factual foundation is so inaccurate that the conclusion is diametrically opposed to the truth. Hence, the correctness score is very low at 1, quantitative accuracy is 2 (only one number correct), qualitative accuracy is 1 (faulty logic), and contextual relevance is 3 (right topic, wrong facts).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 451,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has Disney's approach to scripted programming evolved between 2022 and 2024, particularly in terms of its international general entertainment channels and its strategic shift toward DTC platforms?",
      "original_answer": "In 2022, Disney operated approximately 220 General Entertainment channels outside the U.S., primarily under the Fox, National Geographic, and Star brands, featuring a mix of scripted, reality, and documentary programming across multiple languages and regions. By 2024, there was a notable strategic shift, with increased emphasis on DTC platforms and less focus on traditional linear channels. The 2024 report highlights that Disney, along with Fox Corporation and Warner Bros. Discovery, planned a joint venture (Venu Sports) to distribute sports content via a DTC platform, signaling a broader move toward streaming. Additionally, Disney announced plans to launch a new DTC offering in early fall 2025 that would include live linear streams of ESPN channels and ESPN+. This reflects a strategic pivot from scripted linear content toward live and sports-driven DTC offerings, indicating a transformation in Disney’s programming and distribution priorities.",
      "llm_answer": "By 2022 Disney’s international general‑entertainment channels—Fox, National Geographic and Star—were the primary outlets for scripted series, but the company already warned that its expanding DTC focus would shift monetization away from linear licensing (2022 International Channels). By 2024 Disney still airs scripted content on those channels, yet it has accelerated the DTC pivot—producing series for Disney+ and Disney+ Hotstar, merging Star+ into Disney+ in Latin America, and planning an ESPN tile on Disney+—so scripted programming is increasingly being funneled through its streaming services rather than linear channels (2024 General Entertainment; 2024 Direct‑to‑Consumer).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the strategic shift from linear international channels to DTC platforms. It accurately identifies the key brands (Fox, National Geographic, Star) and notes the continued presence of scripted content on linear channels in 2022 while highlighting the pivot toward DTC. The mention of merging Star+ into Disney+ in Latin America and planning an ESPN tile on Disney+ reflects accurate qualitative understanding of Disney's evolving distribution strategy. However, the LLM omits specific quantitative details from the original answer—namely, the 'approximately 220 General Entertainment channels outside the U.S.' in 2022—which is a notable factual point that enhances completeness. Additionally, while the LLM references the broader DTC shift, it does not mention the Venu Sports joint venture with Fox Corporation and Warner Bros. Discovery, a key multi-hop detail indicating industry-wide strategic movement toward sports-driven DTC platforms. These omissions affect completeness and multi-hop synthesis, but do not undermine the core factual accuracy. All dates (2022, 2024, and implied 2025 via 'early fall 2025' in original) are contextually respected. No numerical inaccuracies are present, hence full marks for quantitative accuracy. The reasoning is sound and contextually relevant, effectively capturing the evolution in scripted programming distribution despite missing some specific collaborative initiatives and exact channel counts.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 417,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How did Tesla's financial and operational challenges related to energy storage products evolve from 2022 to 2023, particularly in terms of accounts receivable and production scaling dependencies?",
      "original_answer": "In 2022, Tesla disclosed significant long-term government rebates receivable related to its energy storage products, with a balance of $627 million as of December 31, 2021, indicating extended collection periods of up to a year or more. By 2023, the focus shifted from financial implications of receivables to operational dependencies, as Tesla highlighted production scaling risks for energy storage products, including bottlenecks, supplier constraints, and facility ramp delays at factories in Nevada, Texas, and other locations. These changes reflect a shift from financial exposure tied to receivables to broader production and supply chain dependencies affecting the company's ability to meet cost and profitability targets.",
      "llm_answer": "In the 2022 filing Tesla’s energy‑storage challenges were framed mainly as a credit‑risk issue – the company’s accounts‑receivable balance (which includes sales of storage systems, financing receivables and regulatory‑credit payments) required an allowance for expected credit losses and could vary with payment timing and government‑rebate cycles, but it was not concentrated in any single counter‑party【page_64】. The 2023 filing, by contrast, shifts the emphasis to operational risk: scaling the production of its storage products now depends on securing enough battery‑cell capacity and raw‑material supply (lithium, nickel, cobalt, etc.) and on successfully ramping new factories; any shortfall could force curtailments or higher‑cost procurement【page_16】【page_17】【page_18】. Thus, the focus moved from managing receivable credit exposure in 2022 to managing supply‑chain and production‑scaling dependencies in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, while the original answer cites a $627 million receivable balance as of December 31, 2021 (disclosed in the 2022 filing), the LLM does not explicitly mention this figure. However, it correctly characterizes the 2022 situation as involving extended payment timing and government rebate cycles, which is consistent with the nature of the $627M receivable. The absence of the exact number is a minor omission but does not introduce inaccuracy. (2) The LLM correctly identifies the shift from financial/credit risk in 2022 to operational/supply chain risk in 2023, which is the core of the multi-hop reasoning required. (3) Entity accuracy is strong: Tesla, energy storage products, 2022 vs 2023 timeframes, and relevant risks (receivables, supplier constraints, factory ramps) are all correctly identified. (4) The reasoning is sound: the LLM synthesizes information across years and domains (financial to operational), correctly inferring a strategic shift. It adds detail not in the original—such as specific raw materials (lithium, nickel, cobalt) and references to factory ramp risks—likely from actual filing content, enhancing depth without contradicting the ground truth. (5) Semantic equivalence is high: the central evolution from receivables exposure to production scaling dependencies is clearly and correctly conveyed. The only reason for not scoring a 10 is the omission of the specific $627M receivable figure, which was present in the ground truth and would strengthen quantitative completeness. However, since the focus is on the evolution of challenges rather than precise numbers, this is a minor shortfall.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 465,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in relation to its bottling partners and fountain retailers?",
      "original_answer": "In 2022, Coca-Cola's relationship with syrups was primarily defined by its sales to both consolidated and unconsolidated bottling partners, with revenue and volume recognition dependent on the ownership structure of those partners. Specifically, concentrate and syrup sales were not recognized until finished products were sold to third parties in the case of consolidated bottlers, while recognition occurred immediately for unconsolidated bottlers. By 2023, the company's description of syrups shifted to emphasize their role as a dependency within a broader operational framework, particularly in relation to fountain retailers. In 2023, the company clarified that it manufactures fountain syrups and sells them directly to fountain retailers or authorized wholesalers and bottlers, highlighting a more integrated and strategic role for syrups in its finished beverage delivery system. This represents a shift from a primarily volume-driven metric to a more operationally embedded component of the business model.",
      "llm_answer": "In the 2022 filing, syrups were treated as part of the concentrate business – sold to bottling partners and accounted for as “concentrates or syrups” with revenue recognized only when a consolidated bottler sold the finished product (or immediately when sold to an unconsolidated partner)【page_45】. By the 2023 filing, Coca‑Cola highlights a distinct fountain‑syrup operation, stating it now manufactures fountain syrups and sells them directly to fountain retailers (or through authorized wholesalers) while still supplying bottling partners, making syrups a separate channel for immediate‑consumption sales【page_37】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the accounting treatment of syrup sales in 2022, distinguishing between consolidated and unconsolidated bottling partners, with revenue recognition timing accurately described. (2) For 2023, it captures the shift in narrative where Coca-Cola emphasizes manufacturing and selling fountain syrups directly to fountain retailers or through authorized wholesalers, marking a more strategic and integrated role. This reflects the evolution from a volume-driven concentrate model to an operationally embedded component. (3) The multi-hop reasoning is sound: it synthesizes information across two years, correctly linking changes in syrup treatment to bottling partners and fountain retailers. (4) All entities (Coca-Cola, bottling partners, fountain retailers, wholesalers) and years (2022, 2023) are accurate. There are no numeric inaccuracies—though no specific dollar figures are mentioned, the qualitative financial logic (revenue recognition rules) is correct. (5) The only minor shortcoming is that the LLM does not explicitly frame the change as a shift from 'volume-driven metric' to 'operationally embedded component' as stated in the original answer, slightly reducing qualitative completeness. However, the core evolution in business model role is clearly conveyed. Wording differences are acceptable under semantic equivalence. Contextual relevance is perfect—directly addresses all parts of the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 415,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did Disney's investment in Other Mortgage- and Asset-Backed Securities (MBS & ABS) evolve from fiscal year 2022 to fiscal year 2024, and what was the trend in its proportion relative to the overall fair value hierarchy?",
      "original_answer": "In fiscal year 2022, Disney's investment in Other MBS & ABS was valued at $96 million, representing 1% of the total plan asset mix. By fiscal year 2024, this investment increased to $120 million, maintaining a 1% share of the total plan asset mix. While the absolute value of the investment grew moderately, its proportional representation within the portfolio remained stable.",
      "llm_answer": "Disney’s Other Mortgage‑ and Asset‑Backed Securities holdings rose from $84 million in FY 2022 (≈ 1% of the fair‑value hierarchy) to $120 million in FY 2023 and $166 million in FY 2024. Despite the dollar increase, the investment’s share of the total fair‑value assets stayed essentially unchanged at about 1% each year.【page_104】【page_107】",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies in the quantitative data. According to the ground truth, Disney's investment in Other MBS & ABS was $96 million in FY 2022, not $84 million as stated. Additionally, the LLM claims the investment increased to $166 million in FY 2024, whereas the correct value is $120 million. The LLM also incorrectly reports data for FY 2023 ($120 million), which is not mentioned in the original answer and not part of the question's scope (2022 to 2024). While the proportion (1%) is correctly noted as stable, this is the only accurate element. (2) The dollar amounts are materially incorrect: $84M vs $96M (FY22) and $166M vs $120M (FY24) represent substantial deviations. The claim of growth to $166M in 2024 contradicts the ground truth of $120M. No correct calculation or trend can be derived from these numbers. (3) The reasoning is flawed in terms of multi-hop synthesis: the model introduces a non-existent FY2023 data point and extrapolates an incorrect upward trend. It fails to accurately reflect the moderate increase from $96M to $120M over two years, instead suggesting a steeper rise. The stability of the 1% proportion is correctly interpreted, but this does not compensate for the numerical inaccuracies. (4) Contextual relevance is fair because the answer addresses the right metric (Other MBS & ABS), time frame (fiscal years), and concept (proportion within fair value hierarchy), but the severe quantitative errors undermine overall correctness. The citation of page numbers does not validate the incorrect figures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1198,
        "completion_tokens": 431,
        "total_tokens": 1630
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How did the focus areas of Skunk Works' advanced development programs evolve between 2022 and 2023 in relation to next-generation military aircraft capabilities?",
      "original_answer": "In 2022, Skunk Works' Advanced Development Programs focused on future systems including unmanned and manned aerial systems and next-generation capabilities for hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. By 2023, the focus had evolved to emphasize air dominance, hypersonics, intelligence, surveillance, reconnaissance, situational awareness, and air mobility. The shift highlights an increased emphasis on air dominance as a core next-generation capability while maintaining focus on hypersonics and ISR. This represents a refinement of priorities rather than a complete overhaul of focus areas.",
      "llm_answer": "Both the 2022 and 2023 Form 10‑K filings describe Skunk Works (the Advanced Development Programs) as concentrating on the same next‑generation capabilities – unmanned and manned aerial systems and “next‑generation” air‑dominance, hypersonics, intelligence‑surveillance‑reconnaissance, situational‑awareness and air‑mobility – while emphasizing rapid‑prototype design, technology insertion and network‑enabled integration. In other words, the focus areas did not shift between 2022 and 2023; they remained consistent.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, claiming no shift in focus areas between 2022 and 2023, while the ground truth explicitly states a refinement with increased emphasis on air dominance. The LLM incorrectly asserts that air dominance was a stated focus in 2022, but the original answer indicates that in 2022 the focus was on 'unmanned and manned aerial systems and next-generation capabilities for hypersonics, ISR, situational awareness, and air mobility'—with no mention of air dominance as a central theme. By 2023, air dominance became a highlighted priority. The LLM also fails to acknowledge the evolution from a broader 'future systems' framing to a more targeted emphasis on air dominance. While the listed capabilities are largely accurate and the years are correctly referenced (quantitative accuracy is high), the reasoning is flawed in synthesizing the shift. The model misses the nuance of a strategic refinement, instead asserting consistency. This represents a significant qualitative error in multi-hop reasoning and interpretation, despite using semantically similar terms. Contextually, the answer is relevant and addresses the question’s scope, but with incorrect synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 341,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Tesla's approach to the Powerwall product evolved from 2022 to 2023, particularly in terms of integration strategy and production emphasis?",
      "original_answer": "In 2022, Tesla emphasized cross-selling Powerwall with residential solar energy products due to better availability and growing grid stability concerns. The company was also focused on improving installation capabilities and price efficiencies for Solar Roof, which is closely related to Powerwall integration. By 2023, Tesla had advanced its integration strategy by designing both Solar Roof and solar energy systems to specifically integrate with Powerwall, indicating a more deliberate and engineered approach to product synergy. This evolution reflects a shift from a sales and availability focus to a deeper technical and strategic integration within Tesla's energy ecosystem.",
      "llm_answer": "In the 2022 filing Tesla said it was improving Powerwall availability and “emphasizing cross‑selling with our residential solar energy products” to capture growing customer interest while ramping production to meet that demand【page_34】. By the 2023 filing the company stresses that Solar Roof and Powerwall are “designed to integrate” and that a modular, vehicle‑technology‑derived battery architecture is being used to “optimize manufacturing capacity of our energy storage products,” reflecting a tighter product integration and a stronger focus on scalable production of Powerwall units【page_7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Tesla's 2022 strategy of emphasizing cross-selling Powerwall with residential solar products due to availability and growing demand, citing page 34. In 2023, it accurately notes the shift toward designed integration between Solar Roof and Powerwall, along with the use of a modular, vehicle-technology-derived battery architecture to optimize manufacturing—information supported by page 7. (2) There are no numeric values (e.g., dollar amounts, percentages, units) in either the question or answers, so quantitative accuracy is not applicable in that sense, but all factual claims about timing (2022 vs 2023) and product strategies are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across two years and two product lines (Powerwall, Solar Roof), correctly identifying the evolution from a sales-driven cross-selling approach to a deeper technical integration and production scalability focus. (4) The LLM captures the core evolution described in the original answer—shift from availability and cross-selling to engineered integration and manufacturing optimization—though it omits minor contextual details about installation capabilities and price efficiencies for Solar Roof mentioned in the 2022 context. This slight omission prevents a perfect 10 but does not undermine the overall correctness. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent as all content directly addresses the question’s focus on integration strategy and production emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 442,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How has Gilead's strategic positioning around Biktarvy evolved between 2022 and 2024, particularly in terms of its role within the company's HIV portfolio and associated commercial risks?",
      "original_answer": "In 2022, Biktarvy was prominently positioned as a key revenue-generating product within Gilead’s HIV portfolio, highlighted as a single-tablet regimen combining bictegravir, emtricitabine, and tenofovir alafenamide (TAF), emphasizing its convenience and efficacy. By 2024, while Biktarvy remained a core product, the company faced heightened commercial risk as it became more dependent on HIV products containing TAF. A shift in treatment paradigms or reduced preference for nucleoside-based therapies could significantly impact Biktarvy’s sales and, by extension, Gilead’s financial stability. This reflects a transition from a focus on product innovation to increased vulnerability due to overreliance on a narrow therapeutic class.",
      "llm_answer": "In the 2022 filing, Gilead presented Biktarvy as a flagship, revenue‑generating HIV product—a once‑daily, single‑tablet regimen that sits at the center of its HIV portfolio (2022 10‑K, p. 5). By the 2024 filing, the company’s discussion of HIV now emphasizes the commercial vulnerability of its TAF‑based suite—including Biktarvy—citing risks such as competitive market‑share loss, generic entry and a possible shift away from nucleoside‑based regimens that could depress sales (2024 10‑K, Risk Factors, p. 18). This marks a shift from positioning Biktarvy as a core growth driver to acknowledging heightened competitive and paradigm‑change risks around the drug.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Biktarvy's role in 2022 as a flagship, revenue-generating, single-tablet HIV regimen is accurately described, and by 2024, the increased commercial risks due to reliance on TAF-based therapies are properly highlighted. The mention of risks such as generic entry, competition, and a potential shift away from nucleoside-based regimens matches the original answer’s emphasis on vulnerability to treatment paradigm shifts. (2) There are no numeric values (e.g., dollar amounts, percentages, patient counts) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across Gilead’s 2022 and 2024 10-K filings to show an evolution in strategic positioning—from innovation and growth emphasis to risk awareness and dependency concerns. The use of specific document references (e.g., 2024 10-K, Risk Factors, p. 18) adds credibility. (4) The only minor shortcoming is that the LLM does not explicitly state that this shift reflects a broader transition from 'product innovation' to 'vulnerability due to overreliance'—a nuance present in the original answer. However, this concept is strongly implied through the discussion of increased risk and dependence on TAF-based products. Wording differs slightly but semantic equivalence is maintained. Contextual relevance is perfect—the answer directly addresses the evolution in strategic positioning, role in the HIV portfolio, and commercial risks between 2022 and 2024.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 446,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How did the composition of the U.S. Retrospective Responsibility Plan change between 2022 and 2023, particularly regarding the mechanisms referenced in relation to the U.S. Litigation Escrow Agreement?",
      "original_answer": "In 2022, the U.S. Retrospective Responsibility Plan included mechanisms such as the U.S. Litigation Escrow Agreement, the conversion feature of Class B common stock, indemnification obligations of Visa U.S.A. members, an interchange judgment sharing agreement, a loss sharing agreement, and an omnibus agreement. By 2023, the composition evolved to include a new element — 'makewhole agreements relating to the Class B-1 common stock exchange offer' — while retaining the U.S. Litigation Escrow Agreement and other previously listed mechanisms. This indicates an expansion of the plan to incorporate additional financial safeguards or compensatory measures.",
      "llm_answer": "In the 2022 10‑K the U.S. Retrospective Responsibility Plan was described as consisting of the U.S. litigation escrow agreement, the conversion feature of the company’s class B common stock, the indemnification obligations of Visa U.S.A. members, an interchange‑judgment‑sharing agreement, a loss‑sharing agreement and an omnibus agreement 【page_71】. The 2023 10‑K keeps all of those components but adds “makewhole agreements relating to the class B‑1 common‑stock exchange offer” to the list of mechanisms 【page_72】. Thus, the plan’s composition expanded in 2023 to include makewhole agreements in addition to the original escrow‑related mechanisms.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original answer. (1) All factual components of the U.S. Retrospective Responsibility Plan in 2022 are accurately listed: U.S. Litigation Escrow Agreement, conversion feature of Class B common stock, indemnification obligations, interchange judgment sharing agreement, loss sharing agreement, and omnibus agreement. (2) The 2023 update is correctly identified: the addition of 'makewhole agreements relating to the Class B-1 common stock exchange offer' while retaining all prior mechanisms. (3) The multi-hop reasoning is sound—comparing the composition across two years and identifying the expansion of the plan is accurately synthesized from the two 10-K filings. (4) There are no numerical inaccuracies; although no specific numbers (e.g., dollar amounts) are involved, the qualitative elements (mechanisms, years, entities) are all correctly referenced. (5) The answer directly addresses the question about changes in composition and specifically notes the retention of the U.S. Litigation Escrow Agreement, which is a key part of the query. Minor formatting differences (e.g., 'class B-1' vs 'Class B-1') do not affect accuracy. All criteria—completeness, entity accuracy, reasoning, and relevance—are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 359,
        "total_tokens": 1700
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How has the strategic importance of Biktarvy evolved for GILD from 2022 to 2024, based on its patent protection timeline and the company's risk disclosures around HIV product dependency?",
      "original_answer": "In 2022, Biktarvy was listed with a U.S. patent expiration in 2033 and no expiration listed in the E.U., indicating strong long-term protection and likely a key revenue driver. By 2024, although patent details were not explicitly mentioned, the company highlighted heightened risk around its HIV products, including Biktarvy, due to market competition and potential shifts in treatment paradigms. This suggests that despite long-term patent protection, Biktarvy's strategic position has become more vulnerable due to external market and regulatory pressures.",
      "llm_answer": "Biktarvy remains a cornerstone of Gilead’s HIV franchise – the 2022 filing shows its primary compound patents run through 2033 in both the United States and the EU (2022 10‑K, patent‑expiration table on page 11). By 2024 the company’s risk‑factor discussion still stresses that a “substantial portion of our revenue” comes from HIV products and warns that loss of market share or generic competition could force a scale‑back of R&D (2024 10‑K, HIV risk factors on page 18 and product‑commercialization risks on page 19). Thus, the long‑term patent protection keeps Biktarvy strategically vital, while the ongoing HIV‑dependency disclosures highlight both its revenue importance and the vulnerability if that protection erodes.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Biktarvy's patent expiration in 2033 in the U.S. based on the 2022 filing, which aligns with the ground truth. However, it incorrectly states that the 2022 10-K lists the EU patent expiration also as 2033; the ground truth specifies that no expiration was listed in the EU, making this a factual inaccuracy. This affects quantitative accuracy but not the overall strategic interpretation. (2) All other numerical and date-related information is accurate: the 2022 and 2024 timeframes are correct, and there are no calculations required beyond correct interpretation of patent and risk disclosure timelines. The citation of page numbers (e.g., page 11 in 2022 10-K, page 18–19 in 2024) adds precision and matches typical disclosure locations, though minor discrepancies here would not affect scoring. (3) The multi-hop reasoning is sound: the model synthesizes patent protection data from 2022 with risk disclosures from 2024, correctly inferring that despite strong IP protection, GILD continues to emphasize revenue dependency and market vulnerability, indicating a nuanced strategic position. The conclusion that Biktarvy remains vital but exposed to risk mirrors the ground truth’s implication of increased vulnerability due to external pressures. (4) The answer is contextually excellent—directly addressing patent timelines, revenue dependency, and evolving risk disclosures. The qualitative reasoning is strong, with only a minor factual error on EU patent status preventing a top score. Thus, correctness is rated 8 due to this specific inaccuracy, though the overall synthesis and strategic interpretation remain highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 459,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "Have there been any modifications to the financial guarantees provided by AT&T for Illinois Bell Telephone Company between 2022 and 2023, particularly in terms of guarantee structure or referenced documentation?",
      "original_answer": "The financial guarantee relationship between AT&T and Illinois Bell Telephone Company remained structurally unchanged between 2022 and 2023. In 2022, AT&T's guarantee for Illinois Bell Telephone Company was referenced under Exhibit 4-d to Form 10-K for the period ending December 31, 2011. In 2023, the same guarantee was still in place and referenced under the identical exhibit number (Exhibit 4-d) and filing history (Form 10-K for the period ending December 31, 2011). There is no indication of modifications to the guarantee structure, terms, or documentation between the two years.",
      "llm_answer": "The 2023 Form 10‑K includes a guarantee for Illinois Bell Telephone Company listed as Exhibit 4‑d (the same 2011‑dated guarantee that covers multiple Bell subsidiaries). The 2022 excerpts contain no guarantee reference for Illinois Bell, and the 2023 filing does not disclose any amendment or new structure—so the guarantee’s structure and the documentation it cites remain unchanged.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It correctly identifies that the financial guarantee for Illinois Bell Telephone Company in 2023 is referenced under Exhibit 4-d and originates from the 2011 Form 10-K, covering multiple Bell subsidiaries. It accurately states there was no amendment or structural change disclosed in 2023. The only minor discrepancy is the claim that 'the 2022 excerpts contain no guarantee reference for Illinois Bell'—while the ground truth confirms the guarantee was still in place in 2022 and referenced under the same exhibit, the LLM may have not had access to that specific excerpt but does not contradict the structural continuity. This does not constitute a factual error but reflects a slight incompleteness in coverage rather than inaccuracy. All dates, exhibit numbers, and corporate entities are correct. The reasoning is sound: the absence of amendments in 2023, combined with the reuse of the same exhibit, supports the conclusion of no structural change. The answer correctly synthesizes information across years and filings, demonstrating valid multi-hop logic. Semantic equivalence is maintained, and the response fully addresses the question about modifications in structure or documentation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 354,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "What does the consistent Class C to Class A common stock conversion rate between 2022 and 2023 suggest about the potential impact on Class A common stockholders' voting power in significant corporate transactions?",
      "original_answer": "In 2022, the Class C common stock had a conversion rate of 4.0000 into Class A common stock, and this rate remained unchanged in 2023. Despite the as-converted Class A common stock value increasing slightly from 38 million in 2022 to 39 million in 2023, the unchanged conversion rate suggests that the relative voting power dilution for Class A common stockholders remained stable. This stability implies that there was no structural change in how Class C stockholders could influence significant corporate decisions through their voting rights tied to Class A equivalents.",
      "llm_answer": "The conversion rate for Class C to Class A common stock remained at 4.0‑to‑1 in both 2022 and 2023 (Note 15‑Stockholders’ Equity, page 87). Because the rate did not change, the number of Class A shares that could be created from a Class C conversion – and thus any dilution of voting power for existing Class A shareholders in a merger or other significant transaction – stays at the same level, not increasing the voting‑power impact (see discussion of voting dilution on page 32).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the conversion rate of 4.0-to-1 (equivalent to 4.0000 in the original) is correctly stated for both 2022 and 2023, and no incorrect numbers are introduced. The slight increase in as-converted Class A value from 38M to 39M is omitted, but this does not affect the core conclusion about voting power stability. (2) The reasoning is sound: the unchanged conversion rate implies no change in potential dilution of Class A voting power during significant corporate transactions, which matches the original answer’s logic. (3) The LLM correctly identifies the key concept—voting power dilution tied to conversion mechanics—and links it to corporate events like mergers, demonstrating proper multi-hop synthesis between conversion terms and governance impact. (4) While the LLM does not explicitly mention the numerical increase in as-converted shares (38M to 39M), it correctly emphasizes the stability of the conversion structure, which is the central point regarding voting power. The omission slightly reduces completeness but does not impair factual correctness. The references to specific filing pages (Note 15, page 87; page 32) add contextual support, though not required. Overall, the answer is semantically equivalent in intent and conclusion, with only minor detail reduction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 379,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How did Tesla's relationship with the Solar Roof evolve from 2022 to 2023 in terms of production focus and strategic dependencies?",
      "original_answer": "In 2022, Tesla directly produced the Solar Roof at Gigafactory New York, indicating active involvement in its manufacturing. However, by 2023, Tesla's disclosures shifted to emphasizing dependencies and risks associated with scaling production, including potential delays, supply chain constraints, and challenges in launching and ramping products like the Solar Roof. This reflects a transition from a production-centric view to a more cautionary outlook on strategic execution risks.",
      "llm_answer": "In 2022 Tesla presented the Solar Roof as a standard part of its energy‑generation portfolio—offered with financing options and produced at its dedicated Gigafactory New York site (2022 p. 9). By the 2023 filing the tone had shifted to risk‑focused language, emphasizing that the Solar Roof’s launch and production ramp could face delays and that its success now hinges on expanding manufacturing capacity and managing supplier and supply‑chain dependencies (2023 p. 15‑16). This marks a move from a product‑offering focus to a production‑ramp and strategic‑dependency focus.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that in 2022, Tesla produced the Solar Roof at Gigafactory New York, citing the correct context (2022 p. 9), and notes the shift in 2023 to risk-focused language around production ramp, supply chain, and dependencies (2023 p. 15–16). These details match the original answer’s core claim of a transition from production focus to strategic risk awareness. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), but the years (2022, 2023) and page references are factually consistent with the knowledge graph source. Format and referencing are precise. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, correctly infers a strategic shift from operational details and risk disclosures, and identifies the evolution in tone and focus. The only minor gap is that the LLM emphasizes 'financing options' and 'product offering' in 2022, which, while plausible, is not explicitly mentioned in the ground truth—this adds slight interpretive content but doesn’t detract from factual correctness. (4) The answer is contextually fully relevant, directly addressing both production focus and strategic dependencies over time. Overall, the response is factually correct, well-supported, and semantically equivalent to the original answer, warranting a high correctness score with only a minor deduction for slight over-interpretation of 2022 emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1261,
        "completion_tokens": 418,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How has the role of syrups in Coca-Cola's business model evolved between 2022 and 2023, particularly in terms of their relationship to finished beverage production and distribution channels?",
      "original_answer": "In 2022, Coca-Cola described syrups as intermediate products used primarily in fountain beverage production, where bottling partners or fountain retailers mix them with water and sweeteners to create finished beverages for immediate consumption. The company emphasized that syrups were a key part of the concentrate operations, which generally yield lower net operating revenues but higher gross profit margins compared to finished product operations. By 2023, the company expanded its description to emphasize that fountain syrup sales in the U.S. were directly managed by Coca-Cola and sold to both fountain retailers and authorized wholesalers or bottling partners. Additionally, the 2023 filing highlighted that fountain syrup operations were specifically included in the North America operating segment, indicating a more structured and regionally focused approach to syrup distribution. This evolution reflects a strategic shift toward tighter control and segmentation of syrup-related revenue streams within the broader beverage production ecosystem.",
      "llm_answer": "In the 2022 filing Coca‑Cola described syrups as an intermediate product sold to its bottling partners, who mix the syrups (or concentrates) with still or sparkling water and sweeteners to create the finished beverages that are then packaged and sold to retailers, wholesalers or fountain‑retail outlets【page_6】.  The 2023 filing repeats that same bottler‑to‑finished‑beverage flow, but shows a modest shift in the business mix: the share of net operating revenue (and case volume) coming from concentrate operations—including syrups—rose from 56 % to 58 % (and from 82 % to 83 % of volume) between 2022 and 2023, indicating a slightly greater reliance on syrups while the distribution channels remain unchanged【page_37】【page_38】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures part of the evolution in Coca-Cola's syrup business model but contains significant inaccuracies and omits key strategic shifts documented in the ground truth. (1) Quantitatively, the claim that concentrate operations (including syrups) rose from 56% to 58% of net operating revenue and 82% to 83% of volume between 2022 and 2023 is not supported by the ground truth, which does not provide these specific percentages or trends. No such figures appear in the original answer derived from the knowledge graph, making this a fabrication or misattribution. This major error undermines the quantitative accuracy. (2) Qualitatively, the LLM correctly identifies syrups as intermediate products used by bottling partners to produce finished beverages, consistent with the 2022 description. However, it fails to mention the critical 2023 shift where Coca-Cola began directly managing fountain syrup sales in the U.S. and selling to both fountain retailers and authorized wholesalers—highlighting a move toward tighter control. Additionally, the LLM misses the reclassification of fountain syrup operations into the North America operating segment, a key organizational and strategic evolution. (3) The reasoning is partially sound in linking syrups to concentrate operations and noting a potential shift in business mix, but the unsupported percentages suggest flawed or hallucinated data synthesis. The model does not demonstrate accurate multi-hop reasoning across the two years’ strategic changes. (4) Contextually, the answer stays focused on the role of syrups in production and distribution, so relevance is high. However, due to the inclusion of incorrect metrics and omission of structural changes in distribution channels, the overall correctness is only moderate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1457,
        "completion_tokens": 483,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has the company's operational focus on Africa/Eurasia evolved between 2022 and 2024, particularly in terms of its geographic reporting structure and financial contribution?",
      "original_answer": "In 2022, Africa/Eurasia was reported as part of the Oral, Personal and Home Care segment with an operating profit of $203 million, indicating a relatively minor financial contribution compared to other regions. By 2024, the company maintained Africa/Eurasia as a distinct reportable operating segment within the Oral, Personal and Home Care geographic structure. Additionally, in 2024, the company realigned its skin health business, shifting it from Europe to North America, signaling a strategic refinement in geographic reporting. This change suggests a more nuanced operational focus in how the company organizes and evaluates its regional performance, including in Africa/Eurasia.",
      "llm_answer": "The Africa/Eurasia market remains a distinct report‑able operating segment of the Oral, Personal & Home Care business in both filings – the 2022 10‑K lists the five geographic segments (North America, Latin America, Europe, Asia‑Pacific and Africa/Eurasia) and the 2024 10‑K repeats the same structure, noting only a broader skin‑health realignment that required a recasting of historic segment data【page_116】【page_114】.  Financially, Africa/Eurasia’s net sales rose modestly from $1.082 billion in 2022 to $1.095 billion in 2024 and operating profit grew from $228 million to $253 million, while capital expenditures fell sharply from $30 million to $12 million, indicating a slightly larger contribution but reduced investment focus【page_116】【page_115】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, in 2022, Africa/Eurasia was not a standalone reportable segment but was included within the Oral, Personal and Home Care segment with an operating profit of $203 million. However, the LLM claims it was a distinct segment in both 2022 and 2024, which contradicts the ground truth. Additionally, the LLM reports operating profit as $228 million in 2022 and $253 million in 2024—both figures are incorrect and not supported by the ground truth. The ground truth does not provide net sales figures, but the LLM fabricates specific numbers ($1.082B and $1.095B), which cannot be verified and appear invented. Capital expenditure figures ($30M to $12M) are also not mentioned in the ground truth and are likely hallucinated. (2) Quantitative accuracy is very low: all financial figures provided by the LLM are either incorrect or unsupported. The only correct detail is the mention of a skin health realignment affecting historical data, which aligns with the ground truth’s note about shifting skin health from Europe to North America. (3) The multi-hop reasoning is flawed. The LLM fails to recognize the structural change from being a sub-region in 2022 to a more defined segment in 2024; instead, it assumes consistent segmentation. It incorrectly infers financial trends based on fabricated data, undermining the synthesis. (4) Despite the incorrect numbers and misrepresentation of the reporting structure, the LLM correctly identifies the continuity of Africa/Eurasia as part of the geographic reporting framework and notes the skin health realignment, showing some contextual understanding. Hence, contextual relevance is moderate, but correctness and quantitative accuracy are severely compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 490,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How has Johnson & Johnson's strategic presentation of its Orthopaedics business evolved between 2023 and 2024, particularly in terms of global sales performance and emphasis on enabling technologies?",
      "original_answer": "In 2023, JNJ's Orthopaedics segment was presented primarily through quantifiable sales figures, with global revenue reaching $8,942 million, showing a 4.1% increase from the prior year. The 2023 data emphasized steady growth, particularly in the U.S. ($5,525 million, up 3.8%) and modest international growth ($3,417 million, up 4.6%). By 2024, the strategic framing of Orthopaedics shifted from financial metrics to a qualitative emphasis on innovation and enabling technologies. The 2024 filing described Orthopaedics as a portfolio 'supported by products and enabling technologies' across hips, knees, trauma, spine, and sports medicine, without revisiting specific revenue figures. This reflects a strategic pivot from highlighting quantitative performance to underscoring technological leadership and product diversification within the segment.",
      "llm_answer": "In the 2023 Form 10‑K Johnson & Johnson reported Orthopaedics as a revenue line within MedTech, showing $8.9 billion of worldwide sales (U.S. $5.5 bn + International $3.4 bn) – a 4.1 % increase versus 2022 – and broke the business out into sub‑segments such as knees ($1.456 bn), trauma ($2.979 bn), spine ($2.947 bn) and others【page_90†L31-L38】【page_91†L1-L27】.  \nThe 2024 filing, however, presents Orthopaedics more as a strategic portfolio, describing it as “products and enabling technologies that support hips, knees, trauma, spine, sports, and others” within the MedTech segment, shifting the emphasis from pure sales figures to the role of technology‑enabled solutions【page_8†L1-L7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $8.9 billion in global sales (matching $8,942 million), U.S. ($5.5 billion ≈ $5,525 million), international ($3.4 billion ≈ $3,417 million), and the 4.1% growth rate are all accurate, with acceptable rounding. Sub-segment figures (knees, trauma, spine) are correctly cited from the source. (2) The qualitative shift in 2024 is accurately described: the pivot from financial metrics to strategic emphasis on 'products and enabling technologies' across hips, knees, trauma, spine, and sports medicine is correctly captured. The LLM correctly notes the absence of revenue figures in 2024 and the framing of Orthopaedics as a technology-enabled portfolio. (3) Multi-hop reasoning is sound—information is synthesized across 2023 and 2024 filings, correctly identifying the evolution in presentation strategy. (4) Minor deduction in qualitative accuracy due to not explicitly stating that the 2024 shift reflects a 'strategic pivot' or 'evolution' in framing (though implied), and slightly less emphasis on the contrast between quantitative vs. qualitative focus compared to the original answer. However, the core reasoning and factual content are intact. Contextual relevance is perfect—directly addresses both parts of the question: sales performance (2023) and emphasis on enabling technologies (2024).",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 391,
        "total_tokens": 1789
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How has Visa's approach to managing litigation liabilities through loss sharing agreements evolved between 2022 and 2023, particularly in terms of the scope of U.S. covered litigation and liability allocation?",
      "original_answer": "In 2022, Visa detailed specific amendments to its loss sharing agreement, including the October 2015 amendment that expanded the scope of U.S. covered litigation to include opt-out actions from the Rule 23(b)(3) Settlement Class in MDL 1720 that arose out of similar facts or circumstances. This amendment was part of a broader framework involving the omnibus agreement, under which Visa assumed 66.6667% of any monetary liability in covered settlements or judgments, with Mastercard assuming 33.3333%. In 2023, Visa consolidated its approach under the U.S. Retrospective Responsibility Plan, which now encompasses the loss sharing agreement as part of a broader set of mechanisms designed to address potential liabilities from U.S. covered litigation. Notably, the 2023 filing emphasizes that U.S. covered litigation now includes matters that have been 'settled or otherwise fully or substantially resolved,' indicating a shift toward resolution and consolidation of past liabilities. The evolution from a focus on specific amendments and liability sharing with Mastercard in 2022 to a more comprehensive and retrospective liability framework in 2023 suggests a strategic pivot toward finalizing and managing legacy litigation exposure.",
      "llm_answer": "In 2022 Visa’s loss‑sharing agreement covered the Interchange Multidistrict Litigation (MDL 1720) and any post‑Oct 22 2015 opt‑out actions that are fact‑wise similar, with each bank’s share of any judgment or settlement calculated by multiplying the total amount by its membership proportion under Visa U.S.A.’s certificate of incorporation【page_72】【page_73】. The 2023 filing keeps that same scope and membership‑proportion allocation (see the 2023 Note 5 description of the loss‑sharing agreement) but shows a markedly larger U.S. litigation escrow balance—$1.8 bn at year‑end 2023 versus $1.4 bn at year‑end 2022—indicating that Visa has bolstered the financial resources backing the unchanged loss‑sharing framework【page_73】.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but significantly misrepresents the evolution of Visa's approach to litigation liabilities between 2022 and 2023, which is the core of the question. (1) Correctly identifies that the 2022 loss sharing agreement covered MDL 1720 and opt-out actions post-October 2015 arising from similar facts, aligning with the ground truth. It also correctly references the membership proportion allocation, though it does not specify the exact 66.6667%/33.3333% split between Visa and Mastercard as stated in the original answer. (2) Quantitatively, the dollar amounts for the escrow balances ($1.8B in 2023 vs $1.4B in 2022) are plausible and may be factually accurate, but these figures are not mentioned in the ground truth, making verification impossible; their inclusion distracts from the actual evolution described in the original answer. The date 'Oct 22 2015' is close but not precisely matching the reference to the October 2015 amendment without a specific day in the ground truth—minor issue. (3) The critical failure is in reasoning and completeness: the LLM claims the scope and allocation 'remained unchanged' in 2022–2023, directly contradicting the ground truth, which states that Visa moved to a new U.S. Retrospective Responsibility Plan in 2023 that broadened the framework and redefined U.S. covered litigation to include 'settled or otherwise fully or substantially resolved' matters. This represents a major strategic shift that the LLM completely misses. Additionally, the omnibus agreement and the specific liability split with Mastercard are omitted. (4) While the answer is relevant to litigation and loss sharing, it fails to capture the key qualitative evolution—consolidation, retrospective focus, and strategic pivot—making the overall correctness low despite some accurate details. The model appears to understate change where the ground truth emphasizes a significant shift.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1507,
        "completion_tokens": 520,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did CL's investment in Guaranteed Investment Contracts evolve between 2022 and 2024, and what does this shift indicate about the company's pension plan asset strategy?",
      "original_answer": "In 2022, CL held $1 million in Guaranteed Investment Contracts under its United States Pension Plans and $55 million under its International Pension Plans. By 2024, the company had completely phased out Guaranteed Investment Contracts from its United States Pension Plans, reducing the International allocation to $34 million. This represents a significant shift away from Guaranteed Investment Contracts in the U.S. and a moderate decrease internationally, indicating a strategic reallocation of pension plan assets.",
      "llm_answer": "In the 2022 filing Colgate‑Palmolive’s defined‑benefit plans carried roughly $1 million of U.S. guaranteed‑investment contracts (GICs) and $51 million of international GICs – about $52 million in total 【page_102】. By the 2024 filing the U.S. GIC position had been eliminated and the international balance had fallen to $30 million 【page_99】. This reduction shows the company is scaling back its reliance on GICs and reallocating pension‑plan assets toward other categories such as cash, fixed‑income and equity‑related investments.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but contains significant quantitative inaccuracies. According to the ground truth, in 2022, CL held $1 million in U.S. Guaranteed Investment Contracts (GICs) and $55 million internationally, totaling $56 million. The LLM incorrectly reports international GICs as $51 million and total as $52 million, which is inconsistent. In 2024, the ground truth states international GICs were reduced to $34 million, but the LLM reports $30 million — another factual error. The U.S. elimination is correctly noted. (2) Calculations: The LLM’s implied total reduction from $52M to $30M suggests a $22M drop, while the actual reduction is from $56M to $34M ($22M as well), so the magnitude is coincidentally similar, but the component values are wrong. (3) Reasoning: The multi-hop synthesis across 2022 and 2024 is present, and the conclusion about strategic reallocation is reasonable and aligns with the original answer’s interpretation. The LLM adds detail about reallocation toward cash, fixed-income, and equity-related investments, which is plausible but not confirmed in the ground truth — a minor overreach but not incorrect. (4) Scores justified: Correctness is 6 due to core trend being right (phase-out in U.S., decline internationally) but key numbers wrong. Quantitative accuracy is 5 because two major dollar figures (2022 international, 2024 international) are incorrect. Qualitative accuracy is 7 — reasoning and entity identification (CL, GICs, pension plans, time frame) are sound. Contextual relevance is 9 — the answer directly addresses the question’s intent and structure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1268,
        "completion_tokens": 446,
        "total_tokens": 1715
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the strategic positioning and functionality of the Mastercard Developer Platform evolved between 2022 and 2024, particularly in terms of its role in enabling integration of digital assets and new technologies?",
      "original_answer": "In 2022, the Mastercard Developer Platform was described as a single access point that enables customers and partners to leverage Mastercard's digital assets and services, with an emphasis on ease of integration into new and existing solutions. By 2024, the platform continued to serve this role but expanded its strategic positioning by explicitly aligning with emerging technologies such as blockchain and digital currencies. In 2024, the platform was referenced in the context of enabling integration with the Mastercard Multi-Token Network™, which supports programmable payments and facilitates secure, scalable, and interoperable blockchain-based transactions. This evolution shows a shift from a general digital integration platform to one that specifically supports next-generation financial technologies and programmable commerce solutions.",
      "llm_answer": "In the 2022 filing Mastercard described its Developer Platform mainly as a “single access point” that “simplifies access to, and integration of, our digital assets,” letting customers and partners find and embed Mastercard APIs and services in new or existing solutions【page_14】. By the 2024 filing the platform had been elevated to a strategic hub for emerging tech – it now supports blockchain‑based business models, offers the Mastercard Multi‑Token Network for programmable payments and enables crypto‑card purchases and spend, signaling a broader role in integrating digital assets and new technologies【page_14】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: in 2022, the Mastercard Developer Platform was described as a 'single access point' for integration of digital assets, which matches the original answer. By 2024, it evolved to support blockchain-based models and the Mastercard Multi-Token Network™, enabling programmable payments and crypto-card integration—this reflects the expanded strategic role detailed in the ground truth. (2) There are no numeric values, dates, or calculations in the response that conflict with the original; all timeframes (2022, 2024) are correctly used. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years and identifies the evolution in functionality and strategic positioning, particularly around digital assets and emerging technologies like blockchain and programmable payments. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'secure, scalable, and interoperable blockchain-based transactions' or the term 'programmable commerce solutions' from the original, slightly reducing qualitative completeness. However, the core meaning—support for blockchain, programmable payments, and digital asset integration—is preserved. Wording differences are acceptable under semantic equivalence. Overall, the answer is factually correct, contextually relevant, and demonstrates strong reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 402,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How has the company's investment in U.S. common stocks within its pension plans evolved between 2022 and 2024, and what does this indicate about its strategic asset allocation?",
      "original_answer": "In 2022, the company reported no investments in U.S. common stocks within its pension plans, while by 2024, there was still no allocation to U.S. common stocks in the U.S. pension plan. However, the international pension plan maintained a $2 million investment in U.S. common stocks in both years. This indicates a continued strategic decision to avoid direct exposure to U.S. common stocks in the domestic pension portfolio while maintaining a minimal presence in the international portfolio.",
      "llm_answer": "Colgate‑Palmolive’s defined‑benefit pension trusts have not held any of the company’s own U.S. common stock – the 2022 filing notes that equity securities in the U.S. plans contained no company stock at December 31 2021 (and likewise for 2020)【page_102】, and the 2024 filing confirms the same for December 31 2024 (and 2023)【page_101】. This unchanged zero holding from 2022 through 2024 reflects a deliberate strategic allocation that excludes the firm’s equity from its pension portfolios, keeping the asset mix focused on other categories such as cash, fixed‑income and pooled funds.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is partially correct but significantly misrepresents the core facts. The original answer states that there was no investment in U.S. common stocks in the U.S. pension plan in both 2022 and 2024, which aligns with the LLM's claim of zero holdings. However, the LLM incorrectly narrows the focus to 'own U.S. common stock' (i.e., Colgate-Palmolive’s own stock), while the question and ground truth refer to U.S. common stocks in general, not just company stock. This is a critical factual error. Additionally, the LLM omits the key fact that the international pension plan held a $2 million investment in U.S. common stocks in both years, which is central to the original answer. (2) Quantitatively, the LLM fails to report the $2 million investment in U.S. common stocks within the international pension plan in both years, making its numerical accuracy low. While it correctly notes zero allocation in the U.S. plan, it mischaracterizes the reason (focusing on self-investment avoidance rather than broader asset allocation). (3) The reasoning is flawed in its multi-hop synthesis: the model conflates 'U.S. common stocks' with 'company’s own common stock,' which are not equivalent. This undermines the logical foundation of the answer. The conclusion about strategic allocation is partially reasonable but based on incorrect premises. (4) The contextual relevance is moderate—the answer addresses pension plan investments and strategic allocation, but misinterprets the scope of the asset class in question, leading to an incomplete and misleading response. The omission of the $2M international holding severely limits completeness and accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 458,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How did Disney's strategic focus on cruise ships evolve between 2022 and 2023, particularly in terms of capital investment plans and operational risk considerations?",
      "original_answer": "In 2022, Disney highlighted cruise ships as a key part of its capital investment strategy within the Parks & Experiences segment, noting that a majority of its capital spending was directed toward theme parks, resorts, and cruise ships. This indicated a growth-oriented approach focused on expanding physical assets. By 2023, the emphasis had shifted toward operational risks associated with cruise ships, particularly in the context of external disruptions like hurricanes and global events (e.g., the impact of Hurricane Milton on Walt Disney World operations). The 2023 filing framed cruise ships more as an operational exposure rather than a growth engine, signaling a shift from investment to risk mitigation. This evolution reflects a recalibration of strategic focus from asset expansion to managing volatility and external threats.",
      "llm_answer": "In the 2022 filing Disney treated cruise ships as a line‑item within its overall Parks & Experiences capital program – “cruise ships” were listed alongside theme‑park and resort expansion as part of the company’s recent capital spend (2022 10‑K p. 17). By the 2023 filing the strategy had shifted to an explicit growth push, announcing plans to add more vessels to the Disney Cruise Line fleet for fiscal 2024 (2023 10‑K p. 22) and warning that such cruise‑ship investments carry heightened operational risk – including the possibility of asset write‑downs if new concepts (e.g., the Star Wars: Galactic Starcruiser) under‑perform and the uncertainty of consumer acceptance (2023 10‑K p. 21‑22).",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in its characterization of Disney's strategic evolution. The original answer states that Disney shifted from a growth-oriented investment focus in 2022 to an emphasis on operational risk mitigation in 2023, particularly due to external disruptions like hurricanes. However, the LLM answer incorrectly claims that in 2023, Disney shifted toward an 'explicit growth push' with plans to add more vessels in fiscal 2024. This directly contradicts the ground truth, which indicates a de-emphasis on growth and a heightened focus on risk. Additionally, the LLM introduces the Star Wars: Galactic Starcruiser underperformance and consumer acceptance risks as central to the 2023 shift, but this nuance is not present in the original answer and misrepresents the nature of the strategic shift. (2) Quantitatively, no specific dollar amounts, percentages, or dates are misstated—the answer references document pages and years correctly (2022 10-K p.17, 2023 10-K pp.21–22), and there are no numerical calculations to verify. Thus, quantitative accuracy is high. (3) The multi-hop reasoning is flawed: while the LLM pulls information from both years’ filings, it synthesizes them incorrectly. It fails to recognize that the strategic shift was from growth/investment (2022) to risk/operations (2023), instead portraying 2023 as a continuation or acceleration of growth with added risk disclosures. This inverts the actual evolution. (4) Contextual relevance is moderate—the answer discusses capital investment and operational risks in both years, which are relevant themes, but the overall interpretation misaligns with the ground truth. The introduction of the Star Wars concept as a key risk factor adds detail not supported in the original answer and distracts from the core shift in strategic framing. Therefore, while some elements are factually grounded, the overall correctness is low due to a fundamental misrepresentation of the strategic direction.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 543,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Mastercard's use of short duration foreign exchange derivative contracts evolved between 2022 and 2024, particularly in terms of their role in managing foreign exchange risk during daily settlement activities?",
      "original_answer": "In 2022, Mastercard used short duration foreign exchange derivative contracts to manage foreign exchange risk associated with daily settlement activities, aiming to reduce exposure to volatility from currency fluctuations on anticipated receipts and disbursements. By 2024, the company continued this practice, maintaining the same stated objective of minimizing volatility in gains and losses due to foreign exchange fluctuations. However, the context changed as the company actively adjusted its hedging strategies involving euro-denominated debt, de-designating and re-designating portions of it in 2023 and 2024, which indicates a more dynamic approach to managing foreign exchange exposure across the period. The continuity in the use of short duration contracts contrasts with the evolving structure of the company’s broader foreign exchange risk management strategy.",
      "llm_answer": "Mastercard’s 2022 Form 10‑K explains that it “may enter into short‑duration foreign‑exchange derivative contracts … to manage … foreign‑exchange risk as part of its daily settlement activities” (page 111). The 2024 filing repeats the same purpose (page 106) but shows a far larger scale of those contracts – non‑designated FX contracts grew from roughly $124 million of assets and $406 million of liabilities in 2022 (page 112) to about $2.7 billion of assets and $30 million of liabilities in 2024 (page 108) – indicating that Mastercard has expanded its use of short‑duration FX derivatives to more aggressively hedge settlement‑related currency volatility.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. While it correctly identifies that Mastercard used short-duration foreign exchange derivative contracts in both 2022 and 2024 for managing FX risk in daily settlement activities—aligning with the original answer’s core continuity claim—the cited financial figures are incorrect. The LLM states non-designated FX contracts were $124M assets and $406M liabilities in 2022, growing to $2.7B assets and $30M liabilities in 2024. However, these numbers do not match the actual data from Mastercard’s 10-K filings: the 2022 amounts were approximately $1.2 billion in notional assets and $1.4 billion in liabilities for non-designated derivatives (not $124M/$406M), and the 2024 figures do not show a spike to $2.7B assets with a drop to $30M liabilities. The LLM likely misread or misattributed line items, possibly confusing fair value with notional amounts or misreading footnotes. This invalidates the conclusion that Mastercard 'expanded its use... more aggressively' due to flawed numerical basis. On qualitative grounds, the model correctly notes the unchanged stated purpose of the contracts between years and ties them to settlement activities, showing proper synthesis across filings. It also attempts multi-hop reasoning by linking scale changes to strategic shifts, but this inference is based on incorrect data. Contextually, the response is well-structured and relevant, citing specific pages and forms, but the critical error in numbers—central to the evolution assessment—reduces the correctness score to partial (5/10). Quantitative accuracy is low (4/10) due to major dollar amount errors; qualitative accuracy is moderate (6/10) as reasoning and entity identification (Mastercard, short-duration FX contracts, 2022 vs 2024) are sound despite faulty inputs; contextual relevance is high (8/10) because the answer directly addresses the question’s focus on evolution and risk management role.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 535,
        "total_tokens": 1935
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How has Salesforce's strategic relationship with enterprise cloud companies evolved from 2023 to 2024, particularly in terms of investment focus and ecosystem integration?",
      "original_answer": "In 2023, Salesforce maintained a portfolio of strategic investments in enterprise cloud companies, technology startups, and system integrators, with a focus on digitally transforming industries and expanding its solution ecosystem. These investments were described as ranging from early to late-stage companies, including those concurrent with initial public offerings. By 2024, Salesforce's relationship with enterprise cloud companies shifted from primarily investing to a broader strategic dependency, leveraging these partners as part of its ecosystem to accelerate reach into new markets and industries. The 2024 filing emphasized the Salesforce Platform's role in enabling third-party developers and ISVs to create and deliver cloud-based applications through the AppExchange, indicating a deepened integration and dependency on enterprise cloud partners beyond mere financial investment.",
      "llm_answer": "In the 2023 filing Salesforce merely noted that it “manages a portfolio of strategic investments in both privately held and publicly traded companies focused primarily on enterprise‑cloud companies, technology startups and system integrators,” treating those stakes as a financial exposure and potential upside. By the 2024 filing the relationship is framed as a growth engine – the firm says it will keep investing in enterprise‑cloud firms to “expand our solution ecosystem … including AI” and is actively deepening integration through its open platform, MuleSoft API management and a robust ISV/SI partner ecosystem, reinvesting proceeds to accelerate ecosystem‑wide adoption.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the evolution in Salesforce's strategic relationship with enterprise cloud companies from 2023 to 2024. In 2023, the focus was on managing a portfolio of strategic investments in enterprise-cloud companies, startups, and system integrators, which aligns with the ground truth description of financial investments across early to late-stage firms. The 2024 shift is correctly portrayed as a transition toward treating these relationships as a growth engine, emphasizing ecosystem expansion and integration—particularly through AI, the Salesforce Platform, MuleSoft, and the ISV/SI partner network. The mention of reinvesting proceeds and deepening integration via open platforms and AppExchange equivalents (implied through ISV ecosystem) reflects the deepened dependency beyond investment. There are no numerical inaccuracies (quantitative accuracy is perfect as no specific figures are involved). The reasoning is sound and synthesizes the multi-hop requirement across years and strategic focus. The only minor gap is that the LLM does not explicitly name AppExchange, though 'robust ISV/SI partner ecosystem' and 'open platform' strongly imply it. This slight omission prevents a perfect 10 on qualitative accuracy, but overall the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 381,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How did the company's approach to accrual rates for vendor funding programs evolve between fiscal 2023 and fiscal 2024, particularly in terms of sensitivity to projected purchase volumes?",
      "original_answer": "The company's approach to accrual rates for vendor funding programs remained methodologically consistent between fiscal 2023 and fiscal 2024, with no material changes in the recognition methodology over the past three fiscal years. However, in fiscal 2023, the company specifically highlighted sensitivity to 'graduated purchase volumes' that could impact accrued amounts, emphasizing the importance of projected volumes in determining accrual rates. In fiscal 2024, this explicit reference to 'graduated purchase volumes' was omitted, suggesting a potential simplification or stabilization in how accrual rates were adjusted throughout the year, despite continued monitoring of historical purchase trends and vendor confirmations.",
      "llm_answer": "The company did not change its methodology – in both FY 2023 and FY 2024 it “develops accrual rates based on the provisions of the agreements in place,” reviews historical purchase trends and volumes throughout the year, and adjusts the rates as appropriate.  In each filing the company stresses that “amounts accrued … could be impacted if actual purchase volumes differ from projected purchase volumes, especially in the case of programs that provide for increased funding when graduated purchase volumes are met” 【page_33】【page_34】.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is factually consistent in methodology and correctly states that the company used the same overall approach in both fiscal years, relying on agreement terms, historical trends, and projected volumes. It accurately cites the sensitivity to 'graduated purchase volumes' affecting accruals if actuals differ from projections, and includes proper page references. However, it fails to capture a key qualitative shift noted in the ground truth: the *omission* of the explicit mention of 'graduated purchase volumes' in fiscal 2024, which suggests a potential simplification or stabilization in the accrual process. By repeating the same language for both years without acknowledging this change in disclosure emphasis, the LLM implies continuity in both practice and communication, whereas the original answer highlights a subtle but meaningful evolution in how the company presented its sensitivity assumptions. This omission affects the completeness and reasoning accuracy of the response, particularly in addressing the evolution of the approach in terms of sensitivity disclosure. While no numbers or dates are incorrect (hence high quantitative accuracy), the qualitative synthesis across years is flawed, reducing the correctness score. Contextual relevance remains high as the answer addresses the core topic and uses appropriate evidence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 375,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How has the strategic relationship between LLY and Boehringer Ingelheim evolved from 2022 to 2024, particularly in terms of legal involvement and collaborative dependency on the Jardiance product?",
      "original_answer": "In 2022, LLY was not a direct party to the Jardiance patent litigation initiated by Boehringer Ingelheim (BI) against generic drug manufacturers under the Hatch-Waxman Act, indicating a more arms-length relationship in legal matters. By 2024, LLY's business became significantly dependent on the Jardiance collaboration, as the product was selected under the Inflation Reduction Act (IRA) for government-set pricing with a 66% discount compared to the 2023 list price, directly impacting LLY's revenue projections and business strategy. This shift reflects a deeper strategic entanglement and dependency on BI's partnership for navigating regulatory and pricing pressures.",
      "llm_answer": "In the 2022 filing the partnership was framed largely around legal safeguards – Boehringer Ingelheim agreed to defend and indemnify Eli Lilly in the five pending Jardiance product‑liability lawsuits and was the sole party pursuing a patent‑infringement case over Jardiance, while Lilly was not a litigant (2022 pp. 103‑102). By the 2024 filing the relationship is presented as a commercial collaboration, noting that Jardiance remains a co‑developed, co‑marketed product with Boehringer Ingelheim and is now subject to government‑set pricing under the IRA, highlighting Lilly’s continued reliance on the partnership rather than new legal entanglements (2024 p. 45).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that in 2022, Boehringer Ingelheim (BI) was the sole party pursuing patent-infringement litigation under the Hatch-Waxman Act, and LLY was not a litigant, which matches the original answer's claim of an 'arms-length relationship' in legal matters. The LLM also accurately notes BI's indemnification of LLY in product-liability lawsuits, adding contextual detail not in the ground truth but consistent with the filing. (2) For 2024, the LLM correctly identifies that Jardiance remains a co-developed, co-marketed product and is subject to government-set pricing under the Inflation Reduction Act (IRA), reflecting increased dependency. While the original answer specifies a '66% discount compared to the 2023 list price', the LLM omits this exact percentage but correctly captures the commercial and strategic implications of IRA pricing. This is a minor omission, not an error. (3) The multi-hop reasoning is sound: the LLM synthesizes information across 2022 and 2024 filings, correctly contrasting legal non-involvement in 2022 with deeper commercial reliance in 2024. (4) All entities (LLY, Boehringer Ingelheim, Jardiance, IRA) and years are correct. Wording differs but semantic meaning is equivalent. The only reason for not scoring 10 is the missing 66% discount detail, which is quantitative but not central to the core conclusion about evolving strategic dependency. Quantitative accuracy is 10 because no stated numbers are incorrect—only one was omitted. Qualitative accuracy is 9 due to excellent reasoning and entity use with minor incompleteness. Contextual relevance is perfect.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 459,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How did Disney's capital investment strategy toward cruise ships evolve from 2022 to 2023, particularly in relation to its broader Parks & Experiences business?",
      "original_answer": "In 2022, Disney's 10-K filing highlighted cruise ships as part of its broader Experiences segment but did not specifically emphasize capital investment in them, instead noting general risks from macroeconomic conditions such as inflation, supply chain delays, and currency fluctuations that could impact the implementation of business plans, including those for parks and resorts. By 2023, Disney explicitly listed cruise ships as part of its significant capital investments, indicating a strategic elevation in focus. The 2023 filing stated that the majority of the company’s capital spend was directed toward parks and experiences, including 'new attractions, cruise ships, capital improvements and systems infrastructure.' This shift demonstrates a clear prioritization of cruise ships as a key growth area within the broader Experiences segment.",
      "llm_answer": "In the 2022 Form 10‑K Disney noted that it “must often invest substantial amounts … in cruise ships” as part of its overall capital outlays, but also warned that COVID‑19 had forced the company to delay or suspend some cruise‑ship projects (2022 p. 25; 23). By the 2023 Form 10‑K the company framed cruise‑ship spending as a core component of its Parks & Experiences capital plan, stating that “the majority of the Company’s capital spend has been at our parks and experiences business…new attractions, cruise ships, capital improvements and systems infrastructure” (2023 p. 12). This reflects a shift from a cautious, risk‑aware investment stance in 2022 to a more integrated, growth‑focused strategy for cruise ships within the broader Parks & Experiences segment in 2023.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution in Disney's capital investment strategy toward cruise ships from 2022 to 2023. In 2022, the LLM correctly notes that Disney acknowledged substantial investments in cruise ships but also highlighted disruptions due to COVID-19 and macroeconomic risks, consistent with the original answer’s emphasis on general risks (e.g., inflation, supply chain). In 2023, the LLM accurately reflects the strategic shift by citing the explicit inclusion of 'cruise ships' in the major capital spend categories within Parks & Experiences, quoting the 10-K directly. (2) There are no numerical values, dates, or financial figures in dispute—both years (2022, 2023) and document references (Form 10-K, page numbers) are correctly cited. While the original answer does not mention page numbers, the LLM’s inclusion of them does not detract from accuracy and may reflect actual filing details. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of 10-K filings, compares the framing of cruise ship investments, and correctly infers a strategic shift from risk-aware caution to growth-focused integration. The only minor shortcoming is that the original answer emphasizes the *absence* of specific emphasis on cruise ships in 2022 capital plans, while the LLM states Disney 'must often invest substantial amounts... in cruise ships'—a slightly stronger characterization than the ground truth, which notes cruise ships were part of the segment but not specifically highlighted in capital investment context. This nuance is minor and does not invalidate the overall correctness. (4) The answer is contextually excellent, directly addressing the evolution in strategy and its relation to the broader Parks & Experiences business. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 536,
        "total_tokens": 1945
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has Mastercard Foundry's role in fostering innovation evolved between 2022 and 2024, particularly in relation to its engagement with emerging technologies and fintech partnerships?",
      "original_answer": "In 2022, Mastercard Foundry (formerly known as Mastercard Labs) was primarily described as a vehicle for bringing customers and partners access to thought leadership, innovation methodologies, new technologies, and early-stage fintech players. By 2024, its role had evolved into a more active innovation engine, with continued emphasis on identifying and experimenting with future technologies, start-ups, and trends. Specifically, in 2024, Foundry was positioned as a key enabler of blockchain-based business models and programmable payments through the Mastercard Multi-Token Network™, indicating a strategic shift toward deeper integration with next-generation financial technologies.",
      "llm_answer": "In the 2022 filing, Mastercard Labs (the precursor to Mastercard Foundry) was portrayed mainly as a research‑and‑thought‑leadership hub that “identifies and experiments with future technologies, start‑ups and trends” and “provides customers and partners access to thought leadership, innovation methodologies, new technologies and relevant early‑stage fintech players”【page_14】. By the 2024 filing the unit had been rebranded as Mastercard Foundry and its role had expanded to run hands‑on programs such as the five‑day “Launchpad” prototyping workshop, deepen fintech collaborations through the Mastercard Developer platform and partnerships with central banks, fintechs and crypto players, and actively drive blockchain, tokenization and other emerging‑technology solutions【page_16】【page_14】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the 2022 role of Mastercard Labs as a thought leadership and innovation hub is accurately described, and the 2024 evolution into Mastercard Foundry with a more active, hands-on innovation role is correctly portrayed. The rebranding from Labs to Foundry is noted, and the emphasis on blockchain, tokenization, and emerging technologies is consistent with the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across 2022 and 2024 timeframes, identifies the evolution in strategy and activities, and supports the shift with specific examples like the 'Launchpad' program and partnerships with central banks and crypto players. The mention of the Mastercard Developer platform adds contextual detail not in the ground truth but does not contradict it. (4) The only minor gap is that the LLM answer does not explicitly name the 'Mastercard Multi-Token Network™'—a specific strategic initiative highlighted in the original answer—which slightly reduces qualitative completeness. However, the reference to 'blockchain, tokenization and other emerging-technology solutions' captures the essence. Overall, the answer is semantically equivalent, highly relevant, and factually correct, warranting a high score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 417,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How has the financial and strategic nature of the collaboration with Boehringer Ingelheim evolved between 2022 and 2024, particularly in terms of regulatory designations and pricing pressures?",
      "original_answer": "In 2022, the collaboration with Boehringer Ingelheim included the development of a therapy that had received Breakthrough Therapy and Fast Track designations from the FDA, indicating early-stage regulatory support and potential expedited development. By 2024, the collaboration faced significant pricing pressures under the Inflation Reduction Act, with Jardiance—part of the LLY-Boehringer Ingelheim partnership—selected for government-set pricing effective in 2026, subject to a 66% discount compared to the 2023 U.S. list price. This marks a shift from regulatory facilitation to regulatory-driven financial constraints.",
      "llm_answer": "In the 2022 filing the Lilly‑Boehringer Ingelheim partnership was presented mainly as a joint development of empagliflozin (Jardiance) that carried FDA regulatory incentives – the drug had been granted Breakthrough‑Therapy, Fast‑Track and priority‑review designations. By the 2024 filing the collaboration is still active, but the emphasis has shifted to pricing risk: Jardiance was named in the Inflation Reduction Act’s first government‑set price list, with HHS announcing a 66 % discount for 2026, highlighting new, substantial pricing pressure on the joint product. This reflects a move from a focus on regulatory designations to managing significant pricing constraints in the partnership.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: in 2022, the collaboration involved Jardiance (empagliflozin) with FDA Breakthrough Therapy, Fast Track, and Priority Review designations (the original answer mentions Breakthrough and Fast Track; the LLM adds Priority Review, which is a minor addition but not incorrect). By 2024, the Inflation Reduction Act imposed pricing pressure with a 66% discount on Jardiance effective in 2026—this matches the ground truth exactly. (2) Quantitative accuracy is perfect: the 66% discount and 2026 effective date are correctly stated; no calculations are required beyond these values. (3) Multi-hop reasoning is sound: the LLM correctly synthesizes information across years (2022 to 2024), entities (Lilly, Boehringer Ingelheim, HHS, FDA), and regulatory/financial shifts. The evolution from regulatory facilitation to pricing constraints is clearly and logically articulated. (4) The only minor gap is that the original answer explicitly frames the shift as 'from regulatory facilitation to regulatory-driven financial constraints,' while the LLM describes it as a 'move from a focus on regulatory designations to managing significant pricing constraints'—semantically equivalent, though slightly less precise in framing the irony of regulatory support turning into regulatory burden. However, this does not detract from factual correctness. Overall, the answer is complete, accurate, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 414,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How has the strategic positioning of the CH-53K King Stallion heavy lift helicopter evolved within Lockheed Martin's Rotary and Mission Systems segment from 2023 to 2024?",
      "original_answer": "In 2023, the CH-53K King Stallion heavy lift helicopter was described as part of Lockheed Martin's near-to-mid-term growth elements, specifically under the Rotary and Mission Systems (RMS) segment, alongside radar surveillance systems. By 2024, the CH-53K remained a highlighted program within RMS, but the emphasis shifted to framing it within a broader context of advancing all-domain mission solutions and digital technologies such as AI/ML and autonomy. While no specific revenue figures are provided, the helicopter's positioning evolved from being a growth driver among several others to being part of a more integrated, technologically advanced portfolio aimed at improving interoperability and supporting multi-domain solutions.",
      "llm_answer": "In the 2023 filing the CH‑53K King Stallion was highlighted as a flagship RMS helicopter already in service with U.S. and foreign customers and was tied to a specific international win – the Israeli Ministry of Defense’s LOA for 12 aircraft (first four awarded in 2022 and the balance in 2023). The 2024 filing still lists the CH‑53K under RMS but now describes it as a “well‑established” program that “continues to experience growth,” positioning the helicopter as a core, ongoing growth pillar of the segment rather than emphasizing a single foreign contract. This shift shows the CH‑53K moving from a highlighted foreign‑order narrative in 2023 to a broader strategic growth driver within RMS in 2024.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually consistent with the ground truth in several key aspects but introduces details not present in the original answer, affecting qualitative accuracy. (1) Quantitatively, there are no numeric inaccuracies—no figures were misstated, and dates (2022 and 2023 for Israeli LOA awards) are plausible and do not contradict the ground truth. However, the original answer does not mention Israel or any foreign customer, so while these details may be factually true in external context, they are not part of the knowledge graph ground truth, making this a hallucination or unsupported addition. (2) The core evolution in strategic positioning—from a near-term growth element in 2023 to a more established, ongoing growth pillar in 2024—is accurately captured. The shift from highlighting specific contracts to broader strategic integration aligns with the ground truth’s description of a move toward framing the program within advanced, multi-domain solutions. (3) However, the LLM omits the key 2024 emphasis on digital technologies (AI/ML, autonomy) and interoperability, which are central to the original answer’s characterization of the strategic evolution. Instead, it substitutes this with a narrative about being a 'core, ongoing growth pillar,' which, while directionally correct, misses the technological and integrative dimension. (4) The reasoning is sound in identifying a shift in narrative tone and strategic framing, but the multi-hop synthesis is incomplete—it captures the 'what' (increased strategic importance) but not the 'how' (integration with digital and all-domain systems). Thus, while contextually relevant and quantitatively accurate, the answer lacks full qualitative fidelity to the ground truth, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 479,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "What does the change in LLY's diabetes product portfolio co-commercialized with Boehringer Ingelheim between 2022 and 2024 indicate about the companies' shifting strategic priorities or market focus?",
      "original_answer": "In 2022, LLY and Boehringer Ingelheim were jointly developing and commercializing a broader portfolio of diabetes products, including Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR, and Basaglar. By 2024, the portfolio had narrowed to include only Jardiance, Glyxambi, Synjardy, and Trijardy XR. This indicates a strategic refocusing, potentially driven by lifecycle management, shifting market demand, or prioritization of products with stronger commercial performance or longer patent protection. The removal of Trajenta, Jentadueto, and Basaglar may reflect declining market relevance, generic competition, or a strategic decision to streamline the collaboration around products with greater growth potential or therapeutic differentiation.",
      "llm_answer": "In the 2022 filing Lilly’s joint diabetes portfolio with Boehringer Ingelheim was limited to Basaglar, Jardiance and Trajenta (LLY 2022 10‑K, p. 5). By the 2024 filing the agreement now covers a much larger set – Trajenta, Jentadueto, Jardiance, Glyxambi, Synjardy, Trijardy XR and Basaglar (LLY 2024 10‑K, p. 7‑8). This expansion shows the two companies are deepening their partnership to capture a broader slice of the diabetes market, emphasizing newer combination therapies and a more diversified, integrated product line rather than a narrow focus on single‑agent insulin and SGLT2 drugs.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and facts. The original answer states that the co-commercialized portfolio *narrowed* from 2022 to 2024, dropping Trajenta, Jentadueto, and Basaglar, while the LLM claims the portfolio *expanded*, adding those same products. This is a complete reversal of the factual trend. The LLM incorrectly cites the 2022 portfolio as including only Basaglar, Jardiance, and Trajenta, whereas the ground truth confirms a broader portfolio in 2022. Similarly, it falsely claims the 2024 portfolio is larger, when in fact it is smaller. These errors invalidate all subsequent reasoning: the conclusion that the companies are 'deepening their partnership' and 'expanding market capture' is the opposite of the true strategic shift—indicating a contraction or refocusing of collaboration. No numerical calculations are involved, but the entity and timeline inaccuracies are severe. The reasoning is internally logical but based on false premises, making it misleading. Contextual relevance is low because the answer addresses the general question frame but with incorrect data, leading to an invalid interpretation of strategic priorities.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 331,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial performance and strategic importance of the JASSM program evolve between 2023 and 2024, particularly in terms of production activity and its contribution to backlog?",
      "original_answer": "In 2023, JASSM was a product under the Missiles and Fire Control (MFC) segment, contributing to the company's portfolio of tactical missiles, but there was no specific mention of significant changes in its production volume or backlog contribution. By 2024, JASSM experienced a production ramp-up, contributing to a $1.2 billion increase in tactical and strike missile programs within MFC. Additionally, JASSM was specifically cited as a key contributor to the increase in backlog alongside PAC-3 and GMLRS. This indicates a notable rise in both production activity and strategic importance for JASSM in 2024.",
      "llm_answer": "In 2023 the JASSM production ramp‑up added roughly $145 million to Missiles & Fire Control (MFC) net sales and helped lift the segment’s backlog, which grew on higher JASSM, LRASM and GMLRS orders 【page_40】. By 2024 the ramp‑up was far larger – JASSM (along with GMLRS and LRASM) drove about $1.2 billion of the $1.4 billion sales increase and was singled out as a key source of the backlog rise, underscoring its heightened strategic role even as MFC’s overall operating profit fell because of profit‑booking adjustments 【page_40】.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. The ground truth states that JASSM contributed to a $1.2 billion increase in tactical and strike missile programs in 2024, but the LLM incorrectly attributes $1.2 billion of the $1.4 billion sales increase in MFC to JASSM, GMLRS, and LRASM combined—this level of specificity and allocation is not supported by the original answer. More critically, the LLM claims that in 2023, JASSM added $145 million to MFC net sales, which is not mentioned in the ground truth; the original answer states there was no specific mention of significant changes in production or backlog contribution in 2023. (2) These numerical claims—$145 million in 2023 and $1.2 billion of $1.4 billion in 2024—are not corroborated by the ground truth and represent fabricated precision. The original answer only notes a general production ramp-up in 2024 contributing to a $1.2 billion increase in tactical and strike programs, without breaking down per-program sales impact or citing 2023 figures. (3) Qualitatively, the LLM correctly identifies the multi-hop evolution: JASSM’s increased production activity and strategic importance in 2024, its role in backlog growth alongside PAC-3 and GMLRS (LLM mentions GMLRS and LRASM, missing PAC-3 but including a correct program), and its growing significance within MFC. The reasoning about heightened strategic role is sound and aligns with the original. (4) Contextually, the answer is highly relevant, addressing production activity and backlog contribution across both years. However, the inclusion of unsupported financial figures severely undermines factual correctness. While the directionality and qualitative trend are accurate, the specific numbers are not, leading to a correctness score of 6—partially correct but with major quantitative errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 501,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How has JPM's focus in evaluating credit risk for Business Banking Loans evolved between 2023 and 2024, and what implications does this shift have for identifying early signs of borrower distress?",
      "original_answer": "In 2023, JPM focused on Business Banking Loans as part of its broader prime consumer credit strategy, emphasizing loan performance and scoring models within the 'Consumer, excluding credit card loan portfolio' segment. By 2024, the focus shifted toward delinquency rates as the primary credit quality indicator, particularly noting that loans more than 30 days past due serve as early warnings of financial difficulty. This evolution suggests a more proactive stance in identifying early signs of borrower distress, aligning Business Banking Loans with broader consumer loan risk frameworks where early delinquency tracking enhances risk mitigation. The shift indicates a strategic move toward earlier intervention and more granular performance monitoring.",
      "llm_answer": "In 2023 JPM still said that “geographic distribution is an indicator of the credit performance of the portfolio” for its scored auto and business‑banking loans (2023 Consumer, excl. credit‑card discussion, p. 242). The 2024 filing repeats the same emphasis – geographic distribution remains the primary risk gauge for those loans (2024 Consumer, excl. credit‑card discussion, p. 250). Because the focus has not shifted, JPM continues to look to regional‑economic trends and the early‑warning signal of 30‑plus‑day delinquencies to spot borrower distress, rather than adding new credit‑risk metrics.",
      "correctness_score": 2,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that JPM's focus on credit risk for Business Banking Loans did not shift between 2023 and 2024. The ground truth states a clear evolution from a broader prime consumer credit strategy emphasizing loan performance and scoring models in 2023 to a 2024 focus on delinquency rates (specifically loans more than 30 days past due) as the primary indicator. In contrast, the LLM claims the focus remained unchanged, with geographic distribution continuing as the primary risk gauge in both years. This contradicts the ground truth and misrepresents the evolution of JPM's risk evaluation approach. (2) Quantitatively, the LLM does not introduce any incorrect numbers, dates, or percentages—it references page numbers and document sections plausibly (e.g., 2023 p.242, 2024 p.250), and the mention of 30-plus-day delinquencies aligns with the ground truth. However, it misattributes the strategic emphasis, implying geographic distribution is primary when the ground truth indicates a shift to delinquency tracking. (3) The multi-hop reasoning is flawed: the question requires synthesizing changes in risk focus across two years and interpreting implications for early distress detection. The LLM fails this synthesis by asserting continuity rather than change, thus missing the core analytical point about a strategic shift toward earlier intervention. (4) While the LLM answer is contextually relevant—discussing credit risk, delinquency, and geographic factors—it is factually inaccurate in its central claim. The correctness score is low due to the fundamental error in portraying no change when a significant shift occurred. Quantitative accuracy is higher because no numeric values are incorrect, and contextual relevance is moderate because the discussion remains within the domain of credit risk evaluation.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 507,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did Target Corporation's SPP II plan terms evolve between the 2022 and 2023 filings, and what does this suggest about the company's executive compensation framework?",
      "original_answer": "In the 2022 filing, the SPP II plan was described under the 2016 Plan Statement, as amended and restated effective April 3, 2016. However, in the 2023 filing, the SPP II plan was updated to the 2022 Plan Statement, as amended and restated effective May 1, 2022. This indicates that Target Corporation revised the SPP II plan within this timeframe, reflecting a shift in the structure or terms of the plan. Such changes could signal adjustments in the company's executive compensation strategy, potentially aligning incentives more closely with updated business objectives or governance standards.",
      "llm_answer": "Both the 2022 and 2023 Form 10‑K exhibit schedules list Target’s “SPP II” as the **2016 Plan Statement, amended and restated effective April 3, 2016** (see page 68 of each filing), with no new amendment or restatement noted in the later filing. The unchanged description indicates that Target’s executive‑compensation framework has remained stable, relying on the same long‑term incentive plan for senior executives rather than revising the SPP II terms year‑to‑year.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim. According to the ground truth, the SPP II plan was updated from the 2016 Plan Statement (effective April 3, 2016) in the 2022 filing to the 2022 Plan Statement (effective May 1, 2022) in the 2023 filing. However, the LLM asserts that both filings reference the same 2016 version with no changes, which contradicts the ground truth. This error undermines both quantitative accuracy (wrong dates: April 3, 2016 vs. May 1, 2022) and qualitative reasoning, as the conclusion about stability in executive compensation is the opposite of what the evidence suggests—there was a material update indicating evolution in the compensation framework. The LLM fails the multi-hop requirement by not detecting the change across filings, and instead incorrectly infers continuity. While the answer addresses the question's intent and is contextually relevant, the factual foundation is wrong, leading to an incorrect interpretation of Target's executive compensation strategy. Minor formatting differences in date or dollar amounts are acceptable, but here the discrepancy involves critical dates and the presence or absence of a plan amendment, which is central to the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1271,
        "completion_tokens": 341,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How did the financial obligations related to Incyte under the Olumiant collaboration evolve from 2022 to 2024, particularly regarding potential future milestone payments?",
      "original_answer": "In 2022, Incyte was eligible to receive up to $100.0 million in additional development-related regulatory milestones and another $100.0 million in sales-based milestones under the Olumiant agreement. By 2024, there is no mention of remaining regulatory milestones, suggesting they were either paid out or no longer applicable, and only ongoing royalty payments based on sales tiers (up to 20%) and a low teens royalty for sales exceeding a threshold in the context of COVID-19 treatment are explicitly referenced. This indicates a shift from a structure with both regulatory and sales milestones to one focused primarily on sales-based compensation.",
      "llm_answer": "In the 2022 Form 10‑K Eli Lilly disclosed that, beyond the $260 million and $210 million of milestone payments already capitalized (for 2021 and 2020), Incyte could still be entitled to up to **$100 million of additional success‑based regulatory milestones and up to $100 million of sales‑based milestones** under the Olumiant license. By the 2024 filing, the Olumiant discussion only mentions the royalty structure and the product’s net revenue and **does not reference any remaining potential milestone payments**, indicating that those future‑milestone obligations are no longer highlighted—likely because they have been satisfied, become immaterial, or are no longer expected.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $100 million in potential regulatory milestones and $100 million in sales-based milestones for 2022 are accurately reported. The absence of mention of these milestones in the 2024 filing is correctly noted, matching the original answer's observation. (2) The LLM correctly identifies the shift from a milestone-based structure to one focused on royalties, with no remaining milestone obligations highlighted in 2024. While the LLM does not explicitly mention the 'up to 20%' royalty rate or the 'low teens' royalty for COVID-19-related sales exceeding a threshold (a minor omission), it correctly infers the transition in payment structure based on the absence of milestone references. (3) The multi-hop reasoning is sound—comparing disclosures across 2022 and 2024 filings to infer evolution in financial obligations. The mention of previously capitalized milestones ($260M and $210M) adds context not in the ground truth but does not contradict it and may reflect additional filing details; however, since the original answer does not reference those amounts, their inclusion is extraneous but not inaccurate. (4) The semantic meaning and conclusion are equivalent: the focus has shifted from potential future milestones to ongoing royalty payments. The only reason for not scoring a 10 is the slight incompleteness in omitting specific royalty tier details present in the ground truth, though the core evolution in obligations is correctly captured.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 430,
        "total_tokens": 1768
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has Cisco's financial exposure in the APJC region evolved between fiscal 2022 and fiscal 2023, based on its segment reporting and asset balances?",
      "original_answer": "In fiscal 2022, Cisco reported its business performance across geographic segments including APJC, though specific financial figures for APJC were not disclosed in the provided data. By fiscal 2023, Cisco's balance sheet showed that its assets in the APJC region stood at $5,382 million as of July 29, 2023, following additions from acquisitions and foreign currency translation adjustments. This indicates a more detailed financial disclosure regarding APJC in 2023 compared to 2022, where segment-level asset values were not explicitly itemized.",
      "llm_answer": "In FY 2022 the APJC segment contributed about $8.0 billion of revenue and $5.24 billion of gross margin (page 105). By FY 2023 the APJC goodwill balance – a key asset‑based exposure – had risen only modestly from $5.36 billion at July 30 2022 to $5.38 billion at July 29 2023 (pages 74‑76), indicating that the region’s financial exposure grew only slightly while its revenue and margin remained essentially unchanged.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that specific financial figures for APJC were not disclosed in fiscal 2022, but the LLM claims $8.0 billion in revenue and $5.24 billion in gross margin for APJC in FY2022, which contradicts the original answer. Additionally, the LLM cites goodwill balances of $5.36 billion and $5.38 billion, while the ground truth reports total APJC assets of $5,382 million in FY2023—note that goodwill is a subset of total assets and not equivalent. The LLM incorrectly equates goodwill with overall financial exposure, which misrepresents the nature of asset-based risk. (2) The numbers cited (e.g., $5.38 billion goodwill) are close in magnitude to the correct total asset figure ($5,382 million), but they refer to a different metric (goodwill vs. total assets) and are thus factually wrong. The dates (July 30, 2022, and July 29, 2023) are plausible fiscal year-ends, but the use of goodwill instead of total assets invalidates the quantitative comparison. (3) The multi-hop reasoning is flawed: the question asks about evolution in financial exposure based on segment reporting and asset balances, but the LLM relies on goodwill (an intangible asset) rather than total or segment-level assets, and fabricates income statement data for 2022 that the ground truth explicitly states was not disclosed. This indicates a failure to correctly synthesize or interpret the available data. (4) The contextual relevance is moderate because the response addresses Cisco, APJC, and fiscal years 2022–2023, and touches on asset evolution, but the incorrect use of metrics and invented figures severely undermines accuracy. The conclusion that exposure grew only slightly may align loosely with the ground truth’s implication of increased disclosure and modest asset growth, but it is based on incorrect premises.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 511,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How has the strategic collaboration between LLY and Boehringer Ingelheim, specifically regarding Jardiance, evolved from 2022 to 2024 in response to regulatory changes?",
      "original_answer": "In 2022, Jardiance revenue was growing significantly, with a 30% increase in the U.S. and 28% outside the U.S., driven by increased demand and volume respectively. By 2024, the collaboration was significantly impacted by the Inflation Reduction Act (IRA), which introduced government-set pricing for certain drugs, including Jardiance. In August 2023, Jardiance was selected as one of the first ten medicines subject to government-set prices, and in August 2024, a 66% discount was applied compared to the 2023 U.S. list price, significantly affecting revenue projections and business strategy.",
      "llm_answer": "In the 2022 Form 10‑K, Lilly highlighted its joint commercial partnership with Boehringer Ingelheim on Jardiance and noted that the Inflation‑Reduction‑Act‑driven price‑setting program had named the drug (among the first ten) for a government‑set price beginning in 2026. By the 2024 filing the collaboration was still intact, but the regulatory development had moved from a selection to an actual price‑setting decision: in August 2024 HHS announced a 66 % discount to the 2023 list price for Jardiance, prompting Lilly to anticipate accelerated revenue erosion and to factor that discount into its commercial strategy.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic collaboration between LLY and Boehringer Ingelheim on Jardiance and the impact of the Inflation Reduction Act (IRA), including the 66% discount applied in August 2024. However, it incorrectly states that the government-set price would begin in 2026, which contradicts the ground truth stating the discount was applied in August 2024. This misrepresents the timeline and regulatory progression. (2) The 66% discount and August 2024 timing are correctly reported, aligning with the ground truth. However, the claim that the price-setting program named Jardiance for a 2026 start is factually incorrect—ground truth confirms selection occurred in August 2023 and pricing took effect in 2024. This is a significant quantitative and temporal error. (3) The reasoning correctly synthesizes multi-hop information: the evolution from 2022 growth to 2024 regulatory impact, the role of the IRA, and strategic implications. The logic connecting regulatory selection to actual pricing and commercial strategy is sound, but the incorrect effective date undermines the accuracy. (4) The answer is contextually relevant and captures the essence of the collaboration’s evolution. Due to the major error in the effective date of price setting—critical to understanding the timeline and business impact—the correctness and quantitative accuracy scores are reduced. The qualitative reasoning and contextual relevance remain strong.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 408,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did GM's emphasis on the financial and reputational risks of product safety recalls evolve between 2022 and 2023, particularly concerning global platforms like the Chevrolet Bolt EV and the company's positioning in EV/AV technologies?",
      "original_answer": "In 2022, GM specifically highlighted the Chevrolet Bolt EV recall as an example of how global platform-related recalls could significantly increase costs due to their scale. The focus was on the financial burden and logistical complexity tied to such large-scale campaigns. By 2023, while the concern around global platforms remained, GM expanded its risk disclosure to emphasize the reputational damage to brand image and equity, particularly in relation to its leadership aspirations in EV and AV technologies. This evolution suggests a shift from a primarily cost-centric concern to a broader strategic risk tied to innovation and market positioning.",
      "llm_answer": "In the 2022 filing GM warned that product‑safety recalls can generate large repair‑cost outlays, civil or criminal penalties and serious brand damage, pointing to the Chevrolet Bolt EV recall as a concrete example of a “global platform” that could amplify those costs and threaten its ability to lead in advanced technologies such as autonomous vehicles【page_24】. By the 2023 filing the company retained the same financial‑and‑reputational warning but dropped the specific Bolt‑EV reference, speaking more generally about any global‑platform recall and explicitly linking the risk to eroding consumer trust and brand equity in its core growth areas of electric‑vehicle and autonomous‑vehicle technologies【page_25】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: GM highlighted the Bolt EV recall in 2022 as a costly example tied to global platforms, with financial and reputational risks, and in 2023 shifted toward broader language emphasizing brand equity and consumer trust in EV/AV technologies. The removal of the specific Bolt EV reference in 2023 is correctly noted. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or ground truth, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years, identifies the evolution in risk emphasis (from cost/logistics to reputation and strategic positioning), and links it to GM’s ambitions in EV/AV innovation. The only minor shortcoming is that the LLM slightly overemphasizes 'brand damage' in 2022—while mentioned, the ground truth stresses 'financial burden and logistical complexity' more centrally—making the 2022 characterization slightly less precise than ideal. (4) Contextual relevance is excellent: the response directly addresses the evolution between 2022 and 2023, covers the Chevrolet Bolt EV, global platforms, and GM’s strategic positioning in EV/AV technologies. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the original with only minor nuance differences in emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 404,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the Guaranteed Senior Notes issued by Costco's Japanese subsidiary evolve between 2022 and 2024, and what does this indicate about the company's long-term financing strategy?",
      "original_answer": "In 2022, the Guaranteed Senior Notes issued by Costco's Japanese subsidiary were described in general terms, indicating only their existence and that they were valued using Level 3 inputs. By 2024, the company provided significantly more detailed information, disclosing that in November 2023, the subsidiary issued four new Guaranteed Senior Notes totaling approximately $500 at fixed interest rates ranging from 1.400% to 2.120%, with maturities extending from 2033 to 2043. Additionally, in July 2024, the subsidiary repaid $77 of these notes. This evolution indicates a more transparent and strategic approach to long-term financing, with a focus on fixed-rate debt and extended maturities to manage future liquidity needs.",
      "llm_answer": "In 2022 Costco’s “Other long‑term debt” – which consists entirely of Guaranteed Senior Notes issued by its Japanese subsidiary – was $590 million (Level 3‑valued) 【page_51】【page_52】. By the 2024 filing the subsidiary had issued four new Guaranteed Senior Notes totaling about $500 million (interest 1.40%‑2.12%, maturing 2033‑2043) and repaid $77 million in July 2024, raising the other long‑term‑debt balance to $919 million 【page_52】. This growth and the addition of longer‑dated, low‑cost notes indicate Costco is actively expanding foreign‑subsidiary financing to diversify its capital sources and lock in inexpensive, long‑term funding.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the issuance of four new Guaranteed Senior Notes totaling approximately $500 million in November 2023 at fixed rates between 1.40% and 2.12%, with maturities from 2033 to 2043, and the July 2024 repayment of $77 million, which aligns with the ground truth. However, it introduces a $590 million figure for 2022 debt and claims the 2024 balance rose to $919 million, which are not present in the original answer and contradict the ground truth’s lack of specific aggregate values for 2022 or 2024. The original answer only states that in 2022 the notes were described generally and valued using Level 3 inputs, without specifying a dollar amount. The $590M and $919M figures appear to be hallucinated or misattributed from the filing. (2) The calculation of a net increase to $919M implies a starting balance of $590M plus $500M minus $77M, but this arithmetic and the initial value are unsupported by the ground truth. The original answer does not provide a total balance for 2024, only the issuance and repayment events. (3) The multi-hop reasoning is partially sound: the LLM correctly infers a strategic shift toward long-term, fixed-rate foreign financing and increased transparency, which is consistent with the ground truth’s conclusion about a more strategic and transparent approach. However, the emphasis on balance growth and diversification is based on incorrect quantitative assumptions. (4) The contextual relevance is high as the answer addresses both the evolution of the notes and the implications for Costco’s financing strategy. The qualitative reasoning is strong but built on flawed quantitative foundations. Thus, while the core events are correct, the inclusion of unsupported aggregate debt figures reduces factual accuracy, warranting a 7 for correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 496,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 81,
      "question": "How did the value of Cisco's available-for-sale debt investments change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, Cisco reported gains from available-for-sale debt investments at $9 million, indicating a relatively minor role in their investment portfolio. By 2023, the total value of these investments dropped significantly from $15,592 million to $9,865 million, a decrease of $5,727 million. This indicates a strategic reduction in the company's holdings of available-for-sale debt instruments, suggesting a shift in investment focus or risk management approach.",
      "llm_answer": "Cisco’s available‑for‑sale debt investments grew from **$11.9 billion at fiscal‑year‑end 2022** to **$15.6 billion at fiscal‑year‑end 2023**, a rise of roughly **$3.6 billion (about 30 %)**【page_50】. This increase shows Cisco is expanding its high‑quality, investment‑grade debt portfolio, a deliberate part of its strategy to keep a strong, liquid cash position that can be tapped for strategic acquisitions, technology investments and shareholder returns such as dividends and share repurchases【page_47】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is fundamentally incorrect in both direction and magnitude of change. The ground truth states that Cisco's available-for-sale debt investments decreased from $15,592 million in 2022 to $9,865 million in 2023 — a drop of $5,727 million. The LLM claims an increase from $11.9 billion to $15.6 billion, which is not only wrong but opposite to the actual trend. Additionally, the LLM cites a gain of $3.6 billion (30%), while the correct change is a decline of $5,727 million (~36.7%). (2) The numbers are significantly off: $11.9B and $15.6B vs. correct values of $15,592M and $9,865M. The LLM also misrepresents the 2022 value — it was $15,592M, not $11.9B. Even allowing for format variation, the discrepancy is too large to be a rounding or presentation difference. (3) The multi-hop reasoning fails completely: the model incorrectly infers growth in debt investments and draws an erroneous conclusion about strategy (expansion) when the data shows a clear strategic reduction. The original answer notes a shift in risk management or investment focus due to the drawdown; the LLM suggests the opposite. (4) The contextual relevance is partially maintained — it discusses Cisco’s investment strategy and references debt instruments — but the factual foundation is so flawed that the conclusion is misleading. Hence, very low scores across correctness and accuracy dimensions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 389,
        "total_tokens": 1635
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How has JPMorgan Chase's exposure to system damage risks evolved from 2023 to 2024, particularly in relation to third-party vendor attacks and data recovery challenges?",
      "original_answer": "In 2023, JPMorgan Chase highlighted risks related to system damage primarily through unauthorized access, zero-day vulnerabilities, and disruptions from distributed denial-of-service attacks. The company emphasized the risk of undetected vulnerabilities due to incomplete system enhancements and the potential for data loss or manipulation. By 2024, the exposure evolved to include more specific emphasis on ransomware attacks targeting third-party vendors and the risk of losses exceeding cyber insurance coverage. Additionally, JPMorgan Chase noted increased complexity in recovering from data theft or destruction, with a new concern around the inability to prevent systems from processing fraudulent transactions. These changes indicate a growing awareness of external cyber threats and their financial implications.",
      "llm_answer": "In the 2023 filing JPMorgan Chase warned that its heavy use of third‑party custodians, cloud‑service and other vendors could expose it to “systems failure or cyber‑attack … experienced by a vendor … or … a systems breakdown … involving another party” and that a breach could leave the firm “unable, or with extended delays, to fully recover and restore data that has been stolen, manipulated or destroyed”【page_23】【page_27】.  \n\nThe 2024 filing expands that view, stressing that the bank’s “increased reliance on third‑party providers” makes it especially vulnerable to ransomware and open‑source‑software attacks on those vendors and that “oversight of third‑party vendors and early detection of attacks … including ransomware attacks” is now a key focus, while again highlighting “the inability, or extended delays … to fully recover and restore data” as a material risk【page_28】【page_27】.  \n\nThus, JPMorgan Chase’s exposure to system‑damage risk has evolved from a general acknowledgment of third‑party and data‑recovery risks in 2023 to a more pointed emphasis in 2024 on heightened vendor reliance, targeted vendor‑attack detection, and the likelihood of prolonged data‑recovery challenges.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original ground truth. (1) All factual elements are correct: the 2023 risks involving third-party vendors, system failures, and data recovery challenges are accurately described, as are the 2024 developments emphasizing ransomware attacks on vendors, increased reliance on third parties, and persistent data recovery issues. The LLM correctly identifies the evolution in risk focus without introducing false claims. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, correctly identifying how the nature of system-damage risks has evolved from general third-party and data-recovery concerns to more specific threats like ransomware and detection challenges. The only minor shortcoming is that the LLM does not explicitly mention the 'risk of losses exceeding cyber insurance coverage' or 'inability to prevent systems from processing fraudulent transactions'—new points in the 2024 filing noted in the ground truth. This omission prevents a perfect 10 on qualitative accuracy. (4) Contextual relevance is excellent: the response directly addresses the question about the evolution of system-damage risks from 2023 to 2024, with clear year-over-year comparison focused on third-party attacks and data recovery. Overall, the answer is factually correct, well-structured, and semantically equivalent to the ground truth with only minor detail omissions.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1509,
        "completion_tokens": 446,
        "total_tokens": 1955
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What operational investments has Costco made by 2024 to support the private-label growth strategy mentioned in its 2022 filing?",
      "original_answer": "In 2022, Costco emphasized increasing the penetration of its private-label items as a merchandising strategy to manage inflationary pressures and maintain competitive pricing. By 2024, Costco had made tangible operational investments to support this strategy, including the operation of various processing, packaging, and manufacturing facilities dedicated to the production of private-label items. These facilities, referenced in the 2024 filing, represent a significant evolution from the earlier strategic focus, demonstrating a shift from sourcing private-label products externally to building internal production capabilities to scale the initiative.",
      "llm_answer": "The 2022 filing said Costco’s strategy was to increase the penetration of its private‑label items【page_22】. By 2024 the company has expanded its operational footprint—operating 890 warehouses with about 130.9 million sq ft of floor space (including 31.9 million sq ft of distribution and logistics space) and adding processing, packaging and manufacturing facilities that produce its private‑label goods—directly supporting that growth strategy【page_20】.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies Costco's private-label growth strategy from the 2022 filing and accurately describes operational investments by 2024, including the addition of processing, packaging, and manufacturing facilities to support private-label production. This aligns with the ground truth's key point about a shift toward internal production capabilities. The qualitative reasoning is sound and demonstrates proper multi-hop synthesis between the 2022 strategy and 2024 operational developments. Contextual relevance is excellent, directly addressing the question with appropriate detail. However, the quantitative accuracy is slightly compromised: while the ground truth does not specify warehouse counts or square footage, the LLM introduces specific numbers (890 warehouses, 130.9 million sq ft, 31.9 million logistics space) that are not present in the original answer and cannot be verified as supporting the private-label strategy investment. These figures may be factually correct in a broader sense but are not tied to the private-label operational investments in the ground truth, introducing extraneous detail that risks misattribution. The core financial and strategic facts are correct, but the inclusion of unsupported metrics reduces quantitative precision. Semantic equivalence is mostly maintained, though the emphasis on warehouse expansion dilutes the focus on dedicated production facilities as the primary operational investment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1272,
        "completion_tokens": 402,
        "total_tokens": 1674
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did UnitedHealth Group's approach to Medicaid managed care contract bidding evolve between 2022 and 2023, particularly in terms of assumptions and risks associated with bid accuracy?",
      "original_answer": "In 2022, UnitedHealth Group emphasized the risk of losing Medicaid members if it failed to renew state Medicaid managed care contracts, highlighting the importance of contract renewals to retain enrolled members. By 2023, the company placed greater emphasis on the assumptions behind its bids, noting that if these assumptions—such as enrollment, utilization, and medical costs—were materially incorrect due to unforeseen program changes or competitor pricing, it could materially affect results of operations and cash flows. This reflects an evolution from a focus on contract renewal risk to a more detailed discussion of the assumptions and competitive dynamics involved in the bidding process itself.",
      "llm_answer": "UnitedHealth’s 2023 filing repeats the same bidding framework it disclosed in 2022. Both years state that its Medicaid‑managed‑care bids are based on “certain assumptions regarding enrollment, utilization, medical costs and other factors,” and that a material error in those assumptions—whether from unforeseen program or policy changes or from competitors submitting lower rates—could “materially and adversely affect” its results of operations, financial position and cash flows (2022 p. 25; 2023 p. 20). Thus, the company’s approach and the associated risk‑assessment around bid accuracy did not materially change between the two years.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is factually incorrect in its core conclusion, despite citing accurate language from both years' filings. While it correctly quotes similar risk factor language about assumptions in Medicaid bidding (e.g., enrollment, utilization, medical costs), it fails to recognize the evolution highlighted in the ground truth: a shift in emphasis from 2022's focus on contract renewal risk (retaining members via renewals) to 2023's deeper focus on bid assumptions and competitive dynamics. The LLM incorrectly asserts 'no material change,' directly contradicting the ground truth, which identifies a qualitative evolution in risk disclosure focus. This is a critical failure in multi-hop reasoning—comparing not just wording but the strategic emphasis across years. Entity accuracy (UnitedHealth, Medicaid managed care, years 2022–2023) and contextual relevance are adequate, and there are no numerical inaccuracies (no numbers involved). However, the qualitative misinterpretation of the evolution in risk discussion severely undermines correctness. The model appears to rely on surface-level textual similarity rather than synthesizing the shift in strategic narrative.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 330,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How did MET's investment in Municipals evolve from 2022 to 2023, particularly in terms of its valuation hierarchy classification?",
      "original_answer": "In 2022, MET's investment in Municipals was valued at $14,212 million and primarily categorized under 'Estimated Fair Value' without a detailed breakdown of valuation hierarchy levels. By 2023, the investment in Municipals decreased to $159 million and was explicitly classified under 'Level 2' of the fair value hierarchy. This indicates a significant reduction in the size of the Municipals investment and a more transparent categorization within the fair value hierarchy in 2023.",
      "llm_answer": "MetLife’s municipal‑bond holdings were recorded entirely in the Level 2 tier of the fair‑value hierarchy. At 31 December 2022 the company held $159 million of municipals in its pension‑benefit plan (and $15 million in other post‑retirement benefits); by 31 December 2023 those balances had slipped to $147 million and $8 million respectively, with no Level 1 or Level 3 exposure in either year【page_308】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual errors and misrepresents key data from the ground truth. (1) Quantitatively, it incorrectly states that MetLife held $159 million in municipals at the end of 2022, while the ground truth reports $14,212 million for that year—a massive discrepancy. It then claims the 2023 balance was $147 million, which contradicts both its own prior statement and the ground truth value of $159 million in 2023. The mention of $15 million and $8 million for other post-retirement benefits introduces granular details not present in the original answer and appears to conflate different line items. (2) The timeline is reversed: the LLM implies a decrease from $159M (2022) to $147M (2023), but the truth shows a dramatic drop from $14,212M (2022) to $159M (2023). (3) Regarding valuation hierarchy, the LLM claims municipals were entirely in Level 2 in 2022, but the original answer states there was no detailed breakdown in 2022—only an aggregate 'Estimated Fair Value'—with explicit Level 2 classification only appearing in 2023. This misrepresents the evolution of transparency in valuation hierarchy disclosure. (4) The reasoning fails on multiple hops: it does not correctly track the magnitude of change, misattributes the year of classification detail, and introduces unverified sub-categories (pension vs. other benefits). While the answer is contextually relevant—discussing MetLife, municipals, fair value hierarchy, and year-over-year changes—the core facts are incorrect, undermining the response. Minor credit is given for correctly identifying Level 2 classification in 2023 and attempting a comparative analysis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1217,
        "completion_tokens": 450,
        "total_tokens": 1667
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How has Microsoft's approach to Office 365 subscriptions evolved in terms of licensing flexibility and customer agreement models from fiscal year 2022 to 2024?",
      "original_answer": "In fiscal year 2022, Office 365 subscriptions were primarily managed under volume licensing programs and were recognized as part of unearned revenue, invoiced annually at the beginning of each contract period and recognized ratably over the coverage period. By fiscal year 2024, Microsoft introduced more structured and flexible customer agreement models, including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement, and Microsoft Products and Services Agreement, which allowed customers to subscribe to cloud services seamlessly and directly, with options for monthly or annual subscriptions and no organization-wide commitment. This represents a shift toward enhanced customer-centric licensing flexibility.",
      "llm_answer": "In FY 2022 Office 365 was described primarily as a cloud‑service subscription that is recognized ratably over the contract period and sold through traditional volume‑licensing programs such as Enterprise Agreements (which bundle on‑premises licenses with Software Assurance) – a model that offered limited flexibility beyond the subscription vs. consumption choice【page_63】【page_64】. By FY 2024 Microsoft had added a set of non‑expiring, digital purchase contracts—including the Microsoft Customer Agreement, Microsoft Online Subscription Agreement and Microsoft Products and Services Agreement—that let customers of any size acquire Office 365 on a subscription or perpetual basis with optional SA, providing a more flexible, simplified licensing framework and broader agreement options【page_17】【page_16】.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the shift in Microsoft's licensing and agreement models from FY2022 to FY2024, naming the key agreements introduced by 2024 (Microsoft Customer Agreement, Microsoft Online Subscription Agreement, Microsoft Products and Services Agreement), which aligns with the ground truth. It accurately notes the move toward greater flexibility and simplified licensing. However, it introduces a significant inaccuracy by stating that customers could acquire Office 365 'on a subscription or perpetual basis with optional SA' in FY2024. This is incorrect—Office 365 (now Microsoft 365) is a cloud-based subscription service and does not offer perpetual licenses. Perpetual licensing applies to on-premises products like Microsoft Office, not cloud subscriptions. The original answer correctly frames the evolution as enhancing subscription flexibility without implying a return to perpetual licensing for cloud services. (2) Quantitatively, there are no numerical claims in either answer, so no discrepancies exist—dates (FY2022, FY2024) are correct and consistent. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes changes in agreement types and licensing models across time. However, the erroneous inclusion of 'perpetual basis' for Office 365 reflects a failure in accurately synthesizing the nature of cloud subscription services, undermining the qualitative accuracy. (4) The contextual relevance is high as the response directly addresses the evolution in licensing and agreement models. Correctness is docked due to the major factual error about perpetual licensing, but core facts about agreement evolution and increased flexibility are preserved, warranting a 7.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 473,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did the composition of MET's Level 3 Fixed Maturity Securities AFS change between 2022 and 2023, and what does this indicate about the company's investment strategy?",
      "original_answer": "In 2022, MET's Level 3 Fixed Maturity Securities AFS included $1 million in Corporate bonds, $1 million in Foreign Bonds, and $11 million in Equity Securities. By 2023, the Level 3 composition shifted significantly, with $54 million in Corporate bonds, $2 million in Foreign Bonds, and $828 million in Other Investments. This indicates a strategic shift toward increasing exposure in Other Investments while maintaining a relatively small position in Level 3 fixed maturity securities overall. The significant increase in Other Investments within Level 3 suggests a more aggressive approach to portfolio diversification or risk management.",
      "llm_answer": "In 2022 MetLife’s Level 3 fixed‑maturity securities held in the AFS pool were almost entirely corporate bonds ($55 million) with only $3 million classified as “Other” (money‑market, mortgage‑backed, ABS, CLO) and no foreign‑bond exposure【page_308】. By 31 December 2023 the corporate holding slipped to $54 million, the “Other” bucket rose to $8 million, and a small $2 million foreign‑bond position appeared, lifting total Level 3 fixed‑maturity assets from $58 million to $64 million【page_308】【page_309】. This modest reallocation toward a broader mix of alternative fixed‑maturity assets (and the addition of foreign bonds) suggests MetLife is diversifying its Level 3 portfolio and seeking higher‑yielding, less‑liquid securities while still keeping corporate exposure low.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative composition of MET's Level 3 Fixed Maturity Securities AFS for both 2022 and 2023. According to the ground truth, in 2022, MET held $1M in Corporate bonds, $1M in Foreign Bonds, and $11M in Equity Securities — but the LLM claims $55M in Corporate bonds and $3M in 'Other', with no foreign bonds. This misrepresents the entire 2022 composition. In 2023, the ground truth reports $54M in Corporate bonds, $2M in Foreign Bonds, and $828M in Other Investments, whereas the LLM reports $54M in Corporate, $2M in Foreign, and only $8M in Other — understating 'Other Investments' by over 99% ($8M vs $828M). This is a catastrophic error in scale and magnitude. (2) Calculations and totals are also incorrect: the LLM computes total Level 3 fixed-maturity securities as $58M in 2022 and $64M in 2023, but the ground truth implies a massive increase due to the $828M 'Other Investments' in 2023, which the LLM completely misses. The LLM treats 'Other' as $8M, likely confusing it with a different category or misreading the data. (3) The multi-hop reasoning is flawed because the LLM fails to recognize that the shift involves a dramatic strategic move into 'Other Investments' — a key insight in the original answer. Instead, it describes a modest reallocation, which contradicts the ground truth's indication of a significant strategic shift. The LLM also incorrectly states that Equity Securities were present in 2022 but omits them entirely in 2023, while introducing 'money-market, mortgage-backed, ABS, CLO' as components of 'Other' without confirming if these align with the 'Other Investments' in the truth. (4) Despite these major errors, the LLM correctly identifies a directional shift toward diversification and inclusion of foreign bonds, which gives it partial credit for qualitative insight and contextual relevance. However, due to severe quantitative inaccuracies and failure to capture the scale and nature of the change — especially the $828M 'Other Investments' — the correctness score is low. The answer is semantically and numerically divergent from the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 581,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How has Microsoft's strategic positioning of Office 365 evolved between 2022 and 2024, particularly in terms of its role within the broader cloud services portfolio and its response to competitive pressures from AI-driven offerings?",
      "original_answer": "In 2022, Office 365 was explicitly listed as a key component of Microsoft's service and other revenue, positioned alongside Azure, Dynamics 365, and Xbox as a core cloud-based solution. By 2024, Office 365 had evolved into a more integrated part of Microsoft’s broader AI-infused cloud services portfolio, reflecting the company's strategic shift to infuse generative AI capabilities into commercial offerings. The 2024 filing notes that Microsoft is devoting significant resources to develop and deploy AI models, platforms, and infrastructure to meet customer needs, indicating that Office 365 is now part of this AI-enhanced competitive strategy. This shift was driven by increasing competitive pressures from companies entering the AI market and offering alternative models such as free applications funded by advertising or open-source AI models, which Microsoft must counter with enhanced, integrated cloud experiences.",
      "llm_answer": "In the 2022 Form 10‑K, Office 365 is described as a core subscription‑based cloud service—grouped with Azure, Dynamics 365 and other “service and other revenue” offerings—whose revenue is recognized ratably over the contract period and accounted for as a single, highly integrated performance obligation (2022 p. 63‑64). By the 2024 filing, Microsoft positions Office 365 as a flagship of its cloud portfolio that has been transformed from on‑premises software to a cloud‑first platform and is now a primary vehicle for embedding generative‑AI capabilities, reflecting the company’s strategy to counter AI‑driven competitive pressures (2024 p. 19‑21).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Office 365 was a core cloud service in 2022, grouped with Azure, Dynamics 365, and part of 'service and other revenue'—this matches the original answer. By 2024, it is positioned as a cloud-first platform and a primary vehicle for generative AI integration, reflecting Microsoft's strategic response to AI-driven competition. The mention of 'ratibly recognized revenue' and 'performance obligation' adds technical detail not in the ground truth but is factually correct and contextually relevant. (2) There are no numeric values (e.g., dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—score is 10. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across 2022 and 2024 filings, identifying the evolution in strategic positioning and linking it to AI integration and competitive pressures. The only minor gap is that the LLM does not explicitly mention 'free applications funded by advertising or open-source AI models' as specific competitive threats, which the original answer includes. This nuance is omitted but does not undermine the core conclusion. (4) The answer is contextually excellent—directly addresses the evolution of Office 365’s role in the cloud portfolio and competitive response. Wording differs but semantic meaning is equivalent. One point deducted from qualitative and overall scores for slight incompleteness in detailing competitive pressures.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 424,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How did UnitedHealth Group's recognition and handling of credit-related impairments evolve between 2022 and 2023, particularly in terms of their evaluation methodology and financial impact?",
      "original_answer": "In 2022, UnitedHealth Group evaluated available-for-sale debt securities for credit-related impairments by analyzing expected cash flows, underlying credit quality, and credit ratings of issuers, concluding that there was no significant credit deterioration since purchase and that unrealized losses were primarily due to interest rate increases. The allowance for credit losses was not material. By 2023, the company formalized its impairment recognition process by distinguishing between credit-related and non-credit-related impairments, recording credit-related impairments as an allowance against investment income and non-credit-related impairments through other comprehensive income. Additionally, the company emphasized a more structured evaluation framework that includes present value of expected cash flows, the extent of fair value decline relative to amortized cost, and issuer-specific financial conditions. This reflects a more detailed and segmented approach to impairment recognition and financial reporting.",
      "llm_answer": "UnitedHealth Group’s credit‑related impairment policy stayed the same. Both the 2022 and 2023 10‑Ks state that the company evaluates available‑for‑sale debt securities by comparing the present value of expected cash flows and any fair‑value shortfall to the security’s amortized cost, and records any impairment as an allowance against investment income (with the full loss taken to earnings if the security is intended to be sold). The 2022 filing explicitly says the allowance for credit losses was “not material,” and the 2023 filing repeats the same methodology without disclosing a material allowance, indicating the financial impact remained negligible.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer is significantly incorrect in its core claim that UnitedHealth Group's policy 'stayed the same' between 2022 and 2023, which directly contradicts the ground truth. While the LLM correctly references evaluating expected cash flows and amortized cost (elements present in both years), it fails to recognize the key evolution in methodology: in 2023, UnitedHealth formalized a distinction between credit-related and non-credit-related impairments, recording the former as an allowance against investment income and the latter through other comprehensive income—a major change not present in 2022. The ground truth states that in 2022, unrealized losses were attributed to interest rate changes and no significant credit deterioration was found, with the allowance being not material. In 2023, the company adopted a more structured, segmented framework emphasizing present value of cash flows, extent of fair value decline, and issuer-specific conditions—indicating a qualitative shift in methodology. The LLM incorrectly asserts continuity and misses this entire evolution. Quantitatively, there are no explicit numbers (e.g., dollar amounts, percentages) in either answer, so no numeric inaccuracies are present—hence a higher score on quantitative accuracy. Contextually, the answer addresses impairment evaluation and financial impact, so it is relevant, but the reasoning is flawed due to failure in multi-hop synthesis: it does not compare the two years’ disclosures to identify changes, instead assuming consistency without evidence. The conclusion that the financial impact remained negligible due to lack of material allowance disclosure is partially reasonable but does not compensate for the incorrect characterization of methodology. Overall, major factual and conceptual errors in reasoning and qualitative accuracy result in a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 504,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did the allocation and valuation of Fixed Maturity Securities AFS in MET's pension and other postretirement benefit plans evolve from 2022 to 2023?",
      "original_answer": "In 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. By 2023, the total estimated fair value of Fixed Maturity Securities AFS was $6,714 million for Pension Benefits and $1,274 million for Other Postretirement Benefits. This indicates a shift from a primarily percentage-based allocation in 2022 to a more detailed valuation breakdown in 2023, showing both the scale and composition of MET's holdings.",
      "llm_answer": "In 2023 MetLife’s pension‑plan target for Fixed‑Maturity Securities AFS was 85 % of assets, but the actual mix was about 82 % – a slight dip from the roughly 83 % target (and similar actual mix) reported for 2022.  The other post‑retirement plans kept an almost‑full allocation, with a 95 % target and about 94 % actual in 2023 versus an actual 96 % in 2022 (page 307).  On a fair‑value basis, the pension‑plan holdings of Fixed‑Maturity Securities AFS fell to $6.7 billion in 2023 from $6.8 billion at year‑end 2022, while the other post‑retirement holdings rose modestly to $1.27 billion from $1.26 billion (page 308).",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partial factual accuracy but introduces significant discrepancies in both percentages and dollar amounts compared to the ground truth. (1) Quantitative Accuracy: The original answer states that in 2022, Fixed Maturity Securities AFS accounted for 84% of U.S. Pension Benefits and 95% of U.S. Other Postretirement Benefits. The LLM claims approximately 83% for 2022 pensions and 96% actual for other benefits, which is close but not exact. For 2023, the LLM reports actual allocations (82% for pensions, 94% for other) and mentions targets (85%, 95%), but the original answer does not mention target allocations at all—only the fair value figures ($6,714 million and $1,274 million). The LLM rounds these to $6.7 billion and $1.27 billion, which is acceptable, but claims a drop from $6.8 billion in 2022, while the original answer provides no 2022 fair value for comparison—only percentages. Thus, the LLM fabricates a prior-year dollar figure not present in the ground truth. (2) Completeness: The question asks about the evolution from 2022 to 2023 in allocation and valuation. The original answer notes a shift from percentage-based reporting in 2022 to valuation-based in 2023. The LLM incorrectly assumes percentage data was available for 2023 and invents dollar values for 2022 that are unsupported. (3) Entity Accuracy: MET is correctly identified, years are correct, and the asset class is accurate. (4) Reasoning: The multi-hop synthesis fails because the LLM assumes comparable percentage and dollar data exist across both years, when the original answer highlights a change in reporting format. It incorrectly implies continuity in reporting style. (5) Semantic Equivalence: While the LLM captures a general trend of high allocation to Fixed Maturity Securities AFS, it misrepresents the nature of the evolution by adding unreported targets, inventing 2022 fair values, and misstating 2022 percentages. The core insight about a shift in reporting focus is lost. Therefore, despite some correct directional trends and plausible numbers, the answer is factually inconsistent with the ground truth on key quantitative and qualitative points.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 579,
        "total_tokens": 1854
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Lowe's strategic positioning of the Kitchens & Bath product category evolve between 2022 and 2023, and what does this suggest about its relative importance in the company's product portfolio?",
      "original_answer": "In 2022, Kitchens & Bath was grouped under the Home Décor division alongside categories like Appliances, Décor, Flooring, and Paint, suggesting a more design-focused positioning. By 2023, Kitchens & Bath was listed among core construction and renovation categories such as Lumber, Building Materials, and Rough Plumbing, indicating a strategic repositioning toward home improvement and remodeling. This shift suggests that Lowe's placed greater strategic emphasis on Kitchens & Bath as a key growth area tied to higher-value home projects, aligning with its broader 'Total Home' strategy.",
      "llm_answer": "In the 2022 filing, Kitchens & Bath was folded into the Home Décor segment— a segment that generated roughly 35 % of total net sales (see page 55). By the 2023 filing, Lowe’s presents Kitchens & Bath as a distinct product line and notes it as a primary driver of its installed‑sales business (see pages 6‑7), indicating the category has been elevated from a sub‑segment to a strategic growth focus and is now relatively more important within the company’s product portfolio.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic repositioning of Kitchens & Bath from being part of Home Décor in 2022 to a more prominent, standalone growth driver in 2023, which aligns with the ground truth's core claim about increased strategic importance. However, it introduces a specific quantitative claim—'35% of total net sales'—that is not present in the original answer and cannot be verified from the provided ground truth. This number may be accurate in the actual filing, but since it's absent from the ground truth and not corroborated, it constitutes a potential factual overreach, reducing quantitative accuracy. (2) There are no calculations in the answer, but the use of '35%' is a specific figure that lacks support in the original answer, which does not mention any percentage related to Home Décor’s sales contribution. This is a key deviation affecting quantitative accuracy. (3) The multi-hop reasoning is sound: the model correctly infers increased strategic importance from the category’s repositioning and references its role in installed sales as evidence of elevated status. The shift from a sub-segment to a highlighted growth area is logically tied to portfolio prioritization, matching the original answer’s reasoning about alignment with the 'Total Home' strategy, though that specific strategy name is omitted. (4) Despite the unsupported percentage, the LLM captures the essential qualitative shift and answers both parts of the question—evolution of positioning and implications for portfolio importance—making it contextually relevant and largely accurate in reasoning. The correctness score is reduced due to the unverified quantitative claim, but the core strategic interpretation remains valid.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 476,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How has Mondelez International's strategic focus on Cheese & Grocery evolved between 2022 and 2024, and what does this suggest about its prioritization of snack categories for long-term growth?",
      "original_answer": "In 2022, Mondelez directly produced Cheese & Grocery products, generating $1,990 million in total net revenues from this category. By 2024, the company no longer reported direct production in this category and instead indicated only a strategic stake in Cheese & Grocery, positioning it as an adjacent category within its broader snacking portfolio. This shift suggests a refocusing on core snack categories like biscuits and chocolate, while maintaining a presence in Cheese & Grocery through a lighter footprint. The change aligns with Mondelez's stated strategy of prioritizing long-term growth in core snacking segments and managing costs amid inflationary pressures.",
      "llm_answer": "In the 2022 filing, the sections provided (pages 127‑131) focus on legal proceedings, tax matters and accounting reclassifications and contain no reference to a cheese‑and‑grocery segment. By the 2024 filing, the Business Overview explicitly lists “cheese & grocery” as an adjacent, locally‑relevant category alongside gum & candy (MDLZ 10‑K 2024, p. 34). This addition signals that Mondelez has broadened its strategic focus to include cheese & grocery, indicating a higher prioritization of diversified snack categories for long‑term growth.",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in both direction and content. The ground truth states that Mondelez *exited direct production* of Cheese & Grocery by 2024 and now only holds a strategic stake, whereas the LLM claims the company *broadened its strategic focus* and *added* cheese & grocery — the exact opposite conclusion. This fundamental error invalidates the core of the response. (2) Quantitative accuracy is extremely low: the ground truth includes a specific revenue figure of $1,990 million in 2022 from Cheese & Grocery, which the LLM completely omits. No numbers are mentioned at all, failing to address a key part of the original answer. (3) Multi-hop reasoning is flawed. The LLM misinterprets the absence of mention in the 2022 filing (attributed to legal/tax sections) as evidence of nonexistence, rather than acknowledging data limitations. Then, it incorrectly infers that mentioning 'cheese & grocery' as an adjacent category in 2024 indicates expansion, when in fact this reflects a reduced, non-core role. The synthesis across years is invalid. (4) Contextual relevance is moderate because the LLM attempts to address the evolution of strategic focus and long-term growth, but due to factual and logical errors, the response misleads rather than informs. The conclusion contradicts the ground truth, making it highly inaccurate despite some structural relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 389,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How did Abbott's presentation of its enteral feeding product lineup, specifically the positioning of Jevity relative to Freego™ products, change between the 2022 and 2023 10-K filings?",
      "original_answer": "In the 2022 10-K filing, Jevity was listed first among enteral feeding products, followed by Glucerna 1.2 Cal, Glucerna 1.5 Cal, Osmolite®, Oxepa®, Freego™ (Enteral Pump), and Freego™ sets. In the 2023 filing, Jevity remained listed first, but the Freego™ (Enteral Pump) and Freego™ sets were now mentioned immediately after Jevity, before the Glucerna and Osmolite® product lines. This change in listing order suggests a shift in product emphasis within the enteral feeding category, with Freego™ products receiving more prominent placement alongside Jevity in 2023 compared to 2022.",
      "llm_answer": "In the 2022 Form 10‑K the enteral‑feeding list reads “including **Jevity®**, … **Freego™** (Enteral Pump) and Freego™ sets…”【page_3】. The 2023 Form 10‑K repeats the same sequence – “including **Jevity**, … **Freego™** (Enteral Pump) and Freego™ sets…”【page_4】. Thus, the positioning of Jevity relative to the Freego™ products did not change; Jevity remains listed before the Freego™ items in both filings.",
      "correctness_score": 2,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is factually incorrect in its core claim that the order of product listing did not change between the 2022 and 2023 10-K filings. According to the ground truth, in 2022, Jevity was listed first, but Freego™ products appeared later in the list, after Glucerna and Osmolite®. In 2023, Freego™ (Enteral Pump) and Freego™ sets were moved immediately after Jevity, before Glucerna and Osmolite®, indicating a repositioning. The LLM incorrectly states that the sequence is identical in both years, which contradicts the ground truth. There are no numeric values to evaluate, so quantitative accuracy is scored as 10 by default. However, the qualitative accuracy is very low because the model failed to detect the change in product order, reflecting a failure in multi-hop reasoning and synthesis across the two filings. The answer is partially relevant to the question but draws an incorrect conclusion, hence low contextual relevance. The citation of page numbers does not compensate for the factual inaccuracy in the described sequence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1256,
        "completion_tokens": 298,
        "total_tokens": 1554
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did MET's investment in municipals evolve from 2022 to 2023 in terms of fair value and classification, and what does this suggest about the company's credit risk management strategy?",
      "original_answer": "In 2022, MET held $14,212 million in municipals, classified under the 'fixed maturity securities AFS' category, with a fair value that included $2,464 million in gross unrealized gains and only $13 million in gross unrealized losses. By 2023, this investment had significantly declined to just $159 million, now categorized under the 'fixed maturity securities AFS' and classified entirely within Level 2 of the fair value hierarchy, indicating a shift in MET's positioning. This dramatic reduction suggests a strategic move to reduce credit exposure to municipals, likely as part of a broader risk management adjustment to limit potential losses in this asset class.",
      "llm_answer": "In the employee‑benefit plan assets, MetLife’s municipal holdings fell from $174 million in 2022 (Level 2 fair‑value assets) to $155 million in 2023 (still Level 2)【page_308】. The modest reduction while keeping the securities in the observable‑input (Level 2) tier shows the company is trimming municipal exposure but remains in a relatively transparent, liquid category—consistent with a prudent credit‑risk strategy that limits concentration without shifting to less‑observable (Level 3) assets.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely incorrect in terms of quantitative accuracy. It reports municipal holdings of $174 million in 2022 and $155 million in 2023, whereas the ground truth states $14,212 million in 2022 and $159 million in 2023. This is a massive discrepancy—off by over $14 billion in 2022. The LLM also references 'employee-benefit plan assets,' which is a narrower scope than the company-wide investment portfolio described in the original answer, thus misrepresenting the context. (2) The numbers cited in the LLM answer do not match the ground truth: $174M vs $14,212M in 2022 is a 98.8% underreporting. While the 2023 figure ($155M vs $159M) is close, it still pertains to a different asset category. The LLM correctly notes Level 2 classification in 2023 but fails to mention that in 2022 the holdings included significant unrealized gains ($2,464M) and minimal losses ($13M), which is critical context. (3) The reasoning is flawed because it draws conclusions from the wrong dataset—employee-benefit assets instead of total fixed maturity AFS securities. The multi-hop synthesis fails: it does not connect the dramatic reduction in municipals from 2022 to 2023 as a strategic credit risk move, instead characterizing it as a 'modest reduction' which contradicts the actual 99% divestment. (4) The contextual relevance is partially met—it addresses evolution in municipal investments and attempts to infer credit risk strategy—but due to incorrect entity and metric identification, the conclusion is unsupported. The qualitative accuracy is low because the entity (portfolio scope), metrics, and scale are wrong, undermining the reasoning. Correctness score is low due to severe factual and quantitative errors despite some structural relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 481,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How did Abbott's use of interest rate hedge contracts evolve between 2022 and 2023, particularly in terms of their notional value and the impact on fixed-rate debt management?",
      "original_answer": "In 2022, Abbott had interest rate hedge contracts totaling approximately $2.2 billion, which were used to manage exposure to changes in the fair value of fixed-rate debt by converting fixed-rate obligations into variable-rate obligations. By 2023, Abbott continued to use these contracts for the same purpose, and the notional value remained consistent at approximately $2.2 billion. However, in 2023, the company provided more detailed disclosures about the impact of these contracts on the carrying value of fixed-rate debt, indicating a more refined approach to interest rate risk management.",
      "llm_answer": "Abbott’s interest‑rate hedge program shrank from about **$2.9 billion in 2022** to roughly **$2.2 billion at year‑end 2023** – a $700 million drop that reflects the maturity of a $700 million block of hedge contracts (and the underlying debt) in 2023【page_65】.  The contracts are designated as **fair‑value hedges** that offset the fair‑value changes of fixed‑rate debt, effectively converting the hedged portion of that debt to a variable‑rate exposure and adjusting the debt’s carrying amount accordingly【page_64】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in the quantitative details. According to the ground truth, Abbott's notional value of interest rate hedge contracts was approximately $2.2 billion in both 2022 and 2023, with no change in amount. However, the LLM claims the value decreased from $2.9 billion in 2022 to $2.2 billion in 2023, citing a $700 million drop due to maturities — a detail not supported by the original answer. This misrepresents the evolution of the notional value, which was stable year-over-year. (2) The calculation of a $700 million drop is incorrect based on ground truth, as there was no change in notional value between the years. The cited page references (64, 65) may contain accurate data in the source document, but the LLM's interpretation contradicts the verified knowledge graph output. (3) While the LLM correctly identifies the purpose of the hedges — as fair-value hedges converting fixed-rate debt to variable-rate exposure — and mentions the impact on carrying value, it fails to note the key qualitative evolution stated in the original answer: that Abbott provided more detailed disclosures in 2023, indicating a more refined risk management approach. This omission weakens the qualitative accuracy. (4) The contextual relevance is high because the answer addresses the core concepts: notional value, hedge purpose, and impact on fixed-rate debt. However, the incorrect numerical trend and missing disclosure refinement result in a partially correct but significantly flawed response. Thus, the correctness score is moderate due to major quantitative errors despite some accurate conceptual framing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1285,
        "completion_tokens": 455,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did 3M's issuance and management of fixed rate registered notes evolve between 2022 and 2024, particularly in terms of repayment activity and interest rate strategies?",
      "original_answer": "In 2022, 3M had a significant amount of fixed rate registered notes, including $600 million of 10-year notes due 2030 with a coupon rate of 3.05%, and $650 million of 30-year notes due 2050 with a coupon rate of 3.70%. The company also issued $3.25 billion in fixed rate registered notes in August 2019, including $1.0 billion of 10-year notes due 2029 and $1.0 billion of 30-year notes due 2049. In 2024, 3M repaid $1.1 billion in medium-term notes that matured, and in 2023, it repaid $500 million in fixed-rate registered notes. Additionally, interest rate swaps initiated in 2021 converted portions of the fixed-rate notes due 2049 and 2050 into floating-rate debt through mid-2028, indicating a strategic shift toward managing interest rate exposure. This shows a decrease in the amount of fixed-rate debt outstanding and a shift toward floating-rate instruments through swaps.",
      "llm_answer": "In the 2022 filing 3M’s fixed‑rate registered‑note portfolio consisted of a mix of issues ranging from a $750 million note at 2.12 % due 2025 to $500 million‑$350 million notes at 3.36 %‑3.75 % due 2049‑2050, and no material repayments of those securities were reported that year【page_87】. By the 2024 filing the company had retired $500 million of maturing fixed‑rate registered notes in 2023, added new lower‑coupon issues (e.g., $750 million at 2.02 % due 2025 and $500 million at 2.66 % due 2025) while still holding longer‑dated notes at 3‑3.8 % (see the 2024 debt table)【page_68】, and it had earlier used $800 million of interest‑rate swaps (in 2021) to convert portions of its 2049/2050 fixed‑rate debt to floating‑rate exposure, reflecting a strategy of refinancing at lower rates and managing interest‑rate risk【page_69】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key dollar amounts, interest rates, and maturities compared to the ground truth. For example, it incorrectly states that in 2022, 3M had a $750 million note at 2.12% due 2025, which is not mentioned in the original answer; the actual 2022 notes were $600M at 3.05% due 2030 and $650M at 3.70% due 2050. It also misrepresents the August 2019 issuance as not being part of the 2022 portfolio, when the original answer includes $1B due 2029 and $1B due 2049 from that issuance. The LLM claims new lower-coupon notes were issued (e.g., $750M at 2.02% due 2025), but the original answer does not mention any new issuances in 2024—only repayments. (2) The repayment activity is partially correct: the LLM correctly notes $500M in fixed-rate notes repaid in 2023, but omits the $1.1B repayment in 2024 of medium-term notes, instead implying only $500M was repaid. The interest rate swap amount is inaccurately stated as $800M, while the original specifies no dollar amount for the swaps, only that portions of the 2049/2050 notes were converted. (3) The multi-hop reasoning is partially sound—the LLM correctly infers a strategy of refinancing at lower rates and managing interest rate risk via swaps, which aligns with the original’s conclusion about a shift toward floating-rate debt. However, this insight is based on incorrect underlying data, weakening the validity. (4) Contextual relevance is high because the answer addresses issuance, repayment, and interest rate strategy across 2022–2024. However, due to major quantitative errors and incomplete/misrepresented data, the correctness score is low. While the strategic interpretation is reasonable, the factual foundation is flawed, leading to a correctness score of 4.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1434,
        "completion_tokens": 487,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has the role of securities issuances in Schwab's capital structure evolved between 2023 and 2024, particularly in relation to its overall funding sources and capital management strategy?",
      "original_answer": "In 2023, securities issuances by CSC were identified as a primary source of capital, directly supporting the company's capital management strategy, which included balance sheet growth and financial support to subsidiaries. By 2024, while still listed as one of several funding sources, securities issuances were positioned among a broader set of liquidity tools, including FHLB borrowings, repurchase agreements, and CDs, indicating a more diversified funding approach. This shift suggests a strategic evolution where securities issuances remain important but are more integrated within a wider capital structure framework.",
      "llm_answer": "In 2023 Schwab’s capital plan still counted “securities issuances by CSC in the capital markets” as a primary source of funding – it raised a series of senior unsecured notes (e.g., the $1.2 bn and $1.3 bn issuances in May 2023 and the $1.35 bn and $1.0 bn issuances in August 2023) to support growth, meet regulatory capital targets and fund dividend and share‑repurchase programs 【page_58】. By 2024 the company had redeemed those floating‑rate notes, cut long‑term debt by $3.7 bn and leaned more on client‑generated cash, FHLB advances, repurchase‑agreement lines and a short‑term revolving credit facility, while keeping a universal shelf registration as a backup but no longer treating new issuances as a core funding pillar 【page_53】【page_54】【page_52】. This shift reflects a capital‑management strategy that moved from active debt issuance toward greater reliance on internal cash flows and liquidity facilities, with securities issuances now serving mainly as an optional source of capital.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2023, securities issuances were a primary funding source for Schwab (CSC), citing specific note issuances ($1.2B, $1.3B, $1.35B, $1.0B) in May and August 2023, which matches the emphasis in the original answer on securities as a primary capital source. (2) For 2024, it accurately notes a strategic shift: redemption of floating-rate notes, a $3.7B reduction in long-term debt, and increased reliance on alternative sources like FHLB advances, repurchase agreements, client cash, and credit facilities—consistent with the original answer’s description of a more diversified funding approach. (3) The LLM correctly infers that while securities issuances are no longer a 'core funding pillar,' they remain available via shelf registration, reflecting the nuanced evolution described in the ground truth. (4) All cited numbers are factually consistent with the context (allowing for format variation), and the reasoning across years and funding mechanisms demonstrates strong multi-hop synthesis. The only minor limitation is that the original answer emphasizes 'balance sheet growth and support to subsidiaries' as strategic goals, which the LLM does not explicitly mention, but it does reference regulatory capital, dividends, and share repurchases, which are closely related. Overall, the answer is semantically equivalent, factually precise, and contextually complete.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1416,
        "completion_tokens": 405,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How did Coca-Cola's contingent payment obligations related to fairlife evolve from 2022 to 2024, and what does this indicate about fairlife's performance against its financial targets?",
      "original_answer": "In 2022, Coca-Cola disclosed that it had a $270 million liability for contingent milestone payments related to its acquisition of fairlife, based on fairlife achieving certain financial targets through 2024. The company also noted that the first milestone payment of $100 million was made in 2021 after fairlife met its 2020 targets. By 2024, the remaining contingent payment was described as a milestone payment contingent on fairlife achieving certain financial targets through 2024 and was payable in 2025. This indicates that fairlife had met at least one set of financial targets (2020), triggering the initial $100 million payment, and that the company remained on track to potentially meet the remaining targets through 2024, as the obligation was still active and had not been rescinded or adjusted downward.",
      "llm_answer": "In the 2022 filing Coca‑Cola reported a $270 million contingent‑consideration liability for fairlife (the initial estimate) plus re‑measurement charges of $51 million in 2020 and $369 million in 2021, and it made a $100 million milestone payment in 2021【page_75】. By the 2024 filing that liability had ballooned to $6.126 billion, and a $275 million milestone was paid in 2023, showing that fairlife has continued to hit the financial targets that trigger the milestone payments and cause the liability to be re‑measured upward【page_111】【page_112】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, Coca-Cola had a $270 million contingent payment obligation in 2022 related to fairlife's performance through 2024, with a $100 million payment already made in 2021 after fairlife met its 2020 targets. However, the LLM claims that by 2024 the liability 'ballooned to $6.126 billion' and that a $275 million milestone was paid in 2023—none of which is supported by the original answer or consistent with the disclosed timeline. These figures are entirely fabricated or misread. (2) Quantitative accuracy is severely lacking: the $51M and $369M re-measurement charges in 2020 and 2021 are not mentioned in the ground truth; the $6.126B figure in 2024 is grossly inflated compared to the original $270M liability; and the supposed $275M payment in 2023 contradicts the original statement that the remaining obligation was still contingent and payable in 2025. (3) The multi-hop reasoning is flawed: while the LLM correctly infers that milestone payments indicate target achievement, it incorrectly assumes escalating payments and liability growth, leading to a false conclusion about performance. The original answer indicates continuity of the obligation without adjustment—suggesting fairlife remained on track—but does not support any increase in the total liability. (4) Contextual relevance is moderate because the answer addresses contingent payments and links them to performance, but the severe factual and numerical errors undermine the validity of the response. The model appears to have hallucinated data from unrelated contexts or misread the source documents, failing the core requirement of factual fidelity to the knowledge graph.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 473,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Infrastructure (OCI) evolved between 2022 and 2024, particularly in terms of its global market positioning and integration with enterprise IT solutions?",
      "original_answer": "In 2022, Oracle's financial disclosures emphasized revenue contributions from cloud and license businesses, which generated $36.052 billion, representing 85% of total revenues, with no explicit strategic language about Oracle Cloud Infrastructure's positioning. By 2024, Oracle significantly elevated OCI's role, describing it as a core component of Oracle Cloud Services alongside SaaS, and emphasizing its ability to provide 'comprehensive and integrated applications and infrastructure services' that enable customers to choose deployment models best suited to their needs. This reflects a clear strategic shift toward positioning OCI as a central pillar in Oracle’s enterprise IT offerings, not just a contributor to cloud revenue.",
      "llm_answer": "By fiscal 2022 Oracle was already shifting resources from hardware toward its cloud‑based infrastructure platform, stressing that “the emphasis we placed on the marketing and sale of our growing cloud‑based infrastructure technologies” was a key driver of cloud‑services revenue growth worldwide (see 2022 10‑K, p. 47‑48). By fiscal 2024 OCI is presented as a core pillar of a globally‑delivered, integrated cloud portfolio—“Oracle Cloud Software‑as‑a‑Service and Oracle Cloud Infrastructure (SaaS and OCI…) provide comprehensive and integrated applications and infrastructure services” that support on‑premise, cloud and hybrid deployments for enterprise IT customers worldwide (see 2024 10‑K, p. 72). Thus Oracle’s focus has evolved from building OCI as a growth engine to positioning it as a central, globally‑available platform tightly integrated with its enterprise applications.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, no specific financial figures are misstated—the original answer notes $36.052 billion in cloud and license revenue for 2022, but the LLM correctly avoids fabricating numbers not explicitly mentioned in its response. It does not contradict any numerical data. (2) The LLM accurately captures the evolution in strategic emphasis: from OCI as a growth driver in 2022 (citing marketing and sales focus from the 2022 10-K, p.47-48) to a core, integrated pillar of Oracle’s global cloud offerings in 2024 (citing 2024 10-K, p.72). (3) The multi-hop reasoning is sound—comparing Oracle’s strategic language across two fiscal years to demonstrate a shift in positioning from infrastructure growth to integrated enterprise platform. (4) The LLM adds contextual detail (e.g., hybrid deployments, global delivery) that enriches the answer without deviating from the original meaning. The only minor gap is that the original answer explicitly notes that in 2022 there was 'no explicit strategic language about OCI’s positioning,' whereas the LLM interprets early signs of shift—slightly overstating the 2022 emphasis. However, this does not undermine the overall correctness. Semantic equivalence is maintained, and all entities (Oracle, OCI, SaaS, fiscal years, enterprise IT integration) are accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 383,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has the treatment and risk profile of PALs evolved between 2023 and 2024, particularly in terms of credit loss allowance and collateralization?",
      "original_answer": "In 2023, there was a slight decrease in PALs, and the allowance for credit losses was influenced by improved credit quality metrics and lower projected loss rates. By 2024, all PALs were fully collateralized by securities with fair values exceeding borrowings, and no allowance for credit losses for PALs was required as they were all subject to the collateral maintenance practical expedient under ASC 326. This indicates a strengthening in the risk profile and treatment of PALs over the period.",
      "llm_answer": "Schwab’s PALs continued to be treated as fully collateralized, with securities covering the balances at fair values in excess of the borrowings, and the company applied the ASC 326 “collateral‑maintenance” practical expedient. As a result, no allowance for credit losses was recorded for PALs in either 2023 or 2024, indicating that the risk profile of these loans remained low and essentially unchanged over the period.【page_88】",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains a significant factual inaccuracy in its core claim about the allowance for credit losses being absent in both 2023 and 2024. According to the ground truth, in 2023, there was a slight decrease in PALs and the allowance for credit losses was still influenced by credit quality and projected loss rates—indicating that an allowance *was* required or at least considered. The elimination of the allowance did not occur until 2024, when all PALs became fully collateralized and the ASC 326 collateral maintenance practical expedient was applied, thus removing the need for an allowance. The LLM incorrectly states that no allowance was recorded in *either* year, which misrepresents the evolution of risk treatment over time. This undermines the qualitative accuracy, as the reasoning suggests the risk profile was 'essentially unchanged,' when in fact the ground truth describes a clear strengthening in risk profile from 2023 to 2024. Entity accuracy (PALs, ASC 326, collateralization) and contextual relevance are strong, and there are no numeric values requiring calculation, so quantitative accuracy is high. However, the failure to correctly represent the change in allowance treatment across the two years—a central point of the question—results in a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 368,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How has Nike's relationship with the Asia Pacific & Latin America (APLA) region evolved between fiscal years 2023 and 2024, particularly in terms of operational structure and strategic emphasis?",
      "original_answer": "In fiscal year 2023, Nike's relationship with APLA was characterized by direct operational involvement, with the region being one of the geographies where certain employees were represented by trade unions, indicating a more localized and embedded workforce structure. By fiscal year 2024, Nike transitioned parts of its APLA operations to third-party distributors, signaling a strategic shift away from direct control toward a more outsourced model. This evolution reflects a broader restructuring effort to optimize the business model and reduce operational complexity in certain international markets.",
      "llm_answer": "Nike still reports Asia Pacific & Latin America (APLA) as a separate geographic operating segment, but in FY 2024 the company began moving some Nike‑Brand businesses in selected APLA markets to third‑party distributors—a shift from the primarily direct‑to‑consumer/wholesale structure it used in FY 2023 (Note 15, page 89).  This operational change is paired with a modest revenue growth in the region, from $6.4 billion in FY 2023 to $6.7 billion in FY 2024, reflecting a strategic emphasis on expanding market share while leveraging partner distribution alongside its direct channels (page 90).",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core operational shift from direct to third-party distribution in APLA between FY2023 and FY2024, which aligns with the ground truth. It correctly identifies the strategic emphasis on restructuring through outsourcing in selected markets. However, it introduces revenue figures ($6.4B in FY2023 and $6.7B in FY2024) that are not present in the original answer and cannot be verified against the provided ground truth, which contains no financial performance data. This undermines quantitative accuracy. While the direction of the operational change is correct, the LLM omits the key qualitative detail about trade union representation in FY2023, which reflects a more embedded, localized workforce structure—a critical aspect of the evolution in Nike's relationship with the region. This omission weakens the completeness and qualitative accuracy of the multi-hop reasoning. The mention of 'Note 15, page 89' and 'page 90' suggests external document references not available in the knowledge graph, raising concerns about source consistency. Despite these issues, the answer remains contextually relevant by addressing both operational structure and strategic emphasis as required by the question.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 342,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How did Abbott's positioning and strategic emphasis on Pedialyte evolve between 2022 and 2023, particularly in relation to its U.S. Pediatric Nutritional business and product portfolio expansion?",
      "original_answer": "In 2022, Pedialyte was highlighted as a key growth driver within Abbott's U.S. Pediatric Nutritional business, with sales increasing 10.3% for the year, alongside Similac and PediaSure. By 2023, Pedialyte was formally included in Abbott's product portfolio under the Nutritional Products segment, listed among major brands such as Ensure, Glucerna, and PediaSure, signaling a more structured integration into Abbott's broader nutritional offerings. This reflects a strategic evolution from being a contributor to growth in 2022 to being a formally recognized and embedded part of the company's core U.S. Pediatric Nutritional product lineup in 2023.",
      "llm_answer": "In the 2022 Form 10‑K Abbott singled out Pedialyte as a primary driver of the U.S. Pediatric Nutritionals segment’s 10.3 % sales increase, highlighting it together with Similac and PediaSure as the core growth engine for that business【page_31】. By the 2023 filing, Pedialyte is simply listed among a broader suite of adult and pediatric nutrition brands—indicating that while it remains a core product, Abbott’s strategy has shifted to emphasize a more diversified nutrition portfolio rather than focusing solely on Pedialyte【page_4】.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that Pedialyte was a key growth driver in 2022 with a 10.3% sales increase, alongside Similac and PediaSure, which matches the ground truth. The citation of the 2022 Form 10-K and specific page reference adds credibility. However, the LLM interprets the 2023 change as a strategic shift toward a 'more diversified nutrition portfolio rather than focusing solely on Pedialyte,' which misrepresents the ground truth. The original answer emphasizes that Pedialyte was formally integrated into the core Nutritional Products segment and listed among major brands—signaling structural recognition and embedding, not a de-emphasis. The LLM incorrectly frames the evolution as a reduction in focus, when it is actually an elevation in strategic positioning. (2) Quantitatively, all numbers (10.3% sales increase, correct years) are accurate and properly cited. (3) The multi-hop reasoning is partially sound—correctly linking 2022 and 2023 disclosures—but the conclusion drawn from the 2023 data is flawed. The model observes a change in presentation but infers the wrong strategic implication. (4) Scores reflect high factual accuracy in numbers and context, but a meaningful error in qualitative interpretation that affects the core of the strategic evolution described in the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 371,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How did RTX's financial position regarding its 7.100% notes due 2027 evolve from 2022 to 2023, and what does this indicate about its debt management strategy?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $6 million for its 7.100% notes due 2027. By 2023, RTX had a stake in the same notes with an aggregate principal balance of $135 million. This indicates a significant increase in RTX's exposure to this particular debt instrument, suggesting a shift in its debt management strategy, possibly involving refinancing or restructuring.",
      "llm_answer": "RTX’s balance sheet shows that the 7.100 % notes due 2027 carried a principal balance of $135 million at both December 31 2022 and December 31 2023, with no increase or reduction (see the long‑term debt table for 2023 and 2022)【page_84】. The unchanged balance indicates that RTX chose to keep this tranche intact—neither refinancing nor retiring it—while actively issuing new debt and repaying other notes, reflecting a targeted debt‑management strategy that preserves existing low‑cost obligations while reshaping the broader debt profile.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in stating that the principal balance of RTX's 7.100% notes due 2027 was $135 million in both 2022 and 2023. According to the ground truth, the balance was $6 million in 2022 and increased to $135 million in 2023. This is a critical error in quantitative accuracy. (2) The numbers are directly contradicted by the original answer: the 2022 figure is off by a factor of more than 20x ($6M vs $135M), and the claim of no change is false. The calculation of change (zero) is incorrect; the actual increase was $129 million. (3) The multi-hop reasoning fails because the model did not correctly synthesize the evolution of the debt over time. Instead, it assumed stability, leading to an erroneous conclusion about debt management strategy. The ground truth suggests a significant strategic shift due to increased exposure, while the LLM interprets no change and infers a different strategy. (4) The contextual relevance is partially maintained as the answer discusses debt management strategy and references the correct debt instrument and years, but the factual foundation is entirely flawed. Due to major errors in core data and resulting incorrect analysis, the correctness score is very low at 1.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 351,
        "total_tokens": 1586
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Nike's relationship with Converse evolved in terms of revenue performance and strategic positioning between fiscal 2023 and fiscal 2024?",
      "original_answer": "In fiscal 2023, Converse revenues decreased by 15% on a currency-neutral basis, driven by declines in North America and Western Europe, with both wholesale and direct-to-consumer channels experiencing drops in unit sales and average selling price. By fiscal 2024, Converse was described as a wholly-owned subsidiary that operates on a stand-alone basis, indicating a strategic shift toward maintaining it as a distinct brand within Nike’s portfolio. This evolution reflects a move from a financially struggling entity in 2023 to a more strategically positioned brand in 2024, despite the earlier revenue contraction.",
      "llm_answer": "Nike’s Converse segment saw its revenues drop from $2.43 billion in FY 2023 to $2.08 billion in FY 2024 – a 14‑15% decline (and EBIT fell 30% to $474 million) as wholesale sales fell 16% and direct‑to‑consumer sales fell 14% with lower ASPs. Despite the slowdown, Converse remains a wholly‑owned, stand‑alone operating segment that Nike positions as a separate casual‑sneaker, apparel and accessories brand, contributing a steady share of the company’s international sales mix (≈58% of total non‑U.S. revenue) and maintaining its own retail and licensing footprint.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies a ~15% revenue decline in Converse between FY2023 and FY2024 and attributes it to drops in both wholesale and direct-to-consumer channels with lower average selling prices (ASPs), which aligns with the ground truth. It also accurately notes Converse’s status as a wholly-owned, stand-alone entity in Nike’s portfolio, reflecting strategic positioning. However, the original answer does not specify exact revenue figures ($2.43B and $2.08B) or EBIT ($474M), nor does it mention Converse contributing ~58% of non-U.S. revenue—details not supported by the ground truth. These specific numbers, while plausible, are not present in the verified knowledge graph and thus introduce unverified quantitative claims. (2) The 14–15% decline is consistent with the 15% currency-neutral drop cited in the original answer, so the percentage is accurate. The EBIT figure and its 30% decline, however, are not mentioned in the ground truth and cannot be verified, reducing quantitative accuracy. The calculation of the revenue drop from $2.43B to $2.08B is mathematically correct (~14.4%), supporting the stated range. (3) The multi-hop reasoning is sound: the model connects financial performance (revenue decline) with strategic positioning (stand-alone brand), synthesizing information across fiscal years and operational dimensions. The conclusion that Converse shifted from a financially struggling brand to a strategically distinct one is logically supported. (4) The correctness score is 8 because core facts—revenue decline, channel performance, and strategic independence—are accurate, but the inclusion of unsupported specific dollar amounts and EBIT data prevents a 9–10. Quantitative accuracy is 7 due to the introduction of unverified precise figures. Qualitative accuracy is 9 due to strong reasoning and correct entity/fiscal year alignment. Contextual relevance is 10 as the response directly addresses revenue performance and strategic evolution as asked.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 540,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Coca-Cola's financial risk assessment regarding digital evolution changed from 2022 to 2024, particularly in terms of its impact on sales growth and margin improvement?",
      "original_answer": "In 2022, Coca-Cola viewed digital evolution as a risk factor that could negatively impact its business if it failed to implement digital transformation initiatives effectively, potentially leading to a loss in sales and brand relevance. By 2024, the company shifted its stance, identifying digital evolution as a strategic dependency, emphasizing that its future success would rely on expanding digital capabilities to increase sales and improve margins. The 2024 filing explicitly states that failure to digitalize operations could adversely impact financial performance, indicating a stronger financial linkage to digital initiatives than in 2022.",
      "llm_answer": "In the 2022 10‑K Coca‑Cola warned that lagging behind the digital evolution could “erode its share of sales, revenue growth and overall financial results,” focusing on the risk to sales growth and cost‑reduction (2022 p. 17). By the 2024 10‑K the risk language was sharpened to state that failure to digitalize “could negatively affect its ability to increase sales **and improve margins**,” explicitly tying the digital risk to margin improvement as well as sales growth (2024 p. 19). This shows a shift from a broad concern about sales/revenue to a more specific emphasis on both sales growth and profitability margins.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies the shift in Coca-Cola's risk assessment from 2022 to 2024: in 2022, digital evolution was framed as a risk to sales and revenue growth; by 2024, the language evolved to explicitly include margin improvement as a key financial outcome tied to digitalization. (2) No numerical values (e.g., dollar amounts, percentages) are present in either answer, so quantitative accuracy is not compromised—dates (2022, 2024) and page references (p. 17, p. 19) are correctly cited and consistent with the expected precision. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of 10-K filings, correctly comparing the evolution in risk language and its financial implications (sales growth → sales + margins). (4) The LLM captures the core conceptual shift—from digital lag as a general business risk to digital transformation as a strategic financial dependency—and supports it with direct, correctly attributed quotes. Wording differs slightly from the original answer but conveys the same meaning with high fidelity. All evaluation dimensions are fully satisfied.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 337,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How has Oracle's strategic emphasis on Oracle Cloud Services evolved from fiscal year 2022 to 2024, particularly in terms of research and development investment and the positioning of cloud offerings relative to on-premise solutions?",
      "original_answer": "In fiscal year 2022, Oracle invested $7.2 billion in research and development, highlighting its commitment to enhancing Oracle Cloud Services, including Oracle SaaS and OCI, as part of a broader strategy to offer flexible and interoperable deployment models. Oracle positioned cloud services as a key differentiator against competitors by emphasizing rapid deployment, security, and integration. By fiscal year 2024, Oracle continued to emphasize cloud services but restructured its messaging to position Oracle Cloud Software-as-a-Service and Oracle Cloud Infrastructure as central to enabling customers to 'choose the best option that meets their specific business needs.' While the 2024 report does not specify the R&D investment amount, the increased focus on cloud-first positioning and integration with customer-specific needs indicates a strategic deepening of Oracle's commitment to cloud services over on-premise offerings.",
      "llm_answer": "In fiscal 2022 Oracle devoted $7.2 billion to research and development – a spend aimed at expanding its cloud portfolio and accelerating the shift of customers from on‑premise products, with cloud services and license‑support revenues already accounting for about 71 % of total revenue【page_6】. By fiscal 2024 the company’s filing frames Oracle Cloud Services as one element of a “flexible and interoperable” set of deployment options that include on‑premise, cloud‑based and hybrid models, emphasizing that customers can choose the best environment for their needs rather than a single‑sided migration push【page_72】. The 2024 filing does not disclose a new R&D amount, indicating the strategic focus has moved toward positioning cloud offerings as part of a broader, choice‑driven architecture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states Oracle's $7.2 billion R&D investment in fiscal year 2022, matching the ground truth exactly. It also accurately notes that the 2024 filing does not disclose a specific R&D amount, which aligns with the original answer. The additional detail that cloud services and license-support revenues accounted for about 71% of total revenue is factually consistent with Oracle’s reporting and adds context without contradicting the ground truth. (2) All numeric values—$7.2 billion, fiscal years 2022 and 2024—are correct and properly attributed. No calculations were required, but the use of percentages and dollar amounts is accurate and appropriately formatted. (3) The multi-hop reasoning is sound: the LLM synthesizes information across fiscal years, correctly identifying the evolution in Oracle’s strategic messaging—from accelerating cloud migration in 2022 to promoting a flexible, choice-driven deployment model in 2024. It captures the shift from pushing cloud over on-premise to positioning cloud as part of an interoperable suite, which reflects the nuanced strategic deepening described in the ground truth. (4) The only minor gap is that the LLM does not explicitly name Oracle SaaS and OCI as central cloud offerings in 2024, as mentioned in the original answer, though it refers to 'Oracle Cloud Services' broadly. This omission slightly reduces qualitative completeness but does not impair factual correctness. Overall, the answer is semantically equivalent, contextually rich, and highly accurate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 427,
        "total_tokens": 1881
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the status and availability of shares under the Norwest Corporation Directors' Formula Stock Award Plan evolved between 2023 and 2024?",
      "original_answer": "In 2023, the Norwest Corporation Directors' Formula Stock Award Plan was described as a plan under which shares of common stock were awarded to non-employee directors, with the ability to defer receipt of awards until a future year. However, it was noted that no future stock awards or deferrals could be made under this plan. In 2024, the 10-K filing further clarified that no future awards or deferrals would be made under the plan and that column (a) of the equity compensation table reflected all shares issuable under the plan upon distribution of outstanding awards or deferred compensation benefits. This indicates that by 2024, the plan was fully closed to any new activity and only existing obligations remained. The number of shares issuable in 2024 related to this plan was minimal (only 391 shares), showing that the plan had effectively concluded its active phase.",
      "llm_answer": "The Norwest Corporation Directors’ Formula Stock Award Plan was described in both years as a plan under which “no future stock awards or deferrals may be made” (2023 footnote 5, page 11; 2024 footnote 5, page 14).  The only shares still available for distribution under the plan fell from 509 shares in the 2023 filing (page 11 footnote 4) to 391 shares in the 2024 filing (page 14 footnote 4).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor discrepancies in completeness and precision. (1) Quantitatively, the LLM correctly reports the reduction in shares from 509 in 2023 to 391 in 2024, which matches the trend in the original answer, though the original does not specify the 2023 number (509), only characterizing the 2024 amount as 'minimal (391 shares)'. The LLM adds a specific 2023 figure not present in the ground truth, which may be accurate but is not confirmed by the provided answer. (2) The LLM accurately cites the continued status of the plan as closed to future awards in both years and references correct footnotes and pages, supporting its claims. (3) Qualitatively, the reasoning is sound: it captures the plan’s inactive status and the declining share availability, reflecting correct multi-hop synthesis across the two years. However, it omits the key contextual detail from the original answer that by 2024, the equity compensation table reflected *all* remaining shares tied to *outstanding awards or deferred compensation*, emphasizing the plan’s finality. This nuance about the comprehensive reflection of obligations in the table is missing. (4) Despite this omission, the core facts—plan closure, no new awards, declining available shares—are correct. The answer is highly relevant and factually consistent, warranting a high score, but not full marks due to the unverified 2023 share number and missing depth on the 2024 clarification about deferred compensation distribution.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 423,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has McDonald's disclosure around food safety concerns evolved between 2022 and 2023, particularly in relation to supply chain risks and cost volatility?",
      "original_answer": "In 2022, McDonald's characterized food safety concerns primarily as reputational risks that could impact brand perception and financial results due to incidents like food-borne illness or contamination. The focus was on the potential damage to consumer trust and the company's image. By 2023, the framing had evolved to emphasize food safety concerns as contributors to supply chain volatility, specifically in relation to commodity cost fluctuations. The 2023 filing noted that food safety issues, along with other macroeconomic and regulatory factors, could exacerbate volatility in the prices of key ingredients like beef, chicken, and pork, thereby affecting profitability. This indicates a shift in emphasis from reputational impact to financial exposure through supply chain disruption and cost pressures.",
      "llm_answer": "In the 2022 10‑K, McDonald’s warned that food‑safety events could damage its brand and earnings and specifically listed “food safety concerns” as one of the factors that make the commodity markets for key ingredients (beef, chicken, pork) volatile and that could trigger supply‑chain interruptions and higher costs (2022 p.31; p.30‑31; p.33). The 2023 filing repeats the same food‑safety risk language but now embeds it more explicitly within a broader supply‑chain and cost‑volatility narrative, adding other external drivers (e.g., geopolitical events) and stressing that the company continues to devote substantial resources to managing food‑safety across the supply chain, restaurants and delivery (2023 p.31; p.33).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in McDonald's disclosure between 2022 and 2023: in 2022, food safety was framed as a reputational and financial risk, and by 2023, it was more explicitly tied to supply chain volatility and cost pressures. The mention of beef, chicken, and pork as key commodities affected is consistent with the original answer. (2) There are no numerical values (e.g., dollar amounts, percentages) in either the question or the ground truth, so quantitative accuracy is not applicable—no errors here. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years of 10-K filings, correctly noting that while the core risk language was repeated, its contextual framing evolved to emphasize supply chain and cost volatility in 2023. It also appropriately adds context about geopolitical events and resource allocation to food safety management, which enriches the answer without contradicting the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly highlight the *shift in emphasis* from reputational impact (2022) to financial exposure via supply chain (2023) as clearly as the original answer does, which slightly weakens the qualitative precision. However, this shift is implied through the description of embedding the risk 'more explicitly within a broader supply-chain and cost-volatility narrative.' Overall, the answer is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 423,
        "total_tokens": 1808
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How has the carrying value and interest rate of TMO's 1.750% 7-Year Senior Notes evolved between 2023 and 2024?",
      "original_answer": "In 2023, TMO's 1.750% 7-Year Senior Notes, due on October 15, 2028, had a carrying value of $700 million and an effective interest rate of 1.89%. In 2024, both the carrying value and effective interest rate remained unchanged at $700 million and 1.89% respectively. This indicates that there was no change in the financial structure or valuation of this particular debt instrument over the period.",
      "llm_answer": "In 2023 the euro‑denominated 1.750 % 7‑Year Senior Notes (due 4/15/2027) were carried at **$662 million** and had an **effective interest rate of 1.97 %**【page_61】. By December 31 2024 the same notes were carried at **$621 million** and the effective rate had slipped to **about 1.96 %**【page_47】—a $41 million reduction in carrying value and a 0.01‑percentage‑point decline in the rate.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect on nearly all key points. The original answer states the notes are due October 15, 2028, but the LLM claims they are due April 15, 2027—wrong maturity date. The LLM incorrectly identifies the notes as euro-denominated, which is not mentioned in the ground truth. The carrying value in 2023 is stated as $662 million in the LLM answer vs. $700 million in the original; in 2024, $621 million vs. $700 million—both significantly off. The effective interest rates are also wrong: 1.97% and 1.96% in the LLM answer vs. 1.89% in both years in the original. (2) All numeric values—dollar amounts, percentages, dates—are incorrect. The claimed $41 million reduction in carrying value and 0.01 percentage point decline are based on false data and do not reflect reality. (3) The multi-hop reasoning is flawed: the LLM appears to have extracted data for a different debt instrument (possibly another tranche or currency) and misattributed it to the 1.750% 7-Year Senior Notes. It failed to correctly identify and track the same financial instrument across years. (4) The contextual relevance is low because the answer discusses a different note (different maturity, currency, values), though it addresses the general topic of carrying value and interest rate evolution. The qualitative reasoning is poor due to incorrect entity matching and lack of synthesis with the correct instrument. The conclusion about a decline is unsupported by ground truth, which states no change occurred.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1187,
        "completion_tokens": 420,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did RTX's exposure to its 7.000% notes due 2038 change between 2022 and 2023, and what does this suggest about its approach to managing long-term debt maturities?",
      "original_answer": "In 2022, RTX disclosed an aggregate principal balance of $11 million for its 7.000% notes due 2038. By 2023, this amount had increased significantly to $148 million. This suggests that RTX either issued additional tranches of this note or restructured its debt to extend maturities, indicating a strategic shift toward increasing exposure to this particular long-term debt instrument.",
      "llm_answer": "RTX reported $148 million of 7.000% notes due 2038 in 2022 and the same $148 million in 2023 (2023 10‑K shows $148 m for both 2023 and 2022; 2022 10‑K shows $148 m for 2022)【page_85】【page_94】. The unchanged amount indicates RTX is maintaining that tranche rather than paying it down, suggesting a deliberate strategy of preserving a stable long‑term debt profile and managing maturities through refinancing and a balanced issuance schedule.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. According to the ground truth, RTX's exposure to the 7.000% notes due 2038 was $11 million in 2022 and increased to $148 million in 2023. However, the LLM states that the amount was $148 million in both 2022 and 2023, which directly contradicts the ground truth. This error fundamentally undermines the answer's validity. (2) The quantitative accuracy is severely compromised: the 2022 figure is off by over 1300% ($11M vs $148M reported), and the change over time (a significant increase) is completely missed. The LLM incorrectly asserts no change, which invalidates any conclusion about debt strategy based on stability. (3) The reasoning is flawed because it fails to recognize the multi-hop nature of the question—comparing two different years' disclosures to assess a trend in debt management. Instead, it assumes consistency across filings without detecting the actual increase. The conclusion about 'maintaining' or 'preserving' the tranche is unsupported given the actual issuance activity implied by the large increase. (4) Contextual relevance is moderate because the answer addresses the right topic (RTX's long-term debt strategy) and references the correct note (7.000% due 2038), but the incorrect data leads to an invalid inference. The citations to page_85 and page_94 may reflect real document locations, but they do not excuse the factual inaccuracy. Overall, the answer fails on correctness due to critical numerical errors and resulting faulty logic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 427,
        "total_tokens": 1638
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did McDonald's financial relationship with its franchisees evolve between 2022 and 2023, particularly regarding the collection of rent and royalties?",
      "original_answer": "In 2022, McDonald's disclosed that it had deferred approximately $1 billion in rent and royalties from franchisees, primarily during the first half of 2020, due to the impact of government restrictions related to COVID-19. By the end of 2021, the company had collected substantially all of these deferred amounts. In contrast, the 2023 filing reflects a return to standard operations, with no mention of ongoing deferrals or pandemic-related financial accommodations. Instead, the 2023 report outlines the normalization of franchise operations, including a detailed breakdown of restaurant ownership types, which indicates that franchisees were operating under regular financial obligations without pandemic-era relief measures.",
      "llm_answer": "McDonald’s franchise‑revenue model stayed the same – rent is comprised of a fixed minimum (recognized straight‑line) plus a variable percent‑of‑sales component, and royalties are also a percent of sales and are recorded when the underlying sales occur【page_44】.  However, the amount of minimum rent the company expects to receive from its franchisees slipped from about $3.06 billion in 2022 to roughly $2.95 billion in 2023, indicating a modest decline in rent receipts while the royalty‑collection structure remained unchanged【page_51】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect and fails to address the core of the question regarding the evolution of McDonald's financial relationship with franchisees between 2022 and 2023, particularly in the context of pandemic-related deferrals and their resolution. (1) The original answer states that the $1 billion deferral occurred primarily in 2020, with substantially all collected by end of 2021, and that 2022–2023 reflect normalized operations with no ongoing deferrals. The LLM instead introduces a narrative about a decline in minimum rent from $3.06B to $2.95B between 2022 and 2023, which is not mentioned or supported in the ground truth. These specific dollar figures and the claim of a 'slip' in rent receipts are factually unsupported and distract from the actual evolution—normalization post-deferral. (2) Quantitatively, the $3.06B and $2.95B figures are not present in the ground truth and appear to be fabricated or misattributed, resulting in severe quantitative inaccuracy. There is no mention of such a decline in the original answer, nor is it relevant to the question about deferrals and their collection. (3) Qualitatively, the reasoning is flawed: the LLM focuses on structural aspects of rent and royalty models (which are stable) but misses the multi-hop synthesis required—tracking the resolution of deferred amounts from 2020 through 2021 and confirming normal operations in 2022–2023. It fails to mention the collection of the $1B deferral by end-2021, which is central to understanding the 2022–2023 context. (4) Contextual relevance is moderate because the answer discusses franchise revenue mechanisms, which are related, but it does not address the actual evolution in the financial relationship—i.e., the end of pandemic accommodations. The answer is technically detailed but factually misaligned with the ground truth, leading to a low correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1318,
        "completion_tokens": 508,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has The Coca-Cola Company's financial stake in Embotelladora Andina S.A. evolved from 2022 to 2024, and what does this indicate about the company's strategic positioning with respect to this equity investment?",
      "original_answer": "In 2022, Coca-Cola recognized a gain of $39 million from the partial sale of its ownership interest in Embotelladora Andina S.A., indicating a strategic refranchising or divestiture move while retaining an equity stake. By 2024, Coca-Cola still held a financial stake in Andina, with a carrying value of $90 million and a fair value of $168 million, showing that the company maintained its involvement but with a relatively modest valuation compared to other equity investments. This indicates a partial exit strategy rather than a complete divestiture, with ongoing but reduced exposure.",
      "llm_answer": "In the 2022 filing the Company noted that, after selling a portion of its holding in 2019, it still “continues to account for our remaining ownership interest in Andina as an equity‑method investment” (KO_10k_2022 p. 76). By the 2024 filing that same investment was recorded at a carrying amount of **$90 million** with a **fair‑value of $168 million** (KO_10k_2024 p. 87), showing that Coca‑Cola has retained the stake and that its value has risen sharply. This appreciation, together with the continued equity‑method accounting, signals that Coca‑Cola views its holding in Embotelladora Andina S.A. as a strategic, long‑term partnership that it expects to benefit from as the bottler grows.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $90 million carrying value and $168 million fair value in 2024, matching the ground truth. It also accurately notes that Coca-Cola retained an equity stake and continues to use equity-method accounting, which is consistent with the original answer. However, it omits the key 2022 gain of $39 million from the partial sale of the stake, which is a critical part of the financial evolution and strategic context. This omission significantly weakens the completeness of the response. (2) All numeric values mentioned—$90 million and $168 million—are accurate and correctly attributed to the 2024 filing. No calculation errors are present. The reference to the 2019 partial sale is factually correct but not directly responsive to the 2022–2024 scope of the question. (3) The multi-hop reasoning is partially sound: the model correctly synthesizes data from the 2022 and 2024 filings to show continued ownership and valuation changes. However, it fails to connect the 2022 financial gain from the partial sale (a key event in the stake’s evolution) to the strategic narrative, instead focusing only on the 2024 valuation and accounting treatment. This leads to an incomplete strategic interpretation. (4) The qualitative accuracy is reduced due to the missing $39 million gain, which shifts the strategic implication from a 'partial exit' (ground truth) to a 'long-term partnership' (LLM interpretation). While the continued equity-method accounting supports ongoing involvement, the omission of the divestiture gain leads to a less accurate strategic conclusion. Contextual relevance is high as the answer addresses the stake’s evolution and strategic meaning, albeit incompletely.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 472,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How has Oracle's strategic investment in cloud infrastructure evolved from 2022 to 2024, particularly regarding internal development efforts and the positioning of Oracle Cloud Infrastructure in its product portfolio?",
      "original_answer": "In 2022, Oracle emphasized internal development as a core strategy, dedicating significant resources to research and development to maintain and improve its existing product suite, including cloud technologies. The company highlighted its global R&D workforce and the importance of innovation in response to evolving market demands. By 2024, this focus had evolved into a more product-specific strategy with the explicit introduction of Oracle Cloud Infrastructure (OCI) as a central offering within Oracle Cloud Services. OCI was positioned as a comprehensive and integrated infrastructure solution, indicating a shift from general cloud development to a structured, customer-facing product portfolio. This evolution demonstrates a strategic deepening of Oracle's cloud infrastructure commitment, aligning internal R&D with the delivery of a defined, market-ready suite of cloud services.",
      "llm_answer": "In 2022 Oracle stressed that it builds most of its cloud and infrastructure offerings internally and was actively expanding the Oracle Cloud data‑center footprint to meet growing demand 【page_16】 【page_15】. By 2024 the firm has positioned Oracle Cloud Infrastructure (OCI) as a core pillar of its Oracle Cloud Services suite—paired with SaaS—and continues to develop the functionality for OCI in‑house, presenting it as an integrated, strategic component of its product portfolio 【page_72】 【page_73】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. (1) It correctly identifies Oracle's internal development focus in 2022 and the strategic positioning of Oracle Cloud Infrastructure (OCI) as a core offering by 2024. The use of citations (e.g., page references) supports the claims and matches the knowledge graph sourcing. (2) There are no numeric values (e.g., dollar amounts, percentages, headcounts) in either the original or LLM answer, so quantitative accuracy is not compromised—scored 10 by default. (3) The multi-hop reasoning is sound: the model synthesizes Oracle’s evolution from general internal R&D emphasis in 2022 to a more structured, product-centric strategy with OCI as a central pillar by 2024. The LLM captures the strategic shift accurately, though it omits minor contextual details such as the mention of the global R&D workforce or 'comprehensive and integrated infrastructure solution' phrasing, which slightly reduces qualitative completeness but does not affect factual correctness. (4) The answer is highly contextually relevant, directly addressing both internal development efforts and OCI’s positioning in the product portfolio across the specified time frame. Minor wording differences do not detract from semantic equivalence. Overall, this is a strong, accurate response with only slight room for enhanced detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 379,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How did TMO's involvement with The Binding Site Group evolve between 2023 and 2024, and what does this indicate about the company's integration and strategic focus post-acquisition?",
      "original_answer": "In 2023, TMO acquired The Binding Site Group for $2.70 billion as part of its Specialty Diagnostics segment, expanding its portfolio in diagnostics for blood cancers and immune disorders. By 2024, the company had integrated the acquisition into its asset base, with The Binding Site Group contributing to the 19-year weighted-average amortization period for customer relationships among definite-lived intangible assets. This evolution indicates a strategic focus on long-term value creation through integration of acquired innovation into its core diagnostics offerings.",
      "llm_answer": "In 2023 Thermo Fisher announced and completed the acquisition of The Binding Site Group, assigning it to the Specialty Diagnostics segment to broaden its assay and instrument portfolio (see the 2023 acquisition note). By the 2024 filing the deal is fully reflected in the financial statements – cash paid, debt settled, goodwill and intangible assets are disclosed – indicating the business has been integrated and that Thermo Fisher is now emphasizing the expansion of its specialty‑diagnostics capabilities as a core post‑acquisition strategic focus.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 2023 acquisition of The Binding Site Group by Thermo Fisher (TMO) and its assignment to the Specialty Diagnostics segment, which aligns with the ground truth. It accurately notes the integration into financial statements by 2024, including cash paid, debt settled, and recognition of goodwill and intangible assets. However, the $2.70 billion purchase price — a key quantitative detail in the original answer — is omitted, which is a notable but not critical gap. (2) Quantitatively, all mentioned figures (though not explicitly stated in the LLM answer) are consistent with proper reporting; the absence of the $2.70 billion amount prevents a perfect score, but no incorrect numbers are presented. Dates (2023 acquisition, 2024 integration) are correct. (3) The reasoning is sound: the model correctly infers from the presence of acquisition-related line items in the 2024 financials that integration is complete and links this to a strategic focus on specialty diagnostics. It synthesizes information across time (2023 event → 2024 outcome) and connects financial reporting changes to strategic intent, satisfying the multi-hop requirement. (4) While the LLM captures the core evolution and strategic implication, it misses the specific detail about the 19-year weighted-average amortization period for customer relationships, which provides concrete evidence of long-term integration planning. This omission reduces completeness and qualitative accuracy slightly. Despite this, the answer remains contextually highly relevant, directly addressing both the evolution and strategic implications of the acquisition.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1289,
        "completion_tokens": 454,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has the disclosure and accessibility of the Directors' Code of Conduct evolved between 2022 and 2024, particularly in terms of website links and scope of application?",
      "original_answer": "In 2022, the Directors' Code of Conduct was posted on BNY Mellon's website at a specific URL: https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-of-conduct.pdf, and it applied to all directors. By 2024, while the scope of application remained the same—applying to all directors—the URL for the Directors' Code of Conduct had changed to https://www.bny.com/content/dam/bnymellon/documents/pdf/investor-relations/directors-code-ofconduct.pdf. This indicates a change in the website structure or domain branding, likely reflecting a broader rebranding from 'BNY Mellon' to 'BNY', while maintaining the same governance policy content and disclosure intent.",
      "llm_answer": "In the 2022 Form 10‑K the company noted that its Directors’ Code of Conduct “applies to all directors of BNY Mellon” and provided a link on the BNY Mellon site – https://www.bnymellon.com/content/dam/bnymellon/documents/pdf/in relations/directors‑code‑of‑conduct.pdf – which contained a space and a less‑direct “in relations” path. By the 2024 filing the scope remained unchanged (“applies to all directors of BNY”), but the document was moved to a cleaner URL on the updated domain (e.g., https://www.bny.com/content/dam/bnymellon/documents/pdf/investor‑relations/directors‑code‑of‑conduct.pdf), eliminating the spacing issue and using a clearer “investor‑relations” folder, thereby improving accessibility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: in 2022, the Directors' Code of Conduct applied to all directors and was hosted at a BNY Mellon URL; by 2024, the scope remained unchanged but the URL shifted to a rebranded 'bny.com' domain with improved structure. The specific URLs are accurately reflected in substance, though the LLM introduces a minor formatting error (e.g., 'in relations' with a space and hyphenation issues like 'in relations' likely due to text encoding), but the intended URL path is clear and semantically correct. (2) Quantitative accuracy is perfect: years (2022, 2024), scope ('applies to all directors'), and URL changes are correctly reported. The domain change from 'bnymellon.com' to 'bny.com' is correctly interpreted as part of a rebranding. (3) Reasoning is sound: the LLM correctly synthesizes information across two time points, identifies consistent policy scope, and infers improved accessibility due to cleaner URL structure—this aligns with the ground truth's interpretation of rebranding and structural updates. (4) The only minor issue is a slight inaccuracy in reproducing the exact 2022 URL path (e.g., 'in relations' vs. 'investor-relations'), but the rest of the path and domain are correct, and the overall message about improved accessibility and rebranding is valid. Thus, the answer earns a 9 for correctness and qualitative accuracy due to this small URL path discrepancy, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 428,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has McDonald's relationship with franchisees evolved in terms of financial reporting and strategic emphasis between 2022 and 2023?",
      "original_answer": "In 2022, McDonald's noted that the results of operations from restaurant businesses purchased and sold in transactions with franchisees were not material to the consolidated financial statements, indicating a limited financial impact from such transactions. By 2023, the company explicitly included franchisees and licensees as key stakeholders in its business model, emphasizing their role alongside company-operated restaurants in a detailed breakdown of restaurant ownership types. This shift reflects a more strategic and transparent focus on franchisees as integral to McDonald's global business structure.",
      "llm_answer": "By 2023 McDonald’s had changed the way it reports franchise‑related revenue and signaled a broader strategic focus on technology‑enabled partnership with its franchisees. In the 2022 filing the company still recorded Dynamic Yield SaaS subscription revenue as a subscription‑based service, whereas the 2023 filing notes that the Dynamic Yield business was sold (‑ “for periods prior to April 1 2022…” ) and now presents technology‑platform services it provides directly to franchisees on a gross‑basis (Revenue Recognition, p. 44). The 2023 filing also adds more detail on cost‑sharing for restaurant improvements and continues to stress franchisee‑paid rent, royalties, advertising‑co‑operative contributions and goodwill arising from purchases of franchisee restaurants, reflecting a strategic shift toward deeper, technology‑driven collaboration while the franchised network grew (Restaurant counts, p. 43; Goodwill, p. 45).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains some accurate details and correctly identifies a shift in reporting between 2022 and 2023, but diverges significantly from the ground truth in focus and factual synthesis. (1) Correct elements: The mention of changes in revenue recognition (e.g., Dynamic Yield sale prior to April 1, 2022) aligns with plausible 10-K disclosures, and the emphasis on technology-enabled services and cost-sharing in 2023 reflects a reasonable interpretation of evolving franchisee relationships. The references to franchisee-paid rent, royalties, advertising contributions, and goodwill are consistent with McDonald's financial structure. (2) Quantitative accuracy: No explicit numerical errors (e.g., dates like April 1, 2022, are plausible), though the ground truth does not mention Dynamic Yield or SaaS revenue, making this detail potentially extraneous or misaligned. The LLM introduces specific document page numbers (e.g., p. 44, p. 45), which are not verifiable from the ground truth and may be hallucinated. (3) Multi-hop reasoning: The LLM attempts synthesis across years and reporting changes but focuses on technology revenue recognition rather than the ground truth’s emphasis on franchisee transactions being immaterial in 2022 and franchisees being elevated as strategic stakeholders in 2023. This misaligns the core narrative. The ground truth highlights transparency in ownership structure and stakeholder inclusion, while the LLM emphasizes technology platforms and cost-sharing—related but not equivalent. (4) The answer is contextually relevant and detailed, but misses the central evolution described in the original: from immaterial transaction impact to strategic stakeholder integration. Thus, while qualitatively plausible and partially accurate, it fails to capture the key multi-hop insight, warranting a moderate correctness score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 502,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How did the accounting treatment or status of the contingent consideration liabilities related to the Clif Bar acquisition evolve between 2023 and 2024, particularly in terms of fair value measurement and purchase price allocation adjustments?",
      "original_answer": "In 2023, the contingent consideration liabilities related to the Clif Bar acquisition were actively measured at fair value using a Monte Carlo simulation, with $548 million classified as long-term liabilities at December 31, 2023. These liabilities were tied to performance targets in 2025 and 2026 and were subject to fair value adjustments recorded in selling, general, and administrative expenses. By 2024, there is no direct mention of the contingent consideration liabilities; instead, the 2024 filing references purchase price allocation adjustments for Clif Bar during 2023. This indicates that the contingent consideration may have been finalized or reclassified as part of the purchase price allocation process, though the 2024 disclosure does not provide updated figures or valuation methods for these liabilities.",
      "llm_answer": "In the 2023 Form 10‑K the Clif Bar contingent‑consideration was recorded as a $548 million long‑term liability measured at fair value using Level‑3 (Monte‑Carlo) inputs, up from $452 million a year earlier, with the change in fair value ($128 million) reflected in earnings (see page 99). By the 2024 filing the company notes that the purchase‑price‑allocation adjustments for the Clif Bar acquisition were completed in 2023 and are now reflected in the intangible‑asset balances (see page 87), while the contingent‑consideration continues to be accounted for at fair value under the same Level‑3 methodology, with no new re‑measurement disclosed.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partially correct information but introduces significant inaccuracies. The $548 million long-term liability for Clif Bar's contingent consideration in 2023 is correct and matches the ground truth. However, the LLM claims the amount was 'up from $452 million a year earlier' and cites a $128 million change in fair value — this is not supported by the original answer, which does not mention the prior year's value or any specific change amount. This introduces a fabricated calculation. Additionally, the LLM states that in 2024, 'contingent-consideration continues to be accounted for at fair value under the same Level-3 methodology,' which directly contradicts the ground truth stating there is 'no direct mention' of contingent consideration in 2024 and suggesting it may have been finalized or reclassified. Instead, the LLM asserts that the purchase price allocation adjustments were 'completed in 2023 and reflected in intangible-asset balances,' which aligns with the ground truth’s mention of 2023 adjustments but overstates finality and misrepresents the absence of 2024 disclosures on contingent consideration. (2) Quantitative accuracy is partially correct: $548 million is accurate, but $452 million and $128 million are unsupported and likely incorrect. No source in the ground truth provides these numbers. (3) Multi-hop reasoning is flawed: the model incorrectly infers continuity in fair value measurement into 2024 when the ground truth implies a lack of disclosure suggests a possible reclassification or finalization. It fails to recognize the absence of 2024 data as a signal of change. (4) Contextual relevance is high — the answer addresses fair value measurement, purchase price allocation, and time evolution — but factual errors reduce correctness. The qualitative accuracy is moderate due to correct terminology (Level-3, Monte Carlo) but incorrect synthesis of 2024 status.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 523,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How has AMD's strategic emphasis on Vulkan API support evolved between 2022 and 2024, and what does this reveal about its approach to maintaining competitiveness in the discrete GPU market?",
      "original_answer": "In 2022, AMD highlighted its support for Vulkan as part of its Radeon™ series discrete GPUs, which were built on the RDNA 2 architecture and aimed at delivering high-performance gaming and creation workloads. By 2024, AMD continued to support Vulkan but shifted its focus toward the newer RDNA 3 architecture, which underpins the Radeon RX 7000 Series GPUs. This evolution suggests AMD is maintaining its commitment to Vulkan while advancing its GPU capabilities to meet the growing demands of immersive gaming and AI/ML computing. This strategic continuity in API support combined with architectural innovation indicates AMD’s effort to stay competitive by offering both backward compatibility and cutting-edge performance enhancements.",
      "llm_answer": "- **2022 filing:** AMD’s 2022 10‑K notes that its Radeon discrete GPUs “support current‑generation application program interfaces (APIs) like DirectX 12 Ultimate **and Vulkan®**, … and are designed to support virtual‑reality (VR) in PC platforms.” (AMD 2022 10‑K p. 8)\n\n- **2024 filing:** The 2024 10‑K still emphasizes Vulkan support, but now ties it to the newer Radeon RX 7000 series (RDNA 3) and says the GPUs “support current‑generation APIs like DirectX 12 Ultimate **and Vulkan**, support high‑refresh‑rate displays and include the latest technologies for immersive gaming experiences and high‑performance AI/ML computing.” (AMD 2024 10‑K p. 8)\n\n**Interpretation:** AMD’s emphasis on Vulkan has shifted from simply ensuring baseline API compatibility (2022) to positioning Vulkan as a core enabler for high‑refresh‑rate, AI‑accelerated and next‑gen graphics on its latest RDNA 3 GPUs (2024). This evolution shows AMD is using Vulkan support to showcase advanced performance and feature integration, reinforcing its strategy to stay competitive in the discrete GPU market by aligning API readiness with cutting‑edge hardware capabilities and emerging workloads.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: AMD supported Vulkan in both 2022 and 2024, with the 2022 focus on RDNA 2-based Radeon GPUs and 2024 on RDNA 3-based Radeon RX 7000 series. The cited 10-K page references (p. 8) and quoted text are consistent with the source data. (2) There are no numeric values requiring calculation, but dates (2022, 2024), product names (Radeon RX 7000), and architectures (RDNA 2, RDNA 3) are correctly identified—quantitative accuracy is perfect. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings to show an evolution in emphasis—from baseline Vulkan support in 2022 to positioning it as an enabler for advanced features (AI/ML, high-refresh gaming) in 2024. The interpretation that this reflects a strategy of aligning API support with cutting-edge hardware matches the ground truth’s conclusion about architectural innovation and competitiveness. (4) The only reason for not scoring a 10 is a slight difference in emphasis: the original answer explicitly mentions 'backward compatibility,' which the LLM answer implies but does not state. However, the core reasoning and factual synthesis are equivalent. Wording differs but semantic meaning is preserved. Contextual relevance is excellent—directly addresses both parts of the question: evolution over time and strategic implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 399,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How did RTX's integration-related charges impact its operating profit trends between 2022 and 2023, particularly with the introduction of the Powder Metal Matter charge in 2023?",
      "original_answer": "In 2022, RTX reported a decrease in Acquisition Accounting Adjustments, which contributed positively to its operating profit. However, in 2023, there was a significant $2.9 billion charge associated with the Powder Metal Matter, which became a major driver of the $1.9 billion decrease in Operating Profit compared to 2022. This reflects a notable shift from a declining trend in integration-related charges in 2022 to a significant new expense in 2023 that directly impacted profitability.",
      "llm_answer": "RTX’s operating profit rose modestly in 2022 – up $0.4 bn versus 2021 – because integration‑related costs fell, most notably a decrease in acquisition‑accounting adjustments (which swung from a $348 m negative impact in 2022 to a $107 m positive impact in 2023) and lower corporate/other charges【page_39】. In 2023, operating profit fell sharply by $1.9 bn versus 2022, driven almost entirely by a $2.9 bn Powder Metal Matter charge (net of tax and partner share) recorded under “Other” that outweighed the modest improvement in acquisition‑accounting and FAS/CAS adjustments【page_41】【page_39】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the key trend: integration-related charges decreased in 2022 (notably acquisition accounting adjustments), contributing positively to operating profit, while in 2023, a $2.9 billion Powder Metal Matter charge caused a $1.9 billion decline in operating profit. (2) Quantitatively, the $1.9 billion decrease in operating profit and the $2.9 billion Powder Metal Matter charge are correctly stated. The mention of acquisition accounting adjustments swinging from a $348M negative impact in 2022 to a $107M positive in 2023 adds detail not in the original answer but does not contradict it—this level of granularity is acceptable and likely from the cited pages. However, the original answer does not specify the 2021-to-2022 operating profit increase of $0.4B, nor does it mention FAS/CAS adjustments; these are plausible additions from the source document but slightly extend beyond the ground truth. (3) The multi-hop reasoning is sound: the model connects reduced integration costs in 2022 to profit stability and contrasts it with the 2023 charge’s negative impact, correctly attributing the year-over-year decline. (4) The answer is contextually excellent, directly addressing the impact of integration-related charges across both years and highlighting the Powder Metal Matter as a key driver. The only minor deviation is the inclusion of extra details (e.g., $348M, $107M) not in the original answer, but they do not introduce errors. Overall, the core facts, numbers, and synthesis are correct—justifying a 9 rather than 10 due to slight over-elaboration with unsolicited specifics that, while likely accurate, are not confirmed by the ground truth.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 475,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How has MDLZ's relationship with Clif Bar evolved between 2023 and 2024, particularly in terms of acquisition-related financial activities?",
      "original_answer": "In 2023, MDLZ acquired Clif Bar, as noted in the 2023 10-K filing, with specific reference to the August 1, 2022 acquisition and related financial impacts such as integration costs and contingent consideration adjustments. By 2024, the relationship had evolved to include purchase price allocation adjustments for Clif Bar during the prior year, as detailed in the 2024 10-K filing. This indicates that the company had moved beyond the initial acquisition phase into a period of financial recalibration and consolidation of the Clif Bar acquisition.",
      "llm_answer": "In the 2023 filing Mondelēz noted that its August 1 2022 purchase of Clif Bar was still a fresh acquisition, generating $529 million of incremental net revenue in its first year and incurring acquisition‑related integration and contingent‑consideration costs (e.g., $0.19 million of acquisition‑related costs and purchase‑price‑allocation adjustments for Clif Bar in 2023)【page_39】,【page_42】,【page_87】. By the 2024 filing the brand was treated as a fully integrated, indefinite‑life intangible asset (part of the brand portfolio) with no new acquisition‑related expenses recorded, showing the relationship had moved from a recent acquisition to an ongoing, integrated asset【page_87】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that MDLZ acquired Clif Bar on August 1, 2022, and discusses the financial impacts in the 2023 and 2024 10-K filings. The $529 million incremental net revenue and $0.19 million acquisition-related costs in 2023 are factually consistent with typical disclosures (though exact figures would need verification against the cited pages). The mention of purchase price allocation adjustments in 2023 and the transition to a fully integrated asset by 2024 matches the evolution described in the original answer. (2) Quantitatively, the dates (August 1, 2022 acquisition) and financial figures ($529M revenue, $0.19M costs) are plausible and contextually accurate; minor rounding or formatting differences (e.g., $0.19 million vs $190,000) are acceptable. No calculation errors are present. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, correctly inferring that the cessation of acquisition-related expenses in 2024 indicates full integration, which reflects a logical progression from acquisition to consolidation. (4) The answer is semantically equivalent to the ground truth, capturing both the financial activities and the evolving relationship. The only minor limitation is the lack of explicit mention of 'contingent consideration adjustments' in the 2024 context, but they are referenced for 2023. Overall, the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 419,
        "total_tokens": 1725
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has Gulfstream's approach to energy efficient engines evolved from 2023 to 2024, and what specific aircraft developments reflect this shift?",
      "original_answer": "In 2023, Gulfstream emphasized its leadership in the use of sustainable aviation fuel (SAF) and energy efficient engines, focusing on continuous R&D investment to develop technologically advanced business jets. However, no new aircraft model powered by energy efficient engines was introduced that year. By 2024, Gulfstream had transitioned from announcement and development phases to actual production of energy efficient engines, as evidenced by the introduction of the G700, which features 'all-new engines' designed for high-speed performance and efficiency. This marks a tangible evolution from strategic positioning in 2023 to operational realization in 2024.",
      "llm_answer": "In 2023 Gulfstream’s energy‑efficiency strategy was built around expanding the use of sustainable aviation fuel (SAF) and extracting more fuel‑burn savings from its existing models – the G500 and G600 were marketed as “faster, more fuel‑efficient…with reduced emissions” and the company celebrated the world’s first 100 %‑SAF trans‑Atlantic flight in November 2023 (see page 6). By 2024 the focus had shifted to embedding next‑generation, high‑efficiency engines into brand‑new aircraft – the ultra‑long‑range G700 entered service in March 2024 and the newly announced G800 and clean‑sheet G400 were highlighted as platforms that combine “high‑speed range and efficiency” with all‑new engines, signalling a move from incremental fuel‑saving measures to platform‑wide, energy‑efficient engine designs (see pages 4‑5).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Gulfstream's 2023 focus on sustainable aviation fuel (SAF) and efficiency improvements in existing models (G500/G600), including the key milestone of the first 100% SAF trans-Atlantic flight in November 2023—this detail is not in the original answer but is factually correct and adds valuable context. (2) For 2024, it accurately notes the G700 entering service in March 2024 (specific date not in ground truth but consistent with public data), and correctly identifies the G700, G800, and G400 as new aircraft featuring all-new, high-efficiency engines. The original answer only mentions the G700, so the inclusion of G800 and G400 is an enhancement supported by Gulfstream’s 2024 announcements and does not contradict the ground truth. (3) The reasoning correctly captures the evolution from R&D and SAF focus in 2023 to operational deployment of new engine designs in 2024, reflecting sound multi-hop synthesis across time and product lines. (4) All dates, percentages (100% SAF), and model names are accurate. The only minor deviation is that the original answer emphasizes the shift from 'announcement/development' to 'production', while the LLM frames it as a shift from 'incremental' to 'platform-wide' design—semantically similar but slightly different emphasis. This does not affect factual correctness. Overall, the LLM provides a richer, fully accurate, and contextually appropriate response.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 412,
        "total_tokens": 1782
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has AMD's relationship with semi-custom SoC products evolved from 2022 to 2024, particularly in terms of revenue structure and strategic positioning?",
      "original_answer": "In 2022, AMD's relationship with semi-custom SoC products was characterized by dependency, with revenue derived from both non-recurring engineering fees and sales of the products themselves, and success was directly tied to third-party product performance. By 2024, AMD's relationship evolved to one of active production and broader strategic integration, as semi-custom SoC products became part of a more diversified product portfolio that includes AI accelerators, GPUs, APUs, and DPUs. This shift indicates a more central and controlled role for AMD in the development and commercialization of these products, aligning them more closely with long-term industry trends and internal innovation strategies.",
      "llm_answer": "In the 2022 filing AMD described its semi‑custom SoC business as a source of **non‑recurring engineering fees and product‑sale revenue that is tied directly to a third‑party’s product success**, making the income highly project‑based and contingent on those customers’ market performance (see 2022 p. 25). By the 2024 filing the same offerings are framed as **“custom products” sold under firm, non‑cancellable purchase orders, with revenue recognized over the production period using a cost‑plus‑margin method and positioned as a core part of the Gaming segment and the broader AMD portfolio** (see 2024 p. 63 and product list on 2024 p. 62). This reflects a shift from a largely fee‑driven, opportunistic model to a more structured, integrated strategic line with predictable revenue recognition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution in AMD's semi-custom SoC business from 2022 to 2024, capturing the shift from a third-party-dependent, fee-driven model to a more integrated and strategically positioned product line. The key elements—non-recurring engineering fees, dependency on third-party success in 2022, and the transition to firm purchase orders with cost-plus-margin revenue recognition in 2024—are all factually correct and well-supported by the cited filing pages. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the original or LLM answer, so quantitative accuracy is not compromised; dates (2022 and 2024) are correct. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, compares framing and revenue recognition methods, and infers a strategic shift. The LLM adds specific detail (e.g., 'cost-plus-margin', 'Gaming segment', 'non-cancellable purchase orders') that enriches the original answer without contradicting it. (4) The only reason for not scoring a 10 in correctness and qualitative accuracy is that the LLM does not explicitly mention the broader diversification into AI accelerators, GPUs, APUs, and DPUs as part of the strategic integration, which is a minor omission in completeness. However, referencing the product list on p.62 of the 2024 filing implies this context. Overall, the answer is semantically equivalent, contextually precise, and factually robust.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 424,
        "total_tokens": 1801
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How has the company's structure of preferred share authorization evolved between fiscal years 2023 and 2024, and what does this indicate about its capital strategy?",
      "original_answer": "The company's preferred share authorization structure remained unchanged between fiscal years 2023 and 2024, with 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value authorized in both years. Additionally, no Preferred Shares or A Preferred Shares were issued or outstanding in either year. This indicates that the company has not utilized or pursued any changes in its preferred share structure as part of its capital strategy during this period.",
      "llm_answer": "The Share Capital table shows that in both FY 2023 and FY 2024 the company was authorized to issue 127.5 million Preferred Shares with a $0.20 par value and 500 thousand “A” Preferred Shares with a $1.00 par value, and no Preferred Shares were issued or outstanding in either year (see Shareholders’ Equity – page 81 of both the 2023 and 2024 10‑K). Because the authorized preferred‑share structure did not change and remains unused, Medtronic’s capital strategy is not focused on raising capital through preferred equity; instead it relies on ordinary‑share repurchases and other equity‑based compensation programs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values are correct: 127.5 million Preferred Shares at $0.20 par value and 500 thousand A Preferred Shares at $1.00 par value are accurately reported for both fiscal years 2023 and 2024. The statement that no preferred shares were issued or outstanding is also correct. (2) Quantitative accuracy is perfect—no calculation errors, and formatting variations (e.g., '500 thousand' vs '500,000') are acceptable and clear. (3) The multi-hop reasoning is sound: the model correctly synthesizes data across two fiscal years and draws a logical inference about capital strategy based on the lack of changes and usage in preferred share authorization. The conclusion that Medtronic is not focusing on preferred equity for capital raising but instead relies on share repurchases and equity compensation is a reasonable qualitative extension supported by the data. (4) The only minor gap is that the original answer explicitly mentions both 'Preferred Shares' and 'A Preferred Shares' as having zero issuance/outsanding, while the LLM answer generalizes to 'no Preferred Shares were issued', potentially omitting specificity around 'A Preferred Shares'. This does not materially mislead but slightly reduces completeness. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 382,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the framing of reputational risk related to adverse publicity evolved between 2022 and 2024 in BK's risk disclosures, particularly in terms of associated impacts or linked concerns?",
      "original_answer": "In 2022, BK identified adverse publicity as a risk that could negatively affect its business, financial condition, and results of operations, and linked it with government scrutiny and other reputational harm. By 2024, the framing of this risk remained present but was expanded to include broader reputational impacts from sustainability concerns such as climate change and diversity, in addition to being tied to new operational models like the platforms operating model transition. This indicates a broadening of the contexts in which adverse publicity could negatively impact BK's reputation and business outcomes.",
      "llm_answer": "In the 2022 Form 10‑K the risk factor states that “our businesses may be negatively affected by adverse events, publicity, government scrutiny or other reputational harm,” and it explicitly links reputational damage to broader sustainability concerns – climate change and diversity – that could also hurt client activity and invite regulatory scrutiny (2022 p. 4‑5). The 2024 filing retains the same adverse‑events/publicity language (2024 p. 4) but isolates climate‑change risk in a separate bullet (“climate change concerns could … damage our reputation”), dropping the wider sustainability/diversity framing. Thus the core description of adverse‑publicity risk is unchanged, while the associated impact narrative has shifted from a broad sustainability focus to a more specific climate‑change emphasis.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in its qualitative analysis, despite correct use of years (2022 and 2024) and proper citation of document locations (e.g., page numbers), which supports a high quantitative accuracy score. However, the core reasoning is flawed: the LLM incorrectly claims that in 2022, BK explicitly linked reputational risk to sustainability concerns like climate change and diversity — this is not supported by the ground truth, which states that such broadening occurred by 2024, not 2022. Furthermore, the LLM asserts that the 2024 filing 'drops' the diversity/sustainability framing and isolates only climate change, which contradicts the ground truth indicating an expansion *to include* broader sustainability concerns in 2024. This misrepresents the evolution of risk framing — the trend is toward broadening, not narrowing. The reasoning is therefore unsound and fails the multi-hop synthesis required to compare how the linkage of reputational risk to sustainability issues evolved over time. While the answer addresses the question’s context and structure (hence moderate contextual relevance), the reversal of the actual progression undermines the answer’s validity, warranting a low correctness and qualitative accuracy score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 356,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How did Amazon's financial investment and valuation approach toward Anthropic, PBC evolve from 2023 to 2024, particularly in terms of investment classification and the factors affecting its valuation?",
      "original_answer": "In 2023, Amazon disclosed a $1.25 billion convertible note investment in Anthropic, PBC, classified as available-for-sale and reported at fair value with unrealized gains and losses included in 'Accumulated other comprehensive income (loss).' The note was categorized as a Level 3 asset, and Amazon had an agreement to invest an additional $2.75 billion in a second convertible note by Q1 2024. By 2024, the investment was still classified as available-for-sale but was noted to be part of a broader portfolio of convertible debt investments in private companies, primarily referencing Anthropic, PBC. The 2024 filing emphasized increased complexity in valuing private company investments due to the lack of readily available market data and global economic uncertainty, indicating a shift toward acknowledging heightened valuation risk. While the classification remained consistent, the 2024 disclosure placed more emphasis on the challenges of valuation rather than the mechanics of the investment itself.",
      "llm_answer": "In the 2023 Form 10‑K Amazon reported that it had invested $1.25 billion in a convertible note from Anthropic, PBC, which was classified as an **available‑for‑sale Level 3 asset** measured at fair value, and it retained the right to invest up to an additional $2.75 billion (2023 p. 50). By the 2024 filing the Anthropic holding is presented as an **available‑for‑sale convertible‑debt investment** still measured at fair value, but Amazon notes that valuing such private‑company securities is especially difficult because of limited market data and heightened global‑economic uncertainty, making market‑sensitivity analyses impracticable (2024 p. 32).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $1.25 billion initial investment in 2023, the $2.75 billion additional commitment, the classification as available-for-sale, Level 3 asset status, fair value measurement, and inclusion in accumulated other comprehensive income (implied via classification). The 2024 update correctly notes the continued available-for-sale classification and emphasizes increased valuation challenges due to lack of market data and global economic uncertainty. (2) Quantitative accuracy is perfect: both dollar amounts ($1.25B and $2.75B) are correctly reported, and no calculations are required beyond accurate restatement. Format variations (e.g., $1.25 billion vs $1.25B) are acceptable and do not affect meaning. (3) Multi-hop reasoning is sound—information is synthesized correctly across 2023 and 2024 filings, showing evolution in disclosure emphasis from investment mechanics to valuation difficulty. The LLM correctly infers that the investment remains part of a broader portfolio of private company convertible debt, even if not explicitly named as such, by contextualizing the 2024 disclosure. (4) The only minor omission is that the original answer notes the second $2.75 billion investment was planned 'by Q1 2024,' which the LLM does not specify—this slight lack of temporal precision prevents a perfect 10 on qualitative accuracy. However, this does not materially distort the overall narrative. Semantic equivalence is maintained, and the answer is fully contextually relevant, directly addressing the evolution in classification and valuation approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 452,
        "total_tokens": 1880
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How has the nature of the risks related to the protection of MDLZ's intellectual property, including know-how, evolved between 2023 and 2024?",
      "original_answer": "In 2023, MDLZ emphasized the importance of protecting its intellectual property rights, particularly trademarks, patents, copyrights, and know-how, through a combination of legal mechanisms such as patent and trademark laws, licensing agreements, and third-party nondisclosure agreements. The company expressed concern that failure to protect these rights or any legal changes reducing intellectual property protections—especially in response to developments in artificial intelligence technologies—could significantly harm its competitiveness and financial condition. In 2024, while the company maintained its emphasis on the significance of intellectual property rights, it did not specifically mention artificial intelligence as a factor affecting protection. Instead, the 2024 disclosure focused on the broader risks of legal or regulatory non-compliance and the potential for civil or criminal penalties, reputational damage, and financial loss due to litigation or enforcement actions. This shift indicates a broadening of the risk context without the specific emphasis on AI-related threats present in 2023.",
      "llm_answer": "In the 2023 10‑K MDLZ warned that its competitiveness could be harmed if it failed to obtain or protect its patents, trademarks, trade‑secrets, know‑how and other IP – especially when faced with third‑party infringement claims, costly litigation, injunctions and any change in law (including emerging AI issues) 【page_26】 【page_27】. By the 2024 filing the company still cites those same core threats, but adds a broader focus on policing IP misuse across traditional retail **and digital environments**, relying on licensing, nondisclosure and assignment agreements, and stresses heightened exposure from AI‑driven technologies 【page_26】 【page_27】—showing a shift from a primarily reactive litigation focus to a more proactive, technology‑driven protection strategy.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies in its qualitative analysis, particularly regarding the evolution of AI-related risks between 2023 and 2024. According to the ground truth, in 2023 MDLZ specifically mentioned artificial intelligence as a potential threat to intellectual property protection, but in 2024 it no longer highlighted AI, instead broadening its risk focus to include legal and regulatory non-compliance, penalties, and reputational damage. The LLM answer incorrectly states the opposite: that AI was emphasized in 2023 and then *re-emphasized or heightened* in 2024, claiming a 'heightened exposure from AI-driven technologies' in the 2024 filing. This directly contradicts the ground truth, which states that AI was *not mentioned specifically* in 2024. Additionally, the LLM claims a strategic shift 'from reactive litigation to proactive, technology-driven protection,' which is an interpretive leap not supported by the original answer. While the core elements of IP protection (patents, trademarks, know-how, legal agreements) are correctly identified and the years (2023, 2024) are accurate, the central claim about the evolution of AI-related risks is inverted. There are no numerical values in the question or answers, so quantitative accuracy is not applicable in a meaningful way—scored as 10 by default since no numbers are misstated. Contextual relevance is moderate: the answer addresses IP protection and attempts to compare years, but misrepresents the key shift. Multi-hop reasoning fails because the synthesis between 2023 and 2024 disclosures is incorrect. The model appears to have reversed the directional change in risk emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 457,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has Goldman Sachs' treatment of Non-Employee Director Equity Award Agreements evolved between the 2023 and 2024 SEC filings, particularly in terms of referenced agreements and their timelines?",
      "original_answer": "In 2023, Goldman Sachs referenced Non-Employee Director Equity Award Agreements through Exhibit 10.17, which pointed to an amendment dated November 28, 2008. By 2024, the company continued to disclose these agreements under the same exhibit number (10.18), but the referenced source shifted to Exhibit 10.69 from the 2008 Annual Report, indicating a formalization or consolidation of prior amendments. This evolution shows a continuation of the policy with deeper historical documentation being emphasized in the later filing.",
      "llm_answer": "In the 2023 Form 10‑K Goldman Sachs disclosed a pre‑2015 Non‑Employee Director RSU award (exhibit 10.8), a current RSU award form (exhibit 10.31) and a cash‑settled version (exhibit 10.32), and it referenced “Amendments to Certain Non‑Employee Director Equity Award Agreements” (exhibit 10.17) that point to an Annual Report for the fiscal year ended Nov 28 2008. In the 2024 filing the same pre‑2015 award is listed as exhibit 10.9, the standard and cash‑settled RSU forms are renumbered to exhibits 10.32 and 10.33, and the amendment is now exhibit 10.18—still tied to the 2008 filing—while the filing adds a broader set of related award agreements but leaves the original timelines unchanged.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies in exhibit numbers and referenced agreements, which undermines quantitative and qualitative accuracy. While it correctly identifies the 2008 Annual Report (ending November 28, 2008) as the source of the amendment, it incorrectly lists the 2023 exhibit for the Non-Employee Director Equity Award Agreements as 10.17 but misrepresents other exhibits: the original answer states only Exhibit 10.17 is relevant for the agreements in 2023, whereas the LLM claims additional exhibits (10.8, 10.31, 10.32) pertain to this topic, which is not supported by the ground truth. In 2024, the LLM states the amendment moves to Exhibit 10.18 (correct), but incorrectly implies continuity with the same 2008 filing without noting the shift in reference to Exhibit 10.69 from the 2008 Annual Report—a key evolution in documentation formalization mentioned in the original answer. The LLM also introduces 'pre-2015 RSU award' and 'cash-settled version' details not present in the ground truth, adding extraneous and unverified information. While the core timeline (2008 amendment) is preserved and the renumbering of exhibits between years is plausibly framed, the answer fails to capture the specific evolution—consolidation into Exhibit 10.69—as the basis for the updated reference. The reasoning is partially sound but based on incorrect exhibit mappings, weakening multi-hop synthesis. Contextually, the response is relevant and structured well, addressing the evolution question with appropriate context, but factual precision is compromised.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 431,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How has BKNG's relationship with travel service providers evolved between 2022 and 2023 in terms of revenue recognition and contractual responsibilities?",
      "original_answer": "In 2022, BKNG described its relationship with travel service providers as one where it connects consumers to providers through its platforms, emphasizing its role as an intermediary without taking responsibility for delivering the travel services. The company highlighted that it earns revenues primarily from facilitating reservations and also mentioned the impact of cancellations during the pandemic recovery phase. By 2023, BKNG provided more detailed accounting treatment around its contracts with travel service providers, specifying that it recognizes revenue on a net basis due to its role as an agent, and further clarified its revenue recognition timing as occurring at the point when travelers begin using the arranged services. This reflects a shift from a general description of the relationship to a more structured and accounting-driven dependency on travel service providers, particularly in how it recognizes commissions and transaction revenues.",
      "llm_answer": "In 2022 Booking.com began moving a larger share of its bookings onto a **merchant‑processing model**, actually collecting travelers’ payments on behalf of travel‑service providers and recording the resulting “merchant revenues” (and the associated payment‑processing, charge‑back and fraud‑prevention costs) while the contracts still left the providers responsible for delivering the travel service【page_50】. By 2023 the filing spells out that the company continues to present revenue on a **net basis**—based on the commission or margin specified in its contracts with providers—and now explicitly recognizes revenue only after its post‑booking obligations are satisfied, classifying it as either merchant or agency revenue, but the underlying contractual arrangement (providers retain delivery responsibility) remains unchanged【page_83】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the original answer in terms of key developments between 2022 and 2023 regarding BKNG's relationship with travel service providers, particularly around revenue recognition and contractual roles. It accurately identifies that in 2022, BKNG (via Booking.com) was shifting toward a merchant-processing model, collecting payments on behalf of providers while not assuming delivery responsibility—consistent with the ground truth's emphasis on BKNG as an intermediary. The 2023 update correctly states that revenue continues to be recognized on a net basis and that revenue recognition timing is tied to satisfaction of post-booking obligations, which matches the original answer’s point about recognizing revenue when travelers begin using services. The distinction between merchant and agency revenue models in 2023 adds useful detail supported by the filing (page 83). However, the original answer emphasizes a broader evolution from a general descriptive stance in 2022 to a more structured, accounting-driven framework in 2023, particularly around contracts and revenue recognition policy. While the LLM captures the accounting treatment well, it places more emphasis on the merchant-processing model shift, which is present but not the central theme in the ground truth. This results in a slightly different framing—still factually sound but with a nuance in focus. There are no numerical inaccuracies (dates, models, and accounting terms are correct), and all entities (BKNG, travel service providers, revenue recognition) are properly identified. The reasoning is logically sound and synthesizes information across years and contractual changes. Minor deduction in qualitative accuracy due to emphasis imbalance, but overall high correctness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 486,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "What specific changes occurred in the structure of Goldman Sachs' executive life insurance policy disclosures between the 2023 and 2024 10-K filings?",
      "original_answer": "In the 2023 10-K filing, Goldman Sachs included the Goldman Sachs & Co. LLC Executive Life Insurance Policy and Certificate with Metropolitan Life Insurance Company (Exhibit 10.11) and a form of the policy with Pacific Life & Annuity Company (Exhibit 10.12). In the 2024 10-K filing, these exhibits were not only retained but renumbered to 10.12 and 10.13 respectively, indicating a reorganization of exhibit numbering. This renumbering and retention of the policies in the 2024 filing demonstrates a structural update in how the policies are presented within the filing, rather than a substantive change in the policies themselves.",
      "llm_answer": "The executive‑life‑insurance exhibit section looks the same in both years. In the 2023 Form 10‑K the two policies were listed as items 10.12 (Metropolitan Life policy + certificate) and 10.13 (Pacific Life policy form), and the 2024 Form 10‑K repeats those exact two items with the same numbering and language. No additional exhibits were added, removed or reordered – the structure of the disclosure did not change.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is factually incorrect in both exhibit numbers and the core conclusion. According to the ground truth, in the 2023 10-K, the Metropolitan Life policy was Exhibit 10.11 and the Pacific Life policy was Exhibit 10.12. In the 2024 10-K, these were renumbered to 10.12 and 10.13 respectively, indicating a structural reorganization. The LLM incorrectly states that the exhibits were numbered 10.12 and 10.13 in 2023 and remained unchanged in 2024, which contradicts the ground truth. This misrepresentation of exhibit numbers (a quantitative and entity error) leads to the wrong conclusion that 'no reordering' occurred, when in fact renumbering did occur. The model fails to identify the key structural change — the renumbering and implied reorganization — which is the central point of the question. While the answer addresses the right topic (disclosure structure of executive life insurance policies), it draws an incorrect conclusion due to faulty data, resulting in low correctness, quantitative, and qualitative accuracy. Contextual relevance is moderate because the response is on-topic and discusses the right type of disclosure, but with incorrect details.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 330,
        "total_tokens": 1592
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has the strategic importance and manufacturing approach for FBAR filters evolved between 2022 and 2024, particularly in terms of internal fabrication and competitive positioning?",
      "original_answer": "In 2022, FBAR filters were highlighted as a key product utilizing Broadcom’s proprietary processes, fabricated internally to protect IP and accelerate time to market, alongside vertical-cavity surface emitting lasers and side emitting lasers. The internal fabrication was specifically emphasized as a means to maintain competitive advantage by safeguarding innovation. By 2024, FBAR filters remained part of the internal fabrication strategy, but the context expanded to include a more comprehensive list of competitors in the semiconductor space, such as Qorvo, Qualcomm, and Skyworks, indicating a more intense competitive environment. This suggests that while the internal manufacturing strategy for FBAR filters remained consistent, the competitive pressure in wireless communications increased significantly, requiring Broadcom to reinforce its IP protections and innovation cycle.",
      "llm_answer": "In the 2022 filing Broadcom said it “uses our internal fabrication facilities for products utilizing our innovative and proprietary processes, such as our FBAR filters for wireless communications” and explicitly listed “FBAR technology” as a core competitive advantage that differentiates its high‑speed products (2022 p. 13; 2022 p. 17). By the 2024 filing the same language appears – FBAR filters are still made in‑house to protect IP and accelerate time‑to‑market – showing the company continues to treat them as strategically important, though the 2024 discussion of competition is broader and does not call out FBAR by name as a distinct advantage (2024 p. 13; 2024 p. 15).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: FBAR filters were highlighted in 2022 as a key product using proprietary processes and fabricated internally to protect IP and accelerate time to market, which matches the original answer. The 2024 update correctly notes that internal fabrication continues, though the competitive landscape is discussed more broadly without explicitly reiterating FBAR as a named advantage. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable in a traditional sense, but all dates (2022, 2024) and page references are consistent and plausible within the context. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings, identifies continuity in manufacturing strategy, and infers a shift in competitive emphasis. The only minor shortcoming is that the LLM does not explicitly name the competitors (Qorvo, Qualcomm, Skyworks) mentioned in 2024 per the ground truth, which slightly weakens the completeness of the competitive positioning analysis. (4) Despite this omission, the core message — that strategic importance and internal fabrication remain unchanged while competitive pressure has intensified — is accurately conveyed. Wording differs but semantic equivalence is preserved. Contextual relevance is perfect as it directly addresses both parts of the question: evolution of strategic importance and manufacturing approach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 424,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How has BMY's strategic positioning of Krazati evolved between 2023 and 2024, particularly in terms of clinical development focus and financial valuation?",
      "original_answer": "In 2023, Krazati was positioned as part of BMY’s oncology portfolio with specific clinical trials listed: KRYSTAL-17 for 1L NSCLC TPS<50%, KRYSTAL-10 for 2L CRC, and KRYSTAL-12* for 2L+ Mutated NSCLC. By 2024, BMY had acquired Mirati for $4.8 billion, securing full rights to Krazati, which had already received FDA and EMA approvals for second-line NSCLC and FDA approval for advanced KRAS-mutated colorectal cancer. Additionally, Krazati was now being developed in combination with a PD-1 inhibitor for first-line NSCLC, indicating a significant expansion in its clinical and commercial strategy.",
      "llm_answer": "In the 2023 filing, Krazati was presented mainly as an approved KRAS‑inhibitor for second‑line NSCLC and KRAS‑mutated colorectal cancer, with the company emphasizing pipeline work to broaden its label—most notably the KRYSTAL‑12 first‑line NSCLC combination and later‑line colorectal indications. By the 2024 filing, after the Mirati acquisition, BMS had integrated Krazati as a fully commercialized product, assigning $640 million of definite‑life intangible assets to its marketed‑product rights while still advancing the KRYSTAL‑12 first‑line NSCLC trial, showing a shift from a development‑focused asset to a higher‑valued, revenue‑generating one.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. Most critically, the $640 million definite-life intangible asset value assigned to Krazati is not present in the ground truth and appears to be fabricated or misattributed. The ground truth states BMY acquired Mirati for $4.8 billion, not that $640 million was assigned specifically to Krazati's marketed rights—this is a major quantitative error. Additionally, the LLM misrepresents the KRYSTAL-12 trial: in 2023, it was for 2L+ mutated NSCLC, not first-line, and the first-line NSCLC combination development (with PD-1 inhibitor) is a 2024 advancement, not an existing focus in 2023. The LLM incorrectly implies Krazati was already approved in 2023 for colorectal cancer, while the ground truth indicates approvals (FDA/EMA for 2L NSCLC and FDA for CRC) were realized by 2024, post-acquisition. (2) The $640 million figure is unsupported and contradicts the original answer, which only mentions the $4.8 billion acquisition cost. No other numbers (e.g., trial phases, dates) are provided in either answer, so no other numeric checks apply. (3) The reasoning partially captures the strategic shift—from development to commercialization post-acquisition—but fails to accurately represent the clinical development timeline and trial focus. It conflates 2023 and 2024 trial strategies, missing the correct multi-hop evolution: 2023 focused on specific trials (KRYSTAL-17, -10, -12), while 2024 expanded into combination therapy in first-line NSCLC. The acquisition is correctly identified as a pivotal event, but the financial valuation claim undermines credibility. (4) Despite these issues, the answer is contextually relevant and captures the high-level strategic shift. The qualitative reasoning is sound in structure but based on incorrect facts. Correctness score is reduced due to significant factual and quantitative errors, particularly the unsupported $640M valuation and misstated trial focus.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 529,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has the relationship between BKNG and travel service providers evolved between 2022 and 2023, particularly in terms of how BKNG manages financial obligations and incentives related to these providers?",
      "original_answer": "In 2022, BKNG primarily competed with travel service providers, highlighting the intense and evolving nature of the competitive landscape in the online travel market. By 2023, BKNG's relationship with travel service providers shifted to a more dependent model, as evidenced by the increase in the 'Deferred merchant bookings' liability on its balance sheet, which reflects amounts estimated to be payable to travel service providers. Additionally, BKNG introduced more incentive programs, such as referral bonuses, rebates, and loyalty points, which are recognized as a reduction of revenue, indicating a strategic shift toward enhancing partnerships and incentivizing collaboration with travel service providers rather than solely competing with them.",
      "llm_answer": "In 2022 Booking Holdings described its ties to travel‑service providers mainly in qualitative terms – as “mutually beneficial relationships” that give providers broader distribution, marketing support and access to payment services – without detailing the mechanics of the financial relationship [page_6]. By the 2023 filing the company had formalized that relationship: it now records cash received from travelers as a “Deferred merchant bookings” liability that represents amounts payable to travel‑service providers, and it accounts for referral bonuses, rebates, credits, discounts and loyalty‑point programs as reductions of revenue at the time they are granted, while recognizing revenue on a net basis (commission or margin) and estimating sales‑incentive amounts [page_83‑84].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies the evolution from a more general, qualitative description of relationships in 2022 to a more formalized, financially structured relationship in 2023. The key financial mechanism — 'Deferred merchant bookings' as a liability — is accurately described, and the treatment of incentives (referral bonuses, rebates, loyalty points) as reductions of revenue is correctly reported. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not applicable beyond correct use of terms; no errors here. (3) The multi-hop reasoning is sound: the LLM synthesizes information across years (2022 vs 2023), entities (BKNG and travel service providers), and accounting practices (liability recognition, revenue recognition). It correctly infers a strategic shift based on financial reporting changes. (4) The only minor shortcoming is that the LLM does not explicitly mention the competitive dynamic in 2022 ('competed with') as stated in the ground truth, instead characterizing the relationship as 'mutually beneficial.' While not incorrect, this softens the contrast implied in the original answer. However, the core evolution — from less formal to more financially integrated and incentive-driven — is accurately captured. Wording differs but semantic meaning is largely equivalent. Contextual relevance is perfect: all information directly addresses the question about financial obligations and incentives.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 424,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How has Broadcom's involvement in the development of Custom Touch Controllers evolved from 2022 to 2024, particularly in terms of their role in the product lifecycle?",
      "original_answer": "In 2022, Broadcom was described as supplying Custom Touch Controllers as part of its semiconductor solutions for the wireless market. By 2024, the company's role had evolved to include producing these controllers as part of its broader custom silicon solutions, reflecting a deeper engagement in their development. This shift indicates a strategic move from being a component supplier to an active producer involved in the design and creation process.",
      "llm_answer": "In the 2022 filing Broadcom merely listed “custom touch controllers” as a wireless‑device product family (see the table of product families for FY 2022) without describing how they are used. By the 2024 filing the company describes its custom touch controllers as devices that “process signals from touch screens in mobile handsets and tablets” (see the Mobile Device Connectivity Solutions section), indicating that Broadcom now positions them as an integrated component that participates in the signal‑processing stage of a device’s design and production lifecycle.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates (2022 and 2024), entities (Broadcom), and the evolution of its role in Custom Touch Controllers. It correctly identifies that in 2022, Broadcom listed custom touch controllers as a product family without elaborating on function, and by 2024, provided a more detailed description of their role in signal processing for touch screens. This reflects a deeper integration into the product lifecycle, aligning with the ground truth's claim of a shift from supplier to active participant in design. The answer does not explicitly use the term 'custom silicon solutions' or state the strategic shift in those terms, but it effectively conveys the same evolution through the lens of increased functional description and integration. There are no numerical inaccuracies (quantitative accuracy is perfect), and all referenced sections (e.g., Mobile Device Connectivity Solutions) are contextually appropriate. The reasoning is sound and synthesizes information across two years of filings, though it stops short of explicitly stating the broader strategic implication noted in the original answer. Thus, while the core facts and progression are correct, the answer lacks full completeness in capturing the depth of the strategic shift described in the ground truth, warranting a high but not perfect score.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 374,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Union Pacific's approach to freight cars evolved from 2023 to 2024, particularly in terms of asset acquisition strategy?",
      "original_answer": "In 2023, Union Pacific primarily leased freight cars as part of its operational strategy, reflecting a reliance on leased assets for rail operations. By 2024, the company's strategy shifted toward acquiring freight cars, including lease buyouts of $143 million in 2024 compared to $57 million in 2023, indicating a more aggressive stance on asset ownership to support replacement and growth opportunities.",
      "llm_answer": "In 2023 Union Pacific’s freight‑car strategy was dominated by leasing – the company added $241 million of leased assets (including freight cars) and held a $1.9 billion lease portfolio of locomotives and freight cars (see 2023 10‑K pages 68‑69). By 2024 the focus shifted to ownership, with $788 million spent on locomotives and freight cars and $143 million of lease buyouts, indicating a move away from leasing toward acquiring freight‑car assets (see 2024 10‑K page 33).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the strategic shift from leasing in 2023 to increased ownership in 2024, including the key $143 million lease buyout figure in 2024, which matches the ground truth. However, it introduces a $241 million leased asset addition and $1.9 billion lease portfolio figure not present in the original answer, which may be accurate per the 10-K but are not part of the ground truth and could misrepresent the focus. The $788 million spent on locomotives and freight cars in 2024 is additional detail not in the original; while potentially correct, it expands beyond the freight-car-specific focus and introduces ambiguity about how much was specifically for freight cars. (2) The $143 million lease buyout in 2024 is correctly stated and aligns with the ground truth; however, the 2023 lease buyout amount of $57 million mentioned in the original answer is missing in the LLM response, weakening the year-over-year comparison. The LLM does not mention the $57 million at all, which is a significant omission for assessing the evolution. (3) The multi-hop reasoning is sound—the model synthesizes data across 2023 and 2024 10-Ks to infer a strategic shift from leasing to ownership. It correctly interprets lease buyouts as indicators of a move toward asset ownership. However, it fails to directly compare the $57M (2023) vs $143M (2024) lease buyouts, which is central to the original answer’s logic. (4) The contextual relevance is high—the answer directly addresses the evolution in freight car strategy. Qualitative accuracy is strong due to correct entity identification (Union Pacific, years, lease vs acquisition) and logical interpretation. Quantitative accuracy is reduced due to inclusion of unverified figures and omission of the $57M 2023 buyout. Correctness score is 8 because core facts about the strategic shift and $143M buyout are correct, but key comparative data is missing and extraneous details may distract.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1215,
        "completion_tokens": 531,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "What were the financial and operational impacts of Nike's structural changes in APLA between FY2022 and FY2023, particularly regarding the transition of certain businesses to third-party distributors?",
      "original_answer": "In FY2022, Nike directly operated within APLA as part of its geographic operating segments, which included associated costs and foreign currency impacts such as non-recurring impairment charges due to the anticipated release of non-cash cumulative foreign currency translation losses from transitioning certain businesses to third-party distributors. By FY2023, Nike had shifted its relationship with APLA from direct operations to a strategic stake, where the company now oversees results through third-party distributors. This transition is reflected in the 2023 filing noting that APLA includes results for the NIKE and Jordan brands and referencing Note 18 on divestitures related to the transition. Operationally, this change represents a strategic shift to reduce direct operational overhead in APLA, likely aiming to improve financial efficiency and focus on brand management rather than local execution.",
      "llm_answer": "Nike’s APLA region saw total revenue rise from $5.96 billion in FY 2022 to $6.43 billion in FY 2023, with wholesale sales climbing to $3.74 billion and direct‑to‑consumer sales to $2.70 billion (page 91), which lifted APLA EBIT from $1.90 billion to $1.93 billion (page 90). The transition of businesses such as Brazil to third‑party distributors – disclosed in Note 20 (page 88) – shifted the sales mix toward wholesale and, after a non‑recurring FY 2020 impairment charge tied to that move (page 90), did not generate further corporate losses, supporting modest earnings improvement in FY 2022‑23.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer includes specific financial figures such as APLA revenue increasing from $5.96 billion in FY2022 to $6.43 billion in FY2023, EBIT rising from $1.90B to $1.93B, and wholesale/DTC sales breakdowns. However, these numbers are not present in the original answer (ground truth), which does not provide any quantitative financial data about APLA's revenue or EBIT. The ground truth emphasizes non-recurring impairment charges related to foreign currency translation losses due to the transition to third-party distributors, but the LLM incorrectly states that the impairment charge occurred in FY2020 (not FY2022 as implied in the context of the transition), which contradicts the original answer’s focus on anticipated charges in FY2022. (2) The quantitative inaccuracies are significant: the cited figures (e.g., $5.96B, $6.43B, $1.90B, $1.93B) appear fabricated or misattributed, as they do not align with the ground truth, which contains no such numbers. Additionally, referencing 'Note 20' instead of 'Note 18' for divestitures is factually incorrect. (3) The multi-hop reasoning is partially sound—the model correctly identifies the transition of certain businesses (e.g., Brazil) to third-party distributors and links this to a shift in sales mix toward wholesale. It also recognizes the strategic intent behind reducing operational burden. However, it fails to accurately describe the structural change from direct operations to a strategic stake in FY2023 and misrepresents the timing and nature of the impairment charge. (4) The contextual relevance is moderate because the answer addresses the operational impact and mentions key elements like third-party distribution and financial implications, but the inclusion of false quantitative data and incorrect note references undermines factual correctness. The qualitative reasoning shows understanding of the strategic shift but lacks alignment with the actual disclosed information. Thus, while the direction of analysis is relevant, the factual foundation is flawed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 551,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How has Broadcom's involvement with InP lasers evolved from 2022 to 2024, particularly in terms of their internal fabrication strategy and competitive positioning?",
      "original_answer": "In 2022, Broadcom disclosed using internal fabrication facilities for products based on proprietary processes, including vertical-cavity surface emitting lasers and side emitting lasers using GaAs and InP lasers for fiber optic communications. By 2024, Broadcom continued this strategy but began emphasizing the competitive landscape more explicitly, listing companies like Coherent Corp., Lumentum Holdings Inc., and others as competitors in semiconductor solutions. This indicates a strategic shift toward highlighting InP laser capabilities as part of its competitive differentiation in the market.",
      "llm_answer": "Broadcom’s 2022 filing notes that it fabricates InP‑based fiber‑optic lasers in‑house at its U.S. and Singapore III‑V facilities, using internal production to protect IP while outsourcing commodity CMOS processes (page 13). The 2024 filing shows the same internal‑fab strategy – now describing VCSEL and side‑emitting lasers built on GaAs and InP – still made in‑house to accelerate time‑to‑market (page 15). In both years Broadcom positions these laser products against the same set of established rivals, such as Coherent, Hamamatsu Photonics, Lumentum and other laser manufacturers (page 17).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates (2022 and 2024), entities (Broadcom, Coherent, Hamamatsu Photonics, Lumentum), and technical details (internal fabrication of InP and GaAs lasers, use of III-V facilities in U.S. and Singapore, in-house production for IP protection and time-to-market). The quantitative and entity accuracy is perfect: no incorrect numbers or misattributions. The answer correctly identifies that Broadcom maintained its internal fabrication strategy across both years, which aligns with the ground truth. However, the LLM slightly misses the evolution aspect emphasized in the original answer—specifically, that Broadcom in 2024 began more explicitly highlighting its InP laser capabilities as a competitive differentiator in response to named competitors. While the LLM notes the same set of rivals are mentioned, it does not fully capture the strategic shift in tone or emphasis that the ground truth describes (i.e., using InP capabilities as a competitive positioning tool). This is a minor gap in qualitative reasoning and synthesis across years, but the core facts and multi-hop elements (internal fab continuity, competitor set, technology base) are sound. Contextual relevance is excellent, directly addressing all parts of the question with appropriate detail.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 363,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How has the ownership structure of Swoosh, LLC in relation to NIKE's Class A and Class B Common Stock evolved between 2022 and 2023, and what implications does this have for shareholder influence?",
      "original_answer": "In 2022, Swoosh, LLC beneficially owned approximately 77% of NIKE's Class A Common Stock, which would translate to approximately 16% ownership of Class B Common Stock if all shares were converted. In 2023, the ownership structure remained consistent with Swoosh, LLC still beneficially owning approximately 77% of Class A Common Stock, with a commensurate ownership percentage of approximately 16% in Class B Common Stock if all shares were converted. Despite the consistency in ownership percentages, the continued concentration of ownership in Swoosh, LLC implies sustained influence by Travis Knight, who has a significant role in managing the Class A Common Stock owned by Swoosh, LLC, potentially affecting shareholder decisions and market dynamics.",
      "llm_answer": "The 10‑K filings show that Swoosh, LLC’s stake has not materially changed – it owned about 77 % of Nike’s Class A Common Stock in both 2022 (as of June 30, 2022) and 2023 (as of June 28, 2024) and, if all of those shares were converted, would hold roughly 16 % of the publicly‑traded Class B shares in each year【page_25†L1-L8】【page_26†L1-L8】.  Because Class A shares elect three‑quarters of the Board, Swoosh, LLC (and the Knight family that controls it) retains dominant voting power, while Class B shareholders continue to have a comparatively modest, non‑controlling influence.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: Swoosh, LLC owned approximately 77% of Class A Common Stock in both 2022 and 2023, and this would translate to roughly 16% ownership of Class B Common Stock if converted—these percentages match the original answer exactly. The dates cited (June 30, 2022, and June 28, 2023—note: LLM says 2024 likely due to fiscal year reporting timing) are consistent with Nike’s fiscal year-end reporting practices (fiscal years end May 31, but proxy disclosures often reference ownership as of June dates), so this is a minor acceptable variance, not a factual error. (2) The answer correctly captures the stability of ownership between the years, addressing the evolution (or lack thereof) in ownership structure. (3) The qualitative reasoning is strong: it correctly infers that because Class A shares elect three-quarters of the board, Swoosh, LLC (controlled by the Knight family) retains dominant voting power, which directly addresses the implication for shareholder influence. It accurately contrasts the control of Class A holders with the limited influence of Class B shareholders. (4) The only minor shortcoming is that the original answer specifically names Travis Knight and his managerial role, while the LLM refers more broadly to the 'Knight family.' This is a slight omission but does not undermine the core accuracy, as the family control implies the same influence. The LLM adds useful context about board elections that enhances the explanation. Overall, the answer is factually correct, contextually relevant, and demonstrates sound multi-hop reasoning across ownership percentages and governance implications.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 471,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How did PMI's strategic positioning of Reduced-Risk Products evolve from 2022 to 2023, particularly in terms of portfolio integration and market availability?",
      "original_answer": "In 2022, PMI classified Reduced-Risk Products (RRPs) as a distinct category, including heated tobacco units, heat-not-burn devices, e-vapor, and oral nicotine products, with separate net revenue reporting. By 2023, RRPs were integrated into a broader category called Smoke-Free Products (SFPs), which now also included wellness and healthcare offerings. Additionally, PMI reported that its smoke-free products were available in 84 markets by the end of 2023, a notable expansion from the unspecified market availability in 2022. This evolution reflects a strategic shift toward consolidating RRPs under a unified smoke-free vision and expanding their global footprint.",
      "llm_answer": "In the 2022 filing PMI still reported reduced‑risk products (RRPs) as a separate product line within each geographic segment – net revenues for RRPs grew to $9.1 billion in 2021 (see page 97) and were highlighted in the segment discussion as part of the “combustible and reduced‑risk product categories sold in the region” (page 95). By the 2023 filing, after the 2022 acquisition of Swedish Match, PMI had merged the ZYN oral‑nicotine franchise with its IQOS heat‑not‑burn platform, presenting a unified “smoke‑free” portfolio and noting that smoke‑free products were now sold in 84 markets worldwide (page 28, also reinforced by the acquisition description on page 29).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the 2022 reporting of RRPs as a distinct category with separate net revenue tracking, and notes the shift in 2023 to a unified 'smoke-free' portfolio, which now includes ZYN (oral nicotine) and IQOS (heat-not-burn), reflecting the integration of RRPs into a broader Smoke-Free Products (SFPs) category. The mention of the Swedish Match acquisition as the catalyst for this integration is factually correct and adds valuable context not explicitly in the original answer but consistent with the knowledge graph. (2) The LLM cites a $9.1 billion RRP revenue figure for 2021 from page 97, which is accurate and relevant context, though the original answer does not include financial figures—this is a minor overreach since the question focuses on 2022–2023 positioning, not financials. However, it does not misstate any numbers. The 84-market availability in 2023 is correctly reported and matches the ground truth. (3) The multi-hop reasoning is sound: the model connects the acquisition of Swedish Match (2022) to the portfolio integration in 2023 and correctly infers that ZYN’s inclusion marks a strategic expansion of the smoke-free category beyond traditional RRPs. (4) The answer is semantically equivalent to the original in terms of strategic evolution, portfolio integration, and market expansion. The only minor gap is that it doesn’t explicitly state that RRPs were rebranded/consolidated into SFPs as a named strategic shift, though this is implied. Overall, the answer is factually correct, well-reasoned, and contextually rich without introducing errors.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 453,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Caterpillar's strategic role in the reciprocating engines business evolved from 2022 to 2024, and what impact has this had on its revenue composition and gross margin potential?",
      "original_answer": "In 2022, Caterpillar primarily sold reciprocating engines through its global dealer network and through subsidiary Perkins Engines Company Limited, which operated 90 distributors across 171 countries. By 2024, Caterpillar expanded its involvement by including the remanufacturing of Caterpillar reciprocating engines and components, as well as offering remanufacturing services for other companies. This evolution from a seller to a full lifecycle service provider likely improved gross margin potential, as remanufacturing typically involves lower material costs compared to new engine production and leverages existing asset value. The shift also diversified revenue composition by incorporating service-based income streams alongside traditional product sales.",
      "llm_answer": "In 2022 Caterpillar treated reciprocating‑engine sales mainly as a distribution‑driven product line – the engines were “sold principally through the dealer network and to other manufacturers” and were supported by a few subsidiaries such as Perkins, FG Wilson and MaK【page_9】. By 2024 the company has elevated the engines to a strategic pillar of its Energy & Transportation segment, adding remanufacturing of engines and components to its responsibilities and highlighting growth in high‑value applications (gas‑compression, data‑center power, marine and rail) that lifted Energy & Transportation sales and profit (the segment’s profit rose to 19.9 % of total sales, up from 17.6 % a year earlier)【page_37】【page_39】. This shift has increased the share of revenue coming from the reciprocating‑engine business and improved gross‑margin potential by moving the mix toward higher‑margin engine products and services.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Caterpillar's 2022 distribution model through dealers and subsidiaries like Perkins, and expands on it by naming additional subsidiaries (FG Wilson, MaK), which is consistent with the broader business structure. The 2024 evolution into remanufacturing is accurately reported, including services for components and other companies, though the latter is implied through 'remanufacturing services' in the original. (2) Quantitatively, the LLM introduces specific segment profit percentages (19.9% in 2024 vs 17.6% a year earlier) that are not in the original answer. These numbers are plausible and contextually relevant but cannot be verified against the ground truth provided; this is a minor overprecision but not demonstrably false. All other numerical references (years: 2022, 2024) are correct. (3) The reasoning is sound: the LLM correctly synthesizes a multi-hop narrative—evolution from product sales to strategic lifecycle services—and links it to improved gross margin potential via higher-margin services and product mix, which matches the original's logic. It adds value by specifying high-value applications (gas compression, data centers, marine, rail), which enriches the answer without contradicting the ground truth. (4) The answer fully addresses the question’s components: strategic evolution, revenue composition impact, and gross margin implications. Wording differs but semantic meaning is equivalent or superior. The only reason for not scoring 10 is the introduction of unverified segment profit percentages, which, while plausible, are not in the original truth and slightly exceed the evidence. Overall, the answer demonstrates strong factual grounding, correct entity identification, and logical synthesis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 494,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How did BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct evolve between 2022 and 2023, particularly in terms of the mechanisms and transparency commitments outlined for informing stakeholders of changes?",
      "original_answer": "BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained consistent between 2022 and 2023, with the company reaffirming its commitment to post any amendments or waivers on its website in both years. There was no change in the specific mechanism or transparency commitment described across the two years, indicating a stable governance communication strategy.",
      "llm_answer": "In the 2022 Form 10‑K BNY Mellon first disclosed that any amendments or waivers to its Directors’ Code of Conduct would be posted on its corporate website. The 2023 filing repeats the same statement—linking to the same web location and reaffirming the intent to disclose any changes there—so the company’s mechanism (website posting) and its transparency commitment remained unchanged between the two years.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that BNY Mellon's approach to disclosing amendments to the Directors' Code of Conduct remained unchanged between 2022 and 2023, with both years referencing the same mechanism—posting amendments or waivers on the corporate website. The answer correctly identifies that the 2022 Form 10-K introduced this disclosure and that the 2023 filing reiterated it, confirming consistency in transparency commitments. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (BNY Mellon, Directors’ Code of Conduct, 2022 and 2023 Form 10-Ks) are correctly identified. The reasoning is sound and reflects proper multi-hop synthesis across two years of filings. The only minor limitation is that the original answer notes the stability as indicating a 'stable governance communication strategy,' a slight interpretive layer absent in the LLM response, but this does not detract from factual correctness. Semantic equivalence is maintained, and the response fully addresses the question’s focus on mechanisms and transparency. Thus, the answer is excellent with only negligible omission of interpretive context.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1221,
        "completion_tokens": 343,
        "total_tokens": 1565
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How has Nike's strategic approach to the APLA market evolved between FY22 and FY23, particularly in terms of operational structure and market participation?",
      "original_answer": "In FY22, Nike operated directly in APLA, maintaining a significant presence through its NIKE Direct operations and wholesale distribution, with APLA contributing to the 14% growth in the NIKE Direct business. By FY23, Nike began transitioning certain businesses within APLA to third-party distributors, signaling a strategic shift away from direct market participation in some parts of the region. This change indicates a move toward a more distributed, partner-driven model in APLA, altering the way Nike engages with that market.",
      "llm_answer": "In FY 22 Nike announced that it would sell its legal entities in Argentina, Uruguay and Chile and transition those APLA markets to third‑party distributors, shifting from a wholesale/direct model to a distributor model to lower selling‑and‑administrative costs and reduce foreign‑exchange exposure【page_32】. By FY 23 the divestitures were reflected in the segment note, which now reports that certain APLA countries are operated by third‑party distributors while the rest of the APLA region continues to be served by Nike Direct and wholesale channels, and APLA revenues grew to $6.43 bn from $5.96 bn the prior year【page_89】【page_90】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Nike's strategic shift in APLA between FY22 and FY23: in FY22, Nike announced the divestiture of its legal entities in Argentina, Uruguay, and Chile, transitioning those markets to third-party distributors, and by FY23 this change was reflected in the financial reporting. This matches the ground truth's description of a move toward a partner-driven model. (2) Quantitatively, the LLM provides precise revenue figures: APLA revenues grew from $5.96 billion in FY22 to $6.43 billion in FY23, which are accurate and correctly cited from the source pages. These numbers support the claim of continued market presence despite structural changes. (3) The multi-hop reasoning is sound—linking the FY22 strategic announcement to the FY23 operational outcome and financial reporting demonstrates synthesis across time and documents. The mention of reduced selling-and-administrative costs and foreign-exchange exposure adds context not in the ground truth but is factually consistent with Nike’s stated rationale. (4) The only minor gap is that the ground truth emphasizes the 14% growth in NIKE Direct in APLA in FY22, which the LLM omits. While not critical to the core question about structural evolution, this contextual detail about direct operations' performance slightly enriches the original answer. However, the LLM fully addresses the question on operational structure and market participation evolution. Wording differs but semantic meaning is equivalent or superior due to added precision on countries and financials.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 442,
        "total_tokens": 1736
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has the impact of Favorable Price Realization on Caterpillar's sales and profitability evolved from 2022 to 2024?",
      "original_answer": "In 2022, favorable price realization contributed to a $9.223 billion increase in total sales and revenues, driven by higher end-user demand and changes in dealer inventories. By 2024, favorable price realization continued to play a key role, partially offsetting a $2.251 billion decrease in sales volume and contributing to an increase in profit from $10.335 billion in 2023 to $10.792 billion in 2024. This indicates that while Caterpillar faced declining sales volume in 2024, the company leveraged pricing strategies more effectively to maintain profitability.",
      "llm_answer": "In the 2022 filing (covering 2021), Caterpillar said the 22 % sales increase and the rise in operating‑profit margin to 13.5 % were driven largely by higher sales volume **and favorable price realization** (MD&A, p. 32; operating‑profit discussion, p. 36). By the 2024 filing, sales fell 3 % to $64.8 bn, but the company noted that the volume decline was **partially offset by favorable price realization**, which helped lift operating‑profit margin to 20.2 % (MD&A, p. 30).",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies in numbers and time periods. It incorrectly states that the 2022 filing covers 2021, when it actually reports on 2022 results. The $64.8 billion sales figure for 2024 is not present in the ground truth and is unverified. The 22% sales increase and 13.5% operating-profit margin are mentioned without clear alignment to the ground truth metrics (e.g., no mention of the $9.223B price realization contribution in 2022). The 20.2% margin in 2024 is new information not in the original answer and cannot be confirmed. (2) The ground truth specifies that favorable price realization increased sales by $9.223B in 2022 and helped increase profit from $10.335B in 2023 to $10.792B in 2024, despite a $2.251B volume decline. The LLM answer omits these exact figures and instead introduces unverified percentages and dollar amounts. There is no mention of the actual profit increase or the exact offsetting role of price realization against volume decline. (3) The reasoning partially captures the multi-hop evolution: it acknowledges that favorable price realization supported margins despite volume declines in 2024, which aligns with the original answer’s logic. However, it fails to synthesize the full trajectory from 2022 to 2024 using consistent, accurate financial figures. The connection between price realization, sales evolution, and profitability over the three-year span is weakened by incorrect data. (4) The contextual relevance is high because the answer addresses the role of favorable price realization in sales and profitability across years. However, due to significant quantitative errors and missing key figures (e.g., $9.223B, $2.251B, exact profit numbers), the correctness score is limited to 5. The qualitative accuracy is moderate due to correct conceptual framing but flawed data sourcing.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1252,
        "completion_tokens": 507,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has General Motors' approach to EV manufacturing capacity evolved between 2023 and 2024, particularly in terms of strategic focus and supply chain development?",
      "original_answer": "In 2023, General Motors emphasized significant investments in EV manufacturing capacity based on expectations for future EV demand, acknowledging the risks and uncertainties associated with such investments, including high fixed costs and limitations on closing facilities. By 2024, GM's strategy had evolved to include a stronger emphasis on developing a resilient, scalable, and sustainable North American-focused EV supply chain. This included advancing strategic sourcing initiatives to secure supply through investments in raw materials suppliers and the execution of multi-year supply agreements. The shift indicates a more structured and regionally focused approach to EV manufacturing, aiming to mitigate supply chain risks and ensure long-term scalability.",
      "llm_answer": "In 2023 GM said it would “make significant investments in EV manufacturing capacity” and that “our transition to EVs will also require developing a more resilient, scalable and sustainable North‑American‑focused EV supply chain…through strategic‑sourcing initiatives, investments in raw‑material suppliers and multi‑year supply agreements” (2023 p. 16). By 2024 the language shifts to a broader, cost‑driven agenda – “scale our EV manufacturing capabilities, reduce battery‑cell and pack costs, efficiently source sufficient materials for battery cells, and leverage strategic joint‑ventures, platform synergies and other relationships” – indicating that GM’s focus has moved from simply building capacity and a regional supply chain to integrating capacity growth with aggressive cost‑reduction, raw‑material security and cross‑vehicle platform leverage (2024 p. 15‑17).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies General Motors (GM) as the company and accurately reflects the evolution of its EV manufacturing strategy between 2023 and 2024. The 2023 focus on significant investments in EV manufacturing capacity and supply chain development is properly cited with a direct quote and page reference (2023 p. 16), matching the original answer’s emphasis on risk, fixed costs, and regional supply chain building. In 2024, the LLM correctly notes a strategic shift toward cost reduction, material sourcing efficiency, and leveraging joint ventures and platform synergies, citing 2024 pages 15–17. This aligns with the ground truth’s description of a more structured, scalable, and risk-mitigating approach. (2) There are no numeric values (e.g., dollar amounts, percentages, capacities) in either the original or LLM answer, so quantitative accuracy is not compromised; all references to years (2023, 2024) are correct. (3) The multi-hop reasoning is sound: the LLM synthesizes information across two years of filings, compares strategic language shifts, and infers a broader strategic evolution—from capacity and regional supply chain building to integrating cost efficiency and scalability. The use of direct quotes supports this reasoning. (4) The only minor shortcoming is that the LLM emphasizes a 'cost-driven agenda' and 'broader' focus more than the original answer does, which might slightly overstate the departure from 2023. However, this interpretation is supported by the 2024 language and does not contradict the ground truth. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with full semantic equivalence.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 478,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved from 2022 to 2024, based on remaining performance obligations disclosed in the 10-K filings?",
      "original_answer": "In 2022, Pfizer's 10-K filing did not disclose specific remaining performance obligations related to Paxlovid. However, by 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, indicating a significant ongoing financial commitment tied to future delivery of the product. This shows a clear evolution from an undefined obligation in 2022 to a quantified $1 billion commitment in 2024.",
      "llm_answer": "Pfizer’s 2022 Form 10‑K disclosed that it had roughly **$2.5 billion** of remaining performance‑obligation revenue tied to Paxlovid contracts as of December 31, 2022【page_7】. By the end of 2024, the Form 10‑K shows that amount had fallen to about **$1 billion**【page_109】, indicating a sizable reduction in the future contractual revenue commitment for the antiviral over the two‑year span.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in its core quantitative claim. The ground truth states that Pfizer did not disclose specific remaining performance obligations (RPOs) for Paxlovid in 2022, but the LLM claims a precise figure of $2.5 billion as of December 31, 2022, which contradicts the original answer. This is a major factual error. The 2024 figure of $1 billion is correct per the ground truth. (2) The calculation of a 'reduction' from $2.5 billion to $1 billion is based on false premises, as there was no disclosed RPO in 2022, so no valid comparison can be made. The direction of change (decrease) may seem plausible, but the premise is wrong. (3) The multi-hop reasoning fails because the model incorrectly assumes data availability in 2022. It should have recognized the absence of specific Paxlovid RPO disclosure in 2022 and contrasted that with the 2024 quantification, showing evolution from undefined to defined commitment. Instead, it fabricates a 2022 figure, undermining the reasoning. (4) Scores are low due to the critical error in quantitative data and flawed reasoning, though the answer is contextually relevant by addressing the right topic and metric (RPOs for Paxlovid) and correctly citing the 2024 amount.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 352,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Caterpillar's approach to monitoring supplier financial viability evolved between 2022 and 2023, particularly in terms of risk mitigation strategies and contractual agreements?",
      "original_answer": "In 2022, Caterpillar indicated that it uses 'a variety of agreements with suppliers to protect our intellectual property and processes to monitor and mitigate risks of the supply base causing a business disruption,' including monitoring supplier financial viability. By 2023, Caterpillar maintained the same monitoring approach but placed a more explicit emphasis on 'supplier financial viability' as a key risk factor, listing it as the first risk under its supply chain disclosures. Additionally, in 2023, Caterpillar reinforced its global strategic sourcing models to build long-term supplier relationships and leverage enterprise spend, suggesting a potentially more structured or prioritized focus on supplier financial health compared to 2022.",
      "llm_answer": "In the 2022 Form 10‑K Caterpillar noted that it relied on “a variety of agreements with suppliers to protect our intellectual property and monitor supplier financial viability” as part of its overall supply‑chain oversight【page_9 (2022)】. By the 2023 filing the language was expanded to a proactive risk‑mitigation framework that “monitor and mitigate risks of the supply base causing a business disruption,” explicitly listing financial‑viability, production‑flexibility, continuity, quality and delivery as monitored risks【page_9 (2023)】, and the company added tighter dealer contracts that require detailed books and records of the dealer’s financial condition and give Caterpillar a 90‑day termination right【page_10 (2023)】—providing stronger contractual levers to manage supplier‑financial risk.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its factual content and accurately reflects Caterpillar's disclosures in both 2022 and 2023 regarding supplier financial viability monitoring. It correctly identifies that in 2022, Caterpillar used agreements to protect intellectual property and monitor supplier financial viability (citing page 9 of the 2022 10-K), and that in 2023, the company expanded its language to include a more structured risk-mitigation framework with explicit mention of financial viability among other risks (citing page 9 of the 2023 10-K). The quantitative accuracy is perfect—no numbers, dates, or document references are incorrect. However, there is a significant factual inaccuracy in the claim about 'tighter dealer contracts' requiring 'detailed books and records' and granting a '90-day termination right' (citing page 10, 2023). This contractual detail pertains to Caterpillar's agreements with its dealers, not suppliers, and thus misrepresents the scope of supplier risk mitigation. The original answer focuses solely on supplier financial viability and does not mention dealer contracts as part of supplier risk strategy. This confusion between 'dealers' and 'suppliers' undermines the qualitative accuracy, as it introduces a misleading element of contractual enforcement that is not relevant to the supplier relationship. While the LLM captures the evolution in tone and emphasis on financial viability as a key risk, it fails to note the structural shift in disclosure order (listing financial viability first) and the reinforcement of strategic sourcing models mentioned in the ground truth. The reasoning is partially sound but flawed in entity mapping (dealers vs. suppliers), which affects multi-hop synthesis. Despite this, the answer remains contextually relevant and conveys much of the correct evolution in risk language and monitoring. Hence, a score of 7 is warranted—core facts are correct, but with a significant mischaracterization affecting completeness and reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 539,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Visa's approach to Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of its strategic positioning and integration within its value-added services?",
      "original_answer": "In 2022, Visa positioned Risk and Identity Solutions as part of a broader set of value-added services aimed at supporting clients, but without detailed elaboration on specific capabilities or strategic direction. By 2024, Risk and Identity Solutions were embedded within a more structured value-added services framework, with a clear three-pillar strategy: (1) services for Visa transactions, (2) network-agnostic services for non-Visa transactions, and (3) services beyond payments. This evolution reflects a more strategic and comprehensive integration of Risk and Identity Solutions into Visa's broader service portfolio, with an emphasis on scalability and business outcomes.",
      "llm_answer": "In the 2022 Form 10‑K, Visa mentioned Risk and Identity Solutions only as one line item among its value‑added services, without further detail or strategic emphasis【page_5】. By the 2024 filing, Visa had repositioned Risk and Identity Solutions as a distinct, AI‑driven pillar—highlighting the Visa Protect suite, new products such as Visa Deep Authorization, Visa Protect for A2A Payments, and Visa Risk Manager, and integrating these tools as a core component of its broader value‑added services strategy【page_12】【page_11】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies the evolution in Visa's approach to Risk and Identity Solutions from 2022 to 2024. In 2022, the LLM correctly notes that Risk and Identity Solutions were mentioned only briefly as a line item among value-added services, which matches the ground truth's description of limited elaboration. By 2024, the LLM accurately captures the strategic repositioning, including integration into a more structured framework and the introduction of specific products like Visa Deep Authorization, Visa Protect for A2A Payments, and Visa Risk Manager. While the ground truth emphasizes a three-pillar strategy (Visa transactions, network-agnostic services, services beyond payments), the LLM does not explicitly mention the three-pillar structure but conveys the essence of broader strategic integration and expansion beyond core payments through references to AI-driven capabilities and core components of value-added services. The mention of 'AI-driven' is a slight addition not in the original, but it does not contradict and may reflect implicit inference from product names. All entities (Visa, Risk and Identity Solutions, correct years) are accurate. No numerical inaccuracies—dates (2022, 2024) are correct and no flawed calculations. The reasoning is sound, showing a clear multi-hop synthesis across two years of filings. The answer is contextually fully relevant. The only minor gap is the omission of the explicit three-pillar framework, which prevents a perfect 10, but the core strategic evolution is correctly conveyed.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 440,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has the company's exposure to shelf space limitations as a risk factor evolved between 2022 and 2023, particularly in relation to changes in retail customer policies and the expansion of alternative retail channels?",
      "original_answer": "In 2022, the company noted that it had been and could continue to be negatively affected by changes in retail customer policies such as limitations on access to shelf space and delisting of products. By 2023, the company was actively impacted by these limitations and described them as part of a broader set of evolving retail dynamics, including the growth of eCommerce and alternative retail channels such as subscription services and direct-to-consumer businesses. This evolution indicates a shift from potential risk to an actively experienced challenge, with the company planning to invest more in digital and analytics capabilities to adapt.",
      "llm_answer": "In the 2022 filing the company flagged shelf‑space limits mainly as a consequence of retail‑customer policy changes—such as inventory de‑stocking, fulfillment requirements, sustainability standards and delisting—that could restrict product placement. By the 2023 filing the same concern remains, but it is broadened to note that the rapid growth of e‑commerce and the emergence of alternative channels (e.g., subscription services, direct‑to‑consumer) are intensifying shelf‑space pressures and creating additional pricing pressures, indicating an expanded exposure to this risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that in 2022, shelf space limitations were presented as a potential risk due to retail customer policies such as delisting and inventory de-stocking, and that by 2023 this evolved into an ongoing challenge. The inclusion of 'sustainability standards' and 'fulfillment requirements' adds detail not contradicted by the original, though not explicitly in the ground truth. (2) There are no numeric values to verify, so quantitative accuracy is满分. (3) The multi-hop reasoning is sound: the model correctly synthesizes the evolution from potential risk (2022) to active impact (2023) and links it to the growth of eCommerce and alternative channels like subscription and DTC models. The only minor gap is that the LLM does not explicitly mention the company's planned response (investment in digital and analytics), which is present in the original answer—this limits completeness slightly but does not undermine the core accuracy. (4) The answer is contextually fully relevant, addressing both the temporal evolution and the role of changing retail dynamics. Wording differs but semantic meaning is equivalent. Thus, correctness is 9/10 due to high accuracy with a small omission in response strategy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 361,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Oracle's approach to hybrid deployments evolved between fiscal years 2023 and 2024, particularly in terms of product offerings and strategic emphasis?",
      "original_answer": "In fiscal 2023, Oracle emphasized hybrid deployments as part of its broader deployment models, including on-premise, cloud-based, and hybrid options such as Oracle Exadata Cloud@Customer and Dedicated Region offerings. The company highlighted its commitment to providing customers with choice and flexibility in how they deploy Oracle technologies. By fiscal 2024, Oracle continued to support hybrid deployments but introduced more specific product integrations and services tailored for hybrid environments, indicating a strategic shift toward deeper integration and support for customer-managed cloud and on-premise IT environments. This evolution reflects Oracle's ongoing investment in making hybrid deployments more interoperable and extensible with other IT and cloud environments.",
      "llm_answer": "In FY 2023 Oracle framed hybrid‑deployment mainly as a migration pathway, spotlighting dedicated “on‑premise‑plus‑cloud” products such as **Oracle Exadata Cloud@Customer and Dedicated Region** and multicloud options, and stressing that offering flexible, interoperable deployment models was a key element of its growth strategy【page_6†L1-L7】【page_7†L15-L22】. By FY 2024 the narrative had shifted to a **license‑centric hybrid model** – Oracle’s applications and license offerings can be run in Oracle Cloud, other public clouds or on‑premise with optional support contracts – and the company highlighted hybrid flexibility as a core growth engine, noting that cloud‑services revenue (which includes hybrid‑enabled SaaS and infrastructure) rose to **37 % of total revenue** (up from 32 % in FY 23)【page_8†L1-L9】【page_8†L10-L14】. This reflects an evolution from promoting specific hybrid appliances to embedding hybrid capability across its entire product portfolio and making it a strategic revenue driver.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Oracle emphasized hybrid deployments in FY2023 with Exadata Cloud@Customer and Dedicated Region, and evolved toward deeper integration and broader portfolio embedding in FY2024. The shift from promoting specific appliances to a license-centric, portfolio-wide hybrid model is correctly identified. (2) Quantitative accuracy is excellent: the LLM correctly states that cloud-services revenue (including hybrid-enabled offerings) rose to 37% of total revenue in FY2024 from 32% in FY2023. These percentages are precise and directly support the claim of hybrid's growing strategic importance. (3) Multi-hop reasoning is sound: the model synthesizes information across fiscal years, connects product evolution (from appliances to licensing flexibility), and links this to revenue impact, demonstrating strong qualitative understanding. (4) The only minor gap is that the original answer emphasizes 'interoperability and extensibility with other IT and cloud environments' as a focus in FY2024, which the LLM mentions implicitly via 'run in Oracle Cloud, other public clouds or on-premise' but could have stated more explicitly. However, this does not detract significantly from the overall correctness. Wording differs but semantic meaning matches. All entities (Oracle, Exadata Cloud@Customer, Dedicated Region, FY2023/FY2024) are accurate. The answer fully addresses product offerings and strategic emphasis across both years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 418,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How has Pfizer's financial commitment to Paxlovid evolved between 2022 and 2024, based on remaining performance obligations and contracted revenue expectations?",
      "original_answer": "In 2022, Pfizer indicated that Paxlovid had the potential to provide ongoing revenue streams, though it acknowledged that post-pandemic revenues might not match the levels seen during the pandemic. By 2024, Pfizer reported that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, with contracted revenue expected to be recognized from 2025 through 2028. This reflects a continued but reduced financial commitment compared to the pandemic period, as the company anticipates delivery and revenue recognition over a multi-year horizon rather than immediate high-volume sales.",
      "llm_answer": "In the 2024 Form 10‑K Pfizer disclosed that, as of December 31 2024, it expects to recognize about **$1 billion of contracted revenue from the remaining performance‑obligation portfolio for Paxlovid** (“Remaining Performance Obligations‑Contracted revenue … for Paxlovid … totaled approximately $1 billion” 【page_109】). The 2022 filing does not provide a comparable remaining‑obligation amount for Paxlovid (the 2022 note only reports Paxlovid revenue of $18.9 billion and contains no disclosed figure for future contracted revenue), indicating that the long‑term financial commitment has shifted from an undefined or larger commitment in 2022 to a clearly quantified $1 billion expectation in 2024 as the product moves toward commercial sales.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $1 billion remaining performance obligation for Paxlovid as of December 31, 2024, is accurately cited from the 2024 10-K (page 109), and the absence of a comparable figure in the 2022 filing is correctly noted. The $18.9 billion Paxlovid revenue in 2022 is not part of the original answer but is factually correct and adds useful context without contradicting the ground truth. (2) The answer correctly identifies that in 2022, Pfizer did not disclose a specific remaining performance obligation for Paxlovid, which supports the inference that the financial commitment was less defined then versus the clearly quantified $1 billion in 2024. (3) The multi-hop reasoning is sound: it synthesizes the absence of future contracted revenue data in 2022 with the explicit $1 billion figure in 2024 to conclude a shift toward a more defined, reduced, long-term commitment. (4) The LLM captures the core evolution—transition from high-volume pandemic-era sales to a structured, multi-year revenue recognition plan—even though it does not explicitly mention '2025 through 2028' as the recognition period. This omission is minor and does not affect the overall correctness, as the focus is on the $1 billion obligation being future-facing. Wording differs slightly but maintains semantic equivalence. No calculation errors. Minor deduction in qualitative accuracy for not specifying the 2025–2028 timeline mentioned in the original answer, but the reasoning and conclusion remain robust.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 438,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Caterpillar's relationship with its independent dealers evolved between 2022 and 2023, particularly in terms of contractual obligations and strategic emphasis?",
      "original_answer": "In 2022, Caterpillar described its relationship with independent dealers in general terms as part of its global sales and marketing strategy. By 2023, the company formalized and detailed these relationships through standardized sales and service agreements, granting dealers the right to purchase, sell, and service Caterpillar products within specified territories. In exchange, dealers were obligated to develop and promote Caterpillar products, maintain adequate sales and support personnel, and keep detailed financial records accessible to Caterpillar. This represents a shift from a general partnership model to a more structured contractual framework, indicating a strategic emphasis on formalizing dealer relationships to enhance control and accountability.",
      "llm_answer": "In 2022 Caterpillar simply noted that it “builds long‑term relationships” through a “global network of independent dealers” (page 4). By 2023 the company has formalized that network: each dealer is bound by standard sales‑and‑service agreements that spell out rights to sell and service products, obligations to promote, staff, keep detailed records and cooperate on product improvements, and allow either side to terminate the relationship at‑will with 90 days’ notice (page 10), while still emphasizing the worldwide, independently‑owned dealer model as the primary channel for sales and service (page 9). This shift reflects a move from a broad relationship focus to a more structured, flexible partnership framework.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies the evolution from a general partnership model in 2022—citing Caterpillar's description of 'long-term relationships' via a 'global network of independent dealers'—to a more formalized structure in 2023 based on standardized sales and service agreements. The key contractual obligations (promotion, staffing, record-keeping) and rights (to sell and service) are accurately reported. The addition of the 90-day termination clause is a precise detail not in the original answer but consistent with a more structured framework, and does not contradict the ground truth. (2) There are no numerical values to verify, so quantitative accuracy is满分. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years and interprets the strategic shift from descriptive to contractual language as a move toward greater structure and accountability. The only minor gap is that the LLM does not explicitly frame the change as a 'shift from general partnership to structured contractual framework' in the same terms as the original, but the semantic meaning is equivalent. (4) The answer is fully relevant, directly addressing both contractual obligations and strategic emphasis as asked. The citation of page numbers adds credibility. Overall, this is a factually correct, well-reasoned response with only negligible differences in framing, warranting a 9/10 for correctness and qualitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 417,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How did the company's financial allocation or operational focus related to Africa/Eurasia evolve from 2022 to 2023, based on capital expenditures and restructuring charges?",
      "original_answer": "In 2022, the company reported capital expenditures for Africa/Eurasia at $33 million, showing a steady increase from $13 million in 2021 and $8 million in 2020. However, in 2023, the company indicated that approximately 10% of the cumulative pretax charges from the 2022 Global Productivity Initiative would relate to initiatives undertaken in Africa/Eurasia, signaling a shift in focus toward restructuring and cost optimization in the region rather than continued capital investment. This reflects a strategic evolution from growth-oriented capital allocation to operational restructuring within Africa/Eurasia.",
      "llm_answer": "Capital spending on Africa/Eurasia had risen to $33 million (up from $13 million in 2020) — the latest disclosed level — signaling a stronger investment emphasis, while the share of the Global‑Productivity‑Initiative restructuring charges allocated to Africa/Eurasia fell sharply from 11 % of total charges in 2022 to just 5 % in 2023, indicating a reduced cost‑cutting focus in that region【page_117】【page_48】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. First, it incorrectly states that capital spending rose to $33 million from $13 million in 2020, while the ground truth shows $33M in 2022, $13M in 2021, and $8M in 2020—so the comparison skips 2021 and misrepresents the trend. Second, and more critically, the LLM claims that Africa/Eurasia’s share of restructuring charges fell from 11% in 2022 to 5% in 2023. This is entirely incorrect: the original answer states that in 2023, approximately 10% of the *cumulative* pretax charges from the 2022 Global Productivity Initiative relate to Africa/Eurasia—there is no data provided about a 11% or 5% allocation in 2022 or 2023, nor any indication of a decline. (2) The dollar amounts for 2022 capex ($33M) are correct, but the baseline year is misrepresented (says 2020 instead of 2021), and the restructuring percentages are fabricated. There is no support for '11%' or '5%' in the ground truth. (3) The multi-hop reasoning is flawed: instead of recognizing the shift from capital investment (capex) to restructuring focus in 2023, the LLM incorrectly infers a *reduction* in restructuring focus, which contradicts the original answer’s claim of a *strategic shift toward* restructuring. This reverses the correct interpretation. (4) The contextual relevance is moderate because the answer addresses capital expenditures and restructuring charges in Africa/Eurasia across years, but the incorrect data and reversed conclusion severely undermine factual correctness. Due to major quantitative and qualitative errors, the correctness score is low at 3.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 443,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Qualcomm's strategic focus on 5G technologies evolved from 2022 to 2024, particularly in terms of investment emphasis and commercialization outcomes?",
      "original_answer": "In 2022, Qualcomm was heavily investing in 5G technologies as part of its broader strategy to expand beyond mobile handsets into areas like automotive and IoT, with an emphasis on developing leading and cost-effective 5G-based technologies and products. The company acknowledged significant risks around the success of these investments due to potential regulatory hurdles, competition, and the long design-in cycles typical of new industries like automotive. By 2024, Qualcomm had transitioned from a primarily investment phase to a more mature stage where it had developed a leading patent portfolio in 5G NR and was actively licensing these technologies. The company reported generating the majority of its QTL revenues from OFDMA-based products, including multimode 3G/4G/5G devices such as smartphones, indicating a successful commercialization phase. This shift shows that Qualcomm moved from strategic investment and development in 5G across multiple industries to a position of market leadership and monetization in 5G technologies.",
      "llm_answer": "In its 2022 filing Qualcomm emphasized that its core strategy remained a heavy‑weight investment in 5G research, patent development and licensing, noting that growth depended on “developing and patenting 5G technologies, and to develop and commercialize products using 5G technologies” (2022 page_20‑22). By the 2024 filing the emphasis had shifted to tangible 5G commercialization – the company now markets 5G‑ready RF front‑end (RFFE) modules, Snapdragon 5G modem‑RF platforms and other 5G‑enabled chips, and expands strategic investments in early‑stage 5G ventures through Qualcomm Ventures, while still deriving licensing revenue from its 5G patent portfolio (2024 page_11‑13).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of the evolution of Qualcomm's strategic focus on 5G from 2022 to 2024. (1) It accurately captures the shift from investment and development in 2022 to commercialization in 2024. The 2022 emphasis on R&D, patenting, and commercializing 5G technologies is correctly cited with a reference to the filing (page_20-22), and the 2024 focus on monetization through products like 5G RF front-end modules, Snapdragon platforms, and licensing is factually sound. (2) There are no numeric values, dates, or financial figures in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is solid: the model connects strategic emphasis across two years and synthesizes information about investment, product development, and licensing. However, the LLM omits key contextual details present in the ground truth, such as the expansion into automotive and IoT, the risks associated with long design-in cycles, and the specific mention that QTL revenues are primarily from OFDMA-based multimode devices. These omissions reduce completeness and qualitative accuracy slightly. (4) Despite these omissions, the answer remains contextually relevant and semantically aligned with the core evolution described in the original answer. Wording differs but meaning is preserved. Hence, correctness is high but not perfect—justifying a score of 8.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 402,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How has Pfizer's financial and strategic positioning of Paxlovid evolved between 2022 and 2024, particularly in terms of revenue contribution and contractual commitments?",
      "original_answer": "In 2022, Paxlovid generated $76 million in revenue, marking its initial contribution as a newly launched product targeting high-risk COVID-19 patients. By 2024, while direct revenue figures for Paxlovid are not explicitly stated, Pfizer disclosed approximately $1 billion in remaining performance obligations tied to future Paxlovid deliveries under existing contracts. This indicates a strategic shift from initial market entry to securing longer-term contractual commitments, despite potential market or regulatory challenges reflected in the context of government returns and adjustments in 2024.",
      "llm_answer": "Pfizer’s Paxlovid revenue dropped dramatically, from $18.9 billion in 2022 (the bulk of Paxlovid sales that year came from government‑sponsored contracts) to $5.7 billion in 2024 as the product moved into commercial markets 【page_108】.  By the end of 2024 the long‑term contract backlog for Paxlovid had shrunk to about $1 billion of remaining performance‑obligation revenue, reflecting the shift away from large government‑supply agreements that had driven the 2022 results 【page_109】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies. According to the ground truth, Paxlovid generated $76 million in revenue in 2022, not $18.9 billion as claimed by the LLM. The 2024 revenue is not explicitly stated in the ground truth, but the LLM incorrectly asserts $5.7 billion in 2024 revenue, which is unsupported. The only number aligning with the ground truth is the $1 billion in remaining performance obligations in 2024, which both answers mention. (2) The quantitative inaccuracies are severe: the 2022 revenue is off by over 24,000% ($76 million vs $18.9 billion), and the 2024 revenue figure is fabricated, as the ground truth does not provide a 2024 revenue number. The $1 billion remaining obligation is correctly cited, but used to support an incorrect narrative. (3) The reasoning is flawed: the LLM infers a 'dramatic drop' in revenue and a 'shrinking backlog' implying decline, while the ground truth frames the $1 billion obligation as evidence of strategic transition to longer-term contracts, not decline. The multi-hop synthesis fails because it misrepresents the 2022 baseline and misinterprets the meaning of performance obligations. (4) Despite incorrect numbers and reasoning, the answer is contextually relevant—it addresses revenue trends and contractual commitments as asked, and cites performance obligations correctly in part—hence a moderate relevance score. However, the severe factual errors drastically reduce correctness and quantitative accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 414,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has the company's exposure to credit market tightness as a supply chain risk evolved between 2022 and 2023, and what does this indicate about its changing vulnerability to external financial conditions?",
      "original_answer": "In 2022, tighter credit or capital markets were described as a risk that 'negatively impacts' suppliers, with a direct concern that this could disrupt the supply of raw and packaging materials. By 2023, the framing shifted to indicate that the company's operations are 'impacted by' these conditions, suggesting a broader recognition of ongoing vulnerability. This evolution reflects a continuation of concern over credit market conditions but with a more integrated perspective on how such financial constraints affect not just suppliers, but the company's overall supply chain resilience.",
      "llm_answer": "In the 2022 filing the company called out “the impact on our suppliers of tighter credit or capital markets” as a specific supply‑chain risk 【page_15】. By the 2023 filing the language had broadened to note “disruptions and volatility in the global capital markets, including rising interest rates, which may increase the cost of capital and adversely impact our access to capital” 【page_13】. The risk of credit‑market tightness therefore remains, but it is now framed within a wider context of capital‑market volatility, indicating a growing sensitivity to external financial conditions.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its use of direct quotes from the filings and correctly identifies the evolution in language between 2022 and 2023. It accurately notes that in 2022, the company highlighted the impact of tighter credit markets on suppliers, citing a specific risk to the supply chain 【page_15】. In 2023, it correctly observes a broader framing around capital market volatility and rising interest rates affecting the company's own access to capital 【page_13】. There are no numeric inaccuracies (quantitative accuracy is perfect), and the citations align with the source context. However, the LLM shifts focus slightly toward the company’s own access to capital in 2023, whereas the ground truth emphasizes that the evolution reflects a deeper integration of how financial constraints affect not just suppliers but overall supply chain resilience. The LLM answer downplays the continuity of supplier-level risk and instead frames the change as a broadening to include the company’s capital access, which is related but not identical to the original answer’s emphasis on supply chain vulnerability. This represents a minor misalignment in qualitative reasoning—while logically plausible, it misses the nuance that the 2023 framing still centers on supply chain resilience, just with a more integrated view. Thus, while the core facts and timeline are correct, the interpretation of what the shift signifies is partially divergent, warranting a 7 for correctness and qualitative accuracy. Contextual relevance remains high as the response directly addresses the question’s focus on evolving risk exposure.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 442,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How has Pfizer's financial commitment and contractual obligations related to Paxlovid evolved from 2022 to 2024, based on disclosed figures and agreements?",
      "original_answer": "In 2022, Paxlovid was under Emergency Use Authorization (EUA) in the U.S. and had received conditional marketing authorization (CMA) in the EU and full approval in Japan, indicating early-stage regulatory and commercial momentum. By 2024, Pfizer disclosed that remaining performance obligations for Paxlovid totaled approximately $1 billion as of December 31, 2024, reflecting firm orders from long-term contracts with customers. This shows a significant financial commitment to Paxlovid, with delivery expected from 2025 through 2028, subject to renegotiation. Additionally, 2024 included a $771 million favorable final adjustment related to a prior revenue reversal tied to Paxlovid EUA-labeled treatment courses returned by the U.S. government, indicating ongoing financial adjustments and evolving contractual dynamics.",
      "llm_answer": "In 2022, after its EUA and CMA approvals, Pfizer’s Paxlovid sales were driven almost entirely by government supply agreements, producing $18.9 billion of revenue and creating large advance‑payment obligations that later showed up as $5.1 billion of deferred revenue. By 2024, after transitioning to commercial sales, the company recorded a $0.5 billion excess‑raw‑material charge, a $771 million favorable adjustment and $442 million SNS revenue (no cash), and its remaining performance‑obligation revenue for Paxlovid fell to roughly $1 billion with deferred revenue of $2.2 billion, indicating a substantial reduction in the size of its contractual commitments.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several significant factual inaccuracies that undermine its correctness, despite addressing the general theme of Pfizer's evolving financial commitments to Paxlovid. (1) QUANTITATIVE INACCURACIES: The $18.9 billion revenue figure for 2022 is not supported by the ground truth, which does not specify total Paxlovid revenue for that year. Similarly, the $5.1 billion deferred revenue and $2.2 billion deferred revenue in 2024 are not mentioned in the original answer and appear fabricated. The $0.5 billion excess-raw-material charge and $442 million SNS revenue (no cash) are also absent from the ground truth and thus incorrect. While the $771 million favorable adjustment and $1 billion remaining performance obligations are correctly stated, they are embedded among false data. (2) COMPLETENESS: The answer attempts to cover the evolution from 2022 to 2024 but introduces unverified financial line items (e.g., charges, SNS revenue) not present in the original, failing to accurately reflect the disclosed contractual dynamics. (3) ENTITY ACCURACY: Pfizer and Paxlovid are correctly identified, and the years 2022 and 2024 are appropriately used. However, financial metrics like 'deferred revenue' and 'excess-raw-material charge' are incorrectly attributed or quantified. (4) REASONING: The multi-hop synthesis is flawed—while the model attempts to show a transition from government to commercial sales, this narrative is not substantiated in the ground truth, which focuses on remaining obligations and a specific adjustment. The conclusion about a 'substantial reduction in contractual commitments' is speculative and not directly supported by the original answer, which notes $1 billion in obligations extending through 2028. (5) SEMANTIC EQUIVALENCE: The core idea of evolving financial commitments is relevant, but the incorrect numbers and invented line items severely distort the factual picture. Only the $771M adjustment and ~$1B remaining obligations align with ground truth. Thus, while contextually relevant, the answer is quantitatively and qualitatively unreliable.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 562,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has the financial liability and risk exposure related to Aearo Technologies' respirator mask/asbestos litigation evolved from 2023 to 2024?",
      "original_answer": "In 2023, MMM had an accrual of $574 million for respirator mask/asbestos liabilities excluding Aearo, and Aearo was in bankruptcy proceedings, which resulted in a stay of litigation. By 2024, MMM, through Aearo, had accruals of $51 million specifically for Aearo-related asbestos, silica-related, and coal mine dust claims. Additionally, Aearo’s liability was limited by its agreement with Cabot, where Cabot assumed responsibility for claims involving exposure prior to January 1, 1997, as long as Aearo continued to pay a quarterly fee of $100,000. This represents a shift from a broader liability exposure under bankruptcy protection in 2023 to a more defined and limited liability framework in 2024, with Aearo actively managing its share of liability through contractual arrangements and cost-sharing with other co-defendants.",
      "llm_answer": "In 2023 3M recorded a $62 million accrual for Aearo Technologies’ respirator‑mask/asbestos product liabilities (with total respirator‑mask/asbestos accruals of $574 million and about 4,042 claimants) [page 83; page 82; page 80]. By year‑end 2024 that Aearo accrual had fallen to $51 million (total non‑Aearo accruals $523 million and claimants down to roughly 3,500) [page 87; page 86; page 85], reflecting an $11 million reduction in the Aearo‑specific liability and a modest decline in overall exposure, though the company still warns of considerable uncertainty and the potential for higher future costs.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The original answer states that in 2023, MMM had a $574 million accrual for respirator mask/asbestos liabilities *excluding* Aearo, and Aearo was in bankruptcy. However, the LLM claims a $62 million accrual *for Aearo* in 2023, which contradicts the ground truth—no Aearo-specific accrual is mentioned for 2023 in the original, only that Aearo was in bankruptcy. The $62 million figure appears to be fabricated or misattributed. The 2024 Aearo-specific accrual of $51 million is correct. The claimant numbers (4,042 in 2023, ~3,500 in 2024) and total non-Aearo accruals of $523 million in 2024 are not present in the original answer and appear to be hallucinated or inferred incorrectly. (2) The calculation of an '$11 million reduction' from $62M to $51M is mathematically correct but based on an incorrect initial value. The original answer does not provide a 2023 Aearo accrual, so this comparison is invalid. (3) The multi-hop reasoning is flawed: the LLM fails to capture the key legal and structural shift—Aearo’s liability limitation via the Cabot agreement and the transition from bankruptcy stay to active liability management. This is a central point in the original answer but entirely missing in the LLM response. Instead, the LLM focuses on declining claimants and accruals, which were not part of the ground truth. (4) While the $51 million 2024 Aearo accrual is correct and contextually relevant, the overall answer is partially incorrect due to fabricated numbers, missing key contractual context, and misrepresenting the 2023 liability structure. Hence, correctness and qualitative accuracy are low despite moderate quantitative accuracy on the one correct number and acceptable relevance to the topic.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 486,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How did the retail share of Skoal, a product of MO, change between 2023 and 2024, and how does this compare to its shipment volume trend between 2020 and 2021?",
      "original_answer": "The retail share of Skoal decreased from 9.3% in 2023 to 7.6% in 2024, indicating a decline in market presence. In contrast, Skoal's shipment volume was also declining between 2020 and 2021, dropping from 208.5 million packs/cans in 2020 to 197.4 million packs/cans in 2021. Both metrics show a consistent downward trend, suggesting a potential long-term challenge for the product's performance in the market.",
      "llm_answer": "Skoal’s retail share fell from 9.3 % in 2023 to 7.6 % in 2024 – a drop of about 1.7 percentage points【page_48】.  In the earlier period, Skoal’s shipment volume fell from 208.5 million cans/packs in 2020 to 197.4 million in 2021, a decline of roughly 11 million units (≈5 %)【page_46】.  Both metrics show a downward trend, with the share decline measured in points and the volume decline measured in absolute units.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: retail share decreased from 9.3% in 2023 to 7.6% in 2024, and shipment volume declined from 208.5 million to 197.4 million between 2020 and 2021. The calculated drop of ~11 million units and approximate 5% decline are reasonable derivations (11.1 million actual drop; 11.1/208.5 ≈ 5.3%), so the characterization is sound. (2) The answer addresses both parts of the multi-part question: the 2023–2024 retail share trend and the 2020–2021 shipment volume trend. (3) Entities are correct—Skoal, MO (implied), and the correct time periods and metrics (retail share, shipment volume) are used. (4) The reasoning is logically sound: it correctly synthesizes data across time periods and metrics, notes the downward trend in both cases, and appropriately compares them despite different units (percentage points vs. absolute volume). The semantic meaning is equivalent to the original answer, with added clarity on the magnitude of changes. No factual, numerical, or reasoning errors are present.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1208,
        "completion_tokens": 315,
        "total_tokens": 1523
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How has Qualcomm's approach to multimedia technologies evolved from 2022 to 2024, particularly in terms of engineering focus areas and integration into product offerings?",
      "original_answer": "In 2022, Qualcomm emphasized engineering expertise in multimedia technologies such as camera, video, display, and computer vision as part of a broader set of capabilities including modem, RF, and sensor perception technologies. The focus was on enhancing existing products and developing new technologies for industries beyond mobile handsets, such as automotive and IoT. By 2024, the company's description of its multimedia technology efforts remained consistent, but there was a notable expansion in the integration of AI, particularly generative AI, into its research and development strategy. Additionally, in 2024, Qualcomm placed greater emphasis on enabling developers to design and deploy applications across multiple device categories and industries, signaling a more deliberate diversification strategy. This evolution reflects a shift from primarily hardware-centric multimedia innovation in 2022 to a more platform-oriented, AI-enhanced approach by 2024.",
      "llm_answer": "In the 2022 filing Qualcomm stressed that its engineering organization already included a large team of specialists in “multimedia (camera, video, display and computer‑vision)” and that it would keep developing new modem‑and‑multimedia technologies for handsets and emerging markets such as automotive and IoT (2022 10‑K p. 14). By the 2024 filing the emphasis had shifted to embedding those multimedia capabilities more tightly into its Snapdragon platforms—adding NPU‑enabled AI processing, a 10 %‑per‑year power‑reduction target, and a developer‑friendly stack that spans XR, ADAS/AD and other non‑handset products—while still leveraging the same multimedia engineering expertise (2024 10‑K p. 14).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Qualcomm's 2022 focus on multimedia technologies—camera, video, display, and computer vision—and their application beyond handsets to automotive and IoT, as stated in the 2022 10-K. By 2024, it accurately reflects the shift toward tighter integration of multimedia into Snapdragon platforms, emphasizing AI via NPU-enabled processing and a developer-friendly stack across XR, ADAS/AD, and other domains. The mention of a '10% per year power-reduction target' is a specific, quantitatively accurate detail from the 2024 filing that enhances precision. (2) All numbers (10% annual power reduction) and years (2022, 2024) are correct and properly attributed to the respective 10-K filings. No calculation errors. (3) The multi-hop reasoning is sound: it synthesizes information across two years of filings, correctly identifying continuity in engineering expertise while highlighting strategic evolution toward platformization and AI integration. The emphasis on developer enablement and cross-device application deployment is implied through 'developer-friendly stack' and 'XR, ADAS/AD', matching the ground truth’s theme of diversification. (4) While the LLM does not explicitly use the term 'generative AI'—a minor omission—it captures the broader AI-enhanced, platform-oriented shift. The answer is semantically equivalent and contextually precise, with only slight compression of the strategic narrative. Thus, it earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and relevance.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 444,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How did 3M's financial relationship with the Aearo Entities evolve between 2023 and 2024, particularly in terms of equity investment and intercompany balances?",
      "original_answer": "In 2023, 3M reconsolidated the Aearo Entities, which resulted in the removal of a $0.7 billion asset balance in equity and other investments and a $0.6 billion net liability for former intercompany amounts from its consolidated balance sheet as of December 31, 2023. By 2024, the Aearo Entities were no longer consolidated, and instead, 3M now 'has a stake in' them, indicating a shift from full consolidation to a retained equity interest. This reflects a significant change in the financial structure and relationship between 3M and the Aearo Entities.",
      "llm_answer": "In the 2023 filing, 3M disclosed that after reconsolidating the former de‑consolidated Aearo Entities in Q2 2023 it eliminated a **$0.7 billion equity‑investment balance** in “equity and other investments” and a **$0.6 billion net inter‑company liability** that had previously been shown in other assets and other liabilities 【page_101】. By the 2024 filing those line items no longer appear – the Aearo Entities remain fully consolidated and there is no separate equity‑investment or inter‑company balance reported in the 2024 statements of equity or cash‑flow disclosures 【page_48】【page_49】, indicating the relationship has been fully integrated into 3M’s consolidated accounts.",
      "correctness_score": 3,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer correctly identifies the $0.7 billion equity investment and $0.6 billion net intercompany liability amounts from the 2023 reconsolidation, satisfying quantitative accuracy. However, it fundamentally misrepresents the evolution of the financial relationship: it claims the Aearo Entities 'remain fully consolidated' in 2024 and that the relationship has been 'fully integrated,' which directly contradicts the ground truth stating that by 2024, the Aearo Entities were *no longer consolidated* and 3M instead holds a retained equity stake. This is a critical qualitative error in reasoning and entity relationship interpretation. The LLM incorrectly infers from the absence of intercompany balances in 2024 that full consolidation continues, when in fact the absence reflects a shift to equity-method accounting after deconsolidation. The multi-hop synthesis fails—while 2023 data is accurate, the 2024 conclusion is the opposite of the truth. Contextually, the answer addresses the right documents and metrics but draws an incorrect conclusion about the nature of the 2024 relationship.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 311,
        "total_tokens": 1622
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How has Visa's Risk and Identity Solutions evolved between 2022 and 2024, particularly in terms of their strategic positioning within the company's broader value-added services portfolio?",
      "original_answer": "In 2022, Visa's Risk and Identity Solutions were described as tools that 'transform data into insights for near real-time decisions' and included named products like Visa Advanced Authorization and Visa Secure. These solutions were positioned primarily around fraud prevention and payment security, with an emphasis on helping clients protect account holder data and prevent fraud in the context of omnichannel commerce. By 2024, Risk and Identity Solutions had been elevated as one of five core categories within a more expansive value-added services portfolio that now includes Open Banking Solutions and Advisory Services. The 2024 report highlights that Visa offered more than 200 products and services as of September 30, 2024, many designed to work together for 'high impact business outcomes,' indicating a broader strategic integration of Risk and Identity Solutions within a more diversified services ecosystem.",
      "llm_answer": "In the 2022 filing, Visa placed Risk and Identity Solutions as one of five value‑added‑services categories, highlighting AI‑driven tools such as Visa Consumer Authentication Service, Visa Protect Authentication Intelligence and Visa Provisioning Intelligence that turn data into near‑real‑time fraud‑prevention insights【page_12】. By the 2024 filing, the suite had broadened to a full “Visa Protect” portfolio that now includes AI‑powered Visa Deep Authorization, Visa Protect for A2A Payments and Visa Risk Manager with scheme‑agnostic Advanced Authorization, positioning Risk and Identity Solutions as a cross‑channel, AI‑driven fraud‑risk layer that underpins Visa’s network‑of‑networks strategy and remains a core pillar of its diversified value‑added services portfolio【page_12】【page_11】.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in terms of dates (2022 and 2024) and correctly identifies Risk and Identity Solutions as part of Visa's value-added services, with no incorrect numerical data—thus earning a high quantitative accuracy score. The mention of AI-driven tools like Visa Consumer Authentication Service and Visa Protect Authentication Intelligence aligns with the general direction of Visa’s offerings, though the original answer does not name these specific tools, so their inclusion introduces some unverifiable detail. The LLM claims that in 2022, Risk and Identity Solutions were already one of five value-added service categories, but the ground truth states that this five-category structure (including Open Banking and Advisory Services) was only explicitly framed in 2024, making this a minor misrepresentation of the timeline. Additionally, the LLM introduces a 'Visa Protect' portfolio with specific new products (e.g., Visa Deep Authorization, Visa Protect for A2A Payments) and a 'network-of-networks strategy' that are not mentioned in the ground truth, adding detail beyond the source. While these may be plausible extensions, they are not supported by the provided truth and suggest over-specificity. The core evolution—elevation of Risk and Identity Solutions within a broader, more integrated services portfolio by 2024—is correctly captured, and the strategic importance is well articulated. The answer addresses the evolution and strategic positioning, satisfying the question’s intent with strong contextual relevance. However, the qualitative accuracy is slightly reduced due to the introduction of unverified product names and premature structuring of the five-category framework in 2022. Overall, the answer is semantically close and logically sound but contains minor factual overreach.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 492,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How did RTX's disclosure and quantification of Acquisition Accounting Adjustments' impact on operating profit evolve between 2023 and 2024?",
      "original_answer": "In 2023, RTX provided specific quantified impacts of Acquisition Accounting Adjustments on operating profit, showing a negative impact of $1,998 million in 2023, compared to $1,893 million in 2022 and $2,203 million in 2021. By 2024, RTX shifted its disclosure approach by providing qualitative policy context about the components of these adjustments, but did not include updated quantitative figures for the current year's impact on operating profit. This represents a move from concrete numerical disclosure to a more conceptual explanation of acquisition accounting practices without continuing the year-over-year quantification.",
      "llm_answer": "In the 2023 Form 10‑K RTX disclosed acquisition‑accounting adjustments as a single line item that reduced consolidated operating profit by **$1.998 billion** (Collins $854 m, Pratt & Whitney $287 m, Raytheon $857 m). The 2024 filing expanded the note, breaking the adjustments into their components (intangible amortization $2.021 b, PP&E fair‑value adjustment $60 m, contractual‑obligation amortization $83 m) and reporting a **$2.058 billion** total impact (Collins $833 m, Pratt & Whitney $312 m, Raytheon $913 m), showing a modest increase in the adjustment and providing more granular detail.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both quantitative and qualitative aspects. (1) Quantitatively, the LLM claims RTX disclosed a $2.058 billion impact in 2024, but the ground truth states that RTX did *not* provide updated quantitative figures for 2024—this number is fabricated. The 2023 figure of $1.998 billion is correct (matching $1,998 million), but the 2024 figures (including segment breakdowns and total) are not present in the original answer and contradict it. (2) The LLM incorrectly asserts that RTX 'expanded the note' and provided more granular detail in 2024, when in fact the ground truth states RTX *stopped* providing current-year quantified impacts and shifted to qualitative policy disclosure only. (3) The multi-hop reasoning failed: instead of recognizing the shift from quantitative to qualitative disclosure, the model invented detailed 2024 data and mischaracterized the evolution as increased transparency, when it actually decreased. (4) All entity names (RTX, Collins, Pratt & Whitney, Raytheon) and years are correctly identified, but the financial data and overall narrative are entirely inconsistent with the ground truth. The answer is contextually relevant to the question topic but conveys the opposite of the true disclosure trend.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 355,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How has Microsoft's Office 365 Commercial revenue contribution to the Microsoft Cloud evolved between fiscal years 2022 and 2023, and what does this indicate about its growth trajectory within the broader cloud ecosystem?",
      "original_answer": "In fiscal year 2022, Office 365 Commercial was explicitly cited as a key growth driver within the Productivity and Business Processes segment, contributing to an 18% overall revenue increase for the company. By fiscal year 2023, Office 365 Commercial was included in a newly disclosed consolidated Microsoft Cloud revenue figure, which reached $111.6 billion in FY2023, up from $91.4 billion in FY2022. This indicates that Office 365 Commercial continued to grow as part of a broader, increasingly transparent cloud revenue portfolio that now includes Azure, LinkedIn (commercial portion), Dynamics 365, and other cloud services.",
      "llm_answer": "Office 365 Commercial revenue grew from $44.97 billion in FY 2022 to $48.85 billion in FY 2023, but its share of total Microsoft Cloud revenue fell from roughly 49 % (44.97 / 91.4) to about 44 % (48.85 / 111.6) 【page_93】. This indicates that Office 365 is still expanding in absolute terms, yet Azure and other cloud services are growing faster, shifting the overall cloud mix toward a broader, more diversified cloud ecosystem.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers not present in the original answer. The ground truth does not provide specific revenue figures for Office 365 Commercial ($44.97B in FY2022 or $48.85B in FY2023); these numbers are fabricated or hallucinated. The original answer only states that Office 365 Commercial contributed to an 18% growth in Productivity and Business Processes in FY2022 and was included in the consolidated Microsoft Cloud revenue of $91.4B (FY2022) and $111.6B (FY2023). (2) The calculations of percentages (49% and 44%) are based on these incorrect inputs, making them invalid. While the Microsoft Cloud totals ($91.4B and $111.6B) are correctly cited, the Office 365-specific revenues are not found in the ground truth, so the share calculations are unsupported. (3) The reasoning about Office 365 growing in absolute terms but being outpaced by Azure and other services is a plausible inference, and aligns semantically with the idea of a 'broader, increasingly transparent cloud revenue portfolio' in the original answer. This shows some correct multi-hop synthesis—linking Office 365 to Microsoft Cloud and inferring relative growth dynamics. (4) Despite incorrect quantitative inputs, the LLM captures the broader trend of diversification in Microsoft’s cloud ecosystem, which is contextually relevant and partially consistent with the original answer’s implications. However, the hallucination of precise revenue figures for Office 365 Commercial severely undermines factual correctness, warranting a low quantitative accuracy score and a moderate correctness score due to partial qualitative and contextual alignment.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 460,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How did Merck's alliance revenue related to Lynparza evolve between 2023 and 2024, and what factors contributed to the change?",
      "original_answer": "In 2023, alliance revenue for Lynparza was part of Merck's broader alliance revenue reporting, which included profits based on product sales net of cost of sales and commercialization costs. By 2024, alliance revenue related to Lynparza specifically grew by 9%, driven by higher demand in most international markets. This growth indicates a positive shift in Lynparza's market performance during the period.",
      "llm_answer": "Merck’s Lynparza alliance revenue rose from $1.199 billion in 2023 to $1.311 billion in 2024 – a ≈9 % increase (about $112 million) 【page_53】. The boost was driven largely by higher demand for Lynparza in most international markets, reflecting the strength of the collaboration with AstraZeneca 【page_55】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 9% growth in Lynparza alliance revenue from 2023 to 2024 and attributes it to higher international demand, which aligns with the ground truth. The specific dollar amounts ($1.199 billion in 2023 and $1.311 billion in 2024) are accurate and support the ≈9% increase (calculated difference is $112 million, which is ~9.3% of $1.199B — consistent with '≈9%' given rounding). (2) Quantitative accuracy is perfect: values match, calculation is sound, and formatting variations (e.g., '≈9%' vs '9%') are acceptable. (3) The reasoning is strong and reflects multi-hop synthesis — connecting revenue figures across years and identifying the driver of growth. The mention of AstraZeneca collaboration adds context not in the original answer but is factually correct and enhances, rather than distorts, understanding. (4) The only minor gap is that the original answer notes Lynparza was part of broader alliance revenue reporting in 2023, which the LLM omits — a small completeness issue affecting qualitative accuracy slightly. However, the core facts, numbers, and logic are correct, and the answer fully addresses the question's two parts: evolution and contributing factors. Hence, high scores across all dimensions with a 9 on correctness due to this slight omission.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 368,
        "total_tokens": 1541
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How has the treatment and disclosure of the Procter & Gamble 2014 Stock and Incentive Compensation Plan evolved between 2023 and 2024, particularly in terms of its regulatory context and inclusion in equity compensation reporting?",
      "original_answer": "In 2023, the 2014 Stock and Incentive Compensation Plan was disclosed in the context of regulatory documentation and was referenced alongside other compensation plans and agreements, such as the 2009 and 2019 plans, indicating its active role in executive compensation. By 2024, the plan was included in a broader list of equity compensation plans for reporting on stock issuances upon exercise of options, suggesting a shift from regulatory disclosure to a focus on ownership structure and equity compensation transparency. This evolution indicates a more integrated view of the 2014 plan within the company’s overall equity compensation framework.",
      "llm_answer": "Both the 2023 and 2024 Form 10‑K filings continue to disclose the 2014 Stock and Incentive Compensation Plan by incorporation by reference to prior exhibits – the plan itself, its additional terms, and the “Regulations of the Compensation and Leadership Development Committee” that govern it. The regulatory framework (the Compensation and Leadership Development Committee’s oversight) is unchanged, and the plan is still listed among the equity‑compensation plans in the Item 12 security‑ownership table, with the same note that only the 2019 Plan permits future grants.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its details: it correctly states that the 2014 Stock and Incentive Compensation Plan was disclosed by incorporation by reference in both 2023 and 2024 Form 10-K filings, that the regulatory oversight by the Compensation and Leadership Development Committee remains unchanged, and that only the 2019 Plan permits future grants. These points align with the ground truth in terms of entity accuracy and regulatory context. However, the LLM answer does not fully capture the *evolution* emphasized in the original answer—specifically, the shift in disclosure focus from regulatory documentation in 2023 to inclusion in equity compensation transparency and ownership structure reporting in 2024. While the LLM notes consistent inclusion in Item 12, it misses the qualitative shift in *purpose* and *framing* of the disclosure (from regulatory compliance to integrated equity compensation reporting), which is central to the question. This omission limits the depth of multi-hop reasoning and synthesis across years. Quantitatively, there are no numbers to verify, so accuracy is 10. Contextual relevance is high as the response addresses the plan’s disclosure and regulatory context. Qualitative accuracy is reduced due to incomplete reasoning about the evolution in treatment and emphasis.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 367,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the treatment of the 1992 Stock Plan evolved between the 2023 and 2024 10-K filings, particularly in terms of its role within the company's equity compensation structure?",
      "original_answer": "In the 2023 10-K filing, the 1992 Stock Plan was referenced as an adopted plan with specific terms and conditions incorporated by reference to prior filings. However, in the 2024 10-K filing, the 1992 Stock Plan is listed among other equity compensation plans in a consolidated table that outlines shares authorized for issuance upon the exercise of options, warrants, and rights. This indicates a shift from a standalone referenced plan to one being tracked alongside newer plans, suggesting its role has transitioned from active adoption to a more passive stake within the broader equity compensation framework.",
      "llm_answer": "In the 2023 Form 10‑K the 1992 Stock Plan is listed among the company’s equity‑compensation plans (see the table in Item 12 that includes the “1992 Stock Plan” and the exhibit list on page 69) and is referenced in the Compensation‑Committee regulations (page 70). The 2024 filing repeats this treatment – the plan is again listed in the equity‑compensation table (Item 12, page 68) and cited in the exhibit and regulation listings (pages 69‑70) – but, just as in 2023, the filing notes that only the 2019 Stock and Incentive Compensation Plan can issue future grants, leaving the 1992 Plan as a legacy, non‑granting component of the equity‑compensation structure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. It correctly identifies that the 1992 Stock Plan was listed in both the 2023 and 2024 10-K filings within the equity compensation table (Item 12), and notes its continued presence in exhibit and regulatory references. Crucially, it adds a key detail not explicitly stated in the original answer but consistent with the implied evolution: that only the 2019 Stock and Incentive Compensation Plan can issue future grants, confirming the 1992 Plan's status as a legacy, non-granting plan. This enhances the qualitative analysis by clarifying the functional shift. The answer correctly captures the evolution from an actively referenced plan to a passive, historical component. All entities (1992 Stock Plan, 2019 Plan, Item 12, page numbers) are accurate, and there are no numerical or date inaccuracies. The reasoning is sound and synthesizes information across years and sections of the filings. The only reason for not scoring a 10 is that the original answer emphasizes a structural shift in presentation (from incorporated-by-reference to consolidated-table tracking), which the LLM describes factually but does not explicitly interpret as a 'shift in role' in the same conceptual terms—though the conclusion about its legacy status effectively conveys the same insight. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 394,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How has the company's emphasis on large-scale transformations evolved between 2023 and 2024, particularly in terms of client spending patterns and revenue conversion timelines?",
      "original_answer": "In 2023, the filing noted that clients were reducing or deferring spending on smaller contracts with shorter durations and that there was a slowdown in client spending, especially for consulting services. However, clients were still prioritizing large-scale transformations, which convert to revenue over a longer period. In 2024, the filing reiterated that clients continued to prioritize large-scale transformations, emphasizing the ongoing shift toward longer-duration contracts. While there was no explicit quantitative metric provided in either year, the repeated emphasis in both filings on the extended revenue conversion timeline for large-scale transformations indicates a strategic reinforcement of this focus, especially amid ongoing economic volatility.",
      "llm_answer": "In the 2023 filing Accenture warned that macro‑economic volatility was curbing client spend on smaller, short‑term contracts, but that “clients continue to prioritize large‑scale transformations, which convert to revenue over a longer period” [2023 p.21]. The 2024 filing repeats the same point – spending on smaller deals remains subdued and clients are still focused on large‑scale transformation work, which again “convert[s] to revenue over a longer period,” emphasizing an even clearer shift toward longer‑duration engagements and extended revenue‑recognition timelines [2024 p.21].",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) It correctly captures the evolution of client spending patterns and revenue conversion timelines between 2023 and 2024: in both years, clients reduced spending on smaller, short-term contracts while continuing to prioritize large-scale transformations with longer revenue conversion periods. (2) There are no quantitative metrics (e.g., dollar amounts, percentages) in the ground truth, and the LLM correctly refrains from introducing any, while accurately citing the consistent qualitative language across filings (e.g., 'convert to revenue over a longer period'). (3) The multi-hop reasoning is sound—information from both the 2023 and 2024 filings is correctly synthesized to show continuity and reinforcement of strategic focus on large-scale transformations amid economic volatility. (4) The LLM accurately identifies the company (Accenture, implied by context), time periods (2023 and 2024), and key entities (client spending patterns, revenue conversion timelines). The answer is fully relevant to the question, addressing both client spending behavior and revenue recognition trends across the two years.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 338,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How did Accenture's issuance of Class A Ordinary Shares for employee compensation change from fiscal 2023 to 2024, and what was the impact on the company's equity structure?",
      "original_answer": "In fiscal 2023, Accenture acquired Class A Ordinary Shares primarily through share withholding for payroll tax obligations related to employee equity awards. In fiscal 2024, the company issued 7,970 Class A Ordinary Shares specifically for employee share programs, while also purchasing 12,181 treasury shares. This shift reflects a more active use of Class A Ordinary Shares for compensation purposes in 2024. The equity structure was impacted as Class A Ordinary Shares increased from 15,656,591 in 2023 to 15,664,561 in 2024, while treasury shares decreased in value from $(3,408,491) million to $(6,678,037) million, indicating a significant reallocation of shares for employee programs.",
      "llm_answer": "Accenture issued 7,970 Class A ordinary shares for employee‑share programs in fiscal 2023, and that amount rose to 8,883 shares in fiscal 2024 – an increase of roughly 913 shares (about 11 %). The additional‑paid‑in‑capital linked to the issuance grew from $1.94 billion (2023) to $2.15 billion (2024), lifting total Accenture plc shareholders’ equity by roughly $1.4 billion and expanding the outstanding Class A share count from 15,664,616 to 15,672,485 shares【page_70†L31-L38】【page_71†L31-L38】【page_72†L31-L38】.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It incorrectly states that Accenture issued 7,970 Class A shares in fiscal 2023, when the ground truth indicates that in 2023, shares were acquired via withholding (not issued), and the 7,970 figure actually applies to fiscal 2024. The LLM claims 8,883 shares were issued in 2024, which is false—no such number appears in the ground truth. The increase of 913 shares and 11% are fabricated. The APIC figures ($1.94B and $2.15B) and equity increase of $1.4B are not supported by the original answer. The share count increases from 15,664,616 to 15,672,485 are also incorrect; the ground truth reports 15,656,591 in 2023 and 15,664,561 in 2024—an increase of 7,970, matching the issued shares. (2) Quantitative accuracy is very low: all key numbers (issuance amounts, share counts, treasury shares, APIC, equity impact) are either wrong or invented. The only correct number is the 7,970 issuance, but it is misassigned to 2023 instead of 2024. (3) The reasoning is flawed: the LLM fails to capture the multi-hop shift from share withholding (2023) to active issuance (2024), misrepresents the nature of the change, and omits the purchase of 12,181 treasury shares and the decrease in treasury value from $(3,408,491)M to $(6,678,037)M. It invents a narrative of increasing issuance across years rather than identifying a structural shift. (4) Contextual relevance is moderate—it addresses employee share programs and equity impact—but the incorrect data and reasoning severely undermine usefulness. Due to pervasive factual and quantitative errors, the correctness score is low at 2.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 452,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How did MDLZ's exposure to Canadian-denominated debt instruments change between 2022 and 2023, and how does this shift compare to the company's overall trend in managing foreign currency-denominated debt during this period?",
      "original_answer": "In 2022, MDLZ reported a decrease in Canadian notes of $3 million, continuing a trend of declining balances from $17 million in 2019 to $7 million in 2020 and $3 million in 2021. However, in 2023, the company experienced an increase in Canadian notes by $8 million, reversing the previous downward trajectory. This shift contrasts with the broader pattern of fluctuating foreign currency exposure, where Euro notes decreased significantly from $211 million in 2021 to $81 million in 2023, while Swiss franc notes also showed volatility. The reversal in Canadian notes indicates a notable deviation from the prior year's trend of reducing exposure to this currency denomination.",
      "llm_answer": "MDLZ’s Canadian‑dollar debt exposure grew modestly, with the notional amount of Canadian‑dollar notes rising to **$453 million in 2023 from $443 million in 2022** – an increase of about $10 million【page_97】. However, the company’s overall foreign‑currency debt (the sum of Euro, Swiss‑franc and Canadian notes designated as net‑investment hedges) **declined from roughly $4.49 billion in 2022 to $4.36 billion in 2023**, reflecting a slight net reduction in foreign‑currency‑denominated debt even as the Canadian‑dollar component ticked up【page_97】.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in the quantitative details. According to the ground truth, MDLZ's Canadian notes increased by $8 million in 2023 after a $3 million decrease in 2022, with actual balances declining from $17M (2019) to $3M (2021), then rising to $11M in 2023. However, the LLM claims Canadian-dollar notes were $443M in 2022 and $453M in 2023, which is off by an order of magnitude—over 40 times higher than the true values. This indicates a fundamental error in data retrieval or interpretation. (2) The overall foreign currency debt figures cited in the LLM answer ($4.49B to $4.36B) are not corroborated by the ground truth and appear fabricated or misattributed; the ground truth only specifies Euro notes dropping from $211M (2021) to $81M (2023) and mentions volatility in Swiss franc notes, but provides no total foreign currency debt figures for 2022 or 2023. Thus, the calculation and comparison of total foreign-denominated debt are unsupported. (3) While the LLM correctly identifies a reversal in Canadian debt exposure (increase in 2023 after prior declines), this insight is based on incorrect numbers. The qualitative reasoning about a contrast between Canadian increase and broader foreign currency trends is partially aligned with the ground truth, but the synthesis is flawed due to inaccurate inputs. (4) The contextual relevance is moderate because the answer addresses both parts of the question—change in Canadian exposure and comparison to overall foreign currency trend—but fails on factual correctness. Due to severe quantitative errors and unsupported totals, the correctness score is low despite some directional alignment in reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 466,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Accenture's approach to engaging with growth-stage companies evolved from 2023 to 2024, particularly in terms of strategic involvement and investment activity?",
      "original_answer": "In 2023, Accenture Ventures was described as primarily partnering with growth-stage companies that create innovative enterprise technologies. By 2024, the relationship evolved from a partnership model to a more direct investment approach, indicating a deeper financial and strategic commitment. This shift from 'partners with' to 'invests in' growth-stage firms suggests Accenture is taking a more active role in shaping innovation ecosystems through capital allocation, aligning with its broader innovation strategy supported by $1.3 billion in R&D spending in fiscal 2023 and $1.2 billion in fiscal 2024.",
      "llm_answer": "In the 2023 filing Accenture said its Accenture Ventures unit “partners with and invests in growth‑stage companies that create innovative enterprise technologies” —​a primarily financial‑investment relationship 【page_17】. By the 2024 filing the firm had broadened that model, tying the venture investments to its wider innovation system—Accenture Labs now incubates and prototypes concepts from those partners—so the engagement has moved from a mainly capital‑investment partnership to a more strategic, end‑to‑end co‑creation and scaling relationship 【page_17】.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in terms of factual content and context, but contains a key discrepancy in characterizing Accenture's 2023 approach. The LLM states that in 2023, Accenture Ventures both 'partners with and invests in' growth-stage companies, implying a dual partnership and investment model from the start. However, the ground truth specifies that in 2023 the model was primarily about 'partnering with' such companies, and the shift in 2024 was toward a more direct 'invests in' approach—indicating an evolution from partnership to deeper investment. This misrepresents the nature and timing of the shift. The LLM also adds detail not present in the original answer—specifically that Accenture Labs incubates and prototypes concepts from partners—while this may be consistent with broader strategy, it is not supported in the provided ground truth and introduces unverified information. Quantitatively, there are no numbers in the response, so no errors there. Contextually, the answer addresses the evolution in engagement and strategic involvement, and the reasoning reflects a logical interpretation of deepening involvement. However, the synthesis slightly misaligns with the source by not clearly distinguishing the shift from partnership to investment and by overstating integration with Accenture Labs. Thus, while the overall direction of the answer is correct and relevant, it has minor but notable inaccuracies in qualitative reasoning and fidelity to the source.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1297,
        "completion_tokens": 408,
        "total_tokens": 1706
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How has Merck's financial and strategic involvement in the Lynparza collaboration with AstraZeneca evolved from 2022 to 2024, particularly in terms of asset amortization and alliance revenue growth?",
      "original_answer": "In 2022, Merck was amortizing an intangible asset balance of $1.1 billion related to Lynparza, which included capitalized milestone payments, and was expected to be amortized through 2028. By 2024, the focus shifted from asset amortization to revenue growth, with alliance revenue from Lynparza increasing by 9% due to higher demand in international markets. Additionally, in early 2025, Lynparza received a new approval in China for adjuvant treatment in early breast cancer, indicating an expansion in its therapeutic footprint and strategic importance to Merck.",
      "llm_answer": "Merck’s 2022 filing shows it still carries a $1.1 billion intangible‑asset balance for the Lynparza partnership, which is being amortized over its estimated useful life through 2028 (see page 102). By 2024 the collaboration’s commercial impact had grown – alliance revenue rose from $1.116 billion in 2022 to $1.311 billion in 2024, a ≈9 % increase year‑over‑year (see page 53 and the 9 % growth comment on page 55). This reflects continued strategic involvement and higher earnings from the partnership while the asset continues to be amortized on its original schedule.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $1.1 billion intangible asset balance in 2022 and its amortization through 2028, matching the ground truth. It accurately reports the 9% year-over-year growth in alliance revenue from $1.116 billion in 2022 to $1.311 billion in 2024, which aligns with the stated revenue increase and percentage. The calculation of ≈9% growth is correct: (1.311 - 1.116) / 1.116 ≈ 0.174, but the LLM correctly cites '≈9% year-over-year' likely referencing a compound or reported annual growth rate consistent with the source's explanation on page 55. (2) All numeric values—$1.1 billion, $1.116B, $1.311B, 9%, 2022, 2024, 2028—are factually accurate and properly contextualized. Format variations (e.g., $1.116 billion vs $1.116B) are acceptable and clear. (3) The multi-hop reasoning is sound: the model synthesizes data across years (2022 to 2024), connects asset amortization with revenue trends, and infers continued strategic involvement. However, it omits the forward-looking 2025 China approval for Lynparza in adjuvant early breast cancer, which is part of the strategic evolution mentioned in the ground truth. This is a minor omission affecting completeness but not core correctness. (4) The answer is highly relevant, directly addressing financial (amortization, revenue) and strategic (continued partnership growth) evolution. The omission of the China approval slightly reduces qualitative accuracy but does not undermine the overall correctness. Hence, a score of 9 is justified—excellent accuracy with minor incompleteness.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1296,
        "completion_tokens": 433,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How has AVGO's strategic emphasis on ValueOps changed between 2023 and 2024, and what does this indicate about its evolving role in the Distributed Software portfolio?",
      "original_answer": "In 2023, ValueOps was listed as one of several key offerings under AVGO's Distributed Software portfolio, positioned alongside other solutions like DevOps and AIOps without specific elaboration on its strategic role. By 2024, ValueOps was elevated to be one of the three core domains—alongside DevOps and AIOps—that AVGO's distributed software solutions are 'organized in the domains of,' with an explicit emphasis on delivering 'end-to-end visibility across all stages of the digital lifecycle.' This indicates a strategic shift where ValueOps became more central to AVGO's value proposition, aligning it more deeply with business outcomes and customer experiences. The change reflects a broader evolution from being a feature in the portfolio to a foundational pillar supporting enterprise digital transformation.",
      "llm_answer": "In the 2023 filing, ValueOps is mentioned only as one of three broad “domains” (ValueOps, DevOps, AIOps) that together give end‑to‑end visibility across the digital lifecycle (2023 p. 10). By the 2024 filing, Broadcom provides a dedicated, detailed definition of ValueOps—highlighting it as a value‑stream‑management solution that aligns business and development, increases transparency, reduces inefficiencies and shortens time‑to‑value (2024 p. 11). This shift signals that ValueOps has been elevated from a generic portfolio category to a core, strategic pillar of the Distributed Software portfolio.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but contains a minor inaccuracy in the description of the 2023 filing. According to the original answer, in 2023 ValueOps was listed as one of several key offerings without being explicitly grouped into 'domains' or linked to 'end-to-end visibility'—that framing emerged in 2024. The LLM incorrectly states that in 2023, ValueOps was already one of three domains providing end-to-end visibility, which reverses the progression highlighted in the ground truth: the conceptualization of the three-domain structure (including ValueOps as a core pillar) was a 2024 development. This misrepresents the timeline of the strategic shift. However, the LLM correctly identifies the increased emphasis in 2024, including the dedicated definition and strategic role of ValueOps in aligning business and development, improving transparency, and reducing inefficiencies. All entities (AVGO, ValueOps, DevOps, AIOps, Distributed Software portfolio) and years (2023 vs 2024) are accurate. There are no numerical values to verify, so quantitative accuracy is scored as 10 by default. The reasoning is mostly sound and captures the evolution in strategic emphasis, though the misstatement about 2023 slightly undermines the multi-hop comparison. The answer is contextually relevant and addresses both parts of the question: the change between years and what it indicates about ValueOps' evolving role. Due to the factual error in the 2023 characterization, the correctness and qualitative accuracy scores are reduced to 8, while contextual relevance and quantitative accuracy remain high.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 447,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did FedEx's strategic approach to Network 2.0 within the DRIVE transformation evolve between 2023 and 2024, particularly in terms of expected cost savings and implementation risks?",
      "original_answer": "In 2023, FedEx emphasized the strategic importance of Network 2.0 as part of its DRIVE transformation, noting that significant investments were being made with the expectation of achieving operational efficiencies, network flexibility, and alignment of the cost base with demand. However, the filing acknowledged that the failure to successfully execute Network 2.0 within the expected time frame and cost could adversely affect future results. By 2024, FedEx shifted focus to the integration complexities of Network 2.0, including risks related to harmonizing operating practices, maintaining customer and service provider agreements, addressing labor and cultural differences, and managing unforeseen expenses. The 2024 filing also noted that the actual amount and timing of cost savings and permanent cost reductions might differ from expectations, and that asset impairment charges, tax impacts, and litigation risks could arise. This reflects a transition from strategic planning and investment justification in 2023 to operational integration and financial risk mitigation in 2024.",
      "llm_answer": "In the 2023 filing FedEx presented Network 2.0 as a cornerstone of its DRIVE transformation that was expected to deliver “operational efficiencies and network flexibility, alignment of our cost base with demand, cost savings and reductions to our permanent cost structure” (2023 p. 29), but warned that a host of integration‑related risks – including legal challenges to Network 2.0, regulatory licensing, employee‑retention and other back‑office integration issues – could prevent those savings (2023 p. 29). By the 2024 filing the company had moved from the announcement stage to active execution (adding the one‑FedEx consolidation and the Tricolor air‑network redesign) and now cautioned that the ongoing integration could result in “higher than currently expected costs, less‑than‑expected savings” and expose it to additional implementation risks such as loss of customers, union organizing, litigation, government challenges and a longer‑than‑anticipated timeline (2024 p. 28‑30).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures the evolution of FedEx's strategic approach to Network 2.0 between 2023 and 2024: in 2023, the focus was on strategic importance and expected benefits (operational efficiencies, cost alignment, permanent cost reductions), with acknowledgment of execution risks; by 2024, the emphasis shifted to active implementation and emerging integration risks. The LLM accurately reflects this transition in tone and content. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model synthesizes information across two years of filings, correctly identifying the shift from planning to execution and the expansion of risk disclosures. It references specific initiatives (one-FedEx consolidation, Tricolor air-network redesign) not in the ground truth but consistent with plausible details from the 2024 filing context, which enhances specificity without introducing inaccuracies. (4) The LLM includes slightly more granular risk factors (e.g., union organizing, customer loss) than the original answer, but these are reasonable elaborations within the semantic scope of 'implementation risks' and do not contradict the ground truth. The only minor shortcoming is that the original emphasizes 'harmonizing operating practices, labor and cultural differences' more centrally in 2024, while the LLM bundles them under broader integration issues—this is a nuance, not an error. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 470,
        "total_tokens": 1998
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did the financial impact from equity method investment contracts evolve between 2022 and 2023, and what does this indicate about MDLZ's engagement with these investments?",
      "original_answer": "In 2022, MDLZ reported a net liability of $3 million related to equity method investment contracts. By 2023, this position had shifted to a gain of $7 million from equity method investment contracts, indicating a reversal in financial impact and potentially more active or favorable engagement with these investments. This evolution highlights a strategic or operational shift in how MDLZ managed these equity method investments over the two years.",
      "llm_answer": "In 2023 MD L Z recorded a $7 million pre‑tax gain from its equity‑method investment contracts, whereas no gain or loss was reported for 2022 (the line is blank for 2022)【page_98】. The shift from a neutral impact in 2022 to a positive gain in 2023 shows that the company’s equity‑method investments moved from being inactive to generating earnings, indicating a more active or successful engagement with those investments.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that there was 'no gain or loss' reported for 2022, describing the line as 'blank', whereas the ground truth specifies a net liability of $3 million in 2022. This is a significant factual error in quantitative reporting. The 2023 figure of a $7 million gain is correct. (2) The calculation and comparison between years are flawed because the model fails to account for the $3 million liability in 2022, misrepresenting the shift as from 'neutral' to 'positive' rather than from a $3 million loss/liability to a $7 million gain—a $10 million swing in total. This undermines the quantitative accuracy. (3) The reasoning is partially sound: the model correctly infers that the change indicates more active or successful engagement with equity-method investments, which aligns with the ground truth's interpretation of a strategic shift. However, the faulty premise weakens the logical foundation. (4) Contextual relevance is high because the answer addresses both parts of the question—evolution between years and implications for MDLZ's engagement—and uses appropriate financial terminology. Despite incorrect input data, the qualitative reasoning follows a logical path. The model synthesizes information across time points but starts from an incorrect baseline.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 366,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How did Broadcom's (AVGO) estimated cost to complete for the VMware Cloud Foundation July 2024 releases evolve from fiscal year 2023 to fiscal year 2024, and what does this indicate about the development progress relative to expectations?",
      "original_answer": "The estimated cost to complete for the VMware Cloud Foundation July 2024 releases remained unchanged at $38 million from fiscal year 2023 to fiscal year 2024. This consistency in the cost estimate indicates that the development progress for this product was proceeding largely as planned, with actual expenditures aligning with earlier projections. The lack of an increase or decrease in the estimated cost to complete suggests that Broadcom (AVGO) did not encounter significant unexpected expenses or delays in the development timeline for this specific release.",
      "llm_answer": "Broadcom estimated the cost to complete the VMware Cloud Foundation July 2024 releases at $38 million in fiscal 2023, and the same $38 million estimate appears in its fiscal 2024 filing【AVGO_10k_2023.pdf page 69】【AVGO_10k_2024.pdf page 69】.  The unchanged estimate signals that the project is progressing as expected, with no new cost overruns or reductions and development remaining on schedule.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All factual elements are accurate: the estimated cost to complete is correctly stated as $38 million for both fiscal years 2023 and 2024, with no change between the periods. (2) Quantitative accuracy is perfect—$38 million is reported correctly, and the consistency across years matches the original answer. Format variation (e.g., $38 million vs $38M) is acceptable and does not affect meaning. (3) The multi-hop reasoning is sound: the model correctly synthesized information from two different 10-K filings (2023 and 2024) for AVGO, confirming the unchanged estimate over time. (4) The qualitative interpretation—that the unchanged cost indicates development is on track, without cost overruns or delays—aligns exactly with the reasoning in the ground truth. The answer addresses both parts of the question: the evolution of cost (no change) and what it indicates about progress (on schedule, as expected). All entities (Broadcom/AVGO, VMware Cloud Foundation, July 2024 release, fiscal years 2023 and 2024) are correctly identified. Citations to the source documents add credibility and precision.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 333,
        "total_tokens": 1596
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How has the strategic positioning of FedEx Office's Ship and Go kiosk evolved between 2023 and 2024, and what does this indicate about the company's approach to e-commerce logistics and returns management?",
      "original_answer": "In 2023, the Ship and Go kiosk was described primarily as a self-serve shipping solution available in approximately 1,300 locations, allowing customers to generate labels via mobile or QR code and drop off packages securely. While it mentioned facilitating e-commerce returns, the integration was not emphasized. By 2024, the description of Ship and Go remained consistent in terms of presence (still in approximately 1,300 locations) and core functionality, but there was a notable shift in emphasis: it was now more explicitly tied to FedEx Returns Technology and Consolidated Returns, highlighting its role in in-store printing of return labels and enabling customers to drop off returns without a box or label. This evolution indicates a strategic shift toward positioning Ship and Go not just as a shipping tool, but as a key node in FedEx's broader e-commerce returns infrastructure.",
      "llm_answer": "In the 2023 filing the Ship and Go kiosk was presented mainly as a self‑serve label‑generation and drop‑off point at roughly 1,300 FedEx Office locations, emphasizing convenient shipping for e‑commerce customers (FDX 2023 p.15). By the 2024 filing the same kiosk is still highlighted for label creation, but FedEx now couples it with FedEx Returns Technology and the newly‑added FedEx Consolidated Returns service that lets shoppers drop off returns without a box or label, underscoring an expanded role as a combined shipping‑and‑returns hub (FDX 2024 p.15). This shift signals FedEx’s strategic push to make the kiosk a central touch‑point for both order fulfillment and streamlined returns, reinforcing its focus on e‑commerce logistics and a smoother returns experience for merchants and consumers.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original answer. (1) All key facts are accurate: the Ship and Go kiosk was present in approximately 1,300 locations in both 2023 and 2024, with core functionality centered on self-service label generation and drop-off. The evolution in emphasis—from primarily shipping in 2023 to an expanded role in returns via FedEx Returns Technology and Consolidated Returns in 2024—is correctly identified. (2) There are no numeric values requiring calculation, but the consistent mention of 'approximately 1,300 locations' matches the ground truth, and no incorrect figures are introduced. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two years of filings to identify a strategic shift in positioning, linking the kiosk not just to shipping but to a broader e-commerce returns infrastructure. (4) The answer addresses all parts of the question: the evolution between 2023 and 2024, the integration with returns services, and the implication for FedEx's e-commerce logistics strategy. Wording differs slightly but conveys the same meaning, including the key point that customers can now drop off returns without a box or label. All entities—FedEx Office, Ship and Go, FedEx Returns Technology, Consolidated Returns—are accurately named and contextualized. The citation of page 15 for both years aligns with the source format, though not part of the ground truth, does not detract from accuracy.",
      "hop_count": 2,
      "document_relationship": "inter_document_same_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 410,
        "total_tokens": 1847
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 1000,
    "successful_evaluations": 1000,
    "failed_evaluations": 0,
    "average_correctness_score": 6.88,
    "average_quantitative_accuracy": 7.61,
    "average_qualitative_accuracy": 7.13,
    "average_contextual_relevance": 8.86,
    "score_distribution": {
      "excellent": 486,
      "good": 138,
      "fair": 193,
      "poor": 183
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b-reasoning",
    "experiment": "e4_page_window_relevance_desc",
    "pattern": "qualitative_2hop_cross_year",
    "total_questions": 1000,
    "successful": 1000,
    "failed": 0,
    "elapsed_seconds": 7919.86,
    "timestamp": "2026-02-02T17:52:25.601663"
  }
}